NIHCC_2014
  SciTegic11012413002D

 17 16  0  0  0  0            999 V2000
    7.6894   -2.6293    0.0000 Cl  0  0
    1.2948   -3.7516    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    3.8912   -5.2578    0.0000 C   0  0
    5.1887   -6.0105    0.0000 C   0  0
    3.8883   -6.7578    0.0000 C   0  0
    2.5909   -6.0056    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 Cl  0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  5  8  1  0
  3  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 17 11  1  0
M  END
> <name>
NIHCC_2014

> <id>
5625

> <plate>
NGP-105-01

> <well>
A02

> <supplier_cmpd_name>
CPD000058423

> <ctcr_id>
6227

> <supplier_cmpd_id>
SAM001246723

> <smiles>
Cl.CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1

> <pd_targets>
{CHRNA3,CHRNB4,CHRNA4,CHRNB2,SLC6A3,SLC6A4,SLC6A2,CHRNA7,ALDH1A1,ITGA5,CHRNA1,CHRNB1,CHRND,CHRNG,CYP2C19,HTR3A}

> <pathway_gtopdb>
{"Ion channel",Transporter,Enzyme,"Ligand-gated ion channel","Electrochemical transporter",Oxidoreductase,"Cytochrome P450","Nicotinic acetylcholine receptor","SLC superfamily of solute carriers","Cyt
ochrome P450 family 2","5HT3 receptor","Nicotinic acetylcholine receptor alpha subunit","SLC06 neurotransmitter transporter family","Cytochrome P450 family 2C","Cytochrome P450 2C19"}

> <pathway_chembl>
{Transporters,"Ion channels",Enzymes,"SLC superfamily of solute carriers","Ligand-gated ion channels","Cytochrome P450","SLC6 neurotransmitter transporter family","Nicotinic acetylcholine receptors","
CYP2 family: drug metabolising subset","5-HT<sub>3</sub> receptors","Monoamine transporter subfamily"}

> <pathway_reactome>
{Disease,"Neuronal System",Metabolism,"Disorders of transmembrane transporters","Transmission across Chemical Synapses","Biological oxidations","SLC transporter disorders","Neurotransmitter clearance"
,"Neurotransmitter receptors and postsynaptic signal transmission","Phase I - Functionalization of compounds","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Serotonin clearance fro
m the synaptic cleft","Defective SLC6A2 causes orthostatic intolerance (OI)","Acetylcholine binding and downstream events","Ethanol oxidation","Cytochrome P450 - arranged by substrate type","Postsynap
tic nicotinic acetylcholine receptors",Xenobiotics,"Highly calcium permeable postsynaptic nicotinic acetylcholine receptors","CYP2E1 reactions"}

> <broad_targets>
{SLC6A2,SLC6A3}

> <broad_moa>
{"dopamine reuptake inhibitor"}

> <synonyms>
{AKOS026750042,"Bupropion hydrochloride",31677-93-7,31677937,"Bupropion Hcl","2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one hydrochloride","2(tertbutylamino)1(3chlorophenyl)propan1one hydrochlori
de",Wellbutrin,"Amfebutamone hydrochloride",Zyban,"Wellbutrin XL","Wellbutrin SR",Budeprion,"Forfivo XL",W,S2452,SAM001246723,1504174,Prestw-249,"Amfebutamone HCl",CPD000058423,BUPROPION}

> <pdid>
PD003148

> <targets>
{"Dopamine Receptor"}

> <classes>
{antidepressant,"Neuronal Signaling"}

> <pubchem_cids>
{657316,62884}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 26  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
    0.0000   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -1.2959   -5.2508    0.0000 C   0  0
   -2.5937   -6.0031    0.0000 O   0  0
    0.0042   -5.9990    0.0000 O   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -3.8971   -3.7500    0.0000 O   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 F   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -2.5983    3.0008    0.0000 C   0  0
   -3.8989    3.7481    0.0000 N   0  0
   -1.2134    2.9359    0.0000 C   0  0
   -1.9648    4.2341    0.0000 C   0  0
  2  1  1  6
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  2  1  0
  7  8  1  0
  8  9  2  3
  9 10  1  0
 10 11  1  0
 10 12  2  0
  9 13  1  0
 13 14  2  0
 13 15  1  0
 15  6  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 19  5  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 23 20  1  0
M  END
> <name>
NIHCC_2014

> <id>
5626

> <plate>
NGP-105-01

> <well>
A03

> <supplier_cmpd_name>
CPD000466380

> <ctcr_id>
2822

> <supplier_cmpd_id>
SAM001246742

> <smiles>
C[C@H]1COc2c3N1C=C(C(O)=O)C(=O)c3cc(F)c2C4(N)CC4

> <pd_targets>
{SKA,ALD,KDM4E,KMT2A,TOP2A,TOP2B,GYRA,GYRB}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator",Kinase,Eraser,Reader,Isomerase,"Lysine demethylase",Bromodomain,"Jumonji domain-containing"}

> <pathway_chembl>
{Enzymes,"Chromatin modifying enzymes","1.14.11.- Histone demethylases","2.1.1.43 Histone methyltransferases (HMTs)"}

> <pathway_reactome>
{"Gene expression (Transcription)","RNA Polymerase II Transcription","Generic Transcription Pathway","Transcriptional regulation by RUNX1","RUNX1 regulates genes involved in megakaryocyte differentiat
ion and platelet function"}

> <broad_targets>
{}

> <broad_moa>
{"topoisomerase inhibitor"}

> <synonyms>
{Pazufloxacin,127045-41-4,127045414,T-3761,T3761,UNII-4CZ1R38NDI,UNII4CZ1R38NDI,4CZ1R38NDI,NCGC00167534-01,NCGC0016753401,DSSTox_CID_26697,DSSToxCID26697,DSSTox-CID-26697,"DSSTox CID 26697",DSSTox_RID
_81831,DSSToxRID81831,DSSTox-RID-81831,"DSSTox RID 81831",DSSTox_GSID_46697,DSSToxGSID46697,DSSTox-GSID-46697,"DSSTox GSID 46697","Pazufloxacin (INN)",SMR000466380,"CCRIS 7312",CAS-127045-41-4,CAS1270
45414,"T 3761",127046-18-8,127046188,PZFX,"Pazufloxacin (JAN/INN)",S,T1620,SAM001246742,"Pazufloxacin Mesylate",CPD000466380}

> <pdid>
PD002924

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{40466872,65957}

$$$$
NIHCC_2014
  SciTegic11012413002D

 32 35  0  0  1  0            999 V2000
    5.0987   -5.2852    0.0000 Cl  0  5
    2.5228   -3.0436    0.0000 C   0  0
    1.2626   -2.2300    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    2.5793    0.0316    0.0000 O   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 O   0  0
    0.0000    1.5000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 N   0  0
   -3.7124   -4.0030    0.0000 C   0  0
   -3.1022   -5.3733    0.0000 C   0  0
   -3.7125   -6.7424    0.0000 C   0  0
   -2.8308   -7.9559    0.0000 C   0  0
   -3.4409   -9.3262    0.0000 C   0  0
   -4.9332   -9.4862    0.0000 C   0  0
   -5.5417  -10.8581    0.0000 N   0  0
   -7.0331  -11.0180    0.0000 C   0  0
   -4.6579  -12.0701    0.0000 C   0  0
   -2.5592  -10.5397    0.0000 C   0  0
   -3.1693  -11.9101    0.0000 O   0  0
   -1.0674  -10.3829    0.0000 C   0  0
   -0.4573   -9.0126    0.0000 C   0  0
   -1.3390   -7.7991    0.0000 C   0  0
   -0.7289   -6.4288    0.0000 N   0  3
   -1.6105   -5.2165    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 O   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  1
  4  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  3
 11  4  1  0
 11 12  1  0
 12 13  2  3
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 19 24  1  0
 24 25  1  0
 24 26  2  0
 26 27  1  0
 27 28  2  0
 28 18  1  0
 28 29  1  0
 29 30  2  0
 30 13  1  0
 30 16  1  0
 14 31  1  0
 31 10  1  0
 31 32  2  0
M  CHG  2   1  -1  29   1
M  END
> <name>
NIHCC_2014

> <id>
5627

> <plate>
NGP-105-01

> <well>
A04

> <supplier_cmpd_name>
CPD000466344

> <ctcr_id>
4742

> <supplier_cmpd_id>
SAM001246651

> <smiles>
[Cl-].CC[C@@]1(O)C(=O)OCC2=C1C=C3N(Cc4cc5c(CN(C)C)c(O)ccc5[nH+]c34)C2=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{NSC609699,"TOPOTECAN HYDROCHLORIDE",119413-54-6,119413546,"Topotecan Hcl",Hycamtin,"Topotecan (Hydrochloride)","Nogitecan hydrochloride","SK&F S-104864-A","SK&F S104864A","NSC 609699",UNII-956S425ZCY
,UNII956S425ZCY,"Topotecan hydrochloride (USAN)",NSC-609699,956S425ZCY,609699,S1231,SAM001246651,"Topotecan hydrochloride",topotecan,CPD000466344}

> <pdid>

> <targets>
{Apoptosis,Autophagy,Topoisomerase}

> <classes>
{Topoisomerase I Inhibitors,Apoptosis,Autophagy,Cell Cycle/DNA Damage}

> <pubchem_cids>
{57525346,11972519,60699}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 32  0  0  0  0            999 V2000
   14.3053   -0.7442    0.0000 C   0  0
   13.0040   -1.4903    0.0000 O   0  0
   12.9985   -2.9911    0.0000 C   0  0
   14.2964   -3.7431    0.0000 C   0  0
   14.2940   -5.2431    0.0000 C   0  0
   12.9938   -5.9911    0.0000 C   0  0
   11.6959   -5.2391    0.0000 C   0  0
   11.6982   -3.7390    0.0000 C   0  0
   10.3985   -2.9887    0.0000 N   0  0
   10.3984   -1.4887    0.0000 C   0  0
    9.0994   -0.7387    0.0000 C   0  0
    7.8003   -1.4887    0.0000 N   0  0
    7.8004   -2.9887    0.0000 C   0  0
    9.0995   -3.7387    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    5.2029   -2.9932    0.0000 O   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14  9  1  0
 12 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 20  1  0
 29 24  1  0
M  END
> <name>
NIHCC_2014

> <id>
5628

> <plate>
NGP-105-01

> <well>
A05

> <supplier_cmpd_name>
CPD000466346

> <ctcr_id>
398

> <supplier_cmpd_id>
SAM001246658

> <smiles>
COc1ccccc1N2CCN(CC2)CC(O)COc3cccc4ccccc34

> <pd_targets>
{ADRA2A,ADRA2B,ADRA2C,ADRA1A,ADRA1B,ADRA1D,CACNA1H,MAPT,MAPK1,LMNA,ADRB2,NFO,GMNN,PMP22,KMT2A,MEN1,HIF1A,HTT,KDM4E,MTOR,CYP2D6,CYP3A4,CYP2C19,ALOX15,CYP1A2,ALDH1A1,CHRM1,TP53,TSHR}

> <pathway_gtopdb>
{"Membrane receptor","Ion channel","Other cytosolic protein",Enzyme,"Other nuclear protein","Unclassified protein","Epigenetic regulator","Transcription factor","Family A G protein-coupled receptor","
Voltage-gated ion channel",Kinase,Hydrolase,Reader,Eraser,"Cytochrome P450",Oxidoreductase,"Small molecule receptor (family A GPCR)","Voltage-gated calcium channel","Protein Kinase",Bromodomain,"Lysin
e demethylase","Cytochrome P450 family 2","Cytochrome P450 family 3","Cytochrome P450 family 1","Peptide receptor (family A GPCR)","Monoamine receptor","CMGC protein kinase group","Jumonji domain-cont
aining","Atypical protein kinase group","Cytochrome P450 family 2D","Cytochrome P450 family 3A","Cytochrome P450 family 2C","Cytochrome P450 family 1A","Glycohormone receptor","Adrenergic receptor","C
MGC protein kinase MAPK family","Atypical protein kinase PIKK family","Cytochrome P450 2D6","Cytochrome P450 3A4","Cytochrome P450 2C19","Cytochrome P450 1A1","Acetylcholine receptor","CMGC protein ki
nase ERK1","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Receptors,"Ion channels",Enzymes,"G protein-coupled receptors","Voltage-gated ion channels","Kinases (EC 2.7.x.x)","Chromatin modifying enzymes","Cytochrome P450","Eicosanoid turnover",Adrenoceptors,
"Voltage-gated calcium channels","CMGC: Containing CDK",MAPK,GSK3,"CLK families","1.14.11.- Histone demethylases",Atypical,"CYP2 family: drug metabolising subset","CYP3 family",Lipoxygenases,"CYP1 fam
ily","Acetylcholine receptors (muscarinic)","Glycoprotein hormone receptors","Mitogen-activated protein kinases (MAP kinases)","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","ERK subf
amily","FRAP subfamily"}

> <pathway_reactome>
{"Signal Transduction","Developmental Biology","Neuronal System","Immune System","Cell Cycle",Disease,"Cellular responses to external stimuli","Gene expression (Transcription)",Metabolism,"Signaling b
y GPCR","Nervous system development","Transmission across Chemical Synapses","Innate Immune System",Mitotic,"Infectious disease","Cellular responses to stress","RNA Polymerase II Transcription","Biolo
gical oxidations","Metabolism of lipids","Cell Cycle Checkpoints","GPCR ligand binding","Axon guidance","Neurotransmitter receptors and postsynaptic signal transmission","Toll-like Receptor Cascades",
"M Phase","Leishmania infection","Mitotic G1 phase and G1/S transition","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Cellular response to hypoxia","Generic Transcription Pathway",
"Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","G1/S DNA Damage Checkpoints","Class A/1 (Rhodopsin-like receptors)","NCAM signaling for neurite 
out-growth","Activation of NMDA receptors and postsynaptic events","Toll Like Receptor 5 (TLR5) Cascade","Mitotic Metaphase and Anaphase","Leishmania parasite growth and survival","G1/S Transition","O
xygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Transcriptional Regulation by MECP2","Transcriptional Regulation by TP53","Cytochrome P450 - arranged by substrate type","Bios
ynthesis of DHA-derived SPMs","Biosynthesis of DPA-derived SPMs","Ethanol oxidation","p53-Dependent G1/S DNA damage checkpoint","Amine ligand-binding receptors","NCAM1 interactions","Post NMDA recepto
r activation events","MyD88 cascade initiated on plasma membrane","Mitotic Anaphase","Anti-inflammatory response favouring Leishmania parasite infection","Activation of the pre-replicative complex","R
egulation of MECP2 expression and activity","Regulation of TP53 Activity",Xenobiotics,"Biosynthesis of maresins","Biosynthesis of DPAn-3 SPMs","p53-Dependent G1 DNA Damage Response",Adrenoceptors,"Act
ivation of AMPK downstream of NMDARs","MAP kinase activation","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Regulation of TP53 Expression and Degradatio
n","CYP2E1 reactions","Biosynthesis of maresin-like SPMs","Biosynthesis of DPAn-3-derived protectins and resolvins","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Muscarinic acety
lcholine receptors","Stabilization of p53","MAPK targets/ Nuclear events mediated by MAP kinases","Initiation of Nuclear Envelope (NE) Reformation","Regulation of TP53 Degradation","Autodegradation of
 the E3 ubiquitin ligase COP1","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{ADRA1A}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{naftopidil,57149-07-2,57149072,KT-611,KT611,Flivas,Avishot,1-(4-(2-methoxyphenyl)piperazin-1-yl)-3-(naphthalen-1-yloxy)propan-2-ol,1(4(2methoxyphenyl)piperazin1yl)3(naphthalen1yloxy)propan2ol,"Naftop
idil (Flivas)",BM-15275,BM15275,CHEMBL142635,4-(2-methoxyphenyl)-alpha-((1-naphthalenyloxy)methyl)-1-piperazineethanol,4(2methoxyphenyl)alpha((1naphthalenyloxy)methyl)1piperazineethanol,NCGC000157,T06
96,S2126,SAM001246658,Naftopidil,Naftopidil,CPD000466346}

> <pdid>
PD000224

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{4418}

$$$$
NIHCC_2014
  SciTegic11012413002D

 33 34  0  0  0  0            999 V2000
    2.5909   -6.0056    0.0000 C   0  0
    3.8912   -5.2578    0.0000 N   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -4.0317   -0.7359    0.0000 S   0  0
   -5.4979   -1.0529    0.0000 C   0  0
   -6.1032   -2.4253    0.0000 O   0  0
   -6.2524    0.2436    0.0000 N   0  0
   -5.2526    1.3618    0.0000 C   0  0
   -5.5608    2.8298    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    5.1894   -6.0109    0.0000 C   0  0
    5.1895   -7.5109    0.0000 C   0  0
    6.4885   -8.2610    0.0000 C   0  0
    7.7875   -7.5110    0.0000 C   0  0
    7.7876   -6.0110    0.0000 C   0  0
    6.4885   -5.2610    0.0000 N   0  0
   11.5876   -0.8402    0.0000 O   0  0
   11.5876   -2.3402    0.0000 C   0  0
   10.2883   -3.0898    0.0000 O   0  0
   12.8875   -3.0902    0.0000 C   0  0
   14.1875   -2.3402    0.0000 C   0  0
   14.1890   -0.8394    0.0000 C   0  0
   12.8904   -0.0886    0.0000 O   0  0
   15.4882   -0.0898    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 11  1  0
 16 17  2  0
  9 18  1  0
 18 19  2  0
 19  6  1  0
  2 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  1  0
 31 33  2  0
M  END
> <name>
NIHCC_2014

> <id>
5629

> <plate>
NGP-105-01

> <well>
A06

> <supplier_cmpd_name>
CPD000471612

> <ctcr_id>
6132

> <supplier_cmpd_id>
SAM001246610

> <smiles>
CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c3ccccn3.OC(=O)\C=C/C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Rosiglitazone maleate",155141-29-0,155141290,Avandia,"Rosiglitazone (maleate)","BRL 49653C",BRL-49653C,BRL49653C,Avandamet,BRL-49653-C,Nyracta,"Rosiglitazone XR","Rosiglitazone Maleate (USAN)",Venvi
a,CHEBI:8892,"BRL 49653-C",SMR000471612,"Avandia (TN)",SB-20684,SB20684,T1622,SAM001246610,CPD000471612}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5281055,25058199,11328950}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 30  0  0  0  0            999 V2000
    5.1983   -3.0012    0.0000 C   0  0
    5.1988   -1.5012    0.0000 C   0  0
    4.3327   -2.0011    0.0000 O   0  0
    3.8990   -0.7508    0.0000 C   0  0
    2.5988   -1.5004    0.0000 S   0  0
    2.5983   -3.0004    0.0000 O   0  0
    3.4646   -2.0008    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 F   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    6.4990   -0.7516    0.0000 C   0  0
    6.4995    0.7484    0.0000 O   0  0
    7.7988   -1.5020    0.0000 N   0  0
    9.0990   -0.7525    0.0000 C   0  0
   10.3991   -1.5006    0.0000 C   0  0
   11.6971   -0.7487    0.0000 C   0  0
   11.6950    0.7512    0.0000 C   0  0
   12.9937    1.5035    0.0000 C   0  0
   14.2917    2.2553    0.0000 N   0  0
   10.3949    1.4994    0.0000 C   0  0
    9.0969    0.7476    0.0000 C   0  0
   10.3928    3.0003    0.0000 C   0  0
   11.6903    3.7529    0.0000 F   0  0
    9.0925    3.7480    0.0000 F   0  0
   10.3900    4.5002    0.0000 F   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  2  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14  8  1  0
  2 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  3  0
 21 24  1  0
 24 25  2  0
 25 18  1  0
 24 26  1  0
 26 27  1  0
 26 28  1  0
 26 29  1  0
M  END
> <name>
NIHCC_2014

> <id>
5630

> <plate>
NGP-105-01

> <well>
A07

> <supplier_cmpd_name>
CPD000466329

> <ctcr_id>
768

> <supplier_cmpd_id>
SAM001246612

> <smiles>
CC(O)(C[S](=O)(=O)c1ccc(F)cc1)C(=O)Nc2ccc(C#N)c(c2)C(F)(F)F

> <pd_targets>
{ABCB11,RORC,AR,PGR,AMPC,CYP2C19}

> <pathway_gtopdb>
{Transporter,"Transcription factor",Enzyme,"Primary active transporter","Nuclear receptor",Hydrolase,"ATP-binding cassette","Nuclear hormone receptor subfamily 1","Nuclear hormone receptor subfamily 3
","ABCB subfamily","Nuclear hormone receptor subfamily 1 group F","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 1 group F member 3","Nuclear hormone receptor subfa
mily 3 group C member 4","Nuclear hormone receptor subfamily 3 group C member 3","Cytochrome P450","Cytochrome P450 family 2","Cytochrome P450 family 2C","Cytochrome P450 2C19"}

> <pathway_chembl>
{Transporters,Receptors,"ATP-binding cassette transporter family","Nuclear hormone receptors","ABCB subfamily","1F. Retinoic acid-related orphans","Steroid hormone receptors","3C. 3-Ketosteroid recept
ors",Enzymes,"Cytochrome P450","CYP2 family: drug metabolising subset"}

> <pathway_reactome>
{Metabolism,"Gene expression (Transcription)","Metabolism of proteins","Metabolism of lipids","RNA Polymerase II Transcription","Post-translational protein modification","Metabolism of steroids","Gene
ric Transcription Pathway",SUMOylation,"Bile acid and bile salt metabolism","Transcriptional regulation by RUNX3","Transcriptional regulation by RUNX2","SUMO E3 ligases SUMOylate target proteins","Syn
thesis of bile acids and bile salts","RUNX3 Regulates Immune Response and Cell Migration","RUNX2 regulates bone development","SUMOylation of intracellular receptors","Synthesis of bile acids and bile 
salts via 7alpha-hydroxycholesterol","RUNX2 regulates osteoblast differentiation","Biological oxidations","Phase I - Functionalization of compounds","Cytochrome P450 - arranged by substrate type",Xeno
biotics,"CYP2E1 reactions"}

> <broad_targets>
{AR}

> <broad_moa>
{"androgen receptor antagonist"}

> <synonyms>
{RESTW123,bicalutamide,90357-06-5,90357065,Casodex,Cosudex,"Bicalutamide (CDX)",Calutide,"ICI 176334",ICI-176334,ICI176334,"Bicalutamide (Casodex)",CHEMBL409,"ICI 176,334",MFCD00869971,Raffolutil,Kalu
mid,(R)-(-)Bicalutamide,(R)()Bicalutamide,SMR000466329,"Casodex (TN)",SR-01000759410,SR01000759410,BRN,T0380,SAM001246612,Prestw-1239,Bicalutamide,CPD000466329}

> <pdid>
PD000730

> <targets>
{Androgen Receptor,Autophagy}

> <classes>
{Autophagy,Others}

> <pubchem_cids>
{2375}

$$$$
NIHCC_2014
  SciTegic11012413002D

 14 15  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 F   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 N   0  0
    0.0000    3.0008    0.0000 C   0  0
    1.2121    3.8625    0.0000 C   0  0
    0.7463    5.2884    0.0000 C   0  0
   -0.7537    5.2860    0.0000 C   0  0
   -1.2149    3.8587    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  5  1  0
  4 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13  2  1  0
 13 14  2  0
M  END
> <name>
NIHCC_2014

> <id>
5631

> <plate>
NGP-105-01

> <well>
A08

> <supplier_cmpd_name>
CPD000059106

> <ctcr_id>
4179

> <supplier_cmpd_id>
SAM001246561

> <smiles>
FC1=CN(C2CCCO2)C(=O)NC1=O

> <pd_targets>
{RORC,MAPT,LMNA,AMPC,TYMS}

> <pathway_gtopdb>
{"Transcription factor","Other cytosolic protein","Other nuclear protein",Enzyme,"Nuclear receptor",Hydrolase,Transferase,"Nuclear hormone receptor subfamily 1","Nuclear hormone receptor subfamily 1 g
roup F","Nuclear hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{Receptors,Enzymes,"Nuclear hormone receptors","2.1.1.- Methyltransferases","1F. Retinoic acid-related orphans"}

> <pathway_reactome>
{"Gene expression (Transcription)","Neuronal System","Cell Cycle","RNA Polymerase II Transcription","Transmission across Chemical Synapses",Mitotic,"Generic Transcription Pathway","Neurotransmitter re
ceptors and postsynaptic signal transmission","M Phase","Mitotic G1 phase and G1/S transition","Transcriptional regulation by RUNX3","Activation of NMDA receptors and postsynaptic events","Mitotic Met
aphase and Anaphase","G1/S Transition","RUNX3 Regulates Immune Response and Cell Migration","Post NMDA receptor activation events","Mitotic Anaphase","G1/S-Specific Transcription","Activation of AMPK 
downstream of NMDARs","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{TYMS}

> <broad_moa>
{"thymidylate synthase inhibitor"}

> <synonyms>
{tegafur,Ftorafur,17902-23-7,17902237,Futraful,Fluorofur,Sinoflurol,Citofur,Florafur,Fental,Neberk,Coparogin,Franroze,Furafluor,Furflucil,Furofutran,Nitobanil,Exonal,Fulfeel,Lifril,Sunfral,Lamar,Riol,
"Tefsiel C",FT-207,FT207,5-fluoro-1-(tetrahydrofuran-2-yl,5fluoro1(tetrahydrofuran2yl,SAM001246561,CPD000059106}

> <pdid>
PD002985

> <targets>
{Nucleoside Antimetabolite/Analog}

> <classes>
{Cell Cycle/DNA Damage}

> <pubchem_cids>
{5386}

$$$$
NIHCC_2014
  SciTegic11012413002D

 33 36  0  0  1  0            999 V2000
   -1.3109   -5.2364    0.0000 O   0  0
   -0.0156   -5.9928    0.0000 C   0  0
    1.2883   -5.2495    0.0000 C   0  0  1  0  0  0
    1.2935   -3.7495    0.0000 O   0  0
    2.5951   -3.0039    0.0000 C   0  0  1  0  0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 O   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
    2.5987    1.5004    0.0000 C   0  0
    3.8991    0.7525    0.0000 C   0  0
    5.1969    1.5046    0.0000 C   0  0
    5.1945    3.0046    0.0000 C   0  0
    6.4923    3.7567    0.0000 O   0  0
    3.8943    3.7525    0.0000 C   0  0
    3.8919    5.2525    0.0000 O   0  0
    2.5964    3.0004    0.0000 C   0  0
    3.8915   -3.7585    0.0000 C   0  0  2  0  0  0
    5.1932   -3.0130    0.0000 O   0  0
    3.8864   -5.2585    0.0000 C   0  0  1  0  0  0
    5.1828   -6.0130    0.0000 O   0  0
    2.5847   -6.0040    0.0000 C   0  0  2  0  0  0
    2.5796   -7.5040    0.0000 O   0  0
  1  2  1  0
  3  2  1  1
  3  4  1  0
  4  5  1  0
  5  6  1  1
  6  7  1  0
  7  8  2  3
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 17 10  1  0
 17 18  1  0
 18  7  1  0
 18 19  2  0
  8 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 23 25  1  0
 25 26  1  0
 25 27  2  0
 27 20  1  0
  5 28  1  0
 28 29  1  6
 28 30  1  0
 30 31  1  1
 30 32  1  0
 32  3  1  0
 32 33  1  6
M  END
> <name>
NIHCC_2014

> <id>
5632

> <plate>
NGP-105-01

> <well>
A09

> <supplier_cmpd_name>
CPD000466391

> <ctcr_id>
4326

> <supplier_cmpd_id>
SAM001246767

> <smiles>
OC[C@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@@H]1O

> <pd_targets>
{KDM1A,XDH,KDM4E,CA4,CA12,MAPT,TGR,EPHX2,AKR1B1,GAA,ALPI,CA7,POLB,ALPL,CA2,AURKB,LMNA,ALD,GLA,CDK5,CDK5R1,REP,MAPK1,MPI,DYRK1A,P4HB,NA,NANH,FASN}

> <pathway_gtopdb>
{"Epigenetic regulator",Enzyme,"Other cytosolic protein",Eraser,Oxidoreductase,Lyase,Protease,Hydrolase,Phosphatase,Kinase,"Lysine demethylase","Serine protease","Protein Kinase","Lysine-specific deme
thylase","Jumonji domain-containing","Serine protease SC clan","Other protein kinase group","Serine protease S33 family","Other protein kinase AUR family","Other nuclear protein","CMGC protein kinase 
group","CMGC protein kinase CDK family","CMGC protein kinase MAPK family","CMGC protein kinase CDC2 subfamily","CMGC protein kinase ERK1",Isomerase,"CMGC protein kinase DYRK family","CMGC protein kina
se Dyrk1 subfamily",Transferase}

> <pathway_chembl>
{Enzymes,Receptors,"Chromatin modifying enzymes","1.-.-.- Oxidoreductases","Carbonic anhydrases",Hydrolases,"3.2.1.- Glycosidases","Catalytic receptors","1.14.11.- Histone demethylases","Receptor kina
ses","Other protein kinases","Aurora kinase (Aur) family","Other protein targets","Anti-infective targets","Kinases (EC 2.7.x.x)","Viral protein targets","CMGC: Containing CDK",MAPK,GSK3,"CLK families
","Coronavirus (CoV) proteins","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily","Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase (DYRK) family","Dyrk1 subfamily","2.3.1
.-  Acyltransferases"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,"Transport of small molecules","Neuronal System",Disease,"DNA Repair","Metabolism of proteins","Cell Cycle","Intracellular signaling by second messengers","Metabolism
 of nucleotides","O2/CO2 exchange in erythrocytes","Reversible hydration of carbon dioxide","Transmission across Chemical Synapses","Metabolism of lipids","Diseases of metabolism","Base Excision Repai
r","Post-translational protein modification",Mitotic,"PIP3 activates AKT signaling","Nucleobase catabolism","Erythrocytes take up carbon dioxide and release oxygen","Neurotransmitter receptors and pos
tsynaptic signal transmission","Biosynthesis of specialized proresolving mediators (SPMs)","Metabolism of steroids","Diseases of carbohydrate metabolism","Phospholipid metabolism","Resolution of Abasi
c Sites (AP sites)","Post-translational modification: synthesis of GPI-anchored proteins","M Phase","PTEN Regulation","Purine catabolism","Activation of NMDA receptors and postsynaptic events","Biosyn
thesis of DHA-derived SPMs","Metabolism of steroid hormones","Glycogen storage diseases","Glycerophospholipid biosynthesis","Resolution of AP sites via the multiple-nucleotide patch replacement pathwa
y","Mitotic Metaphase and Anaphase","Regulation of PTEN gene transcription","Post NMDA receptor activation events","Biosynthesis of maresins","Pregnenolone biosynthesis","Glycogen storage disease type
 II (GAA)","Synthesis of PA","PCNA-Dependent Long Patch Base Excision Repair","Mitotic Anaphase","Activation of AMPK downstream of NMDARs","Separation of Sister Chromatids","Immune System","Infectious
 disease","Innate Immune System","Sphingolipid metabolism","SARS-CoV Infections","Toll-like Receptor Cascades","Glycosphingolipid metabolism","SARS-CoV-1 Infection","Toll Like Receptor 5 (TLR5) Cascad
e","SARS-CoV-1 Genome Replication and Transcription","MyD88 cascade initiated on plasma membrane","Nuclear Envelope (NE) Reassembly","Replication of the SARS-CoV-1 genome","MAP kinase activation","Ini
tiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated","Cytokine Signaling in Immune system","Asparagine N-linke
d glycosylation","Mitotic G1 phase and G1/S transition","Signaling by Interleukins","Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide","LLO) and transfer to a nascent prot
ein","G0 and Early G1","Interleukin-12 family signaling","Synthesis of substrates in N-glycan biosythesis","Interleukin-12 signaling","Synthesis of GDP-mannose","Regulation of cholesterol biosynthesis
 by SREBP (SREBF)","Activation of gene expression by SREBF (SREBP)"}

> <broad_targets>
{}

> <broad_moa>
{antioxidant}

> <synonyms>
{Isoquercetin,Isoquercitrin,482-35-9,482359,"Quercetin 3-glucoside","Quercetin 3glucoside",Hirsutrin,"Quercetin 3-o-glucopyranoside","Quercetin 3oglucopyranoside",3-Glucosylquercetin,3Glucosylquerceti
n,"Glucosyl 3-quercetin","Glucosyl 3quercetin","Quercetol 3-glucoside","Quercetol 3glucoside","Quercetin 3-D-glucoside","Quercetin 3Dglucoside","Quercetin 3-O-glucoside","Quercetin 3Oglucoside","Querc
etin 3-monogluc","Quercetin 3monogluc",SAM001246767,CPD000466391}

> <pdid>
PD002964

> <targets>
{NF-ºB,NO Synthase}

> <classes>
{Immunology/Inflammation,NF-ºB}

> <pubchem_cids>
{5280804}

$$$$
NIHCC_2014
  SciTegic11012413002D

 40 43  0  0  1  0            999 V2000
    6.3990   -6.3774    0.0000 Cl  0  0
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 O   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -3.8971   -3.7500    0.0000 C   0  0
   -5.1961   -3.0000    0.0000 O   0  0
   -3.8971   -5.2500    0.0000 C   0  0
   -5.1961   -6.0000    0.0000 C   0  0
   -5.1961   -7.5000    0.0000 C   0  0  2  0  0  0
   -6.4764   -6.7185    0.0000 O   0  0
   -3.8971   -8.2500    0.0000 C   0  0
   -2.5980   -7.5000    0.0000 C   0  0  2  0  0  0
   -1.2998   -8.2531    0.0000 O   0  0
   -1.3019   -9.7539    0.0000 C   0  0  1  0  0  0
   -0.0055  -10.5085    0.0000 C   0  0
   -0.0107  -12.0085    0.0000 C   0  0  2  0  0  0
    1.2858  -12.7630    0.0000 N   0  0
   -1.3123  -12.7540    0.0000 C   0  0  2  0  0  0
   -1.3175  -14.2540    0.0000 O   0  0
   -2.6087  -11.9995    0.0000 C   0  0  2  0  0  0
   -3.9104  -12.7450    0.0000 C   0  0
   -2.6036  -10.4995    0.0000 O   0  0
   -2.5980   -6.0000    0.0000 C   0  0
   -1.2990   -5.2500    0.0000 C   0  0
    0.0000   -6.0000    0.0000 O   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    1.2991   -3.7500    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -5.1596   -8.9800    0.0000 C   0  0
   -6.4587   -9.7299    0.0000 O   0  0
   -3.8602   -9.7310    0.0000 C   0  0
   -3.8599  -11.2310    0.0000 O   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  1
 16 18  1  0
 18 19  1  0
 19 20  1  1
 21 20  1  1
 21 22  1  0
 22 23  1  0
 23 24  1  6
 23 25  1  0
 25 26  1  6
 25 27  1  0
 27 28  1  6
 27 29  1  0
 29 21  1  0
 19 30  1  0
 30 14  2  0
 30 31  1  0
 31 32  1  0
 31 33  2  0
 33 11  1  0
 33 34  1  0
 34 35  2  0
 34 36  1  0
 36  4  1  0
 36  8  2  0
 16 37  1  0
 37 38  2  0
 37 39  1  0
 39 40  1  0
M  END
> <name>
NIHCC_2014

> <id>
5633

> <plate>
NGP-105-01

> <well>
A10

> <supplier_cmpd_name>
CPD000058570

> <ctcr_id>
4056

> <supplier_cmpd_id>
SAM001246768

> <smiles>
Cl.COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO

> <pd_targets>
{HSP90AA1,HSP90AB1,HIF1A,MAPT,RORC,MAPK1,POLB,SKA,FTL,KEAP1,NFE2L2,S100A4,THRB,STX1,ALDH1A1,FFP,NS1,ALD,GLF,KMT2A,MEN1,RECQL,KDM4E,STAT6,APAF1,BLM,USP2,TGR,NPSR1,CYP3A4,TIM23,BRCA1,POL,"REVERSE TRANSC
RIPTASE",HINDIIIR,NR5A1,TOP1,TOP2A,TOP2B,RAD51,HTR1B,HTR4,CISD1,LANA1,TERT,RNASE1,ALOX15,CASP9,CASP1,MMP2,ABCB1,PAX8,DHCR7,EBP,ABCC1,CHRM1,ERBB2,LCK,EPAS1,SLCO1B3,AURKA,FYN,ABCC4,NS3,HTT}

> <pathway_gtopdb>
{"Other cytosolic protein","Transcription factor",Enzyme,"Unclassified protein","Epigenetic regulator","Membrane receptor",Transporter,"Nuclear receptor",Kinase,Oxidoreductase,Transferase,Isomerase,Re
ader,Eraser,Protease,"Family A G protein-coupled receptor","Cytochrome P450",Hydrolase,"Primary active transporter","Electrochemical transporter","Nuclear hormone receptor subfamily 1","Protein Kinase
",Bromodomain,"Lysine demethylase","Cysteine protease","Peptide receptor (family A GPCR)","Cytochrome P450 family 3","Nuclear hormone receptor subfamily 5","Small molecule receptor (family A GPCR)","M
etallo protease","ATP-binding cassette","SLC superfamily of solute carriers","Nuclear hormone receptor subfamily 1 group F","CMGC protein kinase group","Nuclear hormone receptor subfamily 1 group A","
Jumonji domain-containing","Cysteine protease CA clan","Short peptide receptor (family A GPCR)","Cytochrome P450 family 3A","Nuclear hormone receptor subfamily 5 group A","Monoamine receptor","Cystein
e protease CD clan","Metallo protease MAM clan","ABCB subfamily","ABCC subfamily","TK protein kinase group","SLC21/SLCO family of organic anion transporting polypeptides","Other protein kinase group",
"Nuclear hormone receptor subfamily 1 group F member 3","CMGC protein kinase MAPK family","Nuclear hormone receptor subfamily 1 group A member 2","Cysteine protease C1A family","Cysteine protease C19 
family","Neuropeptide receptor","Cytochrome P450 3A4","Nuclear hormone receptor subfamily 5 group A member 1","Serotonin receptor","Cysteine protease C14 family","Metallo protease M10A subfamily","Ace
tylcholine receptor","Tyrosine protein kinase EGFR family","Tyrosine protein kinase Src family","Other protein kinase AUR family","CMGC protein kinase ERK1","Tyrosine protein kinase SrcA","Serine prot
ease","Serine protease PA clan","Serine protease S29 family"}

> <pathway_chembl>
{Receptors,Enzymes,"Other protein targets",Transporters,"Nuclear hormone receptors","Kinases (EC 2.7.x.x)","Chromatin modifying enzymes","Transcription factors","Peptidases and proteinases","G protein
-coupled receptors","Cytochrome P450","Heat shock proteins","DNA topoisomerases","Eicosanoid turnover","ATP-binding cassette transporter family","Catalytic receptors","SLC superfamily of solute carrie
rs","1F. Retinoic acid-related orphans","CMGC: Containing CDK",MAPK,GSK3,"CLK families","1A. Thyroid hormone receptors","1.14.11.- Histone demethylases","STAT transcription factors","CA: Cysteine (C) 
Peptidases","Neuropeptide S receptor","CYP3 family","5A. Fushi tarazu F1-like receptors","5-Hydroxytryptamine receptors",Lipoxygenases,"CD: Cysteine (C) Peptidases","MA: Metallo (M) Peptidases","ABCB 
subfamily","ABCC subfamily","Acetylcholine receptors (muscarinic)","Receptor kinases","SLCO family of organic anion transporting polypeptides","Mitogen-activated protein kinases (MAP kinases)","C19: U
biquitin-specific protease","C14: Caspase","M10: Matrix metallopeptidase","TK: Tyrosine kinase","Other protein kinases","ERK subfamily","Receptor tyrosine kinases (RTKs)","Non-receptor tyrosine kinase
s (nRTKs)","Aurora kinase (Aur) family","Type I RTKs: ErbB (epidermal growth factor) receptor family","Src family","2.1.1.43 Histone methyltransferases (HMTs)"}

> <pathway_reactome>
{"Cellular responses to external stimuli","Neuronal System","Gene expression (Transcription)","Immune System","DNA Repair","Vesicle-mediated transport","Metabolism of proteins",Metabolism,"Programmed 
Cell Death",Disease,"Cell Cycle","Signal Transduction",Autophagy,"Developmental Biology",Hemostasis,"Cellular responses to stress","Transmission across Chemical Synapses","RNA Polymerase II Transcript
ion","Innate Immune System","Base Excision Repair","Membrane Trafficking","Post-translational protein modification","Biological oxidations",Apoptosis,"DNA Double-Strand Break Repair","Infectious disea
se","Metabolism of lipids",Mitotic,"Signaling by GPCR","Chromosome Maintenance","Chaperone Mediated Autophagy","Nervous system development","Abacavir transport and metabolism","Platelet activation","s
ignaling and aggregation","Cellular response to hypoxia","Neurotransmitter receptors and postsynaptic signal transmission","Generic Transcription Pathway","Toll-like Receptor Cascades","Resolution of 
Abasic Sites (AP sites)","trans-Golgi Network Vesicle Budding",SUMOylation,"Phase I - Functionalization of compounds","Cytosolic sensors of pathogen-associated DNA","Intrinsic Pathway for Apoptosis","
Homology Directed Repair","Leishmania infection","Biosynthesis of specialized proresolving mediators (SPMs)","Mitotic G2-G2/M phases","Mitotic G1 phase and G1/S transition","GPCR ligand binding","Telo
mere Maintenance","Axon guidance","Abacavir transmembrane transport","Fatty acid metabolism","HIV Infection","Metabolism of steroids","Response to elevated platelet cytosolic Ca2+","Oxygen-dependent p
roline hydroxylation of Hypoxia-inducible Factor Alpha","Activation of NMDA receptors and postsynaptic events","Transcriptional regulation by RUNX3","Toll Like Receptor 5 (TLR5) Cascade","Resolution o
f AP sites via the multiple-nucleotide patch replacement pathway","Golgi Associated Vesicle Biogenesis","SUMO E3 ligases SUMOylate target proteins","Ethanol oxidation","STING mediated induction of hos
t immune responses","Apoptotic factor-mediated response","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Transcriptional Regulation by TP53","Leishmania parasite growth 
and survival","Biosynthesis of DHA-derived SPMs","G2/M Transition","G0 and Early G1","Class A/1 (Rhodopsin-like receptors)","Extension of Telomeres","Biosynthesis of DPA-derived SPMs","EPH-Ephrin sign
aling","Arachidonic acid metabolism","Semaphorin interactions","Host Interactions of HIV factors","Bile acid and bile salt metabolism","Platelet degranulation","Post NMDA receptor activation events","
RUNX3 Regulates Immune Response and Cell Migration","MyD88 cascade initiated on plasma membrane","PCNA-Dependent Long Patch Base Excision Repair","SUMOylation of intracellular receptors","STAT6-mediat
ed induction of chemokines","Cytochrome c-mediated apoptotic response","HDR through Homologous Recombination (HRR)","Regulation of TP53 Activity","Anti-inflammatory response favouring Leishmania paras
ite infection","Biosynthesis of maresins","Centrosome maturation","SUMOylation of DNA replication proteins","Transcription of E2F targets under negative control by DREAM complex","Amine ligand-binding
 receptors","Telomere Extension By Telomerase","Biosynthesis of DPAn-3 SPMs","TP53 Regulates Transcription of Cell Death Genes","EPH-ephrin mediated repulsion of cells","Synthesis of Leukotrienes (LT)
 and Eoxins (EX)","Sema4D in semaphorin signaling","The role of Nef in HIV-1 replication and disease pathogenesis","Recycling of bile acids and salts","Activation of AMPK downstream of NMDARs","MAP ki
nase activation","Formation of apoptosome","Homologous DNA Pairing and Strand Exchange","Regulation of TP53 Expression and Degradation","ADORA2B mediated anti-inflammatory cytokines production","Biosy
nthesis of maresin-like SPMs","Loss of proteins required for interphase microtubule organization from the centrosome","Serotonin receptors","Biosynthesis of DPAn-3-derived protectins and resolvins","T
P53 Regulates Transcription of Caspase Activators and Caspases","Muscarinic acetylcholine receptors","Sema4D induced cell migration and growth-cone collapse","Nef-mediates down modulation of cell surf
ace receptors by recruiting them to clathrin adapters","Regulation of TP53 Activity through Phosphorylation","Nef and signal transduction","MAPK targets/ Nuclear events mediated by MAP kinases","Regul
ation of the apoptosome activity","Presynaptic phase of homologous DNA pairing and strand exchange","Regulation of TP53 Degradation","Loss of Nlp from mitotic centrosomes","Nef Mediated CD4 Down-regul
ation","ERK/MAPK targets","ERKs are inactivated","Transcriptional Regulation by MECP2","Transcriptional regulation by RUNX1","Regulation of MECP2 expression and activity","RUNX1 regulates genes involv
ed in megakaryocyte differentiation and platelet function"}

> <broad_targets>
{CHD1,TOP2A}

> <broad_moa>
{"topoisomerase inhibitor"}

> <synonyms>
{"Doxorubicin Hydrochloride",25316-40-9,25316409,"Doxorubicin HCl","ADRIAMYCIN HYDROCHLORIDE",Adriacin,Adriblastina,Rubex,"Doxorubicin (Adriamycin) HCl","Doxorubicin (hydrochloride)","ADRIAMYCIN, HYDR
OCHLORIDE","Hydroxydaunorubicin hydrochloride",UNII-,UNII,SAM001246768,Prestw-438,CPD000058570,"Doxorubicin hydrochloride"}

> <pdid>
PD000383

> <targets>
{ADC Cytotoxin,AMPK,Antibiotic,Apoptosis,Autophagy,Bacterial,HBV,HIV,Mitophagy,Topoisomerase}

> <classes>
{Antibody-drug Conjugate/ADC Related,Anti-infection,Apoptosis,Autophagy,Cell Cycle/DNA Damage,Epigenetics,PI3K/Akt/mTOR}

> <pubchem_cids>
{11387649,443939,657367}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 26  0  0  0  0            999 V2000
    8.0899    0.1334    0.0000 H   0  3
    5.5899    0.1334    0.0000 Cl  0  5
    1.0497   -4.2139    0.0000 C   0  0
    1.5767   -2.8095    0.0000 C   0  0
    3.0226   -2.4104    0.0000 N   0  0
    3.0899   -0.9120    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 C   0  0
    0.0000    1.7286    0.0000 N   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -2.5248    2.0134    0.0000 C   0  0
   -3.9477    1.5416    0.0000 C   0  0
   -5.0711    2.5356    0.0000 C   0  0
   -4.7720    4.0055    0.0000 C   0  0
   -3.3495    4.4814    0.0000 C   0  0
   -2.2261    3.4874    0.0000 C   0  0
   -0.8038    3.9638    0.0000 F   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -3.1695   -0.6090    0.0000 C   0  0
   -3.7175   -2.0053    0.0000 C   0  0
   -5.2007   -2.2289    0.0000 Cl  0  0
   -2.7822   -3.1781    0.0000 C   0  0
   -1.2990   -2.9545    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
    0.7500   -1.5574    0.0000 N   0  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  3
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 16 17  1  0
 10 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 20 22  2  0
 22 23  1  0
 23 24  2  0
 24 18  1  0
 24 25  1  0
 25  4  1  0
 25  7  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5634

> <plate>
NGP-105-01

> <well>
A11

> <supplier_cmpd_name>
CPD000469160

> <ctcr_id>
5963

> <supplier_cmpd_id>
SAM001246585

> <smiles>
[H+].[Cl-].Cc1ncc2CN=C(c3ccccc3F)c4cc(Cl)ccc4n12

> <pd_targets>
{UGT1A6,TSPO,ABCB11,CYP3A4,GABRA1,TRHR,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG3,GABRP,GABRQ,UGT1A1,SLC22A1,ABCB1B,ADRA1B}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor",Transporter,"Ion channel",Transferase,"Primary active transporter","Cytochrome P450","Ligand-gated ion channel","Family A G protein-coupled receptor","Electrochemical trans
porter","ATP-binding cassette","Cytochrome P450 family 3","GABA-A receptor","Peptide receptor (family A GPCR)","SLC superfamily of solute carriers","Small molecule receptor (family A GPCR)","ABCB subf
amily","Cytochrome P450 family 3A","Short peptide receptor (family A GPCR)","SLC22 family of organic cation and anion transporters","Monoamine receptor","Cytochrome P450 3A4","Neuropeptide receptor","
Adrenergic receptor"}

> <pathway_chembl>
{"Other protein targets",Transporters,Enzymes,"Ion channels",Receptors,"Mitochondrial-associated proteins","ATP-binding cassette transporter family","Cytochrome P450","Ligand-gated ion channels","G pr
otein-coupled receptors","UDP glucuronosyltransferases (UGT)","SLC superfamily of solute carriers","ABCB subfamily","CYP3 family","GABA<sub>A</sub> receptors","Thyrotropin-releasing hormone receptors"
,"SLC22 family of organic cation and anion transporters",Adrenoceptors,"Organic cation transporters (OCT)"}

> <pathway_reactome>
{Metabolism,"Neuronal System","Signal Transduction",Disease,"Transport of small molecules","Biological oxidations","Metabolism of lipids","Transmission across Chemical Synapses","Signaling by GPCR","D
iseases of metabolism","SLC-mediated transmembrane transport","Phase II - Conjugation of compounds","Metabolism of steroids","Biosynthesis of specialized proresolving mediators (SPMs)","Neurotransmitt
er receptors and postsynaptic signal transmission","GPCR ligand binding","Metabolic disorders of biological oxidation enzymes","Transport of bile salts and organic acids","metal ions and amine compoun
ds",Glucuronidation,"Metabolism of steroid hormones","Bile acid and bile salt metabolism","Biosynthesis of DHA-derived SPMs","GABA receptor activation","Class A/1 (Rhodopsin-like receptors)","Defectiv
e UGT1A1 causes hyperbilirubinemia","Organic cation/anion/zwitterion transport","Pregnenolone biosynthesis","Synthesis of bile acids and bile salts","Biosynthesis of maresins","Peptide ligand-binding 
receptors","Organic cation transport","Amine ligand-binding receptors","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Biosynthesis of maresin-like SPMs",Adrenoceptors}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"MIDAZOLAM HYDROCHLORIDE",59467-96-8,59467968,"Midazolam Hcl",Dormicum,Versed,Hypnovel,UNII-W7TTW573JJ,UNIIW7TTW573JJ,"Midazolam hydrochloride (USAN)","Ro 21-3981/003","Ro 213981/003",W7TTW573JJ,Roca
m,DSSTox_CID_27824,DSSToxCID27824,DSSTox-CID-27824,"DSSTox CID 27824",DSSTox_RID_82587,DSSToxRID82587,DSSTox-RID-82587,"DSSTox RID 82587",DSSTox_GSID_47846,DSSToxGSID47846,DSSTox-GSID-47846,"DSSTox GS
ID 47846","Ro 21-3981/001","Ro 213981/001",SAM001246585,CPD000469160}

> <pdid>
PD009850

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{92031775,43032}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 24  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
   -2.5987   -1.5004    0.0000 C   0  0
   -2.5964   -3.0004    0.0000 C   0  0
   -3.8943   -3.7525    0.0000 C   0  0
   -3.8919   -5.2525    0.0000 Cl  0  0
   -5.1945   -3.0046    0.0000 C   0  0
   -5.1969   -1.5046    0.0000 C   0  0
   -3.8990   -0.7525    0.0000 C   0  0
   -3.9015    0.7475    0.0000 Cl  0  0
    6.3987    0.7487    0.0000 O   0  0
    6.3987   -0.7513    0.0000 C   0  0
    5.0994   -1.5008    0.0000 O   0  0
    7.6987   -1.5013    0.0000 C   0  0
    8.9987   -0.7513    0.0000 C   0  0
    9.0001    0.7496    0.0000 C   0  0
    7.7016    1.5004    0.0000 O   0  0
   10.2994    1.4992    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  7  8  2  0
  8  2  1  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 13 14  1  0
 14 15  2  0
 15  9  1  0
 15 16  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 22 24  2  0
M  END
> <name>
NIHCC_2014

> <id>
5635

> <plate>
NGP-105-01

> <well>
B02

> <supplier_cmpd_name>
CPD000471621

> <ctcr_id>
4528

> <supplier_cmpd_id>
SAM001246718

> <smiles>
Nc1nc(N)nc(n1)c2cc(Cl)ccc2Cl.OC(=O)\C=C/C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{RESTW117,"irsogladine maleate",84504-69-8,84504698,Gaslon,MN-1695,MN1695,"Irsogladine (maleate)",UNII-66GVU60EPQ,UNII66GVU60EPQ,57381-28-9,57381289,"6-(2,5-DICHLOROPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE 
MALEATE","6(2,5DICHLOROPHENYL)1,3,5TRIAZINE2,4DIAMINE MALEATE",66GVU60EPQ,"84504-69-8 (maleate)","84504698 (maleate)","Irsogladine HBr",DSSTox_CID_20234,DSSToxCID20234,DSSTox-CID-20234,"DSSTox CID 202
34",DSSTox_RID_7945,DSSToxRID7945,DSSTox-RID-7945,"DSSTox RID 7945",SAM001246718,Prestw-1173,CPD000471621,"Irsogladine maleate"}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5282435}

$$$$
NIHCC_2014
  SciTegic11012413002D

 14 14  0  0  1  0            999 V2000
    5.1996   -1.4928    0.0000 O   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0  1  0  0  0
   -0.0031   -3.0008    0.0000 C   0  0
   -1.3032   -3.7490    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  1
  6  8  1  0
  8  9  1  6
  8 10  1  0
 10 11  1  1
 10 12  1  0
 12  4  1  0
 12 13  1  6
 13 14  1  0
M  END
> <name>
NIHCC_2014

> <id>
5636

> <plate>
NGP-105-01

> <well>
B03

> <supplier_cmpd_name>
CPD000466381

> <ctcr_id>
574

> <supplier_cmpd_id>
SAM001246745

> <smiles>
OCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO

> <pd_targets>
{GLB1,GAA,SI,LCT,MGAM,AGLA,GBA,AGL,GANAB,GANC,TDP1}

> <pathway_gtopdb>
{Enzyme,Hydrolase}

> <pathway_chembl>
{Enzymes,"3.2.1.- Glycosidases"}

> <pathway_reactome>
{"Metabolism of proteins",Disease,"Digestion and absorption",Metabolism,"DNA Repair","Post-translational protein modification","Diseases of metabolism",Digestion,"Metabolism of lipids","Metabolism of 
carbohydrates","Infectious disease","DNA Double-Strand Break Repair","Asparagine N-linked glycosylation","Diseases of carbohydrate metabolism","Digestion of dietary carbohydrate","Sphingolipid metabol
ism","Glycogen metabolism","SARS-CoV Infections","Nonhomologous End-Joining (NHEJ)","Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide","LLO) and transfer to a nascent prot
ein","Glycogen storage diseases","Intestinal saccharidase deficiencies","Glycosphingolipid metabolism","Glycogen breakdown (glycogenolysis)","SARS-CoV-1 Infection","Synthesis of substrates in N-glycan
 biosythesis","Glycogen storage disease type II (GAA)","Translation of structural proteins","Sialic acid metabolism","Maturation of spike protein"}

> <broad_targets>
{GAA,GANAB,GANC,MGAM}

> <broad_moa>
{"glucosidase inhibitor"}

> <synonyms>
{DTXSID0023323,MIGLITOL,72432-03-2,72432032,Glyset,"(2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol","(2R,3R,4R,5S)1(2hydroxyethyl)2(hydroxymethyl)piperidine3,4,5triol",Bay-m-
1099,Baym1099,"Bay m 1099",UNII-0V5436JAQW,UNII0V5436JAQW,"Miglitol (Glyset)",Seibule,C8H17NO5,CHEMBL1561,0V5436JAQW,CHEBI:6935,Diastabol,1,5-dideo,5dideo,T1529,SAM001246745,Prestw-1169,Miglitol,CPD00
0466381}

> <pdid>
PD001201

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{441314}

$$$$
NIHCC_2014
  SciTegic11012413002D

 12 12  0  0  1  0            999 V2000
    1.9135   -4.8267    0.0000 C   0  0
    1.0280   -3.6160    0.0000 C   0  0
    1.6332   -2.2426    0.0000 C   0  0  2  0  0  0
    0.7500   -1.0323    0.0000 N   0  0
    1.2135    0.3943    0.0000 C   0  0
    0.0000    1.2760    0.0000 C   0  0
   -1.2135    0.3943    0.0000 C   0  0
   -0.7500   -1.0323    0.0000 C   0  0
   -1.6317   -2.2458    0.0000 O   0  0
    3.1255   -2.0835    0.0000 C   0  0
    3.7332   -0.7121    0.0000 N   0  0
    4.0097   -3.2952    0.0000 O   0  0
  1  2  1  0
  3  2  1  6
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  4  1  0
  8  9  2  0
  3 10  1  0
 10 11  1  0
 10 12  2  0
M  END
> <name>
NIHCC_2014

> <id>
5637

> <plate>
NGP-105-01

> <well>
B04

> <supplier_cmpd_name>
CPD000466303

> <ctcr_id>
3019

> <supplier_cmpd_id>
SAM001246539

> <smiles>
CC[C@H](N1CCCC1=O)C(N)=O

> <pd_targets>
{SV2A,CACNA1B,LMNA}

> <pathway_gtopdb>
{Transporter,"Ion channel","Electrochemical transporter","Voltage-gated ion channel","Vesicular neurotransmitter transporter family","Voltage-gated calcium channel","Other nuclear protein"}

> <pathway_chembl>
{Transporters,"Ion channels","SLC superfamily of solute carriers","Voltage-gated ion channels","SLC22 family of organic cation and anion transporters","Voltage-gated calcium channels","Atypical SLC22B
 subfamily"}

> <pathway_reactome>
{Disease,"Neuronal System","Infectious disease","Transmission across Chemical Synapses","Uptake and actions of bacterial toxins","Presynaptic depolarization and calcium channel opening","Neurotoxicity
 of clostridium toxins","Toxicity of botulinum toxin type A (botA)","Cell Cycle",Mitotic,"M Phase","Mitotic Metaphase and Anaphase","Mitotic Anaphase","Nuclear Envelope (NE) Reassembly","Initiation of
 Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{CACNA1B,SCN1A,SV2A}

> <broad_moa>
{"calcium channel blocker"}

> <synonyms>
{Levetiracetam,102767-28-2,102767282,Keppra,(S)-2-(2-Oxopyrrolidin-1-yl)butanamide,(S)2(2Oxopyrrolidin1yl)butanamide,"Keppra XR","ucb L059","UCB-L 059","UCBL 059",(2S)-2-(2-oxopyrrolidin-1-yl)butanami
de,(2S)2(2oxopyrrolidin1yl)butanamide,UCB-L059,UCBL059,Levetiracetamum,Spritam,(S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide,(S)alphaEthyl2oxo1pyrrolidineacetamide,SIB-S1,SIBS1,(-)-(S)-a,()(S)a,T0192,S
AM001246539,Prestw-1427,CPD000466303}

> <pdid>
PD001324

> <targets>
{DNA Methyltransferase}

> <classes>
{Epigenetics}

> <pubchem_cids>
{5284583}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 31  0  0  0  0            999 V2000
    7.7938   -3.0046    0.0000 C   0  0
    6.4946   -3.7543    0.0000 O   0  0
    5.1945   -3.0045    0.0000 C   0  0
    5.1969   -1.5045    0.0000 C   0  0
    3.8991   -0.7525    0.0000 C   0  0
    2.5987   -1.5004    0.0000 C   0  0
    2.5965   -3.0004    0.0000 C   0  0
    3.8943   -3.7525    0.0000 C   0  0
    3.8888   -5.2533    0.0000 O   0  0
    2.5875   -5.9994    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -2.6012    3.0008    0.0000 O   0  0
   -3.9013    3.7490    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1984    1.4977    0.0000 O   0  0
   -6.4964    0.7459    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -5.1953   -1.5031    0.0000 O   0  0
   -5.1932   -3.0031    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.6011   -3.0008    0.0000 O   0  0
   -3.9013   -3.7490    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  8  9  1  0
  9 10  1  0
  6 11  1  0
 11 12  2  3
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 16 19  1  0
 19 20  1  0
 20 21  1  0
 19 22  2  0
 22 23  1  0
 23 24  1  0
 22 25  1  0
 25 26  1  0
 26 27  1  0
 25 28  2  0
 28 15  1  0
 28 29  1  0
 29 11  1  0
M  END
> <name>
NIHCC_2014

> <id>
5638

> <plate>
NGP-105-01

> <well>
B05

> <supplier_cmpd_name>
CPD000156231

> <ctcr_id>
4520

> <supplier_cmpd_id>
SAM001246662

> <smiles>
COc1ccc(cc1OC)C2=CC(=O)c3c(OC)c(OC)c(OC)c(OC)c3O2

> <pd_targets>
{MAPK1,RORC,AMPC,KDM4E,ALDH1A1,KMT2A,MEN1,MAPT,HPGD,CYP3A4,HSD17B10,FFP,ABCG2,ABCB1}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Epigenetic regulator","Other cytosolic protein",Transporter,Kinase,"Nuclear receptor",Hydrolase,Eraser,Oxidoreductase,Reader,Protease,"Cytochrome P450",Transferase,"Pri
mary active transporter","Protein Kinase","Nuclear hormone receptor subfamily 1","Lysine demethylase",Bromodomain,"Cysteine protease","Cytochrome P450 family 3","ATP-binding cassette","CMGC protein ki
nase group","Nuclear hormone receptor subfamily 1 group F","Jumonji domain-containing","Cysteine protease CA clan","Cytochrome P450 family 3A","ABCG subfamily","ABCB subfamily","CMGC protein kinase MA
PK family","Nuclear hormone receptor subfamily 1 group F member 3","Cysteine protease C1A family","Cytochrome P450 3A4","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Kinases (EC 2.7.x.x)","Nuclear hormone receptors","Chromatin modifying enzymes","Eicosanoid turnover","Cytochrome P450","ATP-binding cassette transporter family","CMGC
: Containing CDK",MAPK,GSK3,"CLK families","1F. Retinoic acid-related orphans","1.14.11.- Histone demethylases","Prostaglandin synthases","CYP3 family","ABCG subfamily","ABCB subfamily","Mitogen-activ
ated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Immune System","Gene expression (Transcription)",Metabolism,"Neuronal System","Innate Immune System","RNA Polymerase II Transcription","Biological oxidations","Transmission across Chemical Synapses"
,"Metabolism of lipids","Metabolism of amino acids and derivatives","Abacavir transport and metabolism","Toll-like Receptor Cascades","Generic Transcription Pathway","Phase I - Functionalization of co
mpounds","Neurotransmitter receptors and postsynaptic signal transmission","Biosynthesis of specialized proresolving mediators (SPMs)","Branched-chain amino acid catabolism","Abacavir transmembrane tr
ansport","Toll Like Receptor 5 (TLR5) Cascade","Transcriptional regulation by RUNX3","Ethanol oxidation","Activation of NMDA receptors and postsynaptic events","Biosynthesis of DHA-derived SPMs","MyD8
8 cascade initiated on plasma membrane","RUNX3 Regulates Immune Response and Cell Migration","Post NMDA receptor activation events","Biosynthesis of D-series resolvins","Biosynthesis of maresins","MAP
 kinase activation","Activation of AMPK downstream of NMDARs","Biosynthesis of maresin-like SPMs","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{MAP2K1}

> <broad_moa>
{"MEK inhibitor"}

> <synonyms>
{HMS3373C14,Nobiletin,478-01-3,478013,Hexamethoxyflavone,"3',4',5,6,7,8-Hexamethoxyflavone","3',4',5,6,7,8Hexamethoxyflavone","5,6,7,8,3',4'-Hexamethoxyflavone","5,6,7,8,3',4'Hexamethoxyflavone",UNII-
D65ILJ7WLY,UNIID65ILJ7WLY,"2-(3,4-Dimethoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one","2(3,4Dimethoxyphenyl)5,6,7,8tetramethoxy4H1benzopyran4one",2-(3,2(3,4-dimethoxyphenyl)-5,4dimethoxypheny
l)5,6,7,T2834,SAM001246662,1505268,CPD000156231,NOBILETIN}

> <pdid>
PD000532

> <targets>
{Apoptosis,Autophagy,Reactive Oxygen Species,ROR}

> <classes>
{matrix metaloproteinase inhibitor,antineoplastic,Apoptosis,Autophagy,Immunology/Inflammation,Metabolic Enzyme/Protease,NF-ºB}

> <pubchem_cids>
{72344}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 31  0  0  1  0            999 V2000
   -5.0019    0.8454    0.0000 C   0  0
   -3.5348    0.5331    0.0000 N   0  0
   -2.5311    1.6478    0.0000 C   0  0
   -3.0705   -0.8941    0.0000 C   0  0
   -1.6026   -1.2066    0.0000 C   0  0
   -1.1384   -2.6339    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0  1  0  0  0
    1.8032   -3.1233    0.0000 O   0  0
    2.4133   -1.7530    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000    3.0008    0.0000 C   0  0
    0.0000    4.5008    0.0000 N   0  0
    0.7935   -4.3741    0.0000 C   0  0
   -0.1925   -5.5045    0.0000 C   0  0
    0.2934   -6.9236    0.0000 C   0  0
    1.7654   -7.2123    0.0000 C   0  0
    2.2513   -8.6314    0.0000 F   0  0
    2.7514   -6.0819    0.0000 C   0  0
    2.2654   -4.6628    0.0000 C   0  0
    6.5514   -0.1902    0.0000 O   0  0
    6.5514   -1.6902    0.0000 C   0  0
    5.2521   -2.4398    0.0000 O   0  0
    7.8514   -2.4402    0.0000 C   0  0
    7.8514   -3.9402    0.0000 O   0  0
    9.1506   -1.6906    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  7  6  1  6
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15  7  1  0
 15 10  1  0
 12 16  1  0
 16 17  3  0
  7 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 23  1  0
 23 24  2  0
 24 18  1  0
 25 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  1  0
 28 30  2  0
M  END
> <name>
NIHCC_2014

> <id>
5639

> <plate>
NGP-105-01

> <well>
B06

> <supplier_cmpd_name>
CPD000469191

> <ctcr_id>
1892

> <supplier_cmpd_id>
SAM001246668

> <smiles>
CN(C)CCC[C@]1(OCc2cc(ccc12)C#N)c3ccc(F)cc3.OC(=O)C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Escitalopram oxalate",219861-08-2,219861082,Lexapro,Cipralex,"Escitalopram (oxalate)","(S)-Citalopram Oxalate","(S)Citalopram Oxalate","(S)-(+)Citalopram oxalate","(S)(+)Citalopram oxalate","(S)-(+)
-Citalopram Oxalate","(S)(+)Citalopram Oxalate",UNII-5U85DBW7LO,UNII5U85DBW7LO,5U85DBW7LO,"Lu 26-054-0","Lu 260540",C22H23FN2O5,Esertia,Seroplex,NCGC00095903-,NCGC00095903,SAM001246668,Prestw-1271,CPD
000469191,Escitalopram}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{146571}

$$$$
NIHCC_2014
  SciTegic11012413002D

 38 40  0  0  1  0            999 V2000
   10.2961    2.2467    0.0000 Cl  0  0
    3.8926   -3.7566    0.0000 C   0  0
    2.5951   -3.0039    0.0000 O   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
   -0.0031    3.0008    0.0000 C   0  0
    1.2946    3.7531    0.0000 O   0  0
   -1.3039    3.7494    0.0000 O   0  0
   -1.3070    5.2502    0.0000 C   0  0  2  0  0  0
   -2.6061    6.0003    0.0000 C   0  0
   -2.6061    7.5003    0.0000 C   0  0
   -1.3071    8.2503    0.0000 C   0  0
   -0.0080    7.5003    0.0000 N   0  0
    1.2933    8.2481    0.0000 C   0  0
    2.5920    7.4959    0.0000 C   0  0
    3.8936    8.2414    0.0000 C   0  0
    5.1901    7.4869    0.0000 C   0  0
    5.1849    5.9869    0.0000 C   0  0
    3.8833    5.2414    0.0000 C   0  0
    2.5869    5.9958    0.0000 C   0  0
   -0.0080    6.0003    0.0000 C   0  0
    2.5987    1.5004    0.0000 C   0  0
    2.6012    3.0005    0.0000 C   0  0
    3.9014    3.7484    0.0000 C   0  0
    5.1993    2.9963    0.0000 C   0  0
    5.1969    1.4963    0.0000 C   0  0
    3.8967    0.7484    0.0000 C   0  0
    6.4939    0.7412    0.0000 N   0  3
    6.4894   -0.7588    0.0000 O   0  0
    7.7954    1.4869    0.0000 O   0  5
    3.8976   -0.7553    0.0000 O   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  3
  8  9  1  0
  8 10  1  0
 10 11  2  3
 11  5  1  0
 11 12  1  0
  7 13  1  0
 13 14  2  0
 13 15  1  0
 16 15  1  6
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 20 28  1  0
 28 16  1  0
  6 29  1  6
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 29  1  0
 33 35  1  0
 35 36  2  0
 35 37  1  0
  4 38  1  0
M  CHG  2  35   1  37  -1
M  END
> <name>
NIHCC_2014

> <id>
5640

> <plate>
NGP-105-01

> <well>
B07

> <supplier_cmpd_name>
CPD000469192

> <ctcr_id>
388

> <supplier_cmpd_id>
SAM001246672

> <smiles>
Cl.CO\C(=C/1\[C@H](C(=C(C)N=C1C)C(=O)O[C@@H]2CCCN(Cc3ccccc3)C2)c4cccc(c4)[N+](=O)[O-])\O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"benidipine hydrochloride",91599-74-5,91599745,"BENIDIPINE HCl","Benidipine (hydrochloride)","rac Benidipine hydrochloride",KW-3049,KW3049,"KW 3049","91599-74-5 (HCl)","91599745 (HCl)",105979-17-7,10
5979177,C28H31N3O6.HCl,"(+-)-Benidipine hydrochloride","(+)Benidipine hydrochloride",129262-07-3,129262073,NCGC00185768-01,NCGC0018576801,Be,SAM001246672,CPD000469192}

> <pdid>
PD156024

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{656667}

$$$$
NIHCC_2014
  SciTegic11012413002D

 55 57  0  0  1  0            999 V2000
   -7.9737   -1.1388    0.0000 C   0  0
   -6.7301   -1.9776    0.0000 C   0  0
   -5.3800   -1.3200    0.0000 C   0  0  1  0  0  0
   -4.1300   -2.2400    0.0000 C   0  0
   -3.0800   -1.1200    0.0000 C   0  0
   -2.1300   -1.9800    0.0000 C   0  0  1  0  0  0
   -2.1500   -3.5200    0.0000 O   0  0
   -0.8200   -4.3000    0.0000 C   0  0  2  0  0  0
    0.4600   -5.0900    0.0000 C   0  0
    0.4400   -6.6600    0.0000 C   0  0
   -0.8700   -7.4000    0.0000 C   0  0  1  0  0  0
   -0.8863   -8.8999    0.0000 C   0  0
   -2.2000   -6.6100    0.0000 C   0  0  1  0  0  0
   -3.5082   -7.3448    0.0000 C   0  0
   -3.5269   -8.8455    0.0000 C   0  0  2  0  0  0
   -2.2371   -9.6112    0.0000 C   0  0
   -4.8347   -9.5801    0.0000 O   0  0
   -2.1800   -5.0700    0.0000 O   0  0
    0.4600   -3.5700    0.0000 C   0  0  2  0  0  0
    1.7498   -4.3358    0.0000 C   0  0
    0.4900   -2.0000    0.0000 C   0  0  1  0  0  0
    1.8400   -1.2700    0.0000 O   0  0
    3.1700   -2.0600    0.0000 C   0  0
    3.1512   -3.5599    0.0000 O   0  0
    4.4900   -1.3200    0.0000 C   0  0
    4.5100    0.2000    0.0000 C   0  0
    5.8900    0.8100    0.0000 C   0  0  1  0  0  0
    7.1228   -0.0445    0.0000 C   0  0
    5.9800    2.3700    0.0000 C   0  0  2  0  0  0
    7.3461    2.9895    0.0000 O   0  0
    4.7600    3.3200    0.0000 C   0  0  1  0  0  0
    3.3975    2.6925    0.0000 C   0  0
    4.8300    4.8400    0.0000 C   0  0
    6.1701    5.5138    0.0000 O   0  0
    3.4500    5.7700    0.0000 C   0  0  1  0  0  0
    3.4645    7.2699    0.0000 C   0  0
    2.1500    4.9300    0.0000 C   0  0  2  0  0  0
    2.0870    3.4313    0.0000 O   0  0
    0.9200    5.8800    0.0000 C   0  0  1  0  0  0
    0.9625    7.3794    0.0000 C   0  0
   -0.3200    5.0300    0.0000 C   0  0
   -0.3617    3.5306    0.0000 O   0  0
   -1.5400    5.9700    0.0000 C   0  0  2  0  0  0
   -1.4832    7.4689    0.0000 C   0  0
   -2.8200    5.1300    0.0000 C   0  0  2  0  0  0
   -2.7875    3.6304    0.0000 O   0  0
   -4.2800    6.0000    0.0000 C   0  0  1  0  0  0
   -4.3125    7.4996    0.0000 C   0  0
   -5.5600    5.1600    0.0000 C   0  0
   -5.5300    3.5700    0.0000 C   0  0
   -6.6600    2.5200    0.0000 C   0  0
   -6.6800    0.9600    0.0000 C   0  0
   -5.3600    0.2000    0.0000 C   0  0
   -0.7700   -1.2500    0.0000 C   0  0  1  0  0  0
   -0.7368    0.2496    0.0000 C   0  0
  1  2  1  0
  3  2  1  6
  3  4  1  0
  4  5  1  0
  6  5  1  6
  6  7  1  0
  8  7  1  6
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  1
 11 13  1  0
 13 14  1  1
 14 15  1  0
 15 16  1  6
 15 17  1  0
 13 18  1  0
 18  8  1  0
  8 19  1  0
 19 20  1  1
 19 21  1  0
 21 22  1  6
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  2  3
 26 27  1  0
 27 28  1  6
 27 29  1  0
 29 30  1  1
 29 31  1  0
 31 32  1  1
 31 33  1  0
 33 34  2  0
 33 35  1  0
 35 36  1  6
 35 37  1  0
 37 38  1  6
 37 39  1  0
 39 40  1  6
 39 41  1  0
 41 42  2  0
 41 43  1  0
 43 44  1  1
 43 45  1  0
 45 46  1  6
 45 47  1  0
 47 48  1  6
 47 49  1  0
 49 50  1  0
 50 51  2  3
 51 52  1  0
 52 53  2  3
 53  3  1  0
 21 54  1  0
 54  6  1  0
 54 55  1  6
M  END
> <name>
NIHCC_2014

> <id>
5641

> <plate>
NGP-105-01

> <well>
B08

> <supplier_cmpd_name>
CPD000466392

> <ctcr_id>
1159

> <supplier_cmpd_id>
SAM001246769

> <smiles>
CC[C@H]1CC[C@H]2O[C@@]3(CC[C@@H](C)[C@@H](C[C@H](C)O)O3)[C@H](C)[C@@H](OC(=O)C=C[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@H](C)[C@H](O)[C@@H](C)CC=CC=C1)[C@H]2C

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{SMR000466392,MLS000759534,MLS001424131,CHEMBL1353042,HMS2051D15,ZINC263591727,CCG-100960,NC00210,Q27166336,SAM001246769,CPD000466392}

> <pdid>
PD007082

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{93857}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 24  0  0  0  0            999 V2000
    5.6396    6.0909    0.0000 C   0  0
    4.2776    5.4624    0.0000 C   0  0
    4.1398    3.9679    0.0000 O   0  0
    2.7771    3.3391    0.0000 C   0  0
    1.5521    4.2048    0.0000 O   0  0
    2.6395    1.8472    0.0000 C   0  0
    3.7691    0.8603    0.0000 N   0  0
    3.1796   -0.5190    0.0000 C   0  0
    1.6852   -0.3846    0.0000 N   0  0
    1.3514    1.0778    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 N   0  0
   -2.5242    2.0130    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -3.1476   -0.7184    0.0000 O   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
   -1.5000   -5.4558    0.0000 F   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10  6  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 20 21  1  0
 21 22  2  0
 22  9  1  0
 22 16  1  0
M  END
> <name>
NIHCC_2014

> <id>
5642

> <plate>
NGP-105-01

> <well>
B09

> <supplier_cmpd_name>
CPD000058450

> <ctcr_id>
1295

> <supplier_cmpd_id>
SAM001246763

> <smiles>
CCOC(=O)c1ncn2c1CN(C)C(=O)c3cc(F)ccc23

> <pd_targets>
{GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG3,GABRP,GABRQ,CYP2C19,GABBR1,ALDH1A1,KMT2A,MEN1,NFO,TSHR,CHRM1,CYP1A2,FFP,RORC}

> <pathway_gtopdb>
{"Ion channel",Enzyme,"Membrane receptor","Epigenetic regulator","Transcription factor","Ligand-gated ion channel","Cytochrome P450","Family C G protein-coupled receptor",Oxidoreductase,Reader,Hydrola
se,"Family A G protein-coupled receptor",Transferase,"Nuclear receptor","GABA-A receptor","Cytochrome P450 family 2","Small molecule receptor (family C GPCR)",Bromodomain,"Peptide receptor (family A G
PCR)","Small molecule receptor (family A GPCR)","Cytochrome P450 family 1","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 2C","Neurotransmitter receptor (family C GPCR)","Glycohormone 
receptor","Monoamine receptor","Cytochrome P450 family 1A","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 2C19","GABA-B receptor","Acetylcholine receptor","Cytochrome P450 1A1","Nucle
ar hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{"Ion channels",Enzymes,Receptors,"Ligand-gated ion channels","Cytochrome P450","G protein-coupled receptors","Nuclear hormone receptors","GABA<sub>A</sub> receptors","CYP2 family: drug metabolising s
ubset","GABA<sub>B</sub> receptors","Glycoprotein hormone receptors","Acetylcholine receptors (muscarinic)","CYP1 family","1F. Retinoic acid-related orphans"}

> <pathway_reactome>
{"Neuronal System",Metabolism,Disease,"Signal Transduction","Gene expression (Transcription)","Transmission across Chemical Synapses","Biological oxidations","Infectious disease","Signaling by GPCR","
RNA Polymerase II Transcription","Neurotransmitter receptors and postsynaptic signal transmission","Phase I - Functionalization of compounds","Leishmania infection","GPCR ligand binding","Generic Tran
scription Pathway","GABA receptor activation","Cytochrome P450 - arranged by substrate type","Ethanol oxidation","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Trans
criptional regulation by RUNX3",Xenobiotics,"GABA B receptor activation","Anti-inflammatory response favouring Leishmania parasite infection","Amine ligand-binding receptors","RUNX3 Regulates Immune R
esponse and Cell Migration","CYP2E1 reactions","Activation of GABAB receptors","ADORA2B mediated anti-inflammatory cytokines production","Muscarinic acetylcholine receptors","Aromatic amines can be N-
hydroxylated or N-dealkylated by CYP1A2","Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"}

> <broad_targets>
{GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG3,GABRP,GABRQ}

> <broad_moa>
{"benzodiazepine receptor antagonist"}

> <synonyms>
{flumazenil,78755-81-4,78755814,Anexate,Flumazepil,Romazicon,Lanexat,Mazicon,"Ro 15-1788","Ro 151788",fumazenil,"Flumazenilum (Latin)","Flumazenilo (Spanish)",Flumazenilo,Flumazenilum,(11C)flumazenil,
"Flumazenil (Ro 15-1788)","Flumazenil (Ro 151788)",Ro-15-1788,Ro151788,UNII-40P7XK9392,UNII40P7XK9392,CH,T1240,S1332,SAM001246763,1505701,Flumazenil,CPD000058450,FUMAZENIL}

> <pdid>
PD000330

> <targets>
{"GABA Receptor"}

> <classes>
{"benzodiazepine antagonist","Neuronal Signaling"}

> <pubchem_cids>
{3373}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 17  0  0  0  0            999 V2000
    6.3990   -1.2679    0.0000 Cl  0  0
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 Cl  0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0031   -3.0008    0.0000 N   0  0
    1.3039   -3.7494    0.0000 C   0  0
    1.4469   -5.2297    0.0000 N   0  0
    2.9152   -5.5365    0.0000 C   0  0
    3.6607   -4.2349    0.0000 C   0  0
    2.6532   -3.1236    0.0000 N   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 11  4  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  3
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 13  1  0
M  END
> <name>
NIHCC_2014

> <id>
5643

> <plate>
NGP-105-01

> <well>
B10

> <supplier_cmpd_name>
CPD000469209

> <ctcr_id>
840

> <supplier_cmpd_id>
SAM001246764

> <smiles>
Cl.COc1nc(C)nc(Cl)c1NC2=NCCN2

> <pd_targets>
{PMP22,TDP1,ALOX15,ADRA2C,LMNA,ADRA2B,ADRA2A,NISCH,CHRM1,HTR1A}

> <pathway_gtopdb>
{"Unclassified protein",Enzyme,"Membrane receptor","Other nuclear protein","Other cytosolic protein",Hydrolase,Oxidoreductase,"Family A G protein-coupled receptor","Small molecule receptor (family A G
PCR)","Monoamine receptor","Adrenergic receptor","Acetylcholine receptor","Serotonin receptor"}

> <pathway_chembl>
{Enzymes,Receptors,"Eicosanoid turnover","G protein-coupled receptors",Lipoxygenases,Adrenoceptors,"Acetylcholine receptors (muscarinic)","5-Hydroxytryptamine receptors"}

> <pathway_reactome>
{"Developmental Biology","DNA Repair",Metabolism,"Signal Transduction","Cell Cycle","Nervous system development","DNA Double-Strand Break Repair","Metabolism of lipids","Signaling by GPCR",Mitotic,"EG
R2 and SOX10-mediated initiation of Schwann cell myelination","Nonhomologous End-Joining (NHEJ)","Biosynthesis of specialized proresolving mediators (SPMs)","GPCR ligand binding","M Phase","Biosynthes
is of DPA-derived SPMs","Class A/1 (Rhodopsin-like receptors)","Mitotic Metaphase and Anaphase","Biosynthesis of DPAn-3 SPMs","Amine ligand-binding receptors","Mitotic Anaphase","Biosynthesis of DPAn-
3-derived protectins and resolvins",Adrenoceptors,"Nuclear Envelope (NE) Reassembly","Muscarinic acetylcholine receptors","Serotonin receptors","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ADRA2A,ADRA2B,ADRA2C}

> <broad_moa>
{"imidazoline receptor agonist"}

> <synonyms>
{"Moxonidine hydrochloride","MOXONIDINE HCl",75536-04-8,75536048,"75536 04 8","Moxonidine (hydrochloride)",UNII-5RYW07SK5E,UNII5RYW07SK5E,"UNII 5RYW07SK5E",5RYW07SK5E,BDF-5895,BDF5895,"BDF 5895",SR-01
000075981,SR01000075981,"SR 01000075981",C9H12ClN5O.HCl,EU-0100753,EU0100753,"EU 0100753",MLS001401450,SCHEMBL1321306,CHEMBL1256287,HY-B0374A,HYB0374A,"HY B0374A",T1028,SAM001246764,Moxonidine,CPD0004
69209}

> <pdid>
PD008988

> <targets>
{Imidazoline Receptor}

> <classes>
{GPCR/G Protein,Neuronal Signaling}

> <pubchem_cids>
{11231255}

$$$$
NIHCC_2014
  SciTegic11012413002D

 15 16  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5987    1.5004    0.0000 C   0  0  2  0  0  0
   -2.7390    2.9810    0.0000 C   0  0
   -4.2067    3.2905    0.0000 S   0  0
   -4.9546    1.9903    0.0000 C   0  0  2  0  0  0
   -6.4447    1.8344    0.0000 C   0  0
   -7.3266    3.0478    0.0000 O   0  0
   -3.9492    0.8772    0.0000 O   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  3
  8  2  1  0
  9  6  1  1
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  1
 13 14  1  0
 12 15  1  0
 15  9  1  0
M  END
> <name>
NIHCC_2014

> <id>
5644

> <plate>
NGP-105-01

> <well>
B11

> <supplier_cmpd_name>
CPD000466319

> <ctcr_id>
512

> <supplier_cmpd_id>
SAM001246582

> <smiles>
NC1=NC(=O)N(C=C1)[C@@H]2CS[C@H](CO)O2

> <pd_targets>
{POL,ALB,LMNA,MAPT,CACNA1C,CACNA1D,CACNA1F,CACNA1S,HSF1,P,POLA1,POLA2,POLD1,POLD2,POLD3,POLD4,POLE,POLE2,POLE3,PRIM1,PRIM2}

> <pathway_gtopdb>
{Enzyme,"Secreted protein","Other nuclear protein","Other cytosolic protein","Ion channel",Hydrolase,"Voltage-gated ion channel",Transferase,"Voltage-gated calcium channel"}

> <pathway_chembl>
{}

> <pathway_reactome>
{Metabolism,"Cell Cycle","Neuronal System","Cellular responses to external stimuli","Metabolism of lipids",Mitotic,"Transmission across Chemical Synapses","Cellular responses to stress","Metabolism of
 steroids","M Phase","Neurotransmitter receptors and postsynaptic signal transmission","Cellular response to heat stress","Bile acid and bile salt metabolism","Mitotic Metaphase and Anaphase","Activat
ion of NMDA receptors and postsynaptic events","HSF1-dependent transactivation","Recycling of bile acids and salts","Mitotic Anaphase","Post NMDA receptor activation events","Attenuation phase","Nucle
ar Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{}

> <broad_moa>
{"nucleoside reverse transcriptase inhibitor"}

> <synonyms>
{lamivudine,134678-17-4,134678174,Epivir,Zeffix,Heptovir,Epivir-HBV,EpivirHBV,Heptodin,3TC,BCH-189,BCH189,(-)-2'-Deoxy-3'-thiacytidine,()2'Deoxy3'thiacytidine,"2',3'-Dideoxy-3'-thiacytidine","2',3'Did
eoxy3'thiacytidine","3'-Thia-2',3'-dideoxycytidine","3'Thia2',3'dideoxycytidine",GR-109714X,GR109714X,(-)-BCH-189,()BCH189,"beta-L-2',3'-Dideoxy-3'-thiacytidine","betaL2',3'Dideoxy3'thiacytidine",beta
-L-3'-,betaL3',T0682,SAM002589994,SAM001246582,Prestw-1298,Lamivudine,CPD000466319}

> <pdid>
PD000853

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{60825}

$$$$
NIHCC_2014
  SciTegic11012413002D

 44 47  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 O   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
    0.0031    3.0008    0.0000 O   0  0
    1.3039    3.7494    0.0000 C   0  0  1  0  0  0
    1.3092    5.2494    0.0000 C   0  0  2  0  0  0
    0.0127    6.0039    0.0000 O   0  0
    2.6108    5.9949    0.0000 C   0  0  1  0  0  0
    2.6160    7.4949    0.0000 O   0  0
    3.9072    5.2405    0.0000 C   0  0  2  0  0  0
    3.9020    3.7405    0.0000 O   0  0
    2.6004    2.9949    0.0000 C   0  0  2  0  0  0
    2.5984    1.4941    0.0000 C   0  0
    3.8959    0.7415    0.0000 O   0  0
    5.2080    5.9891    0.0000 O   0  0
    6.5072    5.2376    0.0000 C   0  0  1  0  0  0
    7.8084    5.9839    0.0000 C   0  0  2  0  0  0
    7.8127    7.4839    0.0000 O   0  0
    9.1053    5.2303    0.0000 C   0  0  1  0  0  0
   10.4065    5.9767    0.0000 O   0  0
    9.1011    3.7303    0.0000 C   0  0
   10.3981    2.9767    0.0000 O   0  0
    7.8000    2.9840    0.0000 O   0  0
    6.5031    3.7376    0.0000 C   0  0  2  0  0  0
    5.2028    2.9881    0.0000 C   0  0
    5.2008    1.4881    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0  2  0  0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -0.0031   -3.0008    0.0000 N   0  0
   -1.3039   -3.7494    0.0000 C   0  0  1  0  0  0
   -2.6004   -2.9949    0.0000 C   0  0
   -3.9021   -3.7405    0.0000 C   0  0
   -5.1977   -2.9829    0.0000 C   0  0
   -5.1903   -1.4829    0.0000 O   0  0
   -3.9072   -5.2404    0.0000 C   0  0  1  0  0  0
   -5.2088   -5.9860    0.0000 O   0  0
   -2.6108   -5.9949    0.0000 C   0  0  2  0  0  0
   -2.6160   -7.4949    0.0000 O   0  0
   -1.3092   -5.2494    0.0000 C   0  0  1  0  0  0
   -0.0127   -6.0039    0.0000 O   0  0
  2  1  1  6
  2  3  1  0
  3  4  1  0
  4  5  1  1
  6  5  1  1
  6  7  1  0
  7  8  1  6
  7  9  1  0
  9 10  1  1
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13  6  1  0
 13 14  1  6
 14 15  1  0
 11 16  1  1
 17 16  1  1
 17 18  1  0
 18 19  1  6
 18 20  1  0
 20 21  1  1
 20 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 25 17  1  0
 25 26  1  6
 26 27  1  0
  4 28  1  0
 28 29  1  1
 28 30  1  0
 30 31  1  6
 30 32  1  0
 32  2  1  0
 32 33  1  1
 34 33  1  6
 34 35  1  0
 35 36  2  3
 36 37  1  0
 37 38  1  0
 36 39  1  0
 39 40  1  6
 39 41  1  0
 41 42  1  1
 41 43  1  0
 43 34  1  0
 43 44  1  6
M  END
> <name>
NIHCC_2014

> <id>
5645

> <plate>
NGP-105-01

> <well>
C02

> <supplier_cmpd_name>
CPD000466376

> <ctcr_id>
1836

> <supplier_cmpd_id>
SAM001246733

> <smiles>
C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O[C@@H]2CO)O[C@H]3[C@H](O)[C@@H](O)C(O)O[C@@H]3CO)[C@H](O)[C@@H](O)[C@@H]1N[C@H]4C=C(CO)[C@@H](O)[C@H](O)[C@H]4O

> <pd_targets>
{IMA1,AMY2,SI,GAA,MGAM,MGAM2,CWH41,MAL12,AMY1A,ALDH1A1}

> <pathway_gtopdb>
{Enzyme,Hydrolase,Oxidoreductase}

> <pathway_chembl>
{Enzymes,"3.2.1.- Glycosidases"}

> <pathway_reactome>
{"Digestion and absorption",Disease,Metabolism,Digestion,"Diseases of metabolism","Biological oxidations","Digestion of dietary carbohydrate","Diseases of carbohydrate metabolism","Phase I - Functiona
lization of compounds","Intestinal saccharidase deficiencies","Glycogen storage diseases","Ethanol oxidation","Glycogen storage disease type II (GAA)"}

> <broad_targets>
{AMY2A,MGAM}

> <broad_moa>
{"glucosidase inhibitor"}

> <synonyms>
{56180-94-0,56180940,Glucobay,Precose,Acarbosum,Prandase,CHEBI:2376,MFCD00869592,"BAY-g 5421","BAYg 5421",C25H43NO18,SMR000466376,SR-01000759407,SR01000759407,Acarbose/,Glucobay;,Prandase;,Precose;,"A
carbose,(S)","Precose (TN)","Acarbose (JAN/USAN/INN)",MLS000759506,MLS001,SAM001246733,1505172,CPD000466376,ACARBOSE}

> <pdid>
PD000582

> <targets>
{}

> <classes>
{antidiabetes,antiobesity,antihyperlipidaemia,"alpha-glucosidase & saccharase inhibitor"}

> <pubchem_cids>
{41774}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 25  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -5.2029    2.9932    0.0000 O   0  0
   -6.4990    0.7409    0.0000 N   0  0
   -7.8003    1.4887    0.0000 C   0  0
   -7.8004    2.9887    0.0000 C   0  0
   -9.0995    3.7387    0.0000 C   0  0
  -10.3985    2.9886    0.0000 C   0  0
  -10.3984    1.4886    0.0000 C   0  0
   -9.0994    0.7387    0.0000 C   0  0
   -9.1025   -0.7622    0.0000 C   0  0
   -7.8048   -1.5144    0.0000 O   0  0
  -10.4026   -1.5103    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3032   -3.7490    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
  6 21  1  0
 21 22  2  0
 22  3  1  0
 22 23  1  0
 23 24  1  0
M  END
> <name>
NIHCC_2014

> <id>
5646

> <plate>
NGP-105-01

> <well>
C03

> <supplier_cmpd_name>
CPD000058373

> <ctcr_id>
4380

> <supplier_cmpd_id>
SAM001246737

> <smiles>
COc1ccc(/C=C/C(=O)Nc2ccccc2C(O)=O)cc1OC

> <pd_targets>
{HPGDS,KDM4E,RAB9A,RORC,PKM,NPC1,TP53,PYK,HIF1A,MAPK1,NFKB1,ALOX12,APEX1,THPO,NPSR1,KMT2A,MEN1,CYP3A4,ALDH1A1,NS1,HPGD,CHRM1,PMP22,ABCC4,ABCB11}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Transcription factor",Transporter,"Other cytosolic protein","Unclassified protein","Membrane receptor",Transferase,Eraser,Hydrolase,"Nuclear receptor",Kinase,"Family A 
G protein-coupled receptor",Reader,"Cytochrome P450",Oxidoreductase,"Primary active transporter","Lysine demethylase","Nuclear hormone receptor subfamily 1","Protein Kinase","Peptide receptor (family 
A GPCR)",Bromodomain,"Cytochrome P450 family 3","Small molecule receptor (family A GPCR)","ATP-binding cassette","Jumonji domain-containing","Nuclear hormone receptor subfamily 1 group F","CMGC protei
n kinase group","Short peptide receptor (family A GPCR)","Cytochrome P450 family 3A","Monoamine receptor","ABCC subfamily","ABCB subfamily","Nuclear hormone receptor subfamily 1 group F member 3","CMG
C protein kinase MAPK family","Neuropeptide receptor","Cytochrome P450 3A4","Acetylcholine receptor","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Eicosanoid turnover","Chromatin modifying enzymes","Nuclear hormone receptors","2.7.1.40 Pyruvate kinases","SLC superfamily of solute carriers","Kinases (EC 2.7.x.x)",
"G protein-coupled receptors","Cytochrome P450","ATP-binding cassette transporter family","Prostaglandin synthases","1.14.11.- Histone demethylases","1F. Retinoic acid-related orphans","SLC65 NPC-type
 cholesterol transporters","CMGC: Containing CDK",MAPK,GSK3,"CLK families",Lipoxygenases,"Neuropeptide S receptor","2.1.1.43 Histone methyltransferases (HMTs)","CYP3 family","Acetylcholine receptors (
muscarinic)","ABCC subfamily","ABCB subfamily","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{Metabolism,"Signal Transduction","Gene expression (Transcription)","Transport of small molecules","Cell Cycle","Cellular responses to external stimuli","Immune System","DNA Repair",Hemostasis,Disease
,"Developmental Biology","Metabolism of lipids","Signaling by Rho GTPases","RNA Polymerase II Transcription","Metabolism of carbohydrates","Plasma lipoprotein assembly",remodeling,"and clearance","Cel
l Cycle Checkpoints","Cellular responses to stress","Innate Immune System","Cytokine Signaling in Immune system","Base Excision Repair","Platelet activation","signaling and aggregation","Infectious di
sease","Biological oxidations","Signaling by GPCR","Nervous system development","Fatty acid metabolism","Rho GTPase cycle","Generic Transcription Pathway","Glucose metabolism","Plasma lipoprotein clea
rance","G1/S DNA Damage Checkpoints","Cellular response to hypoxia","Toll-like Receptor Cascades","Signaling by Interleukins","Biosynthesis of specialized proresolving mediators (SPMs)","Resolution of
 Abasic Sites (AP sites)","Platelet Aggregation (Plug Formation)","Leishmania infection","Phase I - Functionalization of compounds","GPCR ligand binding","EGR2 and SOX10-mediated initiation of Schwann
 cell myelination","Response to elevated platelet cytosolic Ca2+","Metabolism of steroids","Arachidonic acid metabolism","RHOBTB GTPase Cycle","Transcriptional regulation by RUNX3",Glycolysis,"LDL cle
arance","p53-Dependent G1/S DNA damage checkpoint","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Toll Like Receptor 5 (TLR5) Cascade","Interleukin-1 family signaling","Bi
osynthesis of DPA-derived SPMs","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Leishmania parasite growth and survival","Transcriptional regulation by RUNX1","Biosynth
esis of DHA-derived SPMs","Ethanol oxidation","Class A/1 (Rhodopsin-like receptors)","Platelet degranulation","Bile acid and bile salt metabolism","Synthesis of Prostaglandins (PG) and Thromboxanes (T
X)","RHOBTB3 ATPase cycle","RUNX3 Regulates Immune Response and Cell Migration","p53-Dependent G1 DNA Damage Response","MyD88 cascade initiated on plasma membrane","Interleukin-1 signaling","Biosynthe
sis of DPAn-3 SPMs","PCNA-Dependent Long Patch Base Excision Repair","Anti-inflammatory response favouring Leishmania parasite infection","RUNX1 regulates genes involved in megakaryocyte differentiati
on and platelet function","Biosynthesis of maresins","Biosynthesis of D-series resolvins","Amine ligand-binding receptors","Synthesis of bile acids and bile salts","Stabilization of p53","MAP kinase a
ctivation","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Biosynthesis of DPAn-3-derived maresins","ADORA2B mediated anti-inflammatory cytokines production","Biosynthesis of maresin-like SPMs","Muscari
nic acetylcholine receptors","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Autodegradation of the E3 ubiquitin ligase COP1","MAPK targets/ Nuclear events mediated by MAP kina
ses","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{HPGDS,HRH1}

> <broad_moa>
{"angiogenesis inhibitor"}

> <synonyms>
{RESTW119,NCGC00018185-05,NCGC0001818505,SMR000058373,"2-((3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl)amino)benzoic Acid","2((3(3,4Dimethoxyphenyl)1oxo2propenyl)amino)benzoic Acid",tranilast,53902-12-8,
53902128,Rizaben,trans-Tranilast,transTranilast,Tranilastum,70806-55-2,70806552,"MK 341","N-(3,4-Dimethoxycinnamoyl)anthranilic acid","N(3,4Dimethoxycinnamoyl)anthranilic acid",UNII-HVF50SMY6E,UNIIHVF
50SMY6E,SB-252218,SB252218,T2270,T2690,SAM001246737,Prestw-1198,Trans-Tranilast,Tranilast,CPD000058373}

> <pdid>
PD000929

> <targets>
{Angiotensin Receptor,Prostaglandin Receptor}

> <classes>
{GPCR/G Protein}

> <pubchem_cids>
{5282230}

$$$$
NIHCC_2014
  SciTegic11012413002D

 16 15  0  0  1  0            999 V2000
    8.8933   -1.8789    0.0000 Cl  0  5
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 N   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -5.1065    0.0000    0.0000 N   0  0
   -2.7248   -1.2135    0.0000 S   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    6.3933   -1.8789    0.0000 H   0  3
  2  3  1  0
  3  4  1  0
  4  5  1  0
  6  5  1  6
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14  9  2  0
 14 15  1  0
 15  6  1  0
M  CHG  2   1  -1  16   1
M  END
> <name>
NIHCC_2014

> <id>
5647

> <plate>
NGP-105-01

> <well>
C04

> <supplier_cmpd_name>
CPD000469142

> <ctcr_id>
6145

> <supplier_cmpd_id>
SAM001246540

> <smiles>
[Cl-].CCCN[C@H]1CCc2nc(N)sc2C1.[H+]

> <pd_targets>
{DRD3,DRD2,SIGMAR1,DRD4,DRD1,DRD5,HTR1A,ADRA2A,HTR2A,HTR7,ADRA2C,HRH2,ADRB2,HTR1B,ADRA2B}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Dopamine receptor","Serotonin receptor","Adrenergic receptor","Histamine rece
ptor"}

> <pathway_chembl>
{Receptors,"Other protein targets","G protein-coupled receptors","Sigma receptors","Dopamine receptors","5-Hydroxytryptamine receptors",Adrenoceptors,"Histamine receptors"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Signaling by GPCR","Infectious disease","GPCR ligand binding","SARS-CoV Infections","Leishmania infection","Class A/1 (Rhodopsin-like receptors)","Potential therapeutic
s for SARS","Leishmania parasite growth and survival","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Dopamine receptors","Serotonin receptors",A
drenoceptors,"ADORA2B mediated anti-inflammatory cytokines production"}

> <broad_targets>
{ADRA2A,ADRA2B,ADRA2C,DRD1,DRD2,DRD3,DRD4,DRD5,HTR1A,HTR1B,HTR1D,HTR2A,HTR2B,HTR2C}

> <broad_moa>
{"dopamine receptor agonist"}

> <synonyms>
{"PRAMIPEXOLE HCl",SND-919CL2Y,SND919CL2Y,pramipexole-hcl,pramipexolehcl,MLS001401423,SCHEMBL408536,CHEMBL542257,Pharmakon1600-01504202,Pharmakon160001504202,NSC760426,CCG-100929,CCG100929,GS-3187,GS3
187,NC00179,NSC-760426,SMR000469142,SAM001246540,CPD000469142}

> <pdid>
PD002907

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{9964861}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 30  0  0  1  0            999 V2000
   -0.8503   -8.0380    0.0000 C   0  0
   -1.2977   -6.6063    0.0000 C   0  0
   -2.7614   -6.2783    0.0000 C   0  0
   -2.3137   -7.7098    0.0000 C   0  0
   -0.2816   -5.5018    0.0000 N   0  0
   -0.7292   -4.0692    0.0000 C   0  0
   -2.1929   -3.7413    0.0000 O   0  0
    0.2851   -2.9666    0.0000 C   0  0  1  0  0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0  1  0  0  0
    1.2990    5.2500    0.0000 N   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -1.2991    2.2500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -1.2212   -2.3711    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  2  0
  8  6  1  6
  8  9  1  0
  9 10  1  0
 11 10  1  6
 11 12  1  0
 12 13  1  1
 13 14  1  0
 15 14  1  6
 15 16  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  2  3
 20 21  1  0
 21 15  1  0
 21 22  1  6
 21 23  1  0
 23 12  1  0
 23 24  1  6
 24 25  1  0
 25 26  1  0
 26  8  1  0
 26 11  1  0
 26 27  1  6
M  END
> <name>
NIHCC_2014

> <id>
5648

> <plate>
NGP-105-01

> <well>
C05

> <supplier_cmpd_name>
CPD000466304

> <ctcr_id>
3638

> <supplier_cmpd_id>
SAM001246541

> <smiles>
CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C

> <pd_targets>
{SRD5A2,CYP3A4,SRD5A1,HSD3B1,NFKB1,MAPK1,THPO,BLM,LMNA,ABCB11,RORC,ABCC4,CYP2C19,CYP2C9,AKR1D1}

> <pathway_gtopdb>
{Enzyme,"Other cytosolic protein","Unclassified protein","Other nuclear protein",Transporter,"Transcription factor",Oxidoreductase,"Cytochrome P450",Kinase,"Primary active transporter","Nuclear recept
or","Cytochrome P450 family 3","Protein Kinase","ATP-binding cassette","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 2","Cytochrome P450 family 3A","CMGC protein kinase group","ABCB s
ubfamily","Nuclear hormone receptor subfamily 1 group F","ABCC subfamily","Cytochrome P450 family 2C","Cytochrome P450 3A4","CMGC protein kinase MAPK family","Nuclear hormone receptor subfamily 1 grou
p F member 3","Cytochrome P450 2C19","Cytochrome P450 2C9","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Transporters,Receptors,"1.-.-.- Oxidoreductases","Cytochrome P450","Kinases (EC 2.7.x.x)","ATP-binding cassette transporter family","Nuclear hormone receptors","CYP3 family","CMGC: Containing
 CDK",MAPK,GSK3,"CLK families","ABCB subfamily","1F. Retinoic acid-related orphans","ABCC subfamily","CYP2 family: drug metabolising subset","Mitogen-activated protein kinases (MAP kinases)","ERK subf
amily"}

> <pathway_reactome>
{Metabolism,"Immune System",Hemostasis,"DNA Repair","Cell Cycle","Gene expression (Transcription)","Metabolism of lipids","Cytokine Signaling in Immune system","Innate Immune System","Platelet activat
ion","signaling and aggregation","DNA Double-Strand Break Repair",Mitotic,"RNA Polymerase II Transcription","Biological oxidations","Metabolism of steroids","Biosynthesis of specialized proresolving m
ediators (SPMs)","Signaling by Interleukins","Toll-like Receptor Cascades","Platelet Aggregation (Plug Formation)","Homology Directed Repair","M Phase","Generic Transcription Pathway","Response to ele
vated platelet cytosolic Ca2+","Phase I - Functionalization of compounds","Metabolism of steroid hormones","Biosynthesis of DHA-derived SPMs","Interleukin-1 family signaling","Toll Like Receptor 5 (TL
R5) Cascade","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Mitotic Metaphase and Anaphase","Bile acid and bile salt metabolism","Transcriptional regulation by RUNX3","
Platelet degranulation","Cytochrome P450 - arranged by substrate type","Androgen biosynthesis","Biosynthesis of maresins","Interleukin-1 signaling","MyD88 cascade initiated on plasma membrane","HDR th
rough Homologous Recombination (HRR)","Mitotic Anaphase","Synthesis of bile acids and bile salts","RUNX3 Regulates Immune Response and Cell Migration",Xenobiotics,"Biosynthesis of maresin-like SPMs","
MAP3K8 (TPL2)-dependent MAPK1/3 activation","MAP kinase activation","Homologous DNA Pairing and Strand Exchange","Nuclear Envelope (NE) Reassembly","Synthesis of bile acids and bile salts via 7alpha-h
ydroxycholesterol","CYP2E1 reactions","Synthesis of bile acids and bile salts via 24-hydroxycholesterol","MAPK targets/ Nuclear events mediated by MAP kinases","Presynaptic phase of homologous DNA pai
ring and strand exchange","Initiation of Nuclear Envelope (NE) Reformation","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{AKR1D1,SRD5A1,SRD5A2}

> <broad_moa>
{"5 alpha reductase inhibitor"}

> <synonyms>
{RESTW71,finasteride,98319-26-7,98319267,Proscar,Propecia,Finastid,Prostide,Chibro-Proscar,ChibroProscar,MK-906,MK906,Finpecia,Finasterida,Finasteridum,"MK 906",UNII-57GNO57U7G,UNII57GNO57U7G,"(5alpha
,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide","(5alpha,17beta)(1,1Dimethylethyl)3oxo4azaandrost1ene17carboxamide",CHEMBL710,N-tert-Butyl-3-ox,NtertButyl3ox,T0488,SAM001246541,P
restw-717,Finasteride,CPD000466304}

> <pdid>
PD000208

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{57363}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 24  0  0  1  0            999 V2000
    1.5024   -3.3100    0.0000 C   0  0
    1.5000   -1.8100    0.0000 C   0  0
    2.8300   -1.0300    0.0000 C   0  0
    4.1600   -1.8100    0.0000 C   0  0
    5.5000   -1.0300    0.0000 C   0  0
    5.5000    0.5000    0.0000 C   0  0  2  0  0  0
    6.7983    1.2513    0.0000 O   0  0
    4.1600    1.2700    0.0000 C   0  0
    2.8300    0.5000    0.0000 C   0  0
    1.5000    1.2700    0.0000 C   0  0
    0.1600    0.5000    0.0000 C   0  0
   -1.1200    1.2700    0.0000 C   0  0
   -2.4800    0.5000    0.0000 C   0  0
   -3.8100    1.2700    0.0000 C   0  0
   -5.1500    0.5000    0.0000 C   0  0
   -6.4483    1.2513    0.0000 O   0  0
   -5.1500   -1.0300    0.0000 C   0  0
   -3.8100   -1.8100    0.0000 C   0  0
   -3.8076   -3.3100    0.0000 O   0  0
   -2.4800   -1.0300    0.0000 C   0  0
   -1.1200   -1.8100    0.0000 C   0  0
   -1.1001   -3.3099    0.0000 O   0  0
    0.1600   -1.0300    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  1
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 20 13  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23  2  1  0
M  END
> <name>
NIHCC_2014

> <id>
5649

> <plate>
NGP-105-01

> <well>
C06

> <supplier_cmpd_name>
CPD000058866

> <ctcr_id>
1235

> <supplier_cmpd_id>
SAM001246609

> <smiles>
CC1CCC[C@H](O)CCCCCc2cc(O)cc(O)c2C(=O)O1

> <pd_targets>
{RORC,LMNA,MAPT,HSP90AA1,HSP90AB1,ALDH1A1,POLB,NR1I2,ESR2,CYP3A4,AR}

> <pathway_gtopdb>
{"Transcription factor","Other nuclear protein","Nuclear receptor","Nuclear hormone receptor subfamily 1","Nuclear hormone receptor subfamily 1 group F","Nuclear hormone receptor subfamily 1 group F m
ember 3","Other cytosolic protein",Enzyme,Oxidoreductase,"Cytochrome P450","Nuclear hormone receptor subfamily 3","Cytochrome P450 family 3","Nuclear hormone receptor subfamily 1 group I","Nuclear hor
mone receptor subfamily 3 group A","Cytochrome P450 family 3A","Nuclear hormone receptor subfamily 1 group I member 2","Nuclear hormone receptor subfamily 3 group A member 2","Cytochrome P450 3A4","Nu
clear hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 3 group C member 4"}

> <pathway_chembl>
{Receptors,"Nuclear hormone receptors","1F. Retinoic acid-related orphans","Other protein targets",Enzymes,"Heat shock proteins","Cytochrome P450","1I. Vitamin D receptor-like receptors","Steroid horm
one receptors","CYP3 family","3A. Estrogen receptors","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"Gene expression (Transcription)","Cell Cycle","RNA Polymerase II Transcription",Mitotic,"Generic Transcription Pathway","M Phase","Transcriptional regulation by RUNX3","Mitotic Metaphase and Anaphas
e","RUNX3 Regulates Immune Response and Cell Migration","Mitotic Anaphase","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation","Neuronal System",Metabolism,"DNA Repair
","Metabolism of proteins","Signal Transduction","Transmission across Chemical Synapses","Biological oxidations","Base Excision Repair","Post-translational protein modification","Intracellular signali
ng by second messengers","Metabolism of lipids","Neurotransmitter receptors and postsynaptic signal transmission","Phase I - Functionalization of compounds","Resolution of Abasic Sites (AP sites)",SUM
Oylation,"Mitotic G2-G2/M phases","PIP3 activates AKT signaling","Biosynthesis of specialized proresolving mediators (SPMs)","Activation of NMDA receptors and postsynaptic events","Ethanol oxidation",
"Resolution of AP sites via the multiple-nucleotide patch replacement pathway","SUMO E3 ligases SUMOylate target proteins","G2/M Transition","Negative regulation of the PI3K/AKT network","Biosynthesis
 of DHA-derived SPMs","Post NMDA receptor activation events","PCNA-Dependent Long Patch Base Excision Repair","SUMOylation of intracellular receptors","Centrosome maturation",PI5P,"PP2A and IER3 Regul
ate PI3K/AKT Signaling","Biosynthesis of maresins","Activation of AMPK downstream of NMDARs","Loss of proteins required for interphase microtubule organization from the centrosome","Biosynthesis of ma
resin-like SPMs","Loss of Nlp from mitotic centrosomes","Transcriptional regulation by RUNX2","RUNX2 regulates bone development","RUNX2 regulates osteoblast differentiation"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{SMR000058866,CPD000058866,Opera_ID_793,MLS000759436,MLS001424094,CHEMBL1399925,SCHEMBL10773090,CHEBI:94349,HMS2051F11,HMS2232H04,CCG-100945,NC00195,AB00572589-12,Q27166180,SAM001246609}

> <pdid>
PD002944

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{216284}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 24  0  0  0  0            999 V2000
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 N   0  0
   -6.4952    0.7500    0.0000 C   0  0
   -7.7942    1.4999    0.0000 N   0  0
   -6.4952   -0.7500    0.0000 C   0  0
   -5.1961   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -7.7934   -1.5031    0.0000 C   0  0
   -9.0937   -0.7554    0.0000 O   0  0
   -7.7912   -3.0031    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 13 14  1  0
 14 15  2  0
 15  9  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18  7  1  0
 18 19  2  0
 19  4  1  0
 13 20  1  0
 20 21  1  0
 20 22  2  0
M  END
> <name>
NIHCC_2014

> <id>
5650

> <plate>
NGP-105-01

> <well>
C07

> <supplier_cmpd_name>
CPD000466352

> <ctcr_id>
533

> <supplier_cmpd_id>
SAM001246669

> <smiles>
CC(C)c1ccc2Oc3nc(N)c(cc3C(=O)c2c1)C(O)=O

> <pd_targets>
{KDM4E,PYK,RORC,TBK1,IKBKE,GAA,PKM,RAB9A,ALD,NPC1,GPR35,ABCC4,PDE4A,PDE4B,PDE4C,PDE4D,S100A12,S100A13,IL3,FGF1}

> <pathway_gtopdb>
{"Epigenetic regulator",Enzyme,"Transcription factor",Transporter,"Membrane receptor","Secreted protein",Eraser,Transferase,"Nuclear receptor",Kinase,Hydrolase,"Family A G protein-coupled receptor","P
rimary active transporter",Phosphodiesterase,"Lysine demethylase","Nuclear hormone receptor subfamily 1","Protein Kinase","Small molecule receptor (family A GPCR)","ATP-binding cassette","Phosphodiest
erase 4","Jumonji domain-containing","Nuclear hormone receptor subfamily 1 group F","Other protein kinase group","Carboxylic acid receptor","ABCC subfamily","Phosphodiesterase 4A","Nuclear hormone rec
eptor subfamily 1 group F member 3","Other protein kinase IKK family","Kynurenic acid receptor"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Chromatin modifying enzymes","Nuclear hormone receptors","Catalytic receptors","3.2.1.- Glycosidases","2.7.1.40 Pyruvate kinases","SLC superfamily of solute carriers",
"G protein-coupled receptors","ATP-binding cassette transporter family","1.14.11.- Histone demethylases","1F. Retinoic acid-related orphans","Receptor kinases","SLC65 NPC-type cholesterol transporters
","Orphan and other 7TM receptors","ABCC subfamily","Other protein kinases","Class A Orphans","IKK family"}

> <pathway_reactome>
{"Gene expression (Transcription)","Immune System",Disease,Metabolism,"Signal Transduction","Transport of small molecules",Hemostasis,"RNA Polymerase II Transcription","Innate Immune System","Diseases
 of metabolism","Metabolism of carbohydrates","Signaling by Rho GTPases","Plasma lipoprotein assembly",remodeling,"and clearance","Signaling by GPCR","Platelet activation","signaling and aggregation",
"Diseases of signal transduction by growth factor receptors and second messengers","Generic Transcription Pathway","Toll-like Receptor Cascades","Diseases of carbohydrate metabolism","Glucose metaboli
sm","Rho GTPase cycle","Plasma lipoprotein clearance","GPCR ligand binding","Response to elevated platelet cytosolic Ca2+","Signaling by FGFR in disease","Transcriptional regulation by RUNX3","Toll Li
ke Receptor 4 (TLR4) Cascade","Glycogen storage diseases",Glycolysis,"RHOBTB GTPase Cycle","LDL clearance","Class A/1 (Rhodopsin-like receptors)","Platelet degranulation","Toll Like Receptor 5 (TLR5) 
Cascade","Transcriptional regulation by RUNX1","Signaling by FGFR3 in disease","RUNX3 Regulates Immune Response and Cell Migration","MyD88-independent TLR4 cascade","Glycogen storage disease type II (
GAA)","RHOBTB3 ATPase cycle","MyD88 cascade initiated on plasma membrane","RUNX1 regulates transcription of genes involved in interleukin signaling","Signaling by FGFR3 point mutants in cancer","TRIF(
TICAM1)-mediated TLR4 signaling","TAK1 activates NFkB by phosphorylation and activation of IKKs complex","FGFR3 mutant receptor activation","Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon","Sign
aling by activated point mutants of FGFR3"}

> <broad_targets>
{FGF1,IL3,PDE4A,PDE4B,PDE4C,PDE4D,S100A12,S100A13}

> <broad_moa>
{"histamine receptor modulator"}

> <synonyms>
{amlexanox,68302-57-8,68302578,Amoxanox,Aphthasol,"2-Amino-7-isopropyl-5-oxo-5H-chromeno(2,3-b)pyridine-3-carboxylic acid","2Amino7isopropyl5oxo5Hchromeno(2,3b)pyridine3carboxylic acid",Amlenanox,"Aml
exanoxum (Latin)",AA-673,AA673,"Amlexanoxo (Spanish)",Amlexanoxo,Amlexanoxum,"CHX 3673","AA 673",CHX-3673,CHX3673,UNII-BRL1C2459K,UNIIBRL1C2459K,2,T1639,SAM001246669,Amlexanox,CPD000466352}

> <pdid>
PD001296

> <targets>
{"Immunology & Inflammation related",IKK}

> <classes>
{NF-ºB}

> <pubchem_cids>
{2161}

$$$$
NIHCC_2014
  SciTegic11012413002D

 33 33  0  0  1  0            999 V2000
   16.0422   -0.7979    0.0000 Cl  0  5
    0.3470    3.9090    0.0000 C   0  0
    1.8104    3.5799    0.0000 C   0  0
    2.2582    2.1474    0.0000 O   0  0
    3.7225    1.8180    0.0000 C   0  0
    4.7389    2.9212    0.0000 O   0  0
    4.1703    0.3856    0.0000 C   0  0  2  0  0  0
    5.6342    0.0546    0.0000 C   0  0
    6.6534    1.1562    0.0000 C   0  0
    8.1173    0.8252    0.0000 C   0  0
    9.1376    1.9248    0.0000 C   0  0
   10.6000    1.5910    0.0000 C   0  0
   11.0422    0.1577    0.0000 C   0  0
   10.0219   -0.9419    0.0000 C   0  0
    8.5595   -0.6081    0.0000 C   0  0
    3.1510   -0.7161    0.0000 N   0  0
    1.6852   -0.3846    0.0000 C   0  0  1  0  0  0
    1.3514    1.0778    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -2.4523    2.0983    0.0000 C   0  0
   -3.8856    1.6561    0.0000 C   0  0
   -4.2194    0.1937    0.0000 C   0  0
   -3.1198   -0.8265    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 N   0  0
   -1.3993   -2.9127    0.0000 C   0  0
   -0.5521   -4.1515    0.0000 C   0  0
    0.9435   -4.0368    0.0000 O   0  0
   -1.2001   -5.5043    0.0000 O   0  0
    0.7500   -1.5574    0.0000 C   0  0
    1.4008   -2.9088    0.0000 O   0  0
   13.5422   -0.7979    0.0000 H   0  3
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  6
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  7 16  1  0
 17 16  1  6
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 28 30  2  0
 26 31  1  0
 31 17  1  0
 31 32  2  0
M  CHG  2   1  -1  33   1
M  END
> <name>
NIHCC_2014

> <id>
5651

> <plate>
NGP-105-01

> <well>
C08

> <supplier_cmpd_name>
CPD000469199

> <ctcr_id>
1108

> <supplier_cmpd_id>
SAM001246712

> <smiles>
[Cl-].CCOC(=O)[C@H](CCc1ccccc1)N[C@H]2CCc3ccccc3N(CC(O)=O)C2=O.[H+]

> <pd_targets>
{ACE,ABCB11}

> <pathway_gtopdb>
{Enzyme,Transporter,Protease,"Primary active transporter","Metallo protease","ATP-binding cassette","Metallo protease MAE clan","ABCB subfamily","Metallo protease M2 family"}

> <pathway_chembl>
{Enzymes,Transporters,"Peptidases and proteinases","ATP-binding cassette transporter family","MA: Metallo (M) Peptidases","ABCB subfamily","M2: Angiotensin-converting  (ACE and ACE2)"}

> <pathway_reactome>
{"Metabolism of proteins",Metabolism,"Peptide hormone metabolism","Metabolism of lipids","Metabolism of Angiotensinogen to Angiotensins","Metabolism of steroids","Bile acid and bile salt metabolism","
Synthesis of bile acids and bile salts","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"}

> <broad_targets>
{ACE}

> <broad_moa>
{"angiotensin converting enzyme inhibitor"}

> <synonyms>
{"BENAZEPRIL HYDROCHLORIDE",86541-74-4,86541744,"Benazepril HCl",Lotensin,Cibacen,Cibacene,Briem,Tensanil,Zinadril,Cibace,Labopol,"CGS 14824A HCl","Benazepril (hydrochloride)",UNII-N1SN99T69T,UNIIN1SN
99T69T,"CGS 14824A",MFCD00895734,C24H29ClN2O5,CHEBI:3012,N1SN99,T0180,SAM001246712,1505200,Prestw-1129,"Benazepril hydrochloride",CPD000469199}

> <pdid>
PD006990

> <targets>
{}

> <classes>
{antihypertensive,"ACE inhibitor"}

> <pubchem_cids>
{5362123,67107870}

$$$$
NIHCC_2014
  SciTegic11012413002D

 18 18  0  0  0  0            999 V2000
    7.6943   -1.8789    0.0000 Cl  0  0
    5.1937   -3.0093    0.0000 O   0  0
    3.8933   -3.7570    0.0000 C   0  0
    3.8912   -5.2570    0.0000 O   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 N   0  0
   -5.2526    1.3618    0.0000 C   0  0
   -6.2524    0.2436    0.0000 C   0  0
   -5.4979   -1.0529    0.0000 N   0  0
   -4.0317   -0.7359    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 12  1  0
 10 17  1  0
 17 18  2  0
 18  7  1  0
M  END
> <name>
NIHCC_2014

> <id>
5652

> <plate>
NGP-105-01

> <well>
C09

> <supplier_cmpd_name>
CPD000469164

> <ctcr_id>
1846

> <supplier_cmpd_id>
SAM001246593

> <smiles>
Cl.OC(=O)/C=C/c1ccc(Cn2ccnc2)cc1

> <pd_targets>
{CFTR,TBXAS1,CYP1A2,CYP2D6,CYP3A4,CYP2C19,KMT2A,MEN1,FFP}

> <pathway_gtopdb>
{"Ion channel",Enzyme,"Epigenetic regulator","Other ion channel","Cytochrome P450",Reader,Transferase,"Chloride channel","Cytochrome P450 family 5","Cytochrome P450 family 1","Cytochrome P450 family 2
","Cytochrome P450 family 3",Bromodomain,"Cystic fibrosis transmembrane conductance regulator","Cytochrome P450 family 5A","Cytochrome P450 family 1A","Cytochrome P450 family 2D","Cytochrome P450 fami
ly 3A","Cytochrome P450 family 2C","Cytochrome P450 5A1","Cytochrome P450 1A1","Cytochrome P450 2D6","Cytochrome P450 3A4","Cytochrome P450 2C19"}

> <pathway_chembl>
{"Ion channels",Enzymes,"Other ion channels","Cytochrome P450","Chloride channels",CYP5,"CYP7 and CYP8 families","CYP1 family","CYP2 family: drug metabolising subset","CYP3 family",CFTR}

> <pathway_reactome>
{Autophagy,Metabolism,Macroautophagy,"Biological oxidations","Metabolism of lipids","Selective autophagy","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators
 (SPMs)",Aggrephagy,"Cytochrome P450 - arranged by substrate type","Biosynthesis of DHA-derived SPMs",Eicosanoids,Xenobiotics,"Biosynthesis of maresins","Aromatic amines can be N-hydroxylated or N-dea
lkylated by CYP1A2","CYP2E1 reactions","Biosynthesis of maresin-like SPMs"}

> <broad_targets>
{TBXAS1}

> <broad_moa>
{"thromboxane synthase inhibitor"}

> <synonyms>
{"ozagrel hydrochloride",78712-43-3,78712433,"OZAGREL HCl",UNII-W222U960HS,UNIIW222U960HS,"OKY 046","(E)-3-(4-((1H-Imidazol-1-yl)methyl)phenyl)acrylic acid hydrochloride","(E)3(4((1HImidazol1yl)methyl
)phenyl)acrylic acid hydrochloride",OKY-046,OKY046,CHEBI:31954,W222U960HS,"Ozagrel (hydrochloride)",DSSTox_CID_25506,DSSToxCID25506,DSSTox-CID-25506,"DSSTox CID 25506",DSSTox_RID_80920,DSSToxRID80920,
DSSTox-RID-80920,"DSSTox RID 80920",DSSTo,T6625,SAM001246593,Prestw-979,"Ozagrel hydrochloride",CPD000469164}

> <pdid>
PD000221

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{50987034,6438130}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 23  0  0  0  0            999 V2000
    4.8105   -4.8024    0.0000 O   0  5
    3.3277   -4.5763    0.0000 N   0  3
    2.3908   -5.7477    0.0000 O   0  0
    2.7822   -3.1780    0.0000 C   0  0
    3.7175   -2.0053    0.0000 C   0  0
    3.1695   -0.6090    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 N   0  0
    0.0000    1.7286    0.0000 C   0  0
    0.0000    3.2286    0.0000 O   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 N   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.4011   -2.9095    0.0000 C   0  0
   -2.9046   -2.9463    0.0000 C   0  0
   -3.6237   -4.2627    0.0000 C   0  0
   -2.8432   -5.5436    0.0000 C   0  0
   -1.3436   -5.5082    0.0000 C   0  0
   -0.6245   -4.1918    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
    1.2990   -2.9545    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  3
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 13 20  1  0
 20  7  1  0
 20 21  2  0
 21  4  1  0
M  CHG  2   1  -1   2   1
M  END
> <name>
NIHCC_2014

> <id>
5653

> <plate>
NGP-105-01

> <well>
C10

> <supplier_cmpd_name>
CPD000058302

> <ctcr_id>
2414

> <supplier_cmpd_id>
SAM001246711

> <smiles>
[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3)c2c1

> <pd_targets>
{LMNA,HPGD,GABRA1,GABRA2,GABRA3,GABRA4,GABRB1,GABRG2,GABRA5,GABRA6,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG3,GABRP,GABRQ,SCN1A}

> <pathway_gtopdb>
{"Other nuclear protein",Enzyme,"Ion channel","Ligand-gated ion channel","Voltage-gated ion channel","GABA-A receptor","Voltage-gated sodium channel"}

> <pathway_chembl>
{Enzymes,"Ion channels","Eicosanoid turnover","Voltage-gated ion channels","Prostaglandin synthases","Voltage-gated sodium channels"}

> <pathway_reactome>
{"Cell Cycle",Metabolism,"Developmental Biology",Mitotic,"Metabolism of lipids","Nervous system development","M Phase","Biosynthesis of specialized proresolving mediators (SPMs)","Axon guidance","Mito
tic Metaphase and Anaphase","Biosynthesis of DHA-derived SPMs","L1CAM interactions","Mitotic Anaphase","Biosynthesis of D-series resolvins","Interaction between L1 and Ankyrins","Nuclear Envelope (NE)
 Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{nitrazepam,146-22-5,146225,Benzalin,Neozepam,Imeson,Mogadon,Remnos,Neuchlonic,Apodorm,Calsmin,Eunoctin,Imesont,Nitrados,Radedorm,Sonebon,Trazenin,Hipnax,Hipsal,Nelmat,Surem,Epibenzalin,Epinelbon,Nitr
enpax,Somitran,Sonnolin,Unisomnia,Cerson,Dumolid,N,SAM001246711,CPD000058302}

> <pdid>
PD003070

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{4506}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 16  0  0  0  0            999 V2000
    6.3933   -1.1297    0.0000 Cl  0  0
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 N   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -2.6030    2.9977    0.0000 O   0  0
   -3.8990    0.7455    0.0000 N   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.4983    0.7413    0.0000 C   0  0
   -5.2029    2.9932    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
  9 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
M  END
> <name>
NIHCC_2014

> <id>
5654

> <plate>
NGP-105-01

> <well>
C11

> <supplier_cmpd_name>
CPD000469151

> <ctcr_id>
6590

> <supplier_cmpd_id>
SAM001246564

> <smiles>
Cl.CNNCc1ccc(cc1)C(=O)NC(C)C

> <pd_targets>
{ALDH1A1,ALOX15,CYP1A2,CYP2C19,LMNA,MAOA,MAOB}

> <pathway_gtopdb>
{Enzyme,"Other nuclear protein",Oxidoreductase,"Cytochrome P450","Cytochrome P450 family 1","Cytochrome P450 family 2","Cytochrome P450 family 1A","Cytochrome P450 family 2C","Cytochrome P450 1A1","Cy
tochrome P450 2C19"}

> <pathway_chembl>
{Enzymes,"Eicosanoid turnover","Cytochrome P450",Lipoxygenases,"CYP1 family","CYP2 family: drug metabolising subset"}

> <pathway_reactome>
{Metabolism,"Cell Cycle","Biological oxidations","Metabolism of lipids",Mitotic,"Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","M Phase","Ethano
l oxidation","Biosynthesis of DPA-derived SPMs","Cytochrome P450 - arranged by substrate type","Mitotic Metaphase and Anaphase","Biosynthesis of DPAn-3 SPMs",Xenobiotics,"Mitotic Anaphase","Biosynthes
is of DPAn-3-derived protectins and resolvins","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","CYP2E1 reactions","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope 
(NE) Reformation"}

> <broad_targets>
{}

> <broad_moa>
{"monoamine oxidase inhibitor"}

> <synonyms>
{RESTW111,"Procarbazine hydrochloride",366-70-1,366701,"PROCARBAZINE HCl",Matulane,Nathulane,Natunalar,"MIH hydrochloride","PCB hydrochloride","Procarbazine (Hydrochloride)","Ibenzmethyzine hydrochlor
ide",Natulan,NSC-77213,NSC77213,UNII-XH0NPH5ZX8,UNIIXH0NPH5ZX8,NCI-C01810,NCIC01810,N-isoprop,Nisoprop,T1488,77213,S1995,SAM001246564,Prestw-1112,"NSC 77213","Procarbazine HCl",CPD000469151}

> <pdid>
PD001685

> <targets>
{}

> <classes>
{"Alkylating agent"}

> <pubchem_cids>
{9703,441273,74764326}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 29  0  0  0  0            999 V2000
    5.2029   -2.9932    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 C   0  0
   -1.3039   -3.7494    0.0000 C   0  0
   -1.3092   -5.2494    0.0000 C   0  0
   -2.6108   -5.9949    0.0000 C   0  0
   -3.9072   -5.2404    0.0000 C   0  0
   -3.9020   -3.7404    0.0000 C   0  0
   -2.6004   -2.9949    0.0000 C   0  0
    6.4990   -0.7409    0.0000 N   0  0
    7.8007   -1.4864    0.0000 C   0  0
    9.0971   -0.7319    0.0000 C   0  0
    9.0919    0.7681    0.0000 C   0  0
    7.7903    1.5136    0.0000 C   0  0
    6.4939    0.7591    0.0000 C   0  0
   11.5978   -2.9902    0.0000 O   0  0
   12.8971   -2.2407    0.0000 P   0  0
   12.8971   -0.7407    0.0000 O   0  0
   12.8971   -3.7407    0.0000 O   0  0
   14.1964   -2.9902    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
  2 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 18  1  0
 24 25  1  0
 25 26  1  0
 25 27  1  0
 25 28  2  0
M  END
> <name>
NIHCC_2014

> <id>
5655

> <plate>
NGP-105-01

> <well>
D02

> <supplier_cmpd_name>
CPD000469294

> <ctcr_id>
6581

> <supplier_cmpd_id>
SAM001246739

> <smiles>
CC(COc1ccccc1Cc2ccccc2)N3CCCCC3.O[P](O)(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{3563-76-6,3563766,"1-(2-(2-Benzylphenoxy)-1-methylethyl)piperidinium dihydrogen phosphate","1(2(2Benzylphenoxy)1methylethyl)piperidinium dihydrogen phosphate",H362,"benproperine phosphate",19428-14-9
,19428149,Pirexyl,"ASA 158-5","ASA 1585","Benproperine phosphate (JAN)",Blascorid,"Blascorid; Pirexyl; ASA 158-5","Blascorid; Pirexyl; ASA 1585",1-(2-Benzylphenoxy)-2-pi,1(2Benzylphenoxy)2pi,T5007,SAM
001246739,"Benproperine phosphate",CPD000469294}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{90472343,167811}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 25  0  0  0  0            999 V2000
    7.5844   -1.4920    0.0000 C   0  0
    6.1069   -1.2335    0.0000 N   0  0
    5.5920    0.1754    0.0000 C   0  0
    4.1145    0.4339    0.0000 C   0  0
    3.1484   -0.7186    0.0000 N   0  0
    3.6667   -2.1252    0.0000 C   0  0
    5.1442   -2.3838    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 N   0  0
    0.0000    1.7286    0.0000 C   0  0
    0.1115    3.2255    0.0000 C   0  0
   -1.1278    4.0705    0.0000 C   0  0
   -2.4793    3.4196    0.0000 C   0  0
   -2.5914    1.9238    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 N   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.2135   -2.9844    0.0000 S   0  0
    0.0000   -3.8661    0.0000 C   0  0
    0.0000   -5.3661    0.0000 C   0  0
    1.2135   -2.9844    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  2  1  0
  5  8  1  0
  8  9  2  3
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
 21 22  1  0
 22  8  1  0
 22 17  2  0
M  END
> <name>
NIHCC_2014

> <id>
5656

> <plate>
NGP-105-01

> <well>
D03

> <supplier_cmpd_name>
CPD000466345

> <ctcr_id>
363

> <supplier_cmpd_id>
SAM001246652

> <smiles>
CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24

> <pd_targets>
{DRD2,HRH1,HTR2A,HTR2B,HTR2C,ADRA2A,ADRA2B,ADRA2C,DRD3,DRD4,HTR1A,KCNH2,CHRM3,LMNA,KMT2A,MEN1,GFER,ALOX15,HTR1B,ADRA1A,HTR6,ABCB11,NET,CHRM5,GAA,CHRM2,CHRM1,SLC6A2,CHRM4,ADRA1B,DRD5,H1-0,ADRA1D,HTR7,M
APK1,HTR3A,SLC6A4,HTR3B,HTR3C,HTR3D,HTR3E,DRD1,ADRB1,ADRB2,ADRB3,HTR1D,HTR1E,HTR1F,GABRA1,GABRA2,GABRA3,GABRA5,GABRG1,GABRG2,GABRG3,CCKBR,OPRD1,OPRK1,SLC6A3,CYSLTR1,SCN10A,CACNA1C,CCK,ARRB1,SIGMAR1,TB
XA2R,OPRM1,TAC1}

> <pathway_gtopdb>
{"Membrane receptor","Ion channel","Other nuclear protein","Epigenetic regulator",Enzyme,Transporter,"Secreted protein","Unclassified protein","Family A G protein-coupled receptor","Voltage-gated ion 
channel",Reader,Oxidoreductase,"Primary active transporter","Electrochemical transporter",Hydrolase,Kinase,"Ligand-gated ion channel","Small molecule receptor (family A GPCR)","Potassium channels",Bro
modomain,"ATP-binding cassette","SLC superfamily of solute carriers","Protein Kinase","5HT3 receptor","Peptide receptor (family A GPCR)","GABA-A receptor","Voltage-gated sodium channel","Voltage-gated
 calcium channel","Monoamine receptor","Voltage-gated potassium channel","ABCB subfamily","SLC06 neurotransmitter transporter family","CMGC protein kinase group","Short peptide receptor (family A GPCR
)","Lipid-like ligand receptor (family A GPCR)","Dopamine receptor","Histamine receptor","Serotonin receptor","Adrenergic receptor","Acetylcholine receptor","CMGC protein kinase MAPK family","Cholecys
tokinin receptor","Opioid receptor","Leukotriene receptor","Prostanoid receptor","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,"Ion channels",Enzymes,Transporters,"Other protein targets","G protein-coupled receptors","Voltage-gated ion channels","Eicosanoid turnover","ATP-binding cassette transporter family","3.2.1
.- Glycosidases","Kinases (EC 2.7.x.x)","Ligand-gated ion channels","SLC superfamily of solute carriers","Sigma receptors","Dopamine receptors","Histamine receptors","5-Hydroxytryptamine receptors","P
otassium channels","Acetylcholine receptors (muscarinic)",Adrenoceptors,Lipoxygenases,"ABCB subfamily","CMGC: Containing CDK",MAPK,GSK3,"CLK families","5-HT<sub>3</sub> receptors","SLC6 neurotransmitt
er transporter family","Cholecystokinin receptors","Opioid receptors","GABA<sub>A</sub> receptors","Leukotriene receptors","Voltage-gated sodium channels","Voltage-gated calcium channels","Prostanoid 
receptors","Voltage-gated potassium channels","Mitogen-activated protein kinases (MAP kinases)","Monoamine transporter subfamily","ERK subfamily"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Muscle contraction","Cell Cycle","Protein localization",Metabolism,"Cellular responses to external stimuli","Immune System","Neuronal System","Gene expression (Transcri
ption)","Developmental Biology","Signaling by GPCR","Infectious disease","Cardiac conduction",Mitotic,"Mitochondrial protein import","Metabolism of lipids","Diseases of metabolism","Cellular responses
 to stress","Innate Immune System","Transmission across Chemical Synapses","RNA Polymerase II Transcription","Disorders of transmembrane transporters","Nervous system development","Diseases of signal 
transduction by growth factor receptors and second messengers","GPCR ligand binding","Leishmania infection","Phase 3 - rapid repolarisation","M Phase","Biosynthesis of specialized proresolving mediato
rs (SPMs)","Metabolism of steroids","Diseases of carbohydrate metabolism","Cellular Senescence","Toll-like Receptor Cascades","Neurotransmitter receptors and postsynaptic signal transmission","Neurotr
ansmitter clearance","GPCR downstream signalling","Generic Transcription Pathway","SLC transporter disorders","Axon guidance","Oncogenic MAPK signaling","SARS-CoV Infections","Class A/1 (Rhodopsin-lik
e receptors)","Leishmania parasite growth and survival","Mitotic Metaphase and Anaphase","Biosynthesis of DPA-derived SPMs","Bile acid and bile salt metabolism","Glycogen storage diseases","DNA Damage
/Telomere Stress Induced Senescence","Toll Like Receptor 5 (TLR5) Cascade","Serotonin clearance from the synaptic cleft","G alpha (q) signalling events","Transcriptional Regulation by MECP2","GABA rec
eptor activation","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","L1CAM interactions","NCAM signaling for neurite out-growth","Signaling by RAS mutants","Potential therapeutics for 
SARS","G alpha (i) signalling events","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Mitotic Anaphase","Biosynthesis of DPAn-3 SPMs","Synthesis 
of bile acids and bile salts","Glycogen storage disease type II (GAA)","Formation of Senescence-Associated Heterochromatin Foci (SAHF)","MyD88 cascade initiated on plasma membrane","Gastrin-CREB signa
lling pathway via PKC and MAPK","Peptide ligand-binding receptors","MECP2 regulates neuronal receptors and channels","Interaction between L1 and Ankyrins","NCAM1 interactions","Signaling downstream of
 RAS mutants","Eicosanoid ligand-binding receptors","Opioid Signalling","Dopamine receptors","Histamine receptors","Serotonin receptors","ADORA2B mediated anti-inflammatory cytokines production","Musc
arinic acetylcholine receptors",Adrenoceptors,"Nuclear Envelope (NE) Reassembly","Biosynthesis of DPAn-3-derived protectins and resolvins","Synthesis of bile acids and bile salts via 7alpha-hydroxycho
lesterol","MAP kinase activation","LTC4-CYSLTR mediated IL4 production","Prostanoid ligand receptors","G-protein activation","Tachykinin receptors bind tachykinins","Initiation of Nuclear Envelope (NE
) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA2A,ADRA2B,ADRA2C,ADRB1,ADRB2,ADRB3,CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,DRD1,DRD2,DRD3,DRD4,DRD5,GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GA
BRG3,GABRP,GABRQ,HRH1,HRH2,HRH4,HTR1A,HTR1B,HTR1D,HTR1E,HTR1F,HTR2A,HTR2B,HTR2C,HTR3A,HTR5A,HTR6,HTR7}

> <broad_moa>
{"dopamine receptor antagonist","serotonin receptor antagonist"}

> <synonyms>
{AB00639907-07,AB0063990707,AB00639907_08,AB0063990708,AB00639907-08,"AB00639907 08",olanzapine,132539-06-1,132539061,Zyprexa,"Zyprexa Zydis",Olansek,Zalasta,"Zyprexa Intramuscular",Zolafren,Zypadhera
,"Zyprexa Velotab",LY-170053,LY170053,"2-Methyl-4-(4-methylpiperazin-1-yl)-10H-benzo(b)thieno(2,3-e)(1,4)diazepine","2Methyl4(4methylpiperazin1yl)10Hbenzo(b)thieno(2,3e)(1,4)diazepine",Ol,T1567,S2493,
SAM001246652,1505024,Prestw-1455,Olanzapine,CPD000466345,OLANZAPINE}

> <pdid>
PD000646

> <targets>
{"Dopamine Receptor","5-HT Receptor"}

> <classes>
{antipsychotic,"Neuronal Signaling"}

> <pubchem_cids>
{135398745}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 34  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5972    1.5031    0.0000 C   0  0
    2.5951    3.0039    0.0000 C   0  0
    3.8933    3.7570    0.0000 N   0  0
    3.8933    5.2571    0.0000 C   0  0
    5.1924    6.0071    0.0000 C   0  0
    6.4914    5.2571    0.0000 C   0  0
    6.4915    3.7571    0.0000 C   0  0
    5.1925    3.0071    0.0000 C   0  0
    7.7911    6.0075    0.0000 C   0  0
    9.1416    5.3847    0.0000 N   0  0
   10.1469    6.4980    0.0000 O   0  0
    9.3989    7.7973    0.0000 C   0  0
    9.8644    9.2232    0.0000 C   0  0
    8.8623   10.3393    0.0000 C   0  0
    9.3278   11.7652    0.0000 F   0  0
    7.3946   10.0295    0.0000 C   0  0
    6.9291    8.6036    0.0000 C   0  0
    7.9312    7.4874    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11  6  1  0
  9 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 19 20  1  0
 20 21  2  0
 21 12  1  0
 21 15  1  0
  3 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 24  1  0
 29 30  2  3
 30  2  1  0
M  END
> <name>
NIHCC_2014

> <id>
5657

> <plate>
NGP-105-01

> <well>
D04

> <supplier_cmpd_name>
CPD000466323

> <ctcr_id>
4092

> <supplier_cmpd_id>
SAM001246595

> <smiles>
CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1

> <pd_targets>
{HTR3A,ADRB2,HTR1A,HTR1B,SCN10A,HTR2A,DRD2,DRD3,ADRA1A,ADRA1B,ADRA1D,HRH1,ADRA2C,SLC6A4,CYP2C19,PMP22,CYP2D6,HTR2C,ALB,HTR2B,GABRA1,KCNH2,HTR6,CHRM1,HTR1D,SLC6A3,ADRA2B,CACNA1C,CHRM2,TBXA2R,HTR7,H1-0,
HTR1E,DRD4,GLRA1,GSC2,ADRA2A,NET,TSHR,CHRM3,CHRM4,CHRM5,SIGMAR1,HTR1F,ARRB1,ADRB1,CCKBR,OPRK1,DRD5,OPRD1,HTR5A,CCK,CYSLTR1,OPRM1,TAC1,SLC22A2,SLC47A1,HRH2,CACNA1D,CACNA1F,CACNA1S}

> <pathway_gtopdb>
{"Ion channel","Membrane receptor",Transporter,Enzyme,"Unclassified protein","Secreted protein","Other nuclear protein","Ligand-gated ion channel","Family A G protein-coupled receptor","Voltage-gated 
ion channel","Electrochemical transporter","Cytochrome P450",Transferase,"5HT3 receptor","Small molecule receptor (family A GPCR)","Voltage-gated sodium channel","SLC superfamily of solute carriers","
Cytochrome P450 family 2","GABA-A receptor","Potassium channels","Voltage-gated calcium channel","Glycine receptor","Peptide receptor (family A GPCR)","Monoamine receptor","SLC06 neurotransmitter tran
sporter family","Cytochrome P450 family 2C","Cytochrome P450 family 2D","Voltage-gated potassium channel","Lipid-like ligand receptor (family A GPCR)","Glycohormone receptor","Short peptide receptor (
family A GPCR)","SLC22 family of organic cation and anion transporters","SLC47 family of multidrug and toxin extrusion transporters","Adrenergic receptor","Serotonin receptor","Dopamine receptor","His
tamine receptor","Cytochrome P450 2C19","Cytochrome P450 2D6","Acetylcholine receptor","Prostanoid receptor","Cholecystokinin receptor","Opioid receptor","Leukotriene receptor"}

> <pathway_chembl>
{"Ion channels",Receptors,Transporters,Enzymes,"Other protein targets","Ligand-gated ion channels","G protein-coupled receptors","Voltage-gated ion channels","SLC superfamily of solute carriers","Cyto
chrome P450","Sigma receptors","5-HT<sub>3</sub> receptors",Adrenoceptors,"5-Hydroxytryptamine receptors","Voltage-gated sodium channels","Dopamine receptors","Histamine receptors","SLC6 neurotransmit
ter transporter family","CYP2 family: drug metabolising subset","GABA<sub>A</sub> receptors","Potassium channels","Acetylcholine receptors (muscarinic)","Voltage-gated calcium channels","Prostanoid re
ceptors","Glycine receptors","Glycoprotein hormone receptors","Cholecystokinin receptors","Opioid receptors","Leukotriene receptors","SLC22 family of organic cation and anion transporters","SLC47 fami
ly of multidrug and toxin extrusion transporters","Monoamine transporter subfamily","Voltage-gated potassium channels","Organic cation transporters (OCT)"}

> <pathway_reactome>
{"Neuronal System",Disease,"Signal Transduction","Developmental Biology",Metabolism,"Muscle contraction","Cellular responses to external stimuli","Gene expression (Transcription)","Transport of small 
molecules","Transmission across Chemical Synapses","Infectious disease","Signaling by GPCR","Nervous system development","Biological oxidations","Metabolism of lipids","Cardiac conduction","Disorders 
of transmembrane transporters","Cellular responses to stress","Diseases of signal transduction by growth factor receptors and second messengers","RNA Polymerase II Transcription","SLC-mediated transme
mbrane transport","Neurotransmitter receptors and postsynaptic signal transmission","Leishmania infection","GPCR ligand binding","Axon guidance","Neurotransmitter clearance","Phase I - Functionalizati
on of compounds","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Metabolism of steroids","Phase 3 - rapid repolarisation","SLC transporter disorders","Cellular Senescence","SARS-CoV 
Infections","Oncogenic MAPK signaling","GPCR downstream signalling","Generic Transcription Pathway","Transport of bile salts and organic acids","metal ions and amine compounds","Leishmania parasite gr
owth and survival","Class A/1 (Rhodopsin-like receptors)","L1CAM interactions","Serotonin clearance from the synaptic cleft","Cytochrome P450 - arranged by substrate type","Bile acid and bile salt met
abolism","GABA receptor activation","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","NCAM signaling for neurite out-growth","DNA Damage/Telomere Stress Induced Senescence","Potential
 therapeutics for SARS","Signaling by RAS mutants","G alpha (q) signalling events","Transcriptional Regulation by MECP2","G alpha (i) signalling events","Organic cation/anion/zwitterion transport","An
ti-inflammatory response favouring Leishmania parasite infection","Amine ligand-binding receptors","Interaction between L1 and Ankyrins",Xenobiotics,"Recycling of bile acids and salts","NCAM1 interact
ions","Eicosanoid ligand-binding receptors","Formation of Senescence-Associated Heterochromatin Foci (SAHF)","Signaling downstream of RAS mutants","Gastrin-CREB signalling pathway via PKC and MAPK","M
ECP2 regulates neuronal receptors and channels","Peptide ligand-binding receptors","Opioid Signalling","Organic cation transport","ADORA2B mediated anti-inflammatory cytokines production","Serotonin r
eceptors","Dopamine receptors","Histamine receptors",Adrenoceptors,"CYP2E1 reactions","Muscarinic acetylcholine receptors","Prostanoid ligand receptors","LTC4-CYSLTR mediated IL4 production","G-protei
n activation","Tachykinin receptors bind tachykinins"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,ADRA2A,ADRA2B,ADRA2C,DRD1,DRD2,DRD3,DRD4,HRH1,HTR1A,HTR1B,HTR1D,HTR1E,HTR1F,HTR2A,HTR2C,HTR6,HTR7}

> <broad_moa>
{"dopamine receptor antagonist","serotonin receptor antagonist"}

> <synonyms>
{RESTW102,risperidone,106266-06-2,106266062,Risperidal,Risperdal,Rispolept,"Risperdal Consta",Risperin,Rispolin,Sequinan,Apexidone,Risperidonum,Risperidona,"Risperdal M-Tab","Risperdal MTab",Belivon,P
sychodal,Spiron,"R 64 766",C23H27FN4O2,UNII-L6UH7ZF8HC,UNIIL6UH7ZF8HC,"R 64766",R-64766,R64766,"R 64",7,T0351,SAM001246595,Prestw-1029,CPD000466323,Risperidone}

> <pdid>
PD000218

> <targets>
{5-HT Receptor,Dopamine Receptor,P-glycoprotein}

> <classes>
{GPCR/G Protein,Membrane Transporter/Ion Channel,Neuronal Signaling}

> <pubchem_cids>
{5073}

$$$$
NIHCC_2014
  SciTegic11012413002D

 33 34  0  0  0  0            999 V2000
    7.3532   -3.3675    0.0000 C   0  0
    6.3509   -2.2515    0.0000 N   0  0
    6.8167   -0.8257    0.0000 C   0  0
    4.8823   -2.5608    0.0000 C   0  0
    4.5718   -3.5114    0.0000 O   0  0
    3.8794   -1.4442    0.0000 C   0  0
    2.4133   -1.7530    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 N   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.5536   -4.4230    0.0000 C   0  0
    1.9048   -5.7699    0.0000 C   0  0
    2.7504   -7.0088    0.0000 C   0  0
    4.2462   -6.8960    0.0000 C   0  0
    5.0918   -8.1349    0.0000 C   0  0
    4.8963   -5.5442    0.0000 C   0  0
    4.0507   -4.3052    0.0000 C   0  0
   13.7537   -0.6924    0.0000 O   0  0
   13.7537   -2.1924    0.0000 C   0  0
   12.4538   -2.9424    0.0000 C   0  0
   12.4538   -4.4424    0.0000 O   0  0
   11.1538   -2.1924    0.0000 C   0  0
   11.1538   -0.6924    0.0000 O   0  0
    9.8545   -2.9420    0.0000 O   0  0
   15.0537   -2.9424    0.0000 C   0  0
   15.0537   -4.4424    0.0000 O   0  0
   16.3530   -2.1928    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14  8  1  0
 14 15  2  0
 15 16  1  0
 16  7  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 20 22  1  0
 22 23  2  0
 23 17  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 26 28  1  0
 28 29  1  0
 28 30  2  0
 25 31  1  0
 31 32  1  0
 31 33  2  0
M  END
> <name>
NIHCC_2014

> <id>
5658

> <plate>
NGP-105-01

> <well>
D05

> <supplier_cmpd_name>
CPD000469145

> <ctcr_id>
1695

> <supplier_cmpd_id>
SAM001246549

> <smiles>
CN(C)C(=O)Cc1n2cc(C)ccc2nc1c3ccc(C)cc3.OC(C(O)C(O)=O)C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"zolpidem tartarate",SCHEMBL40721,MLS001401453,CHEMBL1723343,HMS2051H09,HMS2232G04,HMS3374C07,HMS3393H09,ACT03353,BCP28267,BCP28445,AKOS016013007,CCG-100938,NC00188,SMR000469145,DB-057774,"Sublinox; 
Bikalm; Zolpidem MR;103188-50-7",A845992,SAM001246549,CPD000469145}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{18004026}

$$$$
NIHCC_2014
  SciTegic11012413002D

 31 32  0  0  1  0            999 V2000
   15.0356    1.3354    0.0000 C   0  0
   14.7321   -0.1336    0.0000 C   0  0
   15.8528   -1.1306    0.0000 C   0  0
   13.3077   -0.6064    0.0000 O   0  0
   13.0040   -2.0761    0.0000 C   0  0
   14.1247   -3.0731    0.0000 O   0  0
   11.5796   -2.5489    0.0000 C   0  0
   11.2759   -4.0187    0.0000 C   0  0
    9.8515   -4.4915    0.0000 C   0  0
    9.5478   -5.9613    0.0000 C   0  0
    8.1234   -6.4341    0.0000 C   0  0
    7.0011   -5.4376    0.0000 C   0  0
    5.5792   -5.9096    0.0000 C   0  0  1  0  0  0
    4.3516   -5.0476    0.0000 C   0  0  1  0  0  0
    4.3275   -3.5478    0.0000 O   0  0
    3.1525   -5.9487    0.0000 C   0  0
    3.6389   -7.3677    0.0000 C   0  0  1  0  0  0
    2.7842   -8.6004    0.0000 O   0  0
    5.1256   -7.3260    0.0000 C   0  0  2  0  0  0
    6.0248   -8.5277    0.0000 C   0  0
    5.4345   -9.9076    0.0000 C   0  0
    6.3337  -11.1092    0.0000 C   0  0  1  0  0  0
    7.8231  -10.9310    0.0000 O   0  0
    5.7435  -12.4891    0.0000 C   0  0
    6.6426  -13.6908    0.0000 C   0  0
    6.0524  -15.0707    0.0000 C   0  0
    6.9493  -16.2730    0.0000 C   0  0
    6.3566  -17.6509    0.0000 C   0  0
    4.8669  -17.8266    0.0000 C   0  0
    3.9700  -16.6243    0.0000 C   0  0
    4.5627  -15.2463    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 13 12  1  6
 13 14  1  0
 14 15  1  6
 14 16  1  0
 16 17  1  0
 17 18  1  6
 17 19  1  0
 19 13  1  0
 19 20  1  1
 20 21  1  0
 21 22  1  0
 22 23  1  1
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
M  END
> <name>
NIHCC_2014

> <id>
5659

> <plate>
NGP-105-01

> <well>
D06

> <supplier_cmpd_name>
CPD000466354

> <ctcr_id>
1091

> <supplier_cmpd_id>
SAM001246671

> <smiles>
CC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc2ccccc2

> <pd_targets>
{PTGFR,MAPT,MAPK1,KMT2A,MEN1,KDM4E,ABCB11,PTGER1}

> <pathway_gtopdb>
{"Membrane receptor","Other cytosolic protein",Enzyme,"Epigenetic regulator",Transporter,"Family A G protein-coupled receptor",Kinase,Reader,Eraser,"Primary active transporter","Small molecule recepto
r (family A GPCR)","Protein Kinase",Bromodomain,"Lysine demethylase","ATP-binding cassette","Lipid-like ligand receptor (family A GPCR)","CMGC protein kinase group","Jumonji domain-containing","ABCB s
ubfamily","Prostanoid receptor","CMGC protein kinase MAPK family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"G protein-coupled receptors","Kinases (EC 2.7.x.x)","Chromatin modifying enzymes","ATP-binding cassette transporter family","Prostanoid receptors","CMGC: Containing CD
K",MAPK,GSK3,"CLK families","1.14.11.- Histone demethylases","ABCB subfamily","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Signal Transduction","Neuronal System","Immune System",Metabolism,"Signaling by GPCR","Transmission across Chemical Synapses","Innate Immune System","Metabolism of lipids","GPCR ligand binding","Neu
rotransmitter receptors and postsynaptic signal transmission","Toll-like Receptor Cascades","Metabolism of steroids","Class A/1 (Rhodopsin-like receptors)","Activation of NMDA receptors and postsynapt
ic events","Toll Like Receptor 5 (TLR5) Cascade","Bile acid and bile salt metabolism","Eicosanoid ligand-binding receptors","Post NMDA receptor activation events","MyD88 cascade initiated on plasma me
mbrane","Synthesis of bile acids and bile salts","Prostanoid ligand receptors","Activation of AMPK downstream of NMDARs","MAP kinase activation","Synthesis of bile acids and bile salts via 7alpha-hydr
oxycholesterol","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{PTGFR}

> <broad_moa>
{"prostanoid receptor agonist"}

> <synonyms>
{130209-82-4,130209824,"130209 82 4",Xalatan,PhXA41,PHXA-41,PHXA41,"PHXA 41","PhXA 41",XA41,UNII-6Z5B6HVF6O,UNII6Z5B6HVF6O,"UNII 6Z5B6HVF6O","Latanoprost, ethanol solution",6Z5B6HVF6O,CHEBI:6384,MFCD0
0216074,XA-41,"XA 41",T-2345,T2345,"T 2345",Catioprost,SMR000466354,"Xalatan (TN)","latanoprost (isopropyl ester)",latanoprostum,T2528,SAM001246671,Latanoprost,CPD000466354}

> <pdid>
PD002939

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5311221}

$$$$
NIHCC_2014
  SciTegic11012413002D

 34 34  0  0  1  0            999 V2000
    6.3982   -3.3809    0.0000 Na  0  3
    3.8926   -3.7566    0.0000 C   0  0
    2.5951   -3.0039    0.0000 O   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5973    1.5031    0.0000 C   0  0
   -2.5951    3.0031    0.0000 C   0  0
   -3.8976    0.7553    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 C   0  0
   -2.5951   -3.0039    0.0000 C   0  0
   -3.8933   -3.7570    0.0000 C   0  0  1  0  0  0
   -5.1937   -3.0093    0.0000 O   0  0
   -3.8912   -5.2578    0.0000 C   0  0
   -5.1894   -6.0109    0.0000 C   0  0  1  0  0  0
   -6.4897   -5.2632    0.0000 O   0  0
   -5.1872   -7.5117    0.0000 C   0  0
   -6.4854   -8.2648    0.0000 C   0  0
   -7.7858   -7.5171    0.0000 O   0  5
   -6.4833   -9.7648    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0008    0.0000 C   0  0
   -1.2978   -3.7529    0.0000 C   0  0
   -1.2955   -5.2529    0.0000 C   0  0
    0.0048   -6.0009    0.0000 C   0  0
    0.0072   -7.5009    0.0000 F   0  0
    1.3026   -5.2488    0.0000 C   0  0
    1.3002   -3.7488    0.0000 C   0  0
    2.5972    1.5031    0.0000 C   0  0
    2.5951    3.0031    0.0000 C   0  0
    3.8976    0.7554    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
  8 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  6
 15 17  1  0
 17 18  1  0
 18 19  1  6
 18 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  2  0
 12 24  2  0
 24  5  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 28 30  1  0
 30 31  2  0
 31 25  1  0
  6 32  1  0
 32 33  1  0
 32 34  1  0
M  CHG  2   1   1  22  -1
M  END
> <name>
NIHCC_2014

> <id>
5660

> <plate>
NGP-105-01

> <well>
D07

> <supplier_cmpd_name>
CPD000469148

> <ctcr_id>
389

> <supplier_cmpd_id>
SAM001246554

> <smiles>
[Na+].COCc1c(nc(C(C)C)c(\C=C\[C@@H](O)C[C@@H](O)CC([O-])=O)c1c2ccc(F)cc2)C(C)C

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"CERIVASTATIN SODIUM",Baycol,Rivastatin,Lipobay,143201-11-0,143201110,Certa,"Bay w 6228","CERIVASTATIN Na",UNII-6Q18G1060S,UNII6Q18G1060S,CPD000469148,CHEBI:3559,"143201-11-0 (sodium)","143201110 (so
dium)",6Q18G1060S,"Cerivastatin (sodium)","Cerivastatin, sodium salt",DSSTox_CID_26488,DSSToxCID26488,DSSTox-CID-26488,"DSSTox CID 26488",DS,SAM001246554}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23663992}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 27  0  0  1  0            999 V2000
   -0.6872   -2.7329    0.0000 C   0  0
    0.2851   -2.9666    0.0000 C   0  0  2  0  0  0
    0.7521   -4.3921    0.0000 O   0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0  1  0  0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -1.2991    2.2500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -0.8141   -2.0807    0.0000 C   0  0
   -2.6004    5.9977    0.0000 C   0  0
   -3.8983    5.2459    0.0000 O   0  0
   -0.0001    7.5000    0.0000 O   0  0
  2  1  1  1
  2  3  1  0
  2  4  1  0
  4  5  1  0
  6  5  1  6
  6  7  1  0
  7  8  1  1
  8  9  1  0
 10  9  1  6
 10 11  1  0
 11 12  1  0
 12 13  2  3
 13 14  1  0
 14 15  1  0
 15 10  1  0
 15 16  1  6
 15 17  1  0
 17  7  1  0
 17 18  1  6
 18 19  1  0
 19 20  1  0
 20  2  1  0
 20  6  1  0
 20 21  1  6
 13 22  1  0
 22 23  2  0
 12 24  1  0
M  END
> <name>
NIHCC_2014

> <id>
5661

> <plate>
NGP-105-01

> <well>
D08

> <supplier_cmpd_name>
CPD000058877

> <ctcr_id>
688

> <supplier_cmpd_id>
SAM001246765

> <smiles>
C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=C(C[C@]4(C)[C@H]3CC[C@]12C)C=O)O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{MCULE-2094970696,MCULE2094970696,SAM001246765,CPD000058877}

> <pdid>
PD002933

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{46386778}

$$$$
NIHCC_2014
  SciTegic11012413002D

 33 36  0  0  1  0            999 V2000
   -1.3109   -5.2364    0.0000 O   0  0
   -0.0156   -5.9928    0.0000 C   0  0
    1.2883   -5.2495    0.0000 C   0  0  1  0  0  0
    1.2935   -3.7495    0.0000 O   0  0
    2.5951   -3.0039    0.0000 C   0  0  1  0  0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 O   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
    2.5987    1.5004    0.0000 C   0  0
    3.8991    0.7525    0.0000 C   0  0
    5.1969    1.5046    0.0000 C   0  0
    5.1945    3.0046    0.0000 C   0  0
    6.4923    3.7567    0.0000 O   0  0
    3.8943    3.7525    0.0000 C   0  0
    3.8919    5.2525    0.0000 O   0  0
    2.5964    3.0004    0.0000 C   0  0
    3.8915   -3.7585    0.0000 C   0  0  2  0  0  0
    5.1932   -3.0130    0.0000 O   0  0
    3.8864   -5.2585    0.0000 C   0  0  1  0  0  0
    5.1828   -6.0130    0.0000 O   0  0
    2.5847   -6.0040    0.0000 C   0  0  1  0  0  0
    2.5796   -7.5040    0.0000 O   0  0
  1  2  1  0
  3  2  1  1
  3  4  1  0
  4  5  1  0
  5  6  1  1
  6  7  1  0
  7  8  2  3
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 17 10  1  0
 17 18  1  0
 18  7  1  0
 18 19  2  0
  8 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 23 25  1  0
 25 26  1  0
 25 27  2  0
 27 20  1  0
  5 28  1  0
 28 29  1  6
 28 30  1  0
 30 31  1  1
 30 32  1  0
 32  3  1  0
 32 33  1  1
M  END
> <name>
NIHCC_2014

> <id>
5662

> <plate>
NGP-105-01

> <well>
D09

> <supplier_cmpd_name>
CPD000466394

> <ctcr_id>
2361

> <supplier_cmpd_id>
SAM001246776

> <smiles>
OC[C@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@H]1O

> <pd_targets>
{KDM1A,XDH,KDM4E,CA4,CA12,MAPT,TGR,EPHX2,AKR1B1,GAA,ALPI,CA7,POLB,ALPL,CA2,AURKB,LMNA,ALD,GLA,CDK5,CDK5R1,REP,MAPK1,MPI,DYRK1A,P4HB,NA,NANH,FASN}

> <pathway_gtopdb>
{"Epigenetic regulator",Enzyme,"Other cytosolic protein",Eraser,Oxidoreductase,Lyase,Protease,Hydrolase,Phosphatase,Kinase,"Lysine demethylase","Serine protease","Protein Kinase","Lysine-specific deme
thylase","Jumonji domain-containing","Serine protease SC clan","Other protein kinase group","Serine protease S33 family","Other protein kinase AUR family","Other nuclear protein","CMGC protein kinase 
group","CMGC protein kinase CDK family","CMGC protein kinase MAPK family","CMGC protein kinase CDC2 subfamily","CMGC protein kinase ERK1",Isomerase,"CMGC protein kinase DYRK family","CMGC protein kina
se Dyrk1 subfamily",Transferase}

> <pathway_chembl>
{Enzymes,Receptors,"Chromatin modifying enzymes","1.-.-.- Oxidoreductases","Carbonic anhydrases",Hydrolases,"3.2.1.- Glycosidases","Catalytic receptors","1.14.11.- Histone demethylases","Receptor kina
ses","Other protein kinases","Aurora kinase (Aur) family","Other protein targets","Anti-infective targets","Kinases (EC 2.7.x.x)","Viral protein targets","CMGC: Containing CDK",MAPK,GSK3,"CLK families
","Coronavirus (CoV) proteins","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily","Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase (DYRK) family","Dyrk1 subfamily","2.3.1
.-  Acyltransferases"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,"Transport of small molecules","Neuronal System",Disease,"DNA Repair","Metabolism of proteins","Cell Cycle","Intracellular signaling by second messengers","Metabolism
 of nucleotides","O2/CO2 exchange in erythrocytes","Reversible hydration of carbon dioxide","Transmission across Chemical Synapses","Metabolism of lipids","Diseases of metabolism","Base Excision Repai
r","Post-translational protein modification",Mitotic,"PIP3 activates AKT signaling","Nucleobase catabolism","Erythrocytes take up carbon dioxide and release oxygen","Neurotransmitter receptors and pos
tsynaptic signal transmission","Biosynthesis of specialized proresolving mediators (SPMs)","Metabolism of steroids","Diseases of carbohydrate metabolism","Phospholipid metabolism","Resolution of Abasi
c Sites (AP sites)","Post-translational modification: synthesis of GPI-anchored proteins","M Phase","PTEN Regulation","Purine catabolism","Activation of NMDA receptors and postsynaptic events","Biosyn
thesis of DHA-derived SPMs","Metabolism of steroid hormones","Glycogen storage diseases","Glycerophospholipid biosynthesis","Resolution of AP sites via the multiple-nucleotide patch replacement pathwa
y","Mitotic Metaphase and Anaphase","Regulation of PTEN gene transcription","Post NMDA receptor activation events","Biosynthesis of maresins","Pregnenolone biosynthesis","Glycogen storage disease type
 II (GAA)","Synthesis of PA","PCNA-Dependent Long Patch Base Excision Repair","Mitotic Anaphase","Activation of AMPK downstream of NMDARs","Separation of Sister Chromatids","Immune System","Infectious
 disease","Innate Immune System","Sphingolipid metabolism","SARS-CoV Infections","Toll-like Receptor Cascades","Glycosphingolipid metabolism","SARS-CoV-1 Infection","Toll Like Receptor 5 (TLR5) Cascad
e","SARS-CoV-1 Genome Replication and Transcription","MyD88 cascade initiated on plasma membrane","Nuclear Envelope (NE) Reassembly","Replication of the SARS-CoV-1 genome","MAP kinase activation","Ini
tiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated","Cytokine Signaling in Immune system","Asparagine N-linke
d glycosylation","Mitotic G1 phase and G1/S transition","Signaling by Interleukins","Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide","LLO) and transfer to a nascent prot
ein","G0 and Early G1","Interleukin-12 family signaling","Synthesis of substrates in N-glycan biosythesis","Interleukin-12 signaling","Synthesis of GDP-mannose","Regulation of cholesterol biosynthesis
 by SREBP (SREBF)","Activation of gene expression by SREBF (SREBP)"}

> <broad_targets>
{}

> <broad_moa>
{antioxidant}

> <synonyms>
{Hyperoside,482-36-0,482360,Hyperin,Hyperosid,"Quercetin 3-galactoside","Quercetin 3galactoside",Hyperozide,Quercetin-3-O-galactoside,Quercetin3Ogalactoside,Quercetin-3-galactoside,Quercetin3galactosi
de,Hyperasid,Jyperin,"Quercetin 3-O-beta-D-galactopyranoside","Quercetin 3ObetaDgalactopyranoside","Quercetin 3-D-galactoside","Quercetin 3Dgalactoside",UNII-8O1CR18L82,UNII8O1CR18L82,"Quercetin 3-bet
","Quercetin 3bet",T2844,T5S0754,T4902,SAM001246776,Isoquercitrin,ISOQUERCITRIN,CPD000466394}

> <pdid>
PD002964

> <targets>
{Fungal,Influenza Virus}

> <classes>
{Anti-infection}

> <pubchem_cids>
{5281643}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 30  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0031    3.0008    0.0000 C   0  0
   -1.2947    3.7531    0.0000 O   0  0
    1.3032    3.7490    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -3.8971   -3.7500    0.0000 F   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -1.2990   -5.2508    0.0000 N   0  0
   -2.5969   -6.0029    0.0000 C   0  0
   -2.5945   -7.5029    0.0000 C   0  0
   -1.2942   -8.2509    0.0000 N   0  0
   -1.2919   -9.7509    0.0000 C   0  0
    0.0036   -7.4988    0.0000 C   0  0
    0.0012   -5.9988    0.0000 C   0  0
    7.6990   -1.4991    0.0000 C   0  0
    7.6990   -2.9991    0.0000 S   0  0
    7.6990   -4.4991    0.0000 O   0  0
    6.3997   -3.7487    0.0000 O   0  0
    8.9983   -3.7487    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  3
  5  6  1  0
  6  7  1  0
  6  8  2  0
  5  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 15 16  1  0
 16 17  2  0
 17  3  1  0
 17 11  1  0
 15 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 18  1  0
 25 26  1  0
 26 27  1  0
 26 28  2  0
 26 29  2  0
M  END
> <name>
NIHCC_2014

> <id>
5663

> <plate>
NGP-105-01

> <well>
D10

> <supplier_cmpd_name>
CPD000387024

> <ctcr_id>
4400

> <supplier_cmpd_id>
SAM001246571

> <smiles>
CCN1C=C(C(O)=O)C(=O)c2cc(F)c(cc12)N3CCN(C)CC3.C[S](O)(=O)=O

> <pd_targets>
{KDM4E,SKA,ALDH1A1,KMT2A,MEN1,HPGD,PARC,GYRA,TOP2A,TOPA}

> <pathway_gtopdb>
{"Epigenetic regulator",Enzyme,Eraser,Kinase,Oxidoreductase,Reader,Isomerase,"Lysine demethylase",Bromodomain,"Jumonji domain-containing"}

> <pathway_chembl>
{Enzymes,"Chromatin modifying enzymes","Eicosanoid turnover","DNA topoisomerases","1.14.11.- Histone demethylases","Prostaglandin synthases"}

> <pathway_reactome>
{Metabolism,"Cell Cycle","Biological oxidations","Metabolism of lipids",Mitotic,"Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","Mitotic G1 phase
 and G1/S transition","Ethanol oxidation","Biosynthesis of DHA-derived SPMs","G0 and Early G1","Biosynthesis of D-series resolvins","Transcription of E2F targets under negative control by DREAM comple
x"}

> <broad_targets>
{TOP2A}

> <broad_moa>
{"bacterial DNA gyrase inhibitor"}

> <synonyms>
{"pefloxacin mesilate",CHEBI:50194,Perti,"Pefloxacin mesylate",70458-95-6,70458956,"Pefloxacin methanesulfonate","PEFLOXACINE MESYLATE","Pefloxacin (mesylate)",UNII-5IAD0UV3FH,UNII5IAD0UV3FH,"41 982 R
P","Pefloxacin mesylate (USAN)",5IAD0UV3FH,"Pefloxacinium mesylate",T0425,T0425L,SAM001246571,1505305,"Pefloxacin Mesylate","Pefloxacin Mesylate Dihydrate",CPD000387024}

> <pdid>
PD009999

> <targets>
{}

> <classes>
{antiproliferative,antibacterial}

> <pubchem_cids>
{24883450,119525}

$$$$
NIHCC_2014
  SciTegic11012413002D

 49 52  0  0  0  0            999 V2000
   22.0494   -1.8531    0.0000 Mg  0  2
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 N   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 N   0  5
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -5.1047   -0.0031    0.0000 S   0  0
   -5.8570    1.2946    0.0000 O   0  0
   -5.8532   -1.3040    0.0000 C   0  0
   -7.3541   -1.3071    0.0000 C   0  0
   -8.1042   -0.0081    0.0000 N   0  0
   -9.6042   -0.0082    0.0000 C   0  0
  -10.3542   -1.3072    0.0000 C   0  0
  -11.8542   -1.3073    0.0000 C   0  0
   -9.6041   -2.6062    0.0000 C   0  0
  -10.3518   -3.9076    0.0000 O   0  0
   -9.5998   -5.2055    0.0000 C   0  0
   -8.1041   -2.6062    0.0000 C   0  0
   -7.3541   -3.9052    0.0000 C   0  0
   19.5473   -3.0031    0.0000 C   0  0
   19.5494   -1.5031    0.0000 O   0  0
   18.2512   -0.7500    0.0000 C   0  0
   18.2512    0.7500    0.0000 C   0  0
   16.9521    1.5000    0.0000 C   0  0
   15.6531    0.7500    0.0000 C   0  0
   14.2274    1.2135    0.0000 N   0  5
   13.3457    0.0000    0.0000 C   0  0
   14.2274   -1.2135    0.0000 N   0  0
   15.6531   -0.7500    0.0000 C   0  0
   16.9522   -1.5000    0.0000 C   0  0
   11.8475   -0.0031    0.0000 S   0  0
   11.0952    1.2946    0.0000 O   0  0
   11.0989   -1.3040    0.0000 C   0  0
    9.5981   -1.3071    0.0000 C   0  0
    8.8479   -0.0081    0.0000 N   0  0
    7.3479   -0.0082    0.0000 C   0  0
    6.5980   -1.3072    0.0000 C   0  0
    5.0980   -1.3073    0.0000 C   0  0
    7.3481   -2.6062    0.0000 C   0  0
    6.6004   -3.9076    0.0000 O   0  0
    7.3523   -5.2055    0.0000 C   0  0
    8.8481   -2.6062    0.0000 C   0  0
    9.5981   -3.9052    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11  7  1  0
 11 12  2  0
 12  4  1  0
  9 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 21 24  2  0
 24 16  1  0
 24 25  1  0
 26 27  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 31  1  0
 35 36  2  0
 36 28  1  0
 33 37  1  0
 37 38  2  0
 37 39  1  0
 39 40  1  0
 40 41  2  0
 41 42  1  0
 42 43  2  0
 43 44  1  0
 43 45  1  0
 45 46  1  0
 46 47  1  0
 45 48  2  0
 48 40  1  0
 48 49  1  0
M  CHG  3   1   2  10  -1  32  -1
M  END
> <name>
NIHCC_2014

> <id>
5664

> <plate>
NGP-105-01

> <well>
D11

> <supplier_cmpd_name>
CPD000469280

> <ctcr_id>
5631

> <supplier_cmpd_id>
SAM001246538

> <smiles>
[Mg++].COc1ccc2nc([n-]c2c1)[S](=O)Cc3ncc(C)c(OC)c3C.COc4ccc5[n-]c(nc5c4)[S](=O)Cc6ncc(C)c(OC)c6C

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Esomeprazole magnesium","Omeprazole magnesium",161973-10-0,161973100,"Prilosec OTC","H 168/68 magnesium",95382-33-5,95382335,"161973-10-0 (magnesium)","161973100 (magnesium)",217087-09-7,217087097,"
Esomeprazole magnesium trihydrate","Esomeprazole magnesium salt","Omeprazole magnesium (USAN:USP)",Pr,S1743,SAM001246538,"Esomeprazole Magnesium",CPD000469280}

> <pdid>

> <targets>
{"5-alpha Reductase","Proton Pump"}

> <classes>
{}

> <pubchem_cids>
{130564,5311083}

$$$$
NIHCC_2014
  SciTegic11012413002D

 13 13  0  0  0  0            999 V2000
    6.4897   -5.2632    0.0000 N   0  0
    5.1894   -6.0109    0.0000 C   0  0
    5.1873   -7.5109    0.0000 O   0  0
    3.8912   -5.2578    0.0000 O   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
M  END
> <name>
NIHCC_2014

> <id>
5665

> <plate>
NGP-105-01

> <well>
E02

> <supplier_cmpd_name>
CPD000466378

> <ctcr_id>
4458

> <supplier_cmpd_id>
SAM001246740

> <smiles>
NC(=O)OCCCc1ccccc1

> <pd_targets>
{LMNA}

> <pathway_gtopdb>
{"Other nuclear protein"}

> <pathway_chembl>
{}

> <pathway_reactome>
{"Cell Cycle",Mitotic,"M Phase","Mitotic Metaphase and Anaphase","Mitotic Anaphase","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{}

> <broad_moa>
{"muscle relaxant"}

> <synonyms>
{phenprobamate,"3-Phenylpropyl carbamate","3Phenylpropyl carbamate",673-31-4,673314,Ansepron,Proformiphen,Actiphan,Actozine,Eirenal,Extacol,Nelaxan,Palmita,Qumamquil,Spantol,Tranquil,Fenprobamato,"Ben
zenepropanol, carbamate","Carbamic acid, 3-phenylpropyl ester","Carbamic acid, 3phenylpropyl ester",3-Phenyl-1-p,3Phenyl1p,SAM001246740,CPD000466378}

> <pdid>
PD002917

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{4770}

$$$$
NIHCC_2014
  SciTegic11012413002D

 35 36  0  0  0  0            999 V2000
   11.5279   -5.8514    0.0000 H   0  3
    9.0279   -5.8514    0.0000 Cl  0  5
    0.7549   -8.5847    0.0000 C   0  0
    2.2459   -8.7488    0.0000 C   0  0
    3.1332   -7.5416    0.0000 C   0  0
    2.6747   -6.1134    0.0000 N   0  0
    3.8912   -5.2578    0.0000 N   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5987    1.5004    0.0000 C   0  0
   -2.6012    3.0004    0.0000 C   0  0
   -3.9015    3.7484    0.0000 C   0  0
   -5.1993    2.9963    0.0000 C   0  0
   -5.1969    1.4963    0.0000 C   0  0
   -6.4947    0.7442    0.0000 Cl  0  0
   -3.8967    0.7484    0.0000 C   0  0
    5.1017   -6.1218    0.0000 C   0  0
    6.5271   -5.6548    0.0000 O   0  0
    4.6332   -7.5468    0.0000 N   0  0
    5.5071   -8.7638    0.0000 C   0  0
    4.8900  -10.1319    0.0000 C   0  0
    5.7654  -11.3509    0.0000 O   0  0
    5.1482  -12.7190    0.0000 C   0  0
    6.0214  -13.9387    0.0000 C   0  0
    5.4018  -15.3047    0.0000 C   0  0
    3.9089  -15.4511    0.0000 C   0  0
    3.0357  -14.2315    0.0000 C   0  0
    3.6553  -12.8655    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  2  3
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 11  1  0
 14 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 21 23  2  0
 23 17  1  0
  7 24  1  0
 24 25  2  0
 24 26  1  0
 26  5  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 35 30  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5666

> <plate>
NGP-105-01

> <well>
E03

> <supplier_cmpd_name>
CPD000449297

> <ctcr_id>
6177

> <supplier_cmpd_id>
SAM001246653

> <smiles>
[H+].[Cl-].CCC1=NN(CCCN2CCN(CC2)c3cccc(Cl)c3)C(=O)N1CCOc4ccccc4

> <pd_targets>
{KMT2A,MEN1,LMNA,MAPT,NPSR1,ACHE,HTR2A,SLC6A4,HTR1A,SLC6A2,CYP3A4,ADRA1A,DRD2,HTR2C,ABCB11,ADRA2A,ADRA2C,SLC6A3,HRH1,CHRM2,ABCB1,ABCC4,ADRA1B,KCNH2}

> <pathway_gtopdb>
{"Epigenetic regulator","Other nuclear protein","Other cytosolic protein","Membrane receptor",Enzyme,Transporter,"Ion channel",Reader,"Family A G protein-coupled receptor",Hydrolase,"Electrochemical t
ransporter","Cytochrome P450","Primary active transporter","Voltage-gated ion channel",Bromodomain,"Peptide receptor (family A GPCR)","Small molecule receptor (family A GPCR)","SLC superfamily of solu
te carriers","Cytochrome P450 family 3","ATP-binding cassette","Potassium channels","Short peptide receptor (family A GPCR)","Monoamine receptor","SLC06 neurotransmitter transporter family","Cytochrom
e P450 family 3A","ABCB subfamily","ABCC subfamily","Voltage-gated potassium channel","Neuropeptide receptor","Serotonin receptor","Cytochrome P450 3A4","Adrenergic receptor","Dopamine receptor","Hist
amine receptor","Acetylcholine receptor"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Ion channels","G protein-coupled receptors","Acetylcholine turnover","SLC superfamily of solute carriers","Cytochrome P450","ATP-binding cassette transporter family","
Voltage-gated ion channels","Neuropeptide S receptor","5-Hydroxytryptamine receptors","SLC6 neurotransmitter transporter family","CYP3 family",Adrenoceptors,"Dopamine receptors","ABCB subfamily","Hist
amine receptors","Acetylcholine receptors (muscarinic)","ABCC subfamily","Potassium channels","Monoamine transporter subfamily","Voltage-gated potassium channels"}

> <pathway_reactome>
{"Cell Cycle","Neuronal System",Disease,Metabolism,"Signal Transduction",Hemostasis,"Muscle contraction",Mitotic,"Transmission across Chemical Synapses","Infectious disease","Metabolism of lipids","Si
gnaling by GPCR","Disorders of transmembrane transporters","Abacavir transport and metabolism","Platelet activation","signaling and aggregation","Cardiac conduction","M Phase","Neurotransmitter recept
ors and postsynaptic signal transmission","Leishmania infection","Phospholipid metabolism","GPCR ligand binding","Neurotransmitter clearance","SLC transporter disorders","Biosynthesis of specialized p
roresolving mediators (SPMs)","Metabolism of steroids","Abacavir transmembrane transport","Response to elevated platelet cytosolic Ca2+","Phase 3 - rapid repolarisation","Mitotic Metaphase and Anaphas
e","Activation of NMDA receptors and postsynaptic events","Leishmania parasite growth and survival","Glycerophospholipid biosynthesis","Class A/1 (Rhodopsin-like receptors)","Serotonin clearance from 
the synaptic cleft","Defective SLC6A2 causes orthostatic intolerance (OI)","Biosynthesis of DHA-derived SPMs","Bile acid and bile salt metabolism","Defective SLC6A3 causes Parkinsonism-dystonia infant
ile (PKDYS)","Platelet degranulation","Mitotic Anaphase","Post NMDA receptor activation events","Anti-inflammatory response favouring Leishmania parasite infection","Synthesis of PC","Amine ligand-bin
ding receptors","Biosynthesis of maresins","Synthesis of bile acids and bile salts","Nuclear Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs","ADORA2B mediated anti-inflammatory cyt
okines production","Serotonin receptors","Biosynthesis of maresin-like SPMs",Adrenoceptors,"Dopamine receptors","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Histamine recept
ors","Muscarinic acetylcholine receptors","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA2A,CYP3A4,HTR1A,HTR2A,HTR2C,SLC6A2,SLC6A3,SLC6A4}

> <broad_moa>
{"adrenergic inhibitor","norepinephrine reuptake inhibitor","serotonin receptor antagonist","serotonin reuptake inhibitor"}

> <synonyms>
{RESTW115,"NEFAZODONE HYDROCHLORIDE",82752-99-6,82752996,"Nefazodone Hcl",Serzone,Dutonin,Menfazona,Rulivan,Reseril,"BMY 13754","Nefazodone (hydrochloride)",BMY-13754,BMY13754,Nefadar,UNII-27X63J94GR,
UNII27X63J94GR,MJ-13754-1,MJ137541,"MJ 13,754-1","MJ 13,7541",CHEBI:7495,27X63J94GR,MFCD00935760,DSSTox_CID_,DSSToxCID,DSSTox-CID-,"DSSTox CID",T3275,SAM001246653,Prestw-1152,"Nefazodone hydrochloride
",CPD000449297,"Nefazodone HCl"}

> <pdid>
PD001694

> <targets>
{5-HT Receptor,Adrenergic Receptor}

> <classes>
{GPCR/G Protein,Neuronal Signaling}

> <pubchem_cids>
{25137870,54911}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 27  0  0  0  0            999 V2000
    5.0973   -2.5078    0.0000 Cl  0  0
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 O   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.8007    1.4864    0.0000 C   0  0
   -9.0971    0.7319    0.0000 C   0  0
   -9.0919   -0.7681    0.0000 C   0  0
  -10.3875   -1.5257    0.0000 C   0  0
  -10.3802   -3.0265    0.0000 C   0  0
   -9.1607   -3.8779    0.0000 S   0  0
   -9.6143   -5.3077    0.0000 C   0  0
   -8.7243   -6.5151    0.0000 O   0  0
  -11.1143   -5.3181    0.0000 N   0  0
  -11.5877   -3.8947    0.0000 C   0  0
  -13.0148   -3.4326    0.0000 O   0  0
   -7.7903   -1.5136    0.0000 C   0  0
   -6.4939   -0.7591    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 16  1  0
 21 22  2  0
 14 23  1  0
 23 24  2  0
 24 11  1  0
  7 25  1  0
 25 26  2  0
 26  4  1  0
M  END
> <name>
NIHCC_2014

> <id>
5667

> <plate>
NGP-105-01

> <well>
E04

> <supplier_cmpd_name>
CPD000469167

> <ctcr_id>
1468

> <supplier_cmpd_id>
SAM001246600

> <smiles>
Cl.CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1

> <pd_targets>
{FABI,ABCB11,PPARA,CISD2,PPARG,CISD1,MAOB,ALDH1A1,AKR1B1,CYP3A4,ABCC4,MAOA,CA2,RXRA,TRPM3}

> <pathway_gtopdb>
{Enzyme,Transporter,"Transcription factor","Unclassified protein",Oxidoreductase,"Primary active transporter","Nuclear receptor","Cytochrome P450",Lyase,"ATP-binding cassette","Nuclear hormone recepto
r subfamily 1","Cytochrome P450 family 3","ABCB subfamily","Nuclear hormone receptor subfamily 1 group C","Cytochrome P450 family 3A","ABCC subfamily","Nuclear hormone receptor subfamily 1 group C mem
ber 1","Nuclear hormone receptor subfamily 1 group C member 3","Cytochrome P450 3A4"}

> <pathway_chembl>
{Transporters,Receptors,Enzymes,"Ion channels","ATP-binding cassette transporter family","Nuclear hormone receptors","Catecholamine turnover","1.-.-.- Oxidoreductases","Cytochrome P450","Carbonic anhy
drases","Voltage-gated ion channels","ABCB subfamily","1C. Peroxisome proliferator-activated receptors","CYP3 family","ABCC subfamily","Transient Receptor Potential channels"}

> <pathway_reactome>
{Metabolism,"Gene expression (Transcription)",Hemostasis,"Transport of small molecules","Metabolism of lipids","RNA Polymerase II Transcription","Biological oxidations","Platelet activation","signalin
g and aggregation","O2/CO2 exchange in erythrocytes","Ion channel transport","Metabolism of steroids","Generic Transcription Pathway","Phase I - Functionalization of compounds","Biosynthesis of specia
lized proresolving mediators (SPMs)","Response to elevated platelet cytosolic Ca2+","Erythrocytes take up carbon dioxide and release oxygen","Stimuli-sensing channels","Bile acid and bile salt metabol
ism","Regulation of cholesterol biosynthesis by SREBP (SREBF)","Transcriptional Regulation by MECP2","Amine Oxidase reactions","Ethanol oxidation","Metabolism of steroid hormones","Biosynthesis of DHA
-derived SPMs","Platelet degranulation","TRP channels","Synthesis of bile acids and bile salts","Activation of gene expression by SREBF (SREBP)","MECP2 regulates transcription factors","Biogenic amine
s are oxidatively deaminated to aldehydes by MAOA and MAOB","Pregnenolone biosynthesis","Biosynthesis of maresins","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Biosynthesis 
of maresin-like SPMs"}

> <broad_targets>
{PPARG,TRPM3}

> <broad_moa>
{"insulin sensitizer","PPAR receptor agonist"}

> <synonyms>
{"pioglitazone hydrochloride",112529-15-4,112529154,"Pioglitazone HCl","Pioglitazone (hydrochloride)",U-72107A,U72107A,MFCD04975446,C19H21ClN2O3S,"112529-15-4 (HCl)","112529154 (HCl)",Glustin,Zactos,N
CGC00095131-01,NCGC0009513101,"Pioditazone hydrochloride","Actos (TN)",DSSTox_,DSSTox,DSSTox-,T0214L,SAM001246600,1504401,"Pioglitazone hydrochloride",CPD000469167,"PIOGLITAZONE HYDROCHLORIDE"}

> <pdid>
PD009788

> <targets>
{Ferroptosis,PPAR}

> <classes>
{antidiabetic,Apoptosis,Cell Cycle/DNA Damage}

> <pubchem_cids>
{60560,23137834,91810984}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 23  0  0  0  0            999 V2000
    0.3640   -4.1274    0.0000 C   0  0
    1.2990   -2.9545    0.0000 C   0  0
    2.7822   -3.1780    0.0000 C   0  0
    3.7175   -2.0053    0.0000 C   0  0
    3.1695   -0.6090    0.0000 N   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 N   0  0
    2.5248    2.0135    0.0000 C   0  0
    3.9474    2.0941    0.0000 C   0  0
    3.0853    3.3217    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
    0.1115    3.2255    0.0000 N   0  0
   -1.1278    4.0705    0.0000 C   0  0
   -2.4793    3.4196    0.0000 C   0  0
   -2.5914    1.9238    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -3.1476   -0.7184    0.0000 O   0  0
   -0.7500   -1.5574    0.0000 N   0  0
    0.7500   -1.5574    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10  8  1  0
  7 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20  2  1  0
 20  6  2  0
M  END
> <name>
NIHCC_2014

> <id>
5668

> <plate>
NGP-105-01

> <well>
E05

> <supplier_cmpd_name>
CPD000048458

> <ctcr_id>
1212

> <supplier_cmpd_id>
SAM001246551

> <smiles>
Cc1ccnc2N(C3CC3)c4ncccc4C(=O)Nc12

> <pd_targets>
{"REVERSE TRANSCRIPTASE",POL,MAPK1,GAG-POL,ALDH1A1,POLB,LMNA}

> <pathway_gtopdb>
{Enzyme,"Unclassified protein","Other nuclear protein",Hydrolase,Kinase,Protease,Transferase,Oxidoreductase,"Protein Kinase","Aspartic protease","CMGC protein kinase group","Aspartic protease AA clan"
,"CMGC protein kinase MAPK family","Aspartic protease A2A subfamily","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,"Kinases (EC 2.7.x.x)","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Immune System",Disease,Metabolism,"DNA Repair","Cell Cycle","Innate Immune System","Infectious disease","Biological oxidations","Base Excision Repair",Mitotic,"Toll-like Receptor Cascades","HIV Infe
ction","Phase I - Functionalization of compounds","Resolution of Abasic Sites (AP sites)","M Phase","Toll Like Receptor 5 (TLR5) Cascade","HIV Life Cycle","Ethanol oxidation","Resolution of AP sites v
ia the multiple-nucleotide patch replacement pathway","Mitotic Metaphase and Anaphase","MyD88 cascade initiated on plasma membrane","Early Phase of HIV Life Cycle","PCNA-Dependent Long Patch Base Exci
sion Repair","Mitotic Anaphase","MAP kinase activation","Integration of provirus","Nuclear Envelope (NE) Reassembly","MAPK targets/ Nuclear events mediated by MAP kinases","2-LTR circle formation","In
itiation of Nuclear Envelope (NE) Reformation","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{CYP1A2,CYP2A6,CYP2B6,CYP2C9,CYP2D6,CYP3A4,CYP3A5}

> <broad_moa>
{"non-nucleoside reverse transcriptase inhibitor"}

> <synonyms>
{nevirapine,129618-40-2,129618402,Viramune,BI-RG-587,BIRG587,"Nevirapine anhydrous","BIRG 0587","Viramune XR",NVP,UNII-99DK7FVK1H,UNII99DK7FVK1H,"Nevirapine (Viramune)",BIRG-0587,BIRG0587,CHEMBL57,"11
-CYCLOPROPYL-4-METHYL-5H-DIPYRIDO(3,2-B:2',3'-E)(1,4)DIAZEPIN-6(11H)-ONE","11CYCLOPROPYL4METHYL5HDIPYRIDO(3,2B:2',3'E)(1,4)DIAZEPIN6(11H)ONE",MFCD00866928,NE,T1595,SAM001246551,Nevirapine,CPD000048458
}

> <pdid>
PD000851

> <targets>
{HIV,Reverse Transcriptase}

> <classes>
{Anti-infection}

> <pubchem_cids>
{4463}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 19  0  0  1  0            999 V2000
   -5.2649   -4.1084    0.0000 O   0  0
   -4.3533   -5.2996    0.0000 C   0  0
   -2.8675   -5.1069    0.0000 C   0  0  2  0  0  0
   -1.8348   -6.1949    0.0000 C   0  0
   -0.4810   -5.5489    0.0000 C   0  0
   -0.6928   -4.0817    0.0000 C   0  0  1  0  0  0
   -2.1519   -3.7886    0.0000 O   0  0
    0.3114   -2.9665    0.0000 N   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 O   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  3  2  1  1
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  3  1  0
  6  8  1  1
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  3
 16 17  1  0
 17  8  1  0
 17 11  2  0
M  END
> <name>
NIHCC_2014

> <id>
5669

> <plate>
NGP-105-01

> <well>
E06

> <supplier_cmpd_name>
CPD000058576

> <ctcr_id>
4950

> <supplier_cmpd_id>
SAM001246673

> <smiles>
OC[C@@H]1CC[C@@H](O1)n2cnc3C(=O)NC=Nc23

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{Didanosine,Prestw-153,Prestw153,CPD000058576,T2578,SAM001246673}

> <pdid>
PD000482

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{50599}

$$$$
NIHCC_2014
  SciTegic11012413002D

 48 52  0  0  1  0            999 V2000
    6.4870   -5.2597    0.0000 C   0  0
    6.4915   -3.7597    0.0000 O   0  0
    5.1945   -3.0045    0.0000 C   0  0
    5.1969   -1.5045    0.0000 C   0  0
    3.8991   -0.7525    0.0000 C   0  0
    2.5987   -1.5004    0.0000 C   0  0
    2.5965   -3.0004    0.0000 C   0  0
    3.8943   -3.7525    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5972    1.5031    0.0000 O   0  0
    2.5951    3.0039    0.0000 C   0  0  2  0  0  0
    1.2934    3.7495    0.0000 O   0  0
    1.2883    5.2495    0.0000 C   0  0  1  0  0  0
   -0.0134    5.9950    0.0000 C   0  0
    2.5847    6.0040    0.0000 C   0  0  2  0  0  0
    2.5795    7.5040    0.0000 O   0  0
    3.8863    5.2585    0.0000 C   0  0  1  0  0  0
    5.1828    6.0130    0.0000 O   0  0
    3.8915    3.7585    0.0000 C   0  0  1  0  0  0
    5.1932    3.0131    0.0000 O   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -2.5981    3.0000    0.0000 O   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -5.1984   -1.4978    0.0000 O   0  0
   -6.4971   -0.7455    0.0000 C   0  0  2  0  0  0
   -6.4920    0.7545    0.0000 O   0  0
   -7.7884    1.5090    0.0000 C   0  0  2  0  0  0
   -7.7802    3.0098    0.0000 C   0  0
   -6.4775    3.7535    0.0000 O   0  0
   -9.0901    0.7635    0.0000 C   0  0  1  0  0  0
  -10.3865    1.5180    0.0000 O   0  0
   -9.0952   -0.7365    0.0000 C   0  0  2  0  0  0
  -10.3968   -1.4820    0.0000 O   0  0
   -7.7988   -1.4910    0.0000 C   0  0  1  0  0  0
   -7.8040   -2.9910    0.0000 O   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.6011   -3.0008    0.0000 C   0  0
   -3.9020   -3.7494    0.0000 C   0  0
   -3.9050   -5.2502    0.0000 C   0  0
   -5.2051   -5.9984    0.0000 C   0  0
   -2.6073   -6.0025    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  6  9  1  0
  9 10  2  3
 10 11  1  0
 12 11  1  6
 12 13  1  0
 13 14  1  0
 14 15  1  1
 14 16  1  0
 16 17  1  6
 16 18  1  0
 18 19  1  1
 18 20  1  0
 20 12  1  0
 20 21  1  1
 10 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  2  0
 25 26  1  0
 25 27  1  0
 27 28  2  0
 28 29  1  0
 30 29  1  1
 30 31  1  0
 31 32  1  0
 32 33  1  1
 33 34  1  0
 32 35  1  0
 35 36  1  6
 35 37  1  0
 37 38  1  1
 37 39  1  0
 39 30  1  0
 39 40  1  6
 28 41  1  0
 41 42  1  0
 42 43  1  0
 43 44  2  3
 44 45  1  0
 44 46  1  0
 41 47  2  0
 47 24  1  0
 47 48  1  0
 48  9  1  0
M  END
> <name>
NIHCC_2014

> <id>
5670

> <plate>
NGP-105-01

> <well>
E07

> <supplier_cmpd_name>
CPD000466309

> <ctcr_id>
6231

> <supplier_cmpd_id>
SAM001246560

> <smiles>
COc1ccc(cc1)C2=C(O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)C(=O)c4c(O)cc(O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)c(CC=C(C)C)c4O2

> <pd_targets>
{KDM1A,POLB,PDE5A}

> <pathway_gtopdb>
{"Epigenetic regulator",Enzyme,Eraser,Phosphodiesterase,"Lysine demethylase","Phosphodiesterase 5","Lysine-specific demethylase","Phosphodiesterase 5A"}

> <pathway_chembl>
{Enzymes,"Chromatin modifying enzymes","Cyclic nucleotide turnover/signalling","1.14.11.- Histone demethylases",Phosphodiesterases,3',"5'-cyclic nucleotide (PDEs)"}

> <pathway_reactome>
{"Signal Transduction","DNA Repair",Hemostasis,"Intracellular signaling by second messengers","Base Excision Repair","Platelet homeostasis","PIP3 activates AKT signaling","Resolution of Abasic Sites (
AP sites)","Nitric oxide stimulates guanylate cyclase","PTEN Regulation","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","cGMP effects","Regulation of PTEN gene transcri
ption","PCNA-Dependent Long Patch Base Excision Repair"}

> <broad_targets>
{PDE5A}

> <broad_moa>
{"phosphodiesterase inhibitor"}

> <synonyms>
{Icariin,489-32-7,489327,Ieariline,UNII-VNM47R2QSQ,UNIIVNM47R2QSQ,CHEBI:78420,VNM47R2QSQ,Icariine,MFCD00210516,SMR000466309,"Horny goat weed",Icariin;,"Epimedium Extract","Epimedii herba icariin",Spec
trum2_001695,Spectrum2001695,Spectrum2-001695,"Spectrum2 001695",Spectrum3_001130,Spectrum3001130,Spectrum3-001130,"Spectrum3 001130",Spectrum4_001975,Spectrum4001975,Spectrum4-001975,"Spectrum4 00197
5",Spectrum5_000933,Spectrum5000933,Spectrum5-000933,"Spectrum5 000933",T2855,SAM001246560,1505257,CPD000466309,ICARIIN}

> <pdid>
PD000540

> <targets>
{}

> <classes>
{hepatoprotective}

> <pubchem_cids>
{5318997}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 23  0  0  0  0            999 V2000
    3.8926   -3.7566    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2948   -3.7516    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -2.5981    3.0000    0.0000 O   0  0
   -5.1968    1.5004    0.0000 C   0  0
   -6.4971    0.7525    0.0000 C   0  0
   -7.7950    1.5045    0.0000 C   0  0
   -7.7926    3.0045    0.0000 C   0  0
   -6.4924    3.7525    0.0000 C   0  0
   -5.1945    3.0004    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  3
 12 13  1  0
 13  8  1  0
 13 14  2  0
 12 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
  9 21  2  0
 21  5  1  0
M  END
> <name>
NIHCC_2014

> <id>
5671

> <plate>
NGP-105-01

> <well>
E08

> <supplier_cmpd_name>
CPD000059060

> <ctcr_id>
996

> <supplier_cmpd_id>
SAM001246714

> <smiles>
CC(C)Oc1ccc2c(OC=C(C2=O)c3ccccc3)c1

> <pd_targets>
{GAA,MAPT,NPC1,CASP3,RAB9A,KMT2A,MEN1,SENP6,RORC,HTT,HIF1A,MAPK1,POLB,SENP7,SENP8,SMN1,ALDH1A1,SLC6A2,PTGS1,STAT1}

> <pathway_gtopdb>
{Enzyme,"Other cytosolic protein",Transporter,"Epigenetic regulator","Transcription factor","Unclassified protein",Hydrolase,Protease,Reader,"Nuclear receptor",Kinase,Oxidoreductase,"Electrochemical t
ransporter","Cysteine protease",Bromodomain,"Nuclear hormone receptor subfamily 1","Protein Kinase","Methyl-lysine/arginine binding protein","SLC superfamily of solute carriers","Cysteine protease CD 
clan","Cysteine protease CE clan","Nuclear hormone receptor subfamily 1 group F","CMGC protein kinase group","Tudor domain","SLC06 neurotransmitter transporter family","Cysteine protease C14 family","
Cysteine protease C48 family","Nuclear hormone receptor subfamily 1 group F member 3","CMGC protein kinase MAPK family","Cysteine protease C14A subfamily","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Transporters,Receptors,"3.2.1.- Glycosidases","SLC superfamily of solute carriers","Peptidases and proteinases","Nuclear hormone receptors","Kinases (EC 2.7.x.x)","Eicosanoid turnover","SLC65
 NPC-type cholesterol transporters","CD: Cysteine (C) Peptidases","CE: Cysteine (C) Peptidases","1F. Retinoic acid-related orphans","CMGC: Containing CDK",MAPK,GSK3,"CLK families","SLC6 neurotransmitt
er transporter family",Cyclooxygenase,"C14: Caspase","C48: Ulp1 endopeptidase","Mitogen-activated protein kinases (MAP kinases)","Monoamine transporter subfamily","ERK subfamily"}

> <pathway_reactome>
{Disease,"Neuronal System","Transport of small molecules","Programmed Cell Death","Signal Transduction","Gene expression (Transcription)","Cellular responses to external stimuli","Immune System","DNA 
Repair","Metabolism of proteins","Metabolism of RNA",Metabolism,"Diseases of metabolism","Transmission across Chemical Synapses","Plasma lipoprotein assembly",remodeling,"and clearance",Apoptosis,"Sig
naling by Rho GTPases","RNA Polymerase II Transcription","Cellular responses to stress","Innate Immune System","Base Excision Repair","Post-translational protein modification","Metabolism of non-codin
g RNA","Biological oxidations","Disorders of transmembrane transporters","Metabolism of lipids","Diseases of signal transduction by growth factor receptors and second messengers","Diseases of carbohyd
rate metabolism","Neurotransmitter receptors and postsynaptic signal transmission","Plasma lipoprotein clearance","Intrinsic Pathway for Apoptosis","Rho GTPase cycle","Generic Transcription Pathway","
Cellular response to hypoxia","Toll-like Receptor Cascades","Resolution of Abasic Sites (AP sites)",Deubiquitination,"snRNP Assembly","Phase I - Functionalization of compounds","SLC transporter disord
ers","Fatty acid metabolism","Signaling by FGFR in disease","Glycogen storage diseases","Activation of NMDA receptors and postsynaptic events","LDL clearance","Apoptotic factor-mediated response","RHO
BTB GTPase Cycle","Transcriptional regulation by RUNX3","Transcriptional Regulation by MECP2","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Toll Like Receptor 5 (TLR5) Ca
scade","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","UCH proteinases","Ethanol oxidation","Defective SLC6A2 causes orthostatic intolerance (OI)","Arachidonic acid met
abolism","Signaling by FGFR1 in disease","Glycogen storage disease type II (GAA)","Post NMDA receptor activation events","Cytochrome c-mediated apoptotic response","RHOBTB3 ATPase cycle","RUNX3 Regula
tes Immune Response and Cell Migration","Regulation of MECP2 expression and activity","MyD88 cascade initiated on plasma membrane","PCNA-Dependent Long Patch Base Excision Repair","Synthesis of Prosta
glandins (PG) and Thromboxanes (TX)","FGFR1 mutant receptor activation","Activation of AMPK downstream of NMDARs","Activation of caspases through apoptosome-mediated cleavage","MAP kinase activation",
"Signaling by cytosolic FGFR1 fusion mutants","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{}

> <broad_moa>
{"bone resorption inhibitor"}

> <synonyms>
{35212-22-7,35212227,Osten,Osteofix,Yambolap,7-Isopropoxyisoflavone,7Isopropoxyisoflavone,Iprosten,Ipriflavonum,Ipriflavona,Osteoquine,7-isopropoxy-3-phenyl-4H-chromen-4-one,7isopropoxy3phenyl4Hchrome
n4one,7-Isopropoxy-3-phenyl-4H-1-benzopyran-4-one,7Isopropoxy3phenyl4H1benzopyran4one,"Ipriflavone (Osteofix)","Ipriflavone (INN:J",T0309,SAM001246714,Ipriflavone,CPD000059060}

> <pdid>
PD002503

> <targets>
{Others}

> <classes>
{Others}

> <pubchem_cids>
{3747}

$$$$
NIHCC_2014
  SciTegic11012413002D

 61 66  0  0  1  0            999 V2000
    7.6899   -0.0398    0.0000 C   0  0
    6.3791   -0.7692    0.0000 O   0  0
    5.0900    0.0000    0.0000 C   0  0  1  0  0  0
    5.0900    1.6400    0.0000 C   0  0
    6.2800    2.4100    0.0000 C   0  0
    6.2800    3.9400    0.0000 O   0  0
    3.9000    3.9400    0.0000 C   0  0  1  0  0  0
    4.9607    2.8793    0.0000 C   0  0
    3.9000    2.4100    0.0000 O   0  0
    2.7100    1.6400    0.0000 C   0  0
    2.7100    0.0000    0.0000 C   0  0
    4.0276   -0.7168    0.0000 C   0  0
    1.5200   -0.7700    0.0000 C   0  0
    1.5200   -2.2700    0.0000 O   0  0
    0.3300    0.0000    0.0000 C   0  0
   -0.8500   -0.7700    0.0000 C   0  0
   -2.0400    0.0000    0.0000 C   0  0
   -3.2300   -0.7700    0.0000 N   0  0
   -3.2300   -2.2000    0.0000 C   0  0
   -1.9103   -2.9129    0.0000 O   0  0
   -4.4200   -2.9800    0.0000 C   0  0
   -4.4200   -4.9700    0.0000 C   0  0
   -3.2300   -5.8400    0.0000 C   0  0
   -2.0400   -4.9700    0.0000 C   0  0
   -0.8500   -5.8400    0.0000 C   0  0  2  0  0  0
   -0.8470   -7.3400    0.0000 C   0  0
    0.3300   -4.9700    0.0000 C   0  0  2  0  0  0
    0.3270   -3.4700    0.0000 O   0  0
    1.5200   -5.8400    0.0000 C   0  0  1  0  0  0
    1.4216   -7.3368    0.0000 C   0  0
    2.7100   -5.1900    0.0000 C   0  0  1  0  0  0
    4.0001   -5.9553    0.0000 O   0  0
    2.7100   -3.2000    0.0000 C   0  0  1  0  0  0
    1.3688   -2.5283    0.0000 C   0  0
    3.9000   -2.3100    0.0000 C   0  0  2  0  0  0
    5.2343   -3.0003    0.0000 O   0  0
    5.3042   -4.4995    0.0000 C   0  0
    4.0412   -5.3088    0.0000 C   0  0
    6.6363   -5.1890    0.0000 O   0  0
    3.9000   -0.7700    0.0000 C   0  0  2  0  0  0
    2.5824   -0.0532    0.0000 C   0  0
   -5.7397   -2.2671    0.0000 C   0  0
   -2.0400    1.6400    0.0000 C   0  0
   -3.2300    2.4100    0.0000 N   0  0
   -3.2300    3.9400    0.0000 C   0  0
   -4.4200    3.1800    0.0000 C   0  0
   -5.6100    3.9400    0.0000 C   0  0
   -5.6100    5.6000    0.0000 N   0  0
   -4.4200    6.3700    0.0000 C   0  0
   -3.2300    5.6000    0.0000 C   0  0
   -6.8932    6.3788    0.0000 C   0  0
   -6.8598    7.8793    0.0000 C   0  0
   -8.1414    8.6588    0.0000 C   0  0
   -5.5442    8.5998    0.0000 C   0  0
   -0.8500    3.9400    0.0000 N   0  0
   -0.8500    2.4100    0.0000 C   0  0
    0.3300    1.6400    0.0000 C   0  0
    1.5200    2.4100    0.0000 C   0  0
    1.5200    3.9400    0.0000 C   0  0
    0.4593    5.0007    0.0000 O   0  0
   -0.8471   -2.2700    0.0000 O   0  0
  1  2  1  0
  3  2  1  6
  3  4  1  0
  4  5  2  3
  5  6  1  0
  6  7  1  0
  7  8  1  6
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 13 15  2  0
 15 16  1  0
 16 17  2  3
 17 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  2  3
 22 23  1  0
 23 24  2  3
 24 25  1  0
 25 26  1  1
 25 27  1  0
 27 28  1  6
 27 29  1  0
 29 30  1  6
 29 31  1  0
 31 32  1  6
 31 33  1  0
 33 34  1  1
 33 35  1  0
 35 36  1  1
 36 37  1  0
 37 38  1  0
 37 39  2  0
 35 40  1  0
 40  3  1  0
 40 41  1  6
 21 42  1  0
 17 43  1  0
 43 44  2  3
 44 45  1  0
 45 46  1  0
 46 47  1  0
 47 48  1  0
 48 49  1  0
 49 50  1  0
 50 45  1  0
 48 51  1  0
 51 52  1  0
 52 53  1  0
 52 54  1  0
 45 55  1  0
 55 56  2  3
 56 43  1  0
 56 57  1  0
 57 15  1  0
 57 58  2  0
 58 10  1  0
 58 59  1  0
 59  7  1  0
 59 60  2  0
 16 61  1  0
M  END
> <name>
NIHCC_2014

> <id>
5672

> <plate>
NGP-105-01

> <well>
E09

> <supplier_cmpd_name>
CPD000466322

> <ctcr_id>
3247

> <supplier_cmpd_id>
SAM001246589

> <smiles>
CO[C@H]1C=CO[C@@]2(C)Oc3c(C)c(O)c4C(=C(NC(=O)C(=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C)C5=NC6(CCN(CC6)CC(C)C)N=C5c4c3C2=O)O

> <pd_targets>
{FTL,NPSR1,POLB,MAPT}

> <pathway_gtopdb>
{"Unclassified protein","Membrane receptor",Enzyme,"Other cytosolic protein","Family A G protein-coupled receptor","Peptide receptor (family A GPCR)","Short peptide receptor (family A GPCR)","Neuropep
tide receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Neuropeptide S receptor"}

> <pathway_reactome>
{"Vesicle-mediated transport",Disease,"DNA Repair","Neuronal System","Membrane Trafficking","Infectious disease","Base Excision Repair","Transmission across Chemical Synapses","trans-Golgi Network Ves
icle Budding","Leishmania infection","Resolution of Abasic Sites (AP sites)","Neurotransmitter receptors and postsynaptic signal transmission","Golgi Associated Vesicle Biogenesis","Leishmania parasit
e growth and survival","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Activation of NMDA receptors and postsynaptic events","Anti-inflammatory response favouring Leish
mania parasite infection","PCNA-Dependent Long Patch Base Excision Repair","Post NMDA receptor activation events","ADORA2B mediated anti-inflammatory cytokines production","Activation of AMPK downstre
am of NMDARs"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{NC00221,SAM001246589,CPD000466322}

> <pdid>
PD002887

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{51619}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 21  0  0  0  0            999 V2000
    7.5973    1.1128    0.0000 H   0  3
    5.0973    1.1128    0.0000 Cl  0  5
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5988    1.5006    0.0000 C   0  0
   -3.8969    0.7474    0.0000 C   0  0
   -3.8946   -0.7535    0.0000 N   0  0
   -5.1920   -1.5063    0.0000 C   0  0
   -2.5942   -1.5010    0.0000 C   0  0
   -2.5994    3.0015    0.0000 C   0  0
   -1.3013    3.7531    0.0000 O   0  0
   -3.8616    2.2295    0.0000 C   0  0
   -5.1613    2.9784    0.0000 C   0  0
   -5.1626    4.4784    0.0000 C   0  0
   -3.8642    5.2295    0.0000 C   0  0
   -2.5645    4.4806    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  8 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 11 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 16  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5673

> <plate>
NGP-105-01

> <well>
E10

> <supplier_cmpd_name>
CPD000469154

> <ctcr_id>
6059

> <supplier_cmpd_id>
SAM001246572

> <smiles>
[H+].[Cl-].COc1ccc(cc1)C(CN(C)C)C2(O)CCCCC2

> <pd_targets>
{SLC6A3,SLC6A2,NET,SLC6A4,ADRA1A,LMNA}

> <pathway_gtopdb>
{Transporter,"Membrane receptor","Other nuclear protein","Electrochemical transporter","Family A G protein-coupled receptor","SLC superfamily of solute carriers","Small molecule receptor (family A GPC
R)","SLC06 neurotransmitter transporter family","Monoamine receptor","Adrenergic receptor"}

> <pathway_chembl>
{Transporters,Receptors,"SLC superfamily of solute carriers","G protein-coupled receptors","SLC6 neurotransmitter transporter family",Adrenoceptors,"Monoamine transporter subfamily"}

> <pathway_reactome>
{Disease,"Neuronal System","Signal Transduction","Cell Cycle","Disorders of transmembrane transporters","Transmission across Chemical Synapses","Signaling by GPCR",Mitotic,"SLC transporter disorders",
"Neurotransmitter clearance","GPCR ligand binding","M Phase","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Serotonin clearance from the synaptic cleft","Class A/1 (Rhodopsin-like 
receptors)","Mitotic Metaphase and Anaphase","Defective SLC6A2 causes orthostatic intolerance (OI)","Amine ligand-binding receptors","Mitotic Anaphase",Adrenoceptors,"Nuclear Envelope (NE) Reassembly"
,"Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{SLC6A2,SLC6A4}

> <broad_moa>
{"adrenergic inhibitor","norepinephrine reuptake inhibitor","serotoninânorepinephrine reuptake inhibitor (SNRI)"}

> <synonyms>
{"Venlafaxine hydrochloride",99300-78-4,99300784,"VENLAFAXINE HCl",Effexor,Efexor,"Effexor XR",Trevilor,Dobupal,Vandral,Wy-45030,Wy45030,"Venlafaxine (hydrochloride)","Wy 45030","Wy-45,030","Wy45,030"
,"Wy 45030 hydrochloride",1-(2-(Dimethylamino)-1-(4-met,1(2(Dimethylamino)1(4met,S1441,SAM001246572,Venlafaxine,CPD000469154}

> <pdid>
PD010124

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{62923,25137858}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 30  0  0  0  0            999 V2000
    2.6030   -2.9977    0.0000 O   0  0
    2.6003   -1.4977    0.0000 C   0  0
    3.8983   -0.7459    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
   -0.0031    3.0008    0.0000 N   0  0
   -1.3039    3.7494    0.0000 N   0  0
   -1.3070    5.2502    0.0000 C   0  0
   -2.6061    6.0003    0.0000 C   0  0
   -2.6061    7.5003    0.0000 C   0  0
   -1.3071    8.2503    0.0000 C   0  0
   -0.0080    7.5003    0.0000 C   0  0
   -0.0080    6.0003    0.0000 C   0  0
   -1.3071    9.7511    0.0000 S   0  0
   -0.0079   10.5008    0.0000 O   0  0
   -1.3065   11.2511    0.0000 O   0  0
   -2.6064   10.5023    0.0000 N   0  0
   -2.6065   12.0032    0.0000 C   0  0
   -3.9040   12.7559    0.0000 C   0  0
   -3.9010   14.2558    0.0000 C   0  0
   -2.6004   15.0032    0.0000 C   0  0
   -1.3029   14.2506    0.0000 C   0  0
   -1.3059   12.7506    0.0000 N   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  9 10  1  0
  6 11  1  0
 11 12  2  3
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 16 19  1  0
 19 20  2  0
 19 21  2  0
 19 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
M  END
> <name>
NIHCC_2014

> <id>
5674

> <plate>
NGP-105-01

> <well>
E11

> <supplier_cmpd_name>
CPD000059146

> <ctcr_id>
6347

> <supplier_cmpd_id>
SAM001246530

> <smiles>
OC(=O)c1cc(ccc1O)N=Nc2ccc(cc2)[S](=O)(=O)Nc3ccccn3

> <pd_targets>
{CASP1,CA1,CA2,LMNA,AKR1B1,MAPK1,AR,HPGD,ALDH1A1,HIF1A,TSHR,MAPT,SLC7A11,MMP1,KMT2A,MEN1,SLC46A1,TNF,SLCO1B3,ABCC3,SLCO2B1,SLCO1B1,TBXAS1,ABCC4,SLC10A1,PTGS1,PTGS2,ALOX5,PPARG,CHUK,IKBKB,ACAT1,PLA2G1B
}

> <pathway_gtopdb>
{Enzyme,"Other nuclear protein","Transcription factor","Membrane receptor","Other cytosolic protein",Transporter,"Epigenetic regulator","Secreted protein",Protease,Lyase,Oxidoreductase,Kinase,"Nuclear
 receptor","Family A G protein-coupled receptor","Electrochemical transporter",Reader,"Primary active transporter","Cytochrome P450",Transferase,Hydrolase,"Cysteine protease","Protein Kinase","Nuclear
 hormone receptor subfamily 3","Peptide receptor (family A GPCR)","SLC superfamily of solute carriers","Metallo protease",Bromodomain,"ATP-binding cassette","Cytochrome P450 family 5","Nuclear hormone
 receptor subfamily 1","Cysteine protease CD clan","CMGC protein kinase group","Nuclear hormone receptor subfamily 3 group C","Glycohormone receptor","SLC03 and SLC07 families of heteromeric amino aci
d transporters (HATs)","Metallo protease MAM clan","SLC46 family of folate transporters","SLC21/SLCO family of organic anion transporting polypeptides","ABCC subfamily","Cytochrome P450 family 5A","SL
C10 family of sodium-bile acid co-transporters","Nuclear hormone receptor subfamily 1 group C","Other protein kinase group","Cysteine protease C14 family","CMGC protein kinase MAPK family","Nuclear ho
rmone receptor subfamily 3 group C member 4","SLC07 Cationic amino acid transporter/glycoprotein-associated family","Metallo protease M10A subfamily","Cytochrome P450 5A1","Nuclear hormone receptor su
bfamily 1 group C member 3","Other protein kinase IKK family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Peptidases and proteinases","Carbonic anhydrases","1.-.-.- Oxidoreductases","Kinases (EC 2.7.x.x)","Nuclear hormone receptors","Eicosanoid turnover","G protein-coupled
 receptors","SLC superfamily of solute carriers","ATP-binding cassette transporter family","Cytochrome P450","Catalytic receptors","Lanosterol biosynthesis pathway","Glycerophospholipid turnover","CD:
 Cysteine (C) Peptidases","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Steroid hormone receptors","Prostaglandin synthases","Glycoprotein hormone receptors","SLC3 and SLC7 families of heteromeric 
amino acid transporters (HATs)","MA: Metallo (M) Peptidases","SLC46 family of folate transporters","SLCO family of organic anion transporting polypeptides","ABCC subfamily",CYP5,"CYP7 and CYP8 familie
s","SLC10 family of sodium-bile acid co-transporters",Lipoxygenases,Cyclooxygenase,"1C. Peroxisome proliferator-activated receptors","Receptor kinases","Phospholipase A<sub>2</sub>","C14: Caspase","Mi
togen-activated protein kinases (MAP kinases)","3C. 3-Ketosteroid receptors","SLC7 family","M10: Matrix metallopeptidase","Other protein kinases","ERK subfamily","IKK family"}

> <pathway_reactome>
{"Gene expression (Transcription)","Immune System","Transport of small molecules","Cell Cycle",Metabolism,"Cellular responses to external stimuli",Disease,"Neuronal System",Hemostasis,"RNA Polymerase 
II Transcription","Cytokine Signaling in Immune system","O2/CO2 exchange in erythrocytes",Mitotic,"Metabolism of lipids","Innate Immune System","Biological oxidations","Cellular responses to stress","
Infectious disease","Transmission across Chemical Synapses","SLC-mediated transmembrane transport","Metabolism of vitamins and cofactors","Platelet activation","signaling and aggregation","Generic Tra
nscription Pathway","Signaling by Interleukins","Erythrocytes take up carbon dioxide and release oxygen","M Phase","Metabolism of steroids","Toll-like Receptor Cascades","Biosynthesis of specialized p
roresolving mediators (SPMs)","Phase I - Functionalization of compounds","Cellular response to hypoxia","Leishmania infection","Neurotransmitter receptors and postsynaptic signal transmission","Transp
ort of inorganic cations/anions and amino acids/oligopeptides","Metabolism of water-soluble vitamins and cofactors","Transport of vitamins",nucleosides,"and related molecules","Response to elevated pl
atelet cytosolic Ca2+","Fatty acid metabolism","Ketone body metabolism","Phospholipid metabolism","Transcriptional Regulation by TP53","Interleukin-12 family signaling","Mitotic Metaphase and Anaphase
","Metabolism of steroid hormones","Toll Like Receptor 5 (TLR5) Cascade","Transcriptional regulation by RUNX2","Biosynthesis of DHA-derived SPMs","Ethanol oxidation","Oxygen-dependent proline hydroxyl
ation of Hypoxia-inducible Factor Alpha","Leishmania parasite growth and survival","Activation of NMDA receptors and postsynaptic events","Amino acid transport across the plasma membrane","Interleukin
-4 and Interleukin-13 signaling","Metabolism of folate and pterines","Interleukin-10 signaling","Bile acid and bile salt metabolism","Transport of organic anions","Cytochrome P450 - arranged by substr
ate type","Platelet degranulation","Biosynthesis of DPA-derived SPMs","Arachidonic acid metabolism","Transcriptional Regulation by MECP2","Toll Like Receptor 4 (TLR4) Cascade","Synthesis of Ketone Bod
ies","Glycerophospholipid biosynthesis","TP53 Regulates Transcription of Cell Death Genes","Interleukin-12 signaling","Mitotic Anaphase","Pregnenolone biosynthesis","MyD88 cascade initiated on plasma 
membrane","RUNX2 regulates bone development","Biosynthesis of D-series resolvins","Anti-inflammatory response favouring Leishmania parasite infection","Post NMDA receptor activation events","Recycling
 of bile acids and salts",Eicosanoids,"Biosynthesis of DPAn-3 SPMs","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","MECP2 regulates transcription factors","MyD88-independent TLR4 cascade","A
cyl chain remodelling of PC","TP53 Regulates Transcription of Caspase Activators and Caspases","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","Nuclear Envelope (N
E) Reassembly","MAP kinase activation","RUNX2 regulates osteoblast differentiation","ADORA2B mediated anti-inflammatory cytokines production","Activation of AMPK downstream of NMDARs","Biosynthesis of
 DPAn-3-derived 13-series resolvins","TRIF(TICAM1)-mediated TLR4 signaling","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","IKK complex recrui
tment mediated by RIP1","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{ACAT1,ALOX5,CHUK,IKBKB,PLA2G1B,PPARG,PTGS1,PTGS2,SLC46A1,SLC7A11,TBXAS1}

> <broad_moa>
{"cyclooxygenase inhibitor"}

> <synonyms>
{sulfasalazine,599-79-1,599791,Azulfidine,Salicylazosulfapyridine,Salazosulfapyridine,Sulphasalazine,Salazopyrin,Asulfidine,Salazopyridin,Accucol,Azopyrin,Sulcolon,Colo-Pleon,ColoPleon,Salazopiridazin
,Azopyrine,Benzosulfa,Reupirin,Salisulf,Salazosulfapyridin,SAM001246530,CPD000059146}

> <pdid>
PD001744

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5339}

$$$$
NIHCC_2014
  SciTegic11012413002D

 15 15  0  0  1  0            999 V2000
    7.4300    0.2350    0.0000 Cl  0  5
    2.4768   -0.6464    0.0000 C   0  0
    1.1700    0.0900    0.0000 C   0  0  2  0  0  0
    1.1700    1.5200    0.0000 C   0  0
    0.0000    2.2400    0.0000 C   0  0
   -1.3200    1.5200    0.0000 C   0  0
   -1.3200    0.0900    0.0000 C   0  0  2  0  0  0
   -2.7075    0.6600    0.0000 C   0  0
    0.0000   -0.6200    0.0000 C   0  0
   -2.1100   -0.8400    0.0000 C   0  0
   -1.0400   -0.3900    0.0000 C   0  0
   -1.3177   -1.8641    0.0000 N   0  0
   -1.0400    1.1000    0.0000 C   0  0
    0.0400   -1.0200    0.0000 C   0  0
    4.9300    0.2350    0.0000 H   0  3
  3  2  1  1
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  1
  7  9  1  0
  9  3  1  0
  7 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13  5  1  0
 11 14  1  0
 14  3  1  0
M  CHG  2   1  -1  15   1
M  END
> <name>
NIHCC_2014

> <id>
5675

> <plate>
NGP-105-01

> <well>
F02

> <supplier_cmpd_name>
CPD000058926

> <ctcr_id>
1576

> <supplier_cmpd_id>
SAM001246743

> <smiles>
[Cl-].C[C@]12CC3C[C@](C)(C1)CC(N)(C3)C2.[H+]

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{}

> <broad_moa>
{"glutamate receptor antagonist"}

> <synonyms>
{MLS001401420,"Memantine HCI","Memantine, HCl","1,3-Dimethylaminoadamantane hydrochloride","1,3Dimethylaminoadamantane hydrochloride","1,3 Dimethylaminoadamantane hydrochloride","3,5-DIMETHYLADAMANTAN
-1-AMINE HCL","3,5DIMETHYLADAMANTAN1AMINE HCL",3,"5DIMETHYLADAMANTAN1AMINE H",SAM001246743,CPD000058926}

> <pdid>
PD009581

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{11229655}

$$$$
NIHCC_2014
  SciTegic11012413002D

 31 33  0  0  1  0            999 V2000
   12.2002   -0.3280    0.0000 Cl  0  5
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5987    1.5004    0.0000 N   0  0
    3.9511    0.8815    0.0000 C   0  0
    4.9523    1.9974    0.0000 C   0  0  2  0  0  0
    6.4523    1.9998    0.0000 C   0  0
    7.2002    3.3000    0.0000 C   0  0
    6.4482    4.5979    0.0000 C   0  0
    4.9482    4.5955    0.0000 N   0  0
    4.2002    3.2953    0.0000 C   0  0  2  0  0  0
    2.7342    2.9815    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 F   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 O   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 N   0  0
    1.2997   -3.7504    0.0000 C   0  0
    1.9725   -5.0026    0.0000 C   0  0
    2.7205   -3.7024    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -3.8963   -3.7531    0.0000 C   0  0
   -5.1966   -3.0054    0.0000 O   0  0
   -3.8941   -5.2531    0.0000 O   0  0
    9.7002   -0.3280    0.0000 H   0  3
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  8  7  1  1
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 13 12  1  1
 13  8  1  0
 13 14  1  0
 14  6  1  0
  5 15  1  0
 15 16  1  0
 15 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  2  3
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 24  1  0
 23 27  1  0
 27  4  1  0
 27 18  2  0
 21 28  1  0
 28 29  1  0
 28 30  2  0
M  CHG  2   1  -1  31   1
M  END
> <name>
NIHCC_2014

> <id>
5676

> <plate>
NGP-105-01

> <well>
F03

> <supplier_cmpd_name>
CPD000469185

> <ctcr_id>
1913

> <supplier_cmpd_id>
SAM001246654

> <smiles>
[Cl-].COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc4C(=O)C(=CN(C5CC5)c14)C(O)=O.[H+]

> <pd_targets>
{SKA,GYRA,GYRB,PARC,KCNH2,SCN5A,PARE,TOP2A}

> <pathway_gtopdb>
{Enzyme,"Ion channel",Kinase,Isomerase,"Voltage-gated ion channel","Potassium channels","Voltage-gated sodium channel","Voltage-gated potassium channel"}

> <pathway_chembl>
{"Ion channels",Enzymes,"Voltage-gated ion channels","DNA topoisomerases","Potassium channels","Voltage-gated sodium channels","Voltage-gated potassium channels"}

> <pathway_reactome>
{"Muscle contraction","Developmental Biology","Cell Cycle","Cardiac conduction","Nervous system development",Mitotic,"Phase 3 - rapid repolarisation","Axon guidance","Mitotic G1 phase and G1/S transit
ion","L1CAM interactions","G0 and Early G1","Interaction between L1 and Ankyrins","Transcription of E2F targets under negative control by DREAM complex"}

> <broad_targets>
{TOP2A}

> <broad_moa>
{"bacterial DNA gyrase inhibitor"}

> <synonyms>
{AC-1275,BCP9000963,"Moxifloxacin hydrochloride",186826-86-8,"Moxifloxacin HCl",Avelox,Avalox,Vigamox,"Moxifloxacin (Hydrochloride)","BAY 12-8039",Izilox,UNII-C53598599T,Bay-12-8039,CHEBI:7008,Moxeza,
MFCD00949117,C53598599T,DSSTox_CID_25921,DSSTox_RID_81224,DSSTox_GSID_45921,"Moxifloxacine hydrochloride","186826-86-8 (HCl); 354812-41-2 (free base)",Octegra,Actira,"Vigamox (TN)","Avelox (TN)",MFLX,
CAS-186826-86-8,Moxivig,Vegamox,"BAY12-8039 HCl","Moxifloxacin, HCl",NCGC00095130-01,BAY12-8039,"Moxifloxacin hydrochloride (USAN:USP)","AVELOX IN SODIUM CHLORIDE 0.8 IN PLASTIC CONTAINER",CPD00046918
5,cc-97,C21H25ClFN3O4,SCHEMBL37285,MLS001401368,CHEMBL1200735,DTXSID4045921,ACT02692,AMY25227,BCP03623,Tox21_111439,AL-15469A,CM0156,"Moxifloxacin hydrochloride (JAN/USP)",AKOS015920132,AKOS016015225,
CCG-100924,CS-1063,KS-1181,NC00174,NCGC00271749-02,AT-15459,HY-66011,O381,SMR000469185,BCP0726000173,AB0016427,"Moxifloxacin hydrochloride, >=98 (HPLC)",M2479,S1465,SW197554-3,D00874,S-3681,826M868,Q2
7107395,"186826-86-8  151096-09-2(base)","Moxifloxacin hydrochloride, VETRANAL(TM), analytical standard","Moxifloxacin hydrochloride, European Pharmacopoeia (EP) Reference Standard",SAM001246654}

> <pdid>
PD010166

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{101526}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 24  0  0  1  0            999 V2000
    3.7951    6.9540    0.0000 Na  0  3
   -2.0578    0.3016    0.0000 C   0  0
   -0.7500   -0.4330    0.0000 C   0  0
   -0.7680   -1.9329    0.0000 C   0  0
    0.7500   -0.4330    0.0000 C   0  0
    0.0000    0.8660    0.0000 C   0  0  2  0  0  0
   -0.0032    2.3561    0.0000 C   0  0
    1.2944    3.1085    0.0000 O   0  0
   -1.3041    3.1045    0.0000 N   0  0
   -1.3073    4.6054    0.0000 C   0  0
   -2.6082    5.3538    0.0000 C   0  0
   -3.9073    4.6023    0.0000 C   0  0
   -5.2082    5.3507    0.0000 C   0  0
   -6.5073    4.5992    0.0000 C   0  0
   -7.8082    5.3476    0.0000 C   0  0
   -9.1073    4.5961    0.0000 S   0  0
  -10.4081    5.3445    0.0000 C   0  0
  -11.7072    4.5930    0.0000 C   0  0  2  0  0  0
  -11.7054    3.0930    0.0000 N   0  0
  -13.0081    5.3414    0.0000 C   0  0
  -13.0099    6.8414    0.0000 O   0  0
  -14.3065    4.5903    0.0000 O   0  0
   -0.0105    5.3608    0.0000 C   0  0
    1.2912    4.6155    0.0000 O   0  5
   -0.0154    6.8608    0.0000 O   0  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  6  3  1  0
  6  7  1  1
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  6
 18 20  1  0
 20 21  1  0
 20 22  2  0
 10 23  1  0
 23 24  1  0
 23 25  2  0
M  CHG  2   1   1  24  -1
M  END
> <name>
NIHCC_2014

> <id>
5677

> <plate>
NGP-105-01

> <well>
F04

> <supplier_cmpd_name>
CPD000469147

> <ctcr_id>
3653

> <supplier_cmpd_id>
SAM001246552

> <smiles>
[Na+].CC1(C)C[C@@H]1C(=O)NC(=C\CCCCSC[C@H](N)C(O)=O)/C([O-])=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Cilastatin sodium",81129-83-1,81129831,"Cilastatin sodium salt","CILASTATIN Na",MLS001401364,MK-791,MK791,DSSTox_CID_26915,DSSToxCID26915,DSSTox-CID-26915,"DSSTox CID 26915",DSSTox_RID_82013,DSSToxR
ID82013,DSSTox-RID-82013,"DSSTox RID 82013",DSSTox_GSID_46915,DSSToxGSID46915,DSSTox-GSID-46915,"DSSTox GSID 46915",CHEBI:59511,CAS-81129-83-1,CAS81129831,NCGC00181346-01,NCGC0018134601,Cilastatino,NC
GC00167838-01,NCGC0016783801,CHEMBL1201057,"Cilastatin s",SAM001246552,CPD000469147}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23663403,73415809,101282945,45480603}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 24  0  0  1  0            999 V2000
    3.3031   -3.1008    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
    1.0340   -4.4110    0.0000 C   0  0
    2.4133   -1.7530    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -1.3959    2.2452    0.0000 C   0  0
   -0.1471    3.0778    0.0000 O   0  0
   -0.2429    4.5755    0.0000 S   0  0
   -1.5873    5.2407    0.0000 N   0  0
    1.0052    5.4077    0.0000 O   0  0
   -0.3392    6.0724    0.0000 O   0  0
   -2.7117    1.2364    0.0000 O   0  0
   -3.6011    0.0285    0.0000 C   0  0
   -4.3232    1.3433    0.0000 C   0  0
   -4.3401   -1.2768    0.0000 C   0  0
   -2.7272   -1.1906    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.3114   -2.9665    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  1
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 11 14  2  0
  8 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 16 19  1  0
 20 19  1  6
 20  8  1  0
 20 21  1  0
 21  5  1  0
 21 22  1  1
 22  2  1  0
M  END
> <name>
NIHCC_2014

> <id>
5678

> <plate>
NGP-105-01

> <well>
F05

> <supplier_cmpd_name>
CPD000466325

> <ctcr_id>
2215

> <supplier_cmpd_id>
SAM001246601

> <smiles>
CC1(C)O[C@@H]2CO[C@@]3(CO[S](N)(=O)=O)OC(C)(C)O[C@H]3[C@@H]2O1

> <pd_targets>
{MTCA2,CA2,CA4,CA9,CA12,CA7,CA5A,CA1,CA5B,CA14,CA13,CA6,CYNT,CA15,MTCA1,NCE103,SCN2A,SCN10A,SCN11A,SCN1A,SCN3A,SCN4A,SCN5A,SCN7A,SCN8A,SCN9A,GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GAB
RB3,GABRD,GABRE,GABRG1,GABRG2,GABRG3,GABRP,GABRQ,GRIK1,GRIK2,GRIK3,GRIK4,GRIK5,GRIA1,GRIA2,GRIA3,GRIA4,CA3,CACNA1C,CACNA1D,CACNA1F,CACNA1S,CACNB1,CACNB2,CACNB3,CACNB4}

> <pathway_gtopdb>
{Enzyme,"Ion channel",Lyase,"Voltage-gated ion channel","Ligand-gated ion channel","Voltage-gated sodium channel","GABA-A receptor","Ionotropic glutamate receptor","Kainate receptor","AMPA receptor"}

> <pathway_chembl>
{Enzymes,"Ion channels","Carbonic anhydrases","Voltage-gated ion channels","Ligand-gated ion channels","Voltage-gated sodium channels","GABA<sub>A</sub> receptors"}

> <pathway_reactome>
{"Transport of small molecules","Cellular responses to external stimuli",Metabolism,"Immune System","Developmental Biology","Neuronal System","O2/CO2 exchange in erythrocytes","Cellular responses to s
tress","Reversible hydration of carbon dioxide","Cytokine Signaling in Immune system","Nervous system development","Transmission across Chemical Synapses","Erythrocytes take up carbon dioxide and rele
ase oxygen","Cellular response to hypoxia","Signaling by Interleukins","Axon guidance","Neurotransmitter receptors and postsynaptic signal transmission","Regulation of gene expression by Hypoxia-induc
ible Factor","Interleukin-12 family signaling","L1CAM interactions","GABA receptor activation","Interleukin-12 signaling","Interaction between L1 and Ankyrins","Gene and protein expression by JAK-STAT
 signaling after Interleukin-12 stimulation"}

> <broad_targets>
{CA1,CA12,CA2,CA4,CA7,GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG3,GABRP,GABRQ,GRIA1,GRIA2,GRIA3,GRIA4,GRIK1,GRIK2,GRIK3,GRIK4,GRIK5,SCN10A,SCN11A,SC
N1A,SCN2A,SCN3A,SCN4A,SCN5A,SCN7A,SCN8A,SCN9A}

> <broad_moa>
{"carbonic anhydrase inhibitor","glutamate receptor antagonist","kainate receptor antagonist"}

> <synonyms>
{97240-79-4,97240794,Topamax,Epitomax,"Topamax Sprinkle",Tipiramate,Topiramatum,McN-4853,McN4853,Tipiramato,Topiramato,"McN 4853",C12H21NO8S,RWJ-17021-000,RWJ17021000,RWJ-17021,RWJ17021,"2,3:4,5-Bis-O
-(1-methylethylidene)-beta-D-fructopyranose sulfamate","2,3:4,5BisO(1methylethylidene)betaDfructopyranose sulfamate",2,3:4,5-Di-O-i,5DiOi,T0675,SAM001246601,1505801,Prestw-1493,Topiramate,CPD000466325
,TOPIRAMATE}

> <pdid>
PD000722

> <targets>
{Calcium Channel,Carbonic Anhydrase,GABA Receptor,iGluR,Potassium Channel,Sodium Channel}

> <classes>
{antimigraine,GABA-A agonist,AMP/kinate glutamate receptor antagonist,anticonvulsant,carbonic anhydrase inhibitor,Membrane Transporter/Ion Channel,Metabolic Enzyme/Protease,Neuronal Signaling}

> <pubchem_cids>
{5284627}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 22  0  0  1  0            999 V2000
    8.8990    0.7516    0.0000 Cl  0  5
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -2.5987    1.5004    0.0000 C   0  0
   -3.8991    0.7525    0.0000 C   0  0
   -5.1969    1.5045    0.0000 C   0  0
   -5.1945    3.0045    0.0000 C   0  0
   -6.4924    3.7566    0.0000 Cl  0  0
   -3.8943    3.7525    0.0000 C   0  0
   -3.8919    5.2525    0.0000 Cl  0  0
   -2.5965    3.0004    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    6.3990    0.7516    0.0000 H   0  3
  2  3  1  0
  4  3  1  6
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  6
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 13 15  2  0
 15  8  1  0
  7 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21  4  1  0
 21 16  1  0
M  CHG  2   1  -1  22   1
M  END
> <name>
NIHCC_2014

> <id>
5679

> <plate>
NGP-105-01

> <well>
F06

> <supplier_cmpd_name>
CPD000466298

> <ctcr_id>
412

> <supplier_cmpd_id>
SAM001246666

> <smiles>
[Cl-].CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c3ccccc13.[H+]

> <pd_targets>
{MAPT,LEF,TP53,LMNA,NFKB1,THPO,CYP3A4,SLC6A3,FTL,RORC,PMP22,ALOX15,MAPK1,SLC6A2,CHRM1,SLC6A4,TSHR,KMT2A,MEN1,GMNN,ADRA1B,CYP1A2,AMPC,ABCB11,CYP2J2,CYP2C19,FFP,LUXR,CYP2D6,SIGMAR1,ADRA2B,ADRA2C,MC5R,CH
RM4,HTR2B,ABCB1,MTOR,HTR2A,CACNA1C,CHRM5,KCNH2,HTR2C,ADRA2A,CHRM2,PGRMC1,HRH1,HTR1A,CHRM3,NET,ADRA1A}

> <pathway_gtopdb>
{"Other cytosolic protein",Enzyme,"Transcription factor","Other nuclear protein","Unclassified protein",Transporter,"Membrane receptor","Epigenetic regulator","Ion channel",Protease,"Cytochrome P450",
"Electrochemical transporter","Nuclear receptor",Oxidoreductase,Kinase,"Family A G protein-coupled receptor",Reader,Hydrolase,"Primary active transporter",Transferase,"Voltage-gated ion channel","Meta
llo protease","Cytochrome P450 family 3","SLC superfamily of solute carriers","Nuclear hormone receptor subfamily 1","Protein Kinase","Small molecule receptor (family A GPCR)","Peptide receptor (famil
y A GPCR)",Bromodomain,"Cytochrome P450 family 1","ATP-binding cassette","Cytochrome P450 family 2","Voltage-gated calcium channel","Potassium channels","Metallo protease MAE clan","Cytochrome P450 fa
mily 3A","SLC06 neurotransmitter transporter family","Nuclear hormone receptor subfamily 1 group F","CMGC protein kinase group","Monoamine receptor","Glycohormone receptor","Cytochrome P450 family 1A"
,"ABCB subfamily","Cytochrome P450 family 2C","Cytochrome P450 family 2D","Short peptide receptor (family A GPCR)","Atypical protein kinase group","Voltage-gated potassium channel","Metallo protease M
34 family","Cytochrome P450 3A4","Nuclear hormone receptor subfamily 1 group F member 3","CMGC protein kinase MAPK family","Acetylcholine receptor","Adrenergic receptor","Cytochrome P450 1A1","Cytochr
ome P450 2C19","Cytochrome P450 2D6","Melanocortin receptor","Serotonin receptor","Atypical protein kinase PIKK family","CMGC protein kinase ERK1","Atypical protein kinase FRAP subfamily","Histamine r
eceptor","Dopamine receptor"}

> <pathway_chembl>
{Enzymes,Transporters,Receptors,"Other protein targets","Ion channels","Cytochrome P450","SLC superfamily of solute carriers","Nuclear hormone receptors","Eicosanoid turnover","Kinases (EC 2.7.x.x)","
G protein-coupled receptors","Chromatin modifying enzymes","ATP-binding cassette transporter family","Sigma receptors","Voltage-gated ion channels","CYP3 family","SLC6 neurotransmitter transporter fam
ily","1F. Retinoic acid-related orphans",Lipoxygenases,"CMGC: Containing CDK",MAPK,GSK3,"CLK families","Acetylcholine receptors (muscarinic)","Glycoprotein hormone receptors","2.1.1.43 Histone methylt
ransferases (HMTs)",Adrenoceptors,"CYP1 family","ABCB subfamily","CYP2 family: drug metabolising subset","Melanocortin receptors","5-Hydroxytryptamine receptors",Atypical,"Voltage-gated calcium channe
ls","Potassium channels","Monoamine transporter subfamily","Mitogen-activated protein kinases (MAP kinases)","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","Voltage-gated potassium ch
annels","ERK subfamily","FRAP subfamily","Histamine receptors","Dopamine receptors"}

> <pathway_reactome>
{"Neuronal System",Disease,"Cell Cycle","Immune System",Hemostasis,Metabolism,"Vesicle-mediated transport","Gene expression (Transcription)","Developmental Biology","Signal Transduction","Muscle contr
action","Transmission across Chemical Synapses","Infectious disease","Cell Cycle Checkpoints",Mitotic,"Cytokine Signaling in Immune system","Platelet activation","signaling and aggregation","Metabolis
m of lipids","Disorders of transmembrane transporters","Membrane Trafficking","RNA Polymerase II Transcription","Nervous system development","Innate Immune System","Signaling by GPCR","Biological oxid
ations","Abacavir transport and metabolism","Cardiac conduction","Neurotransmitter receptors and postsynaptic signal transmission","Uptake and actions of bacterial toxins","G1/S DNA Damage Checkpoints
","M Phase","Signaling by Interleukins","Platelet Aggregation (Plug Formation)","Biosynthesis of specialized proresolving mediators (SPMs)","SLC transporter disorders","trans-Golgi Network Vesicle Bud
ding","Generic Transcription Pathway","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Toll-like Receptor Cascades","GPCR ligand binding","Neurotransmitter clearance","Leishmania infe
ction","Mitotic G1 phase and G1/S transition","Phase I - Functionalization of compounds","Metabolism of steroids","SARS-CoV Infections","Abacavir transmembrane transport","Axon guidance","Phase 3 - ra
pid repolarisation","Activation of NMDA receptors and postsynaptic events","Uptake and function of anthrax toxins","p53-Dependent G1/S DNA damage checkpoint","Mitotic Metaphase and Anaphase","Interleu
kin-1 family signaling","Biosynthesis of DHA-derived SPMs","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Golgi Associated Vesicle Biogenesis","Transcriptional regulation by RUNX3"
,"Biosynthesis of DPA-derived SPMs","Toll Like Receptor 5 (TLR5) Cascade","Class A/1 (Rhodopsin-like receptors)","Serotonin clearance from the synaptic cleft","Leishmania parasite growth and survival"
,"G1/S Transition","Defective SLC6A2 causes orthostatic intolerance (OI)","Transcriptional regulation by RUNX1","Cytochrome P450 - arranged by substrate type","Bile acid and bile salt metabolism","Pot
ential therapeutics for SARS","Transcriptional Regulation by TP53","NCAM signaling for neurite out-growth","Post NMDA receptor activation events","p53-Dependent G1 DNA Damage Response","Mitotic Anapha
se","Interleukin-1 signaling","Biosynthesis of maresins","RUNX3 Regulates Immune Response and Cell Migration","Biosynthesis of DPAn-3 SPMs","MyD88 cascade initiated on plasma membrane","Amine ligand-b
inding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Activation of the pre-replicative complex","RUNX1 regulates genes involved in megakaryocyte differentiation and 
platelet function",Xenobiotics,"Synthesis of bile acids and bile salts","Fatty acids","Regulation of TP53 Activity","NCAM1 interactions","Activation of AMPK downstream of NMDARs","Stabilization of p53
","Nuclear Envelope (NE) Reassembly","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Biosynthesis of maresin-like SPMs","Biosynthesis of DPAn-3-derived protectins and resolvins","MAP kinase activation",
"Muscarinic acetylcholine receptors","ADORA2B mediated anti-inflammatory cytokines production",Adrenoceptors,"Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Synthesis of bile acids
 and bile salts via 7alpha-hydroxycholesterol","CYP2E1 reactions","Serotonin receptors","Regulation of TP53 Expression and Degradation","Autodegradation of the E3 ubiquitin ligase COP1","Initiation of
 Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","Regulation of TP53 Degradation","ERK/MAPK targets","ERKs are inactivated","Histamine receptors"}

> <broad_targets>
{SLC6A3,SLC6A4}

> <broad_moa>
{"selective serotonin reuptake inhibitor (SSRI)"}

> <synonyms>
{AKOS015896266,Zoloft,Lustral,"Cp 51,974-1",Seserine,"Sertraline hydrochloride",79559-97-0,"Sertraline HCl",Gladem,Serad,"Sertraline (hydrochloride)",UNII-UTI8907Y6X,"(+)-sertraline hydrochloride",CHE
BI:9124,UTI8907Y6X,"rac-cis-Sertraline Hydrochloride",C17H18Cl3N,MFCD00895772,Atruline,Tresleen,"Cp-51,974-1",Tatig,CP-51974-1,DSSTox_CID_20243,DSSTox_RID_79456,DSSTox_GSID_40243,79617-95-1,Adjuvin,Ar
emis,MLS001401398,"(+)-cis-(1S,4S)-1-methylamino-4-(3,4-dichlorophenyl)tetralin hydrochloride",CAS-79559-97-0,NCGC00092386-03,SMR000466298,C17H17Cl2N.HCl,Serlift,Sertraline.HCl,79617-99-5,"Sertraline,
 HCl","Sertraline hydrochloride (USAN:USP)","Zoloft (TN)",CPD000466298,CHEMBL1709,SCHEMBL23230,MLS000758929,ARONIS24360,SPECTRUM1505262,"SERTRALINE HYDRECHLORIDE",Methyl2-(Hydroxymethyl)Acrylate,DTXSI
D1040243,"(+/-)-Sertraline Hydrochloride",HY-B0176A,"(1R,4R)-SERTRALINE HCL","(1R,4S)-SERTRALINE HCL",AOB2376,HMS1922P09,Pharmakon1600-01505262,"Sertraline hydrochloride (JAN/USP)",Tox21_111199,Tox21_
500870,AC-740,CCG-39575,CS0024,NSC746308,NSC758948,SBB080777,AKOS005267232,AKOS015846322,Tox21_111199_1,AB07662,CS-2052,KS-1111,LP00870,MCULE-1681469163,NC00198,NC00726,NE57257,NSC-746308,NSC-758948,N
CGC00092386-01,NCGC00092386-13,NCGC00261555-01,"Sertraline hydrochloride Related Compound A","Sertraline hydrochloride, >=98 (HPLC)",CP-5197401,EU-0100870,S4053,D00825,J10439,559S970,Q27108281,"Sertra
line hydrochloride 100 microg/mL in Acetonitrile","Sertraline Hydrochloride 1.0 mg/ml in Methanol (as free base)","Sertraline hydrochloride, British Pharmacopoeia (BP) Reference Standard","Sertraline 
hydrochloride, European Pharmacopoeia (EP) Reference Standard",SAM002700175,SAM001246666,1505262,"SERTRALINE HYDROCHLORIDE"}

> <pdid>
PD004322

> <targets>
{"5-HT Receptor"}

> <classes>
{antidepressant,"5HT uptake inhibitor","Neuronal Signaling"}

> <pubchem_cids>
{50986904,11078406,63009}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 25  0  0  1  0            999 V2000
   -0.6872   -2.7329    0.0000 C   0  0
    0.2851   -2.9666    0.0000 C   0  0  2  0  0  0
    0.7521   -4.3921    0.0000 O   0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0  1  0  0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -1.2991    2.2500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -0.8141   -2.0807    0.0000 C   0  0
  2  1  1  1
  2  3  1  0
  2  4  1  0
  4  5  1  0
  6  5  1  6
  6  7  1  0
  7  8  1  1
  8  9  1  0
  9 10  2  3
 10 11  1  0
 11 12  1  0
 12 13  1  6
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 10  1  0
 16 17  1  6
 16 18  1  0
 18  7  1  0
 18 19  1  6
 19 20  1  0
 20 21  1  0
 21  2  1  0
 21  6  1  0
 21 22  1  6
M  END
> <name>
NIHCC_2014

> <id>
5680

> <plate>
NGP-105-01

> <well>
F07

> <supplier_cmpd_name>
CPD000466310

> <ctcr_id>
573

> <supplier_cmpd_id>
SAM001246562

> <smiles>
C[C@]1(O)CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{Methandriol,Methylandrostenediol,Mestenediol,Madiol,Diolandrone,Metandriol,Methandrolan,Protandren,Androdiol,Neosteron,Neutrosteron,Stenosterone,Cenabolic,Crestabolic,Diolostene,Esjaydiol,Methostan,M
etidione,Metildiolo,Metocryst,Nabad,SAM001246562,CPD000466310}

> <pdid>
PD003098

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{229021}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 24  0  0  0  0            999 V2000
    6.0333   -7.4056    0.0000 O   0  0
    6.9148   -6.1919    0.0000 C   0  0
    8.4065   -6.3489    0.0000 O   0  0
    6.3037   -4.8211    0.0000 C   0  0
    4.8111   -4.6641    0.0000 C   0  0
    4.2010   -3.2956    0.0000 C   0  0
    2.7343   -2.9815    0.0000 O   0  0
    2.5987   -1.5004    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.9511   -0.8815    0.0000 C   0  0
    4.9531   -1.9978    0.0000 N   0  0
    4.2567    0.5878    0.0000 C   0  0
    3.2235    1.6679    0.0000 C   0  0
    3.6446    3.1076    0.0000 C   0  0
    5.1019    3.4627    0.0000 C   0  0
    6.1382    2.3782    0.0000 C   0  0
    5.7171    0.9385    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
  8 15  2  0
 15 16  1  0
 16  6  2  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
M  END
> <name>
NIHCC_2014

> <id>
5681

> <plate>
NGP-105-01

> <well>
F08

> <supplier_cmpd_name>
CPD000058286

> <ctcr_id>
1986

> <supplier_cmpd_id>
SAM001246770

> <smiles>
OC(=O)CCc1oc(c2ccccc2)c(n1)c3ccccc3

> <pd_targets>
{SHMT2,MAPK1,PTGS1,KDM4E,PMP22,EPHX2,HPGD,CYP3A4,C5,TSHR,PTGS2,LMNA,LEF,ABCC4}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Unclassified protein","Secreted protein","Membrane receptor","Other nuclear protein",Transporter,Transferase,Kinase,Oxidoreductase,Eraser,Protease,"Cytochrome P450","Fa
mily A G protein-coupled receptor","Primary active transporter","Protein Kinase","Lysine demethylase","Serine protease","Cytochrome P450 family 3","Peptide receptor (family A GPCR)","Metallo protease"
,"ATP-binding cassette","CMGC protein kinase group","Jumonji domain-containing","Serine protease SC clan","Cytochrome P450 family 3A","Glycohormone receptor","Metallo protease MAE clan","ABCC subfamil
y","CMGC protein kinase MAPK family","Serine protease S33 family","Cytochrome P450 3A4","Metallo protease M34 family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Kinases (EC 2.7.x.x)","Eicosanoid turnover","Chromatin modifying enzymes",Hydrolases,"Cytochrome P450","G protein-coupled receptors","ATP-binding cassette transporter 
family","CMGC: Containing CDK",MAPK,GSK3,"CLK families",Cyclooxygenase,"1.14.11.- Histone demethylases","Prostaglandin synthases","CYP3 family","Glycoprotein hormone receptors","ABCC subfamily","Mitog
en-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{Metabolism,"Immune System","Developmental Biology","Signal Transduction",Disease,"Cell Cycle",Hemostasis,"Metabolism of vitamins and cofactors","Innate Immune System","Metabolism of lipids","Nervous 
system development","Signaling by GPCR","Infectious disease",Mitotic,"Platelet activation","signaling and aggregation","Metabolism of water-soluble vitamins and cofactors","Toll-like Receptor Cascades
","Fatty acid metabolism","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Biosynthesis of specialized proresolving mediators (SPMs)","GPCR ligand binding","Leishmania infection","M P
hase","Uptake and actions of bacterial toxins","Response to elevated platelet cytosolic Ca2+","Metabolism of folate and pterines","Toll Like Receptor 5 (TLR5) Cascade","Arachidonic acid metabolism","B
iosynthesis of DHA-derived SPMs","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","Biosynthesis of DPA-derived SPMs","Mitotic Metaphase and Anaphase","Uptake and functi
on of anthrax toxins","Platelet degranulation","MyD88 cascade initiated on plasma membrane","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","Biosynthesis of maresins","Biosynthesis of D-serie
s resolvins","Peptide ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Biosynthesis of DPAn-3 SPMs","Mitotic Anaphase","MAP kinase activation","Biosynthe
sis of maresin-like SPMs","ADORA2B mediated anti-inflammatory cytokines production","Nuclear Envelope (NE) Reassembly","MAPK targets/ Nuclear events mediated by MAP kinases","Initiation of Nuclear Env
elope (NE) Reformation","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{PTGS1,PTGS2}

> <broad_moa>
{"cyclooxygenase inhibitor"}

> <synonyms>
{RESTW106,oxaprozin,21256-18-8,21256188,Daypro,"3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanoic acid","3(4,5Diphenyl1,3oxazol2yl)propanoic acid",Alvo,"3-(4,5-Diphenyloxazol-2-yl)propanoic acid","3(4,5Diphen
yloxazol2yl)propanoic acid",Oxaprozine,Oxaprozinum,Deflam,"Oxaprozine (INN-French)","Oxaprozine (INNFrench)","Oxaprozinum (INN-Latin)","Oxaprozinum (INNLatin)",WY-21743,WY21743,"Oxaprozina (INN-Spanis
h)","Oxaprozina (INNSpanish)",T0708,SAM001246770,1505267,Prestw-1060,Oxaprozin,CPD000058286,OXAPROZIN}

> <pdid>
PD000533

> <targets>
{COX,NF-ºB}

> <classes>
{antiinflammatory,Immunology/Inflammation,NF-ºB}

> <pubchem_cids>
{4614}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 21  0  0  0  0            999 V2000
   10.1943   -1.5085    0.0000 H   0  3
    7.6943   -1.5085    0.0000 Cl  0  5
    5.1887   -6.0105    0.0000 C   0  0
    3.8912   -5.2578    0.0000 O   0  0
    3.8933   -3.7570    0.0000 C   0  0
    5.1937   -3.0093    0.0000 O   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 O   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -5.2029    2.9932    0.0000 O   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.8003    1.4887    0.0000 N   0  0
   -9.0990    0.7364    0.0000 C   0  0
  -10.3996    1.4837    0.0000 C   0  0
   -9.0964   -0.7636    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 12 22  1  0
 22 23  2  0
 23  9  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5682

> <plate>
NGP-105-01

> <well>
F09

> <supplier_cmpd_name>
CPD000469141

> <ctcr_id>
2228

> <supplier_cmpd_id>
SAM001246533

> <smiles>
[H+].[Cl-].COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1

> <pd_targets>
{ADRB2,ADRB1}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Adrenergic receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors",Adrenoceptors}

> <pathway_reactome>
{Disease,"Infectious disease","Leishmania infection","Leishmania parasite growth and survival","Anti-inflammatory response favouring Leishmania parasite infection","ADORA2B mediated anti-inflammatory 
cytokines production"}

> <broad_targets>
{ADRB1}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{CHEBI:4857,"(+-)-esmolol hydrochloride","(+)esmolol hydrochloride","methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate hydrochloride","methyl p(2hydroxy3(isopropylamino)propoxy)hydrocinnama
te hydrochloride",AKOS026750127,"Esmolol hydrochloride",81161-17-3,81161173,"Esmolol HCL",Brevibloc,"Esmolol (hydrochloride)",ASL-8052,ASL8052,(R)-E,(R)E,T1503,SAM001246533,Prestw-1137,CPD000469141}

> <pdid>
PD010181

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{46878362,57515992,104769}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 28  0  0  0  0            999 V2000
    7.2951   -5.3602    0.0000 Na  0  3
    2.5490  -12.2198    0.0000 C   0  0
    1.7972  -10.9218    0.0000 O   0  0
    2.5450   -9.6205    0.0000 C   0  0
    4.0450   -9.6205    0.0000 C   0  0
    4.7951   -8.3215    0.0000 C   0  0
    4.0452   -7.0225    0.0000 N   0  0
    2.5451   -7.0223    0.0000 C   0  0
    1.7974   -5.7210    0.0000 C   0  0
    2.5497   -4.4224    0.0000 S   0  0
    4.0497   -4.4250    0.0000 O   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  5
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 O   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.1996    1.4928    0.0000 F   0  0
   -3.8964   -0.7545    0.0000 F   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 N   0  0
    1.7951   -8.3214    0.0000 C   0  0
    0.2943   -8.3245    0.0000 O   0  0
   -0.4539   -9.6246    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 17 22  1  0
 22 23  2  0
 23 14  1  0
 23 24  1  0
 24 12  2  0
  8 25  2  0
 25  4  1  0
 25 26  1  0
 26 27  1  0
M  CHG  2   1   1  13  -1
M  END
> <name>
NIHCC_2014

> <id>
5683

> <plate>
NGP-105-01

> <well>
F10

> <supplier_cmpd_name>
CPD000469592

> <ctcr_id>
5093

> <supplier_cmpd_id>
SAM001246591

> <smiles>
[Na+].COc1ccnc(C[S](=O)c2[n-]c3ccc(OC(F)F)cc3n2)c1OC

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Pantoprazole (sodium)",Pantoloc,Protonix,Pantecta,Zurcal,138786-67-1,138786671,"Protonix I.V.","BY1023 (sodium); SKF96022 (sodium)",Controloc,"Protonix DR","Protonix IV","PANTOPRAZOLE SODIUM SALT","
Pantoprazole sodium sesquihydrate","Protonix delayed-","Protonix delayed",T6929,T0161,SAM001246591,"Pantoprazole sodium","Pantoprazole Sodium Hydrate",CPD000469592}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23713799,15008962}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 25  0  0  0  0            999 V2000
    9.0983   -0.7529    0.0000 C   0  0
    7.7988   -1.5020    0.0000 C   0  0
    7.7983   -3.0020    0.0000 C   0  0
    6.4990   -0.7516    0.0000 N   0  0
    5.1988   -1.5012    0.0000 C   0  0
    5.1983   -3.0012    0.0000 O   0  0
    3.8990   -0.7508    0.0000 N   0  0
    2.5988   -1.5004    0.0000 S   0  0
    2.5983   -3.0004    0.0000 O   0  0
    3.8975   -2.2510    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 N   0  0
   -1.3039   -3.7494    0.0000 C   0  0
   -1.3092   -5.2494    0.0000 C   0  0
   -2.6108   -5.9949    0.0000 C   0  0
   -3.9072   -5.2404    0.0000 C   0  0
   -3.9020   -3.7404    0.0000 C   0  0
   -5.1985   -2.9860    0.0000 C   0  0
   -2.6004   -2.9949    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  2  0
  8 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 22 24  2  0
 24 18  1  0
M  END
> <name>
NIHCC_2014

> <id>
5684

> <plate>
NGP-105-01

> <well>
F11

> <supplier_cmpd_name>
CPD000466313

> <ctcr_id>
248

> <supplier_cmpd_id>
SAM001246567

> <smiles>
CC(C)NC(=O)N[S](=O)(=O)c1cnccc1Nc2cccc(C)c2

> <pd_targets>
{HIF1A,KDM4E,CYP3A4,CYP2C9,HSF1,SLC12A1,SLC12A2}

> <pathway_gtopdb>
{"Transcription factor","Epigenetic regulator",Enzyme,"Other cytosolic protein",Transporter,Eraser,"Cytochrome P450","Electrochemical transporter","Lysine demethylase","Cytochrome P450 family 3","Cyto
chrome P450 family 2","SLC superfamily of solute carriers","Jumonji domain-containing","Cytochrome P450 family 3A","Cytochrome P450 family 2C","SLC12 family of cation-coupled chloride transporters","C
ytochrome P450 3A4","Cytochrome P450 2C9"}

> <pathway_chembl>
{Enzymes,Transporters,"Chromatin modifying enzymes","Cytochrome P450","SLC superfamily of solute carriers","1.14.11.- Histone demethylases","CYP3 family","CYP2 family: drug metabolising subset","SLC12
 family of cation-coupled chloride transporters"}

> <pathway_reactome>
{"Cellular responses to external stimuli",Metabolism,Disease,"Transport of small molecules","Cellular responses to stress","Metabolism of lipids","Biological oxidations","Disorders of transmembrane tr
ansporters","SLC-mediated transmembrane transport","Cellular response to hypoxia","Biosynthesis of specialized proresolving mediators (SPMs)","Phase I - Functionalization of compounds","Cellular respo
nse to heat stress","SLC transporter disorders","Transport of inorganic cations/anions and amino acids/oligopeptides","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Biosyn
thesis of DHA-derived SPMs","Cytochrome P450 - arranged by substrate type","HSF1-dependent transactivation","Defective SLC12A1 causes Bartter syndrome 1 (BS1)","Cation-coupled Chloride cotransporters"
,"Biosynthesis of maresins",Xenobiotics,"Attenuation phase","Biosynthesis of maresin-like SPMs","CYP2E1 reactions"}

> <broad_targets>
{SLC12A1}

> <broad_moa>
{"electrolyte reabsorption inhibitor","thromboxane receptor antagonist"}

> <synonyms>
{TORSEMIDE,56211-40-6,56211406,Demadex,Torasemida,Torasemidum,Luprac,"Torasemidum (INN-Latin)","Torasemidum (INNLatin)","Torasemida (INN-Spanish)","Torasemida (INNSpanish)",Torem,Unat,"JDL 464",1-Isop
ropyl-3-((4-m-toluidino-3-pyridyl)sulfonyl)urea,1Isopropyl3((4mtoluidino3pyridyl)sulfonyl)urea,"AC 4464",AC-4464,AC4464,JDL-464,JDL464,"BM 02015",BM-0201,BM0201,T1410,SAM001246567,Prestw-1030,CPD00046
6313,Torsemide,Torasemide}

> <pdid>
PD000562

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{51371498,41781}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 33  0  0  0  0            999 V2000
   15.6025    1.5193    0.0000 C   0  0
   14.3024    0.7712    0.0000 O   0  0
   14.2993   -0.7296    0.0000 C   0  0
   15.5984   -1.4796    0.0000 C   0  0
   15.5984   -2.9796    0.0000 C   0  0
   14.2994   -3.7296    0.0000 C   0  0
   13.0004   -2.9797    0.0000 C   0  0
   13.0002   -1.4796    0.0000 C   0  0
   11.6990   -0.7319    0.0000 O   0  0
   10.4003   -1.4841    0.0000 C   0  0
    9.0990   -0.7364    0.0000 C   0  0
    7.8003   -1.4887    0.0000 N   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    5.2029   -2.9932    0.0000 O   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.4133   -1.7530    0.0000 N   0  0
   -1.8032   -3.1233    0.0000 C   0  0
   -2.4134   -4.4924    0.0000 C   0  0
   -1.5318   -5.7059    0.0000 C   0  0
   -0.0400   -5.5491    0.0000 C   0  0
    0.5701   -4.1788    0.0000 C   0  0
   -0.3114   -2.9665    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 29 30  1  0
 30 18  1  0
 30 22  2  0
M  END
> <name>
NIHCC_2014

> <id>
5685

> <plate>
NGP-105-01

> <well>
G02

> <supplier_cmpd_name>
CPD000449280

> <ctcr_id>
1656

> <supplier_cmpd_id>
SAM001246736

> <smiles>
COc1ccccc1OCCNCC(O)COc2cccc3[nH]c4ccccc4c23

> <pd_targets>
{ADRA2A,ADRA2B,ADRA2C,ADRB1,KDM4E,MAPT,GAA,HTR1B,KCNH2,ADRA1A,ADRA1B,HTR1A,MAPK1,HTR4,ADRB2,ADRA1D,KMT2A,APP,RORC,RYR2,FFP,MTOR,HTR2B,SLC6A4,ADRB3,DRD3,ABCB1,SLC22A2,SLC22A1,SLC6A2,DRD2,HTR2C,SLC6A3,S
LC47A1,TLR4,KCNK2,KCNK10,UGT1A1,HTR2A,HTR6,CACNA1C,NDUFC2,VEGFA,NPPB,GJA1,VCAM1,SELE,HIF1A,KCNJ4,KCNJ2,HCRTR2,HCRTR1}

> <pathway_gtopdb>
{"Membrane receptor","Epigenetic regulator","Other cytosolic protein",Enzyme,"Ion channel","Transcription factor",Transporter,"Secreted protein",Adhesion,"Family A G protein-coupled receptor",Eraser,H
ydrolase,"Voltage-gated ion channel",Kinase,Reader,"Nuclear receptor","Ligand-gated ion channel",Transferase,"Electrochemical transporter","Primary active transporter","Small molecule receptor (family
 A GPCR)","Lysine demethylase","Potassium channels","Protein Kinase",Bromodomain,"Nuclear hormone receptor subfamily 1","Ryanodine receptor","SLC superfamily of solute carriers","ATP-binding cassette"
,"Voltage-gated calcium channel","Peptide receptor (family A GPCR)","Monoamine receptor","Jumonji domain-containing","Voltage-gated potassium channel","CMGC protein kinase group","Nuclear hormone rece
ptor subfamily 1 group F","Atypical protein kinase group","SLC06 neurotransmitter transporter family","ABCB subfamily","SLC22 family of organic cation and anion transporters","SLC47 family of multidru
g and toxin extrusion transporters","Two-pore domain potassium channel","Inwardly rectifying potassium channel","Short peptide receptor (family A GPCR)","Adrenergic receptor","Serotonin receptor","CMG
C protein kinase MAPK family","Nuclear hormone receptor subfamily 1 group F member 3","Atypical protein kinase PIKK family","Dopamine receptor","Orexin receptor","CMGC protein kinase ERK1","Atypical p
rotein kinase FRAP subfamily"}

> <pathway_chembl>
{Receptors,Enzymes,"Ion channels",Transporters,"G protein-coupled receptors","Chromatin modifying enzymes","3.2.1.- Glycosidases","Voltage-gated ion channels","Kinases (EC 2.7.x.x)","Nuclear hormone r
eceptors","SLC superfamily of solute carriers","ATP-binding cassette transporter family","Catalytic receptors","UDP glucuronosyltransferases (UGT)","Other ion channels",Adrenoceptors,"1.14.11.- Histon
e demethylases","5-Hydroxytryptamine receptors","Potassium channels","CMGC: Containing CDK",MAPK,GSK3,"CLK families","2.1.1.43 Histone methyltransferases (HMTs)","1F. Retinoic acid-related orphans","R
yanodine receptors",Atypical,"SLC6 neurotransmitter transporter family","Dopamine receptors","ABCB subfamily","SLC22 family of organic cation and anion transporters","SLC47 family of multidrug and tox
in extrusion transporters","Pattern recognition receptors","Voltage-gated calcium channels","Connexins and Pannexins","Orexin receptors","Voltage-gated potassium channels","Mitogen-activated protein k
inases (MAP kinases)","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","Monoamine transporter subfamily","Organic cation transporters (OCT)","Toll-like receptor family","Two P domain po
tassium channels","Inwardly rectifying potassium channels","ERK subfamily","FRAP subfamily"}

> <pathway_reactome>
{Disease,"Neuronal System","Signal Transduction","Muscle contraction","Immune System","Gene expression (Transcription)",Metabolism,"Transport of small molecules","Developmental Biology","Vesicle-media
ted transport",Hemostasis,"Cellular responses to external stimuli","Infectious disease","Transmission across Chemical Synapses","Diseases of metabolism","Signaling by GPCR","Cardiac conduction","Innat
e Immune System","RNA Polymerase II Transcription","Abacavir transport and metabolism","SLC-mediated transmembrane transport","Disorders of transmembrane transporters","Potassium Channels","Nervous sy
stem development","The citric acid (TCA) cycle and respiratory electron transport","Membrane Trafficking","Cytokine Signaling in Immune system","Cell surface interactions at the vascular wall","Cellul
ar responses to stress","Leishmania infection","Neurotransmitter receptors and postsynaptic signal transmission","Diseases of carbohydrate metabolism","GPCR ligand binding","Phase 3 - rapid repolarisa
tion","Toll-like Receptor Cascades","Generic Transcription Pathway","Ion homeostasis","Neurotransmitter clearance","Abacavir transmembrane transport","Transport of bile salts and organic acids","metal
 ions and amine compounds","SLC transporter disorders","Tandem pore domain potassium channels","Metabolic disorders of biological oxidation enzymes","Axon guidance","Respiratory electron transport","A
TP synthesis by chemiosmotic coupling","and heat production by uncoupling proteins.","Gap junction trafficking and regulation","Interferon Signaling","Cellular response to hypoxia","Leishmania parasit
e growth and survival","Activation of NMDA receptors and postsynaptic events","Glycogen storage diseases","Class A/1 (Rhodopsin-like receptors)","Toll Like Receptor 5 (TLR5) Cascade","Transcriptional 
regulation by RUNX1","Transcriptional regulation by RUNX3","Transcriptional Regulation by TP53","Serotonin clearance from the synaptic cleft","Organic cation/anion/zwitterion transport","Defective SLC
6A2 causes orthostatic intolerance (OI)","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Toll Like Receptor 4 (TLR4) Cascade","TWIK related potassium channel (TREK)","Defective UGT1
A1 causes hyperbilirubinemia","NCAM signaling for neurite out-growth","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","Gap junction trafficking","Interferon gamma sign
aling","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","GABA receptor activation","Anti-inflammatory response favouring Leishmania parasite infection","Post NMDA receptor ac
tivation events","Glycogen storage disease type II (GAA)","Amine ligand-binding receptors","MyD88 cascade initiated on plasma membrane","RUNX1 regulates genes involved in megakaryocyte differentiation
 and platelet function","RUNX3 Regulates Immune Response and Cell Migration","Regulation of TP53 Activity","Organic cation transport","MyD88-independent TLR4 cascade","NCAM1 interactions","Complex I b
iogenesis","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors","Gap junction assembly","GABA B receptor activation","Peptide ligand-binding receptors","ADORA2B mediated
 anti-inflammatory cytokines production","Activation of AMPK downstream of NMDARs","Serotonin receptors",Adrenoceptors,"MAP kinase activation","TAK1 activates NFkB by phosphorylation and activation of
 IKKs complex","Regulation of TP53 Expression and Degradation","Dopamine receptors","TRIF(TICAM1)-mediated TLR4 signaling","Transport of connexons to the plasma membrane","Activation of GABAB receptor
s","Orexin and neuropeptides FF and QRFP bind to their respective receptors","MAPK targets/ Nuclear events mediated by MAP kinases","Regulation of TP53 Degradation","Activation of IRF3/IRF7 mediated b
y TBK1/IKK epsilon","Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane","Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits","ERK/MAPK targets","ERKs ar
e inactivated"}

> <broad_targets>
{ADRB1,ADRB2,ADRB3}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{carvedilol,72956-09-3,72956093,Coreg,Dilatrend,Eucardic,"Carvedilolum (Latin)","BM 14190",Carvedilolum,1-(9H-Carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)-2-propanol,1(9HCarbazol4yloxy)3((2(
2methoxyphenoxy)ethyl)amino)2propanol,BM-14190,BM14190,"SKF 105517",1-((9H-Carbazol-4-yl)oxy)-3-((2-(2-methoxyphenoxy)ethy,1((9HCarbazol4yl)oxy)3((2(2methoxyphenoxy)ethy,T0342,T0447,S1831,SAM001246736
,1504257,Prestw-1262,"Carvedilol phosphate",Carvedilol,CPD000449280,CARVEDILOL}

> <pdid>
PD001210

> <targets>
{Adrenergic Receptor,Autophagy}

> <classes>
{beta-adrenergic blocker,Neuronal Signaling,Autophagy,GPCR/G Protein}

> <pubchem_cids>
{2585}

$$$$
NIHCC_2014
  SciTegic11012413002D

 45 47  0  0  1  0            999 V2000
    6.5048    3.7616    0.0000 C   0  0
    7.8025    3.0093    0.0000 C   0  0
    9.1028    3.7571    0.0000 C   0  0
    9.1054    5.2571    0.0000 O   0  0
   10.4006    3.0048    0.0000 C   0  0
   10.3980    1.5048    0.0000 C   0  0
    9.0977    0.7571    0.0000 C   0  0
    7.7998    1.5093    0.0000 C   0  0
    6.5003    0.7584    0.0000 C   0  0
    5.2013    1.5084    0.0000 O   0  0
    6.4998   -0.7424    0.0000 N   0  0
    5.2003   -1.4932    0.0000 C   0  0  1  0  0  0
    5.1999   -2.9940    0.0000 C   0  0
    3.9003   -3.7449    0.0000 S   0  0
    3.8999   -5.2457    0.0000 C   0  0
    2.6021   -5.9980    0.0000 C   0  0
    2.6047   -7.4980    0.0000 C   0  0
    3.9050   -8.2458    0.0000 C   0  0
    5.2028   -7.4935    0.0000 C   0  0
    5.2002   -5.9935    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0  2  0  0  0
    3.8964    0.7545    0.0000 O   0  0
    2.6003   -1.4977    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  1  0  0  0
    0.0031   -3.0008    0.0000 C   0  0
    1.3039   -3.7477    0.0000 O   0  0
   -1.2946   -3.7547    0.0000 N   0  0
   -1.2915   -5.2556    0.0000 C   0  0
   -2.5886   -6.0091    0.0000 C   0  0
   -1.2877   -6.7556    0.0000 C   0  0
    0.0093   -6.0025    0.0000 C   0  0
   14.2006    0.0060    0.0000 C   0  0
   14.2006   -1.4940    0.0000 S   0  0
   14.2006   -2.9940    0.0000 O   0  0
   12.9013   -2.2436    0.0000 O   0  0
   15.4998   -2.2436    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  2  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 12 11  1  1
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 12 21  1  0
 21 22  1  1
 21 23  1  0
 23 24  1  0
 24 25  1  0
 26 25  1  6
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 31 30  1  6
 31 26  1  0
 31 32  1  0
 32 33  1  0
 33 24  1  0
 33 34  1  6
 34 35  2  0
 34 36  1  0
 36 37  1  0
 37 38  1  0
 37 39  1  0
 37 40  1  0
 41 42  1  0
 42 43  1  0
 42 44  2  0
 42 45  2  0
M  END
> <name>
NIHCC_2014

> <id>
5686

> <plate>
NGP-105-01

> <well>
G03

> <supplier_cmpd_name>
CPD000469186

> <ctcr_id>
400

> <supplier_cmpd_id>
SAM001246655

> <smiles>
Cc1c(O)cccc1C(=O)N[C@@H](CSc2ccccc2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C.C[S](O)(=O)=O

> <pd_targets>
{PROTEASE,ALOX15,PGR,"HIV-1 PROTEASE",POL,ABCB1,CYP3A5,AR,MAPK3,CYP3A4,MAPK14,KCNH2,ABCB11,ALDH1A1,LEF,HIF1A,RORC,ADRB3,OPRD1,OPRK1,TACR2,TBXAS1,SLC22A1,KCNE1,KCNQ1,ADORA3,SLC6A2,SLC6A3,EGFR,ABCC4,CHR
M5,LCK,ABCB1A,FYN,OPRM1,ABCG2,SCN5A}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Unclassified protein",Transporter,"Ion channel","Membrane receptor",Protease,Oxidoreductase,"Nuclear receptor","Primary active transporter","Cytochrome P450",Kinase,"Vo
ltage-gated ion channel","Family A G protein-coupled receptor","Electrochemical transporter","Cysteine protease","Nuclear hormone receptor subfamily 3","Aspartic protease","ATP-binding cassette","Cyto
chrome P450 family 3","Protein Kinase","Potassium channels","Metallo protease","Nuclear hormone receptor subfamily 1","Small molecule receptor (family A GPCR)","Peptide receptor (family A GPCR)","Cyto
chrome P450 family 5","SLC superfamily of solute carriers","Voltage-gated sodium channel","Cysteine protease PAC clan","Nuclear hormone receptor subfamily 3 group C","Aspartic protease AA clan","ABCB 
subfamily","Cytochrome P450 family 3A","CMGC protein kinase group","Voltage-gated potassium channel","Metallo protease MAE clan","Nuclear hormone receptor subfamily 1 group F","Monoamine receptor","Sh
ort peptide receptor (family A GPCR)","Cytochrome P450 family 5A","SLC22 family of organic cation and anion transporters","Nucleotide-like receptor (family A GPCR)","SLC06 neurotransmitter transporter
 family","TK protein kinase group","ABCC subfamily","ABCG subfamily","Cysteine protease C3A subfamily","Nuclear hormone receptor subfamily 3 group C member 3","Aspartic protease A2A subfamily","Cytoch
rome P450 3A5","Nuclear hormone receptor subfamily 3 group C member 4","CMGC protein kinase MAPK family","Cytochrome P450 3A4","Metallo protease M34 family","Nuclear hormone receptor subfamily 1 group
 F member 3","Adrenergic receptor","Opioid receptor","Neurokinin receptor","Cytochrome P450 5A1","Adenosine receptor","Tyrosine protein kinase EGFR family","Dopamine receptor","Acetylcholine receptor"
,"Tyrosine protein kinase Src family","CMGC protein kinase ERK1","CMGC protein kinase p38 subfamily","Tyrosine protein kinase SrcA"}

> <pathway_chembl>
{Enzymes,Transporters,Receptors,"Ion channels","Eicosanoid turnover","ATP-binding cassette transporter family","Cytochrome P450","Nuclear hormone receptors","Kinases (EC 2.7.x.x)","Voltage-gated ion c
hannels","G protein-coupled receptors","SLC superfamily of solute carriers","Catalytic receptors",Lipoxygenases,"ABCB subfamily","CYP3 family","Steroid hormone receptors","CMGC: Containing CDK",MAPK,G
SK3,"CLK families","Potassium channels","1F. Retinoic acid-related orphans",Adrenoceptors,"Opioid receptors","Tachykinin receptors",CYP5,"CYP7 and CYP8 families","SLC22 family of organic cation and an
ion transporters","Adenosine receptors","SLC6 neurotransmitter transporter family","Receptor kinases","ABCC subfamily","Dopamine receptors","Acetylcholine receptors (muscarinic)","ABCG subfamily","Vol
tage-gated sodium channels","3C. 3-Ketosteroid receptors","Mitogen-activated protein kinases (MAP kinases)","Voltage-gated potassium channels","Organic cation transporters (OCT)","Monoamine transporte
r subfamily","TK: Tyrosine kinase","ERK subfamily","p38 subfamily","Receptor tyrosine kinases (RTKs)","Non-receptor tyrosine kinases (nRTKs)","Type I RTKs: ErbB (epidermal growth factor) receptor fami
ly","Src family"}

> <pathway_reactome>
{Metabolism,"Gene expression (Transcription)","Immune System","Muscle contraction",Disease,"Cellular responses to external stimuli","Signal Transduction","Transport of small molecules",Hemostasis,"Dev
elopmental Biology","Metabolism of lipids","Abacavir transport and metabolism","Biological oxidations","RNA Polymerase II Transcription","Innate Immune System","Cardiac conduction","Infectious disease
","Cellular responses to stress","Signaling by GPCR","SLC-mediated transmembrane transport","Disorders of transmembrane transporters","Platelet activation","signaling and aggregation","Nervous system 
development","Biosynthesis of specialized proresolving mediators (SPMs)","Abacavir transmembrane transport","Phase I - Functionalization of compounds","Generic Transcription Pathway","Toll-like Recept
or Cascades","Phase 3 - rapid repolarisation","Metabolism of steroids","Uptake and actions of bacterial toxins","Cellular response to hypoxia","Leishmania infection","GPCR ligand binding","Transport o
f bile salts and organic acids","metal ions and amine compounds","SLC transporter disorders","GPCR downstream signalling","Response to elevated platelet cytosolic Ca2+","HIV Infection","Axon guidance"
,"Biosynthesis of DPA-derived SPMs","Cytochrome P450 - arranged by substrate type","Transcriptional regulation by RUNX2","Toll Like Receptor 5 (TLR5) Cascade","Biosynthesis of DHA-derived SPMs","Bile 
acid and bile salt metabolism","Ethanol oxidation","Uptake and function of anthrax toxins","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Transcriptional regulation by RUN
X3","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Transcriptional Regulation by MECP2","Organic cation/anion/zwitterion transport","Defective SLC6A2 causes orthosta
tic intolerance (OI)","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","G alpha (q) signalling events","Platelet degranulation","Host Interactions of HIV factors","G alpha (i) signall
ing events","L1CAM interactions","Biosynthesis of DPAn-3 SPMs",Xenobiotics,"RUNX2 regulates bone development","MyD88 cascade initiated on plasma membrane","Biosynthesis of maresins","Synthesis of bile
 acids and bile salts","RUNX3 Regulates Immune Response and Cell Migration","Anti-inflammatory response favouring Leishmania parasite infection","Peptide ligand-binding receptors","MECP2 regulates neu
ronal receptors and channels",Eicosanoids,"Organic cation transport","Nucleotide-like (purinergic) receptors","Gastrin-CREB signalling pathway via PKC and MAPK","Amine ligand-binding receptors","The r
ole of Nef in HIV-1 replication and disease pathogenesis","Opioid Signalling","Interaction between L1 and Ankyrins","Biosynthesis of DPAn-3-derived protectins and resolvins","RUNX2 regulates osteoblas
t differentiation","MAP kinase activation","Biosynthesis of maresin-like SPMs","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","ADORA2B mediated anti-inflammatory cytokines prod
uction","Tachykinin receptors bind tachykinins","Adenosine P1 receptors","EGFR Transactivation by Gastrin","Muscarinic acetylcholine receptors","Nef-mediates down modulation of cell surface receptors 
by recruiting them to clathrin adapters","Nef and signal transduction","G-protein activation","MAPK targets/ Nuclear events mediated by MAP kinases","Nef Mediated CD4 Down-regulation","ERK/MAPK target
s","Activation of the AP-1 family of transcription factors","ERKs are inactivated"}

> <broad_targets>
{CYP1A2,CYP2B6,CYP2C19,CYP2C9,CYP2D6,CYP3A4,CYP3A7}

> <broad_moa>
{"HIV protease inhibitor"}

> <synonyms>
{"Nelfinavir mesylate",159989-65-8,159989658,Viracept,"Nelfinavir mesilate","Nelfinavir mesylate hydrate","Nelfinavir Methanesulfonate",AG1343,UNII-98D603VP8V,UNII98D603VP8V,AG-1343,CHEBI:7497,98D603V
P8V,MFCD00931436,"Viracept (TN)",NFV,DSSTox_CID_10777,DSSToxCID10777,DSSTox-CID-10777,"DSSTox CID 10777",DSSTox_RID_790,DSSToxRID790,DSSTox-RID-790,"DSSTox RID 790",T6001,SAM001246655,"Nelfinavir Mesy
late",CPD000469186}

> <pdid>
PD008635

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{64142,10699576}

$$$$
NIHCC_2014
  SciTegic11012413002D

 35 37  0  0  1  0            999 V2000
   11.6915   -3.7599    0.0000 C   0  0
   10.3939   -3.0073    0.0000 C   0  0  2  0  0  0
    9.0934   -3.7547    0.0000 C   0  0
    7.7958   -3.0021    0.0000 C   0  0
    7.7988   -1.5020    0.0000 N   0  0
    9.0994   -0.7547    0.0000 C   0  0  2  0  0  0
   10.3969   -1.5073    0.0000 C   0  0
    9.0993    0.7461    0.0000 C   0  0
   10.3986    1.4958    0.0000 O   0  0
    7.8007    1.4969    0.0000 O   0  0
    6.4990   -0.7516    0.0000 C   0  0
    6.4994    0.7484    0.0000 O   0  0
    5.1988   -1.5013    0.0000 C   0  0  2  0  0  0
    5.1953   -3.0021    0.0000 C   0  0
    3.8942   -3.7503    0.0000 C   0  0
    3.8907   -5.2511    0.0000 C   0  0
    2.5897   -5.9993    0.0000 N   0  0
    2.5862   -7.5001    0.0000 C   0  0
    3.8837   -8.2528    0.0000 N   0  0
    1.2858   -8.2479    0.0000 N   0  0
    3.8990   -0.7508    0.0000 N   0  0
    2.5988   -1.5004    0.0000 S   0  0
    3.8975   -2.2510    0.0000 O   0  0
    2.5983   -3.0004    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -3.8971   -3.7500    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  1  1  6
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  2  1  0
  6  8  1  1
  8  9  1  0
  8 10  2  0
  5 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  6
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 13 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  2  0
 22 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 31 33  1  0
 33 34  1  0
 34 35  1  0
 35 25  1  0
 35 29  2  0
M  END
> <name>
NIHCC_2014

> <id>
5687

> <plate>
NGP-105-01

> <well>
G04

> <supplier_cmpd_name>
CPD000466348

> <ctcr_id>
5011

> <supplier_cmpd_id>
SAM001246661

> <smiles>
C[C@@H]1CCN([C@H](C1)C(O)=O)C(=O)[C@H](CCCNC(N)=N)N[S](=O)(=O)c2cccc3CC(C)CNc23

> <pd_targets>
{F2,PRSS1,PLAT,F10,PRSS2,PRSS3,LMNA}

> <pathway_gtopdb>
{Enzyme,"Other nuclear protein",Protease,"Serine protease","Serine protease PA clan","Serine protease S1A subfamily"}

> <pathway_chembl>
{Enzymes,"Peptidases and proteinases","PA: Serine (S) Peptidases","S1: Chymotrypsin"}

> <pathway_reactome>
{Disease,Metabolism,"Signal Transduction","Cell Cycle","Diseases of hemostasis","Metabolism of vitamins and cofactors","Signaling by Receptor Tyrosine Kinases",Mitotic,"Defects of contact activation s
ystem (CAS) and kallikrein/kinin system (KKS)","Metabolism of water-soluble vitamins and cofactors","Signaling by PDGF","M Phase","Defective factor VIII causes hemophilia A","Cobalamin (Cbl","vitamin 
B12) transport and metabolism","Defective factor IX causes hemophilia B","Mitotic Metaphase and Anaphase","Defective F8 cleavage by thrombin","Defective F9 variant does not activate FX","Mitotic Anaph
ase","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{F2}

> <broad_moa>
{"thrombin inhibitor"}

> <synonyms>
{argatroban,74863-84-6,74863846,"Argatroban anhydrous",MCI-9038,MCI9038,MD-805,MD805,"Argatroban hydrate",GN-1600,GN1600,C23H36N6O5S,"Argatroban Injection",DK-7419,DK7419,CHEMBL1166,"74863-84-6 (anhyd
rous)","74863846 (anhydrous)","Argatroban In Sodium Chloride","Argatroban (INN:JAN)",Argatrobanum,Arga,T0155,SAM001246661,Prestw-1228,Argatroban,CPD000466348}

> <pdid>
PD003142

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{92722}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 27  0  0  1  0            999 V2000
    1.3005   -0.7492    0.0000 C   0  0
    2.5998   -1.4987    0.0000 C   0  0  1  0  0  0
    2.5999   -2.9995    0.0000 C   0  0
    3.9001   -3.7476    0.0000 N   0  0
    3.9022   -5.2476    0.0000 C   0  0
    2.6042   -5.9995    0.0000 N   0  0
    1.3041   -5.2514    0.0000 C   0  0
    1.3020   -3.7514    0.0000 C   0  0
    0.0019   -3.0032    0.0000 F   0  0
    3.8990   -0.7473    0.0000 C   0  0  2  0  0  0
    2.5993    0.0015    0.0000 O   0  0
    5.1998   -1.4960    0.0000 C   0  0
    6.4990   -0.7446    0.0000 N   0  0
    7.8521   -1.3619    0.0000 C   0  0
    8.8527   -0.2444    0.0000 N   0  0
    8.0991    1.0526    0.0000 C   0  0
    6.6328    0.7366    0.0000 N   0  0
    3.8975    0.7534    0.0000 C   0  0
    5.1957    1.5048    0.0000 C   0  0
    5.1942    3.0048    0.0000 C   0  0
    3.8944    3.7534    0.0000 C   0  0
    3.8928    5.2534    0.0000 F   0  0
    2.5961    3.0021    0.0000 C   0  0
    2.5977    1.5021    0.0000 C   0  0
    1.2994    0.7507    0.0000 F   0  0
  2  1  1  6
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  8  9  1  0
  2 10  1  0
 10 11  1  6
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 13  1  0
 10 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 23  1  0
 23 24  2  0
 24 18  1  0
 24 25  1  0
M  END
> <name>
NIHCC_2014

> <id>
5688

> <plate>
NGP-105-01

> <well>
G05

> <supplier_cmpd_name>
CPD000466350

> <ctcr_id>
5875

> <supplier_cmpd_id>
SAM001246664

> <smiles>
C[C@@H](c1ncncc1F)[C@](O)(Cn2cncn2)c3ccc(F)cc3F

> <pd_targets>
{CYP46A1,CYP11A1,CYP2C9,CYP2C19,CYP3A4,CYP3A43,CYP3A5,CYP3A7,CYP2B6,MAPK1,CYP51,CYP51B,ERG11}

> <pathway_gtopdb>
{Enzyme,Oxidoreductase,"Cytochrome P450",Kinase,"Cytochrome P450 family 11","Cytochrome P450 family 2","Cytochrome P450 family 3","Protein Kinase","Cytochrome P450 family 51","Cytochrome P450 family 1
1A","Cytochrome P450 family 2C","Cytochrome P450 family 3A","Cytochrome P450 family 2B","CMGC protein kinase group","Cytochrome P450 family 51A","Cytochrome P450 11A1","Cytochrome P450 2C9","Cytochrom
e P450 2C19","Cytochrome P450 3A4","Cytochrome P450 2B6","CMGC protein kinase MAPK family","Cytochrome P450 51A1","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,"Cytochrome P450","Kinases (EC 2.7.x.x)",CYP39,"CYP46 and CYP51 families",CYP11,CYP17,CYP19,"CYP20 and CYP21 families","CYP2 family: drug metabolising subset","CMGC: Containing CDK",MAPK,GSK3
,"CLK families","CYP3 family","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{Metabolism,"Immune System","Metabolism of lipids","Biological oxidations","Innate Immune System","Metabolism of steroids","Phase I - Functionalization of compounds","Toll-like Receptor Cascades","Bio
synthesis of specialized proresolving mediators (SPMs)","Bile acid and bile salt metabolism","Cytochrome P450 - arranged by substrate type","Toll Like Receptor 5 (TLR5) Cascade","Biosynthesis of DHA-d
erived SPMs","Synthesis of bile acids and bile salts","Endogenous sterols",Xenobiotics,"MyD88 cascade initiated on plasma membrane","Biosynthesis of maresins","Synthesis of bile acids and bile salts v
ia 24-hydroxycholesterol","CYP2E1 reactions","MAP kinase activation","Biosynthesis of maresin-like SPMs","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated
"}

> <broad_targets>
{CYP2C19,CYP2C9,CYP3A4,CYP3A5,PTGS1}

> <broad_moa>
{"cytochrome P450 inhibitor"}

> <synonyms>
{Voriconazole,137234-62-9,137234629,Vfend,UK-109496,UK109496,"UK 109496","UK-109,496","UK109,496",UNII-JFU09I87TR,UNIIJFU09I87TR,C16H14F3N5O,(+/-)-Voriconazole,(+/)Voriconazole,VCZ,CHEMBL638,JFU09I87T
R,CPD000466350,CHEBI:10023,VRC,Voriconazol,DSSTox_CID_26485,DSSToxCID26485,DSSTox-CID-26485,"DSSTox CID 26485",DSSTox_RID_81656,DSSToxRID81656,DSSTox-RID-81656,"DSSTox RID 81656",DSSTox_GSID_46485,DSS
ToxGSID46485,DSSTox-GSID-46485,"DSSTox GSID 46485",T0120,SAM001246664,Prestw-1500}

> <pdid>
PD001669

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{71616}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 33  0  0  1  0            999 V2000
   -0.2823   -5.5001    0.0000 C   0  0
   -0.7300   -4.0685    0.0000 C   0  0  2  0  0  0
   -2.1946   -3.7406    0.0000 C   0  0
   -3.2115   -4.8444    0.0000 C   0  0
   -4.6761   -4.5166    0.0000 C   0  0  1  0  0  0
   -5.1237   -3.0850    0.0000 O   0  0
   -5.6930   -5.6204    0.0000 C   0  0
   -7.0620   -6.0033    0.0000 C   0  0
   -5.9567   -7.0173    0.0000 C   0  0
    0.2851   -2.9666    0.0000 C   0  0  1  0  0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -1.2212   -2.3711    0.0000 C   0  0
    2.5972    1.5031    0.0000 C   0  0
    2.5951    3.0039    0.0000 C   0  0
    3.8933    3.7570    0.0000 C   0  0
    3.8872    5.2571    0.0000 C   0  0
    5.1832    6.0124    0.0000 C   0  0  1  0  0  0
    5.1770    7.5124    0.0000 O   0  0
    6.4853    5.2677    0.0000 C   0  0
    6.4914    3.7677    0.0000 C   0  0  2  0  0  0
    7.7935    3.0231    0.0000 O   0  0
    5.1955    3.0124    0.0000 C   0  0
    5.2017    1.5124    0.0000 C   0  0
  2  1  1  6
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  6
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9  7  1  0
  2 10  1  0
 10 11  1  6
 11 12  1  0
 13 12  1  6
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 10  1  0
 18 13  1  0
 18 19  1  6
 14 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 24 25  1  1
 24 26  1  0
 26 27  1  0
 27 28  1  6
 27 29  1  0
 29 22  1  0
 29 30  2  0
M  END
> <name>
NIHCC_2014

> <id>
5689

> <plate>
NGP-105-01

> <well>
G06

> <supplier_cmpd_name>
CPD000466353

> <ctcr_id>
1744

> <supplier_cmpd_id>
SAM001246670

> <smiles>
C[C@H](\C=C\[C@@H](O)C1CC1)[C@H]2CC[C@H]3\C(CCC[C@]23C)=C\C=C4\C[C@@H](O)C[C@H](O)C4=C

> <pd_targets>
{VDR}

> <pathway_gtopdb>
{"Transcription factor","Nuclear receptor","Nuclear hormone receptor subfamily 1","Nuclear hormone receptor subfamily 1 group I","Nuclear hormone receptor subfamily 1 group I member 1"}

> <pathway_chembl>
{Receptors,"Nuclear hormone receptors","1I. Vitamin D receptor-like receptors"}

> <pathway_reactome>
{"Metabolism of proteins","Post-translational protein modification",SUMOylation,"SUMO E3 ligases SUMOylate target proteins","SUMOylation of intracellular receptors"}

> <broad_targets>
{VDR}

> <broad_moa>
{"vitamin D receptor agonist"}

> <synonyms>
{Calcipotriol,calcipotriene,Dovonex,Daivonex,Psorcutan,Sorilux,112965-21-6,112965216,"112965 21 6",Calcitrene,"MC 903",MC-903,MC903,"Calcipotriol hydrate",UNII-143NQ3779B,UNII143NQ3779B,"UNII 143NQ377
9B",CHEBI:50749,"Dovonex (TN)",143NQ3779B,1,SAM001246670,Prestw-1257,CPD000466353,Calcipotriene}

> <pdid>
PD003124

> <targets>
{VD/VDR}

> <classes>
{Vitamin D Related}

> <pubchem_cids>
{5288783}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 32  0  0  1  0            999 V2000
    5.3385    3.0022    0.0000 C   0  0
    4.3654    1.8606    0.0000 C   0  0
    4.8680    0.4473    0.0000 C   0  0
    2.9000    2.1200    0.0000 C   0  0  2  0  0  0
    3.1600    4.0800    0.0000 O   0  0
    1.5400    2.9300    0.0000 C   0  0  1  0  0  0
    0.2000    2.1200    0.0000 C   0  0  2  0  0  0
   -1.4400    2.1200    0.0000 O   0  0
    0.2000    0.5600    0.0000 C   0  0  1  0  0  0
   -1.1200   -0.1900    0.0000 C   0  0  1  0  0  0
   -1.1342    1.3099    0.0000 C   0  0
   -2.5000    0.5600    0.0000 C   0  0
   -3.8700   -0.1900    0.0000 C   0  0
   -3.8700   -1.8000    0.0000 C   0  0
   -2.5000   -2.5800    0.0000 C   0  0
   -2.7300   -3.8100    0.0000 C   0  0
   -4.1700   -3.9100    0.0000 O   0  0
   -4.8300   -2.6400    0.0000 C   0  0
   -6.3040   -2.3621    0.0000 O   0  0
   -1.1200   -1.8000    0.0000 C   0  0  2  0  0  0
    0.2000   -2.5800    0.0000 C   0  0
    1.5400   -1.8000    0.0000 C   0  0  2  0  0  0
    3.3900   -1.2200    0.0000 O   0  0
    1.5400   -0.1900    0.0000 C   0  0  2  0  0  0
    2.9000    0.5600    0.0000 C   0  0  2  0  0  0
    4.1916   -0.2027    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  4  2  1  1
  4  5  1  0
  6  5  1  6
  6  4  1  0
  6  7  1  0
  7  8  1  1
  9  8  1  1
  9  7  1  0
  9 10  1  0
 10 11  1  1
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  3
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 14  1  0
 18 19  2  0
 15 20  1  0
 20 10  1  0
 20 21  1  1
 22 21  1  1
 22 23  1  0
 24 23  1  1
 24  9  1  0
 24 22  1  0
 24 25  1  0
 25  4  1  0
 25 26  1  1
M  END
> <name>
NIHCC_2014

> <id>
5690

> <plate>
NGP-105-01

> <well>
G07

> <supplier_cmpd_name>
CPD000466307

> <ctcr_id>
5370

> <supplier_cmpd_id>
SAM001246553

> <smiles>
CC(C)[C@]12O[C@H]1[C@@H]3O[C@@]34[C@@]5(C)CCC6=C(COC6=O)[C@@H]5C[C@@H]7O[C@]47[C@@H]2O

> <pd_targets>
{RORC,DCTPP1,PTGS2,LMNA,F2RL1}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Other nuclear protein","Membrane receptor","Nuclear receptor",Hydrolase,Oxidoreductase,"Family A G protein-coupled receptor","Nuclear hormone receptor subfamily 1","Pep
tide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1 group F","Protease-activated receptor","Nuclear hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{Receptors,Enzymes,"Nuclear hormone receptors","Eicosanoid turnover","G protein-coupled receptors","1F. Retinoic acid-related orphans",Cyclooxygenase,"Proteinase-activated receptors"}

> <pathway_reactome>
{"Gene expression (Transcription)",Metabolism,"Cell Cycle","Signal Transduction","RNA Polymerase II Transcription","Metabolism of nucleotides","Metabolism of lipids",Mitotic,"Signaling by GPCR","Gener
ic Transcription Pathway","Interconversion of nucleotide di- and triphosphates","Biosynthesis of specialized proresolving mediators (SPMs)","M Phase","GPCR ligand binding","Transcriptional regulation 
by RUNX3","Biosynthesis of DPA-derived SPMs","Mitotic Metaphase and Anaphase","Class A/1 (Rhodopsin-like receptors)","RUNX3 Regulates Immune Response and Cell Migration","Biosynthesis of DPAn-3 SPMs",
"Mitotic Anaphase","Peptide ligand-binding receptors","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{RELA}

> <broad_moa>
{"RNA polymerase inhibitor"}

> <synonyms>
{triptolide,38748-32-2,38748322,"38748 32 2",Triptolid,PG490,UNII-19ALD1S53J,UNII19ALD1S53J,"UNII 19ALD1S53J","NSC 163062",19ALD1S53J,CHEBI:9747,CHEMBL463763,MFCD00210565,PG-490,"PG 490",NSC-163062,NS
C163062,"Triptolide, Tripterygium wilfordii",SAM001246553,CPD000466307}

> <pdid>
PD000121

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{107985}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 22  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3039   -3.7494    0.0000 C   0  0
   -1.4469   -5.2298    0.0000 C   0  0
   -2.9152   -5.5365    0.0000 C   0  0
   -3.6607   -4.2349    0.0000 C   0  0
   -2.6531   -3.1237    0.0000 C   0  0
   -2.5987    1.5004    0.0000 C   0  0
   -2.7390    2.9810    0.0000 C   0  0
   -4.2067    3.2905    0.0000 N   0  0
   -4.9546    1.9903    0.0000 C   0  0
   -6.4462    1.8312    0.0000 O   0  0
   -3.9492    0.8772    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 10  1  0
  6 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 15  1  0
M  END
> <name>
NIHCC_2014

> <id>
5691

> <plate>
NGP-105-01

> <well>
G08

> <supplier_cmpd_name>
CPD000058510

> <ctcr_id>
4196

> <supplier_cmpd_id>
SAM001246766

> <smiles>
COc1ccc(cc1OC2CCCC2)C3CNC(=O)C3

> <pd_targets>
{PDE4A,PDE4C,PDE4D,KMT2A,PDE4B,PDE5A,CYP3A4,MAPK1,KDM4E,BLM,TNF,PDE1A,PDE1B,PDE1C,CREBBP,MAPT,LEF,CYP1A2,ALOX15,LMNA,ALDH1A1}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Secreted protein",Phosphodiesterase,Reader,Protease,"Cytochrome P450",Kinase,Eraser,"Phosphodiesterase 4",Bromodomain,"Phosphodiesterase 5","Cysteine protease","Cytochr
ome P450 family 3","Protein Kinase","Lysine demethylase","Phosphodiesterase 1","Phosphodiesterase 4A","Phosphodiesterase 4C","Phosphodiesterase 4D","Phosphodiesterase 4B","Phosphodiesterase 5A","Cyste
ine protease CA clan","Cytochrome P450 family 3A","CMGC protein kinase group","Jumonji domain-containing","Phosphodiesterase 1A","Cysteine protease C1A family","Cytochrome P450 3A4","CMGC protein kina
se MAPK family","CMGC protein kinase ERK1","Other cytosolic protein","Other nuclear protein",Writer,Oxidoreductase,"Histone acetyltransferase","Metallo protease","Cytochrome P450 family 1","p300/CBP f
amily","Metallo protease MAE clan","Cytochrome P450 family 1A","Metallo protease M34 family","Cytochrome P450 1A1"}

> <pathway_chembl>
{Enzymes,"Cyclic nucleotide turnover/signalling","Chromatin modifying enzymes","Cytochrome P450","Kinases (EC 2.7.x.x)",Phosphodiesterases,3',"5'-cyclic nucleotide (PDEs)","2.1.1.43 Histone methyltran
sferases (HMTs)","CYP3 family","CMGC: Containing CDK",MAPK,GSK3,"CLK families","1.14.11.- Histone demethylases","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily","Other protein targets
","Bromodomain-containing proteins","Eicosanoid turnover","Non-enzymatic BRD containing proteins","CYP1 family",Lipoxygenases}

> <pathway_reactome>
{"Signal Transduction","Gene expression (Transcription)",Hemostasis,Metabolism,"Immune System","DNA Repair","Signaling by GPCR","RNA Polymerase II Transcription","Platelet homeostasis","Metabolism of 
lipids","Innate Immune System","DNA Double-Strand Break Repair","Cytokine Signaling in Immune system","GPCR downstream signalling","Generic Transcription Pathway","Nitric oxide stimulates guanylate cy
clase","Biosynthesis of specialized proresolving mediators (SPMs)","Toll-like Receptor Cascades","Homology Directed Repair","Signaling by Interleukins","G alpha (i) signalling events","Transcriptional
 regulation by RUNX1","cGMP effects","Biosynthesis of DHA-derived SPMs","Toll Like Receptor 5 (TLR5) Cascade","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Interleukin
-10 signaling","Opioid Signalling","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","Biosynthesis of maresins","MyD88 cascade initiated on plasma membrane","HDR 
through Homologous Recombination (HRR)","DARPP-32 events","Biosynthesis of maresin-like SPMs","MAP kinase activation","Homologous DNA Pairing and Strand Exchange","MAPK targets/ Nuclear events mediate
d by MAP kinases","Presynaptic phase of homologous DNA pairing and strand exchange","ERK/MAPK targets","ERKs are inactivated","Neuronal System",Disease,"Cell Cycle","Transmission across Chemical Synap
ses","Infectious disease","Biological oxidations",Mitotic,"Neurotransmitter receptors and postsynaptic signal transmission","Uptake and actions of bacterial toxins","Phase I - Functionalization of com
pounds","M Phase","Transcriptional Regulation by TP53","Activation of NMDA receptors and postsynaptic events","Uptake and function of anthrax toxins","Cytochrome P450 - arranged by substrate type","Bi
osynthesis of DPA-derived SPMs","Mitotic Metaphase and Anaphase","Ethanol oxidation","TP53 Regulates Transcription of Cell Death Genes","Post NMDA receptor activation events",Xenobiotics,"Biosynthesis
 of DPAn-3 SPMs","Mitotic Anaphase","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","Activation of AMPK downstream of NMDARs","Aromatic amines can be N-hydroxylated or N-dealk
ylated by CYP1A2","Biosynthesis of DPAn-3-derived protectins and resolvins","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{}

> <broad_moa>
{"phosphodiesterase inhibitor"}

> <synonyms>
{rolipram,61413-54-5,61413545,"ZK 62711","(R,S)-rolipram","(R,S)rolipram","Rolipramum (Latin)",(+/-)-Rolipram,(+/)Rolipram,4-(3-(cyclopentyloxy)-4-methoxyphenyl)pyrrolidin-2-one,4(3(cyclopentyloxy)4me
thoxyphenyl)pyrrolidin2one,Rolipramum,4-(3-(Cyclopentyloxy)-4-methoxyphenyl)-2-pyrrolidinone,4(3(Cyclopentyloxy)4methoxyphenyl)2pyrrolidinone,Adeo,ZK-62711,ZK62711,4-(3-cyclopentyloxy-4-m,4(3cyclopent
yloxy4m,T6644,SAM001246766,Prestw-924,S2127,Rolipram,CPD000058510,"S- (+)-Rolipram"}

> <pdid>
PD002618

> <targets>
{PDE,Bacterial,HIV,Phosphodiesterase (PDE)}

> <classes>
{Metabolism,Anti-infection,Metabolic Enzyme/Protease}

> <pubchem_cids>
{5092}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 34  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.3229    1.2135    0.0000 N   0  0
   -6.2045    0.0000    0.0000 C   0  0
   -7.6953   -0.1561    0.0000 C   0  0
   -8.3054   -1.5264    0.0000 C   0  0
   -7.4237   -2.7399    0.0000 C   0  0
   -5.9319   -2.5831    0.0000 C   0  0
   -5.3229   -1.2135    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0  1  0  0  0
   -2.5981    3.0007    0.0000 C   0  0
   -1.3002    3.7529    0.0000 C   0  0
   -1.3026    5.2529    0.0000 C   0  0
   -2.6029    6.0009    0.0000 C   0  0
   -2.9166    7.4668    0.0000 O   0  0
   -4.4087    7.6213    0.0000 C   0  0
   -5.0166    6.2500    0.0000 O   0  0
   -3.9007    5.2488    0.0000 C   0  0
   -3.8983    3.7488    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  1
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17  9  1  0
 17 12  1  0
 10 18  1  0
 18  6  1  0
 18 19  1  1
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 22  1  0
 26 27  2  0
 27 19  1  0
  7 28  1  0
 28  2  1  0
 28 29  2  0
M  END
> <name>
NIHCC_2014

> <id>
5692

> <plate>
NGP-105-01

> <well>
G09

> <supplier_cmpd_name>
CPD000466321

> <ctcr_id>
4144

> <supplier_cmpd_id>
SAM001246586

> <smiles>
CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c5ccc6OCOc6c5)C1=O

> <pd_targets>
{PDE6A,PDE6B,PDE6C,PDE6D,PDE6G,PDE6H,PDE11A,KCNH2,PDE5A,MAPK1,PDE4A,PDE4B,PDE4C,PDE4D,ACHE}

> <pathway_gtopdb>
{Enzyme,"Ion channel",Phosphodiesterase,"Voltage-gated ion channel",Kinase,Hydrolase,"Phosphodiesterase 6","Phosphodiesterase 11","Potassium channels","Phosphodiesterase 5","Protein Kinase","Phosphodi
esterase 4","Phosphodiesterase 6A","Phosphodiesterase 11A","Voltage-gated potassium channel","Phosphodiesterase 5A","CMGC protein kinase group","Phosphodiesterase 4A","Phosphodiesterase 6C","CMGC prot
ein kinase MAPK family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,"Ion channels","Cyclic nucleotide turnover/signalling","Voltage-gated ion channels","Kinases (EC 2.7.x.x)","Acetylcholine turnover",Phosphodiesterases,3',"5'-cyclic nucleotide (PDEs)","Potass
ium channels","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Voltage-gated potassium channels","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{Hemostasis,"Muscle contraction","Immune System",Metabolism,"Signal Transduction","Platelet homeostasis","Cardiac conduction","Innate Immune System","Metabolism of lipids","Signaling by GPCR","Nitric 
oxide stimulates guanylate cyclase","Phase 3 - rapid repolarisation","Toll-like Receptor Cascades","Phospholipid metabolism","GPCR downstream signalling","cGMP effects","Toll Like Receptor 5 (TLR5) Ca
scade","Glycerophospholipid biosynthesis","G alpha (i) signalling events","MyD88 cascade initiated on plasma membrane","Synthesis of PC","Visual phototransduction","MAP kinase activation","The phototr
ansduction cascade","MAPK targets/ Nuclear events mediated by MAP kinases","Activation of the phototransduction cascade","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{PDE11A,PDE5A}

> <broad_moa>
{"phosphodiesterase inhibitor"}

> <synonyms>
{Tadalafil,Cialis,171596-29-5,171596295,Ic351,Tadanafil,ADCIRCA,"IC 351","ICOS 351",Tadalafil(Cialis),"GF 196960",UNII-742SXX0ICT,UNII742SXX0ICT,CHEMBL779,IC-351,IC351,742SXX0ICT,GF-196960,GF196960,"T
adalafil, (6R ,12aS)-","Tadalafil, (6R ,12aS)",CHEBI:71940,LY-450190,LY450190,DSSTox_CID_26786,DSSToxCID26786,DSSTox-CID-26786,"DSSTox CID 26786",DSSTox_RID_81904,DSSToxRID81904,DSSTox-RID-81904,"DSST
ox RID 81904",DSSTox_,DSSTox,DSSTox-,T1398,SAM001246586,1505639,CPD000466321,TADALAFIL}

> <pdid>
PD000348

> <targets>
{Apoptosis,Phosphodiesterase (PDE)}

> <classes>
{erectile dysfunction therapy,Apoptosis,Metabolic Enzyme/Protease}

> <pubchem_cids>
{110635}

$$$$
NIHCC_2014
  SciTegic11012413002D

 34 37  0  0  1  0            999 V2000
   -4.7175   -4.3834    0.0000 C   0  0
   -3.6663   -3.3134    0.0000 C   0  0
   -2.2130   -3.6880    0.0000 C   0  0
   -1.8114   -5.1333    0.0000 O   0  0
   -1.1612   -2.6174    0.0000 O   0  0
    0.2851   -2.9666    0.0000 C   0  0  2  0  0  0
    1.7758   -3.1329    0.0000 C   0  0  2  0  0  0
    2.2703   -4.0021    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0  2  0  0  0
    3.8971    3.7500    0.0000 F   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -0.8660    2.5000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
    0.0000    0.5000    0.0000 F   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -0.8141   -2.0807    0.0000 C   0  0
    0.7499   -4.3804    0.0000 C   0  0
    1.7256   -4.5995    0.0000 O   0  0
   -0.2668   -5.4844    0.0000 S   0  0
    0.1801   -6.9172    0.0000 C   0  0
   -0.8360   -8.0206    0.0000 F   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  6  5  1  1
  6  7  1  0
  7  8  1  1
  7  9  1  0
 10  9  1  6
 10 11  1  0
 11 12  1  1
 12 13  1  0
 13 14  1  1
 13 15  1  0
 15 16  2  3
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  2  3
 20 21  1  0
 21 15  1  0
 21 22  1  6
 21 23  1  0
 23 11  1  0
 23 24  1  1
 23 25  1  0
 25 26  1  6
 25 27  1  0
 27 28  1  0
 28  6  1  0
 28 10  1  0
 28 29  1  6
  6 30  1  0
 30 31  2  0
 30 32  1  0
 32 33  1  0
 33 34  1  0
M  END
> <name>
NIHCC_2014

> <id>
5693

> <plate>
NGP-105-01

> <well>
G10

> <supplier_cmpd_name>
CPD000469159

> <ctcr_id>
6868

> <supplier_cmpd_id>
SAM001246583

> <smiles>
CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)SCF

> <pd_targets>
{NR3C1,PGR,NR3C2,PLA2G4A}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Nuclear receptor","Nuclear hormone receptor subfamily 3","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 3 group C member 1","Nuclear
 hormone receptor subfamily 3 group C member 3","Nuclear hormone receptor subfamily 3 group C member 2"}

> <pathway_chembl>
{Receptors,Enzymes,"Nuclear hormone receptors","Glycerophospholipid turnover","Steroid hormone receptors","Phospholipase A<sub>2</sub>","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"Gene expression (Transcription)","Metabolism of proteins","Signal Transduction","RNA Polymerase II Transcription","Post-translational protein modification","Signaling by GPCR","Generic Transcription
 Pathway",SUMOylation,"GPCR downstream signalling","FOXO-mediated transcription","SUMO E3 ligases SUMOylate target proteins","G alpha (i) signalling events","FOXO-mediated transcription of oxidative s
tress","metabolic and neuronal genes","SUMOylation of intracellular receptors","Opioid Signalling","G-protein mediated events","PLC beta mediated events","Ca-dependent events","phospho-PLA2 pathway"}

> <broad_targets>
{NR3C1,NR3C2,PGR,PLA2G4A}

> <broad_moa>
{"glucocorticoid receptor agonist"}

> <synonyms>
{"FLUTICASONE PROPIONATE",Flovent,Cutivate,Flixotide,Flonase,80474-14-2,80474142,Flixonase,"Flovent HFA",Flunase,Flusonal,Fluspiral,Flutide,Flutivate,Asmatil,Axotide,Brethal,Fluinol,"Flovent Diskus 50
","Flixotide Disks","Flixotide Disk","Flovent Diskus",T0188,SAM001246583,Prestw-997,"Fluticasone propionate",CPD000469159}

> <pdid>
PD000354

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{444036}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 24  0  0  0  0            999 V2000
   -3.5185  -11.1877    0.0000 C   0  0
   -2.5084  -10.0787    0.0000 N   0  0
   -2.0255   -8.7984    0.0000 C   0  0
   -0.5982   -9.0676    0.0000 C   0  0
    0.3883   -9.9779    0.0000 C   0  0
   -1.1605   -9.4210    0.0000 C   0  0
   -1.6595   -7.7040    0.0000 C   0  0
   -1.2256   -6.6258    0.0000 C   0  0
   -2.5188   -7.2317    0.0000 C   0  0
   -0.2234   -5.5086    0.0000 O   0  0
   -0.6890   -4.0818    0.0000 C   0  0
   -2.1567   -3.7722    0.0000 O   0  0
    0.3114   -2.9665    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    4.9133   -4.8441    0.0000 Cl  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  2  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  3  1  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  2  3
 14 15  1  0
 15 16  1  0
 16 17  2  3
 17 18  1  0
 18 19  2  3
 19 20  1  0
 20 21  2  3
 21 16  1  0
 21 13  1  0
M  END
> <name>
NIHCC_2014

> <id>
5694

> <plate>
NGP-105-01

> <well>
G11

> <supplier_cmpd_name>
CPD000469156

> <ctcr_id>
5794

> <supplier_cmpd_id>
SAM001246576

> <smiles>
CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43.Cl

> <pd_targets>
{HTR3A,HTR3B,HTR4,CHRNA7,HTR3C,HTR3D,HTR3E,CHRNA4,CHRNB2,CHRM1,CYP3A4,CYP2D6,HTR1A,CHRNA1,CHRNB1,CHRND,CHRNG,MAPT,CHRM5,CHRNA3,SLC6A4,CHRNB4,GLRB,GLRA2,GLRA1,AMPC,SMN1,HTT,LMNA,RECQL,APEX1,MTOR}

> <pathway_gtopdb>
{"Ion channel","Membrane receptor",Enzyme,"Other cytosolic protein",Transporter,"Epigenetic regulator","Unclassified protein","Other nuclear protein","Ligand-gated ion channel","Family A G protein-cou
pled receptor","Cytochrome P450","Electrochemical transporter",Hydrolase,Reader,Kinase,"5HT3 receptor","Small molecule receptor (family A GPCR)","Nicotinic acetylcholine receptor","Cytochrome P450 fam
ily 3","Cytochrome P450 family 2","SLC superfamily of solute carriers","Glycine receptor","Methyl-lysine/arginine binding protein","Protein Kinase","Monoamine receptor","Nicotinic acetylcholine recept
or alpha subunit","Cytochrome P450 family 3A","Cytochrome P450 family 2D","SLC06 neurotransmitter transporter family","Tudor domain","Atypical protein kinase group","Serotonin receptor","Acetylcholine
 receptor","Cytochrome P450 3A4","Cytochrome P450 2D6","Atypical protein kinase PIKK family","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{"Ion channels",Receptors,Enzymes,Transporters,"Ligand-gated ion channels","G protein-coupled receptors","Cytochrome P450","SLC superfamily of solute carriers","Kinases (EC 2.7.x.x)","5-HT<sub>3</sub>
 receptors","5-Hydroxytryptamine receptors","Nicotinic acetylcholine receptors","Acetylcholine receptors (muscarinic)","CYP3 family","CYP2 family: drug metabolising subset","SLC6 neurotransmitter tran
sporter family","Glycine receptors",Atypical,"Monoamine transporter subfamily","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","FRAP subfamily"}

> <pathway_reactome>
{"Neuronal System",Disease,"Signal Transduction",Metabolism,"Metabolism of RNA","Gene expression (Transcription)","Cell Cycle","DNA Repair","Transmission across Chemical Synapses","Infectious disease"
,"Signaling by GPCR","Metabolism of lipids","Biological oxidations","Metabolism of non-coding RNA","RNA Polymerase II Transcription",Mitotic,"Base Excision Repair","Neurotransmitter receptors and post
synaptic signal transmission","Leishmania infection","GPCR ligand binding","Biosynthesis of specialized proresolving mediators (SPMs)","Phase I - Functionalization of compounds","Neurotransmitter clea
rance","snRNP Assembly","Generic Transcription Pathway","M Phase","Resolution of Abasic Sites (AP sites)","Leishmania parasite growth and survival","Acetylcholine binding and downstream events","Class
 A/1 (Rhodopsin-like receptors)","Biosynthesis of DHA-derived SPMs","Cytochrome P450 - arranged by substrate type","Activation of NMDA receptors and postsynaptic events","Serotonin clearance from the 
synaptic cleft","Transcriptional Regulation by MECP2","Mitotic Metaphase and Anaphase","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Transcriptional Regulation by TP5
3","Anti-inflammatory response favouring Leishmania parasite infection","Postsynaptic nicotinic acetylcholine receptors","Amine ligand-binding receptors","Biosynthesis of maresins",Xenobiotics,"Post N
MDA receptor activation events","Regulation of MECP2 expression and activity","Mitotic Anaphase","PCNA-Dependent Long Patch Base Excision Repair","Regulation of TP53 Activity","ADORA2B mediated anti-i
nflammatory cytokines production","Highly calcium permeable postsynaptic nicotinic acetylcholine receptors","Muscarinic acetylcholine receptors","Biosynthesis of maresin-like SPMs","CYP2E1 reactions",
"Serotonin receptors","Activation of AMPK downstream of NMDARs","Nuclear Envelope (NE) Reassembly","Regulation of TP53 Expression and Degradation","Initiation of Nuclear Envelope (NE) Reformation","Re
gulation of TP53 Degradation"}

> <broad_targets>
{GLRA1,GLRA2,GLRB,HTR3A,HTR4}

> <broad_moa>
{"serotonin receptor antagonist"}

> <synonyms>
{"Tropisetron hydrochloride","TROPISETRON HCl",105826-92-4,105826924,"Tropisetron (Hydrochloride)","Tropisetron monohydrochloride",UNII-A19338Q2YO,UNIIA19338Q2YO,CHEBI:77570,A19338Q2YO,"Navoban (TN)",
"3-Tropanylindole-3-carboxylate hydrochloride","3Tropanylindole3carboxylate hydrochloride",MLS001,T1173,SAM001246576,CPD000469156}

> <pdid>
PD013759

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{656664}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 21  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 O   0  0
    0.0000    1.5000    0.0000 N   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 N   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 N   0  0
   -3.1904   -2.6376    0.0000 C   0  0
   -4.6588   -2.9478    0.0000 C   0  0
   -5.1253   -4.3743    0.0000 C   0  0
   -6.5937   -4.6845    0.0000 C   0  0
   -7.0602   -6.1110    0.0000 C   0  0
   -6.0582   -7.2273    0.0000 C   0  0
   -8.5278   -6.4211    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 10 18  1  0
 18  7  2  0
 18 19  1  0
 19  2  1  0
 19 20  2  0
M  END
> <name>
NIHCC_2014

> <id>
5695

> <plate>
NGP-105-01

> <well>
H02

> <supplier_cmpd_name>
CPD000466379

> <ctcr_id>
3348

> <supplier_cmpd_id>
SAM001246741

> <smiles>
CN1C(=O)N(C)c2ncn(CCCCC(C)=O)c2C1=O

> <pd_targets>
{RXFP1,MAPK1}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Family A G protein-coupled receptor",Kinase,"Peptide receptor (family A GPCR)","Protein Kinase","Relaxin-like peptide receptor (family A GPCR)","CMGC protein kinase group"
,"Relaxin receptor","CMGC protein kinase MAPK family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Kinases (EC 2.7.x.x)","Relaxin family peptide receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Mitogen-activated protein kinases (MAP kinas
es)","ERK subfamily"}

> <pathway_reactome>
{Disease,"Immune System","Infectious disease","Innate Immune System","Leishmania infection","Toll-like Receptor Cascades","Leishmania parasite growth and survival","Toll Like Receptor 5 (TLR5) Cascade
","Anti-inflammatory response favouring Leishmania parasite infection","MyD88 cascade initiated on plasma membrane","ADORA2B mediated anti-inflammatory cytokines production","MAP kinase activation","M
APK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{Lomifylline,10226-54-7,10226547,"1,3-Dimethyl-7-(5-oxohexyl)-1H-purine-2,6(3H,7H)-dione","1,3Dimethyl7(5oxohexyl)1Hpurine2,6(3H,7H)dione",UNII-NA91GV8GDJ,UNIINA91GV8GDJ,NA91GV8GDJ,"1,3-dimethyl-7-(5-
oxohexyl)purine-2,6-dione","1,3dimethyl7(5oxohexyl)purine2,6dione",Lomifilina,Lomifyllinum,SMR000466379,"Lomifylline (INN)","Lomifilina (INN-Spanish)","Lomifilina (INNSpanish)",Lomif,SAM001246741,CPD0
00466379}

> <pdid>
PD003118

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{65599}

$$$$
NIHCC_2014
  SciTegic11012413002D

 31 31  0  0  1  0            999 V2000
   10.3003   -4.5074    0.0000 Na  0  3
    7.7996   -1.4883    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0  2  0  0  0
    5.2029   -2.9932    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    3.8964    0.7545    0.0000 O   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0  2  0  0  0
   -1.2990   -5.2500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0  2  0  0  0
    1.2982   -3.7531    0.0000 C   0  0
    1.2961   -5.2539    0.0000 C   0  0
    2.5943   -6.0070    0.0000 C   0  0  1  0  0  0
    3.8946   -5.2592    0.0000 O   0  0
    2.5922   -7.5078    0.0000 C   0  0
    3.8904   -8.2609    0.0000 C   0  0  1  0  0  0
    5.1907   -7.5131    0.0000 O   0  0
    3.8883   -9.7617    0.0000 C   0  0
    5.1865  -10.5148    0.0000 C   0  0
    6.4868   -9.7671    0.0000 O   0  5
    5.1843  -12.0148    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0  1  0  0  0
  2  3  1  0
  3  4  1  0
  4  5  1  6
  4  6  1  0
  6  7  2  0
  6  8  1  0
  9  8  1  6
  9 10  1  0
 10 11  1  0
 11 12  1  1
 11 13  1  0
 13 14  2  3
 14 15  1  0
 15 16  2  3
 16 17  1  0
 17 18  1  1
 17 19  1  0
 19 20  1  1
 20 21  1  0
 21 22  1  0
 22 23  1  1
 22 24  1  0
 24 25  1  0
 25 26  1  1
 25 27  1  0
 27 28  1  0
 28 29  1  0
 28 30  2  0
 19 31  1  0
 31  9  1  0
 31 14  1  6
M  CHG  2   1   1  29  -1
M  END
> <name>
NIHCC_2014

> <id>
5696

> <plate>
NGP-105-01

> <well>
H03

> <supplier_cmpd_name>
CPD000469187

> <ctcr_id>
2131

> <supplier_cmpd_id>
SAM001246656

> <smiles>
[Na+].CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC([O-])=O)[C@@H]12

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"PRAVASTATIN SODIUM",81131-70-6,81131706,Mevalotin,Selektine,Elisor,Pravachol,Pravaselect,Lipostat,CS-514,CS514,"Pravastatin Sodium Salt","Eptastatin sodium","Pravastatin (sodium)",UNII-3M8608UQ61,UN
II3M8608UQ61,SQ-31000,SQ31000,"SQ-31,000","SQ31,000",CHEBI:8361,Bristacol,Lipemol,Prareduct,SAM001246656,CPD000469187}

> <pdid>

> <targets>
{Autophagy,Ferroptosis,HMG-CoA Reductase (HMGCR)}

> <classes>
{Apoptosis,Autophagy,Metabolic Enzyme/Protease}

> <pubchem_cids>
{16759173}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 24  0  0  0  0            999 V2000
    6.4451   -1.8434    0.0000 C   0  0
    4.9531   -1.9978    0.0000 C   0  0
    4.2010   -3.2956    0.0000 O   0  0
    2.7343   -2.9815    0.0000 N   0  0
    2.5987   -1.5004    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.9511   -0.8815    0.0000 C   0  0
    4.2567    0.5878    0.0000 C   0  0
    3.2235    1.6679    0.0000 C   0  0
    3.6446    3.1076    0.0000 C   0  0
    5.1019    3.4627    0.0000 C   0  0
    6.1382    2.3782    0.0000 C   0  0
    5.7171    0.9385    0.0000 C   0  0
    5.5233    4.9032    0.0000 S   0  0
    6.9808    5.2579    0.0000 N   0  0
    4.4877    5.9884    0.0000 O   0  0
    5.9451    6.3427    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
  5 12  1  0
 12  2  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 16 19  1  0
 19 20  1  0
 19 21  2  0
 19 22  2  0
M  END
> <name>
NIHCC_2014

> <id>
5697

> <plate>
NGP-105-01

> <well>
H04

> <supplier_cmpd_name>
CPD000466327

> <ctcr_id>
222

> <supplier_cmpd_id>
SAM001246603

> <smiles>
Cc1onc(c2ccccc2)c1c3ccc(cc3)[S](N)(=O)=O

> <pd_targets>
{CA1,CA9,NCE103,PTGS1,CA2,PTGS2,CA4,CA12,MT-CO2,LMNA,RAB2A,RAC1,CA5B,CA13,MTCA2,CA3,CA6,CYP3A4,MTCA1,CDC42,CA7,CA5A,1272966,CA15,MT-CO1,RAB7A,CA14,SLC6A2}

> <pathway_gtopdb>
{Enzyme,Transporter,"Other nuclear protein",Lyase,Oxidoreductase,"Primary active transporter",Hydrolase,"Cytochrome P450","Electrochemical transporter","Oxidoreduction-driven transporters","Cytochrome
 P450 family 3","SLC superfamily of solute carriers","Cytochrome P450 family 3A","SLC06 neurotransmitter transporter family","Cytochrome P450 3A4"}

> <pathway_chembl>
{Enzymes,Transporters,"Carbonic anhydrases","Eicosanoid turnover","Cytochrome P450","SLC superfamily of solute carriers",Cyclooxygenase,"CYP3 family","SLC6 neurotransmitter transporter family","Monoam
ine transporter subfamily"}

> <pathway_reactome>
{"Immune System","Cellular responses to external stimuli",Metabolism,"Transport of small molecules","Gene expression (Transcription)","Cell Cycle","Developmental Biology",Disease,"Cytokine Signaling i
n Immune system","Cellular responses to stress","Metabolism of lipids","O2/CO2 exchange in erythrocytes","Reversible hydration of carbon dioxide","RNA Polymerase II Transcription",Mitotic,"Nervous sys
tem development","Infectious disease","Disorders of transmembrane transporters","Signaling by Interleukins","Cellular response to hypoxia","Fatty acid metabolism","Erythrocytes take up carbon dioxide 
and release oxygen","Biosynthesis of specialized proresolving mediators (SPMs)","Generic Transcription Pathway","M Phase","Axon guidance","Leishmania infection","Infection with Mycobacterium tuberculo
sis","SLC transporter disorders","Interleukin-12 family signaling","Regulation of gene expression by Hypoxia-inducible Factor","Arachidonic acid metabolism","Biosynthesis of DPA-derived SPMs","Transcr
iptional Regulation by TP53","Mitotic Metaphase and Anaphase","Mitotic Prophase","Semaphorin interactions","Biosynthesis of DHA-derived SPMs","Parasite infection","Response of Mtb to phagocytosis","De
fective SLC6A2 causes orthostatic intolerance (OI)","Interleukin-12 signaling","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","Biosynthesis of DPAn-3 SPMs","TP53 Regulates Metabolic Genes","
Mitotic Anaphase","Golgi Cisternae Pericentriolar Stack Reorganization","Sema4D in semaphorin signaling","Biosynthesis of maresins","Leishmania phagocytosis","Suppression of phagosomal maturation","Ge
ne and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","Nuclear Envelope (NE) Reassembly","Sema4D mediated inhibition of cell attachment and migration","Biosynthesis of mare
sin-like SPMs","FCGR3A-mediated phagocytosis","Prevention of phagosomal-lysosomal fusion","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{CA12,PTGS2}

> <broad_moa>
{"cyclooxygenase inhibitor"}

> <synonyms>
{HMS3372D12,HMS3393P07,HMS3652I04,HMS3715L18,Valdecoxib,181695-72-7,181695727,Bextra,4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide,4(5methyl3phenylisoxazol4yl)benzenesulfonamide,"SC 65872",SC-6
5872,SC65872,Valdyn,4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide,4(5Methyl3phenyl4isoxazolyl)benzenesulfonamide,Kudeq,Benzenesulfonamide,4-(5-methy,4(5methy,T0219,PZ0179,SAM001246603,1504302,v
aldecoxib,CPD000466327,VALDECOXIB}

> <pdid>
PD002956

> <targets>
{}

> <classes>
{"COX-2 inhibitor",antiinflammatory}

> <pubchem_cids>
{119607}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 27  0  0  0  0            999 V2000
    1.3000    2.2500    0.0000 C   0  0
    1.3000    0.7500    0.0000 S   0  0
    1.3000   -0.7500    0.0000 O   0  0
    0.0007    0.0004    0.0000 O   0  0
    2.5993    0.0004    0.0000 O   0  0
   15.6852    1.1219    0.0000 O   0  0
   14.2076    1.3804    0.0000 C   0  0
   13.6928    2.7893    0.0000 C   0  0
   12.2152    3.0479    0.0000 C   0  0
   11.2491    1.8953    0.0000 C   0  0
   11.7674    0.4887    0.0000 C   0  0
   13.2449    0.2301    0.0000 C   0  0
    9.7860    2.2293    0.0000 C   0  0
    9.4522    3.6917    0.0000 C   0  0
    8.1007    4.3425    0.0000 N   0  0
    6.7493    3.6917    0.0000 C   0  0
    6.4155    2.2293    0.0000 C   0  0
    7.3507    1.0565    0.0000 C   0  0
    6.6007   -0.2438    0.0000 C   0  0
    5.1007   -0.2441    0.0000 Cl  0  0
    7.3507   -1.5428    0.0000 C   0  0
    6.6007   -2.8418    0.0000 O   0  0
    8.8507   -1.5428    0.0000 C   0  0
    9.6007   -2.8418    0.0000 O   0  0
    9.6007   -0.2438    0.0000 C   0  0
    8.8507    1.0565    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  2  0
  2  5  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 10 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 19 21  1  0
 21 22  1  0
 21 23  2  0
 23 24  1  0
 23 25  1  0
 25 26  2  0
 26 13  1  0
 26 18  1  0
M  END
> <name>
NIHCC_2014

> <id>
5698

> <plate>
NGP-105-01

> <well>
H05

> <supplier_cmpd_name>
CPD000469190

> <ctcr_id>
3848

> <supplier_cmpd_id>
SAM001246665

> <smiles>
C[S](O)(=O)=O.Oc1ccc(cc1)C2CNCCc3c(Cl)c(O)c(O)cc23

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{DRD1,DRD4}

> <broad_moa>
{"dopamine receptor agonist"}

> <synonyms>
{"FENOLDOPAM MESYLATE",67227-57-0,67227570,Corlopam,"Fenoldopam (mesylate)","Fenoldopam methanesulfonate","Fenoldopam mesilate","SK&F 82526-J","SK&F 82526J",SK&F-82526J,SK&F82526J,"Corlopam mesylate",
"Fenoldopam methanesulfonate;SKF-82526 mesylate","Fenoldopam methanesulfonate;SKF82526 mesylate",MLS001401388,"SKF 8",SAM001246665,CPD000469190}

> <pdid>
PD009713

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{49659}

$$$$
NIHCC_2014
  SciTegic11012413002D

 40 43  0  0  1  0            999 V2000
    6.3990   -6.3774    0.0000 Cl  0  0
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 O   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -3.8971   -3.7500    0.0000 C   0  0
   -5.1961   -3.0000    0.0000 O   0  0
   -3.8971   -5.2500    0.0000 C   0  0
   -5.1961   -6.0000    0.0000 C   0  0
   -5.1961   -7.5000    0.0000 C   0  0  2  0  0  0
   -6.4764   -6.7185    0.0000 O   0  0
   -3.8971   -8.2500    0.0000 C   0  0
   -2.5980   -7.5000    0.0000 C   0  0  2  0  0  0
   -1.2998   -8.2531    0.0000 O   0  0
   -1.3019   -9.7539    0.0000 C   0  0  1  0  0  0
   -0.0055  -10.5085    0.0000 C   0  0
   -0.0107  -12.0085    0.0000 C   0  0  2  0  0  0
    1.2858  -12.7630    0.0000 N   0  0
   -1.3123  -12.7540    0.0000 C   0  0  1  0  0  0
   -1.3175  -14.2540    0.0000 O   0  0
   -2.6087  -11.9995    0.0000 C   0  0  2  0  0  0
   -3.9104  -12.7450    0.0000 C   0  0
   -2.6036  -10.4995    0.0000 O   0  0
   -2.5980   -6.0000    0.0000 C   0  0
   -1.2990   -5.2500    0.0000 C   0  0
    0.0000   -6.0000    0.0000 O   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    1.2991   -3.7500    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -5.1596   -8.9800    0.0000 C   0  0
   -6.4587   -9.7299    0.0000 O   0  0
   -3.8602   -9.7310    0.0000 C   0  0
   -3.8599  -11.2310    0.0000 O   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  1
 16 18  1  0
 18 19  1  0
 19 20  1  1
 21 20  1  1
 21 22  1  0
 22 23  1  0
 23 24  1  6
 23 25  1  0
 25 26  1  1
 25 27  1  0
 27 28  1  6
 27 29  1  0
 29 21  1  0
 19 30  1  0
 30 14  2  0
 30 31  1  0
 31 32  1  0
 31 33  2  0
 33 11  1  0
 33 34  1  0
 34 35  2  0
 34 36  1  0
 36  4  1  0
 36  8  2  0
 16 37  1  0
 37 38  2  0
 37 39  1  0
 39 40  1  0
M  END
> <name>
NIHCC_2014

> <id>
5699

> <plate>
NGP-105-01

> <well>
H06

> <supplier_cmpd_name>
CPD000466308

> <ctcr_id>
1004

> <supplier_cmpd_id>
SAM001246559

> <smiles>
Cl.COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Epirubicin hydrochloride",139294-EP2270008A1,139294EP2270008A1,139294-EP2292617A1,139294EP2292617A1,Pharmorubicin,Ellence,56390-09-1,56390091,"Epirubicin HCl",Farmorubicin,"Epirubicin Ebewe","epirub
icin (hydrochloride)",IMI-28,IMI28,UNII-22966TX7J5,UNII22966TX7J5,MLS001401404,"NSC 256942",Pidorubicin,22966,256942,SAM001246559,1505708,CPD000466308,"EPIRUBICIN HYDROCHLORIDE"}

> <pdid>
PD000383

> <targets>
{}

> <classes>
{"topoisomerase II inhibitor",antineoplastic}

> <pubchem_cids>
{53630345,65348}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 27  0  0  0  0            999 V2000
   12.7876   -2.7152    0.0000 H   0  3
   10.2876   -2.7152    0.0000 Cl  0  5
    2.5909   -6.0056    0.0000 C   0  0
    3.8912   -5.2578    0.0000 N   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -4.0317   -0.7359    0.0000 S   0  0
   -5.4979   -1.0529    0.0000 C   0  0
   -6.1032   -2.4253    0.0000 O   0  0
   -6.2524    0.2436    0.0000 N   0  0
   -5.2526    1.3618    0.0000 C   0  0
   -5.5608    2.8298    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    5.1894   -6.0109    0.0000 C   0  0
    5.1895   -7.5109    0.0000 C   0  0
    6.4885   -8.2610    0.0000 C   0  0
    7.7875   -7.5110    0.0000 C   0  0
    7.7876   -6.0110    0.0000 C   0  0
    6.4885   -5.2610    0.0000 N   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 13  1  0
 18 19  2  0
 11 20  1  0
 20 21  2  0
 21  8  1  0
  4 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5700

> <plate>
NGP-105-01

> <well>
H07

> <supplier_cmpd_name>
CPD000469170

> <ctcr_id>
2763

> <supplier_cmpd_id>
SAM001246608

> <smiles>
[H+].[Cl-].CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c3ccccn3

> <pd_targets>
{PPARD,TRPC5,PPARA,PPARG,FFAR1,MAOA,CISD2,MAOB,AGTR1A,ABCB11,CISD1,CYP3A4,HSD17B10,KDM4E,HPGD,LMNA,RXRA,RARG,ABCC4,KCNH2,SLC10A1,CA2,TBXAS1,TRPM3,ACSL4}

> <pathway_gtopdb>
{"Transcription factor","Ion channel","Membrane receptor",Enzyme,"Unclassified protein",Transporter,"Epigenetic regulator","Other nuclear protein","Nuclear receptor","Voltage-gated ion channel","Famil
y A G protein-coupled receptor",Oxidoreductase,"Primary active transporter","Cytochrome P450",Eraser,"Electrochemical transporter",Lyase,"Nuclear hormone receptor subfamily 1","Transient receptor pote
ntial channel","Small molecule receptor (family A GPCR)","Peptide receptor (family A GPCR)","ATP-binding cassette","Cytochrome P450 family 3","Lysine demethylase","Nuclear hormone receptor subfamily 2
","Potassium channels","SLC superfamily of solute carriers","Cytochrome P450 family 5","Nuclear hormone receptor subfamily 1 group C","Lipid-like ligand receptor (family A GPCR)","Short peptide recept
or (family A GPCR)","ABCB subfamily","Cytochrome P450 family 3A","Jumonji domain-containing","Nuclear hormone receptor subfamily 2 group B","Nuclear hormone receptor subfamily 1 group B","ABCC subfami
ly","Voltage-gated potassium channel","SLC10 family of sodium-bile acid co-transporters","Cytochrome P450 family 5A","Nuclear hormone receptor subfamily 1 group C member 2","Nuclear hormone receptor s
ubfamily 1 group C member 1","Nuclear hormone receptor subfamily 1 group C member 3","Free fatty acid receptor","Angiotensin receptor","Cytochrome P450 3A4","Nuclear hormone receptor subfamily 2 group
 B member 1","Nuclear hormone receptor subfamily 1 group B member 3","Cytochrome P450 5A1"}

> <pathway_chembl>
{Receptors,"Ion channels",Enzymes,Transporters,"Nuclear hormone receptors","Voltage-gated ion channels","G protein-coupled receptors","Catecholamine turnover","ATP-binding cassette transporter family"
,"Cytochrome P450","Chromatin modifying enzymes","Eicosanoid turnover","SLC superfamily of solute carriers","Carbonic anhydrases","1C. Peroxisome proliferator-activated receptors","Transient Receptor 
Potential channels","Free fatty acid receptors","Angiotensin receptors","ABCB subfamily","CYP3 family","1.14.11.- Histone demethylases","Prostaglandin synthases","2B. Retinoid X receptors","1B. Retino
ic acid receptors","ABCC subfamily","Potassium channels","SLC10 family of sodium-bile acid co-transporters",CYP5,"CYP7 and CYP8 families","Voltage-gated potassium channels"}

> <pathway_reactome>
{Metabolism,"Developmental Biology","Gene expression (Transcription)","Cell Cycle",Hemostasis,"Muscle contraction","Transport of small molecules","The citric acid (TCA) cycle and respiratory electron 
transport","Nervous system development","Metabolism of lipids","RNA Polymerase II Transcription","Integration of energy metabolism","Biological oxidations","Metabolism of amino acids and derivatives",
Mitotic,"Platelet activation","signaling and aggregation","Cardiac conduction","O2/CO2 exchange in erythrocytes","Ion channel transport","Pyruvate metabolism and Citric Acid (TCA) cycle","Axon guidanc
e","Metabolism of steroids","Generic Transcription Pathway","Regulation of insulin secretion","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","Br
anched-chain amino acid catabolism","M Phase","Response to elevated platelet cytosolic Ca2+","Phase 3 - rapid repolarisation","Erythrocytes take up carbon dioxide and release oxygen","Stimuli-sensing 
channels","Pyruvate metabolism","Netrin-1 signaling","Regulation of cholesterol biosynthesis by SREBP (SREBF)","Transcriptional Regulation by MECP2","Free fatty acids regulate insulin secretion","Amin
e Oxidase reactions","Bile acid and bile salt metabolism","Biosynthesis of DHA-derived SPMs","Mitotic Metaphase and Anaphase","Nuclear Receptor transcription pathway","Platelet degranulation","Cytochr
ome P450 - arranged by substrate type","TRP channels","Regulation of pyruvate dehydrogenase (PDH) complex","Role of second messengers in netrin-1 signaling","Activation of gene expression by SREBF (SR
EBP)","MECP2 regulates transcription factors","Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion","Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB","Synthesis of b
ile acids and bile salts","Biosynthesis of maresins","Biosynthesis of D-series resolvins","Mitotic Anaphase","Recycling of bile acids and salts",Eicosanoids,"Intracellular metabolism of fatty acids re
gulates insulin secretion","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Biosynthesis of maresin-like SPMs","Nuclear Envelope (NE) Reassembly","Synthesis of bile acids and bi
le salts via 27-hydroxycholesterol","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{FFAR1,PPARG,TRPC5,TRPM3}

> <broad_moa>
{"insulin sensitizer","PPAR receptor agonist"}

> <synonyms>
{"Rosiglitazone hydrochloride",302543-62-0,302543620,"ROSIGLITAZONE HCl","Rosiglitazone (hydrochloride)","BRL 49653 (hydrochloride)",2-Bromo-3-methylbenzoicacid,2Bromo3methylbenzoicacid,C18H20ClN3O3S,
CPD000469170,ACMC-20p1d3,ACMC20p1d3,MLS001401416,SCHEMBL3375739,CHEMBL1704605,(5R,SAM001246608,Prestw-1337,"Rosiglitazone Hydrochloride"}

> <pdid>
PD010041

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{9865387}

$$$$
NIHCC_2014
  SciTegic11012413002D

 42 43  0  0  0  0            999 V2000
    5.1996   -1.4928    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 Cl  0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 C   0  0
    1.2947   -3.7531    0.0000 O   0  0
   -1.3039   -3.7494    0.0000 N   0  0
   -1.3070   -5.2502    0.0000 C   0  0
   -2.6078   -5.9988    0.0000 C   0  0
   -2.6131   -7.4988    0.0000 C   0  0
   -3.9147   -8.2443    0.0000 N   0  0
   -5.2111   -7.4898    0.0000 C   0  0
   -5.2060   -5.9898    0.0000 C   0  0
   -3.9043   -5.2443    0.0000 O   0  0
   -3.9230   -9.7451    0.0000 C   0  0
   -5.2264  -10.4892    0.0000 C   0  0
   -5.2368  -11.9892    0.0000 C   0  0
   -6.5410  -12.7302    0.0000 C   0  0
   -7.8349  -11.9712    0.0000 C   0  0
   -9.1390  -12.7122    0.0000 F   0  0
   -7.8245  -10.4712    0.0000 C   0  0
   -6.5203   -9.7302    0.0000 C   0  0
    9.0003   -4.1236    0.0000 O   0  0
    9.0003   -5.6236    0.0000 C   0  0
    7.7010   -6.3731    0.0000 O   0  0
   10.3003   -6.3736    0.0000 C   0  0
   11.6003   -5.6236    0.0000 C   0  0
   12.8989   -6.3744    0.0000 O   0  0
   11.6017   -4.1227    0.0000 C   0  0
   12.9017   -3.3727    0.0000 C   0  0
   14.2003   -4.1236    0.0000 O   0  0
   12.9031   -1.8727    0.0000 O   0  0
   11.6015   -7.1535    0.0000 C   0  0
   10.3028   -7.9041    0.0000 O   0  0
   12.9007   -7.9033    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11  4  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 16  1  0
 18 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 26 28  1  0
 28 29  2  0
 29 23  1  0
 30 31  1  0
 31 32  2  0
 31 33  1  0
 33 34  1  0
 34 35  1  0
 34 36  1  0
 36 37  1  0
 37 38  1  0
 37 39  2  0
 34 40  1  0
 40 41  1  0
 40 42  2  0
M  END
> <name>
NIHCC_2014

> <id>
5701

> <plate>
NGP-105-01

> <well>
H08

> <supplier_cmpd_name>
CPD000469200

> <ctcr_id>
1324

> <supplier_cmpd_id>
SAM001246713

> <smiles>
CCOc1cc(N)c(Cl)cc1C(=O)NCC2CN(CCO2)Cc3ccc(F)cc3.OC(=O)CC(O)(CC(O)=O)C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Mosapride citrate",112885-42-4,112885424,AS-4370,AS4370,Gasmotin,"Mosapride (citrate)",TAK-370,TAK370,Gasmot,DSSTox_CID_26207,DSSToxCID26207,DSSTox-CID-26207,"DSSTox CID 26207",DSSTox_RID_81436,DSST
oxRID81436,DSSTox-RID-81436,"DSSTox RID 81436",DSSTox_GSID_46207,DSSToxGSID46207,DSSTox-GSID-46207,"DSSTox GSID 46207",CAS-112885-42-4,CAS112885424,C21H25ClFN3O3.C6H8O7,MLS006011997,C27H33ClFN3O10,SCH
EMBL258620,CHEMBL17331,T6597,S1385,SAM001246713,"Mosapride Citrate",CPD000469200}

> <pdid>

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{119583}

$$$$
NIHCC_2014
  SciTegic11012413002D

 19 20  0  0  0  0            999 V2000
    2.5915   -6.0067    0.0000 N   0  0
    3.8917   -5.2586    0.0000 C   0  0
    5.1894   -6.0108    0.0000 O   0  0
    3.8934   -3.7577    0.0000 C   0  0
    2.5949   -3.0050    0.0000 S   0  0
    1.2948   -3.7531    0.0000 O   0  0
    2.5966   -1.5042    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8990   -0.7582    0.0000 C   0  0
    3.9042    0.7419    0.0000 C   0  0
    5.2058    1.4875    0.0000 C   0  0
    6.5023    0.7331    0.0000 C   0  0
    6.4972   -0.7669    0.0000 C   0  0
    5.1956   -1.5125    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  7 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
M  END
> <name>
NIHCC_2014

> <id>
5702

> <plate>
NGP-105-01

> <well>
H09

> <supplier_cmpd_name>
CPD000058957

> <ctcr_id>
1299

> <supplier_cmpd_id>
SAM001246587

> <smiles>
NC(=O)C[S](=O)C(c1ccccc1)c2ccccc2

> <pd_targets>
{CYP2C19,NET,TGR,SLC6A3,LMNA,MAPK1,ADRA1B,DRD2,DRD3}

> <pathway_gtopdb>
{Enzyme,Transporter,"Other nuclear protein","Membrane receptor","Cytochrome P450","Electrochemical transporter",Kinase,"Family A G protein-coupled receptor","Cytochrome P450 family 2","SLC superfamily
 of solute carriers","Protein Kinase","Small molecule receptor (family A GPCR)","Cytochrome P450 family 2C","SLC06 neurotransmitter transporter family","CMGC protein kinase group","Monoamine receptor"
,"Cytochrome P450 2C19","CMGC protein kinase MAPK family","Adrenergic receptor","CMGC protein kinase ERK1","Dopamine receptor"}

> <pathway_chembl>
{Enzymes,Transporters,Receptors,"Cytochrome P450","SLC superfamily of solute carriers","Kinases (EC 2.7.x.x)","G protein-coupled receptors","CYP2 family: drug metabolising subset","SLC6 neurotransmitt
er transporter family","CMGC: Containing CDK",MAPK,GSK3,"CLK families",Adrenoceptors,"Monoamine transporter subfamily","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily","Dopamine recep
tors"}

> <pathway_reactome>
{Metabolism,Disease,"Cell Cycle","Immune System","Signal Transduction","Biological oxidations","Disorders of transmembrane transporters",Mitotic,"Innate Immune System","Signaling by GPCR","Phase I - F
unctionalization of compounds","SLC transporter disorders","M Phase","Toll-like Receptor Cascades","GPCR ligand binding","Cytochrome P450 - arranged by substrate type","Defective SLC6A3 causes Parkins
onism-dystonia infantile (PKDYS)","Mitotic Metaphase and Anaphase","Toll Like Receptor 5 (TLR5) Cascade","Class A/1 (Rhodopsin-like receptors)",Xenobiotics,"Mitotic Anaphase","MyD88 cascade initiated 
on plasma membrane","Amine ligand-binding receptors","CYP2E1 reactions","Nuclear Envelope (NE) Reassembly","MAP kinase activation",Adrenoceptors,"Initiation of Nuclear Envelope (NE) Reformation","MAPK
 targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated","Dopamine receptors"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{68693-11-8,68693118,"68693 11 8",Provigil,Modiodal,2-((diphenylmethyl)sulfinyl)acetamide,2((diphenylmethyl)sulfinyl)acetamide,"2 ((diphenylmethyl)sulfinyl)acetamide","Modafinilum (Latin)",2-(Benzhydr
ylsulfinyl)acetamide,2(Benzhydrylsulfinyl)acetamide,2(Benzhydryl,SAM001246587,1505361,Prestw-1147,CPD000058957,MODAFINIL,Modafinil}

> <pdid>
PD000912

> <targets>
{}

> <classes>
{analeptic}

> <pubchem_cids>
{4236}

$$$$
NIHCC_2014
  SciTegic11012413002D

 50 53  0  0  1  0            999 V2000
    2.0218  -16.6266    0.0000 C   0  0
    1.5606  -15.1993    0.0000 C   0  0
    2.5664  -14.0865    0.0000 C   0  0
    3.0272  -15.5138    0.0000 C   0  0
    0.0933  -14.8840    0.0000 N   0  0
   -0.3682  -13.4559    0.0000 C   0  0
    0.6376  -12.3431    0.0000 O   0  0
   -1.8356  -13.1405    0.0000 C   0  0  2  0  0  0
   -2.8394  -14.2551    0.0000 C   0  0
   -4.3066  -13.9430    0.0000 N   0  0
   -4.7699  -12.5163    0.0000 C   0  0
   -3.7660  -11.4018    0.0000 C   0  0
   -2.2988  -11.7138    0.0000 N   0  0
   -1.2966  -10.5966    0.0000 C   0  0
   -1.7622   -9.1698    0.0000 C   0  0  1  0  0  0
   -3.2299   -8.8602    0.0000 O   0  0
   -0.7600   -8.0526    0.0000 C   0  0
   -1.2256   -6.6258    0.0000 C   0  0  1  0  0  0
   -0.2201   -5.5116    0.0000 C   0  0
    1.2478   -5.8244    0.0000 C   0  0
    2.2544   -4.7122    0.0000 C   0  0
    3.7208   -5.0278    0.0000 C   0  0
    4.1807   -6.4556    0.0000 C   0  0
    3.1742   -7.5677    0.0000 C   0  0
    1.7078   -7.2522    0.0000 C   0  0
   -2.6938   -6.3147    0.0000 C   0  0
   -3.6965   -7.4303    0.0000 O   0  0
   -3.1594   -4.8879    0.0000 N   0  0
   -4.6251   -4.5772    0.0000 C   0  0  2  0  0  0
   -5.7373   -5.5837    0.0000 C   0  0  2  0  0  0
   -5.5768   -7.0751    0.0000 O   0  0
   -7.0382   -4.8369    0.0000 C   0  0
   -6.7299   -3.3698    0.0000 C   0  0
   -7.6146   -2.1584    0.0000 C   0  0
   -7.0078   -0.7866    0.0000 C   0  0
   -5.5165   -0.6261    0.0000 C   0  0
   -4.6318   -1.8375    0.0000 C   0  0
   -5.2385   -3.2093    0.0000 C   0  0
   -5.3133  -15.0561    0.0000 C   0  0
   -6.7809  -14.7417    0.0000 C   0  0
   -7.7887  -15.8528    0.0000 C   0  0
   -9.2548  -15.5356    0.0000 C   0  0
   -9.7131  -14.1073    0.0000 C   0  0
   -8.7054  -12.9963    0.0000 N   0  0
   -7.2393  -13.3134    0.0000 C   0  0
    6.8280   -6.0637    0.0000 O   0  0
    6.8280   -7.5637    0.0000 S   0  0
    6.8280   -9.0637    0.0000 O   0  0
    5.5287   -8.3133    0.0000 O   0  0
    8.1272   -8.3133    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  2  0
  8  6  1  6
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13  8  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  1
 15 17  1  0
 18 17  1  6
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 18 26  1  0
 26 27  2  0
 26 28  1  0
 29 28  1  6
 29 30  1  0
 30 31  1  6
 30 32  1  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  2  0
 38 29  1  0
 38 33  1  0
 10 39  1  0
 39 40  1  0
 40 41  2  0
 41 42  1  0
 42 43  2  0
 43 44  1  0
 44 45  2  0
 45 40  1  0
 46 47  1  0
 47 48  1  0
 47 49  2  0
 47 50  2  0
M  END
> <name>
NIHCC_2014

> <id>
5703

> <plate>
NGP-105-01

> <well>
H10

> <supplier_cmpd_name>
CPD000469161

> <ctcr_id>
6922

> <supplier_cmpd_id>
SAM001246588

> <smiles>
CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@@H](O)C[C@@H](Cc2ccccc2)C(=O)N[C@@H]3[C@H](O)Cc4ccccc34)Cc5cccnc5.O[S](O)(=O)=O

> <pd_targets>
{POL,PROTEASE,CYP3A4,"HIV-1 PROTEASE",ABCB11,ABCB1,TACR2,TBXAS1,SLC22A1,SLC47A1,ABCC3,SLC47A2,NR1I2}

> <pathway_gtopdb>
{Enzyme,"Unclassified protein",Transporter,"Membrane receptor","Transcription factor",Protease,"Cytochrome P450","Primary active transporter","Family A G protein-coupled receptor","Electrochemical tra
nsporter","Nuclear receptor","Aspartic protease","Cysteine protease","Cytochrome P450 family 3","ATP-binding cassette","Peptide receptor (family A GPCR)","Cytochrome P450 family 5","SLC superfamily of
 solute carriers","Nuclear hormone receptor subfamily 1","Aspartic protease AA clan","Cysteine protease PAC clan","Cytochrome P450 family 3A","ABCB subfamily","Short peptide receptor (family A GPCR)",
"Cytochrome P450 family 5A","SLC22 family of organic cation and anion transporters","SLC47 family of multidrug and toxin extrusion transporters","ABCC subfamily","Nuclear hormone receptor subfamily 1 
group I","Aspartic protease A2A subfamily","Cysteine protease C3A subfamily","Cytochrome P450 3A4","Neurokinin receptor","Cytochrome P450 5A1","Nuclear hormone receptor subfamily 1 group I member 2"}

> <pathway_chembl>
{Enzymes,Transporters,Receptors,"Cytochrome P450","ATP-binding cassette transporter family","G protein-coupled receptors","SLC superfamily of solute carriers","Nuclear hormone receptors","CYP3 family"
,"ABCB subfamily","Tachykinin receptors",CYP5,"CYP7 and CYP8 families","SLC22 family of organic cation and anion transporters","SLC47 family of multidrug and toxin extrusion transporters","ABCC subfam
ily","1I. Vitamin D receptor-like receptors","Organic cation transporters (OCT)"}

> <pathway_reactome>
{Metabolism,"Signal Transduction","Transport of small molecules","Metabolism of proteins","Metabolism of lipids","Abacavir transport and metabolism","Signaling by GPCR","Biological oxidations","SLC-me
diated transmembrane transport","Post-translational protein modification","Biosynthesis of specialized proresolving mediators (SPMs)","Metabolism of steroids","Abacavir transmembrane transport","GPCR 
ligand binding","Phase I - Functionalization of compounds","Transport of bile salts and organic acids","metal ions and amine compounds",SUMOylation,"Biosynthesis of DHA-derived SPMs","Bile acid and bi
le salt metabolism","Class A/1 (Rhodopsin-like receptors)","Cytochrome P450 - arranged by substrate type","Organic cation/anion/zwitterion transport","SUMO E3 ligases SUMOylate target proteins","Biosy
nthesis of maresins","Synthesis of bile acids and bile salts","Peptide ligand-binding receptors",Eicosanoids,"Organic cation transport","Recycling of bile acids and salts","SUMOylation of intracellula
r receptors","Biosynthesis of maresin-like SPMs","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Tachykinin receptors bind tachykinins"}

> <broad_targets>
{CYP3A4,CYP3A5,CYP3A7}

> <broad_moa>
{"HIV protease inhibitor"}

> <synonyms>
{"Indinavir sulfate",157810-81-6,157810816,Crixivan,"INDINAVIR SULPHATE","Indinavir (sulfate)","MK 639",UNII-771H53976Q,UNII771H53976Q,MK-639,MK639,"L 735524","L-735,524","L735,524",CHEBI:5899,"Crixiv
an (TN)",771H53976Q,DSSTox_CID_24221,DSSToxCID24221,DSSTox-CID-24221,"DSSTox CID 24221",DSSTox_RID_80126,DSSToxRID80126,DSSTox-RID-80126,"DSSTox RID 80126",DSSTox_GSID_44221,DSSToxGSID44221,DSSTox-GSI
D-44221,"DSSTox GSID 44221",SMR000,SAM001246588,CPD000469161}

> <pdid>
PD000115

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5462355}

$$$$
NIHCC_2014
  SciTegic11012413002D

 32 33  0  0  0  0            999 V2000
    6.3990   -7.8767    0.0000 Cl  0  0
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3039   -3.7494    0.0000 C   0  0
   -1.3070   -5.2502    0.0000 C   0  0
   -0.0092   -6.0025    0.0000 O   0  0
   -2.6078   -5.9988    0.0000 C   0  0
   -2.6109   -7.4996    0.0000 N   0  0
   -3.9099   -8.2497    0.0000 C   0  0
   -3.9099   -9.7497    0.0000 C   0  0
   -2.6109  -10.4997    0.0000 N   0  0
   -2.6079  -12.0005    0.0000 C   0  0
   -1.3071  -12.7491    0.0000 C   0  0
   -0.0093  -11.9969    0.0000 O   0  0
   -1.3040  -14.2499    0.0000 N   0  0
   -0.0032  -14.9985    0.0000 C   0  0
    0.0020  -16.4985    0.0000 C   0  0
   -1.2944  -17.2531    0.0000 C   0  0
    1.3037  -17.2441    0.0000 C   0  0
    2.6001  -16.4896    0.0000 C   0  0
    2.5950  -14.9896    0.0000 C   0  0
    1.2933  -14.2441    0.0000 C   0  0
    1.2882  -12.7441    0.0000 C   0  0
   -1.3119   -9.7497    0.0000 C   0  0
   -1.3118   -8.2497    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 24 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 23  1  0
 29 30  1  0
 18 31  1  0
 31 32  1  0
 32 15  1  0
M  END
> <name>
NIHCC_2014

> <id>
5704

> <plate>
NGP-105-01

> <well>
H11

> <supplier_cmpd_name>
CPD000326795

> <ctcr_id>
1814

> <supplier_cmpd_id>
SAM001246534

> <smiles>
Cl.COc1ccccc1OCC(O)CN2CCN(CC(=O)Nc3c(C)cccc3C)CC2

> <pd_targets>
{BLM,NPSR1,PMP22,LMNA,SCN5A,KCNH2,SCN4A,SCN10A,SCN11A,SCN1A,SCN1B,SCN2A,SCN2B,SCN3A,SCN3B,SCN4B,SCN7A,SCN8A,SCN9A,KCNJ12,KCNJ14,KCNJ2,KCNJ4,CACNA1C,CACNA1D,CACNA1F,CACNA1S,CACNB1,CACNB2,CACNB3,CACNB4,
ADRA1A,ADRA1B,ADRA1D,ADRB1}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Unclassified protein","Other nuclear protein","Ion channel","Family A G protein-coupled receptor","Voltage-gated ion channel",Kinase,"Peptide receptor (family A GPCR)","Vo
ltage-gated sodium channel","Protein Kinase","Potassium channels","Small molecule receptor (family A GPCR)","Short peptide receptor (family A GPCR)","AGC protein kinase group","Voltage-gated potassium
 channel","Monoamine receptor","Neuropeptide receptor","AGC protein kinase PKC family","Adrenergic receptor","AGC protein kinase PKC iota subfamily"}

> <pathway_chembl>
{Receptors,"Ion channels","G protein-coupled receptors","Voltage-gated ion channels","Neuropeptide S receptor","Voltage-gated sodium channels","Potassium channels",Adrenoceptors,"Voltage-gated potassi
um channels"}

> <pathway_reactome>
{"DNA Repair",Disease,"Developmental Biology","Cell Cycle","Muscle contraction","DNA Double-Strand Break Repair","Infectious disease","Nervous system development",Mitotic,"Cardiac conduction","Homolog
y Directed Repair","Leishmania infection","EGR2 and SOX10-mediated initiation of Schwann cell myelination","M Phase","Axon guidance","Phase 3 - rapid repolarisation","HDR through Homologous Recombinat
ion (HRR) or Single Strand Annealing (SSA)","Leishmania parasite growth and survival","Mitotic Metaphase and Anaphase","L1CAM interactions","HDR through Homologous Recombination (HRR)","Anti-inflammat
ory response favouring Leishmania parasite infection","Mitotic Anaphase","Interaction between L1 and Ankyrins","Homologous DNA Pairing and Strand Exchange","ADORA2B mediated anti-inflammatory cytokine
s production","Nuclear Envelope (NE) Reassembly","Presynaptic phase of homologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{SCN10A,SCN9A}

> <broad_moa>
{"sodium channel blocker"}

> <synonyms>
{SMR000326795,MLS000859934,MLS001401403,SCHEMBL612077,CHEMBL537649,CCG-100990,CCG100990,NC00240,T0207,SAM001246534,"Ranolazine dihydrochloride",CPD000326795}

> <pdid>
PD010150

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581790}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 26  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0  2  0  0  0
   -1.2990   -0.7500    0.0000 S   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.0479    2.0470    0.0000 C   0  0  2  0  0  0
   -3.4926    2.4305    0.0000 N   0  0
   -4.5521    1.3675    0.0000 C   0  0
   -4.1610   -0.0806    0.0000 O   0  0
   -6.0026    1.7526    0.0000 C   0  0  2  0  0  0
   -6.3937    3.2007    0.0000 N   0  0
   -7.0621    0.6896    0.0000 C   0  0
   -8.5125    1.0724    0.0000 C   0  0
   -9.5692    0.0078    0.0000 C   0  0
   -9.1756   -1.4396    0.0000 C   0  0
   -7.7253   -1.8225    0.0000 C   0  0
   -6.6686   -0.7579    0.0000 C   0  0
   -0.7488    2.7970    0.0000 C   0  0
   -0.3606    4.2459    0.0000 O   0  0
    2.6003    1.4978    0.0000 C   0  0
    2.6029    2.9978    0.0000 O   0  0
    3.8983    0.7459    0.0000 O   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  1  0
  5  6  1  6
  6  7  1  0
  7  2  1  0
  5  8  1  0
  8  9  1  6
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  1
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
  8 20  1  0
 20  4  1  0
 20 21  2  0
  3 22  1  0
 22 23  1  0
 22 24  2  0
M  END
> <name>
NIHCC_2014

> <id>
5705

> <plate>
NGP-105-02

> <well>
A02

> <supplier_cmpd_name>
CPD000338536

> <ctcr_id>
1162

> <supplier_cmpd_id>
SAM001246761

> <smiles>
CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c3ccccc3)C2=O)C(O)=O

> <pd_targets>
{KMT2A,BLM,MAPT,ALD,MAPK1,FFP,HPGD,TDP1,ALDH1A1,SLC15A2,PBP3,PBP2A,PBP1B,PENA,PBPA,DACA,DACB,DACC,FTSI,MRCA,MRCB,MRDA}

> <pathway_gtopdb>
{"Epigenetic regulator",Enzyme,"Other cytosolic protein",Transporter,"Unclassified protein",Reader,Kinase,Transferase,Hydrolase,Oxidoreductase,"Electrochemical transporter",Protease,Bromodomain,"Prote
in Kinase","SLC superfamily of solute carriers","Serine protease","CMGC protein kinase group","SLC15 family of peptide transporters","Serine protease SE clan","CMGC protein kinase MAPK family","Serine
 protease S11 family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Transporters,"Chromatin modifying enzymes","Kinases (EC 2.7.x.x)","Eicosanoid turnover","SLC superfamily of solute carriers","2.1.1.43 Histone methyltransferases (HMTs)","CMGC: Containing CDK
",MAPK,GSK3,"CLK families","Prostaglandin synthases","SLC15 family of peptide transporters","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Gene expression (Transcription)","DNA Repair","Neuronal System","Immune System",Metabolism,"Transport of small molecules","RNA Polymerase II Transcription","DNA Double-Strand Break Repair","Transmis
sion across Chemical Synapses","Innate Immune System","Metabolism of lipids","Biological oxidations","SLC-mediated transmembrane transport","Generic Transcription Pathway","Homology Directed Repair","
Neurotransmitter receptors and postsynaptic signal transmission","Toll-like Receptor Cascades","Biosynthesis of specialized proresolving mediators (SPMs)","Nonhomologous End-Joining (NHEJ)","Phase I -
 Functionalization of compounds","Transport of inorganic cations/anions and amino acids/oligopeptides","Transcriptional regulation by RUNX1","HDR through Homologous Recombination (HRR) or Single Stran
d Annealing (SSA)","Activation of NMDA receptors and postsynaptic events","Toll Like Receptor 5 (TLR5) Cascade","Biosynthesis of DHA-derived SPMs","Ethanol oxidation","Proton/oligopeptide cotransporte
rs","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","HDR through Homologous Recombination (HRR)","Post NMDA receptor activation events","MyD88 cascade initiated
 on plasma membrane","Biosynthesis of D-series resolvins","Homologous DNA Pairing and Strand Exchange","Activation of AMPK downstream of NMDARs","MAP kinase activation","Presynaptic phase of homologou
s DNA pairing and strand exchange","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{}

> <broad_moa>
{"bacterial cell wall synthesis inhibitor"}

> <synonyms>
{cephalexin,Carnosporin,Cefaleksin,Cefaseptin,15686-71-2,15686712,Cefalexin,Keflex,Cephacillin,Ceporexin,Cepexin,Cephalexinum,Cepastar,Cephalexine,Celexin,Ceporex,Keflet,Alcephin,Cefablan,Cefalexina,C
efalexine,Cefalexinum,Cefadin,Tepaxin,Keftab,Palitre,T1008,SAM001246761,Cephalexin,CPD000338536}

> <pdid>
PD001422

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{6560168,27447}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 22  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.6003   -1.4978    0.0000 O   0  0
   -3.8983   -0.7459    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0031   -3.0008    0.0000 O   0  0
    1.3032   -3.7490    0.0000 C   0  0
   -0.0031    3.0008    0.0000 C   0  0
    1.2946    3.7531    0.0000 O   0  0
   -1.3039    3.7494    0.0000 N   0  0
   -1.3070    5.2502    0.0000 C   0  0
   -2.6061    6.0003    0.0000 C   0  0
   -2.6061    7.5003    0.0000 C   0  0
   -1.3071    8.2503    0.0000 C   0  0
   -0.0080    7.5003    0.0000 N   0  0
   -0.0080    6.0003    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  7 10  2  0
 10  3  1  0
 10 11  1  0
 11 12  1  0
  5 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 16  1  0
M  END
> <name>
NIHCC_2014

> <id>
5706

> <plate>
NGP-105-02

> <well>
A03

> <supplier_cmpd_name>
CPD000466385

> <ctcr_id>
4506

> <supplier_cmpd_id>
SAM001246756

> <smiles>
COc1cc(cc(OC)c1OC)C(=O)NC2CCCNC2

> <pd_targets>
{MAPK1,TGR}

> <pathway_gtopdb>
{Enzyme,Kinase,"Protein Kinase","CMGC protein kinase group","CMGC protein kinase MAPK family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,"Kinases (EC 2.7.x.x)","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Immune System","Innate Immune System","Toll-like Receptor Cascades","Toll Like Receptor 5 (TLR5) Cascade","MyD88 cascade initiated on plasma membrane","MAP kinase activation","MAPK targets/ Nuclear 
events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{}

> <broad_moa>
{"glucosamine synthetase stimulant"}

> <synonyms>
{KU54,CHEMBL1566956,troxipide,30751-05-4,30751054,"3,4,5-Trimethoxy-N-(3-piperidyl)benzamide","3,4,5TrimethoxyN(3piperidyl)benzamide","Benzamide, 3,4,5-trimethoxy-N-3-piperidinyl-","Benzamide, 3,4,5tr
imethoxyN3piperidinyl",KU-54,"3,4,5-trimethoxy-n-piperidin-3-ylbenzamide","3,4,5trimethoxynpiperidin3ylbenzamide",99777-81-8,99777818,3,4,5-trimethoxy-N-(piperidin-3-yl)benzam,5trimethoxyN(piperidin3y
l)benzam,T6710,SAM001246756,Troxipide,CPD000466385}

> <pdid>
PD000093

> <targets>
{Others}

> <classes>
{Others}

> <pubchem_cids>
{5597}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 24  0  0  1  0            999 V2000
    9.5862   -3.2909    0.0000 C   0  0
    8.1609   -2.8234    0.0000 C   0  0
    7.8525   -1.3573    0.0000 N   0  0
    8.8523   -0.2390    0.0000 C   0  0
    8.0978    1.0574    0.0000 C   0  0
    6.6317    0.7404    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0  1  0  0  0
    5.2003   -1.4932    0.0000 C   0  0
    3.8990   -0.7455    0.0000 N   0  0
    2.6003   -1.4977    0.0000 C   0  0
    2.6030   -2.9977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3032   -3.7490    0.0000 C   0  0
    0.0000    3.0008    0.0000 S   0  0
   -1.2993    3.7504    0.0000 N   0  0
    1.2985    3.7517    0.0000 O   0  0
   -0.0007    4.5008    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  3  1  0
  7  8  1  6
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 17 18  1  0
 18 19  1  0
 14 20  1  0
 20 21  1  0
 20 22  2  0
 20 23  2  0
M  END
> <name>
NIHCC_2014

> <id>
5707

> <plate>
NGP-105-02

> <well>
A04

> <supplier_cmpd_name>
CPD000466366

> <ctcr_id>
4955

> <supplier_cmpd_id>
SAM001246703

> <smiles>
CCN1CCC[C@H]1CNC(=O)c2cc(ccc2OC)[S](N)(=O)=O

> <pd_targets>
{CA9,DRD2,CYP1A2,CYP2D6,DRD4,DRD3,CA2,CA1,CYNT,NCE103,1272966,DRD1,DRD5,CA12,CA5A,BLM,CA7,CA3,CA6,CA15,MAPT,CA4,MTCA1,CA5B,MTCA2,ADRA2A,HTR2A,HTR2B,HTR2C,RORC,LMNA,MPO,TSHR,ADRA1A,ADRA1B,ADRA1D}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Other cytosolic protein",Lyase,"Family A G protein-coupled receptor","Cytochrome P450","Small molecule receptor (family A GPCR)","Cytochrome P450 family 1","Cytochrome P45
0 family 2","Monoamine receptor","Cytochrome P450 family 1A","Cytochrome P450 family 2D","Dopamine receptor","Cytochrome P450 1A1","Cytochrome P450 2D6","Adrenergic receptor","Transcription factor","O
ther nuclear protein","Nuclear receptor",Oxidoreductase,"Nuclear hormone receptor subfamily 1","Peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1 group F","Glycohormone receptor"
,"Serotonin receptor","Nuclear hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{Enzymes,Receptors,"Carbonic anhydrases","G protein-coupled receptors","Cytochrome P450","Dopamine receptors","CYP1 family","CYP2 family: drug metabolising subset",Adrenoceptors,"Nuclear hormone recep
tors","1.-.-.- Oxidoreductases","1F. Retinoic acid-related orphans","Glycoprotein hormone receptors"}

> <pathway_reactome>
{"Cellular responses to external stimuli","Signal Transduction",Metabolism,"Transport of small molecules","Immune System","DNA Repair","Neuronal System","Cellular responses to stress","Signaling by GP
CR","Biological oxidations","O2/CO2 exchange in erythrocytes","Cytokine Signaling in Immune system","Reversible hydration of carbon dioxide","DNA Double-Strand Break Repair","Transmission across Chemi
cal Synapses","Cellular response to hypoxia","GPCR ligand binding","Phase I - Functionalization of compounds","Erythrocytes take up carbon dioxide and release oxygen","Signaling by Interleukins","Homo
logy Directed Repair","Neurotransmitter receptors and postsynaptic signal transmission","Regulation of gene expression by Hypoxia-inducible Factor","Class A/1 (Rhodopsin-like receptors)","Cytochrome P
450 - arranged by substrate type","Interleukin-12 family signaling","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Activation of NMDA receptors and postsynaptic events"
,"Amine ligand-binding receptors",Xenobiotics,"Interleukin-12 signaling","HDR through Homologous Recombination (HRR)","Post NMDA receptor activation events","Dopamine receptors","Aromatic amines can b
e N-hydroxylated or N-dealkylated by CYP1A2","CYP2E1 reactions","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","Homologous DNA Pairing and Strand Exchange","Activ
ation of AMPK downstream of NMDARs",Adrenoceptors,"Presynaptic phase of homologous DNA pairing and strand exchange","Gene expression (Transcription)","Cell Cycle",Disease,"RNA Polymerase II Transcript
ion",Mitotic,"Innate Immune System","Infectious disease","Generic Transcription Pathway","M Phase","ROS and RNS production in phagocytes","Leishmania infection","Transcriptional regulation by RUNX3","
Mitotic Metaphase and Anaphase","Events associated with phagocytolytic activity of PMN cells","Leishmania parasite growth and survival","RUNX3 Regulates Immune Response and Cell Migration","Mitotic An
aphase","Anti-inflammatory response favouring Leishmania parasite infection","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Initiation of Nuclear Envelop
e (NE) Reformation"}

> <broad_targets>
{}

> <broad_moa>
{"dopamine receptor antagonist"}

> <synonyms>
{NCGC0002485302,Levosulpiride,23672-07-3,23672073,(S)-(-)-sulpiride,(S)()sulpiride,(-)-Sulpiride,()Sulpiride,Levopraid,S-(-)-Sulpiride,S()Sulpiride,Levosulpirida,Levosulpiridum,(S)-sulpiride,(S)sulpir
ide,UNII-JTG7R315LK,UNIIJTG7R315LK,"Levosulpiride (INN)",RV-12309,RV12309,JTG7R315LK,CHEBI:64119,(S)-(-)-N-((1-Ethyl-2-pyrroli,(S)()N((1Ethyl2pyrroli,S2104,SAM001246703,CPD000466366}

> <pdid>
PD000494

> <targets>
{"Dopamine Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{688272}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 25  0  0  0  0            999 V2000
    1.0497   -4.2139    0.0000 C   0  0
    1.5767   -2.8095    0.0000 C   0  0
    3.0226   -2.4104    0.0000 N   0  0
    3.0899   -0.9120    0.0000 N   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 C   0  0
    0.0000    1.7286    0.0000 N   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -2.5248    2.0134    0.0000 C   0  0
   -2.2261    3.4874    0.0000 C   0  0
   -3.3495    4.4814    0.0000 C   0  0
   -4.7720    4.0055    0.0000 C   0  0
   -5.0711    2.5356    0.0000 C   0  0
   -3.9477    1.5416    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -3.1695   -0.6090    0.0000 C   0  0
   -3.7175   -2.0053    0.0000 C   0  0
   -5.2007   -2.2289    0.0000 Cl  0  0
   -2.7822   -3.1781    0.0000 C   0  0
   -1.2990   -2.9545    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
    0.7500   -1.5574    0.0000 N   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  3
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
  8 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 19 20  1  0
 20 21  2  0
 21 15  1  0
 21 22  1  0
 22  2  1  0
 22  5  1  0
M  END
> <name>
NIHCC_2014

> <id>
5708

> <plate>
NGP-105-02

> <well>
A05

> <supplier_cmpd_name>
CPD000149316

> <ctcr_id>
4072

> <supplier_cmpd_id>
SAM001246696

> <smiles>
Cc1nnc2CN=C(c3ccccc3)c4cc(Cl)ccc4n12

> <pd_targets>
{GABRA2,CCKAR,GABBR1,GABRA1,BRD4,PTAFR,GABRA5,RORC,GABRA3,GABRA4,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG3,GABRP,GABRQ,HPGD,LMNA}

> <pathway_gtopdb>
{"Ion channel","Membrane receptor","Epigenetic regulator","Transcription factor",Enzyme,"Other nuclear protein","Ligand-gated ion channel","Family A G protein-coupled receptor","Family C G protein-cou
pled receptor",Reader,"Nuclear receptor","GABA-A receptor","Peptide receptor (family A GPCR)","Small molecule receptor (family C GPCR)",Bromodomain,"Small molecule receptor (family A GPCR)","Nuclear h
ormone receptor subfamily 1","Short peptide receptor (family A GPCR)","Neurotransmitter receptor (family C GPCR)","Lipid-like ligand receptor (family A GPCR)","Nuclear hormone receptor subfamily 1 gro
up F","Cholecystokinin receptor","GABA-B receptor","PAF receptor","Nuclear hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{"Ion channels",Receptors,Enzymes,"Ligand-gated ion channels","G protein-coupled receptors","Chromatin modifying enzymes","Nuclear hormone receptors","Eicosanoid turnover","GABA<sub>A</sub> receptors"
,"Cholecystokinin receptors","GABA<sub>B</sub> receptors","Enzymatic bromodomain-containing proteins","Platelet-activating factor receptor","1F. Retinoic acid-related orphans","Prostaglandin synthases
","Bromodomain kinase (BRDK) family"}

> <pathway_reactome>
{"Neuronal System","Signal Transduction",Disease,"Immune System","Gene expression (Transcription)",Metabolism,"Cell Cycle","Transmission across Chemical Synapses","Signaling by GPCR","Infectious disea
se","Cytokine Signaling in Immune system","RNA Polymerase II Transcription","Metabolism of lipids",Mitotic,"Neurotransmitter receptors and postsynaptic signal transmission","GPCR ligand binding","SARS
-CoV Infections","Interferon Signaling","Generic Transcription Pathway","Biosynthesis of specialized proresolving mediators (SPMs)","M Phase","GABA receptor activation","Class A/1 (Rhodopsin-like rece
ptors)","Potential therapeutics for SARS","Interferon gamma signaling","Transcriptional regulation by RUNX3","Biosynthesis of DHA-derived SPMs","Mitotic Metaphase and Anaphase","Peptide ligand-binding
 receptors","GABA B receptor activation","RUNX3 Regulates Immune Response and Cell Migration","Biosynthesis of D-series resolvins","Mitotic Anaphase","Activation of GABAB receptors","Nuclear Envelope 
(NE) Reassembly","Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{alprazolam,Xanax,28981-97-7,28981977,Trankimazin,Tafil,Tranquinal,Alplax,Constan,Frontal,Niravam,Solanax,Xanor,"8-Chloro-1-methyl-6-phenyl-4H-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine","8Chloro1methy
l6phenyl4H(1,2,4)triazolo(4,3a)(1,4)benzodiazepine",Apo-Alpraz,ApoAlpraz,"Xanax XR",Alcelam,Anpress,Relaxol,Tricalma,Valeans,Xan,SAM001246696,CPD000149316}

> <pdid>
PD003153

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{2118}

$$$$
NIHCC_2014
  SciTegic11012413002D

 58 63  0  0  1  0            999 V2000
    2.2495    2.6548    0.0000 C   0  0
    3.6576    2.1380    0.0000 C   0  0
    4.8089    3.0995    0.0000 O   0  0
    3.9139    0.6592    0.0000 O   0  0
    2.7600   -0.3100    0.0000 C   0  0  1  0  0  0
    3.4900    0.9500    0.0000 C   0  0
    4.7600    0.2300    0.0000 O   0  0
    4.0400   -1.0400    0.0000 C   0  0  2  0  0  0
    4.0400   -2.4900    0.0000 C   0  0
    2.7600   -3.2200    0.0000 C   0  0  2  0  0  0
    2.7575   -4.7200    0.0000 O   0  0
    1.4900   -2.4900    0.0000 C   0  0  2  0  0  0
    1.4875   -3.9900    0.0000 C   0  0
    1.4900   -1.0400    0.0000 C   0  0  2  0  0  0
    0.2100   -0.3100    0.0000 C   0  0  2  0  0  0
    0.2081    1.1912    0.0000 O   0  0
    1.5064    1.9441    0.0000 C   0  0
    2.8067    1.1962    0.0000 O   0  0
    1.5045    3.4449    0.0000 C   0  0
    2.8011    4.1993    0.0000 C   0  0
    2.7961    5.6993    0.0000 C   0  0
    1.4946    6.4450    0.0000 C   0  0
    0.1980    5.6907    0.0000 C   0  0
    0.2030    4.1907    0.0000 C   0  0
   -1.0600   -1.0400    0.0000 C   0  0  1  0  0  0
   -1.0600    0.4600    0.0000 O   0  0
   -2.3300   -0.3100    0.0000 C   0  0
   -3.6100   -1.0400    0.0000 C   0  0  2  0  0  0
   -4.9097   -0.2889    0.0000 O   0  0
   -6.2103   -1.0379    0.0000 C   0  0
   -6.2111   -2.0379    0.0000 O   0  0
   -7.5097   -0.2869    0.0000 C   0  0  2  0  0  0
   -7.5086    1.2131    0.0000 O   0  0
   -8.8103   -1.0359    0.0000 C   0  0  1  0  0  0
   -8.8084   -2.5367    0.0000 N   0  0
   -7.5082   -3.2863    0.0000 C   0  0
   -6.6426   -2.7855    0.0000 O   0  0
   -7.5062   -4.7871    0.0000 O   0  0
   -6.2060   -5.5367    0.0000 C   0  0
   -6.2047   -6.5367    0.0000 C   0  0
   -4.9077   -4.7855    0.0000 C   0  0
   -4.9061   -6.2852    0.0000 C   0  0
  -10.1097   -0.2849    0.0000 C   0  0
  -11.4107   -1.0316    0.0000 C   0  0
  -12.7078   -0.2783    0.0000 C   0  0
  -12.7041    1.2217    0.0000 C   0  0
  -11.4032    1.9684    0.0000 C   0  0
  -10.1060    1.2152    0.0000 C   0  0
   -3.6100   -2.4900    0.0000 C   0  0
   -2.3300   -3.2200    0.0000 C   0  0
   -1.0600   -2.4900    0.0000 C   0  0  1  0  0  0
   -1.0600   -1.4900    0.0000 O   0  0
    0.2100   -3.2200    0.0000 C   0  0
    0.2075   -4.7200    0.0000 O   0  0
   -2.0200    0.2800    0.0000 C   0  0
   -0.9882    1.3687    0.0000 C   0  0
   -3.4648    0.6831    0.0000 C   0  0
   -4.9070   -3.2434    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  0
  8  7  1  6
  8  5  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  6
 10 12  1  0
 12 13  1  6
 14 12  1  6
 14  5  1  0
 14 15  1  0
 15 16  1  1
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 15 25  1  0
 25 26  1  6
 25 27  1  0
 27 28  1  0
 28 29  1  1
 29 30  1  0
 30 31  2  0
 30 32  1  0
 32 33  1  1
 32 34  1  0
 34 35  1  1
 35 36  1  0
 36 37  2  0
 36 38  1  0
 38 39  1  0
 39 40  1  0
 39 41  1  0
 39 42  1  0
 34 43  1  0
 43 44  2  0
 44 45  1  0
 45 46  2  0
 46 47  1  0
 47 48  2  0
 48 43  1  0
 28 49  1  0
 49 50  2  3
 50 51  1  0
 51 52  1  1
 51 53  1  0
 53 12  1  0
 53 54  2  0
 50 55  1  0
 55 25  1  0
 55 56  1  0
 55 57  1  0
 49 58  1  0
M  END
> <name>
NIHCC_2014

> <id>
5709

> <plate>
NGP-105-02

> <well>
A06

> <supplier_cmpd_name>
CPD000059010

> <ctcr_id>
4639

> <supplier_cmpd_id>
SAM001246689

> <smiles>
CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)c4ccccc4)[C@@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c6ccccc6)C(=C([C@@H](O)C3=O)C5(C)C)C

> <pd_targets>
{MAPK1,FFP,FTL,KMT2A,MEN1,RORC,KIF11,EGFR,GHRHR,TUBA1A,TUBA1B,TUBA1C,TUBA3C,TUBA3E,TUBA4A,TUBB,TUBB1,TUBB2A,TUBB2B,TUBB3,TUBB4A,TUBB4B,TUBB6,TUBB8,NOD2,ABCB11,CYP3A4,TACR2,TUBB5,NR1I2}

> <pathway_gtopdb>
{Enzyme,"Unclassified protein","Epigenetic regulator","Transcription factor","Other cytosolic protein","Membrane receptor","Structural protein",Transporter,Kinase,Transferase,Reader,"Nuclear receptor"
,"Family B G protein-coupled receptor","Primary active transporter","Cytochrome P450","Family A G protein-coupled receptor","Protein Kinase",Bromodomain,"Nuclear hormone receptor subfamily 1","Peptide
 receptor (family B GPCR)","ATP-binding cassette","Cytochrome P450 family 3","Peptide receptor (family A GPCR)","CMGC protein kinase group","Nuclear hormone receptor subfamily 1 group F","TK protein k
inase group","Glucagon-like receptor","ABCB subfamily","Cytochrome P450 family 3A","Short peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1 group I","CMGC protein kinase MAPK fam
ily","Nuclear hormone receptor subfamily 1 group F member 3","Tyrosine protein kinase EGFR family","Growth hormone-releasing hormone receptor","Cytochrome P450 3A4","Neurokinin receptor","Nuclear horm
one receptor subfamily 1 group I member 2","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Receptors,"Other protein targets",Transporters,"Kinases (EC 2.7.x.x)","Nuclear hormone receptors",Kinesins,"Catalytic receptors","G protein-coupled receptors","ATP-binding cassette transporte
r family","Cytochrome P450",Tubulins,"CMGC: Containing CDK",MAPK,GSK3,"CLK families","1F. Retinoic acid-related orphans","Receptor kinases","Glucagon receptor family","Pattern recognition receptors","
ABCB subfamily","CYP3 family","Tachykinin receptors","1I. Vitamin D receptor-like receptors","Mitogen-activated protein kinases (MAP kinases)","TK: Tyrosine kinase","NOD-like receptor family","ERK sub
family","Receptor tyrosine kinases (RTKs)","Type I RTKs: ErbB (epidermal growth factor) receptor family"}

> <pathway_reactome>
{"Immune System","Vesicle-mediated transport","Gene expression (Transcription)","Signal Transduction",Disease,Metabolism,"Cell Cycle","Metabolism of proteins","Innate Immune System","Membrane Traffick
ing","RNA Polymerase II Transcription","Signaling by GPCR","Infectious disease","Metabolism of lipids",Mitotic,"Post-translational protein modification","Toll-like Receptor Cascades","trans-Golgi Netw
ork Vesicle Budding","Generic Transcription Pathway","Intra-Golgi and retrograde Golgi-to-ER traffic","GPCR downstream signalling","Leishmania infection","Metabolism of steroids","Biosynthesis of spec
ialized proresolving mediators (SPMs)","GPCR ligand binding","Mitotic G2-G2/M phases",SUMOylation,"Toll Like Receptor 5 (TLR5) Cascade","Golgi Associated Vesicle Biogenesis","Transcriptional regulatio
n by RUNX3","Golgi-to-ER retrograde transport","G alpha (q) signalling events","Leishmania parasite growth and survival","Bile acid and bile salt metabolism","Biosynthesis of DHA-derived SPMs","Class 
A/1 (Rhodopsin-like receptors)","G2/M Transition","SUMO E3 ligases SUMOylate target proteins","MyD88 cascade initiated on plasma membrane","RUNX3 Regulates Immune Response and Cell Migration","COPI-de
pendent Golgi-to-ER retrograde traffic","Gastrin-CREB signalling pathway via PKC and MAPK","Anti-inflammatory response favouring Leishmania parasite infection","Synthesis of bile acids and bile salts"
,"Biosynthesis of maresins","Peptide ligand-binding receptors","Centrosome maturation","SUMOylation of intracellular receptors","MAP kinase activation","EGFR Transactivation by Gastrin","ADORA2B media
ted anti-inflammatory cytokines production","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Biosynthesis of maresin-like SPMs","Tachykinin receptors bind tachykinins","Loss of 
proteins required for interphase microtubule organization from the centrosome","MAPK targets/ Nuclear events mediated by MAP kinases","activated TAK1 mediates p38 MAPK activation","Loss of Nlp from mi
totic centrosomes","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{BCL2,MAP2,MAP4,MAPT,NR1I2,TUBA1A,TUBA1B,TUBA1C,TUBA3C,TUBA3D,TUBA3E,TUBA4A,TUBB,TUBB1,TUBB2A,TUBB2B,TUBB3,TUBB4A,TUBB4B,TUBB6,TUBB8}

> <broad_moa>
{"tubulin polymerization inhibitor"}

> <synonyms>
{RESTW118,"Docetaxel (Taxotere)",SMR000059010,Docetaxel/,MLS000069455,MLS000759480,MLS001423968,SCHEMBL5553029,CHEMBL1510899,MolPort-006-823-826,MolPort006823826,HMS2051A12,HMS3715N15,"Docetaxel(Taxot
ere)/UK 427857",ABP000473,ABP000761,BBL102375,STL556176,ZINC95546207,A,T0186,T1034,SAM001246689,Prestw-1180,"Docetaxel trihydrate",Docetaxel,CPD000059010}

> <pdid>
PD003020

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{11970251}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 25  0  0  1  0            999 V2000
   -0.6872   -2.7329    0.0000 C   0  0
    0.2851   -2.9666    0.0000 C   0  0  2  0  0  0
    0.7521   -4.3921    0.0000 O   0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -1.2991    2.2500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -0.8141   -2.0807    0.0000 C   0  0
  2  1  1  1
  2  3  1  0
  2  4  1  0
  4  5  1  0
  6  5  1  6
  6  7  1  0
  7  8  1  1
  8  9  1  0
  9 10  1  0
 10 11  2  3
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 10  1  0
 16 17  1  6
 16 18  1  0
 18  7  1  0
 18 19  1  6
 19 20  1  0
 20 21  1  0
 21  2  1  0
 21  6  1  0
 21 22  1  6
M  END
> <name>
NIHCC_2014

> <id>
5710

> <plate>
NGP-105-02

> <well>
A07

> <supplier_cmpd_name>
CPD000058528

> <ctcr_id>
3902

> <supplier_cmpd_id>
SAM001246682

> <smiles>
C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C

> <pd_targets>
{AR,PGR,SHBG,ALDH1A1,NR3C1}

> <pathway_gtopdb>
{"Transcription factor","Secreted protein",Enzyme,"Nuclear receptor",Oxidoreductase,"Nuclear hormone receptor subfamily 3","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor subf
amily 3 group C member 4","Nuclear hormone receptor subfamily 3 group C member 3","Nuclear hormone receptor subfamily 3 group C member 1"}

> <pathway_chembl>
{Receptors,"Nuclear hormone receptors","Steroid hormone receptors","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"Gene expression (Transcription)",Metabolism,"RNA Polymerase II Transcription","Biological oxidations","Generic Transcription Pathway","Phase I - Functionalization of compounds","Transcriptional regu
lation by RUNX2","Ethanol oxidation","FOXO-mediated transcription","RUNX2 regulates bone development","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","RUNX2 regulates 
osteoblast differentiation"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{methyltestosterone,17-Methyltestosterone,17Methyltestosterone,58-18-4,58184,Testred,Metandren,Android,17alpha-Methyltestosterone,17alphaMethyltestosterone,Androsan,Androsten,Mesterone,Malestrone,Mast
estona,Synandrets,Synandrotabs,Testhormone,Andrometh,Anertan,Dumogran,Homandren,Hormale,Malogen,SAM001246682,CPD000058528}

> <pdid>
PD003096

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{6010}

$$$$
NIHCC_2014
  SciTegic11012413002D

 18 19  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 Cl  0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -2.6030    2.9977    0.0000 O   0  0
   -3.8990    0.7455    0.0000 N   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.8003    1.4887    0.0000 N   0  0
   -9.0994    0.7387    0.0000 C   0  0
  -10.3984    1.4886    0.0000 C   0  0
  -10.3985    2.9886    0.0000 O   0  0
   -9.0995    3.7387    0.0000 C   0  0
   -7.8004    2.9887    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  5  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 13  1  0
M  END
> <name>
NIHCC_2014

> <id>
5711

> <plate>
NGP-105-02

> <well>
A08

> <supplier_cmpd_name>
CPD000012114

> <ctcr_id>
4211

> <supplier_cmpd_id>
SAM001246614

> <smiles>
Clc1ccc(cc1)C(=O)NCCN2CCOCC2

> <pd_targets>
{MAOA,MAOB,KCNH2,HTR1A,ALDH1A1}

> <pathway_gtopdb>
{Enzyme,"Ion channel","Membrane receptor",Oxidoreductase,"Voltage-gated ion channel","Family A G protein-coupled receptor","Potassium channels","Small molecule receptor (family A GPCR)","Voltage-gated
 potassium channel","Monoamine receptor","Serotonin receptor"}

> <pathway_chembl>
{Enzymes,"Ion channels",Receptors,"Catecholamine turnover","Voltage-gated ion channels","G protein-coupled receptors","Potassium channels","5-Hydroxytryptamine receptors","Voltage-gated potassium chan
nels"}

> <pathway_reactome>
{Metabolism,"Muscle contraction","Signal Transduction","Biological oxidations","Cardiac conduction","Signaling by GPCR","Phase I - Functionalization of compounds","Phase 3 - rapid repolarisation","GPC
R ligand binding","Amine Oxidase reactions","Class A/1 (Rhodopsin-like receptors)","Ethanol oxidation","Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB","Amine ligand-binding 
receptors","Serotonin receptors"}

> <broad_targets>
{MAOA,MAOB}

> <broad_moa>
{"monoamine oxidase inhibitor"}

> <synonyms>
{moclobemide,71320-77-9,71320779,Aurorix,Moclobemid,Manerix,Moclamine,Moclaime,Moclobemidum,Moclamide,Moclobemida,4-chloro-N-(2-morpholinoethyl)benzamide,4chloroN(2morpholinoethyl)benzamide,"Moclobemi
dum (INN-Latin)","Moclobemidum (INNLatin)","Moclobemida (INN-Spanish)","Moclobemida (INNSpanish)",p-Chloro-N-(2-morpholinoethyl)benzamide,pChloroN(2morpholinoethyl)benzamide,Mo,T0084,SAM001246614,Pres
tw-353,Moclobemide,CPD000012114}

> <pdid>
PD003171

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{4235}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 25  0  0  0  0            999 V2000
    1.7932   -8.3203    0.0000 C   0  0
    2.5451   -7.0223    0.0000 O   0  0
    1.7974   -5.7210    0.0000 C   0  0
    0.2974   -5.7184    0.0000 O   0  0
    2.5497   -4.4224    0.0000 N   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 N   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -2.6030    2.9977    0.0000 O   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2007    1.4909    0.0000 C   0  0
   -6.4972    0.7364    0.0000 C   0  0
   -6.4920   -0.7636    0.0000 C   0  0
   -7.7884   -1.5181    0.0000 F   0  0
   -5.1903   -1.5091    0.0000 C   0  0
   -3.8939   -0.7546    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 13 14  1  0
 14  6  2  0
 11 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 20 22  1  0
 22 23  2  0
 23 17  1  0
M  END
> <name>
NIHCC_2014

> <id>
5712

> <plate>
NGP-105-02

> <well>
A09

> <supplier_cmpd_name>
CPD000466360

> <ctcr_id>
5812

> <supplier_cmpd_id>
SAM001246685

> <smiles>
COC(=O)Nc1[nH]c2ccc(cc2n1)C(=O)c3ccc(F)cc3

> <pd_targets>
{MAPK1,RXFP1}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor",Kinase,"Family A G protein-coupled receptor","Protein Kinase","Peptide receptor (family A GPCR)","CMGC protein kinase group","Relaxin-like peptide receptor (family A GPCR)"
,"CMGC protein kinase MAPK family","Relaxin receptor","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Receptors,"Kinases (EC 2.7.x.x)","G protein-coupled receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Relaxin family peptide receptors","Mitogen-activated protein kinases (MAP kinas
es)","ERK subfamily"}

> <pathway_reactome>
{"Immune System",Disease,"Innate Immune System","Infectious disease","Toll-like Receptor Cascades","Leishmania infection","Toll Like Receptor 5 (TLR5) Cascade","Leishmania parasite growth and survival
","MyD88 cascade initiated on plasma membrane","Anti-inflammatory response favouring Leishmania parasite infection","MAP kinase activation","ADORA2B mediated anti-inflammatory cytokines production","M
APK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{31430-15-6,31430156,Flubendazol,Flumoxane,Fluvermal,Flubenol,"Methyl (5-(4-fluorobenzoyl)-1H-benzo(d)imidazol-2-yl)carbamate","Methyl (5(4fluorobenzoyl)1Hbenzo(d)imidazol2yl)carbamate",Flubendazolum,
"Methyl 5-(p-fluorobenzoyl)-2-benzimidazolecarbamate","Methyl 5(pfluorobenzoyl)2benzimidazolecarbamate","R 17,889",UNII-R8M46911LR,UNIIR8M46911LR,"Methyl (5-(4-fluo","Methyl (5(4fluo",S1837,SAM0012466
85,Prestw-1416,CPD000466360,Flubendazole}

> <pdid>
PD000634

> <targets>
{Others,Apoptosis,Microtubule/Tubulin,Parasite}

> <classes>
{Others,Anti-infection,Apoptosis,Cell Cycle/DNA Damage,Cytoskeleton}

> <pubchem_cids>
{35802}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 30  0  0  1  0            999 V2000
    3.8983   -0.7459    0.0000 O   0  0
    2.6003   -1.4977    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 O   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
    0.0031    3.0008    0.0000 O   0  0
    1.3039    3.7494    0.0000 C   0  0
    1.3092    5.2494    0.0000 C   0  0
    2.6108    5.9949    0.0000 C   0  0
    2.6160    7.4949    0.0000 O   0  0
    3.9072    5.2405    0.0000 C   0  0
    3.9020    3.7405    0.0000 C   0  0
    5.1976    2.9829    0.0000 C   0  0
    5.1903    1.4821    0.0000 C   0  0
    6.4859    0.7245    0.0000 C   0  0
    6.4808   -0.7755    0.0000 C   0  0
    7.7772   -1.5300    0.0000 C   0  0
    9.0789   -0.7845    0.0000 C   0  0
   10.3753   -1.5390    0.0000 O   0  0
    9.0841    0.7155    0.0000 C   0  0
    7.7877    1.4700    0.0000 C   0  0
    2.6004    2.9949    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  2  0  0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.0000   -3.0000    0.0000 O   0  0
  1  2  1  0
  3  2  1  6
  3  4  1  0
  4  5  1  0
  5  6  1  6
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 21 15  1  0
 12 22  2  0
 22  7  1  0
  5 23  1  0
 23 24  1  1
 23 25  1  0
 25 26  1  6
 25 27  1  0
 27  3  1  0
 27 28  1  1
M  END
> <name>
NIHCC_2014

> <id>
5713

> <plate>
NGP-105-02

> <well>
A10

> <supplier_cmpd_name>
CPD000466371

> <ctcr_id>
5940

> <supplier_cmpd_id>
SAM001246720

> <smiles>
OC[C@H]1O[C@@H](Oc2cc(O)cc(\C=C\c3ccc(O)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O

> <pd_targets>
{MAPT,KDM4E,MAPK1,AKR1B1,PRKCZ,GAA,POLB}

> <pathway_gtopdb>
{"Other cytosolic protein","Epigenetic regulator",Enzyme,Eraser,Kinase,Oxidoreductase,Hydrolase,"Lysine demethylase","Protein Kinase","Jumonji domain-containing","CMGC protein kinase group","AGC prote
in kinase group","CMGC protein kinase MAPK family","AGC protein kinase PKC family","CMGC protein kinase ERK1","AGC protein kinase PKC iota subfamily"}

> <pathway_chembl>
{Enzymes,"Chromatin modifying enzymes","Kinases (EC 2.7.x.x)","1.-.-.- Oxidoreductases","3.2.1.- Glycosidases","1.14.11.- Histone demethylases","CMGC: Containing CDK",MAPK,GSK3,"CLK families","AGC: Co
ntaining PKA",PKG,"PKC families","Mitogen-activated protein kinases (MAP kinases)","Protein kinase C (PKC) family","ERK subfamily","Iota subfamily"}

> <pathway_reactome>
{"Neuronal System","Immune System",Metabolism,"Signal Transduction",Disease,"DNA Repair","Transmission across Chemical Synapses","Innate Immune System","Metabolism of lipids","Signaling by Nuclear Rec
eptors","Diseases of metabolism","Base Excision Repair","Neurotransmitter receptors and postsynaptic signal transmission","Toll-like Receptor Cascades","Metabolism of steroids","ESR-mediated signaling
","Diseases of carbohydrate metabolism","Resolution of Abasic Sites (AP sites)","Activation of NMDA receptors and postsynaptic events","Toll Like Receptor 5 (TLR5) Cascade","Metabolism of steroid horm
ones","Extra-nuclear estrogen signaling","Glycogen storage diseases","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Post NMDA receptor activation events","MyD88 cascad
e initiated on plasma membrane","Pregnenolone biosynthesis","Estrogen-stimulated signaling through PRKCZ","Glycogen storage disease type II (GAA)","PCNA-Dependent Long Patch Base Excision Repair","Act
ivation of AMPK downstream of NMDARs","MAP kinase activation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{ICAM1}

> <broad_moa>
{"ICAM1 expression inhibitor"}

> <synonyms>
{Polydatin,Piceid,65914-17-2,65914172,"65914 17 2",Trans-Piceid,TransPiceid,"Trans Piceid",27208-80-6,27208806,"27208 80 6","3,4,5-Trihydroxystilbene-3-beta-monoglucoside","3,4,5Trihydroxystilbene3bet
amonoglucoside",3,4,"5 Trihydroxystilbene 3 beta",S2391,SAM001246720,Quercetin(Sophoretin),CPD000466371}

> <pdid>
PD001688

> <targets>
{"PI3K / PKC / Src-bcr-Abl",Apoptosis,Autophagy,Mitophagy}

> <classes>
{Apoptosis,Autophagy}

> <pubchem_cids>
{5281718}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 27  0  0  0  0            999 V2000
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 O   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 O   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -3.8964   -0.7545    0.0000 O   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.8003    1.4887    0.0000 C   0  0
   -9.0990    0.7364    0.0000 C   0  0
  -10.4003    1.4841    0.0000 C   0  0
  -11.6990    0.7318    0.0000 N   0  0
  -13.0003    1.4796    0.0000 C   0  0
  -13.0029    2.9796    0.0000 N   0  0
  -14.2982    0.7277    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    7.6982    0.3613    0.0000 C   0  0
    7.6982   -1.1387    0.0000 S   0  0
    7.6982   -2.6387    0.0000 O   0  0
    6.3990   -1.8883    0.0000 O   0  0
    8.9975   -1.8883    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
  9 22  1  0
 22 23  2  0
 23  6  1  0
 24 25  1  0
 25 26  1  0
 25 27  2  0
 25 28  2  0
M  END
> <name>
NIHCC_2014

> <id>
5714

> <plate>
NGP-105-02

> <well>
A11

> <supplier_cmpd_name>
CPD000058918

> <ctcr_id>
5364

> <supplier_cmpd_id>
SAM001246730

> <smiles>
CCOC(=O)c1ccc(OC(=O)CCCCCNC(N)=N)cc1.C[S](O)(=O)=O

> <pd_targets>
{KLK7,CYP2D6,CYP1A2,PLAT,AOC3,LEF,TPSAB1,KMT2A,MEN1,F10,PLAU,F2,PLG,KLKB1,SLC47A2,HPN,SLC22A2,SLC47A1}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator",Transporter,Protease,"Cytochrome P450",Oxidoreductase,Reader,"Electrochemical transporter","Serine protease","Cytochrome P450 family 2","Cytochrome P450 family 1","Metal
lo protease",Bromodomain,"SLC superfamily of solute carriers","Serine protease PA clan","Cytochrome P450 family 2D","Cytochrome P450 family 1A","Metallo protease MAE clan","SLC47 family of multidrug a
nd toxin extrusion transporters","SLC22 family of organic cation and anion transporters","Serine protease S1A subfamily","Cytochrome P450 2D6","Cytochrome P450 1A1","Metallo protease M34 family"}

> <pathway_chembl>
{Enzymes,Transporters,"Peptidases and proteinases","Cytochrome P450","1.-.-.- Oxidoreductases","SLC superfamily of solute carriers","PA: Serine (S) Peptidases","CYP2 family: drug metabolising subset",
"CYP1 family","SLC47 family of multidrug and toxin extrusion transporters","SLC22 family of organic cation and anion transporters","S1: Chymotrypsin","Organic cation transporters (OCT)"}

> <pathway_reactome>
{"Extracellular matrix organization",Metabolism,"Signal Transduction",Disease,"Immune System",Hemostasis,"Transport of small molecules","Degradation of the extracellular matrix","Biological oxidations
","Signaling by Receptor Tyrosine Kinases","Infectious disease","Diseases of hemostasis","Innate Immune System","Platelet activation","signaling and aggregation","SLC-mediated transmembrane transport"
,"Phase I - Functionalization of compounds","Signaling by PDGF","Uptake and actions of bacterial toxins","Activation of Matrix Metalloproteinases","Defects of contact activation system (CAS) and kalli
krein/kinin system (KKS)","Neutrophil degranulation","Response to elevated platelet cytosolic Ca2+","Transport of bile salts and organic acids","metal ions and amine compounds","Signaling by MET","Cyt
ochrome P450 - arranged by substrate type","Uptake and function of anthrax toxins","Defective factor IX causes hemophilia B","Defective factor VIII causes hemophilia A","Platelet degranulation","Defec
tive factor XII causes hereditary angioedema","MET Receptor Activation","Organic cation/anion/zwitterion transport",Xenobiotics,"Defective F9 variant does not activate FX","Defective F8 cleavage by th
rombin","Organic cation transport","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2"}

> <broad_targets>
{PRSS1,TPSAB1}

> <broad_moa>
{"serine protease inhibitor"}

> <synonyms>
{"Gabexate mesylate",56974-61-9,56974619,"Gabexate mesilate","Gabexate (mesylate)","Gabexate monomethanesulfonate",FOY,"Gabexate Methanesulfonate","56974-61-9 (mesylate)","56974619 (mesylate)",CHEMBL1
398351,MFCD00210299,UNII-E3Q07L0649,UNIIE3Q07L0649,NCGC00017121-01,NCGC0001712101,"ethyl 4-((6-guanidino","ethyl 4((6guanidino",T0372,SAM001246730,Prestw-1008,CPD000058918}

> <pdid>
PD013178

> <targets>
{Factor Xa,Proteasome}

> <classes>
{Metabolic Enzyme/Protease}

> <pubchem_cids>
{42080,6604561}

$$$$
NIHCC_2014
  SciTegic11012413002D

 16 17  0  0  1  0            999 V2000
    1.0255   -3.6140    0.0000 O   0  0
    1.6332   -2.2426    0.0000 C   0  0
    3.1247   -2.0836    0.0000 O   0  0
    0.7500   -1.0323    0.0000 C   0  0  2  0  0  0
    1.2135    0.3943    0.0000 C   0  0
    0.0000    1.2760    0.0000 S   0  0
   -1.2135    0.3943    0.0000 C   0  0
   -0.7500   -1.0323    0.0000 N   0  0
   -1.6332   -2.2426    0.0000 C   0  0
   -1.0255   -3.6140    0.0000 O   0  0
   -3.1255   -2.0835    0.0000 C   0  0  2  0  0  0
   -4.1114   -3.1971    0.0000 C   0  0
   -5.4796   -2.5822    0.0000 C   0  0
   -5.3176   -1.0910    0.0000 C   0  0
   -6.4288   -0.0834    0.0000 O   0  0
   -3.8493   -0.7842    0.0000 N   0  0
  1  2  1  0
  2  3  2  0
  4  2  1  1
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  4  1  0
  8  9  1  0
  9 10  2  0
 11  9  1  6
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 11  1  0
M  END
> <name>
NIHCC_2014

> <id>
5715

> <plate>
NGP-105-02

> <well>
B02

> <supplier_cmpd_name>
CPD000466390

> <ctcr_id>
6594

> <supplier_cmpd_id>
SAM001246762

> <smiles>
OC(=O)[C@@H]1CSCN1C(=O)[C@@H]2CCC(=O)N2

> <pd_targets>
{MAPK1}

> <pathway_gtopdb>
{Enzyme,Kinase,"Protein Kinase","CMGC protein kinase group","CMGC protein kinase MAPK family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,"Kinases (EC 2.7.x.x)","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Immune System","Innate Immune System","Toll-like Receptor Cascades","Toll Like Receptor 5 (TLR5) Cascade","MyD88 cascade initiated on plasma membrane","MAP kinase activation","MAPK targets/ Nuclear 
events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{}

> <broad_moa>
{"interferon receptor agonist","interleukin receptor agonist"}

> <synonyms>
{Pidotimod,121808-62-6,121808626,"(R)-3-((S)-5-Oxopyrrolidine-2-carbonyl)thiazolidine-4-carboxylic acid","(R)3((S)5Oxopyrrolidine2carbonyl)thiazolidine4carboxylic acid",Pidotomod,PGT/1A,"Pidotimod (IN
N)",UNII-785363R681,UNII785363R681,NCGC00160516-01,NCGC0016051601,Polimod,785363R681,Pidotimodum,Pigitil,"Pidotimodum (INN-Latin)","Pidotimodum (INNLatin)",SMR000466390,CC,T1532,SAM001246762,CPD000466
390}

> <pdid>
PD001689

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{65944}

$$$$
NIHCC_2014
  SciTegic11012413002D

 14 14  0  0  0  0            999 V2000
    1.2948   -3.7516    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    3.8926   -3.7566    0.0000 O   0  0
    2.5973   -1.5031    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -3.8964   -0.7545    0.0000 O   0  0
   -5.1996    1.4928    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  2  0
  8 13  1  0
 13 14  2  0
 14  5  1  0
M  END
> <name>
NIHCC_2014

> <id>
5716

> <plate>
NGP-105-02

> <well>
B03

> <supplier_cmpd_name>
CPD000466341

> <ctcr_id>
410

> <supplier_cmpd_id>
SAM001246647

> <smiles>
CC(=O)Nc1ccc(CC(O)=O)cc1

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{}

> <broad_moa>
{"interleukin receptor agonist"}

> <synonyms>
{actarit,18699-02-0,18699020,"2-(4-acetamidophenyl)acetic acid","2(4acetamidophenyl)acetic acid","Benzeneacetic acid, 4-(acetylamino)-","Benzeneacetic acid, 4(acetylamino)","4-Acetylaminophenylacetic 
acid","4Acetylaminophenylacetic acid","4-Acetamidophenylacetic acid","4Acetamidophenylacetic acid","(4-(acetylamino)phenyl)acetic acid","(4(acetylamino)phenyl)acetic acid",UNII-HW5B6351RZ,UNIIHW5B6351
RZ,MS-932,MS932,HW5B6351RZ,4-Acetylamino,4Acetylamino,T0310,SAM001246647,Actarit,CPD000466341}

> <pdid>
PD001128

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{2018}

$$$$
NIHCC_2014
  SciTegic11012413002D

 13 14  0  0  0  0            999 V2000
    4.8089   -4.6669    0.0000 N   0  0
    4.2010   -3.2956    0.0000 C   0  0
    4.9531   -1.9978    0.0000 N   0  0
    3.9511   -0.8815    0.0000 C   0  0
    4.2566    0.5871    0.0000 O   0  0
    2.5987   -1.5004    0.0000 C   0  0
    2.7343   -2.9815    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  2  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
M  END
> <name>
NIHCC_2014

> <id>
5717

> <plate>
NGP-105-02

> <well>
B04

> <supplier_cmpd_name>
CPD000238142

> <ctcr_id>
3215

> <supplier_cmpd_id>
SAM001246706

> <smiles>
NC1=NC(=O)C(O1)c2ccccc2

> <pd_targets>
{RAB9A,SLC6A3}

> <pathway_gtopdb>
{Enzyme,Transporter,Hydrolase,"Electrochemical transporter","SLC superfamily of solute carriers","SLC06 neurotransmitter transporter family"}

> <pathway_chembl>
{Transporters,"SLC superfamily of solute carriers","SLC6 neurotransmitter transporter family","Monoamine transporter subfamily"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Signaling by Rho GTPases","Disorders of transmembrane transporters","Rho GTPase cycle","SLC transporter disorders","RHOBTB GTPase Cycle","Defective SLC6A3 causes Parkin
sonism-dystonia infantile (PKDYS)","RHOBTB3 ATPase cycle"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{pemoline,Phenylisohydantoin,Fenoxazol,Phenoxazole,Cylert,Tradon,Azoksodon,2152-34-3,2152343,Azoxodon,Dantromin,Pemolin,Azoxodone,Betanamin,Centramin,Deltamine,Volital,Hyton,Myamin,Nitan,Ronyl,Constim
ol,Kethamed,Phenalone,Phenilone,Phenylpseudohydanto,SAM001246706,CPD000238142}

> <pdid>
PD002922

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{4723}

$$$$
NIHCC_2014
  SciTegic11012413002D

 16 17  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 N   0  0
    0.0000   -1.5000    0.0000 N   0  0
   -2.5987    1.5004    0.0000 C   0  0
   -3.8967    0.7484    0.0000 C   0  0
   -5.1969    1.4963    0.0000 C   0  0
   -5.1993    2.9963    0.0000 C   0  0
   -3.9014    3.7484    0.0000 C   0  0
   -3.9038    5.2484    0.0000 Cl  0  0
   -2.6012    3.0004    0.0000 C   0  0
   -1.3034    3.7525    0.0000 Cl  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  8  2  1  0
  5  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 15  9  1  0
 15 16  1  0
M  END
> <name>
NIHCC_2014

> <id>
5718

> <plate>
NGP-105-02

> <well>
B05

> <supplier_cmpd_name>
CPD000058464

> <ctcr_id>
4982

> <supplier_cmpd_id>
SAM001246697

> <smiles>
Nc1nnc(c(N)n1)c2cccc(Cl)c2Cl

> <pd_targets>
{CYP2D6,MAPK1,BLM,DFRA17,SCN2A,SCN1A,SCN3A,SCN10A,PMP22,CHRM1,SCN4A,SCN5A,SCN9A,SCN11A,SCN7A,SCN8A,CACNA1E,ADORA1,ADORA2A,ADRA1A,ADRA2A,ADRB1,DRD1,DRD5,DRD2,GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,G
ABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG3,GABRP,GABRQ,HRH1,OPRK1,CHRNA1,HTR2A,HTR3A,GRIA1}

> <pathway_gtopdb>
{Enzyme,"Ion channel","Unclassified protein","Membrane receptor","Cytochrome P450",Kinase,Oxidoreductase,"Voltage-gated ion channel","Family A G protein-coupled receptor","Ligand-gated ion channel","C
ytochrome P450 family 2","Protein Kinase","Voltage-gated sodium channel","Small molecule receptor (family A GPCR)","Voltage-gated calcium channel","GABA-A receptor","Peptide receptor (family A GPCR)",
"Nicotinic acetylcholine receptor","5HT3 receptor","Ionotropic glutamate receptor","Cytochrome P450 family 2D","CMGC protein kinase group","Monoamine receptor","Nucleotide-like receptor (family A GPCR
)","Short peptide receptor (family A GPCR)","Nicotinic acetylcholine receptor alpha subunit","AMPA receptor","Cytochrome P450 2D6","CMGC protein kinase MAPK family","Acetylcholine receptor","Adenosine
 receptor","Adrenergic receptor","Dopamine receptor","Histamine receptor","Opioid receptor","Serotonin receptor","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,"Ion channels",Receptors,"Cytochrome P450","Kinases (EC 2.7.x.x)","Voltage-gated ion channels","G protein-coupled receptors","Ligand-gated ion channels","CYP2 family: drug metabolising subset
","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Voltage-gated sodium channels","Acetylcholine receptors (muscarinic)","Voltage-gated calcium channels","Adenosine receptors",Adrenoceptors,"Dopamine 
receptors","Histamine receptors","Opioid receptors","Nicotinic acetylcholine receptors","5-Hydroxytryptamine receptors","5-HT<sub>3</sub> receptors","Ionotropic glutamate receptors","Mitogen-activated
 protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{Metabolism,"Immune System","DNA Repair","Developmental Biology","Signal Transduction",Disease,"Gene expression (Transcription)","Neuronal System","Metabolism of proteins","Biological oxidations","Inn
ate Immune System","DNA Double-Strand Break Repair","Nervous system development","Signaling by GPCR","Integration of energy metabolism","Infectious disease","RNA Polymerase II Transcription","Transmis
sion across Chemical Synapses","Post-translational protein modification","Phase I - Functionalization of compounds","Toll-like Receptor Cascades","Homology Directed Repair","Axon guidance","EGR2 and S
OX10-mediated initiation of Schwann cell myelination","GPCR ligand binding","Regulation of insulin secretion","Leishmania infection","Generic Transcription Pathway","Neurotransmitter receptors and pos
tsynaptic signal transmission","Asparagine N-linked glycosylation","Cytochrome P450 - arranged by substrate type","Toll Like Receptor 5 (TLR5) Cascade","HDR through Homologous Recombination (HRR) or S
ingle Strand Annealing (SSA)","L1CAM interactions","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","Transcriptional Regulation by MECP2","Acetylcholine binding and dow
nstream events","Transport to the Golgi and subsequent modification",Xenobiotics,"MyD88 cascade initiated on plasma membrane","HDR through Homologous Recombination (HRR)","Interaction between L1 and A
nkyrins","Amine ligand-binding receptors","Nucleotide-like (purinergic) receptors","Anti-inflammatory response favouring Leishmania parasite infection","MECP2 regulates neuronal receptors and channels
","Postsynaptic nicotinic acetylcholine receptors","ER to Golgi Anterograde Transport","CYP2E1 reactions","MAP kinase activation","Homologous DNA Pairing and Strand Exchange","Muscarinic acetylcholine
 receptors","Adenosine P1 receptors","ADORA2B mediated anti-inflammatory cytokines production",Adrenoceptors,"Dopamine receptors","Histamine receptors","Highly calcium permeable postsynaptic nicotinic
 acetylcholine receptors","Serotonin receptors","Cargo concentration in the ER","MAPK targets/ Nuclear events mediated by MAP kinases","Presynaptic phase of homologous DNA pairing and strand exchange"
,"ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{SCN10A,SCN11A,SCN1A,SCN2A,SCN3A,SCN4A,SCN5A,SCN7A,SCN8A,SCN9A}

> <broad_moa>
{"serotonin receptor antagonist","sodium channel blocker"}

> <synonyms>
{lamotrigine,84057-84-1,84057841,"6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine","6(2,3Dichlorophenyl)1,2,4triazine3,5diamine",Lamictal,"Lamictal Cd","Lamictal XR","Lamotriginum (Latin)","Lamotrig
ina (Spanish)",Lamotriginum,"BW 430C",BW-430C,BW430C,Lamotrigina,"Lamictal ODT",3,5-Diamino-6-(2,5Diamino6(2,3-dichl,3dichl,T0680,SAM001246697,1505610,Prestw-1492,Lamotrigine,CPD000058464,LAMOTRIGINE}

> <pdid>
PD000352

> <targets>
{Autophagy,Sodium Channel}

> <classes>
{anticonvulsant,Autophagy,Membrane Transporter/Ion Channel}

> <pubchem_cids>
{3878}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 21  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 C   0  0
   -1.3039   -3.7494    0.0000 C   0  0
   -1.3070   -5.2494    0.0000 C   0  0
   -2.5987    1.5004    0.0000 C   0  0
   -3.8967    0.7484    0.0000 C   0  0
   -5.1969    1.4963    0.0000 C   0  0
   -6.4970    0.7465    0.0000 C   0  0
   -7.7969    1.4967    0.0000 C   0  0
   -9.0963    0.7473    0.0000 C   0  0
   -5.1993    2.9963    0.0000 C   0  0
   -3.9014    3.7484    0.0000 C   0  0
   -2.6012    3.0004    0.0000 C   0  0
   -1.3034    3.7525    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  5 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 13 17  2  0
 17 18  1  0
 18 19  2  0
 19 11  1  0
 19 20  1  0
M  END
> <name>
NIHCC_2014

> <id>
5719

> <plate>
NGP-105-02

> <well>
B06

> <supplier_cmpd_name>
CPD000387107

> <ctcr_id>
2818

> <supplier_cmpd_id>
SAM001246690

> <smiles>
Oc1ccc(cc1CC=C)c2cc(CC=C)ccc2O

> <pd_targets>
{RORC,TGR,NA,PTGS2,PTGS1,FTL,POLB,GAA,CNR2,ALOX5,KMT2A,MEN1,MAPT,TIM10,GABRA1,GABRB2,GABRG2,GABRA2,CNR1,RXRA,GABRA3,GABRB1,GABRB3,GABRA5}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Unclassified protein","Membrane receptor","Epigenetic regulator","Other cytosolic protein","Ion channel","Nuclear receptor",Hydrolase,Oxidoreductase,"Family A G protein
-coupled receptor",Reader,"Ligand-gated ion channel","Nuclear hormone receptor subfamily 1","Small molecule receptor (family A GPCR)",Bromodomain,"GABA-A receptor","Nuclear hormone receptor subfamily 
2","Nuclear hormone receptor subfamily 1 group F","Lipid-like ligand receptor (family A GPCR)","Nuclear hormone receptor subfamily 2 group B","Nuclear hormone receptor subfamily 1 group F member 3","C
annabinoid receptor","Nuclear hormone receptor subfamily 2 group B member 1"}

> <pathway_chembl>
{Receptors,Enzymes,"Nuclear hormone receptors","Eicosanoid turnover","3.2.1.- Glycosidases","G protein-coupled receptors","1F. Retinoic acid-related orphans",Cyclooxygenase,"Cannabinoid receptors",Lip
oxygenases,"2B. Retinoid X receptors"}

> <pathway_reactome>
{"Gene expression (Transcription)",Metabolism,"Vesicle-mediated transport","DNA Repair",Disease,"Signal Transduction","Neuronal System","RNA Polymerase II Transcription","Metabolism of lipids","Membra
ne Trafficking","Base Excision Repair","Diseases of metabolism","Signaling by GPCR","Transmission across Chemical Synapses","Generic Transcription Pathway","Biosynthesis of specialized proresolving me
diators (SPMs)","Fatty acid metabolism","trans-Golgi Network Vesicle Budding","Resolution of Abasic Sites (AP sites)","Diseases of carbohydrate metabolism","GPCR downstream signalling","Neurotransmitt
er receptors and postsynaptic signal transmission","Metabolism of steroids","Transcriptional regulation by RUNX3","Biosynthesis of DPA-derived SPMs","Arachidonic acid metabolism","Golgi Associated Ves
icle Biogenesis","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Glycogen storage diseases","G alpha (i) signalling events","Activation of NMDA receptors and postsynapt
ic events","Bile acid and bile salt metabolism","RUNX3 Regulates Immune Response and Cell Migration","Biosynthesis of DPAn-3 SPMs","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","PCNA-Depend
ent Long Patch Base Excision Repair","Glycogen storage disease type II (GAA)","Post NMDA receptor activation events","Synthesis of bile acids and bile salts","Biosynthesis of DPAn-3-derived 13-series 
resolvins","Activation of AMPK downstream of NMDARs","Synthesis of bile acids and bile salts via 27-hydroxycholesterol"}

> <broad_targets>
{ALOX5,PTGS1,PTGS2}

> <broad_moa>
{"AKT inhibitor"}

> <synonyms>
{Honokiol,35354-74-6,35354746,"5,3'-Diallyl-2,4'-dihydroxybiphenyl","5,3'Diallyl2,4'dihydroxybiphenyl","NSC 293100","3,5'-Diallyl-4,2'-dihydroxybiphenyl","3,5'Diallyl4,2'dihydroxybiphenyl","Honokiol,(
S)",UNII-11513CCO0N,UNII11513CCO0N,"3',5-Diallylbiphenyl-2,4'-diol","3',5Diallylbiphenyl2,4'diol",C18H18O2,CPD000387107,CHEMBL16901,CHEBI:5759,3',5-diallyl-(1,5diallyl(1,1'-biph,1'biph,T3001,SAM001246
690}

> <pdid>
PD002976

> <targets>
{AKT,Akt,Autophagy,ERK,HCV}

> <classes>
{Anti-infection,Autophagy,MAPK/ERK Pathway,PI3K/Akt/mTOR,Stem Cell/Wnt}

> <pubchem_cids>
{72303}

$$$$
NIHCC_2014
  SciTegic11012413002D

 40 43  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5988    1.5004    0.0000 S   0  0
   -3.8976    0.7500    0.0000 O   0  0
   -2.5998    3.0004    0.0000 O   0  0
   -3.8982    2.2498    0.0000 O   0  0
   15.1050   -4.5862    0.0000 N   0  0
   14.4970   -3.2149    0.0000 C   0  0
   15.2491   -1.9171    0.0000 C   0  0
   14.2472   -0.8008    0.0000 C   0  0
   12.8948   -1.4196    0.0000 N   0  0
   13.0303   -2.9007    0.0000 C   0  0
   11.5951   -0.6693    0.0000 C   0  0
   11.5951    0.8307    0.0000 N   0  0
   10.2960    1.5807    0.0000 C   0  0
   10.2960    3.0807    0.0000 N   0  0
    8.9970    3.8307    0.0000 C   0  0
    7.6979    3.0807    0.0000 C   0  0
    6.3997    3.8338    0.0000 C   0  0
    5.0994    3.0860    0.0000 O   0  0
    6.4018    5.3338    0.0000 O   0  0
    7.6979    1.5807    0.0000 C   0  0
    6.3989    0.8307    0.0000 O   0  0
    8.9970    0.8307    0.0000 C   0  0
    8.9970   -0.6693    0.0000 C   0  0
   10.2960   -1.4193    0.0000 C   0  0
   10.2960   -2.9193    0.0000 F   0  0
   11.5957    3.8311    0.0000 C   0  0
   11.5934    5.3312    0.0000 C   0  0
   12.8913    6.0832    0.0000 C   0  0
   14.1915    5.3353    0.0000 C   0  0
   15.4893    6.0874    0.0000 F   0  0
   14.1939    3.8353    0.0000 C   0  0
   12.8960    3.0832    0.0000 C   0  0
   12.8985    1.5832    0.0000 F   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  5  8  1  0
  8  9  1  0
  8 10  2  0
  8 11  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 13  1  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  3
 23 24  1  0
 24 25  1  0
 24 26  2  0
 23 27  1  0
 27 28  2  0
 27 29  1  0
 29 20  2  0
 29 30  1  0
 30 31  2  0
 31 18  1  0
 31 32  1  0
 21 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 36 37  1  0
 36 38  1  0
 38 39  2  0
 39 33  1  0
 39 40  1  0
M  END
> <name>
NIHCC_2014

> <id>
5720

> <plate>
NGP-105-02

> <well>
B07

> <supplier_cmpd_name>
CPD000469195

> <ctcr_id>
3298

> <supplier_cmpd_id>
SAM001246686

> <smiles>
Cc1ccc(cc1)[S](O)(=O)=O.NC2CCN(C2)c3nc4N(C=C(C(O)=O)C(=O)c4cc3F)c5ccc(F)cc5F

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{}

> <broad_moa>
{"bacterial DNA gyrase inhibitor"}

> <synonyms>
{"Tosufloxacin tosylate","tosufloxacin tosilate",115964-29-9,115964299,Tosuxacin,Ozex,100490-94-6,100490946,"Tosufloxacin toluenesulfonic acid",CHEBI:77605,"115964-29-9 (tosylate)","115964299 (tosylat
e)",DSSTox_CID_27820,DSSToxCID27820,DSSTox-CID-27820,"DSSTox CID 27820",DSSTox_RID_82583,DSSToxRID82583,DSSTox-RID-82583,"DSSTox RID 82583",DSSTox_GSID_47842,DSSToxGSID47842,DSSTox-GSID-47842,"DSSTox 
GSID 47842",A-61827,A61827,CAS-115964-29-9,CAS115964299,NCGC00,SAM001246686,CPD000469195}

> <pdid>
PD013335

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{93858}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 33  0  0  1  0            999 V2000
    2.2703   -4.0022    0.0000 C   0  0
    1.7758   -3.1329    0.0000 C   0  0  2  0  0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0  2  0  0  0
    3.8971    3.7500    0.0000 F   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -0.8660    2.5000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
    0.0000    0.5000    0.0000 F   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  1  0  0  0
   -0.8141   -2.0807    0.0000 C   0  0
    0.2851   -2.9666    0.0000 C   0  0  2  0  0  0
   -0.6870   -2.7320    0.0000 O   0  0
    0.7500   -4.3800    0.0000 C   0  0
    2.2230   -4.6635    0.0000 O   0  0
   -0.2322   -5.5148    0.0000 C   0  0
    0.2584   -6.9323    0.0000 O   0  0
   -2.5981    6.0000    0.0000 Cl  0  0
  2  1  1  1
  2  3  1  0
  4  3  1  6
  4  5  1  0
  5  6  1  1
  6  7  1  0
  7  8  1  1
  7  9  1  0
  9 10  2  3
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  2  3
 14 15  1  0
 15  9  1  0
 15 16  1  6
 15 17  1  0
 17  5  1  0
 17 18  1  1
 17 19  1  0
 19 20  1  6
 19 21  1  0
 21 22  1  0
 22  4  1  0
 22 23  1  6
 22 24  1  0
 24  2  1  0
 24 25  1  1
 24 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  1  0
 13 30  1  0
M  END
> <name>
NIHCC_2014

> <id>
5721

> <plate>
NGP-105-02

> <well>
B08

> <supplier_cmpd_name>
CPD000466330

> <ctcr_id>
3145

> <supplier_cmpd_id>
SAM001246616

> <smiles>
C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C(=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO)Cl

> <pd_targets>
{GAA}

> <pathway_gtopdb>
{Enzyme,Hydrolase}

> <pathway_chembl>
{Enzymes,"3.2.1.- Glycosidases"}

> <pathway_reactome>
{Disease,"Diseases of metabolism","Diseases of carbohydrate metabolism","Glycogen storage diseases","Glycogen storage disease type II (GAA)"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{HALOMETASONE,50629-82-8,50629828,Sicorten,2-Chloroflumethasone,2Chloroflumethasone,UNII-J69Z9UU41Z,UNIIJ69Z9UU41Z,"HALOMETASONE MONOHYDRATE","Halometasone (INN)","Halometasone hydrate",J69Z9UU41Z,Hal
ometasona,Halometasonum,SMR000466330,"Halometasonum (INN-Latin)","Halometasonum (INNLatin)",Halomet,SAM001246616,CPD000466330}

> <pdid>
PD002980

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{9846332}

$$$$
NIHCC_2014
  SciTegic11012413002D

 57 60  0  0  1  0            999 V2000
   -8.8413   -2.4983    0.0000 C   0  0
   -9.6765   -1.2523    0.0000 O   0  0
   -9.0155    0.0951    0.0000 C   0  0  2  0  0  0
   -7.5187    0.1933    0.0000 C   0  0
   -6.8553    1.5387    0.0000 C   0  0  1  0  0  0
   -7.6888    2.7858    0.0000 C   0  0
   -9.1855    2.6876    0.0000 C   0  0
   -9.8489    1.3423    0.0000 C   0  0  1  0  0  0
  -11.3457    1.2441    0.0000 O   0  0
   -5.3575    1.6339    0.0000 C   0  0
   -4.5253    0.3848    0.0000 C   0  0
   -5.1910   -0.9594    0.0000 C   0  0
   -3.0300    0.4800    0.0000 C   0  0  1  0  0  0
   -2.2500    1.7900    0.0000 O   0  0
   -0.7700    1.7900    0.0000 C   0  0
    0.1282    0.5886    0.0000 O   0  0
   -0.3600    3.1800    0.0000 C   0  0  2  0  0  0
   -1.4000    4.1800    0.0000 C   0  0
   -1.0400    5.5700    0.0000 C   0  0
    0.3400    5.9800    0.0000 C   0  0
    1.3600    4.9600    0.0000 C   0  0
    0.9900    3.5700    0.0000 N   0  0
    2.0600    2.5800    0.0000 C   0  0
    1.8859    1.0901    0.0000 O   0  0
    3.3000    3.2800    0.0000 C   0  0
    3.3684    4.7784    0.0000 O   0  0
    4.5000    2.4500    0.0000 C   0  0  2  0  0  0
    4.6374    3.9437    0.0000 O   0  0
    4.3400    0.9300    0.0000 O   0  0
    5.6200    0.1000    0.0000 C   0  0  2  0  0  0
    5.5000   -1.4500    0.0000 C   0  0  2  0  0  0
    4.3000   -2.4200    0.0000 C   0  0
    4.5700   -3.9100    0.0000 C   0  0  1  0  0  0
    5.9693   -4.4504    0.0000 C   0  0
    3.4100   -4.8000    0.0000 C   0  0
    3.4100   -6.5900    0.0000 C   0  0
    1.2900   -6.0600    0.0000 C   0  0
   -0.4500   -6.6300    0.0000 C   0  0  1  0  0  0
   -0.7848   -8.0861    0.0000 C   0  0
    0.3142   -9.1081    0.0000 C   0  0
   -0.0202  -10.5704    0.0000 C   0  0
   -1.8700   -5.0300    0.0000 C   0  0
   -3.3364   -5.3457    0.0000 O   0  0
   -1.2100   -2.9100    0.0000 C   0  0
   -2.5600   -2.1500    0.0000 C   0  0  2  0  0  0
   -3.9640   -2.6781    0.0000 O   0  0
   -2.0600   -0.7300    0.0000 C   0  0  1  0  0  0
   -0.5813   -0.4783    0.0000 C   0  0
    4.3331   -7.7723    0.0000 C   0  0
    6.8303   -2.1506    0.0000 O   0  0
    7.6766   -1.6179    0.0000 C   0  0
    6.9800    0.7100    0.0000 C   0  0  2  0  0  0
    7.0800    2.2400    0.0000 C   0  0
    5.8600    3.0600    0.0000 C   0  0  1  0  0  0
    5.9875    4.5546    0.0000 C   0  0
    8.2040   -0.1575    0.0000 O   0  0
    8.1116   -1.1532    0.0000 C   0  0
  1  2  1  0
  3  2  1  1
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  3  1  0
  8  9  1  6
  5 10  1  1
 10 11  2  0
 11 12  1  0
 13 11  1  1
 13 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  6
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 17  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  6
 27 29  1  0
 30 29  1  1
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  1
 33 35  1  0
 35 36  1  0
 36 37  2  3
 37 38  1  0
 38 39  1  1
 39 40  1  0
 40 41  2  0
 38 42  1  0
 42 43  2  0
 42 44  1  0
 44 45  1  0
 45 46  1  6
 45 47  1  0
 47 13  1  0
 47 48  1  6
 36 49  1  0
 31 50  1  1
 50 51  1  0
 30 52  1  0
 52 53  1  0
 53 54  1  0
 54 27  1  0
 54 55  1  6
 52 56  1  6
 56 57  1  0
M  END
> <name>
NIHCC_2014

> <id>
5722

> <plate>
NGP-105-02

> <well>
B09

> <supplier_cmpd_name>
CPD000466356

> <ctcr_id>
2128

> <supplier_cmpd_id>
SAM001246677

> <smiles>
CO[C@@H]1C[C@@H](CC[C@H]1O)/C=C(C)/[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC)[C@H](C[C@H]4C)OC

> <pd_targets>
{MTOR,RORC,CYP3A4,CYP3A43,CYP3A5,CYP3A7,FKBP1A,PPP3CA,FKBP5,FKBP1B,NR1I2,FTL,SF3B3,SLCO1B1,ABCC2,ABCB11}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Unclassified protein","Other nuclear protein",Transporter,Kinase,"Nuclear receptor","Cytochrome P450",Isomerase,Phosphatase,"Electrochemical transporter","Primary activ
e transporter","Protein Kinase","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 3","Protein Phosphatase","SLC superfamily of solute carriers","ATP-binding cassette","Atypical protein ki
nase group","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family 3A","Serine/threonine protein phosphatase","Nuclear hormone receptor subfamily 1 group I","SLC21/SLCO family of organ
ic anion transporting polypeptides","ABCC subfamily","ABCB subfamily","Atypical protein kinase PIKK family","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 3A4","Cytochrome P4
50 3A5","Nuclear hormone receptor subfamily 1 group I member 2","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Kinases (EC 2.7.x.x)","Nuclear hormone receptors","Cytochrome P450","Peptidyl-prolyl cis/trans isomerases","SLC superfamily of solute carriers","ATP-binding cassette t
ransporter family",Atypical,"1F. Retinoic acid-related orphans","CYP3 family","1I. Vitamin D receptor-like receptors","SLCO family of organic anion transporting polypeptides","ABCC subfamily","ABCB su
bfamily","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","FRAP subfamily"}

> <pathway_reactome>
{"Gene expression (Transcription)",Metabolism,Disease,"Signal Transduction","Muscle contraction","Metabolism of proteins","Vesicle-mediated transport","Metabolism of RNA","RNA Polymerase II Transcript
ion","Biological oxidations","Diseases of signal transduction by growth factor receptors and second messengers","Signaling by GPCR","Cardiac conduction","Post-translational protein modification","Memb
rane Trafficking","Metabolism of lipids","Processing of Capped Intron-Containing Pre-mRNA","Disorders of transmembrane transporters","Generic Transcription Pathway","Phase I - Functionalization of com
pounds","Signaling by TGF-beta Receptor Complex in Cancer","GPCR downstream signalling","Ion homeostasis",SUMOylation,"trans-Golgi Network Vesicle Budding","Biosynthesis of specialized proresolving me
diators (SPMs)","mRNA Splicing","Metabolism of steroids","ABC transporter disorders","Transcriptional Regulation by TP53","Transcriptional regulation by RUNX3","Cytochrome P450 - arranged by substrate
 type","Loss of Function of TGFBR1 in Cancer","G alpha (i) signalling events","Transcriptional Regulation by MECP2","SUMO E3 ligases SUMOylate target proteins","Golgi Associated Vesicle Biogenesis","B
iosynthesis of DHA-derived SPMs","mRNA Splicing - Major Pathway","Bile acid and bile salt metabolism","Defective ABCC2 causes DJS","Regulation of TP53 Activity","RUNX3 Regulates Immune Response and Ce
ll Migration",Xenobiotics,"TGFBR1 LBD Mutants in Cancer","Opioid Signalling","MECP2 regulates neuronal receptors and channels","SUMOylation of intracellular receptors","Biosynthesis of maresins","Recy
cling of bile acids and salts","Synthesis of bile acids and bile salts","Regulation of TP53 Expression and Degradation","DARPP-32 events","Biosynthesis of maresin-like SPMs","Synthesis of bile acids a
nd bile salts via 7alpha-hydroxycholesterol","Regulation of TP53 Degradation"}

> <broad_targets>
{FKBP1A}

> <broad_moa>
{"calcineurin inhibitor"}

> <synonyms>
{CPD000466356,SMR000466356,104987-11-3,104987113,MLS000759471,MLS001424054,CHEMBL1518873,SCHEMBL13933941,HMS2051C18,"1,1-BIS(METHYLSELENO)-ETHANE","1,1BIS(METHYLSELENO)ETHANE",CCG-100888,CCG100888,NC0
0138,MRF-0000173,MRF0000173,SAM001246677}

> <pdid>
PD002855

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581796}

$$$$
NIHCC_2014
  SciTegic11012413002D

 13 13  0  0  0  0            999 V2000
   -0.4763   -3.7706    0.0000 C   0  0
    1.0157   -3.6164    0.0000 C   0  0
    1.8949   -4.8318    0.0000 O   0  0
    1.6281   -2.2462    0.0000 C   0  0
    0.7500   -1.0323    0.0000 N   0  0
    1.2135    0.3943    0.0000 C   0  0
    2.6401    0.8578    0.0000 C   0  0
    0.0000    1.2760    0.0000 N   0  0
   -1.2135    0.3943    0.0000 C   0  0
   -0.7500   -1.0323    0.0000 C   0  0
   -1.6332   -2.2426    0.0000 N   0  3
   -1.0255   -3.6140    0.0000 O   0  5
   -3.1247   -2.0836    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
M  CHG  2  11   1  12  -1
M  END
> <name>
NIHCC_2014

> <id>
5723

> <plate>
NGP-105-02

> <well>
B10

> <supplier_cmpd_name>
CPD000149359

> <ctcr_id>
59

> <supplier_cmpd_id>
SAM001246716

> <smiles>
CC(O)Cn1c(C)ncc1[N+]([O-])=O

> <pd_targets>
{ATM,MAPK1,FABH}

> <pathway_gtopdb>
{Enzyme,Kinase,"Protein Kinase","Atypical protein kinase group","CMGC protein kinase group","Atypical protein kinase PIKK family","CMGC protein kinase MAPK family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,"Kinases (EC 2.7.x.x)",Atypical,"CMGC: Containing CDK",MAPK,GSK3,"CLK families","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","Mitogen-activated protein kinases (MAP kinases
)","Other PIKK family kinases","ERK subfamily"}

> <pathway_reactome>
{"Cell Cycle","Immune System","Cell Cycle Checkpoints","Innate Immune System","G1/S DNA Damage Checkpoints","Toll-like Receptor Cascades","p53-Dependent G1/S DNA damage checkpoint","Toll Like Receptor
 5 (TLR5) Cascade","p53-Dependent G1 DNA Damage Response","MyD88 cascade initiated on plasma membrane","Stabilization of p53","MAP kinase activation","Autodegradation of the E3 ubiquitin ligase COP1",
"MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{}

> <broad_moa>
{"acetylcholinesterase inhibitor","microtubule inhibitor"}

> <synonyms>
{Secnidazole,3366-95-8,3366958,Secnidazol,Flagentyl,Secnidazolum,"Secnidazolum (INN-Latin)","Secnidazolum (INNLatin)","RP 14539","PM 185184",1-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-ol,1(2methyl5
nitro1Himidazol1yl)propan2ol,1-(2-Methyl-5-nitro-1-imidazolyl)-2-propanol,1(2Methyl5nitro1imidazolyl)2propanol,PM-185184,PM185184,"Secnidazole (Flagentyl)",SYM-12,SYM12,T0195,SAM001246716,1505304,Pres
tw-1340,CPD000149359,SECNIDAZOLE}

> <pdid>
PD000955

> <targets>
{}

> <classes>
{antiameobic,antitrichomonas}

> <pubchem_cids>
{71815}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 31  0  0  0  0            999 V2000
    1.3000    2.2500    0.0000 O   0  0
    1.3000    0.7500    0.0000 N   0  3
    0.0007    0.0004    0.0000 O   0  5
    2.5993    0.0004    0.0000 O   0  0
   14.0959   -4.5248    0.0000 Cl  0  0
   12.7968   -3.7748    0.0000 C   0  0
   12.7968   -2.2748    0.0000 C   0  0
   11.4978   -1.5248    0.0000 C   0  0
   10.1987   -2.2748    0.0000 C   0  0
    8.9005   -1.5217    0.0000 C   0  0
    8.9027   -0.0209    0.0000 O   0  0
    7.6044    0.7322    0.0000 N   0  0
    7.6066    2.2330    0.0000 C   0  0
    6.3084    2.9861    0.0000 C   0  0
    6.3105    4.4869    0.0000 N   0  0
    5.1000    5.3510    0.0000 C   0  0
    5.5685    6.7759    0.0000 C   0  0
    7.0684    6.7707    0.0000 N   0  0
    7.5270    5.3425    0.0000 C   0  0
    8.9076    2.9811    0.0000 C   0  0
   10.2044    2.2272    0.0000 C   0  0
   11.5057    2.9732    0.0000 C   0  0
   11.5104    4.4732    0.0000 C   0  0
   12.8117    5.2191    0.0000 Cl  0  0
   10.2137    5.2272    0.0000 C   0  0
    8.9123    4.4812    0.0000 C   0  0
    8.0479    4.9839    0.0000 Cl  0  0
   10.1987   -3.7748    0.0000 C   0  0
    8.8997   -4.5248    0.0000 Cl  0  0
   11.4978   -4.5248    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  3
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 15  1  0
 13 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 23 25  1  0
 25 26  2  0
 26 20  1  0
 26 27  1  0
  9 28  1  0
 28 29  1  0
 28 30  2  0
 30  6  1  0
M  CHG  2   2   1   3  -1
M  END
> <name>
NIHCC_2014

> <id>
5724

> <plate>
NGP-105-02

> <well>
B11

> <supplier_cmpd_name>
CPD000469293

> <ctcr_id>
2460

> <supplier_cmpd_id>
SAM001246724

> <smiles>
O[N+]([O-])=O.Clc1ccc(CON=C(Cn2ccnc2)c3ccc(Cl)cc3Cl)c(Cl)c1

> <pd_targets>
{SKA,MAPT,MAPK1,RORC,LMNA,USP2,CYP3A4,IDO1,ABCB11,CYP2C19,CYP2C9,SLC6A3,SLC6A4,TBXAS1,ADORA3,ADRA2A,ADRA2B,DRD3,HTR1A,ACHE,SLC6A2,ADRA2C,ADRB3,CHRM1,HTR2A,HTR2B,CHRM3,TACR2,CYP2D6,OPRD1,ERG11,ERG7,NR1
I2}

> <pathway_gtopdb>
{Enzyme,"Other cytosolic protein","Transcription factor","Other nuclear protein",Transporter,"Membrane receptor",Kinase,"Nuclear receptor",Protease,"Cytochrome P450",Oxidoreductase,"Primary active tra
nsporter","Electrochemical transporter","Family A G protein-coupled receptor",Hydrolase,Isomerase,"Protein Kinase","Nuclear hormone receptor subfamily 1","Cysteine protease","Cytochrome P450 family 3"
,"ATP-binding cassette","Cytochrome P450 family 2","SLC superfamily of solute carriers","Cytochrome P450 family 5","Small molecule receptor (family A GPCR)","Peptide receptor (family A GPCR)","Cytochr
ome P450 family 51","CMGC protein kinase group","Nuclear hormone receptor subfamily 1 group F","Cysteine protease CA clan","Cytochrome P450 family 3A","ABCB subfamily","Cytochrome P450 family 2C","SLC
06 neurotransmitter transporter family","Cytochrome P450 family 5A","Monoamine receptor","Nucleotide-like receptor (family A GPCR)","Short peptide receptor (family A GPCR)","Cytochrome P450 family 2D"
,"Cytochrome P450 family 51A","Nuclear hormone receptor subfamily 1 group I","CMGC protein kinase MAPK family","Nuclear hormone receptor subfamily 1 group F member 3","Cysteine protease C19 family","C
ytochrome P450 3A4","Cytochrome P450 2C19","Cytochrome P450 2C9","Cytochrome P450 5A1","Dopamine receptor","Adenosine receptor","Adrenergic receptor","Serotonin receptor","Acetylcholine receptor","Neu
rokinin receptor","Cytochrome P450 2D6","Opioid receptor","Cytochrome P450 51A1","Nuclear hormone receptor subfamily 1 group I member 2","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Kinases (EC 2.7.x.x)","Nuclear hormone receptors","Peptidases and proteinases","Cytochrome P450","1.13.11.- Dioxygenases","ATP-binding cassette transporter family","SL
C superfamily of solute carriers","G protein-coupled receptors","Acetylcholine turnover","CMGC: Containing CDK",MAPK,GSK3,"CLK families","1F. Retinoic acid-related orphans","CA: Cysteine (C) Peptidase
s","CYP3 family","ABCB subfamily","CYP2 family: drug metabolising subset","SLC6 neurotransmitter transporter family",CYP5,"CYP7 and CYP8 families","Dopamine receptors","Adenosine receptors",Adrenocept
ors,"5-Hydroxytryptamine receptors","Acetylcholine receptors (muscarinic)","Tachykinin receptors","Opioid receptors","1I. Vitamin D receptor-like receptors","Mitogen-activated protein kinases (MAP kin
ases)","C19: Ubiquitin-specific protease","Monoamine transporter subfamily","ERK subfamily"}

> <pathway_reactome>
{"Neuronal System","Immune System","Gene expression (Transcription)","Cell Cycle",Metabolism,Disease,"Signal Transduction","Metabolism of proteins","Transmission across Chemical Synapses","Innate Immu
ne System","RNA Polymerase II Transcription",Mitotic,"Metabolism of lipids","Metabolism of amino acids and derivatives","Biological oxidations","Disorders of transmembrane transporters","Infectious di
sease","Signaling by GPCR","Post-translational protein modification","Neurotransmitter receptors and postsynaptic signal transmission","Toll-like Receptor Cascades","Generic Transcription Pathway","M 
Phase","Biosynthesis of specialized proresolving mediators (SPMs)","Tryptophan catabolism","Metabolism of steroids","Phase I - Functionalization of compounds","SLC transporter disorders","Neurotransmi
tter clearance","Leishmania infection","GPCR ligand binding","Phospholipid metabolism",SUMOylation,"Activation of NMDA receptors and postsynaptic events","Toll Like Receptor 5 (TLR5) Cascade","Transcr
iptional regulation by RUNX3","Mitotic Metaphase and Anaphase","Transcriptional Regulation by TP53","Biosynthesis of DHA-derived SPMs","Bile acid and bile salt metabolism","Cytochrome P450 - arranged 
by substrate type","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Serotonin clearance from the synaptic cleft","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like 
receptors)","Glycerophospholipid biosynthesis","Defective SLC6A2 causes orthostatic intolerance (OI)","SUMO E3 ligases SUMOylate target proteins","Post NMDA receptor activation events","MyD88 cascade 
initiated on plasma membrane","RUNX3 Regulates Immune Response and Cell Migration","Mitotic Anaphase","Regulation of TP53 Activity","Biosynthesis of maresins","Synthesis of bile acids and bile salts",
Xenobiotics,Eicosanoids,"Anti-inflammatory response favouring Leishmania parasite infection","Nucleotide-like (purinergic) receptors","Amine ligand-binding receptors","Synthesis of PC","Peptide ligand
-binding receptors","SUMOylation of intracellular receptors","Activation of AMPK downstream of NMDARs","MAP kinase activation","Nuclear Envelope (NE) Reassembly","Regulation of TP53 Expression and Deg
radation","Biosynthesis of maresin-like SPMs","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","CYP2E1 reactions","ADORA2B mediated anti-inflammatory cytokines production","Adeno
sine P1 receptors",Adrenoceptors,"Dopamine receptors","Serotonin receptors","Muscarinic acetylcholine receptors","Tachykinin receptors bind tachykinins","MAPK targets/ Nuclear events mediated by MAP k
inases","Initiation of Nuclear Envelope (NE) Reformation","Regulation of TP53 Degradation","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{}

> <broad_moa>
{"bacterial cell wall synthesis inhibitor"}

> <synonyms>
{"Oxiconazole nitrate","Ro 13-8996","Ro 138996",64211-46-7,64211467,HMS2051C22,HMS3393C22,CCG-100904,CCG100904,NC00154,CPD000469293,FT-0630744,FT0630744,SAM001246724}

> <pdid>
PD013091

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{47316}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 32  0  0  1  0            999 V2000
   -3.4595   -4.0717    0.0000 C   0  0
   -2.5817   -5.2880    0.0000 C   0  0
   -1.0885   -5.1368    0.0000 O   0  0
   -0.2102   -6.3538    0.0000 C   0  0
   -0.8251   -7.7220    0.0000 O   0  0
    1.2830   -6.2026    0.0000 C   0  0  2  0  0  0
    2.1626   -7.4186    0.0000 C   0  0
    1.5502   -8.7888    0.0000 C   0  0
    2.4298  -10.0049    0.0000 C   0  0
    1.8197  -11.3752    0.0000 C   0  0
    2.7014  -12.5888    0.0000 C   0  0
    4.1932  -12.4320    0.0000 C   0  0
    4.8033  -11.0617    0.0000 C   0  0
    3.9217   -9.8482    0.0000 C   0  0
    1.8954   -4.8324    0.0000 N   0  0
    1.0157   -3.6164    0.0000 C   0  0  1  0  0  0
   -0.4763   -3.7706    0.0000 C   0  0
    1.6281   -2.2462    0.0000 C   0  0
    3.1202   -2.0921    0.0000 O   0  0
    0.7500   -1.0323    0.0000 N   0  0
    1.2135    0.3943    0.0000 C   0  0  1  0  0  0
    2.4258    1.2743    0.0000 C   0  0
    1.9623    2.7009    0.0000 C   0  0
    0.4623    2.7009    0.0000 C   0  0
    0.0000    1.2760    0.0000 C   0  0  1  0  0  0
   -1.2135    0.3943    0.0000 C   0  0
   -0.7500   -1.0323    0.0000 C   0  0  1  0  0  0
   -1.6281   -2.2462    0.0000 C   0  0
   -3.1202   -2.0921    0.0000 O   0  0
   -1.0160   -3.6157    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  1
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
  6 15  1  0
 15 16  1  0
 16 17  1  1
 16 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  6
 22 23  1  0
 23 24  1  0
 25 24  1  6
 25 21  1  0
 25 26  1  0
 26 27  1  0
 27 20  1  0
 27 28  1  6
 28 29  1  0
 28 30  2  0
M  END
> <name>
NIHCC_2014

> <id>
5725

> <plate>
NGP-105-02

> <well>
C02

> <supplier_cmpd_name>
CPD000466386

> <ctcr_id>
1822

> <supplier_cmpd_id>
SAM001246757

> <smiles>
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(O)=O

> <pd_targets>
{ACE,CYP3A4,ALOX15,KMT2A,MEN1,LMNA}

> <pathway_gtopdb>
{Enzyme,Protease,"Cytochrome P450",Oxidoreductase,"Metallo protease","Cytochrome P450 family 3","Metallo protease MAE clan","Cytochrome P450 family 3A","Metallo protease M2 family","Cytochrome P450 3A
4","Epigenetic regulator","Other nuclear protein",Reader,"Cysteine protease",Bromodomain,"Cysteine protease CA clan","Cysteine protease C1A family"}

> <pathway_chembl>
{Enzymes,"Peptidases and proteinases","Cytochrome P450","Eicosanoid turnover","MA: Metallo (M) Peptidases","CYP3 family",Lipoxygenases,"M2: Angiotensin-converting  (ACE and ACE2)"}

> <pathway_reactome>
{"Metabolism of proteins",Metabolism,"Peptide hormone metabolism","Metabolism of lipids","Metabolism of Angiotensinogen to Angiotensins","Biosynthesis of specialized proresolving mediators (SPMs)","Bi
osynthesis of DHA-derived SPMs","Biosynthesis of DPA-derived SPMs","Biosynthesis of maresins","Biosynthesis of DPAn-3 SPMs","Biosynthesis of maresin-like SPMs","Biosynthesis of DPAn-3-derived protecti
ns and resolvins","Cell Cycle",Mitotic,"M Phase","Mitotic Metaphase and Anaphase","Mitotic Anaphase","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ACE}

> <broad_moa>
{"angiotensin converting enzyme inhibitor"}

> <synonyms>
{Vesdil,ramipril,87333-19-5,87333195,Tritace,Altace,Carasel,Ramace,Triatec,Delix,Hoe-498,Hoe498,"Ramiprilum (Latin)",Ramiprilum,"HOE 498",Cardace,Quark,"Altace (TN)",Pramace,UNII-L35JN3I7SJ,UNIIL35JN3
I7SJ,Acovil,C23H32N2O5,Lostapres,MFCD00865775,Hytren,CHEMBL1168,L35JN3I7SJ,Uni,SAM002699899,SAM001246757,1505214,Prestw-1107,CPD000466386,RAMIPRIL,Ramipril}

> <pdid>
PD000535

> <targets>
{}

> <classes>
{antihypertensive,"ACE inhibitor"}

> <pubchem_cids>
{6992028,5362129}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 30  0  0  0  0            999 V2000
   10.9237    0.4742    0.0000 H   0  3
    8.4237    0.4742    0.0000 Cl  0  5
    5.9232   -5.0458    0.0000 C   0  0
    5.0802   -3.8051    0.0000 N   0  0
    5.8323   -2.5073    0.0000 C   0  0
    5.2865   -1.1101    0.0000 C   0  0
    3.8538   -0.6657    0.0000 C   0  0
    2.5987   -1.5004    0.0000 C   0  0
    2.4987   -3.0043    0.0000 C   0  0
    3.5966   -4.0263    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0031    3.0008    0.0000 C   0  0
    1.3039    3.7494    0.0000 C   0  0
    1.3092    5.2494    0.0000 C   0  0
    2.6108    5.9949    0.0000 C   0  0
    3.9072    5.2405    0.0000 C   0  0
    5.2088    5.9860    0.0000 Cl  0  0
    3.9020    3.7405    0.0000 C   0  0
    2.6004    2.9949    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10  4  1  0
  8 11  1  0
 11 12  1  0
 12 13  2  3
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 21 15  1  0
 13 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 27 28  1  0
 28 11  1  0
 28 29  2  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5726

> <plate>
NGP-105-02

> <well>
C03

> <supplier_cmpd_name>
CPD000469183

> <ctcr_id>
6774

> <supplier_cmpd_id>
SAM001246645

> <smiles>
[H+].[Cl-].CN1CCCC(CC1)N2N=C(Cc3ccc(Cl)cc3)c4ccccc4C2=O

> <pd_targets>
{LMNA,CYP3A4,CYP2D6,ADRA1B,ADRA1A,KCNH2,HRH1,CACNA1C,HRH3,HTR2B,ABCB1,CHRM1,HTR2C,HRH2,PLA2G1B,LTC4S}

> <pathway_gtopdb>
{"Other nuclear protein",Enzyme,"Membrane receptor","Ion channel",Transporter,"Cytochrome P450","Family A G protein-coupled receptor","Voltage-gated ion channel","Primary active transporter",Hydrolase
,Lyase,"Cytochrome P450 family 3","Cytochrome P450 family 2","Small molecule receptor (family A GPCR)","Potassium channels","Voltage-gated calcium channel","ATP-binding cassette","Cytochrome P450 fami
ly 3A","Cytochrome P450 family 2D","Monoamine receptor","Voltage-gated potassium channel","ABCB subfamily","Cytochrome P450 3A4","Cytochrome P450 2D6","Adrenergic receptor","Histamine receptor","Serot
onin receptor","Acetylcholine receptor"}

> <pathway_chembl>
{Enzymes,Receptors,"Ion channels",Transporters,"Cytochrome P450","G protein-coupled receptors","Voltage-gated ion channels","ATP-binding cassette transporter family","Glycerophospholipid turnover","Ei
cosanoid turnover","CYP3 family","CYP2 family: drug metabolising subset",Adrenoceptors,"Potassium channels","Histamine receptors","Voltage-gated calcium channels","5-Hydroxytryptamine receptors","ABCB
 subfamily","Acetylcholine receptors (muscarinic)","Phospholipase A<sub>2</sub>","Leukotriene and lipoxin metabolism","Voltage-gated potassium channels"}

> <pathway_reactome>
{"Cell Cycle",Metabolism,"Signal Transduction","Muscle contraction","Developmental Biology",Disease,Mitotic,"Metabolism of lipids","Biological oxidations","Signaling by GPCR","Cardiac conduction","Ner
vous system development","Abacavir transport and metabolism","Infectious disease","M Phase","Biosynthesis of specialized proresolving mediators (SPMs)","Phase I - Functionalization of compounds","GPCR
 ligand binding","Phase 3 - rapid repolarisation","Axon guidance","Abacavir transmembrane transport","Leishmania infection","Phospholipid metabolism","Mitotic Metaphase and Anaphase","Biosynthesis of 
DHA-derived SPMs","Cytochrome P450 - arranged by substrate type","Class A/1 (Rhodopsin-like receptors)","NCAM signaling for neurite out-growth","Leishmania parasite growth and survival","Glycerophosph
olipid biosynthesis","Mitotic Anaphase","Biosynthesis of maresins",Xenobiotics,"Amine ligand-binding receptors","NCAM1 interactions","Anti-inflammatory response favouring Leishmania parasite infection
","Acyl chain remodelling of PC","Biosynthesis of DHA-derived sulfido conjugates","Nuclear Envelope (NE) Reassembly","Biosynthesis of maresin-like SPMs","CYP2E1 reactions",Adrenoceptors,"Histamine rec
eptors","Serotonin receptors","Muscarinic acetylcholine receptors","ADORA2B mediated anti-inflammatory cytokines production","Biosynthesis of maresin conjugates in tissue regeneration (MCTR)","Initiat
ion of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{HRH1}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{"AZELASTINE HYDROCHLORIDE","AZELASTINE HCl",79307-93-0,79307930,Astelin,Optivar,Allergodil,Rhinolast,Azeptin,"Azelastine (hydrochloride)",Astepro,Optilast,W-2979M,W2979M,A-5610,A5610,E-0659,E0659,379
32-96-0,37932960,CHEBI:2951,MFCD00242783,NCGC00095173-01,NCGC0009517301,DSSTox_CID_25945,DSSToxCID25945,DSSTox-CID-25945,"DSSTox CID 25945",DSSTox_RID_81,DSSToxRID81,DSSTox-RID-81,"DSSTox RID 81",T021
1L,S2552,SAM001246645,1505340,Prestw-1130,"Azelastine hydrochloride","Azelastine HCl",CPD000469183}

> <pdid>
PD009611

> <targets>
{Histamine Receptor,SARS-CoV}

> <classes>
{H1 antihistamine (nonsedating),leucotriene synthesis blocker,Neuronal Signaling,Anti-infection,GPCR/G Protein,Immunology/Inflammation}

> <pubchem_cids>
{54360,50986914}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 24  0  0  0  0            999 V2000
    3.8978   -2.2504    0.0000 N   0  0
    2.5988   -1.5004    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 N   0  0
   -5.2526    1.3618    0.0000 C   0  0
   -6.2524    0.2436    0.0000 N   0  0
   -5.4979   -1.0529    0.0000 C   0  0
   -4.0317   -0.7359    0.0000 N   0  0
   -2.6030    2.9985    0.0000 C   0  0
   -3.9023    3.7481    0.0000 C   0  0
   -3.9029    5.2481    0.0000 C   0  0
   -2.6041    5.9986    0.0000 C   0  0
   -1.3048    5.2491    0.0000 C   0  0
   -1.3042    3.7491    0.0000 C   0  0
   -2.6047    7.4994    0.0000 C   0  0
   -2.6053    8.9994    0.0000 N   0  0
  1  2  3  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  6  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 10  1  0
  9 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 18 21  1  0
 21 22  3  0
M  END
> <name>
NIHCC_2014

> <id>
5727

> <plate>
NGP-105-02

> <well>
C04

> <supplier_cmpd_name>
CPD000466343

> <ctcr_id>
4575

> <supplier_cmpd_id>
SAM001246649

> <smiles>
N#Cc1ccc(cc1)C(n2cncn2)c3ccc(cc3)C#N

> <pd_targets>
{CYP19A1,TSHR,CYP2C19,CYP3A4,CYP11B2,CYP11B1}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Cytochrome P450","Family A G protein-coupled receptor","Cytochrome P450 family 19","Peptide receptor (family A GPCR)","Cytochrome P450 family 2","Cytochrome P450 family 3"
,"Cytochrome P450 family 11","Cytochrome P450 family 19A","Glycohormone receptor","Cytochrome P450 family 2C","Cytochrome P450 family 3A","Cytochrome P450 family 11B","Cytochrome P450 19A1","Cytochrom
e P450 2C19","Cytochrome P450 3A4","Cytochrome P450 11B2","Cytochrome P450 11B1"}

> <pathway_chembl>
{Enzymes,Receptors,"Cytochrome P450","G protein-coupled receptors",CYP11,CYP17,CYP19,"CYP20 and CYP21 families","Glycoprotein hormone receptors","CYP2 family: drug metabolising subset","CYP3 family"}

> <pathway_reactome>
{Metabolism,Disease,"Biological oxidations","Infectious disease","Metabolism of lipids","Phase I - Functionalization of compounds","Leishmania infection","Biosynthesis of specialized proresolving medi
ators (SPMs)","Cytochrome P450 - arranged by substrate type","Leishmania parasite growth and survival","Biosynthesis of DHA-derived SPMs","Endogenous sterols","Anti-inflammatory response favouring Lei
shmania parasite infection",Xenobiotics,"Biosynthesis of maresins","ADORA2B mediated anti-inflammatory cytokines production","CYP2E1 reactions","Biosynthesis of maresin-like SPMs"}

> <broad_targets>
{CYP19A1}

> <broad_moa>
{"aromatase inhibitor"}

> <synonyms>
{112809-51-5,112809515,Femara,"4,4'-((1h-1,2,4-triazol-1-yl)methylene)dibenzonitrile","4,4'((1h1,2,4triazol1yl)methylene)dibenzonitrile",Letrozol,"CGS 20267",CGS-20267,CGS20267,"4-((4-cyanophenyl)-(1,
2,4-triazol-1-yl)methyl)benzonitrile","4((4cyanophenyl)(1,2,4triazol1yl)methyl)benzonitrile",LETRAZOLE,Femera,Benzonitrile,4,4'-(1H-1,4'(1H1,2,4-triazol-1-ylmethyl,4triazol1ylmethyl,T1590,719345,SAM00
1246649,Prestw-1025,"NSC 719345",Letrozole,CPD000466343}

> <pdid>
PD001661

> <targets>
{Aromatase,Autophagy}

> <classes>
{Non-steroidal aromatase inhibitor,Autophagy,Others}

> <pubchem_cids>
{3902}

$$$$
NIHCC_2014
  SciTegic11012413002D

 15 15  0  0  0  0            999 V2000
    3.9075   -3.7444    0.0000 C   0  0
    2.6060   -2.9986    0.0000 C   0  0
    2.6003   -1.4977    0.0000 N   0  0
    3.8990   -0.7455    0.0000 C   0  0
    3.8964    0.7545    0.0000 O   0  0
    5.2003   -1.4932    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0
    7.7996   -1.4883    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  3  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 14 15  1  0
M  END
> <name>
NIHCC_2014

> <id>
5728

> <plate>
NGP-105-02

> <well>
C05

> <supplier_cmpd_name>
CPD000059145

> <ctcr_id>
3840

> <supplier_cmpd_id>
SAM001246702

> <smiles>
CCN(C(=O)\C=C\C)c1ccccc1C

> <pd_targets>
{CYP3A4}

> <pathway_gtopdb>
{Enzyme,"Cytochrome P450","Cytochrome P450 family 3","Cytochrome P450 family 3A","Cytochrome P450 3A4"}

> <pathway_chembl>
{Enzymes,"Cytochrome P450","CYP3 family"}

> <pathway_reactome>
{Metabolism,"Metabolism of lipids","Biosynthesis of specialized proresolving mediators (SPMs)","Biosynthesis of DHA-derived SPMs","Biosynthesis of maresins","Biosynthesis of maresin-like SPMs"}

> <broad_targets>
{}

> <broad_moa>
{antipruritic}

> <synonyms>
{crotamiton,483-63-6,483636,N-Ethyl-o-crotonotoluidide,NEthylocrotonotoluidide,Crotamitone,Eurax,Crotalgin,Veteusan,Eurasil,Euraxil,trans-Crotamiton,transCrotamiton,Crotamitonum,Crotamitex,"2-Butenami
de, N-ethyl-N-(2-methylphenyl)-","2Butenamide, NethylN(2methylphenyl)",Crotonyl-N-ethyl-o-toluidine,CrotonylNethylotoluidine,124236-29-9,124236299,(E)-N-ethyl-N-(2-m,(E)NethylN(2m,T0376,SAM001246702,1
505271,Prestw-951,Crotamiton,CPD000059145,CROTAMITON}

> <pdid>
PD000529

> <targets>
{}

> <classes>
{antipruritic,scabicide}

> <pubchem_cids>
{688020}

$$$$
NIHCC_2014
  SciTegic11012413002D

 34 34  0  0  1  0            999 V2000
    5.1884   -7.5113    0.0000 C   0  0
    5.1901   -6.0113    0.0000 C   0  0
    6.4902   -5.2631    0.0000 C   0  0
    3.8917   -5.2586    0.0000 N   0  0
    3.8934   -3.7577    0.0000 C   0  0
    2.5949   -3.0050    0.0000 C   0  0
    2.5966   -1.5042    0.0000 C   0  0  2  0  0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8990   -0.7582    0.0000 C   0  0
    5.1956   -1.5125    0.0000 C   0  0
    6.4972   -0.7669    0.0000 C   0  0
    7.7937   -1.5213    0.0000 C   0  0
    6.5023    0.7331    0.0000 C   0  0
    5.2058    1.4875    0.0000 C   0  0
    3.9042    0.7419    0.0000 C   0  0
    2.6078    1.4964    0.0000 O   0  0
    2.5893   -6.0044    0.0000 C   0  0
    1.2924   -5.2507    0.0000 C   0  0
    2.5845   -7.5044    0.0000 C   0  0
   14.1943   -1.1310    0.0000 O   0  0
   14.1943   -2.6310    0.0000 C   0  0
   12.8943   -3.3810    0.0000 C   0  0
   12.8943   -4.8810    0.0000 O   0  0
   11.5943   -2.6310    0.0000 C   0  0
   11.5943   -1.1310    0.0000 O   0  0
   10.2951   -3.3806    0.0000 O   0  0
   15.4943   -3.3810    0.0000 C   0  0
   15.4943   -4.8810    0.0000 O   0  0
   16.7936   -2.6315    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  7  6  1  6
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  7 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
 18 19  1  0
 19 20  2  0
 20 14  1  0
 20 21  1  0
  4 22  1  0
 22 23  1  0
 22 24  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 27 29  1  0
 29 30  1  0
 29 31  2  0
 26 32  1  0
 32 33  1  0
 32 34  2  0
M  END
> <name>
NIHCC_2014

> <id>
5729

> <plate>
NGP-105-02

> <well>
C06

> <supplier_cmpd_name>
CPD000469196

> <ctcr_id>
4188

> <supplier_cmpd_id>
SAM001246691

> <smiles>
CC(C)N(CC[C@H](c1ccccc1)c2cc(C)ccc2O)C(C)C.OC(C(O)C(O)=O)C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Tolterodine tartrate",124937-52-6,124937526,"Tolterodine L-Tartrate","Tolterodine LTartrate","PNU 200583E",SMR000469196,SCHEMBL36881,MLS001401389,MLS006010051,CHEMBL1722209,HMS2051E12,HMS2230P06,"TO
LTERODIN HYDROGEN TARTRATE",ACT03352,ANW-44905,ANW44905,AKOS015920262,AB14347,CCG-1008,CCG1008,T0099,SAM001246691,CPD000469196}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{9847786}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 24  0  0  1  0            999 V2000
    0.1194   -2.3933    0.0000 C   0  0
    0.7500   -1.0323    0.0000 C   0  0
    2.2393   -0.8534    0.0000 C   0  0
    1.2135    0.3943    0.0000 S   0  0
    0.0000    1.2760    0.0000 C   0  0  2  0  0  0
   -0.8796    2.4866    0.0000 C   0  0  2  0  0  0
   -0.6422    3.9624    0.0000 N   0  0
    0.7599    4.4978    0.0000 C   0  0
    0.9982    5.9795    0.0000 N   0  0
    2.4376    6.4268    0.0000 C   0  0
    2.9965    7.8188    0.0000 C   0  0
    2.2568    9.1237    0.0000 C   0  0
    0.7753    9.3589    0.0000 C   0  0
   -0.3322    8.3473    0.0000 C   0  0
   -0.2319    6.8506    0.0000 C   0  0
   -2.0931    1.6049    0.0000 C   0  0
   -3.5746    1.8395    0.0000 O   0  0
   -1.2135    0.3943    0.0000 N   0  0
   -0.7500   -1.0323    0.0000 C   0  0  1  0  0  0
   -1.6332   -2.2426    0.0000 C   0  0
   -1.0255   -3.6140    0.0000 O   0  0
   -3.1247   -2.0836    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  1
  7  8  2  3
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15  9  1  0
  6 16  1  0
 16 17  2  0
 16 18  1  0
 18  5  1  0
 18 19  1  0
 19  2  1  0
 19 20  1  6
 20 21  1  0
 20 22  2  0
M  END
> <name>
NIHCC_2014

> <id>
5730

> <plate>
NGP-105-02

> <well>
C07

> <supplier_cmpd_name>
CPD000466361

> <ctcr_id>
6191

> <supplier_cmpd_id>
SAM001246687

> <smiles>
CC1(C)S[C@@H]2[C@H](N=CN3CCCCCC3)C(=O)N2[C@H]1C(O)=O

> <pd_targets>
{PBP2A,MRDA,PBP3,PBPA,PENA,PBP1B}

> <pathway_gtopdb>
{Enzyme,"Unclassified protein",Protease,"Serine protease","Serine protease unclassified"}

> <pathway_chembl>
{}

> <pathway_reactome>
{}

> <broad_targets>
{}

> <broad_moa>
{"bacterial cell wall synthesis inhibitor"}

> <synonyms>
{Mecillinam,AMDINOCILLIN,"Penicillin HX",Coactin,32887-01-7,32887017,"32887 01 7",Mecilinamo,Mecillinamum,"FL 1060","Ro 10-9070","Ro 109070","Ro 10 9070","Mecillinam (INN)",UNII-V10579P3QZ,UNIIV10579P
3QZ,"UNII V10579P3QZ",Hexacillin,Selexidin,SAM001246687,CPD000466361}

> <pdid>
PD003111

> <targets>
{Antibiotic,Bacterial}

> <classes>
{Anti-infection}

> <pubchem_cids>
{36273,40467053}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 23  0  0  0  0            999 V2000
    1.7978   -5.7203    0.0000 C   0  0
    2.5497   -4.4224    0.0000 S   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0031    3.0008    0.0000 O   0  0
    1.3039    3.7494    0.0000 C   0  0
    2.6004    2.9949    0.0000 C   0  0
    3.9020    3.7405    0.0000 C   0  0
    3.9072    5.2405    0.0000 C   0  0
    2.6108    5.9949    0.0000 C   0  0
    2.6159    7.4949    0.0000 Cl  0  0
    1.3092    5.2494    0.0000 C   0  0
    0.0127    6.0039    0.0000 Cl  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 Cl  0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 15  9  1  0
 15 16  1  0
  7 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  2  0
 20  5  1  0
 20 21  1  0
 21  3  2  0
M  END
> <name>
NIHCC_2014

> <id>
5731

> <plate>
NGP-105-02

> <well>
C08

> <supplier_cmpd_name>
CPD000466357

> <ctcr_id>
4229

> <supplier_cmpd_id>
SAM001246681

> <smiles>
CSc1[nH]c2cc(Oc3cccc(Cl)c3Cl)c(Cl)cc2n1

> <pd_targets>
{RORC,FFP,KMT2A,MEN1,SKA,MAPT,HSP90AA1,ALD,NPSR1,CAT-1,ENO,ND3}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Epigenetic regulator","Other cytosolic protein","Unclassified protein","Membrane receptor","Nuclear receptor",Transferase,Reader,Protease,Kinase,"Family A G protein-cou
pled receptor","Nuclear hormone receptor subfamily 1",Bromodomain,"Cysteine protease","Peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1 group F","Cysteine protease CA clan","Sho
rt peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1 group F member 3","Cysteine protease C1A family","Neuropeptide receptor"}

> <pathway_chembl>
{Receptors,"Other protein targets","Nuclear hormone receptors","Heat shock proteins","G protein-coupled receptors","1F. Retinoic acid-related orphans","Neuropeptide S receptor"}

> <pathway_reactome>
{"Gene expression (Transcription)","Neuronal System","Cell Cycle",Disease,"RNA Polymerase II Transcription","Transmission across Chemical Synapses",Mitotic,"Infectious disease","Generic Transcription 
Pathway","Neurotransmitter receptors and postsynaptic signal transmission","Mitotic G2-G2/M phases","Leishmania infection","Transcriptional regulation by RUNX3","Activation of NMDA receptors and posts
ynaptic events","G2/M Transition","Leishmania parasite growth and survival","RUNX3 Regulates Immune Response and Cell Migration","Post NMDA receptor activation events","Centrosome maturation","Anti-in
flammatory response favouring Leishmania parasite infection","Activation of AMPK downstream of NMDARs","Loss of proteins required for interphase microtubule organization from the centrosome","ADORA2B 
mediated anti-inflammatory cytokines production","Loss of Nlp from mitotic centrosomes"}

> <broad_targets>
{DNMT1}

> <broad_moa>
{"microtubule inhibitor"}

> <synonyms>
{Triclabendazole,68786-66-3,68786663,Fasinex,"6-Chloro-5-(2,3-dichlorophenoxy)-2-(methylthio)-1H-benzo(d)imidazole","6Chloro5(2,3dichlorophenoxy)2(methylthio)1Hbenzo(d)imidazole","6-chloro-5-(2,3-dich
lorophenoxy)-2-methylsulfanyl-1H-benzimidazole","6chloro5(2,3dichlorophenoxy)2methylsulfanyl1Hbenzimidazole",UNII-4784C8E03O,UNII4784C8E03O,NVP-EGA230,NVPEGA230,CPD000466357,EGA230B,MLS001424101,CHEMB
L,S4114,SAM001246681}

> <pdid>
PD000272

> <targets>
{Others}

> <classes>
{Others}

> <pubchem_cids>
{50248}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 24  0  0  1  0            999 V2000
    7.5987   -6.3787    0.0000 Cl  0  5
   -2.8348  -14.2572    0.0000 C   0  0
   -1.8332  -13.1406    0.0000 C   0  0
   -0.3655  -13.4502    0.0000 C   0  0
   -2.2988  -11.7138    0.0000 C   0  0  2  0  0  0
   -3.7665  -11.4042    0.0000 N   0  0
   -1.2966  -10.5966    0.0000 C   0  0
    0.1711  -10.9062    0.0000 O   0  0
   -1.7622   -9.1698    0.0000 O   0  0
   -0.7600   -8.0526    0.0000 C   0  0
   -1.2256   -6.6258    0.0000 C   0  0
   -0.2234   -5.5086    0.0000 O   0  0
   -0.6890   -4.0818    0.0000 C   0  0
    0.3114   -2.9665    0.0000 N   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 O   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    5.0987   -6.3787    0.0000 H   0  3
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  6
  5  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  2  3
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 14  1  0
 24 17  2  0
M  CHG  2   1  -1  25   1
M  END
> <name>
NIHCC_2014

> <id>
5732

> <plate>
NGP-105-02

> <well>
C09

> <supplier_cmpd_name>
CPD000469208

> <ctcr_id>
2524

> <supplier_cmpd_id>
SAM001246749

> <smiles>
[Cl-].CC(C)[C@H](N)C(=O)OCCOCn1cnc2C(=O)N=C(N)Nc12.[H+]

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{}

> <broad_moa>
{"DNA polymerase inhibitor"}

> <synonyms>
{"VALACICLOVIR HYDROCHLORIDE",Prestw-1505,Prestw1505,"VALACYCLOVIR HYDROCHLORIDE","Valacyclovir hydrochloride","Valganciclovir HCl",SAM001246749,S1876,T1087,1505368,CPD000469208}

> <pdid>

> <targets>
{Others}

> <classes>
{antiviral}

> <pubchem_cids>
{60772,67201313}

$$$$
NIHCC_2014
  SciTegic11012413002D

 31 30  0  0  0  0            999 V2000
    7.5987    6.0114    0.0000 H   0  3
    5.0987    6.0114    0.0000 Cl  0  5
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 O   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5973    1.5031    0.0000 N   0  0
   -2.5951    3.0039    0.0000 C   0  0
   -3.8933    3.7570    0.0000 C   0  0
   -3.8912    5.2578    0.0000 N   0  0
   -2.5917    6.0086    0.0000 C   0  0
   -2.5912    7.5095    0.0000 C   0  0
   -1.2924    8.2599    0.0000 O   0  0
   -5.1894    6.0109    0.0000 C   0  0
   -5.1873    7.5117    0.0000 C   0  0
   -6.4855    8.2648    0.0000 C   0  0
   -6.4834    9.7656    0.0000 C   0  0
   -7.7798   10.5202    0.0000 C   0  0
   -7.7746   12.0202    0.0000 C   0  0
   -6.4730   12.7657    0.0000 C   0  0
   -5.1765   12.0112    0.0000 C   0  0
   -5.1817   10.5112    0.0000 C   0  0
   -6.4647   14.2665    0.0000 N   0  3
   -7.7598   15.0232    0.0000 O   0  5
   -5.1620   15.0102    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 N   0  0
   -2.5981   -1.5000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  3
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 12 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 22 25  1  0
 25 26  1  0
 25 27  2  0
  8 28  1  0
 28 29  1  0
 28 30  1  0
 30  4  1  0
 30 31  2  0
M  CHG  4   1   1   2  -1  25   1  26  -1
M  END
> <name>
NIHCC_2014

> <id>
5733

> <plate>
NGP-105-02

> <well>
C10

> <supplier_cmpd_name>
CPD000466369

> <ctcr_id>
516

> <supplier_cmpd_id>
SAM001246717

> <smiles>
[H+].[Cl-].CN1C(=O)C=C(NCCN(CCO)CCCc2ccc(cc2)[N+]([O-])=O)N(C)C1=O

> <pd_targets>
{KCNH2,SLC47A2,SLC47A1,SLC22A2}

> <pathway_gtopdb>
{"Ion channel",Transporter,"Voltage-gated ion channel","Electrochemical transporter","Potassium channels","SLC superfamily of solute carriers","Voltage-gated potassium channel","SLC47 family of multid
rug and toxin extrusion transporters","SLC22 family of organic cation and anion transporters"}

> <pathway_chembl>
{"Ion channels",Transporters,"Voltage-gated ion channels","SLC superfamily of solute carriers","Potassium channels","SLC47 family of multidrug and toxin extrusion transporters","SLC22 family of organi
c cation and anion transporters","Voltage-gated potassium channels","Organic cation transporters (OCT)"}

> <pathway_reactome>
{"Muscle contraction","Transport of small molecules","Cardiac conduction","SLC-mediated transmembrane transport","Phase 3 - rapid repolarisation","Transport of bile salts and organic acids","metal ion
s and amine compounds","Organic cation/anion/zwitterion transport","Organic cation transport"}

> <broad_targets>
{}

> <broad_moa>
{"potassium channel blocker"}

> <synonyms>
{"Nifekalant hydrochloride",130656-51-8,130656518,nifekalant,"NIFEKALANT HCl","MS 551",MS-551,MS551,UNII-TPP5R0MDQS,UNIITPP5R0MDQS,TPP5R0MDQS,130636-43-0,130636430,Shinbit,DSSTox_CID_26495,DSSToxCID26
495,DSSTox-CID-26495,"DSSTox CID 26495",DSSTox_RID_81665,DSSToxRID81665,DSSTox-RID-81665,"DSSTox RID 81665",DSSTox_GSID_46495,DSSToxGSID46495,DSSTox-GSID-46495,"DSSTox GSID 46495",SMR000466369,CAS-130
636-43-0,CAS130636430,NCGC00164637-01,NCGC0016463701,"Shinbit (TN)",T2712,SAM001246717,CPD000466369}

> <pdid>
PD013077

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{122188,57516083}

$$$$
NIHCC_2014
  SciTegic11012413002D

 58 60  0  0  1  0            999 V2000
    0.2238    2.7435    0.0000 C   0  0
   -0.2912    1.3347    0.0000 O   0  0
    0.6711    0.1830    0.0000 C   0  0  1  0  0  0
    0.1581   -1.2265    0.0000 C   0  0  1  0  0  0
    1.1232   -2.3759    0.0000 C   0  0
    2.6013   -2.1158    0.0000 C   0  0
    3.1143   -0.7062    0.0000 O   0  0
    3.5664   -3.2652    0.0000 O   0  0
    5.0445   -3.0050    0.0000 C   0  0  2  0  0  0
    5.5575   -1.5955    0.0000 C   0  0
    6.0096   -4.1544    0.0000 C   0  0
    7.4877   -3.8943    0.0000 C   0  0
    8.0007   -2.4847    0.0000 C   0  0
    7.0356   -1.3353    0.0000 C   0  0
    7.5487    0.0742    0.0000 C   0  0
    6.5836    1.2236    0.0000 C   0  0  2  0  0  0
    7.0966    2.6331    0.0000 O   0  0
    5.1055    0.9635    0.0000 C   0  0  2  0  0  0
    4.5924   -0.4461    0.0000 C   0  0
    4.1404    2.1129    0.0000 C   0  0
    2.6623    1.8527    0.0000 C   0  0  2  0  0  0
    1.6999    3.0044    0.0000 C   0  0
    2.2153    4.4140    0.0000 C   0  0
    1.2535    5.5650    0.0000 O   0  0
    2.1492    0.4432    0.0000 C   0  0  2  0  0  0
    1.6388   -0.9682    0.0000 O   0  0
    0.1615   -1.2328    0.0000 C   0  0  2  0  0  0
   -1.1381   -0.4836    0.0000 O   0  0
   -2.4367   -1.2345    0.0000 C   0  0  2  0  0  0
   -3.7362   -0.4853    0.0000 C   0  0
   -2.4357   -2.7345    0.0000 C   0  0  1  0  0  0
   -3.7365   -3.4831    0.0000 O   0  0
   -5.0357   -2.7316    0.0000 C   0  0  1  0  0  0
   -6.3369   -3.4779    0.0000 C   0  0
   -7.6338   -2.7243    0.0000 C   0  0  1  0  0  0
   -8.9119   -1.9391    0.0000 C   0  0
   -7.6015   -4.2043    0.0000 O   0  0
   -6.3042   -4.9590    0.0000 C   0  0
   -5.0030   -4.2128    0.0000 O   0  0
   -6.3081   -6.4598    0.0000 C   0  0
   -5.0108   -7.2144    0.0000 C   0  0
   -5.0147   -8.7144    0.0000 C   0  0
   -3.7096   -6.4682    0.0000 C   0  0
   -7.6296   -1.2243    0.0000 C   0  0  1  0  0  0
   -8.9265   -0.4706    0.0000 O   0  0
   -6.3285   -0.4779    0.0000 C   0  0  2  0  0  0
   -6.3243    1.0221    0.0000 C   0  0
   -5.0316   -1.2316    0.0000 O   0  0
   -1.1362   -3.4836    0.0000 C   0  0  1  0  0  0
    0.1624   -2.7328    0.0000 C   0  0  1  0  0  0
    1.4619   -3.4820    0.0000 O   0  0
   -1.1383   -4.9845    0.0000 N   0  0
   -2.4379   -5.7334    0.0000 C   0  0
    0.1599   -5.7359    0.0000 C   0  0
   -1.1432   -1.9743    0.0000 O   0  0
   -2.4419   -1.2220    0.0000 C   0  0
   -2.4393    0.2780    0.0000 C   0  0
   -3.7425   -1.9693    0.0000 O   0  0
  1  2  1  0
  3  2  1  6
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  6
  9 11  1  0
 11 12  1  0
 12 13  2  3
 13 14  1  0
 14 15  2  3
 15 16  1  0
 16 17  1  1
 16 18  1  0
 18 19  1  6
 18 20  1  0
 20 21  1  0
 21 22  1  1
 22 23  1  0
 23 24  2  0
 21 25  1  0
 25  3  1  0
 25 26  1  6
 27 26  1  1
 27 28  1  0
 28 29  1  0
 29 30  1  1
 29 31  1  0
 31 32  1  6
 33 32  1  1
 33 34  1  0
 34 35  1  0
 35 36  1  6
 35 37  1  0
 37 38  1  0
 38 39  2  0
 38 40  1  0
 40 41  1  0
 41 42  1  0
 41 43  1  0
 35 44  1  0
 44 45  1  1
 44 46  1  0
 46 47  1  6
 46 48  1  0
 48 33  1  0
 31 49  1  0
 49 50  1  0
 50 27  1  0
 50 51  1  6
 49 52  1  1
 52 53  1  0
 52 54  1  0
  4 55  1  1
 55 56  1  0
 56 57  1  0
 56 58  2  0
M  END
> <name>
NIHCC_2014

> <id>
5734

> <plate>
NGP-105-02

> <well>
C11

> <supplier_cmpd_name>
CPD000469235

> <ctcr_id>
6159

> <supplier_cmpd_id>
SAM001246731

> <smiles>
CO[C@H]1[C@@H](CC(=O)O[C@H](C)CC=CC=C[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(OC(=O)CC(C)C)[C@@H](O)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)OC(C)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{MLS001401410,CHEMBL1599033,HMS2051E22,ZINC253987407,CCG-100905,CCG100905,NC00155,SMR000469235,SR-01000763694,SR01000763694,SR-01000763694-3,SR010007636943,SAM001246731,CPD000469235}

> <pdid>
PD002959

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581794}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 27  0  0  0  0            999 V2000
    6.3609   -2.9917    0.0000 Br  0  5
    4.1437   -1.6252    0.0000 C   0  0
    2.6733   -1.9218    0.0000 N   0  3
    3.1863   -0.5122    0.0000 C   0  0
    2.2221    0.6368    0.0000 C   0  0
    0.7449    0.3764    0.0000 C   0  0
    0.2319   -1.0332    0.0000 C   0  0
    1.1961   -2.1823    0.0000 C   0  0
    2.1328   -3.3000    0.0000 C   0  0
    0.6549   -3.5613    0.0000 C   0  0
    0.1413   -4.9715    0.0000 C   0  0
   -0.8401   -3.7978    0.0000 C   0  0
   -2.3176   -4.0561    0.0000 N   0  0
   -0.3254   -2.3888    0.0000 O   0  0
   -1.3366   -5.2327    0.0000 C   0  0
   -1.3359   -6.7328    0.0000 C   0  0
   -2.6347   -7.4833    0.0000 C   0  0
   -3.9340   -6.7339    0.0000 C   0  0
   -3.9347   -5.2339    0.0000 C   0  0
   -2.6359   -4.4833    0.0000 C   0  0
    1.1061   -6.1210    0.0000 C   0  0
    0.5932   -7.5306    0.0000 C   0  0
    1.5576   -8.6796    0.0000 C   0  0
    3.0347   -8.4190    0.0000 C   0  0
    3.5476   -7.0094    0.0000 C   0  0
    2.5833   -5.8604    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  3  1  0
  3  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 11 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 11 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
M  CHG  2   1  -1   3   1
M  END
> <name>
NIHCC_2014

> <id>
5735

> <plate>
NGP-105-02

> <well>
D02

> <supplier_cmpd_name>
CPD000469284

> <ctcr_id>
4598

> <supplier_cmpd_id>
SAM001246642

> <smiles>
[Br-].C[N+]1(CCCCC1)CCC(C(N)=O)(c2ccccc2)c3ccccc3

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Fenpiverinium bromide",125-60-0,125600,"Fenpiverinium bromide (INN)",UNII-36479UA8GL,UNII36479UA8GL,Resantin,36479UA8GL,"Hoechst 12494",DSSTox_CID_26484,DSSToxCID26484,DSSTox-CID-26484,"DSSTox CID 2
6484",DSSTox_RID_81655,DSSToxRID81655,DSSTox-RID-81655,"DSSTox RID 81655",DSSTox_GSID_46484,DSSToxGSID46484,DSSTox-GSID-46484,"DSSTox GSID 46484","12494 Hoechst",4-(1-methylpiperidin-1-ium-1-yl)-2,4(1
methylpiperidin1ium1yl)2,2-diphenylbutanamide;br,2diphenylbutanamide;br,SAM001246642,CPD000469284}

> <pdid>
PD014258

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{71489}

$$$$
NIHCC_2014
  SciTegic11012413002D

 14 14  0  0  0  0            999 V2000
    5.1937   -3.0093    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    3.8912   -5.2570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2948   -3.7516    0.0000 O   0  0
    2.5973   -1.5031    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  7  1  0
 13 14  1  0
M  END
> <name>
NIHCC_2014

> <id>
5736

> <plate>
NGP-105-02

> <well>
D03

> <supplier_cmpd_name>
CPD000466388

> <ctcr_id>
5998

> <supplier_cmpd_id>
SAM001246759

> <smiles>
CC(N)C(=O)Nc1c(C)cccc1C

> <pd_targets>
{SCN10A,SCN11A,SCN1A,SCN2A,SCN3A,SCN4A,SCN5A,SCN7A,SCN8A,SCN9A}

> <pathway_gtopdb>
{"Ion channel","Voltage-gated ion channel","Voltage-gated sodium channel"}

> <pathway_chembl>
{"Ion channels","Voltage-gated ion channels","Voltage-gated sodium channels"}

> <pathway_reactome>
{"Developmental Biology","Nervous system development","Axon guidance","L1CAM interactions","Interaction between L1 and Ankyrins"}

> <broad_targets>
{SCN5A}

> <broad_moa>
{"sodium channel blocker"}

> <synonyms>
{tocainide,41708-72-9,41708729,"Alanyl-2,6-xylidide","Alanyl2,6xylidide",Tocainidum,"2-AMINO-N-(2,6-DIMETHYLPHENYL)PROPANAMIDE","2AMINON(2,6DIMETHYLPHENYL)PROPANAMIDE",Tocainida,"Tocainidum (INN-Latin
)","Tocainidum (INNLatin)","Tocainida (INN-Spanish)","Tocainida (INNSpanish)","2-Amino-2',6'-propionoxylidide","2Amino2',6'propionoxylidide",Tonocard,W-36095,W36095,N-(2,N(2,6-dimethylphenyl)alaninami
d,6dimethylphenyl)alaninamid,SAM001246759,CPD000466388}

> <pdid>
PD002838

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{38945}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 28  0  0  1  0            999 V2000
    1.4157   -5.0351    0.0000 C   0  0
    1.8059   -3.5867    0.0000 C   0  0  1  0  0  0
    3.2554   -3.2009    0.0000 O   0  0
    0.7500   -2.5287    0.0000 C   0  0  2  0  0  0
    0.7500   -1.0323    0.0000 C   0  0  1  0  0  0
    1.2135    0.3943    0.0000 C   0  0  1  0  0  0
    2.6401    0.8578    0.0000 C   0  0
    0.0000    1.2760    0.0000 C   0  0
   -1.2135    0.3943    0.0000 C   0  0
   -0.7500   -1.0323    0.0000 N   0  0
   -0.7500   -2.5287    0.0000 C   0  0
   -1.8107   -3.5893    0.0000 O   0  0
   -2.6375    0.8602    0.0000 C   0  0
   -3.7540   -0.1415    0.0000 O   0  0
   -2.9472    2.3279    0.0000 O   0  0
   -0.0031    2.7742    0.0000 S   0  0
   -1.3040    3.5228    0.0000 C   0  0  2  0  0  0
   -1.4470    5.0031    0.0000 C   0  0
   -2.9153    5.3098    0.0000 N   0  0
   -3.6608    4.0082    0.0000 C   0  0  1  0  0  0
   -2.6532    2.8970    0.0000 C   0  0
   -5.1499    3.8433    0.0000 C   0  0
   -6.0380    5.0521    0.0000 O   0  0
   -5.7536    2.4692    0.0000 N   0  0
   -7.2445    2.3041    0.0000 C   0  0
   -4.8655    1.2603    0.0000 C   0  0
  2  1  1  6
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  6
  6  8  1  0
  8  9  2  3
  9 10  1  0
  5 10  1  6
 10 11  1  0
  4 11  1  1
 11 12  2  0
  9 13  1  0
 13 14  1  0
 13 15  2  0
  8 16  1  0
 17 16  1  1
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 17  1  0
 20 22  1  1
 22 23  2  0
 22 24  1  0
 24 25  1  0
 24 26  1  0
M  END
> <name>
NIHCC_2014

> <id>
5737

> <plate>
NGP-105-02

> <well>
D04

> <supplier_cmpd_name>
CPD000469184

> <ctcr_id>
3621

> <supplier_cmpd_id>
SAM001246650

> <smiles>
C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(=C(N2C1=O)C(O)=O)S[C@@H]3CN[C@@H](C3)C(=O)N(C)C

> <pd_targets>
{SKA,BLAVIM-2,"BLA OXA-48",BLANDM-1,DACA,DACB,DACC,FTSI,MRCA,MRCB,MRDA,LEF}

> <pathway_gtopdb>
{Enzyme,Kinase,Hydrolase,Protease,"Serine protease","Metallo protease","Serine protease SE clan","Metallo protease MAE clan","Serine protease S11 family","Metallo protease M34 family"}

> <pathway_chembl>
{}

> <pathway_reactome>
{Disease,"Infectious disease","Uptake and actions of bacterial toxins","Uptake and function of anthrax toxins"}

> <broad_targets>
{}

> <broad_moa>
{"bacterial cell wall synthesis inhibitor"}

> <synonyms>
{SR-01000762894,SR01000762894,meropenem,96036-03-2,96036032,Merrem,"Meropenem anhydrous",Meropenemum,"Antibiotic SM 7338",MERONEM,SM-7338,SM7338,119478-56-7,119478567,MEPM,UNII-YOP6PX0BAO,UNIIYOP6PX0B
AO,CHEBI:43968,"Meropenemum (INN-Latin)","Meropenemum (INNLatin)","Meropenem (INN)","Meropenem Hydrate",YOP6PX0BAO,SAM001246650,Prestw-1106,CPD000469184,Meropenem}

> <pdid>
PD001697

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{40466974,441130}

$$$$
NIHCC_2014
  SciTegic11012413002D

 16 16  0  0  0  0            999 V2000
    1.2948   -3.7516    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    3.8912   -5.2578    0.0000 C   0  0
    5.1887   -6.0105    0.0000 C   0  0
    3.8883   -6.7578    0.0000 C   0  0
    2.5909   -6.0056    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 Cl  0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  4  7  1  0
  2  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 16 10  1  0
M  END
> <name>
NIHCC_2014

> <id>
5738

> <plate>
NGP-105-02

> <well>
D05

> <supplier_cmpd_name>
CPD000472526

> <ctcr_id>
2483

> <supplier_cmpd_id>
SAM001246699

> <smiles>
CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1

> <pd_targets>
{CHRNA3,CHRNB4,CHRNA4,CHRNB2,SLC6A3,SLC6A4,SLC6A2,CHRNA7,ALDH1A1,ITGA5,CHRNA1,CHRNB1,CHRND,CHRNG,CYP2C19,HTR3A}

> <pathway_gtopdb>
{"Ion channel",Transporter,Enzyme,"Ligand-gated ion channel","Electrochemical transporter",Oxidoreductase,"Cytochrome P450","Nicotinic acetylcholine receptor","SLC superfamily of solute carriers","Cyt
ochrome P450 family 2","5HT3 receptor","Nicotinic acetylcholine receptor alpha subunit","SLC06 neurotransmitter transporter family","Cytochrome P450 family 2C","Cytochrome P450 2C19"}

> <pathway_chembl>
{Transporters,"Ion channels",Enzymes,"SLC superfamily of solute carriers","Ligand-gated ion channels","Cytochrome P450","SLC6 neurotransmitter transporter family","Nicotinic acetylcholine receptors","
CYP2 family: drug metabolising subset","5-HT<sub>3</sub> receptors","Monoamine transporter subfamily"}

> <pathway_reactome>
{Disease,"Neuronal System",Metabolism,"Disorders of transmembrane transporters","Transmission across Chemical Synapses","Biological oxidations","SLC transporter disorders","Neurotransmitter clearance"
,"Neurotransmitter receptors and postsynaptic signal transmission","Phase I - Functionalization of compounds","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Serotonin clearance fro
m the synaptic cleft","Defective SLC6A2 causes orthostatic intolerance (OI)","Acetylcholine binding and downstream events","Ethanol oxidation","Cytochrome P450 - arranged by substrate type","Postsynap
tic nicotinic acetylcholine receptors",Xenobiotics,"Highly calcium permeable postsynaptic nicotinic acetylcholine receptors","CYP2E1 reactions"}

> <broad_targets>
{SLC6A2,SLC6A3}

> <broad_moa>
{"dopamine reuptake inhibitor"}

> <synonyms>
{bupropion,Amfebutamone,34911-55-2,34911552,2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one,2(tertbutylamino)1(3chlorophenyl)propan1one,Amfebutamon,Wellbutrin,amfebutamonum,Amfebutamona,(+-)-Buprop
ion,(+)Bupropion,34841-39-9,34841399,Elontril,Wellbatrin,Zyban,"AMFEBUTAMONE HCl","Bupropion SR","Bupropion hydroclori",T1150,SAM001246699,"Bupropion hydrochloride",CPD000472526}

> <pdid>
PD003148

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{444}

$$$$
NIHCC_2014
  SciTegic11012413002D

 18 18  0  0  0  0            999 V2000
   11.6982   -0.7323    0.0000 C   0  0
   10.4003   -1.4841    0.0000 C   0  0
    9.0990   -0.7364    0.0000 C   0  0
    7.8003   -1.4887    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    3.8990   -0.7455    0.0000 N   0  0
    2.6003   -1.4977    0.0000 C   0  0
    2.6030   -2.9977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 F   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  2  3
 12 13  1  0
 12 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 10  1  0
 17 18  2  0
M  END
> <name>
NIHCC_2014

> <id>
5739

> <plate>
NGP-105-02

> <well>
D06

> <supplier_cmpd_name>
CPD000466363

> <ctcr_id>
5295

> <supplier_cmpd_id>
SAM001246692

> <smiles>
CCCCCCNC(=O)N1C=C(F)C(=O)NC1=O

> <pd_targets>
{LMNA,CYP3A4,SQOR,REP,MAPK3,ASAH1,CYP2D6}

> <pathway_gtopdb>
{"Other nuclear protein",Enzyme,"Cytochrome P450",Oxidoreductase,Transferase,Kinase,Hydrolase,"Cytochrome P450 family 3","Protein Kinase","Cytochrome P450 family 2","Cytochrome P450 family 3A","CMGC p
rotein kinase group","Cytochrome P450 family 2D","Cytochrome P450 3A4","CMGC protein kinase MAPK family","Cytochrome P450 2D6","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,"Other protein targets","Cytochrome P450","Anti-infective targets","Kinases (EC 2.7.x.x)","Ceramide turnover","CYP3 family","Viral protein targets","CMGC: Containing CDK",MAPK,GSK3,"CLK famil
ies","Acid ceramidase","CYP2 family: drug metabolising subset","Coronavirus (CoV) proteins","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Cell Cycle",Metabolism,Disease,"Immune System",Mitotic,"Metabolism of lipids","Metabolism of amino acids and derivatives","Infectious disease","Innate Immune System","Biological oxidations","M Phase
","Biosynthesis of specialized proresolving mediators (SPMs)","Sulfur amino acid metabolism","SARS-CoV Infections","Toll-like Receptor Cascades","Sphingolipid metabolism","Phase I - Functionalization 
of compounds","Mitotic Metaphase and Anaphase","Biosynthesis of DHA-derived SPMs","Degradation of cysteine and homocysteine","SARS-CoV-2 Infection","Toll Like Receptor 5 (TLR5) Cascade","Glycosphingol
ipid metabolism","Cytochrome P450 - arranged by substrate type","Mitotic Anaphase","Biosynthesis of maresins","Sulfide oxidation to sulfate","SARS-CoV-2 Genome Replication and Transcription","MyD88 ca
scade initiated on plasma membrane",Xenobiotics,"Nuclear Envelope (NE) Reassembly","Biosynthesis of maresin-like SPMs","Replication of the SARS-CoV-2 genome","MAP kinase activation","CYP2E1 reactions"
,"Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{TYMS}

> <broad_moa>
{"thymidylate synthase inhibitor"}

> <synonyms>
{carmofur,61422-45-5,61422455,Mifurol,1-Hexylcarbamoyl-5-fluorouracil,1Hexylcarbamoyl5fluorouracil,Yamafur,UNII-HA82M3RAB2,UNIIHA82M3RAB2,"1(2H)-Pyrimidinecarboxamide, 5-fluoro-N-hexyl-3,4-dihydro-2,4
-dioxo-","1(2H)Pyrimidinecarboxamide, 5fluoroNhexyl3,4dihydro2,4dioxo","5-fluoro-N-hexyl-2,4-dioxo-3,4-dihydropyrimidine-1(2H)-carboxamide","5fluoroNhexyl2,4dioxo3,4dihydropyrimidine1(2H)carboxamide",
HA82M3RAB2,5-fluo,5fluo,T1307,SAM001246692,1505317,Carmofur,CPD000466363,CARMOFUR}

> <pdid>
PD000944

> <targets>
{Nucleoside Antimetabolite/Analog,SARS-CoV,Virus Protease}

> <classes>
{antineoplastic,Anti-infection,Cell Cycle/DNA Damage}

> <pubchem_cids>
{2577}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 20  0  0  1  0            999 V2000
   10.3056    0.0059    0.0000 Cl  0  5
    1.2844    3.7485    0.0000 C   0  0
    2.5857    3.0025    0.0000 N   0  3
    2.5914    1.5017    0.0000 C   0  0
    3.8934    0.7553    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0  1  0  0  0
    2.6003   -1.4978    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    5.2003   -1.4933    0.0000 C   0  0
    5.2076   -2.9933    0.0000 C   0  0
    6.5102   -3.7370    0.0000 C   0  0
    7.8056   -2.9808    0.0000 C   0  0
    7.7984   -1.4808    0.0000 C   0  0
    6.4958   -0.7371    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  6  5  1  6
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 13 14  1  0
  6 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
M  CHG  2   1  -1   3   1
M  END
> <name>
NIHCC_2014

> <id>
5740

> <plate>
NGP-105-02

> <well>
D07

> <supplier_cmpd_name>
CPD000469177

> <ctcr_id>
1715

> <supplier_cmpd_id>
SAM001246626

> <smiles>
[Cl-].C[NH2+]CC[C@@H](Oc1ccccc1C)c2ccccc2

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{AKOS015896138,"Atomoxetine hydrochloride","Atomoxetine HCL",82248-59-7,82248597,Strattera,"TOMOXETINE HYDROCHLORIDE","(R)-Tomoxetine hydrochloride","(R)Tomoxetine hydrochloride","(R)-N-Methyl-3-pheny
l-3-(o-tolyloxy)propan-1-amine hydrochloride","(R)NMethyl3phenyl3(otolyloxy)propan1amine hydrochloride","(R)-(-)-Tomoxetine h","(R)()Tomoxetine h",S3175,SAM001246626,Prestw-1463,"Atomoxetine HCl",CPD0
00469177,"Tomoxetine hydrochloride"}

> <pdid>

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{45108252,54840,11426336}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 24  0  0  0  0            999 V2000
    2.5983   -3.0004    0.0000 C   0  0
    2.5988   -1.5004    0.0000 S   0  0
    3.8983   -0.7512    0.0000 O   0  0
    3.8975   -2.2510    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5987    1.5004    0.0000 C   0  0
   -2.7390    2.9810    0.0000 C   0  0
   -4.2067    3.2905    0.0000 C   0  0
   -4.8190    4.6599    0.0000 O   0  0
   -4.9546    1.9903    0.0000 O   0  0
   -3.9492    0.8772    0.0000 C   0  0
   -1.6193    3.9804    0.0000 C   0  0
   -0.1673    3.6256    0.0000 C   0  0
    0.8689    4.7101    0.0000 C   0  0
    0.4478    6.1498    0.0000 C   0  0
   -1.0096    6.5049    0.0000 C   0  0
   -2.0458    5.4204    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  8 11  1  0
 11 12  2  3
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 11  1  0
 12 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
M  END
> <name>
NIHCC_2014

> <id>
5741

> <plate>
NGP-105-02

> <well>
D08

> <supplier_cmpd_name>
CPD000466331

> <ctcr_id>
3968

> <supplier_cmpd_id>
SAM001246617

> <smiles>
C[S](=O)(=O)c1ccc(cc1)C2=C(C(=O)OC2)c3ccccc3

> <pd_targets>
{PTGS2,PTGS1,ALDH1A1,MT-CO2,ABCB11,PTGER2,PTGER3,IMPA1,ELN}

> <pathway_gtopdb>
{Enzyme,Transporter,"Membrane receptor","Structural protein",Oxidoreductase,"Primary active transporter",Protease,"Family A G protein-coupled receptor",Hydrolase,"Oxidoreduction-driven transporters","
Cysteine protease","ATP-binding cassette","Small molecule receptor (family A GPCR)","Cysteine protease CA clan","ABCB subfamily","Lipid-like ligand receptor (family A GPCR)","Cysteine protease C1A fam
ily","Prostanoid receptor"}

> <pathway_chembl>
{Enzymes,Transporters,Receptors,"Eicosanoid turnover","ATP-binding cassette transporter family","G protein-coupled receptors","Inositol phosphate turnover",Cyclooxygenase,"ABCB subfamily","Prostanoid 
receptors","Inositol monophosphatase"}

> <pathway_reactome>
{Metabolism,"Gene expression (Transcription)",Disease,"Signal Transduction","Extracellular matrix organization","Metabolism of lipids","Biological oxidations","RNA Polymerase II Transcription","Infect
ious disease","Signaling by GPCR","Inositol phosphate metabolism","Elastic fibre formation","Biosynthesis of specialized proresolving mediators (SPMs)","Fatty acid metabolism","Phase I - Functionaliza
tion of compounds","Generic Transcription Pathway","Metabolism of steroids","Leishmania infection","GPCR ligand binding","Synthesis of IP2",IP,"and Ins in the cytosol","Molecules associated with elast
ic fibres","Biosynthesis of DPA-derived SPMs","Arachidonic acid metabolism","Ethanol oxidation","Transcriptional Regulation by TP53","Bile acid and bile salt metabolism","Leishmania parasite growth an
d survival","Class A/1 (Rhodopsin-like receptors)","Biosynthesis of DPAn-3 SPMs","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","TP53 Regulates Metabolic Genes","Synthesis of bile acids and 
bile salts","Anti-inflammatory response favouring Leishmania parasite infection","Eicosanoid ligand-binding receptors","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","ADORA2B m
ediated anti-inflammatory cytokines production","Prostanoid ligand receptors"}

> <broad_targets>
{ELN,PTGS2}

> <broad_moa>
{"cyclooxygenase inhibitor"}

> <synonyms>
{rofecoxib,162011-90-7,162011907,Vioxx,Ceoxx,"MK 966",4-(4-(Methylsulfonyl)phenyl)-3-phenylfuran-2(5H)-one,4(4(Methylsulfonyl)phenyl)3phenylfuran2(5H)one,4-(4-(methylsulfonyl)phenyl)-3-phenylfuran-2(5
H)-one,4(4(methylsulfonyl)phenyl)3phenylfuran2(5H)one,MK-966,MK966,"MK 0966",MK-0966,MK0966,4-(4-(methylsulfonyl)phenyl)-3-phenyl-2(5H)-furanone,4(4(methylsulfonyl)phenyl)3phenyl2(5H)furanone,UNII-0QT
W8Z,UNII0QTW8Z,T1185,SAM001246617,1504235,Prestw-1336,Rofecoxib,CPD000466331,ROFECOXIB}

> <pdid>
PD002879

> <targets>
{COX2}

> <classes>
{"COX2 inhibitor",antiinflammatory,antiarthritic}

> <pubchem_cids>
{5090}

$$$$
NIHCC_2014
  SciTegic11012413002D

 52 54  0  0  1  0            999 V2000
   -2.5993   -0.0041    0.0000 C   0  0
   -1.3013    0.7478    0.0000 C   0  0
    0.0000    0.0000    0.0000 C   0  0  1  0  0  0
    0.0000   -1.5000    0.0000 O   0  0
    1.3000   -2.2500    0.0000 C   0  0
    1.3000   -3.7500    0.0000 O   0  0
    2.6000   -1.5000    0.0000 C   0  0  2  0  0  0
    2.6000    0.0000    0.0000 C   0  0
    3.9000   -2.2500    0.0000 C   0  0  1  0  0  0
    4.4104   -3.6614    0.0000 O   0  0
    3.4441   -4.8097    0.0000 C   0  0  1  0  0  0
    3.9521   -6.2211    0.0000 C   0  0
    2.9840   -7.3668    0.0000 C   0  0  1  0  0  0
    1.9881   -8.4884    0.0000 C   0  0
    4.4471   -7.5929    0.0000 O   0  0
    5.4157   -6.4476    0.0000 C   0  0
    1.5077   -7.1012    0.0000 C   0  0  1  0  0  0
    0.5395   -8.2469    0.0000 O   0  0
    0.9995   -5.6899    0.0000 C   0  0  2  0  0  0
   -0.4768   -5.4243    0.0000 C   0  0
    1.9677   -4.5442    0.0000 O   0  0
    5.2000   -1.5000    0.0000 C   0  0  2  0  0  0
    5.2000    0.0000    0.0000 C   0  0
    6.5000   -2.2500    0.0000 C   0  0  1  0  0  0
    6.4969   -3.7508    0.0000 O   0  0
    7.7946   -4.5047    0.0000 C   0  0  2  0  0  0
    9.0943   -3.7556    0.0000 O   0  0
   10.3928   -4.5065    0.0000 C   0  0  2  0  0  0
   11.6923   -3.7573    0.0000 C   0  0
   10.3918   -6.0065    0.0000 C   0  0
    9.0923   -6.7556    0.0000 C   0  0  1  0  0  0
    7.7937   -6.0048    0.0000 C   0  0  1  0  0  0
    6.4942   -6.7539    0.0000 O   0  0
    9.0882   -8.2564    0.0000 N   0  0
    7.7876   -9.0037    0.0000 C   0  0
   10.3855   -9.0096    0.0000 C   0  0
    7.8000   -1.5000    0.0000 C   0  0  1  0  0  0
    9.0804   -0.7186    0.0000 C   0  0
    7.8000    0.0000    0.0000 C   0  0
    6.5000    0.7500    0.0000 C   0  0  1  0  0  0
    6.5000    2.2500    0.0000 C   0  0
    5.2000    0.0000    0.0000 C   0  0
    5.2000   -1.5000    0.0000 O   0  0
    3.9000    0.7500    0.0000 C   0  0  2  0  0  0
    3.9000    2.2500    0.0000 C   0  0
    2.6000    0.0000    0.0000 C   0  0  1  0  0  0
    2.6000   -1.5000    0.0000 O   0  0
    1.3000    0.7500    0.0000 C   0  0  1  0  0  0
   -0.0164    1.4691    0.0000 C   0  0
    2.6163    1.4692    0.0000 O   0  0
    7.7633   -2.9800    0.0000 O   0  0
    6.4645   -3.7303    0.0000 C   0  0
  1  2  1  0
  3  2  1  6
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  6
  7  9  1  0
  9 10  1  6
 11 10  1  1
 11 12  1  0
 12 13  1  0
 13 14  1  6
 13 15  1  0
 15 16  1  0
 13 17  1  0
 17 18  1  1
 17 19  1  0
 19 20  1  6
 19 21  1  0
 21 11  1  0
  9 22  1  0
 22 23  1  6
 22 24  1  0
 24 25  1  6
 26 25  1  6
 26 27  1  0
 27 28  1  0
 28 29  1  6
 28 30  1  0
 30 31  1  0
 31 32  1  0
 32 26  1  0
 32 33  1  1
 31 34  1  6
 34 35  1  0
 34 36  1  0
 24 37  1  0
 37 38  1  6
 37 39  1  0
 39 40  1  0
 40 41  1  6
 40 42  1  0
 42 43  2  0
 42 44  1  0
 44 45  1  1
 44 46  1  0
 46 47  1  1
 46 48  1  0
 48  3  1  0
 48 49  1  6
 48 50  1  0
 37 51  1  0
 51 52  1  0
M  END
> <name>
NIHCC_2014

> <id>
5742

> <plate>
NGP-105-02

> <well>
D09

> <supplier_cmpd_name>
CPD000466382

> <ctcr_id>
6484

> <supplier_cmpd_id>
SAM001246748

> <smiles>
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC

> <pd_targets>
{KCNH2,CYP3A4,GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG3,GABRP,GABRQ,MAPK1,SLCO1B1,ABCB1,SLCO1B3,RPLJ}

> <pathway_gtopdb>
{"Ion channel",Enzyme,Transporter,"Voltage-gated ion channel","Cytochrome P450","Ligand-gated ion channel",Kinase,"Electrochemical transporter","Primary active transporter","Potassium channels","Cytoc
hrome P450 family 3","GABA-A receptor","Protein Kinase","SLC superfamily of solute carriers","ATP-binding cassette","Voltage-gated potassium channel","Cytochrome P450 family 3A","CMGC protein kinase g
roup","SLC21/SLCO family of organic anion transporting polypeptides","ABCB subfamily","Cytochrome P450 3A4","CMGC protein kinase MAPK family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{"Ion channels",Enzymes,Transporters,"Voltage-gated ion channels","Cytochrome P450","Kinases (EC 2.7.x.x)","SLC superfamily of solute carriers","ATP-binding cassette transporter family","Potassium cha
nnels","CYP3 family","CMGC: Containing CDK",MAPK,GSK3,"CLK families","SLCO family of organic anion transporting polypeptides","ABCB subfamily","Voltage-gated potassium channels","Mitogen-activated pro
tein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Muscle contraction",Metabolism,"Immune System","Cardiac conduction","Metabolism of lipids","Innate Immune System","Abacavir transport and metabolism","Phase 3 - rapid repolarisation","Biosynthesis o
f specialized proresolving mediators (SPMs)","Toll-like Receptor Cascades","Metabolism of steroids","Abacavir transmembrane transport","Biosynthesis of DHA-derived SPMs","Toll Like Receptor 5 (TLR5) C
ascade","Bile acid and bile salt metabolism","Biosynthesis of maresins","MyD88 cascade initiated on plasma membrane","Recycling of bile acids and salts","Biosynthesis of maresin-like SPMs","MAP kinase
 activation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{CYP3A4}

> <broad_moa>
{"bacterial 50S ribosomal subunit inhibitor"}

> <synonyms>
{clarithromycin,81103-11-9,81103119,Biaxin,6-O-Methylerythromycin,6OMethylerythromycin,Klaricid,"6-O-Methylerythromycin a","6OMethylerythromycin a",Clarithromycine,Clathromycin,Abbott-56268,Abbott5626
8,"Erythromycin, 6-O-methyl-","Erythromycin, 6Omethyl",A-56268,A56268,Macladin,Clarith,Klacid,Kofron,Veclam,Clarithromycinum,Naxy,TE-031,TE031,Bi,T1434,SAM001246748,1504231,Prestw-1378,Clarithromycin,
CPD000466382,CLARITHROMYCIN}

> <pdid>
PD001219

> <targets>
{Antibiotic,Autophagy,Bacterial,Cytochrome P450}

> <classes>
{antibacterial,Anti-infection,Autophagy,Metabolic Enzyme/Protease}

> <pubchem_cids>
{84029}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 24  0  0  0  0            999 V2000
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -2.6030    2.9977    0.0000 O   0  0
   -3.8990    0.7455    0.0000 N   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.8003    1.4887    0.0000 C   0  0
   -9.0994    0.7387    0.0000 C   0  0
  -10.3984    1.4886    0.0000 C   0  0
  -10.3985    2.9886    0.0000 C   0  0
   -9.0995    3.7387    0.0000 C   0  0
   -7.8004    2.9887    0.0000 C   0  0
   -5.2060    2.9940    0.0000 C   0  0
   -6.5074    3.7399    0.0000 O   0  0
   -3.9096    3.7485    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  4  1  0
  7 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  3
 16 17  1  0
 17 18  2  3
 18 19  1  0
 19 20  2  3
 20 15  1  0
 13 21  1  0
 21 22  2  0
 21 23  1  0
M  END
> <name>
NIHCC_2014

> <id>
5743

> <plate>
NGP-105-02

> <well>
D10

> <supplier_cmpd_name>
CPD000466372

> <ctcr_id>
6258

> <supplier_cmpd_id>
SAM001246721

> <smiles>
CC(C)C1CCC(CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O

> <pd_targets>
{SLC15A2,SLC22A6,ABCC8,KCNJ11,PPARG,LMNA,ALD}

> <pathway_gtopdb>
{Transporter,"Ion channel","Transcription factor","Other nuclear protein",Enzyme,"Electrochemical transporter","Voltage-gated ion channel","Primary active transporter","Nuclear receptor",Protease,"SLC
 superfamily of solute carriers","Potassium channels","ATP-binding cassette","Nuclear hormone receptor subfamily 1","Cysteine protease","SLC15 family of peptide transporters","SLC22 family of organic 
cation and anion transporters","Inwardly rectifying potassium channel","ABCC subfamily","Nuclear hormone receptor subfamily 1 group C","Cysteine protease CA clan","Nuclear hormone receptor subfamily 1
 group C member 3","Cysteine protease C1A family"}

> <pathway_chembl>
{Transporters,Receptors,"SLC superfamily of solute carriers","ATP-binding cassette transporter family","Nuclear hormone receptors","SLC15 family of peptide transporters","SLC22 family of organic catio
n and anion transporters","ABCC subfamily","1C. Peroxisome proliferator-activated receptors","Organic anion transporters (OATs)"}

> <pathway_reactome>
{"Transport of small molecules",Disease,"Gene expression (Transcription)","Cell Cycle","SLC-mediated transmembrane transport","Disorders of transmembrane transporters","RNA Polymerase II Transcription
",Mitotic,"Transport of inorganic cations/anions and amino acids/oligopeptides","Transport of bile salts and organic acids","metal ions and amine compounds","ABC transporter disorders","Generic Transc
ription Pathway","M Phase","Proton/oligopeptide cotransporters","Organic cation/anion/zwitterion transport","Defective ABCC8 can cause hypo- and hyper-glycemias","Transcriptional Regulation by MECP2",
"Mitotic Metaphase and Anaphase","Organic anion transport","MECP2 regulates transcription factors","Mitotic Anaphase","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformatio
n"}

> <broad_targets>
{ABCC8,KCNJ10,KCNJ11,PPARG}

> <broad_moa>
{"insulin secretagogue"}

> <synonyms>
{nateglinide,105816-04-4,Starlix,Fastic,Starsis,Trazec,A-4166,AY-4166,SDZ-DJN-608,"DJN 608",DJN-608,UNII-41X3PWK4O2,AY4166,"SDZ-DJN 608","AY 4166","A 4166",MFCD00875706,CHEMBL783,"SDZ DJN 608",41X3PWK
4O2,N-((trans-4-Isopropylcyclohexyl)carbonyl)-D-phenylalanine,senaglinide,CHEMBL2114389,CHEBI:31897,"(2R)-3-phenyl-2-((4-propan-2-ylcyclohexanecarbonyl)amino)propanoic acid","Nateglinide (INN)",(-)-N-
(trans-4-Isopropylcyclohexanecarbonyl)-D-phenylalanine,n-((trans-4-(1-methylethyl)cyclohexyl)carbonyl)-d-phenylalanine,N-((trans-4-(propan-2-yl)cyclohexyl)carbonyl)-D-phenylalanine,"D-Phenylalanine, N
-((trans-4-(1-methylethyl)cyclohexyl)carbonyl)-","(2R)-2-((oxo-(4-propan-2-ylcyclohexyl)methyl)amino)-3-phenylpropanoic acid","(r)-2-((1r,4r)-4-isopropylcyclohexanecarboxamido)-3-phenylpropanoic acid"
,DSSTox_CID_20687,DSSTox_RID_79543,DSSTox_GSID_40687,trans-N-((4-(1-Methylethyl)cyclohexyl)carbonyl)-D-phenylalanine,"D-phenylalanine, N-((trans-4-(1-methylethyl)cyclohexyl)carbonyl)-",105816-06-6,SMR
000466372,CAS-105816-04-4,nateglinida,nateglinidum,trans-N-((4-(1-methylethyl)cyclohexyl)carbonyl)-D-phenylalanine,NCGC00095121-01,"Nateglinide (USAN:USP:INN:BAN)","Starsis (TN)","Nateglinide, Starlix
",YM-026,"Nateglinide (Starlix)","Nateglinide cis Impurity",SCHEMBL22088,MLS000759500,MLS001424043,MLS003915639,MLS006011429,BIDD:GT0257,SCHEMBL303827,GTPL6833,SCHEMBL7880361,SCHEMBL9232138,ZINC9689,"
Nateglinide (JP17/USP/INN)",DTXSID9040687,SCHEMBL13753829,CHEBI:94617,N-((trans-4-isopropylcyclohexyl)-carbonyl)-D-phenylalanine,HMS2051G20,HMS2089A10,HMS2235O08,HMS3675G17,HMS3715F12,n-(trans-4-Isopr
opylcylolohexylcarboxyl)-d-phenylpropylicacid,BCP28400,"carboxamido)-3-phenylpropanoic acid",EBD10749,HY-B0422,Tox21_111432,BBL033469,BDBM50344967,s2489,STK647123,AKOS005577723,AKOS015841612,AKOS01596
0899,"Nateglinide, >=98 (HPLC), solid",Tox21_111432_1,ZINC100015346,ZINC101489663,AC-1690,CCG-100898,DB00731,KS-5143,MCULE-4748076858,NC00148,SB17322,NCGC00178741-03,NCGC00271534-02,NCGC00271534-03,"(
R)-2-((1r,4R)-4-isopropylcyclohexane",AB0011153,N0912,SW197528-2,C12508,D01111,K-0514,AB00639979-06,AB00639979-08,AB00639979-09,AB00639979-11,AB00639979_12,816N044,A-4166;,A801324,A1-02996,Q-201449,Q2
254797,Q27166439,"N-(Trans-4-Isopropylcyclohexylcarbonyl)-D-Phenyl Alanine",n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine,(trans-4-isopropylcyclohexane-1-carbonyl)-D-phenylalanine,N-((4-(1-m
ethylethyl)cyclohexyl)carbonyl)-D-phenylalanine,"Nateglinide, European Pharmacopoeia (EP) Reference Standard","((1r,4R)-4-isopropylcyclohexane-1-carbonyl)-D-phenylalanine","2-((4-Isopropyl-cyclohexane
carbonyl)-amino)-3-phenyl-propionic acid",N-(4alpha-Isopropylcyclohexane-1alpha-yl)carbonyl-D-phenylalanine,"Nateglinide, United States Pharmacopeia (USP) Reference Standard","(2R)-2-((4-isopropylcycl
ohexanecarbonyl)amino)-3-phenyl-propanoic acid","(2R)-3-phenyl-2-((4-propan-2-ylcyclohexyl)carbonylamino)propanoic acid","D-Phenylalanine, N-((4-(1-methylethyl)cyclohexyl)carbonyl)-, trans-",105746-37
-0,SAM001246721,CPD000466372}

> <pdid>
PD001209

> <targets>
{Dipeptidyl Peptidase,Potassium Channel}

> <classes>
{Membrane Transporter/Ion Channel,Metabolic Enzyme/Protease}

> <pubchem_cids>
{5311309}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 24  0  0  0  0            999 V2000
    0.1711  -10.9062    0.0000 C   0  0
   -1.2966  -10.5966    0.0000 C   0  0
   -2.2982  -11.7132    0.0000 O   0  0
   -1.7622   -9.1698    0.0000 O   0  0
   -0.7600   -8.0526    0.0000 C   0  0
   -1.2256   -6.6258    0.0000 C   0  0
   -0.2234   -5.5086    0.0000 C   0  0
   -0.6890   -4.0818    0.0000 C   0  0
    0.3114   -2.9665    0.0000 N   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6935   -6.3130    0.0000 C   0  0
   -3.1574   -4.8857    0.0000 O   0  0
   -4.6253   -4.5730    0.0000 C   0  0
   -5.6292   -5.6875    0.0000 C   0  0
   -5.0890   -3.1464    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18  9  1  0
 18 12  1  0
  6 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  2  0
M  END
> <name>
NIHCC_2014

> <id>
5744

> <plate>
NGP-105-02

> <well>
D11

> <supplier_cmpd_name>
CPD000466375

> <ctcr_id>
4025

> <supplier_cmpd_id>
SAM001246732

> <smiles>
CC(=O)OCC(CCn1cnc2cnc(N)nc12)COC(C)=O

> <pd_targets>
{ALDH1A1,RXFP1,HPGD,KDM4E,HSD17B10}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Epigenetic regulator",Protease,Oxidoreductase,"Family A G protein-coupled receptor",Eraser,Transferase,"Cysteine protease","Peptide receptor (family A GPCR)","Lysine demet
hylase","Cysteine protease CA clan","Relaxin-like peptide receptor (family A GPCR)","Jumonji domain-containing","Cysteine protease C1A family","Relaxin receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Eicosanoid turnover","Chromatin modifying enzymes","Relaxin family peptide receptors","Prostaglandin synthases","1.14.11.- Histone demethylases"}

> <pathway_reactome>
{Metabolism,Disease,"Biological oxidations","Infectious disease","Metabolism of lipids","Metabolism of amino acids and derivatives","Phase I - Functionalization of compounds","Leishmania infection","B
iosynthesis of specialized proresolving mediators (SPMs)","Branched-chain amino acid catabolism","Ethanol oxidation","Leishmania parasite growth and survival","Biosynthesis of DHA-derived SPMs","Anti-
inflammatory response favouring Leishmania parasite infection","Biosynthesis of D-series resolvins","ADORA2B mediated anti-inflammatory cytokines production"}

> <broad_targets>
{}

> <broad_moa>
{"DNA polymerase inhibitor"}

> <synonyms>
{famciclovir,104227-87-4,104227874,Famvir,BRL-42810,BRL42810,Famciclovirum,"2-(2-(2-Amino-9H-purin-9-yl)ethyl)propane-1,3-diyl diacetate","2(2(2Amino9Hpurin9yl)ethyl)propane1,3diyl diacetate","Famcicl
ovirum (INN-Latin)","Famciclovirum (INNLatin)","BRL 42810","Famciclovir (Famvir)","(2-(acetyloxymethyl)-4-(2-aminopurin-9-yl)butyl) acetate","(2(acetyloxymethyl)4(2aminopurin9yl)butyl) acetate",UNI,T1
646,SAM001246732,1505201,Prestw-1249,Famciclovir,CPD000466375,FAMCICLOVIR}

> <pdid>
PD000571

> <targets>
{}

> <classes>
{antiviral}

> <pubchem_cids>
{3324}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 23  0  0  1  0            999 V2000
    2.6640   -0.1280    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0
   -6.4952    3.7500    0.0000 O   0  0
   -3.8971    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0  2  0  0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.3326   -2.9571    0.0000 C   0  0
    1.8253   -3.1044    0.0000 C   0  0
    2.4266   -1.7302    0.0000 C   0  0  2  0  0  0
    3.8900   -1.4008    0.0000 O   0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  6
  7  8  1  0
  8  9  1  0
  9 10  2  3
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 15 14  1  6
 15  5  1  0
 15  9  1  0
  6 16  1  0
 16  2  1  0
 16 17  1  1
 17 18  1  0
 18 19  1  0
 19  2  1  0
 19 20  1  1
M  END
> <name>
NIHCC_2014

> <id>
5745

> <plate>
NGP-105-02

> <well>
E02

> <supplier_cmpd_name>
CPD000058610

> <ctcr_id>
3417

> <supplier_cmpd_id>
SAM001246751

> <smiles>
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@H]2O

> <pd_targets>
{AR,SHBG,ALDH1A1,PGR,SERPINA6,SLC22A1}

> <pathway_gtopdb>
{"Transcription factor","Secreted protein",Enzyme,Transporter,"Nuclear receptor",Oxidoreductase,"Electrochemical transporter","Nuclear hormone receptor subfamily 3","SLC superfamily of solute carriers
","Nuclear hormone receptor subfamily 3 group C","SLC22 family of organic cation and anion transporters","Nuclear hormone receptor subfamily 3 group C member 4","Nuclear hormone receptor subfamily 3 g
roup C member 3"}

> <pathway_chembl>
{Receptors,Transporters,"Nuclear hormone receptors","SLC superfamily of solute carriers","Steroid hormone receptors","SLC22 family of organic cation and anion transporters","3C. 3-Ketosteroid receptor
s","Organic cation transporters (OCT)"}

> <pathway_reactome>
{"Gene expression (Transcription)",Metabolism,"Transport of small molecules","RNA Polymerase II Transcription","Biological oxidations","Metabolism of lipids","SLC-mediated transmembrane transport","Ge
neric Transcription Pathway","Phase I - Functionalization of compounds","Metabolism of steroids","Transport of bile salts and organic acids","metal ions and amine compounds","Transcriptional regulatio
n by RUNX2","Ethanol oxidation","Metabolism of steroid hormones","Organic cation/anion/zwitterion transport","RUNX2 regulates bone development","Glucocorticoid biosynthesis","Organic cation transport"
,"RUNX2 regulates osteoblast differentiation"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{nandrolone,19-Nortestosterone,19Nortestosterone,"19 Nortestosterone",434-22-0,434220,"434 22 0",19-Norandrostenolone,19Norandrostenolone,"19 Norandrostenolone",Nortestosterone,17beta-Hydroxy-4-estren
-3-one,17betaHydroxy4estren3one,"17beta Hydro",SAM001246751,Prestw-982,CPD000058610,Nandrolone}

> <pdid>
PD003204

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{9904}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 24  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    0.0000    1.5000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 O   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
    2.5987    1.5004    0.0000 C   0  0
    2.6012    3.0005    0.0000 C   0  0
    3.9014    3.7484    0.0000 C   0  0
    5.1993    2.9963    0.0000 C   0  0
    6.4995    3.7443    0.0000 O   0  0
    5.1969    1.4963    0.0000 C   0  0
    6.4947    0.7443    0.0000 O   0  0
    3.8967    0.7484    0.0000 C   0  0
  2  1  1  6
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  7  9  2  0
  9 10  1  0
 10 11  1  0
 10 12  2  0
 12  5  1  0
 12 13  1  0
 13  2  1  0
 13 14  2  0
  3 15  1  6
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 20 22  2  0
 22 15  1  0
M  END
> <name>
NIHCC_2014

> <id>
5746

> <plate>
NGP-105-02

> <well>
E03

> <supplier_cmpd_name>
CPD000499525

> <ctcr_id>
3768

> <supplier_cmpd_id>
SAM001246760

> <smiles>
O[C@H]1[C@H](Oc2cc(O)cc(O)c2C1=O)c3ccc(O)c(O)c3

> <pd_targets>
{GAA,RECQL,MAPT,KDM4E,TGR,POLB,APP,BACE1,AMPC,KIT,PYGM,MMP3,CA4,FTL,SMN1,MMP12,UREA,UREB,KMT2A,MEN1,CYP3A4,MMP9,PMP22,BLM,HPGD,MMP2,CA12,ABCB1A,GMNN,MMP13,CA7,ADORA3}

> <pathway_gtopdb>
{Enzyme,"Other cytosolic protein","Epigenetic regulator",Hydrolase,Eraser,"Lysine demethylase","Jumonji domain-containing","Membrane receptor","Unclassified protein",Transporter,Protease,Kinase,Transf
erase,Lyase,Reader,"Cytochrome P450","Primary active transporter","Family A G protein-coupled receptor","Aspartic protease","Protein Kinase","Metallo protease","Methyl-lysine/arginine binding protein"
,Bromodomain,"Cytochrome P450 family 3","ATP-binding cassette","Small molecule receptor (family A GPCR)","Aspartic protease AA clan","TK protein kinase group","Metallo protease MAM clan","Tudor domain
","Cytochrome P450 family 3A","ABCB subfamily","Nucleotide-like receptor (family A GPCR)","Aspartic protease A1A subfamily","Tyrosine protein kinase PDGFR family","Metallo protease M10A subfamily","Cy
tochrome P450 3A4","Adenosine receptor"}

> <pathway_chembl>
{Enzymes,"3.2.1.- Glycosidases","Chromatin modifying enzymes","1.14.11.- Histone demethylases",Receptors,Transporters,"Peptidases and proteinases","Catalytic receptors","Carbonic anhydrases","Cytochro
me P450","Eicosanoid turnover","ATP-binding cassette transporter family","G protein-coupled receptors","AA: Aspartic (A) Peptidases","Receptor kinases","MA: Metallo (M) Peptidases","CYP3 family","Pros
taglandin synthases","ABCB subfamily","Adenosine receptors","A1: Pepsin","TK: Tyrosine kinase","M10: Matrix metallopeptidase","Receptor tyrosine kinases (RTKs)","Type III RTKs: PDGFR",CSFR,Kit,"FLT3 r
eceptor family"}

> <pathway_reactome>
{Disease,"Neuronal System","DNA Repair","Diseases of metabolism","Transmission across Chemical Synapses","Base Excision Repair","Diseases of carbohydrate metabolism","Neurotransmitter receptors and po
stsynaptic signal transmission","Resolution of Abasic Sites (AP sites)","Glycogen storage diseases","Activation of NMDA receptors and postsynaptic events","Resolution of AP sites via the multiple-nucl
eotide patch replacement pathway","Glycogen storage disease type II (GAA)","Post NMDA receptor activation events","PCNA-Dependent Long Patch Base Excision Repair","Activation of AMPK downstream of NMD
ARs","Immune System","Metabolism of proteins",Metabolism,"Signal Transduction","Transport of small molecules","Vesicle-mediated transport","Metabolism of RNA","Extracellular matrix organization","Deve
lopmental Biology","Cell Cycle","Gene expression (Transcription)","Innate Immune System","Amyloid fiber formation","Diseases of signal transduction by growth factor receptors and second messengers","M
etabolism of carbohydrates","Signaling by GPCR","O2/CO2 exchange in erythrocytes","Membrane Trafficking","Metabolism of non-coding RNA","Degradation of the extracellular matrix","Metabolism of lipids"
,"Nervous system development","DNA Double-Strand Break Repair","Reversible hydration of carbon dioxide",Mitotic,"RNA Polymerase II Transcription","Toll-like Receptor Cascades","Signaling by KIT in dis
ease","Glycogen metabolism","GPCR downstream signalling","Erythrocytes take up carbon dioxide and release oxygen","trans-Golgi Network Vesicle Budding","snRNP Assembly","Collagen degradation","Biosynt
hesis of specialized proresolving mediators (SPMs)","Axon guidance","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Homology Directed Repair","Mitotic G1 phase and G1/S transition","
Generic Transcription Pathway","GPCR ligand binding","Toll Like Receptor 5 (TLR5) Cascade","Drug resistance of KIT mutants","Glycogen breakdown (glycogenolysis)","G alpha (q) signalling events","Golgi
 Associated Vesicle Biogenesis","Biosynthesis of DHA-derived SPMs","EPH-Ephrin signaling","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","G1/S Transition","Transcription
al regulation by RUNX2","Class A/1 (Rhodopsin-like receptors)","MyD88 cascade initiated on plasma membrane","Dasatinib-resistant KIT mutants","Gastrin-CREB signalling pathway via PKC and MAPK","Biosyn
thesis of maresins","EPH-ephrin mediated repulsion of cells","HDR through Homologous Recombination (HRR)","Biosynthesis of D-series resolvins","Activation of the pre-replicative complex","RUNX2 regula
tes genes involved in cell migration","Nucleotide-like (purinergic) receptors","TAK1 activates NFkB by phosphorylation and activation of IKKs complex","EGFR Transactivation by Gastrin","Biosynthesis o
f maresin-like SPMs","Homologous DNA Pairing and Strand Exchange","Adenosine P1 receptors","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{ADIPOR2}

> <broad_moa>
{"opioid receptor antagonist"}

> <synonyms>
{AXIFOLIN(+/,(-)-epitaxifolin,()epitaxifolin,TAXIFOLIN-(+/-),TAXIFOLIN(+/),"(2R,3S)-epitaxifolin","(2R,3S)epitaxifolin",CHEBI:75747,SMR000499525,(?)-Epitaxifolin,(?)Epitaxifolin,MLS000759526,MLS001423
978,CHEMBL221328,SCHEMBL1707803,HMS2051I06,ZINC105086,(2R,3S)-2-(3,3S)2(3,4-dihydroxyphenyl)-3,4dihydroxyphenyl)3,5,7-trihydroxy-2,7trihydroxy2,3-dihydrochro,3dihydrochro,T1738,T4652,SAM001246760,Taxi
folin,(+)-Taxifolin,CPD000499525}

> <pdid>
PD002852

> <targets>
{VEGFR}

> <classes>
{}

> <pubchem_cids>
{712318}

$$$$
NIHCC_2014
  SciTegic11012413002D

 35 35  0  0  1  0            999 V2000
    7.8272  -16.0505    0.0000 C   0  0
    7.8241  -14.5505    0.0000 C   0  0
    6.5232  -13.8020    0.0000 C   0  0
    6.5201  -12.3012    0.0000 C   0  0
    5.2192  -11.5527    0.0000 C   0  0
    5.2160  -10.0519    0.0000 C   0  0
    3.9152   -9.3034    0.0000 C   0  0
    3.9120   -7.8025    0.0000 C   0  0
    2.6112   -7.0540    0.0000 C   0  0
    2.6080   -5.5532    0.0000 C   0  0
    1.3072   -4.8047    0.0000 C   0  0
    1.3040   -3.3039    0.0000 C   0  0  1  0  0  0
    0.0032   -2.5554    0.0000 C   0  0
    0.0000   -1.0607    0.0000 C   0  0  2  0  0  0
    1.0607    0.0000    0.0000 O   0  0
    0.0000    1.0607    0.0000 C   0  0
    0.0000    2.5607    0.0000 O   0  0
   -1.0607    0.0000    0.0000 C   0  0  1  0  0  0
   -2.5554    0.0031    0.0000 C   0  0
   -3.3039    1.3040    0.0000 C   0  0
   -4.8047    1.3071    0.0000 C   0  0
   -5.5532    2.6080    0.0000 C   0  0
   -7.0541    2.6111    0.0000 C   0  0
   -7.8022    3.9113    0.0000 C   0  0
    2.6009   -2.5485    0.0000 O   0  0
    2.5961   -1.0477    0.0000 C   0  0
    1.7283   -0.5507    0.0000 O   0  0
    3.8929   -0.2923    0.0000 C   0  0  2  0  0  0
    5.1969   -1.0354    0.0000 C   0  0
    6.4929   -0.2786    0.0000 C   0  0
    7.7961   -1.0213    0.0000 C   0  0
    6.4850    1.2214    0.0000 C   0  0
    3.8881    1.2085    0.0000 N   0  0
    5.1850    1.9639    0.0000 C   0  0
    5.1801    3.4639    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 12 11  1  1
 12 13  1  0
 14 13  1  1
 14 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 14  1  0
 18 19  1  6
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 12 25  1  0
 25 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  1  1
 29 30  1  0
 30 31  1  0
 30 32  1  0
 28 33  1  0
 33 34  1  0
 34 35  2  0
M  END
> <name>
NIHCC_2014

> <id>
5747

> <plate>
NGP-105-02

> <well>
E04

> <supplier_cmpd_name>
CPD000466339

> <ctcr_id>
3467

> <supplier_cmpd_id>
SAM001246637

> <smiles>
CCCCCCCCCCC[C@@H](C[C@@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@H](CC(C)C)NC=O

> <pd_targets>
{PNLIP,FASN,DAGLB,ABHD12,KMT2A,MEN1,NR1I2,DAGLA,MAPT,FAAH,ABHD16A,CNR1,ABHD6,LIPC,PLA2G7,LIPG,LPL,LIPF,HSD17B10,USP2,CYP3A4,KDM4E}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Transcription factor","Other cytosolic protein","Membrane receptor",Hydrolase,Transferase,Reader,"Nuclear receptor","Family A G protein-coupled receptor",Oxidoreductase
,Protease,"Cytochrome P450",Eraser,Bromodomain,"Nuclear hormone receptor subfamily 1","Small molecule receptor (family A GPCR)","Cysteine protease","Cytochrome P450 family 3","Lysine demethylase","Nuc
lear hormone receptor subfamily 1 group I","Lipid-like ligand receptor (family A GPCR)","Cysteine protease CA clan","Cytochrome P450 family 3A","Jumonji domain-containing","Nuclear hormone receptor su
bfamily 1 group I member 2","Cannabinoid receptor","Cysteine protease C19 family","Cytochrome P450 3A4"}

> <pathway_chembl>
{Enzymes,Receptors,Hydrolases,"2.3.1.-  Acyltransferases","Endocannabinoid turnover","Nuclear hormone receptors","G protein-coupled receptors","Glycerophospholipid turnover","Peptidases and proteinase
s","Cytochrome P450","Chromatin modifying enzymes","2-Acylglycerol ester turnover","1I. Vitamin D receptor-like receptors","<i>N</i>-Acylethanolamine turnover","Cannabinoid receptors","Phospholipase A
<sub>2</sub>","SC: Serine (S) Peptidases","CA: Cysteine (C) Peptidases","CYP3 family","1.14.11.- Histone demethylases","S33: Prolyl aminopeptidase","C19: Ubiquitin-specific protease"}

> <pathway_reactome>
{Metabolism,Hemostasis,"Metabolism of proteins","Neuronal System","Signal Transduction","Transport of small molecules","Digestion and absorption","Gene expression (Transcription)","Metabolism of vitam
ins and cofactors","Metabolism of lipids","Platelet activation","signaling and aggregation","Post-translational protein modification","Transmission across Chemical Synapses","Signaling by GPCR","Plasm
a lipoprotein assembly",remodeling,"and clearance","Peptide hormone metabolism",Digestion,"Metabolism of amino acids and derivatives","RNA Polymerase II Transcription","Metabolism of fat-soluble vitam
ins","Metabolism of steroids","Effects of PIP2 hydrolysis",SUMOylation,"Neurotransmitter receptors and postsynaptic signal transmission","Fatty acid metabolism","GPCR downstream signalling","Plasma li
poprotein clearance",Synthesis,secretion,"and deacylation of Ghrelin","Plasma lipoprotein remodeling","Digestion of dietary lipid","Branched-chain amino acid catabolism","Generic Transcription Pathway
","Biosynthesis of specialized proresolving mediators (SPMs)","Retinoid metabolism and transport","Regulation of cholesterol biosynthesis by SREBP (SREBF)","Arachidonate production from DAG","SUMO E3 
ligases SUMOylate target proteins","Activation of NMDA receptors and postsynaptic events","Arachidonic acid metabolism","G alpha (i) signalling events","Chylomicron clearance","HDL remodeling","Transc
riptional Regulation by TP53","Biosynthesis of DHA-derived SPMs","Activation of gene expression by SREBF (SREBP)","SUMOylation of intracellular receptors","Post NMDA receptor activation events","Regul
ation of TP53 Activity","Biosynthesis of maresins","Activation of AMPK downstream of NMDARs","Regulation of TP53 Expression and Degradation","Biosynthesis of maresin-like SPMs","Regulation of TP53 Deg
radation"}

> <broad_targets>
{CNR1,DAGLA,DAGLB,FASN,LIPF,PNLIP}

> <broad_moa>
{"lipase inhibitor"}

> <synonyms>
{orlistat,96829-58-2,96829582,Tetrahydrolipstatin,Xenical,Alli,Orlipastat,(-)-Tetrahydrolipstatin,()Tetrahydrolipstatin,"Orlipastatum (INN-Latin)","Orlipastatum (INNLatin)",Ro-18-0647,Ro180647,"Ro 18-
0647/002","Ro 180647/002",UNII-95M8R751W8,UNII95M8R751W8,"Orlistat (Alli, Xenical)",C29H53NO5,MLS002207022,CHEMBL175247,MFCD05662360,95M8R75,T0686,SAM001246637,Orlistat,CPD000466339}

> <pdid>
PD001193

> <targets>
{Apoptosis,Fatty Acid Synthase (FASN)}

> <classes>
{Apoptosis,Metabolic Enzyme/Protease}

> <pubchem_cids>
{3034010}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 30  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 N   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 N   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3032   -3.7490    0.0000 C   0  0
   -1.3022    5.2508    0.0000 N   0  0
   -0.0044    6.0031    0.0000 C   0  0
   -2.6030    5.9994    0.0000 C   0  0
   -2.6061    7.5002    0.0000 C   0  0
   -3.9069    8.2488    0.0000 C   0  0
   -3.9100    9.7496    0.0000 N   0  0
   -5.2108   10.4981    0.0000 C   0  0
   -6.5086    9.7459    0.0000 O   0  0
   -5.2139   11.9989    0.0000 C   0  0
   -6.4275   12.8588    0.0000 C   0  0
   -5.9640   14.2853    0.0000 C   0  0
   -4.4640   14.2854    0.0000 C   0  0
   -4.0004   12.8588    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 11  5  1  0
 11 12  1  0
 12 13  2  0
 13  3  1  0
 13 14  1  0
 14 15  1  0
  7 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 24  1  0
M  END
> <name>
NIHCC_2014

> <id>
5748

> <plate>
NGP-105-02

> <well>
E05

> <supplier_cmpd_name>
CPD000466340

> <ctcr_id>
5108

> <supplier_cmpd_id>
SAM001246638

> <smiles>
COc1cc2nc(nc(N)c2cc1OC)N(C)CCCNC(=O)C3CCCO3

> <pd_targets>
{ADRA1B,ADRA1A,HSD17B10,GLA,GAA,ADRA1D,KDM4E,ACHE,ALDH1A1,HPGD,KCNH2,SLC22A1}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Epigenetic regulator","Ion channel",Transporter,"Family A G protein-coupled receptor",Oxidoreductase,Hydrolase,Eraser,"Voltage-gated ion channel","Electrochemical transpor
ter","Small molecule receptor (family A GPCR)","Lysine demethylase","Potassium channels","SLC superfamily of solute carriers","Monoamine receptor","Jumonji domain-containing","Voltage-gated potassium 
channel","SLC22 family of organic cation and anion transporters","Adrenergic receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"Ion channels",Transporters,"G protein-coupled receptors","3.2.1.- Glycosidases","Chromatin modifying enzymes","Acetylcholine turnover","Eicosanoid turnover","Voltage-gated ion chan
nels","SLC superfamily of solute carriers",Adrenoceptors,"1.14.11.- Histone demethylases","Prostaglandin synthases","Potassium channels","SLC22 family of organic cation and anion transporters","Voltag
e-gated potassium channels","Organic cation transporters (OCT)"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,Disease,"Muscle contraction","Transport of small molecules","Signaling by GPCR","Metabolism of amino acids and derivatives","Metabolism of lipids","Diseases of metabo
lism","Biological oxidations","Cardiac conduction","SLC-mediated transmembrane transport","GPCR ligand binding","Branched-chain amino acid catabolism","Sphingolipid metabolism","Diseases of carbohydra
te metabolism","Phospholipid metabolism","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","Phase 3 - rapid repolarisation","Transport of bile salt
s and organic acids","metal ions and amine compounds","Class A/1 (Rhodopsin-like receptors)","Glycosphingolipid metabolism","Glycogen storage diseases","Glycerophospholipid biosynthesis","Ethanol oxid
ation","Biosynthesis of DHA-derived SPMs","Organic cation/anion/zwitterion transport","Amine ligand-binding receptors","Glycogen storage disease type II (GAA)","Synthesis of PC","Biosynthesis of D-ser
ies resolvins","Organic cation transport",Adrenoceptors}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,SCN10A,SCN11A,SCN1A,SCN2A,SCN3A,SCN4A,SCN5A,SCN7A,SCN8A,SCN9A}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{alfuzosin,81403-80-7,81403807,Alfuzosina,Alfuzosine,Alfuzosinum,Uroxatral,"SL 77499",ALFLUZOCIN,ALFLUZOSIN,CHEMBL709,CHEBI:51141,"Alfuzosine (French)","Alfuzosinum (Latin)",Alfusosine,"Alfuzosina (Sp
anish)","Alfuzosin (INN:BAN)","SL 77499-10","SL 7749910",Alfuzos,T0091,SAM001246638,1505263,"Alfuzosin hydrochloride",CPD000466340}

> <pdid>
PD003155

> <targets>
{}

> <classes>
{"alpha(1)-adrenergic blocker"}

> <pubchem_cids>
{2092}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 28  0  0  1  0            999 V2000
    5.1924   -7.5070    0.0000 C   0  0
    5.1924   -6.0070    0.0000 N   0  0
    6.4915   -5.2571    0.0000 C   0  0
    6.4915   -3.7571    0.0000 C   0  0
    5.1925   -3.0070    0.0000 C   0  0  2  0  0  0
    3.8933   -3.7570    0.0000 C   0  0  2  0  0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 O   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8934   -5.2570    0.0000 C   0  0
    5.1925   -1.5063    0.0000 C   0  0
    3.8947   -0.7541    0.0000 C   0  0
    3.8971    0.7459    0.0000 C   0  0
    5.1974    1.4938    0.0000 C   0  0
    5.1998    2.9938    0.0000 F   0  0
    6.4952    0.7417    0.0000 C   0  0
    6.4928   -0.7583    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  1
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 12  1  0
 16 17  2  0
 17  9  1  0
  6 18  1  0
 18  2  1  0
  5 19  1  6
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 22 24  1  0
 24 25  2  0
 25 19  1  0
M  END
> <name>
NIHCC_2014

> <id>
5749

> <plate>
NGP-105-02

> <well>
E06

> <supplier_cmpd_name>
CPD000469181

> <ctcr_id>
3763

> <supplier_cmpd_id>
SAM001246633

> <smiles>
CN1CC[C@H]([C@H](COc2ccc3OCOc3c2)C1)c4ccc(F)cc4

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{N-Methylparoxetine,NMethylparoxetine,110429-36-2,110429362,"N-Methyl Paroxetine","NMethyl Paroxetine",Methylparoxetine,"Paroxetine Related Compound F",UNII-3X658583PO,UNII3X658583PO,3X658583PO,"(3S,4
R)-N-Methylparoxetine","(3S,4R)NMethylparoxetine",PubChem15206,CPD000469181,MLS001424004,trans-(-)-N-methylparoxetine,trans()Nmethylparoxetine,CHEMBL322363,CHE,SAM001246633}

> <pdid>
PD002927

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{10947895}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 30  0  0  1  0            999 V2000
   -0.6010    4.3285    0.0000 C   0  0
    0.1500    3.0300    0.0000 C   0  0  2  0  0  0
    1.8400    3.0300    0.0000 C   0  0
    2.6900    1.5700    0.0000 C   0  0
    1.8400    0.1000    0.0000 C   0  0  1  0  0  0
    2.6900   -1.3600    0.0000 C   0  0  1  0  0  0
    4.1900   -1.3600    0.0000 C   0  0
    1.8400   -2.8200    0.0000 C   0  0  2  0  0  0
    0.1500   -2.8200    0.0000 O   0  0
   -0.6900   -1.3600    0.0000 C   0  0  2  0  0  0
   -1.9100   -1.3600    0.0000 O   0  0
   -2.7600   -0.5000    0.0000 C   0  0  1  0  0  0
   -1.3725    0.0700    0.0000 C   0  0
   -2.7600    0.7100    0.0000 C   0  0
   -1.9100    1.5700    0.0000 C   0  0
   -0.6900    1.5700    0.0000 C   0  0  2  0  0  0
    0.1500    0.1000    0.0000 C   0  0  1  0  0  0
   -1.1700    0.6900    0.0000 O   0  0
   -2.1000    0.1500    0.0000 O   0  0
    2.5900   -4.1179    0.0000 O   0  0
    4.0908   -4.1184    0.0000 C   0  0
    4.8407   -2.8193    0.0000 O   0  0
    4.8416   -5.4179    0.0000 C   0  0
    6.3425   -5.4183    0.0000 C   0  0
    7.0933   -6.7178    0.0000 C   0  0
    6.3434   -8.0169    0.0000 O   0  0
    8.5933   -6.7182    0.0000 O   0  0
  2  1  1  6
  2  3  1  0
  3  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  1
  6  8  1  0
  8  9  1  0
 10  9  1  6
 10 11  1  0
 11 12  1  0
 12 13  1  6
 12 14  1  0
 14 15  1  0
 16 15  1  1
 16  2  1  0
 16 17  1  0
 17  5  1  0
 17 10  1  0
 17 18  1  6
 18 19  1  0
 19 12  1  0
  8 20  1  1
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 25 27  2  0
M  END
> <name>
NIHCC_2014

> <id>
5750

> <plate>
NGP-105-02

> <well>
E07

> <supplier_cmpd_name>
CPD000466336

> <ctcr_id>
3635

> <supplier_cmpd_id>
SAM001246628

> <smiles>
C[C@@H]1CC[C@H]2[C@@H](C)[C@H](O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4)OC(=O)CCC(O)=O

> <pd_targets>
{EXP-1,HTT}

> <pathway_gtopdb>
{"Unclassified protein"}

> <pathway_chembl>
{}

> <pathway_reactome>
{"Gene expression (Transcription)","RNA Polymerase II Transcription","Generic Transcription Pathway","Transcriptional Regulation by MECP2","Regulation of MECP2 expression and activity"}

> <broad_targets>
{}

> <broad_moa>
{"DNA synthesis inhibitor"}

> <synonyms>
{Artesunate,beta-Artesunate,betaArtesunate,88495-63-0,88495630,UNII-USD5X0Z99I,UNIIUSD5X0Z99I,USD5X0Z99I,CPD000466336,182824-33-5,182824335,SMR000466336,SR-01000763413,SR01000763413,"4-oxo-4-(trimethy
l(?)yl)oxy-butanoic acid","4oxo4(trimethyl(?)yl)oxybutanoic acid",MLS000759445,MLS001424053,SCHEMBL5694921,DTXSID3042681,CHEBI:94751,HMS2051I14,ZI,T0433,SAM001246628}

> <pdid>
PD000729

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{65664}

$$$$
NIHCC_2014
  SciTegic11012413002D

 31 30  0  0  0  0            999 V2000
    6.4848   -8.2644    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    3.8869   -8.2595    0.0000 C   0  0
    5.1894   -6.0109    0.0000 N   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    5.1937   -3.0093    0.0000 O   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 O   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.8003    1.4887    0.0000 O   0  0
   -9.0990    0.7364    0.0000 C   0  0
  -10.3996    1.4837    0.0000 C   0  0
   -9.0964   -0.7636    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   10.2855   -1.5074    0.0000 O   0  0
   10.2855   -3.0074    0.0000 C   0  0
    8.9862   -3.7570    0.0000 O   0  0
   11.5855   -3.7574    0.0000 C   0  0
   12.8854   -3.0074    0.0000 C   0  0
   14.1854   -3.7574    0.0000 C   0  0
   14.1854   -5.2574    0.0000 O   0  0
   15.4847   -3.0078    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 13 22  1  0
 22 23  2  0
 23 10  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  1  0
 29 31  2  0
M  END
> <name>
NIHCC_2014

> <id>
5751

> <plate>
NGP-105-02

> <well>
E08

> <supplier_cmpd_name>
CPD000471619

> <ctcr_id>
2678

> <supplier_cmpd_id>
SAM001246618

> <smiles>
CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1.OC(=O)\C=C\C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Bisoprolol fumarate",104344-23-2,104344232,Zebeta,"Bisoprolol hemifumarate","Bisoprolol monofumarate",Fondril,Maintate,Monocor,Concor,Emcor,Soprol,"Bisoprolol hemifumarate salt",105878-43-1,10587843
1,TA-4708,TA4708,CL-297939,CL297939,Euradal,SMR000471619,EMD-33512,EMD33512,MFC,SAM001246618,1505704,CPD000471619,"BISOPROLOL FUMARATE"}

> <pdid>

> <targets>
{}

> <classes>
{antihypertensive,beta-blocker}

> <pubchem_cids>
{6917733}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 33  0  0  0  0            999 V2000
    7.7546  -15.0257    0.0000 Cl  0  0
    6.4594  -14.2692    0.0000 C   0  0
    5.1566  -15.0126    0.0000 C   0  0
    3.8613  -14.2561    0.0000 C   0  0
    3.8689  -12.7561    0.0000 C   0  0
    5.1717  -12.0125    0.0000 C   0  0
    5.1769  -10.5118    0.0000 N   0  0
    6.4785   -9.7663    0.0000 C   0  0
    6.4837   -8.2663    0.0000 C   0  0
    5.1873   -7.5117    0.0000 N   0  0
    5.1894   -6.0109    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -5.1961   -1.5000    0.0000 O   0  0
   -2.5981   -1.5000    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8856   -8.2573    0.0000 C   0  0
    3.8804   -9.7573    0.0000 C   0  0
    6.4669  -12.7692    0.0000 C   0  0
    7.7698  -12.0258    0.0000 Cl  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 19  1  0
 25 26  2  0
 26 16  1  0
 10 27  1  0
 27 28  1  0
 28  7  1  0
  6 29  2  0
 29  2  1  0
 29 30  1  0
M  END
> <name>
NIHCC_2014

> <id>
5752

> <plate>
NGP-105-02

> <well>
E09

> <supplier_cmpd_name>
CPD000466383

> <ctcr_id>
4649

> <supplier_cmpd_id>
SAM001246750

> <smiles>
Clc1cccc(N2CCN(CCCCOc3ccc4CCC(=O)Nc4c3)CC2)c1Cl

> <pd_targets>
{RORC,HTR3A,DRD4,HTR1A,HTR2C,KCNH2,HRH1,HTR2A,ADRA2A,ADRA2B,HTR1D,DRD3,ADRB1,GSC2,ADRA1A,HTR7,DRD2,HTR2B,SLC6A3,H1-0,HTR1B,GAA,HTR6,MAPT,ADRA2C,ADRA1B,ADRA1D,DRD5,ADRB2,CHRM1,SLC6A4,CHRM5,KMT2A,MEN1,N
PSR1,HTR5A,CHRM4,GRIN1,CHRM2,SLC6A2,CHRM3,HRH3,PRKCG,HTR1E,ABCB1,HTR3B,HTR3C,HTR3D,HTR3E}

> <pathway_gtopdb>
{"Transcription factor","Ion channel","Membrane receptor",Enzyme,Transporter,"Other nuclear protein","Other cytosolic protein","Epigenetic regulator","Nuclear receptor","Ligand-gated ion channel","Fam
ily A G protein-coupled receptor","Voltage-gated ion channel",Transferase,"Electrochemical transporter",Hydrolase,Reader,Kinase,"Primary active transporter","Nuclear hormone receptor subfamily 1","5HT
3 receptor","Small molecule receptor (family A GPCR)","Potassium channels","SLC superfamily of solute carriers",Bromodomain,"Peptide receptor (family A GPCR)","Ionotropic glutamate receptor","Protein 
Kinase","ATP-binding cassette","Nuclear hormone receptor subfamily 1 group F","Monoamine receptor","Voltage-gated potassium channel","SLC06 neurotransmitter transporter family","Short peptide receptor
 (family A GPCR)","NMDA receptor","AGC protein kinase group","ABCB subfamily","Nuclear hormone receptor subfamily 1 group F member 3","Dopamine receptor","Serotonin receptor","Histamine receptor","Adr
energic receptor","Acetylcholine receptor","Neuropeptide receptor","AGC protein kinase PKC family","AGC protein kinase PKC alpha subfamily"}

> <pathway_chembl>
{Receptors,"Ion channels",Transporters,Enzymes,"Nuclear hormone receptors","Ligand-gated ion channels","G protein-coupled receptors","Voltage-gated ion channels","SLC superfamily of solute carriers","
3.2.1.- Glycosidases","Kinases (EC 2.7.x.x)","ATP-binding cassette transporter family","1F. Retinoic acid-related orphans","5-HT<sub>3</sub> receptors","Dopamine receptors","5-Hydroxytryptamine recept
ors","Potassium channels","Histamine receptors",Adrenoceptors,"SLC6 neurotransmitter transporter family","Acetylcholine receptors (muscarinic)","Neuropeptide S receptor","Ionotropic glutamate receptor
s","AGC: Containing PKA",PKG,"PKC families","ABCB subfamily","Voltage-gated potassium channels","Monoamine transporter subfamily","Protein kinase C (PKC) family","Alpha subfamily"}

> <pathway_reactome>
{"Gene expression (Transcription)","Neuronal System","Signal Transduction","Muscle contraction",Disease,"Cellular responses to external stimuli",Metabolism,"RNA Polymerase II Transcription","Transmiss
ion across Chemical Synapses","Signaling by GPCR","Cardiac conduction","Infectious disease","Disorders of transmembrane transporters","Cellular responses to stress","Diseases of metabolism","Abacavir 
transport and metabolism","Generic Transcription Pathway","Neurotransmitter receptors and postsynaptic signal transmission","GPCR ligand binding","Phase 3 - rapid repolarisation","Leishmania infection
","SLC transporter disorders","Cellular Senescence","Diseases of carbohydrate metabolism","Neurotransmitter clearance","Abacavir transmembrane transport","Transcriptional regulation by RUNX3","Class A
/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","DNA Damage/Telomere Stress Induced Senescence","Glycogen sto
rage diseases","Activation of NMDA receptors and postsynaptic events","Serotonin clearance from the synaptic cleft","Defective SLC6A2 causes orthostatic intolerance (OI)","Glutamate binding","activati
on of AMPA receptors and synaptic plasticity","RUNX3 Regulates Immune Response and Cell Migration","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection"
,"Formation of Senescence-Associated Heterochromatin Foci (SAHF)","Glycogen storage disease type II (GAA)","Post NMDA receptor activation events","Trafficking of AMPA receptors","Dopamine receptors","
Serotonin receptors","Histamine receptors",Adrenoceptors,"ADORA2B mediated anti-inflammatory cytokines production","Activation of AMPK downstream of NMDARs","Muscarinic acetylcholine receptors","CREB1
 phosphorylation through NMDA receptor-mediated activation of RAS signaling","Trafficking of GluR2-containing AMPA receptors","Ras activation upon Ca2+ influx through NMDA receptor"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA2A,ADRA2B,ADRA2C,CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,DRD1,DRD2,DRD3,DRD4,DRD5,HRH1,HTR1A,HTR1B,HTR1D,HTR1E,HTR2A,HTR2C,HTR3A,HTR6,HTR7}

> <broad_moa>
{"serotonin receptor agonist","serotonin receptor antagonist"}

> <synonyms>
{RESTW122,Aripiprazole,"7-(4-(-4-(2,3-dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydrocarbostyril","7(4(4(2,3dichlorophenyl)1piperazinyl)butoxy)3,4dihydrocarbostyril","7-(4-(4-(2,3-dichlorophenyl)-1-
piperazinyl)butoxy)-3, 4-dihydrocarbostyril","7(4(4(2,3dichlorophenyl)1piperazinyl)butoxy)3, 4dihydrocarbostyril",1026778-41-5,1026778415,24-29-3,24293,129722-12-9,129722129,Abilify,Abilitat,"Abilify 
Discmelt",OPC-145,OPC145,T1566,S1975,SAM001246750,1505851,Prestw-1229,CPD000466383,ARIPIPRAZOLE}

> <pdid>
PD000697

> <targets>
{"5-HT Receptor"}

> <classes>
{antipsychotic,"5HT2A antagonist","Neuronal Signaling"}

> <pubchem_cids>
{60795}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 31  0  0  1  0            999 V2000
   -1.8114   -5.1333    0.0000 C   0  0
   -2.2130   -3.6880    0.0000 C   0  0
   -3.6655   -3.3136    0.0000 O   0  0
   -1.1612   -2.6174    0.0000 O   0  0
    0.2851   -2.9666    0.0000 C   0  0  2  0  0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    3.8971    3.7500    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -1.2991    2.2500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -0.8141   -2.0807    0.0000 C   0  0
    0.7499   -4.3804    0.0000 C   0  0
   -0.2673   -5.4828    0.0000 C   0  0
    2.2131   -4.7105    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  0
  8  7  1  6
  8  9  1  0
  9 10  1  1
 10 11  2  3
 11 12  1  0
 11 13  1  0
 13 14  2  3
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 13  1  0
 19 20  1  6
 19 21  1  0
 21  9  1  0
 21 22  1  6
 22 23  1  0
 23 24  1  0
 24  5  1  0
 24  8  1  0
 24 25  1  6
  5 26  1  0
 26 27  1  0
 26 28  2  0
M  END
> <name>
NIHCC_2014

> <id>
5753

> <plate>
NGP-105-02

> <well>
E10

> <supplier_cmpd_name>
CPD000058691

> <ctcr_id>
5247

> <supplier_cmpd_id>
SAM001246722

> <smiles>
CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)=O

> <pd_targets>
{POLB,AR,HIF1A,NPSR1,PGR,LMNA,NR3C1,ABCB11,CYP2C9}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Membrane receptor","Other nuclear protein",Transporter,Protease,"Nuclear receptor","Family A G protein-coupled receptor","Primary active transporter","Cytochrome P450",
"Cysteine protease","Nuclear hormone receptor subfamily 3","Peptide receptor (family A GPCR)","ATP-binding cassette","Cytochrome P450 family 2","Cysteine protease CA clan","Nuclear hormone receptor su
bfamily 3 group C","Short peptide receptor (family A GPCR)","ABCB subfamily","Cytochrome P450 family 2C","Cysteine protease C1A family","Nuclear hormone receptor subfamily 3 group C member 4","Neurope
ptide receptor","Nuclear hormone receptor subfamily 3 group C member 3","Nuclear hormone receptor subfamily 3 group C member 1","Cytochrome P450 2C9"}

> <pathway_chembl>
{Receptors,Transporters,Enzymes,"Nuclear hormone receptors","G protein-coupled receptors","ATP-binding cassette transporter family","Cytochrome P450","Steroid hormone receptors","Neuropeptide S recept
or","ABCB subfamily","CYP2 family: drug metabolising subset","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"DNA Repair","Gene expression (Transcription)","Cellular responses to external stimuli",Disease,"Cell Cycle",Metabolism,"Metabolism of proteins","Base Excision Repair","RNA Polymerase II Transcriptio
n","Cellular responses to stress","Infectious disease",Mitotic,"Metabolism of lipids","Biological oxidations","Post-translational protein modification","Resolution of Abasic Sites (AP sites)","Generic
 Transcription Pathway","Cellular response to hypoxia","Leishmania infection","M Phase","Metabolism of steroids","Phase I - Functionalization of compounds",SUMOylation,"Resolution of AP sites via the 
multiple-nucleotide patch replacement pathway","Transcriptional regulation by RUNX2","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Leishmania parasite growth and survival
","Mitotic Metaphase and Anaphase","FOXO-mediated transcription","Bile acid and bile salt metabolism","Cytochrome P450 - arranged by substrate type","SUMO E3 ligases SUMOylate target proteins","PCNA-D
ependent Long Patch Base Excision Repair","RUNX2 regulates bone development","Anti-inflammatory response favouring Leishmania parasite infection","Mitotic Anaphase","FOXO-mediated transcription of oxi
dative stress","metabolic and neuronal genes","Synthesis of bile acids and bile salts",Xenobiotics,"SUMOylation of intracellular receptors","RUNX2 regulates osteoblast differentiation","ADORA2B mediat
ed anti-inflammatory cytokines production","Nuclear Envelope (NE) Reassembly","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","CYP2E1 reactions","Initiation of Nuclear Envelope 
(NE) Reformation"}

> <broad_targets>
{NR3C1,PGR}

> <broad_moa>
{"progesterone receptor agonist"}

> <synonyms>
{"MEGESTROL ACETATE",595-33-5,595335,Megace,"Megace ES",Magestin,Niagestin,"Megestryl acetate",Megeron,Megestat,Ovaban,Ovarid,Maygace,Pallace,"BDH 1298","SC 10363",Megestrol-17-acetate,Megestrol17acet
ate,NSC-71423,NSC71423,Volidan,SC10363,UNII-TJ2M0FR8ES,UNIITJ2M0FR8ES,17alpha-Hydroxy-6-methylpregn,17alphaHydroxy6methylpregn,T1284,71423,S1304,SAM001246722,Prestw-956,"NSC 71423","Megestrol acetate"
,"Megestrol Acetate",CPD000058691}

> <pdid>
PD001872

> <targets>
{"Androgen Receptor"}

> <classes>
{"synthetic progestin","Endocrinology & Hormones"}

> <pubchem_cids>
{11683}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 18  0  0  0  0            999 V2000
   10.1894   -2.2554    0.0000 H   0  3
    7.6894   -2.2554    0.0000 Cl  0  5
    5.1887   -6.0105    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    2.5909   -6.0056    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 N   0  0
   -3.8990    0.7455    0.0000 S   0  0
   -3.8964   -0.7545    0.0000 C   0  0
   -5.1996    1.4928    0.0000 O   0  0
   -5.1966   -0.0070    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 15 18  2  0
 13 19  1  0
 19 20  2  0
 20 10  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5754

> <plate>
NGP-105-02

> <well>
E11

> <supplier_cmpd_name>
CPD000326828

> <ctcr_id>
6494

> <supplier_cmpd_id>
SAM001246725

> <smiles>
[H+].[Cl-].CC(C)NCC(O)c1ccc(N[S](C)(=O)=O)cc1

> <pd_targets>
{BLM,GLA,ADRB1,ADRB2,ADRB3,LMNA,KCNH2}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Other nuclear protein","Ion channel",Hydrolase,"Family A G protein-coupled receptor","Voltage-gated ion channel","Small molecule receptor (family A GPCR)","Potassium chann
els","Monoamine receptor","Voltage-gated potassium channel","Adrenergic receptor"}

> <pathway_chembl>
{Receptors,"Ion channels","G protein-coupled receptors","Voltage-gated ion channels",Adrenoceptors,"Potassium channels","Voltage-gated potassium channels"}

> <pathway_reactome>
{"DNA Repair",Metabolism,"Cell Cycle",Disease,"Muscle contraction","DNA Double-Strand Break Repair","Metabolism of lipids",Mitotic,"Infectious disease","Cardiac conduction","Homology Directed Repair",
"Sphingolipid metabolism","M Phase","Leishmania infection","Phase 3 - rapid repolarisation","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Glycosphingolipid metabolism"
,"Mitotic Metaphase and Anaphase","Leishmania parasite growth and survival","HDR through Homologous Recombination (HRR)","Mitotic Anaphase","Anti-inflammatory response favouring Leishmania parasite in
fection","Homologous DNA Pairing and Strand Exchange","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Presynaptic phase of homologous DNA pairing and stra
nd exchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ADRB1,ADRB2,KCNH2}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{MCULE-8589076631,MCULE8589076631,"Sotalol hydrochloride",959-24-0,959240,"Sotalol HCL",Betapace,"Betapace AF",Sotalex,Sotacor,"Sotalol (hydrochloride)","MJ 1999","Mead johnson 1999",Sorine,"(+/-)-Sot
alol hydrochloride","(+/)Sotalol hydrochloride","Betapace (TN)","Sotalol (Betapace)",S2509,SAM001246725,Prestw-966,Sotalol,CPD000326828}

> <pdid>
PD009998

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{45371387,66245,67108155}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 21  0  0  0  0            999 V2000
   -0.5529  -10.3163    0.0000 C   0  0
    0.0576   -8.9462    0.0000 N   0  0
    1.5502   -8.7888    0.0000 C   0  0
    2.1626   -7.4186    0.0000 N   0  0
    1.2830   -6.2026    0.0000 C   0  0
    1.8954   -4.8324    0.0000 C   0  0
    1.0157   -3.6164    0.0000 S   0  0
    1.6281   -2.2462    0.0000 C   0  0
    0.7500   -1.0323    0.0000 C   0  0
    1.2135    0.3943    0.0000 C   0  0
    0.0000    1.2760    0.0000 S   0  0
   -1.2135    0.3943    0.0000 C   0  0
   -2.6394    0.8543    0.0000 C   0  0
   -3.7533   -0.1515    0.0000 N   0  0
   -5.1808    0.3090    0.0000 C   0  0
   -3.4388   -1.6182    0.0000 C   0  0
   -0.7500   -1.0323    0.0000 N   0  0
    2.4298  -10.0049    0.0000 C   0  0
    1.8174  -11.3750    0.0000 N   0  3
    0.3254  -11.5292    0.0000 O   0  5
    2.6966  -12.5904    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 12 17  2  0
 17  9  1  0
  3 18  2  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
M  CHG  2  19   1  20  -1
M  END
> <name>
NIHCC_2014

> <id>
5755

> <plate>
NGP-105-02

> <well>
F02

> <supplier_cmpd_name>
CPD000466384

> <ctcr_id>
6396

> <supplier_cmpd_id>
SAM001246752

> <smiles>
CNC(/NCCSCc1csc(CN(C)C)n1)=C\[N+]([O-])=O

> <pd_targets>
{ACHE,HRH2}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor",Hydrolase,"Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Histamine receptor"}

> <pathway_chembl>
{Enzymes,Receptors,"Acetylcholine turnover","G protein-coupled receptors","Histamine receptors"}

> <pathway_reactome>
{Metabolism,Disease,"Metabolism of lipids","Infectious disease","Phospholipid metabolism","Leishmania infection","Glycerophospholipid biosynthesis","Leishmania parasite growth and survival","Synthesis
 of PC","Anti-inflammatory response favouring Leishmania parasite infection","ADORA2B mediated anti-inflammatory cytokines production"}

> <broad_targets>
{HRH2}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{nizatidine,76963-41-2,76963412,Axid,Acinon,Zanizal,Nizax,LY-139037,LY139037,Niaztidine,Nizatidinum,Nizatidina,Nizatidine-d3,Nizatidined3,ZE-101,ZE101,ZL-101,ZL101,SMR000466384,"Acinon (TN)","Axid (TN
)",CHEBI:7601,MFCD00865660,NCGC00016934-01,NCGC0001693401,CAS-76963-41-2,CAS76963412,Prestwick2_000921,Prestwick2000921,Prestwick2-000921,"Prestwick2 000921",SCHEMBL769,SAM001246752,1505985,CPD0004663
84,NIZATIDINE}

> <pdid>
PD003067

> <targets>
{}

> <classes>
{"H2 antagonist",antiulcer}

> <pubchem_cids>
{3033637}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 29  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -2.5981    3.0007    0.0000 N   0  0
   -1.3003    3.7529    0.0000 C   0  0
   -1.3026    5.2529    0.0000 C   0  0
   -2.6029    6.0009    0.0000 N   0  0
   -2.6053    7.5009    0.0000 C   0  0
   -3.9007    5.2488    0.0000 C   0  0
   -3.8983    3.7488    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 F   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -3.8971   -3.7500    0.0000 O   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -1.2959   -5.2508    0.0000 C   0  0
   -2.5936   -6.0031    0.0000 O   0  0
    0.0042   -5.9990    0.0000 O   0  0
  2  1  1  6
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 13  7  1  0
  6 14  1  0
 14 15  1  0
 14 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  2  3
 21 22  1  0
 22  2  1  0
 22 23  1  0
 23  5  1  0
 23 17  2  0
 20 24  1  0
 24 25  1  0
 24 26  2  0
M  END
> <name>
NIHCC_2014

> <id>
5756

> <plate>
NGP-105-02

> <well>
F03

> <supplier_cmpd_name>
CPD000466387

> <ctcr_id>
3987

> <supplier_cmpd_id>
SAM001246758

> <smiles>
C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc4C(=O)C(=CN1c24)C(O)=O

> <pd_targets>
{GYRA,POLB,SKA,KDM4E,RCE1,SLC47A1,PARC,PARE,GYRB,HSD17B10,ALDH1A1,HPGD,ALB,STE24,GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG3,GABRP,GABRQ,TOP2A,CHRM1
}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator",Transporter,Isomerase,Kinase,Eraser,Protease,"Electrochemical transporter","Lysine demethylase","Metallo protease","SLC superfamily of solute carriers","Jumonji domain-c
ontaining","Metallo protease unclassified clan","SLC47 family of multidrug and toxin extrusion transporters","Metallo protease M79 family","Secreted protein","Ion channel",Oxidoreductase,"Ligand-gated
 ion channel","GABA-A receptor","Serine protease","Metallo protease MAE clan","Serine protease PA clan","Metallo protease M48A subfamily","Serine protease S1A subfamily","Membrane receptor","Family A 
G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Acetylcholine receptor"}

> <pathway_chembl>
{Enzymes,Transporters,"Chromatin modifying enzymes","Peptidases and proteinases","SLC superfamily of solute carriers","1.14.11.- Histone demethylases","M-: Metallo (M) Peptidases","SLC47 family of mul
tidrug and toxin extrusion transporters","M79: Prenyl protease 2","Eicosanoid turnover","DNA topoisomerases","Prostaglandin synthases",Receptors,"G protein-coupled receptors","Acetylcholine receptors 
(muscarinic)"}

> <pathway_reactome>
{"DNA Repair","Signal Transduction","Transport of small molecules","Base Excision Repair","MAPK family signaling cascades","SLC-mediated transmembrane transport","Resolution of Abasic Sites (AP sites)
","MAPK1/MAPK3 signaling","Transport of bile salts and organic acids","metal ions and amine compounds","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","RAF/MAP kinase ca
scade","PCNA-Dependent Long Patch Base Excision Repair","RAS processing",Metabolism,"Cell Cycle","Metabolism of amino acids and derivatives","Biological oxidations","Metabolism of lipids",Mitotic,"Bra
nched-chain amino acid catabolism","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","Metabolism of steroids","Mitotic G1 phase and G1/S transition
","Ethanol oxidation","Biosynthesis of DHA-derived SPMs","Bile acid and bile salt metabolism","G0 and Early G1","Biosynthesis of D-series resolvins","Recycling of bile acids and salts","Transcription 
of E2F targets under negative control by DREAM complex","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Amine ligand-binding receptors","Muscarinic acetylcholine rece
ptors"}

> <broad_targets>
{}

> <broad_moa>
{"bacterial DNA gyrase inhibitor"}

> <synonyms>
{S-(-)-Ofloxacin,S()Ofloxacin,"CCRIS 4074",LEVOFLOXACIN,100986-85-4,100986854,Levaquin,Quixin,Iquix,Cravit,(-)-Ofloxacin,()Ofloxacin,"Ofloxacin S-(-)-form","Ofloxacin S()form",Levofloxacine,(S)-Ofloxa
cin,(S)Ofloxacin,Tavanic,Levofloxacino,Levofloxacinum,Oftaquix,L-Ofloxacin,LOfloxacin,Floxacin,DR-3355,DR3355,"Levofloxacin hydra",T0902,T1451,SAM001246758,1504260,Ofloxacin,"Levofloxacin Hemihydrate"
,CPD000466387}

> <pdid>
PD001207

> <targets>
{}

> <classes>
{antibacterial}

> <pubchem_cids>
{149096,6956357}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 25  0  0  0  0            999 V2000
    8.8813   -0.2065    0.0000 H   0  3
    6.3813   -0.2065    0.0000 Cl  0  5
    3.8805   -1.4410    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5973    1.5031    0.0000 C   0  0
   -2.5951    3.0039    0.0000 N   0  0
   -1.3786    3.8595    0.0000 C   0  0
   -1.8372    5.2877    0.0000 C   0  0
   -3.3372    5.2929    0.0000 N   0  0
   -3.8056    3.8679    0.0000 C   0  0
   -5.2311    3.4009    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
   -0.5701   -4.1788    0.0000 C   0  0
    0.0400   -5.5491    0.0000 C   0  0
    1.5318   -5.7059    0.0000 C   0  0
    2.4135   -4.4923    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 10  1  0
 14 15  1  0
  8 16  1  0
 16 17  2  0
 16 18  1  0
 18  5  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24  4  1  0
 24 19  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5757

> <plate>
NGP-105-02

> <well>
F04

> <supplier_cmpd_name>
CPD000469179

> <ctcr_id>
6325

> <supplier_cmpd_id>
SAM001246631

> <smiles>
[H+].[Cl-].Cn1c2CCC(Cn3ccnc3C)C(=O)c2c4ccccc14

> <pd_targets>
{HTR3A,HTR3B,HTR2C,HTR4,CCKBR,KCNH2,HTR3C,HTR3D,HTR3E,OPRM1,CHRNA7,HTR1D,HTR2A,HTR2B,CHRM1,SIGMAR1,CHRNA4,CHRNB2,CYP3A4,GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG
1,GABRG2,GABRG3,GABRP,GABRQ,HTR1B,CHRNA3,CHRNB4,SLC47A2,SLC22A1,SLC22A2,SLC47A1,SLC22A3,HTR1A}

> <pathway_gtopdb>
{"Ion channel","Membrane receptor",Enzyme,Transporter,"Ligand-gated ion channel","Family A G protein-coupled receptor","Voltage-gated ion channel","Cytochrome P450","Electrochemical transporter","5HT3
 receptor","Small molecule receptor (family A GPCR)","Peptide receptor (family A GPCR)","Potassium channels","Nicotinic acetylcholine receptor","Cytochrome P450 family 3","GABA-A receptor","SLC superf
amily of solute carriers","Monoamine receptor","Short peptide receptor (family A GPCR)","Voltage-gated potassium channel","Nicotinic acetylcholine receptor alpha subunit","Cytochrome P450 family 3A","
SLC47 family of multidrug and toxin extrusion transporters","SLC22 family of organic cation and anion transporters","Serotonin receptor","Cholecystokinin receptor","Opioid receptor","Acetylcholine rec
eptor","Cytochrome P450 3A4"}

> <pathway_chembl>
{"Ion channels",Receptors,"Other protein targets",Enzymes,Transporters,"Ligand-gated ion channels","G protein-coupled receptors","Voltage-gated ion channels","Sigma receptors","Cytochrome P450","SLC s
uperfamily of solute carriers","5-HT<sub>3</sub> receptors","5-Hydroxytryptamine receptors","Cholecystokinin receptors","Potassium channels","Opioid receptors","Nicotinic acetylcholine receptors","Ace
tylcholine receptors (muscarinic)","CYP3 family","SLC47 family of multidrug and toxin extrusion transporters","SLC22 family of organic cation and anion transporters","Voltage-gated potassium channels"
,"Organic cation transporters (OCT)"}

> <pathway_reactome>
{"Neuronal System","Signal Transduction",Disease,"Muscle contraction",Metabolism,"Transport of small molecules","Transmission across Chemical Synapses","Signaling by GPCR","Infectious disease","Cardia
c conduction","Metabolism of lipids","SLC-mediated transmembrane transport","Neurotransmitter receptors and postsynaptic signal transmission","GPCR ligand binding","Leishmania infection","GPCR downstr
eam signalling","Phase 3 - rapid repolarisation","SARS-CoV Infections","Biosynthesis of specialized proresolving mediators (SPMs)","Transport of bile salts and organic acids","metal ions and amine com
pounds","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","G alpha (q) signalling events","G alpha (i) signalling events","Acetylcholine binding and downstream events","
Potential therapeutics for SARS","Biosynthesis of DHA-derived SPMs","Organic cation/anion/zwitterion transport","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasi
te infection","Gastrin-CREB signalling pathway via PKC and MAPK","Opioid Signalling","Postsynaptic nicotinic acetylcholine receptors","Biosynthesis of maresins","Organic cation transport","Serotonin r
eceptors","ADORA2B mediated anti-inflammatory cytokines production","G-protein activation","Highly calcium permeable postsynaptic nicotinic acetylcholine receptors","Muscarinic acetylcholine receptors
","Biosynthesis of maresin-like SPMs"}

> <broad_targets>
{HTR3A,HTR3B}

> <broad_moa>
{"serotonin receptor antagonist"}

> <synonyms>
{MCULE-4423935922,MCULE4423935922,"MCULE 4423935922",FT-0659335,FT0659335,"FT 0659335","ONDANSETRON HYDROCHLORIDE","ONDANSETRON HCl",99614-01-4,99614014,"99614 01 4",Zofran,Zophren,"Ondansetron (Hydro
chloride)","SN 307","Ondansetron hydrochloride hyd",S1390,SAM001246631,Prestw-1058,"Ondansetron HCl",CPD000469179,"Ondansetron Hydrochloride"}

> <pdid>
PD002938

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{44661392,66766733,68647}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 26  0  0  0  0            999 V2000
    9.5862   -3.2909    0.0000 C   0  0
    8.1609   -2.8234    0.0000 C   0  0
    7.8525   -1.3573    0.0000 N   0  0
    8.8523   -0.2390    0.0000 C   0  0
    8.0978    1.0574    0.0000 C   0  0
    6.6317    0.7404    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    3.8990   -0.7455    0.0000 N   0  0
    2.6003   -1.4977    0.0000 C   0  0
    2.6030   -2.9977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3032   -3.7490    0.0000 C   0  0
    0.0000    3.0008    0.0000 S   0  0
   -1.2993    3.7504    0.0000 O   0  0
   -0.0007    4.5008    0.0000 O   0  0
    1.2993    3.7521    0.0000 C   0  0
    1.2992    5.2521    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  3  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 12  1  0
 18 19  1  0
 19 20  1  0
 14 21  1  0
 21 22  2  0
 21 23  2  0
 21 24  1  0
 24 25  1  0
M  END
> <name>
NIHCC_2014

> <id>
5758

> <plate>
NGP-105-02

> <well>
F05

> <supplier_cmpd_name>
CPD000449309

> <ctcr_id>
2986

> <supplier_cmpd_id>
SAM001246639

> <smiles>
CCN1CCCC1CNC(=O)c2cc(c(N)cc2OC)[S](=O)(=O)CC

> <pd_targets>
{TSHR,ALOX15,FFP,LMNA,DRD2,MAPK1,DRD3,ADRA2A,ADRA2B,ADRA2C,HTR2A,HTR2B,HTR7,HTR1A,HTR1B,HTR1D,HTR1E,HTR1F,HTR2C,HTR3A,HTR3B,HTR3C,HTR3D,HTR3E,HTR4,HTR5A,HTR6}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Other nuclear protein","Family A G protein-coupled receptor",Oxidoreductase,Transferase,Kinase,"Peptide receptor (family A GPCR)","Small molecule receptor (family A GPCR)"
,"Protein Kinase","Glycohormone receptor","Monoamine receptor","CMGC protein kinase group","Dopamine receptor","CMGC protein kinase MAPK family","Adrenergic receptor","Serotonin receptor","CMGC protei
n kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Eicosanoid turnover","Kinases (EC 2.7.x.x)","Glycoprotein hormone receptors",Lipoxygenases,"Dopamine receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK 
families","5-Hydroxytryptamine receptors","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{Disease,Metabolism,"Cell Cycle","Signal Transduction","Immune System","Infectious disease","Metabolism of lipids",Mitotic,"Signaling by GPCR","Innate Immune System","Leishmania infection","Biosynthes
is of specialized proresolving mediators (SPMs)","M Phase","GPCR ligand binding","Toll-like Receptor Cascades","Leishmania parasite growth and survival","Biosynthesis of DPA-derived SPMs","Mitotic Met
aphase and Anaphase","Class A/1 (Rhodopsin-like receptors)","Toll Like Receptor 5 (TLR5) Cascade","Anti-inflammatory response favouring Leishmania parasite infection","Biosynthesis of DPAn-3 SPMs","Mi
totic Anaphase","Amine ligand-binding receptors","MyD88 cascade initiated on plasma membrane","ADORA2B mediated anti-inflammatory cytokines production","Biosynthesis of DPAn-3-derived protectins and r
esolvins","Nuclear Envelope (NE) Reassembly","Dopamine receptors","MAP kinase activation","Serotonin receptors","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated
 by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{DRD2}

> <broad_moa>
{"dopamine receptor antagonist"}

> <synonyms>
{amisulpride,71675-85-9,71675859,Solian,Aminosultopride,Deniban,Amisulprida,"DAN 2163",Amisulpridum,DAN-2163,DAN2163,C17H27N3O4S,"Amisulpride free base",APD421,4-Amino-N-((1-ethyl-2-pyrrolidinyl)methy
l)-5-(ethylsulfonyl)-o-anisamide,4AminoN((1ethyl2pyrrolidinyl)methyl)5(ethylsulfonyl)oanisamide,CHEBI:64045,"71675-85-9 (fr","71675859 (fr",T0811,S1280,SAM001246639,Prestw-1217,Amisulpride,CPD00044930
9}

> <pdid>
PD001316

> <targets>
{Dopamine Receptor}

> <classes>
{Neuronal Signaling,GPCR/G Protein}

> <pubchem_cids>
{2159}

$$$$
NIHCC_2014
  SciTegic11012413002D

 33 36  0  0  0  0            999 V2000
   -2.5894   -3.9005    0.0000 C   0  0
   -1.1671   -4.3770    0.0000 C   0  0
   -0.0420   -3.3837    0.0000 C   0  0
    1.3786   -3.8595    0.0000 C   0  0
    1.8372   -5.2877    0.0000 N   0  0
    3.3372   -5.2929    0.0000 C   0  0
    3.8056   -3.8679    0.0000 C   0  0
    2.5951   -3.0039    0.0000 N   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5987    1.5004    0.0000 C   0  0
   -3.8967    0.7484    0.0000 C   0  0
   -5.1969    1.4963    0.0000 C   0  0
   -5.1993    2.9963    0.0000 C   0  0
   -3.9014    3.7484    0.0000 C   0  0
   -2.6012    3.0004    0.0000 C   0  0
   -1.3027    3.7529    0.0000 C   0  0
    0.0506    3.1362    0.0000 N   0  0
    1.0508    4.2541    0.0000 N   0  0
    0.2966    5.5507    0.0000 N   0  0
   -1.1696    5.2342    0.0000 N   0  0
    5.2276   -3.3960    0.0000 C   0  0
    6.3483   -4.3930    0.0000 O   0  0
    5.5311   -1.9271    0.0000 O   0  0
    4.2136   -6.5081    0.0000 C   0  0
    5.7059   -6.3560    0.0000 C   0  0
    5.0916   -7.7242    0.0000 C   0  0
    3.5996   -7.8766    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  4  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 13 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 22  2  0
  7 27  1  0
 27 28  1  0
 27 29  2  0
  6 30  1  0
 30 31  1  0
 30 32  1  0
 30 33  1  0
M  END
> <name>
NIHCC_2014

> <id>
5759

> <plate>
NGP-105-02

> <well>
F06

> <supplier_cmpd_name>
CPD000466337

> <ctcr_id>
4395

> <supplier_cmpd_id>
SAM001246634

> <smiles>
CCCc1nc(c(n1Cc2ccc(cc2)c3ccccc3c4[nH]nnn4)C(O)=O)C(C)(C)O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{Olmesartan,144689-24-7,144689247,"Olmesartan Acid",RNH-6270,RNH6270,"RNH 6270",UNII-8W1IQP3U10,UNII8W1IQP3U10,CS-088,CS088,CHEMBL1516,8W1IQP3U10,CHEBI:48416,MFCD00914967,"Olmesartan-d6 Acid","Olmesar
tand6 Acid",Votum,omesartan,"Olme sartan",SMR000466337,"Olmesartan (USAN:INN:BAN)",Benicar;O,SAM001246634,CPD000466337}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{158781}

$$$$
NIHCC_2014
  SciTegic11012413002D

 49 55  0  0  0  0            999 V2000
    8.8145   -2.9122    0.0000 C   0  0
    7.3222   -3.0635    0.0000 C   0  0
    6.4437   -1.8466    0.0000 C   0  0
    7.0583   -0.4784    0.0000 C   0  0
    4.9531   -1.9978    0.0000 N   0  0
    4.2010   -3.2956    0.0000 N   0  0
    2.7343   -2.9815    0.0000 C   0  0
    2.5987   -1.5004    0.0000 N   0  0
    3.9511   -0.8815    0.0000 C   0  0
    4.2566    0.5871    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5987    1.5004    0.0000 N   0  0
   -2.6012    3.0004    0.0000 C   0  0
   -3.9015    3.7484    0.0000 C   0  0
   -5.1993    2.9963    0.0000 N   0  0
   -5.1969    1.4963    0.0000 C   0  0
   -3.8967    0.7484    0.0000 C   0  0
   -6.5002    3.7446    0.0000 C   0  0
   -6.5050    5.2446    0.0000 C   0  0
   -7.8065    5.9905    0.0000 C   0  0
   -9.1031    5.2364    0.0000 C   0  0
  -10.4068    5.9800    0.0000 O   0  0
  -11.7031    5.2236    0.0000 C   0  0
  -13.0067    5.9672    0.0000 C   0  0
  -14.3561    5.3419    0.0000 C   0  0
  -15.3634    6.4534    0.0000 O   0  0
  -14.6175    7.7548    0.0000 C   0  0
  -16.0996    7.8819    0.0000 C   0  0
  -16.9783    6.6652    0.0000 N   0  0
  -18.4648    6.6588    0.0000 C   0  0
  -18.9050    5.2249    0.0000 N   0  0
  -17.6773    4.3631    0.0000 C   0  0
  -16.4783    5.2644    0.0000 N   0  0
  -13.1493    7.4476    0.0000 O   0  0
  -13.7278    8.9473    0.0000 C   0  0
  -12.2381    8.7717    0.0000 C   0  0
  -11.3411    9.9739    0.0000 C   0  0
  -11.9338   11.3519    0.0000 C   0  0
  -11.0369   12.5541    0.0000 Cl  0  0
  -13.4235   11.5275    0.0000 C   0  0
  -14.3205   10.3253    0.0000 C   0  0
  -15.8102   10.5009    0.0000 Cl  0  0
   -9.0983    3.7364    0.0000 C   0  0
   -7.7969    2.9905    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  6  7  2  3
  7  8  1  0
  8  9  1  0
  9  5  1  0
  9 10  2  0
  8 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 14 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 17  1  0
 20 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  2  0
 38 34  1  0
 32 39  1  0
 39 29  1  0
 32 40  1  0
 40 41  2  0
 41 42  1  0
 42 43  2  0
 43 44  1  0
 43 45  1  0
 45 46  2  0
 46 40  1  0
 46 47  1  0
 26 48  1  0
 48 49  2  0
 49 23  1  0
M  END
> <name>
NIHCC_2014

> <id>
5760

> <plate>
NGP-105-02

> <well>
F07

> <supplier_cmpd_name>
CPD000058959

> <ctcr_id>
6413

> <supplier_cmpd_id>
SAM001246679

> <smiles>
CCC(C)N1N=CN(C1=O)c2ccc(cc2)N3CCN(CC3)c4ccc(OCC5COC(Cn6cncn6)(O5)c7ccc(Cl)cc7Cl)cc4

> <pd_targets>
{MAPK1,LMNA,MAPT,CYP3A4,CYP8B1,HIF1A,ABCB1,KMT2A,MEN1,CYP51B,ABCB11,AVPR2,ABCB1A,ABCB1B,CCR4,CXCR1,FYN,CYP51A1,ERG11}

> <pathway_gtopdb>
{Enzyme,"Other nuclear protein","Other cytosolic protein","Transcription factor",Transporter,"Epigenetic regulator","Membrane receptor",Kinase,"Cytochrome P450",Oxidoreductase,"Primary active transpor
ter",Protease,Reader,"Family A G protein-coupled receptor","Protein Kinase","Cytochrome P450 family 3","ATP-binding cassette","Cysteine protease",Bromodomain,"Cytochrome P450 family 51","Peptide recep
tor (family A GPCR)","CMGC protein kinase group","Cytochrome P450 family 3A","ABCB subfamily","Cysteine protease CA clan","Cytochrome P450 family 51A","Short peptide receptor (family A GPCR)","Chemoki
ne receptor","TK protein kinase group","CMGC protein kinase MAPK family","Cytochrome P450 3A4","Cysteine protease C1A family","Cytochrome P450 51A1","Vasopressin and oxytocin receptor","CC chemokine r
eceptor","CXC chemokine receptor","Tyrosine protein kinase Src family","CMGC protein kinase ERK1","Tyrosine protein kinase SrcA"}

> <pathway_chembl>
{Enzymes,Transporters,Receptors,"Kinases (EC 2.7.x.x)","Cytochrome P450","ATP-binding cassette transporter family","G protein-coupled receptors","Catalytic receptors","CMGC: Containing CDK",MAPK,GSK3,
"CLK families","CYP3 family",CYP5,"CYP7 and CYP8 families","ABCB subfamily","Vasopressin and oxytocin receptors","Chemokine receptors","Receptor kinases",CYP39,"CYP46 and CYP51 families","Mitogen-acti
vated protein kinases (MAP kinases)","TK: Tyrosine kinase","ERK subfamily","Non-receptor tyrosine kinases (nRTKs)","Src family"}

> <pathway_reactome>
{"Immune System","Cell Cycle","Neuronal System",Metabolism,"Cellular responses to external stimuli",Disease,"Signal Transduction","Innate Immune System",Mitotic,"Transmission across Chemical Synapses"
,"Metabolism of lipids","Biological oxidations","Cellular responses to stress","Abacavir transport and metabolism","Infectious disease","Signaling by GPCR","Toll-like Receptor Cascades","M Phase","Neu
rotransmitter receptors and postsynaptic signal transmission","Biosynthesis of specialized proresolving mediators (SPMs)","Phase I - Functionalization of compounds","Cellular response to hypoxia","Aba
cavir transmembrane transport","Metabolism of steroids","Leishmania infection","GPCR ligand binding","HIV Infection","Toll Like Receptor 5 (TLR5) Cascade","Mitotic Metaphase and Anaphase","Activation 
of NMDA receptors and postsynaptic events","Biosynthesis of DHA-derived SPMs","Cytochrome P450 - arranged by substrate type","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha",
"Bile acid and bile salt metabolism","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Host Interactions of HIV factors","MyD88 cascade initiated on plasma membrane","M
itotic Anaphase","Post NMDA receptor activation events","Biosynthesis of maresins","Endogenous sterols","Synthesis of bile acids and bile salts","Anti-inflammatory response favouring Leishmania parasi
te infection","Peptide ligand-binding receptors","The role of Nef in HIV-1 replication and disease pathogenesis","MAP kinase activation","Nuclear Envelope (NE) Reassembly","Activation of AMPK downstre
am of NMDARs","Biosynthesis of maresin-like SPMs","Sterols are 12-hydroxylated by CYP8B1","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","ADORA2B mediated anti-inflammatory cyt
okines production","Chemokine receptors bind chemokines","Nef and signal transduction","MAPK targets/ Nuclear events mediated by MAP kinases","Initiation of Nuclear Envelope (NE) Reformation","ERK/MAP
K targets","ERKs are inactivated"}

> <broad_targets>
{}

> <broad_moa>
{"cytochrome P450 inhibitor"}

> <synonyms>
{itraconazole,84625-61-6,84625616,Sporanox,"Itraconazolum (Latin)",ITRAZOLE,Itraconazol,MLS000863291,SMR000058959,"R 51211",R-51211,R51211,1217512-35-0,1217512350,"Itraconazole Impurity E",SR-01000003
153,SR01000003153,252964-65-1,252964651,Itraconzaole,Itraconazole-d3,Itraconazoled3,Itraconazole-d5,Itraconazoled5,t,T1011,I6657,SAM001246679,Prestw-1139,S2476,Itraconazole,CPD000058959}

> <pdid>
PD002960

> <targets>
{Others}

> <classes>
{Others}

> <pubchem_cids>
{3793}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 33  0  0  1  0            999 V2000
    8.2751   -4.8006    0.0000 O   0  0
    6.9736   -5.5462    0.0000 C   0  0  1  0  0  0
    5.6766   -4.7910    0.0000 C   0  0
    5.6812   -3.2902    0.0000 C   0  0
    4.3895   -2.5380    0.0000 C   0  0  2  0  0  0
    4.0035   -1.0885    0.0000 C   0  0  2  0  0  0
    2.5987   -1.5004    0.0000 N   0  0
    2.9400   -2.9240    0.0000 C   0  0
    2.1718   -4.2123    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 F   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    4.7397    0.2193    0.0000 C   0  0
    4.2416    1.6213    0.0000 C   0  0
    5.2155    2.7621    0.0000 C   0  0
    6.6905    2.4891    0.0000 C   0  0
    7.6644    3.6300    0.0000 O   0  0
    7.1915    1.0753    0.0000 C   0  0
    6.2177   -0.0656    0.0000 C   0  0
    6.9690   -7.0470    0.0000 C   0  0
    5.6687   -7.7950    0.0000 C   0  0
    5.6662   -9.2949    0.0000 C   0  0
    6.9639  -10.0471    0.0000 C   0  0
    6.9614  -11.5471    0.0000 F   0  0
    8.2642   -9.2993    0.0000 C   0  0
    8.2668   -7.7993    0.0000 C   0  0
  2  1  1  6
  2  3  1  0
  3  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  5  1  0
  8  9  2  0
  7 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 16 10  1  0
  6 17  1  6
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 20 22  1  0
 22 23  2  0
 23 17  1  0
  2 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 27 29  1  0
 29 30  2  0
 30 24  1  0
M  END
> <name>
NIHCC_2014

> <id>
5761

> <plate>
NGP-105-02

> <well>
F08

> <supplier_cmpd_name>
CPD000466334

> <ctcr_id>
4942

> <supplier_cmpd_id>
SAM001246623

> <smiles>
O[C@@H](CC[C@@H]1[C@H](N(C1=O)c2ccc(F)cc2)c3ccc(O)cc3)c4ccc(F)cc4

> <pd_targets>
{NPSR1,RORC,NPC1L1,ABCB11,SOAT1,ANPEP,LMNA,CYP3A4}

> <pathway_gtopdb>
{"Membrane receptor","Transcription factor","Other membrane protein",Transporter,Enzyme,"Other nuclear protein","Family A G protein-coupled receptor","Nuclear receptor","Primary active transporter",Tr
ansferase,Protease,"Cytochrome P450","Peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1","ATP-binding cassette","Metallo protease","Cytochrome P450 family 3","Short peptide recep
tor (family A GPCR)","Nuclear hormone receptor subfamily 1 group F","ABCB subfamily","Metallo protease MAE clan","Cytochrome P450 family 3A","Neuropeptide receptor","Nuclear hormone receptor subfamily
 1 group F member 3","Metallo protease M1 family","Cytochrome P450 3A4"}

> <pathway_chembl>
{Receptors,Transporters,Enzymes,"G protein-coupled receptors","Nuclear hormone receptors","SLC superfamily of solute carriers","ATP-binding cassette transporter family","Peptidases and proteinases","C
ytochrome P450","Neuropeptide S receptor","1F. Retinoic acid-related orphans","SLC65 NPC-type cholesterol transporters","ABCB subfamily","MA: Metallo (M) Peptidases","CYP3 family","M1: Aminopeptidase 
N"}

> <pathway_reactome>
{Disease,"Gene expression (Transcription)","Digestion and absorption",Metabolism,"Transport of small molecules","Immune System","Cell Cycle","Infectious disease","RNA Polymerase II Transcription","Int
estinal absorption","Metabolism of lipids","Plasma lipoprotein assembly",remodeling,"and clearance","Innate Immune System",Mitotic,"Leishmania infection","Generic Transcription Pathway","Intestinal li
pid absorption","Metabolism of steroids","Plasma lipoprotein clearance","Neutrophil degranulation","M Phase","Biosynthesis of specialized proresolving mediators (SPMs)","Leishmania parasite growth and
 survival","Transcriptional regulation by RUNX3","Bile acid and bile salt metabolism","LDL clearance","Mitotic Metaphase and Anaphase","Biosynthesis of DHA-derived SPMs","Anti-inflammatory response fa
vouring Leishmania parasite infection","RUNX3 Regulates Immune Response and Cell Migration","Synthesis of bile acids and bile salts","Mitotic Anaphase","Biosynthesis of maresins","ADORA2B mediated ant
i-inflammatory cytokines production","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Nuclear Envelope (NE) Reassembly","Biosynthesis of maresin-like SPMs","Initiation of Nuclea
r Envelope (NE) Reformation"}

> <broad_targets>
{ANPEP,NPC1L1,SOAT1}

> <broad_moa>
{"cholesterol inhibitor","Niemann-Pick C1-like 1 protein antagonist"}

> <synonyms>
{Ezetimibe,163222-33-1,163222331,Zetia,Ezetrol,Ezedoc,"Sch 58235",SCH-58235,SCH58235,UNII-EOR26LQQ24,UNIIEOR26LQQ24,"Ezetimibe (Zetia)",EOR26LQQ24,CHEBI:49040,DSSTox_CID_24223,DSSToxCID24223,DSSTox-CI
D-24223,"DSSTox CID 24223",DSSTox_RID_80127,DSSToxRID80127,DSSTox-RID-80127,"DSSTox RID 80127",DSSTox_GSID_44223,DSSToxGSID44223,DSSTox-GSID-44223,"DSSTox GSID 44223",Zient,"(-)-Sch 58235","()Sch 5823
5",SMR000466334,CAS-163222-33-1,CAS163222331,SAM001246623,CPD000466334}

> <pdid>
PD000569

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{150311}

$$$$
NIHCC_2014
  SciTegic11012413002D

 36 36  0  0  0  0            999 V2000
    2.5866   -7.5059    0.0000 C   0  0
    2.5902   -6.0059    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    5.1937   -3.0076    0.0000 O   0  0
    5.1958   -1.5068    0.0000 C   0  0
    6.4961   -0.7590    0.0000 O   0  0
    3.8976   -0.7537    0.0000 C   0  0
    3.8976    0.7463    0.0000 C   0  0
    2.5985    1.4963    0.0000 C   0  0
    2.6016    2.9971    0.0000 O   0  0
    3.9017    3.7453    0.0000 C   0  0
    1.2995    0.7463    0.0000 C   0  0
   -0.0018    1.4940    0.0000 O   0  0
   -1.2998    0.7422    0.0000 C   0  0
    1.2995   -0.7537    0.0000 C   0  0
    0.0013   -1.5068    0.0000 O   0  0
    0.0034   -3.0068    0.0000 C   0  0
    2.5986   -1.5037    0.0000 C   0  0
    2.5693   -4.4875    0.0000 N   0  0
    2.5745   -2.9875    0.0000 C   0  0
    1.2675   -5.2326    0.0000 C   0  0
    5.1894   -6.0109    0.0000 C   0  0
    5.1863   -7.5109    0.0000 C   0  0
    6.4838   -8.2636    0.0000 C   0  0
    7.7844   -7.5162    0.0000 C   0  0
    7.7875   -6.0162    0.0000 C   0  0
    6.4900   -5.2636    0.0000 C   0  0
   11.5875   -0.3821    0.0000 O   0  0
   11.5875   -1.8821    0.0000 C   0  0
   10.2882   -2.6317    0.0000 O   0  0
   12.8875   -2.6321    0.0000 C   0  0
   14.1874   -1.8821    0.0000 C   0  0
   14.1889   -0.3813    0.0000 C   0  0
   12.8903    0.3696    0.0000 O   0  0
   15.4881    0.3683    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 10 13  2  0
 13 14  1  0
 14 15  1  0
 13 16  1  0
 16 17  1  0
 17 18  1  0
 16 19  2  0
 19  8  1  0
  3 20  1  0
 20 21  1  0
 20 22  1  0
  3 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 29 30  1  0
 30 31  2  0
 30 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  1  0
 34 36  2  0
M  END
> <name>
NIHCC_2014

> <id>
5762

> <plate>
NGP-105-02

> <well>
F09

> <supplier_cmpd_name>
CPD000471622

> <ctcr_id>
534

> <supplier_cmpd_id>
SAM001246747

> <smiles>
CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(N(C)C)c2ccccc2.OC(=O)\C=C/C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"2-(Dimethylamino)-2-phenylbutyl 3,4,5-trimethoxybenzoate maleate","2(Dimethylamino)2phenylbutyl 3,4,5trimethoxybenzoate maleate","Trimebutine maleate",34140-59-5,34140595,"Trimebutine (maleate)","Tr
imebutine maleate salt",Polibutin,UNII-DKM38HXX5A,UNIIDKM38HXX5A,UNII-H4XZJ9GX7T,UNIIH4XZJ9GX7T,Debridat,DKM38HXX5A,H4XZJ9GX7T,SMR000058893,MLS00,T1197,SAM001246747,1505011,CPD000471622,"TRIMEBUTINE M
ALEATE"}

> <pdid>

> <targets>
{}

> <classes>
{"opiod receptor agonist",antispasmodic}

> <pubchem_cids>
{5282423,5388977}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 21  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -3.8939   -0.7546    0.0000 C   0  0
   -5.1903   -1.5091    0.0000 N   0  0
   -6.4920   -0.7636    0.0000 C   0  0
   -7.7884   -1.5181    0.0000 N   0  0
   -6.4972    0.7364    0.0000 N   0  0
   -5.2007    1.4909    0.0000 C   0  0
   -5.2060    2.9909    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3032   -3.7490    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  5  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
 15  9  1  0
 15 16  1  0
  7 17  1  0
 17 18  2  0
 18  3  1  0
 18 19  1  0
 19 20  1  0
M  END
> <name>
NIHCC_2014

> <id>
5763

> <plate>
NGP-105-02

> <well>
F10

> <supplier_cmpd_name>
CPD000466374

> <ctcr_id>
6155

> <supplier_cmpd_id>
SAM001246728

> <smiles>
COc1cc(C)c(Cc2cnc(N)nc2N)cc1OC

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{ORMETOPRIM,6981-18-6,6981186,"6981 18 6",Ormethoprim,Ormetorprim,"5-((4,5-dimethoxy-2-methylphenyl)methyl)pyrimidine-2,4-diamine","5((4,5dimethoxy2methylphenyl)methyl)pyrimidine2,4diamine","5 ((4","5
 dimethoxy 2 methylphenyl)methyl)pyrimidine 2",4,SAM001246728,CPD000466374}

> <pdid>
PD002936

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23418}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 28  0  0  0  0            999 V2000
    6.4924   -3.7566    0.0000 C   0  0
    5.1945   -3.0045    0.0000 N   0  0
    5.1969   -1.5045    0.0000 C   0  0
    3.8991   -0.7525    0.0000 C   0  0
    2.5987   -1.5004    0.0000 N   0  0
    2.5965   -3.0004    0.0000 C   0  0
    3.8943   -3.7525    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 F   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -2.5981    3.0000    0.0000 O   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 N   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 S   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -5.1984    1.4977    0.0000 C   0  0
   -5.2011    2.9977    0.0000 O   0  0
   -6.4964    0.7459    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  2  1  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  2  3
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21  8  1  0
 21 22  2  0
 22 12  1  0
 22 17  1  0
 15 23  1  0
 23 24  1  0
 23 25  2  0
M  END
> <name>
NIHCC_2014

> <id>
5764

> <plate>
NGP-105-02

> <well>
F11

> <supplier_cmpd_name>
CPD000466373

> <ctcr_id>
5538

> <supplier_cmpd_id>
SAM001246726

> <smiles>
CN1CCN(CC1)c2c(F)cc3C(=O)C(=CN4CCSc2c34)C(O)=O

> <pd_targets>
{KDM4E,MAPK1,HSD17B10,IMPA1,HPGD,ALDH1A1,AMPC}

> <pathway_gtopdb>
{"Epigenetic regulator",Enzyme,Eraser,Kinase,Oxidoreductase,Hydrolase,"Lysine demethylase","Protein Kinase","Jumonji domain-containing","CMGC protein kinase group","CMGC protein kinase MAPK family","C
MGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,"Chromatin modifying enzymes","Kinases (EC 2.7.x.x)","Inositol phosphate turnover","Eicosanoid turnover","1.14.11.- Histone demethylases","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Inos
itol monophosphatase","Prostaglandin synthases","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Immune System",Metabolism,"Innate Immune System","Metabolism of amino acids and derivatives","Inositol phosphate metabolism","Metabolism of lipids","Biological oxidations","Toll-like Receptor Cascad
es","Branched-chain amino acid catabolism","Synthesis of IP2",IP,"and Ins in the cytosol","Biosynthesis of specialized proresolving mediators (SPMs)","Phase I - Functionalization of compounds","Toll L
ike Receptor 5 (TLR5) Cascade","Biosynthesis of DHA-derived SPMs","Ethanol oxidation","MyD88 cascade initiated on plasma membrane","Biosynthesis of D-series resolvins","MAP kinase activation","MAPK ta
rgets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{}

> <broad_moa>
{"bacterial DNA gyrase inhibitor"}

> <synonyms>
{Rufloxacin,BBL008945,NSC759835,STK711124,AKOS004120047,CCG-100908,CCG100908,CS-4367,CS4367,DB13772,NC00158,NSC-759835,VA11705,FT-0631011,FT0631011,C11240,D02474,AB00474020-18,AB0047402018,AB00474020-
20,AB0047402020,AB00474020_21,AB0047402021,AB00474020-21,"AB00474020 21",363R104,Q3942356,SR-01000612324-5,SR010006123245,SR-01000612324-6,SR010006123246,101363-10-4,101363104,"MF 9",SAM001246726,Pres
tw-1338,CPD000466373}

> <pdid>
PD002874

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{58258,4979271}

$$$$
NIHCC_2014
  SciTegic11012413002D

  9  9  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 F   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  3
  8  2  1  0
  8  9  1  0
M  END
> <name>
NIHCC_2014

> <id>
5765

> <plate>
NGP-105-02

> <well>
G02

> <supplier_cmpd_name>
CPD000059047

> <ctcr_id>
6014

> <supplier_cmpd_id>
SAM001246753

> <smiles>
NC1=NC(=O)NC=C1F

> <pd_targets>
{TMP1,DNMT1}

> <pathway_gtopdb>
{"Other cytosolic protein",Enzyme,"Epigenetic regulator",Transferase,Writer,"DNA methyltransferase"}

> <pathway_chembl>
{Enzymes,"2.1.1.- Methyltransferases"}

> <pathway_reactome>
{"Metabolism of proteins","Post-translational protein modification",SUMOylation,"SUMO E3 ligases SUMOylate target proteins","SUMOylation of DNA methylation proteins"}

> <broad_targets>
{DNMT1}

> <broad_moa>
{"other antifungal"}

> <synonyms>
{RESTW93,"RESTW 93",5-Fluorocytosine,5Fluorocytosine,"5 Fluorocytosine",flucytosine,2022-85-7,2022857,"2022 85 7",Ancobon,Ancotil,5-Fluorocystosine,5Fluorocystosine,"5 Fluorocystosine",5-FC,5FC,"5 FC"
,Flucytosin,Fluocytosine,5-Fluorocytosin,5Fluorocytosin,5Flu,SAM001246753,Prestw-934,CPD000059047,Flucytosine}

> <pdid>
PD000417

> <targets>
{Antibiotic,Fungal}

> <classes>
{Anti-infection}

> <pubchem_cids>
{3366}

$$$$
NIHCC_2014
  SciTegic11012413002D

 36 38  0  0  1  0            999 V2000
    1.3000    2.2500    0.0000 C   0  0
    1.3000    0.7500    0.0000 C   0  0
    0.0007    0.0004    0.0000 O   0  0
    2.6000    0.0000    0.0000 C   0  0
    3.8993    0.7496    0.0000 O   0  0
   19.0372    0.1693    0.0000 N   0  0
   17.9749   -0.8897    0.0000 C   0  0  1  0  0  0
   16.5259   -0.4985    0.0000 C   0  0
   15.4636   -1.5575    0.0000 O   0  0
   16.1394    0.9517    0.0000 N   0  0
   14.6963    1.3413    0.0000 C   0  0  1  0  0  0
   13.9474    2.6383    0.0000 C   0  0  1  0  0  0
   13.9474    4.1383    0.0000 S   0  0
   12.6484    4.8883    0.0000 C   0  0
   11.3494    4.1383    0.0000 C   0  0
   11.3494    2.6383    0.0000 C   0  0
   12.6484    1.8883    0.0000 N   0  0
   13.3972    0.5913    0.0000 C   0  0
   13.0090   -0.8575    0.0000 O   0  0
   10.0481    1.8906    0.0000 C   0  0
   10.0455    0.3906    0.0000 O   0  0
    8.7501    2.6424    0.0000 O   0  0
   10.0511    4.8914    0.0000 C   0  0
   10.0533    6.3922    0.0000 S   0  0
    8.7551    7.1453    0.0000 C   0  0
    8.6172    8.6262    0.0000 C   0  0
    7.1500    8.9380    0.0000 N   0  0
    6.4000    7.6390    0.0000 N   0  0
    7.4037    6.5243    0.0000 N   0  0
   18.3615   -2.3399    0.0000 C   0  0
   17.3009   -3.4008    0.0000 C   0  0
   17.6893   -4.8496    0.0000 C   0  0
   19.1382   -5.2377    0.0000 C   0  0
   19.5266   -6.6866    0.0000 O   0  0
   20.1988   -4.1769    0.0000 C   0  0
   19.8104   -2.7281    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  7  6  1  6
  7  8  1  0
  8  9  2  0
  8 10  1  0
 11 10  1  6
 11 12  1  0
 12 13  1  6
 13 14  1  0
 14 15  1  0
 15 16  2  3
 16 17  1  0
 17 12  1  0
 17 18  1  0
 18 11  1  0
 18 19  2  0
 16 20  1  0
 20 21  1  0
 20 22  2  0
 15 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 28 29  2  0
 29 25  1  0
  7 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 33 35  1  0
 35 36  2  0
 36 30  1  0
M  END
> <name>
NIHCC_2014

> <id>
5766

> <plate>
NGP-105-02

> <well>
G03

> <supplier_cmpd_name>
CPD000469182

> <ctcr_id>
483

> <supplier_cmpd_id>
SAM001246643

> <smiles>
CC(O)CO.N[C@@H](C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(O)=O)CSc3c[nH]nn3)c4ccc(O)cc4

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Cefatrizine propylene glycolate",57235-40-2,57235402,"Cefatrizine compd with propylene glycol",64217-62-5,64217625,"CEFATRIZINE PROPYLENE GLYCOL",Cefatrizine-propyleneglycol,Cefatrizinepropyleneglyc
ol,Propyleneglycol-cefatrizine,Propyleneglycolcefatrizine,Seapuron,UNII-3731IA5GI9,UNII3731IA5GI9,"Seapuron (TN)","EINECS 260-642-","EINECS 260642",SAM001246643,CPD000469182}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{6410757}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 26  0  0  1  0            999 V2000
    0.1423    1.5763    0.0000 C   0  0
    0.0479    0.0793    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0
   -6.4952    3.7500    0.0000 O   0  0
   -3.8971    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0  2  0  0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.3326   -2.9571    0.0000 C   0  0
    1.8253   -3.1044    0.0000 C   0  0
    2.4266   -1.7302    0.0000 C   0  0  2  0  0  0
    2.8524   -0.2919    0.0000 O   0  0
    3.4192   -2.8384    0.0000 C   0  0
    4.4371   -3.9401    0.0000 C   0  0
  1  2  1  0
  3  2  1  1
  3  4  1  0
  4  5  1  0
  6  5  1  1
  6  7  1  0
  7  8  1  6
  8  9  1  0
  9 10  1  0
 10 11  2  3
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 16 15  1  6
 16  6  1  0
 16 10  1  0
  7 17  1  0
 17  3  1  0
 17 18  1  1
 18 19  1  0
 19 20  1  0
 20  3  1  0
 20 21  1  1
 20 22  1  0
 22 23  3  0
M  END
> <name>
NIHCC_2014

> <id>
5767

> <plate>
NGP-105-02

> <well>
G04

> <supplier_cmpd_name>
CPD000059117

> <ctcr_id>
2850

> <supplier_cmpd_id>
SAM001246694

> <smiles>
CC[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C

> <pd_targets>
{PGR,SRD5A1,ESR1,AR,SHBG,NR3C1,LMNA,KMT2A,MEN1,AMPC,SLC6A4}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Secreted protein","Nuclear receptor",Oxidoreductase,"Nuclear hormone receptor subfamily 3","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor subf
amily 3 group A","Nuclear hormone receptor subfamily 3 group C member 3","Nuclear hormone receptor subfamily 3 group A member 1","Nuclear hormone receptor subfamily 3 group C member 4","Nuclear hormon
e receptor subfamily 3 group C member 1","Other nuclear protein","Epigenetic regulator",Transporter,Reader,Hydrolase,"Electrochemical transporter",Bromodomain,"SLC superfamily of solute carriers","SLC
06 neurotransmitter transporter family"}

> <pathway_chembl>
{Receptors,"Nuclear hormone receptors","Steroid hormone receptors","3C. 3-Ketosteroid receptors","3A. Estrogen receptors",Transporters,"SLC superfamily of solute carriers","SLC6 neurotransmitter trans
porter family","Monoamine transporter subfamily"}

> <pathway_reactome>
{"Metabolism of proteins",Metabolism,"Gene expression (Transcription)","Post-translational protein modification","Metabolism of lipids","RNA Polymerase II Transcription",SUMOylation,"Metabolism of ste
roids","Generic Transcription Pathway","SUMO E3 ligases SUMOylate target proteins","Metabolism of steroid hormones","Transcriptional regulation by RUNX1","Transcriptional regulation by RUNX2","FOXO-me
diated transcription","SUMOylation of intracellular receptors","Androgen biosynthesis","RUNX1 regulates estrogen receptor mediated transcription","RUNX2 regulates bone development","FOXO-mediated tran
scription of oxidative stress","metabolic and neuronal genes","RUNX2 regulates osteoblast differentiation","Cell Cycle","Neuronal System",Mitotic,"Transmission across Chemical Synapses","M Phase","Neu
rotransmitter clearance","Mitotic Metaphase and Anaphase","Serotonin clearance from the synaptic cleft","Mitotic Anaphase","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Refor
mation"}

> <broad_targets>
{AR,ESR1,PGR,SRD5A1}

> <broad_moa>
{"progesterone receptor agonist"}

> <synonyms>
{ORGESTREL(),"ORGESTREL ( )",Levonorgestrel,norgestrel,797-63-7,797637,"797 63 7",D-Norgestrel,DNorgestrel,"D Norgestrel",Mirena,(-)-Norgestrel,()Norgestrel,"( ) Norgestrel",Levonova,Microval,Postinor
,Jadelle,"Plan B",NORPLANT,Follistrel,1,SAM001246694,Prestw-773,CPD000059117,Norgestrel-(-)-D}

> <pdid>
PD001660

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{13109}

$$$$
NIHCC_2014
  SciTegic11012413002D

 31 33  0  0  0  0            999 V2000
   15.7462   -1.8669    0.0000 Cl  0  0
    4.4707   -5.0263    0.0000 C   0  0
    5.4929   -3.9285    0.0000 N   0  0
    5.0525   -2.4938    0.0000 C   0  0
    3.5900   -2.1568    0.0000 C   0  0
    3.1497   -0.7220    0.0000 C   0  0
    1.6852   -0.3846    0.0000 N   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.5913    1.9239    0.0000 C   0  0
    2.4792    3.4197    0.0000 C   0  0
    1.1278    4.0705    0.0000 C   0  0
   -0.1116    3.2255    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
    6.9554   -4.2655    0.0000 C   0  0
    7.3957   -5.7002    0.0000 C   0  0
    6.3736   -6.7981    0.0000 O   0  0
    8.8582   -6.0372    0.0000 C   0  0
    9.3005   -7.4706    0.0000 C   0  0
   10.7629   -7.8044    0.0000 C   0  0
   11.7831   -6.7048    0.0000 C   0  0
   13.2455   -7.0386    0.0000 Cl  0  0
   11.3410   -5.2714    0.0000 C   0  0
    9.8786   -4.9376    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21  7  1  0
 21 16  1  0
  3 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 28 30  1  0
 30 31  2  0
 31 25  1  0
M  END
> <name>
NIHCC_2014

> <id>
5768

> <plate>
NGP-105-02

> <well>
G05

> <supplier_cmpd_name>
CPD000469292

> <ctcr_id>
5255

> <supplier_cmpd_id>
SAM001246632

> <smiles>
Cl.CN(CCCN1c2ccccc2CCc3ccccc13)CC(=O)c4ccc(Cl)cc4

> <pd_targets>
{FFP,CHRM2,CHRM3,SLC6A4,SLC6A3,SLC6A2,DRD2,ADRA2A,HTR2C,CHRM5,CHRM4,ADRA1A,HRH1,CHRM1,HTR2A,HTR1A,ADRA2C}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor",Transporter,Transferase,"Family A G protein-coupled receptor","Electrochemical transporter","Small molecule receptor (family A GPCR)","SLC superfamily of solute carriers","
Monoamine receptor","SLC06 neurotransmitter transporter family","Acetylcholine receptor","Dopamine receptor","Adrenergic receptor","Serotonin receptor","Histamine receptor"}

> <pathway_chembl>
{Receptors,Transporters,"G protein-coupled receptors","SLC superfamily of solute carriers","Acetylcholine receptors (muscarinic)","SLC6 neurotransmitter transporter family","Dopamine receptors",Adreno
ceptors,"5-Hydroxytryptamine receptors","Histamine receptors","Monoamine transporter subfamily"}

> <pathway_reactome>
{"Signal Transduction","Neuronal System",Disease,"Signaling by GPCR","Transmission across Chemical Synapses","Infectious disease","Disorders of transmembrane transporters","GPCR ligand binding","Neuro
transmitter clearance","Leishmania infection","SLC transporter disorders","Class A/1 (Rhodopsin-like receptors)","Serotonin clearance from the synaptic cleft","Leishmania parasite growth and survival"
,"Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Defective SLC6A2 causes orthostatic intolerance (OI)","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishma
nia parasite infection","Muscarinic acetylcholine receptors","ADORA2B mediated anti-inflammatory cytokines production","Dopamine receptors",Adrenoceptors,"Serotonin receptors","Histamine receptors"}

> <broad_targets>
{HTR1A,SLC6A2,SLC6A4}

> <broad_moa>
{"norepinephrine reuptake inhibitor","serotoninânorepinephrine reuptake inhibitor (SNRI)"}

> <synonyms>
{"lofepramine hydrochloride",26786-32-3,26786323,"Clopepramine hydrochloride",UNII-Z24K96F991,UNIIZ24K96F991,"Lopramine (hydrochloride)","Lofepramine (hydrochloride)",CHEBI:31780,WHR-2908A,WHR2908A,Ga
manil,Z24K96F991,DSSTox_CID_27809,DSSToxCID27809,DSSTox-CID-27809,"DSSTox CID 27809",DSSTox_RID_82576,DSSToxRID82576,DSSTox-RID-82576,"DSSTox RID 82576",DSSTox_GSID_47833,DSSToxGSID47833,DSSTox-GSID-4
7833,"DSSTox GSID 47833",Iopram,SAM001246632,CPD000469292}

> <pdid>
PD013071

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{57516046,33611}

$$$$
NIHCC_2014
  SciTegic11012413002D

 31 33  0  0  0  0            999 V2000
    8.0312   -0.4797    0.0000 K   0  3
   -3.7146   -4.8930    0.0000 C   0  0
   -2.5902   -3.9002    0.0000 C   0  0
   -1.1671   -4.3770    0.0000 C   0  0
   -0.0420   -3.3837    0.0000 C   0  0
    1.3786   -3.8595    0.0000 C   0  0
    1.8372   -5.2877    0.0000 N   0  0
    3.3372   -5.2929    0.0000 C   0  0
    4.2146   -6.5095    0.0000 Cl  0  0
    3.8056   -3.8679    0.0000 C   0  0
    5.2276   -3.3960    0.0000 C   0  0
    5.5311   -1.9271    0.0000 O   0  0
    2.5951   -3.0039    0.0000 N   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5987    1.5004    0.0000 C   0  0
   -3.8967    0.7484    0.0000 C   0  0
   -5.1969    1.4963    0.0000 C   0  0
   -5.1993    2.9963    0.0000 C   0  0
   -3.9014    3.7484    0.0000 C   0  0
   -2.6012    3.0004    0.0000 C   0  0
   -1.3027    3.7529    0.0000 C   0  0
    0.0506    3.1362    0.0000 N   0  5
    1.0508    4.2541    0.0000 N   0  0
    0.2966    5.5507    0.0000 N   0  0
   -1.1696    5.2342    0.0000 N   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  8 10  2  0
 10 11  1  0
 11 12  1  0
 10 13  1  0
 13  6  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 18 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 27  2  0
M  CHG  2   1   1  28  -1
M  END
> <name>
NIHCC_2014

> <id>
5769

> <plate>
NGP-105-02

> <well>
G06

> <supplier_cmpd_name>
CPD000469593

> <ctcr_id>
4433

> <supplier_cmpd_id>
SAM001246635

> <smiles>
[K+].CCCCc1nc(Cl)c(CO)n1Cc2ccc(cc2)c3ccccc3c4[n-]nnn4

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"LOSARTAN POTASSIUM",124750-99-8,124750998,Cozaar,ERYTHROPOIETIN,Lorzaar,Losaprex,"losartan potassium salt",Hyzaar,losartanpotassium,"MK 954",Lortaan,UNII-3ST302B24A,UNII3ST302B24A,"Losartan Potassiu
m (DuP 753)",MK-0954,MK0954,3ST302B24A,L-158086,L158086,"DuP 753",124750-99,12475099,T0215,SAM001246635,"Losartan potassium",CPD000469593}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{11751549,11476710}

$$$$
NIHCC_2014
  SciTegic11012413002D

 37 39  0  0  1  0            999 V2000
    3.8926   -3.7566    0.0000 C   0  0
    2.5951   -3.0039    0.0000 O   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0  2  0  0  0
   -1.2990   -0.7500    0.0000 S   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.0479    2.0470    0.0000 C   0  0  2  0  0  0
   -3.4926    2.4305    0.0000 N   0  0
   -4.5521    1.3675    0.0000 C   0  0
   -4.1610   -0.0806    0.0000 O   0  0
   -6.0026    1.7526    0.0000 C   0  0
   -6.3910    3.2024    0.0000 N   0  0
   -5.3303    4.2642    0.0000 O   0  0
   -5.7184    5.7131    0.0000 C   0  0
   -7.0621    0.6896    0.0000 C   0  0
   -8.5291    0.9343    0.0000 C   0  0
   -9.2051   -0.4048    0.0000 S   0  0
   -8.1405   -1.4615    0.0000 C   0  0
   -8.3696   -2.9439    0.0000 N   0  0
   -6.8065   -0.7755    0.0000 N   0  0
   -0.7488    2.7970    0.0000 C   0  0
   -0.3606    4.2459    0.0000 O   0  0
    2.6003    1.4978    0.0000 C   0  0
    2.6029    2.9978    0.0000 O   0  0
    3.8990    0.7455    0.0000 O   0  0
    5.2003    1.4932    0.0000 C   0  0
    5.2029    2.9932    0.0000 C   0  0
    6.4990    0.7410    0.0000 O   0  0
    7.8003    1.4887    0.0000 C   0  0
    7.8029    2.9887    0.0000 O   0  0
    9.0990    0.7365    0.0000 O   0  0
   10.4003    1.4842    0.0000 C   0  0
   11.6982    0.7324    0.0000 C   0  0
   10.4029    2.9842    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  3
  5  6  1  0
  6  7  1  0
  7  8  1  6
  8  9  1  0
  9  4  1  0
  7 10  1  0
 10 11  1  6
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  3
 15 16  1  0
 16 17  1  0
 14 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  2  0
 23 18  1  0
 10 24  1  0
 24  6  1  0
 24 25  2  0
  5 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  1  0
 29 30  1  0
 29 31  1  0
 31 32  1  0
 32 33  2  0
 32 34  1  0
 34 35  1  0
 35 36  1  0
 35 37  1  0
M  END
> <name>
NIHCC_2014

> <id>
5770

> <plate>
NGP-105-02

> <well>
G07

> <supplier_cmpd_name>
CPD000469193

> <ctcr_id>
6974

> <supplier_cmpd_id>
SAM001246674

> <smiles>
COCC1=C(N2[C@H](SC1)[C@H](NC(=O)C(=NOC)c3csc(N)n3)C2=O)C(=O)OC(C)OC(=O)OC(C)C

> <pd_targets>
{SKA,ABCB11,DACA,DACB,DACC,FTSI,MRCA,MRCB,MRDA}

> <pathway_gtopdb>
{Enzyme,Transporter,Kinase,"Primary active transporter",Protease,"ATP-binding cassette","Serine protease","ABCB subfamily","Serine protease SE clan","Serine protease S11 family"}

> <pathway_chembl>
{Transporters,"ATP-binding cassette transporter family","ABCB subfamily"}

> <pathway_reactome>
{Metabolism,"Metabolism of lipids","Metabolism of steroids","Bile acid and bile salt metabolism","Synthesis of bile acids and bile salts","Synthesis of bile acids and bile salts via 7alpha-hydroxychol
esterol"}

> <broad_targets>
{}

> <broad_moa>
{"bacterial cell wall synthesis inhibitor"}

> <synonyms>
{87239-81-4,C21H27N5O9S2,HMS2051M14,HMS2231C24,AKOS030242963,CCG-100877,NC00127,K558,Q27166320,SAM001246674,CPD000469193}

> <pdid>
PD000349

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{441393}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 27  0  0  1  0            999 V2000
   12.5445   -3.4946    0.0000 Cl  0  5
    4.2066   -8.4888    0.0000 C   0  0
    5.3273   -7.4917    0.0000 C   0  0
    6.7945   -7.8036    0.0000 C   0  0
    7.5445   -6.5046    0.0000 C   0  0
    6.5408   -5.3899    0.0000 S   0  0
    5.1894   -6.0109    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 C   0  0
   -3.8976   -0.7554    0.0000 O   0  0
   -2.5951   -3.0031    0.0000 O   0  0
    2.5902   -6.0059    0.0000 C   0  0
    2.4517   -7.4867    0.0000 S   0  0
    0.9844   -7.7980    0.0000 C   0  0
    0.2349   -6.4987    0.0000 C   0  0
    1.2390   -5.3844    0.0000 C   0  0
    0.9364   -3.9152    0.0000 C   0  0
   10.0445   -3.4946    0.0000 H   0  3
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  3  2  0
  7  8  1  0
  8  9  2  3
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 12  1  0
 16 18  1  6
 18 19  1  0
 18 20  2  0
  8 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 21  2  0
 25 26  1  0
M  CHG  2   1  -1  27   1
M  END
> <name>
NIHCC_2014

> <id>
5771

> <plate>
NGP-105-02

> <well>
G08

> <supplier_cmpd_name>
CPD000469176

> <ctcr_id>
345

> <supplier_cmpd_id>
SAM001246625

> <smiles>
[Cl-].Cc1ccsc1C(=CCCN2CCC[C@H](C2)C(O)=O)c3sccc3C.[H+]

> <pd_targets>
{SLC6A1,SLC6A12}

> <pathway_gtopdb>
{Transporter,"Electrochemical transporter","SLC superfamily of solute carriers","SLC06 neurotransmitter transporter family"}

> <pathway_chembl>
{Transporters,"SLC superfamily of solute carriers","SLC6 neurotransmitter transporter family","GABA transporter subfamily"}

> <pathway_reactome>
{"Neuronal System","Transmission across Chemical Synapses","Neurotransmitter release cycle","GABA synthesis",release,"reuptake and degradation","Reuptake of GABA"}

> <broad_targets>
{SLC6A1}

> <broad_moa>
{"GABA uptake inhibitor"}

> <synonyms>
{"Tiagabine hydrochloride",145821-59-6,145821596,"145821 59 6","TIAGABINE HCl",Gabitril,"Abbott 70569.HCl",NNC-05-0328,NNC050328,"NNC 05 0328","Tiagabine (hydrochloride)",UNII-DQH6T6D8OY,UNIIDQH6T6D8O
Y,"UNII DQH6T6D8OY",Abbott-70569.1,Abbott70569.1,"Abbott 70569.1",NO-05-0328,NO050328,"NO 05 0328",DQH6T6D8OY,ABT-569,ABT569,"ABT 569",ABBOTT-70569.HCL,ABBOTT70569.HCL,"ABBOTT 70569.HCL",CHEBI:85388,M
FCD07369025,"Gabitril (TN)",T2407,SAM001246625,Tiagabine,CPD000469176}

> <pdid>
PD009653

> <targets>
{GABA Receptor}

> <classes>
{Membrane Transporter/Ion Channel,Neuronal Signaling}

> <pubchem_cids>
{91274,74765398}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 25  0  0  1  0            999 V2000
   -0.6872   -2.7329    0.0000 C   0  0
    0.2851   -2.9666    0.0000 C   0  0  2  0  0  0
    0.7521   -4.3921    0.0000 O   0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0  1  0  0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -1.2991    2.2500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -0.8141   -2.0807    0.0000 C   0  0
  2  1  1  1
  2  3  1  0
  2  4  1  0
  4  5  1  0
  6  5  1  6
  6  7  1  0
  7  8  1  1
  8  9  1  0
 10  9  1  6
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 10  1  0
 16 17  1  6
 16 18  1  0
 18  7  1  0
 18 19  1  6
 19 20  1  0
 20 21  1  0
 21  2  1  0
 21  6  1  0
 21 22  1  6
M  END
> <name>
NIHCC_2014

> <id>
5772

> <plate>
NGP-105-02

> <well>
G09

> <supplier_cmpd_name>
CPD000238198

> <ctcr_id>
4130

> <supplier_cmpd_id>
SAM001246746

> <smiles>
C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C

> <pd_targets>
{SHBG,MAPK1,POLB}

> <pathway_gtopdb>
{"Secreted protein",Enzyme,Kinase,"Protein Kinase","CMGC protein kinase group","CMGC protein kinase MAPK family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,"Kinases (EC 2.7.x.x)","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Immune System","DNA Repair","Innate Immune System","Base Excision Repair","Toll-like Receptor Cascades","Resolution of Abasic Sites (AP sites)","Toll Like Receptor 5 (TLR5) Cascade","Resolution of A
P sites via the multiple-nucleotide patch replacement pathway","MyD88 cascade initiated on plasma membrane","PCNA-Dependent Long Patch Base Excision Repair","MAP kinase activation","MAPK targets/ Nucl
ear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{mestanolone,Methylantalon,Assimil,Andoron,Methybol,Preroide,Tantarone,521-11-9,521119,Methyldihydrotestosterone,Mesanolon,Mestalone,Androstalone,"NSC 18219","RU 143",UNII-S712YZ168E,UNIIS712YZ168E,17
beta-Hydroxy-17alpha-methyl-5alpha-androstan-3-one,17betaHydroxy17alphamethyl5alphaandrostan3one,S712YZ168E,17.,SAM001246746,CPD000238198}

> <pdid>
PD003102

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{10633}

$$$$
NIHCC_2014
  SciTegic11012413002D

 16 17  0  0  0  0            999 V2000
    4.0497   -4.4250    0.0000 C   0  0
    2.5497   -4.4224    0.0000 C   0  0
    1.7974   -5.7210    0.0000 N   0  0
    0.2974   -5.7184    0.0000 O   0  0
    2.5451   -7.0223    0.0000 C   0  0
    4.0451   -7.0250    0.0000 N   0  0
    1.7932   -8.3203    0.0000 O   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 S   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  5  7  2  0
  2  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 15 16  1  0
 16  8  2  0
M  END
> <name>
NIHCC_2014

> <id>
5773

> <plate>
NGP-105-02

> <well>
G10

> <supplier_cmpd_name>
CPD000466377

> <ctcr_id>
6917

> <supplier_cmpd_id>
SAM001246738

> <smiles>
CC(N(O)C(N)=O)c1sc2ccccc2c1

> <pd_targets>
{PTGES,ALOX5,ALOX5AP,ALOX15,LTA4H,LMNA,ALOX12,LTB4R,EPHX2,GAA,CYP1A2}

> <pathway_gtopdb>
{Enzyme,"Other cytosolic protein","Other nuclear protein","Membrane receptor",Isomerase,Oxidoreductase,Protease,"Family A G protein-coupled receptor",Hydrolase,"Cytochrome P450","Metallo protease","Sm
all molecule receptor (family A GPCR)","Serine protease","Cytochrome P450 family 1","Metallo protease MAE clan","Lipid-like ligand receptor (family A GPCR)","Serine protease SC clan","Cytochrome P450 
family 1A","Metallo protease M1 family","Leukotriene receptor","Serine protease S33 family","Cytochrome P450 1A1"}

> <pathway_chembl>
{Enzymes,Receptors,"Eicosanoid turnover","Peptidases and proteinases","G protein-coupled receptors",Hydrolases,"3.2.1.- Glycosidases","Cytochrome P450","Prostaglandin synthases",Lipoxygenases,"MA: Met
allo (M) Peptidases","Leukotriene receptors","CYP1 family","M1: Aminopeptidase N"}

> <pathway_reactome>
{Metabolism,"Cell Cycle","Signal Transduction",Disease,"Metabolism of lipids",Mitotic,"Signaling by GPCR","Diseases of metabolism","Biological oxidations","Fatty acid metabolism","Biosynthesis of spec
ialized proresolving mediators (SPMs)","M Phase","GPCR ligand binding","Diseases of carbohydrate metabolism","Phase I - Functionalization of compounds","Arachidonic acid metabolism","Biosynthesis of D
PA-derived SPMs","Biosynthesis of DHA-derived SPMs","Mitotic Metaphase and Anaphase","Class A/1 (Rhodopsin-like receptors)","Glycogen storage diseases","Cytochrome P450 - arranged by substrate type","
Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","Biosynthesis of DPAn-3 SPMs","Synthesis of 5-eicosatetraenoic acids","Biosynthesis of aspirin-triggered D-series resolvins","Mitotic Anaphase",
"Eicosanoid ligand-binding receptors","Biosynthesis of maresins","Glycogen storage disease type II (GAA)",Xenobiotics,"Biosynthesis of DPAn-3-derived 13-series resolvins","Biosynthesis of DPAn-3-deriv
ed protectins and resolvins","Nuclear Envelope (NE) Reassembly","Biosynthesis of DPAn-3-derived maresins","Leukotriene receptors","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","In
itiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ALOX5}

> <broad_moa>
{"leukotriene synthesis inhibitor","lipoxygenase inhibitor"}

> <synonyms>
{CCG-213571,CCG213571,CS-1563,CS1563,ZILEUTON,111406-87-2,111406872,Zyflo,Leutrol,1-(1-(Benzo(b)thiophen-2-yl)ethyl)-1-hydroxyurea,1(1(Benzo(b)thiophen2yl)ethyl)1hydroxyurea,Zileutonum,"Abbott 64077",
"Zileutonum (INN-Latin)","Zileutonum (INNLatin)",1-(1-(1-benzothiophen-2-yl)ethyl)-1-hydroxyurea,1(1(1benzothiophen2yl)ethyl)1hydroxyurea,A-64077,A64077,N-(1-Benzo(b)thien-2-ylethyl)-N-hydr,N(1Benzo(b
)thien2ylethyl)Nhydr,T0477,SAM001246738,1505906,Prestw-1365,Zileuton,CPD000466377}

> <pdid>
PD000269

> <targets>
{Ferroptosis,Lipoxygenase}

> <classes>
{5-lipoxygenase inhibitor,Apoptosis,Metabolic Enzyme/Protease}

> <pubchem_cids>
{60490}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 24  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    0.0000    1.5000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 O   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
    2.5987    1.5004    0.0000 C   0  0
    2.6012    3.0005    0.0000 C   0  0
    3.9014    3.7484    0.0000 C   0  0
    5.1993    2.9963    0.0000 C   0  0
    6.4995    3.7443    0.0000 O   0  0
    5.1969    1.4963    0.0000 C   0  0
    6.4947    0.7443    0.0000 O   0  0
    3.8967    0.7484    0.0000 C   0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  7  9  2  0
  9 10  1  0
 10 11  1  0
 10 12  2  0
 12  5  1  0
 12 13  1  0
 13  2  1  0
 13 14  2  0
  3 15  1  6
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 20 22  2  0
 22 15  1  0
M  END
> <name>
NIHCC_2014

> <id>
5774

> <plate>
NGP-105-02

> <well>
G11

> <supplier_cmpd_name>
CPD000466389

> <ctcr_id>
5415

> <supplier_cmpd_id>
SAM001246778

> <smiles>
O[C@@H]1[C@H](Oc2cc(O)cc(O)c2C1=O)c3ccc(O)c(O)c3

> <pd_targets>
{GAA,RECQL,MAPT,KDM4E,TGR,POLB,APP,BACE1,AMPC,KIT,PYGM,MMP3,CA4,FTL,SMN1,MMP12,UREA,UREB,KMT2A,MEN1,CYP3A4,MMP9,PMP22,BLM,HPGD,MMP2,CA12,ABCB1A,GMNN,MMP13,CA7,ADORA3}

> <pathway_gtopdb>
{Enzyme,"Other cytosolic protein","Epigenetic regulator",Hydrolase,Eraser,"Lysine demethylase","Jumonji domain-containing","Membrane receptor","Unclassified protein",Transporter,Protease,Kinase,Transf
erase,Lyase,Reader,"Cytochrome P450","Primary active transporter","Family A G protein-coupled receptor","Aspartic protease","Protein Kinase","Metallo protease","Methyl-lysine/arginine binding protein"
,Bromodomain,"Cytochrome P450 family 3","ATP-binding cassette","Small molecule receptor (family A GPCR)","Aspartic protease AA clan","TK protein kinase group","Metallo protease MAM clan","Tudor domain
","Cytochrome P450 family 3A","ABCB subfamily","Nucleotide-like receptor (family A GPCR)","Aspartic protease A1A subfamily","Tyrosine protein kinase PDGFR family","Metallo protease M10A subfamily","Cy
tochrome P450 3A4","Adenosine receptor"}

> <pathway_chembl>
{Enzymes,"3.2.1.- Glycosidases","Chromatin modifying enzymes","1.14.11.- Histone demethylases",Receptors,Transporters,"Peptidases and proteinases","Catalytic receptors","Carbonic anhydrases","Cytochro
me P450","Eicosanoid turnover","ATP-binding cassette transporter family","G protein-coupled receptors","AA: Aspartic (A) Peptidases","Receptor kinases","MA: Metallo (M) Peptidases","CYP3 family","Pros
taglandin synthases","ABCB subfamily","Adenosine receptors","A1: Pepsin","TK: Tyrosine kinase","M10: Matrix metallopeptidase","Receptor tyrosine kinases (RTKs)","Type III RTKs: PDGFR",CSFR,Kit,"FLT3 r
eceptor family"}

> <pathway_reactome>
{Disease,"Neuronal System","DNA Repair","Diseases of metabolism","Transmission across Chemical Synapses","Base Excision Repair","Diseases of carbohydrate metabolism","Neurotransmitter receptors and po
stsynaptic signal transmission","Resolution of Abasic Sites (AP sites)","Glycogen storage diseases","Activation of NMDA receptors and postsynaptic events","Resolution of AP sites via the multiple-nucl
eotide patch replacement pathway","Glycogen storage disease type II (GAA)","Post NMDA receptor activation events","PCNA-Dependent Long Patch Base Excision Repair","Activation of AMPK downstream of NMD
ARs","Immune System","Metabolism of proteins",Metabolism,"Signal Transduction","Transport of small molecules","Vesicle-mediated transport","Metabolism of RNA","Extracellular matrix organization","Deve
lopmental Biology","Cell Cycle","Gene expression (Transcription)","Innate Immune System","Amyloid fiber formation","Diseases of signal transduction by growth factor receptors and second messengers","M
etabolism of carbohydrates","Signaling by GPCR","O2/CO2 exchange in erythrocytes","Membrane Trafficking","Metabolism of non-coding RNA","Degradation of the extracellular matrix","Metabolism of lipids"
,"Nervous system development","DNA Double-Strand Break Repair","Reversible hydration of carbon dioxide",Mitotic,"RNA Polymerase II Transcription","Toll-like Receptor Cascades","Signaling by KIT in dis
ease","Glycogen metabolism","GPCR downstream signalling","Erythrocytes take up carbon dioxide and release oxygen","trans-Golgi Network Vesicle Budding","snRNP Assembly","Collagen degradation","Biosynt
hesis of specialized proresolving mediators (SPMs)","Axon guidance","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Homology Directed Repair","Mitotic G1 phase and G1/S transition","
Generic Transcription Pathway","GPCR ligand binding","Toll Like Receptor 5 (TLR5) Cascade","Drug resistance of KIT mutants","Glycogen breakdown (glycogenolysis)","G alpha (q) signalling events","Golgi
 Associated Vesicle Biogenesis","Biosynthesis of DHA-derived SPMs","EPH-Ephrin signaling","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","G1/S Transition","Transcription
al regulation by RUNX2","Class A/1 (Rhodopsin-like receptors)","MyD88 cascade initiated on plasma membrane","Dasatinib-resistant KIT mutants","Gastrin-CREB signalling pathway via PKC and MAPK","Biosyn
thesis of maresins","EPH-ephrin mediated repulsion of cells","HDR through Homologous Recombination (HRR)","Biosynthesis of D-series resolvins","Activation of the pre-replicative complex","RUNX2 regula
tes genes involved in cell migration","Nucleotide-like (purinergic) receptors","TAK1 activates NFkB by phosphorylation and activation of IKKs complex","EGFR Transactivation by Gastrin","Biosynthesis o
f maresin-like SPMs","Homologous DNA Pairing and Strand Exchange","Adenosine P1 receptors","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{ADIPOR2}

> <broad_moa>
{"opioid receptor antagonist"}

> <synonyms>
{AXIFOLIN(+,"AXIFOLIN (+",TAXIFOLIN,480-18-2,480182,"480 18 2",(+)-Taxifolin,(+)Taxifolin,"(+) Taxifolin",dihydroquercetin,Distylin,Taxifoliol,"(2R,3R)-Dihydroquercetin","(2R,3R)Dihydroquercetin","(2R
,3R) Dihydroquercetin",(+)-Dihydroquerceti,(+)Dihydroquerceti,SAM001246778,CPD000466389}

> <pdid>
PD002852

> <targets>
{VEGFR}

> <classes>
{}

> <pubchem_cids>
{439533}

$$$$
NIHCC_2014
  SciTegic11012413002D

 19 21  0  0  0  0            999 V2000
    4.1718    0.3758    0.0000 N   0  0
    3.1497   -0.7220    0.0000 C   0  0
    3.5898   -2.1560    0.0000 O   0  0
    1.6852   -0.3846    0.0000 N   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.5913    1.9239    0.0000 C   0  0
    2.4792    3.4197    0.0000 C   0  0
    1.1278    4.0705    0.0000 C   0  0
   -0.1116    3.2255    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -3.1476   -0.7184    0.0000 O   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19  4  1  0
 19 14  1  0
M  END
> <name>
NIHCC_2014

> <id>
5775

> <plate>
NGP-105-02

> <well>
H02

> <supplier_cmpd_name>
CPD000048684

> <ctcr_id>
249

> <supplier_cmpd_id>
SAM001246754

> <smiles>
NC(=O)N1c2ccccc2CC(=O)c3ccccc13

> <pd_targets>
{KMT2A,ALD,BLM,FFP,CYP3A4,MAPT,KDM4E,NS1,MEN1,ALDH1A1,SCN10A,SCN11A,SCN1A,SCN2A,SCN3A,SCN4A,SCN5A,SCN7A,SCN8A,SCN9A,SCN1B,SCN2B,SCN3B,SCN4B}

> <pathway_gtopdb>
{"Epigenetic regulator",Enzyme,"Other cytosolic protein","Unclassified protein","Ion channel",Reader,Transferase,"Cytochrome P450",Eraser,Oxidoreductase,"Voltage-gated ion channel",Bromodomain,"Cytoch
rome P450 family 3","Lysine demethylase","Voltage-gated sodium channel","Cytochrome P450 family 3A","Jumonji domain-containing","Cytochrome P450 3A4"}

> <pathway_chembl>
{Enzymes,"Chromatin modifying enzymes","Cytochrome P450","2.1.1.43 Histone methyltransferases (HMTs)","CYP3 family","1.14.11.- Histone demethylases"}

> <pathway_reactome>
{"Gene expression (Transcription)","DNA Repair",Metabolism,"Neuronal System","RNA Polymerase II Transcription","DNA Double-Strand Break Repair","Metabolism of lipids","Transmission across Chemical Syn
apses","Biological oxidations","Generic Transcription Pathway","Homology Directed Repair","Biosynthesis of specialized proresolving mediators (SPMs)","Neurotransmitter receptors and postsynaptic signa
l transmission","Phase I - Functionalization of compounds","Transcriptional regulation by RUNX1","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Biosynthesis of DHA-deri
ved SPMs","Activation of NMDA receptors and postsynaptic events","Ethanol oxidation","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","HDR through Homologous Rec
ombination (HRR)","Biosynthesis of maresins","Post NMDA receptor activation events","Homologous DNA Pairing and Strand Exchange","Biosynthesis of maresin-like SPMs","Activation of AMPK downstream of N
MDARs","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{SCN10A,SCN11A,SCN1A,SCN2A,SCN3A,SCN4A,SCN5A,SCN7A,SCN8A,SCN9A}

> <broad_moa>
{"sodium channel blocker"}

> <synonyms>
{OXCARBAZEPINE,28721-07-5,28721075,Trileptal,Oxcarbamazepine,Oxcarbazepina,Oxcarbazepinum,"10-Oxo-10,11-dihydro-5H-dibenzo(b,f)azepine-5-carboxamide","10Oxo10,11dihydro5Hdibenzo(b,f)azepine5carboxamid
e","GP 47680",5-oxo-6H-benzo(b)(1)benzazepine-11-carboxamide,5oxo6Hbenzo(b)(1)benzazepine11carboxamide,KIN-493,KIN493,GP-47680,GP47680,10,11-Dihydro-10-oxo-5H-d,11Dihydro10oxo5Hd,T0440,SAM001246754,15
04243,Prestw-1156,Oxcarbazepine,CPD000048684}

> <pdid>
PD001213

> <targets>
{Apoptosis,Sodium Channel}

> <classes>
{antipsychotic,Apoptosis,Membrane Transporter/Ion Channel}

> <pubchem_cids>
{34312}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 24  0  0  0  0            999 V2000
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5972    1.5031    0.0000 O   0  0
    2.5951    3.0031    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.8003    1.4887    0.0000 C   0  0
   -9.0990    0.7364    0.0000 C   0  0
  -10.4003    1.4841    0.0000 C   0  0
  -11.6990    0.7318    0.0000 C   0  0
  -13.0003    1.4796    0.0000 C   0  0
  -14.2989    0.7273    0.0000 C   0  0
  -15.5995    1.4746    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  3
  4  5  1  0
  5  6  1  0
  4  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  2  3
 10 11  1  0
 10 12  1  0
 12  3  1  0
 12 13  2  0
  9 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
M  END
> <name>
NIHCC_2014

> <id>
5776

> <plate>
NGP-105-02

> <well>
H03

> <supplier_cmpd_name>
CPD000466364

> <ctcr_id>
6287

> <supplier_cmpd_id>
SAM001246700

> <smiles>
COC1=C(OC)C(=O)C(=C(C)C1=O)CCCCCCCCCCO

> <pd_targets>
{LMNA,RORC,MAPT,TGR,FTL,MAPK1,SIRT2,ALD,HTT,CYP2C9,CYP2D6,CYP3A4,CYP2C19}

> <pathway_gtopdb>
{"Other nuclear protein","Transcription factor","Other cytosolic protein",Enzyme,"Unclassified protein","Epigenetic regulator","Nuclear receptor",Kinase,Eraser,"Cytochrome P450",Transferase,"Nuclear h
ormone receptor subfamily 1","Protein Kinase","Histone deacetylase","Cytochrome P450 family 2","Cytochrome P450 family 3","Nuclear hormone receptor subfamily 1 group F","CMGC protein kinase group","HD
AC class III","Cytochrome P450 family 2C","Cytochrome P450 family 2D","Cytochrome P450 family 3A","Nuclear hormone receptor subfamily 1 group F member 3","CMGC protein kinase MAPK family","Cytochrome 
P450 2C9","Cytochrome P450 2D6","Cytochrome P450 3A4","Cytochrome P450 2C19","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,"Nuclear hormone receptors","Kinases (EC 2.7.x.x)","Chromatin modifying enzymes","Cytochrome P450","1F. Retinoic acid-related orphans","CMGC: Containing CDK",MAPK,GSK3,"CLK families
","3.5.1.- Histone deacetylases (HDACs)","CYP2 family: drug metabolising subset","CYP3 family","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Cell Cycle","Gene expression (Transcription)","Neuronal System","Vesicle-mediated transport","Immune System",Metabolism,Mitotic,"RNA Polymerase II Transcription","Transmission across Chemical Synaps
es","Membrane Trafficking","Innate Immune System","Biological oxidations","Metabolism of lipids","M Phase","Generic Transcription Pathway","Neurotransmitter receptors and postsynaptic signal transmiss
ion","trans-Golgi Network Vesicle Budding","Toll-like Receptor Cascades","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","Mitotic Metaphase and A
naphase","Transcriptional regulation by RUNX3","Activation of NMDA receptors and postsynaptic events","Golgi Associated Vesicle Biogenesis","Toll Like Receptor 5 (TLR5) Cascade","Transcriptional Regul
ation by MECP2","Cytochrome P450 - arranged by substrate type","Biosynthesis of DHA-derived SPMs","Mitotic Anaphase","RUNX3 Regulates Immune Response and Cell Migration","Post NMDA receptor activation
 events","MyD88 cascade initiated on plasma membrane","Regulation of MECP2 expression and activity",Xenobiotics,"Biosynthesis of maresins","Nuclear Envelope (NE) Reassembly","Activation of AMPK downst
ream of NMDARs","MAP kinase activation","CYP2E1 reactions","Biosynthesis of maresin-like SPMs","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases",
"ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{}

> <broad_moa>
{"calcium channel modulator"}

> <synonyms>
{idebenone,58186-27-9,58186279,Idebenona,Idebenonum,"CV 2619","2-(10-hydroxydecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione","2(10hydroxydecyl)5,6dimethoxy3methylcyclohexa2,5diene1,4dione",
CV-2619,CV2619,UNII-HB6PN45W4J,UNIIHB6PN45W4J,"BRN 2001459",CHEBI:31687,"2-(10-Hydroxydecyl)-5,6-dimethoxy-3-methyl-p-benzoquinone","2(10Hydroxydecyl)5,6dimethoxy3methylpbenzoquinone",2-(10,2(10,T0412
,SAM001246700,Prestw-1288,Idebenone,CPD000466364}

> <pdid>
PD000297

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{3686}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 23  0  0  1  0            999 V2000
    5.0973    2.2485    0.0000 Cl  0  0
    2.5951   -3.0031    0.0000 N   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  2  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -2.6030    2.9977    0.0000 O   0  0
   -3.8990    0.7455    0.0000 O   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.4994    0.7432    0.0000 C   0  0
   -7.7985    1.4932    0.0000 C   0  0
   -7.7985    2.9932    0.0000 C   0  0
   -9.0967    3.7462    0.0000 C   0  0
   -9.0947    5.2471    0.0000 C   0  0
  -10.3929    6.0001    0.0000 C   0  0
  -10.3908    7.5001    0.0000 O   0  0
  -11.6932    5.2523    0.0000 O   0  0
   -6.4995    3.7432    0.0000 C   0  0
   -5.2004    2.9933    0.0000 C   0  0
  2  3  1  0
  4  3  1  1
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  4  1  0
  7 10  1  6
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 16 22  1  0
 22 23  2  0
 23 13  1  0
M  END
> <name>
NIHCC_2014

> <id>
5777

> <plate>
NGP-105-02

> <well>
H04

> <supplier_cmpd_name>
CPD000469197

> <ctcr_id>
425

> <supplier_cmpd_id>
SAM001246695

> <smiles>
Cl.NC[C@@H]1CC[C@H](CC1)C(=O)Oc2ccc(CCC(=O)O)cc2

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{27724-96-5,27724965,27724_96_5,"27724 96 5","Cetraxate, Hydrochloride","CETRAXATE HCl",Neuer,DV-1006,DV1006,DV_1006,"DV 1006",UNII-08IT6P8VHY,UNII08IT6P8VHY,UNII_08IT6P8VHY,"UNII 08IT6P8VHY","Cetraxa
te (hydrochloride)",08IT6P8VHY,"27724-96-5 (HCl)","27724965 (HCl)","27724_96_5 (HCl)","27724 96 5 (HCl)",C17H24ClNO4,DSSTox_CID_26459,DSSToxCID26459,DSSTox-CID-26459,"DSSTox CID 26459",DSSTox_RID_8163
3,DSSToxRID81633,DSSTox-RID-81633,"DSSTox RID 81633",DSSTox_GSID_46459,DSSToxGSID46459,DSSTox-GSID-46459,"DSSTox GSID 46459",MLS0014013,SAM001246695,CPD000469197}

> <pdid>
PD013451

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{34001}

$$$$
NIHCC_2014
  SciTegic11012413002D

 32 34  0  0  1  0            999 V2000
   18.6453   -5.8824    0.0000 Cl  0  5
    3.8805   -1.4410    0.0000 O   0  0
    2.4133   -1.7530    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.3114   -2.9665    0.0000 C   0  0
   -0.6923   -4.0811    0.0000 O   0  0
    1.8032   -3.1233    0.0000 N   0  0
    2.5551   -4.4192    0.0000 C   0  0
    4.0559   -4.4171    0.0000 C   0  0
    4.8090   -5.7153    0.0000 C   0  0
    6.3098   -5.7131    0.0000 C   0  0
    7.0629   -7.0113    0.0000 N   0  0
    8.5629   -7.0113    0.0000 C   0  0
    9.3130   -8.3103    0.0000 C   0  0
    8.5631   -9.6094    0.0000 N   0  0
    7.0631   -9.6095    0.0000 C   0  0
    6.3130   -8.3105    0.0000 C   0  0
    9.3135  -10.9091    0.0000 C   0  0
    8.6906  -12.2596    0.0000 N   0  0
    9.8040  -13.2649    0.0000 S   0  0
   11.1032  -12.5168    0.0000 C   0  0
   12.5292  -12.9823    0.0000 C   0  0
   13.6453  -11.9802    0.0000 C   0  0
   13.3354  -10.5125    0.0000 C   0  0
   11.9095  -10.0470    0.0000 C   0  0
   10.7934  -11.0492    0.0000 C   0  0
   16.1453   -5.8824    0.0000 H   0  3
  2  3  2  0
  3  4  1  0
  4  5  1  1
  5  6  1  0
  6  7  1  0
  7  8  1  0
  9  8  1  1
  9  4  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12  3  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 17  1  0
 20 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 23  1  0
 31 26  1  0
M  CHG  2   1  -1  32   1
M  END
> <name>
NIHCC_2014

> <id>
5778

> <plate>
NGP-105-02

> <well>
H05

> <supplier_cmpd_name>
CPD000466362

> <ctcr_id>
5283

> <supplier_cmpd_id>
SAM001246688

> <smiles>
[Cl-].O=C1[C@@H]2CCCC[C@@H]2C(=O)N1CCCCN3CCN(CC3)c4nsc5ccccc45.[H+]

> <pd_targets>
{LMNA,HTR2A,DRD4,DRD3,DRD2,HTR1A,HRH1,ADRA1A,ADRA1B,ADRA1D}

> <pathway_gtopdb>
{"Other nuclear protein","Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Serotonin receptor","Dopamine receptor","Histamine re
ceptor","Adrenergic receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","5-Hydroxytryptamine receptors","Dopamine receptors","Histamine receptors"}

> <pathway_reactome>
{"Cell Cycle","Signal Transduction",Mitotic,"Signaling by GPCR","M Phase","GPCR ligand binding","Mitotic Metaphase and Anaphase","Class A/1 (Rhodopsin-like receptors)","Mitotic Anaphase","Amine ligand
-binding receptors","Nuclear Envelope (NE) Reassembly","Serotonin receptors","Dopamine receptors","Histamine receptors","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{DRD2,DRD3,DRD4}

> <broad_moa>
{"dopamine receptor antagonist","serotonin receptor antagonist"}

> <synonyms>
{"Perospirone hydrochloride",129273-38-7,129273387,"PEROSPIRONE HCl",SM-9018,SM9018,UNII-T884I76TMN,UNIIT884I76TMN,"Perospirone (hydrochloride)",T884I76TMN,Lullan,"129273-38-7 (HCl)","129273387 (HCl)"
,DSSTox_CID_26449,DSSToxCID26449,DSSTox-CID-26449,"DSSTox CID 26449",DSSTox_RID_81623,DSSToxRID81623,DSSTox-RID-81623,"DSSTox RID 81623",DSSTox_GSID_46449,DSSToxGSID46449,DSSTox-GSID-46449,"DSSTox GSI
D 46449",SMR000466362,"SM 9018",CAS-129273-38-7,CAS129273387,N,T4576,SAM001246688,Perospirone,CPD000466362}

> <pdid>
PD013068

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{67108545,115367}

$$$$
NIHCC_2014
  SciTegic11012413002D

 14 15  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
   -2.7248   -1.2135    0.0000 C   0  0
   -3.6065    0.0000    0.0000 N   0  0
   -2.7248    1.2135    0.0000 C   0  0
   -3.1905    2.6376    0.0000 C   0  0
   -2.1885    3.7539    0.0000 N   0  0
   -4.6581    2.9476    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  3
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  2  0
  9 10  1  0
 10 11  1  0
 10 12  2  0
  6 13  1  0
 13  2  1  0
 13 14  2  0
M  END
> <name>
NIHCC_2014

> <id>
5779

> <plate>
NGP-105-02

> <well>
H06

> <supplier_cmpd_name>
CPD000466338

> <ctcr_id>
5602

> <supplier_cmpd_id>
SAM001246636

> <smiles>
CN1N=Nc2n(cnc2C(N)=O)C1=O

> <pd_targets>
{KMT2A,MEN1}

> <pathway_gtopdb>
{"Epigenetic regulator",Reader,Bromodomain}

> <pathway_chembl>
{}

> <pathway_reactome>
{}

> <broad_targets>
{MGMT}

> <broad_moa>
{"DNA alkylating agent"}

> <synonyms>
{temozolomide,85622-93-1,85622931,Methazolastone,Temodal,Temodar,Temozolamide,"3-methyl-4-oxo-3,4-dihydroimidazo(5,1-d)(1,2,3,5)tetrazine-8-carboxamide","3methyl4oxo3,4dihydroimidazo(5,1d)(1,2,3,5)tet
razine8carboxamide","Temozolomidum (Latin)","Sch 52365","Temozolodida (Spanish)",Temozolomidum,"CCRG 81045",CCRG-81045,CCRG81045,T1178,362856,S1237,SAM001246636,Prestw-1183,"NSC 362856",Temozolomide,C
PD000466338}

> <pdid>
PD001314

> <targets>
{Apoptosis,Autophagy,DNA Alkylator/Crosslinker}

> <classes>
{Alkylating agent,Apoptosis,Autophagy,Cell Cycle/DNA Damage}

> <pubchem_cids>
{5394}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 23  0  0  0  0            999 V2000
    7.5973    0.3727    0.0000 H   0  3
    5.0973    0.3727    0.0000 Cl  0  5
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0031    3.0008    0.0000 O   0  0
    1.3032    3.7490    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -2.6030    2.9977    0.0000 O   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.8003    1.4887    0.0000 N   0  0
   -9.1517    0.8676    0.0000 C   0  0
  -10.1554    1.9823    0.0000 C   0  0
   -9.4054    3.2814    0.0000 C   0  0
   -7.9382    2.9695    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 O   0  0
   -2.5951   -3.0031    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  7 10  2  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 16  1  0
 10 21  1  0
 21 22  1  0
 22 23  1  0
 21 24  2  0
 24  5  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5780

> <plate>
NGP-105-02

> <well>
H07

> <supplier_cmpd_name>
CPD000058803

> <ctcr_id>
618

> <supplier_cmpd_id>
SAM001246680

> <smiles>
[H+].[Cl-].COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1

> <pd_targets>
{SIGMAR1,ERG2,EBP,CYP2D6,LMNA}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Other nuclear protein",Isomerase,"Cytochrome P450","Cytochrome P450 family 2","Cytochrome P450 family 2D","Cytochrome P450 2D6"}

> <pathway_chembl>
{"Other protein targets",Enzymes,"Sigma receptors","Cytochrome P450","CYP2 family: drug metabolising subset"}

> <pathway_reactome>
{Disease,Metabolism,"Cell Cycle","Infectious disease","Metabolism of lipids","Biological oxidations",Mitotic,"SARS-CoV Infections","Metabolism of steroids","Phase I - Functionalization of compounds","
M Phase","Potential therapeutics for SARS","Cholesterol biosynthesis","Cytochrome P450 - arranged by substrate type","Mitotic Metaphase and Anaphase","Cholesterol biosynthesis via desmosterol",Xenobio
tics,"Mitotic Anaphase","CYP2E1 reactions","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ADRA1A}

> <broad_moa>
{"adrenergic receptor antagonist","calcium channel blocker"}

> <synonyms>
{"1-(3-(2,4,6-Trimethoxybenzoyl)propyl)pyrrolidinium chloride","1(3(2,4,6Trimethoxybenzoyl)propyl)pyrrolidinium chloride","1 (3 (2,4,6 Trimethoxybenzoyl)propyl)pyrrolidinium chloride","Botamiral (TN)"
,ACMC-20ap06,ACMC20ap06,ACMC,SAM001246680,Prestw-426,CPD000058803,"Buflomedil hydrochloride"}

> <pdid>
PD013131

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{37170,6420013}

$$$$
NIHCC_2014
  SciTegic11012413002D

 38 40  0  0  1  0            999 V2000
   12.7994   -2.2704    0.0000 Cl  0  5
    5.1852    3.0091    0.0000 C   0  0
    5.1903    1.5091    0.0000 C   0  0  2  0  0  0
    3.8939    0.7546    0.0000 O   0  0
    3.8990   -0.7455    0.0000 C   0  0  2  0  0  0
    5.2007   -1.4909    0.0000 C   0  0
    6.4972   -0.7364    0.0000 C   0  0  2  0  0  0
    7.7988   -1.4819    0.0000 N   0  0
    6.4920    0.7636    0.0000 C   0  0  2  0  0  0
    7.7884    1.5180    0.0000 O   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
    1.3170    2.2180    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 O   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -3.8971   -3.7500    0.0000 C   0  0
   -5.1961   -3.0000    0.0000 O   0  0
   -3.8971   -5.2500    0.0000 C   0  0
   -5.1961   -6.0000    0.0000 C   0  0
   -5.1961   -7.5000    0.0000 C   0  0
   -3.8971   -8.2500    0.0000 C   0  0
   -2.5980   -7.5000    0.0000 C   0  0
   -2.5980   -6.0000    0.0000 C   0  0
   -1.2990   -5.2500    0.0000 C   0  0
    0.0000   -6.0000    0.0000 O   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    1.2991   -3.7500    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -1.2999    2.2084    0.0000 C   0  0
   -1.2998    3.7084    0.0000 C   0  0
   -2.5993    1.4590    0.0000 O   0  0
   10.2994   -2.2704    0.0000 H   0  3
  3  2  1  1
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  1
  7  9  1  0
  9  3  1  0
  9 10  1  1
  5 11  1  6
 12 11  1  6
 12 13  1  0
 13 14  1  0
 14 15  1  6
 14 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 28 29  1  0
 29 30  2  0
 29 31  1  0
 31 20  2  0
 31 32  1  0
 32 33  1  0
 32 34  2  0
 34 12  1  0
 34 17  1  0
 14 35  1  0
 35 36  1  0
 35 37  2  0
M  CHG  2   1  -1  38   1
M  END
> <name>
NIHCC_2014

> <id>
5781

> <plate>
NGP-105-02

> <well>
H08

> <supplier_cmpd_name>
CPD000466355

> <ctcr_id>
2024

> <supplier_cmpd_id>
SAM001246676

> <smiles>
[Cl-].C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]2C[C@@](O)(Cc3c(O)c4C(=O)c5ccccc5C(=O)c4c(O)c23)C(C)=O.[H+]

> <pd_targets>
{PMP22,SKA,THRB,RECQL,KMT2A,MEN1,KDM4E,BLM,HSF1,ALDH1A1,LMNA,NFO,MAPT,USP2,APEX1,RORC,POLB,HTT,MAPK1,MTOR,TOP2A,CHRM1,HBB,DAF-12,GNAI1,RGS12,STAT6,BRCA1,CYP1A2,HIF1A,ALOX15,TP53,THPO,CYP3A4,NFKB1,TSHR
,NR1H2,S100A4,PAX8}

> <pathway_gtopdb>
{"Unclassified protein",Enzyme,"Transcription factor","Epigenetic regulator","Other cytosolic protein","Other nuclear protein",Kinase,"Nuclear receptor",Reader,Eraser,Oxidoreductase,Hydrolase,Protease
,Isomerase,"Nuclear hormone receptor subfamily 1",Bromodomain,"Lysine demethylase","Cysteine protease","Protein Kinase","Nuclear hormone receptor subfamily 1 group A","Jumonji domain-containing","Cyst
eine protease CA clan","Nuclear hormone receptor subfamily 1 group F","CMGC protein kinase group","Atypical protein kinase group","Nuclear hormone receptor subfamily 1 group A member 2","Cysteine prot
ease C19 family","Nuclear hormone receptor subfamily 1 group F member 3","CMGC protein kinase MAPK family","Atypical protein kinase PIKK family","CMGC protein kinase ERK1","Atypical protein kinase FRA
P subfamily","Membrane receptor","Secreted protein","Family A G protein-coupled receptor","Cytochrome P450","Small molecule receptor (family A GPCR)","Cytochrome P450 family 1","Cytochrome P450 family
 3","Peptide receptor (family A GPCR)","Monoamine receptor","Cytochrome P450 family 1A","Cytochrome P450 family 3A","Glycohormone receptor","Nuclear hormone receptor subfamily 1 group H","Acetylcholin
e receptor","Cytochrome P450 1A1","Cytochrome P450 3A4","Nuclear hormone receptor subfamily 1 group H member 3"}

> <pathway_chembl>
{Receptors,Enzymes,"Nuclear hormone receptors","Chromatin modifying enzymes","Peptidases and proteinases","Kinases (EC 2.7.x.x)","DNA topoisomerases","1A. Thyroid hormone receptors","1.14.11.- Histone
 demethylases","CA: Cysteine (C) Peptidases","2.1.1.43 Histone methyltransferases (HMTs)","1F. Retinoic acid-related orphans","CMGC: Containing CDK",MAPK,GSK3,"CLK families",Atypical,"C19: Ubiquitin-s
pecific protease","Mitogen-activated protein kinases (MAP kinases)","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","ERK subfamily","FRAP subfamily","Other protein targets","G protein-
coupled receptors","Transcription factors","Cytochrome P450","Eicosanoid turnover","Acetylcholine receptors (muscarinic)","STAT transcription factors","CYP1 family",Lipoxygenases,"CYP3 family","Glycop
rotein hormone receptors","1H. Liver X receptor-like receptors"}

> <pathway_reactome>
{"Developmental Biology","Metabolism of proteins","DNA Repair","Cellular responses to external stimuli",Metabolism,"Cell Cycle","Neuronal System","Gene expression (Transcription)","Immune System","Ner
vous system development","Post-translational protein modification","DNA Double-Strand Break Repair","Cellular responses to stress","Biological oxidations",Mitotic,"Transmission across Chemical Synapse
s","RNA Polymerase II Transcription","Base Excision Repair","Innate Immune System","EGR2 and SOX10-mediated initiation of Schwann cell myelination",SUMOylation,"Homology Directed Repair","Cellular res
ponse to heat stress","Phase I - Functionalization of compounds","M Phase","Neurotransmitter receptors and postsynaptic signal transmission","Generic Transcription Pathway","Resolution of Abasic Sites
 (AP sites)","Toll-like Receptor Cascades","Mitotic G1 phase and G1/S transition","SUMO E3 ligases SUMOylate target proteins","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SS
A)","HSF1-dependent transactivation","Ethanol oxidation","Mitotic Metaphase and Anaphase","Activation of NMDA receptors and postsynaptic events","Transcriptional Regulation by TP53","Transcriptional r
egulation by RUNX1","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Transcriptional regulation by RUNX3","Transcriptional Regulation by MECP2","Toll Like Receptor 5 (TL
R5) Cascade","G0 and Early G1","SUMOylation of intracellular receptors","HDR through Homologous Recombination (HRR)","Attenuation phase","Mitotic Anaphase","Post NMDA receptor activation events","Regu
lation of TP53 Activity","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","PCNA-Dependent Long Patch Base Excision Repair","RUNX3 Regulates Immune Response and C
ell Migration","Regulation of MECP2 expression and activity","MyD88 cascade initiated on plasma membrane","Transcription of E2F targets under negative control by DREAM complex","Homologous DNA Pairing
 and Strand Exchange","Nuclear Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs","Regulation of TP53 Expression and Degradation","MAP kinase activation","Presynaptic phase of homolog
ous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation","Regulation of TP53 Degradation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs 
are inactivated","Signal Transduction",Hemostasis,Disease,"Signaling by GPCR","Metabolism of lipids","Cell Cycle Checkpoints","Platelet activation","signaling and aggregation","Cytokine Signaling in I
mmune system","Infectious disease","GPCR ligand binding","Neutrophil degranulation","Cytosolic sensors of pathogen-associated DNA","Cellular response to hypoxia","Biosynthesis of specialized proresolv
ing mediators (SPMs)","G1/S DNA Damage Checkpoints","Platelet Aggregation (Plug Formation)","Signaling by Interleukins","Leishmania infection","Class A/1 (Rhodopsin-like receptors)","STING mediated in
duction of host immune responses","Cytochrome P450 - arranged by substrate type","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Biosynthesis of DPA-derived SPMs","p53-Depe
ndent G1/S DNA damage checkpoint","Biosynthesis of DHA-derived SPMs","Interleukin-1 family signaling","Leishmania parasite growth and survival","Amine ligand-binding receptors","STAT6-mediated inducti
on of chemokines",Xenobiotics,"Biosynthesis of DPAn-3 SPMs","p53-Dependent G1 DNA Damage Response","Biosynthesis of maresins","Interleukin-1 signaling","Anti-inflammatory response favouring Leishmania
 parasite infection","Muscarinic acetylcholine receptors","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Biosynthesis of DPAn-3-derived protectins and resolvins","Stabilization of
 p53","Biosynthesis of maresin-like SPMs","MAP3K8 (TPL2)-dependent MAPK1/3 activation","ADORA2B mediated anti-inflammatory cytokines production","Autodegradation of the E3 ubiquitin ligase COP1"}

> <broad_targets>
{TOP2A}

> <broad_moa>
{"topoisomerase inhibitor"}

> <synonyms>
{"idarubicin hydrochloride","Idarubicin Hcl",57852-57-0,57852570,"57852 57 0",Zavedos,Idamycin,"Idarubicin (hydrochloride)",UNII-5VV3MDU5IE,UNII5VV3MDU5IE,"UNII 5VV3MDU5IE","IMI 30",5VV3MDU5IE,Idarubi
cinhydrochloride,CPD000466355,IMI-30,IMI30,256439,"Idarubicin hydrochloride",SAM001246676}

> <pdid>
PD002710

> <targets>
{Antibiotic,Autophagy,Bacterial,Fungal,Topoisomerase}

> <classes>
{Topoisomerase II Inhibitors,Anti-infection,Autophagy,Cell Cycle/DNA Damage}

> <pubchem_cids>
{636362}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 29  0  0  0  0            999 V2000
    3.8926   -3.7566    0.0000 C   0  0
    2.5951   -3.0039    0.0000 O   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.2637    1.8997    0.0000 C   0  0
    1.7485    3.3085    0.0000 C   0  0
    2.7108    4.4591    0.0000 C   0  0
    4.1885    4.2009    0.0000 C   0  0
    4.7037    2.7922    0.0000 C   0  0
    3.7414    1.6416    0.0000 C   0  0
    3.7469    0.1408    0.0000 N   0  3
    2.4504   -0.6136    0.0000 O   0  5
    5.0483   -0.6052    0.0000 O   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
   -0.0031    3.0008    0.0000 C   0  0
    1.2946    3.7531    0.0000 O   0  0
   -1.3039    3.7494    0.0000 O   0  0
   -1.3070    5.2502    0.0000 C   0  0
   -2.6078    5.9988    0.0000 C   0  0
   -2.6109    7.4988    0.0000 C   0  0
   -3.9056    5.2465    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
  6 16  1  0
 16 17  2  3
 17 18  1  0
 17 19  1  0
 19 20  2  3
 20  5  1  0
 20 21  1  0
 16 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 26 28  1  0
M  CHG  2  13   1  14  -1
M  END
> <name>
NIHCC_2014

> <id>
5782

> <plate>
NGP-105-02

> <well>
H09

> <supplier_cmpd_name>
CPD000466370

> <ctcr_id>
978

> <supplier_cmpd_id>
SAM001246719

> <smiles>
COC(/O)=C1/C(c2ccccc2[N+]([O-])=O)C(=C(C)N=C1C)C(=O)OCC(C)C

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{63675-72-9,Sular,Nisocor,Zadipina,"Bay k 5552",Nisoldipinum,Baymycard,Syscor,"Nisoldipinum (INN-Latin)","Nisoldipino (INN-Spanish)",Bay-k-5552,"BAY-k 5552",CHEBI:76917,MFCD00478055,CHEMBL441428,Nisol
dipin,Nisoldipino,NCGC00164633-01,DSSTox_CID_3371,DSSTox_RID_76999,DSSTox_GSID_23371,SMR000466370,CAS-63675-72-9,"Sular (TN)",SR-05000002009,"EINECS 264-407-7","BRN 0454188","Nisoldipine (JAN/USAN/INN
)",Nisoldipine;,"Nisoldipine,(S)","Nisoldipine (USAN:INN:BAN:JAN)",1219795-47-7,"Nisoldipine, ~97",(.+/-.)-Nisoldipine,CHEMBL1726,SCHEMBL39779,MLS000759498,MLS001424102,MLS002153943,BIDD:GT0684,GTPL25
24,CHEMBL3192341,DTXSID0023371,"Nisoldipine, >=98 (HPLC)",HMS2051O18,HMS2089K20,HMS2093F15,HMS2097E13,HMS2231L20,HMS3393O18,HMS3651K17,HMS3714E13,HMS3744O19,HMS3884I08,Pharmakon1600-01505390,BCP22696,
Tox21_112251,Tox21_302365,AC-987,BBL028683,BDBM50101963,BDBM50227259,DL-255,KM0774,NSC759106,s1748,STK631543,AKOS005563632,Tox21_112251_1,CCG-100894,CCG-213412,CS-1131,DB00401,KS-5188,MCULE-5009799152
,NC00144,"Nisoldipine 100 microg/mL in Methanol",NSC-759106,"Bay K 5552;BAY-K 5552;Sular",NCGC00164633-02,NCGC00164633-03,NCGC00255136-01,"6-BROMO-2,3-DIMETHOXYBENZOICACID",AK143131,HY-17402,SBI-02068
30.P001,((c)I)-Nisoldipine-d4(2-nitrophenyl-d4),AB0106136,FT-0601599,N0900,SW219237-1,C07699,D00618,J10291,AB01275444-01,AB01275444_02,675N729,A834466,Q3342150,SR-05000002009-1,SR-05000002009-2,SR-050
00002009-3,BRD-A84465106-001-01-2,Z277942268,SAM001246719,CPD000466370}

> <pdid>
PD003071

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{4499}

$$$$
NIHCC_2014
  SciTegic11012413002D

 16 17  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 N   0  0
    0.0000    3.0008    0.0000 C   0  0  2  0  0  0
    1.2121    3.8625    0.0000 O   0  0
    0.7463    5.2884    0.0000 C   0  0  2  0  0  0
    1.6276    6.5001    0.0000 C   0  0
    3.1194    6.3435    0.0000 O   0  0
   -0.7537    5.2860    0.0000 C   0  0
   -1.2149    3.8587    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  0
  7  8  1  1
  8  9  1  0
  7 10  1  0
 10 11  2  3
 11  5  1  0
  4 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15  2  1  0
 15 16  2  0
M  END
> <name>
NIHCC_2014

> <id>
5783

> <plate>
NGP-105-02

> <well>
H10

> <supplier_cmpd_name>
CPD000058350

> <ctcr_id>
6699

> <supplier_cmpd_id>
SAM001246729

> <smiles>
CC1=CN([C@@H]2O[C@H](CO)C=C2)C(=O)NC1=O

> <pd_targets>
{BLM,POLB,CHRM1,ALB,"REVERSE TRANSCRIPTASE",POL,LMNA,ALDH1A1}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Secreted protein","Other nuclear protein","Family A G protein-coupled receptor",Hydrolase,Oxidoreductase,"Small molecule receptor (family A GPCR)","Monoamine receptor","Ac
etylcholine receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Acetylcholine receptors (muscarinic)"}

> <pathway_reactome>
{"DNA Repair","Signal Transduction",Metabolism,"Cell Cycle","DNA Double-Strand Break Repair","Base Excision Repair","Signaling by GPCR","Metabolism of lipids",Mitotic,"Biological oxidations","Homology
 Directed Repair","Resolution of Abasic Sites (AP sites)","GPCR ligand binding","Metabolism of steroids","M Phase","Phase I - Functionalization of compounds","HDR through Homologous Recombination (HRR
) or Single Strand Annealing (SSA)","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Class A/1 (Rhodopsin-like receptors)","Bile acid and bile salt metabolism","Mitotic 
Metaphase and Anaphase","Ethanol oxidation","HDR through Homologous Recombination (HRR)","PCNA-Dependent Long Patch Base Excision Repair","Amine ligand-binding receptors","Recycling of bile acids and 
salts","Mitotic Anaphase","Homologous DNA Pairing and Strand Exchange","Muscarinic acetylcholine receptors","Nuclear Envelope (NE) Reassembly","Presynaptic phase of homologous DNA pairing and strand e
xchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{}

> <broad_moa>
{"DNA directed DNA polymerase inhibitor","nucleoside reverse transcriptase inhibitor"}

> <synonyms>
{3056-17-5,3056175,sanilvudine,Zerit,"2',3'-Didehydro-3'-deoxythymidine","2',3'Didehydro3'deoxythymidine","Zerit Xr",BMY-27857,BMY27857,Estavudina,Stavudinum,"Stavudinum (INN-Latin)","Stavudinum (INNL
atin)","2',3'-Anhydrothymidine","2',3'Anhydrothymidine","Estavudina (INN-Spanish)","Estavudina (INNSpanish)",d4T,"Thymidine, 2',3'-didehydro-3'-deoxy-","Thymidine, 2',3'didehydro3'deoxy",3'-Deoxy,3'De
oxy,SAM002589948,SAM001246729,Prestw-1279,CPD000673569,CPD000058350,Stavudine}

> <pdid>
PD001676

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{18283}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 25  0  0  0  0            999 V2000
    6.3813   -0.2065    0.0000 Cl  0  0
    3.8805   -1.4410    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -2.5973    1.5031    0.0000 C   0  0
   -2.5951    3.0039    0.0000 C   0  0
   -1.3786    3.8595    0.0000 N   0  0
   -1.8372    5.2877    0.0000 C   0  0
   -3.3372    5.2929    0.0000 N   0  0
   -3.8056    3.8679    0.0000 C   0  0
   -5.2311    3.4009    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
   -0.5701   -4.1788    0.0000 C   0  0
    0.0400   -5.5491    0.0000 C   0  0
    1.5318   -5.7059    0.0000 C   0  0
    2.4135   -4.4923    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13  9  2  0
 13 14  1  0
  7 15  1  0
 15 16  2  0
 15 17  1  0
 17  4  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23  3  1  0
 23 18  1  0
M  END
> <name>
NIHCC_2014

> <id>
5784

> <plate>
NGP-105-02

> <well>
H11

> <supplier_cmpd_name>
CPD000469211

> <ctcr_id>
3243

> <supplier_cmpd_id>
SAM001246782

> <smiles>
Cl.Cn1c2CCN(Cc3nc[nH]c3C)C(=O)c2c4ccccc14

> <pd_targets>
{HTR3A,KCNH2,CYP3A4,SENP8,CASP6,CYP1A2,HTR2B}

> <pathway_gtopdb>
{"Ion channel",Enzyme,"Membrane receptor","Ligand-gated ion channel","Voltage-gated ion channel","Cytochrome P450",Protease,"Family A G protein-coupled receptor","5HT3 receptor","Potassium channels","
Cytochrome P450 family 3","Cysteine protease","Cytochrome P450 family 1","Small molecule receptor (family A GPCR)","Voltage-gated potassium channel","Cytochrome P450 family 3A","Cysteine protease CE c
lan","Cysteine protease CD clan","Cytochrome P450 family 1A","Monoamine receptor","Cytochrome P450 3A4","Cysteine protease C48 family","Cysteine protease C14 family","Cytochrome P450 1A1","Serotonin r
eceptor"}

> <pathway_chembl>
{"Ion channels",Enzymes,Receptors,"Ligand-gated ion channels","Voltage-gated ion channels","Cytochrome P450","Peptidases and proteinases","G protein-coupled receptors","5-HT<sub>3</sub> receptors","Po
tassium channels","CYP3 family","CE: Cysteine (C) Peptidases","CD: Cysteine (C) Peptidases","CYP1 family","5-Hydroxytryptamine receptors","Voltage-gated potassium channels","C48: Ulp1 endopeptidase","
C14: Caspase"}

> <pathway_reactome>
{"Neuronal System","Muscle contraction",Metabolism,"Metabolism of proteins","Gene expression (Transcription)","Signal Transduction","Transmission across Chemical Synapses","Cardiac conduction","Metabo
lism of lipids","Post-translational protein modification","RNA Polymerase II Transcription","Biological oxidations","Signaling by GPCR","Neurotransmitter receptors and postsynaptic signal transmission
","Phase 3 - rapid repolarisation","Biosynthesis of specialized proresolving mediators (SPMs)",Deubiquitination,"Generic Transcription Pathway","Phase I - Functionalization of compounds","GPCR ligand 
binding","Biosynthesis of DHA-derived SPMs","UCH proteinases","Transcriptional Regulation by TP53","Cytochrome P450 - arranged by substrate type","Class A/1 (Rhodopsin-like receptors)","Biosynthesis o
f maresins","TP53 Regulates Transcription of Cell Death Genes",Xenobiotics,"Amine ligand-binding receptors","Biosynthesis of maresin-like SPMs","TP53 Regulates Transcription of Caspase Activators and 
Caspases","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Serotonin receptors"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"ALOSETRON HYDROCHLORIDE",122852-69-1,122852691,"Alosetron HCl","GR 68755c","Alosetron (Hydrochloride)",UNII-2F5R1A46YW,UNII2F5R1A46YW,"Alosetron Hydrochloride(1:X)","Alosetron hydrochloride (USAN)",
132414-02-9,132414029,"Alosetron (Hydrochloride(1:X))","GR 68",T2525,SAM001246782,"Alosetron hydrochloride",CPD000469211}

> <pdid>
PD009613

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{60758,44558893}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 22  0  0  1  0            999 V2000
    7.7808  -10.5183    0.0000 C   0  0
    6.4833   -9.7656    0.0000 C   0  0
    5.1830  -10.5134    0.0000 C   0  0
    6.4855   -8.2648    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0  2  0  0  0
    5.1894   -6.0109    0.0000 N   0  0
    3.8912   -5.2578    0.0000 C   0  0
    2.5909   -6.0056    0.0000 O   0  0
    3.8933   -3.7570    0.0000 C   0  0  1  0  0  0
    5.1937   -3.0093    0.0000 O   0  0
    2.5951   -3.0039    0.0000 C   0  0  2  0  0  0
    1.2948   -3.7516    0.0000 N   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8847   -8.2572    0.0000 C   0  0
    3.8794   -9.7572    0.0000 O   0  0
    2.5880   -7.5031    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  6
  9 11  1  0
 11 12  1  6
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
  5 20  1  0
 20 21  1  0
 20 22  2  0
M  END
> <name>
NIHCC_2014

> <id>
5785

> <plate>
NGP-105-03

> <well>
A02

> <supplier_cmpd_name>
CPD000059165

> <ctcr_id>
728

> <supplier_cmpd_id>
SAM001246806

> <smiles>
CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(O)=O

> <pd_targets>
{ANPEP,LNPEP,LAP3,NPEPPS,LTA4H,MMP2,RNPEP,SLC15A2,LMNA,APEX1,PMP22,NPSR1,ERAP1,MAPT,GAA,LEF,BLM}

> <pathway_gtopdb>
{Enzyme,Transporter,"Other nuclear protein","Unclassified protein","Membrane receptor","Other cytosolic protein",Protease,"Electrochemical transporter","Family A G protein-coupled receptor",Hydrolase,
"Metallo protease","SLC superfamily of solute carriers","Peptide receptor (family A GPCR)","Metallo protease MAE clan","Metallo protease MF clan","Metallo protease MAM clan","Metallo protease MH clan"
,"SLC15 family of peptide transporters","Short peptide receptor (family A GPCR)","Metallo protease M1 family","Metallo protease M17 family","Metallo protease M10A subfamily","Metallo protease M28 fami
ly","Neuropeptide receptor","Metallo protease M34 family","Metallo protease M28A subfamily"}

> <pathway_chembl>
{Enzymes,Transporters,Receptors,"Peptidases and proteinases","SLC superfamily of solute carriers","G protein-coupled receptors","3.2.1.- Glycosidases","MA: Metallo (M) Peptidases","MF: Metallo (M) Pep
tidases","SLC15 family of peptide transporters","Neuropeptide S receptor","M1: Aminopeptidase N","M17: Leucyl aminopeptidase","M10: Matrix metallopeptidase"}

> <pathway_reactome>
{"Immune System",Metabolism,"Developmental Biology","Transport of small molecules","Cell Cycle","DNA Repair",Disease,"Neuronal System","Innate Immune System","Adaptive Immune System","Metabolism of li
pids","Nervous system development","SLC-mediated transmembrane transport",Mitotic,"Base Excision Repair","Infectious disease","Transmission across Chemical Synapses","Diseases of metabolism","Neutroph
il degranulation","Class I MHC mediated antigen processing & presentation","Biosynthesis of specialized proresolving mediators (SPMs)","Axon guidance","Transport of inorganic cations/anions and amino 
acids/oligopeptides","M Phase","Resolution of Abasic Sites (AP sites)","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Leishmania infection","Neurotransmitter receptors and postsynap
tic signal transmission","Diseases of carbohydrate metabolism","Uptake and actions of bacterial toxins","Antigen processing-Cross presentation","Antigen processing: Ubiquitination & Proteasome degrada
tion","Biosynthesis of DHA-derived SPMs","EPH-Ephrin signaling","Proton/oligopeptide cotransporters","Mitotic Metaphase and Anaphase","Resolution of AP sites via the multiple-nucleotide patch replacem
ent pathway","Leishmania parasite growth and survival","Antigen Presentation: Folding","assembly and peptide loading of class I MHC","Activation of NMDA receptors and postsynaptic events","Glycogen st
orage diseases","Uptake and function of anthrax toxins","Endosomal/Vacuolar pathway","Biosynthesis of aspirin-triggered D-series resolvins","EPH-ephrin mediated repulsion of cells","Mitotic Anaphase",
"PCNA-Dependent Long Patch Base Excision Repair","Anti-inflammatory response favouring Leishmania parasite infection","Post NMDA receptor activation events","Glycogen storage disease type II (GAA)","N
uclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Activation of AMPK downstream of NMDARs","Initiation of Nuclear Envelope (NE) Reformation","DNA Double-Stran
d Break Repair","Homology Directed Repair","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","HDR through Homologous Recombination (HRR)","Homologous DNA Pairing and Strand
 Exchange","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{LTA4H,RNPEP}

> <broad_moa>
{"leukotriene synthesis inhibitor"}

> <synonyms>
{BRD-K59574735-001-05-0,BRDK59574735001050,Q10909912,Bestatin,Ubenimex,58970-76-6,58970766,"(S)-2-((2S,3R)-3-amino-2-hydroxy-4-phenylbutanamido)-4-methylpentanoic acid","(S)2((2S,3R)3amino2hydroxy4phe
nylbutanamido)4methylpentanoic acid","Ubenimex (Bestatin)",UNII-I0J33N5627,UNIII0J33N5627,"N-((2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl)-L-leucine","N((2S,3R)3Amino2hydroxy4phenylbutyryl)Lleucine",MFC
D00,T1257,T3529,SAM001246806,"Bestatin hydrochloride",CPD000059165}

> <pdid>
PD003128

> <targets>
{Aminopeptidase,Antibiotic,Bacterial}

> <classes>
{Anti-infection,Metabolic Enzyme/Protease}

> <pubchem_cids>
{72172,6992132}

$$$$
NIHCC_2014
  SciTegic11012413002D

 13 15  0  0  0  0            999 V2000
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
   -2.4133    1.7530    0.0000 N   0  0
   -1.8032    3.1233    0.0000 C   0  0
   -2.4135    4.4923    0.0000 C   0  0
   -1.5318    5.7059    0.0000 C   0  0
   -0.0400    5.5491    0.0000 C   0  0
    0.5701    4.1788    0.0000 C   0  0
   -0.3115    2.9665    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  1  1  0
  4  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  3  1  0
 13  8  1  0
M  END
> <name>
NIHCC_2014

> <id>
5786

> <plate>
NGP-105-03

> <well>
A03

> <supplier_cmpd_name>
CPD000059115

> <ctcr_id>
1275

> <supplier_cmpd_id>
SAM001246862

> <smiles>
C1Cc2c(CN1)[nH]c3ccccc23

> <pd_targets>
{HTR5A,ADRA2A,ADRA2B,ADRA2C,HTR2A,NISCH,ACHE,KDM4E}

> <pathway_gtopdb>
{"Membrane receptor","Other cytosolic protein",Enzyme,"Epigenetic regulator","Family A G protein-coupled receptor",Hydrolase,Eraser,"Small molecule receptor (family A GPCR)","Lysine demethylase","Mono
amine receptor","Jumonji domain-containing","Serotonin receptor","Adrenergic receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Acetylcholine turnover","Chromatin modifying enzymes","5-Hydroxytryptamine receptors","1.14.11.- Histone demethylases"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,"Signaling by GPCR","Metabolism of lipids","GPCR ligand binding","Phospholipid metabolism","Class A/1 (Rhodopsin-like receptors)","Glycerophospholipid biosynthesis","
Amine ligand-binding receptors","Synthesis of PC","Serotonin receptors"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{Tryptoline,16502-01-5,16502015,"16502 01 5","2,3,4,9-tetrahydro-1H-Pyrido(3,4-b)indole","2,3,4,9tetrahydro1HPyrido(3,4b)indole","2,3,4,9 tetrahydro 1H Pyrido(3,4 b)indole",Noreleagnine,"1,2,3,4-Tetra
hydro-9H-pyrido(3,4-b)indole","1,2,3,4Tetrahydro9Hpyrido(3,4b)indole","1,2,3,4 Tetrahydro 9H pyrido(3,4 b)indole",Tetrahydro-beta-carboline,Tetrahydrobetacarboline,"Tetrahydro beta carboline","1,2,3,4
-Tetrahydro-beta-carboline","1,2,3,4Tetrahydrobetacarboline","1,2,3,4 Tetrahydro beta carboline",THBC,Tetrahydronorharman,1H-Pyrido(3,1HPyrido(3,"1H Pyrido(3",4-b)indole,4b)indole,"4 b)indole",2,3,4,9
,SAM001246862,CPD000059115}

> <pdid>
PD002831

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{107838}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 18  0  0  0  0            999 V2000
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
   -2.5987   -1.5004    0.0000 N   0  0
   -2.7343   -2.9815    0.0000 N   0  0
   -4.2010   -3.2957    0.0000 C   0  0
   -4.8089   -4.6670    0.0000 C   0  0
   -4.9530   -1.9978    0.0000 C   0  0
   -3.9511   -0.8815    0.0000 C   0  0
   -4.2568    0.5852    0.0000 O   0  0
   -5.6812    1.0554    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  5  7  2  0
  7  8  1  0
  8  9  2  0
  9  3  1  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
 15 10  1  0
 15 16  1  0
 16 17  1  0
M  END
> <name>
NIHCC_2014

> <id>
5787

> <plate>
NGP-105-03

> <well>
A04

> <supplier_cmpd_name>
CPD000058715

> <ctcr_id>
4768

> <supplier_cmpd_id>
SAM001246891

> <smiles>
COc1cc(C)nc(n1)n2nc(C)cc2OC

> <pd_targets>
{NS1,RORC,CYP1A2,KMT2A,MEN1,AMPC,FFP}

> <pathway_gtopdb>
{"Unclassified protein","Transcription factor",Enzyme,"Epigenetic regulator","Nuclear receptor","Cytochrome P450",Reader,Hydrolase,Transferase,"Nuclear hormone receptor subfamily 1","Cytochrome P450 f
amily 1",Bromodomain,"Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family 1A","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 1A1"}

> <pathway_chembl>
{Receptors,Enzymes,"Nuclear hormone receptors","Cytochrome P450","1F. Retinoic acid-related orphans","CYP1 family"}

> <pathway_reactome>
{"Gene expression (Transcription)",Metabolism,"RNA Polymerase II Transcription","Biological oxidations","Generic Transcription Pathway","Phase I - Functionalization of compounds","Transcriptional regu
lation by RUNX3","Cytochrome P450 - arranged by substrate type","RUNX3 Regulates Immune Response and Cell Migration",Xenobiotics,"Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2"}

> <broad_targets>
{PTGS1,PTGS2}

> <broad_moa>
{"cyclooxygenase inhibitor"}

> <synonyms>
{Prestwick2_000032,Prestwick2000032,Prestwick2-000032,"Prestwick2 000032",Prestwick3_000032,Prestwick3000032,Prestwick3-000032,"Prestwick3 000032",epirizole,Mepirizole,18694-40-1,18694401,"18694 40 1"
,Methopyrimazole,Mebron,4-Methoxy-2-(5-meth,4Methoxy2(5meth,SAM001246891,Prestw-32,CPD000058715,Epirizole}

> <pdid>
PD003104

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{3242}

$$$$
NIHCC_2014
  SciTegic11012413002D

 13 13  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.1996    1.4928    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3032   -3.7490    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  6 10  1  0
 10 11  2  0
 11  3  1  0
 11 12  1  0
 12 13  1  0
M  END
> <name>
NIHCC_2014

> <id>
5788

> <plate>
NGP-105-03

> <well>
A05

> <supplier_cmpd_name>
CPD000112358

> <ctcr_id>
4802

> <supplier_cmpd_id>
SAM001246869

> <smiles>
COc1ccc(CCN)cc1OC

> <pd_targets>
{HTR1A,HTR1B,HTR1D,HTR1F,HTR2A,HTR2B,HTR2C,HTR3A,HTR3B,HTR4,HTR5A,HTR5B,HTR6,HTR7}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Serotonin receptor"}

> <pathway_chembl>
{}

> <pathway_reactome>
{}

> <broad_targets>
{}

> <broad_moa>
{"monoamine oxidase inhibitor"}

> <synonyms>
{"3,4-Dimethoxyphenethylamine",Homoveratrylamine,120-20-7,"2-(3,4-Dimethoxyphenyl)ethanamine","3,4-Dimethoxyphenylethylamine","2-(3,4-Dimethoxyphenyl)ethylamine",Dimethoxyphenylethylamine,Dimethoxydop
amine,Dimethylmescaline,DMPEA,"Benzeneethanamine, 3,4-dimethoxy-",DIMPEA,"Dopamine dimethyl ether","O,O-Dimethyldopamine","3,4-Dimethoxybenzeneethanamine","3,4-Dimethoxydopamine","3,4-Di-O-methyldopam
ine","3,4-Dimethoxy-beta-phenylethylamine","3,4-Dimethoxyphenylethylamine(base)","beta-(3,4-Dimethyoxyphenyl)ethylamine","3,4-Dimethoxy phenethylamine","2-(3,4-dimethoxyphenyl)-ethylamine","2-(3,4-Dim
ethoxy-phenyl)-ethylamine","2-(3,4-Dimethoxyphenyl)Ethan-1-Amine",UNII-IQF9T435OP,"NSC 16948","3,4-dimethoxy phenylethylamine","PHENETHYLAMINE, 3,4-DIMETHOXY-",HOMOVERATRILAMINE,CHEBI:136995,MFCD00008
188,"3,4-Dimethoxypheneethylamine",IQF9T435OP,"3,4-dimethyloxyphenylethylamine","3,4-Dimethoxy-.beta.-phenethylamine","beta-(3,4-Dimethoxyphenyl)ethylamine","3,4-Dimethoxy-.beta.-phenylethylamine",".b
eta.-(3,4-Dimethoxyphenyl)ethylamine","Phenethylamine,4-dimethoxy-","3,4-Dimethoxyphenethylamine (Homoveratrylamine)","Benzeneethanamine,4-dimethoxy-","WLN: Z2R CO1 DO1",SMR000112358,"EINECS 204-376-9
","3,4-Dimethoxyphenylethylamine (base)","BRN 0474393",AI3-23876,"homoveratryl amine","3,4-DIMETHOXY-PHENETHYLAMINE",PubChem22139,ACMC-1C6FO,"Epitope ID:119694","EC 204-376-9",NCIOpen2_005995,Oprea1_3
97610,"3, 4-Dimethoxyphenethylamine","4-13-00-02604 (Beilstein Handbook Reference)",MLS000515889,MLS001424180,CHEMBL26019,SCHEMBL210639,"3,4-di-methoxy-phenethylamine","3,4-dimethyoxyphenylethylamine"
,"3,4-dimethoxy-phenylethylamine","3,4-Dimethoxy-Benzenethanamine",SCHEMBL7319619,"3, 4-Dimethoxybenzeneethanamine","b-3,4-dimethoxyphenylethylamine","3,4-Dimethoxy-Benzeneethanamine",DTXSID8059506,"P
henethyl amine, 3,4-dimethoxy",NSC6328,"2(3,4-dimethoxyphenyl)ethylamine","Benzenethanamine, 3,4-dimethoxy-","3,4-Dimethoxy-beta-phenethylamine","b-(3,4-dimethoxyphenyl)ethylamine",HMS2052A09,HMS2269O
22,HMS3394A09,ZINC388739,"3,4-Dimethoxyphenethylamine, 97","3, 4-Dimethoxy-beta-phenethylamine",HY-Y0935,NSC-6328,NSC16948,NSC26152,"AKOS BBS-00003591","b-(3,4-dimethoxyphenyl)ethyl amine","2-(3,4-dim
ethoxy-phenyl)ethylamine","2-(3,4-dimethoxyphenyl) ethylamine","3,4-Dimethoxyphenethylamine, Pract.",ANW-17472,BBL023006,NSC-16948,NSC-26152,SBB008220,STK397473,"3, 4-Dimethoxy-beta-phenylethylamine",
"3, 4-Dimethoxyphenylethylamine(base)","3,4-dimethoxy-beta-phenyl-ethylamine","(2-(3,4-dimethoxyphenyl)ethyl)amine","2-(3,4-dimethoxy phenyl)ethyl amine","2-(3,4-dimethoxy-phenyl)ethyl amine","2-(3,4-
Dimethoxyphenyl)ethanamine #",AKOS000104026,"beta-(3,4-dimethoxyphenyl)-ethylamine",AC-8488,CCG-101095,CS-W023192,FS-4041,MCULE-5517861565,NC00345,"2-(3',4'-dimethoxyphenyl)-ethylamine","beta-(3,4 -di
methoxyphenyl) ethylamine",NCGC00247022-01,DB-001827,DB-003355,AM20060494,D0678,FT-0608529,ST45026146,AZ0001-0098,X-1983,120H207,"Dopamine Impurity C (3,4-Dimethoxyphenethylamine)",Q4634069,W-108484,"
2-(3,4-Dimethoxyphenyl)ethanamine (ACD/Name 4.0)","2-(3,4-Dimethoxyphenyl)ethylamine (ACD/Name 4.0)",F2190-0398,SAM001246869,CPD000112358}

> <pdid>
PD002977

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{8421}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 32  0  0  1  0            999 V2000
   -0.2823   -5.5001    0.0000 C   0  0
   -0.7300   -4.0685    0.0000 C   0  0  2  0  0  0
   -2.1946   -3.7406    0.0000 C   0  0
   -3.2115   -4.8444    0.0000 C   0  0
   -4.6761   -4.5166    0.0000 C   0  0
   -5.1237   -3.0850    0.0000 O   0  0
   -5.6924   -5.6198    0.0000 O   0  0
    0.2851   -2.9666    0.0000 C   0  0  1  0  0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  1  0  0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -1.2212   -2.3711    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -1.2991    2.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -1.2991    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
    0.0000    7.5000    0.0000 O   0  0
    1.2990    5.2500    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0  1  0  0  0
    2.5981    3.0000    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    3.8971    0.7500    0.0000 O   0  0
  2  1  1  6
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  2  0
  2  8  1  0
  8  9  1  6
  9 10  1  0
 11 10  1  6
 11 12  1  0
 12 13  1  0
 13 14  1  6
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17  8  1  0
 17 11  1  0
 17 18  1  6
 13 19  1  0
 19 20  1  6
 19 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 26 25  1  1
 26 19  1  0
 26 27  1  0
 27 28  1  0
 12 28  1  1
 28 29  2  0
M  END
> <name>
NIHCC_2014

> <id>
5789

> <plate>
NGP-105-03

> <well>
A06

> <supplier_cmpd_name>
CPD000058603

> <ctcr_id>
6447

> <supplier_cmpd_id>
SAM001246857

> <smiles>
C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@H]3[C@H](CC(=O)[C@]12C)[C@@]4(C)CCC(=O)C[C@H]4CC3=O

> <pd_targets>
{LMNA,FFP}

> <pathway_gtopdb>
{"Other nuclear protein",Enzyme,Transferase}

> <pathway_chembl>
{}

> <pathway_reactome>
{"Cell Cycle",Mitotic,"M Phase","Mitotic Metaphase and Anaphase","Mitotic Anaphase","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{}

> <broad_moa>
{}

> <synonyms>
{"dehydrocholic acid",Decholin,81-23-2,81232,"81 23 2",Dehystolin,Felacrinos,Sanocholen,"Ketocholanic acid",Chologon,Oxycholin,Dilabil,Bilidren,Bilostat,Cholagon,Cholimed,Dehychol,Didrocolo,Drenobyl,N
ovocolin,Procholon,Acolen,Dehycon,Didocol,E,SAM001246857,Prestw-123,CPD000058603,"Dehydrocholic acid"}

> <pdid>
PD001529

> <targets>
{Others}

> <classes>
{Others}

> <pubchem_cids>
{6674}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 28  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
   -1.2990    0.7500    0.0000 C   0  0  2  0  0  0
   -2.5981    1.5000    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0  1  0  0  0
   -2.1132    4.3307    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
    1.0956    4.0166    0.0000 C   0  0
    0.4768    5.3830    0.0000 C   0  0
   -1.0140    5.2166    0.0000 C   0  0  1  0  0  0
   -1.9861    4.9820    0.0000 O   0  0
   -0.5491    6.6300    0.0000 C   0  0
   -1.5661    7.7325    0.0000 C   0  0
    0.9142    6.9599    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    0.0000    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -1.2990   -5.2500    0.0000 O   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  1  1  6
  2  3  1  0
  4  3  1  6
  4  5  1  0
  5  6  1  1
  6  7  1  0
  7  8  1  0
  8  9  1  1
  8 10  1  0
 10  4  1  0
 10 11  1  1
 11 12  1  0
 12 13  1  0
 13  8  1  0
 13 14  1  6
 13 15  1  0
 15 16  1  0
 15 17  2  0
  5 18  1  0
 18 19  1  1
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  2  3
 25  2  1  0
 25 18  1  0
M  END
> <name>
NIHCC_2014

> <id>
5790

> <plate>
NGP-105-03

> <well>
A07

> <supplier_cmpd_name>
CPD000058769

> <ctcr_id>
5035

> <supplier_cmpd_id>
SAM001246906

> <smiles>
C[C@H]1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(O)C(C)=O)[C@@]4(C)CCC(=O)C=C14

> <pd_targets>
{MAPT,HIF1A,PGR,KMT2A,MEN1,LMNA,AR,NR3C1,CYP2C19}

> <pathway_gtopdb>
{"Other cytosolic protein","Transcription factor","Epigenetic regulator","Other nuclear protein",Enzyme,"Nuclear receptor",Reader,"Cytochrome P450","Nuclear hormone receptor subfamily 3",Bromodomain,"
Cytochrome P450 family 2","Nuclear hormone receptor subfamily 3 group C","Cytochrome P450 family 2C","Nuclear hormone receptor subfamily 3 group C member 3","Nuclear hormone receptor subfamily 3 group
 C member 4","Nuclear hormone receptor subfamily 3 group C member 1","Cytochrome P450 2C19"}

> <pathway_chembl>
{Receptors,Enzymes,"Nuclear hormone receptors","Cytochrome P450","Steroid hormone receptors","CYP2 family: drug metabolising subset","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"Neuronal System","Cellular responses to external stimuli","Metabolism of proteins","Cell Cycle","Gene expression (Transcription)",Metabolism,"Transmission across Chemical Synapses","Cellular respons
es to stress","Post-translational protein modification",Mitotic,"RNA Polymerase II Transcription","Biological oxidations","Neurotransmitter receptors and postsynaptic signal transmission","Cellular re
sponse to hypoxia",SUMOylation,"M Phase","Generic Transcription Pathway","Phase I - Functionalization of compounds","Activation of NMDA receptors and postsynaptic events","Oxygen-dependent proline hyd
roxylation of Hypoxia-inducible Factor Alpha","SUMO E3 ligases SUMOylate target proteins","Mitotic Metaphase and Anaphase","Transcriptional regulation by RUNX2","FOXO-mediated transcription","Cytochro
me P450 - arranged by substrate type","Post NMDA receptor activation events","SUMOylation of intracellular receptors","Mitotic Anaphase","RUNX2 regulates bone development","FOXO-mediated transcription
 of oxidative stress","metabolic and neuronal genes",Xenobiotics,"Activation of AMPK downstream of NMDARs","Nuclear Envelope (NE) Reassembly","RUNX2 regulates osteoblast differentiation","CYP2E1 react
ions","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{PGR}

> <broad_moa>
{"progesterone receptor agonist"}

> <synonyms>
{medroxyprogesterone,520-85-4,520854,Medroxyprogesteron,Medroxiprogesteronum,Medroxiprogesterona,Medroxyprogesteronum,17-Hydroxy-6alpha-methylprogesterone,17Hydroxy6alphamethylprogesterone,Hydroxymeth
ylprogesterone,Medrossiprogesterone,17alpha-Hydroxy-6alpha-methylprogesterone,17alphaHydroxy6alphamethylprogesterone,6alpha,T5040,SAM001246906,Medroxyprogesterone,CPD000058769}

> <pdid>
PD003109

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{10631}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 29  0  0  0  0            999 V2000
   11.3211   -5.2273    0.0000 C   0  0
    9.8959   -4.7598    0.0000 C   0  0
    9.5870   -3.2911    0.0000 C   0  0
    8.1609   -2.8234    0.0000 C   0  0
    7.8525   -1.3573    0.0000 N   0  0
    8.8523   -0.2390    0.0000 C   0  0
    8.0978    1.0574    0.0000 C   0  0
    6.6317    0.7404    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    3.8990   -0.7455    0.0000 N   0  0
    2.6003   -1.4977    0.0000 C   0  0
    2.6030   -2.9977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0008    0.0000 C   0  0
    0.0000    4.5008    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0031   -3.0008    0.0000 O   0  0
    1.3032   -3.7490    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  5  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  3  0
 16 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 19  1  0
 24 25  2  0
 25 14  1  0
 25 26  1  0
 26 27  1  0
M  END
> <name>
NIHCC_2014

> <id>
5791

> <plate>
NGP-105-03

> <well>
A08

> <supplier_cmpd_name>
CPD000466292

> <ctcr_id>
1447

> <supplier_cmpd_id>
SAM001247092

> <smiles>
CCCCN1CCCC1CNC(=O)c2cc(C#N)c3ccccc3c2OC

> <pd_targets>
{DRD2,DRD4,KDM4E,MAPK1,DRD3,HTR1A,CYP2C9,ALOX15,LEF,CYP3A4,CYP2D6,ALDH1A1,CYP1A2}

> <pathway_gtopdb>
{"Membrane receptor","Epigenetic regulator",Enzyme,"Family A G protein-coupled receptor",Eraser,Kinase,"Cytochrome P450",Oxidoreductase,Protease,"Small molecule receptor (family A GPCR)","Lysine demet
hylase","Protein Kinase","Cytochrome P450 family 2","Metallo protease","Cytochrome P450 family 3","Cytochrome P450 family 1","Monoamine receptor","Jumonji domain-containing","CMGC protein kinase group
","Cytochrome P450 family 2C","Metallo protease MAE clan","Cytochrome P450 family 3A","Cytochrome P450 family 2D","Cytochrome P450 family 1A","Dopamine receptor","CMGC protein kinase MAPK family","Ser
otonin receptor","Cytochrome P450 2C9","Metallo protease M34 family","Cytochrome P450 3A4","Cytochrome P450 2D6","Cytochrome P450 1A1","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Chromatin modifying enzymes","Kinases (EC 2.7.x.x)","Cytochrome P450","Eicosanoid turnover","Dopamine receptors","1.14.11.- Histone demethylases","CMG
C: Containing CDK",MAPK,GSK3,"CLK families","5-Hydroxytryptamine receptors","CYP2 family: drug metabolising subset",Lipoxygenases,"CYP3 family","CYP1 family","Mitogen-activated protein kinases (MAP ki
nases)","ERK subfamily"}

> <pathway_reactome>
{"Signal Transduction","Immune System",Metabolism,Disease,"Signaling by GPCR","Innate Immune System","Biological oxidations","Metabolism of lipids","Infectious disease","GPCR ligand binding","Toll-lik
e Receptor Cascades","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","Uptake and actions of bacterial toxins","Class A/1 (Rhodopsin-like receptor
s)","Toll Like Receptor 5 (TLR5) Cascade","Cytochrome P450 - arranged by substrate type","Biosynthesis of DPA-derived SPMs","Uptake and function of anthrax toxins","Biosynthesis of DHA-derived SPMs","
Ethanol oxidation","Amine ligand-binding receptors","MyD88 cascade initiated on plasma membrane",Xenobiotics,"Biosynthesis of DPAn-3 SPMs","Biosynthesis of maresins","Dopamine receptors","MAP kinase a
ctivation","Serotonin receptors","CYP2E1 reactions","Biosynthesis of DPAn-3-derived protectins and resolvins","Biosynthesis of maresin-like SPMs","Aromatic amines can be N-hydroxylated or N-dealkylate
d by CYP1A2","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{DRD2,DRD3,HTR1A}

> <broad_moa>
{"dopamine receptor antagonist"}

> <synonyms>
{Nafadotride,149649-22-9,149649229,(+-)-nafadotride,(+)nafadotride,CHEMBL286252,CHEBI:64191,SMR000466292,GTPL44,MLS000758952,MLS001424218,SCHEMBL635866,DTXSID1042603,HMS2052A15,HMS2232B11,HMS3267P15,H
MS3370D02,HMS3394A15,HMS3414K11,HMS3678K11,BCP27779,BDBM50133923,AKO,SAM001247092,CPD000466292}

> <pdid>
PD003083

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{3408722}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 30  0  0  0  0            999 V2000
    7.5987   -3.0028    0.0000 H   0  3
    5.0987   -3.0028    0.0000 Cl  0  5
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 C   0  0
   -2.5951   -3.0039    0.0000 C   0  0
   -3.8933   -3.7570    0.0000 N   0  0
   -3.8934   -5.2570    0.0000 C   0  0
   -5.1924   -6.0071    0.0000 C   0  0
   -6.4914   -5.2571    0.0000 C   0  0
   -6.4915   -3.7571    0.0000 C   0  0
   -5.1925   -3.0071    0.0000 C   0  0
   -7.7927   -6.0049    0.0000 C   0  0
   -7.7953   -7.5049    0.0000 O   0  0
   -9.0914   -5.2527    0.0000 C   0  0
  -10.3931   -5.9981    0.0000 C   0  0
  -11.6896   -5.2437    0.0000 C   0  0
  -11.6844   -3.7437    0.0000 C   0  0
  -12.9800   -2.9861    0.0000 N   0  0
  -12.9727   -1.4853    0.0000 S   0  0
  -11.6698   -0.7421    0.0000 C   0  0
  -14.2676   -0.7282    0.0000 O   0  0
  -12.9647    0.0146    0.0000 O   0  0
  -10.3828   -2.9982    0.0000 C   0  0
   -9.0863   -3.7526    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 11  1  0
 14 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  2  0
 24 27  2  0
 22 28  1  0
 28 29  2  0
 29 19  1  0
  8 30  2  0
 30  4  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5792

> <plate>
NGP-105-03

> <well>
A09

> <supplier_cmpd_name>
CPD000466291

> <ctcr_id>
3755

> <supplier_cmpd_id>
SAM001247091

> <smiles>
[H+].[Cl-].Cc1cccc(CCN2CCC(CC2)C(=O)c3ccc(N[S](C)(=O)=O)cc3)n1

> <pd_targets>
{KCNH2,POLB,KDM4E,CYP2C19,CYP3A4,KCNH1,GSC2,FFP,CYP2D6,KCNH7,KCNH6}

> <pathway_gtopdb>
{"Ion channel",Enzyme,"Epigenetic regulator","Voltage-gated ion channel",Eraser,"Cytochrome P450",Transferase,"Potassium channels","Lysine demethylase","Cytochrome P450 family 2","Cytochrome P450 fami
ly 3","Voltage-gated potassium channel","Jumonji domain-containing","Cytochrome P450 family 2C","Cytochrome P450 family 3A","Cytochrome P450 family 2D","Cytochrome P450 2C19","Cytochrome P450 3A4","Cy
tochrome P450 2D6"}

> <pathway_chembl>
{"Ion channels",Enzymes,"Voltage-gated ion channels","Chromatin modifying enzymes","Cytochrome P450","Potassium channels","1.14.11.- Histone demethylases","CYP2 family: drug metabolising subset","CYP3
 family","Voltage-gated potassium channels"}

> <pathway_reactome>
{"Muscle contraction","DNA Repair",Metabolism,"Neuronal System","Cardiac conduction","Base Excision Repair","Biological oxidations","Metabolism of lipids","Potassium Channels","Phase 3 - rapid repolar
isation","Resolution of Abasic Sites (AP sites)","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","Voltage gated Potassium channels","Resolution o
f AP sites via the multiple-nucleotide patch replacement pathway","Cytochrome P450 - arranged by substrate type","Biosynthesis of DHA-derived SPMs","PCNA-Dependent Long Patch Base Excision Repair",Xen
obiotics,"Biosynthesis of maresins","CYP2E1 reactions","Biosynthesis of maresin-like SPMs"}

> <broad_targets>
{KCNH1,KCNH2}

> <broad_moa>
{"potassium channel blocker"}

> <synonyms>
{SMR000466291,MLS000758940,MLS001424207,CCG-101127,CCG101127,NC00377,SAM001247091,CPD000466291}

> <pdid>
PD050373

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{10433231}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 20  0  0  1  0            999 V2000
    7.5973   -2.2722    0.0000 Cl  0  5
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5987   -1.5006    0.0000 C   0  0  1  0  0  0
   -2.5956   -3.0006    0.0000 O   0  0
   -2.5644   -0.0213    0.0000 C   0  0
   -3.8643    0.7273    0.0000 C   0  0
   -5.1625   -0.0242    0.0000 C   0  0
   -5.1608   -1.5242    0.0000 C   0  0
   -3.8609   -2.2727    0.0000 C   0  0  2  0  0  0
   -3.8388   -3.7732    0.0000 C   0  0
   -5.1267   -4.5437    0.0000 N   0  0
   -5.1044   -6.0435    0.0000 C   0  0
   -6.4370   -3.8135    0.0000 C   0  0
    5.0973   -2.2722    0.0000 H   0  3
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  8 10  1  0
 10 11  1  1
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 10  1  0
 16 17  1  1
 17 18  1  0
 18 19  1  0
 18 20  1  0
M  CHG  2   1  -1  21   1
M  END
> <name>
NIHCC_2014

> <id>
5793

> <plate>
NGP-105-03

> <well>
A10

> <supplier_cmpd_name>
CPD000449308

> <ctcr_id>
1393

> <supplier_cmpd_id>
SAM001246847

> <smiles>
[Cl-].COc1cccc(c1)[C@@]2(O)CCCC[C@@H]2CN(C)C.[H+]

> <pd_targets>
{OPRM1,SLC22A1,SLC6A4,OPRD1,SLC6A2,OPRK1,HTR2C,CHRNA7,CHRM3,CHRM1,TACR1,SCN2A,TRPV1,GRIN1,GRIN2A,GRIN2B,GRIN2C,GRIN2D,GRIN3A,GRIN3B,ADORA1,ADRA2A,ADRA2B,ADRA2C}

> <pathway_gtopdb>
{"Membrane receptor",Transporter,"Ion channel","Family A G protein-coupled receptor","Electrochemical transporter","Voltage-gated ion channel","Ligand-gated ion channel","Peptide receptor (family A GP
CR)","SLC superfamily of solute carriers","Small molecule receptor (family A GPCR)","Voltage-gated sodium channel","Transient receptor potential channel","Ionotropic glutamate receptor","Short peptide
 receptor (family A GPCR)","SLC22 family of organic cation and anion transporters","SLC06 neurotransmitter transporter family","Monoamine receptor","NMDA receptor","Nucleotide-like receptor (family A 
GPCR)","Opioid receptor","Serotonin receptor","Acetylcholine receptor","Neurokinin receptor","Adenosine receptor","Adrenergic receptor"}

> <pathway_chembl>
{Receptors,Transporters,"Ion channels","G protein-coupled receptors","SLC superfamily of solute carriers","Voltage-gated ion channels","Opioid receptors","SLC22 family of organic cation and anion tran
sporters","SLC6 neurotransmitter transporter family","5-Hydroxytryptamine receptors","Acetylcholine receptors (muscarinic)","Tachykinin receptors","Voltage-gated sodium channels","Transient Receptor P
otential channels","Adenosine receptors","Organic cation transporters (OCT)","Monoamine transporter subfamily"}

> <pathway_reactome>
{"Signal Transduction","Transport of small molecules","Neuronal System",Disease,"Gene expression (Transcription)","Developmental Biology","Signaling by GPCR","SLC-mediated transmembrane transport","Tr
ansmission across Chemical Synapses","Disorders of transmembrane transporters","RNA Polymerase II Transcription","Nervous system development","Ion channel transport","GPCR downstream signalling","Tran
sport of bile salts and organic acids","metal ions and amine compounds","Neurotransmitter clearance","GPCR ligand binding","SLC transporter disorders","Generic Transcription Pathway","Axon guidance","
Stimuli-sensing channels","G alpha (i) signalling events","Organic cation/anion/zwitterion transport","Serotonin clearance from the synaptic cleft","Class A/1 (Rhodopsin-like receptors)","Defective SL
C6A2 causes orthostatic intolerance (OI)","Transcriptional Regulation by MECP2","L1CAM interactions","TRP channels","Opioid Signalling","Organic cation transport","Peptide ligand-binding receptors","M
ECP2 regulates neuronal receptors and channels","Amine ligand-binding receptors","Interaction between L1 and Ankyrins","Nucleotide-like (purinergic) receptors","G-protein activation","Serotonin recept
ors","Muscarinic acetylcholine receptors","Tachykinin receptors bind tachykinins","Adenosine P1 receptors"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"tramadol hydrochloride","Tramadol HCl",36282-47-0,36282470,"36282 47 0",22204-88-2,22204882,"22204 88 2",CG-315E,CG315E,"CG 315E",148229-78-1,148229781,"148229 78 1","Zydol hydrochloride",Crispin,Ry
zolt,Tramal,Bellatram,Contramal,Omnidol,Zum,SAM001246847,Prestw-1465,CPD000449308,"Tramadol hydrochloride"}

> <pdid>
PD010176

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{63013,67108333}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 29  0  0  1  0            999 V2000
    2.5981    0.0000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    1.2990   -3.7500    0.0000 C   0  0
    2.5981   -3.0000    0.0000 C   0  0  1  0  0  0
    3.8971   -3.7500    0.0000 C   0  0  2  0  0  0
    4.2297   -5.2071    0.0000 C   0  0
    5.7224   -5.3544    0.0000 C   0  0
    6.3238   -3.9802    0.0000 C   0  0  2  0  0  0
    6.6067   -3.0210    0.0000 O   0  0
    7.3153   -5.0895    0.0000 C   0  0
    8.7787   -4.7600    0.0000 O   0  0
    6.8692   -6.5225    0.0000 C   0  0
    7.8858   -7.6254    0.0000 O   0  0
    5.1962   -3.0000    0.0000 C   0  0  2  0  0  0
    6.1061   -2.5853    0.0000 C   0  0
    5.1962   -1.5000    0.0000 C   0  0
    3.8971   -0.7500    0.0000 C   0  0
    3.8971    0.7500    0.0000 O   0  0
    2.5981   -1.5000    0.0000 C   0  0  2  0  0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  3
  8  2  1  0
  8  9  1  0
  9 10  1  0
 11 10  1  6
 11 12  1  0
 12 13  1  1
 13 14  1  0
 14 15  1  0
 15 16  1  6
 15 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 15 21  1  0
 21 12  1  0
 21 22  1  1
 21 23  1  0
 23 24  1  0
 24 25  2  0
 26 24  1  1
 26  2  1  0
 26 11  1  0
M  END
> <name>
NIHCC_2014

> <id>
5794

> <plate>
NGP-105-03

> <well>
A11

> <supplier_cmpd_name>
CPD000058334

> <ctcr_id>
4370

> <supplier_cmpd_id>
SAM001246882

> <smiles>
C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)CC(=O)[C@H]23

> <pd_targets>
{PMP22,CHRM1,HSD17B10,CYP3A4,ALDH1A1}

> <pathway_gtopdb>
{"Unclassified protein","Membrane receptor",Enzyme,"Family A G protein-coupled receptor",Oxidoreductase,"Cytochrome P450","Small molecule receptor (family A GPCR)","Cytochrome P450 family 3","Monoamin
e receptor","Cytochrome P450 family 3A","Acetylcholine receptor","Cytochrome P450 3A4"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Cytochrome P450","Acetylcholine receptors (muscarinic)","CYP3 family"}

> <pathway_reactome>
{"Developmental Biology","Signal Transduction",Metabolism,"Nervous system development","Signaling by GPCR","Metabolism of amino acids and derivatives","Metabolism of lipids","Biological oxidations","E
GR2 and SOX10-mediated initiation of Schwann cell myelination","GPCR ligand binding","Branched-chain amino acid catabolism","Biosynthesis of specialized proresolving mediators (SPMs)","Phase I - Funct
ionalization of compounds","Class A/1 (Rhodopsin-like receptors)","Biosynthesis of DHA-derived SPMs","Ethanol oxidation","Amine ligand-binding receptors","Biosynthesis of maresins","Muscarinic acetylc
holine receptors","Biosynthesis of maresin-like SPMs"}

> <broad_targets>
{NR3C1}

> <broad_moa>
{"glucocorticoid receptor agonist"}

> <synonyms>
{cortisone,53-06-5,53065,"Kendall's compound E",Andreson,Cortisal,Cortisate,Cortistal,Cortivite,Cortogen,Cortone,"Reichstein's substance FA",Adrenalex,"Reichstein Fa","Wintersteiner's compound F",11-D
ehydro-17-hydroxycorticosterone,11Dehydro17hydroxycorticosterone,17-Hydroxy-11-dehydr,17Hydroxy11dehydr,SAM001246882,Prestw-273,CPD000058334,Cortisone}

> <pdid>
PD000442

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{222786}

$$$$
NIHCC_2014
  SciTegic11012413002D

 42 43  0  0  0  0            999 V2000
    5.1887   -6.0105    0.0000 C   0  0
    3.8912   -5.2578    0.0000 N   0  0
    2.5909   -6.0056    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.1981    1.4971    0.0000 C   0  0
   -5.1976    2.9979    0.0000 C   0  0
   -6.4959    3.7492    0.0000 Cl  0  0
   -3.8978   -0.7554    0.0000 C   0  0
   -5.1947   -1.5091    0.0000 C   0  0
   -5.1905   -3.0091    0.0000 C   0  0
   -3.8893   -3.7554    0.0000 C   0  0
   -2.5924   -3.0018    0.0000 C   0  0
   -2.5967   -1.5018    0.0000 C   0  0
   -2.6030    2.9985    0.0000 C   0  0
   -3.9023    3.7481    0.0000 C   0  0
   -3.9029    5.2481    0.0000 C   0  0
   -2.6041    5.9986    0.0000 C   0  0
   -1.3048    5.2491    0.0000 C   0  0
   -1.3042    3.7491    0.0000 C   0  0
    8.9894    0.7350    0.0000 O   0  0
    8.9894   -0.7650    0.0000 C   0  0
    7.6901   -1.5146    0.0000 O   0  0
   10.2894   -1.5150    0.0000 C   0  0
   11.5894   -0.7650    0.0000 C   0  0
   12.8879   -1.5158    0.0000 O   0  0
   11.5908    0.7358    0.0000 C   0  0
   12.8908    1.4858    0.0000 C   0  0
   14.1894    0.7350    0.0000 O   0  0
   12.8922    2.9858    0.0000 O   0  0
   11.5906   -2.2950    0.0000 C   0  0
   10.2919   -3.0456    0.0000 O   0  0
   12.8897   -3.0447    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 10 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 14 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 13 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 30 31  1  0
 31 32  2  0
 31 33  1  0
 33 34  1  0
 34 35  1  0
 34 36  1  0
 36 37  1  0
 37 38  1  0
 37 39  2  0
 34 40  1  0
 40 41  1  0
 40 42  2  0
M  END
> <name>
NIHCC_2014

> <id>
5795

> <plate>
NGP-105-03

> <well>
B02

> <supplier_cmpd_name>
CPD000469213

> <ctcr_id>
5611

> <supplier_cmpd_id>
SAM001246774

> <smiles>
CN(C)CCOc1ccc(cc1)\C(=C(\CCCl)c2ccccc2)c3ccccc3.OC(=O)CC(O)(CC(O)=O)C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"TOREMIFENE CITRATE",89778-27-8,89778278,Fareston,"Toremifene (Citrate)",UNII-2498Y783QT,UNII2498Y783QT,"89778-27-8 (citrate)","89778278 (citrate)",NSC613680,2498Y783QT,NSC-613680,"Toremifene Citrate
 (Fareston, Acapodene)",DSSTox_CID_1367,DSSToxCID1367,DSSTox-CID-1367,"DSSTox CID 1367",DSSTox_RID_76113,DSSToxRID76113,DSSTox-RID-76113,"DSSTox RID 76113",DSSTox_GSID_21367,DSSToxGSID21367,DSSTox-GSI
D-21367,"DSSTox GSID 21367",FC,T1464,S1776,SAM001246774,1505682,"Toremifene citrate","Toremifene Citrate",CPD000469213,"TOREMIPHENE CITRATE"}

> <pdid>

> <targets>
{Others}

> <classes>
{antineoplastic,anti-estrogen,"Endocrinology & Hormones"}

> <pubchem_cids>
{3005572}

$$$$
NIHCC_2014
  SciTegic11012413002D

 32 33  0  0  0  0            999 V2000
   10.1876   -4.1268    0.0000 H   0  3
    7.6876   -4.1268    0.0000 Cl  0  5
    2.5608  -12.0027    0.0000 O   0  0
    2.5691  -10.5028    0.0000 C   0  0
    3.8725   -9.7587    0.0000 C   0  0
    3.8808   -8.2579    0.0000 N   0  0
    5.1824   -7.5124    0.0000 C   0  0
    5.1876   -6.0124    0.0000 C   0  0
    3.8912   -5.2578    0.0000 N   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 S   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -1.2990   -5.2508    0.0000 C   0  0
   -2.5976   -6.0017    0.0000 F   0  0
    0.0003   -6.0004    0.0000 F   0  0
   -1.2983   -6.7508    0.0000 F   0  0
    2.5895   -6.0034    0.0000 C   0  0
    2.5844   -7.5034    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 13  1  0
 26 21  1  0
 24 27  1  0
 27 28  1  0
 27 29  1  0
 27 30  1  0
  9 31  1  0
 31 32  1  0
 32  6  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5796

> <plate>
NGP-105-03

> <well>
B03

> <supplier_cmpd_name>
CPD000058411

> <ctcr_id>
255

> <supplier_cmpd_id>
SAM001246863

> <smiles>
[H+].[Cl-].OCCN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1

> <pd_targets>
{RORC,UBE2N,RAD52,LMNA,MAPT,RECQL,NPSR1,TIM10,GAA,GLA,MAPK1,GMNN,CYP3A4,NFO,KMT2A,MEN1,PMP22,ADRA2C,HTR7,SCN1A,SCN2A,SCN3A,NFKB1,CYP2D6,CYP1A2,ADRA1A,HRH1,DRD2,ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY
8,HTR2C,HTR6,HTR2A,ATP2A1,TPR,AR,ADRA2A,DRD3,S,ALB,CHRM1,TP53,PDR5,ADRA1B,SIGMAR1,LEF,THPO,HTR1B,CHRM2,DRD4,ADRA2B,CHRM3,ABCB11,FFP,DRD5,HTR1A,KCNK2,REP,ADRA1D,ADRB3,HRH2,HTR2B,TACR2,ABCB1,ADORA3,SLC6
A3,SLC6A2,OPRK1,MTOR,OPRD1,OPRM1,KCNH2,EGFR,ERBB2,SLC6A4,MC5R,CHRM4,FYN,CALM1}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Other nuclear protein","Other cytosolic protein","Membrane receptor","Unclassified protein","Epigenetic regulator","Ion channel",Transporter,"Secreted protein","Nuclear
 receptor",Aminoacyltransferase,"Family A G protein-coupled receptor",Hydrolase,Kinase,"Cytochrome P450",Reader,"Voltage-gated ion channel",Lyase,"Primary active transporter",Oxidoreductase,Protease,T
ransferase,"Electrochemical transporter","Nuclear hormone receptor subfamily 1","Peptide receptor (family A GPCR)","Protein Kinase","Cytochrome P450 family 3",Bromodomain,"Small molecule receptor (fam
ily A GPCR)","Voltage-gated sodium channel","Cytochrome P450 family 2","Cytochrome P450 family 1","P-type ATPase","Nuclear hormone receptor subfamily 3","Metallo protease","ATP-binding cassette","Pota
ssium channels","SLC superfamily of solute carriers","Nuclear hormone receptor subfamily 1 group F","Short peptide receptor (family A GPCR)","CMGC protein kinase group","Cytochrome P450 family 3A","Mo
noamine receptor","Cytochrome P450 family 2D","Cytochrome P450 family 1A","Calcium ATPase","Nuclear hormone receptor subfamily 3 group C","Metallo protease MAE clan","ABCB subfamily","Two-pore domain 
potassium channel","Nucleotide-like receptor (family A GPCR)","SLC06 neurotransmitter transporter family","Atypical protein kinase group","Voltage-gated potassium channel","TK protein kinase group","N
uclear hormone receptor subfamily 1 group F member 3","Neuropeptide receptor","CMGC protein kinase MAPK family","Cytochrome P450 3A4","Adrenergic receptor","Serotonin receptor","Cytochrome P450 2D6","
Cytochrome P450 1A1","Histamine receptor","Dopamine receptor","Nuclear hormone receptor subfamily 3 group C member 4","Acetylcholine receptor","Metallo protease M34 family","Neurokinin receptor","Aden
osine receptor","Opioid receptor","Atypical protein kinase PIKK family","Tyrosine protein kinase EGFR family","Melanocortin receptor","Tyrosine protein kinase Src family","CMGC protein kinase ERK1","A
typical protein kinase FRAP subfamily","Tyrosine protein kinase SrcA"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Other protein targets","Ion channels","Nuclear hormone receptors","G protein-coupled receptors","3.2.1.- Glycosidases","Kinases (EC 2.7.x.x)","Cytochrome P450","P-type
 ATPases","Sigma receptors","Anti-infective targets","ATP-binding cassette transporter family","Voltage-gated ion channels","SLC superfamily of solute carriers","Catalytic receptors","1F. Retinoic aci
d-related orphans","Neuropeptide S receptor","CMGC: Containing CDK",MAPK,GSK3,"CLK families","CYP3 family",Adrenoceptors,"5-Hydroxytryptamine receptors","CYP2 family: drug metabolising subset","CYP1 f
amily","Histamine receptors","Dopamine receptors","P2A P-type ATPases: Ca<sup>2+</sup>-ATPases","Steroid hormone receptors","Acetylcholine receptors (muscarinic)","Viral protein targets","ABCB subfami
ly","Potassium channels","Tachykinin receptors","Adenosine receptors","SLC6 neurotransmitter transporter family","Opioid receptors",Atypical,"Receptor kinases","Melanocortin receptors","Mitogen-activa
ted protein kinases (MAP kinases)","3C. 3-Ketosteroid receptors","Coronavirus (CoV) proteins","Two P domain potassium channels","Monoamine transporter subfamily","Phosphatidyl inositol 3' kinase-relat
ed kinases (PIKK) family","Voltage-gated potassium channels","TK: Tyrosine kinase","ERK subfamily","FRAP subfamily","Receptor tyrosine kinases (RTKs)","Non-receptor tyrosine kinases (nRTKs)","Type I R
TKs: ErbB (epidermal growth factor) receptor family","Src family"}

> <pathway_reactome>
{"Gene expression (Transcription)","Immune System","DNA Repair","Cell Cycle","Neuronal System",Disease,Metabolism,"Developmental Biology","Signal Transduction",Hemostasis,"Muscle contraction","RNA Pol
ymerase II Transcription","Innate Immune System","DNA Double-Strand Break Repair",Mitotic,"Transmission across Chemical Synapses","Infectious disease","Diseases of metabolism","Metabolism of lipids","
Nervous system development","Signaling by GPCR","Cytokine Signaling in Immune system","Biological oxidations","Platelet homeostasis","Cell Cycle Checkpoints","Platelet activation","signaling and aggre
gation","Potassium Channels","Abacavir transport and metabolism","Disorders of transmembrane transporters","Cardiac conduction","Generic Transcription Pathway","Toll-like Receptor Cascades","Homology 
Directed Repair","M Phase","Neurotransmitter receptors and postsynaptic signal transmission","Leishmania infection","Diseases of carbohydrate metabolism","Sphingolipid metabolism","Mitotic G1 phase an
d G1/S transition","Biosynthesis of specialized proresolving mediators (SPMs)","EGR2 and SOX10-mediated initiation of Schwann cell myelination","GPCR ligand binding","Signaling by Interleukins","Phase
 I - Functionalization of compounds","Platelet calcium homeostasis","Metabolism of steroids","G1/S DNA Damage Checkpoints","SARS-CoV Infections","Uptake and actions of bacterial toxins","Platelet Aggr
egation (Plug Formation)","Tandem pore domain potassium channels","Abacavir transmembrane transport","SLC transporter disorders","GPCR downstream signalling","Phase 3 - rapid repolarisation","Axon gui
dance","Neurotransmitter clearance","HIV Infection","Transcriptional regulation by RUNX3","Toll Like Receptor 4 (TLR4) Cascade","HDR through Homologous Recombination (HRR) or Single Strand Annealing (
SSA)","Mitotic Metaphase and Anaphase","Activation of NMDA receptors and postsynaptic events","Leishmania parasite growth and survival","Glycogen storage diseases","Glycosphingolipid metabolism","Toll
 Like Receptor 5 (TLR5) Cascade","G1/S Transition","Biosynthesis of DHA-derived SPMs","Class A/1 (Rhodopsin-like receptors)","Interleukin-1 family signaling","Cytochrome P450 - arranged by substrate t
ype","Reduction of cytosolic Ca++ levels","Transcriptional regulation by RUNX2","Bile acid and bile salt metabolism","p53-Dependent G1/S DNA damage checkpoint","Potential therapeutics for SARS","SARS-
CoV-1 Infection","Uptake and function of anthrax toxins","TWIK related potassium channel (TREK)","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Defective SLC6A2 causes orthostatic 
intolerance (OI)","Transcriptional Regulation by MECP2","Transcriptional Regulation by TP53","G alpha (i) signalling events","G alpha (q) signalling events","Semaphorin interactions","Serotonin cleara
nce from the synaptic cleft","Host Interactions of HIV factors","RUNX3 Regulates Immune Response and Cell Migration","MyD88-independent TLR4 cascade","HDR through Single Strand Annealing (SSA)","Mitot
ic Anaphase","Post NMDA receptor activation events","Anti-inflammatory response favouring Leishmania parasite infection","Glycogen storage disease type II (GAA)","MyD88 cascade initiated on plasma mem
brane","Activation of the pre-replicative complex","Biosynthesis of maresins","Amine ligand-binding receptors","Interleukin-1 signaling",Xenobiotics,"RUNX2 regulates bone development","Recycling of bi
le acids and salts","p53-Dependent G1 DNA Damage Response","Translation of structural proteins","Synthesis of bile acids and bile salts","SARS-CoV-1 Genome Replication and Transcription","Peptide liga
nd-binding receptors","Nucleotide-like (purinergic) receptors","MECP2 regulates neuronal receptors and channels","Regulation of TP53 Activity","Opioid Signalling","Gastrin-CREB signalling pathway via 
PKC and MAPK","Sema4D in semaphorin signaling","The role of Nef in HIV-1 replication and disease pathogenesis","TRIF(TICAM1)-mediated TLR4 signaling","Nuclear Envelope (NE) Reassembly","Activation of 
AMPK downstream of NMDARs","ADORA2B mediated anti-inflammatory cytokines production","MAP kinase activation","Biosynthesis of maresin-like SPMs",Adrenoceptors,"MAP3K8 (TPL2)-dependent MAPK1/3 activati
on","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Histamine receptors","Dopamine receptors","Serotonin receptors","RUNX2 regulates osteoblast differentiation",
"Muscarinic acetylcholine receptors","Stabilization of p53","Maturation of spike protein","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Replication of the SARS-CoV-1 genome",
"Tachykinin receptors bind tachykinins","Adenosine P1 receptors","Regulation of TP53 Expression and Degradation","G-protein activation","EGFR Transactivation by Gastrin","Sema4D induced cell migration
 and growth-cone collapse","Nef and signal transduction","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","IKK complex recruitment mediated by RIP1","Initiation of Nu
clear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","Autodegradation of the E3 ubiquitin ligase COP1","Regulation of TP53 Degradation","Ras activation upon Ca2+ inf
lux through NMDA receptor","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{CALM1,DRD1,DRD2,DRD5,HRH1,HTR2A,HTR6,HTR7}

> <broad_moa>
{"dopamine receptor antagonist"}

> <synonyms>
{MCULE-5643291638,MCULE5643291638,Prolixin,CPD000058411,MLS000028415,Calmansial,Flufenazin,Lyorodin,Liogen,SMR000058411,"Fluphenazine chloride",MLS001076508,"Fluorophenazine dihydrochloride",NSC62323,
NSC-62323,NSC-179197,NSC179197,"A 4077","WLN: T C666 BN ISJ EXFFF B3-","WLN: T C666 BN ISJ EXFFF B3",T0068,SAM001246863,"Fluphenazine hydrochloride"}

> <pdid>
PD009883

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{657374,6602611}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 18  0  0  1  0            999 V2000
    3.9200   -5.8774    0.0000 O   0  0
    4.8054   -4.6666    0.0000 C   0  0
    4.2010   -3.2956    0.0000 C   0  0  1  0  0  0
    2.7343   -2.9815    0.0000 O   0  0
    2.5987   -1.5004    0.0000 C   0  0  2  0  0  0
    3.9511   -0.8815    0.0000 C   0  0  2  0  0  0
    4.2566    0.5871    0.0000 O   0  0
    4.9531   -1.9978    0.0000 C   0  0  2  0  0  0
    6.4451   -1.8434    0.0000 O   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
  1  2  1  0
  3  2  1  1
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  6
  6  8  1  0
  8  3  1  0
  8  9  1  6
  5 10  1  1
 10 11  1  0
 11 12  2  3
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 10  1  0
 16 17  2  0
M  END
> <name>
NIHCC_2014

> <id>
5797

> <plate>
NGP-105-03

> <well>
B04

> <supplier_cmpd_name>
CPD000058273

> <ctcr_id>
4743

> <supplier_cmpd_id>
SAM001246876

> <smiles>
OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2N=CC(=O)NC2=O

> <pd_targets>
{URA3,TP53,SMN1,LMNA,PYRF,JAK2}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Epigenetic regulator","Other nuclear protein",Lyase,Reader,Kinase,"Methyl-lysine/arginine binding protein","Protein Kinase","Tudor domain","TK protein kinase group","Ty
rosine protein kinase JakA family"}

> <pathway_chembl>
{Receptors,"Catalytic receptors","Receptor kinases","TK: Tyrosine kinase","Non-receptor tyrosine kinases (nRTKs)","Janus kinase (JakA) family"}

> <pathway_reactome>
{"Cell Cycle","Metabolism of RNA","Cell Cycle Checkpoints","Metabolism of non-coding RNA",Mitotic,"G1/S DNA Damage Checkpoints","snRNP Assembly","M Phase","Mitotic G1 phase and G1/S transition","p53-D
ependent G1/S DNA damage checkpoint","Mitotic Metaphase and Anaphase","G1 Phase","p53-Dependent G1 DNA Damage Response","Mitotic Anaphase","Cyclin D associated events in G1","Stabilization of p53","Nu
clear Envelope (NE) Reassembly","Autodegradation of the E3 ubiquitin ligase COP1","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{6-AZAURIDINE,6AZAURIDINE,6-Azuridine,6Azuridine,Azauridine,54-25-1,54251,Riboazauracil,Riboazauratsil,"6-Azauracil 1-riboside","6Azauracil 1riboside",Ribo-azuracil,Riboazuracil,"6-Azauracil riboside"
,"6Azauracil riboside",AzUR,6-Azur,6Azur,UNII-7BVB29RCPR,UNII7BVB29RCPR,6-aza-uridine,6azauridine,"NSC 32074",2-beta-D-Ribofuranosyl-1,2betaDRibofuranosyl1,2,4-triazine-3,4triazine3,5(2H,4H)-dio,4H)di
o,SAM001246876,CPD000058273}

> <pdid>
PD003164

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5901}

$$$$
NIHCC_2014
  SciTegic11012413002D

 16 16  0  0  0  0            999 V2000
    2.1621   -7.4180    0.0000 C   0  0
    1.2830   -6.2026    0.0000 C   0  0
    1.8954   -4.8324    0.0000 S   0  0
    3.3874   -4.6783    0.0000 O   0  0
    2.7751   -6.0474    0.0000 O   0  0
    1.0157   -3.6164    0.0000 C   0  0
    1.6281   -2.2462    0.0000 C   0  0
    0.7500   -1.0323    0.0000 N   0  0
    1.2135    0.3943    0.0000 C   0  0
    2.6401    0.8578    0.0000 C   0  0
    0.0000    1.2760    0.0000 N   0  0
   -1.2135    0.3943    0.0000 C   0  0
   -0.7500   -1.0323    0.0000 C   0  0
   -1.6332   -2.2426    0.0000 N   0  3
   -1.0255   -3.6140    0.0000 O   0  5
   -3.1247   -2.0836    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  2  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
M  CHG  2  14   1  15  -1
M  END
> <name>
NIHCC_2014

> <id>
5798

> <plate>
NGP-105-03

> <well>
B05

> <supplier_cmpd_name>
CPD000058194

> <ctcr_id>
6469

> <supplier_cmpd_id>
SAM001246913

> <smiles>
CC[S](=O)(=O)CCn1c(C)ncc1[N+]([O-])=O

> <pd_targets>
{LMNA}

> <pathway_gtopdb>
{"Other nuclear protein"}

> <pathway_chembl>
{}

> <pathway_reactome>
{"Cell Cycle",Mitotic,"M Phase","Mitotic Metaphase and Anaphase","Mitotic Anaphase","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{}

> <broad_moa>
{"antiprotozoal agent"}

> <synonyms>
{RESTW76,tinidazole,19387-91-8,19387918,Tindamax,Fasigyn,1-(2-(Ethylsulfonyl)ethyl)-2-methyl-5-nitro-1H-imidazole,1(2(Ethylsulfonyl)ethyl)2methyl5nitro1Himidazole,Trimonase,Tinidazolum,1-(2-ethylsulfo
nylethyl)-2-methyl-5-nitroimidazole,1(2ethylsulfonylethyl)2methyl5nitroimidazole,"1H-Imidazole, 1-(2-(ethylsulfonyl)ethyl)-2-methyl-5-nitro-","1HImidazole, 1(2(ethylsulfonyl)ethyl)2methyl5nitro",timid
azole,UNI,T0893,SAM001246913,1502127,Prestw-766,Tinidazole,CPD000058194,TINIDAZOLE}

> <pdid>
PD001375

> <targets>
{}

> <classes>
{antiprotozoal}

> <pubchem_cids>
{5479}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 26  0  0  1  0            999 V2000
    6.3888   -3.2190    0.0000 N   0  0
    5.3265   -4.2780    0.0000 C   0  0  1  0  0  0
    3.8775   -3.8868    0.0000 C   0  0
    2.8152   -4.9458    0.0000 O   0  0
    3.4909   -2.4366    0.0000 N   0  0
    2.0479   -2.0470    0.0000 C   0  0  1  0  0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 S   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
    0.7488   -2.7970    0.0000 C   0  0
    0.3606   -4.2459    0.0000 O   0  0
   -2.6003   -1.4978    0.0000 C   0  0
   -2.6029   -2.9978    0.0000 O   0  0
   -3.8983   -0.7459    0.0000 O   0  0
   -2.5981    1.5000    0.0000 Cl  0  0
    5.7131   -5.7282    0.0000 C   0  0
    4.6525   -6.7891    0.0000 C   0  0
    5.0409   -8.2379    0.0000 C   0  0
    6.4898   -8.6260    0.0000 C   0  0
    7.5504   -7.5653    0.0000 C   0  0
    7.1620   -6.1164    0.0000 C   0  0
  2  1  1  6
  2  3  1  0
  3  4  2  0
  3  5  1  0
  6  5  1  6
  6  7  1  0
  7  8  1  6
  8  9  1  0
  9 10  1  0
 10 11  2  3
 11 12  1  0
 12  7  1  0
 12 13  1  0
 13  6  1  0
 13 14  2  0
 11 15  1  0
 15 16  1  0
 15 17  2  0
 10 18  1  0
  2 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
M  END
> <name>
NIHCC_2014

> <id>
5799

> <plate>
NGP-105-03

> <well>
B06

> <supplier_cmpd_name>
CPD000058250

> <ctcr_id>
1720

> <supplier_cmpd_id>
SAM001246884

> <smiles>
N[C@@H](C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(O)=O)Cl)c3ccccc3

> <pd_targets>
{ALD,FFP,KMT2A,MEN1,MAPT,KDM4E,ALDH1A1,HPGD,SKA,CTDSP1,SLC15A2,DACA,DACB,DACC,FTSI,MRCA,MRCB,MRDA,PBP3,PBPA,LMNA,HSD17B10,TDP1,CYP3A4}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Other cytosolic protein",Transporter,"Other nuclear protein",Transferase,Reader,Eraser,Oxidoreductase,Kinase,Phosphatase,"Electrochemical transporter",Protease,Hydrolas
e,"Cytochrome P450",Bromodomain,"Lysine demethylase","Protein Phosphatase","SLC superfamily of solute carriers","Serine protease","Cytochrome P450 family 3","Jumonji domain-containing","Serine/threoni
ne protein phosphatase","SLC15 family of peptide transporters","Serine protease SE clan","Cytochrome P450 family 3A","Serine protease S11 family","Cytochrome P450 3A4"}

> <pathway_chembl>
{Enzymes,Transporters,"Chromatin modifying enzymes","Eicosanoid turnover","SLC superfamily of solute carriers","Cytochrome P450","1.14.11.- Histone demethylases","Prostaglandin synthases","SLC15 famil
y of peptide transporters","CYP3 family"}

> <pathway_reactome>
{"Neuronal System",Metabolism,"Transport of small molecules","Cell Cycle","DNA Repair","Transmission across Chemical Synapses","Biological oxidations","Metabolism of lipids","SLC-mediated transmembran
e transport",Mitotic,"Metabolism of amino acids and derivatives","DNA Double-Strand Break Repair","Neurotransmitter receptors and postsynaptic signal transmission","Phase I - Functionalization of comp
ounds","Biosynthesis of specialized proresolving mediators (SPMs)","Transport of inorganic cations/anions and amino acids/oligopeptides","M Phase","Branched-chain amino acid catabolism","Nonhomologous
 End-Joining (NHEJ)","Activation of NMDA receptors and postsynaptic events","Ethanol oxidation","Biosynthesis of DHA-derived SPMs","Proton/oligopeptide cotransporters","Mitotic Metaphase and Anaphase"
,"Post NMDA receptor activation events","Biosynthesis of D-series resolvins","Mitotic Anaphase","Biosynthesis of maresins","Activation of AMPK downstream of NMDARs","Nuclear Envelope (NE) Reassembly",
"Biosynthesis of maresin-like SPMs","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{}

> <broad_moa>
{"bacterial cell wall synthesis inhibitor"}

> <synonyms>
{cefaclor,53994-73-3,53994733,Cephaclor,Ceclor,"Cefaclor anhydrous",Cefaclorum,Kefral,Panoral,Raniclor,"Cefaclor hydrate","Cefaclorum (INN-Latin)","Cefaclorum (INNLatin)",UNII-3Z6FS3IK0K,UNII3Z6FS3IK0
K,"3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid","3Chloro7D(2phenylglycinamido)3cephem4carboxylic acid","S 6472",CHEBI:3478,CCL,3,T1495,SAM001246884,1500771,"Cefaclor monohydrate",CPD
000058250,CEFACLOR}

> <pdid>
PD001586

> <targets>
{}

> <classes>
{antibacterial}

> <pubchem_cids>
{51039,7048572}

$$$$
NIHCC_2014
  SciTegic11012413002D

 19 18  0  0  0  0            999 V2000
    8.9904   -3.0059    0.0000 O   0  0
    2.5909   -6.0056    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2925   -3.7494    0.0000 N   0  0
   -0.0048   -2.9949    0.0000 C   0  0
   -1.3015   -2.2408    0.0000 N   0  0
    2.5973   -1.5031    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    5.1894   -6.0109    0.0000 C   0  0
    5.1873   -7.5109    0.0000 C   0  0
    6.4897   -5.2632    0.0000 C   0  0
    6.4873   -6.7630    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  3
  5  6  1  0
  6  7  1  0
  7  8  3  0
  5  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  3 16  1  0
 16 17  1  0
 16 18  1  0
 16 19  1  0
M  END
> <name>
NIHCC_2014

> <id>
5800

> <plate>
NGP-105-03

> <well>
B07

> <supplier_cmpd_name>
CPD000466919

> <ctcr_id>
1855

> <supplier_cmpd_id>
SAM001246907

> <smiles>
O.CC(N=C(NC#N)Nc1ccncc1)C(C)(C)C

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"PINACIDIL MONOHYDRATE",85371-64-8,85371648,Pindac,"Pinacidil hydrate",C13H19N5,CHEBI:34923,DSSTox_CID_25682,DSSToxCID25682,DSSTox-CID-25682,"DSSTox CID 25682",DSSTox_RID_81055,DSSToxRID81055,DSSTox-
RID-81055,"DSSTox RID 81055",DSSTox_GSID_45682,DSSToxGSID45682,DSSTox-GSID-45682,"DSSTox GSID 45682","Pinacidil (USAN:INN)","1-cyano-2-(3,3-dimethylbutan-2-yl)-3-pyridin-4-ylguanidine;hydrate","1cyano
2(3,3dimethylbutan2yl)3pyridin4ylguanidine;hydrate",SMR000466919,NCGC00025,S4366,SAM001246907,Pinacidil,CPD000466919}

> <pdid>

> <targets>
{Others,Potassium Channel}

> <classes>
{Membrane Transporter/Ion Channel}

> <pubchem_cids>
{55329}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 30  0  0  1  0            999 V2000
    2.5175   -4.4368    0.0000 C   0  0
    1.7758   -3.1329    0.0000 C   0  0  2  0  0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -1.2991    2.2500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
    0.0000    0.0000    0.0000 F   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  1  0  0  0
   -1.2212   -2.3711    0.0000 C   0  0
    0.2851   -2.9666    0.0000 C   0  0  1  0  0  0
   -0.7338   -4.0650    0.0000 C   0  0
   -0.2910   -5.4982    0.0000 O   0  0
   -2.1972   -3.7322    0.0000 C   0  0
   -3.2173   -4.8319    0.0000 O   0  0
  2  1  1  1
  2  3  1  0
  4  3  1  6
  4  5  1  0
  5  6  1  1
  6  7  1  0
  7  8  1  0
  8  9  2  3
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  3
 13 14  1  0
 14  8  1  0
 14 15  1  6
 14 16  1  0
 16  5  1  0
 16 17  1  1
 16 18  1  0
 18 19  1  6
 18 20  1  0
 20 21  1  0
 21  4  1  0
 21 22  1  6
 21 23  1  0
 23  2  1  0
 23 24  1  6
 24 25  2  0
 24 26  1  0
 26 27  1  0
M  END
> <name>
NIHCC_2014

> <id>
5801

> <plate>
NGP-105-03

> <well>
B08

> <supplier_cmpd_name>
CPD000058856

> <ctcr_id>
6010

> <supplier_cmpd_id>
SAM001246885

> <smiles>
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO

> <pd_targets>
{PGR,HIF1A,NR3C1,LMNA,ABCB11,NR1I2}

> <pathway_gtopdb>
{"Transcription factor","Other nuclear protein",Transporter,"Nuclear receptor","Primary active transporter","Nuclear hormone receptor subfamily 3","ATP-binding cassette","Nuclear hormone receptor subf
amily 1","Nuclear hormone receptor subfamily 3 group C","ABCB subfamily","Nuclear hormone receptor subfamily 1 group I","Nuclear hormone receptor subfamily 3 group C member 3","Nuclear hormone recepto
r subfamily 3 group C member 1","Nuclear hormone receptor subfamily 1 group I member 2"}

> <pathway_chembl>
{Receptors,Transporters,"Nuclear hormone receptors","ATP-binding cassette transporter family","Steroid hormone receptors","ABCB subfamily","1I. Vitamin D receptor-like receptors","3C. 3-Ketosteroid re
ceptors"}

> <pathway_reactome>
{"Cellular responses to external stimuli","Gene expression (Transcription)","Cell Cycle",Metabolism,"Metabolism of proteins","Cellular responses to stress","RNA Polymerase II Transcription",Mitotic,"M
etabolism of lipids","Post-translational protein modification","Cellular response to hypoxia","Generic Transcription Pathway","M Phase","Metabolism of steroids",SUMOylation,"Oxygen-dependent proline h
ydroxylation of Hypoxia-inducible Factor Alpha","FOXO-mediated transcription","Mitotic Metaphase and Anaphase","Bile acid and bile salt metabolism","SUMO E3 ligases SUMOylate target proteins","FOXO-me
diated transcription of oxidative stress","metabolic and neuronal genes","Mitotic Anaphase","Synthesis of bile acids and bile salts","SUMOylation of intracellular receptors","Nuclear Envelope (NE) Rea
ssembly","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{NR3C1,PLA2G1B}

> <broad_moa>
{"glucocorticoid receptor agonist"}

> <synonyms>
{desoximetasone,382-67-2,382672,Desoxymethasone,Desoximetasona,Desoximetasonum,Topicort,"Topicort LP",Desoxymetasone,17-Deoxydexamethasone,17Deoxydexamethasone,HOE-304,HOE304,UNII-4E07GXB7AU,UNII4E07G
XB7AU,Deoxymethasone,Topisolon,A-41-304,A41304,"HOE 304",CHEBI:691037,R-2113,R2113,4E07GXB7AU,9-Fluoro-11,9Fluoro11,T4572,SAM001246885,Desoximetasone,CPD000058856}

> <pdid>
PD000315

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5311067}

$$$$
NIHCC_2014
  SciTegic11012413002D

 32 34  0  0  0  0            999 V2000
   11.7561   -3.1897    0.0000 O   0  0
    9.2561   -3.1897    0.0000 Cl  0  0
    1.4336   -5.8620    0.0000 O   0  0
    1.1732   -4.3848    0.0000 C   0  0
    2.2152   -3.3058    0.0000 N   0  0
    3.7013   -3.5145    0.0000 C   0  0
    4.3634   -4.8550    0.0000 C   0  0
    5.8604   -4.9512    0.0000 C   0  0
    6.6921   -3.7029    0.0000 C   0  0
    6.0270   -2.3585    0.0000 C   0  0
    4.5301   -2.2622    0.0000 C   0  0
    1.5111   -1.9822    0.0000 C   0  0
    2.0241   -0.5727    0.0000 C   0  0
    1.0599    0.5764    0.0000 C   0  0
   -0.4173    0.3159    0.0000 C   0  0
   -0.9303   -1.0936    0.0000 C   0  0
    0.0339   -2.2427    0.0000 C   0  0
   -0.1750   -3.7273    0.0000 C   0  0
   -1.6248   -3.3946    0.0000 C   0  0
   -2.0891   -1.9674    0.0000 C   0  0
   -3.5763   -2.1572    0.0000 C   0  0
   -4.4846   -0.9635    0.0000 C   0  0
   -3.9050    0.4200    0.0000 N   0  0
   -2.4171    0.6098    0.0000 C   0  0
   -1.5087   -0.5839    0.0000 C   0  0
   -0.2035   -5.2149    0.0000 C   0  0
   -1.5282   -5.9203    0.0000 C   0  0
   -1.5664   -7.4206    0.0000 C   0  0
   -2.8840   -8.1376    0.0000 C   0  0
   -4.1637   -7.3550    0.0000 N   0  0
   -4.1258   -5.8555    0.0000 C   0  0
   -2.8082   -5.1385    0.0000 C   0  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
  5 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 17 18  1  0
 18  4  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 18 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 27  1  0
M  END
> <name>
NIHCC_2014

> <id>
5802

> <plate>
NGP-105-03

> <well>
B09

> <supplier_cmpd_name>
CPD000466279

> <ctcr_id>
2937

> <supplier_cmpd_id>
SAM001247076

> <smiles>
O.Cl.O=C1N(c2ccccc2)c3ccccc3C1(Cc4ccncc4)Cc5ccncc5

> <pd_targets>
{MAPK1,CYP2D6,CYP3A4,KCNQ1,THPO,KCNQ5,CYP2C19,CYP1A2,KCNQ3,KCNQ4,KCNQ2,CYP2C9,ALDH1A1}

> <pathway_gtopdb>
{Enzyme,"Ion channel","Unclassified protein",Kinase,"Cytochrome P450","Voltage-gated ion channel",Oxidoreductase,"Protein Kinase","Cytochrome P450 family 2","Cytochrome P450 family 3","Potassium chann
els","Cytochrome P450 family 1","CMGC protein kinase group","Cytochrome P450 family 2D","Cytochrome P450 family 3A","Voltage-gated potassium channel","Cytochrome P450 family 2C","Cytochrome P450 famil
y 1A","CMGC protein kinase MAPK family","Cytochrome P450 2D6","Cytochrome P450 3A4","Cytochrome P450 2C19","Cytochrome P450 1A1","Cytochrome P450 2C9","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,"Ion channels","Kinases (EC 2.7.x.x)","Cytochrome P450","Voltage-gated ion channels","CMGC: Containing CDK",MAPK,GSK3,"CLK families","CYP2 family: drug metabolising subset","CYP3 family","Pot
assium channels","CYP1 family","Mitogen-activated protein kinases (MAP kinases)","Voltage-gated potassium channels","ERK subfamily"}

> <pathway_reactome>
{"Immune System",Metabolism,"Muscle contraction",Hemostasis,"Neuronal System","Developmental Biology","Innate Immune System","Biological oxidations","Metabolism of lipids","Cardiac conduction","Platel
et activation","signaling and aggregation","Potassium Channels","Nervous system development","Toll-like Receptor Cascades","Phase I - Functionalization of compounds","Biosynthesis of specialized prore
solving mediators (SPMs)","Phase 2 - plateau phase","Platelet Aggregation (Plug Formation)","Voltage gated Potassium channels","Axon guidance","Toll Like Receptor 5 (TLR5) Cascade","Cytochrome P450 - 
arranged by substrate type","Biosynthesis of DHA-derived SPMs","L1CAM interactions","Ethanol oxidation","MyD88 cascade initiated on plasma membrane",Xenobiotics,"Biosynthesis of maresins","Interaction
 between L1 and Ankyrins","MAP kinase activation","CYP2E1 reactions","Biosynthesis of maresin-like SPMs","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","MAPK targets/ Nuclear event
s mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{KCNQ2,KCNQ3,KCNQ4,KCNQ5}

> <broad_moa>
{"potassium channel blocker"}

> <synonyms>
{"2H-Indol-2-one, 1,3-dihydro-1-phenyl-3,3-bis(4-pyridinylmethyl)- (CAS)","2HIndol2one, 1,3dihydro1phenyl3,3bis(4pyridinylmethyl) (CAS)",SMR000466279,MLS000758292,MLS001424219,CHEMBL1612640,CCG-101128
,CCG101128,NC00378,SAM001247076,CPD000466279}

> <pdid>
PD002692

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581818}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 23  0  0  0  0            999 V2000
    3.5898   -2.1560    0.0000 C   0  0
    3.1497   -0.7220    0.0000 N   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 N   0  0
    0.0000    1.7286    0.0000 C   0  0
    0.1115    3.2255    0.0000 C   0  0
   -1.1278    4.0705    0.0000 C   0  0
   -2.4793    3.4196    0.0000 C   0  0
   -3.7186    4.2646    0.0000 Cl  0  0
   -2.5914    1.9238    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 N   0  3
   -1.4008   -2.9088    0.0000 O   0  5
    0.7500   -1.5574    0.0000 C   0  0
   -3.1484   -0.7186    0.0000 C   0  0
   -4.1145    0.4339    0.0000 C   0  0
   -5.5920    0.1754    0.0000 C   0  0
   -6.1069   -1.2335    0.0000 C   0  0
   -5.1442   -2.3838    0.0000 C   0  0
   -3.6667   -2.1253    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  3
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11  5  1  0
 11 12  1  0
 12 13  2  3
 13 14  1  0
 13 15  1  0
 15  3  1  0
 12 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
M  CHG  2  13   1  14  -1
M  END
> <name>
NIHCC_2014

> <id>
5803

> <plate>
NGP-105-03

> <well>
B10

> <supplier_cmpd_name>
CPD000469226

> <ctcr_id>
6946

> <supplier_cmpd_id>
SAM001246815

> <smiles>
CNC1=Nc2ccc(Cl)cc2C(=[N+]([O-])C1)c3ccccc3

> <pd_targets>
{BCHE,ACHE,CCKAR,CCKBR,GABRA1,GABRA2,GABRA3,GABRA4,GABRB1,GABRG2,GABRB3,GABRA5,GABRA6,GABRB2,GABRD,GABRE,GABRG1,GABRG3,GABRP,GABRQ,TRHR,TSPO,ABCB11,HRH1}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Ion channel",Transporter,Hydrolase,"Family A G protein-coupled receptor","Ligand-gated ion channel","Primary active transporter","Peptide receptor (family A GPCR)","GABA-A
 receptor","ATP-binding cassette","Small molecule receptor (family A GPCR)","Short peptide receptor (family A GPCR)","ABCB subfamily","Monoamine receptor","Cholecystokinin receptor","Neuropeptide rece
ptor","Histamine receptor"}

> <pathway_chembl>
{Enzymes,Receptors,"Other protein targets",Transporters,"Acetylcholine turnover","G protein-coupled receptors","Mitochondrial-associated proteins","ATP-binding cassette transporter family","Thyrotropi
n-releasing hormone receptors","ABCB subfamily","Histamine receptors"}

> <pathway_reactome>
{Metabolism,"Signal Transduction","Metabolism of lipids","Signaling by GPCR","Phospholipid metabolism","GPCR ligand binding","Metabolism of steroids","Glycerophospholipid biosynthesis","Class A/1 (Rho
dopsin-like receptors)","Metabolism of steroid hormones","Bile acid and bile salt metabolism","Synthesis of PC","Peptide ligand-binding receptors","Pregnenolone biosynthesis","Synthesis of bile acids 
and bile salts","Amine ligand-binding receptors","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Histamine receptors"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{chlordiazepoxide,58-25-3,58253,Methaminodiazepoxide,Librium,Chlordiazepoxid,Zetran,Clopoxide,Lygen,Radepur,Chlordiazachel,"7-Chloro-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-amine 4-oxide","7ChloroNme
thyl5phenyl3H1,4benzodiazepin2amine 4oxide",A-Poxide,APoxide,3H-1,3H1,4-Benzodiazepin-2-amine,4Benzodiazepin2amine,7-chloro-N-methyl-5-,7chloroNmethyl5,SAM001246815,CPD000469226}

> <pdid>
PD003049

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{2712}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 25  0  0  0  0            999 V2000
   12.5852   -0.0431    0.0000 H   0  3
   10.0852   -0.0431    0.0000 Cl  0  5
    7.5844   -1.4920    0.0000 C   0  0
    6.1069   -1.2335    0.0000 N   0  0
    5.5920    0.1754    0.0000 C   0  0
    4.1145    0.4339    0.0000 C   0  0
    3.1484   -0.7186    0.0000 C   0  0
    3.6667   -2.1252    0.0000 C   0  0
    5.1442   -2.3838    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.5913    1.9239    0.0000 C   0  0
    2.4792    3.4197    0.0000 C   0  0
    1.1278    4.0705    0.0000 C   0  0
   -0.1116    3.2255    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  4  1  0
  7 10  2  3
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 16 17  1  0
 17 18  2  3
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 10  1  0
 24 19  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5804

> <plate>
NGP-105-03

> <well>
B11

> <supplier_cmpd_name>
CPD000058431

> <ctcr_id>
1615

> <supplier_cmpd_id>
SAM001246883

> <smiles>
[H+].[Cl-].CN1CCC(CC1)=C2c3ccccc3C=Cc4ccccc24

> <pd_targets>
{HTR1A,HTR1B,HTR1D,HTR1F,HTR2A,HTR2B,HTR2C,HTR3A,HTR3B,HTR4,HTR5A,HTR5B,HTR6,HTR7,CYP2C19,CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,HRH4,SLC6A2,SETD7,ADRA1A,HRH1,TSHR,ALDH1A1,TP53,CYP2D6,DRD2,DRD3,SCN1A,SCN2A,SCN
3A,FFP,LEF,ADRA1B,SLC6A4,HTT,ADRA1D,DRD1,DRD4,DRD5,CYP1A2,HSD17B10,PMP22,RORC,LMNA,MAPT,KMT2A,MEN1,ADRA2B,HRH2,KCNH2,ADRA2C,CACNA1C,ADRA2A,MTOR}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,Transporter,"Epigenetic regulator","Transcription factor","Ion channel","Unclassified protein","Other nuclear protein","Other cytosolic protein","Family A G protein-coupled
 receptor","Cytochrome P450","Electrochemical transporter",Writer,Oxidoreductase,"Voltage-gated ion channel",Transferase,Protease,"Ligand-gated ion channel","Nuclear receptor",Reader,Kinase,"Small mol
ecule receptor (family A GPCR)","Cytochrome P450 family 2","SLC superfamily of solute carriers","Protein methyltransferase","Peptide receptor (family A GPCR)","Voltage-gated sodium channel","Metallo p
rotease","5HT3 receptor","Cytochrome P450 family 1","Nuclear hormone receptor subfamily 1",Bromodomain,"Potassium channels","Voltage-gated calcium channel","Protein Kinase","Monoamine receptor","Cytoc
hrome P450 family 2C","SLC06 neurotransmitter transporter family","SET domain","Glycohormone receptor","Cytochrome P450 family 2D","Metallo protease MAE clan","Cytochrome P450 family 1A","Nuclear horm
one receptor subfamily 1 group F","Voltage-gated potassium channel","Atypical protein kinase group","Serotonin receptor","Cytochrome P450 2C19","Acetylcholine receptor","Histamine receptor","Adrenergi
c receptor","Cytochrome P450 2D6","Dopamine receptor","Metallo protease M34 family","Cytochrome P450 1A1","Nuclear hormone receptor subfamily 1 group F member 3","Atypical protein kinase PIKK family",
"Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Ion channels","Cytochrome P450","G protein-coupled receptors","SLC superfamily of solute carriers","Chromatin modifying enzymes","Ligand-gated ion channels","Nuclear h
ormone receptors","Voltage-gated ion channels","Kinases (EC 2.7.x.x)","CYP2 family: drug metabolising subset","5-Hydroxytryptamine receptors","Histamine receptors","SLC6 neurotransmitter transporter f
amily","2.1.1.43 Histone methyltransferases (HMTs)",Adrenoceptors,"Glycoprotein hormone receptors","Acetylcholine receptors (muscarinic)","Dopamine receptors","5-HT<sub>3</sub> receptors","CYP1 family
","1F. Retinoic acid-related orphans","Potassium channels","Voltage-gated calcium channels",Atypical,"Monoamine transporter subfamily","Voltage-gated potassium channels","Phosphatidyl inositol 3' kina
se-related kinases (PIKK) family","FRAP subfamily"}

> <pathway_reactome>
{Metabolism,Disease,"Signal Transduction","Chromatin organization","Cell Cycle","Neuronal System","Gene expression (Transcription)","Developmental Biology","Muscle contraction","Biological oxidations"
,"Infectious disease","Signaling by GPCR","Disorders of transmembrane transporters","Chromatin modifying enzymes","Cell Cycle Checkpoints","Transmission across Chemical Synapses","RNA Polymerase II Tr
anscription","Metabolism of amino acids and derivatives","Nervous system development",Mitotic,"Cardiac conduction","Phase I - Functionalization of compounds","Leishmania infection","GPCR ligand bindin
g","SLC transporter disorders","PKMTs methylate histone lysines","G1/S DNA Damage Checkpoints","Uptake and actions of bacterial toxins","Neurotransmitter clearance","Neurotransmitter receptors and pos
tsynaptic signal transmission","Generic Transcription Pathway","Branched-chain amino acid catabolism","EGR2 and SOX10-mediated initiation of Schwann cell myelination","M Phase","Phase 3 - rapid repola
risation","Axon guidance","Cytochrome P450 - arranged by substrate type","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Defective SLC6A2 causes orthostatic intoleran
ce (OI)","Ethanol oxidation","p53-Dependent G1/S DNA damage checkpoint","Uptake and function of anthrax toxins","Serotonin clearance from the synaptic cleft","Transcriptional Regulation by MECP2","Tra
nscriptional regulation by RUNX3","Mitotic Metaphase and Anaphase","Activation of NMDA receptors and postsynaptic events","NCAM signaling for neurite out-growth","Transcriptional Regulation by TP53",X
enobiotics,"Anti-inflammatory response favouring Leishmania parasite infection","Amine ligand-binding receptors","p53-Dependent G1 DNA Damage Response","Regulation of MECP2 expression and activity","R
UNX3 Regulates Immune Response and Cell Migration","Mitotic Anaphase","Post NMDA receptor activation events","NCAM1 interactions","Regulation of TP53 Activity","CYP2E1 reactions","ADORA2B mediated ant
i-inflammatory cytokines production","Serotonin receptors","Histamine receptors",Adrenoceptors,"Muscarinic acetylcholine receptors","Stabilization of p53","Dopamine receptors","Aromatic amines can be 
N-hydroxylated or N-dealkylated by CYP1A2","Nuclear Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs","Regulation of TP53 Expression and Degradation","Autodegradation of the E3 ubiqu
itin ligase COP1","Initiation of Nuclear Envelope (NE) Reformation","Regulation of TP53 Degradation"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,CHRM1,CHRM2,CHRM3,HRH1,HTR2A,HTR2C,HTR6,HTR7}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{RESTW10,"RESTW 10",AKOS024366257,MCULE-4137922083,MCULE4137922083,"MCULE 4137922083",ST50999681,"4-dibenzo(b,f)(7)annulen-5-ylidene-1-methylpiperidine, chloride","4dibenzo(b,f)(7)annulen5ylidene1meth
ylpiperidine, chloride","4 dibenzo(b",f)(7)ann,S2044,SAM001246883,1505973,Prestw-103,"Cyproheptadine HCl",CPD000058431,"CYPROHEPTADINE HYDROCHLORIDE","Cyproheptadine hydrochloride"}

> <pdid>
PD010029

> <targets>
{"Histamine Receptor"}

> <classes>
{antipruritic,H1-antihistamine,"Neuronal Signaling"}

> <pubchem_cids>
{43834424,657241,13770}

$$$$
NIHCC_2014
  SciTegic11012413002D

 95 99  0  0  1  0            999 V2000
   -7.2473  -13.3378    0.0000 C   0  0
   -8.7153  -13.0296    0.0000 C   0  0
   -9.0264  -12.0792    0.0000 C   0  0
   -9.7174  -14.1468    0.0000 C   0  0
  -11.1862  -13.8384    0.0000 C   0  0
  -11.6502  -12.4111    0.0000 N   0  0
  -10.6468  -11.2950    0.0000 C   0  0
   -9.6686  -11.5025    0.0000 O   0  0
  -11.1108   -9.8677    0.0000 C   0  0
  -12.5783   -9.5533    0.0000 C   0  0
  -13.0407   -8.1255    0.0000 O   0  0
  -14.5083   -7.8111    0.0000 C   0  0
  -14.9704   -6.3841    0.0000 C   0  0
  -15.9751   -7.4976    0.0000 C   0  0
  -15.5134   -8.9245    0.0000 C   0  0
  -10.1074   -8.7516    0.0000 N   0  0
  -10.5714   -7.3243    0.0000 C   0  0
  -12.0387   -7.0131    0.0000 O   0  0
   -9.5680   -6.2082    0.0000 C   0  0
   -8.0992   -6.5166    0.0000 C   0  0
   -7.0970   -5.3994    0.0000 C   0  0
   -7.5602   -3.9726    0.0000 C   0  0
   -6.5564   -2.8581    0.0000 C   0  0
   -5.0892   -3.1702    0.0000 C   0  0
   -4.0853   -2.0556    0.0000 O   0  0
   -4.6259   -4.5968    0.0000 C   0  0
   -5.6298   -5.7114    0.0000 C   0  0
  -10.0320   -4.7809    0.0000 N   0  0
   -9.0286   -3.6648    0.0000 C   0  0
   -8.0503   -3.8723    0.0000 O   0  0
   -9.4925   -2.2375    0.0000 C   0  0
  -10.9601   -1.9231    0.0000 C   0  0
  -11.4222   -0.4961    0.0000 O   0  0
   -8.4892   -1.1214    0.0000 N   0  0
   -8.9531    0.3059    0.0000 C   0  0
  -10.4205    0.6171    0.0000 O   0  0
   -7.9497    1.4220    0.0000 C   0  0
   -6.4809    1.1137    0.0000 C   0  0
   -5.4805    2.2289    0.0000 C   0  0
   -5.7978    3.6950    0.0000 C   0  0
   -4.5016    4.4499    0.0000 N   0  0
   -3.3839    3.4507    0.0000 C   0  0
   -1.8927    3.6131    0.0000 C   0  0
   -1.0065    2.4029    0.0000 C   0  0
   -1.6115    1.0303    0.0000 C   0  0
   -3.1027    0.8679    0.0000 C   0  0
   -3.9889    2.0781    0.0000 C   0  0
   -8.4137    2.8493    0.0000 N   0  0
   -7.4103    3.9654    0.0000 C   0  0
   -6.4321    3.7579    0.0000 O   0  0
   -7.8743    5.3927    0.0000 C   0  0
   -9.3418    5.7071    0.0000 C   0  0
   -9.8042    7.1349    0.0000 C   0  0
  -11.2227    7.5820    0.0000 C   0  0
  -11.2182    9.0820    0.0000 N   0  0
   -9.7902    9.5412    0.0000 C   0  0
   -8.9122    8.3250    0.0000 N   0  0
   -6.8709    6.5088    0.0000 N   0  0
   -7.3349    7.9361    0.0000 C   0  0
   -8.3131    8.1436    0.0000 O   0  0
   -6.3315    9.0522    0.0000 C   0  0
   -6.6561   10.5036    0.0000 C   0  0
   -5.3561   11.2520    0.0000 C   0  0
   -4.2427   10.2468    0.0000 C   0  0
   -2.7750   10.5568    0.0000 O   0  0
   -4.8545    8.8773    0.0000 N   0  0
  -12.1896  -14.9545    0.0000 C   0  0
  -13.6570  -14.6433    0.0000 O   0  0
  -11.7257  -16.3818    0.0000 N   0  0
  -12.7291  -17.4979    0.0000 C   0  0  1  0  0  0
  -14.1966  -17.1835    0.0000 C   0  0
  -14.6590  -15.7557    0.0000 C   0  0
  -16.1265  -15.4413    0.0000 C   0  0
  -16.5889  -14.0135    0.0000 N   0  0
  -18.0564  -13.6991    0.0000 C   0  0
  -18.5186  -12.2721    0.0000 N   0  0
  -19.0616  -14.8125    0.0000 N   0  0
  -12.2651  -18.9253    0.0000 C   0  0
  -10.7977  -19.2365    0.0000 O   0  0
  -13.2685  -20.0414    0.0000 N   0  0
  -14.7454  -19.8664    0.0000 C   0  0
  -15.3573  -21.2360    0.0000 C   0  0
  -14.2439  -22.2411    0.0000 C   0  0
  -12.9439  -21.4927    0.0000 C   0  0
  -11.5726  -22.0962    0.0000 C   0  0
  -10.3632  -21.2089    0.0000 O   0  0
  -11.4083  -23.5880    0.0000 N   0  0
  -10.0345  -24.1925    0.0000 N   0  0
   -9.8702  -25.6843    0.0000 C   0  0
  -11.0796  -26.5716    0.0000 N   0  0
   -8.4973  -26.2884    0.0000 O   0  0
   13.0680   -7.2820    0.0000 C   0  0
   13.0680   -8.7820    0.0000 C   0  0
   11.7687   -9.5316    0.0000 O   0  0
   14.3672   -9.5316    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 12 15  1  0
  9 16  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 24 26  1  0
 26 27  2  0
 27 21  1  0
 19 28  1  0
 28 29  1  0
 29 30  2  0
 29 31  1  0
 31 32  1  0
 32 33  1  0
 31 34  1  0
 34 35  1  0
 35 36  2  0
 35 37  1  0
 37 38  1  0
 38 39  1  0
 39 40  2  0
 40 41  1  0
 41 42  1  0
 42 43  2  0
 43 44  1  0
 44 45  2  0
 45 46  1  0
 46 47  2  0
 47 39  1  0
 47 42  1  0
 37 48  1  0
 48 49  1  0
 49 50  2  0
 49 51  1  0
 51 52  1  0
 52 53  1  0
 53 54  2  0
 54 55  1  0
 55 56  1  0
 56 57  2  0
 57 53  1  0
 51 58  1  0
 58 59  1  0
 59 60  2  0
 59 61  1  0
 61 62  1  0
 62 63  1  0
 63 64  1  0
 64 65  2  0
 64 66  1  0
 66 61  1  0
  5 67  1  0
 67 68  2  0
 67 69  1  0
 70 69  1  6
 70 71  1  0
 71 72  1  0
 72 73  1  0
 73 74  1  0
 74 75  2  3
 75 76  1  0
 75 77  1  0
 70 78  1  0
 78 79  2  0
 78 80  1  0
 80 81  1  0
 81 82  1  0
 82 83  1  0
 83 84  1  0
 84 80  1  0
 84 85  1  0
 85 86  2  0
 85 87  1  0
 87 88  1  0
 88 89  1  0
 89 90  1  0
 89 91  2  0
 92 93  1  0
 93 94  1  0
 93 95  2  0
M  END
> <name>
NIHCC_2014

> <id>
5805

> <plate>
NGP-105-03

> <well>
C02

> <supplier_cmpd_name>
CPD000469214

> <ctcr_id>
6895

> <supplier_cmpd_id>
SAM001246784

> <smiles>
CC(C)CC(NC(=O)C(COC(C)(C)C)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CO)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc4c[nH]cn4)NC(=O)C5CCC(=O)N5)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N6CCCC6C(=O)NNC(N)=O.CC(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{MLS001424201,HMS2052E03,CCG-101073,CCG101073,NC00323,SMR000469214,SAM001246784,CPD000469214}

> <pdid>
PD070291

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581804}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 26  0  0  1  0            999 V2000
   10.8279    0.2172    0.0000 Cl  0  5
    2.5981   -1.5000    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    2.5987    1.5004    0.0000 C   0  0  2  0  0  0
    3.2934    2.6608    0.0000 C   0  0
    4.6008    2.7144    0.0000 N   0  0
    5.8279    1.6149    0.0000 C   0  0
    5.1150    0.3667    0.0000 C   0  0
    3.9905    1.5229    0.0000 C   0  0
    4.4442    3.2932    0.0000 C   0  0
    5.2075    4.1844    0.0000 C   0  0
    8.3279    0.2172    0.0000 H   0  3
  2  3  2  0
  3  4  1  0
  4  5  1  0
  6  5  1  6
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14  3  1  0
 14 15  2  0
 15  6  1  0
 15 10  1  0
 16  4  1  6
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 16  1  0
 21 22  1  0
 22 23  1  0
 23 18  1  0
M  CHG  2   1  -1  24   1
M  END
> <name>
NIHCC_2014

> <id>
5806

> <plate>
NGP-105-03

> <well>
C03

> <supplier_cmpd_name>
CPD000469233

> <ctcr_id>
6382

> <supplier_cmpd_id>
SAM001246791

> <smiles>
[Cl-].O=C1N(C[C@H]2CCCc3cccc1c23)[C@@H]4CN5CCC4CC5.[H+]

> <pd_targets>
{HTR3A,HTR3B,KCNH2,SCN5A,KCNE1,KCNQ1}

> <pathway_gtopdb>
{"Ion channel","Ligand-gated ion channel","Voltage-gated ion channel","5HT3 receptor","Potassium channels","Voltage-gated sodium channel","Voltage-gated potassium channel"}

> <pathway_chembl>
{"Ion channels","Ligand-gated ion channels","Voltage-gated ion channels","5-HT<sub>3</sub> receptors","Potassium channels","Voltage-gated sodium channels","Voltage-gated potassium channels"}

> <pathway_reactome>
{"Neuronal System","Muscle contraction","Developmental Biology","Transmission across Chemical Synapses","Cardiac conduction","Nervous system development","Neurotransmitter receptors and postsynaptic s
ignal transmission","Phase 3 - rapid repolarisation","Axon guidance","L1CAM interactions","Interaction between L1 and Ankyrins"}

> <broad_targets>
{HTR3A}

> <broad_moa>
{"serotonin receptor antagonist"}

> <synonyms>
{"Palonosetron hydrochloride",135729-62-3,135729623,Aloxi,"PALONOSETRON HCl",Onicit,"Palonosetron (Hydrochloride)",UNII-23310D4I19,UNII23310D4I19,RS-25259-197,RS25259197,"(3aS)-palonosetron hydrochlor
ide","(3aS)palonosetron hydrochloride",CHEBI:85157,"RS 25259-197","RS 25259197",23310D4I19,"Aloxi (TN)",DSSTox_CID_26610,DSSToxCID26610,DSSTox-CID-26610,"DSSTox CID 26610",DSSTox,T1156,SAM001246791,CP
D000469233}

> <pdid>
PD013065

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{6918303}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 28  0  0  0  0            999 V2000
    2.5981    0.0000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    1.2990   -3.7500    0.0000 C   0  0
    2.5981   -3.0000    0.0000 C   0  0
    2.5981   -1.5000    0.0000 C   0  0
    3.8971   -0.7500    0.0000 C   0  0
    5.1962   -1.5000    0.0000 C   0  0
    5.1962   -3.0000    0.0000 C   0  0
    6.1061   -2.5853    0.0000 C   0  0
    3.8971   -3.7500    0.0000 C   0  0
    4.2297   -5.2071    0.0000 C   0  0
    5.7224   -5.3544    0.0000 C   0  0
    6.3238   -3.9802    0.0000 C   0  0
    6.6067   -3.0210    0.0000 O   0  0
    7.3153   -5.0895    0.0000 C   0  0
    8.7787   -4.7600    0.0000 O   0  0
    6.8692   -6.5225    0.0000 C   0  0
    7.8858   -7.6254    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  3
  8  2  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12  2  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 17 11  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 15  1  0
 20 21  1  0
 20 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
M  END
> <name>
NIHCC_2014

> <id>
5807

> <plate>
NGP-105-03

> <well>
C04

> <supplier_cmpd_name>
CPD000466922

> <ctcr_id>
235

> <supplier_cmpd_id>
SAM001246889

> <smiles>
CC12CCC(=O)C=C1CCC3C2CCC4(C)C3CCC4(O)C(=O)CO

> <pd_targets>
{SERPINA6,SHBG,PMP22,FFP,CYP3A4,CHRM1,HSD17B10,BLM,LMNA}

> <pathway_gtopdb>
{"Secreted protein","Unclassified protein",Enzyme,"Membrane receptor","Other nuclear protein",Transferase,"Cytochrome P450","Family A G protein-coupled receptor",Oxidoreductase,"Cytochrome P450 family
 3","Small molecule receptor (family A GPCR)","Cytochrome P450 family 3A","Monoamine receptor","Cytochrome P450 3A4","Acetylcholine receptor"}

> <pathway_chembl>
{Enzymes,Receptors,"Cytochrome P450","G protein-coupled receptors","CYP3 family","Acetylcholine receptors (muscarinic)"}

> <pathway_reactome>
{Metabolism,"Developmental Biology","Signal Transduction","DNA Repair","Cell Cycle","Metabolism of lipids","Nervous system development","Signaling by GPCR","Metabolism of amino acids and derivatives",
"DNA Double-Strand Break Repair",Mitotic,"Metabolism of steroids","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Biosynthesis of specialized proresolving mediators (SPMs)","GPCR lig
and binding","Branched-chain amino acid catabolism","Homology Directed Repair","M Phase","Metabolism of steroid hormones","Biosynthesis of DHA-derived SPMs","Class A/1 (Rhodopsin-like receptors)","HDR
 through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Mitotic Metaphase and Anaphase","Glucocorticoid biosynthesis","Biosynthesis of maresins","Amine ligand-binding receptors","HD
R through Homologous Recombination (HRR)","Mitotic Anaphase","Biosynthesis of maresin-like SPMs","Muscarinic acetylcholine receptors","Homologous DNA Pairing and Strand Exchange","Nuclear Envelope (NE
) Reassembly","Presynaptic phase of homologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{AR}

> <broad_moa>
{"androgen receptor antagonist"}

> <synonyms>
{"Reichsteins Substance S","Substance S",SMR000466922,17.alpha.-Hydroxycortexone,17.alpha.Hydroxycortexone,"Cortisol, 11-dioxy-","Cortisol, 11dioxy","17,20-dione","17,20dione",Oprea1_732056,Oprea17320
56,Oprea1-732056,"Oprea1 732056",MLS001076465,MLS001240241,MLS001424203,CHEMBL1705958,SCHEMBL13352414,"17Alpha,21dihydroxy progesterone",CHEBI:12,T2748,SAM001246889,Cortodoxone,CPD000466922}

> <pdid>
PD000440

> <targets>
{Endogenous Metabolite,Glucocorticoid Receptor}

> <classes>
{GPCR/G Protein,Metabolic Enzyme/Protease}

> <pubchem_cids>
{227112}

$$$$
NIHCC_2014
  SciTegic11012413002D

 31 32  0  0  0  0            999 V2000
    0.7077   -8.3622    0.0000 C   0  0
   -0.7600   -8.0526    0.0000 N   0  0
   -1.7622   -9.1698    0.0000 C   0  0
   -1.2966  -10.5966    0.0000 C   0  0
   -2.2982  -11.7132    0.0000 O   0  0
   -1.2256   -6.6258    0.0000 C   0  0
   -0.2234   -5.5086    0.0000 C   0  0
    1.2443   -5.8182    0.0000 O   0  0
   -0.6890   -4.0818    0.0000 C   0  0
    0.3114   -2.9665    0.0000 N   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    2.5981    1.5000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
   10.2954   -4.3599    0.0000 O   0  0
    8.9950   -5.1077    0.0000 C   0  0
    8.9929   -6.6077    0.0000 O   0  0
    7.6968   -4.3546    0.0000 C   0  0
    7.6968   -2.8546    0.0000 C   0  0
    6.3978   -2.1046    0.0000 C   0  0
    5.0987   -2.8546    0.0000 C   0  0
    5.0987   -4.3546    0.0000 N   0  0
    6.3978   -5.1046    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  2  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 20 22  1  0
 22 10  1  0
 22 13  2  0
 23 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
M  END
> <name>
NIHCC_2014

> <id>
5808

> <plate>
NGP-105-03

> <well>
C05

> <supplier_cmpd_name>
CPD000058741

> <ctcr_id>
536

> <supplier_cmpd_id>
SAM001246912

> <smiles>
CN(CCO)CC(O)Cn1cnc2N(C)C(=O)N(C)C(=O)c12.OC(=O)c3cccnc3

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Xanthinol nicotinate","XANTHINOL NIACINATE",437-74-1,437741,"Xantinol nicotinate",Complamin,Angioamin,Complamex,Contamex,Landrina,Sadamine,Stenalgil,Teonicol,Xanidil,Vedrin,"Complamin retard",Xavin,
"SK 331 A","Xanthinol niacinate (USAN)",SAM001246912,CPD000058741}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{9912}

$$$$
NIHCC_2014
  SciTegic11012413002D

 12 13  0  0  0  0            999 V2000
    2.5973   -1.5031    0.0000 C   0  0
    2.5951   -3.0039    0.0000 N   0  0
    3.8056   -3.8679    0.0000 C   0  0
    3.3372   -5.2929    0.0000 C   0  0
    1.8372   -5.2877    0.0000 N   0  0
    1.3786   -3.8595    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  2  1  0
  1  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
M  END
> <name>
NIHCC_2014

> <id>
5809

> <plate>
NGP-105-03

> <well>
C06

> <supplier_cmpd_name>
CPD000059044

> <ctcr_id>
6153

> <supplier_cmpd_id>
SAM001246858

> <smiles>
C(n1ccnc1)c2ccccc2

> <pd_targets>
{CYP3A4,QPCT,CYP17A1,CAMC,CYP19A1,MAPT,POLB,CYP11B1,CYP11B2,CYP2D6,TBXAS1,CYP1A2}

> <pathway_gtopdb>
{Enzyme,"Other cytosolic protein","Cytochrome P450",Aminoacyltransferase,"Cytochrome P450 family 3","Cytochrome P450 family 17","Cytochrome P450 CAM family","Cytochrome P450 family 19","Cytochrome P45
0 family 11","Cytochrome P450 family 2","Cytochrome P450 family 5","Cytochrome P450 family 1","Cytochrome P450 family 3A","Cytochrome P450 family 17A","Cytochrome P450 family 19A","Cytochrome P450 fam
ily 11B","Cytochrome P450 family 2D","Cytochrome P450 family 5A","Cytochrome P450 family 1A","Cytochrome P450 3A4","Cytochrome P450 17A1","Cytochrome P450 19A1","Cytochrome P450 11B1","Cytochrome P450
 11B2","Cytochrome P450 2D6","Cytochrome P450 5A1","Cytochrome P450 1A1"}

> <pathway_chembl>
{Enzymes,"Cytochrome P450","Peptidases and proteinases","CYP3 family","MH: Metallo (M) Peptidases",CYP11,CYP17,CYP19,"CYP20 and CYP21 families","CYP2 family: drug metabolising subset",CYP5,"CYP7 and C
YP8 families","CYP1 family","M28: Aminopeptidase Y"}

> <pathway_reactome>
{Metabolism,"Immune System","Neuronal System","DNA Repair","Metabolism of lipids","Innate Immune System","Biological oxidations","Transmission across Chemical Synapses","Base Excision Repair","Biosynt
hesis of specialized proresolving mediators (SPMs)","Neutrophil degranulation","Metabolism of steroids","Phase I - Functionalization of compounds","Neurotransmitter receptors and postsynaptic signal t
ransmission","Resolution of Abasic Sites (AP sites)","Biosynthesis of DHA-derived SPMs","Metabolism of steroid hormones","Cytochrome P450 - arranged by substrate type","Activation of NMDA receptors an
d postsynaptic events","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Biosynthesis of maresins","Androgen biosynthesis","Endogenous sterols","Post NMDA receptor activa
tion events","PCNA-Dependent Long Patch Base Excision Repair",Xenobiotics,Eicosanoids,"Biosynthesis of maresin-like SPMs","Activation of AMPK downstream of NMDARs","CYP2E1 reactions","Aromatic amines 
can be N-hydroxylated or N-dealkylated by CYP1A2"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{1-Benzylimidazole,1Benzylimidazole,1-Benzyl-1H-imidazole,1Benzyl1Himidazole,4238-71-5,4238715,N-Benzylimidazole,NBenzylimidazole,"Imidazole, 1-benzyl-","Imidazole, 1benzyl","1H-Imidazole, 1-(phenylme
thyl)-","1HImidazole, 1(phenylmethyl)","1-BENZYL IMIDAZOLE","1BENZYL IMIDAZOLE",MFCD00005296,"1-Benzylimidazole, 99","1Benzylimidazole, 99",UNII-W4C9Z5BCV7,UNIIW4C9Z5BCV7,W4C9Z5BCV7,CHEMBL14192,MLS000
069473,SMR0000,SAM001246858,CPD000059044}

> <pdid>
PD003190

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{77918}

$$$$
NIHCC_2014
  SciTegic11012413002D

 12 13  0  0  0  0            999 V2000
    2.6030   -2.9977    0.0000 O   0  5
    2.6003   -1.4977    0.0000 N   0  3
    3.8983   -0.7459    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.4133   -1.7530    0.0000 C   0  0
   -1.8032   -3.1233    0.0000 N   0  0
   -0.3114   -2.9665    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12  4  1  0
 12  8  2  0
M  CHG  2   1  -1   2   1
M  END
> <name>
NIHCC_2014

> <id>
5810

> <plate>
NGP-105-03

> <well>
C07

> <supplier_cmpd_name>
CPD000058266

> <ctcr_id>
6753

> <supplier_cmpd_id>
SAM001246908

> <smiles>
[O-][N+](=O)c1cccc2cn[nH]c12

> <pd_targets>
{KDM4E,HPGD,CYP3A4,NOS1,NOS3,KMT2A,MEN1,HSD17B10,NOS2,TDP1,NPSR1,APEX1,MAPT,ALD,BLM,CHRM1,CYP2C19,NFO,CYP1A2,RECQL,THRB,TSHR,RORC}

> <pathway_gtopdb>
{"Epigenetic regulator",Enzyme,"Membrane receptor","Other cytosolic protein","Transcription factor",Eraser,"Cytochrome P450",Reader,Oxidoreductase,Hydrolase,"Family A G protein-coupled receptor","Nucl
ear receptor","Lysine demethylase","Cytochrome P450 family 3",Bromodomain,"Peptide receptor (family A GPCR)","Small molecule receptor (family A GPCR)","Cytochrome P450 family 2","Cytochrome P450 famil
y 1","Nuclear hormone receptor subfamily 1","Jumonji domain-containing","Cytochrome P450 family 3A","Short peptide receptor (family A GPCR)","Monoamine receptor","Cytochrome P450 family 2C","Cytochrom
e P450 family 1A","Nuclear hormone receptor subfamily 1 group A","Glycohormone receptor","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 3A4","Neuropeptide receptor","Acetylcholine rec
eptor","Cytochrome P450 2C19","Cytochrome P450 1A1","Nuclear hormone receptor subfamily 1 group A member 2","Nuclear hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{Enzymes,Receptors,"Chromatin modifying enzymes","Eicosanoid turnover","Cytochrome P450","L-Arginine turnover","G protein-coupled receptors","Nuclear hormone receptors","1.14.11.- Histone demethylases
","Prostaglandin synthases","CYP3 family","Nitric oxide synthases","Neuropeptide S receptor","Acetylcholine receptors (muscarinic)","CYP2 family: drug metabolising subset","CYP1 family","1A. Thyroid h
ormone receptors","Glycoprotein hormone receptors","1F. Retinoic acid-related orphans"}

> <pathway_reactome>
{Metabolism,Hemostasis,"Signal Transduction",Disease,"DNA Repair","Neuronal System","Metabolism of proteins","Gene expression (Transcription)","Metabolism of lipids","Platelet homeostasis","Signaling 
by Receptor Tyrosine Kinases","Metabolism of amino acids and derivatives","Infectious disease","DNA Double-Strand Break Repair","Base Excision Repair","Transmission across Chemical Synapses","Signalin
g by GPCR","Biological oxidations","Post-translational protein modification","RNA Polymerase II Transcription","Biosynthesis of specialized proresolving mediators (SPMs)","Nitric oxide stimulates guan
ylate cyclase","Signaling by VEGF","Branched-chain amino acid catabolism","Infection with Mycobacterium tuberculosis","Nonhomologous End-Joining (NHEJ)","Leishmania infection","Resolution of Abasic Si
tes (AP sites)","Neurotransmitter receptors and postsynaptic signal transmission","Homology Directed Repair","GPCR ligand binding","Phase I - Functionalization of compounds",SUMOylation,"Generic Trans
cription Pathway","Biosynthesis of DHA-derived SPMs","VEGFA-VEGFR2 Pathway","Response of Mtb to phagocytosis","Leishmania parasite growth and survival","Resolution of AP sites via the multiple-nucleot
ide patch replacement pathway","Activation of NMDA receptors and postsynaptic events","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Class A/1 (Rhodopsin-like receptors
)","Cytochrome P450 - arranged by substrate type","SUMO E3 ligases SUMOylate target proteins","Transcriptional regulation by RUNX3","Biosynthesis of D-series resolvins","Biosynthesis of maresins","VEG
FR2 mediated vascular permeability","Suppression of phagosomal maturation","Anti-inflammatory response favouring Leishmania parasite infection","PCNA-Dependent Long Patch Base Excision Repair","Post N
MDA receptor activation events","HDR through Homologous Recombination (HRR)","Amine ligand-binding receptors",Xenobiotics,"SUMOylation of intracellular receptors","RUNX3 Regulates Immune Response and 
Cell Migration","Biosynthesis of maresin-like SPMs","Inhibition of nitric oxide production","ADORA2B mediated anti-inflammatory cytokines production","Activation of AMPK downstream of NMDARs","Homolog
ous DNA Pairing and Strand Exchange","Muscarinic acetylcholine receptors","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Presynaptic phase of homologous DNA pai
ring and strand exchange"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{7nitroindazole,7-Nitro-1H-indazole,7Nitro1Hindazole,2942-42-9,2942429,"1H-Indazole, 7-nitro-","1HIndazole, 7nitro",7-NI,7NI,UNII-UX0N37CMVH,UNIIUX0N37CMVH,MFCD00022789,UX0N37CMVH,MLS000028452,CHEMBL2
47378,SMR000058266,7-nitro-indazole,"CCRIS 3309","2h-indazole,7-nitro-","2hindazole,7nitro",SR-01000075512,SR01000075512,"EINECS 220-934-","EINECS 220934",SAM001246908,1505342,CPD000058266,7-NITROINDA
ZOLE}

> <pdid>
PD000923

> <targets>
{}

> <classes>
{"NO synthetase inhibitor"}

> <pubchem_cids>
{1893}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 27  0  0  1  0            999 V2000
    5.1894   -6.0108    0.0000 C   0  0
    3.8917   -5.2586    0.0000 N   0  0
    2.5915   -6.0067    0.0000 C   0  0
    3.8934   -3.7577    0.0000 C   0  0
    2.5949   -3.0050    0.0000 C   0  0
    2.5966   -1.5042    0.0000 C   0  0  1  0  0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 Cl  0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8990   -0.7582    0.0000 C   0  0
    3.9042    0.7419    0.0000 C   0  0
    5.2058    1.4875    0.0000 C   0  0
    6.5023    0.7331    0.0000 C   0  0
    6.4972   -0.7669    0.0000 C   0  0
    5.1956   -1.5125    0.0000 N   0  0
   10.3023   -0.3804    0.0000 O   0  0
   10.3023   -1.8804    0.0000 C   0  0
    9.0030   -2.6300    0.0000 O   0  0
   11.6023   -2.6304    0.0000 C   0  0
   12.9023   -1.8804    0.0000 C   0  0
   12.9037   -0.3796    0.0000 C   0  0
   11.6051    0.3712    0.0000 O   0  0
   14.2030    0.3700    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  6  5  1  1
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13  7  1  0
  6 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 25 27  2  0
M  END
> <name>
NIHCC_2014

> <id>
5811

> <plate>
NGP-105-03

> <well>
C08

> <supplier_cmpd_name>
CPD000471617

> <ctcr_id>
2298

> <supplier_cmpd_id>
SAM001246557

> <smiles>
CN(C)CC[C@@H](c1ccc(Cl)cc1)c2ccccn2.OC(=O)\C=C/C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Dexchlorpheniramine maleate",2438-32-6,2438326,"2438 32 6","(+)-Chlorpheniramine maleate","(+)Chlorpheniramine maleate","(+) Chlorpheniramine maleate",Polaramine,"d-Chlorpheniramine maleate","dChlor
pheniramine maleate","d Chlorpheniramine ma",SAM001246557,CPD000471617}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5281070}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 31  0  0  1  0            999 V2000
    2.2703   -4.0022    0.0000 C   0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
   -0.8660    2.5000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
    0.0000    0.5000    0.0000 Cl  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.8141   -2.0807    0.0000 C   0  0
    0.2851   -2.9666    0.0000 C   0  0
   -0.6870   -2.7320    0.0000 O   0  0
    0.7500   -4.3800    0.0000 C   0  0
    2.2230   -4.6635    0.0000 O   0  0
   -0.2322   -5.5148    0.0000 C   0  0
    0.2584   -6.9323    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  3
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  3
 13 14  1  0
 14  8  1  0
 14 15  1  0
 14 16  1  0
 16  5  1  0
 16 17  1  1
 16 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21  4  1  0
 21 22  1  0
 21 23  1  0
 23  2  1  0
 23 24  1  0
 23 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
M  END
> <name>
NIHCC_2014

> <id>
5812

> <plate>
NGP-105-03

> <well>
C09

> <supplier_cmpd_name>
CPD000466920

> <ctcr_id>
673

> <supplier_cmpd_id>
SAM001246898

> <smiles>
CC1CC2C3CCC4=CC(=O)C=CC4(C)[C@@]3(Cl)C(O)CC2(C)C1(O)C(=O)CO

> <pd_targets>
{PLA2G5,CYP3A4,PGR,NR1I2,NR3C1,NR3C2,FABP1,AR,PLA2G1B,TSHR,PTGS2,NR0B1,ANXA1,NOS2,ABCB11,HIF1A,GAA,RORC,DUSP6}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Auxiliary transport protein","Membrane receptor","Ion channel",Hydrolase,"Cytochrome P450","Nuclear receptor","Fatty acid binding protein family","Family A G protein-co
upled receptor",Oxidoreductase,"Other ion channel","Cytochrome P450 family 3","Nuclear hormone receptor subfamily 3","Nuclear hormone receptor subfamily 1","Peptide receptor (family A GPCR)","Nuclear 
hormone receptor subfamily 0",Annexin,"Cytochrome P450 family 3A","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 1 group I","Glycohormone receptor","Nuclear hormone
 receptor subfamily 0 group B","Cytochrome P450 3A4","Nuclear hormone receptor subfamily 3 group C member 3","Nuclear hormone receptor subfamily 1 group I member 2","Nuclear hormone receptor subfamily
 3 group C member 1","Nuclear hormone receptor subfamily 3 group C member 2","Nuclear hormone receptor subfamily 3 group C member 4","Nuclear hormone receptor subfamily 0 group B member 1",Transporter
,"Primary active transporter",Phosphatase,"ATP-binding cassette","Protein Phosphatase","ABCB subfamily","Nuclear hormone receptor subfamily 1 group F","Serine/threonine/tyrosine protein phosphatase","
Nuclear hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{Enzymes,Receptors,"Other protein targets","Glycerophospholipid turnover","Cytochrome P450","Nuclear hormone receptors","Fatty acid-binding proteins","G protein-coupled receptors","Eicosanoid turnover
","L-Arginine turnover","Phospholipase A<sub>2</sub>","CYP3 family","1I. Vitamin D receptor-like receptors","Steroid hormone receptors","Glycoprotein hormone receptors",Cyclooxygenase,"0B. DAX-like re
ceptors","Nitric oxide synthases","3C. 3-Ketosteroid receptors",Transporters,"ATP-binding cassette transporter family","3.2.1.- Glycosidases","ABCB subfamily","1F. Retinoic acid-related orphans"}

> <pathway_reactome>
{Metabolism,"Metabolism of proteins","Gene expression (Transcription)",Disease,"Signal Transduction","Metabolism of lipids","Post-translational protein modification","RNA Polymerase II Transcription",
"Infectious disease","Signaling by GPCR","Phospholipid metabolism","Biosynthesis of specialized proresolving mediators (SPMs)",SUMOylation,"Generic Transcription Pathway","Regulation of lipid metaboli
sm by PPARalpha","Leishmania infection","GPCR ligand binding","Infection with Mycobacterium tuberculosis","Glycerophospholipid biosynthesis","Biosynthesis of DHA-derived SPMs","SUMO E3 ligases SUMOyla
te target proteins","FOXO-mediated transcription","PPARA activates gene expression","Transcriptional regulation by RUNX2","Leishmania parasite growth and survival","Biosynthesis of DPA-derived SPMs","
Nuclear Receptor transcription pathway","Class A/1 (Rhodopsin-like receptors)","Response of Mtb to phagocytosis","Acyl chain remodelling of PC","Biosynthesis of maresins","SUMOylation of intracellular
 receptors","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","RUNX2 regulates bone development","Anti-inflammatory response favouring Leishmania parasite infection","Bi
osynthesis of DPAn-3 SPMs","Peptide ligand-binding receptors","Suppression of phagosomal maturation","Biosynthesis of maresin-like SPMs","RUNX2 regulates osteoblast differentiation","ADORA2B mediated 
anti-inflammatory cytokines production","Formyl peptide receptors bind formyl peptides and many other ligands","Inhibition of nitric oxide production","Cellular responses to external stimuli","Immune 
System","Cellular responses to stress","Diseases of metabolism","Innate Immune System","Metabolism of steroids","Cellular response to hypoxia","Diseases of carbohydrate metabolism","Toll-like Receptor
 Cascades","Bile acid and bile salt metabolism","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Glycogen storage diseases","Transcriptional regulation by RUNX3","Toll Like 
Receptor 5 (TLR5) Cascade","Synthesis of bile acids and bile salts","Glycogen storage disease type II (GAA)","RUNX3 Regulates Immune Response and Cell Migration","MyD88 cascade initiated on plasma mem
brane","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","MAP kinase activation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{ANXA1,NOS2,NR0B1,NR3C1,NR3C2}

> <broad_moa>
{"glucocorticoid receptor agonist"}

> <synonyms>
{beclomethasone,SMR000466920,"Beclomethasone, >=99",MLS001333211,MLS001333212,MLS001424231,MLS002153387,CHEMBL1881863,CHEBI:94337,HMS2052E17,HMS2232J17,HMS3372K11,HMS3394E17,CCG-101129,CCG101129,NC003
79,Q27166163,SAM001246898,CPD000466920}

> <pdid>
PD002388

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{16218996}

$$$$
NIHCC_2014
  SciTegic11012413002D

 31 32  0  0  1  0            999 V2000
   10.2325   -3.2645    0.0000 O   0  0
    5.0488   -9.5322    0.0000 N   0  0
    5.5842   -8.1310    0.0000 C   0  0
    4.7653   -6.8742    0.0000 N   0  0
    5.7131   -5.7282    0.0000 C   0  0
    7.1086   -6.2424    0.0000 C   0  0
    7.0325   -7.7405    0.0000 S   0  0
    5.3266   -4.2780    0.0000 C   0  0
    6.3873   -3.2163    0.0000 N   0  0
    5.9992   -1.7665    0.0000 O   0  0
    7.0599   -0.7048    0.0000 C   0  0
    6.6718    0.7450    0.0000 C   0  0
    7.7320    1.8061    0.0000 O   0  0
    5.2228    1.1330    0.0000 O   0  0
    3.8775   -3.8868    0.0000 C   0  0
    2.8152   -4.9458    0.0000 O   0  0
    3.4909   -2.4366    0.0000 N   0  0
    2.0479   -2.0470    0.0000 C   0  0  1  0  0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 S   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
    0.7488   -2.7970    0.0000 C   0  0
    0.3606   -4.2459    0.0000 O   0  0
   -2.6003   -1.4978    0.0000 C   0  0
   -3.8983   -0.7459    0.0000 O   0  0
   -2.6029   -2.9978    0.0000 O   0  0
   -2.5973    1.5031    0.0000 C   0  0
   -2.5951    3.0031    0.0000 C   0  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  3  1  0
  5  8  1  0
  8  9  2  3
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
  8 15  1  0
 15 16  2  0
 15 17  1  0
 18 17  1  6
 18 19  1  0
 19 20  1  6
 20 21  1  0
 21 22  1  0
 22 23  2  3
 23 24  1  0
 24 19  1  0
 24 25  1  0
 25 18  1  0
 25 26  2  0
 23 27  1  0
 27 28  2  0
 27 29  1  0
 22 30  1  0
 30 31  2  0
M  END
> <name>
NIHCC_2014

> <id>
5813

> <plate>
NGP-105-03

> <well>
C10

> <supplier_cmpd_name>
CPD000469225

> <ctcr_id>
4915

> <supplier_cmpd_id>
SAM001246816

> <smiles>
O.Nc1nc(cs1)C(=NOCC(=O)O)C(=O)N[C@H]2[C@H]3SCC(=C(N3C2=O)C(=O)O)C=C

> <pd_targets>
{APAF1,PSIP1,TDP1,L3MBTL1,SIRT5,PLCG1,ABCC2,DACA,DACB,DACC,FTSI,MRCA,MRCB,MRDA,PSMD14,NADD,F2}

> <pathway_gtopdb>
{"Unclassified protein",Enzyme,"Epigenetic regulator",Transporter,Hydrolase,Reader,Eraser,"Primary active transporter",Protease,"Methyl-lysine/arginine binding protein","Histone deacetylase","ATP-bind
ing cassette","Serine protease","MBT domain","HDAC class III","ABCC subfamily","Serine protease SE clan","Serine protease S11 family",Transferase,"Metallo protease","Metallo protease MP clan","Serine 
protease PA clan","Metallo protease M67 family","Serine protease S1A subfamily","Metallo protease M67A subfamily"}

> <pathway_chembl>
{Enzymes,Transporters,"Chromatin modifying enzymes","Glycerophospholipid turnover","ATP-binding cassette transporter family","3.5.1.- Histone deacetylases (HDACs)","Phosphoinositide-specific phospholi
pase C","ABCC subfamily","Peptidases and proteinases","MP: Metallo (M) Peptidases","PA: Serine (S) Peptidases","M67: PSMD14 peptidase","S1: Chymotrypsin"}

> <pathway_reactome>
{"Programmed Cell Death",Disease,"DNA Repair","Gene expression (Transcription)","Organelle biogenesis and maintenance",Apoptosis,"Infectious disease","DNA Double-Strand Break Repair","RNA Polymerase I
I Transcription","Mitochondrial biogenesis","Disorders of transmembrane transporters","Intrinsic Pathway for Apoptosis","HIV Infection","Nonhomologous End-Joining (NHEJ)","Generic Transcription Pathwa
y","Transcriptional activation of mitochondrial biogenesis","Leishmania infection","ABC transporter disorders","Apoptotic factor-mediated response","HIV Life Cycle","Transcriptional Regulation by TP53
","Leishmania parasite growth and survival","Defective ABCC2 causes DJS","Cytochrome c-mediated apoptotic response","Early Phase of HIV Life Cycle","Regulation of TP53 Activity","Anti-inflammatory res
ponse favouring Leishmania parasite infection","Formation of apoptosome","Integration of provirus","Regulation of TP53 Activity through Methylation","FCGR3A-mediated IL10 synthesis","Regulation of the
 apoptosome activity","2-LTR circle formation","Cell Cycle",Mitotic,"Diseases of hemostasis","Regulation of mitotic cell cycle","Defects of contact activation system (CAS) and kallikrein/kinin system 
(KKS)","APC/C-mediated degradation of cell cycle proteins","Defective factor VIII causes hemophilia A","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins","Defective F8 clea
vage by thrombin","APC/C:Cdc20 mediated degradation of mitotic proteins","APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint","Cdc20:Phospho-APC/C 
mediated degradation of Cyclin A"}

> <broad_targets>
{}

> <broad_moa>
{"bacterial cell wall synthesis inhibitor"}

> <synonyms>
{HMS2052E19,MLS006010856,CCG-101137,CCG101137,NC00387,SMR004701776,SAM001246816,CPD000469225}

> <pdid>
PD009856

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581806}

$$$$
NIHCC_2014
  SciTegic11012413002D

 39 43  0  0  1  0            999 V2000
    9.2971    4.6579    0.0000 C   0  0
    8.0391    3.8409    0.0000 O   0  0
    8.1168    2.3421    0.0000 C   0  0
    9.4532    1.6608    0.0000 O   0  0
    6.8582    1.5246    0.0000 C   0  0
    6.9359    0.0258    0.0000 C   0  0  2  0  0  0
    5.5999    0.7078    0.0000 O   0  0
    8.2730   -0.6559    0.0000 C   0  0
    9.5324    0.1605    0.0000 C   0  0
   10.8695   -0.5212    0.0000 C   0  0
   12.1289    0.2951    0.0000 C   0  0
   13.3872    1.1116    0.0000 C   0  0
   12.0512    1.7931    0.0000 C   0  0
   13.4653   -0.3862    0.0000 O   0  0
    5.6765   -0.7905    0.0000 C   0  0
    5.7542   -2.2885    0.0000 O   0  0
    4.3394   -0.1088    0.0000 O   0  0
    3.0821   -0.9238    0.0000 C   0  0  1  0  0  0
    1.6852   -0.3846    0.0000 C   0  0  1  0  0  0
    1.3514    1.0778    0.0000 C   0  0
    2.5913    1.9239    0.0000 C   0  0
    2.4792    3.4197    0.0000 C   0  0
    3.5155    4.5031    0.0000 O   0  0
    2.8046    5.8240    0.0000 C   0  0
    1.3287    5.5562    0.0000 O   0  0
    1.1278    4.0705    0.0000 C   0  0
   -0.1116    3.2255    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 N   0  0
   -1.2172   -2.9891    0.0000 C   0  0
   -0.0039   -3.8711    0.0000 C   0  0
    1.2099   -2.9897    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0  2  0  0  0
    1.5613   -2.8152    0.0000 C   0  0
    3.0088   -2.4220    0.0000 C   0  0
    4.1745   -3.3632    0.0000 O   0  0
    3.9429   -4.8452    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  1
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 11 14  1  0
  6 15  1  0
 15 16  2  0
 15 17  1  0
 18 17  1  6
 18 19  1  0
 19 20  1  6
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 22  2  0
 26 27  1  0
 27 28  2  0
 28 20  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 35 34  1  1
 35 19  1  0
 35 31  1  0
 35 36  1  0
 36 37  2  3
 37 18  1  0
 37 38  1  0
 38 39  1  0
M  END
> <name>
NIHCC_2014

> <id>
5814

> <plate>
NGP-105-03

> <well>
C11

> <supplier_cmpd_name>
CPD000469230

> <ctcr_id>
4036

> <supplier_cmpd_id>
SAM001246822

> <smiles>
COC(=O)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@H]1[C@H]2c3cc4OCOc4cc3CCN5CCC[C@]25C=C1OC

> <pd_targets>
{RPL3,HTT,RORC,LEF,CYP3A4}

> <pathway_gtopdb>
{"Unclassified protein","Transcription factor",Enzyme,"Nuclear receptor",Protease,"Cytochrome P450","Nuclear hormone receptor subfamily 1","Metallo protease","Cytochrome P450 family 3","Nuclear hormon
e receptor subfamily 1 group F","Metallo protease MAE clan","Cytochrome P450 family 3A","Nuclear hormone receptor subfamily 1 group F member 3","Metallo protease M34 family","Cytochrome P450 3A4"}

> <pathway_chembl>
{Receptors,Enzymes,"Nuclear hormone receptors","Cytochrome P450","1F. Retinoic acid-related orphans","CYP3 family"}

> <pathway_reactome>
{"Developmental Biology","Nervous system development","Axon guidance","Signaling by ROBO receptors","Regulation of expression of SLITs and ROBOs","Gene expression (Transcription)",Disease,Metabolism,"
RNA Polymerase II Transcription","Infectious disease","Metabolism of lipids","Generic Transcription Pathway","Uptake and actions of bacterial toxins","Biosynthesis of specialized proresolving mediator
s (SPMs)","Transcriptional Regulation by MECP2","Transcriptional regulation by RUNX3","Uptake and function of anthrax toxins","Biosynthesis of DHA-derived SPMs","Regulation of MECP2 expression and act
ivity","RUNX3 Regulates Immune Response and Cell Migration","Biosynthesis of maresins","Biosynthesis of maresin-like SPMs"}

> <broad_targets>
{RPL3}

> <broad_moa>
{"protein synthesis inhibitor"}

> <synonyms>
{homoharringtonine,"Omacetaxine mepesuccinate",Synribo,26833-87-4,26833874,Ceflatonin,Myelostat,CGX-635,CGX635,(-)-homoharringtonine,()homoharringtonine,Omapro,NSC-141633,NSC141633,UNII-6FG8041S5B,UNI
I6FG8041S5B,CHEBI:71019,C29H39NO9,"(2'R,3S,4S,5R)-(-)-homoharringtonine","(2'R,3S,4S,5R)()homoharringtonine",6FG8041S5B,NSC,T3380,758253,1416,SAM001246822,Homoharringtonine,CPD000469230}

> <pdid>
PD003333

> <targets>
{STAT3,STAT}

> <classes>
{Protein synthesis inhibitor,JAK/STAT Signaling,Stem Cell/Wnt}

> <pubchem_cids>
{285033}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 27  0  0  1  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -0.0031    3.0008    0.0000 C   0  0
   -1.3039    3.7494    0.0000 C   0  0  1  0  0  0
   -2.6008    2.9940    0.0000 C   0  0
   -2.5961    1.4940    0.0000 O   0  0
   -1.3070    5.2502    0.0000 C   0  0  2  0  0  0
   -0.0101    6.0056    0.0000 C   0  0
   -0.0149    7.5056    0.0000 O   0  0
   -2.6078    5.9988    0.0000 C   0  0
   -2.6109    7.4996    0.0000 C   0  0
   -3.9100    8.2496    0.0000 C   0  0
   -3.9100    9.7496    0.0000 C   0  0
   -2.6110   10.4997    0.0000 C   0  0
   -2.6111   11.9997    0.0000 O   0  0
   -1.3119    9.7497    0.0000 C   0  0
   -0.0107   10.4975    0.0000 O   0  0
    1.2873    9.7457    0.0000 C   0  0
   -1.3119    8.2497    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  7  6  1  1
  7  8  1  0
  8  9  1  0
  7 10  1  0
 10 11  1  1
 11 12  1  0
 10 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 19 22  2  0
 22 14  1  0
  5 23  2  0
 23 24  1  0
 24 25  2  0
 25  3  1  0
 25 26  1  0
M  END
> <name>
NIHCC_2014

> <id>
5815

> <plate>
NGP-105-03

> <well>
D02

> <supplier_cmpd_name>
CPD000469212

> <ctcr_id>
833

> <supplier_cmpd_id>
SAM001246678

> <smiles>
COc1cc(C[C@@H](CO)[C@H](CO)Cc2ccc(O)c(OC)c2)ccc1O

> <pd_targets>
{CYP3A4,MMP1}

> <pathway_gtopdb>
{Enzyme,"Cytochrome P450",Protease,"Cytochrome P450 family 3","Metallo protease","Cytochrome P450 family 3A","Metallo protease MAM clan","Cytochrome P450 3A4","Metallo protease M10A subfamily"}

> <pathway_chembl>
{Enzymes,"Cytochrome P450","Peptidases and proteinases","CYP3 family","MA: Metallo (M) Peptidases","M10: Matrix metallopeptidase"}

> <pathway_reactome>
{Metabolism,"Immune System","Metabolism of lipids","Cytokine Signaling in Immune system","Biosynthesis of specialized proresolving mediators (SPMs)","Signaling by Interleukins","Biosynthesis of DHA-de
rived SPMs","Interleukin-4 and Interleukin-13 signaling","Biosynthesis of maresins","Biosynthesis of maresin-like SPMs"}

> <broad_targets>
{}

> <broad_moa>
{}

> <synonyms>
{Secoisolariciresinol,29388-59-8,29388598,(-)-Secoisolariciresinol,()Secoisolariciresinol,UNII-M8QRJ7JEJH,UNIIM8QRJ7JEJH,M8QRJ7JEJH,"(2R,3R)-2,3-bis((4-hydroxy-3-methoxyphenyl)methyl)butane-1,4-diol",
"(2R,3R)2,3bis((4hydroxy3methoxyphenyl)methyl)butane1,4diol",CHEMBL368347,CHEBI:65004,"(2R,3R)-2,3-bis(4-hydroxy-3-methoxybenzyl)butane-1,4-diol","(2R,3R)2,3bis(4hydroxy3methoxybenzyl)butane1,4diol",C
CRI,SAM001246678,CPD000469212}

> <pdid>
PD002865

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{65373}

$$$$
NIHCC_2014
  SciTegic11012413002D

 18 18  0  0  1  0            999 V2000
    5.0973    0.3740    0.0000 Na  0  3
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -5.1979    1.4986    0.0000 C   0  0  2  0  0  0
   -6.4957    0.7465    0.0000 C   0  0
   -5.2009    2.9995    0.0000 C   0  0
   -3.9031    3.7516    0.0000 O   0  5
   -6.5009    3.7477    0.0000 O   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12  7  1  0
 12 13  2  0
 13  4  1  0
  9 14  1  0
 14 15  1  6
 14 16  1  0
 16 17  1  0
 16 18  2  0
M  CHG  2   1   1  17  -1
M  END
> <name>
NIHCC_2014

> <id>
5816

> <plate>
NGP-105-03

> <well>
D03

> <supplier_cmpd_name>
CPD000058746

> <ctcr_id>
6454

> <supplier_cmpd_id>
SAM001246874

> <smiles>
[Na+].COc1ccc2cc(ccc2c1)[C@H](C)C([O-])=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"naproxen sodium",26159-34-2,26159342,Anaprox,Naprelan,"Naproxen sodium salt","(-)-Naproxen sodium","()Naproxen sodium","Naproxen (sodium)",Naprium,Naprux,Proxen,Aleve,Apo-Napro-NA,ApoNaproNA,UNII-9T
N87S3A3C,UNII9TN87S3A3C,"sodium naproxen",BAYH6689,"sodium (S)-2-(6-methoxynaphthalen-2-yl)propano","sodium (S)2(6methoxynaphthalen2yl)propano",SAM001246874,CPD000058746}

> <pdid>

> <targets>
{Autophagy,COX}

> <classes>
{Autophagy,Immunology/Inflammation}

> <pubchem_cids>
{23681059}

$$$$
NIHCC_2014
  SciTegic11012413002D

  8  8  0  0  0  0            999 V2000
    2.5951   -3.0031    0.0000 O   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
M  END
> <name>
NIHCC_2014

> <id>
5817

> <plate>
NGP-105-03

> <well>
D04

> <supplier_cmpd_name>
CPD000059086

> <ctcr_id>
3471

> <supplier_cmpd_id>
SAM001246894

> <smiles>
OCc1cccnc1

> <pd_targets>
{KDM4E}

> <pathway_gtopdb>
{"Epigenetic regulator",Eraser,"Lysine demethylase","Jumonji domain-containing"}

> <pathway_chembl>
{Enzymes,"Chromatin modifying enzymes","1.14.11.- Histone demethylases"}

> <pathway_reactome>
{}

> <broad_targets>
{}

> <broad_moa>
{}

> <synonyms>
{3-PYRIDINEMETHANOL,3PYRIDINEMETHANOL,100-55-0,100550,"Nicotinyl alcohol",pyridin-3-ylmethanol,pyridin3ylmethanol,3-(Hydroxymethyl)pyridine,3(Hydroxymethyl)pyridine,3-Pyridylmethanol,3Pyridylmethanol,
"Nicotinic alcohol",3-Pyridylcarbinol,3Pyridylcarbinol,Roniacol,3-Pyridinylmethanol,3Pyridinylmethanol,Pyridylcarbinol,Pyridine-3-carbinol,Pyridine3carbinol,Pyridine-3-methanol,Pyridine3methanol,beta-
P,betaP,T1581,T1299,SAM001246894,Picolamine,CPD000059086}

> <pdid>
PD000170

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{7510}

$$$$
NIHCC_2014
  SciTegic11012413002D

 12 12  0  0  0  0            999 V2000
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12  6  1  0
M  END
> <name>
NIHCC_2014

> <id>
5818

> <plate>
NGP-105-03

> <well>
D05

> <supplier_cmpd_name>
CPD000059111

> <ctcr_id>
3322

> <supplier_cmpd_id>
SAM001246896

> <smiles>
CNCC(O)c1ccc(O)cc1

> <pd_targets>
{AMPC,THPO,ALDH1A1,BLM,CHRM1,SMN1,HTR1A,NMUR2,HIF1A,CYP2C9}

> <pathway_gtopdb>
{Enzyme,"Unclassified protein","Membrane receptor","Epigenetic regulator",Hydrolase,Oxidoreductase,"Family A G protein-coupled receptor",Reader,"Small molecule receptor (family A GPCR)","Methyl-lysine
/arginine binding protein","Peptide receptor (family A GPCR)","Monoamine receptor","Tudor domain","Short peptide receptor (family A GPCR)","Acetylcholine receptor","Serotonin receptor","Neuromedin U r
eceptor","Transcription factor","Cytochrome P450","Cytochrome P450 family 2","Cytochrome P450 family 2C","Cytochrome P450 2C9"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Acetylcholine receptors (muscarinic)","5-Hydroxytryptamine receptors","Neuromedin U receptors",Enzymes,"Cytochrome P450","CYP2 family: drug metabolising subse
t"}

> <pathway_reactome>
{Hemostasis,Metabolism,"DNA Repair","Signal Transduction","Metabolism of RNA","Platelet activation","signaling and aggregation","Biological oxidations","DNA Double-Strand Break Repair","Signaling by G
PCR","Metabolism of non-coding RNA","Platelet Aggregation (Plug Formation)","Phase I - Functionalization of compounds","Homology Directed Repair","GPCR ligand binding","snRNP Assembly","Ethanol oxidat
ion","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Class A/1 (Rhodopsin-like receptors)","HDR through Homologous Recombination (HRR)","Amine ligand-binding receptors",
"Peptide ligand-binding receptors","Homologous DNA Pairing and Strand Exchange","Muscarinic acetylcholine receptors","Serotonin receptors","Presynaptic phase of homologous DNA pairing and strand excha
nge","Cellular responses to external stimuli","Cellular responses to stress","Cellular response to hypoxia","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Cytochrome P450 
- arranged by substrate type",Xenobiotics,"CYP2E1 reactions"}

> <broad_targets>
{ADRA1A}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{Synephrine,Oxedrine,94-07-5,94075,p-Synephrine,pSynephrine,Parasympatol,Sympaethamine,Sympatol,Sympaethamin,Analeptin,Simpatol,Simpalon,Synephrin,Synthenate,(+/-)-Synephrine,(+/)Synephrine,Sympathol,
p-Oxedrine,pOxedrine,4-(1-Hydroxy-2-(methylamino)ethyl)phenol,4(1Hydroxy2(methylamino)ethyl)phenol,Ethaphene,DL-SYNEPHRINE,DLSYNEPHRINE,T1287,S2362,SAM001246896,Prestw-1088,CPD000059111,"(+,-)-Synephr
ine"}

> <pdid>
PD000201

> <targets>
{Androgen Receptor,Adrenergic Receptor,Endogenous Metabolite}

> <classes>
{GPCR & G Protein,GPCR/G Protein,Metabolic Enzyme/Protease,Neuronal Signaling}

> <pubchem_cids>
{7172}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 23  0  0  1  0            999 V2000
   12.5577   -0.0006    0.0000 Cl  0  5
    1.2844    3.7485    0.0000 C   0  0
    2.5857    3.0025    0.0000 N   0  0
    2.5914    1.5017    0.0000 C   0  0
    3.8934    0.7553    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0  2  0  0  0
    2.6003   -1.4978    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    5.2003   -1.4933    0.0000 C   0  0
    5.3453   -2.9734    0.0000 S   0  0
    6.8141   -3.2782    0.0000 C   0  0
    7.5577   -1.9755    0.0000 C   0  0
    6.5486   -0.8657    0.0000 C   0  0
   10.0577   -0.0006    0.0000 H   0  3
  2  3  1  0
  3  4  1  0
  4  5  1  0
  6  5  1  1
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17  8  1  0
 17 12  1  0
  6 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 18  2  0
M  CHG  2   1  -1  23   1
M  END
> <name>
NIHCC_2014

> <id>
5819

> <plate>
NGP-105-03

> <well>
D06

> <supplier_cmpd_name>
CPD000469136

> <ctcr_id>
276

> <supplier_cmpd_id>
SAM001246523

> <smiles>
[Cl-].CNCC[C@H](Oc1cccc2ccccc12)c3sccc3.[H+]

> <pd_targets>
{HTR2A,KMT2A,HTR6,CYP1A2,CYP3A4,SLC6A2,SLC6A3,SLC6A4,NET,HTT,GAA,CYP2C9,HTR2C,CYP2D6,SHMT2,CYP2C19,KCNH2,CACNA1C,CACNA1D,CACNA1F,CACNA1S,KCND3,SCN5A,KCNE1,KCNQ1}

> <pathway_gtopdb>
{"Membrane receptor","Epigenetic regulator",Enzyme,Transporter,"Unclassified protein","Ion channel","Family A G protein-coupled receptor",Reader,"Cytochrome P450","Electrochemical transporter",Hydrola
se,Transferase,"Voltage-gated ion channel","Small molecule receptor (family A GPCR)",Bromodomain,"Cytochrome P450 family 1","Cytochrome P450 family 3","SLC superfamily of solute carriers","Cytochrome 
P450 family 2","Potassium channels","Voltage-gated calcium channel","Voltage-gated sodium channel","Monoamine receptor","Cytochrome P450 family 1A","Cytochrome P450 family 3A","SLC06 neurotransmitter 
transporter family","Cytochrome P450 family 2C","Cytochrome P450 family 2D","Voltage-gated potassium channel","Serotonin receptor","Cytochrome P450 1A1","Cytochrome P450 3A4","Cytochrome P450 2C9","Cy
tochrome P450 2D6","Cytochrome P450 2C19"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Ion channels","G protein-coupled receptors","Chromatin modifying enzymes","Cytochrome P450","SLC superfamily of solute carriers","3.2.1.- Glycosidases","Voltage-gated 
ion channels","5-Hydroxytryptamine receptors","2.1.1.43 Histone methyltransferases (HMTs)","CYP1 family","CYP3 family","SLC6 neurotransmitter transporter family","CYP2 family: drug metabolising subset
","Potassium channels","Voltage-gated calcium channels","Voltage-gated sodium channels","Monoamine transporter subfamily","Voltage-gated potassium channels"}

> <pathway_reactome>
{"Signal Transduction","Gene expression (Transcription)",Disease,Metabolism,"Neuronal System","Muscle contraction","Developmental Biology","Signaling by GPCR","RNA Polymerase II Transcription","Infect
ious disease","Biological oxidations","Metabolism of lipids","Disorders of transmembrane transporters","Transmission across Chemical Synapses","Diseases of metabolism","Metabolism of vitamins and cofa
ctors","Cardiac conduction","Nervous system development","GPCR ligand binding","Generic Transcription Pathway","Leishmania infection","Phase I - Functionalization of compounds","Biosynthesis of specia
lized proresolving mediators (SPMs)","SLC transporter disorders","Neurotransmitter clearance","Diseases of carbohydrate metabolism","Metabolism of water-soluble vitamins and cofactors","Phase 3 - rapi
d repolarisation","Axon guidance","Phase 1 - inactivation of fast Na+ channels","Class A/1 (Rhodopsin-like receptors)","Transcriptional regulation by RUNX1","Leishmania parasite growth and survival","
Cytochrome P450 - arranged by substrate type","Biosynthesis of DHA-derived SPMs","Defective SLC6A2 causes orthostatic intolerance (OI)","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)
","Serotonin clearance from the synaptic cleft","Transcriptional Regulation by MECP2","Glycogen storage diseases","Metabolism of folate and pterines","NCAM signaling for neurite out-growth","L1CAM int
eractions","Amine ligand-binding receptors","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","Anti-inflammatory response favouring Leishmania parasite infection"
,Xenobiotics,"Biosynthesis of maresins","Regulation of MECP2 expression and activity","Glycogen storage disease type II (GAA)","NCAM1 interactions","Interaction between L1 and Ankyrins","Serotonin rec
eptors","ADORA2B mediated anti-inflammatory cytokines production","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Biosynthesis of maresin-like SPMs","CYP2E1 reactions"}

> <broad_targets>
{HTR2A,HTR2C,HTR6,SLC6A2,SLC6A3,SLC6A4}

> <broad_moa>
{"norepinephrine reuptake inhibitor","serotoninânorepinephrine reuptake inhibitor (SNRI)"}

> <synonyms>
{"DULOXETINE HYDROCHLORIDE",136434-34-9,136434349,"Duloxetine HCl",Cymbalta,"(S)-duloxetine hydrochloride","(S)duloxetine hydrochloride","Duloxetine (hydrochloride)","(S)-Duloxetine HCl","(S)Duloxetin
e HCl",UNII-9044SC542W,UNII9044SC542W,C18H20ClNOS,C18H19NOS.HCl,CPD000469136,"LY248686 HCl",CHEBI:31526,Ariclaim,Xeris,S2084,SAM001246523,1505387}

> <pdid>
PD003013

> <targets>
{"5-HT Receptor"}

> <classes>
{antidepressant,"Neuronal Signaling"}

> <pubchem_cids>
{60834,57515987,11966296}

$$$$
NIHCC_2014
  SciTegic11012413002D

 14 15  0  0  0  0            999 V2000
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 N   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 C   0  0
   -3.1904   -2.6376    0.0000 C   0  0
   -4.6588   -2.9478    0.0000 C   0  0
   -5.1250   -4.3735    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  9 13  1  0
 13  6  1  0
 13 14  2  0
 14  3  1  0
M  END
> <name>
NIHCC_2014

> <id>
5820

> <plate>
NGP-105-03

> <well>
D07

> <supplier_cmpd_name>
CPD000112269

> <ctcr_id>
4051

> <supplier_cmpd_id>
SAM001246909

> <smiles>
COc1ccc2[nH]cc(CCN)c2c1

> <pd_targets>
{NS1,HTR2C,HTR4,HTR6,HTR7,HTR2A,HTR1A,SLC6A3,HTR1B,NFKB1,TSHR,HTR2B,CYP1A2,HTR1D,HTR1E,SLC6A4,HTR1F,MAPT,PMP22,BLM,NPSR1,TRPM8,CYP2D6,MTNR1B,MTNR1A}

> <pathway_gtopdb>
{"Unclassified protein","Membrane receptor",Transporter,"Other cytosolic protein",Enzyme,"Ion channel","Family A G protein-coupled receptor","Electrochemical transporter","Cytochrome P450","Voltage-ga
ted ion channel","Small molecule receptor (family A GPCR)","SLC superfamily of solute carriers","Peptide receptor (family A GPCR)","Cytochrome P450 family 1","Transient receptor potential channel","Mo
noamine receptor","SLC06 neurotransmitter transporter family","Glycohormone receptor","Cytochrome P450 family 1A","Short peptide receptor (family A GPCR)","Serotonin receptor","Cytochrome P450 1A1","N
europeptide receptor","Cytochrome P450 family 2","Cytochrome P450 family 2D","Monoamine-derivative receptor (family A GPCR)","Cytochrome P450 2D6","Melatonin receptor"}

> <pathway_chembl>
{Receptors,Transporters,Enzymes,"Ion channels","G protein-coupled receptors","SLC superfamily of solute carriers","Cytochrome P450","Voltage-gated ion channels","5-Hydroxytryptamine receptors","SLC6 n
eurotransmitter transporter family","Glycoprotein hormone receptors","CYP1 family","Neuropeptide S receptor","Transient Receptor Potential channels","Monoamine transporter subfamily","CYP2 family: dru
g metabolising subset","Melatonin receptors"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Immune System",Metabolism,"Neuronal System","Developmental Biology","DNA Repair","Transport of small molecules","Signaling by GPCR","Infectious disease","Disorders of t
ransmembrane transporters","Cytokine Signaling in Immune system","Biological oxidations","Transmission across Chemical Synapses","Nervous system development","DNA Double-Strand Break Repair","Ion chan
nel transport","GPCR ligand binding","Leishmania infection","SLC transporter disorders","Signaling by Interleukins","Phase I - Functionalization of compounds","Neurotransmitter clearance","Neurotransm
itter receptors and postsynaptic signal transmission","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Homology Directed Repair","Stimuli-sensing channels","Class A/1 (Rhodopsin-like 
receptors)","Leishmania parasite growth and survival","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Interleukin-1 family signaling","Cytochrome P450 - arranged by substrate type",
"Serotonin clearance from the synaptic cleft","Activation of NMDA receptors and postsynaptic events","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","TRP channels","Amine
 ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Interleukin-1 signaling",Xenobiotics,"Post NMDA receptor activation events","HDR through Homologous Rec
ombination (HRR)","Serotonin receptors","ADORA2B mediated anti-inflammatory cytokines production","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Aromatic amines can be N-hydroxylated or N-dealkylated b
y CYP1A2","Activation of AMPK downstream of NMDARs","Homologous DNA Pairing and Strand Exchange","Presynaptic phase of homologous DNA pairing and strand exchange","GPCR downstream signalling","G alpha
 (i) signalling events","CYP2E1 reactions"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"5-Methoxytryptamine (5-MT)","5Methoxytryptamine (5MT)",5-METHOXYTRYPTAMINE,5METHOXYTRYPTAMINE,608-07-1,608071,2-(5-Methoxy-1H-indol-3-yl)ethanamine,2(5Methoxy1Hindol3yl)ethanamine,Mexamine,3-(2-Amin
oethyl)-5-methoxyindole,3(2Aminoethyl)5methoxyindole,Methoxytryptamine,"Mexamine base",5MOT,"1H-Indole-3-ethanamine, 5-methoxy-","1HIndole3ethanamine, 5methoxy",5-Mot,5Mot,2-(5-Methoxyindol-3-yl,2(5Me
thoxyindol3yl,SAM001246909,CPD000112269}

> <pdid>
PD003168

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{1833}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 17  0  0  0  0            999 V2000
    5.1873   -7.5109    0.0000 C   0  0
    5.1894   -6.0109    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    2.5909   -6.0056    0.0000 C   0  0
    3.8883   -6.7578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    1.2925   -3.7494    0.0000 N   0  0
   -0.0048   -2.9949    0.0000 C   0  0
   -1.3015   -2.2408    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
  7 15  2  3
 15 16  1  0
 16 17  3  0
M  END
> <name>
NIHCC_2014

> <id>
5821

> <plate>
NGP-105-03

> <well>
D08

> <supplier_cmpd_name>
CPD000466288

> <ctcr_id>
623

> <supplier_cmpd_id>
SAM001247088

> <smiles>
CCC(C)(C)NC(Nc1cccnc1)=NC#N

> <pd_targets>
{CYP3A4,CYP2D6,CYP1A2,ABCC8,ABCC9,KCNJ11,KCNJ8,KMT2A,MEN1,FFP,LEF}

> <pathway_gtopdb>
{Enzyme,"Ion channel","Epigenetic regulator",Transporter,"Cytochrome P450","Voltage-gated ion channel",Reader,Transferase,Protease,"Primary active transporter","Cytochrome P450 family 3","Cytochrome P
450 family 2","Cytochrome P450 family 1","Potassium channels",Bromodomain,"Metallo protease","ATP-binding cassette","Cytochrome P450 family 3A","Cytochrome P450 family 2D","Cytochrome P450 family 1A",
"Inwardly rectifying potassium channel","Metallo protease MAE clan","ABCC subfamily","Cytochrome P450 3A4","Cytochrome P450 2D6","Cytochrome P450 1A1","Metallo protease M34 family"}

> <pathway_chembl>
{Enzymes,Transporters,"Cytochrome P450","ATP-binding cassette transporter family","CYP3 family","CYP2 family: drug metabolising subset","CYP1 family","ABCC subfamily"}

> <pathway_reactome>
{Metabolism,Disease,"Metabolism of lipids","Biological oxidations","Infectious disease","Disorders of transmembrane transporters","Biosynthesis of specialized proresolving mediators (SPMs)","Phase I -
 Functionalization of compounds","Uptake and actions of bacterial toxins","ABC transporter disorders","Biosynthesis of DHA-derived SPMs","Cytochrome P450 - arranged by substrate type","Uptake and func
tion of anthrax toxins","Defective ABCC9 causes CMD10","ATFB12 and Cantu syndrome","Biosynthesis of maresins",Xenobiotics,"Biosynthesis of maresin-like SPMs","CYP2E1 reactions","Aromatic amines can be
 N-hydroxylated or N-dealkylated by CYP1A2"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{60559-98-0,P-1075,P1075,"N-Cyano-N'-(1,1-dimethylpropyl)-N''-3-pyridylguanidine","N-cyano-N'-(1,1-dimethylpropyl)-N''-(3-pyridinyl)guanidine",UNII-RA77IZ6B2F,RA77IZ6B2F,CHEMBL11458,"Guanidine, N-cyan
o-N'-(1,1-dimethylpropyl)-N''-3-pyridinyl-",1-cyano-2-(2-methylbutan-2-yl)-3-pyridin-3-ylguanidine,1-cyano-2-(2-methylbutan-2-yl)-3-(3-pyridinyl)guanidine,"Guanidine, N-cyano-N'-(1,1-dimethylpropyl)-N
''-3-pyridinyl- (CAS)",SMR000466288,"BRN 0480738",2-Cyano-1-tert-pentyl-3-(3-pyridyl)guanidine,"P 1075",Tocris-1355,MLS000758317,MLS001424147,SCHEMBL2129487,SCHEMBL8747731,BDBM86250,CHEBI:92004,DTXSID
60209335,"GUANIDINE, 2-CYANO-1-tert-PENTYL-3-(3-PYRIDYL)-",HMS2052G15,HMS2232A04,HMS3267B04,HMS3371P02,HMS3394G15,BDBM50062397,NSC_43345,ZINC13579814,AKOS024456545,CCG-101122,NC00372,NCGC00025121-01,C
AS_60559-98-0,DB-053648,HY-108573,B6700,CS-0029185,FT-0640699,N-cyano-N-tert-pentyl-N'-3-pyridylguanidine,SR-01000597574,3N-cyanoimino(tert-pentylamino)methyl-3-pyridinamine,SR-01000597574-1,BRD-K0020
6590-001-01-2,Q27163801,3N-cyanoimino(tert-pentylamino)methyl-3-pyridinamineP1075),"N-cyano-N'-(1,1-dimethylpropyl)-N'-3-pyridinyl-guanidine","N''''-cyano-N-(1,1-dimethylpropyl)-N''-pyridin-3-ylguanid
ine","N-cyano-N''''-(1,1-dimethylpropyl)-N''-pyridin-3-ylguanidine",SAM001247088,CPD000466288}

> <pdid>
PD002981

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{43345}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 26  0  0  0  0            999 V2000
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 N   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -5.1047   -0.0031    0.0000 S   0  0
   -5.8570    1.2946    0.0000 O   0  0
   -5.8532   -1.3040    0.0000 C   0  0
   -7.3541   -1.3071    0.0000 C   0  0
   -8.1042   -0.0081    0.0000 N   0  0
   -9.6042   -0.0082    0.0000 C   0  0
  -10.3542   -1.3072    0.0000 C   0  0
  -11.8542   -1.3073    0.0000 C   0  0
   -9.6041   -2.6062    0.0000 C   0  0
  -10.3518   -3.9076    0.0000 O   0  0
   -9.5998   -5.2055    0.0000 C   0  0
   -8.1041   -2.6062    0.0000 C   0  0
   -7.3541   -3.9052    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10  6  1  0
 10 11  2  0
 11  3  1  0
  8 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 20 23  2  0
 23 15  1  0
 23 24  1  0
M  END
> <name>
NIHCC_2014

> <id>
5822

> <plate>
NGP-105-03

> <well>
D09

> <supplier_cmpd_name>
CPD000058847

> <ctcr_id>
1111

> <supplier_cmpd_id>
SAM001246900

> <smiles>
COc1ccc2nc([nH]c2c1)[S](=O)Cc3ncc(C)c(OC)c3C

> <pd_targets>
{FASN,CYP2C9,HPGD,DDAH1,CYP3A4,KDM4E,ALDH1A1,FFP,ALD,RORC,CYP1A2,ATP4A,ATP4B,HSD17B10,HTT,MCL1,ABCB1,CYP2C19,MAPT,PKM,ABCB11,GSTO1,ATP1A1,ATP1A2,ATP1A3,ATP1A4,ATP1B1,ATP1B2,ATP1B3,FXYD2,KMT2A,MEN1,ENG
ASE,BRS3,CLCN2,AHR}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Transcription factor",Transporter,"Unclassified protein","Other cytosolic protein","Membrane receptor","Ion channel",Transferase,"Cytochrome P450",Hydrolase,Eraser,Oxid
oreductase,"Nuclear receptor","Primary active transporter",Reader,"Family A G protein-coupled receptor","Other ion channel","Cytochrome P450 family 2","Cytochrome P450 family 3","Lysine demethylase","
Nuclear hormone receptor subfamily 1","Cytochrome P450 family 1","P-type ATPase","ATP-binding cassette",Bromodomain,"Peptide receptor (family A GPCR)","Chloride channel","Cytochrome P450 family 2C","C
ytochrome P450 family 3A","Jumonji domain-containing","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family 1A","Hydrogen potassium ATPase","ABCB subfamily","Sodium potassium ATPase",
"Short peptide receptor (family A GPCR)","ClC chloride channel","Cytochrome P450 2C9","Cytochrome P450 3A4","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 1A1","Cytochrome P4
50 2C19","GRP-related receptor"}

> <pathway_chembl>
{Enzymes,Receptors,"Other protein targets",Transporters,"Ion channels","2.3.1.-  Acyltransferases","Cytochrome P450","Eicosanoid turnover","L-Arginine turnover","Chromatin modifying enzymes","Nuclear 
hormone receptors","B-cell lymphoma 2 (Bcl-2) protein family","ATP-binding cassette transporter family","2.7.1.40 Pyruvate kinases","2.5.1.18 Glutathione transferases","G protein-coupled receptors","P
-type ATPases","Other ion channels","Aryl hydrocarbon receptor","CYP2 family: drug metabolising subset","Prostaglandin synthases","Dimethylarginine dimethylaminohydrolases","CYP3 family","1.14.11.- Hi
stone demethylases","1F. Retinoic acid-related orphans","CYP1 family","ABCB subfamily","Orphan and other 7TM receptors","P2C P-type ATPases","Chloride channels","Class A Orphans",H<sup>+</sup>/K<sup>+
</sup>-ATPases,"ClC family"}

> <pathway_reactome>
{Metabolism,"Gene expression (Transcription)","Immune System","Neuronal System","Metabolism of proteins","Signal Transduction","Transport of small molecules","Metabolism of lipids","Biological oxidati
ons","Metabolism of nitric oxide: NOS3 activation and regulation","RNA Polymerase II Transcription","Metabolism of amino acids and derivatives","Cytokine Signaling in Immune system","Abacavir transpor
t and metabolism","Transmission across Chemical Synapses","Metabolism of carbohydrates","Post-translational protein modification","Signaling by GPCR","Ion channel transport","Metabolism of steroids","
Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","eNOS activation","Generic Transcription Pathway","Branched-chain amino acid catabolism","Signalin
g by Interleukins","Abacavir transmembrane transport","Neurotransmitter receptors and postsynaptic signal transmission","Glucose metabolism","Asparagine N-linked glycosylation","GPCR ligand binding","
Ion transport by P-type ATPases","Stimuli-sensing channels","Regulation of cholesterol biosynthesis by SREBP (SREBF)","Cytochrome P450 - arranged by substrate type","Biosynthesis of DHA-derived SPMs",
"Ethanol oxidation","Transcriptional regulation by RUNX3","Transcriptional Regulation by MECP2","Interleukin-4 and Interleukin-13 signaling","Activation of NMDA receptors and postsynaptic events",Glyc
olysis,"Bile acid and bile salt metabolism","Interleukin-12 family signaling","N-glycan trimming in the ER and Calnexin/Calreticulin cycle","Class A/1 (Rhodopsin-like receptors)","Activation of gene e
xpression by SREBF (SREBP)",Xenobiotics,"Biosynthesis of D-series resolvins","Biosynthesis of maresins","RUNX3 Regulates Immune Response and Cell Migration","Regulation of MECP2 expression and activit
y","Post NMDA receptor activation events","Synthesis of bile acids and bile salts","Interleukin-12 signaling","Peptide ligand-binding receptors","Endogenous sterols","CYP2E1 reactions","Biosynthesis o
f maresin-like SPMs","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Activation of AMPK downstream of NMDARs","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"
,"Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation"}

> <broad_targets>
{ATP4A,CLCN2}

> <broad_moa>
{"ATPase inhibitor"}

> <synonyms>
{SR-01000003003,SR01000003003,Omperazole,omeprazole,73590-58-6,73590586,Prilosec,Losec,Antra,Esomeprazole,Omeprazon,Audazol,Omapren,Omepral,Parizac,Zegerid,Mopral,Miol,Belmazol,Ceprandal,Dizprazol,Dud
encer,Emeproton,Epirazole,Gastrimut,Gastroloc,Gibancer,Indurgan,Inhi,SAM001246900,1505693,Prestw-493,CPD000058847,OMEPRAZOLE,Omeprazole}

> <pdid>
PD000331

> <targets>
{}

> <classes>
{"gastric acid depressant"}

> <pubchem_cids>
{4594}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 28  0  0  1  0            999 V2000
    5.0302   -9.5289    0.0000 N   0  0
    5.5724   -8.1304    0.0000 C   0  0
    7.0226   -7.7470    0.0000 S   0  0
    7.1061   -6.2493    0.0000 C   0  0
    5.7131   -5.7282    0.0000 C   0  0
    4.7596   -6.8697    0.0000 N   0  0
    5.3265   -4.2780    0.0000 C   0  0
    6.3872   -3.2163    0.0000 N   0  0
    5.9992   -1.7673    0.0000 O   0  0
    3.8775   -3.8868    0.0000 C   0  0
    2.8152   -4.9458    0.0000 O   0  0
    3.4909   -2.4366    0.0000 N   0  0
    2.0479   -2.0470    0.0000 C   0  0  1  0  0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 S   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
    0.7488   -2.7970    0.0000 C   0  0
    0.3606   -4.2459    0.0000 O   0  0
   -2.6003   -1.4978    0.0000 C   0  0
   -2.6029   -2.9978    0.0000 O   0  0
   -3.8983   -0.7459    0.0000 O   0  0
   -2.5973    1.5031    0.0000 C   0  0
   -2.5951    3.0031    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  2  2  0
  5  7  1  0
  7  8  2  3
  8  9  1  0
  7 10  1  0
 10 11  2  0
 10 12  1  0
 13 12  1  6
 13 14  1  0
 14 15  1  6
 15 16  1  0
 16 17  1  0
 17 18  2  3
 18 19  1  0
 19 14  1  0
 19 20  1  0
 20 13  1  0
 20 21  2  0
 18 22  1  0
 22 23  1  0
 22 24  2  0
 17 25  1  0
 25 26  2  0
M  END
> <name>
NIHCC_2014

> <id>
5823

> <plate>
NGP-105-03

> <well>
D10

> <supplier_cmpd_name>
CPD000469224

> <ctcr_id>
2757

> <supplier_cmpd_id>
SAM001246818

> <smiles>
Nc1scc(n1)C(=NO)C(=O)N[C@H]2[C@H]3SCC(=C(N3C2=O)C(O)=O)C=C

> <pd_targets>
{MEX-5,CTDSP1,POS-1,ABCC4,DACA,DACB,DACC,FTSI,MRCA,MRCB,MRDA,PENA,PBP3,MPO}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,Transporter,Phosphatase,"Primary active transporter",Protease,Oxidoreductase,"Protein Phosphatase","ATP-binding cassette","Serine protease","Serine/threonine protein pho
sphatase","ABCC subfamily","Serine protease SE clan","Serine protease S11 family"}

> <pathway_chembl>
{Transporters,Enzymes,"ATP-binding cassette transporter family","1.-.-.- Oxidoreductases","ABCC subfamily"}

> <pathway_reactome>
{Hemostasis,"Immune System","Platelet activation","signaling and aggregation","Innate Immune System","Response to elevated platelet cytosolic Ca2+","ROS and RNS production in phagocytes","Platelet deg
ranulation","Events associated with phagocytolytic activity of PMN cells"}

> <broad_targets>
{MPO}

> <broad_moa>
{"bacterial cell wall synthesis inhibitor"}

> <synonyms>
{cefdinir,DSSTox_GSID_46084,DSSToxGSID46084,DSSTox-GSID-46084,"DSSTox GSID 46084",DSSTox_CID_26084,DSSToxCID26084,DSSTox-CID-26084,"DSSTox CID 26084",DSSTox_RID_81325,DSSToxRID81325,DSSTox-RID-81325,"
DSSTox RID 81325",91832-40-5,91832405,CAS-91832-40-5,CAS91832405,NCGC00095138-01,NCGC0009513801,"Spectrum 001824",Spectrum_001824,Spectrum001824,Spectrum-001824,Spectrum2_001685,Spectrum2001685,Spectr
um2-001685,"Spectrum2 001685",Spectrum3_001008,Spectrum3001008,Spectrum3-001008,"Spectrum3 001008",Spectrum4_001136,Spectrum4001136,Spectrum4-001136,"Spectrum4 001136",KBioGR_001651,KBioGR001651,KBioG
R-001651,"KBioGR 001651",KBioSS_002329,KBioSS002329,KBioSS-002329,"KBioSS 002329",SPBio_001610,SPBio001610,SPBio-001610,"SPBio 001610",CHEMBL1417821,T0133,SAM001246818,Cefdinir,CPD000469224}

> <pdid>
PD000564

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{6398970}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 28  0  0  1  0            999 V2000
    2.6640   -0.1280    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0
   -6.4952    3.7500    0.0000 O   0  0
   -3.8971    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0  2  0  0  0
   -1.2990    2.2500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.3326   -2.9571    0.0000 C   0  0
    1.8253   -3.1044    0.0000 C   0  0
    2.4266   -1.7302    0.0000 C   0  0  2  0  0  0
    3.8873   -1.3970    0.0000 C   0  0
    4.9070   -2.4971    0.0000 O   0  0
    4.3308    0.0368    0.0000 C   0  0
    5.7932    0.3704    0.0000 O   0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  1  1
  6  4  1  1
  6  7  1  0
  7  8  1  6
  8  9  1  0
  9 10  1  0
 10 11  2  3
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16  6  1  0
 16 10  1  0
 16 17  1  1
  7 18  1  0
 18  2  1  0
 18 19  1  1
 19 20  1  0
 20 21  1  0
 21  2  1  0
 21 22  1  1
 22 23  2  0
 22 24  1  0
 24 25  1  0
M  END
> <name>
NIHCC_2014

> <id>
5824

> <plate>
NGP-105-03

> <well>
D11

> <supplier_cmpd_name>
CPD000058318

> <ctcr_id>
737

> <supplier_cmpd_id>
SAM001246879

> <smiles>
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2C(=O)CO

> <pd_targets>
{NR3C1,NFKB1,HIF1A,THPO,SIGMAR1,SHBG,SERPINA6,AR,NR3C2,CYP3A4,HSD17B10,NS1,SLC22A2,MTOR,SLC22A1,SLCO1A1,SLC22A3,BLM,LMNA,MAPT}

> <pathway_gtopdb>
{"Transcription factor","Other cytosolic protein","Unclassified protein","Membrane receptor","Secreted protein",Enzyme,Transporter,"Other nuclear protein","Nuclear receptor","Cytochrome P450",Oxidored
uctase,"Electrochemical transporter",Kinase,"Nuclear hormone receptor subfamily 3","Cytochrome P450 family 3","SLC superfamily of solute carriers","Protein Kinase","Nuclear hormone receptor subfamily 
3 group C","Cytochrome P450 family 3A","SLC22 family of organic cation and anion transporters","Atypical protein kinase group","SLC21/SLCO family of organic anion transporting polypeptides","Nuclear h
ormone receptor subfamily 3 group C member 1","Nuclear hormone receptor subfamily 3 group C member 4","Nuclear hormone receptor subfamily 3 group C member 2","Cytochrome P450 3A4","Atypical protein ki
nase PIKK family","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Receptors,"Other protein targets",Enzymes,Transporters,"Nuclear hormone receptors","Sigma receptors","Cytochrome P450","SLC superfamily of solute carriers","Kinases (EC 2.7.x.x)","Steroid hormone rec
eptors","CYP3 family","SLC22 family of organic cation and anion transporters",Atypical,"3C. 3-Ketosteroid receptors","Organic cation transporters (OCT)","Phosphatidyl inositol 3' kinase-related kinase
s (PIKK) family","FRAP subfamily"}

> <pathway_reactome>
{"Gene expression (Transcription)","Immune System","Cellular responses to external stimuli",Hemostasis,Disease,Metabolism,"Metabolism of proteins","Transport of small molecules","DNA Repair","Cell Cyc
le","Neuronal System","RNA Polymerase II Transcription","Cytokine Signaling in Immune system","Cellular responses to stress","Platelet activation","signaling and aggregation","Infectious disease","Met
abolism of lipids","Post-translational protein modification","Metabolism of amino acids and derivatives","SLC-mediated transmembrane transport","DNA Double-Strand Break Repair",Mitotic,"Transmission a
cross Chemical Synapses","Generic Transcription Pathway","Signaling by Interleukins","Cellular response to hypoxia","Platelet Aggregation (Plug Formation)","SARS-CoV Infections","Metabolism of steroid
s",SUMOylation,"Biosynthesis of specialized proresolving mediators (SPMs)","Branched-chain amino acid catabolism","Transport of bile salts and organic acids","metal ions and amine compounds","Homology
 Directed Repair","M Phase","Neurotransmitter receptors and postsynaptic signal transmission","FOXO-mediated transcription","Interleukin-1 family signaling","Oxygen-dependent proline hydroxylation of 
Hypoxia-inducible Factor Alpha","Potential therapeutics for SARS","Metabolism of steroid hormones","Transcriptional regulation by RUNX2","SUMO E3 ligases SUMOylate target proteins","Biosynthesis of DH
A-derived SPMs","Organic cation/anion/zwitterion transport","Transcriptional Regulation by TP53","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Mitotic Metaphase and An
aphase","Activation of NMDA receptors and postsynaptic events","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","Interleukin-1 signaling","Glucocorticoid biosynthesis",
"RUNX2 regulates bone development","SUMOylation of intracellular receptors","Biosynthesis of maresins","Organic cation transport","Regulation of TP53 Activity","HDR through Homologous Recombination (H
RR)","Mitotic Anaphase","Post NMDA receptor activation events","MAP3K8 (TPL2)-dependent MAPK1/3 activation","RUNX2 regulates osteoblast differentiation","Biosynthesis of maresin-like SPMs","Regulation
 of TP53 Expression and Degradation","Homologous DNA Pairing and Strand Exchange","Nuclear Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs","Regulation of TP53 Degradation","Presyna
ptic phase of homologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{HSD11B1,NCOA1,NR3C2}

> <broad_moa>
{"mineralocorticoid receptor agonist"}

> <synonyms>
{RESTW43,CORTICOSTERONE,50-22-6,50226,17-Deoxycortisol,17Deoxycortisol,"Reichstein's substance H","Kendall's compound B",Corticosteron,"11beta,21-Dihydroxyprogesterone","11beta,21Dihydroxyprogesterone
","Compound B","Reichstein's B","(11beta)-11,21-Dihydroxypregn-4-ene-3,20-dione","(11beta)11,21Dihydroxypregn4ene3,20dione",11-Hydroxycorticoaldosteron,11Hydroxycorticoaldosteron,T0948L,SAM001246879,P
restw-432,Corticosterone,CPD000058318}

> <pdid>
PD002785

> <targets>
{Endogenous Metabolite,Glucocorticoid Receptor}

> <classes>
{GPCR/G Protein,Metabolic Enzyme/Protease}

> <pubchem_cids>
{5753}

$$$$
NIHCC_2014
  SciTegic11012413002D

 32 34  0  0  1  0            999 V2000
    1.2948   -3.7516    0.0000 C   0  0
    2.5951   -3.0039    0.0000 N   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 N   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 N   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    4.0312   -5.2378    0.0000 S   0  0
    5.4984   -5.5497    0.0000 C   0  0
    6.2484   -4.2507    0.0000 C   0  0
    5.2447   -3.1359    0.0000 C   0  0
    6.1107   -6.9172    0.0000 C   0  0
    5.2311   -8.1322    0.0000 O   0  0
    7.6035   -7.0719    0.0000 N   0  0
    8.2168   -8.4417    0.0000 C   0  0  1  0  0  0
    9.7096   -8.5964    0.0000 C   0  0
   10.3229   -9.9662    0.0000 C   0  0
   11.8157  -10.1210    0.0000 C   0  0
   12.6952   -8.9059    0.0000 O   0  0
   12.4286  -11.4900    0.0000 O   0  0
    7.3392   -9.6593    0.0000 C   0  0
    5.8469   -9.5077    0.0000 O   0  0
    7.9537  -11.0276    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  3
  9 10  1  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14  7  1  0
 14 15  2  0
 15  4  1  0
  2 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 16  2  0
 18 21  1  0
 21 22  2  0
 21 23  1  0
 24 23  1  1
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 27 29  2  0
 24 30  1  0
 30 31  1  0
 30 32  2  0
M  END
> <name>
NIHCC_2014

> <id>
5825

> <plate>
NGP-105-03

> <well>
E02

> <supplier_cmpd_name>
CPD000469217

> <ctcr_id>
1323

> <supplier_cmpd_id>
SAM001246796

> <smiles>
CN(Cc1ccc2N=C(C)NC(=O)c2c1)c3sc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O

> <pd_targets>
{TYMS,THYA,DHFR,DFRA17,FOLR2,SLC19A1,FOLR1,SLC46A1,FPGS}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor",Transporter,Transferase,Oxidoreductase,"Electrochemical transporter",Ligase,"SLC superfamily of solute carriers","SLC19 family of vitamin transporters","SLC46 family of fol
ate transporters"}

> <pathway_chembl>
{Enzymes,Transporters,"2.1.1.- Methyltransferases","1.-.-.- Oxidoreductases","SLC superfamily of solute carriers","SLC19 family of vitamin transporters","SLC46 family of folate transporters"}

> <pathway_reactome>
{"Cell Cycle",Metabolism,"Metabolism of proteins",Mitotic,"Metabolism of vitamins and cofactors","Post-translational protein modification","Mitotic G1 phase and G1/S transition","Metabolism of water-s
oluble vitamins and cofactors","Asparagine N-linked glycosylation","G1/S Transition","Metabolism of folate and pterines","Transport to the Golgi and subsequent modification","G1/S-Specific Transcripti
on","ER to Golgi Anterograde Transport","Cargo concentration in the ER"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{RALTITREXED,S1192,Raltitrexed,CPD000469217,T6632,SAM001246796}

> <pdid>
PD002892

> <targets>
{"DNA/RNA Synthesis"}

> <classes>
{}

> <pubchem_cids>
{104758}

$$$$
NIHCC_2014
  SciTegic11012413002D

 19 19  0  0  0  0            999 V2000
    5.0987   -3.3752    0.0000 Cl  0  5
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  3
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 C   0  0
    1.2947   -3.7531    0.0000 O   0  0
   -1.3039   -3.7494    0.0000 N   0  0
   -1.3070   -5.2502    0.0000 C   0  0
   -2.6060   -6.0003    0.0000 C   0  0
   -3.9051   -5.2503    0.0000 C   0  0
   -2.6060   -7.5003    0.0000 C   0  0
   -1.3070   -8.2503    0.0000 C   0  0
   -0.0080   -7.5003    0.0000 C   0  0
   -0.0079   -6.0003    0.0000 C   0  0
    1.2911   -5.2504    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  3  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 12  1  0
 18 19  1  0
M  CHG  2   1  -1   3   1
M  END
> <name>
NIHCC_2014

> <id>
5826

> <plate>
NGP-105-03

> <well>
E03

> <supplier_cmpd_name>
CPD000058904

> <ctcr_id>
3000

> <supplier_cmpd_id>
SAM001246875

> <smiles>
[Cl-].C[NH+]1CCCCC1C(=O)Nc2c(C)cccc2C

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Pipecoloxylidide, 1-methyl-,hydrochloride","Pipecoloxylidide, 1methyl,hydrochloride",AKOS026749980,"Mepivacaine hydrochloride",1722-62-9,1722629,"Mepivacaine HCL","N-(2,6-dimethylphenyl)-1-methylpip
eridine-2-carboxamide hydrochloride","N(2,6dimethylphenyl)1methylpiperidine2carboxamide hydrochloride",Carbocain,"Mepivacaine (hydrochloride)",P,SAM001246875,1504148,Prestw-1280,CPD000058904,"MEPIVACA
INE HYDROCHLORIDE"}

> <pdid>

> <targets>
{}

> <classes>
{"anesthetic (local)"}

> <pubchem_cids>
{517315,657372,66070}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 28  0  0  0  0            999 V2000
    7.5632   -1.4954    0.0000 H   0  3
    5.0632   -1.4954    0.0000 Cl  0  5
    2.5800    0.0305    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -6.4964   -0.7591    0.0000 O   0  0
   -7.8003    1.4887    0.0000 C   0  0
   -9.0994    0.7387    0.0000 C   0  0
  -10.3984    1.4886    0.0000 C   0  0
  -10.3985    2.9886    0.0000 C   0  0
  -11.6975    3.7386    0.0000 F   0  0
   -9.0995    3.7387    0.0000 C   0  0
   -7.8004    2.9887    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    1.2643   -2.2302    0.0000 C   0  0
    2.5453   -3.0105    0.0000 C   0  0
    2.5101   -4.5101    0.0000 C   0  0
    1.1938   -5.2294    0.0000 C   0  0
    1.1586   -6.7290    0.0000 Cl  0  0
   -0.0872   -4.4491    0.0000 C   0  0
   -0.0520   -2.9495    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 19 13  1  0
  7 20  1  0
 20 21  1  0
 21  4  1  0
  4 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 25 27  1  0
 27 28  2  0
 28 22  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5827

> <plate>
NGP-105-03

> <well>
E04

> <supplier_cmpd_name>
CPD000449283

> <ctcr_id>
1908

> <supplier_cmpd_id>
SAM001246979

> <smiles>
[H+].[Cl-].OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3

> <pd_targets>
{CYP3A4,CYP1A2,CYP2D6,DRD3,CHRM5,DRD2,CHRM4,CHRM1,CHRM2,CHRM3,AMPC,NET,HTR1A,HTR2A,HTR2B,HTR2C,HTR7,KCNH1,ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY8,SIGMAR1,ABCB11,DRD4,DRD1,DRD5,KCNH2,HRH1,OPRD1,OPRK1
,OPRM1,TMEM97,POL,ADRA1A,ADRA2C,CACNA1C,CCK,GABRA1,SCN10A,TAC1,THPO,HTR3A,ADRA1B,ADRA1D,ADRA2A,ADRA2B,PROTEASE,CYP2J2,GRIN1,ERG2,ZNF664,ABCB1,EBP,NFKB1,RORC,SLC6A2,CYP2C19,HTR1B,HTR6,KCNJ6,LEF,SLC6A4,
CCKBR,SLC6A3,CYSLTR1,ADRB2,NISCH,SCN11A,SCN1A,SCN2A,SCN3A,SCN4A,SCN5A,SCN7A,SCN8A,SCN9A,H1-0,HTR1D,PMP22,AP2S1,ALB,ALOX15,CACNA1D,CACNA1F,CACNA1S,HTR1F,ARRB1,KMT2A,MEN1,HTR1E,TBXA2R,MTOR,HRH2,KCNK2,SL
C18A3,GRIN2B}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Cytochrome P450","Family A G protein-coupled receptor",Hydrolase,"Cytochrome P450 family 3","Cytochrome P450 family 1","Cytochrome P450 family 2","Small molecule receptor 
(family A GPCR)","Cytochrome P450 family 3A","Cytochrome P450 family 1A","Cytochrome P450 family 2D","Monoamine receptor","Cytochrome P450 3A4","Cytochrome P450 1A1","Cytochrome P450 2D6","Dopamine re
ceptor","Acetylcholine receptor",Transporter,"Ion channel","Unclassified protein","Secreted protein","Other cytosolic protein","Transcription factor","Other nuclear protein","Epigenetic regulator","El
ectrochemical transporter","Voltage-gated ion channel",Lyase,"Primary active transporter",Protease,"Ligand-gated ion channel",Isomerase,"Nuclear receptor",Oxidoreductase,Reader,Kinase,"SLC superfamily
 of solute carriers","Potassium channels","ATP-binding cassette","Peptide receptor (family A GPCR)","Aspartic protease","Voltage-gated calcium channel","GABA-A receptor","Voltage-gated sodium channel"
,"5HT3 receptor","Cysteine protease","Ionotropic glutamate receptor","Nuclear hormone receptor subfamily 1","Metallo protease",Bromodomain,"Protein Kinase","SLC06 neurotransmitter transporter family",
"Voltage-gated potassium channel","ABCB subfamily","Short peptide receptor (family A GPCR)","Aspartic protease AA clan","Cysteine protease PAC clan","NMDA receptor","Nuclear hormone receptor subfamily
 1 group F","Cytochrome P450 family 2C","Inwardly rectifying potassium channel","Metallo protease MAE clan","Lipid-like ligand receptor (family A GPCR)","Atypical protein kinase group","Two-pore domai
n potassium channel","SLC18 family of vesicular amine transporters","Serotonin receptor","Histamine receptor","Opioid receptor","Aspartic protease A2A subfamily","Adrenergic receptor","Cysteine protea
se C3A subfamily","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 2C19","Metallo protease M34 family","Cholecystokinin receptor","Leukotriene receptor","Prostanoid receptor","
Atypical protein kinase PIKK family","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Enzymes,Receptors,"Cytochrome P450","G protein-coupled receptors","CYP3 family","CYP1 family","CYP2 family: drug metabolising subset","Dopamine receptors","Acetylcholine receptors (muscarinic)","Ion 
channels","Other protein targets",Transporters,"Voltage-gated ion channels","Sigma receptors","ATP-binding cassette transporter family","Ligand-gated ion channels","Nuclear hormone receptors","SLC sup
erfamily of solute carriers","Eicosanoid turnover","Kinases (EC 2.7.x.x)","5-Hydroxytryptamine receptors","Potassium channels","ABCB subfamily","Histamine receptors",Adrenoceptors,"Voltage-gated calci
um channels","GABA<sub>A</sub> receptors","Opioid receptors","Voltage-gated sodium channels","5-HT<sub>3</sub> receptors","Ionotropic glutamate receptors","1F. Retinoic acid-related orphans","SLC6 neu
rotransmitter transporter family","Cholecystokinin receptors","Leukotriene receptors",Lipoxygenases,"Prostanoid receptors",Atypical,"SLC18 family of vesicular amine transporters","Voltage-gated potass
ium channels","Monoamine transporter subfamily","Inwardly rectifying potassium channels","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","Two P domain potassium channels","FRAP subfami
ly"}

> <pathway_reactome>
{Metabolism,Disease,"Signal Transduction","Metabolism of lipids","Biological oxidations","Infectious disease","Signaling by GPCR","Biosynthesis of specialized proresolving mediators (SPMs)","Phase I -
 Functionalization of compounds","Leishmania infection","GPCR ligand binding","Biosynthesis of DHA-derived SPMs","Cytochrome P450 - arranged by substrate type","Leishmania parasite growth and survival
","Class A/1 (Rhodopsin-like receptors)","Biosynthesis of maresins",Xenobiotics,"Anti-inflammatory response favouring Leishmania parasite infection","Amine ligand-binding receptors","Biosynthesis of m
aresin-like SPMs","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","CYP2E1 reactions","ADORA2B mediated anti-inflammatory cytokines production","Dopamine receptors","Muscarinic acety
lcholine receptors","Neuronal System","Muscle contraction","Developmental Biology",Hemostasis,"Immune System","Gene expression (Transcription)","Cellular responses to external stimuli","Potassium Chan
nels","Cardiac conduction","Nervous system development","Transmission across Chemical Synapses","Platelet activation","signaling and aggregation","Abacavir transport and metabolism","Cytokine Signalin
g in Immune system","RNA Polymerase II Transcription","Disorders of transmembrane transporters","Cellular responses to stress","Diseases of signal transduction by growth factor receptors and second me
ssengers","Voltage gated Potassium channels","SARS-CoV Infections","Metabolism of steroids","Phase 3 - rapid repolarisation","Axon guidance","Neurotransmitter receptors and postsynaptic signal transmi
ssion","GPCR downstream signalling","Platelet Aggregation (Plug Formation)","Abacavir transmembrane transport","Signaling by Interleukins","Generic Transcription Pathway","SLC transporter disorders","
Uptake and actions of bacterial toxins","Neurotransmitter clearance","Cellular Senescence","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Oncogenic MAPK signaling","Tandem pore doma
in potassium channels","Neurotransmitter release cycle","Potential therapeutics for SARS","Bile acid and bile salt metabolism","NCAM signaling for neurite out-growth","GABA receptor activation","G alp
ha (i) signalling events","L1CAM interactions","Activation of NMDA receptors and postsynaptic events","Cholesterol biosynthesis","Interleukin-1 family signaling","Transcriptional regulation by RUNX3",
"Defective SLC6A2 causes orthostatic intolerance (OI)","Uptake and function of anthrax toxins","Serotonin clearance from the synaptic cleft","G alpha (q) signalling events","Defective SLC6A3 causes Pa
rkinsonism-dystonia infantile (PKDYS)","DNA Damage/Telomere Stress Induced Senescence","Biosynthesis of DPA-derived SPMs","Transcriptional Regulation by MECP2","Signaling by RAS mutants","Transcriptio
nal Regulation by TP53","TWIK related potassium channel (TREK)","Acetylcholine Neurotransmitter Release Cycle","Synthesis of bile acids and bile salts","NCAM1 interactions","Peptide ligand-binding rec
eptors","Opioid Signalling","Interaction between L1 and Ankyrins","Fatty acids","Post NMDA receptor activation events","Cholesterol biosynthesis via desmosterol","Interleukin-1 signaling","RUNX3 Regul
ates Immune Response and Cell Migration","GABA B receptor activation","Gastrin-CREB signalling pathway via PKC and MAPK","Formation of Senescence-Associated Heterochromatin Foci (SAHF)","Recycling of 
bile acids and salts","Biosynthesis of DPAn-3 SPMs","MECP2 regulates neuronal receptors and channels","Signaling downstream of RAS mutants","Eicosanoid ligand-binding receptors","Regulation of TP53 Ac
tivity","Serotonin receptors","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Histamine receptors",Adrenoceptors,"G-protein activation","Tachykinin receptors bind tachykinins",
"CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Activation of GABAB receptors","LTC4-CYSLTR mediated IL4 production","B
iosynthesis of DPAn-3-derived protectins and resolvins","Prostanoid ligand receptors","Regulation of TP53 Expression and Degradation","Ras activation upon Ca2+ influx through NMDA receptor","Inhibitio
n  of voltage gated Ca2+ channels via Gbeta/gamma subunits","Regulation of TP53 Degradation"}

> <broad_targets>
{DRD1,DRD2,DRD3,DRD4,DRD5,GRIN2B,HRH1,HTR1A,HTR1D,HTR2A,HTR2B,HTR7,KCNH1}

> <broad_moa>
{"dopamine receptor antagonist"}

> <synonyms>
{"haloperidol hydrochloride",1511-16-6,1511166,"Haloperidol (hydrochloride)",UNII-UM06W2ADRY,UNIIUM06W2ADRY,UM06W2ADRY,CHEMBL545608,"Haloperidol chloride",SMR000449283,"Haloperidol chlorohydrate","Hal
operidol hydrochloride (MI)",CPD000449283,C21H23ClFNO2.ClH,C21H23C,SAM001246979}

> <pdid>
PD000252

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{11495267}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 18  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.4994    0.7432    0.0000 C   0  0
   -7.7985    1.4932    0.0000 C   0  0
   -9.0975    0.7432    0.0000 O   0  0
   -7.7985    2.9932    0.0000 C   0  0
   -6.4995    3.7432    0.0000 C   0  0
   -6.4995    5.2432    0.0000 O   0  0
   -5.2004    2.9933    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 17 10  1  0
M  END
> <name>
NIHCC_2014

> <id>
5828

> <plate>
NGP-105-03

> <well>
E05

> <supplier_cmpd_name>
CPD000058206

> <ctcr_id>
2636

> <supplier_cmpd_id>
SAM001246888

> <smiles>
Oc1ccc(cc1)/C=C/c2cc(O)cc(O)c2

> <pd_targets>
{MAOB,APP,CYP1B1,RELA,DPP4,CYP19A1,CA2,CA4,KDM4E,STK33,TYR,POLB,MAL12,MAPT,RORC,ALDH1A1,HPGD,TP53,HTT,GFER,MAOA,NQO2,PTGS2,PTGS1,CA6,CA12,CA7,CA15,SIRT1,TTR,CA3,CA14,LMNA,RAB9A,SMN1,HIF1A,BLM,CYP3A4,H
SD17B10,KMT2A,MEN1,AKR1B1,ADRA1D,VACV_BRZ_SERRO2_026,PPO2,CA5B,CA13,AMPC,GAA,PRKCZ,NPC1,PAK1,PPARG,AHR,CA9,CA5A,CA1,PMP22,KDM1A,PYK,NFKB1,NFKB2,CYP1A1,PIK3CB,TRPA1,MTOR,PIK3CA,NOS2,SLC6A2,CYP2C19,ABCB
1,ODC1,CYP1A2,CYP2C9,ABL1,BCR,MYC,ESR1,TERT,NFE2L2,ALOX5,CBR1,AKT1,YARS1,CYP2D6,LEF,THPO,ALOX15,PKM,USP2}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Transcription factor","Epigenetic regulator","Other cytosolic protein","Unclassified protein","Secreted protein","Other nuclear protein",Transporter,"Ion channel",Oxidored
uctase,"Cytochrome P450",Protease,Lyase,Eraser,Kinase,Hydrolase,"Nuclear receptor",Reader,"Family A G protein-coupled receptor",Transferase,"Voltage-gated ion channel","Electrochemical transporter","P
rimary active transporter",Ligase,"Cytochrome P450 family 1","Serine protease","Cytochrome P450 family 19","Lysine demethylase","Protein Kinase","Nuclear hormone receptor subfamily 1","Histone deacety
lase","Methyl-lysine/arginine binding protein","Cytochrome P450 family 3",Bromodomain,"Small molecule receptor (family A GPCR)","Transient receptor potential channel","SLC superfamily of solute carrie
rs","Cytochrome P450 family 2","ATP-binding cassette","Nuclear hormone receptor subfamily 3","Cytochrome P450 family 1B","Serine protease SC clan","Cytochrome P450 family 19A","Jumonji domain-containi
ng","CAMK protein kinase group","Nuclear hormone receptor subfamily 1 group F","HDAC class III","Tudor domain","Cytochrome P450 family 3A","Monoamine receptor","AGC protein kinase group","STE protein 
kinase group","Nuclear hormone receptor subfamily 1 group C","Lysine-specific demethylase","Cytochrome P450 family 1A","Atypical protein kinase group","SLC06 neurotransmitter transporter family","Cyto
chrome P450 family 2C","ABCB subfamily","Nuclear hormone receptor subfamily 3 group A","Cytochrome P450 1B1","Serine protease S9B subfamily","Cytochrome P450 19A1","CAMK protein kinase unique family",
"Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 3A4","Adrenergic receptor","AGC protein kinase PKC family","STE protein kinase STE20 family","Nuclear hormone receptor subfamil
y 1 group C member 3","Cytochrome P450 1A1","Atypical protein kinase PIKK family","Cytochrome P450 2C19","Cytochrome P450 2C9","Atypical protein kinase BCR family","Nuclear hormone receptor subfamily 
3 group A member 1","AGC protein kinase AKT family","AGC protein kinase PKC iota subfamily","STE protein kinase PAKA subfamily","Atypical protein kinase FRAP subfamily","Metallo protease","Cysteine pr
otease","Cytochrome P450 family 2D","Metallo protease MAE clan","Cysteine protease CA clan","Cytochrome P450 2D6","Metallo protease M34 family","Cysteine protease C19 family"}

> <pathway_chembl>
{Enzymes,Receptors,"Other protein targets",Transporters,"Ion channels","Catecholamine turnover","Cytochrome P450","Peptidases and proteinases","Carbonic anhydrases","Chromatin modifying enzymes","Kina
ses (EC 2.7.x.x)","1.-.-.- Oxidoreductases","Nuclear hormone receptors","Eicosanoid turnover",Transthyretin,"G protein-coupled receptors","3.2.1.- Glycosidases","SLC superfamily of solute carriers","A
ryl hydrocarbon receptor","Voltage-gated ion channels","L-Arginine turnover","ATP-binding cassette transporter family","Carboxylases and decarboxylases","Transcription factors","CYP1 family","SC: Seri
ne (S) Peptidases",CYP11,CYP17,CYP19,"CYP20 and CYP21 families","1.14.11.- Histone demethylases","CAMK: Calcium/calmodulin-dependent protein kinases","1F. Retinoic acid-related orphans","Prostaglandin
 synthases",Cyclooxygenase,"3.5.1.- Histone deacetylases (HDACs)","CYP3 family",Adrenoceptors,"AGC: Containing PKA",PKG,"PKC families","SLC65 NPC-type cholesterol transporters","STE: Homologs of yeast
 Sterile 7","Sterile 11","Sterile 20 kinases","1C. Peroxisome proliferator-activated receptors","Lipid modifying kinases","Transient Receptor Potential channels",Atypical,"Nitric oxide synthases","SLC
6 neurotransmitter transporter family","CYP2 family: drug metabolising subset","ABCB subfamily",Decarboxylases,"Steroid hormone receptors","Basic leucine zipper domain TFs",Lipoxygenases,"S9: Prolyl o
ligopeptidase","CAMK-unique family","Protein kinase C (PKC) family","STE20 family",Phosphatidylinositol-4,"5-bisphosphate 3-kinase family","Phosphatidyl inositol 3' kinase-related kinases (PIKK) famil
y","Monoamine transporter subfamily","3A. Estrogen receptors","Akt (Protein kinase B","PKB) family","Iota subfamily","PAKA subfamily","FRAP subfamily","2.7.1.40 Pyruvate kinases","CA: Cysteine (C) Pep
tidases","C19: Ubiquitin-specific protease"}

> <pathway_reactome>
{Metabolism,"Immune System","Metabolism of proteins","Transport of small molecules","DNA Repair","Neuronal System","Gene expression (Transcription)","Cell Cycle","Protein localization","Signal Transdu
ction","Metabolism of RNA","Cellular responses to external stimuli",Disease,"Developmental Biology","Biological oxidations","Innate Immune System","Peptide hormone metabolism","O2/CO2 exchange in eryt
hrocytes","Metabolism of amino acids and derivatives","Base Excision Repair","Transmission across Chemical Synapses","RNA Polymerase II Transcription","Metabolism of lipids","Cell Cycle Checkpoints","
Mitochondrial protein import","Reversible hydration of carbon dioxide","Signaling by GPCR",Mitotic,"Signaling by Rho GTPases","Metabolism of non-coding RNA","Cellular responses to stress","DNA Double-
Strand Break Repair","Diseases of metabolism","Signaling by Nuclear Receptors","Plasma lipoprotein assembly",remodeling,"and clearance","Nervous system development","Cytokine Signaling in Immune syste
m","Intracellular signaling by second messengers","Signaling by Receptor Tyrosine Kinases","Ion channel transport","Diseases of signal transduction by growth factor receptors and second messengers","I
nfectious disease","Disorders of transmembrane transporters","Abacavir transport and metabolism","Chromosome Maintenance",Translation,"Phase I - Functionalization of compounds","Toll-like Receptor Cas
cades","Incretin synthesis",secretion,"and inactivation","Erythrocytes take up carbon dioxide and release oxygen","Melanin biosynthesis","Resolution of Abasic Sites (AP sites)","Neurotransmitter recep
tors and postsynaptic signal transmission","Generic Transcription Pathway","Biosynthesis of specialized proresolving mediators (SPMs)","G1/S DNA Damage Checkpoints","Fatty acid metabolism","GPCR downs
tream signalling","M Phase","Rho GTPase cycle","snRNP Assembly","Cellular response to hypoxia","Homology Directed Repair","Branched-chain amino acid catabolism","Metabolism of steroids","GPCR ligand b
inding","Diseases of carbohydrate metabolism","ESR-mediated signaling","Plasma lipoprotein clearance","Axon guidance","Signaling by Interleukins","EGR2 and SOX10-mediated initiation of Schwann cell my
elination","PIP3 activates AKT signaling","Signaling by Insulin receptor","Stimuli-sensing channels","Signaling by FGFR in disease","Infection with Mycobacterium tuberculosis","SLC transporter disorde
rs","Abacavir transmembrane transport","Metabolism of polyamines","Mitotic G1 phase and G1/S transition","Telomere Maintenance","tRNA Aminoacylation","Amine Oxidase reactions","Toll Like Receptor 5 (T
LR5) Cascade","Cytochrome P450 - arranged by substrate type",Synthesis,"and inactivation of Glucagon-like Peptide-1 (GLP-1)","Resolution of AP sites via the multiple-nucleotide patch replacement pathw
ay","Activation of NMDA receptors and postsynaptic events","Transcriptional regulation by RUNX3","Ethanol oxidation","Biosynthesis of DHA-derived SPMs","p53-Dependent G1/S DNA damage checkpoint","Tran
scriptional Regulation by MECP2","Biosynthesis of DPA-derived SPMs","Arachidonic acid metabolism","FOXO-mediated transcription","G alpha (i) signalling events","Mitotic Metaphase and Anaphase","RHOBTB
 GTPase Cycle","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Metabolism of steroid hormones"
,"Class A/1 (Rhodopsin-like receptors)","Glycogen storage diseases","Extra-nuclear estrogen signaling","LDL clearance","EPH-Ephrin signaling","Regulation of gene expression by Hypoxia-inducible Factor
","Interleukin-12 family signaling","PTEN Regulation","Insulin receptor signalling cascade","TRP channels","Transcriptional Regulation by TP53","Signaling by FGFR1 in disease","Response of Mtb to phag
ocytosis","Defective SLC6A2 causes orthostatic intolerance (OI)","Regulation of ornithine decarboxylase (ODC)","G0 and Early G1","Transcriptional regulation by RUNX1","Extension of Telomeres","Cytosol
ic tRNA aminoacylation","Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB","MyD88 cascade initiated on plasma membrane","Endogenous sterols","PCNA-Dependent Long Patch Base Exc
ision Repair","Post NMDA receptor activation events","RUNX3 Regulates Immune Response and Cell Migration","Biosynthesis of D-series resolvins","p53-Dependent G1 DNA Damage Response","Regulation of MEC
P2 expression and activity","Biosynthesis of DPAn-3 SPMs","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","Regulation of FOXO transcriptional activity by acetylation","Visual phototransductio
n","Mitotic Anaphase","RHOBTB3 ATPase cycle","HDR through Homologous Recombination (HRR)","Biosynthesis of maresins","Pregnenolone biosynthesis","Amine ligand-binding receptors","Glycogen storage dise
ase type II (GAA)","Estrogen-stimulated signaling through PRKCZ","EPHB-mediated forward signaling","MECP2 regulates transcription factors","Interleukin-12 signaling","Regulation of PTEN gene transcrip
tion",Xenobiotics,"IRS-mediated signalling","Regulation of TP53 Activity","FGFR1 mutant receptor activation","Suppression of phagosomal maturation","Transcription of E2F targets under negative control
 by DREAM complex","RUNX1 regulates estrogen receptor mediated transcription","Telomere Extension By Telomerase","TAK1 activates NFkB by phosphorylation and activation of IKKs complex","Activation of 
AMPK downstream of NMDARs","Stabilization of p53","The canonical retinoid cycle in rods (twilight vision)","Nuclear Envelope (NE) Reassembly","Homologous DNA Pairing and Strand Exchange","Biosynthesis
 of maresin-like SPMs",Adrenoceptors,"Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","PI3K Cascade","Regulation of TP53 Expression and Degradation","Signaling by c
ytosolic FGFR1 fusion mutants","Inhibition of nitric oxide production","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Biosynthesis of DPAn-3-derived 13-series r
esolvins","Autodegradation of the E3 ubiquitin ligase COP1","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pairing and strand exchange","Regulation of TP53 Degr
adation",Hemostasis,"Platelet activation","signaling and aggregation","Metabolism of carbohydrates","Uptake and actions of bacterial toxins","Platelet Aggregation (Plug Formation)","Glucose metabolism
","Uptake and function of anthrax toxins",Glycolysis,"Biosynthesis of DPAn-3-derived protectins and resolvins"}

> <broad_targets>
{CSNK2A1,NQO2,PTGS1,PTGS2}

> <broad_moa>
{"cytochrome P450 inhibitor","SIRT activator"}

> <synonyms>
{resveratrol,501-36-0,501360,trans-resveratrol,transresveratrol,"3,4',5-Trihydroxystilbene","3,4',5Trihydroxystilbene","(E)-5-(4-Hydroxystyryl)benzene-1,3-diol","(E)5(4Hydroxystyryl)benzene1,3diol","3
,5,4'-Trihydroxystilbene","3,5,4'Trihydroxystilbene",(E)-resveratrol,(E)resveratrol,"3,4',5-Stilbenetriol","3,4',5Stilbenetriol","5-((E)-2-(4-hydroxyphenyl)ethenyl)benzene-1,3-diol","5((E)2(4hydroxyph
enyl)ethenyl)benzene1,3diol",Resvida,3,4',T1558,SAM001246888,1502223,Resveratrol,CPD000058206,RESVERATROL}

> <pdid>
PD001353

> <targets>
{Antibiotic,Apoptosis,Autophagy,Bacterial,Fungal,IKK,Keap1-Nrf2,Mitophagy,Sirtuin}

> <classes>
{antifungal,antibacterial,Anti-infection,Apoptosis,Autophagy,Cell Cycle/DNA Damage,Epigenetics,NF-ºB}

> <pubchem_cids>
{445154}

$$$$
NIHCC_2014
  SciTegic11012413002D

 47 49  0  0  0  0            999 V2000
    5.1250    4.3735    0.0000 C   0  0
    4.6588    2.9478    0.0000 C   0  0
    3.1904    2.6376    0.0000 C   0  0
    2.7248    1.2135    0.0000 C   0  0
    3.6065    0.0000    0.0000 N   0  0
    2.7248   -1.2135    0.0000 C   0  0
    3.1882   -2.6401    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
   -2.5987    1.5004    0.0000 C   0  0
   -3.8967    0.7484    0.0000 C   0  0
   -5.1969    1.4963    0.0000 C   0  0
   -5.1993    2.9963    0.0000 C   0  0
   -3.9014    3.7484    0.0000 C   0  0
   -2.6012    3.0004    0.0000 C   0  0
   -1.3042    3.7556    0.0000 O   0  0
   -1.3088    5.2564    0.0000 C   0  0
   -0.0126    6.0112    0.0000 C   0  0
   -6.4955    0.7438    0.0000 S   0  0
   -7.7955    1.4922    0.0000 O   0  0
   -6.4976    2.2438    0.0000 O   0  0
   -6.4940   -0.7570    0.0000 N   0  0
   -7.7924   -1.5082    0.0000 C   0  0
   -7.7909   -3.0082    0.0000 C   0  0
   -6.4912   -3.7570    0.0000 N   0  0
   -6.4867   -5.2578    0.0000 C   0  0
   -5.1858   -6.0047    0.0000 C   0  0
   -5.1929   -3.0058    0.0000 C   0  0
   -5.1943   -1.5058    0.0000 C   0  0
    8.9253    0.7444    0.0000 O   0  0
    8.9253   -0.7556    0.0000 C   0  0
    7.6260   -1.5052    0.0000 O   0  0
   10.2253   -1.5056    0.0000 C   0  0
   11.5253   -0.7556    0.0000 C   0  0
   12.8238   -1.5064    0.0000 O   0  0
   11.5267    0.7452    0.0000 C   0  0
   12.8267    1.4952    0.0000 C   0  0
   14.1252    0.7444    0.0000 O   0  0
   12.8281    2.9952    0.0000 O   0  0
   11.5265   -2.2856    0.0000 C   0  0
   10.2278   -3.0362    0.0000 O   0  0
   12.8256   -3.0353    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  8  9  1  0
  9  4  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  3
 12 13  1  0
 13  8  1  0
 13 14  2  0
 11 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 17 24  1  0
 24 25  2  0
 24 26  2  0
 24 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 30 33  1  0
 33 34  1  0
 34 27  1  0
 35 36  1  0
 36 37  2  0
 36 38  1  0
 38 39  1  0
 39 40  1  0
 39 41  1  0
 41 42  1  0
 42 43  1  0
 42 44  2  0
 39 45  1  0
 45 46  1  0
 45 47  2  0
M  END
> <name>
NIHCC_2014

> <id>
5829

> <plate>
NGP-105-03

> <well>
E06

> <supplier_cmpd_name>
CPD000469155

> <ctcr_id>
601

> <supplier_cmpd_id>
SAM001246573

> <smiles>
CCCc1nc(C)c2n1NC(=NC2=O)c3cc(ccc3OCC)[S](=O)(=O)N4CCN(CC)CC4.OC(=O)CC(O)(CC(O)=O)C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{CPD000469155,SAM001246573}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581791}

$$$$
NIHCC_2014
  SciTegic11012413002D

 14 16  0  0  0  0            999 V2000
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 S   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  1  1  0
 14  9  1  0
M  END
> <name>
NIHCC_2014

> <id>
5830

> <plate>
NGP-105-03

> <well>
E07

> <supplier_cmpd_name>
CPD000059045

> <ctcr_id>
1922

> <supplier_cmpd_id>
SAM001246855

> <smiles>
N1c2ccccc2Sc3ccccc13

> <pd_targets>
{RORC,BCHE,ACHE,ALOX12,SNCA,NOX1,MAPT,CNR1,ALOX15,LEF,POLB,KMT2A,MEN1,CYP3A4,GAA,PTGS1,PTGS2,CYP1A2,SLC6A3,ADORA3,HTR2C,ALOX5,SLC6A2,MAOA}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Unclassified protein","Other cytosolic protein","Membrane receptor","Epigenetic regulator",Transporter,"Nuclear receptor",Hydrolase,Isomerase,"Family A G protein-couple
d receptor",Oxidoreductase,Protease,Reader,"Cytochrome P450","Electrochemical transporter","Nuclear hormone receptor subfamily 1","Small molecule receptor (family A GPCR)","Metallo protease",Bromodoma
in,"Cytochrome P450 family 3","Cytochrome P450 family 1","SLC superfamily of solute carriers","Nuclear hormone receptor subfamily 1 group F","Lipid-like ligand receptor (family A GPCR)","Metallo prote
ase MAE clan","Cytochrome P450 family 3A","Cytochrome P450 family 1A","SLC06 neurotransmitter transporter family","Nucleotide-like receptor (family A GPCR)","Monoamine receptor","Nuclear hormone recep
tor subfamily 1 group F member 3","Cannabinoid receptor","Metallo protease M34 family","Cytochrome P450 3A4","Cytochrome P450 1A1","Adenosine receptor","Serotonin receptor"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Nuclear hormone receptors","Acetylcholine turnover","Eicosanoid turnover","NADPH oxidases","G protein-coupled receptors","Cytochrome P450","3.2.1.- Glycosidases","SLC 
superfamily of solute carriers","Catecholamine turnover","1F. Retinoic acid-related orphans",Lipoxygenases,"Cannabinoid receptors","CYP3 family",Cyclooxygenase,"CYP1 family","SLC6 neurotransmitter tra
nsporter family","Adenosine receptors","5-Hydroxytryptamine receptors","Monoamine transporter subfamily"}

> <pathway_reactome>
{"Gene expression (Transcription)",Metabolism,"Metabolism of proteins",Disease,"Neuronal System","Signal Transduction","DNA Repair","RNA Polymerase II Transcription","Metabolism of lipids","Amyloid fi
ber formation","Infectious disease","Transmission across Chemical Synapses","Signaling by GPCR","Base Excision Repair","Diseases of metabolism","Biological oxidations","Disorders of transmembrane tran
sporters","Generic Transcription Pathway","Phospholipid metabolism","Biosynthesis of specialized proresolving mediators (SPMs)","Leishmania infection","Neurotransmitter receptors and postsynaptic sign
al transmission","GPCR downstream signalling","Uptake and actions of bacterial toxins","Resolution of Abasic Sites (AP sites)","Diseases of carbohydrate metabolism","Fatty acid metabolism","Phase I - 
Functionalization of compounds","SLC transporter disorders","GPCR ligand binding","Transcriptional regulation by RUNX3","Glycerophospholipid biosynthesis","Biosynthesis of DPA-derived SPMs","Killing m
echanisms","Activation of NMDA receptors and postsynaptic events","G alpha (i) signalling events","Uptake and function of anthrax toxins","Resolution of AP sites via the multiple-nucleotide patch repl
acement pathway","Biosynthesis of DHA-derived SPMs","Glycogen storage diseases","Arachidonic acid metabolism","Cytochrome P450 - arranged by substrate type","Defective SLC6A3 causes Parkinsonism-dysto
nia infantile (PKDYS)","Class A/1 (Rhodopsin-like receptors)","Defective SLC6A2 causes orthostatic intolerance (OI)","Amine Oxidase reactions","RUNX3 Regulates Immune Response and Cell Migration","Syn
thesis of PC","Biosynthesis of DPAn-3 SPMs","WNT5:FZD7-mediated leishmania damping","Post NMDA receptor activation events","PCNA-Dependent Long Patch Base Excision Repair","Biosynthesis of maresins","
Glycogen storage disease type II (GAA)","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)",Xenobiotics,"Nucleotide-like (purinergic) receptors","Amine ligand-binding receptors","Biogenic amines 
are oxidatively deaminated to aldehydes by MAOA and MAOB","Biosynthesis of DPAn-3-derived maresins","Activation of AMPK downstream of NMDARs","Biosynthesis of DPAn-3-derived protectins and resolvins",
"Biosynthesis of maresin-like SPMs","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Adenosine P1 receptors","Serotonin receptors","Biosynthesis of DPAn-3-derived 13-series resolvin
s"}

> <broad_targets>
{}

> <broad_moa>
{"dopamine receptor antagonist"}

> <synonyms>
{10H-Phenothiazine,10HPhenothiazine,92-84-2,92842,Thiodiphenylamine,"Dibenzo-1,4-thiazine","Dibenzo1,4thiazine",Feeno,Dibenzothiazine,Nemazine,Phenosan,Phenthiazine,Penthazine,Souframine,Agrazine,Anti
verm,Contaverm,Fenoverm,Fentiazin,Helmetina,Lethelmin,Nemazene,Nexarbol,P,T0776,SAM001246855,Phenothiazine,CPD000059045}

> <pdid>
PD000166

> <targets>
{Antibiotic,Bacterial,Fungal}

> <classes>
{Anti-infection}

> <pubchem_cids>
{7108}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 32  0  0  0  0            999 V2000
    7.4531   -4.5227    0.0000 O   0  0
   -0.8393   -7.9632    0.0000 C   0  0
   -0.2385   -9.3376    0.0000 S   0  0
   -1.1288  -10.5448    0.0000 O   0  0
   -1.7292   -9.1704    0.0000 O   0  0
    1.2531   -9.5042    0.0000 N   0  0
    2.1438   -8.2963    0.0000 C   0  0
    3.6348   -8.4606    0.0000 C   0  0
    4.5226   -7.2516    0.0000 C   0  0
    3.9195   -5.8781    0.0000 C   0  0
    4.8054   -4.6666    0.0000 C   0  0
    4.2010   -3.2956    0.0000 C   0  0
    4.9531   -1.9978    0.0000 N   0  0
    3.9511   -0.8815    0.0000 O   0  0
    2.5987   -1.5004    0.0000 C   0  0
    2.7343   -2.9815    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 N   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 C   0  0
   -3.1904   -2.6376    0.0000 C   0  0
   -4.6588   -2.9478    0.0000 C   0  0
   -5.1250   -4.3735    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    2.4285   -5.7138    0.0000 C   0  0
    1.5407   -6.9229    0.0000 C   0  0
  2  3  1  0
  3  4  2  0
  3  5  2  0
  3  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 12  1  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 23 27  1  0
 27 20  1  0
 27 28  2  0
 28 17  1  0
 10 29  1  0
 29 30  2  0
 30  7  1  0
M  END
> <name>
NIHCC_2014

> <id>
5831

> <plate>
NGP-105-03

> <well>
E08

> <supplier_cmpd_name>
CPD000466290

> <ctcr_id>
6486

> <supplier_cmpd_id>
SAM001247090

> <smiles>
O.CS(=O)(=O)Nc1ccc(Cc2noc(n2)c3ccc4[nH]cc(CCN)c4c3)cc1

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{HTR1A,HTR1B,HTR1D}

> <broad_moa>
{"serotonin receptor agonist"}

> <synonyms>
{694,24,SMR000466290,MLS000758928,MLS001424159,CHEMBL1377173,HMS2052I15,HMS3394I15,CCG-101123,CCG101123,NC00373,SAM001247090,CPD000466290}

> <pdid>
PD035704

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581822}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 32  0  0  0  0            999 V2000
    1.3000    2.2500    0.0000 C   0  0
    1.3000    0.7500    0.0000 S   0  0
    0.0007    0.0004    0.0000 O   0  0
    2.5993    0.0004    0.0000 O   0  0
    1.3000   -0.7500    0.0000 O   0  0
    7.5715    2.6954    0.0000 C   0  0
    6.4115    3.3755    0.0000 C   0  0
    9.4516    4.1755    0.0000 C   0  0
    9.9317    5.4556    0.0000 C   0  0
   11.0917    4.7355    0.0000 C   0  0
   11.0917    3.3755    0.0000 C   0  0
    9.9317    2.6954    0.0000 C   0  0
    8.7316    3.3755    0.0000 C   0  0
    8.7316    4.7355    0.0000 N   0  0
    7.5715    5.4556    0.0000 C   0  0
    6.4115    4.7355    0.0000 C   0  0
    5.1006    5.4647    0.0000 O   0  0
   12.3914    2.6219    0.0000 O   0  0
   12.3895    1.1211    0.0000 C   0  0
   11.0893    0.3731    0.0000 O   0  0
   13.6878    0.3682    0.0000 C   0  0
   15.0392    0.9891    0.0000 C   0  0
   16.0429   -0.1256    0.0000 N   0  0
   15.2930   -1.4238    0.0000 C   0  0
   15.7565   -2.8504    0.0000 C   0  0
   14.7528   -3.9651    0.0000 C   0  0
   13.2856   -3.6532    0.0000 C   0  0
   12.8221   -2.2266    0.0000 C   0  0
   13.8258   -1.1119    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13  6  1  0
 13 14  1  0
 14  9  1  0
 14 15  1  0
 15 16  1  0
 16  7  1  0
 16 17  2  0
 11 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  2  3
 22 23  1  0
 23 24  1  0
 24 25  2  3
 25 26  1  0
 26 27  2  3
 27 28  1  0
 28 29  2  3
 29 24  1  0
 29 21  1  0
M  END
> <name>
NIHCC_2014

> <id>
5832

> <plate>
NGP-105-03

> <well>
E09

> <supplier_cmpd_name>
CPD000469228

> <ctcr_id>
5835

> <supplier_cmpd_id>
SAM001246842

> <smiles>
CS(=O)(=O)O.C1C2CC3CC(CC1N3CC2=O)OC(=O)C4=CNC5=CC=CC=C54

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{HTR3A}

> <broad_moa>
{"serotonin receptor antagonist"}

> <synonyms>
{"DOLASETRON MESYLATE",115956-13-3,115956133,"Dolasetron (Mesylate)","Dalasetron Mesylate",NCGC00181048-01,NCGC0018104801,C19H20N2O3.CH4O3S,"Dalasetron (Mesylate)",DSSTox_CID_26827,DSSToxCID26827,DSST
ox-CID-26827,"DSSTox CID 26827",DSSTox_RID_81939,DSSToxRID81939,DSSTox-RID-81939,"DSSTox RID 81939",DSSTox_GSID_46827,DSSToxGSID46827,DSSTox-GSID-46827,"DSSTox GSID 46827",SCHEMBL41145,MLS001424160,CH
EMBL1237113,CHEMBL237332,SAM001246842,CPD000469228}

> <pdid>
PD013087

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{3033817}

$$$$
NIHCC_2014
  SciTegic11012413002D

 18 17  0  0  0  0            999 V2000
   11.2484   -2.0247    0.0000 H   0  3
    8.7484   -2.0247    0.0000 Cl  0  5
    1.2948   -3.7516    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 Cl  0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 Cl  0  0
    3.8933   -3.7570    0.0000 C   0  0
    4.0312   -5.2378    0.0000 N   0  0
    5.4984   -5.5497    0.0000 C   0  0
    6.2484   -4.2507    0.0000 C   0  0
    5.2447   -3.1359    0.0000 N   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  6  1  0
 12 13  1  0
  4 14  1  0
 14 15  2  3
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 14  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5833

> <plate>
NGP-105-03

> <well>
E10

> <supplier_cmpd_name>
CPD000469232

> <ctcr_id>
5346

> <supplier_cmpd_id>
SAM001246820

> <smiles>
[H+].[Cl-].CC(Oc1c(Cl)cccc1Cl)C2=NCCN2

> <pd_targets>
{ADRA1A,ADRA1B,ADRA1D,ADRA2A,ADRA2B,ADRA2C,HTR1A,NISCH,HTR7,HTR2C,HTR1D}

> <pathway_gtopdb>
{"Membrane receptor","Other cytosolic protein","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Adrenergic receptor","Serotonin receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors",Adrenoceptors,"5-Hydroxytryptamine receptors"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Signaling by GPCR","Infectious disease","GPCR ligand binding","Leishmania infection","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","A
mine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection",Adrenoceptors,"Serotonin receptors","ADORA2B mediated anti-inflammatory cytokines production"}

> <broad_targets>
{}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{"Lofexidine hydrochloride",21498-08-8,21498088,"LOFEXIDINE HCl","Lofexidine (hydrochloride)",Britlofex,"MDL 14,042","2-(1-(2,6-dichlorophenoxy)ethyl)-4,5-dihydro-1H-imidazole hydrochloride","2(1(2,6d
ichlorophenoxy)ethyl)4,5dihydro1Himidazole hydrochloride","Lofexidine hydrochloride (USAN)",2-(1-(2,2(1(2,6-di,6di,SAM001246820,CPD000469232}

> <pdid>
PD009343

> <targets>
{Adrenergic Receptor}

> <classes>
{GPCR/G Protein,Neuronal Signaling}

> <pubchem_cids>
{30667,57516047}

$$$$
NIHCC_2014
  SciTegic11012413002D

 41 45  0  0  1  0            999 V2000
    7.7003    1.6096    0.0000 Br  0  5
    3.8964    0.7545    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    5.1996   -1.4928    0.0000 O   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0  2  0  0  0
   -2.5981    1.5000    0.0000 C   0  0  2  0  0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0  1  0  0  0
   -6.5611    2.3779    0.0000 C   0  0
   -3.8971    3.7500    0.0000 C   0  0  1  0  0  0
   -4.2297    5.2071    0.0000 C   0  0
   -5.7225    5.3543    0.0000 C   0  0  1  0  0  0
   -6.3238    3.9802    0.0000 C   0  0  2  0  0  0
   -7.7858    3.6531    0.0000 O   0  0
   -8.8026    4.7570    0.0000 C   0  0
   -8.3548    6.1886    0.0000 C   0  0
  -10.2664    4.4294    0.0000 O   0  0
   -6.4799    6.6470    0.0000 N   0  3
   -7.9799    6.6344    0.0000 C   0  0
   -5.0005    6.6221    0.0000 C   0  0
   -4.2602    7.9267    0.0000 C   0  0
   -5.0198    9.2201    0.0000 C   0  0
   -6.5198    9.2089    0.0000 C   0  0
   -7.2601    7.9043    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  2  0  0  0
   -2.5981    0.0000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.0000   -3.0008    0.0000 N   0  0
    1.2979   -3.7529    0.0000 C   0  0
    1.2955   -5.2529    0.0000 C   0  0
   -0.0047   -6.0009    0.0000 C   0  0
   -1.3026   -5.2488    0.0000 C   0  0
   -1.3002   -3.7488    0.0000 C   0  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  6  5  1  6
  6  7  1  0
  8  7  1  1
  8  9  1  0
  9 10  1  0
 11 10  1  6
 11 12  1  0
 12 13  1  1
 13 14  1  0
 14 15  1  0
 15 16  1  1
 15 17  1  0
 17 11  1  0
 17 18  1  1
 18 19  1  0
 19 20  1  0
 20 15  1  0
 20 21  1  1
 21 22  1  0
 22 23  1  0
 22 24  2  0
 19 25  1  1
 25 26  1  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 25  1  0
 12 32  1  0
 32  8  1  0
 32 33  1  1
 32 34  1  0
 34 35  1  0
 35  6  1  0
 35 36  1  1
 36 37  1  0
 37 38  1  0
 38 39  1  0
 39 40  1  0
 40 41  1  0
 41 36  1  0
M  CHG  2   1  -1  25   1
M  END
> <name>
NIHCC_2014

> <id>
5834

> <plate>
NGP-105-03

> <well>
E11

> <supplier_cmpd_name>
CPD000471625

> <ctcr_id>
4244

> <supplier_cmpd_id>
SAM001246821

> <smiles>
[Br-].CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@@H]([C@@H]4OC(C)=O)[N+]5(C)CCCCC5)[C@@]2(C)C[C@@H]1N6CCCCC6

> <pd_targets>
{SLC47A2,SLC47A1,SLC22A2,CHRNA1,CHRNB1,CHRND,CHRNE,CHRNG,CHRNA2}

> <pathway_gtopdb>
{Transporter,"Ion channel","Electrochemical transporter","Ligand-gated ion channel","SLC superfamily of solute carriers","Nicotinic acetylcholine receptor","SLC47 family of multidrug and toxin extrusi
on transporters","SLC22 family of organic cation and anion transporters","Nicotinic acetylcholine receptor alpha subunit"}

> <pathway_chembl>
{Transporters,"Ion channels","SLC superfamily of solute carriers","Ligand-gated ion channels","SLC47 family of multidrug and toxin extrusion transporters","SLC22 family of organic cation and anion tra
nsporters","Nicotinic acetylcholine receptors","Organic cation transporters (OCT)"}

> <pathway_reactome>
{"Transport of small molecules","Neuronal System","SLC-mediated transmembrane transport","Transmission across Chemical Synapses","Transport of bile salts and organic acids","metal ions and amine compo
unds","Neurotransmitter receptors and postsynaptic signal transmission","Organic cation/anion/zwitterion transport","Acetylcholine binding and downstream events","Organic cation transport","Postsynapt
ic nicotinic acetylcholine receptors","Highly calcium permeable postsynaptic nicotinic acetylcholine receptors"}

> <broad_targets>
{CHRNA2}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{"VECURONIUM BROMIDE",50700-72-6,50700726,Norcuron,"ORG NC 45","Vecuronii bromidum","Bromuro de vecuronio","Vecuronium (bromide)","Bromure de vecuronium",UNII-7E4PHP5N1D,UNII7E4PHP5N1D,"ORG-NC 45","OR
GNC 45",7E4PHP5N1D,acetate;bromide,CHEBI:9940,MFCD00867762,DSSTox_CID_,DSSToxCID,DSSTox-CID-,"DSSTox CID",SAM001246821,Prestw-1359,CPD000471625,"Vecuronium bromide"}

> <pdid>
PD009547

> <targets>
{nAChR}

> <classes>
{Membrane Transporter/Ion Channel,Neuronal Signaling}

> <pubchem_cids>
{39764}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 31  0  0  0  0            999 V2000
   13.3466   -4.0599    0.0000 H   0  3
   10.8466   -4.0599    0.0000 Cl  0  5
    8.6231   -5.3021    0.0000 C   0  0
    7.7381   -4.0910    0.0000 C   0  0
    6.2484   -4.2507    0.0000 N   0  0
    5.2447   -3.1359    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.9310   -2.6053    0.0000 C   0  0
    3.4463   -1.1957    0.0000 C   0  0
    2.4839   -0.0440    0.0000 N   0  0
    2.9970    1.3655    0.0000 C   0  0
    2.0328    2.5146    0.0000 C   0  0
    0.5556    2.2541    0.0000 O   0  0
    0.0426    0.8445    0.0000 C   0  0
    1.0067   -0.3045    0.0000 C   0  0
    4.0312   -5.2378    0.0000 C   0  0
    5.4984   -5.5497    0.0000 C   0  0
    5.9051   -6.4633    0.0000 O   0  0
    2.6260   -4.7492    0.0000 C   0  0
    1.4910   -5.7299    0.0000 C   0  0
    0.0742   -5.2373    0.0000 C   0  0
   -0.2076   -3.7640    0.0000 C   0  0
    0.9274   -2.7833    0.0000 C   0  0
    2.3442   -3.2759    0.0000 C   0  0
    4.3528   -6.6907    0.0000 C   0  0
    3.2466   -7.7038    0.0000 C   0  0
    3.5708   -9.1683    0.0000 C   0  0
    5.0013   -9.6198    0.0000 C   0  0
    6.1075   -8.6068    0.0000 C   0  0
    5.7833   -7.1422    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 10  1  0
  7 16  1  0
 16 17  1  0
 17  5  1  0
 17 18  2  0
 16 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 16 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5835

> <plate>
NGP-105-03

> <well>
F02

> <supplier_cmpd_name>
CPD000469229

> <ctcr_id>
3874

> <supplier_cmpd_id>
SAM001246792

> <smiles>
[H+].[Cl-].CCN1CC(CCN2CCOCC2)C(C1=O)(c3ccccc3)c4ccccc4

> <pd_targets>
{KCNK9,KCNK3,CYP2D6}

> <pathway_gtopdb>
{"Ion channel",Enzyme,"Voltage-gated ion channel","Cytochrome P450","Potassium channels","Cytochrome P450 family 2","Two-pore domain potassium channel","Cytochrome P450 family 2D","Cytochrome P450 2D6
"}

> <pathway_chembl>
{"Ion channels",Enzymes,"Voltage-gated ion channels","Cytochrome P450","Potassium channels","CYP2 family: drug metabolising subset","Two P domain potassium channels"}

> <pathway_reactome>
{"Neuronal System",Metabolism,"Potassium Channels","Biological oxidations","Tandem pore domain potassium channels","Phase I - Functionalization of compounds","TWIK-releated acid-sensitive K+ channel (
TASK)","Cytochrome P450 - arranged by substrate type",Xenobiotics,"CYP2E1 reactions"}

> <broad_targets>
{}

> <broad_moa>
{"potassium channel blocker"}

> <synonyms>
{"Doxapram hydrochloride",113-07-5,113075,"Doxapram HCL",Stimulexin,"Doxapram (hydrochloride)","1-ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-onemonohydrochloride","1ethyl4(2morpholinoethyl)3
,3diphenylpyrrolidin2onemonohydrochloride",DSSTox_CID_27815,DSSToxCID27815,DSSTox-CID-27815,"DSSTox CID 27815",DSSTox_RID_82579,DSSToxRID82579,DSSTox-RID-82579,"DSSTox RID 82579",DSSTox_GSID_47837,DSS
ToxGSID47837,DSSTox-GSID-47837,"DSSTox GSID 47837",CHEBI:59837,AHR-619,AHR619,CAS-1,CAS1,SAM001246792,CPD000469229}

> <pdid>
PD009963

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{91981259,64647,46878539}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 24  0  0  0  0            999 V2000
    4.0551   -4.4171    0.0000 C   0  0
    2.5551   -4.4192    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
   -0.6890   -4.0818    0.0000 C   0  0
   -2.1567   -3.7722    0.0000 O   0  0
   -0.2234   -5.5086    0.0000 C   0  0
   -1.2234   -6.6267    0.0000 C   0  0
   -0.7552   -8.0517    0.0000 C   0  0
   -1.7552   -9.1697    0.0000 Br  0  0
    0.7130   -8.3588    0.0000 C   0  0
    1.1812   -9.7838    0.0000 O   0  0
    1.7131   -7.2408    0.0000 C   0  0
    3.1813   -7.5478    0.0000 Br  0  0
    1.2449   -5.8157    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 10 11  1  0
 11  3  2  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 20 22  2  0
 22 14  1  0
M  END
> <name>
NIHCC_2014

> <id>
5836

> <plate>
NGP-105-03

> <well>
F03

> <supplier_cmpd_name>
CPD000058310

> <ctcr_id>
6114

> <supplier_cmpd_id>
SAM001246877

> <smiles>
CCc1oc2ccccc2c1C(=O)c3cc(Br)c(O)c(Br)c3

> <pd_targets>
{PLIN5,CYP2C19,AKR1C1,MAPT,HIF1A,SKA,ENV,RECA,EYA3,CYP2C9,KMT2A,MEN1,MAPK1,USP2,GROES,GROL,GUAB,PLIN1,SLC22A12,HSD17B10,ALD,ABCB11,S1PR1,LMNA,TSHR,CYP1A2,RECQL,ALDH1A1,DNAB,PA,PTPN1,HPGD,CYP2J2,CYP3A4
,NCOR2,PPARG,POLB,EYA2,HSPD1,HSPE1,MAPK14,SLC16A1,SLC22A6,ABCC2,ADORA3,ABCC1,HTR2B,SLC16A7,ABCC4,FFP,BIRC5,CALM1}

> <pathway_gtopdb>
{Enzyme,"Other cytosolic protein","Transcription factor","Surface antigen","Epigenetic regulator","Unclassified protein",Transporter,"Membrane receptor","Other nuclear protein","Cytochrome P450",Oxido
reductase,Kinase,Hydrolase,Reader,Protease,"Electrochemical transporter","Primary active transporter","Family A G protein-coupled receptor",Phosphatase,"Nuclear receptor","Cytochrome P450 family 2",Br
omodomain,"Protein Kinase","Cysteine protease","SLC superfamily of solute carriers","ATP-binding cassette","Small molecule receptor (family A GPCR)","Peptide receptor (family A GPCR)","Cytochrome P450
 family 1","Protein Phosphatase","Metallo protease","Cytochrome P450 family 3","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 2C","CMGC protein kinase group","Cysteine protease CA clan
","SLC22 family of organic cation and anion transporters","ABCB subfamily","Lipid-like ligand receptor (family A GPCR)","Glycohormone receptor","Cytochrome P450 family 1A","Tyrosine protein phosphatas
e","Metallo protease MAE clan","Cytochrome P450 family 3A","Nuclear hormone receptor subfamily 1 group C","SLC16 family of monocarboxylate transporters","ABCC subfamily","Nucleotide-like receptor (fam
ily A GPCR)","Monoamine receptor","Cytochrome P450 2C19","Cytochrome P450 2C9","CMGC protein kinase MAPK family","Cysteine protease C19 family","EDG receptor","Cytochrome P450 1A1","Metallo protease M
1 family","Cytochrome P450 3A4","Nuclear hormone receptor subfamily 1 group C member 3","Adenosine receptor","Serotonin receptor","CMGC protein kinase ERK1","CMGC protein kinase p38 subfamily",Transfe
rase}

> <pathway_chembl>
{Enzymes,Transporters,Receptors,"Cytochrome P450","Kinases (EC 2.7.x.x)","Peptidases and proteinases","SLC superfamily of solute carriers","ATP-binding cassette transporter family","G protein-coupled 
receptors",Phosphatases,"Eicosanoid turnover","CYP2 family: drug metabolising subset","CMGC: Containing CDK",MAPK,GSK3,"CLK families","CA: Cysteine (C) Peptidases","SLC22 family of organic cation and 
anion transporters","ABCB subfamily","Lysophospholipid (S1P) receptors","Glycoprotein hormone receptors","CYP1 family","Protein tyrosine phosphatases non-receptor type (PTPN)","Prostaglandin synthases
","CYP3 family","SLC16 family of monocarboxylate transporters","ABCC subfamily","Adenosine receptors","5-Hydroxytryptamine receptors","Mitogen-activated protein kinases (MAP kinases)","C19: Ubiquitin-
specific protease","Urate transporter","Organic anion transporters (OATs)","ERK subfamily","p38 subfamily","Other protein targets","Inhibitors of apoptosis (IAP) protein family"}

> <pathway_reactome>
{Metabolism,"Neuronal System","Cellular responses to external stimuli","DNA Repair","Immune System","Gene expression (Transcription)","Transport of small molecules","Signal Transduction","Cell Cycle",
Disease,Hemostasis,"Biological oxidations","Metabolism of lipids","Transmission across Chemical Synapses","Cellular responses to stress","DNA Double-Strand Break Repair","Innate Immune System","RNA Po
lymerase II Transcription","SLC-mediated transmembrane transport","Metabolism of amino acids and derivatives","Signaling by GPCR",Mitotic,"Infectious disease","Base Excision Repair","Disorders of tran
smembrane transporters","Platelet activation","signaling and aggregation","Phase I - Functionalization of compounds","Metabolism of steroids","Neurotransmitter receptors and postsynaptic signal transm
ission","Cellular response to hypoxia","DNA Double Strand Break Response","Toll-like Receptor Cascades","Generic Transcription Pathway","Triglyceride metabolism","Transport of bile salts and organic a
cids","metal ions and amine compounds","Branched-chain amino acid catabolism","GPCR ligand binding","M Phase","Leishmania infection","Influenza Infection","Biosynthesis of specialized proresolving med
iators (SPMs)","Resolution of Abasic Sites (AP sites)","SLC transporter disorders","ABC transporter disorders","Fatty acid metabolism","Response to elevated platelet cytosolic Ca2+","Cytochrome P450 -
 arranged by substrate type","Bile acid and bile salt metabolism","Activation of NMDA receptors and postsynaptic events","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Rec
ruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","Toll Like Receptor 5 (TLR5) Cascade","Transcriptional Regulation by TP53","Triglyceride catabol
ism","Organic cation/anion/zwitterion transport","Class A/1 (Rhodopsin-like receptors)","Mitotic Metaphase and Anaphase","Leishmania parasite growth and survival","Ethanol oxidation","Export of Viral 
Ribonucleoproteins from Nucleus","Transcriptional Regulation by MECP2","Biosynthesis of DHA-derived SPMs","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Defective SLC1
6A1 causes symptomatic deficiency in lactate transport (SDLT)","Defective ABCC2 causes DJS","Arachidonic acid metabolism","Platelet degranulation",Xenobiotics,"Synthesis of bile acids and bile salts",
"Post NMDA receptor activation events","MyD88 cascade initiated on plasma membrane","Regulation of TP53 Activity","Organic anion transport","Lysosphingolipid and LPA receptors","Mitotic Anaphase","Ant
i-inflammatory response favouring Leishmania parasite infection","NEP/NS2 Interacts with the Cellular Export Machinery","MECP2 regulates neuronal receptors and channels","Biosynthesis of D-series reso
lvins","Fatty acids","Biosynthesis of maresins","PCNA-Dependent Long Patch Base Excision Repair","Nucleotide-like (purinergic) receptors","Synthesis of Leukotrienes (LT) and Eoxins (EX)","Amine ligand
-binding receptors","CYP2E1 reactions","Synthesis of bile acids and bile salts via 24-hydroxycholesterol","Activation of AMPK downstream of NMDARs","MAP kinase activation","Regulation of TP53 Expressi
on and Degradation","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Aromatic amines
 can be N-hydroxylated or N-dealkylated by CYP1A2","Biosynthesis of maresin-like SPMs","Adenosine P1 receptors","Serotonin receptors","MAPK targets/ Nuclear events mediated by MAP kinases","Regulation
 of TP53 Degradation","Initiation of Nuclear Envelope (NE) Reformation","ERK/MAPK targets","Activation of the AP-1 family of transcription factors","ERKs are inactivated","Separation of Sister Chromat
ids","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","Ras activation upon Ca2+ influx through NMDA receptor"}

> <broad_targets>
{ABCC1}

> <broad_moa>
{"chloride channel blocker"}

> <synonyms>
{benzbromarone,3562-84-3,3562843,Desuric,Benzbromaron,Urinorm,Normurat,Uricovac,Minuric,Exurate,Hipurik,Azubromaron,Narcaricin,"L 2214-Labaz","L 2214Labaz","Uroleap (TN)","MJ 10061","Methanone, (3,5-d
ibromo-4-hydroxyphenyl)(2-ethyl-3-benzofuranyl)-","Methanone, (3,5dibromo4hydroxyphenyl)(2ethyl3benzofuranyl)",3,5-Dibromo-4-,5Dibromo4,T1274,NSC85433,SAM001246877,1505971,Prestw-370,"NSC 85433",Benzb
romarone,CPD000058310,BENZBROMARONE}

> <pdid>
PD000253

> <targets>
{}

> <classes>
{uricosuric}

> <pubchem_cids>
{2333}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 18  0  0  0  0            999 V2000
    5.1887   -6.0105    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    2.5909   -6.0056    0.0000 C   0  0
    3.8883   -6.7578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    5.1937   -3.0093    0.0000 O   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 O   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 12  1  0
 16 17  2  0
 17  9  1  0
M  END
> <name>
NIHCC_2014

> <id>
5837

> <plate>
NGP-105-03

> <well>
F04

> <supplier_cmpd_name>
CPD000449279

> <ctcr_id>
1300

> <supplier_cmpd_id>
SAM001247042

> <smiles>
CC(C)(C)C(O)/C=C/c1ccc2OCOc2c1

> <pd_targets>
{GABRA1,GABRB2,GABRG2,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB3,GABRD,GABRE,GABRG1,GABRG3,GABRP,GABRQ,LDHA,LDHB}

> <pathway_gtopdb>
{"Ion channel",Enzyme,"Ligand-gated ion channel",Oxidoreductase,"GABA-A receptor"}

> <pathway_chembl>
{}

> <pathway_reactome>
{Metabolism,"The citric acid (TCA) cycle and respiratory electron transport","Pyruvate metabolism and Citric Acid (TCA) cycle","Pyruvate metabolism"}

> <broad_targets>
{GABRA3}

> <broad_moa>
{"GABA uptake inhibitor"}

> <synonyms>
{STIRIPENTOL,Diacomit,49763-96-4,49763964,"BCX 2600",BCX-2600,BCX2600,"1-(Benzo(d)(1,3)dioxol-5-yl)-4,4-dimethylpent-1-en-3-ol","1(Benzo(d)(1,3)dioxol5yl)4,4dimethylpent1en3ol",MFCD00869310,"1-(1,3-Be
nzodioxol-5-yl)-4,4-dimethyl-1-penten-3-ol","1(1,3Benzodioxol5yl)4,4dimethyl1penten3ol","4,4-Dimethyl-1-((3,4-methylenedioxy)phenyl)-1-penten-3-ol","4,4Dimethyl1((3,4methylenedioxy)phenyl)1penten3ol",
NCGC0,T4498,SAM001247042,Stiripentol,CPD000449279}

> <pdid>
PD002858

> <targets>
{Cytochrome P450}

> <classes>
{Metabolic Enzyme/Protease}

> <pubchem_cids>
{5311454}

$$$$
NIHCC_2014
  SciTegic11012413002D

  9  9  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 O   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 O   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  3  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  3
  8  9  1  0
  9  2  1  0
M  END
> <name>
NIHCC_2014

> <id>
5838

> <plate>
NGP-105-03

> <well>
F05

> <supplier_cmpd_name>
CPD000059093

> <ctcr_id>
5704

> <supplier_cmpd_id>
SAM001246871

> <smiles>
CC1=C(O)C(=O)C=CO1

> <pd_targets>
{LMNA,KDM4E,FFP}

> <pathway_gtopdb>
{"Other nuclear protein","Epigenetic regulator",Enzyme,Eraser,Transferase,"Lysine demethylase","Jumonji domain-containing"}

> <pathway_chembl>
{Enzymes,"Chromatin modifying enzymes","1.14.11.- Histone demethylases"}

> <pathway_reactome>
{"Cell Cycle",Mitotic,"M Phase","Mitotic Metaphase and Anaphase","Mitotic Anaphase","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{1871,MALTOL,118-71-8,118718,3-Hydroxy-2-methyl-4-pyrone,3Hydroxy2methyl4pyrone,3-Hydroxy-2-methyl-4H-pyran-4-one,3Hydroxy2methyl4Hpyran4one,"Larixinic acid",Talmon,Palatone,Vetol,"Larixic acid","Corp
s praline","4H-Pyran-4-one, 3-hydroxy-2-methyl-","4HPyran4one, 3hydroxy2methyl","2-Methyl pyromeconic acid","2Methyl pyromeconic acid",3-hydroxy-2-methylpyran-4-one,3hydroxy2methylpyran4one,Ve,SAM0012
46871,310025,CPD000059093,"LARIXINIC ACID"}

> <pdid>
PD001958

> <targets>
{Endogenous Metabolite}

> <classes>
{Metabolic Enzyme/Protease}

> <pubchem_cids>
{8369}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 21  0  0  1  0            999 V2000
   10.2003   -3.3752    0.0000 Cl  0  5
    5.1996   -1.4928    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  1  0  0  0
    0.0031   -3.0008    0.0000 C   0  0
   -1.2946   -3.7531    0.0000 O   0  0
    1.3039   -3.7494    0.0000 N   0  0
    1.3070   -5.2502    0.0000 C   0  0
    2.6060   -6.0003    0.0000 C   0  0
    3.9051   -5.2503    0.0000 C   0  0
    2.6061   -7.5003    0.0000 C   0  0
    1.3071   -8.2503    0.0000 C   0  0
    0.0080   -7.5003    0.0000 C   0  0
    0.0080   -6.0003    0.0000 C   0  0
   -1.2911   -5.2504    0.0000 C   0  0
    7.7003   -3.3752    0.0000 H   0  3
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10  5  1  0
 10 11  1  6
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 14  1  0
 20 21  1  0
M  CHG  2   1  -1  22   1
M  END
> <name>
NIHCC_2014

> <id>
5839

> <plate>
NGP-105-03

> <well>
F06

> <supplier_cmpd_name>
CPD000469137

> <ctcr_id>
2795

> <supplier_cmpd_id>
SAM001246524

> <smiles>
[Cl-].CCCN1CCCC[C@H]1C(=O)Nc2c(C)cccc2C.[H+]

> <pd_targets>
{SCN5A,LMNA,KCNK3,SCN10A,SCN11A,SCN1A,SCN2A,SCN3A,SCN4A,SCN7A,SCN8A,SCN9A}

> <pathway_gtopdb>
{"Ion channel","Other nuclear protein","Voltage-gated ion channel","Voltage-gated sodium channel","Potassium channels","Two-pore domain potassium channel"}

> <pathway_chembl>
{"Ion channels","Voltage-gated ion channels","Voltage-gated sodium channels","Potassium channels","Two P domain potassium channels"}

> <pathway_reactome>
{"Developmental Biology","Cell Cycle","Neuronal System","Nervous system development",Mitotic,"Potassium Channels","Axon guidance","M Phase","Tandem pore domain potassium channels","L1CAM interactions"
,"Mitotic Metaphase and Anaphase","TWIK-releated acid-sensitive K+ channel (TASK)","Interaction between L1 and Ankyrins","Mitotic Anaphase","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear En
velope (NE) Reformation"}

> <broad_targets>
{SCN10A}

> <broad_moa>
{"sodium channel blocker"}

> <synonyms>
{"Ropivacaine hydrochloride",98717-15-8,98717158,"98717 15 8",AKOS015918210,"(2S)-N-(2,6-dimethylphenyl)-1-propyl-piperidine-2-carboxamide hydrochloride","(2S)N(2,6dimethylphenyl)1propylpiperidine2car
boxamide hydrochloride","(2S) N (2,6 dimethylphenyl) 1 propyl piperidine 2 carboxamide hydrochloride","ROPIVACAINE HCl",132112-35-7,132112357,"132112 35 7",Naropin,"Ropivacaine monohydrochloride",UNII
-35504LBE2T,UNII35504LBE2T,"UNII 35504LBE2T",Ropivacai,T0386L,T0386,SAM001246524,Ropivacaine,CPD000469137}

> <pdid>
PD010117

> <targets>
{Potassium Channel,Sodium Channel}

> <classes>
{Membrane Transporter/Ion Channel}

> <pubchem_cids>
{46856340,175804,53262295}

$$$$
NIHCC_2014
  SciTegic11012413002D

 19 21  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 Cl  0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.4133   -1.7530    0.0000 N   0  0
   -1.8032   -3.1233    0.0000 C   0  0
   -0.3114   -2.9665    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -3.8813   -1.4408    0.0000 C   0  0  1  0  0  0
   -4.5721   -0.1292    0.0000 C   0  0
   -6.0471   -0.4022    0.0000 C   0  0  2  0  0  0
   -7.1349    0.6306    0.0000 O   0  0
   -6.2433   -1.8893    0.0000 C   0  0  1  0  0  0
   -7.5616   -2.6011    0.0000 C   0  0
   -8.8392   -1.8152    0.0000 O   0  0
   -4.8896   -2.5354    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11  2  1  0
 11  7  2  0
 12  8  1  6
 12 13  1  0
 13 14  1  0
 14 15  1  1
 14 16  1  0
 16 17  1  6
 17 18  1  0
 16 19  1  0
 19 12  1  0
M  END
> <name>
NIHCC_2014

> <id>
5840

> <plate>
NGP-105-03

> <well>
F07

> <supplier_cmpd_name>
CPD000058553

> <ctcr_id>
403

> <supplier_cmpd_id>
SAM001246526

> <smiles>
Nc1nc(Cl)nc2n(cnc12)[C@H]3C[C@H](O)[C@@H](CO)O3

> <pd_targets>
{NR5A1,ADORA2A,ADORA1,LMNA,RXFP1,RORC,HTT,TP53,RRM1,RRM2,RRM2B,POLA1,POLE,POLE2,POLE3,POLE4,PNP,HSF1,ADCY5}

> <pathway_gtopdb>
{"Transcription factor","Membrane receptor","Other nuclear protein","Unclassified protein",Enzyme,"Other cytosolic protein","Nuclear receptor","Family A G protein-coupled receptor",Oxidoreductase,Tran
sferase,"Nuclear hormone receptor subfamily 5","Small molecule receptor (family A GPCR)","Peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1","Nuclear hormone receptor subfamily 5
 group A","Nucleotide-like receptor (family A GPCR)","Relaxin-like peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1 group F","Nuclear hormone receptor subfamily 5 group A member
 1","Adenosine receptor","Relaxin receptor","Nuclear hormone receptor subfamily 1 group F member 3",Lyase}

> <pathway_chembl>
{Receptors,Enzymes,"Nuclear hormone receptors","G protein-coupled receptors","1.17.4.1 Ribonucleoside-diphosphate reductases","2.4.2.1 Purine-nucleoside phosphorylase","5A. Fushi tarazu F1-like recept
ors","Adenosine receptors","Relaxin family peptide receptors","1F. Retinoic acid-related orphans","Cyclic nucleotide turnover/signalling","Adenylyl cyclases (ACs)"}

> <pathway_reactome>
{"Metabolism of proteins",Disease,"Signal Transduction","Cell Cycle","Gene expression (Transcription)",Metabolism,"Cellular responses to external stimuli","Post-translational protein modification","In
fectious disease","Signaling by GPCR",Mitotic,"RNA Polymerase II Transcription","Cell Cycle Checkpoints","Metabolism of nucleotides","Cellular responses to stress",SUMOylation,"Leishmania infection","
GPCR ligand binding","M Phase","Generic Transcription Pathway","G1/S DNA Damage Checkpoints","Interconversion of nucleotide di- and triphosphates","Mitotic G1 phase and G1/S transition","Nucleobase ca
tabolism","Cellular response to heat stress","SUMO E3 ligases SUMOylate target proteins","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Mitotic Metaphase and Anaphas
e","Transcriptional regulation by RUNX3","Transcriptional Regulation by MECP2","p53-Dependent G1/S DNA damage checkpoint","G1/S Transition","Transcriptional Regulation by TP53","Purine catabolism","HS
F1-dependent transactivation","SUMOylation of intracellular receptors","Anti-inflammatory response favouring Leishmania parasite infection","Nucleotide-like (purinergic) receptors","Mitotic Anaphase",
"RUNX3 Regulates Immune Response and Cell Migration","Regulation of MECP2 expression and activity","p53-Dependent G1 DNA Damage Response","G1/S-Specific Transcription","TP53 Regulates Metabolic Genes"
,"E2F mediated regulation of DNA replication","Activation of the pre-replicative complex","Attenuation phase","ADORA2B mediated anti-inflammatory cytokines production","Adenosine P1 receptors","Nuclea
r Envelope (NE) Reassembly","Stabilization of p53","Inhibition of replication initiation of damaged DNA by RB1/E2F1","Initiation of Nuclear Envelope (NE) Reformation","Autodegradation of the E3 ubiqui
tin ligase COP1","Neuronal System","Transmission across Chemical Synapses","Neurotransmitter receptors and postsynaptic signal transmission","GABA receptor activation","GABA B receptor activation","Ac
tivation of GABAB receptors","Adenylate cyclase inhibitory pathway"}

> <broad_targets>
{ADA,PNP,POLA1,POLE,POLE2,POLE3,POLE4,RRM1,RRM2,RRM2B}

> <broad_moa>
{"adenosine deaminase inhibitor","ribonucleotide reductase inhibitor"}

> <synonyms>
{Cladribine,2-Chloro-2'-deoxyadenosine,2Chloro2'deoxyadenosine,4291-63-8,4291638,Leustatin,2-Chlorodeoxyadenosine,2Chlorodeoxyadenosine,2-CdA,2CdA,Chlorodeoxyadenosine,CldAdo,"ADENOSINE, 2-CHLORO-2'-D
EOXY-","ADENOSINE, 2CHLORO2'DEOXY",Litak,2-Chloro-2'-deoxy-beta-adenosine,2Chloro2'deoxybetaadenosine,Cladaribine,"RWJ 26251",2-chloro-deoxyadenosine,2chlorodeoxyadenosine,2ClAdo,UNI,T2558,SAM00124652
6,Prestw-1484,CPD000058553}

> <pdid>
PD003181

> <targets>
{Adenosine Deaminase,Apoptosis}

> <classes>
{Apoptosis,Metabolic Enzyme/Protease}

> <pubchem_cids>
{20279}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 33  0  0  0  0            999 V2000
    6.4451   -1.8434    0.0000 C   0  0
    4.9531   -1.9978    0.0000 C   0  0
    4.2010   -3.2956    0.0000 C   0  0
    2.7343   -2.9815    0.0000 N   0  0
    2.5987   -1.5004    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 Cl  0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 Cl  0  0
    3.9511   -0.8815    0.0000 C   0  0
    4.2567    0.5878    0.0000 C   0  0
    3.2235    1.6679    0.0000 C   0  0
    3.6446    3.1076    0.0000 C   0  0
    5.1019    3.4627    0.0000 C   0  0
    5.5231    4.9024    0.0000 I   0  0
    6.1382    2.3782    0.0000 C   0  0
    5.7171    0.9385    0.0000 C   0  0
    4.8054   -4.6666    0.0000 C   0  0
    6.2966   -4.8284    0.0000 O   0  0
    3.9195   -5.8781    0.0000 N   0  0
    4.5250   -7.2514    0.0000 N   0  0
    3.6414   -8.4636    0.0000 C   0  0
    4.2492   -9.8349    0.0000 C   0  0
    5.7408   -9.9941    0.0000 C   0  0
    6.6244   -8.7820    0.0000 C   0  0
    6.0165   -7.4107    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12  6  1  0
 12 13  1  0
  5 14  1  0
 14  2  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 21 15  1  0
  3 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 25  1  0
M  END
> <name>
NIHCC_2014

> <id>
5841

> <plate>
NGP-105-03

> <well>
F08

> <supplier_cmpd_name>
CPD000466284

> <ctcr_id>
2683

> <supplier_cmpd_id>
SAM001247081

> <smiles>
Cc1c(nn(c2ccc(Cl)cc2Cl)c1c3ccc(I)cc3)C(=O)NN4CCCCC4

> <pd_targets>
{GPR18,CNR1,CNR2,CYP1A2,LMNA,CYP2D6,CYP2C9,MAPT,CYP2C19,GPR55,NPSR1,CYP3A4,GSP1,KCNH2,FABP1,GSP2,ABCC4,ABCB11,ABCC1,ACHE}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Other nuclear protein","Other cytosolic protein","Family A G protein-coupled receptor","Cytochrome P450","Small molecule receptor (family A GPCR)","Cytochrome P450 family 
1","Cytochrome P450 family 2","Peptide receptor (family A GPCR)","Cytochrome P450 family 3","Lipid-like ligand receptor (family A GPCR)","Cytochrome P450 family 1A","Cytochrome P450 family 2D","Cytoch
rome P450 family 2C","Short peptide receptor (family A GPCR)","Cytochrome P450 family 3A","Cannabinoid receptor","Cytochrome P450 1A1","Cytochrome P450 2D6","Cytochrome P450 2C9","Cytochrome P450 2C19
","Lysophosphatidylinositol receptor","Neuropeptide receptor","Cytochrome P450 3A4","Ion channel","Auxiliary transport protein",Transporter,"Voltage-gated ion channel","Fatty acid binding protein fami
ly","Primary active transporter",Hydrolase,"Potassium channels","ATP-binding cassette","Voltage-gated potassium channel","ABCC subfamily","ABCB subfamily"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Cytochrome P450","Orphan and other 7TM receptors","Cannabinoid receptors","CYP1 family","CYP2 family: drug metabolising subset","Neuropeptide S recept
or","CYP3 family","Class A Orphans","Ion channels","Other protein targets",Transporters,"Voltage-gated ion channels","Fatty acid-binding proteins","ATP-binding cassette transporter family","Acetylchol
ine turnover","Potassium channels","ABCC subfamily","ABCB subfamily","Voltage-gated potassium channels"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,"Cell Cycle","Neuronal System",Disease,"Signaling by GPCR","Biological oxidations",Mitotic,"Transmission across Chemical Synapses","Infectious disease","Metabolism of
 lipids","GPCR downstream signalling","Phase I - Functionalization of compounds","M Phase","Neurotransmitter receptors and postsynaptic signal transmission","Leishmania infection","Biosynthesis of spe
cialized proresolving mediators (SPMs)","G alpha (i) signalling events","Cytochrome P450 - arranged by substrate type","Mitotic Metaphase and Anaphase","Activation of NMDA receptors and postsynaptic e
vents","Leishmania parasite growth and survival","Biosynthesis of DHA-derived SPMs",Xenobiotics,"Mitotic Anaphase","Post NMDA receptor activation events","Anti-inflammatory response favouring Leishman
ia parasite infection","Biosynthesis of maresins","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Nuclear Envelope (NE) Reassembly","CYP2E1 reactions","Activation of AMPK downstrea
m of NMDARs","ADORA2B mediated anti-inflammatory cytokines production","Biosynthesis of maresin-like SPMs","Initiation of Nuclear Envelope (NE) Reformation","Muscle contraction",Hemostasis,"Cardiac co
nduction","Platelet activation","signaling and aggregation","Phase 3 - rapid repolarisation","Regulation of lipid metabolism by PPARalpha","Response to elevated platelet cytosolic Ca2+","Metabolism of
 steroids","Fatty acid metabolism","Phospholipid metabolism","PPARA activates gene expression","Platelet degranulation","Bile acid and bile salt metabolism","Arachidonic acid metabolism","Glycerophosp
holipid biosynthesis","Synthesis of bile acids and bile salts","Synthesis of Leukotrienes (LT) and Eoxins (EX)","Synthesis of PC","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"
}

> <broad_targets>
{CNR1,GPR55}

> <broad_moa>
{"cannabinoid receptor antagonist"}

> <synonyms>
{AM251,183232-66-8,183232668,AM-251,"AM 251",UNII-3I4FA44MAI,UNII3I4FA44MAI,3I4FA44MAI,C22H21Cl2IN4O,CHEMBL285932,CHEBI:90724,MFCD01861181,SMR000466284,SR-01000597360,SR01000597360,"AM 251 (pharmaceut
ical)",Tocris-1117,Tocris1117,CPD000466284,CBiol_001833,CBiol001833,CBiol-001833,"CBiol 001833",BSPBio_001525,BSPBio001525,BSPBio-001525,"BSPBio 001525",KBioGR_000245,KBioGR000245,KBioGR-000245,"KBioG
R 000245",KBioSS_00,KBioSS00,KBioSS-00,"KBioSS 00",S2819,SAM001247081}

> <pdid>
PD003150

> <targets>
{"Cannabinoid Receptor"}

> <classes>
{"GPCR & G Protein"}

> <pubchem_cids>
{2125}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 23  0  0  1  0            999 V2000
   -0.7603   -8.0518    0.0000 C   0  0
   -1.2256   -6.6258    0.0000 N   0  0
   -2.6933   -6.3162    0.0000 C   0  0
   -0.2234   -5.5086    0.0000 C   0  0
   -0.6890   -4.0818    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0  1  0  0  0
   -5.2526    1.3618    0.0000 C   0  0
   -6.2524    0.2436    0.0000 O   0  0
   -5.4979   -1.0529    0.0000 C   0  0
   -6.1032   -2.4253    0.0000 O   0  0
   -4.0317   -0.7359    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 14 13  1  6
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 14  1  0
 12 20  1  0
 20 21  2  0
 21  6  1  0
 21  9  1  0
M  END
> <name>
NIHCC_2014

> <id>
5842

> <plate>
NGP-105-03

> <well>
F09

> <supplier_cmpd_name>
CPD000449310

> <ctcr_id>
3086

> <supplier_cmpd_id>
SAM001246841

> <smiles>
CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12

> <pd_targets>
{HTR1E,HTR1F,HTR1A,HTR1D,HTR1B,ADRA2A,ADRA2B,ADRA2C,DRD2,HTR7,HTR2A,HTR2B,KMT2A}

> <pathway_gtopdb>
{"Membrane receptor","Epigenetic regulator","Family A G protein-coupled receptor",Reader,"Small molecule receptor (family A GPCR)",Bromodomain,"Monoamine receptor","Serotonin receptor","Adrenergic rec
eptor","Dopamine receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Chromatin modifying enzymes","5-Hydroxytryptamine receptors","Dopamine receptors","2.1.1.43 Histone methyltransferases (HMTs)"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Gene expression (Transcription)","Signaling by GPCR","Infectious disease","RNA Polymerase II Transcription","GPCR ligand binding","Leishmania infection","Generic Transc
ription Pathway","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","Transcriptional regulation by RUNX1","Amine ligand-binding receptors","Anti-inflammatory response fav
ouring Leishmania parasite infection","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","Serotonin receptors","ADORA2B mediated anti-inflammatory cytokines produc
tion","Dopamine receptors"}

> <broad_targets>
{HTR1A,HTR1B,HTR1D,HTR1E,HTR1F}

> <broad_moa>
{"serotonin receptor agonist"}

> <synonyms>
{zolmitriptan,139264-17-8,139264178,Zomig,Zomigoro,Zomigon,Flezol,311C90,Zomig-ZMT,ZomigZMT,C16H21N3O2,UNII-2FS66TH3YW,UNII2FS66TH3YW,(S)-4-(3-(2-Dimethylamino-ethyl)-1H-indol-5-ylmethyl)-oxazolidin-2
-one,(S)4(3(2Dimethylaminoethyl)1Hindol5ylmethyl)oxazolidin2one,"Zolmitriptan (Zomig)",(S)-4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl),(S)4((3(2(dimethylamino)ethyl)1Hindol5yl),T1092,S1649,SAM001246
841,1505281,Zolmitriptan,Zolmitriptan,CPD000449310,ZOLMITRIPTAN}

> <pdid>
PD000525

> <targets>
{Others}

> <classes>
{"Neuronal Signaling",antimigraine,"5HT[1B/1D] agonist"}

> <pubchem_cids>
{60857}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 27  0  0  0  0            999 V2000
    6.4897   -5.2632    0.0000 O   0  0
    5.1894   -6.0109    0.0000 C   0  0
    5.1873   -7.5109    0.0000 O   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 N   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 N   0  0
   -3.8990    0.7455    0.0000 N   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.4994    0.7432    0.0000 C   0  0
   -7.7985    1.4932    0.0000 C   0  0
   -7.7985    2.9932    0.0000 C   0  0
   -9.0976    3.7432    0.0000 O   0  0
   -6.4995    3.7432    0.0000 C   0  0
   -5.2004    2.9933    0.0000 C   0  0
   -6.4965    5.2441    0.0000 C   0  0
   -7.7942    5.9963    0.0000 O   0  0
   -5.1964    5.9922    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 12 15  1  0
 15 16  2  3
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 20 22  1  0
 22 23  2  0
 23 17  1  0
 22 24  1  0
 24 25  1  0
 24 26  2  0
M  END
> <name>
NIHCC_2014

> <id>
5843

> <plate>
NGP-105-03

> <well>
F10

> <supplier_cmpd_name>
CPD000469221

> <ctcr_id>
225

> <supplier_cmpd_id>
SAM001246804

> <smiles>
OC(=O)CCNC(=O)c1ccc(cc1)N=Nc2ccc(O)c(c2)C(O)=O

> <pd_targets>
{TDP1,ALOX5,PPARG,PTGS1,PTGS2}

> <pathway_gtopdb>
{Enzyme,"Transcription factor",Hydrolase,Oxidoreductase,"Nuclear receptor","Nuclear hormone receptor subfamily 1","Nuclear hormone receptor subfamily 1 group C","Nuclear hormone receptor subfamily 1 g
roup C member 3"}

> <pathway_chembl>
{Enzymes,Receptors,"Eicosanoid turnover","Nuclear hormone receptors",Lipoxygenases,"1C. Peroxisome proliferator-activated receptors",Cyclooxygenase}

> <pathway_reactome>
{"DNA Repair",Metabolism,"Gene expression (Transcription)","DNA Double-Strand Break Repair","Metabolism of lipids","RNA Polymerase II Transcription","Nonhomologous End-Joining (NHEJ)","Biosynthesis of
 specialized proresolving mediators (SPMs)","Generic Transcription Pathway","Fatty acid metabolism","Biosynthesis of DPA-derived SPMs","Transcriptional Regulation by MECP2","Arachidonic acid metabolis
m","Biosynthesis of DPAn-3 SPMs","MECP2 regulates transcription factors","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","Biosynthesis of DPAn-3-derived 13-series resolvins"}

> <broad_targets>
{ALOX5,PPARG,PTGS1,PTGS2}

> <broad_moa>
{"cyclooxygenase inhibitor"}

> <synonyms>
{BALSALAZIDE,80573-04-2,80573042,Balsalazido,Balsalazida,Balsalazidum,"Balsalazidum (Latin)","Balsalazida (Spanish)","Balsalazido (Spanish)","Balsalazide Disodium","(E)-5-((4-((2-Carboxyethyl)carbamoy
l)phenyl)diazenyl)-2-hydroxybenzoic acid","(E)5((4((2Carboxyethyl)carbamoyl)phenyl)diazenyl)2hydroxybenzoic acid",UNII-P80AL,UNIIP80AL,SAM001246804,CPD000469221}

> <pdid>
PD003136

> <targets>
{Interleukin Related,STAT}

> <classes>
{Immunology/Inflammation,JAK/STAT Signaling,Stem Cell/Wnt}

> <pubchem_cids>
{54585}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 26  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -1.2991    5.2500    0.0000 O   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0  1  0  0  0
   -2.1131   -4.3307    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0  1  0  0  0
    1.0957   -4.0166    0.0000 C   0  0
    0.4768   -5.3829    0.0000 C   0  0
   -1.0139   -5.2166    0.0000 C   0  0  2  0  0  0
   -1.9863   -4.9830    0.0000 O   0  0
   -0.5505   -6.6303    0.0000 C   0  0
   -0.1053   -8.0627    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  2  3
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10  4  1  0
  5 11  1  0
 11 12  1  6
 12 13  1  0
 13 14  1  0
 14 15  1  6
 14 16  1  0
 16 17  1  6
 17 18  1  0
 18 19  1  0
 19 14  1  0
 19 20  1  6
 19 21  1  0
 21 22  3  0
 23 16  1  1
 23  2  1  0
 23 11  1  0
M  END
> <name>
NIHCC_2014

> <id>
5844

> <plate>
NGP-105-03

> <well>
F11

> <supplier_cmpd_name>
CPD000469219

> <ctcr_id>
1957

> <supplier_cmpd_id>
SAM001246801

> <smiles>
C[C@@H]1CC2=C(CCC(=O)C2)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@H]13

> <pd_targets>
{PGR,AR,ESR1,SLC6A4,CYP2C19}

> <pathway_gtopdb>
{"Transcription factor",Transporter,Enzyme,"Nuclear receptor","Electrochemical transporter","Cytochrome P450","Nuclear hormone receptor subfamily 3","SLC superfamily of solute carriers","Cytochrome P4
50 family 2","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 3 group A","SLC06 neurotransmitter transporter family","Cytochrome P450 family 2C","Nuclear hormone rece
ptor subfamily 3 group C member 3","Nuclear hormone receptor subfamily 3 group C member 4","Nuclear hormone receptor subfamily 3 group A member 1","Cytochrome P450 2C19"}

> <pathway_chembl>
{Receptors,Transporters,Enzymes,"Nuclear hormone receptors","SLC superfamily of solute carriers","Cytochrome P450","Steroid hormone receptors","SLC6 neurotransmitter transporter family","CYP2 family: 
drug metabolising subset","3C. 3-Ketosteroid receptors","3A. Estrogen receptors","Monoamine transporter subfamily"}

> <pathway_reactome>
{"Gene expression (Transcription)","Neuronal System",Metabolism,"RNA Polymerase II Transcription","Transmission across Chemical Synapses","Biological oxidations","Generic Transcription Pathway","Neuro
transmitter clearance","Phase I - Functionalization of compounds","Transcriptional regulation by RUNX2","Transcriptional regulation by RUNX1","Serotonin clearance from the synaptic cleft","Cytochrome 
P450 - arranged by substrate type","RUNX2 regulates bone development","RUNX1 regulates estrogen receptor mediated transcription",Xenobiotics,"RUNX2 regulates osteoblast differentiation","CYP2E1 reacti
ons"}

> <broad_targets>
{ESR1}

> <broad_moa>
{"androgen receptor agonist","estrogen receptor agonist","progesterone receptor agonist"}

> <synonyms>
{tibolone,5630-53-5,5630535,Liviella,Livial,Tibolona,Tibolonum,Xyvion,"Org OD 14",Boltin,UNII-FF9X0205V2,UNIIFF9X0205V2,17-Hydroxy-7alpha-methyl-19-nor-17alpha-pregn-5(10)-en-20-yn-3-one,17Hydroxy7alp
hamethyl19nor17alphapregn5(10)en20yn3one,CHEBI:32223,FF9X0205V2,DSSTox_CID_3667,DSSToxCID3667,DSSTox-CID-3667,"DSSTox CID 3667",(7alpha,17alpha)-17-hydroxy-7-methyl-19-nor,17alpha)17hydroxy7methyl19no
r,T4549,SAM001246801,Prestw-1181,Tibolone,CPD000469219}

> <pdid>
PD001672

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{444008}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 26  0  0  0  0            999 V2000
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 N   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 C   0  0
   -3.1884   -2.6409    0.0000 C   0  0
   -4.6234   -3.0602    0.0000 C   0  0
   -4.9781   -4.5176    0.0000 C   0  0
   -3.8933   -5.5536    0.0000 N   0  0
   -2.4537   -5.1320    0.0000 C   0  0
   -2.0990   -3.6745    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    6.3972   -0.1518    0.0000 O   0  0
    6.3972   -1.6518    0.0000 C   0  0
    5.0980   -2.4014    0.0000 O   0  0
    7.6972   -2.4018    0.0000 C   0  0
    8.9972   -1.6518    0.0000 C   0  0
   10.2972   -2.4018    0.0000 C   0  0
   10.2972   -3.9018    0.0000 O   0  0
   11.5965   -1.6522    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  3
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 10  1  0
  9 16  1  0
 16  6  1  0
 16 17  2  0
 17  3  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  2  0
M  END
> <name>
NIHCC_2014

> <id>
5845

> <plate>
NGP-105-03

> <well>
G02

> <supplier_cmpd_name>
CPD000466294

> <ctcr_id>
1697

> <supplier_cmpd_id>
SAM001247095

> <smiles>
COc1ccc2[nH]cc(C3=CCNCC3)c2c1.OC(=O)CCC(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{UNIIRKG24J8KJR,"UNII RKG24J8KJR",RKG24J8KJR,SMR000466294,MLS001424154,ACMC-20c9db,ACMC20c9db,"ACMC 20c9db",MLS000758988,DTXSID40995628,HMS2052M03,HMS3394M03,BCP08976,MFCD31540074,AKOS015962510,CCG-10
1077,CCG101077,"CCG 101077",NC00327,"5,6-Dimethyl-2-(pyridin-4-yl)-2,3-dihydro-1H-benzo(d)imidazole","5,6Dimethyl2(pyridin4yl)2,3dihydro1Hbenzo(d)imidazole","5,6 Dimethyl 2 (pyridin 4 yl) 2,3 dihydro 
1H benzo(d)imidazole",5-methox,5methox,"5 methox",T2289,SAM001247095,"RU 24969 hemisuccinate",CPD000466294}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{108028}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 31  0  0  0  0            999 V2000
    5.1873   -7.5109    0.0000 C   0  0
    5.1894   -6.0109    0.0000 O   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 O   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5987    1.5004    0.0000 C   0  0
    3.8991    0.7525    0.0000 C   0  0
    5.1969    1.5046    0.0000 C   0  0
    5.1945    3.0046    0.0000 C   0  0
    3.8943    3.7525    0.0000 C   0  0
    2.5964    3.0004    0.0000 C   0  0
    3.8888    5.2533    0.0000 N   0  3
    5.1853    6.0077    0.0000 O   0  5
    2.5875    5.9994    0.0000 O   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
   -0.0031    3.0008    0.0000 C   0  0
    1.2946    3.7531    0.0000 O   0  0
   -1.3039    3.7494    0.0000 O   0  0
   -1.3070    5.2502    0.0000 C   0  0
   -2.6071    5.9984    0.0000 C   0  0
   -0.0093    6.0025    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 14 16  1  0
 16 17  1  0
 16 18  2  0
  9 19  1  0
 19 20  2  3
 20 21  1  0
 20 22  1  0
 22 23  2  3
 23  8  1  0
 23 24  1  0
 19 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 28 30  1  0
M  CHG  2  16   1  17  -1
M  END
> <name>
NIHCC_2014

> <id>
5846

> <plate>
NGP-105-03

> <well>
G03

> <supplier_cmpd_name>
CPD000058300

> <ctcr_id>
428

> <supplier_cmpd_id>
SAM001246890

> <smiles>
COCCOC(/O)=C1/C(c2cccc(c2)[N+]([O-])=O)C(=C(C)N=C1C)C(=O)OC(C)C

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{66085-59-4,Nimotop,Periplum,Nimodipino,"BAY e 9736",Nimodipinum,Admon,"Nimodipinum (INN-Latin)","Nimodipino (INN-Spanish)","Bay-E 9736",Bay-e-9736,Nimodipine-d7,CHEBI:7575,"Nimodipine (Nimotop)",C21H
26N2O7,MLS000863294,Nymalize,MFCD00153848,NCGC00015714-09,SMR000058300,DSSTox_CID_3370,DSSTox_RID_76998,DSSTox_GSID_23370,NimoGel,DRG-0139,Nimotop(TM),1246815-36-0,SR-01000075335,"NIMOTOP (TN)","EINEC
S 266-127-0","BRN 0459792",NimoVent,"Nimodipime,(S)","Nimodipine (USAN:USP:INN:BAN)","Nymalize (TN)",CAS-66085-59-4,EG-1961,Opera_ID_14,PubChem16211,Spectrum_001880,SpecPlus_000716,"Nimodipine (USP/IN
N)",Prestwick0_000918,Prestwick1_000918,Prestwick2_000918,Prestwick3_000918,Spectrum2_001562,Spectrum3_000766,Spectrum4_000791,Spectrum5_001687,N-149,CBiol_001832,Lopac0_000891,SCHEMBL34041,BSPBio_000
796,BSPBio_001397,BSPBio_002412,KBioGR_000117,KBioGR_001262,KBioSS_000117,KBioSS_002408,MLS000069381,MLS001076550,MLS001424155,MLS002154061,MLS002172461,MLS003899190,DivK1c_006812,SPECTRUM1503600,SPBi
o_001464,SPBio_002985,BPBio1_000876,GTPL2523,CHEMBL3197349,DTXSID5023370,SCHEMBL22882841,KBio1_001756,KBio2_000117,KBio2_002403,KBio2_002685,KBio2_004971,KBio2_005253,KBio2_007539,KBio3_000233,KBio3_0
00234,KBio3_001632,"3-isopropyl 5-(2-methoxyethyl)",BRD8407,Bio1_000118,Bio1_000607,Bio1_001096,Bio2_000117,Bio2_000597,HMS1361F19,HMS1570H18,HMS1791F19,HMS1922E04,HMS1989F19,HMS2052M05,HMS2089H13,HMS
2093G11,HMS2097H18,HMS2234B05,HMS3262D04,HMS3266O22,HMS3369G07,HMS3394M05,HMS3402F19,HMS3411I12,HMS3657I03,HMS3675I12,HMS3714H18,Pharmakon1600-01503600,"3,5-pyridinecarboxylic acid 2-methoxyethyl 1-me
thylethyl ester",ACT02628,ALBB-015317,AMY40399,BCP21152,BRD-8407,HY-B0265,"2,6-dimethyl-4-(3-nitrophenyl)-","Nimotop|||Admon|||BAY-e 9736",Tox21_110202,Tox21_500891,BBL028286,BDBM50101971,CA-211,CCG-3
9340,NSC758476,s1747,STK642934,AKOS005174934,AKOS015852459,"Nimodipine - CAS 66085-59-4",Tox21_110202_1,AC-8484,CCG-101085,DB00393,KS-1304,LP00891,MCULE-4717687158,NC00335,NSC-758476,SDCCGSBI-0050866.
P004,IDI1_033867,NCGC00015714-04,NCGC00015714-05,NCGC00015714-06,NCGC00015714-07,NCGC00015714-08,NCGC00015714-10,NCGC00015714-11,NCGC00015714-12,NCGC00015714-13,NCGC00015714-16,NCGC00015714-28,NCGC000
21456-02,NCGC00024675-02,NCGC00024675-03,NCGC00024675-04,NCGC00024675-05,NCGC00024675-06,NCGC00024675-07,NCGC00024675-08,NCGC00024675-09,NCGC00261576-01,SMR002530605,ST082783,SBI-0050866.P003,AB001234
6,AB00513963,EU-0100891,FT-0602600,N0896,R2304,SW219238-1,C07267,D00438,"1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-",AB00053314-03,AB00053314-04,AB00053314_05,AB00053314_06,085N594,Q421429,SR-0100007
5335-1,SR-01000075335-2,SR-01000075335-4,SR-01000075335-5,SR-01000075335-7,BRD-A58048407-001-06-3,BRD-A58048407-001-09-7,"BAY E 9736 pound>> BAY-E-9736 pound>> BAYE97","Nimodipine, British Pharmacopoe
ia (BP) Reference Standard","Nimodipine, European Pharmacopoeia (EP) Reference Standard","Nimodipine, United States Pharmacopeia (USP) Reference Standard","Nimodipine, Pharmaceutical Secondary Standar
d; Certified Reference Material",SAM001246890,CPD000058300}

> <pdid>
PD003072

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{4497}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 26  0  0  0  0            999 V2000
    7.5844   -1.4920    0.0000 C   0  0
    6.1069   -1.2335    0.0000 N   0  0
    5.5920    0.1754    0.0000 C   0  0
    4.1145    0.4339    0.0000 C   0  0
    3.1484   -0.7186    0.0000 N   0  0
    3.6667   -2.1252    0.0000 C   0  0
    5.1442   -2.3838    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 N   0  0
    0.0000    1.7286    0.0000 C   0  0
    0.1115    3.2255    0.0000 C   0  0
   -1.1278    4.0705    0.0000 C   0  0
   -1.0157    5.5663    0.0000 F   0  0
   -2.4793    3.4196    0.0000 C   0  0
   -2.5914    1.9238    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  2  1  0
  5  8  1  0
  8  9  2  3
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 15 16  2  0
 16 10  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23  8  1  0
 23 18  1  0
M  END
> <name>
NIHCC_2014

> <id>
5847

> <plate>
NGP-105-03

> <well>
G04

> <supplier_cmpd_name>
CPD000449303

> <ctcr_id>
3793

> <supplier_cmpd_id>
SAM001247034

> <smiles>
CN1CCN(CC1)C2=Nc3cc(F)ccc3Cc4ccccc24

> <pd_targets>
{CHRM2,CHRM5,HTR6,HTR2A,DRD2,DRD4,HTR7,CHRM4,CHRM3,DRD5,DRD3,HTR2C,HTR2B,CHRM1,MAPK1}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Family A G protein-coupled receptor",Kinase,"Small molecule receptor (family A GPCR)","Protein Kinase","Monoamine receptor","CMGC protein kinase group","Acetylcholine rece
ptor","Serotonin receptor","Dopamine receptor","CMGC protein kinase MAPK family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Kinases (EC 2.7.x.x)","Acetylcholine receptors (muscarinic)","5-Hydroxytryptamine receptors","Dopamine receptors","CMGC: Containing CDK",MAPK,GSK3,"CL
K families","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Immune System","Signaling by GPCR","Infectious disease","Innate Immune System","GPCR ligand binding","Leishmania infection","Toll-like Receptor Cascades","Class A/1 (Rh
odopsin-like receptors)","Leishmania parasite growth and survival","Toll Like Receptor 5 (TLR5) Cascade","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infe
ction","MyD88 cascade initiated on plasma membrane","Muscarinic acetylcholine receptors","ADORA2B mediated anti-inflammatory cytokines production","Serotonin receptors","Dopamine receptors","MAP kinas
e activation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{FLUPERLAPINE,67121-76-0,67121760,Fluperlapina,Fluperlapinum,"Fluperlapinum (INN-Latin)","Fluperlapinum (INNLatin)","Fluperlapina (INN-Spanish)","Fluperlapina (INNSpanish)",UNII-EWG253M961,UNIIEWG253M
961,3-fluoro-6-(4-methylpiperazin-1-yl)-11H-benzo(c)(1)benzazepine,3fluoro6(4methylpiperazin1yl)11Hbenzo(c)(1)benzazepine,CHEMBL63756,CHEBI:5122,C10967,EWG253M961,3-Fluoro-6-(4-,3Fluoro6(4,SAM00124703
4,CPD000449303}

> <pdid>
PD002990

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{49381}

$$$$
NIHCC_2014
  SciTegic11012413002D

 10 11  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 C   0  0
   -3.6065    0.0000    0.0000 N   0  0
   -2.7248   -1.2135    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9  5  1  0
  9 10  2  0
 10  2  1  0
M  END
> <name>
NIHCC_2014

> <id>
5848

> <plate>
NGP-105-03

> <well>
G05

> <supplier_cmpd_name>
CPD000059077

> <ctcr_id>
3705

> <supplier_cmpd_id>
SAM001246854

> <smiles>
Nc1ccc2cn[nH]c2c1

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{6-Aminoindazole,6Aminoindazole,1H-Indazol-6-amine,1HIndazol6amine,6967-12-0,6967120,6-Amino-1H-indazole,6Amino1Hindazole,2h-indazol-6-amine,2hindazol6amine,6-amino-indazole,6aminoindazole,1H-indazol-
6-ylamine,1Hindazol6ylamine,6-Aminoimidazole,6Aminoimidazole,6343-52-8,6343528,1H-indazole-6-ylamine,1Hindazole6ylamine,UNII-KN72RH56SR,UNIIKN72RH56SR,KN72RH56SR,MLS000069415,CHEMBL594707,MFCD00005696
,Indaz,SAM001246854,CPD000059077}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{81423}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 23  0  0  0  0            999 V2000
    2.5983   -3.0004    0.0000 C   0  0
    2.5988   -1.5004    0.0000 C   0  0
    3.8975   -2.2510    0.0000 C   0  0
    3.8990   -0.7508    0.0000 C   0  0
    5.1985   -0.0016    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -0.0031    3.0008    0.0000 C   0  0
   -1.3039    3.7494    0.0000 N   0  0
   -1.4470    5.2297    0.0000 C   0  0
   -2.9153    5.5365    0.0000 N   0  0
   -3.6607    4.2349    0.0000 C   0  0
   -2.6532    3.1236    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5988   -1.5004    0.0000 C   0  0
   -2.5983   -3.0004    0.0000 C   0  0
   -3.8975   -2.2510    0.0000 C   0  0
   -3.8990   -0.7508    0.0000 C   0  0
   -5.1985   -0.0017    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  3  0
  2  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 10  1  0
  8 15  2  0
 15 16  1  0
 16 17  2  0
 17  6  1  0
 16 18  1  0
 18 19  1  0
 18 20  1  0
 18 21  1  0
 21 22  3  0
M  END
> <name>
NIHCC_2014

> <id>
5849

> <plate>
NGP-105-03

> <well>
G06

> <supplier_cmpd_name>
CPD000466301

> <ctcr_id>
4554

> <supplier_cmpd_id>
SAM001246525

> <smiles>
CC(C)(C#N)c1cc(Cn2cncn2)cc(c1)C(C)(C)C#N

> <pd_targets>
{CYP19A1,UGT1A4}

> <pathway_gtopdb>
{Enzyme,"Cytochrome P450",Transferase,"Cytochrome P450 family 19","Cytochrome P450 family 19A","Cytochrome P450 19A1"}

> <pathway_chembl>
{Enzymes,"Cytochrome P450",CYP11,CYP17,CYP19,"CYP20 and CYP21 families"}

> <pathway_reactome>
{Metabolism,Disease,"Biological oxidations","Diseases of metabolism","Phase I - Functionalization of compounds","Metabolic disorders of biological oxidation enzymes","Cytochrome P450 - arranged by sub
strate type","Defective UGT1A4 causes hyperbilirubinemia","Endogenous sterols"}

> <broad_targets>
{CYP19A1}

> <broad_moa>
{"aromatase inhibitor"}

> <synonyms>
{anastrozole,120511-73-1,120511731,Arimidex,anastrazole,Anastrozol,ZD1033,ZD-1033,"ICI D1033",UNII-2Z07MYW1AZ,UNII2Z07MYW1AZ,ICI-D1033,ICID1033,2Z07MYW1AZ,CHEMBL1399,CHEBI:2704,"Anastrozole, 98",NSC71
9344,NCGC00164619-01,NCGC0016461901,Asiolex,DSSTox_CID_2607,DSSToxCID2607,DSSTox-CID-2607,"DSSTox CID 2607",DSSTox_RID_76656,DSSToxRID76656,DSSTox-RID-76656,"DSSTox RID 76656",DSSTox_GSID_226,DSSToxGS
ID226,DSSTox-GSID-226,"DSSTox GSID 226",T0393,719344,SAM001246525,Prestw-1222,"NSC 719344",Anastrozole,CPD000466301}

> <pdid>
PD003143

> <targets>
{}

> <classes>
{"Aromatase Inhibitor"}

> <pubchem_cids>
{2187}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 26  0  0  1  0            999 V2000
   12.6008    1.2633    0.0000 Cl  0  0
   -0.4790    3.2447    0.0000 C   0  0
   -0.4497    1.7450    0.0000 N   0  0
    0.0899   -0.9624    0.0000 C   0  0  2  0  0  0
   -1.2593   -1.0074    0.0000 C   0  0
   -2.2487   -1.7270    0.0000 C   0  0
   -1.9429   -0.3058    0.0000 C   0  0
   -0.6656    0.3688    0.0000 C   0  0  1  0  0  0
    0.7196   -0.2249    0.0000 C   0  0
    1.9159   -0.1079    0.0000 C   0  0
    1.2773   -1.5561    0.0000 C   0  0
    3.1391    0.7273    0.0000 N   0  0
    4.4927    0.0791    0.0000 C   0  0
    4.6076   -1.4165    0.0000 O   0  0
    5.7314    0.9265    0.0000 C   0  0
    5.7531    2.4136    0.0000 N   0  0
    7.1915    2.8392    0.0000 N   0  0
    7.6927    4.2530    0.0000 C   0  0
    8.0400    1.6033    0.0000 C   0  0
    9.5272    1.4071    0.0000 C   0  0
   10.1008    0.0211    0.0000 C   0  0
    9.1873   -1.1687    0.0000 C   0  0
    7.7002   -0.9725    0.0000 C   0  0
    7.1266    0.4135    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  1
  5  6  1  0
  6  7  1  0
  8  7  1  6
  8  3  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11  4  1  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 15  1  0
 24 19  1  0
M  END
> <name>
NIHCC_2014

> <id>
5850

> <plate>
NGP-105-03

> <well>
G07

> <supplier_cmpd_name>
CPD000469138

> <ctcr_id>
2972

> <supplier_cmpd_id>
SAM001246527

> <smiles>
Cl.CN1[C@@H]2CCC[C@H]1CC(C2)NC(=O)c3nn(C)c4ccccc34

> <pd_targets>
{KCNH2,HTR3A,HTR3B,HTR3C,HTR3D,HTR3E,CHRNA4,CHRNB2,SLC22A2,SLC47A1,CHRNA3}

> <pathway_gtopdb>
{"Ion channel",Transporter,"Voltage-gated ion channel","Ligand-gated ion channel","Electrochemical transporter","Potassium channels","5HT3 receptor","Nicotinic acetylcholine receptor","SLC superfamily
 of solute carriers","Voltage-gated potassium channel","Nicotinic acetylcholine receptor alpha subunit","SLC22 family of organic cation and anion transporters","SLC47 family of multidrug and toxin ext
rusion transporters"}

> <pathway_chembl>
{"Ion channels",Transporters,"Voltage-gated ion channels","Ligand-gated ion channels","SLC superfamily of solute carriers","Potassium channels","5-HT<sub>3</sub> receptors","SLC22 family of organic ca
tion and anion transporters","SLC47 family of multidrug and toxin extrusion transporters","Nicotinic acetylcholine receptors","Voltage-gated potassium channels","Organic cation transporters (OCT)"}

> <pathway_reactome>
{"Muscle contraction","Neuronal System","Transport of small molecules","Cardiac conduction","Transmission across Chemical Synapses","SLC-mediated transmembrane transport","Phase 3 - rapid repolarisati
on","Neurotransmitter receptors and postsynaptic signal transmission","Transport of bile salts and organic acids","metal ions and amine compounds","Organic cation/anion/zwitterion transport","Acetylch
oline binding and downstream events","Organic cation transport","Postsynaptic nicotinic acetylcholine receptors","Highly calcium permeable postsynaptic nicotinic acetylcholine receptors"}

> <broad_targets>
{HTR3A}

> <broad_moa>
{"serotonin receptor antagonist"}

> <synonyms>
{"Granisetron hydrochloride","Granisetron HCl",107007-99-8,107007998,Kytril,Granisol,UNII-318F6L70J8,UNII318F6L70J8,MFCD01747034,318F6L70J8,"BRL 43694A","107007-99-8 (HCl)","107007998 (HCl)","Kytril I
njection","Granisetron Hydrocholride",BRL-43694,BRL43694,BEMA-Granisetron,BEMAGranisetron,Granisetron-MDTS,GranisetronMDTS,NCGC,T1042,SAM001246527,CPD000469138}

> <pdid>
PD009662

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{6918003}

$$$$
NIHCC_2014
  SciTegic11012413002D

 35 35  0  0  0  0            999 V2000
    7.7858   -7.5171    0.0000 C   0  0
    6.4855   -8.2648    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    5.1894   -6.0109    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2948   -3.7516    0.0000 O   0  0
    2.5973   -1.5031    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5988    1.5004    0.0000 C   0  0
   -2.5998    3.0004    0.0000 F   0  0
   -3.8976    0.7500    0.0000 F   0  0
   -3.8982    2.2498    0.0000 F   0  0
    6.4833   -9.7656    0.0000 N   0  0
    7.7815  -10.5187    0.0000 C   0  0
    7.7794  -12.0195    0.0000 C   0  0
    9.0776  -12.7726    0.0000 C   0  0
    9.2155  -14.2535    0.0000 C   0  0
   10.6827  -14.5653    0.0000 N   0  0
   11.4327  -13.2663    0.0000 C   0  0
   10.4290  -12.1516    0.0000 N   0  0
   15.2327   -3.9071    0.0000 O   0  0
   15.2327   -5.4071    0.0000 C   0  0
   13.9334   -6.1566    0.0000 O   0  0
   16.5327   -6.1571    0.0000 C   0  0
   17.8327   -5.4071    0.0000 C   0  0
   17.8341   -3.9062    0.0000 C   0  0
   16.5355   -3.1554    0.0000 O   0  0
   19.1334   -3.1566    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 13 16  1  0
 16 17  1  0
 16 18  1  0
 16 19  1  0
  2 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 27 23  1  0
 28 29  1  0
 29 30  2  0
 29 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  1  0
 33 35  2  0
M  END
> <name>
NIHCC_2014

> <id>
5851

> <plate>
NGP-105-03

> <well>
G08

> <supplier_cmpd_name>
CPD000466289

> <ctcr_id>
3669

> <supplier_cmpd_id>
SAM001247089

> <smiles>
CC(CCCCC(=O)Nc1ccc(cc1)C(F)(F)F)NCCc2c[nH]cn2.OC(=O)\C=C/C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{HTMT,SMR000466289,MLS000758916,MLS001424183,CHEMBL1698287,HMS2052M15,HMS2232H15,CCG-101125,CCG101125,NC00375,SAM001247089,CPD000466289}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581821}

$$$$
NIHCC_2014
  SciTegic11012413002D

 38 41  0  0  1  0            999 V2000
    3.8983   -0.7459    0.0000 O   0  0
    2.6003   -1.4977    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 O   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
    0.0031    3.0008    0.0000 O   0  0
    1.3039    3.7494    0.0000 C   0  0
    2.6004    2.9949    0.0000 C   0  0
    3.9020    3.7405    0.0000 C   0  0
    3.9072    5.2405    0.0000 C   0  0
    2.6108    5.9949    0.0000 C   0  0
    1.3092    5.2494    0.0000 C   0  0
    0.0136    6.0070    0.0000 C   0  0
    0.0209    7.5078    0.0000 O   0  0
   -1.2746    8.2654    0.0000 C   0  0
   -2.5776    7.5222    0.0000 O   0  0
   -1.2673    9.7662    0.0000 C   0  0
   -2.5624   10.5230    0.0000 O   0  0
   -0.0082    8.9890    0.0000 C   0  0
    1.2946    9.7324    0.0000 C   0  0
    1.3022   11.2324    0.0000 C   0  0
    0.0070   11.9890    0.0000 C   0  0
   -1.2959   11.2456    0.0000 C   0  0
   -2.6002   11.9863    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0  2  0  0  0
   -2.5973    1.5031    0.0000 O   0  0
   -2.5951    3.0039    0.0000 C   0  0
   -1.2948    3.7516    0.0000 O   0  0
   -3.8933    3.7570    0.0000 C   0  0
   -3.8934    5.2570    0.0000 C   0  0
   -5.1924    6.0070    0.0000 C   0  0
   -6.4915    5.2571    0.0000 C   0  0
   -6.4915    3.7571    0.0000 C   0  0
   -5.1925    3.0070    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.0000   -3.0000    0.0000 O   0  0
  1  2  1  0
  3  2  1  6
  3  4  1  0
  4  5  1  0
  5  6  1  6
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 17 19  1  0
 19 20  2  3
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 17  1  0
 23 24  2  0
  5 25  1  0
 25 26  1  1
 26 27  1  0
 27 28  2  0
 27 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 29  1  0
 25 35  1  0
 35 36  1  6
 35 37  1  0
 37  3  1  0
 37 38  1  1
M  END
> <name>
NIHCC_2014

> <id>
5852

> <plate>
NGP-105-03

> <well>
G09

> <supplier_cmpd_name>
CPD000469223

> <ctcr_id>
4048

> <supplier_cmpd_id>
SAM001246852

> <smiles>
OC[C@H]1O[C@@H](Oc2ccccc2COC(=O)C3(O)C=CCCC3=O)[C@H](OC(=O)c4ccccc4)[C@@H](O)[C@@H]1O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{Tremulacin,29836-40-6,29836406,MLS001424184,CHEBI:9657,AC1L9D1T,Tremulacin(8CI),SureCN1055476,CHEMBL462996,MEGxp0_001328,MEGxp0001328,MEGxp0-001328,"MEGxp0 001328",SCHEMBL1055476,ACon1_001370,ACon100
1370,ACon1-001370,"ACon1 001370",DTXSID10952263,HMS2052M17,HMS2232H17,CCG-101133,CCG101133,NC00383,NCGC00180579-01,NCGC0018057901,SMR000469223,C09973,AB00698351-0,AB006983510,SAM001246852,CPD000469223
}

> <pdid>
PD002834

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{442544}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 27  0  0  0  0            999 V2000
    9.4554   -1.3402    0.0000 Cl  0  0
    6.9546   -4.2653    0.0000 C   0  0
    5.4929   -3.9285    0.0000 N   0  0
    4.4707   -5.0263    0.0000 C   0  0
    5.0525   -2.4938    0.0000 C   0  0
    3.5900   -2.1568    0.0000 C   0  0
    3.1497   -0.7220    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.5913    1.9239    0.0000 C   0  0
    2.4792    3.4197    0.0000 C   0  0
    1.1278    4.0705    0.0000 C   0  0
   -0.1116    3.2255    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 O   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5031   -5.4549    0.0000 C   0  0
    3.0039   -5.4528    0.0000 C   0  0
    3.7517   -4.1524    0.0000 O   0  0
    3.7566   -6.7503    0.0000 O   0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  2  0
 20 25  1  0
 25 26  2  0
 26  8  1  0
 26 17  1  0
M  END
> <name>
NIHCC_2014

> <id>
5853

> <plate>
NGP-105-03

> <well>
G10

> <supplier_cmpd_name>
CPD000469220

> <ctcr_id>
5705

> <supplier_cmpd_id>
SAM001246802

> <smiles>
Cl.CN(C)CC\C=C/1c2ccccc2COc3ccc(CC(O)=O)cc13

> <pd_targets>
{HRH1,HRH2,HRH3,S100A1,S100A12,S100B,S100A13,S100A2,LMNA}

> <pathway_gtopdb>
{"Membrane receptor","Other cytosolic protein","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Histamine receptor","Other nuclear protein"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Histamine receptors"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Immune System","Signaling by GPCR","Infectious disease","Innate Immune System","GPCR ligand binding","Leishmania infection","Toll-like Receptor Cascades","Class A/1 (Rh
odopsin-like receptors)","Leishmania parasite growth and survival","Regulation of TLR by endogenous ligand","Toll Like Receptor 5 (TLR5) Cascade","Amine ligand-binding receptors","Anti-inflammatory re
sponse favouring Leishmania parasite infection","MyD88 cascade initiated on plasma membrane","Histamine receptors","ADORA2B mediated anti-inflammatory cytokines production","TAK1 activates NFkB by pho
sphorylation and activation of IKKs complex","Cell Cycle",Mitotic,"M Phase","Mitotic Metaphase and Anaphase","Mitotic Anaphase","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) 
Reformation"}

> <broad_targets>
{HRH1,S100A1,S100A12,S100A13,S100A2,S100B}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{AKOS026750048,"OLOPATADINE HYDROCHLORIDE","OLOPATADINE HCl",140462-76-6,140462766,Pataday,Allelock,Patanase,Opatanol,ALO4943A,"Olopatadine (hydrochloride)",UNII-2XG66W44KF,UNII2XG66W44KF,Pazeo,KW-467
9,KW4679,2XG66W44KF,AL-4943A,AL4943A,MFCD00875716,ALO-4943A,DSSTox_CID_26486,DSSToxCID26486,DSSTox-CID-26486,"DSSTox CID 26486",S2494,SAM001246802,Prestw-1307,"Olopatadine HCl",CPD000469220,"Olopatadi
ne hydrochloride"}

> <pdid>
PD009730

> <targets>
{"Histamine Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{67108011,5282402}

$$$$
NIHCC_2014
  SciTegic11012413002D

  9  9  0  0  0  0            999 V2000
    3.8976   -0.7553    0.0000 N   0  0
    2.5973   -1.5031    0.0000 C   0  0
    2.5951   -3.0031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
M  END
> <name>
NIHCC_2014

> <id>
5854

> <plate>
NGP-105-03

> <well>
G11

> <supplier_cmpd_name>
CPD000058212

> <ctcr_id>
809

> <supplier_cmpd_id>
SAM001246860

> <smiles>
NC(=O)c1cccnc1

> <pd_targets>
{SIRT2,SIRT1,SIRT3,HST2,PARP1,FAAH,SIRT5,SIR2RP1,SARM1}

> <pathway_gtopdb>
{"Epigenetic regulator",Enzyme,Eraser,Transferase,Hydrolase,"Histone deacetylase","HDAC class III"}

> <pathway_chembl>
{Enzymes,"Chromatin modifying enzymes","Poly ADP-ribose polymerases","Endocannabinoid turnover","3.5.1.- Histone deacetylases (HDACs)","<i>N</i>-Acylethanolamine turnover"}

> <pathway_reactome>
{"Cell Cycle","Gene expression (Transcription)",Disease,Metabolism,"Organelle biogenesis and maintenance","Immune System",Mitotic,"RNA Polymerase II Transcription","Infectious disease","Metabolism of 
lipids","Mitochondrial biogenesis","Innate Immune System","M Phase","Generic Transcription Pathway","Influenza Infection","Fatty acid metabolism","Transcriptional activation of mitochondrial biogenesi
s","Toll-like Receptor Cascades","Mitotic Metaphase and Anaphase","FOXO-mediated transcription","Influenza Viral RNA Transcription and Replication","Arachidonic acid metabolism","Toll Like Receptor 4 
(TLR4) Cascade","Mitotic Anaphase","Regulation of FOXO transcriptional activity by acetylation","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","vRNA Synthesis","MyD88
-independent TLR4 cascade","Nuclear Envelope (NE) Reassembly","TRIF(TICAM1)-mediated TLR4 signaling","Initiation of Nuclear Envelope (NE) Reformation","Activation of IRF3/IRF7 mediated by TBK1/IKK eps
ilon"}

> <broad_targets>
{BST1,LDHA,PARP1,SIRT5}

> <broad_moa>
{"protein synthesis stimulant"}

> <synonyms>
{"3 Pyridinecarboxamide",SR-01000721872,SR01000721872,"Nicotinsaureamid Jenapharm","EINECS 202-713-4","EINECS 2027134","Jenapharm, Nicotinsaureamid",nicotinamide,niacinamide,98-92-0,98920,3-Pyridineca
rboxamide,3Pyridinecarboxamide,"Nicotinic acid amide",pyridine-3-carboxamide,pyridine3carboxamide,"vitamin PP",Papulex,Ami,T0934,SAM001246860,1505397,Prestw-1449,Nicotinamide,CPD000058212,NIACINAMIDE}

> <pdid>
PD000511

> <targets>
{Endogenous Metabolite,Sirtuin}

> <classes>
{Vitamin B3,enzyme cofactor,anti-pellagra,Cell Cycle/DNA Damage,Epigenetics,Metabolic Enzyme/Protease}

> <pubchem_cids>
{936}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 35  0  0  1  0            999 V2000
   -7.0175   -4.2121    0.0000 C   0  0
   -6.7971   -2.7283    0.0000 O   0  0
   -5.4015   -2.1786    0.0000 C   0  0
   -4.3932   -3.1329    0.0000 C   0  0
   -3.1149   -2.7008    0.0000 C   0  0
   -1.8725   -3.2589    0.0000 N   0  0
   -0.9543   -2.2326    0.0000 C   0  0  1  0  0  0
    0.3601   -2.5387    0.0000 C   0  0  2  0  0  0
    0.7742   -3.8531    0.0000 C   0  0  2  0  0  0
    0.0000   -4.8794    0.0000 C   0  0
   -1.4584   -4.5733    0.0000 C   0  0
   -2.4657   -5.6848    0.0000 O   0  0
    2.0166   -4.3572    0.0000 O   0  0
    3.2229   -3.6370    0.0000 C   0  0
    3.5830   -2.5027    0.0000 C   0  0
    2.7728   -1.4944    0.0000 C   0  0
    2.0166    0.9003    0.0000 C   0  0
   -0.8822    1.4404    0.0000 N   0  0
   -2.4487    1.0083    0.0000 C   0  0
   -2.5927   -0.3241    0.0000 C   0  0
   -1.3684   -0.9183    0.0000 C   0  0  1  0  0  0
   -0.4681    0.1080    0.0000 C   0  0  2  0  0  0
    0.8462    0.0000    0.0000 C   0  0
    1.2604   -1.4944    0.0000 C   0  0  2  0  0  0
   -2.7188   -0.9183    0.0000 C   0  0
   -3.7090    0.0180    0.0000 C   0  0
   -5.0234   -0.4141    0.0000 C   0  0
   -6.0621    0.6678    0.0000 O   0  0
   -5.6429    2.1080    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  7  6  1  6
  8  7  1  1
  8  9  1  0
  9 10  1  1
 10 11  1  0
 11  6  1  0
 11 12  2  0
  9 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  3
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 21 20  1  1
 21  7  1  0
 21 22  1  0
 22 18  1  0
 22 23  1  1
 24 23  1  1
 24  8  1  0
 24 16  1  0
 21 25  1  0
 25  5  2  0
 25 26  1  0
 26 27  2  0
 27  3  1  0
 27 28  1  0
 28 29  1  0
M  END
> <name>
NIHCC_2014

> <id>
5855

> <plate>
NGP-105-03

> <well>
H02

> <supplier_cmpd_name>
CPD000112281

> <ctcr_id>
5361

> <supplier_cmpd_id>
SAM001246865

> <smiles>
COc1cc2N3[C@H]4[C@@H]5[C@H](CC3=O)OCC=C6CN7CC[C@]4([C@@H]7C[C@H]56)c2cc1OC

> <pd_targets>
{CHRM2,CHRM1,CHRM4,CHRM3,TAS2R10,CHRM5}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Taste family G protein-coupled receptor","Small molecule receptor (family A GPCR)","Taste receptor (taste family GPCR)","Monoamine receptor"
,"Acetylcholine receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Acetylcholine receptors (muscarinic)","Orphan and other 7TM receptors","Taste 2 receptors"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","GPCR downstream signalling","Class A/1 (Rhodopsin-like receptors)","G alpha (i) signalling events","Amine ligand-binding receptors","M
uscarinic acetylcholine receptors"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3,CHRM4,CHRM5}

> <broad_moa>
{"glycine receptor antagonist"}

> <synonyms>
{BRUCINE,357-57-3,357573,"10,11-Dimethoxystrychnine","10,11Dimethoxystrychnine",Brucinum,(-)-Brucine,()Brucine,l-Brucine,lBrucine,"2,3-Dimethoxystrychnine","2,3Dimethoxystrychnine","2,3-Dimethoxystryc
hnidin-10-one","2,3Dimethoxystrychnidin10one","10,11-Dimethystrychnine","10,11Dimethystrychnine",UNII-6NG17YCK6H,UNII6NG17YCK6H,Brucina,Brucin,6NG17YCK6H,"Brucine alkaloid",CHEBI:3193,"Dimethoxy st",S
AM001246865,CPD000112281}

> <pdid>
PD001567

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{442021}

$$$$
NIHCC_2014
  SciTegic11012413002D

 38 42  0  0  0  0            999 V2000
    2.5800    0.0305    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    3.8971    3.7500    0.0000 C   0  0
    3.8971    5.2500    0.0000 C   0  0
    5.1961    6.0001    0.0000 O   0  0
    2.5980    6.0000    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2991    3.7500    0.0000 O   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 O   0  0
   -2.5981    1.5000    0.0000 O   0  0
    0.0000    4.5000    0.0000 O   0  0
    0.0000    6.0000    0.0000 O   0  0
    2.5949    7.5009    0.0000 C   0  0
    3.8927    8.2531    0.0000 O   0  0
    1.2941    8.2494    0.0000 N   0  0
    1.2910    9.7502    0.0000 C   0  0
   -0.0098   10.4988    0.0000 N   0  0
   -0.1529   11.9791    0.0000 C   0  0
   -1.6212   12.2859    0.0000 C   0  0
   -2.3666   10.9842    0.0000 C   0  0
   -1.3591    9.8730    0.0000 C   0  0
    5.1984    3.0023    0.0000 N   0  0
    6.4964    3.7542    0.0000 C   0  0
    5.2010    1.5023    0.0000 C   0  0
    1.2638   -2.2496    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  2  3
 10 11  1  0
 11  5  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14  3  1  0
 14 15  2  3
 15 16  1  0
 16 17  2  3
 17  2  1  0
 17 18  1  0
 18 19  2  3
 19 20  1  0
 20 21  2  3
 21 16  1  0
 21 22  1  0
 15 23  1  0
 11 24  1  0
 10 25  1  0
  9 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 30  1  0
  6 35  1  0
 35 36  1  0
 35 37  1  0
  2 38  1  0
M  END
> <name>
NIHCC_2014

> <id>
5856

> <plate>
NGP-105-03

> <well>
H03

> <supplier_cmpd_name>
CPD000058701

> <ctcr_id>
4967

> <supplier_cmpd_id>
SAM001246892

> <smiles>
CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)NCN5CCCC5)N(C)C)O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{MLS000028710,SMR000058701,SR-01000695439,SR01000695439,Prestwick_1045,Prestwick1045,Prestwick-1045,"Prestwick 1045",Opera_ID_1598,OperaID1598,Opera-ID-1598,"Opera ID 1598",Prestwick0_000849,Prestwick
0000849,Prestwick0-000849,"Prestwick0 000849",Prestwick1_000849,Prestwick1000849,Prestwick1-000849,"Prestwick1 000849",Prestwick2_000849,Prestwick2000849,Prestwick2-000849,"Prestwick2 000849",Prestwic
k3_000849,Prestwick3000849,Prestwick3-000849,"Prestwick3 000849",BSPBio_000837,BSPBio000837,BSPBio-000837,"BSPBio 000837",MLS001424167,SPBio_002758,SPBio002758,SPBio-002758,"SPBio 002758",BPBio1_00092
1,BPBio1000921,BPBio1-000921,"BPBio1 000921",CHEMBL1504113,SCHEMBL13782518,HMS1570J19,HMS20,SAM001246892,CPD000058701}

> <pdid>
PD118123

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{54679406}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 26  0  0  0  0            999 V2000
   14.1998   -2.2507    0.0000 Br  0  5
   11.6991   -0.7641    0.0000 C   0  0
   10.3987   -1.5118    0.0000 C   0  0
    9.0999   -0.7599    0.0000 N   0  3
    9.0977   -2.2599    0.0000 C   0  0
    9.1020    0.7408    0.0000 C   0  0
   10.4017    1.4898    0.0000 C   0  0
    7.7988   -1.5080    0.0000 C   0  0
    6.4999   -0.7561    0.0000 C   0  0
    5.1988   -1.5042    0.0000 O   0  0
    3.8999   -0.7523    0.0000 C   0  0
    3.9021    0.7477    0.0000 O   0  0
    2.5988   -1.5004    0.0000 C   0  0
    2.6001   -0.0004    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    2.5996   -3.0013    0.0000 C   0  0
    1.3010   -3.7520    0.0000 C   0  0
    1.3018   -5.2520    0.0000 C   0  0
    2.6012   -6.0013    0.0000 C   0  0
    3.8998   -5.2506    0.0000 C   0  0
    3.8990   -3.7506    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  4  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 15  1  0
 13 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
M  CHG  2   1  -1   4   1
M  END
> <name>
NIHCC_2014

> <id>
5857

> <plate>
NGP-105-03

> <well>
H04

> <supplier_cmpd_name>
CPD000058660

> <ctcr_id>
1281

> <supplier_cmpd_id>
SAM001246887

> <smiles>
[Br-].CC[N+](C)(CC)CCOC(=O)C(O)(C1CCCCC1)c2ccccc2

> <pd_targets>
{CHRM4,CHRM1,CHRM3}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Acetylcholine receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Acetylcholine receptors (muscarinic)"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Amine ligand-binding receptors","Muscarinic acetylcholine receptors"}

> <broad_targets>
{CHRM1,CHRM3}

> <broad_moa>
{"cholinergic receptor antagonist"}

> <synonyms>
{50-10-2,50102,"50 10 2",ANTRENYL,C21H34BrNO3,"Oxyphenonium (bromide)",MLS000028620,Spasmophen,Oxifenon,Oxyfenon,Oxyphenon,SMR000058660,Subranyl,"Antrenyl bromide",DSSTox_CID_25632,DSSToxCID25632,DSST
ox-CID-25632,"DSSTox CID 25632",DSSTox_RID_81014,DSSToxRID81014,DSSTox-RID-81014,"DSSTox RID 81014",DSSTox_GSID_45632,DSSToxGSID45632,DSSTox-GSID-45632,"DSSTox GSID 45632",Oxyphenoniumbromide,SAM00124
6887,CPD000058660}

> <pdid>
PD010165

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5748}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 29  0  0  0  0            999 V2000
    6.4870   -5.2597    0.0000 C   0  0
    6.4915   -3.7597    0.0000 C   0  0
    5.1945   -3.0045    0.0000 N   0  0
    5.1969   -1.5045    0.0000 C   0  0
    3.8991   -0.7525    0.0000 C   0  0
    2.5987   -1.5004    0.0000 N   0  0
    2.5965   -3.0004    0.0000 C   0  0
    3.8943   -3.7525    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 N   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -3.8963    3.7531    0.0000 C   0  0
   -5.1967    3.0053    0.0000 O   0  0
   -3.8942    5.2531    0.0000 O   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 F   0  0
    1.2997    3.7504    0.0000 C   0  0
    2.7206    3.7070    0.0000 C   0  0
    1.9685    5.0048    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  3  1  0
  6  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  3
 14 15  1  0
 15 16  1  0
 15 17  2  0
 14 18  1  0
 18 19  2  0
 18 20  1  0
 20 11  2  0
 20 21  1  0
 21 22  2  0
 22  9  1  0
 22 23  1  0
 12 24  1  0
 24 25  1  0
 25 26  1  0
 26 24  1  0
M  END
> <name>
NIHCC_2014

> <id>
5858

> <plate>
NGP-105-03

> <well>
H05

> <supplier_cmpd_name>
CPD000059011

> <ctcr_id>
602

> <supplier_cmpd_id>
SAM001246856

> <smiles>
CCN1CCN(CC1)c2cc3N(C=C(C(O)=O)C(=O)c3cc2F)C4CC4

> <pd_targets>
{LMNA,HPGD,KDM4E,ALDH1A1,SKA,MAPT,HSD17B10}

> <pathway_gtopdb>
{"Other nuclear protein",Enzyme,"Epigenetic regulator","Other cytosolic protein",Eraser,Oxidoreductase,Kinase,"Lysine demethylase","Jumonji domain-containing"}

> <pathway_chembl>
{Enzymes,"Eicosanoid turnover","Chromatin modifying enzymes","Prostaglandin synthases","1.14.11.- Histone demethylases"}

> <pathway_reactome>
{"Cell Cycle",Metabolism,"Neuronal System",Mitotic,"Metabolism of lipids","Biological oxidations","Transmission across Chemical Synapses","Metabolism of amino acids and derivatives","M Phase","Biosynt
hesis of specialized proresolving mediators (SPMs)","Phase I - Functionalization of compounds","Neurotransmitter receptors and postsynaptic signal transmission","Branched-chain amino acid catabolism",
"Mitotic Metaphase and Anaphase","Biosynthesis of DHA-derived SPMs","Ethanol oxidation","Activation of NMDA receptors and postsynaptic events","Mitotic Anaphase","Biosynthesis of D-series resolvins","
Post NMDA receptor activation events","Nuclear Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{}

> <broad_moa>
{"bacterial DNA gyrase inhibitor"}

> <synonyms>
{Enrofloxacin,93106-60-6,93106606,Baytril,Enrofloxacine,CFPQ,"BAY VP 2674",Enrofloxacino,Enrofloxacinum,Enroxil,UNII-3DX3XEK1BN,UNII3DX3XEK1BN,"Baytril (TN)",N-Ethylciprofloxacin,NEthylciprofloxacin,E
RFX,C19H22FN3O3,3DX3XEK1BN,MLS000069441,CHEBI:35720,MFCD00792463,"BAY Vp 2674;PD160788",T1617,SAM001246856,1503721,CPD000059011,ENROFLOXACIN}

> <pdid>
PD000881

> <targets>
{}

> <classes>
{antibacterial}

> <pubchem_cids>
{6957639,71188}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 32  0  0  0  0            999 V2000
    7.5844   -1.4920    0.0000 C   0  0
    6.1069   -1.2335    0.0000 N   0  0
    5.5920    0.1754    0.0000 C   0  0
    4.1145    0.4339    0.0000 C   0  0
    3.1484   -0.7186    0.0000 C   0  0
    3.6667   -2.1252    0.0000 C   0  0
    5.1442   -2.3838    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.5913    1.9239    0.0000 C   0  0
    2.4792    3.4197    0.0000 C   0  0
    1.1278    4.0705    0.0000 C   0  0
   -0.1116    3.2255    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -3.1476   -0.7184    0.0000 O   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.2135   -2.9844    0.0000 S   0  0
    0.0000   -3.8661    0.0000 C   0  0
    1.2135   -2.9844    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
   11.3852    1.9772    0.0000 O   0  0
   11.3852    0.4772    0.0000 C   0  0
   10.0859   -0.2724    0.0000 O   0  0
   12.6852   -0.2728    0.0000 C   0  0
   13.9852    0.4772    0.0000 C   0  0
   15.2851   -0.2728    0.0000 C   0  0
   15.2851   -1.7728    0.0000 O   0  0
   16.5844    0.4768    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  2  1  0
  5  8  2  3
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22  8  1  0
 22 18  2  0
 23 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 28 30  2  0
M  END
> <name>
NIHCC_2014

> <id>
5859

> <plate>
NGP-105-03

> <well>
H06

> <supplier_cmpd_name>
CPD000058462

> <ctcr_id>
4499

> <supplier_cmpd_id>
SAM001246984

> <smiles>
CN1CCC(CC1)=C2c3ccccc3CC(=O)c4sccc24.OC(=O)\C=C\C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{RESTW37,"KETOTIFEN FUMARATE",34580-14-8,34580148,Zaditen,"Ketotifen hydrogen fumarate","HC 20,511 fumarate","Ketotifen (fumarate)","Ketotifen fumarate salt",UNII-HBD503WORO,UNIIHBD503WORO,"Ketotifen 
fumarate (Zaditor)",HBD503WORO,MLS000069701,C23H23NO5S,MFCD00079394,SMR000058,T0994,S2024,SAM001246984,1500668,Prestw-371,"Ketotifen fumarate","Ketotifen Fumarate",CPD000058462}

> <pdid>

> <targets>
{"Histamine Receptor"}

> <classes>
{antiasthmatic,"Neuronal Signaling"}

> <pubchem_cids>
{5282408}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 27  0  0  1  0            999 V2000
   16.2911   -2.9185    0.0000 O   0  0
   13.7911   -2.9185    0.0000 Cl  0  0
   11.2903   -3.8721    0.0000 C   0  0
    9.8221   -4.1791    0.0000 C   0  0  2  0  0  0
    8.8221   -3.0611    0.0000 C   0  0
    7.3538   -3.3681    0.0000 N   0  0
    6.3509   -2.2515    0.0000 C   0  0
    4.8823   -2.5608    0.0000 C   0  0
    3.8794   -1.4442    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
   -0.5701   -4.1788    0.0000 C   0  0
    0.0400   -5.5491    0.0000 C   0  0
    1.5318   -5.7059    0.0000 C   0  0
    2.4135   -4.4923    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
    6.8856   -4.7932    0.0000 C   0  0
    7.8857   -5.9112    0.0000 C   0  0  2  0  0  0
    7.4175   -7.3363    0.0000 C   0  0
    9.3539   -5.6042    0.0000 N   0  0
  4  3  1  1
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 10  1  0
 22 17  1  0
  6 23  1  0
 23 24  1  0
 24 25  1  1
 24 26  1  0
 26  4  1  0
M  END
> <name>
NIHCC_2014

> <id>
5860

> <plate>
NGP-105-03

> <well>
H07

> <supplier_cmpd_name>
CPD000466293

> <ctcr_id>
6697

> <supplier_cmpd_id>
SAM001247094

> <smiles>
O.Cl.C[C@@H]1CN(CCCn2c3ccccc3c4ccccc24)C[C@H](C)N1

> <pd_targets>
{SIGMAR1,HTR2A,HTR2B,HTR2C,SLC6A2,KMT2A,MEN1,HTT,SLC6A4,ALOX15,RORC,CYP2C19,LEF,CYP3A4,SLC6A3,CYP2D6,TSHR,ALDH1A1,CYP2C9,TP53,MAPK1,CYP1A2,KDM4E,SCARB1}

> <pathway_gtopdb>
{"Membrane receptor",Transporter,"Epigenetic regulator","Unclassified protein",Enzyme,"Transcription factor","Family A G protein-coupled receptor","Electrochemical transporter",Reader,Oxidoreductase,"
Nuclear receptor","Cytochrome P450",Protease,Kinase,Eraser,"Small molecule receptor (family A GPCR)","SLC superfamily of solute carriers",Bromodomain,"Nuclear hormone receptor subfamily 1","Cytochrome
 P450 family 2","Metallo protease","Cytochrome P450 family 3","Peptide receptor (family A GPCR)","Protein Kinase","Cytochrome P450 family 1","Lysine demethylase","Monoamine receptor","SLC06 neurotrans
mitter transporter family","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family 2C","Metallo protease MAE clan","Cytochrome P450 family 3A","Cytochrome P450 family 2D","Glycohormone 
receptor","CMGC protein kinase group","Cytochrome P450 family 1A","Jumonji domain-containing","Serotonin receptor","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 2C19","Metal
lo protease M34 family","Cytochrome P450 3A4","Cytochrome P450 2D6","Cytochrome P450 2C9","CMGC protein kinase MAPK family","Cytochrome P450 1A1","CMGC protein kinase ERK1"}

> <pathway_chembl>
{"Other protein targets",Transporters,Enzymes,Receptors,"Sigma receptors","SLC superfamily of solute carriers","Eicosanoid turnover","Nuclear hormone receptors","Cytochrome P450","G protein-coupled re
ceptors","Kinases (EC 2.7.x.x)","Chromatin modifying enzymes","SLC6 neurotransmitter transporter family",Lipoxygenases,"1F. Retinoic acid-related orphans","CYP2 family: drug metabolising subset","CYP3
 family","Glycoprotein hormone receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK families","CYP1 family","1.14.11.- Histone demethylases","Monoamine transporter subfamily","Mitogen-activated protein ki
nases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{Disease,"Gene expression (Transcription)","Neuronal System",Metabolism,"Cell Cycle","Immune System","Transport of small molecules","Infectious disease","RNA Polymerase II Transcription","Transmission
 across Chemical Synapses","Metabolism of lipids","Biological oxidations","Disorders of transmembrane transporters","Cell Cycle Checkpoints","Innate Immune System","Plasma lipoprotein assembly",remode
ling,"and clearance","SARS-CoV Infections","Generic Transcription Pathway","Neurotransmitter clearance","Biosynthesis of specialized proresolving mediators (SPMs)","Phase I - Functionalization of comp
ounds","Uptake and actions of bacterial toxins","SLC transporter disorders","Leishmania infection","G1/S DNA Damage Checkpoints","Toll-like Receptor Cascades","Plasma lipoprotein clearance","Potential
 therapeutics for SARS","Transcriptional Regulation by MECP2","Serotonin clearance from the synaptic cleft","Biosynthesis of DPA-derived SPMs","Transcriptional regulation by RUNX3","Cytochrome P450 - 
arranged by substrate type","Uptake and function of anthrax toxins","Biosynthesis of DHA-derived SPMs","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Leishmania parasite growth and
 survival","Ethanol oxidation","p53-Dependent G1/S DNA damage checkpoint","Toll Like Receptor 5 (TLR5) Cascade","HDL clearance","Regulation of MECP2 expression and activity","Biosynthesis of DPAn-3 SP
Ms","RUNX3 Regulates Immune Response and Cell Migration",Xenobiotics,"Biosynthesis of maresins","Anti-inflammatory response favouring Leishmania parasite infection","p53-Dependent G1 DNA Damage Respon
se","MyD88 cascade initiated on plasma membrane","Biosynthesis of DPAn-3-derived protectins and resolvins","CYP2E1 reactions","Biosynthesis of maresin-like SPMs","ADORA2B mediated anti-inflammatory cy
tokines production","Stabilization of p53","MAP kinase activation","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Autodegradation of the E3 ubiquitin ligase COP1","MAPK targets/ N
uclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{SIGMAR1}

> <broad_moa>
{"sigma receptor antagonist"}

> <synonyms>
{SMR000466293,CPD000466293,MLS000758976,MLS001424206,CHEMBL1488731,AKOS024360138,CCG-101118,CCG101118,NC00368,ST50989930,"(3S,5R)-1-(3-carbazol-9-ylpropyl)-3,5-dimethylpiperazine, chloride, hydrate","
(3S,5R)1(3carbazol9ylpropyl)3,5dimethylpiperazine, chloride, hydrate",SAM001247094}

> <pdid>
PD014554

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{18528119}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 23  0  0  1  0            999 V2000
    7.5987    0.3746    0.0000 O   0  0
    5.0987    0.3746    0.0000 Cl  0  0
    2.5981   -1.5000    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0  1  0  0  0
   -3.8971    3.7500    0.0000 N   0  0
   -5.1962    3.0000    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -6.4952    0.7500    0.0000 C   0  0
   -6.4952   -0.7500    0.0000 C   0  0
   -5.1961   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0  2  0  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  9  8  1  6
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 18 17  1  1
 18  9  1  0
 18 19  1  0
 19  6  2  0
 19 20  1  0
 20 21  2  0
 21  4  1  0
 21 22  1  0
M  END
> <name>
NIHCC_2014

> <id>
5861

> <plate>
NGP-105-03

> <well>
H08

> <supplier_cmpd_name>
CPD000466286

> <ctcr_id>
359

> <supplier_cmpd_id>
SAM001247083

> <smiles>
O.Cl.Oc1cc2CC[C@H]3NCc4ccccc4[C@@H]3c2cc1O

> <pd_targets>
{PMP22,KDM4E,HPGD,MAPT,BLM,LMNA,ALDH1A1,GMNN,REP,MAPK1,ADCY5,DRD2,ADRB2,HSD17B10,THPO,TP53,CYP2D6,PKM,CYP3A4,HTR2C,NFKB1,CYP2C9,ALOX15,ADRB1,HIF1A,ADRA2A,ADRA2B,ADRA2C,LEF,CYP1A2,TGR,GAA,POLB,PYK,FFP,
RORC,DRD3,DRD5,DRD4}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Dopamine receptor","Unclassified protein","Epigenetic regulator",Enzyme,"Othe
r cytosolic protein","Other nuclear protein","Transcription factor",Eraser,Oxidoreductase,Transferase,Kinase,Lyase,"Cytochrome P450",Protease,Hydrolase,"Nuclear receptor","Lysine demethylase","Protein
 Kinase","Cytochrome P450 family 2","Cytochrome P450 family 3","Metallo protease","Cytochrome P450 family 1","Nuclear hormone receptor subfamily 1","Jumonji domain-containing","CMGC protein kinase gro
up","Cytochrome P450 family 2D","Cytochrome P450 family 3A","Cytochrome P450 family 2C","Metallo protease MAE clan","Cytochrome P450 family 1A","Nuclear hormone receptor subfamily 1 group F","CMGC pro
tein kinase MAPK family","Adrenergic receptor","Cytochrome P450 2D6","Cytochrome P450 3A4","Serotonin receptor","Cytochrome P450 2C9","Metallo protease M34 family","Cytochrome P450 1A1","Nuclear hormo
ne receptor subfamily 1 group F member 3","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Dopamine receptors",Enzymes,"Other protein targets","Chromatin modifying enzymes","Eicosanoid turnover","Anti-infective targets","Kinases (EC 2.7.x.x)","Cycli
c nucleotide turnover/signalling","Cytochrome P450","2.7.1.40 Pyruvate kinases","3.2.1.- Glycosidases","Nuclear hormone receptors","1.14.11.- Histone demethylases","Prostaglandin synthases","Viral pro
tein targets","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Adenylyl cyclases (ACs)",Adrenoceptors,"CYP2 family: drug metabolising subset","CYP3 family","5-Hydroxytryptamine receptors",Lipoxygenase
s,"CYP1 family","1F. Retinoic acid-related orphans","Coronavirus (CoV) proteins","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{Disease,"Infectious disease","Leishmania infection","Leishmania parasite growth and survival","Anti-inflammatory response favouring Leishmania parasite infection","ADORA2B mediated anti-inflammatory 
cytokines production","Developmental Biology",Metabolism,"Neuronal System","DNA Repair","Cell Cycle","Immune System","Signal Transduction",Hemostasis,"Cellular responses to external stimuli","Gene exp
ression (Transcription)","Nervous system development","Metabolism of lipids","Transmission across Chemical Synapses","DNA Double-Strand Break Repair",Mitotic,"Biological oxidations","Innate Immune Sys
tem","Signaling by GPCR","Metabolism of amino acids and derivatives","Platelet activation","signaling and aggregation","Cell Cycle Checkpoints","Metabolism of carbohydrates","Cytokine Signaling in Imm
une system","Cellular responses to stress","Diseases of metabolism","Base Excision Repair","RNA Polymerase II Transcription","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Biosynthe
sis of specialized proresolving mediators (SPMs)","Neurotransmitter receptors and postsynaptic signal transmission","Homology Directed Repair","M Phase","Phase I - Functionalization of compounds","Mit
otic G1 phase and G1/S transition","SARS-CoV Infections","Toll-like Receptor Cascades","GPCR ligand binding","Branched-chain amino acid catabolism","Platelet Aggregation (Plug Formation)","G1/S DNA Da
mage Checkpoints","Glucose metabolism","Signaling by Interleukins","Cellular response to hypoxia","Uptake and actions of bacterial toxins","Diseases of carbohydrate metabolism","Resolution of Abasic S
ites (AP sites)","Generic Transcription Pathway","Biosynthesis of DHA-derived SPMs","Activation of NMDA receptors and postsynaptic events","HDR through Homologous Recombination (HRR) or Single Strand 
Annealing (SSA)","Mitotic Metaphase and Anaphase","Ethanol oxidation","G1/S Transition","SARS-CoV-2 Infection","Toll Like Receptor 5 (TLR5) Cascade","GABA receptor activation","Class A/1 (Rhodopsin-li
ke receptors)","p53-Dependent G1/S DNA damage checkpoint","Cytochrome P450 - arranged by substrate type",Glycolysis,"Interleukin-1 family signaling","Biosynthesis of DPA-derived SPMs","Oxygen-dependen
t proline hydroxylation of Hypoxia-inducible Factor Alpha","Uptake and function of anthrax toxins","Glycogen storage diseases","Resolution of AP sites via the multiple-nucleotide patch replacement pat
hway","Transcriptional regulation by RUNX3","Biosynthesis of D-series resolvins","Post NMDA receptor activation events","HDR through Homologous Recombination (HRR)","Mitotic Anaphase","Activation of t
he pre-replicative complex","SARS-CoV-2 Genome Replication and Transcription","MyD88 cascade initiated on plasma membrane","GABA B receptor activation","Amine ligand-binding receptors","p53-Dependent 
G1 DNA Damage Response",Xenobiotics,"Biosynthesis of maresins","Interleukin-1 signaling","Biosynthesis of DPAn-3 SPMs","Glycogen storage disease type II (GAA)","PCNA-Dependent Long Patch Base Excision
 Repair","RUNX3 Regulates Immune Response and Cell Migration","Activation of AMPK downstream of NMDARs","Homologous DNA Pairing and Strand Exchange","Nuclear Envelope (NE) Reassembly","Replication of 
the SARS-CoV-2 genome","MAP kinase activation","Activation of GABAB receptors","Dopamine receptors","Stabilization of p53","CYP2E1 reactions","Biosynthesis of maresin-like SPMs","Serotonin receptors",
"MAP3K8 (TPL2)-dependent MAPK1/3 activation","Biosynthesis of DPAn-3-derived protectins and resolvins","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Presynaptic phase of homologo
us DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","Adenylate cyclase inhibitory pathway","Autodegradation of 
the E3 ubiquitin ligase COP1","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{DRD1,DRD2,DRD3,DRD4,DRD5}

> <broad_moa>
{"dopamine receptor agonist"}

> <synonyms>
{ENZO(A)PHENANTHRIDINE10,11-DIOL,11DIOL,5,6,6A,7,8,12B-HEXAHYDRO-,12BHEXAHYDRO,"TRANS- (CAS","TRANS (CAS","Benzo(a)phenanthridine-10,11-diol, 5,6,6a,7,8,12b-hexahydro-, trans- (CAS)","Benzo(a)phenanth
ridine10,11diol, 5,6,6a,7,8,12bhexahydro, trans (CAS)",SMR000466286,MLS000758257,MLS001424195,CHEMBL1461491,CCG-101126,CCG101126,NC00376,SAM001247083,CPD000466286}

> <pdid>
PD047361

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581820}

$$$$
NIHCC_2014
  SciTegic11012413002D

 90 96  0  0  0  0            999 V2000
  -25.0441    1.8756    0.0000 C   0  0
  -23.8393    0.9821    0.0000 C   0  0
  -24.0111   -0.5080    0.0000 C   0  0
  -22.4620    1.5803    0.0000 C   0  0
  -21.8418    0.4814    0.0000 N   0  0
  -20.3226    0.5164    0.0000 C   0  0
  -19.5669   -0.7794    0.0000 O   0  0
  -19.5831    1.7557    0.0000 C   0  0
  -19.4478    3.2444    0.0000 N   0  0
  -18.0861    3.8755    0.0000 C   0  0
  -16.8597    3.0118    0.0000 O   0  0
  -17.9508    5.3702    0.0000 C   0  0
  -19.3994    5.7599    0.0000 C   0  0
  -19.7862    7.2092    0.0000 C   0  0
  -18.7245    8.2688    0.0000 C   0  0
  -19.1114    9.7181    0.0000 C   0  0
  -17.2760    7.8792    0.0000 C   0  0
  -16.2143    8.9388    0.0000 O   0  0
  -14.7658    8.5492    0.0000 C   0  0
  -13.7041    9.6088    0.0000 C   0  0
  -14.0909   11.0581    0.0000 C   0  0
  -12.2556    9.2192    0.0000 C   0  0
  -11.1939   10.2788    0.0000 O   0  0
  -11.8688    7.7699    0.0000 C   0  0
  -12.9305    6.7103    0.0000 C   0  0
  -13.0597    5.2150    0.0000 C   0  0
  -14.4186    4.5801    0.0000 O   0  0
  -11.8299    4.3548    0.0000 N   0  0
  -11.9590    2.8595    0.0000 C   0  0
  -13.0979    3.8523    0.0000 C   0  0
  -14.5060    3.3353    0.0000 C   0  0
  -12.8675    5.3772    0.0000 O   0  0
  -11.4585    5.8395    0.0000 C   0  0
  -11.1703    7.3115    0.0000 O   0  0
  -10.2401    4.8055    0.0000 C   0  0
  -10.5949    3.3523    0.0000 C   0  0
   -9.5102    2.3163    0.0000 C   0  0
  -12.0344    2.9305    0.0000 C   0  0
   -9.4286    5.7434    0.0000 N   0  0
   -8.9906    7.1780    0.0000 C   0  0
   -7.9329    5.6628    0.0000 C   0  0
   -6.9751    6.8172    0.0000 O   0  0
   -7.5764    4.2029    0.0000 C   0  0
   -8.3866    3.2482    0.0000 N   0  0
   -9.3833    3.1666    0.0000 C   0  0
   -7.1955    2.2374    0.0000 C   0  0
   -5.8135    2.8205    0.0000 O   0  0
   -7.3114    0.5527    0.0000 C   0  0
   -6.4672   -0.6642    0.0000 C   0  0
   -7.4471   -1.8189    0.0000 C   0  0
   -8.9400   -1.2559    0.0000 C   0  0
   -8.8013    0.2530    0.0000 N   0  0
  -10.0715    1.2997    0.0000 C   0  0
  -10.1603    2.2957    0.0000 O   0  0
  -11.0977    0.0904    0.0000 C   0  0
  -12.3418    0.3015    0.0000 N   0  0
  -12.8237    1.7427    0.0000 C   0  0
  -14.3025    1.9936    0.0000 O   0  0
  -10.6755   -1.3506    0.0000 C   0  0
  -11.7120   -2.4350    0.0000 C   0  0
   -9.2184   -1.7065    0.0000 C   0  0
  -14.3790    7.0999    0.0000 C   0  0
  -15.4407    6.0403    0.0000 N   0  0
  -16.8892    6.4299    0.0000 C   0  0
  -10.4203    7.3803    0.0000 N   0  0
  -18.2448    0.9731    0.0000 C   0  0
  -18.2699   -0.5267    0.0000 C   0  0
  -16.8882    1.7067    0.0000 O   0  0
  -16.9307    3.1889    0.0000 C   0  0
  -15.6434    3.9588    0.0000 O   0  0
  -18.3163    3.9849    0.0000 C   0  0
  -19.7707    3.6350    0.0000 C   0  0
  -20.8031    4.7232    0.0000 C   0  0
  -20.1974    2.1970    0.0000 C   0  0
  -17.7089    5.0662    0.0000 N   0  0
  -16.2113    4.9820    0.0000 C   0  0
  -18.2915    6.4461    0.0000 C   0  0
  -17.7838    7.3076    0.0000 O   0  0
  -19.7858    6.2868    0.0000 C   0  0
  -20.4095    5.2011    0.0000 N   0  0
  -20.1486    4.2357    0.0000 C   0  0
  -21.7642    5.9792    0.0000 C   0  0
  -21.6839    7.4771    0.0000 O   0  0
  -23.3099    5.2994    0.0000 C   0  0
  -24.7409    5.6813    0.0000 C   0  0
  -25.4953    4.3680    0.0000 C   0  0
  -24.4597    3.1542    0.0000 C   0  0
  -23.0871    3.7960    0.0000 N   0  0
  -21.6719    2.9556    0.0000 C   0  0
  -20.7047    3.2095    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  3
 20 21  1  0
 20 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  2  3
 25 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 30 32  1  0
 32 33  1  0
 33 34  2  0
 33 35  1  0
 35 36  1  0
 36 37  1  0
 36 38  1  0
 35 39  1  0
 39 40  1  0
 39 41  1  0
 41 42  2  0
 41 43  1  0
 43 44  1  0
 44 45  1  0
 44 46  1  0
 46 47  2  0
 46 48  1  0
 48 49  1  0
 49 50  1  0
 50 51  1  0
 51 52  1  0
 52 48  1  0
 52 53  1  0
 53 54  2  0
 53 55  1  0
 55 56  1  0
 56 57  1  0
 57 29  1  0
 57 58  2  0
 55 59  1  0
 59 60  1  0
 59 61  1  0
 25 62  1  0
 62 19  1  0
 62 63  2  3
 63 64  1  0
 64 12  1  0
 64 17  2  0
 24 65  1  0
  8 66  1  0
 66 67  1  0
 66 68  1  0
 68 69  1  0
 69 70  2  0
 69 71  1  0
 71 72  1  0
 72 73  1  0
 72 74  1  0
 71 75  1  0
 75 76  1  0
 75 77  1  0
 77 78  2  0
 77 79  1  0
 79 80  1  0
 80 81  1  0
 80 82  1  0
 82 83  2  0
 82 84  1  0
 84 85  1  0
 85 86  1  0
 86 87  1  0
 87 88  1  0
 88 84  1  0
 88 89  1  0
 89  4  1  0
 89 90  2  0
M  END
> <name>
NIHCC_2014

> <id>
5862

> <plate>
NGP-105-03

> <well>
H09

> <supplier_cmpd_name>
CPD000469227

> <ctcr_id>
6998

> <supplier_cmpd_id>
SAM001246846

> <smiles>
CC(C)C1NC(=O)C(NC(=O)c2ccc(C)c3OC4=C(C)C(=O)C(=C(C(=O)NC5C(C)OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C6CCCN6C(=O)C(NC5=O)C(C)C)C4=Nc23)N)C(C)OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C7CCCN7C1=O

> <pd_targets>
{RPOC,HTT,RORC,BLM,NGLY1,KMT2A,RAD51,ALDH1A1,ALOX15,RECQL,CASP7,ALD,GRB2,HIF1A,CASP1,MAPT,CYP3A4,OST1,HSD17B10,DDR2,TOP2A,TOP2B}

> <pathway_gtopdb>
{"Unclassified protein","Transcription factor",Enzyme,"Epigenetic regulator","Other cytosolic protein","Nuclear receptor",Hydrolase,Reader,Protease,Oxidoreductase,"Cytochrome P450",Kinase,Isomerase,"N
uclear hormone receptor subfamily 1",Bromodomain,"Cysteine protease","Cytochrome P450 family 3","Protein Kinase","Nuclear hormone receptor subfamily 1 group F","Cysteine protease CA clan","Cysteine pr
otease CD clan","Cytochrome P450 family 3A","TK protein kinase group","Nuclear hormone receptor subfamily 1 group F member 3","Cysteine protease C1A family","Cysteine protease C14 family","Cytochrome 
P450 3A4","Tyrosine protein kinase DDR family"}

> <pathway_chembl>
{Receptors,Enzymes,"Nuclear hormone receptors","Chromatin modifying enzymes","Eicosanoid turnover","Peptidases and proteinases","Cytochrome P450","Catalytic receptors","1F. Retinoic acid-related orpha
ns","2.1.1.43 Histone methyltransferases (HMTs)",Lipoxygenases,"CD: Cysteine (C) Peptidases","CYP3 family","Receptor kinases","C14: Caspase","TK: Tyrosine kinase","Receptor tyrosine kinases (RTKs)","T
ype XVI RTKs: DDR (collagen receptor) family"}

> <pathway_reactome>
{"Gene expression (Transcription)","DNA Repair","Metabolism of proteins",Metabolism,"Programmed Cell Death",Disease,"Cellular responses to external stimuli","Neuronal System","Extracellular matrix org
anization","RNA Polymerase II Transcription","DNA Double-Strand Break Repair","Post-translational protein modification","Biological oxidations","Metabolism of lipids",Apoptosis,"Diseases of signal tra
nsduction by growth factor receptors and second messengers","Cellular responses to stress","Transmission across Chemical Synapses","Metabolism of amino acids and derivatives","Non-integrin membrane-EC
M interactions","Generic Transcription Pathway","Homology Directed Repair","Asparagine N-linked glycosylation","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving medi
ators (SPMs)","Intrinsic Pathway for Apoptosis","Signaling by FGFR in disease","Cellular response to hypoxia","Neurotransmitter receptors and postsynaptic signal transmission","Branched-chain amino ac
id catabolism","Transcriptional Regulation by MECP2","Transcriptional regulation by RUNX3","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","N-glycan trimming in the ER an
d Calnexin/Calreticulin cycle","Transcriptional regulation by RUNX1","Ethanol oxidation","Biosynthesis of DPA-derived SPMs","Apoptotic factor-mediated response","Signaling by FGFR1 in disease","Oxygen
-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Transcriptional Regulation by TP53","Activation of NMDA receptors and postsynaptic events","Biosynthesis of DHA-derived SPMs","Regu
lation of MECP2 expression and activity","RUNX3 Regulates Immune Response and Cell Migration","HDR through Homologous Recombination (HRR)","RUNX1 regulates genes involved in megakaryocyte differentiat
ion and platelet function","Biosynthesis of DPAn-3 SPMs","Cytochrome c-mediated apoptotic response","FGFR1 mutant receptor activation","TP53 Regulates Transcription of Cell Death Genes","Post NMDA rec
eptor activation events","Biosynthesis of maresins","Homologous DNA Pairing and Strand Exchange","Biosynthesis of DPAn-3-derived protectins and resolvins","Activation of caspases through apoptosome-me
diated cleavage","Signaling by cytosolic FGFR1 fusion mutants","TP53 Regulates Transcription of Caspase Activators and Caspases","Activation of AMPK downstream of NMDARs","Biosynthesis of maresin-like
 SPMs","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{POLR2A}

> <broad_moa>
{"RNA polymerase inhibitor"}

> <synonyms>
{"actinomycin D",50-76-0,50760,"Actinomycin Aiv","Actinomycin I","Dactinomycin D","Oncostatin K","Chounghwamycin B","Actinomycin 7","Actinomycin I1","Lyovac cosmegen","Actinomycin A IV",Acto-D,ActoD,"
Actinomycin 11 cosmegen","Dilactone actinomycin D acid",NSC18268,NSC3053,SAM001246846,"NSC 18268",CPD000469227,Dactinomycin}

> <pdid>
PD003038

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{2019}

$$$$
NIHCC_2014
  SciTegic11012413002D

 63 68  0  0  1  0            999 V2000
   24.4700   -3.5054    0.0000 Ca  0  2
    6.4897   -5.2632    0.0000 O   0  0
    5.1894   -6.0109    0.0000 C   0  0  2  0  0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0  2  0  0  0
    5.1937   -3.0093    0.0000 O   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0008    0.0000 C   0  0
   -1.2978   -3.7529    0.0000 C   0  0
   -1.2955   -5.2529    0.0000 C   0  0
    0.0048   -6.0009    0.0000 C   0  0
    0.0072   -7.5009    0.0000 F   0  0
    1.3026   -5.2488    0.0000 C   0  0
    1.3002   -3.7488    0.0000 C   0  0
    2.5987    1.5004    0.0000 C   0  0
    4.0196    1.4570    0.0000 C   0  0
    3.2676    2.7548    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    6.4855   -8.2648    0.0000 C   0  0
    7.7858   -7.5171    0.0000 O   0  5
    6.4833   -9.7648    0.0000 O   0  0
   20.6733   -5.2632    0.0000 O   0  0
   19.3730   -6.0109    0.0000 C   0  0  2  0  0  0
   18.0748   -5.2578    0.0000 C   0  0
   18.0769   -3.7570    0.0000 C   0  0  2  0  0  0
   19.3773   -3.0093    0.0000 O   0  0
   16.7787   -3.0039    0.0000 C   0  0
   16.7808   -1.5031    0.0000 C   0  0
   15.4826   -0.7500    0.0000 C   0  0
   15.4826    0.7500    0.0000 C   0  0
   14.1836    1.5000    0.0000 N   0  0
   12.8845    0.7500    0.0000 C   0  0
   11.5855    1.5000    0.0000 C   0  0
   10.2865    0.7500    0.0000 C   0  0
   10.2865   -0.7500    0.0000 C   0  0
   11.5855   -1.5000    0.0000 C   0  0
   12.8845   -0.7500    0.0000 C   0  0
   14.1836   -1.5000    0.0000 C   0  0
   14.1836   -3.0008    0.0000 C   0  0
   12.8857   -3.7529    0.0000 C   0  0
   12.8881   -5.2529    0.0000 C   0  0
   14.1884   -6.0009    0.0000 C   0  0
   14.1907   -7.5009    0.0000 F   0  0
   15.4862   -5.2488    0.0000 C   0  0
   15.4838   -3.7488    0.0000 C   0  0
   16.7823    1.5004    0.0000 C   0  0
   18.2032    1.4570    0.0000 C   0  0
   17.4512    2.7548    0.0000 C   0  0
   19.3709   -7.5117    0.0000 C   0  0
   20.6691   -8.2648    0.0000 C   0  0
   21.9694   -7.5171    0.0000 O   0  5
   20.6669   -9.7648    0.0000 O   0  0
  3  2  1  1
  3  4  1  0
  4  5  1  0
  5  6  1  1
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 12  1  0
 17 18  2  0
 18  9  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 22 24  1  0
 24 25  2  0
 25 19  1  0
 10 26  1  0
 26 27  1  0
 27 28  1  0
 28 26  1  0
  3 29  1  0
 29 30  1  0
 30 31  1  0
 30 32  2  0
 34 33  1  1
 34 35  1  0
 35 36  1  0
 36 37  1  1
 36 38  1  0
 38 39  2  0
 39 40  1  0
 40 41  2  0
 41 42  1  0
 42 43  2  0
 43 44  1  0
 44 45  2  0
 45 46  1  0
 46 47  2  0
 47 48  1  0
 48 43  1  0
 48 49  2  0
 49 40  1  0
 49 50  1  0
 50 51  2  0
 51 52  1  0
 52 53  2  0
 53 54  1  0
 53 55  1  0
 55 56  2  0
 56 50  1  0
 41 57  1  0
 57 58  1  0
 58 59  1  0
 59 57  1  0
 34 60  1  0
 60 61  1  0
 61 62  1  0
 61 63  2  0
M  CHG  3   1   2  31  -1  62  -1
M  END
> <name>
NIHCC_2014

> <id>
5863

> <plate>
NGP-105-03

> <well>
H10

> <supplier_cmpd_name>
CPD000469287

> <ctcr_id>
6181

> <supplier_cmpd_id>
SAM001246803

> <smiles>
[Ca++].O[C@H](C[C@H](O)/C=C/c1c(nc2ccccc2c1c3ccc(F)cc3)C4CC4)CC([O-])=O.O[C@H](C[C@H](O)/C=C/c5c(nc6ccccc6c5c7ccc(F)cc7)C8CC8)CC([O-])=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Pitavastatin calcium",147526-32-7,147526327,Livalo,"Pitavastatin hemicalcium",NK-104,NK104,UNII-IYD54XEG3W,UNIIIYD54XEG3W,"Pitavastatin calcium salt","NK 104",IYD54XEG3W,CHEBI:71258,"Itavastatin cal
cium","Pitavastatin calcium (JAN)",Alipza,Flovas,Livazo,"NK 104 (acid)",Re,SAM001246803,CPD000469287}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5282451,11251522}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 23  0  0  0  0            999 V2000
    3.8869   -8.2595    0.0000 O   0  0
    5.1873   -7.5117    0.0000 C   0  0
    5.1894   -6.0109    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 N   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    6.4855   -8.2648    0.0000 N   0  0
    6.4833   -9.7656    0.0000 C   0  0
    7.7815  -10.5187    0.0000 C   0  0
    7.7816  -12.0187    0.0000 C   0  0
    9.0806  -12.7688    0.0000 C   0  0
   10.3797  -12.0188    0.0000 C   0  0
   10.3797  -10.5188    0.0000 C   0  0
    9.0807   -9.7688    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
  2 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
M  END
> <name>
NIHCC_2014

> <id>
5864

> <plate>
NGP-105-03

> <well>
H11

> <supplier_cmpd_name>
CPD000059131

> <ctcr_id>
2967

> <supplier_cmpd_id>
SAM001246861

> <smiles>
O=C(CCNNC(=O)c1ccncc1)NCc2ccccc2

> <pd_targets>
{CYP2C9,CYP1A2,NFO,NFKB1,CYP2D6,KDM4E,TGR,CYP3A4,LMNA,CYP2C19,TSHR,ALDH1A1,MAOA,MAOB}

> <pathway_gtopdb>
{Enzyme,"Other cytosolic protein","Epigenetic regulator","Other nuclear protein","Membrane receptor","Cytochrome P450",Hydrolase,Eraser,Protease,"Family A G protein-coupled receptor",Oxidoreductase,"C
ytochrome P450 family 2","Cytochrome P450 family 1","Lysine demethylase","Cytochrome P450 family 3","Cysteine protease","Peptide receptor (family A GPCR)","Cytochrome P450 family 2C","Cytochrome P450 
family 1A","Cytochrome P450 family 2D","Jumonji domain-containing","Cytochrome P450 family 3A","Cysteine protease CA clan","Glycohormone receptor","Cytochrome P450 2C9","Cytochrome P450 1A1","Cytochro
me P450 2D6","Cytochrome P450 3A4","Cytochrome P450 2C19","Cysteine protease C1A family"}

> <pathway_chembl>
{Enzymes,Receptors,"Cytochrome P450","Chromatin modifying enzymes","G protein-coupled receptors","CYP2 family: drug metabolising subset","CYP1 family","1.14.11.- Histone demethylases","CYP3 family","G
lycoprotein hormone receptors"}

> <pathway_reactome>
{Metabolism,"Immune System","Cell Cycle",Disease,"Biological oxidations","Cytokine Signaling in Immune system","Metabolism of lipids",Mitotic,"Infectious disease","Phase I - Functionalization of compo
unds","Signaling by Interleukins","Biosynthesis of specialized proresolving mediators (SPMs)","M Phase","Leishmania infection","Cytochrome P450 - arranged by substrate type","Interleukin-1 family sign
aling","Biosynthesis of DHA-derived SPMs","Mitotic Metaphase and Anaphase","Leishmania parasite growth and survival","Ethanol oxidation",Xenobiotics,"Interleukin-1 signaling","Biosynthesis of maresins
","Mitotic Anaphase","Anti-inflammatory response favouring Leishmania parasite infection","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","MAP3K8 (TPL2)-dependent
 MAPK1/3 activation","Biosynthesis of maresin-like SPMs","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{COMT,MAOA,MAOB}

> <broad_moa>
{"monoamine oxidase inhibitor"}

> <synonyms>
{Nialamide,Nialamid,Niamidal,Niamid,51-12-7,51127,Niaquitil,Niazin,Psicodisten,Novazid,Nuredal,Nyazin,Surgex,Mygal,BEIH,Delmoneurina,Isalizina,Espril,Delmoneurinaesprilisalizina,N-(2-(Benzylcarbamyl)e
thylamino)isonicotinamide,N(2(Benzylcarbamyl)ethylamino)isonicotinamide,2-(2-(Benzylcarbamyl)ethy,2(2(Benzylcarbamyl)ethy,T1455,SAM001246861,1505986,Prestw-1099,CPD000059131,NIALAMIDE}

> <pdid>
PD000240

> <targets>
{}

> <classes>
{"MAO inhibitor"}

> <pubchem_cids>
{4472}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 22  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 Cl  0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.4133   -1.7530    0.0000 N   0  0
   -1.8032   -3.1233    0.0000 C   0  0
   -0.3114   -2.9665    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -3.8813   -1.4408    0.0000 C   0  0  2  0  0  0
   -4.8896   -2.5354    0.0000 O   0  0
   -6.2433   -1.8893    0.0000 C   0  0  2  0  0  0
   -7.5587   -2.6066    0.0000 C   0  0
   -7.5961   -4.1061    0.0000 O   0  0
   -6.0471   -0.4022    0.0000 C   0  0  1  0  0  0
   -7.1349    0.6307    0.0000 O   0  0
   -4.5721   -0.1292    0.0000 C   0  0  1  0  0  0
   -3.9177    1.2205    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11  2  1  0
 11  7  2  0
 12  8  1  6
 12 13  1  0
 13 14  1  0
 14 15  1  6
 15 16  1  0
 14 17  1  0
 17 18  1  1
 17 19  1  0
 19 12  1  0
 19 20  1  1
M  END
> <name>
NIHCC_2014

> <id>
5865

> <plate>
NGP-105-04

> <well>
A02

> <supplier_cmpd_name>
CPD000058612

> <ctcr_id>
531

> <supplier_cmpd_id>
SAM001246886

> <smiles>
Nc1nc(Cl)nc2n(cnc12)[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O

> <pd_targets>
{RRM2,HIF1A,ADORA2A,ADORA1,RRM1,LMNA,ADORA3,POLA1,DCK,ADORA2B,MAPK1,TP53,RXFP1,ADA,AMPC,HSF1}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Membrane receptor","Other nuclear protein",Oxidoreductase,"Family A G protein-coupled receptor",Transferase,"Small molecule receptor (family A GPCR)","Nucleotide-like r
eceptor (family A GPCR)","Adenosine receptor",Kinase,Hydrolase,"Protein Kinase","Peptide receptor (family A GPCR)","CMGC protein kinase group","Relaxin-like peptide receptor (family A GPCR)","CMGC pro
tein kinase MAPK family","Relaxin receptor","CMGC protein kinase ERK1","Other cytosolic protein"}

> <pathway_chembl>
{Enzymes,Receptors,"1.17.4.1 Ribonucleoside-diphosphate reductases","G protein-coupled receptors","Adenosine receptors","Kinases (EC 2.7.x.x)","Adenosine turnover","CMGC: Containing CDK",MAPK,GSK3,"CL
K families","Relaxin family peptide receptors","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Cell Cycle","Cellular responses to external stimuli",Disease,"Signal Transduction",Metabolism,Mitotic,"Cellular responses to stress","Infectious disease","Signaling by GPCR","Metabolism of nucleotid
es","Mitotic G1 phase and G1/S transition","Cellular response to hypoxia","Leishmania infection","GPCR ligand binding","Interconversion of nucleotide di- and triphosphates","M Phase","Nucleotide salva
ge","G1/S Transition","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Mitotic Metaphase and
 Anaphase","Purine salvage","G1/S-Specific Transcription","Anti-inflammatory response favouring Leishmania parasite infection","Nucleotide-like (purinergic) receptors","Mitotic Anaphase","E2F mediated
 regulation of DNA replication","ADORA2B mediated anti-inflammatory cytokines production","Adenosine P1 receptors","Nuclear Envelope (NE) Reassembly","Inhibition of replication initiation of damaged D
NA by RB1/E2F1","Initiation of Nuclear Envelope (NE) Reformation","Immune System","Innate Immune System","Cell Cycle Checkpoints","Toll-like Receptor Cascades","G1/S DNA Damage Checkpoints","Toll Like
 Receptor 5 (TLR5) Cascade","p53-Dependent G1/S DNA damage checkpoint","MyD88 cascade initiated on plasma membrane","p53-Dependent G1 DNA Damage Response","MAP kinase activation","Stabilization of p53
","MAPK targets/ Nuclear events mediated by MAP kinases","Autodegradation of the E3 ubiquitin ligase COP1","ERK/MAPK targets","ERKs are inactivated","Cellular response to heat stress","HSF1-dependent 
transactivation","Attenuation phase"}

> <broad_targets>
{ADORA1,ADORA2A,ADORA2B}

> <broad_moa>
{"adenosine receptor agonist"}

> <synonyms>
{2-Chloroadenosine,2Chloroadenosine,146-77-0,146770,"6-Amino-2-chloropurine riboside","6Amino2chloropurine riboside","ADENOSINE, 2-CHLORO-","ADENOSINE, 2CHLORO",2-Chloroadenosinehemihydrate,2Chloroade
nosinehemihydrate,CADO,UNII-7W7ZUG45G8,UNII7W7ZUG45G8,Cl-Ado,ClAdo,MLS000028365,7W7ZUG45G8,CHEMBL285819,2-CADO,2CADO,MFCD00005734,SMR000058612,"2 Chloroadenosine","2-Chloro A","2Chloro A",SAM001246886
,CPD000058612}

> <pdid>
PD002993

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{8974}

$$$$
NIHCC_2014
  SciTegic11012413002D

 31 32  0  0  0  0            999 V2000
   17.9815   -3.0026    0.0000 O   0  0
   15.4815   -3.0026    0.0000 Cl  0  0
   12.9809   -2.9892    0.0000 F   0  0
   11.6844   -3.7436    0.0000 C   0  0
   11.6896   -5.2436    0.0000 C   0  0
   10.3931   -5.9981    0.0000 C   0  0
    9.0914   -5.2526    0.0000 C   0  0
    9.0864   -3.7526    0.0000 C   0  0
   10.3828   -2.9981    0.0000 C   0  0
    7.7928   -6.0048    0.0000 C   0  0
    7.7953   -7.5048    0.0000 O   0  0
    6.4915   -5.2571    0.0000 C   0  0
    5.1924   -6.0070    0.0000 C   0  0
    3.8934   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    5.1925   -3.0070    0.0000 C   0  0
    6.4915   -3.7571    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 S   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  7 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 12  1  0
 15 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 29 30  1  0
 30 20  1  0
 30 31  2  0
M  END
> <name>
NIHCC_2014

> <id>
5866

> <plate>
NGP-105-04

> <well>
A03

> <supplier_cmpd_name>
CPD000466283

> <ctcr_id>
4553

> <supplier_cmpd_id>
SAM001247080

> <smiles>
O.Cl.Fc1ccc(cc1)C(=O)C2CCN(CC2)CCN3C(=S)Nc4ccccc4C3=O

> <pd_targets>
{CHRM1,PMP22,HPGD,CYP2D6,NPSR1,HIF1A,NS1,KDM4E,ADRA1D,ALDH1A1,CYP3A4,HSD17B10,TP53,ALOX12,DRD5,HTR1B,HTR2C,ADRA1B,SLC18A1,HTR2A,HTR2B,ADORA3,DRD2,HTR7,HTR6,HTR5A,CYP2C19,SIGMAR1,CYP2C9,HTR1F,KMT2A,MEN
1,HTR1D,ADRA2B,ADRA2C,HTR1A,ADRA1A,HTR5B,SLC18A2,MAPT,LMNA,CYP1A2,HRH1,ADRA2A,DRD4,HTR4,FTL,RORC}

> <pathway_gtopdb>
{"Membrane receptor","Unclassified protein",Enzyme,"Transcription factor","Epigenetic regulator",Transporter,"Other cytosolic protein","Other nuclear protein","Family A G protein-coupled receptor","Cy
tochrome P450",Eraser,Oxidoreductase,"Electrochemical transporter",Reader,"Small molecule receptor (family A GPCR)","Cytochrome P450 family 2","Peptide receptor (family A GPCR)","Lysine demethylase","
Cytochrome P450 family 3","SLC superfamily of solute carriers",Bromodomain,"Cytochrome P450 family 1","Monoamine receptor","Cytochrome P450 family 2D","Short peptide receptor (family A GPCR)","Jumonji
 domain-containing","Cytochrome P450 family 3A","SLC18 family of vesicular amine transporters","Nucleotide-like receptor (family A GPCR)","Cytochrome P450 family 2C","Cytochrome P450 family 1A","Acety
lcholine receptor","Cytochrome P450 2D6","Neuropeptide receptor","Adrenergic receptor","Cytochrome P450 3A4","Dopamine receptor","Serotonin receptor","Adenosine receptor","Cytochrome P450 2C19","Cytoc
hrome P450 2C9","Cytochrome P450 1A1","Histamine receptor","Nuclear receptor","Nuclear hormone receptor subfamily 1","Nuclear hormone receptor subfamily 1 group F","Nuclear hormone receptor subfamily 
1 group F member 3"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Other protein targets","G protein-coupled receptors","Eicosanoid turnover","Cytochrome P450","Chromatin modifying enzymes","SLC superfamily of solute carriers","Sigma 
receptors","Acetylcholine receptors (muscarinic)","Prostaglandin synthases","CYP2 family: drug metabolising subset","Neuropeptide S receptor","1.14.11.- Histone demethylases",Adrenoceptors,"CYP3 famil
y",Lipoxygenases,"Dopamine receptors","5-Hydroxytryptamine receptors","SLC18 family of vesicular amine transporters","Adenosine receptors","CYP1 family","Histamine receptors","Nuclear hormone receptor
s","1F. Retinoic acid-related orphans"}

> <pathway_reactome>
{"Signal Transduction","Developmental Biology",Metabolism,Disease,"Cellular responses to external stimuli","Cell Cycle","Transport of small molecules","Neuronal System","Signaling by GPCR","Nervous sy
stem development","Metabolism of lipids","Biological oxidations","Infectious disease","Cellular responses to stress","Metabolism of amino acids and derivatives","Cell Cycle Checkpoints","SLC-mediated 
transmembrane transport","Transmission across Chemical Synapses",Mitotic,"GPCR ligand binding","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Biosynthesis of specialized proresolvin
g mediators (SPMs)","Phase I - Functionalization of compounds","Leishmania infection","Cellular response to hypoxia","Branched-chain amino acid catabolism","G1/S DNA Damage Checkpoints","Transport of 
bile salts and organic acids","metal ions and amine compounds","SARS-CoV Infections","Neurotransmitter release cycle","Neurotransmitter receptors and postsynaptic signal transmission","M Phase","Class
 A/1 (Rhodopsin-like receptors)","Biosynthesis of DHA-derived SPMs","Cytochrome P450 - arranged by substrate type","Leishmania parasite growth and survival","Oxygen-dependent proline hydroxylation of 
Hypoxia-inducible Factor Alpha","Ethanol oxidation","p53-Dependent G1/S DNA damage checkpoint","Biosynthesis of DPA-derived SPMs","Na+/Cl- dependent neurotransmitter transporters","Potential therapeut
ics for SARS","Dopamine Neurotransmitter Release Cycle","Activation of NMDA receptors and postsynaptic events","Mitotic Metaphase and Anaphase","Amine ligand-binding receptors","Biosynthesis of D-seri
es resolvins",Xenobiotics,"Anti-inflammatory response favouring Leishmania parasite infection","Biosynthesis of maresins","p53-Dependent G1 DNA Damage Response","Biosynthesis of DPAn-3 SPMs","Nucleoti
de-like (purinergic) receptors","Post NMDA receptor activation events","Mitotic Anaphase","Muscarinic acetylcholine receptors","CYP2E1 reactions","ADORA2B mediated anti-inflammatory cytokines producti
on",Adrenoceptors,"Biosynthesis of maresin-like SPMs","Stabilization of p53","Biosynthesis of DPAn-3-derived maresins","Serotonin receptors","Adenosine P1 receptors","Dopamine receptors","Activation o
f AMPK downstream of NMDARs","Nuclear Envelope (NE) Reassembly","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Histamine receptors","Autodegradation of the E3 ubiquitin ligase COP
1","Initiation of Nuclear Envelope (NE) Reformation","Vesicle-mediated transport","Gene expression (Transcription)","Membrane Trafficking","RNA Polymerase II Transcription","trans-Golgi Network Vesicl
e Budding","Generic Transcription Pathway","Golgi Associated Vesicle Biogenesis","Transcriptional regulation by RUNX3","RUNX3 Regulates Immune Response and Cell Migration"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,DRD1,DRD5,HTR1A,HTR1B,HTR1D,HTR2A,HTR2B,HTR2C,HTR5A,HTR7,SLC18A1,SLC18A2}

> <broad_moa>
{"serotonin receptor antagonist"}

> <synonyms>
{SMR000466283,CPD000466283,MLS000758221,MLS001424187,CHEMBL1371857,CCG-101056,CCG101056,NC00306,"Altanserin hydrochloride hydrate, >=98 (HPLC), solid",T1066,SAM001247080,Ketanserin}

> <pdid>
PD000921

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581819}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 27  0  0  0  0            999 V2000
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 O   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0008    0.0000 C   0  0
   -1.2978   -3.7529    0.0000 C   0  0
   -1.2955   -5.2529    0.0000 C   0  0
    0.0048   -6.0009    0.0000 C   0  0
    1.3026   -5.2488    0.0000 C   0  0
    1.3002   -3.7488    0.0000 C   0  0
   -2.5925   -6.0081    0.0000 N   0  3
   -2.5879   -7.5081    0.0000 O   0  0
   -3.8940   -5.2624    0.0000 O   0  5
   -2.5972   -1.5031    0.0000 C   0  0
   -3.8976   -0.7554    0.0000 O   0  0
   -2.5951   -3.0039    0.0000 O   0  0
   -3.8926   -3.7566    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  2  3
  7  8  1  0
  8  9  1  0
  9 10  2  3
 10 11  1  0
 11  6  1  0
 11 12  1  0
 12 13  2  3
 13 14  1  0
 14 15  2  3
 15 16  1  0
 16 17  2  3
 17 12  1  0
 14 18  1  0
 18 19  2  0
 18 20  1  0
 10 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
  9 25  1  0
  7 26  1  0
M  CHG  2  18   1  20  -1
M  END
> <name>
NIHCC_2014

> <id>
5867

> <plate>
NGP-105-04

> <well>
A04

> <supplier_cmpd_name>
CPD000058366

> <ctcr_id>
5916

> <supplier_cmpd_id>
SAM001246531

> <smiles>
CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C

> <pd_targets>
{BLM,CACNA1C,CACNA1D,CACNA1F,CACNA1S,PTAFR,LMNA,MAPT,ABCB11,KCNN4,SCN1A,SCN2A,SCN3A,FTL,ADORA2A,KCNH2,ADORA1,PMP22,SCN10A,SCN11A,SCN4A,SCN5A,SCN7A,SCN8A,SCN9A,GMNN,ADORA3,ABCB1,CYP2C19,MTOR,TRPA1,CYP2
C9,CACNA2D1,CACNB2,CACNA2D2,CACNA1H,CYP1A2,NFKB1,THPO,KMT2A,MEN1,TSHR,CYP3A4,HIF1A,CYP2D6,LEF}

> <pathway_gtopdb>
{Enzyme,"Ion channel","Membrane receptor","Other nuclear protein","Other cytosolic protein",Transporter,"Unclassified protein","Auxiliary transport protein","Voltage-gated ion channel","Family A G pro
tein-coupled receptor","Primary active transporter","Cytochrome P450",Kinase,"Calcium channel auxiliary subunit alpha2delta family","Calcium channel auxiliary subunit beta family","Voltage-gated calci
um channel","Small molecule receptor (family A GPCR)","ATP-binding cassette","Potassium channels","Voltage-gated sodium channel","Cytochrome P450 family 2","Protein Kinase","Transient receptor potenti
al channel","Lipid-like ligand receptor (family A GPCR)","ABCB subfamily","Calcium-activated potassium channel","Nucleotide-like receptor (family A GPCR)","Voltage-gated potassium channel","Cytochrome
 P450 family 2C","Atypical protein kinase group","PAF receptor","Adenosine receptor","Cytochrome P450 2C19","Atypical protein kinase PIKK family","Cytochrome P450 2C9","Atypical protein kinase FRAP su
bfamily","Epigenetic regulator","Transcription factor",Reader,"Cytochrome P450 family 1",Bromodomain,"Peptide receptor (family A GPCR)","Cytochrome P450 family 3","Cytochrome P450 family 1A","Glycohor
mone receptor","Cytochrome P450 family 3A","Cytochrome P450 family 2D","Cytochrome P450 1A1","Cytochrome P450 3A4","Cytochrome P450 2D6",Protease,"Metallo protease","Metallo protease MAE clan","Metall
o protease M34 family"}

> <pathway_chembl>
{Receptors,Transporters,"Ion channels",Enzymes,"G protein-coupled receptors","ATP-binding cassette transporter family","Voltage-gated ion channels","Cytochrome P450","Kinases (EC 2.7.x.x)","Platelet-a
ctivating factor receptor","ABCB subfamily","Potassium channels","Voltage-gated calcium channels","Adenosine receptors","CYP2 family: drug metabolising subset",Atypical,"Transient Receptor Potential c
hannels","Calcium- and sodium-activated potassium channels","Voltage-gated potassium channels","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","FRAP subfamily","CYP1 family","Glycoprot
ein hormone receptors","CYP3 family"}

> <pathway_reactome>
{"DNA Repair","Immune System","Cell Cycle","Neuronal System",Metabolism,"Vesicle-mediated transport","Developmental Biology",Disease,"Muscle contraction","Signal Transduction","Gene expression (Transc
ription)","Transport of small molecules","DNA Double-Strand Break Repair","Cytokine Signaling in Immune system",Mitotic,"Transmission across Chemical Synapses","Metabolism of lipids","Potassium Channe
ls","Membrane Trafficking","Nervous system development","Infectious disease","Cardiac conduction","Signaling by GPCR","Abacavir transport and metabolism","Biological oxidations","RNA Polymerase II Tra
nscription","Ion channel transport","Integration of energy metabolism","Homology Directed Repair","Interferon Signaling","M Phase","Neurotransmitter receptors and postsynaptic signal transmission","Me
tabolism of steroids","Ca2+ activated K+ channels","trans-Golgi Network Vesicle Budding","Axon guidance","Leishmania infection","Phase 3 - rapid repolarisation","GPCR ligand binding","EGR2 and SOX10-m
ediated initiation of Schwann cell myelination","Mitotic G1 phase and G1/S transition","Abacavir transmembrane transport","Phase I - Functionalization of compounds","Generic Transcription Pathway","St
imuli-sensing channels","Regulation of insulin secretion","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Interferon gamma signaling","Mitotic Metaphase and Anaphase","A
ctivation of NMDA receptors and postsynaptic events","Bile acid and bile salt metabolism","Golgi Associated Vesicle Biogenesis","NCAM signaling for neurite out-growth","Leishmania parasite growth and 
survival","Class A/1 (Rhodopsin-like receptors)","G1/S Transition","Cytochrome P450 - arranged by substrate type","Transcriptional Regulation by TP53","TRP channels",Adrenaline,"noradrenaline inhibits
 insulin secretion","HDR through Homologous Recombination (HRR)","Mitotic Anaphase","Post NMDA receptor activation events","Synthesis of bile acids and bile salts","NCAM1 interactions","Anti-inflammat
ory response favouring Leishmania parasite infection","Nucleotide-like (purinergic) receptors","Activation of the pre-replicative complex",Xenobiotics,"Regulation of TP53 Activity","Homologous DNA Pai
ring and Strand Exchange","Nuclear Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","ADORA2B mediated anti-inf
lammatory cytokines production","Adenosine P1 receptors","CYP2E1 reactions","Regulation of TP53 Expression and Degradation","Presynaptic phase of homologous DNA pairing and strand exchange","Initiatio
n of Nuclear Envelope (NE) Reformation","Regulation of TP53 Degradation",Hemostasis,"Cellular responses to external stimuli","Platelet activation","signaling and aggregation","Cellular responses to st
ress","Signaling by Interleukins","Platelet Aggregation (Plug Formation)","Biosynthesis of specialized proresolving mediators (SPMs)","Cellular response to hypoxia","Interleukin-1 family signaling","B
iosynthesis of DHA-derived SPMs","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Interleukin-1 signaling","Biosynthesis of maresins","Aromatic amines can be N-hydroxylated 
or N-dealkylated by CYP1A2","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Biosynthesis of maresin-like SPMs","Uptake and actions of bacterial toxins","Uptake and function of anthrax toxins"}

> <broad_targets>
{CACNA1D,CACNA2D1,KCNN4}

> <broad_moa>
{"calcium channel blocker"}

> <synonyms>
{nitrendipine,39562-70-4,Baypress,Bayotensin,Nidrel,Nitrendipin,Nitrendipinum,Bay-e-5009,Nitrendipino,Bylotensin,Deiten,"BAY e 5009","Nitrendipinum (INN-Latin)","Nitrendipino (INN-Spanish)",CHEBI:7582
,MFCD00082255,MLS000069349,NCGC00015713-07,SMR000058366,DSSTox_CID_3373,DSSTox_RID_77001,DSSTox_GSID_23373,Baylotensin,"Baypress (TN)",SR-01000075334,"EINECS 254-513-1","BRN 0498823","Nitrendipine,(S)
","Nitrendipine (USAN:INN:BAN:JAN)",CAS-39562-70-4,Spectrum_001901,Opera_ID_928,SpecPlus_000742,Prestwick0_000916,Prestwick1_000916,Prestwick2_000916,Prestwick3_000916,Spectrum2_001565,Spectrum3_00096
8,Spectrum4_001088,Spectrum5_001655,N-144,(.+/-.)-Nitrendipine,CBiol_001834,Lopac0_000881,Oprea1_472855,Oprea1_703261,SCHEMBL38972,BSPBio_000792,BSPBio_001399,BSPBio_002575,KBioGR_000119,KBioGR_001476
,KBioSS_000119,KBioSS_002432,MLS000759400,MLS001148149,MLS001424133,MLS002153303,MLS002154060,DivK1c_006838,"Nitrendipine, >95, powder",SPECTRUM1503609,SPBio_001470,SPBio_002981,BPBio1_000872,GTPL2334
,CHEMBL3195219,DTXSID0023373,KBio1_001782,KBio2_000119,KBio2_002426,KBio2_002687,KBio2_004994,KBio2_005255,KBio2_007562,KBio3_000237,KBio3_000238,KBio3_001795,BRD6392,"Nitrendipine (JP17/USAN/INN)",Bi
o1_000120,Bio1_000609,Bio1_001098,Bio2_000119,Bio2_000599,HMS1361F21,HMS1570H14,HMS1791F21,HMS1989F21,HMS2051B04,HMS2089H15,HMS2093G17,HMS2097H14,HMS2230F04,HMS3262B04,HMS3266B03,HMS3371J07,HMS3393B04
,HMS3402F21,HMS3411I14,HMS3651F05,HMS3675I14,HMS3714H14,HMS3884H21,Pharmakon1600-01503609,BCP07540,BRD-6392,HY-B0424,Tox21_110201,Tox21_500881,AC-648,BBL028163,BDBM50237611,CA-212,CCG-39343,NSC758466,
STK368903,AKOS000622913,AKOS015894921,Tox21_110201_1,CCG-100991,DB01054,KS-1305,LP00881,MCULE-3680092622,NC00241,NSC-758466,SDCCGSBI-0050856.P004,IDI1_033869,NCGC00015713-04,NCGC00015713-05,NCGC000157
13-06,NCGC00015713-08,NCGC00015713-09,NCGC00015713-10,NCGC00015713-11,NCGC00015713-13,NCGC00015713-26,NCGC00024013-02,NCGC00024676-02,NCGC00024676-03,NCGC00024676-04,NCGC00024676-05,NCGC00024676-06,NC
GC00024676-07,NCGC00261566-01,86052-02-0,AK163638,ST078195,SY058769,SBI-0050856.P003,AB0012200,AB00513962,EU-0100881,FT-0601600,S2491,SW219737-1,C07713,D00629,K-8501,AB00053154-03,AB00053154_04,AB0005
3154_05,562N704,Q416584,SR-01000075334-1,SR-01000075334-2,SR-01000075334-4,SR-01000075334-6,W-106422,BRD-A02006392-001-06-5,BRD-A02006392-001-09-9,"Nitrendipine, European Pharmacopoeia (EP) Reference 
Standard",SAM001246531,CPD000058366}

> <pdid>
PD002662

> <targets>
{Autophagy,Calcium Channel}

> <classes>
{Autophagy,Membrane Transporter/Ion Channel,Neuronal Signaling}

> <pubchem_cids>
{4507}

$$$$
NIHCC_2014
  SciTegic11012413002D

 43 47  0  0  1  0            999 V2000
   -3.9277   -9.7248    0.0000 C   0  0
   -3.9224   -8.2248    0.0000 C   0  0  2  0  0  0
   -2.6208   -7.4793    0.0000 O   0  0
   -2.6155   -5.9793    0.0000 C   0  0  1  0  0  0
   -1.3117   -5.2360    0.0000 O   0  0
   -0.0156   -5.9928    0.0000 C   0  0
    1.2883   -5.2495    0.0000 C   0  0  1  0  0  0
    1.2935   -3.7495    0.0000 O   0  0
    2.5951   -3.0039    0.0000 C   0  0  1  0  0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 O   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
    2.5987    1.5004    0.0000 C   0  0
    3.8991    0.7525    0.0000 C   0  0
    5.1969    1.5046    0.0000 C   0  0
    5.1945    3.0046    0.0000 C   0  0
    6.4923    3.7567    0.0000 O   0  0
    3.8943    3.7525    0.0000 C   0  0
    3.8919    5.2525    0.0000 O   0  0
    2.5964    3.0004    0.0000 C   0  0
    3.8915   -3.7585    0.0000 C   0  0  2  0  0  0
    5.1932   -3.0130    0.0000 O   0  0
    3.8864   -5.2585    0.0000 C   0  0  1  0  0  0
    5.1828   -6.0130    0.0000 O   0  0
    2.5847   -6.0040    0.0000 C   0  0  2  0  0  0
    2.5796   -7.5040    0.0000 O   0  0
   -3.9120   -5.2248    0.0000 C   0  0  2  0  0  0
   -3.9068   -3.7248    0.0000 O   0  0
   -5.2137   -5.9703    0.0000 C   0  0  2  0  0  0
   -6.5101   -5.2158    0.0000 O   0  0
   -5.2189   -7.4703    0.0000 C   0  0  1  0  0  0
   -6.5205   -8.2158    0.0000 O   0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  1  6
  5  6  1  0
  7  6  1  1
  7  8  1  0
  8  9  1  0
  9 10  1  1
 10 11  1  0
 11 12  2  3
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
 21 14  1  0
 21 22  1  0
 22 11  1  0
 22 23  2  0
 12 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 27 29  1  0
 29 30  1  0
 29 31  2  0
 31 24  1  0
  9 32  1  0
 32 33  1  6
 32 34  1  0
 34 35  1  1
 34 36  1  0
 36  7  1  0
 36 37  1  6
  4 38  1  0
 38 39  1  1
 38 40  1  0
 40 41  1  1
 40 42  1  0
 42  2  1  0
 42 43  1  6
M  END
> <name>
NIHCC_2014

> <id>
5868

> <plate>
NGP-105-04

> <well>
A05

> <supplier_cmpd_name>
CPD000112560

> <ctcr_id>
3610

> <supplier_cmpd_id>
SAM001246528

> <smiles>
C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O

> <pd_targets>
{XDH,NA,ADRA2C,ALB,KDM1A,ACHE,TGR,PRSS1,PRSS2,PRSS3,ADRA2A,AKR1B1,POLB,GAA,MAPK1,EPHX2,ALD,NANH,KDM4E,MAPT,NMUR2,CYP3A4,L3MBTL1,APEX1,RECQL,AMPC,DYRK1A}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Secreted protein","Epigenetic regulator","Other cytosolic protein",Oxidoreductase,Hydrolase,"Family A G protein-coupled receptor",Eraser,Protease,Kinase,"Cytochrome P450",
"Small molecule receptor (family A GPCR)","Lysine demethylase","Serine protease","Protein Kinase","Peptide receptor (family A GPCR)","Cytochrome P450 family 3","Monoamine receptor","Lysine-specific de
methylase","Serine protease PA clan","CMGC protein kinase group","Serine protease SC clan","Jumonji domain-containing","Short peptide receptor (family A GPCR)","Cytochrome P450 family 3A","Adrenergic 
receptor","Serine protease S1A subfamily","CMGC protein kinase MAPK family","Serine protease S33 family","Neuromedin U receptor","Cytochrome P450 3A4","CMGC protein kinase ERK1",Reader,"Methyl-lysine/
arginine binding protein","MBT domain","CMGC protein kinase DYRK family","CMGC protein kinase Dyrk1 subfamily"}

> <pathway_chembl>
{Enzymes,Receptors,"1.-.-.- Oxidoreductases","G protein-coupled receptors","Chromatin modifying enzymes","Acetylcholine turnover","3.2.1.- Glycosidases","Kinases (EC 2.7.x.x)",Hydrolases,"Cytochrome P
450",Adrenoceptors,"1.14.11.- Histone demethylases","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Neuromedin U receptors","CYP3 family","Mitogen-activated protein kinases (MAP kinases)","ERK subfam
ily","Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase (DYRK) family","Dyrk1 subfamily"}

> <pathway_reactome>
{Metabolism,"Signal Transduction","DNA Repair",Disease,"Immune System","Neuronal System","Metabolism of nucleotides","Signaling by GPCR","Metabolism of lipids","Intracellular signaling by second messe
ngers","Base Excision Repair","Diseases of metabolism","Innate Immune System","Transmission across Chemical Synapses","Nucleobase catabolism","GPCR ligand binding","Metabolism of steroids","PIP3 activ
ates AKT signaling","Phospholipid metabolism","Resolution of Abasic Sites (AP sites)","Diseases of carbohydrate metabolism","Toll-like Receptor Cascades","Biosynthesis of specialized proresolving medi
ators (SPMs)","Neurotransmitter receptors and postsynaptic signal transmission","Purine catabolism","Class A/1 (Rhodopsin-like receptors)","Bile acid and bile salt metabolism","PTEN Regulation","Glyce
rophospholipid biosynthesis","Metabolism of steroid hormones","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Glycogen storage diseases","Toll Like Receptor 5 (TLR5) Ca
scade","Biosynthesis of DHA-derived SPMs","Activation of NMDA receptors and postsynaptic events","Amine ligand-binding receptors","Recycling of bile acids and salts","Regulation of PTEN gene transcrip
tion","Synthesis of PC","Pregnenolone biosynthesis","PCNA-Dependent Long Patch Base Excision Repair","Glycogen storage disease type II (GAA)","MyD88 cascade initiated on plasma membrane","Biosynthesis
 of maresins","Post NMDA receptor activation events","Peptide ligand-binding receptors",Adrenoceptors,"MAP kinase activation","Activation of AMPK downstream of NMDARs","Biosynthesis of maresin-like SP
Ms","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated","Gene expression (Transcription)","RNA Polymerase II Transcription","Generic Transcription Pathway"
,"Transcriptional Regulation by TP53","Regulation of TP53 Activity","Regulation of TP53 Activity through Methylation","Cell Cycle",Mitotic,"Mitotic G1 phase and G1/S transition","G0 and Early G1"}

> <broad_targets>
{AKR1C3}

> <broad_moa>
{antioxidant,"capillary stabilizing agent","nitric oxide scavenger"}

> <synonyms>
{Globularicitrin,RUTIN,153-18-4,153184,rutoside,Phytomelin,"Quercetin 3-rutinoside","Quercetin 3rutinoside",Birutan,Eldrin,"Rutin trihydrate",Bioflavonoid,Myrticolorin,Rutabion,Venoruton,"3-Rutinosyl 
quercetin","3Rutinosyl quercetin",Violaquercitrin,Osyritrin,Paliuroside,Tanrutin,3-Rhamnoglucosyl,3Rhamnoglucosyl,T0795,SAM001246528,Rutin,CPD000112560}

> <pdid>
PD001996

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5280805}

$$$$
NIHCC_2014
  SciTegic11012413002D

 50 53  0  0  1  0            999 V2000
   11.7060   -0.7866    0.0000 C   0  0
   10.4033   -1.5302    0.0000 C   0  0
    9.1082   -0.7735    0.0000 C   0  0
   10.3950   -3.0311    0.0000 C   0  0  2  0  0  0
   11.6924   -3.7856    0.0000 N   0  0
   12.9950   -3.0401    0.0000 C   0  0
   13.0002   -1.5401    0.0000 O   0  0
   14.2924   -3.7946    0.0000 N   0  0
   14.2871   -5.2946    0.0000 C   0  0
   15.5949   -3.0491    0.0000 C   0  0
   16.8923   -3.8037    0.0000 C   0  0
   18.2469   -3.1897    0.0000 C   0  0
   19.2448   -4.3096    0.0000 S   0  0
   18.4880   -5.6048    0.0000 C   0  0
   17.0225   -5.2852    0.0000 N   0  0
   19.0874   -6.9779    0.0000 C   0  0
   18.1977   -8.1855    0.0000 C   0  0
   20.5781   -7.1451    0.0000 C   0  0
    9.0924   -3.7765    0.0000 C   0  0
    9.0872   -5.2765    0.0000 O   0  0
    7.7951   -3.0220    0.0000 N   0  0
    6.4925   -3.7675    0.0000 C   0  0  2  0  0  0
    5.1951   -3.0130    0.0000 C   0  0
    5.1989   -1.5121    0.0000 C   0  0  2  0  0  0
    6.5000   -0.7658    0.0000 O   0  0
    3.9015   -0.7576    0.0000 C   0  0  2  0  0  0
    2.5981   -1.5017    0.0000 C   0  0
    1.3015   -0.7457    0.0000 C   0  0
   -0.0022   -1.4875    0.0000 C   0  0
   -1.2965   -0.7293    0.0000 C   0  0
   -1.2870    0.7707    0.0000 C   0  0
    0.0168    1.5125    0.0000 C   0  0
    1.3110    0.7543    0.0000 C   0  0
    3.9053    0.7432    0.0000 N   0  0
    5.2065    1.4911    0.0000 C   0  0
    6.5039    0.7383    0.0000 O   0  0
    5.2103    2.9920    0.0000 O   0  0
    6.5114    3.7399    0.0000 C   0  0
    6.5152    5.2407    0.0000 C   0  0
    7.7291    6.1000    0.0000 S   0  0
    7.2663    7.5268    0.0000 C   0  0
    5.7663    7.5275    0.0000 N   0  0
    5.3021    6.1011    0.0000 C   0  0
    6.4842   -5.2683    0.0000 C   0  0
    5.1807   -6.0123    0.0000 C   0  0
    5.1702   -7.5123    0.0000 C   0  0
    3.8660   -8.2533    0.0000 C   0  0
    2.5722   -7.4943    0.0000 C   0  0
    2.5826   -5.9943    0.0000 C   0  0
    3.8868   -5.2534    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  6
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 11  1  0
 14 16  1  0
 16 17  1  0
 16 18  1  0
  4 19  1  0
 19 20  2  0
 19 21  1  0
 22 21  1  1
 22 23  1  0
 23 24  1  0
 24 25  1  1
 24 26  1  0
 26 27  1  6
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 28  1  0
 26 34  1  0
 34 35  1  0
 35 36  2  0
 35 37  1  0
 37 38  1  0
 38 39  1  0
 39 40  1  0
 40 41  1  0
 41 42  2  0
 42 43  1  0
 43 39  2  0
 22 44  1  0
 44 45  1  0
 45 46  2  0
 46 47  1  0
 47 48  2  0
 48 49  1  0
 49 50  2  0
 50 45  1  0
M  END
> <name>
NIHCC_2014

> <id>
5869

> <plate>
NGP-105-04

> <well>
A06

> <supplier_cmpd_name>
CPD000466395

> <ctcr_id>
4324

> <supplier_cmpd_id>
SAM001246783

> <smiles>
CC(C)[C@H](NC(=O)N(C)Cc1csc(n1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc3scnc3)Cc4ccccc4

> <pd_targets>
{FTL,NPSR1,CYP2D6,CYP3A4,ABCB1,CYP2C19,CYP3A5,POL,UGT1A1,PROTEASE,CYP2B6,MAPK1,ABCB11,ALDH1A1,KMT2A,MEN1,CYP2C9,MAPT,RORC,AVPR1A,SLCO1B3,SLCO1B1,SLC47A2,OPRK1,TACR2,OPRM1,SLC47A1,SLC22A1,ABCC3,ABCB1A,
NR1I2,TBXAS1,SLCO2B1,SLC22A2,ABCG2,ABCC4}

> <pathway_gtopdb>
{"Unclassified protein","Membrane receptor",Enzyme,Transporter,"Epigenetic regulator","Other cytosolic protein","Transcription factor","Family A G protein-coupled receptor","Cytochrome P450","Primary 
active transporter",Protease,Transferase,Kinase,Oxidoreductase,Reader,"Nuclear receptor","Electrochemical transporter","Peptide receptor (family A GPCR)","Cytochrome P450 family 2","Cytochrome P450 fa
mily 3","ATP-binding cassette","Cysteine protease","Aspartic protease","Protein Kinase",Bromodomain,"Nuclear hormone receptor subfamily 1","SLC superfamily of solute carriers","Cytochrome P450 family 
5","Short peptide receptor (family A GPCR)","Cytochrome P450 family 2D","Cytochrome P450 family 3A","ABCB subfamily","Cysteine protease CA clan","Cytochrome P450 family 2C","Aspartic protease AA clan"
,"Cysteine protease PAC clan","Cytochrome P450 family 2B","CMGC protein kinase group","Nuclear hormone receptor subfamily 1 group F","SLC21/SLCO family of organic anion transporting polypeptides","SLC
47 family of multidrug and toxin extrusion transporters","SLC22 family of organic cation and anion transporters","ABCC subfamily","Nuclear hormone receptor subfamily 1 group I","Cytochrome P450 family
 5A","ABCG subfamily","Neuropeptide receptor","Cytochrome P450 2D6","Cytochrome P450 3A4","Cysteine protease C1A family","Cytochrome P450 2C19","Cytochrome P450 3A5","Aspartic protease A2A subfamily",
"Cysteine protease C3A subfamily","Cytochrome P450 2B6","CMGC protein kinase MAPK family","Cytochrome P450 2C9","Nuclear hormone receptor subfamily 1 group F member 3","Vasopressin and oxytocin recept
or","Opioid receptor","Neurokinin receptor","Nuclear hormone receptor subfamily 1 group I member 2","Cytochrome P450 5A1","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"G protein-coupled receptors","Cytochrome P450","ATP-binding cassette transporter family","UDP glucuronosyltransferases (UGT)","Kinases (EC 2.7.x.x)","Nuclear hormone r
eceptors","SLC superfamily of solute carriers","Neuropeptide S receptor","CYP2 family: drug metabolising subset","CYP3 family","ABCB subfamily","CMGC: Containing CDK",MAPK,GSK3,"CLK families","1F. Ret
inoic acid-related orphans","Vasopressin and oxytocin receptors","SLCO family of organic anion transporting polypeptides","SLC47 family of multidrug and toxin extrusion transporters","Opioid receptors
","Tachykinin receptors","SLC22 family of organic cation and anion transporters","ABCC subfamily","1I. Vitamin D receptor-like receptors",CYP5,"CYP7 and CYP8 families","ABCG subfamily","Mitogen-activa
ted protein kinases (MAP kinases)","Organic cation transporters (OCT)","ERK subfamily"}

> <pathway_reactome>
{"Vesicle-mediated transport",Disease,Metabolism,"Immune System","Neuronal System","Gene expression (Transcription)","Signal Transduction","Transport of small molecules","Metabolism of proteins",Hemos
tasis,"Membrane Trafficking","Infectious disease","Biological oxidations","Metabolism of lipids","Abacavir transport and metabolism","Diseases of metabolism","Innate Immune System","Transmission acros
s Chemical Synapses","RNA Polymerase II Transcription","Signaling by GPCR","SLC-mediated transmembrane transport","Post-translational protein modification","Platelet activation","signaling and aggrega
tion","trans-Golgi Network Vesicle Budding","Leishmania infection","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","Abacavir transmembrane transp
ort","Metabolic disorders of biological oxidation enzymes","Toll-like Receptor Cascades","Metabolism of steroids","Neurotransmitter receptors and postsynaptic signal transmission","Generic Transcripti
on Pathway","GPCR ligand binding","Transport of bile salts and organic acids","metal ions and amine compounds","GPCR downstream signalling",SUMOylation,"Transport of vitamins",nucleosides,"and related
 molecules","Response to elevated platelet cytosolic Ca2+","Golgi Associated Vesicle Biogenesis","Leishmania parasite growth and survival","Cytochrome P450 - arranged by substrate type","Biosynthesis 
of DHA-derived SPMs","Defective UGT1A1 causes hyperbilirubinemia","Toll Like Receptor 5 (TLR5) Cascade","Bile acid and bile salt metabolism","Ethanol oxidation","Activation of NMDA receptors and posts
ynaptic events","Transcriptional regulation by RUNX3","Class A/1 (Rhodopsin-like receptors)","Transcriptional Regulation by MECP2","G alpha (i) signalling events","Organic cation/anion/zwitterion tran
sport","SUMO E3 ligases SUMOylate target proteins","Transport of organic anions","Platelet degranulation","Anti-inflammatory response favouring Leishmania parasite infection",Xenobiotics,"Biosynthesis
 of maresins","MyD88 cascade initiated on plasma membrane","Synthesis of bile acids and bile salts","Post NMDA receptor activation events","RUNX3 Regulates Immune Response and Cell Migration","Peptide
 ligand-binding receptors","Recycling of bile acids and salts","MECP2 regulates neuronal receptors and channels","Opioid Signalling","Organic cation transport","SUMOylation of intracellular receptors"
,Eicosanoids,"ADORA2B mediated anti-inflammatory cytokines production","CYP2E1 reactions","Biosynthesis of maresin-like SPMs","MAP kinase activation","Synthesis of bile acids and bile salts via 7alpha
-hydroxycholesterol","Activation of AMPK downstream of NMDARs","Vasopressin-like receptors","Tachykinin receptors bind tachykinins","G-protein activation","MAPK targets/ Nuclear events mediated by MAP
 kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{CYP1A2,CYP2B6,CYP2C19,CYP2C8,CYP2C9,CYP2D6,CYP2E1,CYP3A4,CYP3A5,CYP3A7}

> <broad_moa>
{"HIV protease inhibitor"}

> <synonyms>
{ritonavir,155213-67-5,155213675,Norvir,ABT-538,ABT538,"Abbott 84538",A-84538,A84538,ABBOTT-84538,ABBOTT84538,UNII-O3J8G9O825,UNIIO3J8G9O825,RTV,CHEBI:45409,O3J8G9O825,MFCD00927142,NSC693184,"Ritonavi
r, 98",NSC-693184,NCGC00159462-02,NCGC0015946202,NCGC00183130-01,NCGC0018313001,"Norvir Softgel",DSSTox_CID_28553,DSSToxCID28553,DSSTox-CID-28553,"DSSTox CID 28553",DSSTox_RID_82,DSSToxRID82,DSSTox-RI
D-82,"DSSTox RID 82",T1525,SAM001246783,Ritonavir,CPD000466395}

> <pdid>
PD001134

> <targets>
{Apoptosis,HIV,HIV Protease,SARS-CoV}

> <classes>
{Anti-infection,Apoptosis,Metabolic Enzyme/Protease}

> <pubchem_cids>
{392622}

$$$$
NIHCC_2014
  SciTegic11012413002D

 19 20  0  0  0  0            999 V2000
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -0.0031    3.0008    0.0000 O   0  0
   -1.3032    3.7490    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 C   0  0
   -2.5951   -3.0039    0.0000 C   0  0
   -3.8933   -3.7570    0.0000 C   0  0
   -3.8934   -5.2570    0.0000 C   0  0
   -5.1924   -6.0071    0.0000 C   0  0
   -6.4914   -5.2571    0.0000 C   0  0
   -7.7905   -6.0071    0.0000 O   0  0
   -6.4915   -3.7571    0.0000 C   0  0
   -5.1925   -3.0071    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 12  1  0
  9 19  2  0
 19  3  1  0
M  END
> <name>
NIHCC_2014

> <id>
5870

> <plate>
NGP-105-04

> <well>
A07

> <supplier_cmpd_name>
CPD000440694

> <ctcr_id>
6632

> <supplier_cmpd_id>
SAM001246605

> <smiles>
COc1cc(OC)cc(\C=C\c2ccc(O)cc2)c1

> <pd_targets>
{ALOX5,CYP1A1,PTGS2,RORC,PTGS1,MAPK1,NQO2,KMT2A,MEN1,CYP1B1,RAB9A,FFP,NPC1,KDM4E,MAPT,GAA,GFER,ABCB1,TRPA1,ABL1,BCR}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Epigenetic regulator",Transporter,"Other cytosolic protein","Ion channel",Oxidoreductase,"Cytochrome P450","Nuclear receptor",Kinase,Reader,Hydrolase,Transferase,Eraser
,"Primary active transporter","Voltage-gated ion channel","Cytochrome P450 family 1","Nuclear hormone receptor subfamily 1","Protein Kinase",Bromodomain,"Lysine demethylase","ATP-binding cassette","Tr
ansient receptor potential channel","Cytochrome P450 family 1A","Nuclear hormone receptor subfamily 1 group F","CMGC protein kinase group","Cytochrome P450 family 1B","Jumonji domain-containing","ABCB
 subfamily","Atypical protein kinase group","Cytochrome P450 1A1","Nuclear hormone receptor subfamily 1 group F member 3","CMGC protein kinase MAPK family","Cytochrome P450 1B1","Atypical protein kina
se BCR family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Ion channels","Eicosanoid turnover","Cytochrome P450","Nuclear hormone receptors","Kinases (EC 2.7.x.x)","SLC superfamily of solute carriers","Chromatin modifying enzy
mes","3.2.1.- Glycosidases","ATP-binding cassette transporter family","Voltage-gated ion channels",Lipoxygenases,"CYP1 family",Cyclooxygenase,"1F. Retinoic acid-related orphans","CMGC: Containing CDK"
,MAPK,GSK3,"CLK families","SLC65 NPC-type cholesterol transporters","1.14.11.- Histone demethylases","ABCB subfamily","Transient Receptor Potential channels","Mitogen-activated protein kinases (MAP ki
nases)","ERK subfamily"}

> <pathway_reactome>
{Metabolism,"Gene expression (Transcription)","Immune System","Signal Transduction","Transport of small molecules","Neuronal System",Disease,"Protein localization","Metabolism of lipids","Biological o
xidations","RNA Polymerase II Transcription","Innate Immune System","Signaling by Rho GTPases","Plasma lipoprotein assembly",remodeling,"and clearance","Transmission across Chemical Synapses","Disease
s of metabolism","Mitochondrial protein import","Abacavir transport and metabolism","Ion channel transport","Biosynthesis of specialized proresolving mediators (SPMs)","Phase I - Functionalization of 
compounds","Generic Transcription Pathway","Fatty acid metabolism","Toll-like Receptor Cascades","Rho GTPase cycle","Plasma lipoprotein clearance","Neurotransmitter receptors and postsynaptic signal t
ransmission","Diseases of carbohydrate metabolism","Abacavir transmembrane transport","Stimuli-sensing channels","Biosynthesis of DPA-derived SPMs","Cytochrome P450 - arranged by substrate type","Tran
scriptional regulation by RUNX3","Arachidonic acid metabolism","Toll Like Receptor 5 (TLR5) Cascade","RHOBTB GTPase Cycle","LDL clearance","Activation of NMDA receptors and postsynaptic events","Glyco
gen storage diseases","TRP channels","Biosynthesis of DPAn-3 SPMs",Xenobiotics,"RUNX3 Regulates Immune Response and Cell Migration","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","MyD88 casc
ade initiated on plasma membrane","Endogenous sterols","RHOBTB3 ATPase cycle","Post NMDA receptor activation events","Glycogen storage disease type II (GAA)","Biosynthesis of DPAn-3-derived 13-series 
resolvins","MAP kinase activation","Activation of AMPK downstream of NMDARs","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{PTGS2}

> <broad_moa>
{"cyclooxygenase inhibitor","PPAR receptor agonist"}

> <synonyms>
{Pterostilbene,537-42-8,537428,trans-pterostilbene,transpterostilbene,"4-(3,5-Dimethoxystyryl)phenol","4(3,5Dimethoxystyryl)phenol","(E)-4-(3,5-dimethoxystyryl)phenol","(E)4(3,5dimethoxystyryl)phenol"
,"3',5'-Dimethoxy-4-stilbenol","3',5'Dimethoxy4stilbenol","4-((E)-2-(3,5-dimethoxyphenyl)ethenyl)phenol","4((E)2(3,5dimethoxyphenyl)ethenyl)phenol","4-((E)-2-(3,5-dimethoxyphenyl)vinyl)phenol","4((E)2
(3,5dimethoxyphenyl)vinyl)phenol",pterostil,T2888,SAM001246605,CPD000440694}

> <pdid>
PD000962

> <targets>
{Autophagy}

> <classes>
{Autophagy}

> <pubchem_cids>
{5281727}

$$$$
NIHCC_2014
  SciTegic11012413002D

 18 19  0  0  0  0            999 V2000
    7.6938   -2.2520    0.0000 Cl  0  5
    5.1932   -3.0130    0.0000 Cl  0  0
    3.8915   -3.7585    0.0000 C   0  0
    3.8864   -5.2585    0.0000 C   0  0
    2.5847   -6.0040    0.0000 C   0  0
    1.2883   -5.2495    0.0000 C   0  0
    1.2935   -3.7495    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  3
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 S   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 13  2  0
 17 18  1  0
 18 10  1  0
M  CHG  2   1  -1  10   1
M  END
> <name>
NIHCC_2014

> <id>
5871

> <plate>
NGP-105-04

> <well>
A08

> <supplier_cmpd_name>
CPD000048468

> <ctcr_id>
5244

> <supplier_cmpd_id>
SAM001246558

> <smiles>
[Cl-].Clc1ccccc1C[NH+]2CCc3sccc3C2

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"TICLOPIDINE HYDROCHLORIDE",53885-35-1,53885351,"Ticlopidine HCL",Ticlodix,Ticlodone,Ticlid,Panaldine,Tiklid,"5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine hydrochloride","5(2chlorobenzy
l)4,5,6,7tetrahydrothieno(3,2c)pyridine hydrochloride","Ticlopidine (hydrochloride)",53-32C,5332C,UNII-A1L4914FMF,UNIIA1L4914FMF,SAM001246558,1505677,Prestw-47,CPD000048468,"Ticlopidine hydrochloride"
}

> <pdid>

> <targets>
{}

> <classes>
{"PAF inhibitor"}

> <pubchem_cids>
{65335,657310,11301025}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 26  0  0  1  0            999 V2000
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2948   -3.7516    0.0000 O   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 N   0  0
   -3.1882    2.6401    0.0000 C   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -5.0133   -0.4928    0.0000 N   0  0
   -6.2410    0.3691    0.0000 C   0  0
   -4.9986   -1.9927    0.0000 C   0  0
   -3.5675   -2.4422    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 C   0  0  2  0  0  0
   -1.8266   -2.4149    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    7.6933    0.1915    0.0000 O   0  0
    7.6933   -1.3085    0.0000 S   0  0
    7.6933   -2.8085    0.0000 O   0  0
    6.3940   -2.0581    0.0000 O   0  0
    8.9926   -2.0581    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 12  1  0
 17 18  1  1
 17 19  1  0
 19  9  1  0
 19 20  2  0
 20  6  1  0
 21 22  1  0
 22 23  1  0
 22 24  2  0
 22 25  2  0
M  END
> <name>
NIHCC_2014

> <id>
5872

> <plate>
NGP-105-04

> <well>
A09

> <supplier_cmpd_name>
CPD000449286

> <ctcr_id>
6253

> <supplier_cmpd_id>
SAM001246992

> <smiles>
CNC(=O)Oc1ccc2N(C)C3N(C)CC[C@@]3(C)c2c1.O[S](O)(=O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{SMR000449286,MLS000758201,MLS001424124,HMS2051B14,HMS2232P24,HMS3371P06,HMS3393B14,CCG-101031,CCG101031,NC00281,SAM001246992,CPD000449286}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581807}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 31  0  0  0  0            999 V2000
   -0.7603   -8.0518    0.0000 C   0  0
   -1.2256   -6.6258    0.0000 N   0  0
   -2.6933   -6.3162    0.0000 C   0  0
   -0.2234   -5.5086    0.0000 C   0  0
   -0.6890   -4.0818    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 N   0  0
   -5.2526    1.3618    0.0000 C   0  0
   -6.2524    0.2436    0.0000 N   0  0
   -5.4979   -1.0529    0.0000 C   0  0
   -4.0317   -0.7359    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   10.1100   -3.2797    0.0000 O   0  0
    8.8096   -4.0274    0.0000 C   0  0
    8.8075   -5.5274    0.0000 O   0  0
    7.5114   -3.2743    0.0000 C   0  0
    7.5114   -1.7743    0.0000 C   0  0
    6.2124   -1.0243    0.0000 C   0  0
    4.9133   -1.7743    0.0000 C   0  0
    4.9133   -3.2743    0.0000 C   0  0
    6.2124   -4.0243    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 14  1  0
 12 19  1  0
 19 20  2  0
 20  6  1  0
 20  9  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
M  END
> <name>
NIHCC_2014

> <id>
5873

> <plate>
NGP-105-04

> <well>
A10

> <supplier_cmpd_name>
CPD000525252

> <ctcr_id>
2902

> <supplier_cmpd_id>
SAM001246615

> <smiles>
CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12.OC(=O)c4ccccc4

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{AKOS015855933,AB07521,"Rizatriptan benzoate",145202-66-0,145202660,Maxalt,"Rizatriptan (benzoate)",Maxalt-MLT,MaxaltMLT,"MK 462",MK-462,MK462,MK-0462,MK0462,UNII-WR978S7QHH,UNIIWR978S7QHH,WR978S7QHH,
"Rizatriptan Benzoate (Maxalt)","MK 0462","Rizatriptan-d6 Benzoate","Rizatriptand6 Benzoate","L 705126",L,T1512,SAM001246615,1505189,CPD000525252,"RIZATRIPTAN BENZOATE"}

> <pdid>

> <targets>
{}

> <classes>
{antimigraine,"5HT-1B/1D agonist"}

> <pubchem_cids>
{77997}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 27  0  0  0  0            999 V2000
    8.8990   -1.5220    0.0000 H   0  3
    6.3990   -1.5220    0.0000 Cl  0  5
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3032   -3.7490    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -2.6030    2.9977    0.0000 O   0  0
   -3.8990    0.7455    0.0000 N   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.8007    1.4864    0.0000 C   0  0
   -9.0971    0.7319    0.0000 C   0  0
   -9.0919   -0.7681    0.0000 C   0  0
  -10.3875   -1.5257    0.0000 O   0  0
  -10.3802   -3.0265    0.0000 C   0  0
  -11.6758   -3.7841    0.0000 C   0  0
  -11.6685   -5.2849    0.0000 N   0  0
  -12.9633   -6.0421    0.0000 C   0  0
  -10.3655   -6.0281    0.0000 C   0  0
   -7.7903   -1.5136    0.0000 C   0  0
   -6.4939   -0.7591    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 10 11  1  0
 11 12  1  0
  8 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  1  0
 20 27  1  0
 27 28  2  0
 28 17  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5874

> <plate>
NGP-105-04

> <well>
A11

> <supplier_cmpd_name>
CPD000469143

> <ctcr_id>
6986

> <supplier_cmpd_id>
SAM001246542

> <smiles>
[H+].[Cl-].COc1ccc(cc1OC)C(=O)NCc2ccc(OCCN(C)C)cc2

> <pd_targets>
{ACHE}

> <pathway_gtopdb>
{Enzyme,Hydrolase}

> <pathway_chembl>
{Enzymes,"Acetylcholine turnover"}

> <pathway_reactome>
{Metabolism,"Metabolism of lipids","Phospholipid metabolism","Glycerophospholipid biosynthesis","Synthesis of PC"}

> <broad_targets>
{DRD2}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{122892-31-3,122892313,"ITOPRIDE HCl",Ganaton,"Itopride (hydrochloride)",HSR803,HSR-803,UNII-2H9NV66W0I,UNII2H9NV66W0I,Itax,"Hsr 803",2H9NV66W0I,MFCD00881710,"n-(4-(2-dimethylaminoethoxy)benzyl)-3,4-d
imethoxybenzamide hcl","n(4(2dimethylaminoethoxy)benzyl)3,4dimethoxybenzamide hcl","122892-31-3 (HCl)","122892313 (HCl)",SAM001246542,CPD000469143}

> <pdid>
PD001662

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{129791,45108251}

$$$$
NIHCC_2014
  SciTegic11012413002D

 14 14  0  0  0  0            999 V2000
    1.6317   -2.2458    0.0000 C   0  0
    0.7500   -1.0323    0.0000 C   0  0
    1.2135    0.3943    0.0000 N   0  0
    0.0000    1.2760    0.0000 C   0  0
   -1.2135    0.3943    0.0000 C   0  0
   -0.7500   -1.0323    0.0000 N   0  0
   -1.6281   -2.2462    0.0000 C   0  0
   -1.0157   -3.6164    0.0000 C   0  0
    0.4764   -3.7706    0.0000 O   0  0
   -1.8953   -4.8324    0.0000 C   0  0
   -1.2833   -6.2019    0.0000 Cl  0  0
   -2.6375    0.8602    0.0000 N   0  3
   -3.7540   -0.1415    0.0000 O   0  5
   -2.9472    2.3279    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  2  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
  5 12  1  0
 12 13  1  0
 12 14  2  0
M  CHG  2  12   1  13  -1
M  END
> <name>
NIHCC_2014

> <id>
5875

> <plate>
NGP-105-04

> <well>
B02

> <supplier_cmpd_name>
CPD000058726

> <ctcr_id>
2064

> <supplier_cmpd_id>
SAM001246873

> <smiles>
Cc1ncc(n1CC(O)CCl)[N+]([O-])=O

> <pd_targets>
{AMPC}

> <pathway_gtopdb>
{Enzyme,Hydrolase}

> <pathway_chembl>
{}

> <pathway_reactome>
{}

> <broad_targets>
{}

> <broad_moa>
{"antiprotozoal agent"}

> <synonyms>
{Ornidazole,16773-42-5,16773425,Tiberal,"Ro 7-0207","Ro 70207",Ornidazolum,Madelen,Ornidazol,1-(3-Chloro-2-hydroxypropyl)-2-methyl-5-nitroimidazole,1(3Chloro2hydroxypropyl)2methyl5nitroimidazole,1-chl
oro-3-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-ol,1chloro3(2methyl5nitro1Himidazol1yl)propan2ol,1-Chloro-3-(2-methyl-5-nitro-1H-imidazol-1-yl)-2-propanol,1Chloro3(2methyl5nitro1Himidazol1yl)2propan
ol,T1556,SAM001246873,1505981,Prestw-164,CPD000058726,ORNIDAZOLE}

> <pdid>
PD000244

> <targets>
{}

> <classes>
{antiinfective}

> <pubchem_cids>
{28061}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 21  0  0  0  0            999 V2000
    8.9915   -2.2547    0.0000 Cl  0  0
    1.2980   -2.2506    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5030    0.0000 C   0  0
    3.8977   -0.7537    0.0000 C   0  0
    3.9020    0.7463    0.0000 C   0  0
    5.2032    1.4925    0.0000 C   0  0
    6.5001    0.7388    0.0000 C   0  0
    6.4957   -0.7612    0.0000 C   0  0
    5.1946   -1.5074    0.0000 C   0  0
    1.2926   -3.7495    0.0000 N   0  0
   -0.0048   -2.9950    0.0000 C   0  0
    0.0003   -1.4950    0.0000 O   0  0
   -1.3074   -3.7406    0.0000 C   0  0
   -2.6041   -2.9866    0.0000 N   0  0
    3.8934   -3.7569    0.0000 C   0  0
    3.8905   -5.2569    0.0000 C   0  0
    5.1881   -6.0095    0.0000 C   0  0
    6.4886   -5.2620    0.0000 C   0  0
    6.4915   -3.7620    0.0000 C   0  0
    5.1939   -3.0095    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  3 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
  3 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
M  END
> <name>
NIHCC_2014

> <id>
5876

> <plate>
NGP-105-04

> <well>
B03

> <supplier_cmpd_name>
CPD000466281

> <ctcr_id>
5781

> <supplier_cmpd_id>
SAM001247078

> <smiles>
Cl.CC(Cc1ccccc1)(NC(=O)CN)c2ccccc2

> <pd_targets>
{MAPK1,LEF,CYP3A4,RECQL,CYP1A2}

> <pathway_gtopdb>
{Enzyme,Kinase,Protease,"Cytochrome P450","Protein Kinase","Metallo protease","Cytochrome P450 family 3","Cytochrome P450 family 1","CMGC protein kinase group","Metallo protease MAE clan","Cytochrome 
P450 family 3A","Cytochrome P450 family 1A","CMGC protein kinase MAPK family","Metallo protease M34 family","Cytochrome P450 3A4","Cytochrome P450 1A1","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,"Kinases (EC 2.7.x.x)","Cytochrome P450","CMGC: Containing CDK",MAPK,GSK3,"CLK families","CYP3 family","CYP1 family","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Immune System",Disease,Metabolism,"Innate Immune System","Infectious disease","Metabolism of lipids","Biological oxidations","Toll-like Receptor Cascades","Uptake and actions of bacterial toxins","B
iosynthesis of specialized proresolving mediators (SPMs)","Phase I - Functionalization of compounds","Toll Like Receptor 5 (TLR5) Cascade","Uptake and function of anthrax toxins","Biosynthesis of DHA-
derived SPMs","Cytochrome P450 - arranged by substrate type","MyD88 cascade initiated on plasma membrane","Biosynthesis of maresins",Xenobiotics,"MAP kinase activation","Biosynthesis of maresin-like S
PMs","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{GRIN1}

> <broad_moa>
{"glutamate receptor antagonist"}

> <synonyms>
{"REMACEMIDE HYDROCHLORIDE",111686-79-4,111686794,"Remacemide HCl","FPL 12924AA","PR 934-423A","PR 934423A","Remacemide hydrochloride (USAN)","2-AMINO-N-(1-METHYL-1,2-DIPHENYLETHYL)ACETAMIDE HYDROCHLO
RIDE","2AMINON(1METHYL1,2DIPHENYLETHYL)ACETAMIDE HYDROCHLORIDE","2-amino-N-(1,2-diphenylpropan-2-yl)acetamide hydrochloride","2aminoN(1,2diphenylpropan2yl)acetamide hydrochloride",SAM001247078,CPD0004
66281}

> <pdid>
PD013943

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{60510,74764185}

$$$$
NIHCC_2014
  SciTegic11012413002D

 54 57  0  0  1  0            999 V2000
   -3.9250   -5.2215    0.0000 C   0  0
   -3.9115   -3.7216    0.0000 C   0  0
   -5.2039   -2.9603    0.0000 C   0  0
   -5.2171   -4.4600    0.0000 C   0  0
   -2.6055   -2.9821    0.0000 N   0  0
   -2.5919   -1.4813    0.0000 C   0  0
   -3.8844   -0.7200    0.0000 O   0  0
   -1.2859   -0.7418    0.0000 C   0  0  2  0  0  0
   -1.2764    0.7582    0.0000 C   0  0
    0.0273    1.4999    0.0000 C   0  0  2  0  0  0
    0.0368    2.9999    0.0000 C   0  0
    1.3406    3.7416    0.0000 C   0  0
    2.6348    2.9834    0.0000 C   0  0
    2.6254    1.4835    0.0000 C   0  0
    1.3216    0.7417    0.0000 C   0  0  2  0  0  0
    1.3121   -0.7583    0.0000 C   0  0
    0.0083   -1.5000    0.0000 N   0  0
    0.0019   -3.0008    0.0000 C   0  0
    1.2980   -3.7576    0.0000 C   0  0  1  0  0  0
    2.6005   -3.0136    0.0000 O   0  0
    1.2916   -5.2584    0.0000 C   0  0  2  0  0  0
   -0.0101   -6.0056    0.0000 C   0  0
   -0.0148   -7.5064    0.0000 C   0  0
    1.2803   -8.2632    0.0000 C   0  0
    1.2725   -9.7632    0.0000 C   0  0
   -0.0304  -10.5064    0.0000 C   0  0
   -1.3256   -9.7497    0.0000 C   0  0
   -1.3178   -8.2497    0.0000 C   0  0
    2.5876   -6.0152    0.0000 N   0  0
    2.5812   -7.5160    0.0000 C   0  0
    1.7129   -8.0120    0.0000 O   0  0
    3.8773   -8.2728    0.0000 C   0  0  2  0  0  0
    5.1820   -7.5310    0.0000 C   0  0
    6.4772   -8.2892    0.0000 C   0  0
    6.4709   -9.2892    0.0000 N   0  0
    7.7812   -7.5479    0.0000 O   0  0
    3.8709   -9.7736    0.0000 N   0  0
    5.1669  -10.5304    0.0000 C   0  0
    6.0352  -10.0344    0.0000 O   0  0
    5.1605  -12.0312    0.0000 C   0  0
    6.4548  -12.7895    0.0000 C   0  0
    6.4453  -14.2894    0.0000 C   0  0
    5.1416  -15.0312    0.0000 C   0  0
    5.1321  -16.5312    0.0000 C   0  0
    3.8284  -17.2730    0.0000 C   0  0
    2.5341  -16.5148    0.0000 C   0  0
    2.5436  -15.0149    0.0000 C   0  0
    3.8473  -14.2731    0.0000 C   0  0
    3.8568  -12.7731    0.0000 N   0  0
   10.3012   -5.2493    0.0000 C   0  0
   10.3012   -6.7493    0.0000 S   0  0
   10.3012   -8.2493    0.0000 O   0  0
    9.0019   -7.4988    0.0000 O   0  0
   11.6005   -7.4988    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  2  0
  8  6  1  6
  8  9  1  0
 10  9  1  6
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 15 14  1  6
 15 10  1  0
 15 16  1  0
 16 17  1  0
 17  8  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  1
 19 21  1  0
 21 22  1  1
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 21 29  1  0
 29 30  1  0
 30 31  2  0
 30 32  1  0
 32 33  1  6
 33 34  1  0
 34 35  1  0
 34 36  2  0
 32 37  1  0
 37 38  1  0
 38 39  2  0
 38 40  1  0
 40 41  2  0
 41 42  1  0
 42 43  2  0
 43 44  1  0
 44 45  2  0
 45 46  1  0
 46 47  2  0
 47 48  1  0
 48 43  1  0
 48 49  2  0
 49 40  1  0
 50 51  1  0
 51 52  1  0
 51 53  2  0
 51 54  2  0
M  END
> <name>
NIHCC_2014

> <id>
5877

> <plate>
NGP-105-04

> <well>
B04

> <supplier_cmpd_name>
CPD000469290

> <ctcr_id>
6806

> <supplier_cmpd_id>
SAM001246578

> <smiles>
CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc3ccccc3)NC(=O)[C@H](CC(N)=O)NC(=O)c4ccc5ccccc5n4.C[S](O)(=O)=O

> <pd_targets>
{POL,PROTEASE,"HIV-1 PROTEASE",CYP3A4,ABCB11,ABCB1,AMPC,CRT,FTL,HIF1A,TP53,LMNA,ALDH1A1,DRD3,SLC6A3,SLC22A1,CACNA1C,CACNA1D,CACNA1F,CACNA1S,OPRD1,TACR2,HTR1A,OPRK1,TBXAS1,AVPR1A,ABCG2,OPRM1,ABCC3,ABCC
4}

> <pathway_gtopdb>
{Enzyme,"Unclassified protein",Transporter,"Transcription factor","Other nuclear protein","Membrane receptor","Ion channel",Protease,"Cytochrome P450","Primary active transporter",Hydrolase,Oxidoreduc
tase,"Family A G protein-coupled receptor","Electrochemical transporter","Voltage-gated ion channel","Aspartic protease","Cysteine protease","Cytochrome P450 family 3","ATP-binding cassette","Small mo
lecule receptor (family A GPCR)","SLC superfamily of solute carriers","Voltage-gated calcium channel","Peptide receptor (family A GPCR)","Cytochrome P450 family 5","Aspartic protease AA clan","Cystein
e protease PAC clan","Cytochrome P450 family 3A","ABCB subfamily","Cysteine protease CA clan","Monoamine receptor","SLC06 neurotransmitter transporter family","SLC22 family of organic cation and anion
 transporters","Short peptide receptor (family A GPCR)","Cytochrome P450 family 5A","ABCG subfamily","ABCC subfamily","Aspartic protease A2A subfamily","Cysteine protease C3A subfamily","Cytochrome P4
50 3A4","Cysteine protease C1A family","Dopamine receptor","Opioid receptor","Neurokinin receptor","Serotonin receptor","Cytochrome P450 5A1","Vasopressin and oxytocin receptor"}

> <pathway_chembl>
{Enzymes,Transporters,Receptors,"Cytochrome P450","ATP-binding cassette transporter family","G protein-coupled receptors","SLC superfamily of solute carriers","CYP3 family","ABCB subfamily","Dopamine 
receptors","SLC6 neurotransmitter transporter family","SLC22 family of organic cation and anion transporters","Opioid receptors","Tachykinin receptors","5-Hydroxytryptamine receptors",CYP5,"CYP7 and C
YP8 families","Vasopressin and oxytocin receptors","ABCG subfamily","ABCC subfamily","Monoamine transporter subfamily","Organic cation transporters (OCT)"}

> <pathway_reactome>
{Metabolism,"Vesicle-mediated transport","Cellular responses to external stimuli","Cell Cycle","Signal Transduction",Disease,"Transport of small molecules","Gene expression (Transcription)",Hemostasis
,"Metabolism of lipids","Abacavir transport and metabolism","Membrane Trafficking","Cellular responses to stress","Cell Cycle Checkpoints",Mitotic,"Biological oxidations","Signaling by GPCR","Disorder
s of transmembrane transporters","SLC-mediated transmembrane transport","RNA Polymerase II Transcription","Platelet activation","signaling and aggregation","Biosynthesis of specialized proresolving me
diators (SPMs)","Metabolism of steroids","Abacavir transmembrane transport","trans-Golgi Network Vesicle Budding","Cellular response to hypoxia","G1/S DNA Damage Checkpoints","M Phase","Phase I - Func
tionalization of compounds","GPCR ligand binding","SLC transporter disorders","Transport of bile salts and organic acids","metal ions and amine compounds","Generic Transcription Pathway","GPCR downstr
eam signalling","Response to elevated platelet cytosolic Ca2+","Biosynthesis of DHA-derived SPMs","Bile acid and bile salt metabolism","Golgi Associated Vesicle Biogenesis","Oxygen-dependent proline h
ydroxylation of Hypoxia-inducible Factor Alpha","p53-Dependent G1/S DNA damage checkpoint","Mitotic Metaphase and Anaphase","Ethanol oxidation","Class A/1 (Rhodopsin-like receptors)","Defective SLC6A3
 causes Parkinsonism-dystonia infantile (PKDYS)","Organic cation/anion/zwitterion transport","Transcriptional Regulation by MECP2","Cytochrome P450 - arranged by substrate type","G alpha (i) signallin
g events","Platelet degranulation","Biosynthesis of maresins","Synthesis of bile acids and bile salts","p53-Dependent G1 DNA Damage Response","Mitotic Anaphase","Amine ligand-binding receptors","Organ
ic cation transport","Peptide ligand-binding receptors","MECP2 regulates neuronal receptors and channels",Eicosanoids,"Opioid Signalling","Recycling of bile acids and salts","Biosynthesis of maresin-l
ike SPMs","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Stabilization of p53","Nuclear Envelope (NE) Reassembly","Dopamine receptors","Tachykinin receptors bind tachykinins",
"Serotonin receptors","Vasopressin-like receptors","G-protein activation","Autodegradation of the E3 ubiquitin ligase COP1","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{CYP3A4}

> <broad_moa>
{"HIV protease inhibitor"}

> <synonyms>
{"Saquinavir mesylate",149845-06-7,149845067,Invirase,Fortovase,"Saquinavir mesilate",UNII-UHB9Z3841A,UNIIUHB9Z3841A,"Saquinavir, Mesylate","Ro 31-8959/003","Ro 318959/003",UHB9Z3841A,CHEBI:32121,NCGC
00091469-01,NCGC0009146901,DSSTox_CID_3835,DSSToxCID3835,DSSTox-CID-3835,"DSSTox CID 3835",DSSTox_RID_77202,DSSToxRID77202,DSSTox-RID-77202,"DSSTox RID 77202",DSSTox_GSID_23835,DSSToxGSID23835,DSSTox-
GSID-23835,"DSSTox GSID 23835","Ro 31-8959","Ro 318959",SAM001246578,Prestw-1114,CPD000469290}

> <pdid>
PD012384

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{60934}

$$$$
NIHCC_2014
  SciTegic11012413002D

 18 19  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
   -0.3115    2.9665    0.0000 N   0  0
    0.6890    4.0818    0.0000 C   0  0
    0.2234    5.5086    0.0000 C   0  0
    1.2255    6.6258    0.0000 C   0  0
    0.7600    8.0526    0.0000 C   0  0
    1.7616    9.1692    0.0000 O   0  0
    2.6947    6.3191    0.0000 C   0  0
    3.6951    7.4368    0.0000 O   0  0
   -1.8032    3.1233    0.0000 C   0  0
   -2.4133    1.7530    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 N   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  8 11  1  0
 11 12  1  0
  5 13  1  0
 13 14  2  0
 14 15  1  0
 15  4  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18  2  1  0
M  END
> <name>
NIHCC_2014

> <id>
5878

> <plate>
NGP-105-04

> <well>
B05

> <supplier_cmpd_name>
CPD000466317

> <ctcr_id>
6887

> <supplier_cmpd_id>
SAM001246580

> <smiles>
NC1=Nc2n(CCC(CO)CO)cnc2C(=O)N1

> <pd_targets>
{TK,UL23}

> <pathway_gtopdb>
{Enzyme,Transferase}

> <pathway_chembl>
{}

> <pathway_reactome>
{}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{SAM001246580,CPD000466317,PENCICLOVIR,Penciclovir,S4184,Prestw-1488}

> <pdid>
PD001690

> <targets>
{Others}

> <classes>
{Others}

> <pubchem_cids>
{4725}

$$$$
NIHCC_2014
  SciTegic11012413002D

 67 74  0  0  1  0            999 V2000
   -9.8785   -1.2799    0.0000 C   0  0
  -10.6159    0.0263    0.0000 C   0  0
   -9.8539    1.3170    0.0000 C   0  0
   -8.7906    1.7767    0.0000 C   0  0
   -7.6213    2.8080    0.0000 C   0  0  1  0  0  0
   -9.3949    5.3852    0.0000 C   0  0
   -9.0562    3.7760    0.0000 N   0  0
   -9.9666    2.2821    0.0000 C   0  0
   -7.2598    3.9925    0.0000 C   0  0
   -6.3969    4.7752    0.0000 C   0  0
   -5.0847    4.7896    0.0000 C   0  0
   -4.4469    5.9968    0.0000 N   0  0
   -5.4807    6.7939    0.0000 C   0  0
   -5.3783    7.9659    0.0000 C   0  0
   -6.4350    8.5643    0.0000 C   0  0
   -7.7902    7.7717    0.0000 C   0  0
   -7.7896    6.6020    0.0000 C   0  0
   -6.6978    6.0821    0.0000 C   0  0
   -4.6571    3.9977    0.0000 C   0  0  1  0  0  0
   -5.4925    3.1494    0.0000 C   0  0
   -3.4221    4.8504    0.0000 C   0  0
   -2.0670    4.2072    0.0000 O   0  0
   -3.5421    6.3465    0.0000 O   0  0
   -2.3077    7.1987    0.0000 C   0  0
   -4.0318    2.6323    0.0000 C   0  0
   -2.5657    2.5157    0.0000 C   0  0
   -1.9493    1.1329    0.0000 C   0  0
   -2.7823    0.0000    0.0000 C   0  0
   -4.2817    0.1000    0.0000 C   0  0
   -4.8982    1.4328    0.0000 C   0  0
   -6.3927    1.5708    0.0000 O   0  0
   -7.2597    0.3467    0.0000 C   0  0
   -1.9493   -1.2495    0.0000 N   0  0
   -2.4335   -2.6692    0.0000 C   0  0
   -0.5665   -0.7830    0.0000 C   0  0  1  0  0  0
    0.6997   -1.5161    0.0000 C   0  0  2  0  0  0
   -0.6257   -2.2184    0.0000 O   0  0
    2.0326   -0.7830    0.0000 C   0  0  2  0  0  0
    3.3301   -1.5369    0.0000 O   0  0
    3.3273   -3.0377    0.0000 C   0  0
    2.4602   -3.5358    0.0000 C   0  0
    4.6244   -3.7910    0.0000 O   0  0
    2.0326    0.6831    0.0000 C   0  0  2  0  0  0
    3.3312   -0.0685    0.0000 C   0  0
    4.1981    0.4300    0.0000 C   0  0
    3.2821    1.3995    0.0000 C   0  0
    3.2821    2.8989    0.0000 C   0  0
    1.5328    3.8485    0.0000 C   0  0
    0.4165    2.8656    0.0000 N   0  0
   -1.0329    3.0488    0.0000 C   0  0
   -1.6660    1.6994    0.0000 C   0  0
   -0.5665    0.6997    0.0000 C   0  0  2  0  0  0
    0.7331    1.4328    0.0000 C   0  0  2  0  0  0
    1.9918   -2.2373    0.0000 C   0  0
    1.9807   -3.2373    0.0000 O   0  0
    3.3001   -1.5018    0.0000 O   0  0
    4.5909   -2.2657    0.0000 C   0  0
   11.0251    4.2614    0.0000 O   0  0
   11.0251    2.7614    0.0000 C   0  0
    9.7251    2.0114    0.0000 C   0  0
    9.7251    0.5114    0.0000 O   0  0
    8.4251    2.7614    0.0000 C   0  0
    8.4251    4.2614    0.0000 O   0  0
    7.1258    2.0119    0.0000 O   0  0
   12.3251    2.0114    0.0000 C   0  0
   12.3251    0.5114    0.0000 O   0  0
   13.6244    2.7610    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  3
  5  4  1  1
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  3  1  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 10  1  0
 18 13  1  0
 11 19  1  0
 19 20  1  0
 20  5  1  0
 19 21  1  6
 21 22  2  0
 21 23  1  0
 23 24  1  0
 19 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
 30 31  1  0
 31 32  1  0
 28 33  1  0
 33 34  1  0
 35 33  1  6
 35 36  1  0
 36 37  1  1
 36 38  1  0
 38 39  1  1
 39 40  1  0
 40 41  1  0
 40 42  2  0
 38 43  1  0
 43 44  1  6
 44 45  1  0
 43 46  1  0
 46 47  2  3
 47 48  1  0
 48 49  1  0
 49 50  1  0
 50 51  1  0
 52 51  1  1
 52 27  1  0
 52 35  1  0
 52 53  1  0
 53 43  1  0
 53 49  1  1
 36 54  1  0
 54 55  2  0
 54 56  1  0
 56 57  1  0
 58 59  1  0
 59 60  1  0
 60 61  1  0
 60 62  1  0
 62 63  1  0
 62 64  2  0
 59 65  1  0
 65 66  1  0
 65 67  2  0
M  END
> <name>
NIHCC_2014

> <id>
5879

> <plate>
NGP-105-04

> <well>
B06

> <supplier_cmpd_name>
CPD000469210

> <ctcr_id>
1173

> <supplier_cmpd_id>
SAM001246780

> <smiles>
CCC1=C[C@H]2CN(C1)Cc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC.OC(C(O)C(O)=O)C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"VINORELBINE BITATRATE",MLS001401463,HMS2051D08,CCG-101008,CCG101008,NC00258,SMR000469210,AB01274128-01,AB0127412801,T6213,SAM001246780,"Vinorelbine Tartrate",CPD000469210}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581803}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 26  0  0  0  0            999 V2000
   14.0825   -5.2598    0.0000 H   0  3
   11.5825   -5.2598    0.0000 Cl  0  5
    9.0819   -9.7710    0.0000 C   0  0
    7.7815  -10.5187    0.0000 C   0  0
    7.7794  -12.0187    0.0000 O   0  0
    6.4833   -9.7656    0.0000 O   0  0
    6.4855   -8.2648    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    3.8869   -8.2595    0.0000 O   0  0
    5.1894   -6.0109    0.0000 N   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 C   0  0
   -2.5951   -3.0039    0.0000 N   0  0
   -3.8915   -3.7585    0.0000 C   0  0
   -3.8863   -5.2585    0.0000 C   0  0
   -2.5847   -6.0040    0.0000 C   0  0
   -1.2883   -5.2495    0.0000 C   0  0
   -1.2935   -3.7495    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 21  1  0
 19 27  2  0
 27 15  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5880

> <plate>
NGP-105-04

> <well>
B07

> <supplier_cmpd_name>
CPD000469144

> <ctcr_id>
5802

> <supplier_cmpd_id>
SAM001246547

> <smiles>
[H+].[Cl-].CC(=O)OCC(=O)NCCCOc1cccc(CN2CCCCC2)c1

> <pd_targets>
{HRH2}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Histamine receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Histamine receptors"}

> <pathway_reactome>
{Disease,"Infectious disease","Leishmania infection","Leishmania parasite growth and survival","Anti-inflammatory response favouring Leishmania parasite infection","ADORA2B mediated anti-inflammatory 
cytokines production"}

> <broad_targets>
{HRH2}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{AKOS026749808,AKOS005067597,"roxatidine acetate hydrochloride",93793-83-0,93793830,"ROXATIDINE ACETATE HCl",Roxit,Gastralgin,Altat,"HOE 760",TZU-0460,TZU0460,"Roxatidine (Acetate Hydrochloride)",Hoe-
760,Hoe760,UNII-60426GOR1E,UNII60426GOR1E,2-Acetoxy-N-(3-(3-(1-piperi,2AcetoxyN(3(3(1piperi,T0157,S1880,SAM001246547,Prestw-428,"Roxatidine Acetate hydrochloride","Roxatidine Acetate HCl",CPD000469144
}

> <pdid>
PD009203

> <targets>
{"Histamine Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{67108342,16640927,10949026,56704}

$$$$
NIHCC_2014
  SciTegic11012413002D

 19 19  0  0  0  0            999 V2000
    6.3982   -0.4632    0.0000 Na  0  3
    3.8976   -0.7553    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2948   -3.7516    0.0000 O   0  5
    3.8926   -3.7566    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -4.0317   -0.7359    0.0000 C   0  0
   -5.4979   -1.0529    0.0000 C   0  0
   -6.2524    0.2436    0.0000 C   0  0
   -5.2526    1.3618    0.0000 C   0  0
   -5.5608    2.8298    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  3  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 12  1  0
 16 17  2  0
 10 18  1  0
 18 19  2  0
 19  7  1  0
M  CHG  2   1   1   5  -1
M  END
> <name>
NIHCC_2014

> <id>
5881

> <plate>
NGP-105-04

> <well>
B08

> <supplier_cmpd_name>
CPD000469165

> <ctcr_id>
4081

> <supplier_cmpd_id>
SAM001246594

> <smiles>
[Na+].CC(C([O-])=O)c1ccc(CC2CCCC2=O)cc1

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Loxoprofen sodium",80382-23-6,80382236,"Sodium 2-(4-((2-oxocyclopentyl)methyl)phenyl)propanoate","Sodium 2(4((2oxocyclopentyl)methyl)phenyl)propanoate","Loxoprofen sodium salt",Loxonin,UNII-NDC2M739
9S,UNIINDC2M7399S,"Loxoprofen (sodium)",LX-A,LXA,"Loxoprofen sodium hydrate",NDC2M7399S,CHEBI:76198,CS-600,CS600,SAM001246594,CPD000469165}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23663407}

$$$$
NIHCC_2014
  SciTegic11012413002D

 32 34  0  0  0  0            999 V2000
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 N   0  0
   -3.1905    2.6376    0.0000 C   0  0
   -4.6589    2.9478    0.0000 C   0  0
   -5.1272    4.3728    0.0000 C   0  0
   -6.5954    4.6799    0.0000 C   0  0
   -7.5955    3.5619    0.0000 C   0  0
   -9.0637    3.8689    0.0000 Cl  0  0
   -7.1272    2.1368    0.0000 C   0  0
   -5.6590    1.8298    0.0000 C   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -5.1047   -0.0031    0.0000 C   0  0
   -5.8532   -1.3040    0.0000 C   0  0
   -5.1009   -2.6017    0.0000 C   0  0
   -4.3532   -1.3016    0.0000 C   0  0
   -7.3541   -1.3071    0.0000 C   0  0
   -8.1063   -0.0094    0.0000 O   0  0
   -8.1022   -2.6072    0.0000 O   0  0
   -2.7248   -1.2135    0.0000 C   0  0
   -3.1904   -2.6376    0.0000 S   0  0
   -2.1890   -3.7554    0.0000 C   0  0
   -2.6552   -5.1812    0.0000 C   0  0
   -0.7211   -3.4468    0.0000 C   0  0
   -1.1876   -4.8722    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 16 10  1  0
  8 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 19 22  1  0
 22 23  1  0
 22 24  2  0
 17 25  2  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 27 29  1  0
 27 30  1  0
 25 31  1  0
 31  7  1  0
 31 32  2  0
 32  4  1  0
M  END
> <name>
NIHCC_2014

> <id>
5882

> <plate>
NGP-105-04

> <well>
B09

> <supplier_cmpd_name>
CPD000466278

> <ctcr_id>
6219

> <supplier_cmpd_id>
SAM001247075

> <smiles>
CC(C)c1ccc2n(Cc3ccc(Cl)cc3)c(CC(C)(C)C(O)=O)c(SC(C)(C)C)c2c1

> <pd_targets>
{ALOX5AP,PTGES,PTGS1,MAPT,KMT2A,MEN1,BLM,REP,ALOX5,PTGES2,ALOX15,NPSR1,CYP2C9,TP53,CYP3A4,MAPK1,SKA,PTGS2,KDM4E,RORC,HPGD,POLB,CYP1A2,HSD17B10,PPARA,RECQL,ALD,LEF,USP2,LMNA,HIF1A,THPO,FTL,NFO,TBXAS1,A
PEX1,CASP7,CYP2C19,NFKB1,TSHR,AMPC,CHRM1,PMP22,GMNN,MPEG1,MTOR}

> <pathway_gtopdb>
{"Other cytosolic protein",Enzyme,"Epigenetic regulator","Membrane receptor","Transcription factor","Other nuclear protein","Unclassified protein",Isomerase,Oxidoreductase,Reader,Transferase,"Family A
 G protein-coupled receptor","Cytochrome P450",Kinase,Eraser,"Nuclear receptor",Protease,Hydrolase,Bromodomain,"Peptide receptor (family A GPCR)","Cytochrome P450 family 2","Cytochrome P450 family 3",
"Protein Kinase","Lysine demethylase","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 1","Metallo protease","Cysteine protease","Cytochrome P450 family 5","Small molecule receptor (fami
ly A GPCR)","Short peptide receptor (family A GPCR)","Cytochrome P450 family 2C","Cytochrome P450 family 3A","CMGC protein kinase group","Jumonji domain-containing","Nuclear hormone receptor subfamily
 1 group F","Cytochrome P450 family 1A","Nuclear hormone receptor subfamily 1 group C","Metallo protease MAE clan","Cysteine protease CA clan","Cytochrome P450 family 5A","Cysteine protease CD clan","
Glycohormone receptor","Monoamine receptor","Atypical protein kinase group","Neuropeptide receptor","Cytochrome P450 2C9","Cytochrome P450 3A4","CMGC protein kinase MAPK family","Nuclear hormone recep
tor subfamily 1 group F member 3","Cytochrome P450 1A1","Nuclear hormone receptor subfamily 1 group C member 1","Metallo protease M34 family","Cysteine protease C19 family","Cysteine protease C1A fami
ly","Cytochrome P450 5A1","Cysteine protease C14 family","Cytochrome P450 2C19","Acetylcholine receptor","Atypical protein kinase PIKK family","CMGC protein kinase ERK1","Atypical protein kinase FRAP 
subfamily"}

> <pathway_chembl>
{Enzymes,"Other protein targets",Receptors,"Eicosanoid turnover","Anti-infective targets","G protein-coupled receptors","Cytochrome P450","Kinases (EC 2.7.x.x)","Chromatin modifying enzymes","Nuclear 
hormone receptors","Peptidases and proteinases","Prostaglandin synthases",Cyclooxygenase,"Viral protein targets",Lipoxygenases,"Neuropeptide S receptor","CYP2 family: drug metabolising subset","CYP3 f
amily","CMGC: Containing CDK",MAPK,GSK3,"CLK families","1.14.11.- Histone demethylases","1F. Retinoic acid-related orphans","CYP1 family","2.1.1.43 Histone methyltransferases (HMTs)","1C. Peroxisome p
roliferator-activated receptors","CA: Cysteine (C) Peptidases",CYP5,"CYP7 and CYP8 families","CD: Cysteine (C) Peptidases","Glycoprotein hormone receptors","Acetylcholine receptors (muscarinic)",Atypi
cal,"Coronavirus (CoV) proteins","Mitogen-activated protein kinases (MAP kinases)","C19: Ubiquitin-specific protease","C14: Caspase","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","ER
K subfamily","FRAP subfamily"}

> <pathway_reactome>
{Metabolism,"Neuronal System","DNA Repair",Disease,"Cell Cycle","Immune System","Gene expression (Transcription)","Cellular responses to external stimuli",Hemostasis,"Vesicle-mediated transport","Prog
rammed Cell Death","Signal Transduction","Developmental Biology","Metabolism of lipids","Transmission across Chemical Synapses","DNA Double-Strand Break Repair","Infectious disease","Biological oxidat
ions","Cell Cycle Checkpoints","Innate Immune System","RNA Polymerase II Transcription","Base Excision Repair","Metabolism of amino acids and derivatives",Mitotic,"Cellular responses to stress","Plate
let activation","signaling and aggregation","Membrane Trafficking",Apoptosis,"Cytokine Signaling in Immune system","Signaling by GPCR","Nervous system development","Fatty acid metabolism","Neurotransm
itter receptors and postsynaptic signal transmission","Homology Directed Repair","SARS-CoV Infections","Biosynthesis of specialized proresolving mediators (SPMs)","Leishmania infection","Phase I - Fun
ctionalization of compounds","G1/S DNA Damage Checkpoints","Toll-like Receptor Cascades","Generic Transcription Pathway","Resolution of Abasic Sites (AP sites)","Branched-chain amino acid catabolism",
"Metabolism of steroids","Uptake and actions of bacterial toxins","M Phase","Cellular response to hypoxia","Platelet Aggregation (Plug Formation)","trans-Golgi Network Vesicle Budding","Intrinsic Path
way for Apoptosis","Signaling by Interleukins","GPCR ligand binding","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Mitotic G1 phase and G1/S transition","Arachidonic acid metabolis
m","Activation of NMDA receptors and postsynaptic events","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","SARS-CoV-2 Infection","Biosynthesis of DPA-derived SPMs","Leish
mania parasite growth and survival","Cytochrome P450 - arranged by substrate type","p53-Dependent G1/S DNA damage checkpoint","Biosynthesis of DHA-derived SPMs","Toll Like Receptor 5 (TLR5) Cascade","
Transcriptional regulation by RUNX3","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Transcriptional regulation by RUNX1","Regulation of cholesterol biosynthesis by SRE
BP (SREBF)","Uptake and function of anthrax toxins","Transcriptional Regulation by TP53","Mitotic Metaphase and Anaphase","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Go
lgi Associated Vesicle Biogenesis","Apoptotic factor-mediated response","Interleukin-1 family signaling","Class A/1 (Rhodopsin-like receptors)","G1/S Transition","Synthesis of 5-eicosatetraenoic acids
","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","Post NMDA receptor activation events","HDR through Homologous Recombination (HRR)","SARS-CoV-2 Genome Replication and Transcription","Biosyn
thesis of DPAn-3 SPMs","Anti-inflammatory response favouring Leishmania parasite infection",Xenobiotics,"p53-Dependent G1 DNA Damage Response","Biosynthesis of maresins","MyD88 cascade initiated on pl
asma membrane","RUNX3 Regulates Immune Response and Cell Migration","Biosynthesis of D-series resolvins","PCNA-Dependent Long Patch Base Excision Repair","RUNX1 regulates genes involved in megakaryocy
te differentiation and platelet function","Activation of gene expression by SREBF (SREBP)","Regulation of TP53 Activity","Mitotic Anaphase",Eicosanoids,"Cytochrome c-mediated apoptotic response","Inte
rleukin-1 signaling","Amine ligand-binding receptors","Activation of the pre-replicative complex","Activation of AMPK downstream of NMDARs","Homologous DNA Pairing and Strand Exchange","Replication of
 the SARS-CoV-2 genome","Biosynthesis of DPAn-3-derived 13-series resolvins","Biosynthesis of DPAn-3-derived protectins and resolvins","ADORA2B mediated anti-inflammatory cytokines production","CYP2E1
 reactions","Stabilization of p53","Biosynthesis of maresin-like SPMs","MAP kinase activation","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Regulation of TP53 Expression and Deg
radation","Nuclear Envelope (NE) Reassembly","Activation of caspases through apoptosome-mediated cleavage","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Muscarinic acetylcholine receptors","Presynapti
c phase of homologous DNA pairing and strand exchange","Autodegradation of the E3 ubiquitin ligase COP1","MAPK targets/ Nuclear events mediated by MAP kinases","Regulation of TP53 Degradation","Initia
tion of Nuclear Envelope (NE) Reformation","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{}

> <broad_moa>
{"lipoxygenase inhibitor"}

> <synonyms>
{SR-01000076049,SR01000076049,NCGC00025106-01,NCGC0002510601,MK-886,MK886,118414-82-7,118414827,"MK 886",UNII-080626SQ8C,UNII080626SQ8C,"L-663,536","L663,536",CHEMBL29097,CHEBI:75390,"L 663536","MK-88
6 (L-663,536)","MK886 (L663,536)",L-663536,L663536,080626SQ8C,SMR000466278,Tocris-1311,Tocris1311,Curator_000017,Curator000017,Curator-000017,"Curator 000017",Lopac0_000774,Lopac0000774,Lopac0-000774,
"Lopac0 000774",cc-719,cc719,MLS000758280,T6893,SAM001247075,CPD000466278}

> <pdid>
PD003183

> <targets>
{Apoptosis,FLAP,Leukotriene Receptor,PPAR}

> <classes>
{Apoptosis,Cell Cycle/DNA Damage,GPCR/G Protein,Immunology/Inflammation}

> <pubchem_cids>
{3651377}

$$$$
NIHCC_2014
  SciTegic11012413002D

 63 68  0  0  1  0            999 V2000
   -7.4552   -3.5838    0.0000 C   0  0
   -6.0104   -3.9870    0.0000 O   0  0
   -4.9400   -2.9400    0.0000 C   0  0  1  0  0  0
   -3.3500   -3.2400    0.0000 C   0  0
   -3.1000   -4.8300    0.0000 C   0  0
   -1.5200   -5.1200    0.0000 O   0  0
   -0.7000   -3.7400    0.0000 C   0  0  1  0  0  0
   -2.1973   -3.6507    0.0000 C   0  0
   -1.3600   -2.2500    0.0000 O   0  0
   -0.1600   -1.1700    0.0000 C   0  0
   -0.1600    0.4200    0.0000 C   0  0
   -1.0286    0.9155    0.0000 C   0  0
    1.2100    1.2300    0.0000 C   0  0
    1.2029    2.7300    0.0000 O   0  0
    2.6100    0.4200    0.0000 C   0  0
    4.0000    1.2300    0.0000 C   0  0
    3.9954    2.7300    0.0000 O   0  0
    5.4100    0.4200    0.0000 C   0  0
    6.8200    1.2300    0.0000 N   0  0
    6.4200    3.1700    0.0000 C   0  0
    7.6031    4.0921    0.0000 O   0  0
    5.2400    3.7400    0.0000 C   0  0
    3.6200    3.7900    0.0000 C   0  0
    2.3600    2.7300    0.0000 C   0  0
    1.1200    3.8200    0.0000 C   0  0
   -0.2200    3.0400    0.0000 C   0  0  2  0  0  0
   -0.3675    1.5473    0.0000 C   0  0
   -1.4300    4.1100    0.0000 C   0  0  2  0  0  0
   -1.2537    5.5996    0.0000 O   0  0
   -2.8600    3.3500    0.0000 C   0  0  1  0  0  0
   -4.2023    4.0195    0.0000 C   0  0
   -2.6100    1.7700    0.0000 C   0  0  1  0  0  0
   -1.7116    1.3309    0.0000 O   0  0
   -4.0400    0.9800    0.0000 C   0  0  1  0  0  0
   -5.3935    1.6266    0.0000 C   0  0
   -3.7700   -0.5500    0.0000 C   0  0  2  0  0  0
   -2.4087   -1.1738    0.0000 O   0  0
   -2.2675   -2.6680    0.0000 C   0  0
   -3.0828   -3.2470    0.0000 C   0  0
   -1.3585   -3.0848    0.0000 O   0  0
   -5.2000   -1.3500    0.0000 C   0  0  2  0  0  0
   -6.5511   -0.6985    0.0000 C   0  0
    5.5972    5.1969    0.0000 C   0  0
    5.4100   -1.1700    0.0000 C   0  0
    6.7110   -1.9161    0.0000 C   0  0
    6.7165   -3.4169    0.0000 N   0  0
    8.0185   -4.1634    0.0000 N   0  0
    8.0262   -5.6634    0.0000 C   0  0
    9.3291   -6.4068    0.0000 C   0  0
   10.6243   -5.6502    0.0000 N   0  0
   10.6167   -4.1502    0.0000 C   0  0
    9.3138   -3.4068    0.0000 C   0  0
   11.9278   -6.3940    0.0000 C   0  0
   12.0755   -7.8739    0.0000 C   0  0
   13.5448   -8.1760    0.0000 C   0  0
   14.2861   -6.8719    0.0000 C   0  0
   13.2750   -5.7639    0.0000 C   0  0
    4.0000   -1.9800    0.0000 C   0  0
    3.9954   -3.4800    0.0000 O   0  0
    2.6100   -1.1700    0.0000 C   0  0
    1.2100   -1.9800    0.0000 C   0  0
    0.8800   -3.5500    0.0000 C   0  0
    1.8933   -4.6560    0.0000 O   0  0
  1  2  1  0
  3  2  1  6
  3  4  1  0
  4  5  2  3
  5  6  1  0
  6  7  1  0
  7  8  1  6
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 13 15  2  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  2  3
 23 24  1  0
 24 25  2  3
 25 26  1  0
 26 27  1  6
 26 28  1  0
 28 29  1  1
 28 30  1  0
 30 31  1  6
 30 32  1  0
 32 33  1  1
 32 34  1  0
 34 35  1  6
 34 36  1  0
 36 37  1  6
 37 38  1  0
 38 39  1  0
 38 40  2  0
 36 41  1  0
 41  3  1  0
 41 42  1  1
 22 43  1  0
 18 44  1  0
 44 45  1  0
 45 46  2  3
 46 47  1  0
 47 48  1  0
 48 49  1  0
 49 50  1  0
 50 51  1  0
 51 52  1  0
 52 47  1  0
 50 53  1  0
 53 54  1  0
 54 55  1  0
 55 56  1  0
 56 57  1  0
 57 53  1  0
 44 58  2  0
 58 59  1  0
 58 60  1  0
 60 15  1  0
 60 61  2  0
 61 10  1  0
 61 62  1  0
 62  7  1  0
 62 63  2  0
M  END
> <name>
NIHCC_2014

> <id>
5883

> <plate>
NGP-105-04

> <well>
B10

> <supplier_cmpd_name>
CPD000466332

> <ctcr_id>
1517

> <supplier_cmpd_id>
SAM001246620

> <smiles>
CO[C@H]1C=CO[C@@]2(C)Oc3c(C)c(O)c4c(O)c(NC(=O)C(=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C)c(C=NN5CCN(CC5)C6CCCC6)c(O)c4c3C2=O

> <pd_targets>
{KMT2A,MEN1,KDM4E,MAPT,ALD,FTL,MAPK1,GAA,ABCC4,ABCB11,ABCC3,ABCC2,RPOA,RPOB,RPOC,RPOZ}

> <pathway_gtopdb>
{"Epigenetic regulator","Other cytosolic protein",Enzyme,"Unclassified protein",Reader,Eraser,Kinase,Hydrolase,Bromodomain,"Lysine demethylase","Protein Kinase","Jumonji domain-containing","CMGC prote
in kinase group","CMGC protein kinase MAPK family","CMGC protein kinase ERK1",Transporter,"Primary active transporter",Transferase,"ATP-binding cassette","ABCC subfamily","ABCB subfamily"}

> <pathway_chembl>
{Enzymes,"Chromatin modifying enzymes","Kinases (EC 2.7.x.x)","3.2.1.- Glycosidases","1.14.11.- Histone demethylases","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Mitogen-activated protein kinases
 (MAP kinases)","ERK subfamily",Transporters,"ATP-binding cassette transporter family","ABCC subfamily","ABCB subfamily"}

> <pathway_reactome>
{"Neuronal System","Vesicle-mediated transport","Immune System",Disease,"Transmission across Chemical Synapses","Membrane Trafficking","Innate Immune System","Diseases of metabolism","Neurotransmitter
 receptors and postsynaptic signal transmission","trans-Golgi Network Vesicle Budding","Toll-like Receptor Cascades","Diseases of carbohydrate metabolism","Activation of NMDA receptors and postsynapti
c events","Golgi Associated Vesicle Biogenesis","Toll Like Receptor 5 (TLR5) Cascade","Glycogen storage diseases","Post NMDA receptor activation events","MyD88 cascade initiated on plasma membrane","G
lycogen storage disease type II (GAA)","Activation of AMPK downstream of NMDARs","MAP kinase activation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated
",Hemostasis,Metabolism,"Platelet activation","signaling and aggregation","Metabolism of lipids","Disorders of transmembrane transporters","Infectious disease","Response to elevated platelet cytosolic
 Ca2+","Metabolism of steroids","ABC transporter disorders","Infection with Mycobacterium tuberculosis","Platelet degranulation","Bile acid and bile salt metabolism","Defective ABCC2 causes DJS","Anti
microbial action and antimicrobial resistance in Mtb","Synthesis of bile acids and bile salts","Recycling of bile acids and salts","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
"}

> <broad_targets>
{CYP2C8,CYP2C9,CYP3A4}

> <broad_moa>
{"RNA polymerase inhibitor"}

> <synonyms>
{RIFAPENTINE,SMR000466332,"DL 473;Cyclopentylrifampicin",61379-65-5,61379655,"61379 65 5",MLS000759441,MLS001424209,MLS003882561,CHEMBL3190412,HMS2051D16,HMS2231H16,CCG-101040,CCG101040,"CCG 101040",S
R-01000759427,SR01000759427,"SR 01000759427",SAM001246620,CPD000466332}

> <pdid>
PD002884

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{135749824}

$$$$
NIHCC_2014
  SciTegic11012413002D

 57 62  0  0  1  0            999 V2000
    6.9692    0.5880    0.0000 C   0  0
    5.6521   -0.1299    0.0000 O   0  0
    4.3700    0.6500    0.0000 C   0  0  1  0  0  0
    4.3700    2.3400    0.0000 C   0  0
    5.5900    3.1300    0.0000 C   0  0
    5.5900    4.7100    0.0000 O   0  0
    3.1600    4.7100    0.0000 C   0  0  1  0  0  0
    4.2207    3.6493    0.0000 C   0  0
    3.1600    3.1300    0.0000 O   0  0
    1.9400    2.3400    0.0000 C   0  0
    1.9400    0.6500    0.0000 C   0  0
    3.2536   -0.0742    0.0000 C   0  0
    0.7200   -0.1200    0.0000 C   0  0
    0.7172   -1.6200    0.0000 O   0  0
   -0.4900    0.6500    0.0000 C   0  0
   -1.7000   -0.1200    0.0000 C   0  0
   -1.6972   -1.6200    0.0000 O   0  0
   -2.9200    0.6500    0.0000 C   0  0
   -4.1300   -0.1200    0.0000 N   0  0
   -4.1300   -1.5800    0.0000 C   0  0
   -2.8122   -2.2966    0.0000 O   0  0
   -5.3500   -2.3700    0.0000 C   0  0
   -5.3500   -4.4000    0.0000 C   0  0
   -4.1300   -5.3100    0.0000 C   0  0
   -2.9200   -4.4000    0.0000 C   0  0
   -1.7000   -5.3100    0.0000 C   0  0  2  0  0  0
   -1.6970   -6.8100    0.0000 C   0  0
   -0.4900   -4.4000    0.0000 C   0  0  2  0  0  0
   -0.4900   -2.9000    0.0000 O   0  0
    0.7200   -5.3100    0.0000 C   0  0  1  0  0  0
    0.6178   -6.8065    0.0000 C   0  0
    1.9400   -4.6300    0.0000 C   0  0  1  0  0  0
    3.2333   -5.3898    0.0000 O   0  0
    1.9400   -2.6000    0.0000 C   0  0  1  0  0  0
    0.6010   -1.9239    0.0000 C   0  0
    3.1600   -1.7000    0.0000 C   0  0  2  0  0  0
    4.4905   -2.3967    0.0000 O   0  0
    4.5529   -3.8962    0.0000 C   0  0
    3.2860   -4.6992    0.0000 C   0  0
    5.8816   -4.5923    0.0000 O   0  0
    3.1600   -0.1200    0.0000 C   0  0  2  0  0  0
    1.8451    0.6018    0.0000 C   0  0
   -6.6678   -1.6534    0.0000 C   0  0
   -2.9200    2.3400    0.0000 C   0  0
   -4.1300    3.1300    0.0000 N   0  0
   -5.3500    2.3400    0.0000 C   0  0
   -6.5700    3.1300    0.0000 C   0  0
   -6.5700    4.7100    0.0000 C   0  0
   -7.8878    5.4266    0.0000 C   0  0
   -5.3500    5.5000    0.0000 C   0  0
   -4.1300    4.7100    0.0000 C   0  0
   -1.7000    4.7100    0.0000 N   0  0
   -1.7000    3.1300    0.0000 C   0  0
   -0.4900    2.3400    0.0000 C   0  0
    0.7200    3.1300    0.0000 C   0  0
    0.7200    4.7100    0.0000 C   0  0
   -0.3407    5.7707    0.0000 O   0  0
  1  2  1  0
  3  2  1  6
  3  4  1  0
  4  5  2  3
  5  6  1  0
  6  7  1  0
  7  8  1  6
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 13 15  2  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  2  3
 23 24  1  0
 24 25  2  3
 25 26  1  0
 26 27  1  1
 26 28  1  0
 28 29  1  6
 28 30  1  0
 30 31  1  6
 30 32  1  0
 32 33  1  6
 32 34  1  0
 34 35  1  1
 34 36  1  0
 36 37  1  1
 37 38  1  0
 38 39  1  0
 38 40  2  0
 36 41  1  0
 41  3  1  0
 41 42  1  6
 22 43  1  0
 18 44  1  0
 44 45  1  0
 45 46  1  0
 46 47  2  0
 47 48  1  0
 48 49  1  0
 48 50  2  0
 50 51  1  0
 51 45  1  0
 51 52  2  0
 52 53  1  0
 53 44  2  0
 53 54  1  0
 54 15  1  0
 54 55  2  0
 55 10  1  0
 55 56  1  0
 56  7  1  0
 56 57  2  0
M  END
> <name>
NIHCC_2014

> <id>
5884

> <plate>
NGP-105-04

> <well>
B11

> <supplier_cmpd_name>
CPD000466324

> <ctcr_id>
477

> <supplier_cmpd_id>
SAM001246597

> <smiles>
CO[C@H]1C=CO[C@@]2(C)Oc3c(C)c(O)c4c(O)c(NC(=O)C(=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C)c5n6ccc(C)cc6nc5c4c3C2=O

> <pd_targets>
{ALD,MAPK1,MAPT,THRB,GAA,FTL,NR1I2,ABCB11,ABCC3,ABCC2,ABCC4,RPOA,RPOB,RPOC,RPOZ}

> <pathway_gtopdb>
{Enzyme,"Other cytosolic protein","Transcription factor","Unclassified protein",Transporter,Kinase,"Nuclear receptor",Hydrolase,"Primary active transporter",Transferase,"Protein Kinase","Nuclear hormo
ne receptor subfamily 1","ATP-binding cassette","CMGC protein kinase group","Nuclear hormone receptor subfamily 1 group A","Nuclear hormone receptor subfamily 1 group I","ABCB subfamily","ABCC subfami
ly","CMGC protein kinase MAPK family","Nuclear hormone receptor subfamily 1 group A member 2","Nuclear hormone receptor subfamily 1 group I member 2","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Kinases (EC 2.7.x.x)","Nuclear hormone receptors","3.2.1.- Glycosidases","ATP-binding cassette transporter family","CMGC: Containing CDK",MAPK,GSK3,"CLK families","1A.
 Thyroid hormone receptors","1I. Vitamin D receptor-like receptors","ABCB subfamily","ABCC subfamily","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Immune System","Neuronal System","Metabolism of proteins",Disease,"Vesicle-mediated transport",Metabolism,Hemostasis,"Innate Immune System","Transmission across Chemical Synapses","Post-translationa
l protein modification","Diseases of metabolism","Membrane Trafficking","Metabolism of lipids","Disorders of transmembrane transporters","Platelet activation","signaling and aggregation","Toll-like Re
ceptor Cascades","Neurotransmitter receptors and postsynaptic signal transmission",SUMOylation,"Diseases of carbohydrate metabolism","trans-Golgi Network Vesicle Budding","Metabolism of steroids","ABC
 transporter disorders","Response to elevated platelet cytosolic Ca2+","Toll Like Receptor 5 (TLR5) Cascade","Activation of NMDA receptors and postsynaptic events","SUMO E3 ligases SUMOylate target pr
oteins","Glycogen storage diseases","Golgi Associated Vesicle Biogenesis","Bile acid and bile salt metabolism","Defective ABCC2 causes DJS","Platelet degranulation","MyD88 cascade initiated on plasma 
membrane","Post NMDA receptor activation events","SUMOylation of intracellular receptors","Glycogen storage disease type II (GAA)","Synthesis of bile acids and bile salts","Recycling of bile acids and
 salts","MAP kinase activation","Activation of AMPK downstream of NMDARs","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","MAPK targets/ Nuclear events mediated by MAP kinases",
"ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{}

> <broad_moa>
{"RNA synthesis inhibitor"}

> <synonyms>
{Rifaximin,SMR000466324,80621-81-4,MLS000759430,MLS001424186,MLS003882589,CHEMBL1467058,HMS2051D18,HMS2232N07,CCG-101048,MCULE-1303528930,NC00298,SBI-0206751.P001,SR-01000759340,SR-01000759340-4,SAM00
1246597,CPD000466324}

> <pdid>
PD002883

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{72111}

$$$$
NIHCC_2014
  SciTegic11012413002D

 15 15  0  0  0  0            999 V2000
    5.0632    0.7591    0.0000 I   0  5
    2.5800    0.0305    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  3
    1.2638   -2.2496    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5987    1.5004    0.0000 C   0  0
   -2.6012    3.0004    0.0000 C   0  0
   -3.9015    3.7484    0.0000 C   0  0
   -5.1993    2.9963    0.0000 C   0  0
   -5.1969    1.4963    0.0000 C   0  0
   -3.8967    0.7484    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  3  1  0
  7 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
M  CHG  2   1  -1   3   1
M  END
> <name>
NIHCC_2014

> <id>
5885

> <plate>
NGP-105-04

> <well>
C02

> <supplier_cmpd_name>
CPD000058572

> <ctcr_id>
4478

> <supplier_cmpd_id>
SAM001246914

> <smiles>
[I-].C[N+]1(C)CCN(CC1)c2ccccc2

> <pd_targets>
{KMT2A,MEN1,APOBEC3A,NFKB1,CHRNA4,CHRNB2,PMP22,APOBEC3G,CHRNA10,CHRNA2,CHRNA3,CHRNA5,CHRNA6,CHRNA7,CHRNA9,CHRNB3,CHRNB4,POLB,HIF1A,CHRM1,NACHRALPHA5,CYP3A4,ALOX15,HSD17B10,CHRNA1}

> <pathway_gtopdb>
{"Epigenetic regulator",Enzyme,"Other cytosolic protein","Ion channel","Unclassified protein","Transcription factor","Membrane receptor",Reader,Hydrolase,"Ligand-gated ion channel","Family A G protein
-coupled receptor","Cytochrome P450",Oxidoreductase,Bromodomain,"Nicotinic acetylcholine receptor","Small molecule receptor (family A GPCR)","Cytochrome P450 family 3","Nicotinic acetylcholine recepto
r alpha subunit","Monoamine receptor","Cytochrome P450 family 3A","Acetylcholine receptor","Cytochrome P450 3A4"}

> <pathway_chembl>
{"Ion channels",Receptors,Enzymes,"Ligand-gated ion channels","G protein-coupled receptors","Cytochrome P450","Eicosanoid turnover","Nicotinic acetylcholine receptors","Acetylcholine receptors (muscar
inic)","CYP3 family",Lipoxygenases}

> <pathway_reactome>
{"Metabolism of RNA","Immune System","Neuronal System","Developmental Biology",Disease,"DNA Repair","Cellular responses to external stimuli","Signal Transduction",Metabolism,"mRNA Editing","Cytokine S
ignaling in Immune system","Transmission across Chemical Synapses","Nervous system development","Infectious disease","Base Excision Repair","Cellular responses to stress","Signaling by GPCR","Metaboli
sm of lipids","Metabolism of amino acids and derivatives","mRNA Editing: C to U Conversion","Signaling by Interleukins","Neurotransmitter receptors and postsynaptic signal transmission","EGR2 and SOX1
0-mediated initiation of Schwann cell myelination","HIV Infection","Resolution of Abasic Sites (AP sites)","Cellular response to hypoxia","GPCR ligand binding","Biosynthesis of specialized proresolvin
g mediators (SPMs)","Branched-chain amino acid catabolism","Formation of the Editosome","Interleukin-1 family signaling","Acetylcholine binding and downstream events","Host Interactions of HIV factors
","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Class A/1 (Rhodopsin-like receptors)","Bios
ynthesis of DHA-derived SPMs","Biosynthesis of DPA-derived SPMs","Interleukin-1 signaling","Postsynaptic nicotinic acetylcholine receptors","APOBEC3G mediated resistance to HIV-1 infection","PCNA-Depe
ndent Long Patch Base Excision Repair","Amine ligand-binding receptors","Biosynthesis of maresins","Biosynthesis of DPAn-3 SPMs","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Highly calcium permeable 
postsynaptic nicotinic acetylcholine receptors","Muscarinic acetylcholine receptors","Biosynthesis of maresin-like SPMs","Biosynthesis of DPAn-3-derived protectins and resolvins"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"1,1-Dimethyl-4-phenylpiperazinium iodide","1,1Dimethyl4phenylpiperazinium iodide",54-77-3,54773,DMPP,"Dimethylphenylpiperazinium iodide","DMPP iodide","1,1-dimethyl-4-phenylpiperazin-1-ium iodide","
1,1dimethyl4phenylpiperazin1ium iodide","1,1-Dimethyl-4-phenylpiperazine iodide","1,1Dimethyl4phenylpiperazine iodide","1,1-Dimethyl-4-phenyl-piperazinium iodide",N,N-,SAM001246914,CPD000058572}

> <pdid>
PD049205

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5911}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 23  0  0  0  0            999 V2000
   11.4855   -2.7614    0.0000 H   0  3
    8.9855   -2.7614    0.0000 Cl  0  5
    6.4848   -8.2644    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    3.8869   -8.2595    0.0000 C   0  0
    5.1894   -6.0109    0.0000 N   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    5.1937   -3.0093    0.0000 O   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 O   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.8003    1.4887    0.0000 C   0  0
   -9.2211    1.4430    0.0000 C   0  0
   -8.4711    2.7420    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 20  1  0
 15 23  1  0
 23 24  2  0
 24 12  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5886

> <plate>
NGP-105-04

> <well>
C03

> <supplier_cmpd_name>
CPD000058420

> <ctcr_id>
6508

> <supplier_cmpd_id>
SAM001247084

> <smiles>
[H+].[Cl-].CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1

> <pd_targets>
{ADRB1,ADRB3,ADRB2,BLM,LMNA,GAA,AMPC,CYP2D6,CYP1A2,CHRM1,CYP2C9,KMT2A,MEN1,LEF}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Adrenergic receptor",Enzyme,"Other nuclear protein","Epigenetic regulator",Hy
drolase,"Cytochrome P450",Reader,Protease,"Cytochrome P450 family 2","Cytochrome P450 family 1",Bromodomain,"Metallo protease","Cytochrome P450 family 2D","Cytochrome P450 family 1A","Cytochrome P450 
family 2C","Metallo protease MAE clan","Cytochrome P450 2D6","Cytochrome P450 1A1","Acetylcholine receptor","Cytochrome P450 2C9","Metallo protease M34 family"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors",Adrenoceptors,Enzymes,"3.2.1.- Glycosidases","Cytochrome P450","CYP2 family: drug metabolising subset","CYP1 family","Acetylcholine receptors (muscarinic)"}

> <pathway_reactome>
{Disease,"Infectious disease","Leishmania infection","Leishmania parasite growth and survival","Anti-inflammatory response favouring Leishmania parasite infection","ADORA2B mediated anti-inflammatory 
cytokines production","DNA Repair","Cell Cycle",Metabolism,"Signal Transduction","DNA Double-Strand Break Repair",Mitotic,"Diseases of metabolism","Biological oxidations","Signaling by GPCR","Homology
 Directed Repair","M Phase","Diseases of carbohydrate metabolism","Phase I - Functionalization of compounds","GPCR ligand binding","Uptake and actions of bacterial toxins","HDR through Homologous Reco
mbination (HRR) or Single Strand Annealing (SSA)","Mitotic Metaphase and Anaphase","Glycogen storage diseases","Cytochrome P450 - arranged by substrate type","Class A/1 (Rhodopsin-like receptors)","Up
take and function of anthrax toxins","HDR through Homologous Recombination (HRR)","Mitotic Anaphase","Glycogen storage disease type II (GAA)",Xenobiotics,"Amine ligand-binding receptors","Homologous D
NA Pairing and Strand Exchange","Nuclear Envelope (NE) Reassembly","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Muscarinic acetylcholine receptors","Presynapt
ic phase of homologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ADRB1,ADRB2}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{"Betaxolol hydrochloride",63659-19-8,63659198,"Betaxolol HCL",Betoptima,Betoptic,Kerlone,Lokren,"Betaxolol (hydrochloride)","Betaxolo Hydrochloride","alo 1401-02","alo 140102","Betaxolol hydrochlorid
e (Betoptic)",MFCD00242959,SL75212,"Betoptic S",MLS0,S1827,SAM001247084,Prestw-382,S4085,Betaxolol,CPD000058420,"Levobetaxolol HCl"}

> <pdid>
PD008960

> <targets>
{"Adrenergic Receptor",Others}

> <classes>
{Others,"Neuronal Signaling"}

> <pubchem_cids>
{107952,45259220,657296}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 27  0  0  0  0            999 V2000
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 N   0  0
   -5.2526    1.3618    0.0000 C   0  0
   -6.2524    0.2436    0.0000 C   0  0
   -5.4979   -1.0529    0.0000 N   0  0
   -4.0317   -0.7359    0.0000 C   0  0
   -2.6030    2.9985    0.0000 C   0  0
   -3.9023    3.7481    0.0000 C   0  0
   -3.9029    5.2481    0.0000 C   0  0
   -2.6041    5.9986    0.0000 C   0  0
   -1.3048    5.2491    0.0000 C   0  0
   -1.3042    3.7491    0.0000 C   0  0
   -2.6047    7.4994    0.0000 C   0  0
   -3.9028    8.2510    0.0000 C   0  0
   -3.9010    9.7510    0.0000 C   0  0
   -2.6011   10.4995    0.0000 C   0  0
   -1.3029    9.7479    0.0000 C   0  0
   -1.3048    8.2479    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  8  1  0
  7 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 16 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
M  END
> <name>
NIHCC_2014

> <id>
5887

> <plate>
NGP-105-04

> <well>
C04

> <supplier_cmpd_name>
CPD000058970

> <ctcr_id>
3321

> <supplier_cmpd_id>
SAM001246775

> <smiles>
c1ccc(cc1)C(n2ccnc2)c3ccc(cc3)c4ccccc4

> <pd_targets>
{ALD,CYP17A1,MAPT,RORC,FFP,MAPK1,HIF1A,USP2,NPSR1,PLA2G1B,HPGD,ATG4B,CYP3A4,KMT2A,MEN1,HSP90AA1,IDO1,STX1,ALDH1A1,TP53,CYP51A1,ABCB11,ERG11}

> <pathway_gtopdb>
{Enzyme,"Other cytosolic protein","Transcription factor","Membrane receptor","Unclassified protein","Epigenetic regulator",Transporter,"Cytochrome P450","Nuclear receptor",Transferase,Kinase,Protease,
"Family A G protein-coupled receptor",Hydrolase,Reader,Oxidoreductase,"Primary active transporter","Cytochrome P450 family 17","Nuclear hormone receptor subfamily 1","Protein Kinase","Cysteine proteas
e","Peptide receptor (family A GPCR)","Cytochrome P450 family 3",Bromodomain,"Cytochrome P450 family 51","ATP-binding cassette","Cytochrome P450 family 17A","Nuclear hormone receptor subfamily 1 group
 F","CMGC protein kinase group","Cysteine protease CA clan","Short peptide receptor (family A GPCR)","Cytochrome P450 family 3A","Cytochrome P450 family 51A","ABCB subfamily","Cytochrome P450 17A1","N
uclear hormone receptor subfamily 1 group F member 3","CMGC protein kinase MAPK family","Cysteine protease C19 family","Neuropeptide receptor","Cytochrome P450 3A4","Cytochrome P450 51A1","CMGC protei
n kinase ERK1"}

> <pathway_chembl>
{Enzymes,Receptors,"Other protein targets",Transporters,"Cytochrome P450","Nuclear hormone receptors","Kinases (EC 2.7.x.x)","Peptidases and proteinases","G protein-coupled receptors","Glycerophosphol
ipid turnover","Eicosanoid turnover","Heat shock proteins","1.13.11.- Dioxygenases","ATP-binding cassette transporter family",CYP11,CYP17,CYP19,"CYP20 and CYP21 families","1F. Retinoic acid-related or
phans","CMGC: Containing CDK",MAPK,GSK3,"CLK families","CA: Cysteine (C) Peptidases","Neuropeptide S receptor","Phospholipase A<sub>2</sub>","Prostaglandin synthases","CYP3 family",CYP39,"CYP46 and CY
P51 families","ABCB subfamily","Mitogen-activated protein kinases (MAP kinases)","C19: Ubiquitin-specific protease","C54: Aut2 peptidase","ERK subfamily"}

> <pathway_reactome>
{Metabolism,"Neuronal System","Gene expression (Transcription)","Immune System","Cellular responses to external stimuli",Disease,Autophagy,"Cell Cycle","Metabolism of lipids","Transmission across Chem
ical Synapses","RNA Polymerase II Transcription","Innate Immune System","Cellular responses to stress","Infectious disease",Macroautophagy,Mitotic,"Metabolism of amino acids and derivatives","Biologic
al oxidations","Cell Cycle Checkpoints","Metabolism of steroids","Neurotransmitter receptors and postsynaptic signal transmission","Generic Transcription Pathway","Toll-like Receptor Cascades","Cellul
ar response to hypoxia","Leishmania infection","Phospholipid metabolism","Biosynthesis of specialized proresolving mediators (SPMs)","Mitotic G2-G2/M phases","Tryptophan catabolism","Phase I - Functio
nalization of compounds","G1/S DNA Damage Checkpoints","Metabolism of steroid hormones","Activation of NMDA receptors and postsynaptic events","Transcriptional regulation by RUNX3","Toll Like Receptor
 5 (TLR5) Cascade","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Transcriptional Regulation by TP53","Leishmania parasite growth and survival","Glycerophospholipid biosyn
thesis","Biosynthesis of DHA-derived SPMs","G2/M Transition","Ethanol oxidation","p53-Dependent G1/S DNA damage checkpoint","Cytochrome P450 - arranged by substrate type","Bile acid and bile salt meta
bolism","Androgen biosynthesis","Post NMDA receptor activation events","RUNX3 Regulates Immune Response and Cell Migration","MyD88 cascade initiated on plasma membrane","Regulation of TP53 Activity","
Anti-inflammatory response favouring Leishmania parasite infection","Acyl chain remodelling of PC","Biosynthesis of D-series resolvins","Biosynthesis of maresins","Centrosome maturation","p53-Dependen
t G1 DNA Damage Response","Endogenous sterols","Synthesis of bile acids and bile salts","Activation of AMPK downstream of NMDARs","MAP kinase activation","Regulation of TP53 Expression and Degradation
","ADORA2B mediated anti-inflammatory cytokines production","Biosynthesis of maresin-like SPMs","Loss of proteins required for interphase microtubule organization from the centrosome","Stabilization o
f p53","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","MAPK targets/ Nuclear events mediated by MAP kinases","Regulation of TP53 Degradation","Loss of Nlp from mitotic centroso
mes","Autodegradation of the E3 ubiquitin ligase COP1","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{}

> <broad_moa>
{"sterol demethylase inhibitor"}

> <synonyms>
{IMI028,"Bifonazole (JP17/USAN/INN)",bifonazole,60628-96-8,60628968,Mycospor,Bifonazol,Trifonazole,"BAY H 4502",Amycor,Azolmen,1-(phenyl-(4-phenylphenyl)methyl)imidazole,1(phenyl(4phenylphenyl)methyl)
imidazole,"Bifonazol (INN-Spanish)","Bifonazol (INNSpanish)","Bifonazolum (INN-Latin)","Bifonazolum (INNLatin)",1-((4-Biphenylyl)phenylmethyl)-1,1((4Biphenylyl)phenylmethyl)1,T1187,SAM001246775,150530
9,Prestw-1241,Bifonazole,CPD000058970,BIFONAZOLE}

> <pdid>
PD000951

> <targets>
{}

> <classes>
{"calmodulin antagonist",antifungal}

> <pubchem_cids>
{2378}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 32  0  0  1  0            999 V2000
   -0.2823   -5.5001    0.0000 C   0  0
   -0.7300   -4.0685    0.0000 C   0  0  2  0  0  0
   -2.1946   -3.7406    0.0000 C   0  0
   -3.2115   -4.8444    0.0000 C   0  0
   -4.6761   -4.5166    0.0000 C   0  0
   -5.6930   -5.6204    0.0000 C   0  0
   -6.7088   -6.7241    0.0000 C   0  0
   -5.2453   -7.0520    0.0000 C   0  0
   -7.1567   -5.2927    0.0000 O   0  0
    0.2851   -2.9666    0.0000 C   0  0  1  0  0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -1.2212   -2.3711    0.0000 C   0  0
    2.5972    1.5031    0.0000 C   0  0
    2.5951    3.0039    0.0000 C   0  0
    3.8933    3.7570    0.0000 C   0  0
    3.8872    5.2571    0.0000 C   0  0
    5.1832    6.0124    0.0000 C   0  0  1  0  0  0
    5.1770    7.5124    0.0000 O   0  0
    6.4853    5.2677    0.0000 C   0  0
    6.4914    3.7677    0.0000 C   0  0  2  0  0  0
    7.7935    3.0231    0.0000 O   0  0
    5.1955    3.0124    0.0000 C   0  0
    5.2017    1.5124    0.0000 C   0  0
  2  1  1  6
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  6  9  1  0
  2 10  1  0
 10 11  1  6
 11 12  1  0
 13 12  1  6
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 10  1  0
 18 13  1  0
 18 19  1  6
 14 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 24 25  1  1
 24 26  1  0
 26 27  1  0
 27 28  1  6
 27 29  1  0
 29 22  1  0
 29 30  2  0
M  END
> <name>
NIHCC_2014

> <id>
5888

> <plate>
NGP-105-04

> <well>
C05

> <supplier_cmpd_name>
CPD000466393

> <ctcr_id>
3503

> <supplier_cmpd_id>
SAM001246772

> <smiles>
C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2\C(CCC[C@]12C)=C\C=C3\C[C@@H](O)C[C@H](O)C3=C

> <pd_targets>
{VDR,TGR,MAPK1,RORC,MAPT,GC,FTL,RXRA,VDRA,ABCB11}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Other cytosolic protein","Secreted protein","Unclassified protein",Transporter,"Nuclear receptor",Kinase,"Primary active transporter","Nuclear hormone receptor subfamil
y 1","Protein Kinase","ATP-binding cassette","Nuclear hormone receptor subfamily 1 group I","CMGC protein kinase group","Nuclear hormone receptor subfamily 1 group F","ABCB subfamily","Nuclear hormone
 receptor subfamily 1 group I member 1","CMGC protein kinase MAPK family","Nuclear hormone receptor subfamily 1 group F member 3","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Nuclear hormone receptors","Kinases (EC 2.7.x.x)","ATP-binding cassette transporter family","1I. Vitamin D receptor-like receptors","CMGC: Containing CDK",MAPK,GSK3,"C
LK families","1F. Retinoic acid-related orphans","ABCB subfamily","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Metabolism of proteins","Immune System","Gene expression (Transcription)","Neuronal System",Metabolism,"Vesicle-mediated transport","Post-translational protein modification","Innate Immune System","
RNA Polymerase II Transcription","Transmission across Chemical Synapses","Metabolism of lipids","Membrane Trafficking",SUMOylation,"Toll-like Receptor Cascades","Generic Transcription Pathway","Neurot
ransmitter receptors and postsynaptic signal transmission","Metabolism of steroids","trans-Golgi Network Vesicle Budding","SUMO E3 ligases SUMOylate target proteins","Toll Like Receptor 5 (TLR5) Casca
de","Transcriptional regulation by RUNX3","Activation of NMDA receptors and postsynaptic events","Vitamin D (calciferol) metabolism","Golgi Associated Vesicle Biogenesis","Bile acid and bile salt meta
bolism","SUMOylation of intracellular receptors","MyD88 cascade initiated on plasma membrane","RUNX3 Regulates Immune Response and Cell Migration","Post NMDA receptor activation events","Synthesis of 
bile acids and bile salts","MAP kinase activation","Activation of AMPK downstream of NMDARs","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","MAPK targets/ Nuclear events mediat
ed by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{VDR}

> <broad_moa>
{"vitamin D receptor agonist"}

> <synonyms>
{calcitriol,Rocaltrol,Calcijex,32222-06-3,32222063,Topitriol,"1alpha,25-Dihydroxyvitamin D3","1alpha,25Dihydroxyvitamin D3",Silkis,Soltriol,"1alpha,25-Dihydroxycholecalciferol","1alpha,25Dihydroxychol
ecalciferol","1,25-DHCC","1,25DHCC","1,25-Dihydroxyvitamin D","1,25Dihydroxyvitamin D",Calcitriolum,"1,25-DIHYDROXYCHOLECALCIFEROL","1,25DIHYDROXYCHOLECALCIFEROL",Vectical,1,25-Dihydrox,25Dihydrox,T63
16,SAM001246772,Calcitriol,CPD000466393}

> <pdid>
PD003123

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5280453}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 26  0  0  1  0            999 V2000
    6.0333   -7.4056    0.0000 C   0  0
    6.9148   -6.1919    0.0000 C   0  0
    8.4065   -6.3489    0.0000 O   0  0
    6.3037   -4.8211    0.0000 N   0  0
    4.8111   -4.6641    0.0000 C   0  0
    4.2010   -3.2956    0.0000 C   0  0  1  0  0  0
    2.7343   -2.9815    0.0000 C   0  0
    2.5987   -1.5004    0.0000 N   0  0
    3.9511   -0.8815    0.0000 C   0  0
    4.2566    0.5871    0.0000 O   0  0
    4.9531   -1.9978    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5987    1.5004    0.0000 N   0  0
   -2.6012    3.0004    0.0000 C   0  0
   -3.9015    3.7484    0.0000 C   0  0
   -5.1993    2.9963    0.0000 O   0  0
   -5.1969    1.4963    0.0000 C   0  0
   -3.8967    0.7484    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 F   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  6  5  1  1
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11  6  1  0
  8 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 16  1  0
 15 22  1  0
 22 23  1  0
 22 24  2  0
 24 12  1  0
M  END
> <name>
NIHCC_2014

> <id>
5889

> <plate>
NGP-105-04

> <well>
C06

> <supplier_cmpd_name>
CPD000466335

> <ctcr_id>
3583

> <supplier_cmpd_id>
SAM001246624

> <smiles>
CC(=O)NC[C@H]1CN(C(=O)O1)c2ccc(N3CCOCC3)c(F)c2

> <pd_targets>
{SKA,MAOA,LMNA,SDHA,MAOB,PTGS1}

> <pathway_gtopdb>
{Enzyme,"Other nuclear protein",Kinase,Oxidoreductase}

> <pathway_chembl>
{Enzymes,"Catecholamine turnover","Eicosanoid turnover",Cyclooxygenase}

> <pathway_reactome>
{Metabolism,"Cell Cycle","Biological oxidations",Mitotic,"The citric acid (TCA) cycle and respiratory electron transport","Metabolism of lipids","Phase I - Functionalization of compounds","M Phase","P
yruvate metabolism and Citric Acid (TCA) cycle","Fatty acid metabolism","Amine Oxidase reactions","Mitotic Metaphase and Anaphase","Citric acid cycle (TCA cycle)","Arachidonic acid metabolism","Biogen
ic amines are oxidatively deaminated to aldehydes by MAOA and MAOB","Mitotic Anaphase","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","Nuclear Envelope (NE) Reassembly","Initiation of Nuclea
r Envelope (NE) Reformation"}

> <broad_targets>
{}

> <broad_moa>
{"protein synthesis inhibitor"}

> <synonyms>
{linezolid,165800-03-3,165800033,Zyvox,Zyvoxid,PNU-100766,PNU100766,U-100766,U100766,Zyvoxam,"PNU 100766","U 100766",C16H20FN3O4,UNII-ISQ9I6J12J,UNIIISQ9I6J12J,CHEMBL126,ISQ9I6J12J,CHEBI:63607,"Linezo
lid, 98",MFCD00937825,"U-100,766","U100,766",ZLD,Zivoxid,Zyvoxa,SMR000466335,"Zyvox (TN)","HSDB 7478",T0391,SAM001246624,Prestw-1429,Linezolid,CPD000466335}

> <pdid>
PD001291

> <targets>
{Antibiotic,Bacterial}

> <classes>
{Anti-infection}

> <pubchem_cids>
{441401}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 27  0  0  1  0            999 V2000
    5.1894   -6.0108    0.0000 C   0  0
    3.8917   -5.2586    0.0000 N   0  0
    2.5915   -6.0067    0.0000 C   0  0
    3.8934   -3.7577    0.0000 C   0  0
    2.5949   -3.0050    0.0000 C   0  0
    2.5966   -1.5042    0.0000 C   0  0  1  0  0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 Br  0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8990   -0.7582    0.0000 C   0  0
    3.9042    0.7419    0.0000 C   0  0
    5.2058    1.4875    0.0000 C   0  0
    6.5023    0.7331    0.0000 C   0  0
    6.4972   -0.7669    0.0000 C   0  0
    5.1956   -1.5125    0.0000 N   0  0
   10.3023   -0.3804    0.0000 O   0  0
   10.3023   -1.8804    0.0000 C   0  0
    9.0030   -2.6300    0.0000 O   0  0
   11.6023   -2.6304    0.0000 C   0  0
   12.9023   -1.8804    0.0000 C   0  0
   12.9037   -0.3796    0.0000 C   0  0
   11.6051    0.3712    0.0000 O   0  0
   14.2030    0.3700    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  6  5  1  1
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13  7  1  0
  6 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 25 27  2  0
M  END
> <name>
NIHCC_2014

> <id>
5890

> <plate>
NGP-105-04

> <well>
C07

> <supplier_cmpd_name>
CPD000471616

> <ctcr_id>
5810

> <supplier_cmpd_id>
SAM001246556

> <smiles>
CN(C)CC[C@@H](c1ccc(Br)cc1)c2ccccn2.OC(=O)\C=C/C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"DEXBROMPHENIRAMINE MALEATE",2391-03-9,2391039,"(+)-Brompheniramine maleate","(+)Brompheniramine maleate",Disomer,"(S)-Brompheniramine Maleate","(S)Brompheniramine Maleate",CHEBI:59273,UNII-BPA9UT29B
S,UNIIBPA9UT29BS,"Dexbrompheniramine fumarate",BPA9UT29BS,"2391-03-9 (maleate)","2391039 (maleate)",DSSTox_CID_27795,DSSToxCID27795,DSSTox-CID-27795,"DSSTox CID 27795",DSSTox_RID_82567,DSSToxRID82567,
DSSTox-RID-82567,"DSSTox RID 82567",DSSTox_GSI,DSSToxGSI,DSSTox-GSI,"DSSTox GSI",SAM001246556,CPD000471616}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{6433334}

$$$$
NIHCC_2014
  SciTegic11012413002D

 41 45  0  0  0  0            999 V2000
   -3.6915   -7.4420    0.0000 C   0  0
   -2.6931   -6.3225    0.0000 O   0  0
   -1.2234   -6.6267    0.0000 C   0  0
   -0.7552   -8.0517    0.0000 C   0  0
    0.7130   -8.3588    0.0000 C   0  0
    1.7131   -7.2408    0.0000 C   0  0
    1.2449   -5.8157    0.0000 C   0  0
   -0.2234   -5.5086    0.0000 C   0  0
   -0.6890   -4.0818    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    3.8805   -1.4410    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 N   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -3.8964   -0.7545    0.0000 O   0  0
   -5.2003    1.4932    0.0000 O   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.8525    1.3572    0.0000 C   0  0
   -8.8524    0.2390    0.0000 C   0  0
   -8.0978   -1.0574    0.0000 C   0  0
   -6.6317   -0.7404    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    1.1844   -9.7837    0.0000 C   0  0
    0.1863  -10.9034    0.0000 O   0  0
    2.6539  -10.0888    0.0000 N   0  0
    3.1253  -11.5137    0.0000 S   0  0
    1.6565  -11.2094    0.0000 O   0  0
    2.1272  -12.6334    0.0000 O   0  0
    4.5948  -11.8188    0.0000 C   0  0
    5.0650  -13.2432    0.0000 C   0  0
    6.5337  -13.5481    0.0000 C   0  0
    7.5321  -12.4287    0.0000 C   0  0
    7.0619  -11.0043    0.0000 C   0  0
    5.5932  -10.6994    0.0000 C   0  0
    5.1230   -9.2750    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 22  1  0
 17 27  1  0
 27 28  2  0
 28 10  1  0
 28 14  1  0
  5 29  1  0
 29 30  2  0
 29 31  1  0
 31 32  1  0
 32 33  2  0
 32 34  2  0
 32 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  2  0
 38 39  1  0
 39 40  2  0
 40 35  1  0
 40 41  1  0
M  END
> <name>
NIHCC_2014

> <id>
5891

> <plate>
NGP-105-04

> <well>
C08

> <supplier_cmpd_name>
CPD000466316

> <ctcr_id>
1572

> <supplier_cmpd_id>
SAM001246577

> <smiles>
COc1cc(ccc1Cc2cn(C)c3ccc(NC(=O)OC4CCCC4)cc23)C(=O)N[S](=O)(=O)c5ccccc5C

> <pd_targets>
{CYSLTR1,MAPK14,PPARG,KMT2A,MEN1,POLB,ABCB11,CYSLTR2,NPSR1,RECQL,MAPT,RORC,MAPK3,MAPK1,SKA,CYP2C9,NR1I2,EPHX2,PLA2G4A,LTB4R2,LTB4R,SLC47A1,ABCC4,SLC10A1,TBXAS1,SLC47A2,PTGES,ABCC2,ADORA3,EGFR,SLC22A2}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Transcription factor","Epigenetic regulator",Transporter,"Other cytosolic protein","Family A G protein-coupled receptor",Kinase,"Nuclear receptor",Reader,"Primary active t
ransporter","Cytochrome P450",Protease,"Electrochemical transporter",Isomerase,"Small molecule receptor (family A GPCR)","Protein Kinase","Nuclear hormone receptor subfamily 1",Bromodomain,"ATP-bindin
g cassette","Peptide receptor (family A GPCR)","Cytochrome P450 family 2","Serine protease","SLC superfamily of solute carriers","Cytochrome P450 family 5","Lipid-like ligand receptor (family A GPCR)"
,"CMGC protein kinase group","Nuclear hormone receptor subfamily 1 group C","ABCB subfamily","Short peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 fa
mily 2C","Nuclear hormone receptor subfamily 1 group I","Serine protease SC clan","SLC47 family of multidrug and toxin extrusion transporters","ABCC subfamily","SLC10 family of sodium-bile acid co-tra
nsporters","Cytochrome P450 family 5A","Nucleotide-like receptor (family A GPCR)","TK protein kinase group","SLC22 family of organic cation and anion transporters","Leukotriene receptor","CMGC protein
 kinase MAPK family","Nuclear hormone receptor subfamily 1 group C member 3","Neuropeptide receptor","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 2C9","Nuclear hormone rece
ptor subfamily 1 group I member 2","Serine protease S33 family","Cytochrome P450 5A1","Adenosine receptor","Tyrosine protein kinase EGFR family","CMGC protein kinase p38 subfamily","CMGC protein kinas
e ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"G protein-coupled receptors","Kinases (EC 2.7.x.x)","Nuclear hormone receptors","ATP-binding cassette transporter family","Cytochrome P450",Hydrolases,"Glycerophosphol
ipid turnover","SLC superfamily of solute carriers","Eicosanoid turnover","Catalytic receptors","Leukotriene receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK families","1C. Peroxisome proliferator-act
ivated receptors","ABCB subfamily","Neuropeptide S receptor","1F. Retinoic acid-related orphans","CYP2 family: drug metabolising subset","1I. Vitamin D receptor-like receptors","Phospholipase A<sub>2<
/sub>","SLC47 family of multidrug and toxin extrusion transporters","ABCC subfamily","SLC10 family of sodium-bile acid co-transporters",CYP5,"CYP7 and CYP8 families","Prostaglandin synthases","Adenosi
ne receptors","Receptor kinases","SLC22 family of organic cation and anion transporters","Mitogen-activated protein kinases (MAP kinases)","TK: Tyrosine kinase","Organic cation transporters (OCT)","p3
8 subfamily","ERK subfamily","Receptor tyrosine kinases (RTKs)","Type I RTKs: ErbB (epidermal growth factor) receptor family"}

> <pathway_reactome>
{Disease,"Immune System","Gene expression (Transcription)","DNA Repair",Metabolism,"Neuronal System","Metabolism of proteins","Signal Transduction","Transport of small molecules",Hemostasis,"Infectiou
s disease","Innate Immune System","RNA Polymerase II Transcription","Base Excision Repair","Metabolism of lipids","Transmission across Chemical Synapses","Biological oxidations","Post-translational pr
otein modification","Signaling by GPCR","SLC-mediated transmembrane transport","Platelet activation","signaling and aggregation","Disorders of transmembrane transporters","Leishmania infection","Toll-
like Receptor Cascades","Generic Transcription Pathway","Resolution of Abasic Sites (AP sites)","Metabolism of steroids","Neurotransmitter receptors and postsynaptic signal transmission","Phase I - Fu
nctionalization of compounds",SUMOylation,"Biosynthesis of specialized proresolving mediators (SPMs)","GPCR downstream signalling","GPCR ligand binding","Transport of bile salts and organic acids","me
tal ions and amine compounds","Response to elevated platelet cytosolic Ca2+","Fatty acid metabolism","ABC transporter disorders","Leishmania parasite growth and survival","Toll Like Receptor 5 (TLR5) 
Cascade","Transcriptional Regulation by MECP2","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Bile acid and bile salt metabolism","Activation of NMDA receptors and pos
tsynaptic events","Transcriptional regulation by RUNX3","Cytochrome P450 - arranged by substrate type","SUMO E3 ligases SUMOylate target proteins","Biosynthesis of DHA-derived SPMs","G alpha (i) signa
lling events","Class A/1 (Rhodopsin-like receptors)","Platelet degranulation","Arachidonic acid metabolism","Defective ABCC2 causes DJS","G alpha (q) signalling events","Organic cation/anion/zwitterio
n transport","Anti-inflammatory response favouring Leishmania parasite infection","MyD88 cascade initiated on plasma membrane","MECP2 regulates transcription factors","PCNA-Dependent Long Patch Base E
xcision Repair","Synthesis of bile acids and bile salts","Post NMDA receptor activation events","RUNX3 Regulates Immune Response and Cell Migration",Xenobiotics,"SUMOylation of intracellular receptors
","Biosynthesis of maresins","Opioid Signalling","Eicosanoid ligand-binding receptors","Recycling of bile acids and salts",Eicosanoids,"Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","Nucleot
ide-like (purinergic) receptors","Gastrin-CREB signalling pathway via PKC and MAPK","Organic cation transport","LTC4-CYSLTR mediated IL4 production","MAP kinase activation","Synthesis of bile acids an
d bile salts via 7alpha-hydroxycholesterol","ADORA2B mediated anti-inflammatory cytokines production","Activation of AMPK downstream of NMDARs","CYP2E1 reactions","G-protein mediated events","Leukotri
ene receptors","Adenosine P1 receptors","EGFR Transactivation by Gastrin","MAPK targets/ Nuclear events mediated by MAP kinases","PLC beta mediated events","Activation of the AP-1 family of transcript
ion factors","ERK/MAPK targets","Ca-dependent events","ERKs are inactivated","phospho-PLA2 pathway"}

> <broad_targets>
{CYSLTR1,CYSLTR2}

> <broad_moa>
{"leukotriene receptor antagonist"}

> <synonyms>
{RESTW136,zafirlukast,107753-78-6,107753786,Accolate,Olmoran,ICI-204219,ICI204219,Accoleit,"ICI 204219","ICI 204,219",C31H33N3O6S,UNII-XZ629S5L50,UNIIXZ629S5L50,"Zafirlukast (Accolate)",CHEMBL603,Aero
nix,CHEBI:10100,XZ629S5L50,MFCD00864775,NCGC00164547-01,NCGC0016454701,NCGC00164547-06,NCGC0016454706,Vanticon,DSSTox_,DSSTox,DSSTox-,T6736,SAM001246577,Prestw-1364,Zafirlukast,CPD000466316}

> <pdid>
PD002945

> <targets>
{Leukotriene Receptor}

> <classes>
{GPCR/G Protein}

> <pubchem_cids>
{5717}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 28  0  0  0  0            999 V2000
    9.0991   -0.7603    0.0000 C   0  0
    7.7988   -1.5080    0.0000 N   0  0
    7.7966   -3.0080    0.0000 C   0  0
    6.4999   -0.7561    0.0000 C   0  0
    5.1988   -1.5042    0.0000 C   0  0
    3.8999   -0.7523    0.0000 O   0  0
    2.5988   -1.5004    0.0000 C   0  0
    2.6001   -0.0004    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    2.5996   -3.0013    0.0000 C   0  0
    1.3010   -3.7520    0.0000 C   0  0
    1.3018   -5.2520    0.0000 C   0  0
    2.6012   -6.0013    0.0000 C   0  0
    3.8998   -5.2506    0.0000 C   0  0
    3.8990   -3.7506    0.0000 N   0  0
   12.8998   -0.3757    0.0000 O   0  0
   12.8998   -1.8757    0.0000 C   0  0
   11.6006   -2.6252    0.0000 O   0  0
   14.1998   -2.6257    0.0000 C   0  0
   15.4998   -1.8757    0.0000 C   0  0
   16.7998   -2.6257    0.0000 C   0  0
   16.7998   -4.1257    0.0000 O   0  0
   18.0991   -1.8761    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
  7 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 26 28  2  0
M  END
> <name>
NIHCC_2014

> <id>
5892

> <plate>
NGP-105-04

> <well>
C09

> <supplier_cmpd_name>
CPD000058436

> <ctcr_id>
5924

> <supplier_cmpd_id>
SAM001247030

> <smiles>
CN(C)CCOC(C)(c1ccccc1)c2ccccn2.OC(=O)CCC(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Doxylamine succinate",562-10-7,562107,"562 10 7",Decapryn,"Doxylamine (succinate)","Doxylamine succinate salt","Evigoa D","A-H Injection","AH Injection","A H Injection","Decapryn Succinate",Unisom,"
Doxylamine hydrogen succinate",D,T1115,SAM001247030,1500267,Prestw-27,CPD000058436,"DOXYLAMINE SUCCINATE"}

> <pdid>

> <targets>
{}

> <classes>
{hypnotic,antihistaminic}

> <pubchem_cids>
{11224,43833352}

$$$$
NIHCC_2014
  SciTegic11012413002D

 32 35  0  0  1  0            999 V2000
   -6.1706   -4.0096    0.0000 C   0  0
   -4.7181   -4.3840    0.0000 C   0  0
   -3.6663   -3.3134    0.0000 O   0  0
   -2.2130   -3.6880    0.0000 C   0  0
   -1.8114   -5.1333    0.0000 O   0  0
   -1.1612   -2.6174    0.0000 O   0  0
    0.2851   -2.9666    0.0000 C   0  0  2  0  0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -1.2991    2.2500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -0.8141   -2.0807    0.0000 C   0  0
    0.7499   -4.3804    0.0000 C   0  0
   -0.2673   -5.4828    0.0000 O   0  0
    2.2139   -4.7107    0.0000 O   0  0
    2.6608   -6.1435    0.0000 C   0  0
    4.1240   -6.4736    0.0000 Cl  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  7  6  1  1
  7  8  1  0
  8  9  1  0
 10  9  1  6
 10 11  1  0
 11 12  1  1
 12 13  1  0
 13 14  1  0
 14 15  2  3
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  2  3
 19 20  1  0
 20 14  1  0
 20 21  1  6
 22 20  1  6
 22 11  1  0
 22 23  1  0
 23 24  1  6
 23 25  1  0
 25 26  1  0
 26  7  1  0
 26 10  1  0
 26 27  1  6
  7 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 31 32  1  0
M  END
> <name>
NIHCC_2014

> <id>
5893

> <plate>
NGP-105-04

> <well>
C10

> <supplier_cmpd_name>
CPD000469178

> <ctcr_id>
4428

> <supplier_cmpd_id>
SAM001246630

> <smiles>
CCOC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C)C(=O)OCCl

> <pd_targets>
{ABCC3,ABCB11,NR3C1}

> <pathway_gtopdb>
{Transporter,"Transcription factor","Primary active transporter","Nuclear receptor","ATP-binding cassette","Nuclear hormone receptor subfamily 3","ABCC subfamily","ABCB subfamily","Nuclear hormone rec
eptor subfamily 3 group C","Nuclear hormone receptor subfamily 3 group C member 1"}

> <pathway_chembl>
{Transporters,Receptors,"ATP-binding cassette transporter family","Nuclear hormone receptors","ABCC subfamily","ABCB subfamily","Steroid hormone receptors","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{Metabolism,"Gene expression (Transcription)","Metabolism of lipids","RNA Polymerase II Transcription","Metabolism of steroids","Generic Transcription Pathway","Bile acid and bile salt metabolism","FO
XO-mediated transcription","Recycling of bile acids and salts","Synthesis of bile acids and bile salts","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","Synthesis of b
ile acids and bile salts via 7alpha-hydroxycholesterol"}

> <broad_targets>
{NR3C1}

> <broad_moa>
{"glucocorticoid receptor agonist","phospholipase inhibitor"}

> <synonyms>
{"Loteprednol etabonate",Lotemax,Alrex,82034-46-6,82034466,HGP-1,HGP1,Inveltys,P-5604,P5604,CDDD-5604,CDDD5604,UNII-YEH1EZ96K6,UNIIYEH1EZ96K6,CHEBI:31784,"CDDD 5604",YEH1EZ96K6,DSSTox_CID_26468,DSSTox
CID26468,DSSTox-CID-26468,"DSSTox CID 26468",DSSTox_RID_81641,DSSToxRID81641,DSSTox-RID-81641,"DSSTox RID 81641",DSSTox_GSID_46468,DSSToxGSID46468,DSSTox-GSID-46468,"DSSTox GSID 46468",Loterox,Locort,
"Lotemax (TN)","Loteprednol etab",T0181,SAM001246630,CPD000469178}

> <pdid>
PD003115

> <targets>
{Antibiotic,Bacterial,Glucocorticoid Receptor}

> <classes>
{Anti-infection,GPCR/G Protein}

> <pubchem_cids>
{444025}

$$$$
NIHCC_2014
  SciTegic11012413002D

 42 45  0  0  1  0            999 V2000
   14.2784   -3.0066    0.0000 Na  0  3
    3.8858   -0.7535    0.0000 C   0  0
    3.8860    0.7465    0.0000 C   0  0
    2.5870   -0.0036    0.0000 C   0  0
    2.5868    1.4962    0.0000 O   0  0
    5.1860    1.4964    0.0000 C   0  0
    5.1866    2.9964    0.0000 C   0  0
    6.4859    3.7459    0.0000 C   0  0
    7.7847    2.9954    0.0000 C   0  0
    7.7841    1.4954    0.0000 C   0  0
    6.4848    0.7458    0.0000 C   0  0
    6.4872   -0.7550    0.0000 C   0  0
    7.7877   -1.5041    0.0000 C   0  0
    7.7902   -3.0050    0.0000 C   0  0  1  0  0  0
    9.0907   -3.7541    0.0000 S   0  0
    9.0932   -5.2549    0.0000 C   0  0
   10.3937   -6.0040    0.0000 C   0  0
   11.7784   -6.0690    0.0000 C   0  0
   11.0269   -4.7708    0.0000 C   0  0
   10.3957   -7.5052    0.0000 C   0  0
    9.0974   -8.2582    0.0000 C   0  0
    7.7971   -7.5103    0.0000 O   0  5
    9.0994   -9.7582    0.0000 O   0  0
    6.4915   -3.7571    0.0000 C   0  0
    6.4915   -5.2571    0.0000 C   0  0
    5.1924   -6.0070    0.0000 C   0  0
    3.8934   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -5.1961   -1.5000    0.0000 Cl  0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
    5.1925   -3.0070    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  3  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
 11 12  1  0
 12 13  1  0
 14 13  1  1
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 17  1  0
 17 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  2  0
 14 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  1  0
 37 39  2  0
 39 40  1  0
 40 34  1  0
 40 41  2  0
 41 31  1  0
 28 42  2  0
 42 24  1  0
M  CHG  2   1   1  22  -1
M  END
> <name>
NIHCC_2014

> <id>
5894

> <plate>
NGP-105-04

> <well>
C11

> <supplier_cmpd_name>
CPD000469188

> <ctcr_id>
5120

> <supplier_cmpd_id>
SAM001246657

> <smiles>
[Na+].CC(C)(O)c1ccccc1CC[C@@H](SCC2(CC2)CC([O-])=O)c3cccc(\C=C\c4ccc5ccc(Cl)cc5n4)c3

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"MONTELUKAST SODIUM",151767-02-1,151767021,Singulair,Montair,"Montelukast (sodium)",MK-0476,MK0476,UNII-U1O3J18SFL,UNIIU1O3J18SFL,"MONTELUKAST Na",MK-476,MK476,U1O3J18SFL,CHEBI:6993,"151767-02-1 (sod
ium)","151767021 (sodium)","Montelukast sodium salt",DSSTox_CID_26450,DSSToxCID26450,DSSTox-CID-26450,"DSSTox CID 26450",DSSTox_RID_81624,DSSToxRID81624,DSSTox-RID-81624,"DSSTox RID 81624",DSSTox_GSID
_464,DSSToxGSID464,DSSTox-GSID-464,"DSSTox GSID 464",T1677L,SAM001246657,"Montelukast sodium",CPD000469188}

> <pdid>

> <targets>
{Leukotriene Receptor}

> <classes>
{GPCR/G Protein}

> <pubchem_cids>
{23663996}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 32  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5972    1.5031    0.0000 C   0  0
    2.5951    3.0039    0.0000 C   0  0
    3.8933    3.7570    0.0000 N   0  0
    3.8933    5.2571    0.0000 C   0  0
    5.1924    6.0071    0.0000 C   0  0
    6.4914    5.2571    0.0000 C   0  0
    6.4915    3.7571    0.0000 C   0  0
    5.1925    3.0071    0.0000 C   0  0
    7.7927    6.0049    0.0000 C   0  0
    7.7953    7.5049    0.0000 O   0  0
    9.0914    5.2527    0.0000 C   0  0
   10.3931    5.9982    0.0000 C   0  0
   11.6895    5.2437    0.0000 C   0  0
   11.6844    3.7437    0.0000 C   0  0
   12.9809    2.9893    0.0000 F   0  0
   10.3828    2.9982    0.0000 C   0  0
    9.0863    3.7526    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11  6  1  0
  9 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  2  0
 20 14  1  0
  3 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  2  3
 25 26  1  0
 26 27  2  3
 27 28  1  0
 28 23  1  0
 28 29  2  3
 29  2  1  0
M  END
> <name>
NIHCC_2014

> <id>
5895

> <plate>
NGP-105-04

> <well>
D02

> <supplier_cmpd_name>
CPD000058507

> <ctcr_id>
2046

> <supplier_cmpd_id>
SAM001246893

> <smiles>
CC1=C(CCN2CCC(CC2)C(=O)c3ccc(F)cc3)C(=O)N4C=CC=CC4=N1

> <pd_targets>
{HTR1A,KDM4E,TSHR,PMP22,CYP2D6,ADRA1A,ADRA2C,HTR2B,KMT2A,MEN1,CHRM1,HTR7,HTR2C,HTR2A,HPGD,CYP3A4,THPO,HTR1B,MAPT,SMN1,PKM}

> <pathway_gtopdb>
{"Membrane receptor","Epigenetic regulator","Unclassified protein",Enzyme,"Other cytosolic protein","Family A G protein-coupled receptor",Eraser,"Cytochrome P450",Reader,"Small molecule receptor (fami
ly A GPCR)","Lysine demethylase","Peptide receptor (family A GPCR)","Cytochrome P450 family 2",Bromodomain,"Cytochrome P450 family 3","Methyl-lysine/arginine binding protein","Monoamine receptor","Jum
onji domain-containing","Glycohormone receptor","Cytochrome P450 family 2D","Cytochrome P450 family 3A","Tudor domain","Serotonin receptor","Cytochrome P450 2D6","Adrenergic receptor","Acetylcholine r
eceptor","Cytochrome P450 3A4"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Chromatin modifying enzymes","Cytochrome P450","Eicosanoid turnover","2.7.1.40 Pyruvate kinases","5-Hydroxytryptamine receptors","1.14.11.- Histone de
methylases","Glycoprotein hormone receptors","CYP2 family: drug metabolising subset",Adrenoceptors,"Acetylcholine receptors (muscarinic)","Prostaglandin synthases","CYP3 family"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Developmental Biology",Metabolism,Hemostasis,"Neuronal System","Metabolism of RNA","Signaling by GPCR","Infectious disease","Nervous system development","Biological oxi
dations","Metabolism of lipids","Platelet activation","signaling and aggregation","Transmission across Chemical Synapses","Metabolism of non-coding RNA","Metabolism of carbohydrates","GPCR ligand bind
ing","Leishmania infection","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","Pla
telet Aggregation (Plug Formation)","Neurotransmitter receptors and postsynaptic signal transmission","snRNP Assembly","Glucose metabolism","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite 
growth and survival","Cytochrome P450 - arranged by substrate type","Biosynthesis of DHA-derived SPMs","Activation of NMDA receptors and postsynaptic events",Glycolysis,"Amine ligand-binding receptors
","Anti-inflammatory response favouring Leishmania parasite infection",Xenobiotics,"Biosynthesis of D-series resolvins","Biosynthesis of maresins","Post NMDA receptor activation events","Serotonin rec
eptors","ADORA2B mediated anti-inflammatory cytokines production","CYP2E1 reactions",Adrenoceptors,"Muscarinic acetylcholine receptors","Biosynthesis of maresin-like SPMs","Activation of AMPK downstre
am of NMDARs"}

> <broad_targets>
{HTR2A,HTR7}

> <broad_moa>
{"serotonin receptor antagonist"}

> <synonyms>
{Pirenperone,75444-65-4,75444654,"R-47,465","R47,465",UNII-Y9FMC4513X,UNIIY9FMC4513X,CHEMBL18331,MLS000069365,Y9FMC4513X,NCGC00015784-07,NCGC0001578407,SMR000058507,DSSTox_CID_25182,DSSToxCID25182,DSS
Tox-CID-25182,"DSSTox CID 25182",DSSTox_RID_80730,DSSToxRID80730,DSSTox-RID-80730,"DSSTox RID 80730",DSSTox_GSID_45182,DSSToxGSID45182,DSSTox-GSID-45182,"DSSTox GSID 45182","R 47465",Pirenperona,Piren
peronum,"Pirenperonum (INN-Latin)","Pirenperonum (INNLatin)","Pirenperona (",SAM001246893,1504188,Prestw-531,CPD000058507,PIRENPERONE}

> <pdid>
PD002686

> <targets>
{}

> <classes>
{"5HT2 receptor antagonist"}

> <pubchem_cids>
{4847}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 23  0  0  0  0            999 V2000
    2.5532   -4.4223    0.0000 O   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
   -0.6928   -4.0817    0.0000 C   0  0
   -0.2491   -5.5022    0.0000 N   0  0
   -1.4850   -6.3508    0.0000 C   0  0
   -1.6812   -7.8379    0.0000 C   0  0
   -3.0671   -8.4116    0.0000 C   0  0
   -4.2569   -7.4981    0.0000 C   0  0
   -4.0607   -6.0110    0.0000 C   0  0
   -2.6748   -5.4373    0.0000 C   0  0
   -2.1742   -4.0242    0.0000 C   0  0
   -3.0159   -2.7826    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  9 10  1  0
 10  2  2  0
 10 11  1  0
 11 12  2  3
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 18 19  1  0
 19 11  1  0
 19 20  2  0
M  END
> <name>
NIHCC_2014

> <id>
5896

> <plate>
NGP-105-04

> <well>
D03

> <supplier_cmpd_name>
CPD000466311

> <ctcr_id>
4732

> <supplier_cmpd_id>
SAM001246563

> <smiles>
Oc1[nH]c2ccccc2c1C3=Nc4ccccc4C3=O

> <pd_targets>
{CTRB1,SRC,CDK2,MDH,CDK1}

> <pathway_gtopdb>
{Enzyme,Kinase,Oxidoreductase,"Protein Kinase","TK protein kinase group","CMGC protein kinase group","Tyrosine protein kinase Src family","CMGC protein kinase CDK family","CMGC protein kinase CDC2 sub
family"}

> <pathway_chembl>
{Receptors,Enzymes,"Catalytic receptors","Kinases (EC 2.7.x.x)","Receptor kinases","CMGC: Containing CDK",MAPK,GSK3,"CLK families","TK: Tyrosine kinase","Cyclin-dependent kinase (CDK) family","Non-rec
eptor tyrosine kinases (nRTKs)","CDK1 subfamily","Src family"}

> <pathway_reactome>
{"Signal Transduction","Gene expression (Transcription)","Cell Cycle","Signaling by Receptor Tyrosine Kinases","RNA Polymerase II Transcription",Mitotic,"Signaling by NTRKs","Generic Transcription Pat
hway","Regulation of mitotic cell cycle","Signaling by NTRK1 (TRKA)","Transcriptional Regulation by TP53","APC/C-mediated degradation of cell cycle proteins","Signalling to ERKs","Regulation of TP53 A
ctivity","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins","Signalling to RAS","Regulation of TP53 Expression and Degradation","APC/C:Cdc20 mediated degradation of mitotic
 proteins","p38MAPK events","Regulation of TP53 Degradation","APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint","Cdc20:Phospho-APC/C mediated deg
radation of Cyclin A"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{Indirubin,479-41-4,479414,"Indigo Red","Couroupitine B",Indigopurpurin,"(Z)-(2,3'-biindolinylidene)-2',3-dione","(Z)(2,3'biindolinylidene)2',3dione",906748-38-7,906748387,3-(3-oxo-1H-indol-2-ylidene)
-1H-indol-2-one,3(3oxo1Hindol2ylidene)1Hindol2one,UNII-V86L8P74GI,UNIIV86L8P74GI,NSC-105327,NSC105327,"C.I. 73200",UNII-1LXW6D3W2Z,UNII1LXW6D3W2Z,1LXW6D3W2Z,2H-Indol-2-on,2HIndol2on,SAM001246563,CPD00
0466311}

> <pdid>
PD003207

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{10177}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 28  0  0  0  0            999 V2000
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 S   0  0
    1.2948   -3.7516    0.0000 O   0  0
    2.5923   -4.5039    0.0000 O   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 N   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 C   0  0
   -3.1904   -2.6376    0.0000 C   0  0
   -4.6588   -2.9478    0.0000 C   0  0
   -5.1253   -4.3743    0.0000 N   0  0
   -6.5929   -4.6844    0.0000 C   0  0
   -4.1233   -5.4906    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    7.6933   -0.1206    0.0000 O   0  0
    7.6933   -1.6206    0.0000 C   0  0
    6.3940   -2.3702    0.0000 O   0  0
    8.9933   -2.3706    0.0000 C   0  0
   10.2933   -1.6206    0.0000 C   0  0
   11.5933   -2.3706    0.0000 C   0  0
   11.5933   -3.8706    0.0000 O   0  0
   12.8926   -1.6210    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  2  0
  3  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 13 19  1  0
 19 10  1  0
 19 20  2  0
 20  7  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 26 28  2  0
M  END
> <name>
NIHCC_2014

> <id>
5897

> <plate>
NGP-105-04

> <well>
D04

> <supplier_cmpd_name>
CPD000469158

> <ctcr_id>
1770

> <supplier_cmpd_id>
SAM001246579

> <smiles>
CN[S](=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1.OC(=O)CCC(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"SUMATRIPTAN SUCCINATE",103628-48-4,103628484,Imitrex,Imigran,Suminat,"Sumavel DosePro",Alsuma,"Sumatriptan (succinate)","GR 43175C",UNII-J8BDZ68989,UNIIJ8BDZ68989,MFCD00902856,"GR 43175","sumatripta
n hydrogen succinate",C18H27N3O6S,CHEBI:64359,J8BDZ68989,"103628-48-4 (succ","103628484 (succ",T0203,S1432,SAM001246579,Prestw-1346,"Sumatriptan succinate","Sumatriptan Succinate",CPD000469158}

> <pdid>

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{59772}

$$$$
NIHCC_2014
  SciTegic11012413002D

 36 37  0  0  0  0            999 V2000
    8.8634   -0.3655    0.0000 H   0  3
    6.3634   -0.3655    0.0000 Cl  0  5
    3.8634    3.7731    0.0000 C   0  0
    3.8627    2.2731    0.0000 C   0  0
    2.5631    1.5224    0.0000 O   0  0
    2.5625    0.0216    0.0000 C   0  0
    3.8615   -0.7286    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.4982    0.7397    0.0000 C   0  0
   -7.7955   -0.0134    0.0000 N   0  0
   -5.2044    2.9940    0.0000 C   0  0
   -3.9074    3.7475    0.0000 C   0  0
   -3.9114    5.2475    0.0000 C   0  0
   -5.2125    5.9940    0.0000 C   0  0
   -6.5095    5.2405    0.0000 C   0  0
   -6.5054    3.7405    0.0000 C   0  0
   -5.1970   -0.0076    0.0000 C   0  0
   -3.8963   -0.7547    0.0000 C   0  0
   -3.8930   -2.2547    0.0000 C   0  0
   -5.1903   -3.0075    0.0000 C   0  0
   -6.4910   -2.2604    0.0000 C   0  0
   -6.4944   -0.7604    0.0000 C   0  0
    1.2628   -2.2303    0.0000 C   0  0
    2.5430   -3.0120    0.0000 C   0  0
    2.5063   -4.5115    0.0000 C   0  0
    1.1893   -5.2294    0.0000 C   0  0
   -0.0910   -4.4478    0.0000 C   0  0
   -0.0543   -2.9483    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13  8  1  0
 11 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  3  0
 16 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 16 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
  8 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 36 31  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5898

> <plate>
NGP-105-04

> <well>
D05

> <supplier_cmpd_name>
CPD000469140

> <ctcr_id>
2457

> <supplier_cmpd_id>
SAM001246532

> <smiles>
[H+].[Cl-].CCOC(=O)C1(CCN(CC1)CCC(C#N)(c2ccccc2)c3ccccc3)c4ccccc4

> <pd_targets>
{KCNA3,OPRM1,OPRD1}

> <pathway_gtopdb>
{"Ion channel","Membrane receptor","Voltage-gated ion channel","Family A G protein-coupled receptor","Potassium channels","Peptide receptor (family A GPCR)","Voltage-gated potassium channel","Short pe
ptide receptor (family A GPCR)","Opioid receptor"}

> <pathway_chembl>
{"Ion channels",Receptors,"Voltage-gated ion channels","G protein-coupled receptors","Potassium channels","Opioid receptors","Voltage-gated potassium channels"}

> <pathway_reactome>
{"Neuronal System","Signal Transduction","Potassium Channels","Signaling by GPCR","Voltage gated Potassium channels","GPCR downstream signalling","GPCR ligand binding","G alpha (i) signalling events",
"Class A/1 (Rhodopsin-like receptors)","Opioid Signalling","Peptide ligand-binding receptors","G-protein activation"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{118391-EP2275420A1,118391EP2275420A1,118391-EP2280008A2,118391EP2280008A2,118391-EP2298764A1,118391EP2298764A1,118391-EP2298765A1,118391EP2298765A1,CHEBI:59784,"Diphenoxylate hydrochloride","Diphenox
ylate HCl",3810-80-8,3810808,UNII-W24OD7YW48,UNIIW24OD7YW48,W24OD7YW48,"Diphenoxylate hydrochloride (USP)",DSSTox_CID_27821,DSSToxCID27821,DSSTox-CID-27821,"DSSTox CID 27821",DSSTox_RID_825,DSSToxRID8
25,DSSTox-RID-825,"DSSTox RID 825",SAM001246532,CPD000469140}

> <pdid>
PD009819

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{53630037,19650,6432394}

$$$$
NIHCC_2014
  SciTegic11012413002D

 35 37  0  0  0  0            999 V2000
    6.3990    3.3937    0.0000 Cl  0  0
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5973    1.5031    0.0000 C   0  0
   -2.5951    3.0039    0.0000 N   0  0
   -3.8916    3.7585    0.0000 C   0  0
   -3.8864    5.2585    0.0000 C   0  0
   -2.5847    6.0040    0.0000 N   0  0
   -1.2883    5.2495    0.0000 C   0  0
   -1.2935    3.7495    0.0000 C   0  0
   -2.5775    7.5047    0.0000 C   0  0
   -1.2740    8.2485    0.0000 C   0  0
    0.0228    7.4945    0.0000 C   0  0
    1.3242    8.2405    0.0000 C   0  0
    1.3288    9.7405    0.0000 C   0  0
    2.6301   10.4865    0.0000 F   0  0
    0.0321   10.4945    0.0000 C   0  0
   -1.2693    9.7485    0.0000 C   0  0
   -3.8739    8.2610    0.0000 C   0  0
   -5.1779    7.5195    0.0000 C   0  0
   -6.4720    8.2780    0.0000 C   0  0
   -6.4622    9.7779    0.0000 C   0  0
   -7.7563   10.5364    0.0000 F   0  0
   -5.1583   10.5194    0.0000 C   0  0
   -3.8642    9.7610    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 O   0  0
   -2.5951   -3.0031    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0031   -3.0008    0.0000 O   0  0
    1.3032   -3.7490    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14  9  1  0
 12 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 19 21  1  0
 21 22  2  0
 22 16  1  0
 15 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 26 28  1  0
 28 29  2  0
 29 23  1  0
  7 30  1  0
 30 31  1  0
 31 32  1  0
 30 33  2  0
 33  4  1  0
 33 34  1  0
 34 35  1  0
M  END
> <name>
NIHCC_2014

> <id>
5899

> <plate>
NGP-105-04

> <well>
D06

> <supplier_cmpd_name>
CPD000469203

> <ctcr_id>
1430

> <supplier_cmpd_id>
SAM001246727

> <smiles>
Cl.COc1ccc(CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4)c(OC)c1OC

> <pd_targets>
{FFP,HTT,LMNA,RCE1,CACNA1B,CACNA2D1,CACNB1,ABCB1}

> <pathway_gtopdb>
{Enzyme,"Unclassified protein","Other nuclear protein","Ion channel",Transporter,Transferase,"Voltage-gated ion channel","Primary active transporter","Voltage-gated calcium channel","ATP-binding casse
tte","ABCB subfamily"}

> <pathway_chembl>
{"Ion channels",Transporters,"Voltage-gated ion channels","ATP-binding cassette transporter family","Voltage-gated calcium channels","ABCB subfamily"}

> <pathway_reactome>
{"Gene expression (Transcription)","Cell Cycle","Neuronal System",Metabolism,"RNA Polymerase II Transcription",Mitotic,"Transmission across Chemical Synapses","Abacavir transport and metabolism","Gene
ric Transcription Pathway","M Phase","Presynaptic depolarization and calcium channel opening","Abacavir transmembrane transport","Transcriptional Regulation by MECP2","Mitotic Metaphase and Anaphase",
"Regulation of MECP2 expression and activity","Mitotic Anaphase","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{CACNA1B,SCN5A}

> <broad_moa>
{"calcium channel blocker"}

> <synonyms>
{"LOMERIZINE DiHCl",MLS001401390,SCHEMBL404179,CHEMBL1404407,AKOS015961667,CCG-101010,CCG101010,NC00260,SMR000469203,101L547,T6571,SAM001246727,"Lomerizine hydrochloride",CPD000469203}

> <pdid>
PD013067

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{13579832}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 18  0  0  0  0            999 V2000
    5.0987   -0.7504    0.0000 Cl  0  0
    2.5981   -1.5000    0.0000 Cl  0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 N   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.3229    1.2135    0.0000 N   0  0
   -6.2045    0.0000    0.0000 C   0  0
   -7.7045   -0.0001    0.0000 O   0  0
   -5.3228   -1.2136    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 N   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 Cl  0  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  3
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13  8  1  0
 13 14  1  0
 14 15  1  0
 15  6  1  0
 15 16  2  0
 16  3  1  0
 16 17  1  0
M  END
> <name>
NIHCC_2014

> <id>
5900

> <plate>
NGP-105-04

> <well>
D07

> <supplier_cmpd_name>
CPD000469168

> <ctcr_id>
2001

> <supplier_cmpd_id>
SAM001246604

> <smiles>
Cl.Clc1ccc2NC3=NC(=O)CN3Cc2c1Cl

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"ANAGRELIDE HYDROCHLORIDE",SAM001246604,"Anagrelide HCl","anagrelide hydrochloride",S3172,Anagrelide,T0160,1505590,CPD000469168}

> <pdid>

> <targets>
{PDE}

> <classes>
{antithrombotic,Metabolism}

> <pubchem_cids>
{57515909,42786}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 23  0  0  0  0            999 V2000
   17.9976   -0.7406    0.0000 H   0  3
   15.4976   -0.7406    0.0000 Cl  0  5
    3.8964    0.7545    0.0000 C   0  0
    3.8990   -0.7455    0.0000 N   0  0
    5.2003   -1.4932    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0
    7.8003   -1.4887    0.0000 C   0  0
    9.0990   -0.7364    0.0000 C   0  0
   10.3977    0.0159    0.0000 C   0  0
   11.6963    0.7681    0.0000 C   0  0
   12.9969    0.0208    0.0000 C   0  0
   12.9939    1.5206    0.0000 C   0  0
   11.6937    2.2681    0.0000 C   0  0
    2.6003   -1.4977    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  3  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 10 13  1  0
  4 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 15  1  0
 24 19  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5901

> <plate>
NGP-105-04

> <well>
D08

> <supplier_cmpd_name>
CPD000469152

> <ctcr_id>
5596

> <supplier_cmpd_id>
SAM001246565

> <smiles>
[H+].[Cl-].CN(C\C=C\C#CC(C)(C)C)Cc1cccc2ccccc12

> <pd_targets>
{SQLE,RORC,LMNA,SLC6A2,SIGMAR1,ADRA2A,CYP2D6,ERG1}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Other nuclear protein",Transporter,"Membrane receptor","Other cytosolic protein",Oxidoreductase,"Nuclear receptor","Electrochemical transporter","Family A G protein-cou
pled receptor","Cytochrome P450","Nuclear hormone receptor subfamily 1","SLC superfamily of solute carriers","Small molecule receptor (family A GPCR)","Cytochrome P450 family 2","Nuclear hormone recep
tor subfamily 1 group F","SLC06 neurotransmitter transporter family","Monoamine receptor","Cytochrome P450 family 2D","Nuclear hormone receptor subfamily 1 group F member 3","Adrenergic receptor","Cyt
ochrome P450 2D6"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Other protein targets","Lanosterol biosynthesis pathway","Nuclear hormone receptors","SLC superfamily of solute carriers","Sigma receptors","G protein-coupled receptor
s","Cytochrome P450","1F. Retinoic acid-related orphans","SLC6 neurotransmitter transporter family",Adrenoceptors,"CYP2 family: drug metabolising subset","Monoamine transporter subfamily"}

> <pathway_reactome>
{Metabolism,"Gene expression (Transcription)","Cell Cycle",Disease,"Signal Transduction","Metabolism of lipids","RNA Polymerase II Transcription",Mitotic,"Disorders of transmembrane transporters","Inf
ectious disease","Signaling by GPCR","Biological oxidations","Metabolism of steroids","Generic Transcription Pathway","M Phase","SLC transporter disorders","SARS-CoV Infections","GPCR ligand binding",
"Phase I - Functionalization of compounds","Regulation of cholesterol biosynthesis by SREBP (SREBF)","Transcriptional regulation by RUNX3","Mitotic Metaphase and Anaphase","Defective SLC6A2 causes ort
hostatic intolerance (OI)","Potential therapeutics for SARS","Class A/1 (Rhodopsin-like receptors)","Cytochrome P450 - arranged by substrate type","Activation of gene expression by SREBF (SREBP)","RUN
X3 Regulates Immune Response and Cell Migration","Mitotic Anaphase","Amine ligand-binding receptors",Xenobiotics,"Nuclear Envelope (NE) Reassembly",Adrenoceptors,"CYP2E1 reactions","Initiation of Nucl
ear Envelope (NE) Reformation"}

> <broad_targets>
{SQLE}

> <broad_moa>
{"fungal squalene epoxidase inhibitor"}

> <synonyms>
{AKOS026750103,AC-761,AC761,CT0259,"Terbinafine hydrochloride","Terbinafine HCl",78628-80-5,78628805,Lamisil,"Lamisil AT",Terbinafina,Terbinafinum,UNII-012C11ZU6G,UNII012C11ZU6G,Zabel,"Terbinafine (hy
drochloride)",C21H26ClN,CPD000469152,CHEBI:77614,012C11ZU6,SAM001246565,1505392,"TERBINAFINE HYDROCHLORIDE"}

> <pdid>
PD009684

> <targets>
{}

> <classes>
{antifungal}

> <pubchem_cids>
{50986900,11324905,5282481}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 19  0  0  1  0            999 V2000
   11.4936   -2.0085    0.0000 Cl  0  5
    5.1889   -6.0106    0.0000 C   0  0
    3.8914   -5.2578    0.0000 C   0  0
    3.8937   -3.7570    0.0000 N   0  0
    5.1963   -3.0116    0.0000 C   0  0
    6.4929   -3.7658    0.0000 C   0  0
    2.5955   -3.0038    0.0000 C   0  0
    1.2951   -3.7514    0.0000 O   0  0
    2.5978   -1.5030    0.0000 C   0  0  2  0  0  0
    3.9823   -1.5719    0.0000 C   0  0
    3.2345   -0.2716    0.0000 C   0  0  2  0  0  0
    3.2075    1.2189    0.0000 C   0  0
    4.4919    1.9936    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    8.9936   -2.0085    0.0000 H   0  3
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  4  7  1  0
  7  8  2  0
  9  7  1  1
  9 10  1  0
 10 11  1  0
 11  9  1  0
 11 12  1  1
 12 13  1  0
  9 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
M  CHG  2   1  -1  20   1
M  END
> <name>
NIHCC_2014

> <id>
5902

> <plate>
NGP-105-04

> <well>
D09

> <supplier_cmpd_name>
CPD000449266

> <ctcr_id>
1874

> <supplier_cmpd_id>
SAM001247035

> <smiles>
[Cl-].CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)c2ccccc2.[H+]

> <pd_targets>
{SLC6A4,SLC6A3,SLC6A2,GRIN1,GRIN2A,GRIN2B,GRIN2C,GRIN2D,GRIN3A,GRIN3B,MAPK1,KDM4E,CYP2D6,NET}

> <pathway_gtopdb>
{Transporter,"Ion channel","Electrochemical transporter","Ligand-gated ion channel","SLC superfamily of solute carriers","Ionotropic glutamate receptor","SLC06 neurotransmitter transporter family","NM
DA receptor",Enzyme,"Epigenetic regulator",Kinase,Eraser,"Cytochrome P450","Protein Kinase","Lysine demethylase","Cytochrome P450 family 2","CMGC protein kinase group","Jumonji domain-containing","Cyt
ochrome P450 family 2D","CMGC protein kinase MAPK family","Cytochrome P450 2D6","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Transporters,"SLC superfamily of solute carriers","SLC6 neurotransmitter transporter family","Monoamine transporter subfamily",Enzymes,"Kinases (EC 2.7.x.x)","Chromatin modifying enzymes","Cytochrome
 P450","CMGC: Containing CDK",MAPK,GSK3,"CLK families","1.14.11.- Histone demethylases","CYP2 family: drug metabolising subset","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Neuronal System",Disease,"Transmission across Chemical Synapses","Disorders of transmembrane transporters","Neurotransmitter clearance","SLC transporter disorders","Serotonin clearance from the syna
ptic cleft","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Defective SLC6A2 causes orthostatic intolerance (OI)","Immune System",Metabolism,"Innate Immune System","Biological oxida
tions","Toll-like Receptor Cascades","Phase I - Functionalization of compounds","Toll Like Receptor 5 (TLR5) Cascade","Cytochrome P450 - arranged by substrate type","MyD88 cascade initiated on plasma 
membrane",Xenobiotics,"MAP kinase activation","CYP2E1 reactions","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{SLC6A2,SLC6A4}

> <broad_moa>
{"serotoninânorepinephrine reuptake inhibitor (SNRI)"}

> <synonyms>
{"Milnacipran hydrochloride","Milnacipran HCl",101152-94-7,101152947,"101152 94 7",Savella,Milnacipran,"Milnacipran (hydrochloride)","F 2207",175131-61-0,175131610,"175131 61 0","(1R-cis)-Milnacipran 
Hydrochloride","(1Rcis)Milnacipran Hydrochloride","(1Rcis)Milnacipran Hydrochl",T2594,SAM001247035,Levomilnacipran,CPD000449266}

> <pdid>
PD009171

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{55480,67108486,163701}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 26  0  0  1  0            999 V2000
    6.4897   -5.2632    0.0000 C   0  0
    5.1894   -6.0109    0.0000 C   0  0  2  0  0  0
    3.8912   -5.2578    0.0000 N   0  0
    3.8933   -3.7570    0.0000 C   0  0  1  0  0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    5.1929   -3.0062    0.0000 C   0  0
    6.4919   -3.7562    0.0000 O   0  0
    5.1933   -1.5062    0.0000 O   0  0
    5.1873   -7.5117    0.0000 C   0  0
    3.8869   -8.2595    0.0000 O   0  0
    6.4855   -8.2648    0.0000 N   0  0
    7.8369   -7.6438    0.0000 C   0  0
    8.8406   -8.7585    0.0000 C   0  0
    8.0906  -10.0575    0.0000 C   0  0
    6.6233   -9.7456    0.0000 C   0  0  1  0  0  0
    5.5002  -10.7372    0.0000 C   0  0
    5.7982  -12.2073    0.0000 O   0  0
    4.0780  -10.2606    0.0000 O   0  0
  2  1  1  1
  2  3  1  0
  4  3  1  1
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  4 13  1  0
 13 14  1  0
 13 15  2  0
  2 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 18  1  0
 22 23  1  1
 23 24  1  0
 23 25  2  0
M  END
> <name>
NIHCC_2014

> <id>
5903

> <plate>
NGP-105-04

> <well>
D10

> <supplier_cmpd_name>
CPD000466359

> <ctcr_id>
5366

> <supplier_cmpd_id>
SAM001246684

> <smiles>
C[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N2CCC[C@H]2C(O)=O

> <pd_targets>
{ACE,ACE2}

> <pathway_gtopdb>
{Enzyme,Protease,"Metallo protease","Metallo protease MAE clan","Metallo protease M2 family"}

> <pathway_chembl>
{Enzymes,"Peptidases and proteinases","MA: Metallo (M) Peptidases","M2: Angiotensin-converting  (ACE and ACE2)"}

> <pathway_reactome>
{"Metabolism of proteins",Disease,"Peptide hormone metabolism","Infectious disease","Metabolism of Angiotensinogen to Angiotensins","SARS-CoV Infections","SARS-CoV-1 Infection","Attachment and Entry"}

> <broad_targets>
{ACE}

> <broad_moa>
{"angiotensin converting enzyme inhibitor"}

> <synonyms>
{Enalaprilat,76420-72-9,76420729,"Enalapril acid",Enalaprilate,Enalaprilatum,"Enalapril diacid","Enalaprilic acid","Enalaprilat anhydrous",N-((1S)-1-carboxy-3-phenylpropyl)-L-alanyl-L-proline,N((1S)1c
arboxy3phenylpropyl)LalanylLproline,"enalaprilat (anhydrous)",MK-422,MK422,UNII-Q508Q118JM,UNIIQ508Q118JM,84680-54-6,84680546,SAM001246684,CPD000466359}

> <pdid>
PD003008

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5462501}

$$$$
NIHCC_2014
  SciTegic11012413002D

 15 16  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5987    1.5004    0.0000 C   0  0  1  0  0  0
   -2.7390    2.9810    0.0000 C   0  0
   -4.2067    3.2905    0.0000 C   0  0
   -4.9546    1.9903    0.0000 C   0  0  1  0  0  0
   -6.4447    1.8344    0.0000 C   0  0
   -7.3266    3.0478    0.0000 O   0  0
   -3.9492    0.8772    0.0000 O   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  3
  8  2  1  0
  9  6  1  6
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  6
 13 14  1  0
 12 15  1  0
 15  9  1  0
M  END
> <name>
NIHCC_2014

> <id>
5904

> <plate>
NGP-105-04

> <well>
D11

> <supplier_cmpd_name>
CPD000058253

> <ctcr_id>
5855

> <supplier_cmpd_id>
SAM001246779

> <smiles>
NC1=NC(=O)N(C=C1)[C@H]2CC[C@@H](CO)O2

> <pd_targets>
{NFKB1,POL,LMNA,MAPT,ALB,MAPK1,KMT2A,MEN1,CXCR4}

> <pathway_gtopdb>
{"Other cytosolic protein",Enzyme,"Other nuclear protein","Secreted protein","Epigenetic regulator","Membrane receptor",Hydrolase,Kinase,Reader,"Family A G protein-coupled receptor","Protein Kinase",B
romodomain,"Peptide receptor (family A GPCR)","CMGC protein kinase group","Chemokine receptor","CMGC protein kinase MAPK family","CXC chemokine receptor","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Receptors,"Kinases (EC 2.7.x.x)","G protein-coupled receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Chemokine receptors","Mitogen-activated protein kinases (MAP kinases)","ERK sub
family"}

> <pathway_reactome>
{"Immune System","Cell Cycle","Neuronal System",Metabolism,Disease,"Cytokine Signaling in Immune system",Mitotic,"Transmission across Chemical Synapses","Metabolism of lipids","Innate Immune System","
Infectious disease","Signaling by Interleukins","M Phase","Neurotransmitter receptors and postsynaptic signal transmission","Metabolism of steroids","Toll-like Receptor Cascades","HIV Infection","Inte
rleukin-1 family signaling","Mitotic Metaphase and Anaphase","Activation of NMDA receptors and postsynaptic events","Bile acid and bile salt metabolism","Toll Like Receptor 5 (TLR5) Cascade","HIV Life
 Cycle","Interleukin-1 signaling","Mitotic Anaphase","Post NMDA receptor activation events","Recycling of bile acids and salts","MyD88 cascade initiated on plasma membrane","Early Phase of HIV Life Cy
cle","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Nuclear Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs","MAP kinase activation","Binding and entry of HIV virion","Initiation of 
Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{}

> <broad_moa>
{"nucleoside reverse transcriptase inhibitor"}

> <synonyms>
{RESTW103,zalcitabine,7481-89-2,7481892,"2',3'-DIDEOXYCYTIDINE","2',3'DIDEOXYCYTIDINE",Dideoxycytidine,ddCyd,HIVID,"Cytidine, 2',3'-dideoxy-","Cytidine, 2',3'dideoxy",ddC,Zalcitibine,"Ro 24-2027/000",
"Ro 242027/000",UNII-6L3XT8CB3I,UNII6L3XT8CB3I,MFCD00012188,CHEMBL853,6L3XT8CB3I,78798-EP2305695A2,78798EP2305695A2,CHEBI:10101,NCGC00090705-08,NCGC0009070508,DSSTox_CID_37,DSSToxCID37,DSSTox-CID-37,"
DSSTox CID 37",T0110,SAM001246779,Prestw-1037,Zalcitabine,CPD000058253}

> <pdid>
PD001308

> <targets>
{HIV,Reverse Transcriptase}

> <classes>
{Anti-infection}

> <pubchem_cids>
{24066}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 26  0  0  1  0            999 V2000
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0  1  0  0  0
   -2.5981    3.0000    0.0000 C   0  0
   -3.8972    3.7500    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0  1  0  0  0
   -5.2920    3.9954    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0  1  0  0  0
   -6.6243    1.0594    0.0000 C   0  0
   -7.4983    2.2785    0.0000 C   0  0
   -6.6089    3.4864    0.0000 C   0  0  2  0  0  0
   -5.9204    4.2117    0.0000 O   0  0
   -8.0649    3.7919    0.0000 C   0  0
   -9.5280    4.1225    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0  2  0  0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  6
  8  9  1  0
  9 10  1  0
 10 11  1  6
 10 12  1  0
 12 13  1  6
 13 14  1  0
 14 15  1  0
 15 10  1  0
 15 16  1  6
 15 17  1  0
 17 18  3  0
 12 19  1  0
 19  7  1  0
 19 20  1  1
 20 21  1  0
 21 22  1  0
 22  6  1  0
 22 23  2  0
 23  3  1  0
M  END
> <name>
NIHCC_2014

> <id>
5905

> <plate>
NGP-105-04

> <well>
E02

> <supplier_cmpd_name>
CPD000059128

> <ctcr_id>
5063

> <supplier_cmpd_id>
SAM001246866

> <smiles>
COc1ccc2[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@@H]3CCc2c1

> <pd_targets>
{PGR,LMNA,AR,RORC,CNR1,SLC6A4,ESR1,SLC6A2}

> <pathway_gtopdb>
{"Transcription factor","Other nuclear protein","Membrane receptor",Transporter,"Nuclear receptor","Family A G protein-coupled receptor","Electrochemical transporter","Nuclear hormone receptor subfami
ly 3","Nuclear hormone receptor subfamily 1","Small molecule receptor (family A GPCR)","SLC superfamily of solute carriers","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor sub
family 1 group F","Lipid-like ligand receptor (family A GPCR)","SLC06 neurotransmitter transporter family","Nuclear hormone receptor subfamily 3 group A","Nuclear hormone receptor subfamily 3 group C 
member 3","Nuclear hormone receptor subfamily 3 group C member 4","Nuclear hormone receptor subfamily 1 group F member 3","Cannabinoid receptor","Nuclear hormone receptor subfamily 3 group A member 1"
}

> <pathway_chembl>
{Receptors,Transporters,"Nuclear hormone receptors","G protein-coupled receptors","SLC superfamily of solute carriers","Steroid hormone receptors","1F. Retinoic acid-related orphans","Cannabinoid rece
ptors","SLC6 neurotransmitter transporter family","3C. 3-Ketosteroid receptors","Monoamine transporter subfamily","3A. Estrogen receptors"}

> <pathway_reactome>
{"Cell Cycle","Gene expression (Transcription)","Signal Transduction","Neuronal System",Disease,Mitotic,"RNA Polymerase II Transcription","Signaling by GPCR","Transmission across Chemical Synapses","D
isorders of transmembrane transporters","M Phase","Generic Transcription Pathway","GPCR downstream signalling","Neurotransmitter clearance","SLC transporter disorders","Mitotic Metaphase and Anaphase"
,"Transcriptional regulation by RUNX2","Transcriptional regulation by RUNX3","G alpha (i) signalling events","Serotonin clearance from the synaptic cleft","Transcriptional regulation by RUNX1","Defect
ive SLC6A2 causes orthostatic intolerance (OI)","Mitotic Anaphase","RUNX2 regulates bone development","RUNX3 Regulates Immune Response and Cell Migration","RUNX1 regulates estrogen receptor mediated t
ranscription","Nuclear Envelope (NE) Reassembly","RUNX2 regulates osteoblast differentiation","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ESR1}

> <broad_moa>
{"estrogen receptor agonist"}

> <synonyms>
{RESTW84,mestranol,72-33-3,72333,Norquen,Menophase,Devocin,Ovastol,"Ethynylestradiol 3-methyl ether","Ethynylestradiol 3methyl ether",Mestranolum,3-Methoxyethynylestradiol,3Methoxyethynylestradiol,EE(
sub3)ME,"Ethynylestradiol methyl ether",3-Methylethynylestradiol,3Methylethynylestradiol,EE3ME,3-O-Methylethynylestradiol,3OMethylethynylestradiol,"Compound 33355",In,SAM001246866,Prestw-846,CPD000059
128}

> <pdid>
PD001868

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{6291}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 27  0  0  0  0            999 V2000
    5.0987   -1.6638    0.0000 Cl  0  0
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 O   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -1.2990   -5.2500    0.0000 Cl  0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8994   -0.7523    0.0000 C   0  0
   -3.9020    0.7477    0.0000 O   0  0
   -5.1981   -1.5045    0.0000 N   0  0
   -6.4994   -0.7568    0.0000 C   0  0
   -7.1958    0.4025    0.0000 C   0  0
   -8.5033    0.4542    0.0000 N   0  0
   -9.7286   -0.6473    0.0000 C   0  0
   -9.0139   -1.8943    0.0000 C   0  0
   -7.8911   -0.7365    0.0000 C   0  0
   -8.3476    1.0332    0.0000 C   0  0
   -9.1122    1.9232    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  3  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14  8  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 18  1  0
 23 24  1  0
 24 25  1  0
 25 20  1  0
M  END
> <name>
NIHCC_2014

> <id>
5906

> <plate>
NGP-105-04

> <well>
E03

> <supplier_cmpd_name>
CPD000466285

> <ctcr_id>
3427

> <supplier_cmpd_id>
SAM001247082

> <smiles>
Cl.CN1C(=O)COc2c1cc(Cl)cc2C(=O)NC3CN4CCC3CC4

> <pd_targets>
{TDP1,HTR3A,HTR3B}

> <pathway_gtopdb>
{Enzyme,"Ion channel",Hydrolase,"Ligand-gated ion channel","5HT3 receptor"}

> <pathway_chembl>
{"Ion channels","Ligand-gated ion channels","5-HT<sub>3</sub> receptors"}

> <pathway_reactome>
{"DNA Repair","Neuronal System","DNA Double-Strand Break Repair","Transmission across Chemical Synapses","Nonhomologous End-Joining (NHEJ)","Neurotransmitter receptors and postsynaptic signal transmis
sion"}

> <broad_targets>
{HTR3A,HTR3B}

> <broad_moa>
{"serotonin receptor antagonist"}

> <synonyms>
{AKOS026750135,"azasetron hydrochloride",123040-16-4,123040164,"Azasetron HCl",Serotone,123040-69-7,123040697,Nazasetron,"Azasetron (hydrochloride)","Y-25130 hydrochloride","Y25130 hydrochloride","Aza
setron hydrochloride (JAN)",141922-90-9,141922909,SMR000466285,1329611-23-5,1329611235,C17H20ClN3O3.HCl,Y-2,Y2,T1528,SAM001247082,"Azasetron hydrochloride",CPD000466285}

> <pdid>
PD014471

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{67108127,115000}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 25  0  0  1  0            999 V2000
    2.6640   -0.1280    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -5.1961   -1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0
   -6.4952    3.7500    0.0000 O   0  0
   -3.8971    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0  2  0  0  0
   -1.2990    2.2500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.3326   -2.9571    0.0000 C   0  0
    1.8253   -3.1044    0.0000 C   0  0
    2.4266   -1.7302    0.0000 C   0  0
    3.8900   -1.4008    0.0000 O   0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  6
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  2  3
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  3
 15 16  1  0
 16  5  1  0
 16 10  1  0
 16 17  1  1
  6 18  1  0
 18  2  1  0
 18 19  1  1
 19 20  1  0
 20 21  1  0
 21  2  1  0
 21 22  2  0
M  END
> <name>
NIHCC_2014

> <id>
5907

> <plate>
NGP-105-04

> <well>
E04

> <supplier_cmpd_name>
CPD000466314

> <ctcr_id>
5719

> <supplier_cmpd_id>
SAM001246574

> <smiles>
C[C@]12CC[C@H]3[C@@H](CC(=C)C4=CC(=O)C=C[C@]34C)[C@@H]1CCC2=O

> <pd_targets>
{TGR,CYP19A1,ABCB11}

> <pathway_gtopdb>
{Enzyme,Transporter,"Cytochrome P450","Primary active transporter","Cytochrome P450 family 19","ATP-binding cassette","Cytochrome P450 family 19A","ABCB subfamily","Cytochrome P450 19A1"}

> <pathway_chembl>
{Enzymes,Transporters,"Cytochrome P450","ATP-binding cassette transporter family",CYP11,CYP17,CYP19,"CYP20 and CYP21 families","ABCB subfamily"}

> <pathway_reactome>
{Metabolism,"Biological oxidations","Metabolism of lipids","Phase I - Functionalization of compounds","Metabolism of steroids","Cytochrome P450 - arranged by substrate type","Bile acid and bile salt m
etabolism","Endogenous sterols","Synthesis of bile acids and bile salts","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"}

> <broad_targets>
{CYP19A1}

> <broad_moa>
{"aromatase inhibitor"}

> <synonyms>
{EXEMESTANE,107868-30-4,107868304,"107868 30 4",Aromasin,Aromasine,"6-Methyleneandrosta-1,4-diene-3,17-dione","6Methyleneandrosta1,4diene3,17dione","6 Methyleneandrosta 1,4 diene 3,17 dione","Fce 2430
4",Exemestano,Exemestanum,"Exemestanum (INN",713563,SAM001246574,Prestw-1410,"NSC 713563",Exemestane,CPD000466314}

> <pdid>
PD000653

> <targets>
{Aromatase}

> <classes>
{aromatase inhibitor,Others}

> <pubchem_cids>
{60198}

$$$$
NIHCC_2014
  SciTegic11012413002D

 18 17  0  0  0  0            999 V2000
   10.2972   -2.2554    0.0000 O   0  0
    2.5909   -6.0056    0.0000 N   0  0
    3.8912   -5.2578    0.0000 C   0  0
    5.1887   -6.0105    0.0000 O   0  0
    3.8933   -3.7570    0.0000 O   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8999   -0.7576    0.0000 C   0  0
    5.1972   -1.5121    0.0000 O   0  0
    6.4998   -0.7667    0.0000 C   0  0
    7.7965   -1.5208    0.0000 O   0  0
    6.5050    0.7333    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
  7 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
M  END
> <name>
NIHCC_2014

> <id>
5908

> <plate>
NGP-105-04

> <well>
E05

> <supplier_cmpd_name>
CPD000449307

> <ctcr_id>
1552

> <supplier_cmpd_id>
SAM001247005

> <smiles>
O.NC(=O)OCC(COC(=O)N)c1ccccc1

> <pd_targets>
{SMN1,CYP2D6,NPSR1,PKM,CHRM1,CYP1A2,GRIN1,GRIN2A,GRIN2B,GRIN2C,GRIN2D,GRIN3A,GRIN3B}

> <pathway_gtopdb>
{"Epigenetic regulator",Enzyme,"Membrane receptor","Ion channel",Reader,"Cytochrome P450","Family A G protein-coupled receptor","Ligand-gated ion channel","Methyl-lysine/arginine binding protein","Cyt
ochrome P450 family 2","Peptide receptor (family A GPCR)","Small molecule receptor (family A GPCR)","Cytochrome P450 family 1","Ionotropic glutamate receptor","Tudor domain","Cytochrome P450 family 2D
","Short peptide receptor (family A GPCR)","Monoamine receptor","Cytochrome P450 family 1A","NMDA receptor","Cytochrome P450 2D6","Neuropeptide receptor","Acetylcholine receptor","Cytochrome P450 1A1"
}

> <pathway_chembl>
{Enzymes,Receptors,"Ion channels","Cytochrome P450","G protein-coupled receptors","2.7.1.40 Pyruvate kinases","Ligand-gated ion channels","CYP2 family: drug metabolising subset","Neuropeptide S recept
or","Acetylcholine receptors (muscarinic)","CYP1 family","Ionotropic glutamate receptors"}

> <pathway_reactome>
{"Metabolism of RNA",Metabolism,Disease,"Signal Transduction","Neuronal System","Metabolism of non-coding RNA","Biological oxidations","Infectious disease","Metabolism of carbohydrates","Signaling by 
GPCR","Transmission across Chemical Synapses","snRNP Assembly","Phase I - Functionalization of compounds","Leishmania infection","Glucose metabolism","GPCR ligand binding","Neurotransmitter receptors 
and postsynaptic signal transmission","Cytochrome P450 - arranged by substrate type","Leishmania parasite growth and survival",Glycolysis,"Class A/1 (Rhodopsin-like receptors)","Activation of NMDA rec
eptors and postsynaptic events",Xenobiotics,"Anti-inflammatory response favouring Leishmania parasite infection","Amine ligand-binding receptors","Post NMDA receptor activation events","CYP2E1 reactio
ns","ADORA2B mediated anti-inflammatory cytokines production","Muscarinic acetylcholine receptors","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","CREB1 phosphorylation through NMD
A receptor-mediated activation of RAS signaling","Long-term potentiation","Ras activation upon Ca2+ influx through NMDA receptor"}

> <broad_targets>
{GRIN1,GRIN2A,GRIN2B,GRIN2C,GRIN2D,GRIN3A,GRIN3B}

> <broad_moa>
{"glutamate receptor antagonist"}

> <synonyms>
{"Felbamate hydrate","Felbamate (hydrate)",1177501-39-1,1177501391,"2-Phenylpropane-1,3-diyl dicarbamate hydrate","2Phenylpropane1,3diyl dicarbamate hydrate",SMR000449307,MLS000758238,MLS001401392,CHE
MBL2130858,HY-B0184A,HYB0184A,HMS2051J06,HMS2230I13,HMS3371C18,HMS3393J06,2153AH,CCG-101003,CCG101003,CS-2069,CS2069,NC00253,(,SAM001247005,CPD000449307}

> <pdid>
PD002715

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581812}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 23  0  0  1  0            999 V2000
    3.8623   -0.7303    0.0000 F   0  0
    2.5636    0.0202    0.0000 C   0  0
    3.8630    0.7695    0.0000 F   0  0
    2.5646    1.5202    0.0000 F   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 O   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -1.2990   -5.2500    0.0000 Cl  0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    1.2641   -2.2299    0.0000 C   0  0
    1.2655   -3.7307    0.0000 C   0  0
    1.2669   -5.2315    0.0000 C   0  0
    0.5181   -6.4397    0.0000 C   0  0
    2.0181   -6.4383    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 16  5  1  0
 16 10  1  0
  5 17  1  1
 17 18  3  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 19  1  0
M  END
> <name>
NIHCC_2014

> <id>
5909

> <plate>
NGP-105-04

> <well>
E06

> <supplier_cmpd_name>
CPD000466351

> <ctcr_id>
1315

> <supplier_cmpd_id>
SAM001246667

> <smiles>
FC(F)(F)[C@]1(OC(=O)Nc2ccc(Cl)cc12)C#CC3CC3

> <pd_targets>
{"REVERSE TRANSCRIPTASE",POL,FTL,MAPK1,NPSR1,RORC,CYP3A4,MAPT,ENV}

> <pathway_gtopdb>
{Enzyme,"Unclassified protein","Membrane receptor","Transcription factor","Other cytosolic protein","Surface antigen",Hydrolase,Kinase,"Family A G protein-coupled receptor","Nuclear receptor","Cytochr
ome P450","Protein Kinase","Peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 3","CMGC protein kinase group","Short peptide receptor (family A GPCR)","Nu
clear hormone receptor subfamily 1 group F","Cytochrome P450 family 3A","CMGC protein kinase MAPK family","Neuropeptide receptor","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P4
50 3A4","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Receptors,"Kinases (EC 2.7.x.x)","G protein-coupled receptors","Nuclear hormone receptors","Cytochrome P450","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Neuropeptide S receptor","1F. Ret
inoic acid-related orphans","CYP3 family","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Vesicle-mediated transport","Immune System",Disease,"Gene expression (Transcription)",Metabolism,"Neuronal System","Membrane Trafficking","Innate Immune System","Infectious disease","RNA Polymerase 
II Transcription","Metabolism of lipids","Transmission across Chemical Synapses","trans-Golgi Network Vesicle Budding","Toll-like Receptor Cascades","Leishmania infection","Generic Transcription Pathw
ay","Biosynthesis of specialized proresolving mediators (SPMs)","Neurotransmitter receptors and postsynaptic signal transmission","Golgi Associated Vesicle Biogenesis","Toll Like Receptor 5 (TLR5) Cas
cade","Leishmania parasite growth and survival","Transcriptional regulation by RUNX3","Biosynthesis of DHA-derived SPMs","Activation of NMDA receptors and postsynaptic events","MyD88 cascade initiated
 on plasma membrane","Anti-inflammatory response favouring Leishmania parasite infection","RUNX3 Regulates Immune Response and Cell Migration","Biosynthesis of maresins","Post NMDA receptor activation
 events","MAP kinase activation","ADORA2B mediated anti-inflammatory cytokines production","Biosynthesis of maresin-like SPMs","Activation of AMPK downstream of NMDARs","MAPK targets/ Nuclear events m
ediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{CYP1A2,CYP2B6,CYP2C19,CYP2C9,CYP2D6,CYP3A4}

> <broad_moa>
{"HIV protease inhibitor"}

> <synonyms>
{efavirenz,154598-52-4,154598524,Sustiva,Stocrin,DMP-266,DMP266,"DMP 266",EFV,(Rac)-Efavirenz,(Rac)Efavirenz,"L-743,726","L743,726",UNII-JE6H2O27P8,UNIIJE6H2O27P8,L-743726,L743726,JE6H2O27P8,CHEBI:119
486,MFCD05662344,NSC742403,DSSTox_CID_26029,DSSToxCID26029,DSSTox-CID-26029,"DSSTox CID 26029",DSSTox_RID_81298,DSSToxRID81298,DSSTox-RID-81298,"DSSTox RID 81298",DSSTox_GSID_46029,DSSToxGSID46029,DSS
Tox-GSID-46029,"DSSTox GSID 46029","(Rac)-DMP 266; (Rac)-EFV; (Rac)-","(Rac)DMP 266; (Rac)EFV; (Rac)",T2393,SAM001246667,Prestw-1400,Efavirenz,CPD000466351}

> <pdid>
PD003010

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{64139}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 30  0  0  0  0            999 V2000
   -2.3701  -15.6838    0.0000 C   0  0
   -2.8354  -14.2578    0.0000 C   0  0
   -1.8332  -13.1406    0.0000 C   0  0
   -2.2988  -11.7138    0.0000 C   0  0
   -1.2966  -10.5966    0.0000 C   0  0
   -1.7622   -9.1698    0.0000 N   0  0
   -0.7600   -8.0526    0.0000 C   0  0
    0.7077   -8.3622    0.0000 N   0  0
   -1.2256   -6.6258    0.0000 N   0  0
   -0.2234   -5.5086    0.0000 N   0  0
   -0.6890   -4.0818    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 O   0  0
   -3.8983    0.7459    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    6.2133   -5.2173    0.0000 O   0  0
    6.2133   -6.7173    0.0000 C   0  0
    4.9141   -7.4669    0.0000 O   0  0
    7.5133   -7.4673    0.0000 C   0  0
    8.8133   -6.7173    0.0000 C   0  0
    8.8147   -5.2165    0.0000 C   0  0
    7.5162   -4.4657    0.0000 O   0  0
   10.1140   -4.4669    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  3
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 18 21  1  0
 21 22  2  0
 22 12  1  0
 22 15  1  0
 23 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 28 30  2  0
M  END
> <name>
NIHCC_2014

> <id>
5910

> <plate>
NGP-105-04

> <well>
E07

> <supplier_cmpd_name>
CPD000471618

> <ctcr_id>
5375

> <supplier_cmpd_id>
SAM001246606

> <smiles>
CCCCCNC(=N)NN=Cc1c[nH]c2ccc(OC)cc12.OC(=O)\C=C/C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Tegaserod maleate",CPD000471618,189188-57-6,189188576,HMS2051J10,HMS2231G21,CT0137,CCG-101019,CCG101019,SR-01000763155,SR01000763155,SR-01000763155-3,SR010007631553,T1551,SAM001246606}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{135860280}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 29  0  0  0  0            999 V2000
    6.4971   -0.7566    0.0000 C   0  0
    5.1969   -1.5045    0.0000 C   0  0
    3.8991   -0.7525    0.0000 C   0  0
    2.5987   -1.5004    0.0000 C   0  0
    2.5965   -3.0004    0.0000 C   0  0
    3.8943   -3.7525    0.0000 C   0  0
    5.1945   -3.0045    0.0000 N   0  0
    3.8919   -5.2525    0.0000 C   0  0
    1.2971   -3.7515    0.0000 C   0  0
    0.4310   -3.2517    0.0000 O   0  0
    1.2969   -5.2523    0.0000 O   0  0
   -0.0025   -6.0034    0.0000 C   0  0
   -0.0026   -7.5034    0.0000 C   0  0
   -1.3016   -5.2537    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.4133   -1.7530    0.0000 N   0  0
   -1.8032   -3.1233    0.0000 O   0  0
   -0.3114   -2.9665    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8984    0.7484    0.0000 C   0  0
    5.1974    1.4985    0.0000 O   0  0
    2.5988    1.4990    0.0000 O   0  0
    2.5982    2.9990    0.0000 C   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  1  0
  5  6  2  3
  6  7  1  0
  7  2  1  0
  6  8  1  0
  5  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
  4 15  1  0
 15 16  2  3
 16 17  1  0
 17 18  2  3
 18 19  1  0
 19 20  2  3
 20 21  1  0
 21 22  1  0
 22 23  2  3
 23 19  1  0
 23 15  1  0
  3 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
M  END
> <name>
NIHCC_2014

> <id>
5911

> <plate>
NGP-105-04

> <well>
E08

> <supplier_cmpd_name>
CPD000466320

> <ctcr_id>
5944

> <supplier_cmpd_id>
SAM001246584

> <smiles>
CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC

> <pd_targets>
{CACNA1F,CYP2C19,CYP3A4,CYP2C9,CACNA1C,ALOX15,CYP1A2,KMT2A,MEN1,CACNA1D,LEF,CYP2D6,CYP2C8,ABCB11,CACNA1S,CACNA2D1,CACNB2,CACNA1H,CACNA2D2}

> <pathway_gtopdb>
{"Ion channel",Enzyme,"Epigenetic regulator",Transporter,"Auxiliary transport protein","Voltage-gated ion channel","Cytochrome P450",Oxidoreductase,Reader,Protease,"Primary active transporter","Calciu
m channel auxiliary subunit alpha2delta family","Calcium channel auxiliary subunit beta family","Voltage-gated calcium channel","Cytochrome P450 family 2","Cytochrome P450 family 3","Cytochrome P450 f
amily 1",Bromodomain,"Metallo protease","ATP-binding cassette","Cytochrome P450 family 2C","Cytochrome P450 family 3A","Cytochrome P450 family 1A","Metallo protease MAE clan","Cytochrome P450 family 2
D","ABCB subfamily","Cytochrome P450 2C19","Cytochrome P450 3A4","Cytochrome P450 2C9","Cytochrome P450 1A1","Metallo protease M34 family","Cytochrome P450 2D6","Cytochrome P450 2C8"}

> <pathway_chembl>
{"Ion channels",Enzymes,Transporters,"Voltage-gated ion channels","Cytochrome P450","Eicosanoid turnover","ATP-binding cassette transporter family","Voltage-gated calcium channels","CYP2 family: drug 
metabolising subset","CYP3 family",Lipoxygenases,"CYP1 family","ABCB subfamily"}

> <pathway_reactome>
{Metabolism,"Developmental Biology",Disease,"Biological oxidations","Metabolism of lipids","Nervous system development","Infectious disease","Integration of energy metabolism","Phase I - Functionaliza
tion of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","Axon guidance","Uptake and actions of bacterial toxins","Metabolism of steroids","Regulation of insulin secretion","Cyto
chrome P450 - arranged by substrate type","Biosynthesis of DHA-derived SPMs","NCAM signaling for neurite out-growth","Biosynthesis of DPA-derived SPMs","Uptake and function of anthrax toxins","Bile ac
id and bile salt metabolism",Adrenaline,"noradrenaline inhibits insulin secretion",Xenobiotics,"Biosynthesis of maresins","NCAM1 interactions","Biosynthesis of DPAn-3 SPMs","Synthesis of bile acids an
d bile salts","CYP2E1 reactions","Biosynthesis of maresin-like SPMs","Biosynthesis of DPAn-3-derived protectins and resolvins","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Synth
esis of bile acids and bile salts via 7alpha-hydroxycholesterol"}

> <broad_targets>
{CACNA1D,CACNA1F,CACNA2D1}

> <broad_moa>
{"calcium channel blocker"}

> <synonyms>
{KBio2_005834,KBio2005834,KBio2-005834,"KBio2 005834",isradipine,75695-93-1,75695931,DynaCirc,Isradipin,Lomir,Isrodipine,Prescal,Esradin,"Dynacirc CR",Clivoten,Dynacrine,"Isradipinum (Latin)","PN 200-
110","PN 200110","Isradipino (Spanish)",Rebriden,(+-)-Isradipine,(+)Isradipine,DynaCire,PN-200-110,PN200110,"DynaCire CR",(+/-)-I,(+/)I,SAM001246584,CPD000466320}

> <pdid>
PD010132

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{3784}

$$$$
NIHCC_2014
  SciTegic11012413002D

  8  8  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 F   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  3
  8  2  1  0
M  END
> <name>
NIHCC_2014

> <id>
5912

> <plate>
NGP-105-04

> <well>
E09

> <supplier_cmpd_name>
CPD000449315

> <ctcr_id>
1510

> <supplier_cmpd_id>
SAM001247017

> <smiles>
FC1=CNC(=O)N=C1

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{TYMS}

> <broad_moa>
{"thymidylate synthase inhibitor"}

> <synonyms>
{2022-78-8,2022788,5-fluoropyrimidin-2-ol,5fluoropyrimidin2ol,5-Fluoropyrimidin-2(1H)-one,5Fluoropyrimidin2(1H)one,5-Fluoro-2-hydroxypyrimidine,5Fluoro2hydroxypyrimidine,5-Fluoropyrimidin-2-one,5Fluor
opyrimidin2one,2-Hydroxy-5-fluoropyrimidine,2Hydroxy5fluoropyrimidine,5-Fluoro-2(1H)-pyrimidinone,5Fluoro2(1H)pyrimidinone,"2(1H)-Pyrimidinone, 5-fluoro-","2(1H)Pyrimidinone, 5fluoro",214290-48-9,2142
90489,5-fluoro-1H-pyrimidin-2-one,5fluoro1Hpyrimidin2one,SAM001247017,CPD000449315}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{101498}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 31  0  0  0  0            999 V2000
    9.9701    3.5733    0.0000 H   0  3
    7.4701    3.5733    0.0000 Cl  0  5
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -0.3115    2.9665    0.0000 C   0  0
   -1.8032    3.1233    0.0000 C   0  0
   -2.5497    4.4223    0.0000 C   0  0
   -1.7974    5.7210    0.0000 C   0  0
   -2.5428    7.0227    0.0000 C   0  0
   -1.7883    8.3192    0.0000 C   0  0
   -0.2883    8.3139    0.0000 N   0  0
    0.4571    7.0123    0.0000 C   0  0
   -0.2974    5.7159    0.0000 C   0  0
    0.4693    9.6095    0.0000 C   0  0
    1.9701    9.6022    0.0000 C   0  0
    2.7291   10.8960    0.0000 C   0  0
    4.2291   10.8856    0.0000 C   0  0
    4.9701    9.5814    0.0000 C   0  0
    4.2111    8.2876    0.0000 C   0  0
    2.7111    8.2980    0.0000 C   0  0
   -2.4133    1.7530    0.0000 C   0  0
   -3.8805    1.4409    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3032   -3.7490    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 11  1  0
 14 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
  9 24  1  0
 24 25  2  0
 24 26  1  0
 26  7  2  0
 26 27  1  0
 27 28  2  0
 28  5  1  0
 28 29  1  0
 29 30  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5913

> <plate>
NGP-105-04

> <well>
E10

> <supplier_cmpd_name>
CPD000449292

> <ctcr_id>
472

> <supplier_cmpd_id>
SAM001246627

> <smiles>
[H+].[Cl-].COc1cc2CC(CC3CCN(CC3)Cc4ccccc4)C(=O)c2cc1OC

> <pd_targets>
{ACHE,BCHE,CHAT,BACE1,SIGMAR1,MAOB,CYP3A4,KCNH2,HRH3,KDM4E,ABCB11,ABCC4,ABCB1,CACNA1C,CACNA1D,CACNA1F,CACNA1S,HTR2A,NOS1,TNFAIP6,IL1B,NFKB1,NFKB2,GRIN1,GRIN2A,GRIN2B,GRIN2C,GRIN2D,GRIN3A,GRIN3B}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Ion channel","Epigenetic regulator",Transporter,"Secreted protein",Hydrolase,Transferase,Protease,Oxidoreductase,"Cytochrome P450","Voltage-gated ion channel","Family A G 
protein-coupled receptor",Eraser,"Primary active transporter","Ligand-gated ion channel","Aspartic protease","Cytochrome P450 family 3","Potassium channels","Small molecule receptor (family A GPCR)","
Lysine demethylase","ATP-binding cassette","Voltage-gated calcium channel","Ionotropic glutamate receptor","Aspartic protease AA clan","Cytochrome P450 family 3A","Voltage-gated potassium channel","Mo
noamine receptor","Jumonji domain-containing","ABCB subfamily","ABCC subfamily","NMDA receptor","Aspartic protease A1A subfamily","Cytochrome P450 3A4","Histamine receptor","Serotonin receptor"}

> <pathway_chembl>
{Enzymes,"Other protein targets","Ion channels",Receptors,Transporters,"Acetylcholine turnover","Peptidases and proteinases","Sigma receptors","Catecholamine turnover","Cytochrome P450","Voltage-gated
 ion channels","G protein-coupled receptors","Chromatin modifying enzymes","ATP-binding cassette transporter family","L-Arginine turnover","AA: Aspartic (A) Peptidases","CYP3 family","Potassium channe
ls","Histamine receptors","1.14.11.- Histone demethylases","ABCB subfamily","ABCC subfamily","5-Hydroxytryptamine receptors","Nitric oxide synthases","A1: Pepsin","Voltage-gated potassium channels"}

> <pathway_reactome>
{Metabolism,"Metabolism of proteins",Disease,"Muscle contraction","Signal Transduction",Hemostasis,"Immune System","Metabolism of lipids","Amyloid fiber formation","Infectious disease","Biological oxi
dations","Cardiac conduction","Signaling by GPCR","Platelet activation","signaling and aggregation","Abacavir transport and metabolism","Platelet homeostasis","Innate Immune System","Phospholipid meta
bolism","SARS-CoV Infections","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","Phase 3 - rapid repolarisation","GPCR ligand binding","Metabolism 
of steroids","Response to elevated platelet cytosolic Ca2+","Abacavir transmembrane transport","Nitric oxide stimulates guanylate cyclase","Neutrophil degranulation","Leishmania infection","Glyceropho
spholipid biosynthesis","Potential therapeutics for SARS","Amine Oxidase reactions","Biosynthesis of DHA-derived SPMs","Class A/1 (Rhodopsin-like receptors)","Bile acid and bile salt metabolism","Plat
elet degranulation","Cell recruitment (pro-inflammatory response)","Synthesis of PC","Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB","Biosynthesis of maresins","Amine ligand
-binding receptors","Synthesis of bile acids and bile salts","Purinergic signaling in leishmaniasis infection","Biosynthesis of maresin-like SPMs","Histamine receptors","Synthesis of bile acids and bi
le salts via 7alpha-hydroxycholesterol","Serotonin receptors"}

> <broad_targets>
{ACHE}

> <broad_moa>
{"acetylcholinesterase inhibitor"}

> <synonyms>
{"Donepezil hydrochloride",120011-70-3,120011703,"Donepezil HCl",Aricept,BNAG,110119-84-1,110119841,E-2020,E2020,"Aricept ODT","E 2020",donepezilhcl,"Donepezil (Hydrochloride)","Donepezil, HCl",C24H30
ClNO3,CHEMBL1678,"120011-70-3 (HCl)","120011703 (HCl)",E2020;E-2020,E2020;E2020,DSSTox_CID_26,DSSToxCID26,DSSTox-CID-26,"DSSTox CID 26",T6478,T7041,SAM001246627,1504403,Donepezil,CPD000449292,"DONEPEZ
IL HYDROCHLORIDE"}

> <pdid>
PD005540

> <targets>
{}

> <classes>
{"acetylcholinesterase inhibitor (reversible)","cognitive enhancer"}

> <pubchem_cids>
{10916711,5741,44263804}

$$$$
NIHCC_2014
  SciTegic11012413002D

 15 15  0  0  0  0            999 V2000
    6.1607   -2.0183    0.0000 Cl  0  0
    2.5981   -1.5000    0.0000 Cl  0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 Cl  0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0031   -3.0008    0.0000 N   0  0
    1.3039   -3.7494    0.0000 C   0  0
    1.4469   -5.2297    0.0000 N   0  0
    2.9152   -5.5365    0.0000 C   0  0
    3.6607   -4.2349    0.0000 C   0  0
    2.6532   -3.1236    0.0000 N   0  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  7  9  2  0
  9  3  1  0
  9 10  1  0
 10 11  2  3
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 11  1  0
M  END
> <name>
NIHCC_2014

> <id>
5914

> <plate>
NGP-105-04

> <well>
E11

> <supplier_cmpd_name>
CPD000466276

> <ctcr_id>
2184

> <supplier_cmpd_id>
SAM001247073

> <smiles>
Cl.Clc1cccc(Cl)c1N=C2NCCN2

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Clonidine HCI","2-((2,6-Dichlorophenyl)imino)imidazolidine monohydrochloride","2((2,6Dichlorophenyl)imino)imidazolidine monohydrochloride",AKOS026750072,"CLONIDINE HYDROCHLORIDE",4205-91-8,4205918,"
Clonidine HCl","2-(2,6-Dichloroanilino)-2-imidazoline hydrochloride","2(2,6Dichloroanilino)2imidazoline hydrochloride",Kapvay,N-(2,N(2,6-dichlorophenyl)-4,6dichlorophenyl)4,5-dihyd,5dihyd,S2458,SAM001
247073,1500198,Prestw-248,"Clonidine HCl",CPD000466276,"Clonidine hydrochloride"}

> <pdid>

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling",antihypertensive}

> <pubchem_cids>
{91824207,50986872,20179}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 25  0  0  0  0            999 V2000
   16.6998   -2.2507    0.0000 H   0  3
   14.1998   -2.2507    0.0000 Cl  0  5
   11.6991   -0.7641    0.0000 C   0  0
   10.3987   -1.5118    0.0000 C   0  0
    9.0999   -0.7599    0.0000 N   0  0
    9.0990    0.7409    0.0000 C   0  0
    7.7999    1.4910    0.0000 C   0  0
    7.7988   -1.5080    0.0000 C   0  0
    6.4999   -0.7561    0.0000 C   0  0
    5.1988   -1.5042    0.0000 O   0  0
    3.8999   -0.7523    0.0000 C   0  0
    3.9021    0.7477    0.0000 O   0  0
    2.5988   -1.5004    0.0000 C   0  0
    2.6001   -0.0004    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    2.5996   -3.0013    0.0000 C   0  0
    1.3010   -3.7520    0.0000 C   0  0
    1.3018   -5.2520    0.0000 C   0  0
    2.6012   -6.0013    0.0000 C   0  0
    3.8998   -5.2506    0.0000 C   0  0
    3.8990   -3.7506    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 13 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5915

> <plate>
NGP-105-04

> <well>
F02

> <supplier_cmpd_name>
CPD000059142

> <ctcr_id>
1105

> <supplier_cmpd_id>
SAM001246868

> <smiles>
[H+].[Cl-].CCN(CC)CCOC(=O)C(O)(c1ccccc1)c2ccccc2

> <pd_targets>
{AMPC,KMT2A,MEN1}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator",Hydrolase,Reader,Bromodomain}

> <pathway_chembl>
{}

> <pathway_reactome>
{}

> <broad_targets>
{}

> <broad_moa>
{"butyrylcholinesterase inhibitor"}

> <synonyms>
{AKOS026750542,"Benactyzine hydrochloride",57-37-4,57374,Tranquilline,Amitakon,Benaktin,Destendo,Ibiotyzil,Leucidil,Nervacton,Nervatil,Neuraktil,Neurobenzil,Suavitil,Valladan,Valladon,Aktozin,Amisil,A
misyl,Amizil,Amysyl,Amyzyl,Arkadin,Cafron,Cevanol,SAM001246868,CPD000059142}

> <pdid>
PD009067

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{57446134,71773962,66448}

$$$$
NIHCC_2014
  SciTegic11012413002D

 35 36  0  0  0  0            999 V2000
    3.8926   -3.7566    0.0000 C   0  0
    2.5951   -3.0039    0.0000 O   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 C   0  0
   -2.5951   -3.0039    0.0000 N   0  0
   -3.8056   -3.8680    0.0000 C   0  0
   -3.3371   -5.2929    0.0000 C   0  0
   -1.8371   -5.2877    0.0000 C   0  0
   -1.3786   -3.8595    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5973    1.5031    0.0000 C   0  0
   -3.8976    0.7553    0.0000 O   0  0
   -2.5951    3.0039    0.0000 C   0  0
   -3.8933    3.7570    0.0000 C   0  0
   -3.8934    5.2570    0.0000 C   0  0
   -5.1924    6.0070    0.0000 C   0  0
   -6.4915    5.2571    0.0000 C   0  0
   -7.7905    6.0071    0.0000 Cl  0  0
   -6.4915    3.7571    0.0000 C   0  0
   -7.7906    3.0071    0.0000 Cl  0  0
   -5.1925    3.0070    0.0000 C   0  0
    7.6982    2.2323    0.0000 O   0  0
    7.6982    0.7323    0.0000 C   0  0
    6.3990   -0.0173    0.0000 O   0  0
    8.9982   -0.0177    0.0000 C   0  0
   10.2982    0.7323    0.0000 C   0  0
   11.5982   -0.0177    0.0000 C   0  0
   11.5982   -1.5177    0.0000 O   0  0
   12.8975    0.7319    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 11  1  0
  9 16  1  0
 16  5  1  0
  8 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 23 25  1  0
 25 26  1  0
 25 27  2  0
 27 20  1  0
 28 29  1  0
 29 30  2  0
 29 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  1  0
 33 35  2  0
M  END
> <name>
NIHCC_2014

> <id>
5916

> <plate>
NGP-105-04

> <well>
F03

> <supplier_cmpd_name>
CPD000466287

> <ctcr_id>
5901

> <supplier_cmpd_id>
SAM001247087

> <smiles>
COC(=O)N1CCN(C(CN2CCCC2)C1)C(=O)Cc3ccc(Cl)c(Cl)c3.OC(=O)\C=C\C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"GR 89696 fumarate",126766-32-3,126766323,"GR-89696 fumarate","GR89696 fumarate","GR 89696 fumarate salt","GR 89696",GR-89696,GR89696,"GR 85571",SMR000466287,SR-01000075500,SR01000075500,"GR 103545",
"1-((3,4-Dichlorophenyl)acetyl)-4-acetyl-2-(1-pyrrolidinylmethyl)piperazine","1((3,4Dichlorophenyl)acetyl)4acetyl2(1pyrrolidinylmethyl)piperazine",MLS000758305,MLS0,SAM001247087,CPD000466287}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{6442840}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 22  0  0  0  0            999 V2000
    3.8964    0.7545    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    5.1996   -1.4928    0.0000 O   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 C   0  0
    1.2947   -3.7531    0.0000 O   0  0
   -1.3039   -3.7494    0.0000 N   0  0
   -1.3070   -5.2502    0.0000 C   0  0
   -2.5205   -6.1100    0.0000 S   0  0
   -2.0570   -7.5366    0.0000 C   0  0
   -0.5570   -7.5366    0.0000 C   0  0
   -0.0934   -6.1100    0.0000 N   0  0
   -2.9351   -8.7506    0.0000 N   0  3
   -4.4272   -8.5964    0.0000 O   0  5
   -2.3230  -10.1200    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 14  2  0
 16 19  1  0
 19 20  1  0
 19 21  2  0
M  CHG  2  19   1  20  -1
M  END
> <name>
NIHCC_2014

> <id>
5917

> <plate>
NGP-105-04

> <well>
F04

> <supplier_cmpd_name>
CPD000466367

> <ctcr_id>
2715

> <supplier_cmpd_id>
SAM001246708

> <smiles>
CC(=O)Oc1ccccc1C(=O)Nc2sc(cn2)[N+]([O-])=O

> <pd_targets>
{HTT,RORC,ALD,KMT2A,MEN1,NPC1,TP53,MAPT,PKM,FFP,AKR1B1,SMN1,CYP3A4,LMNA,TSHR,ALDH1A1,HSD17B10,NPSR1,RAB9A,PYK,LEF,MAPK1,PFOR}

> <pathway_gtopdb>
{"Unclassified protein","Transcription factor",Enzyme,"Epigenetic regulator",Transporter,"Other cytosolic protein","Other nuclear protein","Membrane receptor","Nuclear receptor",Reader,Transferase,Oxi
doreductase,"Cytochrome P450","Family A G protein-coupled receptor",Hydrolase,Protease,Kinase,"Nuclear hormone receptor subfamily 1",Bromodomain,"Methyl-lysine/arginine binding protein","Cytochrome P4
50 family 3","Peptide receptor (family A GPCR)","Metallo protease","Protein Kinase","Nuclear hormone receptor subfamily 1 group F","Tudor domain","Cytochrome P450 family 3A","Glycohormone receptor","S
hort peptide receptor (family A GPCR)","Metallo protease MAE clan","CMGC protein kinase group","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 3A4","Neuropeptide receptor","Me
tallo protease M34 family","CMGC protein kinase MAPK family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Transporters,Enzymes,"Nuclear hormone receptors","SLC superfamily of solute carriers","2.7.1.40 Pyruvate kinases","1.-.-.- Oxidoreductases","Cytochrome P450","G protein-coupled receptors","
Kinases (EC 2.7.x.x)","1F. Retinoic acid-related orphans","SLC65 NPC-type cholesterol transporters","CYP3 family","Glycoprotein hormone receptors","Neuropeptide S receptor","CMGC: Containing CDK",MAPK
,GSK3,"CLK families","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Gene expression (Transcription)","Transport of small molecules","Cell Cycle","Neuronal System",Metabolism,"Metabolism of RNA",Disease,"Signal Transduction","Immune System","RNA Polymerase II Transcr
iption","Plasma lipoprotein assembly",remodeling,"and clearance","Cell Cycle Checkpoints","Transmission across Chemical Synapses","Metabolism of carbohydrates","Metabolism of lipids","Metabolism of no
n-coding RNA",Mitotic,"Infectious disease","Biological oxidations","Metabolism of amino acids and derivatives","Signaling by Rho GTPases","Innate Immune System","Generic Transcription Pathway","Plasma
 lipoprotein clearance","G1/S DNA Damage Checkpoints","Neurotransmitter receptors and postsynaptic signal transmission","Glucose metabolism","Metabolism of steroids","snRNP Assembly","Biosynthesis of 
specialized proresolving mediators (SPMs)","M Phase","Leishmania infection","Phase I - Functionalization of compounds","Branched-chain amino acid catabolism","Rho GTPase cycle","Uptake and actions of 
bacterial toxins","Toll-like Receptor Cascades","Transcriptional Regulation by MECP2","Transcriptional regulation by RUNX3","LDL clearance","p53-Dependent G1/S DNA damage checkpoint","Activation of NM
DA receptors and postsynaptic events",Glycolysis,"Metabolism of steroid hormones","Biosynthesis of DHA-derived SPMs","Mitotic Metaphase and Anaphase","Leishmania parasite growth and survival","Ethanol
 oxidation","RHOBTB GTPase Cycle","Uptake and function of anthrax toxins","Toll Like Receptor 5 (TLR5) Cascade","Regulation of MECP2 expression and activity","RUNX3 Regulates Immune Response and Cell 
Migration","p53-Dependent G1 DNA Damage Response","Post NMDA receptor activation events","Pregnenolone biosynthesis","Biosynthesis of maresins","Mitotic Anaphase","Anti-inflammatory response favouring
 Leishmania parasite infection","RHOBTB3 ATPase cycle","MyD88 cascade initiated on plasma membrane","Stabilization of p53","Activation of AMPK downstream of NMDARs","Biosynthesis of maresin-like SPMs"
,"Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","MAP kinase activation","Autodegradation of the E3 ubiquitin ligase COP1","Initiation of Nuclear Envelope 
(NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{}

> <broad_moa>
{"pyruvate ferredoxin oxidoreductase inhibitor"}

> <synonyms>
{NITAZOXANIDE,55981-09-4,55981094,Alinia,Nitazoxamide,"2-((5-nitrothiazol-2-yl)carbamoyl)phenyl acetate","2((5nitrothiazol2yl)carbamoyl)phenyl acetate",Daxon,"Nitazoxanidum (INN-Latin)","Nitazoxanidum
 (INNLatin)","Nitazoxanida (INN-Spanish)","Nitazoxanida (INNSpanish)","Benzamide, 2-(acetyloxy)-N-(5-nitro-2-thiazolyl)-","Benzamide, 2(acetyloxy)N(5nitro2thiazolyl)",2-((5-nitro-1,2((5nitro1,3-thiazo
l-2-yl)ca,3thiazol2yl)ca,T1546,SAM001246708,Nitazoxanide,CPD000466367}

> <pdid>
PD000850

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{41684}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 31  0  0  0  0            999 V2000
  -12.2597  -11.5113    0.0000 F   0  0
  -11.1748  -10.4754    0.0000 C   0  0
  -11.5295   -9.0179    0.0000 C   0  0
  -10.4446   -7.9820    0.0000 C   0  0
   -9.0050   -8.4035    0.0000 C   0  0
   -8.6504   -9.8611    0.0000 C   0  0
   -9.7353  -10.8970    0.0000 C   0  0
   -7.9175   -7.3693    0.0000 C   0  0
   -8.2696   -5.9112    0.0000 O   0  0
   -6.4777   -7.7931    0.0000 C   0  0
   -5.3902   -6.7589    0.0000 C   0  0
   -3.9504   -7.1827    0.0000 C   0  0
   -2.8628   -6.1485    0.0000 N   0  0
   -1.4233   -6.5700    0.0000 C   0  0
   -0.3384   -5.5341    0.0000 C   0  0
   -0.6928   -4.0817    0.0000 C   0  0
   -2.1327   -3.6551    0.0000 C   0  0
   -3.2175   -4.6910    0.0000 C   0  0
    0.3114   -2.9665    0.0000 N   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.5532   -4.4223    0.0000 O   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  5  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  3
 17 18  1  0
 18 13  1  0
 16 19  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 19  1  0
 28 23  1  0
M  END
> <name>
NIHCC_2014

> <id>
5918

> <plate>
NGP-105-04

> <well>
F05

> <supplier_cmpd_name>
CPD000058855

> <ctcr_id>
5208

> <supplier_cmpd_id>
SAM001247013

> <smiles>
Fc1ccc(cc1)C(=O)CCCN2CCC(=CC2)N3C(=O)Nc4ccccc34

> <pd_targets>
{KDM4E,CYP3A4,HTR4,KCNH2,LMNA,HIF1A,ADRA1A,DRD2,RORC,CYP2D6,SCN1A,SCN2A,SCN3A,KMT2A,MEN1,POLB,MAPT,LEF,ADRA1B,AMPC,MAPK1,ADRA1D,DRD3,CHRM4,HTR1A,ADRA2A,HRH1,HTR2C,HTR2A,ADRA2C,ADRA2B,CHRM5,CACNA1C,CAC
NA1D,CACNA1F,CACNA1S,HTR2B,DRD4,PMP22,FTL}

> <pathway_gtopdb>
{"Epigenetic regulator",Enzyme,"Membrane receptor","Ion channel","Other nuclear protein","Transcription factor","Other cytosolic protein","Unclassified protein",Eraser,"Cytochrome P450","Family A G pr
otein-coupled receptor","Voltage-gated ion channel","Nuclear receptor",Reader,Protease,Hydrolase,Kinase,"Lysine demethylase","Cytochrome P450 family 3","Small molecule receptor (family A GPCR)","Potas
sium channels","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 2","Voltage-gated sodium channel",Bromodomain,"Metallo protease","Protein Kinase","Voltage-gated calcium channel","Jumonji
 domain-containing","Cytochrome P450 family 3A","Monoamine receptor","Voltage-gated potassium channel","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family 2D","Metallo protease MAE 
clan","CMGC protein kinase group","Cytochrome P450 3A4","Serotonin receptor","Adrenergic receptor","Dopamine receptor","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 2D6","Me
tallo protease M34 family","CMGC protein kinase MAPK family","Acetylcholine receptor","Histamine receptor","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Receptors,"Ion channels","Chromatin modifying enzymes","Cytochrome P450","G protein-coupled receptors","Voltage-gated ion channels","Nuclear hormone receptors","Kinases (EC 2.7.x.x)","1.14.11
.- Histone demethylases","CYP3 family","5-Hydroxytryptamine receptors","Potassium channels",Adrenoceptors,"Dopamine receptors","1F. Retinoic acid-related orphans","CYP2 family: drug metabolising subse
t","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Acetylcholine receptors (muscarinic)","Histamine receptors","Voltage-gated potassium channels","Mitogen-activated protein kinases (MAP kinases)","ER
K subfamily"}

> <pathway_reactome>
{Metabolism,Disease,"Muscle contraction","Cell Cycle","Cellular responses to external stimuli","Signal Transduction","Gene expression (Transcription)","DNA Repair","Neuronal System","Immune System","D
evelopmental Biology","Vesicle-mediated transport","Metabolism of lipids","Infectious disease","Cardiac conduction",Mitotic,"Cellular responses to stress","Signaling by GPCR","RNA Polymerase II Transc
ription","Biological oxidations","Base Excision Repair","Transmission across Chemical Synapses","Innate Immune System","Nervous system development","Membrane Trafficking","Biosynthesis of specialized 
proresolving mediators (SPMs)","Leishmania infection","Phase 3 - rapid repolarisation","M Phase","Cellular response to hypoxia","GPCR ligand binding","Generic Transcription Pathway","Phase I - Functio
nalization of compounds","Resolution of Abasic Sites (AP sites)","Neurotransmitter receptors and postsynaptic signal transmission","Uptake and actions of bacterial toxins","Toll-like Receptor Cascades
","EGR2 and SOX10-mediated initiation of Schwann cell myelination","trans-Golgi Network Vesicle Budding","Biosynthesis of DHA-derived SPMs","Leishmania parasite growth and survival","Mitotic Metaphase
 and Anaphase","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Class A/1 (Rhodopsin-like receptors)","Transcriptional regulation by RUNX3","Cytochrome P450 - arranged by su
bstrate type","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Activation of NMDA receptors and postsynaptic events","Uptake and function of anthrax toxins","Toll Like R
eceptor 5 (TLR5) Cascade","Golgi Associated Vesicle Biogenesis","Biosynthesis of maresins","Anti-inflammatory response favouring Leishmania parasite infection","Mitotic Anaphase","Amine ligand-binding
 receptors","RUNX3 Regulates Immune Response and Cell Migration",Xenobiotics,"PCNA-Dependent Long Patch Base Excision Repair","Post NMDA receptor activation events","MyD88 cascade initiated on plasma 
membrane","Biosynthesis of maresin-like SPMs","ADORA2B mediated anti-inflammatory cytokines production","Nuclear Envelope (NE) Reassembly",Adrenoceptors,"Dopamine receptors","CYP2E1 reactions","Activa
tion of AMPK downstream of NMDARs","MAP kinase activation","Muscarinic acetylcholine receptors","Serotonin receptors","Histamine receptors","Initiation of Nuclear Envelope (NE) Reformation","MAPK targ
ets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{ADRA1A,DRD2,DRD3,DRD4,HTR2A}

> <broad_moa>
{"dopamine receptor antagonist"}

> <synonyms>
{droperidol,548-73-2,548732,Droleptan,Inapsine,Dehydrobenzperidol,Dridol,Properidol,Sintodril,Sintosian,Inapsin,Vetkalm,Halkan,Deidrobenzperidolo,Inopsin,Innovar,Inappin,Innovan,McN-JR-4749,McNJR4749,
Inoval,Dehidrobenzperidol,Droperidolum,Droperidolo,Leptanal,Le,T0990,SAM001247013,1501002,Prestw-360,Droperidol,CPD000058855,DROPERIDOL}

> <pdid>
PD001512

> <targets>
{}

> <classes>
{neuroleptic}

> <pubchem_cids>
{3168}

$$$$
NIHCC_2014
  SciTegic11012413002D

 32 36  0  0  0  0            999 V2000
    0.5586   -5.1668    0.0000 C   0  0
    1.1640   -3.7944    0.0000 C   0  0
    0.2783   -2.5827    0.0000 C   0  0
    0.8840   -1.2095    0.0000 C   0  0
    0.0000    0.0000    0.0000 C   0  0
   -1.5043    0.0000    0.0000 N   0  0
   -1.9556    1.4291    0.0000 C   0  0
   -2.4219    2.8581    0.0000 C   0  0
   -3.9262    2.8581    0.0000 C   0  0
   -4.3925    1.4291    0.0000 C   0  0
   -3.1740    0.5415    0.0000 C   0  0
   -0.7521    2.3016    0.0000 C   0  0
   -0.7521    3.8016    0.0000 O   0  0
    0.4513    1.4291    0.0000 N   0  0
    1.8744    1.8982    0.0000 C   0  0
    2.9947    0.8995    0.0000 C   0  0
    4.4200    1.3670    0.0000 C   0  0
    5.5376    0.3665    0.0000 C   0  0
    5.2299   -1.1016    0.0000 C   0  0
    3.8047   -1.5692    0.0000 C   0  0
    2.6871   -0.5687    0.0000 C   0  0
    6.3481   -2.1025    0.0000 C   0  0
    6.0382   -3.5703    0.0000 C   0  0
    7.1542   -4.5725    0.0000 C   0  0
    8.5802   -4.1071    0.0000 C   0  0
    8.8902   -2.6395    0.0000 C   0  0
    7.7742   -1.6372    0.0000 C   0  0
    8.0843   -0.1689    0.0000 C   0  0
    7.0764    0.9248    0.0000 N   0  0
    7.8268    2.2236    0.0000 N   0  0
    9.2939    1.9113    0.0000 N   0  0
    9.4503    0.4195    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  3
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11  7  1  0
  7 12  1  0
 12 13  2  0
 12 14  1  0
 14  5  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 19 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 28  2  0
M  END
> <name>
NIHCC_2014

> <id>
5919

> <plate>
NGP-105-04

> <well>
F06

> <supplier_cmpd_name>
CPD000466306

> <ctcr_id>
2839

> <supplier_cmpd_id>
SAM001246548

> <smiles>
CCCCC1=NC2(CCCC2)C(=O)N1Cc3ccc(cc3)c4ccccc4c5[nH]nnn5

> <pd_targets>
{AGTR1,CYP3A4,EDNRA,AGTR1B,AGTR2,GAA,ABCB11,SLC10A1,LMNA,MAPK1,ABCC4,ABCC3,JUN}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,Transporter,"Other nuclear protein","Transcription factor","Family A G protein-coupled receptor",Protease,"Cytochrome P450",Hydrolase,"Primary active transporter","Electroc
hemical transporter",Kinase,"Peptide receptor (family A GPCR)","Cysteine protease","Cytochrome P450 family 3","ATP-binding cassette","SLC superfamily of solute carriers","Protein Kinase","Short peptid
e receptor (family A GPCR)","Cysteine protease CA clan","Cytochrome P450 family 3A","ABCB subfamily","SLC10 family of sodium-bile acid co-transporters","CMGC protein kinase group","ABCC subfamily","An
giotensin receptor","Cysteine protease C1A family","Cytochrome P450 3A4","Endothelin receptor","CMGC protein kinase MAPK family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"G protein-coupled receptors","Cytochrome P450","3.2.1.- Glycosidases","ATP-binding cassette transporter family","SLC superfamily of solute carriers","Kinases (EC 2.7.x
.x)","Angiotensin receptors","CYP3 family","Endothelin receptors","ABCB subfamily","SLC10 family of sodium-bile acid co-transporters","CMGC: Containing CDK",MAPK,GSK3,"CLK families","ABCC subfamily","
Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,Disease,"Cell Cycle","Immune System",Hemostasis,"Signaling by GPCR","Metabolism of lipids","Diseases of metabolism",Mitotic,"Innate Immune System","Platelet activatio
n","signaling and aggregation","GPCR ligand binding","Biosynthesis of specialized proresolving mediators (SPMs)","Diseases of carbohydrate metabolism","Metabolism of steroids","M Phase","Toll-like Rec
eptor Cascades","Response to elevated platelet cytosolic Ca2+","Class A/1 (Rhodopsin-like receptors)","Biosynthesis of DHA-derived SPMs","Glycogen storage diseases","Bile acid and bile salt metabolism
","Mitotic Metaphase and Anaphase","Toll Like Receptor 5 (TLR5) Cascade","Platelet degranulation","Peptide ligand-binding receptors","Biosynthesis of maresins","Glycogen storage disease type II (GAA)"
,"Synthesis of bile acids and bile salts","Recycling of bile acids and salts","Mitotic Anaphase","MyD88 cascade initiated on plasma membrane","Biosynthesis of maresin-like SPMs","Synthesis of bile aci
ds and bile salts via 7alpha-hydroxycholesterol","Nuclear Envelope (NE) Reassembly","MAP kinase activation","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by 
MAP kinases","ERK/MAPK targets","Activation of the AP-1 family of transcription factors","ERKs are inactivated"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{irbesartan,138402-11-6,138402116,Avapro,Aprovel,Karvea,SR-47436,SR47436,BMS-186295,BMS186295,"BMS 186295","SR 47436","Irbesartan free base",UNII-J0E2756Z7N,UNIIJ0E2756Z7N,CHEMBL1513,CHEBI:5959,J0E275
6Z7N,"138402-11-6 (free base)","138402116 (free base)",MFCD00864464,NCGC00095122-01,NCGC0009512201,DSSTox_CID_3169,DSSToxCID3169,DSSTox-CID-3169,"DSSTox CID 3169",DSSTox_RID_7,DSSToxRID7,DSSTox-RID-7,
"DSSTox RID 7",S1507,SAM001246548,1504259,Irbesartan,CPD000466306,IRBESARTAN}

> <pdid>
PD001208

> <targets>
{RAAS,Angiotensin Receptor,Apoptosis}

> <classes>
{angiotensin 2 receptor antagonist,Endocrinology & Hormones,Apoptosis,GPCR/G Protein}

> <pubchem_cids>
{3749}

$$$$
NIHCC_2014
  SciTegic11012413002D

 16 17  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5988    1.5004    0.0000 C   0  0
   -3.8978    2.2504    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 N   0  0
    2.5987    1.5004    0.0000 C   0  0
    3.8991    0.7525    0.0000 C   0  0
    5.1969    1.5046    0.0000 C   0  0
    5.1945    3.0046    0.0000 N   0  0
    3.8943    3.7525    0.0000 C   0  0
    2.5964    3.0004    0.0000 C   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  2  3
  5  6  1  0
  6  7  3  0
  5  8  1  0
  8  9  2  0
  8 10  1  0
 10  2  1  0
  3 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
M  END
> <name>
NIHCC_2014

> <id>
5920

> <plate>
NGP-105-04

> <well>
F07

> <supplier_cmpd_name>
CPD000058475

> <ctcr_id>
6778

> <supplier_cmpd_id>
SAM001246611

> <smiles>
CC1=C(C=C(C#N)C(=O)N1)c2ccncc2

> <pd_targets>
{PDE3A,PDE3B,PDE4A,PDE5A,TSHR,PDE4B,PDE4C,PDE4D,AMPC,PDE2A,PTGS1,KDM4E,LMNA,BLM,HPGD,CHRM1}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Epigenetic regulator","Other nuclear protein",Phosphodiesterase,"Family A G protein-coupled receptor",Hydrolase,Oxidoreductase,Eraser,"Phosphodiesterase 3","Phosphodiester
ase 4","Phosphodiesterase 5","Peptide receptor (family A GPCR)","Phosphodiesterase 2","Lysine demethylase","Small molecule receptor (family A GPCR)","Phosphodiesterase 3A","Phosphodiesterase 4A","Phos
phodiesterase 5A","Glycohormone receptor","Phosphodiesterase 3B","Phosphodiesterase 2A","Jumonji domain-containing","Monoamine receptor","Acetylcholine receptor"}

> <pathway_chembl>
{Enzymes,Receptors,"Cyclic nucleotide turnover/signalling","G protein-coupled receptors","Eicosanoid turnover","Chromatin modifying enzymes",Phosphodiesterases,3',"5'-cyclic nucleotide (PDEs)","Glycop
rotein hormone receptors",Cyclooxygenase,"1.14.11.- Histone demethylases","Prostaglandin synthases","Acetylcholine receptors (muscarinic)"}

> <pathway_reactome>
{Hemostasis,Disease,"Signal Transduction",Metabolism,"Cell Cycle","DNA Repair","Platelet homeostasis","Infectious disease","Signaling by Receptor Tyrosine Kinases","Signaling by GPCR","Metabolism of l
ipids",Mitotic,"DNA Double-Strand Break Repair","Nitric oxide stimulates guanylate cyclase","Leishmania infection","Signaling by Insulin receptor","GPCR downstream signalling","Fatty acid metabolism",
"M Phase","Homology Directed Repair","Biosynthesis of specialized proresolving mediators (SPMs)","GPCR ligand binding","cGMP effects","Leishmania parasite growth and survival","Insulin receptor signal
ling cascade","G alpha (s) signalling events","Arachidonic acid metabolism","G alpha (i) signalling events","Mitotic Metaphase and Anaphase","HDR through Homologous Recombination (HRR) or Single Stran
d Annealing (SSA)","Biosynthesis of DHA-derived SPMs","Class A/1 (Rhodopsin-like receptors)","Anti-inflammatory response favouring Leishmania parasite infection","IRS-mediated signalling","Synthesis o
f Prostaglandins (PG) and Thromboxanes (TX)","Opioid Signalling","Mitotic Anaphase","HDR through Homologous Recombination (HRR)","Biosynthesis of D-series resolvins","Amine ligand-binding receptors","
ADORA2B mediated anti-inflammatory cytokines production","PI3K Cascade","DARPP-32 events","Nuclear Envelope (NE) Reassembly","Homologous DNA Pairing and Strand Exchange","Muscarinic acetylcholine rece
ptors","PKB-mediated events","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pairing and strand exchange","PDE3B signalling"}

> <broad_targets>
{PDE2A,PDE3A,PDE3B,PDE5A}

> <broad_moa>
{"phosphodiesterase inhibitor"}

> <synonyms>
{milrinone,78415-72-2,78415722,Primacor,Milrinona,Milrinonum,6-methyl-2-oxo-5-pyridin-4-yl-1H-pyridine-3-carbonitrile,6methyl2oxo5pyridin4yl1Hpyridine3carbonitrile,"WIN 47203","2-methyl-6-oxo-1,6-dihy
dro-(3,4'-bipyridine)-5-carbonitrile","2methyl6oxo1,6dihydro(3,4'bipyridine)5carbonitrile",UNII-JU9YAX04C7,UNIIJU9YAX04C7,3-Cyano-6-methyl-5-(4-pyridyl)-2-pyridone,3Cyano6methyl5(4pyridyl)2pyridone,MF
CD0,T1096,SAM001246611,Prestw-1065,Milrinone,CPD000058475}

> <pdid>
PD000378

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{4197}

$$$$
NIHCC_2014
  SciTegic11012413002D

 32 34  0  0  1  0            999 V2000
    6.4848   -8.2644    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    5.1894   -6.0109    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    5.1937   -3.0093    0.0000 O   0  0
    2.5951   -3.0039    0.0000 N   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5987    1.5004    0.0000 C   0  0
   -3.8967    0.7484    0.0000 C   0  0
   -5.1969    1.4963    0.0000 C   0  0
   -5.1993    2.9963    0.0000 C   0  0
   -3.9014    3.7484    0.0000 C   0  0
   -2.6012    3.0004    0.0000 C   0  0
   -1.3027    3.7529    0.0000 C   0  0
    0.0506    3.1362    0.0000 N   0  0
    1.0508    4.2541    0.0000 N   0  0
    0.2966    5.5507    0.0000 N   0  0
   -1.1696    5.2342    0.0000 N   0  0
    1.2941   -3.7520    0.0000 C   0  0  1  0  0  0
   -0.0052   -3.0008    0.0000 C   0  0
   -0.0052   -2.0008    0.0000 C   0  0
   -1.3045   -3.7503    0.0000 C   0  0
    1.2939   -5.2529    0.0000 C   0  0
   -0.0054   -6.0024    0.0000 O   0  0
    2.5924   -6.0038    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 12 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 21  2  0
 26  7  1  6
 26 27  1  0
 27 28  1  0
 27 29  1  0
 26 30  1  0
 30 31  1  0
 30 32  2  0
M  END
> <name>
NIHCC_2014

> <id>
5921

> <plate>
NGP-105-04

> <well>
F08

> <supplier_cmpd_name>
CPD000466318

> <ctcr_id>
6139

> <supplier_cmpd_id>
SAM001246581

> <smiles>
CCCCC(=O)N(Cc1ccc(cc1)c2ccccc2c3[nH]nnn3)[C@@H](C(C)C)C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{valsartan,137862-53-4,137862534,Diovan,Tareg,"CGP 48933",Provas,CGP-48933,CGP48933,Exforge,UNII-80M03YXJ7I,UNII80M03YXJ7I,MFCD00865840,N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine,N(p(o1
HTetrazol5ylphenyl)benzyl)NvalerylLvaline,CHEMBL1069,80M03YXJ7I,CHEBI:9927,137863-60-6,137863606,Kalpress,Miten,Nisis,Vals,(S)-N-valeryl-N,(S)NvalerylN,SAM001246581,1505209,CPD000466318,VALSARTAN}

> <pdid>
PD013554

> <targets>
{}

> <classes>
{antihypertensive,"Angiotensin II inhibitor"}

> <pubchem_cids>
{60846}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 27  0  0  0  0            999 V2000
    5.1894   -6.0108    0.0000 C   0  0
    3.8917   -5.2586    0.0000 N   0  0
    2.5915   -6.0067    0.0000 C   0  0
    3.8934   -3.7577    0.0000 C   0  0
    2.5949   -3.0050    0.0000 C   0  0
    2.5966   -1.5042    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 Cl  0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8990   -0.7582    0.0000 C   0  0
    3.9042    0.7419    0.0000 C   0  0
    5.2058    1.4875    0.0000 C   0  0
    6.5023    0.7331    0.0000 C   0  0
    6.4972   -0.7669    0.0000 C   0  0
    5.1956   -1.5125    0.0000 N   0  0
   10.3023   -0.3804    0.0000 O   0  0
   10.3023   -1.8804    0.0000 C   0  0
    9.0030   -2.6300    0.0000 O   0  0
   11.6023   -2.6304    0.0000 C   0  0
   12.9023   -1.8804    0.0000 C   0  0
   12.9037   -0.3796    0.0000 C   0  0
   11.6051    0.3712    0.0000 O   0  0
   14.2030    0.3700    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13  7  1  0
  6 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  0
 25 27  2  0
M  END
> <name>
NIHCC_2014

> <id>
5922

> <plate>
NGP-105-04

> <well>
F09

> <supplier_cmpd_name>
CPD000466271

> <ctcr_id>
6680

> <supplier_cmpd_id>
SAM001247022

> <smiles>
CN(C)CCC(c1ccc(Cl)cc1)c2ccccn2.OC(=O)\C=C/C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Chlorpheniramine maleate",113-92-8,113928,Piriton,"Chlorphenamine Maleate",Antagonate,Kloromin,"Chlorphenamine hydrogen maleate","Chlorpheniramine (maleate)",MFCD00069225,Polaronil,C16H19ClN2.C4H4O4
,"Chlorphenamine maleates","Chloropheniramine male",T1553,T0785,T0205,S1816,SAM001247022,Prestw-117,"Dexchlorpheniramine Maleate","Brompheniramine hydrogen maleate","Chlorpheniramine Maleate",CPD00046
6271}

> <pdid>

> <targets>
{"Histamine Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{5281068,5284366}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 24  0  0  0  0            999 V2000
    3.1476   -0.7184    0.0000 C   0  0
    1.6852   -0.3846    0.0000 N   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.5242    2.0130    0.0000 O   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 N   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -3.1484   -0.7186    0.0000 C   0  0
   -4.1145    0.4339    0.0000 C   0  0
   -5.5920    0.1754    0.0000 C   0  0
   -6.1069   -1.2335    0.0000 C   0  0
   -5.1442   -2.3838    0.0000 C   0  0
   -3.6667   -2.1253    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
   -1.4977   -5.4580    0.0000 N   0  3
   -2.9977   -5.4607    0.0000 O   0  5
   -0.7459   -6.7560    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  2  3
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  7 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19  2  1  0
 19 14  1  0
 16 20  1  0
 20 21  1  0
 20 22  2  0
M  CHG  2  20   1  21  -1
M  END
> <name>
NIHCC_2014

> <id>
5923

> <plate>
NGP-105-04

> <well>
F10

> <supplier_cmpd_name>
CPD000238177

> <ctcr_id>
3057

> <supplier_cmpd_id>
SAM001246755

> <smiles>
CN1C(=O)CN=C(c2ccccc2)c3cc(ccc13)[N+]([O-])=O

> <pd_targets>
{LMNA}

> <pathway_gtopdb>
{"Other nuclear protein"}

> <pathway_chembl>
{}

> <pathway_reactome>
{"Cell Cycle",Mitotic,"M Phase","Mitotic Metaphase and Anaphase","Mitotic Anaphase","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{nimetazepam,2011-67-8,2011678,1-Methylnitrazepam,1Methylnitrazepam,Elimin,Methylnitrazepam,"1,3-Dihydro-1-methyl-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one","1,3Dihydro1methyl7nitro5phenyl2H1,4benzo
diazepin2one",Nimetazepamum,Erimin,"Ro 5-3453","Ro 53453","S 1530","1-Methyl-5-phenyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one","1Methyl5phenyl7nitro1,3dihydro2H1,4benzodiazepin2one",SAM00124675
5,CPD000238177}

> <pdid>
PD003073

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{4496}

$$$$
NIHCC_2014
  SciTegic11012413002D

 31 34  0  0  0  0            999 V2000
    4.3463   -8.9980    0.0000 C   0  0
    3.9021   -7.5652    0.0000 C   0  0
    4.9206   -6.4629    0.0000 N   0  0
    6.3851   -6.7913    0.0000 C   0  0
    7.4019   -5.6885    0.0000 C   0  0
    4.4762   -5.0294    0.0000 C   0  0
    5.4947   -3.9271    0.0000 C   0  0
    6.9571   -4.2609    0.0000 C   0  0
    7.9774   -3.1613    0.0000 C   0  0
    7.5353   -1.7280    0.0000 C   0  0
    6.0729   -1.3942    0.0000 C   0  0
    5.0525   -2.4938    0.0000 N   0  0
    3.5900   -2.1568    0.0000 C   0  0
    3.1497   -0.7220    0.0000 C   0  0
    4.1718    0.3758    0.0000 O   0  0
    1.6852   -0.3846    0.0000 N   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.5913    1.9239    0.0000 C   0  0
    2.4792    3.4197    0.0000 C   0  0
    1.1278    4.0705    0.0000 C   0  0
   -0.1116    3.2255    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -2.5242    2.0130    0.0000 O   0  0
   -1.6852   -0.3847    0.0000 N   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 N   0  0
    0.7500   -1.5574    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12  7  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 16  1  0
 31 26  1  0
M  END
> <name>
NIHCC_2014

> <id>
5924

> <plate>
NGP-105-04

> <well>
F11

> <supplier_cmpd_name>
CPD000466280

> <ctcr_id>
884

> <supplier_cmpd_id>
SAM001247077

> <smiles>
CCN(CC)CC1CCCCN1CC(=O)N2c3ccccc3C(=O)Nc4cccnc24

> <pd_targets>
{CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,MACHR-A,MAPK1}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Family A G protein-coupled receptor",Kinase,"Small molecule receptor (family A GPCR)","Protein Kinase","Monoamine receptor","CMGC protein kinase group","Acetylcholine rece
ptor","CMGC protein kinase MAPK family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Kinases (EC 2.7.x.x)","Acetylcholine receptors (muscarinic)","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Mitogen-activated protein kinases (MAP k
inases)","ERK subfamily"}

> <pathway_reactome>
{"Signal Transduction","Immune System","Signaling by GPCR","Innate Immune System","GPCR ligand binding","Toll-like Receptor Cascades","Class A/1 (Rhodopsin-like receptors)","Toll Like Receptor 5 (TLR5
) Cascade","Amine ligand-binding receptors","MyD88 cascade initiated on plasma membrane","Muscarinic acetylcholine receptors","MAP kinase activation","MAPK targets/ Nuclear events mediated by MAP kina
ses","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3,CHRM4,CHRM5}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{DSSTox_GSID_45674,DSSToxGSID45674,DSSTox-GSID-45674,"DSSTox GSID 45674",121029-35-4,121029354,Otenzepad,"AF-DX 116","AFDX 116",102394-31-0,102394310,"Otenzepad, (+)-","Otenzepad, (+)",AF-DX-116,AFDX1
16,UNII-SX2WTG9R3Z,UNIISX2WTG9R3Z,UNII-WW6A9TFL2C,UNIIWW6A9TFL2C,SX2WTG9R3Z,WW6A9TFL2C,CHEMBL17045,100158-38-1,100158381,NSC664529,NCGC00025002-02,NCGC0002500202,DSSTox_CID_25674,DSSToxCID25674,DSSTox
-CID-25674,"DSSTox CID 25674",DSSTox_RID_81048,DSSToxRID81048,DSSTox-RID-81048,"DSSTox RID 81048","Otenzepad (",SAM001247077,CPD000466280}

> <pdid>
PD003162

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{107867}

$$$$
NIHCC_2014
  SciTegic11012413002D

  9  9  0  0  0  0            999 V2000
    3.8926   -3.7566    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
M  END
> <name>
NIHCC_2014

> <id>
5925

> <plate>
NGP-105-04

> <well>
G02

> <supplier_cmpd_name>
CPD000059100

> <ctcr_id>
5928

> <supplier_cmpd_id>
SAM001246867

> <smiles>
NCCc1ccccn1

> <pd_targets>
{HRH1}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Histamine receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Histamine receptors"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Amine ligand-binding receptors","Histamine receptors"}

> <broad_targets>
{HRH1}

> <broad_moa>
{"histamine receptor agonist"}

> <synonyms>
{2-(2-Aminoethyl)pyridine,2(2Aminoethyl)pyridine,2706-56-1,2706561,2-Pyridylethylamine,2Pyridylethylamine,2-(2-Pyridyl)ethylamine,2(2Pyridyl)ethylamine,2-(pyridin-2-yl)ethanamine,2(pyridin2yl)ethanami
ne,2-Pyridineethanamine,2Pyridineethanamine,2-pyridin-2-ylethanamine,2pyridin2ylethanamine,Demethylbetahistine,alpha-Pyridylethylamine,alphaPyridylethylamine,"Lilly 04432",2-(pyridin-2-yl)ethan-1-amin
e,2(pyridin2yl)ethan1amine,Py,SAM001246867,CPD000059100}

> <pdid>
PD003182

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{75919}

$$$$
NIHCC_2014
  SciTegic11012413002D

 34 36  0  0  1  0            999 V2000
    9.0955   -4.0658    0.0000 Na  0  3
    2.2090   -0.3353    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0
   -6.4952    3.7500    0.0000 O   0  0
   -3.8971    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0  2  0  0  0
   -1.2990    2.2500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.3326   -2.9571    0.0000 C   0  0
    1.8253   -3.1044    0.0000 C   0  0
    2.4266   -1.7302    0.0000 C   0  0  1  0  0  0
    2.7095   -0.7710    0.0000 O   0  0
    3.4182   -2.8395    0.0000 C   0  0
    4.8815   -2.5100    0.0000 O   0  0
    2.9720   -4.2725    0.0000 C   0  0
    3.9893   -5.3760    0.0000 O   0  0
    3.5431   -6.8090    0.0000 C   0  0
    2.0798   -7.1384    0.0000 O   0  0
    4.5603   -7.9125    0.0000 C   0  0
    4.1142   -9.3454    0.0000 C   0  0
    5.1314  -10.4489    0.0000 C   0  0
    6.5948  -10.1195    0.0000 O   0  5
    4.6855  -11.8811    0.0000 O   0  0
  3  2  1  1
  3  4  1  0
  4  5  1  0
  5  6  1  1
  7  5  1  1
  7  8  1  0
  8  9  1  6
  9 10  1  0
 10 11  1  0
 11 12  2  3
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  2  3
 16 17  1  0
 17  7  1  0
 17 11  1  0
 17 18  1  1
  8 19  1  0
 19  3  1  0
 19 20  1  1
 20 21  1  0
 21 22  1  0
 22  3  1  0
 22 23  1  6
 22 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 32 34  2  0
M  CHG  2   1   1  33  -1
M  END
> <name>
NIHCC_2014

> <id>
5926

> <plate>
NGP-105-04

> <well>
G03

> <supplier_cmpd_name>
CPD000058773

> <ctcr_id>
6525

> <supplier_cmpd_id>
SAM001246897

> <smiles>
[Na+].C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)CCC([O-])=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"PREDNISOLONE SODIUM SUCCINATE",1715-33-9,1715339,"Prednisolone 21-hemisuccinate sodium salt","Prednisolone 21hemisuccinate sodium salt",UNII-8223RR9DWF,UNII8223RR9DWF,Meticortelane,Solu-Decortin,Sol
uDecortin,"Prednisolone sodium hemisuccinate","Prednisolone 21-hemisuccinate sodium","Prednisolone 21hemisuccinate sodium","Prednisolone sodium 21-hemisuccinate","Prednisolone sodium 21hemisuccinate",
SAM001246897,CPD000058773}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23680518}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 22  0  0  0  0            999 V2000
    3.1476   -0.7184    0.0000 C   0  0
    1.6852   -0.3846    0.0000 N   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.5242    2.0130    0.0000 O   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 N   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -3.1484   -0.7186    0.0000 C   0  0
   -4.1145    0.4339    0.0000 C   0  0
   -5.5920    0.1754    0.0000 C   0  0
   -6.1069   -1.2335    0.0000 C   0  0
   -5.1442   -2.3838    0.0000 C   0  0
   -3.6667   -2.1253    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
   -1.5000   -5.4558    0.0000 Cl  0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  2  3
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  7 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
 18 19  1  0
 19 20  2  0
 20  2  1  0
 20 14  1  0
M  END
> <name>
NIHCC_2014

> <id>
5927

> <plate>
NGP-105-04

> <well>
G04

> <supplier_cmpd_name>
CPD000058398

> <ctcr_id>
4688

> <supplier_cmpd_id>
SAM001246536

> <smiles>
CN1C(=O)CN=C(c2ccccc2)c3cc(Cl)ccc13

> <pd_targets>
{AKR1C3,GABRA5,GABRB3,GABRG2,ACHE,AKR1C1,GABBR1,GABRA3,GABRA1,GABRA2,GABRA4,GABRA6,GABRB1,GABRB2,GABRD,GABRE,GABRG1,GABRG3,GABRP,GABRQ,TSPO,ALB,ADORA3,BCHE,AKR1C2,FABP1,TRHR,CACNA1C,CACNA1D,CACNA1F,CA
CNA1S,GAA,LMNA}

> <pathway_gtopdb>
{Enzyme,"Ion channel","Membrane receptor","Secreted protein","Auxiliary transport protein","Ligand-gated ion channel",Hydrolase,Oxidoreductase,"Family C G protein-coupled receptor","Family A G protein
-coupled receptor","Fatty acid binding protein family","Voltage-gated ion channel","GABA-A receptor","Small molecule receptor (family C GPCR)","Small molecule receptor (family A GPCR)","Peptide recept
or (family A GPCR)","Voltage-gated calcium channel","Neurotransmitter receptor (family C GPCR)","Nucleotide-like receptor (family A GPCR)","Short peptide receptor (family A GPCR)","GABA-B receptor","A
denosine receptor","Neuropeptide receptor","Other nuclear protein"}

> <pathway_chembl>
{Enzymes,Receptors,"Ion channels","Other protein targets","Eicosanoid turnover","Acetylcholine turnover","G protein-coupled receptors","Ligand-gated ion channels","Mitochondrial-associated proteins","
Fatty acid-binding proteins","Prostaglandin synthases","GABA<sub>B</sub> receptors","GABA<sub>A</sub> receptors","Adenosine receptors","Thyrotropin-releasing hormone receptors","3.2.1.- Glycosidases"}

> <pathway_reactome>
{Metabolism,"Neuronal System","Signal Transduction","Metabolism of lipids","Transmission across Chemical Synapses","Signaling by GPCR","Metabolism of steroids","Phospholipid metabolism","Neurotransmit
ter receptors and postsynaptic signal transmission","GPCR ligand binding","Regulation of lipid metabolism by PPARalpha","Bile acid and bile salt metabolism","Glycerophospholipid biosynthesis","GABA re
ceptor activation","Metabolism of steroid hormones","Class A/1 (Rhodopsin-like receptors)","PPARA activates gene expression","Synthesis of bile acids and bile salts","Synthesis of PC","GABA B receptor
 activation","Pregnenolone biosynthesis","Recycling of bile acids and salts","Nucleotide-like (purinergic) receptors","Peptide ligand-binding receptors","Synthesis of bile acids and bile salts via 24-
hydroxycholesterol","Activation of GABAB receptors","Adenosine P1 receptors","Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits",Disease,"Cell Cycle","Diseases of metabolism",Mitotic
,"Diseases of carbohydrate metabolism","M Phase","Glycogen storage diseases","Mitotic Metaphase and Anaphase","Glycogen storage disease type II (GAA)","Mitotic Anaphase","Nuclear Envelope (NE) Reassem
bly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{diazepam,Valium,439-14-5,439145,Diazemuls,Ansiolisina,Apaurin,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Methyldiazepinone,Ansiolin,Apozepam,Atensine,Bensedin,Bialzepam,Calmocitene,Calmpose,Ceregulart
,Condition,Diacepan,Diazepan,Diazetard,Dipezona,Do,SAM001246536,CPD000058398}

> <pdid>
PD003026

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{3016}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 21  0  0  0  0            999 V2000
   -0.6923   -4.0811    0.0000 C   0  0
    0.3114   -2.9665    0.0000 N   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    2.5981    1.5000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.8003    1.4887    0.0000 C   0  0
   -7.8029    2.9887    0.0000 C   0  0
   -9.0983    0.7368    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 10 18  1  0
 18 19  2  0
 18 20  1  0
 20  2  1  0
 20  5  2  0
M  END
> <name>
NIHCC_2014

> <id>
5928

> <plate>
NGP-105-04

> <well>
G05

> <supplier_cmpd_name>
CPD000035998

> <ctcr_id>
2338

> <supplier_cmpd_id>
SAM001247011

> <smiles>
Cn1cnc2N(C)C(=O)N(CCCCC(C)=O)C(=O)c12

> <pd_targets>
{CHRM1,ACHE,LMNA,CHIT1,TSHR,IMPA1,CYP1A2,ADORA2B,PMP22,RXFP1,PDE4A,PDE4B,PDE4C,PDE4D,NFO,TNF,NFKB1,CHIB1,PDE10A,PDE1A,PDE1B,PDE1C,PDE2A,PDE3A,PDE3B,PDE5A,PDE6A,PDE6B,PDE6C,PDE6D,PDE6G,PDE6H,PDE7A,PDE7
B,PDE8A,PDE8B,PDE9A,ADORA2A,ADORA1,NT5E}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Other nuclear protein","Unclassified protein","Secreted protein","Other cytosolic protein","Family A G protein-coupled receptor",Hydrolase,"Cytochrome P450",Phosphodiester
ase,Phosphatase,"Small molecule receptor (family A GPCR)","Peptide receptor (family A GPCR)","Cytochrome P450 family 1","Phosphodiesterase 4","Phosphodiesterase 1","Monoamine receptor","Glycohormone r
eceptor","Cytochrome P450 family 1A","Nucleotide-like receptor (family A GPCR)","Relaxin-like peptide receptor (family A GPCR)","Phosphodiesterase 4A","Phosphodiesterase 1A","Acetylcholine receptor","
Cytochrome P450 1A1","Adenosine receptor","Relaxin receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Acetylcholine turnover","Inositol phosphate turnover","Cytochrome P450","Adenosine turnover","Acetylcholine receptors (muscarinic)","Glycoprotein horm
one receptors","Inositol monophosphatase","CYP1 family","Adenosine receptors","Relaxin family peptide receptors"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,"Cell Cycle","Digestion and absorption",Disease,"Developmental Biology","Immune System","Signaling by GPCR","Metabolism of lipids",Mitotic,Digestion,"Infectious disea
se","Inositol phosphate metabolism","Biological oxidations","Nervous system development","Cytokine Signaling in Immune system","GPCR ligand binding","Phospholipid metabolism","M Phase","Digestion of d
ietary carbohydrate","Leishmania infection","Synthesis of IP2",IP,"and Ins in the cytosol","Phase I - Functionalization of compounds","EGR2 and SOX10-mediated initiation of Schwann cell myelination","
Signaling by Interleukins","Class A/1 (Rhodopsin-like receptors)","Glycerophospholipid biosynthesis","Mitotic Metaphase and Anaphase","Leishmania parasite growth and survival","Cytochrome P450 - arran
ged by substrate type","Interleukin-10 signaling","Interleukin-1 family signaling","Cell recruitment (pro-inflammatory response)","Amine ligand-binding receptors","Synthesis of PC","Mitotic Anaphase",
"Anti-inflammatory response favouring Leishmania parasite infection",Xenobiotics,"Interleukin-1 signaling","Nucleotide-like (purinergic) receptors","Purinergic signaling in leishmaniasis infection","M
uscarinic acetylcholine receptors","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","MAP3
K8 (TPL2)-dependent MAPK1/3 activation","Adenosine P1 receptors","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ADORA1,ADORA2A,ADORA2B,ADRA2B,NT5E,PDE10A,PDE1A,PDE1B,PDE1C,PDE2A,PDE3A,PDE3B,PDE4A,PDE4B,PDE4C,PDE4D,PDE5A,PDE6A,PDE6B,PDE6C,PDE6D,PDE6G,PDE6H,PDE7A,PDE7B,PDE8A,PDE8B,PDE9A,TNF}

> <broad_moa>
{"phosphodiesterase inhibitor"}

> <synonyms>
{pentoxifylline,Trental,6493-05-6,6493056,Oxpentifylline,Pentoxifyllin,Torental,Pentoxyphylline,Dimethyloxohexylxanthine,Pentoxiphyllium,Vazofirin,Pentoxiphylline,Rentylin,"3,7-Dimethyl-1-(5-oxohexyl)
xanthine","3,7Dimethyl1(5oxohexyl)xanthine","BL 191",Pentoxyphyllin,3,7-Dihydro-3,7Dihydro3,T0070,NSC637086,SAM001247011,1503611,Prestw-196,"NSC 637086",Pentoxifylline,CPD000035998,PENTOXIFYLLINE}

> <pdid>
PD000975

> <targets>
{Autophagy,HIV,Phosphodiesterase (PDE)}

> <classes>
{bronchodilator,PDE inhibitor,vasodilator,Anti-infection,Autophagy,Metabolic Enzyme/Protease}

> <pubchem_cids>
{4740}

$$$$
NIHCC_2014
  SciTegic11012413002D

 33 35  0  0  1  0            999 V2000
    5.1996   -1.4928    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -0.0031    3.0008    0.0000 C   0  0
   -1.3039    3.7494    0.0000 C   0  0
   -2.1691    3.2479    0.0000 O   0  0
   -1.3070    5.2502    0.0000 N   0  0
   -2.6078    5.9988    0.0000 C   0  0  1  0  0  0
   -3.9047    5.2434    0.0000 C   0  0
   -3.9000    3.7426    0.0000 C   0  0
   -5.1962    2.9877    0.0000 C   0  0
   -3.0322    3.2456    0.0000 C   0  0
   -2.6109    7.4996    0.0000 C   0  0
   -1.3119    8.2497    0.0000 C   0  0
   -1.3120    9.7497    0.0000 C   0  0
   -2.6110   10.4997    0.0000 C   0  0
   -3.9100    9.7496    0.0000 C   0  0
   -3.9100    8.2496    0.0000 C   0  0
   -5.2097    7.4993    0.0000 N   0  0
   -5.2121    5.9992    0.0000 C   0  0
   -6.5123    5.2512    0.0000 C   0  0
   -7.8102    6.0033    0.0000 C   0  0
   -7.8078    7.5033    0.0000 C   0  0
   -6.5076    8.2512    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 C   0  0
    1.2947   -3.7531    0.0000 O   0  0
   -1.3032   -3.7490    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 11 10  1  1
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  1  0
 11 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 22  1  0
  6 28  2  0
 28 29  1  0
 29 30  2  0
 30  4  1  0
 30 31  1  0
 31 32  1  0
 31 33  2  0
M  END
> <name>
NIHCC_2014

> <id>
5929

> <plate>
NGP-105-04

> <well>
G06

> <supplier_cmpd_name>
CPD000466305

> <ctcr_id>
3695

> <supplier_cmpd_id>
SAM001246546

> <smiles>
CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3)ccc1C(O)=O

> <pd_targets>
{CYP3A4,ABCC8,MAPK1,ALD,LMNA,RORC,ABCC2,SLC22A1,ABCC3,ABCC4,ABCB11,KCNJ11,PPARG}

> <pathway_gtopdb>
{Enzyme,Transporter,"Other nuclear protein","Transcription factor","Ion channel","Cytochrome P450","Primary active transporter",Kinase,"Nuclear receptor","Electrochemical transporter","Voltage-gated i
on channel","Cytochrome P450 family 3","ATP-binding cassette","Protein Kinase","Nuclear hormone receptor subfamily 1","SLC superfamily of solute carriers","Potassium channels","Cytochrome P450 family 
3A","ABCC subfamily","CMGC protein kinase group","Nuclear hormone receptor subfamily 1 group F","SLC22 family of organic cation and anion transporters","ABCB subfamily","Inwardly rectifying potassium 
channel","Nuclear hormone receptor subfamily 1 group C","Cytochrome P450 3A4","CMGC protein kinase MAPK family","Nuclear hormone receptor subfamily 1 group F member 3","Nuclear hormone receptor subfam
ily 1 group C member 3","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Transporters,Receptors,"Cytochrome P450","ATP-binding cassette transporter family","Kinases (EC 2.7.x.x)","Nuclear hormone receptors","SLC superfamily of solute carriers","CYP3 family","ABCC 
subfamily","CMGC: Containing CDK",MAPK,GSK3,"CLK families","1F. Retinoic acid-related orphans","SLC22 family of organic cation and anion transporters","ABCB subfamily","1C. Peroxisome proliferator-act
ivated receptors","Mitogen-activated protein kinases (MAP kinases)","Organic cation transporters (OCT)","ERK subfamily"}

> <pathway_reactome>
{Metabolism,Disease,"Immune System","Cell Cycle","Gene expression (Transcription)","Transport of small molecules",Hemostasis,"Metabolism of lipids","Disorders of transmembrane transporters","Innate Im
mune System",Mitotic,"RNA Polymerase II Transcription","SLC-mediated transmembrane transport","Platelet activation","signaling and aggregation","Biosynthesis of specialized proresolving mediators (SPM
s)","ABC transporter disorders","Toll-like Receptor Cascades","M Phase","Generic Transcription Pathway","Transport of bile salts and organic acids","metal ions and amine compounds","Metabolism of ster
oids","Response to elevated platelet cytosolic Ca2+","Biosynthesis of DHA-derived SPMs","Defective ABCC8 can cause hypo- and hyper-glycemias","Toll Like Receptor 5 (TLR5) Cascade","Mitotic Metaphase a
nd Anaphase","Transcriptional regulation by RUNX3","Defective ABCC2 causes DJS","Organic cation/anion/zwitterion transport","Bile acid and bile salt metabolism","Platelet degranulation","Transcription
al Regulation by MECP2","Biosynthesis of maresins","MyD88 cascade initiated on plasma membrane","Mitotic Anaphase","RUNX3 Regulates Immune Response and Cell Migration","Organic cation transport","Recy
cling of bile acids and salts","Synthesis of bile acids and bile salts","MECP2 regulates transcription factors","Biosynthesis of maresin-like SPMs","MAP kinase activation","Nuclear Envelope (NE) Reass
embly","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","MAPK targets/ Nuclear events mediated by MAP kinases","Initiation of Nuclear Envelope (NE) Reformation","ERK/MAPK targets
","ERKs are inactivated"}

> <broad_targets>
{ABCC8,KCNJ11,PPARG}

> <broad_moa>
{"insulin secretagogue"}

> <synonyms>
{RESTW104,Prestwick1_001046,Prestwick1001046,Prestwick1-001046,"Prestwick1 001046",Prestwick2_001046,Prestwick2001046,Prestwick2-001046,"Prestwick2 001046",Repaglinide,135062-02-1,135062021,Prandin,No
voNorm,GlucoNorm,"AG-EE 623 ZW","AGEE 623 ZW","Repaglinidum (INN-Latin)","Repaglinidum (INNLatin)","Repaglinida (INN-Spanish)","Repaglinida (INNSpanish)","AG-EE 388 ZW","AGEE 388 ZW",AGEE-623ZW,AGEE62
3ZW,C27H36N2O4,"AG-EE 623ZW","AGEE 623ZW",UNII-668Z8C33LU,UNII668Z8C33LU,CHEMBL1272,AG-EE-3,AGEE3,T1088,SAM001246546,Prestw-1046,CPD000466305}

> <pdid>
PD000219

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{65981}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 29  0  0  1  0            999 V2000
    6.4897   -5.2632    0.0000 O   0  0
    5.1894   -6.0109    0.0000 C   0  0
    5.1873   -7.5109    0.0000 O   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 O   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5998    1.4986    0.0000 C   0  0  2  0  0  0
   -3.8983    0.7460    0.0000 C   0  0
   -5.1997    1.4920    0.0000 C   0  0
   -6.4964    0.7381    0.0000 C   0  0
   -6.4919   -0.7619    0.0000 C   0  0
   -5.1906   -1.5080    0.0000 C   0  0
   -3.8938   -0.7540    0.0000 C   0  0
   -2.6013    2.9994    0.0000 C   0  0
   -3.9001    3.7500    0.0000 C   0  0
   -3.8996    5.2500    0.0000 C   0  0
   -2.6003    5.9996    0.0000 C   0  0
   -2.5999    7.4996    0.0000 Cl  0  0
   -1.3016    5.2491    0.0000 C   0  0
   -1.3020    3.7491    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13  8  1  0
 14 11  1  6
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 14 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 24 26  1  0
 26 27  2  0
 27 21  1  0
M  END
> <name>
NIHCC_2014

> <id>
5930

> <plate>
NGP-105-04

> <well>
G07

> <supplier_cmpd_name>
CPD000466315

> <ctcr_id>
382

> <supplier_cmpd_id>
SAM001246575

> <smiles>
OC(=O)COCCN1CCN(CC1)[C@H](c2ccccc2)c3ccc(Cl)cc3

> <pd_targets>
{HRH1,TEK,KCNH2}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Ion channel",Protease,"Family A G protein-coupled receptor",Kinase,"Voltage-gated ion channel","Cysteine protease","Small molecule receptor (family A GPCR)","Protein Kinas
e","Potassium channels","Cysteine protease CA clan","Monoamine receptor","TK protein kinase group","Voltage-gated potassium channel","Cysteine protease C1A family","Histamine receptor","Tyrosine prote
in kinase Tie family"}

> <pathway_chembl>
{Receptors,"Ion channels","G protein-coupled receptors","Catalytic receptors","Voltage-gated ion channels","Histamine receptors","Receptor kinases","Potassium channels","TK: Tyrosine kinase","Voltage-
gated potassium channels","Receptor tyrosine kinases (RTKs)","Type XII RTKs: TIE family of angiopoietin receptors"}

> <pathway_reactome>
{"Signal Transduction","Muscle contraction","Signaling by GPCR","MAPK family signaling cascades","Cardiac conduction","GPCR ligand binding","MAPK1/MAPK3 signaling","Phase 3 - rapid repolarisation","Cl
ass A/1 (Rhodopsin-like receptors)","RAF/MAP kinase cascade","Amine ligand-binding receptors","Histamine receptors"}

> <broad_targets>
{HRH1}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{H230000000,Levocetirizine,130018-77-8,130018778,"130018 77 8",Xyzal,(R)-cetirizine,(R)cetirizine,"(R) cetirizine",(-)-Cetirizine,()Cetirizine,"( ) Cetirizine",UNII-6U5EA9RT2O,UNII6U5EA9RT2O,"UNII 6U5
EA9RT2O","(R)-Cetirizine dihydrochloride","(R)Cetirizine dihydrochloride","(R) Cetirizine dihydrochloride",6U5EA9RT2O,Xarlin,"(2-(4-((R)-(4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic aci
d","(2(4((R)(4chlorophenyl)(phenyl)methyl)piperazin1yl)ethoxy)acetic acid","(2 (4 ((R) (4 chlorophenyl)(phenyl)methyl)piperazin 1 yl)ethoxy)acetic acid",SMR000466315,Vozet,R-,R,T1469,T0089,SAM00124657
5,"Cetirizine dihydrochloride",CPD000466315}

> <pdid>
PD003052

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{1549000,28145931}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 25  0  0  0  0            999 V2000
    8.9915    1.8986    0.0000 O   0  0
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 S   0  0
   -1.3164   -2.2191    0.0000 O   0  0
    1.3163   -2.2193    0.0000 O   0  0
    2.5972    1.5031    0.0000 C   0  0
    3.8976    0.7554    0.0000 O   0  0
    2.5951    3.0039    0.0000 N   0  0
    3.8933    3.7570    0.0000 C   0  0
    3.8933    5.2571    0.0000 C   0  0
    5.1924    6.0071    0.0000 C   0  0
    6.4914    5.2571    0.0000 C   0  0
    6.4915    3.7571    0.0000 C   0  0
    5.1925    3.0071    0.0000 N   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  3
  5  6  1  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 12 13  1  0
 13  3  1  0
 13 14  2  0
 13 15  2  0
  4 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
M  END
> <name>
NIHCC_2014

> <id>
5931

> <plate>
NGP-105-04

> <well>
G08

> <supplier_cmpd_name>
CPD000449291

> <ctcr_id>
3659

> <supplier_cmpd_id>
SAM001247048

> <smiles>
O.CN1C(=C(O)c2ccccc2S1(=O)=O)C(=O)Nc3ccccn3

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{PTGS1,PTGS2}

> <broad_moa>
{"cyclooxygenase inhibitor"}

> <synonyms>
{"Piroxicam monohydrate",UNII-28MQO4N66D,UNII28MQO4N66D,28MQO4N66D,90936-70-2,90936702,SMR000449291,MLS000758266,MLS001424100,SCHEMBL6759456,CHEMBL1418195,DTXSID00238326,HMS2051N12,HMS2232H05,HMS3370D
18,HMS3393N12,CCG-101029,CCG101029,NC00279,Q27254336,SAM001247048,CPD000449291}

> <pdid>
PD001795

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{54705052}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 30  0  0  0  0            999 V2000
    2.5909   -6.0056    0.0000 C   0  0
    3.8912   -5.2578    0.0000 N   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 N   0  0
   -3.8990    0.7455    0.0000 S   0  0
   -3.8964   -0.7545    0.0000 C   0  0
   -5.1996    1.4928    0.0000 O   0  0
   -5.1966   -0.0070    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    5.1894   -6.0109    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    6.4855   -8.2648    0.0000 C   0  0
    6.4855   -9.7648    0.0000 C   0  0
    7.7846  -10.5149    0.0000 C   0  0
    9.0836   -9.7649    0.0000 C   0  0
   10.3849  -10.5127    0.0000 N   0  0
   11.6836   -9.7604    0.0000 S   0  0
   11.6810   -8.2604    0.0000 C   0  0
   12.9842  -10.5078    0.0000 O   0  0
   12.9812   -9.0080    0.0000 O   0  0
    9.0836   -8.2649    0.0000 C   0  0
    7.7846   -7.5149    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 11 14  2  0
  9 15  1  0
 15 16  2  0
 16  6  1  0
  2 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  2  0
 24 27  2  0
 22 28  1  0
 28 29  2  0
 29 19  1  0
M  END
> <name>
NIHCC_2014

> <id>
5932

> <plate>
NGP-105-04

> <well>
G09

> <supplier_cmpd_name>
CPD000466333

> <ctcr_id>
3554

> <supplier_cmpd_id>
SAM001246621

> <smiles>
CN(CCOc1ccc(N[S](C)(=O)=O)cc1)CCc2ccc(N[S](C)(=O)=O)cc2

> <pd_targets>
{GSC2,KCNH2,CACNA1C,CACNA1D,CACNA1F,CACNA1S,KCNH1,KCNK2,KCNJ12}

> <pathway_gtopdb>
{Enzyme,"Ion channel",Transferase,"Voltage-gated ion channel","Potassium channels","Voltage-gated calcium channel","Voltage-gated potassium channel","Two-pore domain potassium channel"}

> <pathway_chembl>
{"Ion channels","Voltage-gated ion channels","Potassium channels","Voltage-gated potassium channels","Two P domain potassium channels","Inwardly rectifying potassium channels"}

> <pathway_reactome>
{"Muscle contraction","Neuronal System","Cardiac conduction","Potassium Channels","Transmission across Chemical Synapses","Phase 3 - rapid repolarisation","Voltage gated Potassium channels","Tandem po
re domain potassium channels","Neurotransmitter receptors and postsynaptic signal transmission","TWIK related potassium channel (TREK)","GABA receptor activation","GABA B receptor activation","Activat
ion of GABAB receptors","Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits"}

> <broad_targets>
{KCNH1,KCNH2,KCNJ12,KCNK2}

> <broad_moa>
{"potassium channel blocker"}

> <synonyms>
{Dofetilide,115256-11-6,115256116,Tikosyn,Dofetilida,Dofetilidum,"Dofetilidum (INN-Latin)","Dofetilidum (INNLatin)","Dofetilida (INN-Spanish)","Dofetilida (INNSpanish)","UK 68798","UK-68,798","UK68,79
8",UK-68798,UK68798,"Dofetilide (Tikosyn)",UNII-R4Z9X1N2ND,UNIIR4Z9X1N2ND,C19H27N3O5S2,CHEMBL473,R4Z9X1N2ND,CHEBI:4681,NCGC00164549-01,NCGC0016454901,DSSTo,T6476,SAM001246621,CPD000466333}

> <pdid>
PD003019

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{71329}

$$$$
NIHCC_2014
  SciTegic11012413002D

 15 15  0  0  0  0            999 V2000
    3.8869   -8.2595    0.0000 O   0  5
    5.1873   -7.5117    0.0000 N   0  3
    6.4848   -8.2644    0.0000 O   0  0
    5.1894   -6.0109    0.0000 O   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 N   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
M  CHG  2   1  -1   2   1
M  END
> <name>
NIHCC_2014

> <id>
5933

> <plate>
NGP-105-04

> <well>
G10

> <supplier_cmpd_name>
CPD000466365

> <ctcr_id>
4345

> <supplier_cmpd_id>
SAM001246701

> <smiles>
[O-][N+](=O)OCCNC(=O)c1cccnc1

> <pd_targets>
{CYP2C19,KMT2A,MEN1,CYP2C9,ALOX15,LEF,KCNJ8,KCNJ11,ABCC9}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Ion channel",Transporter,"Cytochrome P450",Reader,Oxidoreductase,Protease,"Voltage-gated ion channel","Primary active transporter","Cytochrome P450 family 2",Bromodomai
n,"Metallo protease","Potassium channels","ATP-binding cassette","Cytochrome P450 family 2C","Metallo protease MAE clan","Inwardly rectifying potassium channel","ABCC subfamily","Cytochrome P450 2C19"
,"Cytochrome P450 2C9","Metallo protease M34 family"}

> <pathway_chembl>
{Enzymes,"Ion channels",Transporters,"Cytochrome P450","Eicosanoid turnover","Voltage-gated ion channels","ATP-binding cassette transporter family","CYP2 family: drug metabolising subset",Lipoxygenase
s,"Potassium channels","ABCC subfamily","Inwardly rectifying potassium channels"}

> <pathway_reactome>
{Metabolism,Disease,"Neuronal System","Biological oxidations","Metabolism of lipids","Infectious disease","Potassium Channels","Disorders of transmembrane transporters","Phase I - Functionalization of
 compounds","Biosynthesis of specialized proresolving mediators (SPMs)","Uptake and actions of bacterial toxins","Inwardly rectifying K+ channels","ABC transporter disorders","Cytochrome P450 - arrang
ed by substrate type","Biosynthesis of DPA-derived SPMs","Uptake and function of anthrax toxins","ATP sensitive Potassium channels","Defective ABCC8 can cause hypo- and hyper-glycemias","Defective ABC
C9 causes CMD10","ATFB12 and Cantu syndrome",Xenobiotics,"Biosynthesis of DPAn-3 SPMs","CYP2E1 reactions","Biosynthesis of DPAn-3-derived protectins and resolvins"}

> <broad_targets>
{KCNJ11}

> <broad_moa>
{"nitric oxide donor","potassium channel activator"}

> <synonyms>
{NICORANDIL,65141-46-0,65141460,Ikorel,"2-Nicotinamidoethyl nitrate","2Nicotinamidoethyl nitrate",SG-75,SG75,Dancor,Adancor,Sigmart,Nicorandilum,"SG 75","2-(nicotinamido)ethyl nitrate","2(nicotinamido
)ethyl nitrate","N-(2-Hydroxyethyl)nicotinamide nitrate","N(2Hydroxyethyl)nicotinamide nitrate","2-(pyridine-3-carbonylamino)ethyl nitrate","2(pyridine3carbonylamino)ethyl nitrate",N-(2-Hydroxyeth,N(2
Hydroxyeth,T0075,SAM001246701,Prestw-106,Nicorandil,CPD000466365}

> <pdid>
PD000223

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{47528}

$$$$
NIHCC_2014
  SciTegic11012413002D

 19 20  0  0  1  0            999 V2000
    5.0987   -0.6759    0.0000 O   0  0
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.3114   -2.9665    0.0000 N   0  0
   -1.8032   -3.1233    0.0000 C   0  0
   -2.4133   -1.7530    0.0000 N   0  0
   -3.8813   -1.4408    0.0000 C   0  0  2  0  0  0
   -4.3570   -0.0307    0.0000 O   0  0
   -5.8565   -0.0702    0.0000 C   0  0  2  0  0  0
   -6.7662    1.1202    0.0000 C   0  0
   -6.1904    2.5053    0.0000 O   0  0
   -6.2823   -1.5085    0.0000 C   0  0
   -5.0460   -2.3579    0.0000 C   0  0  2  0  0  0
   -4.9973   -3.8571    0.0000 O   0  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11  7  1  0
 12 11  1  1
 12 13  1  0
 13 14  1  0
 14 15  1  1
 15 16  1  0
 14 17  1  0
 17 18  1  0
 18 12  1  0
 18 19  1  1
M  END
> <name>
NIHCC_2014

> <id>
5934

> <plate>
NGP-105-04

> <well>
G11

> <supplier_cmpd_name>
CPD000449316

> <ctcr_id>
3878

> <supplier_cmpd_id>
SAM001246964

> <smiles>
O.Nc1ncnc2c1ncn2[C@@H]3O[C@H](CO)C[C@@H]3O

> <pd_targets>
{RORC,ALOX15,TIM23,NS5B,ADORA1}

> <pathway_gtopdb>
{"Transcription factor","Nuclear receptor","Nuclear hormone receptor subfamily 1","Nuclear hormone receptor subfamily 1 group F","Nuclear hormone receptor subfamily 1 group F member 3",Enzyme,Oxidored
uctase,"Unclassified protein","Membrane receptor",Transferase,"Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Nucleotide-like receptor (family A GPCR)","Adenosine rece
ptor"}

> <pathway_chembl>
{Receptors,"Nuclear hormone receptors","1F. Retinoic acid-related orphans",Enzymes,"Eicosanoid turnover",Lipoxygenases,"G protein-coupled receptors","Adenosine receptors"}

> <pathway_reactome>
{"Gene expression (Transcription)","RNA Polymerase II Transcription","Generic Transcription Pathway","Transcriptional regulation by RUNX3","RUNX3 Regulates Immune Response and Cell Migration",Metaboli
sm,"Metabolism of lipids","Biosynthesis of specialized proresolving mediators (SPMs)","Biosynthesis of DPA-derived SPMs","Biosynthesis of DPAn-3 SPMs","Biosynthesis of DPAn-3-derived protectins and re
solvins",Disease,"Signal Transduction","Infectious disease","Signaling by GPCR","SARS-CoV Infections","GPCR ligand binding","Potential therapeutics for SARS","Class A/1 (Rhodopsin-like receptors)","Nu
cleotide-like (purinergic) receptors","Adenosine P1 receptors"}

> <broad_targets>
{}

> <broad_moa>
{"DNA inhibitor"}

> <synonyms>
{3'-deoxydenosine,3'deoxydenosine,SMR000449316,MLS000758234,MLS001423993,CHEMBL1334535,HMS2051I03,CCG-100755,CCG100755,NC00005,SAM001246964,CPD000449316}

> <pdid>
PD006989

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581797}

$$$$
NIHCC_2014
  SciTegic11012413002D

  6  5  0  0  0  0            999 V2000
    1.3000    2.2500    0.0000 O   0  0
    1.3000    0.7500    0.0000 C   0  0
    0.0007    0.0004    0.0000 O   0  0
    2.6000    0.0000    0.0000 C   0  0
    3.8993    0.7496    0.0000 Cl  0  0
    2.6000   -1.5000    0.0000 Cl  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  4  6  1  0
M  END
> <name>
NIHCC_2014

> <id>
5935

> <plate>
NGP-105-04

> <well>
H02

> <supplier_cmpd_name>
CPD000059158

> <ctcr_id>
592

> <supplier_cmpd_id>
SAM001246870

> <smiles>
OC(=O)C(Cl)Cl

> <pd_targets>
{PDK4,LMNA,LEF,PDK1,PDK2,PDK3}

> <pathway_gtopdb>
{Enzyme,"Other nuclear protein",Kinase,Protease,"Protein Kinase","Metallo protease","Atypical protein kinase group","Metallo protease MAE clan","Atypical protein kinase PDHK subfamily","Metallo protea
se M34 family"}

> <pathway_chembl>
{Enzymes,"Kinases (EC 2.7.x.x)",Atypical,"PDHK family"}

> <pathway_reactome>
{Metabolism,"Cell Cycle",Disease,"The citric acid (TCA) cycle and respiratory electron transport",Mitotic,"Infectious disease","Pyruvate metabolism and Citric Acid (TCA) cycle","M Phase","Uptake and a
ctions of bacterial toxins","Pyruvate metabolism","Mitotic Metaphase and Anaphase","Uptake and function of anthrax toxins","Regulation of pyruvate dehydrogenase (PDH) complex","Mitotic Anaphase","Nucl
ear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{}

> <broad_moa>
{"pyruvate dehydrogenase kinase inhibitor"}

> <synonyms>
{"DICHLOROACETIC ACID",79-43-6,79436,"2,2-Dichloroacetic acid","2,2Dichloroacetic acid","Dichloracetic acid","Acetic acid, dichloro-","Acetic acid, dichloro","Dichloroethanoic acid","Urner's liquid","
Dichlorethanoic acid","Bichloracetic acid","Acetic acid, 2,2-dichloro-","Acetic acid, 2,2dichloro","DCA (acid)",DICHLORO-ACE,DICHLOROACE,SAM001246870,CPD000059158}

> <pdid>
PD003025

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{6597}

$$$$
NIHCC_2014
  SciTegic11012413002D

 14 15  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -3.8971    3.7500    0.0000 Cl  0  0
   -2.5981    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 S   0  0
   -2.5800    0.0304    0.0000 O   0  0
   -1.2638   -2.2496    0.0000 O   0  0
    0.0000   -1.5000    0.0000 N   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
 10  4  1  0
 10 11  1  0
 11 12  2  0
 11 13  2  0
 11 14  1  0
 14  2  1  0
M  END
> <name>
NIHCC_2014

> <id>
5936

> <plate>
NGP-105-04

> <well>
H03

> <supplier_cmpd_name>
CPD000058392

> <ctcr_id>
5769

> <supplier_cmpd_id>
SAM001246872

> <smiles>
CC1=Nc2ccc(Cl)cc2[S](=O)(=O)N1

> <pd_targets>
{RORC,LMNA,CYP2D6,AMPC,TSHR,CYP3A4,CYP1A2,ABCC8,KCNJ11,THRB,KCNJ8,CA1,CA2,ATP1A1,KCNMA1}

> <pathway_gtopdb>
{"Transcription factor","Other nuclear protein",Enzyme,"Membrane receptor","Ion channel",Transporter,"Nuclear receptor","Cytochrome P450",Hydrolase,"Family A G protein-coupled receptor","Voltage-gated
 ion channel",Lyase,"Primary active transporter","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 2","Peptide receptor (family A GPCR)","Cytochrome P450 family 3","Cytochrome P450 family
 1","Potassium channels","P-type ATPase","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family 2D","Glycohormone receptor","Cytochrome P450 family 3A","Cytochrome P450 family 1A","Inw
ardly rectifying potassium channel","Nuclear hormone receptor subfamily 1 group A","Sodium potassium ATPase","Calcium-activated potassium channel","Nuclear hormone receptor subfamily 1 group F member 
3","Cytochrome P450 2D6","Cytochrome P450 3A4","Cytochrome P450 1A1","Nuclear hormone receptor subfamily 1 group A member 2"}

> <pathway_chembl>
{Receptors,Enzymes,"Ion channels",Transporters,"Nuclear hormone receptors","Cytochrome P450","G protein-coupled receptors","Voltage-gated ion channels","Carbonic anhydrases","P-type ATPases","1F. Reti
noic acid-related orphans","CYP2 family: drug metabolising subset","Glycoprotein hormone receptors","CYP3 family","CYP1 family","Potassium channels","1A. Thyroid hormone receptors","P2C P-type ATPases
","Inwardly rectifying potassium channels",Na<sup>+</sup>/K<sup>+</sup>-ATPases,"Calcium- and sodium-activated potassium channels"}

> <pathway_reactome>
{"Gene expression (Transcription)","Cell Cycle",Metabolism,Disease,"Metabolism of proteins","Neuronal System","Immune System","Transport of small molecules",Hemostasis,"RNA Polymerase II Transcription
",Mitotic,"Biological oxidations","Infectious disease","Metabolism of lipids","Disorders of transmembrane transporters","Post-translational protein modification","Potassium Channels","Cytokine Signali
ng in Immune system","O2/CO2 exchange in erythrocytes","Platelet homeostasis","Generic Transcription Pathway","M Phase","Phase I - Functionalization of compounds","Leishmania infection","Biosynthesis 
of specialized proresolving mediators (SPMs)","ABC transporter disorders",SUMOylation,"Inwardly rectifying K+ channels","Signaling by Interleukins","Erythrocytes take up carbon dioxide and release oxy
gen","SARS-CoV Infections","Nitric oxide stimulates guanylate cyclase","Transcriptional regulation by RUNX3","Mitotic Metaphase and Anaphase","Cytochrome P450 - arranged by substrate type","Leishmania
 parasite growth and survival","Biosynthesis of DHA-derived SPMs","Defective ABCC8 can cause hypo- and hyper-glycemias","SUMO E3 ligases SUMOylate target proteins","ATP sensitive Potassium channels","
Interleukin-12 family signaling","Potential therapeutics for SARS","cGMP effects","RUNX3 Regulates Immune Response and Cell Migration","Mitotic Anaphase",Xenobiotics,"Anti-inflammatory response favour
ing Leishmania parasite infection","Biosynthesis of maresins","SUMOylation of intracellular receptors","Interleukin-12 signaling","Nuclear Envelope (NE) Reassembly","CYP2E1 reactions","ADORA2B mediate
d anti-inflammatory cytokines production","Biosynthesis of maresin-like SPMs","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Gene and protein expression by JAK-STAT signaling afte
r Interleukin-12 stimulation","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ATP1A1,CA1,CA2,KCNJ11,KCNJ8,KCNMA1,SLC12A3}

> <broad_moa>
{"potassium channel activator"}

> <synonyms>
{364-98-7,364987,Proglycem,Eudemine,Hyperstat,Hypertonalum,Proglicem,Dizoxide,Mutabase,"7-Chloro-3-methyl-2H-1,2,4-benzothiadiazine 1,1-dioxide","7Chloro3methyl2H1,2,4benzothiadiazine 1,1dioxide",Diaz
ossido,"Sch 6783",Sch-6783,Sch6783,Diazoxido,Diazoxidum,"SRG 95213",SRG-95213,SRG95213,C8H7ClN2O2S,2H-1,2H1,2,4-Be,4Be,SAM001246872,2300206,Prestw-87,CPD000058392,DIAZOXIDE,Diazoxide}

> <pdid>
PD000067

> <targets>
{Autophagy,Potassium Channel}

> <classes>
{antihypertensive,diuretic,activates K channels and AMPA receptors,Autophagy,Membrane Transporter/Ion Channel}

> <pubchem_cids>
{3019}

$$$$
NIHCC_2014
  SciTegic11012413002D

 35 37  0  0  0  0            999 V2000
   12.0795   -6.2491    0.0000 O   0  0
   11.5667   -4.8395    0.0000 C   0  0
   10.0888   -4.5777    0.0000 C   0  0
    9.5757   -3.1673    0.0000 O   0  0
    8.0979   -2.9056    0.0000 C   0  0
    7.5847   -1.4952    0.0000 C   0  0
    6.1069   -1.2335    0.0000 N   0  0
    5.5920    0.1754    0.0000 C   0  0
    4.1145    0.4339    0.0000 C   0  0
    3.1484   -0.7186    0.0000 N   0  0
    3.6667   -2.1252    0.0000 C   0  0
    5.1442   -2.3838    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 N   0  0
    0.0000    1.7286    0.0000 C   0  0
    0.1115    3.2255    0.0000 C   0  0
   -1.1278    4.0705    0.0000 C   0  0
   -2.4793    3.4196    0.0000 C   0  0
   -2.5914    1.9238    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 S   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
   15.8798    0.7853    0.0000 O   0  0
   15.8798   -0.7147    0.0000 C   0  0
   14.5805   -1.4643    0.0000 O   0  0
   17.1798   -1.4647    0.0000 C   0  0
   18.4798   -0.7147    0.0000 C   0  0
   19.7797   -1.4647    0.0000 C   0  0
   19.7797   -2.9647    0.0000 O   0  0
   21.0790   -0.7151    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12  7  1  0
 10 13  1  0
 13 14  2  3
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 13  1  0
 27 22  1  0
 28 29  1  0
 29 30  2  0
 29 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  1  0
 33 35  2  0
M  END
> <name>
NIHCC_2014

> <id>
5937

> <plate>
NGP-105-04

> <well>
H04

> <supplier_cmpd_name>
CPD000471623

> <ctcr_id>
1142

> <supplier_cmpd_id>
SAM001246777

> <smiles>
OCCOCCN1CCN(CC1)C2=Nc3ccccc3Sc4ccccc24.OC(=O)\C=C\C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Quetiapine fumarate",Seroquel,"Seroquel XR",ZD-5077,ZD5077,"ICI 204636",ICI-204636,ICI204636,"ZM 204636",ZM-204636,ZM204636,"Seroquel XL",SCHEMBL41336,SCHEMBL41338,MLS000758301,MLS001401462,CHEMBL12
00911,FK-949E,FK949E,HMS2051P04,HMS2233D18,FK-949,FK949,AKOS025397177,CCG-100998,CCG100998,N,T6241,SAM001246777,"Quetiapine Fumarate",CPD000471623}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{6918224}

$$$$
NIHCC_2014
  SciTegic11012413002D

 18 19  0  0  1  0            999 V2000
   -3.7081   -4.9146    0.0000 C   0  0
   -2.5871   -3.9179    0.0000 C   0  0
   -1.1624   -4.3898    0.0000 O   0  0
   -0.0407   -3.3927    0.0000 C   0  0
   -0.3437   -1.9236    0.0000 O   0  0
    1.3815   -3.8637    0.0000 C   0  0
    1.8450   -5.2903    0.0000 C   0  0
    3.3450   -5.2904    0.0000 N   0  0
    3.8086   -3.8638    0.0000 C   0  0
    2.5951   -3.0039    0.0000 N   0  0
    2.5973   -1.5031    0.0000 C   0  0  2  0  0  0
    3.8976   -0.7553    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10  6  1  0
 10 11  1  0
 11 12  1  1
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
M  END
> <name>
NIHCC_2014

> <id>
5938

> <plate>
NGP-105-04

> <well>
H05

> <supplier_cmpd_name>
CPD000466277

> <ctcr_id>
4604

> <supplier_cmpd_id>
SAM001247074

> <smiles>
CCOC(=O)c1cncn1[C@H](C)c2ccccc2

> <pd_targets>
{GABRA1,GABRB2,GABRG2,ABCB11,CYP11B1,CHRNA1,CHRNB1,CHRND,CHRNG,CYP11B2,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB3,GABRD,GABRE,GABRG1,GABRG3,GABRP,GABRQ,ADRA2B,LEF,CYP1A2,RORC,CYP3A4,CYP2C19,FFP,
LMNA,CYP2C9,AMPC}

> <pathway_gtopdb>
{"Ion channel",Transporter,Enzyme,"Membrane receptor","Transcription factor","Other nuclear protein","Ligand-gated ion channel","Primary active transporter","Cytochrome P450","Family A G protein-coupl
ed receptor",Protease,"Nuclear receptor",Transferase,Hydrolase,"GABA-A receptor","ATP-binding cassette","Cytochrome P450 family 11","Nicotinic acetylcholine receptor","Small molecule receptor (family 
A GPCR)","Metallo protease","Cytochrome P450 family 1","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 3","Cytochrome P450 family 2","ABCB subfamily","Cytochrome P450 family 11B","Nicot
inic acetylcholine receptor alpha subunit","Monoamine receptor","Metallo protease MAE clan","Cytochrome P450 family 1A","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family 3A","Cyto
chrome P450 family 2C","Cytochrome P450 11B1","Cytochrome P450 11B2","Adrenergic receptor","Metallo protease M34 family","Cytochrome P450 1A1","Nuclear hormone receptor subfamily 1 group F member 3","
Cytochrome P450 3A4","Cytochrome P450 2C19","Cytochrome P450 2C9"}

> <pathway_chembl>
{Transporters,Enzymes,"Ion channels",Receptors,"ATP-binding cassette transporter family","Cytochrome P450","Ligand-gated ion channels","G protein-coupled receptors","Nuclear hormone receptors","ABCB s
ubfamily",CYP11,CYP17,CYP19,"CYP20 and CYP21 families","GABA<sub>A</sub> receptors",Adrenoceptors,"CYP1 family","1F. Retinoic acid-related orphans","CYP3 family","CYP2 family: drug metabolising subset
"}

> <pathway_reactome>
{Metabolism,"Neuronal System","Signal Transduction",Disease,"Gene expression (Transcription)","Cell Cycle","Metabolism of lipids","Biological oxidations","Transmission across Chemical Synapses","Signa
ling by GPCR","Infectious disease","RNA Polymerase II Transcription",Mitotic,"Metabolism of steroids","Phase I - Functionalization of compounds","Neurotransmitter receptors and postsynaptic signal tra
nsmission","GPCR ligand binding","Uptake and actions of bacterial toxins","Generic Transcription Pathway","Biosynthesis of specialized proresolving mediators (SPMs)","M Phase","Bile acid and bile salt
 metabolism","Cytochrome P450 - arranged by substrate type","GABA receptor activation","Class A/1 (Rhodopsin-like receptors)","Uptake and function of anthrax toxins","Transcriptional regulation by RUN
X3","Biosynthesis of DHA-derived SPMs","Mitotic Metaphase and Anaphase","Synthesis of bile acids and bile salts","Endogenous sterols","Amine ligand-binding receptors",Xenobiotics,"RUNX3 Regulates Immu
ne Response and Cell Migration","Biosynthesis of maresins","Mitotic Anaphase","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol",Adrenoceptors,"Aromatic amines can be N-hydroxylate
d or N-dealkylated by CYP1A2","Biosynthesis of maresin-like SPMs","CYP2E1 reactions","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ADRA2B,GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG3,GABRP,GABRQ}

> <broad_moa>
{"GABA receptor modulator"}

> <synonyms>
{Etomidate,33125-97-2,33125972,(+)-Etomidate,(+)Etomidate,Hypnomidate,D-Etomidate,DEtomidate,Amidate,Etomidato,Etomidatum,"(R)-ETHYL 1-(1-PHENYLETHYL)-1H-IMIDAZOLE-5-CARBOXYLATE","(R)ETHYL 1(1PHENYLET
HYL)1HIMIDAZOLE5CARBOXYLATE","ethyl 1-((1R)-1-phenylethyl)-1H-imidazole-5-carboxylate","ethyl 1((1R)1phenylethyl)1Himidazole5carboxylate","ethyl 3-((1R)-1-phenylethyl)imidazole-","ethyl 3((1R)1phenyle
thyl)imidazole",SAM001247074,CPD000466277}

> <pdid>
PD000355

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{667484}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 24  0  0  1  0            999 V2000
    2.2133   -4.7099    0.0000 C   0  0
    0.7500   -4.3800    0.0000 C   0  0
    0.2851   -2.9666    0.0000 C   0  0  2  0  0  0
   -0.6870   -2.7320    0.0000 O   0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  2  0  0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -0.8141   -2.0807    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  6
  3  5  1  0
  5  6  1  0
  7  6  1  6
  7  8  1  0
  8  9  1  1
  9 10  1  0
 10 11  1  0
 11 12  2  3
 12 13  1  0
 13 14  1  0
 14 15  1  0
 16 15  1  1
 16 11  1  0
 16 17  1  0
 17  8  1  0
 17 18  1  6
 18 19  1  0
 19 20  1  0
 20  3  1  0
 20  7  1  0
 20 21  1  6
M  END
> <name>
NIHCC_2014

> <id>
5939

> <plate>
NGP-105-04

> <well>
H06

> <supplier_cmpd_name>
CPD000238204

> <ctcr_id>
330

> <supplier_cmpd_id>
SAM001246555

> <smiles>
CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@]12C

> <pd_targets>
{PGR,AR,SLC6A4,CYP2C19,SLC6A2,ESR1,ACHE,CHRM2}

> <pathway_gtopdb>
{"Transcription factor",Transporter,Enzyme,"Membrane receptor","Nuclear receptor","Electrochemical transporter","Cytochrome P450",Hydrolase,"Family A G protein-coupled receptor","Nuclear hormone recep
tor subfamily 3","SLC superfamily of solute carriers","Cytochrome P450 family 2","Small molecule receptor (family A GPCR)","Nuclear hormone receptor subfamily 3 group C","SLC06 neurotransmitter transp
orter family","Cytochrome P450 family 2C","Nuclear hormone receptor subfamily 3 group A","Monoamine receptor","Nuclear hormone receptor subfamily 3 group C member 3","Nuclear hormone receptor subfamil
y 3 group C member 4","Cytochrome P450 2C19","Nuclear hormone receptor subfamily 3 group A member 1","Acetylcholine receptor"}

> <pathway_chembl>
{Receptors,Transporters,Enzymes,"Nuclear hormone receptors","SLC superfamily of solute carriers","Cytochrome P450","Acetylcholine turnover","G protein-coupled receptors","Steroid hormone receptors","S
LC6 neurotransmitter transporter family","CYP2 family: drug metabolising subset","Acetylcholine receptors (muscarinic)","3C. 3-Ketosteroid receptors","Monoamine transporter subfamily","3A. Estrogen re
ceptors"}

> <pathway_reactome>
{"Gene expression (Transcription)","Neuronal System",Metabolism,Disease,"Signal Transduction","RNA Polymerase II Transcription","Transmission across Chemical Synapses","Biological oxidations","Disorde
rs of transmembrane transporters","Metabolism of lipids","Signaling by GPCR","Generic Transcription Pathway","Neurotransmitter clearance","Phase I - Functionalization of compounds","SLC transporter di
sorders","Phospholipid metabolism","GPCR ligand binding","Transcriptional regulation by RUNX2","Serotonin clearance from the synaptic cleft","Cytochrome P450 - arranged by substrate type","Defective S
LC6A2 causes orthostatic intolerance (OI)","Transcriptional regulation by RUNX1","Glycerophospholipid biosynthesis","Class A/1 (Rhodopsin-like receptors)","RUNX2 regulates bone development",Xenobiotic
s,"RUNX1 regulates estrogen receptor mediated transcription","Synthesis of PC","Amine ligand-binding receptors","RUNX2 regulates osteoblast differentiation","CYP2E1 reactions","Muscarinic acetylcholin
e receptors"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{ethylestrenol,Maxibolin,Orabolin,Ethylnandrol,Ethylestrenolum,Etilestrenol,Ethyloestrenol,Neodurabolin,Duraboral,Maxibalin,Orgabolin,Orgaboral,Durabolin-O,DurabolinO,"Durabolin O",965-90-2,965902,"96
5 90 2",UNII-ADC79EK5Q8,UNIIADC79EK5Q8,UNI,SAM001246555,CPD000238204}

> <pdid>
PD003003

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{13765}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 26  0  0  0  0            999 V2000
    7.7514   -2.0652    0.0000 H   0  3
    5.2514   -2.0652    0.0000 Br  0  5
   -5.0019    0.8454    0.0000 C   0  0
   -3.5348    0.5331    0.0000 N   0  0
   -2.5311    1.6478    0.0000 C   0  0
   -3.0705   -0.8941    0.0000 C   0  0
   -1.6026   -1.2066    0.0000 C   0  0
   -1.1384   -2.6339    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
    1.8032   -3.1233    0.0000 O   0  0
    2.4133   -1.7530    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000    3.0008    0.0000 C   0  0
    0.0000    4.5008    0.0000 N   0  0
    0.7935   -4.3741    0.0000 C   0  0
   -0.1925   -5.5045    0.0000 C   0  0
    0.2934   -6.9236    0.0000 C   0  0
    1.7654   -7.2123    0.0000 C   0  0
    2.2513   -8.6314    0.0000 F   0  0
    2.7514   -6.0819    0.0000 C   0  0
    2.2654   -4.6628    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17  9  1  0
 17 12  1  0
 14 18  1  0
 18 19  3  0
  9 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 23 25  1  0
 25 26  2  0
 26 20  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5940

> <plate>
NGP-105-04

> <well>
H07

> <supplier_cmpd_name>
CPD000326936

> <ctcr_id>
2315

> <supplier_cmpd_id>
SAM001246599

> <smiles>
[H+].[Br-].CN(C)CCCC1(OCc2cc(ccc12)C#N)c3ccc(F)cc3

> <pd_targets>
{SLC6A2,SLC6A4,NET,ADRA1A,ADRA1B,KCNH2,SLC6A3,NPC1,HTR1A,ALDH1A1,MAPK1,BLM,PMP22,NPSR1,SLC22A1,HRH1,HTR2C,HTR2B,SIGMAR1,ADRA1D,CACNA1C,LMNA,RORC,ALOX15,CHRM1,CYP3A4,CYP2C9,CYP2D6,CYP2C19,NFKB1,HTR2A,A
DRA2A,ADRA2B,ADRA2C,DRD2}

> <pathway_gtopdb>
{Transporter,"Membrane receptor","Ion channel",Enzyme,"Unclassified protein","Electrochemical transporter","Family A G protein-coupled receptor","Voltage-gated ion channel",Oxidoreductase,Kinase,"SLC 
superfamily of solute carriers","Small molecule receptor (family A GPCR)","Potassium channels","Protein Kinase","Peptide receptor (family A GPCR)","Voltage-gated calcium channel","SLC06 neurotransmitt
er transporter family","Monoamine receptor","Voltage-gated potassium channel","CMGC protein kinase group","Short peptide receptor (family A GPCR)","SLC22 family of organic cation and anion transporter
s","Adrenergic receptor","Serotonin receptor","CMGC protein kinase MAPK family","Neuropeptide receptor","Histamine receptor","CMGC protein kinase ERK1","Other nuclear protein","Transcription factor","
Other cytosolic protein","Nuclear receptor","Cytochrome P450","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 3","Cytochrome P450 family 2","Nuclear hormone receptor subfamily 1 group F
","Cytochrome P450 family 3A","Cytochrome P450 family 2C","Cytochrome P450 family 2D","Nuclear hormone receptor subfamily 1 group F member 3","Acetylcholine receptor","Cytochrome P450 3A4","Cytochrome
 P450 2C9","Cytochrome P450 2D6","Cytochrome P450 2C19","Dopamine receptor"}

> <pathway_chembl>
{Transporters,Receptors,"Ion channels",Enzymes,"Other protein targets","SLC superfamily of solute carriers","G protein-coupled receptors","Voltage-gated ion channels","Kinases (EC 2.7.x.x)","Sigma rec
eptors","SLC6 neurotransmitter transporter family",Adrenoceptors,"Potassium channels","SLC65 NPC-type cholesterol transporters","5-Hydroxytryptamine receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK fa
milies","Neuropeptide S receptor","SLC22 family of organic cation and anion transporters","Histamine receptors","Voltage-gated calcium channels","Monoamine transporter subfamily","Voltage-gated potass
ium channels","Mitogen-activated protein kinases (MAP kinases)","Organic cation transporters (OCT)","ERK subfamily","Nuclear hormone receptors","Eicosanoid turnover","Cytochrome P450","1F. Retinoic ac
id-related orphans",Lipoxygenases,"Acetylcholine receptors (muscarinic)","CYP3 family","CYP2 family: drug metabolising subset","Dopamine receptors"}

> <pathway_reactome>
{"Neuronal System","Signal Transduction","Muscle contraction",Disease,"Transport of small molecules",Metabolism,"Immune System","DNA Repair","Developmental Biology","Transmission across Chemical Synap
ses","Signaling by GPCR","Cardiac conduction","Disorders of transmembrane transporters","Plasma lipoprotein assembly",remodeling,"and clearance","Biological oxidations","Innate Immune System","DNA Dou
ble-Strand Break Repair","Nervous system development","Infectious disease","SLC-mediated transmembrane transport","Neurotransmitter clearance","GPCR ligand binding","Phase 3 - rapid repolarisation","S
LC transporter disorders","Plasma lipoprotein clearance","Phase I - Functionalization of compounds","Toll-like Receptor Cascades","Homology Directed Repair","EGR2 and SOX10-mediated initiation of Schw
ann cell myelination","Leishmania infection","Transport of bile salts and organic acids","metal ions and amine compounds","SARS-CoV Infections","Axon guidance","Serotonin clearance from the synaptic c
left","Class A/1 (Rhodopsin-like receptors)","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","LDL clearance","Ethanol oxidation","Toll Like Receptor 5 (TLR5) Cascade","HDR through Ho
mologous Recombination (HRR) or Single Strand Annealing (SSA)","Leishmania parasite growth and survival","Organic cation/anion/zwitterion transport","Potential therapeutics for SARS","Defective SLC6A2
 causes orthostatic intolerance (OI)","NCAM signaling for neurite out-growth","Amine ligand-binding receptors","MyD88 cascade initiated on plasma membrane","HDR through Homologous Recombination (HRR)"
,"Anti-inflammatory response favouring Leishmania parasite infection","Organic cation transport","NCAM1 interactions",Adrenoceptors,"Serotonin receptors","MAP kinase activation","Homologous DNA Pairin
g and Strand Exchange","ADORA2B mediated anti-inflammatory cytokines production","Histamine receptors","MAPK targets/ Nuclear events mediated by MAP kinases","Presynaptic phase of homologous DNA pairi
ng and strand exchange","ERK/MAPK targets","ERKs are inactivated","Cell Cycle","Gene expression (Transcription)",Mitotic,"RNA Polymerase II Transcription","Metabolism of lipids","Cytokine Signaling in
 Immune system","M Phase","Generic Transcription Pathway","Biosynthesis of specialized proresolving mediators (SPMs)","Signaling by Interleukins","Mitotic Metaphase and Anaphase","Transcriptional regu
lation by RUNX3","Biosynthesis of DPA-derived SPMs","Biosynthesis of DHA-derived SPMs","Cytochrome P450 - arranged by substrate type","Interleukin-1 family signaling","Mitotic Anaphase","RUNX3 Regulat
es Immune Response and Cell Migration","Biosynthesis of DPAn-3 SPMs","Biosynthesis of maresins",Xenobiotics,"Interleukin-1 signaling","Nuclear Envelope (NE) Reassembly","Biosynthesis of DPAn-3-derived
 protectins and resolvins","Muscarinic acetylcholine receptors","Biosynthesis of maresin-like SPMs","CYP2E1 reactions","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Dopamine receptors","Initiation of 
Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{SLC6A4}

> <broad_moa>
{"selective serotonin reuptake inhibitor (SSRI)"}

> <synonyms>
{Celexa,AKOS026750117,MCULE-1202550254,MCULE1202550254,"MCULE 1202550254",Q-200866,Q200866,"Q 200866","citalopram hydrobromide",59729-32-7,59729327,"59729 32 7","Citalopram HBr",Cipramil,Elopram,Serop
ram,"Citalopram (hydrobromide)","Lu 10-171-","Lu 10171",SAM001246599,Prestw-692,CPD000326936,"Citalopram Hydrobromide"}

> <pdid>
PD000475

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{67107999,23657881,77995}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 25  0  0  0  0            999 V2000
   12.0827   -1.5276    0.0000 Br  0  5
    9.5953    1.1799    0.0000 C   0  0
    8.1015    1.0434    0.0000 N   0  3
    7.2002    2.2424    0.0000 C   0  0
    8.8534   -0.2546    0.0000 C   0  0
    7.8513   -1.3707    0.0000 C   0  0
    6.4990   -0.7516    0.0000 C   0  0
    6.6348    0.7294    0.0000 C   0  0
    5.1988   -1.5012    0.0000 O   0  0
    3.8990   -0.7508    0.0000 C   0  0
    3.8995    0.7492    0.0000 O   0  0
    2.5988   -1.5004    0.0000 C   0  0
    2.5993   -0.0004    0.0000 O   0  0
    2.5983   -3.0012    0.0000 C   0  0
    3.8116   -3.8613    0.0000 C   0  0
    3.3476   -5.2877    0.0000 C   0  0
    1.8476   -5.2872    0.0000 C   0  0
    1.3845   -3.8605    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  3  1  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 14  1  0
 12 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
M  CHG  2   1  -1   3   1
M  END
> <name>
NIHCC_2014

> <id>
5941

> <plate>
NGP-105-04

> <well>
H08

> <supplier_cmpd_name>
CPD000469282

> <ctcr_id>
976

> <supplier_cmpd_id>
SAM001246629

> <smiles>
[Br-].C[N+]1(C)CCC(C1)OC(=O)C(O)(C2CCCC2)c3ccccc3

> <pd_targets>
{CHRM5,CHRM1,CHRM4,CHRM3,CHRM2}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Acetylcholine receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Acetylcholine receptors (muscarinic)"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Amine ligand-binding receptors","Muscarinic acetylcholine receptors"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3,CHRM4,CHRM5}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{"RESTW 74",GLYCOPYRROLATE,596-51-0,596510,"596 51 0","glycopyrronium bromide","Glycopyrrolate bromide",Robinul,Gastrodyn,Asecryl,Nodapton,Tarodyl,Tarodyn,Copyrrolate,Cuvposa,"Glycopyrronii bromidum",
AHR-504,AHR504,"AHR 504","Bromuro de glicopirronio","Bromure de glycopyrronium",NVA-237,NVA237,"NVA 237",Rob,T2387,SAM002589987,SAM001246629,Prestw-746,Glycopyrrolate,CPD000469282}

> <pdid>
PD009604

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{11693,521843}

$$$$
NIHCC_2014
  SciTegic11012413002D

 34 33  0  0  1  0            999 V2000
   14.0972   -1.1372    0.0000 O   0  0
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0  2  0  0  0
   -3.8964   -0.7545    0.0000 C   0  0
   -5.2003    1.4932    0.0000 N   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.8003    1.4887    0.0000 C   0  0  1  0  0  0
   -7.8029    2.9887    0.0000 O   0  0
   -9.0990    0.7364    0.0000 C   0  0
  -10.4007    1.4818    0.0000 C   0  0
  -11.6971    0.7273    0.0000 C   0  0
  -11.6919   -0.7727    0.0000 C   0  0
  -12.9883   -1.5272    0.0000 O   0  0
  -10.3903   -1.5182    0.0000 C   0  0
  -10.3820   -3.0190    0.0000 N   0  0
   -9.0786   -3.7630    0.0000 C   0  0
   -9.0703   -5.2630    0.0000 O   0  0
   -9.0939   -0.7637    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    6.3972    0.7378    0.0000 O   0  0
    6.3972   -0.7622    0.0000 C   0  0
    5.0980   -1.5118    0.0000 O   0  0
    7.6972   -1.5122    0.0000 C   0  0
    8.9972   -0.7622    0.0000 C   0  0
   10.2972   -1.5122    0.0000 C   0  0
   11.5965   -0.7626    0.0000 O   0  0
   10.2972   -3.0122    0.0000 O   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  6
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  6
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 20 24  2  0
 24 15  1  0
  7 25  1  0
 25 26  2  0
 26  4  1  0
 27 28  1  0
 28 29  2  0
 28 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 32 34  1  0
M  END
> <name>
NIHCC_2014

> <id>
5942

> <plate>
NGP-105-04

> <well>
H09

> <supplier_cmpd_name>
CPD000471620

> <ctcr_id>
4303

> <supplier_cmpd_id>
SAM001246675

> <smiles>
O.COc1ccc(C[C@H](C)NC[C@@H](O)c2ccc(O)c(NC=O)c2)cc1.OC(=O)\C=C\C(=O)O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{MLS001401438,CHEMBL1895091,HMS2051P14,HMS2233M10,CCG-101038,CCG101038,NC00288,SMR000471620,SAM001246675,CPD000471620}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581795}

$$$$
NIHCC_2014
  SciTegic11012413002D

 39 44  0  0  0  0            999 V2000
    4.8086   -5.7146    0.0000 C   0  0
    4.0559   -4.4171    0.0000 C   0  0
    2.5551   -4.4192    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 N   0  0
   -0.6890   -4.0818    0.0000 C   0  0
   -0.2234   -5.5086    0.0000 C   0  0
   -1.2234   -6.6267    0.0000 C   0  0
   -0.7552   -8.0517    0.0000 C   0  0
    0.7130   -8.3588    0.0000 C   0  0
    1.7131   -7.2408    0.0000 C   0  0
    1.2449   -5.8157    0.0000 C   0  0
    1.1815   -9.7846    0.0000 C   0  0
    2.6502  -10.0894    0.0000 C   0  0
    3.1207  -11.5137    0.0000 C   0  0
    2.1224  -12.6333    0.0000 C   0  0
    0.6537  -12.3286    0.0000 C   0  0
    0.1832  -10.9042    0.0000 C   0  0
   -1.2869  -10.6024    0.0000 C   0  0
   -1.7599   -9.1790    0.0000 O   0  0
   -2.2836  -11.7235    0.0000 O   0  0
   -2.5987    1.5004    0.0000 C   0  0
   -3.9492    0.8772    0.0000 N   0  0
   -4.9539    1.9899    0.0000 C   0  0
   -6.4539    1.9875    0.0000 C   0  0
   -7.2060    3.2854    0.0000 C   0  0
   -6.4580    4.5856    0.0000 C   0  0
   -4.9580    4.5880    0.0000 C   0  0
   -4.2060    3.2901    0.0000 C   0  0
   -2.7390    2.9810    0.0000 N   0  0
   -1.6200    3.9799    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  6  1  0
 12 13  1  0
 13  4  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 18 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 26 27  1  0
 27 28  1  0
 27 29  2  0
 10 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 32  1  0
 37 38  1  0
 38 30  1  0
 38 39  1  0
M  END
> <name>
NIHCC_2014

> <id>
5943

> <plate>
NGP-105-04

> <well>
H10

> <supplier_cmpd_name>
CPD000466326

> <ctcr_id>
6179

> <supplier_cmpd_id>
SAM001246602

> <smiles>
CCCc1nc2c(C)cc(cc2n1Cc3ccc(cc3)c4ccccc4C(O)=O)c5nc6ccccc6n5C

> <pd_targets>
{PPARG,AGTR1,HSD17B10,CYP3A4,CYP2J2,CYP2C9,AGTR2,AGTR1A,AGTR1B,KDM4E,ACE,ABCB11,ALDH1A1,NPSR1,MAPK1,GLRA1,SLCO1B3,SLCO1B1,SLC47A1,ABCC3,ABCC4}

> <pathway_gtopdb>
{"Transcription factor","Membrane receptor",Enzyme,"Epigenetic regulator",Transporter,"Ion channel","Nuclear receptor","Family A G protein-coupled receptor",Oxidoreductase,"Cytochrome P450",Eraser,Pro
tease,"Primary active transporter",Kinase,"Ligand-gated ion channel","Electrochemical transporter","Nuclear hormone receptor subfamily 1","Peptide receptor (family A GPCR)","Cytochrome P450 family 3",
"Cytochrome P450 family 2","Lysine demethylase","Metallo protease","ATP-binding cassette","Protein Kinase","Glycine receptor","SLC superfamily of solute carriers","Nuclear hormone receptor subfamily 1
 group C","Short peptide receptor (family A GPCR)","Cytochrome P450 family 3A","Cytochrome P450 family 2C","Jumonji domain-containing","Metallo protease MAE clan","ABCB subfamily","CMGC protein kinase
 group","SLC21/SLCO family of organic anion transporting polypeptides","SLC47 family of multidrug and toxin extrusion transporters","ABCC subfamily","Nuclear hormone receptor subfamily 1 group C membe
r 3","Angiotensin receptor","Cytochrome P450 3A4","Cytochrome P450 2C9","Metallo protease M2 family","Neuropeptide receptor","CMGC protein kinase MAPK family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Ion channels","Nuclear hormone receptors","G protein-coupled receptors","Cytochrome P450","Chromatin modifying enzymes","Peptidases and proteinases","ATP-binding casse
tte transporter family","Kinases (EC 2.7.x.x)","Ligand-gated ion channels","SLC superfamily of solute carriers","1C. Peroxisome proliferator-activated receptors","Angiotensin receptors","CYP3 family",
"CYP2 family: drug metabolising subset","1.14.11.- Histone demethylases","MA: Metallo (M) Peptidases","ABCB subfamily","Neuropeptide S receptor","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Glycin
e receptors","SLCO family of organic anion transporting polypeptides","SLC47 family of multidrug and toxin extrusion transporters","ABCC subfamily","M2: Angiotensin-converting  (ACE and ACE2)","Mitoge
n-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Gene expression (Transcription)","Signal Transduction",Metabolism,"Metabolism of proteins",Disease,"Immune System","Neuronal System","Transport of small molecules",Hemostasis,"RNA Polymerase II Tran
scription","Signaling by GPCR","Metabolism of amino acids and derivatives","Metabolism of lipids","Biological oxidations","Peptide hormone metabolism","Infectious disease","Innate Immune System","Tran
smission across Chemical Synapses","SLC-mediated transmembrane transport","Platelet activation","signaling and aggregation","Generic Transcription Pathway","GPCR ligand binding","Branched-chain amino 
acid catabolism","Biosynthesis of specialized proresolving mediators (SPMs)","Phase I - Functionalization of compounds","Metabolism of Angiotensinogen to Angiotensins","Metabolism of steroids","Leishm
ania infection","Toll-like Receptor Cascades","Neurotransmitter receptors and postsynaptic signal transmission","Transport of bile salts and organic acids","metal ions and amine compounds","Response t
o elevated platelet cytosolic Ca2+","Transcriptional Regulation by MECP2","Class A/1 (Rhodopsin-like receptors)","Biosynthesis of DHA-derived SPMs","Cytochrome P450 - arranged by substrate type","Bile
 acid and bile salt metabolism","Ethanol oxidation","Leishmania parasite growth and survival","Toll Like Receptor 5 (TLR5) Cascade","Platelet degranulation","MECP2 regulates transcription factors","Pe
ptide ligand-binding receptors","Biosynthesis of maresins","Fatty acids",Xenobiotics,"Synthesis of bile acids and bile salts","Anti-inflammatory response favouring Leishmania parasite infection","MyD8
8 cascade initiated on plasma membrane","Recycling of bile acids and salts","Biosynthesis of maresin-like SPMs","CYP2E1 reactions","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
","ADORA2B mediated anti-inflammatory cytokines production","MAP kinase activation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{AGTR1,PPARG}

> <broad_moa>
{"angiotensin receptor antagonist"}

> <synonyms>
{Telmisartan,144701-48-4,144701484,Micardis,Pritor,"BIBR 277",Kinzalmono,BIBR-277,BIBR277,"BIBR 277SE",Telmisattan,"Telmisartan (INN)",UNII-U5SYW473RQ,UNIIU5SYW473RQ,BIBR-277SE,BIBR277SE,BIBR-277-SE,C
33H30N4O2,MFCD00918125,CHEMBL1017,U5SYW473RQ,"BIBR 277 SE",CHEBI:9434,tolura,NCGC000951,T1570,SAM001246602,1505261,Prestw-1350,CPD000466326,TELMISARTAN}

> <pdid>
PD000538

> <targets>
{}

> <classes>
{antihypertensive,"angiotensin II blocker"}

> <pubchem_cids>
{65999}

$$$$
NIHCC_2014
  SciTegic11012413002D

 35 35  0  0  0  0            999 V2000
   23.1895   -2.2533    0.0000 O   0  0
    1.2948   -3.7516    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    3.8934   -5.2570    0.0000 C   0  0
    5.1924   -6.0070    0.0000 C   0  0
    6.4915   -5.2571    0.0000 C   0  0
    7.7928   -6.0048    0.0000 C   0  0
    9.0914   -5.2526    0.0000 C   0  0
   10.3931   -5.9981    0.0000 C   0  0
   11.6896   -5.2436    0.0000 C   0  0
   11.6844   -3.7436    0.0000 C   0  0
   10.3828   -2.9981    0.0000 C   0  0
    9.0864   -3.7526    0.0000 C   0  0
    6.4915   -3.7571    0.0000 C   0  0
    5.1925   -3.0070    0.0000 C   0  0
   18.0896   -0.3783    0.0000 O   0  0
   18.0896   -1.8783    0.0000 C   0  0
   16.7896   -2.6283    0.0000 C   0  0
   16.7896   -4.1283    0.0000 O   0  0
   15.4896   -1.8783    0.0000 C   0  0
   14.1903   -2.6279    0.0000 O   0  0
   15.4896   -0.3783    0.0000 O   0  0
   19.3895   -2.6283    0.0000 C   0  0
   20.6888   -1.8788    0.0000 O   0  0
   19.3895   -4.1283    0.0000 O   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12  6  1  0
  3 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 16 24  1  0
 24 25  1  0
 25 13  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 28 30  1  0
 30 31  2  0
 30 32  1  0
 27 33  1  0
 33 34  2  0
 33 35  1  0
M  END
> <name>
NIHCC_2014

> <id>
5944

> <plate>
NGP-105-04

> <well>
H11

> <supplier_cmpd_name>
CPD000449296

> <ctcr_id>
2074

> <supplier_cmpd_id>
SAM001246980

> <smiles>
O.CC(C(O)c1ccc(O)cc1)N2CCC(Cc3ccccc3)CC2.OC(C(O)C(=O)O)C(=O)O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{SMR000449296,CPD000449296,MLS000758307,MLS001401411,CHEMBL1597876,HMS2051K17,HMS2231G24,HMS3370G01,HMS3393K17,CCG-100812,CCG100812,NC00062,SAM001246980}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581801}

$$$$
NIHCC_2014
  SciTegic11012413002D

 11 11  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 C   0  0
   -3.8976   -0.7554    0.0000 O   0  0
   -2.5951   -3.0031    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  8  2  1  0
  7  9  1  0
  9 10  1  0
  9 11  2  0
M  END
> <name>
NIHCC_2014

> <id>
5945

> <plate>
NGP-105-05

> <well>
A02

> <supplier_cmpd_name>
CPD000145728

> <ctcr_id>
2249

> <supplier_cmpd_id>
SAM001247020

> <smiles>
Nc1ccc(O)c(c1)C(O)=O

> <pd_targets>
{RECQL,TDP1,CYP2C19,FFP,CASP1,CYP3A4,CYP2C9,EGFR,THRB,HSD17B10,KDM4E,ALDH1A1,ALOX15,ALD,KMT2A,MEN1,HSPD1,HSPE1,PTGS2,TNF,GROES,GROL,HIF1A,BRCA1,HPGD,TST,CASP7,HAO1,PTGS1,PPARG,ALOX5,CHUK,IKBKB}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Epigenetic regulator","Other cytosolic protein","Secreted protein","Unclassified protein",Hydrolase,"Cytochrome P450",Transferase,Protease,Kinase,"Nuclear receptor",Oxi
doreductase,Eraser,Reader,"Cytochrome P450 family 2","Cysteine protease","Cytochrome P450 family 3","Protein Kinase","Nuclear hormone receptor subfamily 1","Lysine demethylase",Bromodomain,"Cytochrome
 P450 family 2C","Cysteine protease CD clan","Cytochrome P450 family 3A","TK protein kinase group","Nuclear hormone receptor subfamily 1 group A","Jumonji domain-containing","Nuclear hormone receptor 
subfamily 1 group C","Other protein kinase group","Cytochrome P450 2C19","Cysteine protease C14 family","Cytochrome P450 3A4","Cytochrome P450 2C9","Tyrosine protein kinase EGFR family","Nuclear hormo
ne receptor subfamily 1 group A member 2","Nuclear hormone receptor subfamily 1 group C member 3","Other protein kinase IKK family"}

> <pathway_chembl>
{Enzymes,Receptors,"Cytochrome P450","Peptidases and proteinases","Catalytic receptors","Nuclear hormone receptors","Chromatin modifying enzymes","Eicosanoid turnover","CYP2 family: drug metabolising 
subset","CD: Cysteine (C) Peptidases","CYP3 family","Receptor kinases","1A. Thyroid hormone receptors","1.14.11.- Histone demethylases",Lipoxygenases,Cyclooxygenase,"Prostaglandin synthases","1C. Pero
xisome proliferator-activated receptors","C14: Caspase","TK: Tyrosine kinase","Other protein kinases","Receptor tyrosine kinases (RTKs)","IKK family","Type I RTKs: ErbB (epidermal growth factor) recep
tor family"}

> <pathway_reactome>
{"DNA Repair",Metabolism,"Gene expression (Transcription)","Signal Transduction","Metabolism of proteins","Immune System","Cellular responses to external stimuli","Programmed Cell Death","DNA Double-S
trand Break Repair","Biological oxidations","RNA Polymerase II Transcription","Metabolism of lipids","Signaling by GPCR","Post-translational protein modification","Metabolism of amino acids and deriva
tives","Cytokine Signaling in Immune system","Cellular responses to stress",Apoptosis,"Innate Immune System","Nonhomologous End-Joining (NHEJ)","Phase I - Functionalization of compounds","Generic Tran
scription Pathway","Biosynthesis of specialized proresolving mediators (SPMs)","GPCR downstream signalling",SUMOylation,"Branched-chain amino acid catabolism","Signaling by Interleukins","Cellular res
ponse to hypoxia","Homology Directed Repair","Sulfur amino acid metabolism","Intrinsic Pathway for Apoptosis","Glyoxylate metabolism and glycine degradation","Fatty acid metabolism","Toll-like Recepto
r Cascades","Cytochrome P450 - arranged by substrate type","Transcriptional Regulation by TP53","Biosynthesis of DHA-derived SPMs","G alpha (q) signalling events","SUMO E3 ligases SUMOylate target pro
teins","Ethanol oxidation","Biosynthesis of DPA-derived SPMs","Interleukin-10 signaling","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","HDR through Homologous Recombinatio
n (HRR) or Single Strand Annealing (SSA)","Degradation of cysteine and homocysteine","Apoptotic factor-mediated response","Arachidonic acid metabolism","Transcriptional Regulation by MECP2","Toll Like
 Receptor 4 (TLR4) Cascade",Xenobiotics,"TP53 Regulates Transcription of Cell Death Genes","Biosynthesis of maresins","Gastrin-CREB signalling pathway via PKC and MAPK","SUMOylation of intracellular r
eceptors","Biosynthesis of DPAn-3 SPMs","HDR through Homologous Recombination (HRR)","Biosynthesis of D-series resolvins","Sulfide oxidation to sulfate","Cytochrome c-mediated apoptotic response","Syn
thesis of Prostaglandins (PG) and Thromboxanes (TX)","MECP2 regulates transcription factors","MyD88-independent TLR4 cascade","CYP2E1 reactions","TP53 Regulates Transcription of Caspase Activators and
 Caspases","Biosynthesis of maresin-like SPMs","EGFR Transactivation by Gastrin","Biosynthesis of DPAn-3-derived protectins and resolvins","Homologous DNA Pairing and Strand Exchange","Activation of c
aspases through apoptosome-mediated cleavage","Biosynthesis of DPAn-3-derived 13-series resolvins","TRIF(TICAM1)-mediated TLR4 signaling","Presynaptic phase of homologous DNA pairing and strand exchan
ge","IKK complex recruitment mediated by RIP1"}

> <broad_targets>
{ALOX5,CHUK,IKBKB,MPO,PPARG,PTGS1,PTGS2}

> <broad_moa>
{"cyclooxygenase inhibitor","lipoxygenase inhibitor","prostanoid receptor antagonist"}

> <synonyms>
{"5Aminosalicylic acid",mesalamine,Mesalazine,"5-Amino-2-hydroxybenzoic acid","5Amino2hydroxybenzoic acid",89-57-6,89576,Asacol,Pentasa,Claversal,Canasa,5-ASA,5ASA,Salofalk,Rowasa,"m-Aminosalicylic ac
id","mAminosalicylic acid",Mesasal,Lialda,"Benzoic acid, 5-amino-2-hydroxy-","Benzoic acid, 5amino2hydroxy",Fisalamine,Lixacol,Apriso,p-Am,pAm,T0646,SAM001247020,Prestw-1069,Mesalamine,CPD000145728}

> <pdid>
PD000235

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{4075}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 23  0  0  0  0            999 V2000
   13.3108   -2.6982    0.0000 O   0  0
   10.8108   -2.6982    0.0000 Cl  0  0
    8.3099   -1.7900    0.0000 C   0  0
    6.8229   -1.9866    0.0000 O   0  0
    6.2485   -3.3732    0.0000 C   0  0
    7.1641   -4.5614    0.0000 C   0  0
    6.5930   -5.9484    0.0000 C   0  0
    7.5086   -7.1365    0.0000 N   0  0
    5.1062   -6.1472    0.0000 C   0  0
    4.5350   -7.5342    0.0000 Cl  0  0
    4.1906   -4.9591    0.0000 C   0  0
    4.7617   -3.5720    0.0000 C   0  0
    3.8432   -2.3851    0.0000 C   0  0
    4.4120   -0.9971    0.0000 O   0  0
    2.3559   -2.5861    0.0000 N   0  0
    1.4440   -1.4074    0.0000 C   0  0
    1.1881    0.0000    0.0000 C   0  0
    0.0000    0.5484    0.0000 N   0  0
   -1.5537    0.0000    0.0000 C   0  0
   -1.3709   -1.4257    0.0000 C   0  0
    0.1097   -0.7860    0.0000 C   0  0
    0.3656    1.0236    0.0000 C   0  0
    0.0000    2.1386    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  7  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12  5  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 16  1  0
 21 22  1  0
 22 23  1  0
 23 18  1  0
M  END
> <name>
NIHCC_2014

> <id>
5946

> <plate>
NGP-105-05

> <well>
A03

> <supplier_cmpd_name>
CPD000449271

> <ctcr_id>
292

> <supplier_cmpd_id>
SAM001247069

> <smiles>
O.Cl.COc1cc(N)c(Cl)cc1C(=O)NC2CN3CCC2CC3

> <pd_targets>
{MAPK1,HTR3A,HTR3B,HTR4,HTR5A,HTR3C,HTR3D,HTR3E,CHRNA7,HTR2A,HTR2B,HTR2C,CYP2C19,CYP2D6,CYP2C9,KMT2A,MEN1}

> <pathway_gtopdb>
{Enzyme,"Ion channel","Membrane receptor",Kinase,"Ligand-gated ion channel","Family A G protein-coupled receptor","Protein Kinase","5HT3 receptor","Small molecule receptor (family A GPCR)","Nicotinic 
acetylcholine receptor","CMGC protein kinase group","Monoamine receptor","Nicotinic acetylcholine receptor alpha subunit","CMGC protein kinase MAPK family","Serotonin receptor","CMGC protein kinase ER
K1","Epigenetic regulator","Cytochrome P450",Reader,"Cytochrome P450 family 2",Bromodomain,"Cytochrome P450 family 2C","Cytochrome P450 family 2D","Cytochrome P450 2C19","Cytochrome P450 2D6","Cytochr
ome P450 2C9"}

> <pathway_chembl>
{Enzymes,"Ion channels",Receptors,"Kinases (EC 2.7.x.x)","Ligand-gated ion channels","G protein-coupled receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK families","5-HT<sub>3</sub> receptors","5-Hydro
xytryptamine receptors","Nicotinic acetylcholine receptors","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily","Cytochrome P450","CYP2 family: drug metabolising subset"}

> <pathway_reactome>
{"Immune System","Neuronal System",Disease,"Signal Transduction","Innate Immune System","Transmission across Chemical Synapses","Infectious disease","Signaling by GPCR","Toll-like Receptor Cascades","
Neurotransmitter receptors and postsynaptic signal transmission","Leishmania infection","GPCR ligand binding","Toll Like Receptor 5 (TLR5) Cascade","Leishmania parasite growth and survival","Class A/1
 (Rhodopsin-like receptors)","Acetylcholine binding and downstream events","MyD88 cascade initiated on plasma membrane","Anti-inflammatory response favouring Leishmania parasite infection","Amine liga
nd-binding receptors","Postsynaptic nicotinic acetylcholine receptors","MAP kinase activation","ADORA2B mediated anti-inflammatory cytokines production","Serotonin receptors","Highly calcium permeable
 postsynaptic nicotinic acetylcholine receptors","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated",Metabolism,"Biological oxidations","Phase I - Function
alization of compounds","Cytochrome P450 - arranged by substrate type",Xenobiotics,"CYP2E1 reactions"}

> <broad_targets>
{HTR3A,HTR3B,HTR4,HTR5A}

> <broad_moa>
{"serotonin receptor antagonist"}

> <synonyms>
{"Zacopride hydrochloride hydrate",99617-34-2,99617342,AHR-11190-B,AHR11190B,"Zacopride HCl",SMR000449271,"Zacopride hydrochloride (USAN:INN)",MLS000758244,MLS001423969,SCHEMBL9598323,"Zacopride hydro
chloride (USAN)",CHEMBL1516756,CCG-100753,CCG100753,NC00003,D06353,Zacopri,T5336,SAM001247069,"Zacopride hydrochloride",CPD000449271}

> <pdid>
PD014511

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{19849157}

$$$$
NIHCC_2014
  SciTegic11012413002D

 31 33  0  0  0  0            999 V2000
    7.5844   -1.4920    0.0000 C   0  0
    6.1069   -1.2335    0.0000 N   0  0
    5.5920    0.1754    0.0000 C   0  0
    4.1145    0.4339    0.0000 C   0  0
    3.1484   -0.7186    0.0000 N   0  0
    3.6667   -2.1252    0.0000 C   0  0
    5.1442   -2.3838    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 N   0  0
    0.0000    1.7286    0.0000 C   0  0
    0.1115    3.2255    0.0000 C   0  0
   -1.1278    4.0705    0.0000 C   0  0
   -2.4793    3.4196    0.0000 C   0  0
   -2.5914    1.9238    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 O   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -5.4558    0.0000 Cl  0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
   11.3852    1.1820    0.0000 O   0  0
   11.3852   -0.3180    0.0000 C   0  0
   10.0859   -1.0675    0.0000 O   0  0
   12.6852   -1.0680    0.0000 C   0  0
   13.9852   -0.3180    0.0000 C   0  0
   15.2851   -1.0680    0.0000 C   0  0
   15.2851   -2.5680    0.0000 O   0  0
   16.5844   -0.3184    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  2  1  0
  5  8  1  0
  8  9  2  3
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 20 22  1  0
 22 23  2  0
 23  8  1  0
 23 17  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 29 31  2  0
M  END
> <name>
NIHCC_2014

> <id>
5947

> <plate>
NGP-105-05

> <well>
A04

> <supplier_cmpd_name>
CPD000058470

> <ctcr_id>
3983

> <supplier_cmpd_id>
SAM001247061

> <smiles>
CN1CCN(CC1)C2=Nc3ccccc3Oc4ccc(Cl)cc24.OC(=O)CCC(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Loxapine succinate",27833-64-3,27833643,"Loxapine succinate salt",Cloxazepin,Loxapac,"Loxapine (succinate)",UNII-X59SG0MRYU,UNIIX59SG0MRYU,"Loxapine,succinate","CL 71563",X59SG0MRYU,CPD000058470,C22
H24ClN3O5,MLS000069383,Daxolin,MFCD00069298,NCGC00016160-02,NCGC0001616002,T1412,SAM001247061,2300242,Prestw-132,"LOXAPINE SUCCINATE"}

> <pdid>

> <targets>
{}

> <classes>
{antipsychotic}

> <pubchem_cids>
{71399,25137852}

$$$$
NIHCC_2014
  SciTegic11012413002D

 42 46  0  0  1  0            999 V2000
    7.7003    1.3595    0.0000 Br  0  5
    3.8964    0.7545    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    5.1996   -1.4928    0.0000 O   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0  2  0  0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0
   -6.5611    2.3779    0.0000 C   0  0
   -3.8971    3.7500    0.0000 C   0  0  1  0  0  0
   -4.2297    5.2071    0.0000 C   0  0
   -5.7225    5.3543    0.0000 C   0  0
   -6.3238    3.9802    0.0000 C   0  0
   -7.7858    3.6531    0.0000 O   0  0
   -8.2353    2.2211    0.0000 C   0  0
   -9.6991    1.8937    0.0000 O   0  0
   -7.2201    1.1168    0.0000 C   0  0
   -6.4798    6.6471    0.0000 N   0  3
   -5.7355    7.9494    0.0000 C   0  0
   -7.1813    5.3443    0.0000 C   0  0
   -8.6813    5.3363    0.0000 C   0  0
   -9.4382    6.6313    0.0000 C   0  0
   -8.6952    7.9343    0.0000 C   0  0
   -7.1952    7.9423    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    0.0000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0002   -3.0008    0.0000 N   0  3
   -1.3008   -3.7481    0.0000 C   0  0
    1.2638   -2.2315    0.0000 C   0  0
    2.5620   -2.9829    0.0000 C   0  0
    2.5603   -4.4829    0.0000 C   0  0
    1.2605   -5.2315    0.0000 C   0  0
   -0.0378   -4.4800    0.0000 C   0  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  6  5  1  6
  6  7  1  0
  8  7  1  1
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  1
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 17 11  1  0
 17 18  1  1
 18 19  1  0
 19 20  1  0
 20 15  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 19 25  1  0
 25 26  1  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 25  1  0
 12 32  1  0
 32  8  1  0
 32 33  1  0
 32 34  1  0
 34 35  1  0
 35  6  1  0
 35 36  1  0
 36 37  1  0
 36 38  1  0
 38 39  1  0
 39 40  1  0
 40 41  1  0
 41 42  1  0
 42 36  1  0
M  CHG  3   1  -1  25   1  36   1
M  END
> <name>
NIHCC_2014

> <id>
5948

> <plate>
NGP-105-05

> <well>
A05

> <supplier_cmpd_name>
CPD000466270

> <ctcr_id>
5782

> <supplier_cmpd_id>
SAM001247003

> <smiles>
[Br-].CC(=O)O[C@H]1C[C@@H]2CCC3[C@H](CCC4(C)[C@H]3CC(C4OC(=O)C)[N+]5(C)CCCCC5)C2(C)CC1[N+]6(C)CCCCC6

> <pd_targets>
{RAD52,LMNA,KCNN1,KCNN2,KCNN3,MTOR,CHRNA1,CHRNB1,CHRND,CHRNE,CHRNG,CHRNA2,CHRM2,CHRM3}

> <pathway_gtopdb>
{"Other nuclear protein","Ion channel",Enzyme,"Membrane receptor","Voltage-gated ion channel",Kinase,"Ligand-gated ion channel","Family A G protein-coupled receptor","Potassium channels","Protein Kina
se","Nicotinic acetylcholine receptor","Small molecule receptor (family A GPCR)","Calcium-activated potassium channel","Atypical protein kinase group","Nicotinic acetylcholine receptor alpha subunit",
"Monoamine receptor","Atypical protein kinase PIKK family","Acetylcholine receptor","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Enzymes,"Ion channels",Receptors,"Kinases (EC 2.7.x.x)","Ligand-gated ion channels","G protein-coupled receptors",Atypical,"Nicotinic acetylcholine receptors","Acetylcholine receptors (muscarinic)","
Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","FRAP subfamily"}

> <pathway_reactome>
{"DNA Repair","Cell Cycle","Gene expression (Transcription)","Neuronal System","Signal Transduction","DNA Double-Strand Break Repair",Mitotic,"RNA Polymerase II Transcription","Transmission across Che
mical Synapses","Signaling by GPCR","Homology Directed Repair","M Phase","Generic Transcription Pathway","Neurotransmitter receptors and postsynaptic signal transmission","GPCR ligand binding","HDR th
rough Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Mitotic Metaphase and Anaphase","Transcriptional Regulation by TP53","Acetylcholine binding and downstream events","Class A/1 (R
hodopsin-like receptors)","HDR through Single Strand Annealing (SSA)","Mitotic Anaphase","Regulation of TP53 Activity","Postsynaptic nicotinic acetylcholine receptors","Amine ligand-binding receptors"
,"Nuclear Envelope (NE) Reassembly","Regulation of TP53 Expression and Degradation","Highly calcium permeable postsynaptic nicotinic acetylcholine receptors","Muscarinic acetylcholine receptors","Init
iation of Nuclear Envelope (NE) Reformation","Regulation of TP53 Degradation"}

> <broad_targets>
{CHRM2,CHRM3,CHRNA1,CHRNA2}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{MLS001401382,SMR000466270,MLS000758214,HMS2051E07,HMS2233M21,CCG-100769,CCG100769,SAM001247003,CPD000466270}

> <pdid>
PD009549

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23641206}

$$$$
NIHCC_2014
  SciTegic11012413002D

 43 51  0  0  1  0            999 V2000
    1.1714   -4.2487    0.0000 C   0  0
   -0.1286   -3.5003    0.0000 C   0  0
   -1.4265   -4.2524    0.0000 C   0  0
   -0.1300   -2.0000    0.0000 C   0  0  2  0  0  0
   -1.6000   -1.2300    0.0000 C   0  0  1  0  0  0
   -0.6200   -0.7100    0.0000 O   0  0
    0.3900   -0.7100    0.0000 C   0  0
    0.7526    0.7455    0.0000 O   0  0
    1.3500   -1.2200    0.0000 C   0  0  2  0  0  0
    1.3700    0.3200    0.0000 C   0  0  2  0  0  0
    2.7930   -0.1545    0.0000 O   0  0
    2.2900    1.5800    0.0000 C   0  0
    1.4000    2.8300    0.0000 C   0  0  1  0  0  0
    0.2300    3.9100    0.0000 O   0  0
   -0.1100    2.3500    0.0000 C   0  0  2  0  0  0
   -1.6100    2.8400    0.0000 C   0  0
   -2.0771    4.2654    0.0000 O   0  0
   -2.5200    1.5700    0.0000 O   0  0
   -1.6100    0.3100    0.0000 C   0  0  1  0  0  0
   -0.1100    0.7900    0.0000 C   0  0  2  0  0  0
   -0.1089   -0.2100    0.0000 C   0  0
    8.9804   -3.8766    0.0000 C   0  0
    7.6820   -3.1255    0.0000 C   0  0
    7.6809   -4.6255    0.0000 C   0  0
    6.3825   -3.8748    0.0000 O   0  0
    7.6837   -1.6252    0.0000 C   0  0  2  0  0  0
    6.2137   -0.8552    0.0000 C   0  0  1  0  0  0
    7.1937   -0.3352    0.0000 O   0  0
    8.2037   -0.3352    0.0000 C   0  0
    8.5663    1.1203    0.0000 O   0  0
    9.1637   -0.8452    0.0000 C   0  0  2  0  0  0
    9.1837    0.6948    0.0000 C   0  0  2  0  0  0
   10.6067    0.2204    0.0000 O   0  0
   10.1037    1.9548    0.0000 C   0  0
    9.2137    3.2048    0.0000 C   0  0  1  0  0  0
    8.0437    4.2848    0.0000 O   0  0
    7.7037    2.7248    0.0000 C   0  0  2  0  0  0
    6.2037    3.2148    0.0000 C   0  0
    5.7366    4.6403    0.0000 O   0  0
    5.2937    1.9448    0.0000 O   0  0
    6.2037    0.6848    0.0000 C   0  0  1  0  0  0
    7.7037    1.1648    0.0000 C   0  0  2  0  0  0
    7.7048    0.1648    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  4  2  1  6
  4  5  1  0
  5  6  1  1
  6  7  1  0
  7  8  2  0
  9  7  1  1
  9  4  1  0
  9 10  1  0
 10 11  1  6
 10 12  1  0
 13 12  1  6
 13 14  1  0
 15 14  1  6
 15 13  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 19 18  1  1
 19  5  1  0
 19 20  1  0
 20 10  1  0
 20 15  1  0
 20 21  1  6
 22 23  1  0
 23 24  1  0
 23 25  1  0
 26 23  1  6
 26 27  1  0
 27 28  1  1
 28 29  1  0
 29 30  2  0
 31 29  1  1
 31 26  1  0
 31 32  1  0
 32 33  1  6
 32 34  1  0
 35 34  1  6
 35 36  1  0
 37 36  1  6
 37 35  1  0
 37 38  1  0
 38 39  2  0
 38 40  1  0
 41 40  1  1
 41 27  1  0
 41 42  1  0
 42 32  1  0
 42 37  1  0
 42 43  1  6
M  END
> <name>
NIHCC_2014

> <id>
5949

> <plate>
NGP-105-05

> <well>
A06

> <supplier_cmpd_name>
CPD000469289

> <ctcr_id>
1384

> <supplier_cmpd_id>
SAM001246993

> <smiles>
CC(=C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]3(O)C[C@H]4O[C@]45C(=O)O[C@H]2[C@]35C.CC(C)(O)[C@@H]6[C@H]7OC(=O)[C@@H]6[C@]8(O)C[C@H]9O[C@]9%10C(=O)O[C@H]7[C@]8%10C

> <pd_targets>
{HTR3A,HTR3B,GLRA1,GLRA2,GLRA3,GLRB,GABRA1,GABRA3,GABRA6,GABRG2,GABRA5,GABRA2,GABRB1,GABRB3,GABRB2,GABRG1,GABRG3,GABRD,GABRE,GABRQ,GABRP,GABRR1,GABRR2,GABRR3,GABRA4}

> <pathway_gtopdb>
{"Ion channel","Ligand-gated ion channel","5HT3 receptor","Glycine receptor","GABA-A receptor"}

> <pathway_chembl>
{"Ion channels","Ligand-gated ion channels","5-HT<sub>3</sub> receptors","Glycine receptors","GABA<sub>A</sub> receptors"}

> <pathway_reactome>
{"Neuronal System","Transmission across Chemical Synapses","Neurotransmitter receptors and postsynaptic signal transmission","GABA receptor activation"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"ICROTIN  PICROTOXINI",PICROTOXIN,"Picrotin - Picrotoxinin","Picrotin  Picrotoxinin",Sesquiterpene,Cocculin,124-87-8,124878,UNII-ZLT174DL7U,UNIIZLT174DL7U,ZLT174DL7U,Lopac0_000916,Lopac0000916,Lopac0
-000916,"Lopac0 000916",SCHEMBL28587,MLS001423995,CHEMBL506977,HMS2051E09,HMS2235M10,HMS3262H14,Tox21_500916,Tox21500916,Tox21-500916,"Tox21 500916",AKOS024456403,CCG-100777,CCG100777,LP00916,N,SAM001
246993,CPD000469289}

> <pdid>
PD002652

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{6473767}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 28  0  0  0  0            999 V2000
    3.2900   -2.6972    0.0000 Cl  0  0
    2.3258   -1.5481    0.0000 C   0  0
    2.8388   -0.1385    0.0000 C   0  0
    1.8747    1.0105    0.0000 C   0  0
    0.3975    0.7500    0.0000 C   0  0
   -0.1156   -0.6595    0.0000 C   0  0
    0.8486   -1.8086    0.0000 C   0  0
    0.8486   -3.3094    0.0000 C   0  0
   -0.4507   -4.0606    0.0000 N   0  0
   -0.0728   -5.4990    0.0000 C   0  0
   -1.3443   -6.2947    0.0000 C   0  0
   -2.4940   -5.3313    0.0000 N   0  0
   -1.9330   -3.9401    0.0000 C   0  0
    2.1485   -4.0593    0.0000 C   0  0
    2.1490   -5.5594    0.0000 C   0  0
    3.4483   -6.3089    0.0000 C   0  0
    4.7471   -5.5585    0.0000 C   0  0
    4.7466   -4.0585    0.0000 C   0  0
    3.4473   -3.3089    0.0000 C   0  0
   -0.4513   -2.5594    0.0000 C   0  0
   -1.7501   -3.3098    0.0000 C   0  0
   -3.0494   -2.5603    0.0000 C   0  0
   -3.0499   -1.0603    0.0000 C   0  0
   -1.7511   -0.3098    0.0000 C   0  0
   -0.4518   -1.0594    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  9  1  0
  8 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
  8 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
M  END
> <name>
NIHCC_2014

> <id>
5950

> <plate>
NGP-105-05

> <well>
A07

> <supplier_cmpd_name>
CPD000058306

> <ctcr_id>
6877

> <supplier_cmpd_id>
SAM001247056

> <smiles>
Clc1ccccc1C(n2ccnc2)(c3ccccc3)c4ccccc4

> <pd_targets>
{CYP8B1,CYP2C19,RORC,KMT2A,MEN1,BLM,NPSR1,ADRB2,AMPC,CYP17A1,ABCB1,NR1I3,CYP3A4,NFKB1,CYP1A2,ADRA1A,CYP121,KCNN4,HIF1A,TP53,SKA,CYP2C9,CYP125,CYP130,CYP2C8,FTL,MAPK1,CYP2D6,HMOX1,L3MBTL1,KCNH2,LMNA,HT
T,VCP,MAPT,USP2,THPO,CYP142,NFO,CHRM1,CYP19A1,PYK,PGR,HTR1B,ATP2A1,CYP51,AR,GMNN,CYP144,MDH1,CYP51B,ATP4A,ATP4B,TSHR,PMP22,ALOX15,GLA,NR1H4,ABCB1A,ABCB1B,ADRA2B,CA2,DRD2,DRD4,CYSLTR1,CHRM2,CHRM4,OPRK1
,PTAFR,HTR2A,HTR6,SLC6A4,TACR2,AVPR2,CACNA1C,ADORA1,ADRB1,HRH1,HTR1A,IDO1,SLC22A1,ADORA2A,ADRA2A,ADRB3,OPRD1,HTR2B,TACR1,CXCR1,ADORA3,DRD3,CHRM3,ADRA1D,NR3C1,FYN,HRH2,OPRM1,HTR2C,TBXAS1,CCR4,KCNA3,SLC
6A2,PTGS2,SLC6A3,ERBB2,IDO2,CYP51A1,ACHE,EGFR,TRPM2,TRPM4,TRPM8,NR1I2,ERG11,HCAR2}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Epigenetic regulator","Membrane receptor",Transporter,"Other cytosolic protein","Ion channel","Unclassified protein","Other nuclear protein",Oxidoreductase,"Cytochrome 
P450","Nuclear receptor",Reader,"Family A G protein-coupled receptor",Hydrolase,"Primary active transporter","Voltage-gated ion channel",Kinase,Protease,Transferase,Lyase,"Electrochemical transporter"
,"Cytochrome P450 family 2","Nuclear hormone receptor subfamily 1",Bromodomain,"Peptide receptor (family A GPCR)","Small molecule receptor (family A GPCR)","Cytochrome P450 family 17","ATP-binding cas
sette","Cytochrome P450 family 3","Cytochrome P450 family 1","Potassium channels","Protein Kinase","Methyl-lysine/arginine binding protein","Endoplasmic reticular retrotranslocon family","Cysteine pro
tease","Serine protease","Cytochrome P450 family 19","Nuclear hormone receptor subfamily 3","P-type ATPase","Cytochrome P450 family 51","SLC superfamily of solute carriers","Voltage-gated calcium chan
nel","Cytochrome P450 family 5","Transient receptor potential channel","Cytochrome P450 family 2C","Nuclear hormone receptor subfamily 1 group F","Short peptide receptor (family A GPCR)","Monoamine re
ceptor","Cytochrome P450 family 17A","ABCB subfamily","Nuclear hormone receptor subfamily 1 group I","Cytochrome P450 family 3A","Cytochrome P450 family 1A","Calcium-activated potassium channel","CMGC
 protein kinase group","Cytochrome P450 family 2D","MBT domain","Voltage-gated potassium channel","Cysteine protease CA clan","Serine protease PA clan","Cytochrome P450 family 19A","Nuclear hormone re
ceptor subfamily 3 group C","Calcium ATPase","Cytochrome P450 family 51A","Hydrogen potassium ATPase","Glycohormone receptor","Nuclear hormone receptor subfamily 1 group H","Lipid-like ligand receptor
 (family A GPCR)","SLC06 neurotransmitter transporter family","Nucleotide-like receptor (family A GPCR)","SLC22 family of organic cation and anion transporters","Chemokine receptor","TK protein kinase
 group","Cytochrome P450 family 5A","Carboxylic acid receptor","Cytochrome P450 2C19","Nuclear hormone receptor subfamily 1 group F member 3","Neuropeptide receptor","Adrenergic receptor","Cytochrome 
P450 17A1","Nuclear hormone receptor subfamily 1 group I member 3","Cytochrome P450 3A4","Cytochrome P450 1A1","Cytochrome P450 2C9","Cytochrome P450 2C8","CMGC protein kinase MAPK family","Cytochrome
 P450 2D6","Cysteine protease C19 family","Serine protease S1A subfamily","Acetylcholine receptor","Cytochrome P450 19A1","Nuclear hormone receptor subfamily 3 group C member 3","Serotonin receptor","
Cytochrome P450 51A1","Nuclear hormone receptor subfamily 3 group C member 4","Nuclear hormone receptor subfamily 1 group H member 4","Dopamine receptor","Leukotriene receptor","Opioid receptor","PAF 
receptor","Neurokinin receptor","Vasopressin and oxytocin receptor","Adenosine receptor","Histamine receptor","CXC chemokine receptor","Nuclear hormone receptor subfamily 3 group C member 1","Tyrosine
 protein kinase Src family","Cytochrome P450 5A1","CC chemokine receptor","Tyrosine protein kinase EGFR family","Nuclear hormone receptor subfamily 1 group I member 2","Hydroxycarboxylic acid receptor
","CMGC protein kinase ERK1","Tyrosine protein kinase SrcA"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Ion channels","Cytochrome P450","Nuclear hormone receptors","G protein-coupled receptors","ATP-binding cassette transporter family","Voltage-gated ion channels","Kinas
es (EC 2.7.x.x)","Haem oxygenase","Peptidases and proteinases","P-type ATPases","Eicosanoid turnover","Carbonic anhydrases","SLC superfamily of solute carriers","1.13.11.- Dioxygenases","Catalytic rec
eptors","Acetylcholine turnover",CYP5,"CYP7 and CYP8 families","CYP2 family: drug metabolising subset","1F. Retinoic acid-related orphans","Neuropeptide S receptor",Adrenoceptors,CYP11,CYP17,CYP19,"CY
P20 and CYP21 families","ABCB subfamily","1I. Vitamin D receptor-like receptors","CYP3 family","CYP1 family","Potassium channels","CMGC: Containing CDK",MAPK,GSK3,"CLK families","CA: Cysteine (C) Pept
idases","Acetylcholine receptors (muscarinic)","5-Hydroxytryptamine receptors","P2A P-type ATPases: Ca<sup>2+</sup>-ATPases","Steroid hormone receptors","Glycoprotein hormone receptors",Lipoxygenases,
"1H. Liver X receptor-like receptors","Dopamine receptors","Leukotriene receptors","Opioid receptors","Platelet-activating factor receptor","SLC6 neurotransmitter transporter family","Tachykinin recep
tors","Vasopressin and oxytocin receptors","Voltage-gated calcium channels","Adenosine receptors","Histamine receptors","SLC22 family of organic cation and anion transporters","Chemokine receptors","R
eceptor kinases",Cyclooxygenase,CYP39,"CYP46 and CYP51 families","Transient Receptor Potential channels","Hydroxycarboxylic acid receptors","Calcium- and sodium-activated potassium channels","Mitogen-
activated protein kinases (MAP kinases)","Voltage-gated potassium channels","C19: Ubiquitin-specific protease","3C. 3-Ketosteroid receptors","Monoamine transporter subfamily","Organic cation transport
ers (OCT)","TK: Tyrosine kinase","ERK subfamily","Non-receptor tyrosine kinases (nRTKs)","Receptor tyrosine kinases (RTKs)","Src family","Type I RTKs: ErbB (epidermal growth factor) receptor family"}

> <pathway_reactome>
{Metabolism,"Gene expression (Transcription)","DNA Repair",Disease,"Immune System","Signal Transduction","Neuronal System","Cellular responses to external stimuli","Cell Cycle","Vesicle-mediated trans
port","Muscle contraction",Hemostasis,"Developmental Biology","Transport of small molecules","Metabolism of proteins","Biological oxidations","RNA Polymerase II Transcription","DNA Double-Strand Break
 Repair","Infectious disease","Metabolism of lipids","Abacavir transport and metabolism","Cytokine Signaling in Immune system","Signaling by GPCR","Potassium Channels","Cellular responses to stress","
Cell Cycle Checkpoints","Membrane Trafficking","Innate Immune System","Cardiac conduction",Mitotic,"Transmission across Chemical Synapses","Platelet activation","signaling and aggregation","Platelet h
omeostasis","Metabolism of carbohydrates","Nervous system development","O2/CO2 exchange in erythrocytes","Metabolism of amino acids and derivatives","SLC-mediated transmembrane transport","Disorders o
f transmembrane transporters","Ion channel transport","Post-translational protein modification","Phase I - Functionalization of compounds","Generic Transcription Pathway","Homology Directed Repair","L
eishmania infection","Metabolism of steroids","Abacavir transmembrane transport","Biosynthesis of specialized proresolving mediators (SPMs)","Signaling by Interleukins","GPCR ligand binding","Ca2+ act
ivated K+ channels","Cellular response to hypoxia","G1/S DNA Damage Checkpoints","trans-Golgi Network Vesicle Budding","Toll-like Receptor Cascades","Phase 3 - rapid repolarisation","M Phase","SARS-Co
V Infections","Neurotransmitter receptors and postsynaptic signal transmission","Platelet Aggregation (Plug Formation)","Platelet calcium homeostasis","Mitotic G1 phase and G1/S transition","Glucose m
etabolism","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Sphingolipid metabolism","Erythrocytes take up carbon dioxide and release oxygen","Interferon Signaling","Neurotransmitter 
clearance","Axon guidance","Tryptophan catabolism","Transport of bile salts and organic acids","metal ions and amine compounds","HIV Infection","GPCR downstream signalling","Voltage gated Potassium ch
annels","SLC transporter disorders","Phospholipid metabolism","Stimuli-sensing channels",SUMOylation,"Cytochrome P450 - arranged by substrate type","Transcriptional regulation by RUNX3","HDR through H
omologous Recombination (HRR) or Single Strand Annealing (SSA)","Leishmania parasite growth and survival","Metabolism of steroid hormones","Nuclear Receptor transcription pathway","Biosynthesis of DHA
-derived SPMs","Interleukin-1 family signaling","Class A/1 (Rhodopsin-like receptors)","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","p53-Dependent G1/S DNA damage checkpo
int","Golgi Associated Vesicle Biogenesis","Toll Like Receptor 5 (TLR5) Cascade","Interleukin-4 and Interleukin-13 signaling","Transcriptional Regulation by TP53","Mitotic Metaphase and Anaphase","Tra
nscriptional Regulation by MECP2","SARS-CoV-1 Infection","Activation of NMDA receptors and postsynaptic events","Reduction of cytosolic Ca++ levels","Transcriptional regulation by RUNX2","G1/S Transit
ion",Gluconeogenesis,"Biosynthesis of DPA-derived SPMs","Glycosphingolipid metabolism","Bile acid and bile salt metabolism","Interferon gamma signaling","Serotonin clearance from the synaptic cleft","
NCAM signaling for neurite out-growth","Organic cation/anion/zwitterion transport","FOXO-mediated transcription","Host Interactions of HIV factors","G alpha (i) signalling events","Defective SLC6A2 ca
uses orthostatic intolerance (OI)","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Semaphorin interactions","Glycerophospholipid biosynthesis","G alpha (q) signalling events","TRP c
hannels","SUMO E3 ligases SUMOylate target proteins","Endogenous sterols",Xenobiotics,"RUNX3 Regulates Immune Response and Cell Migration","HDR through Homologous Recombination (HRR)","Anti-inflammato
ry response favouring Leishmania parasite infection","Androgen biosynthesis","Biosynthesis of maresins","Interleukin-1 signaling","Amine ligand-binding receptors","p53-Dependent G1 DNA Damage Response
","MyD88 cascade initiated on plasma membrane","Regulation of TP53 Activity","Mitotic Anaphase","Regulation of MECP2 expression and activity","Attachment and Entry","Post NMDA receptor activation even
ts","RUNX2 regulates bone development","Activation of the pre-replicative complex","Biosynthesis of DPAn-3 SPMs","Synthesis of bile acids and bile salts","MECP2 regulates neuronal receptors and channe
ls","Peptide ligand-binding receptors","NCAM1 interactions","Nucleotide-like (purinergic) receptors","Organic cation transport","FOXO-mediated transcription of oxidative stress","metabolic and neurona
l genes","The role of Nef in HIV-1 replication and disease pathogenesis","Opioid Signalling",Eicosanoids,"Sema4D in semaphorin signaling","Synthesis of PC","Gastrin-CREB signalling pathway via PKC and
 MAPK","SUMOylation of intracellular receptors","Hydroxycarboxylic acid-binding receptors","Sterols are 12-hydroxylated by CYP8B1","CYP2E1 reactions","Homologous DNA Pairing and Strand Exchange","ADOR
A2B mediated anti-inflammatory cytokines production","Biosynthesis of maresin-like SPMs","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2"
,Adrenoceptors,"Stabilization of p53","MAP kinase activation","Regulation of TP53 Activity through Methylation","Nuclear Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs","Regulation
 of TP53 Expression and Degradation","Muscarinic acetylcholine receptors","Serotonin receptors","RUNX2 regulates osteoblast differentiation","Biosynthesis of DPAn-3-derived protectins and resolvins","
Synthesis of bile acids and bile salts via 27-hydroxycholesterol","Dopamine receptors","LTC4-CYSLTR mediated IL4 production","Tachykinin receptors bind tachykinins","Adenosine P1 receptors","Histamine
 receptors","Chemokine receptors bind chemokines","Nef and signal transduction","G-protein activation","Sema4D induced cell migration and growth-cone collapse","EGFR Transactivation by Gastrin","Presy
naptic phase of homologous DNA pairing and strand exchange","Autodegradation of the E3 ubiquitin ligase COP1","MAPK targets/ Nuclear events mediated by MAP kinases","Initiation of Nuclear Envelope (NE
) Reformation","Regulation of TP53 Degradation","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{}

> <broad_moa>
{"sterol demethylase inhibitor"}

> <synonyms>
{clotrimazole,23593-75-1,23593751,Lotrimin,Canesten,Mycelex,Clotrimazol,Mycosporin,Empecid,Mykosporin,"Gyne lotrimin",Chlotrimazole,Trimysten,1-(o-Chlorotrityl)imidazole,1(oChlorotrityl)imidazole,"Myc
elex G",Rimazole,"Mycelex 7",Tibatin,Mono-baycuten,Monobaycuten,"Lotrimin AF Cream",Mycele,T0506,NSC257473,SAM001247056,1500200,Prestw-267,"NSC 257473",Clotrimazole,CPD000058306,CLOTRIMAZOLE}

> <pdid>
PD002411

> <targets>
{}

> <classes>
{antifungal}

> <pubchem_cids>
{2812}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 25  0  0  0  0            999 V2000
   14.0990   -4.4998    0.0000 O   0  0
   11.5990   -4.4998    0.0000 Cl  0  0
    9.0983   -0.7368    0.0000 C   0  0
    7.8003   -1.4887    0.0000 N   0  0
    7.8029   -2.9887    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 S   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 N   0  0
   -1.3039   -3.7494    0.0000 C   0  0
   -2.6016   -2.9971    0.0000 O   0  0
   -1.3070   -5.2502    0.0000 C   0  0
   -2.6078   -5.9988    0.0000 C   0  0
   -2.6109   -7.4996    0.0000 C   0  0
   -3.9099   -8.2497    0.0000 C   0  0
   -3.9099   -9.7497    0.0000 C   0  0
   -2.6109  -10.4997    0.0000 C   0  0
   -1.3119   -9.7497    0.0000 C   0  0
   -1.3118   -8.2497    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
M  END
> <name>
NIHCC_2014

> <id>
5951

> <plate>
NGP-105-05

> <well>
A08

> <supplier_cmpd_name>
CPD000449287

> <ctcr_id>
3631

> <supplier_cmpd_id>
SAM001246974

> <smiles>
O.Cl.CN(C)CCCSc1ccccc1NC(=O)\C=C\c2ccccc2

> <pd_targets>
{PYK,HTR1B,SIGMAR1,HTR2A,HTR1A,HTR1D,HTR1F,HTR2C,HTR2B,GP6}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,Adhesion,"Family A G protein-coupled receptor",Transferase,"Small molecule receptor (family A GPCR)","Monoamine receptor","Dopamine receptor","Serotonin receptor"}

> <pathway_chembl>
{Receptors,"Other protein targets","G protein-coupled receptors","Sigma receptors","Dopamine receptors","5-Hydroxytryptamine receptors"}

> <pathway_reactome>
{Disease,"Signal Transduction",Hemostasis,"Infectious disease","Signaling by GPCR","Platelet activation","signaling and aggregation","Leishmania infection","GPCR ligand binding","SARS-CoV Infections",
"GPVI-mediated activation cascade","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Potential therapeutics for SARS","Anti-inflammatory response favouring Leishmania p
arasite infection","Amine ligand-binding receptors","ADORA2B mediated anti-inflammatory cytokines production","Serotonin receptors"}

> <broad_targets>
{HTR2A}

> <broad_moa>
{"serotonin receptor antagonist"}

> <synonyms>
{SMR000449287,CPD000449287,MLS000758235,MLS001423973,CHEMBL1560190,CCG-100793,CCG100793,NC00043,SAM001246974}

> <pdid>
PD013879

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581800}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 29  0  0  0  0            999 V2000
    6.4848   -8.2644    0.0000 C   0  0
    5.1873   -7.5117    0.0000 O   0  0
    5.1894   -6.0109    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8999   -0.7576    0.0000 N   0  0
    5.1972   -1.5121    0.0000 O   0  0
    6.4998   -0.7667    0.0000 C   0  0
    7.7972   -1.5212    0.0000 C   0  0
    9.0991   -0.7761    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5988    1.5004    0.0000 C   0  0
   -2.5998    3.0004    0.0000 F   0  0
   -3.8976    0.7500    0.0000 F   0  0
   -3.8982    2.2498    0.0000 F   0  0
   12.8998   -0.7568    0.0000 O   0  0
   12.8998   -2.2568    0.0000 C   0  0
   11.6005   -3.0064    0.0000 O   0  0
   14.1998   -3.0068    0.0000 C   0  0
   15.4998   -2.2568    0.0000 C   0  0
   15.5012   -0.7560    0.0000 C   0  0
   14.2026   -0.0051    0.0000 O   0  0
   16.8005   -0.0064    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  3
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  7 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 16 19  1  0
 19 20  1  0
 19 21  1  0
 19 22  1  0
 23 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 28 30  2  0
M  END
> <name>
NIHCC_2014

> <id>
5952

> <plate>
NGP-105-05

> <well>
A09

> <supplier_cmpd_name>
CPD000466268

> <ctcr_id>
1677

> <supplier_cmpd_id>
SAM001246977

> <smiles>
COCCCCC(=NOCCN)c1ccc(cc1)C(F)(F)F.OC(=O)\C=C/C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{SCHEMBL7339196,HMS2051E15,HMS2230K05,HMS2231G22,HMS2235A12,CCG-100801,CCG100801,NC00051,"5-Methoxy-4'-trifluoromethylvalerophenone O-(2-aminoethyl) oxime maleate","5Methoxy4'trifluoromethylvalerophen
one O(2aminoethyl) oxime maleate",SAM001246977,CPD000466268}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5281089}

$$$$
NIHCC_2014
  SciTegic11012413002D

 14 13  0  0  0  0            999 V2000
    1.3000    2.2500    0.0000 C   0  0
    1.3000    0.7500    0.0000 C   0  0
    0.0007    0.0004    0.0000 O   0  0
    2.6000    0.0000    0.0000 N   0  0
    3.9000    0.7500    0.0000 C   0  0
    5.2000    0.0000    0.0000 C   0  0
    6.5000    0.7500    0.0000 C   0  0
    7.7999    0.0000    0.0000 C   0  0
    9.0999    0.7500    0.0000 C   0  0
   10.3999    0.0000    0.0000 C   0  0
   11.6999    0.7500    0.0000 N   0  0
   12.9999    0.0000    0.0000 C   0  0
   12.9999   -1.5000    0.0000 C   0  0
   14.2992    0.7496    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
M  END
> <name>
NIHCC_2014

> <id>
5953

> <plate>
NGP-105-05

> <well>
A10

> <supplier_cmpd_name>
CPD000059046

> <ctcr_id>
2490

> <supplier_cmpd_id>
SAM001247019

> <smiles>
CC(=O)NCCCCCCNC(C)=O

> <pd_targets>
{KDM4E,HIF1A,AMPC,MAPK1}

> <pathway_gtopdb>
{"Epigenetic regulator","Transcription factor",Enzyme,Eraser,Hydrolase,Kinase,"Lysine demethylase","Protein Kinase","Jumonji domain-containing","CMGC protein kinase group","CMGC protein kinase MAPK fa
mily","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,"Chromatin modifying enzymes","Kinases (EC 2.7.x.x)","1.14.11.- Histone demethylases","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Mitogen-activated protein kinases (MAP kinases)","ERK su
bfamily"}

> <pathway_reactome>
{"Cellular responses to external stimuli","Immune System","Cellular responses to stress","Innate Immune System","Cellular response to hypoxia","Toll-like Receptor Cascades","Oxygen-dependent proline h
ydroxylation of Hypoxia-inducible Factor Alpha","Toll Like Receptor 5 (TLR5) Cascade","MyD88 cascade initiated on plasma membrane","MAP kinase activation","MAPK targets/ Nuclear events mediated by MAP
 kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{AKT1}

> <broad_moa>
{"AKT inhibitor","differentiation inducer","NFKB pathway inhibitor"}

> <synonyms>
{"Hexamethylene bisacetamide",3073-59-4,3073594,Hexamethylenebisacetamide,"N,N'-Hexamethylenebisacetamide","N,N'Hexamethylenebisacetamide","N,N'-DIACETYL-1,6-DIAMINOHEXANE","N,N'DIACETYL1,6DIAMINOHEXA
NE",Hexamethylenediacetamide,"N,N'-(Hexane-1,6-diyl)diacetamide","N,N'(Hexane1,6diyl)diacetamide",N-(6-acetamidohexyl)acetamide,N(6acetamidohexyl)acetamide,N,N'-Diacetylhexam,N'Diacetylhexam,NSC95580,
SAM001247019,"NSC 95580",CPD000059046,HMBA}

> <pdid>
PD003084

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{3616}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 15  0  0  0  0            999 V2000
   11.4990    0.0000    0.0000 O   0  0
    8.9990    0.0000    0.0000 Cl  0  0
    5.2029   -2.9932    0.0000 N   0  0
    5.2003   -1.4932    0.0000 C   0  0
    6.4983   -0.7414    0.0000 N   0  0
    3.8990   -0.7455    0.0000 N   0  0
    2.6003   -1.4977    0.0000 C   0  0
    2.6030   -2.9977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 Cl  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 N   0  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 16  9  1  0
 16 17  1  0
M  END
> <name>
NIHCC_2014

> <id>
5954

> <plate>
NGP-105-05

> <well>
A11

> <supplier_cmpd_name>
CPD000449325

> <ctcr_id>
5572

> <supplier_cmpd_id>
SAM001246996

> <smiles>
O.Cl.NC(=N)NC(=O)c1nc(Cl)c(N)nc1N

> <pd_targets>
{SLC9A3,CYP1A2,KDM4E,GAA,LMNA,HSD17B10,ALDH1A1,TDP1,HPGD,GLA,RORC,PLAU,THRB,SLC9A5,ASIC2,ADORA1,AOC3,SLC9A1,SLC9A2,SCNN1A,CYP2D6,CYP2C19,PRSS1,TSHR,ASIC3,PRKD1,PLK1,SCN5A,ASIC1,BLM,HTT,DYRK1A,MAOA,SLC
22A1,ADORA2A,SLC22A2,SCNN1B,SCNN1G,TRPC7,TRPV2,PKD2L1,TRPA1,TRPC6,SCNN1D,AOC1}

> <pathway_gtopdb>
{Transporter,Enzyme,"Epigenetic regulator","Other nuclear protein","Transcription factor","Ion channel","Membrane receptor","Unclassified protein","Electrochemical transporter","Cytochrome P450",Erase
r,Hydrolase,Protease,Oxidoreductase,"Nuclear receptor","Ligand-gated ion channel","Family A G protein-coupled receptor",Kinase,"Voltage-gated ion channel","SLC superfamily of solute carriers","Cytochr
ome P450 family 1","Lysine demethylase","Serine protease","Nuclear hormone receptor subfamily 1","Acid-sensing ion channel","Small molecule receptor (family A GPCR)","Epithelial sodium channel","Cytoc
hrome P450 family 2","Peptide receptor (family A GPCR)","Protein Kinase","Voltage-gated sodium channel","Transient receptor potential channel","SLC09 family of sodium/hydrogen exchangers","Cytochrome 
P450 family 1A","Jumonji domain-containing","Serine protease PA clan","Nuclear hormone receptor subfamily 1 group F","Nuclear hormone receptor subfamily 1 group A","Nucleotide-like receptor (family A 
GPCR)","Cytochrome P450 family 2D","Cytochrome P450 family 2C","Glycohormone receptor","CAMK protein kinase group","Other protein kinase group","CMGC protein kinase group","SLC22 family of organic cat
ion and anion transporters","Cytochrome P450 1A1","Serine protease S1A subfamily","Nuclear hormone receptor subfamily 1 group F member 3","Nuclear hormone receptor subfamily 1 group A member 2","Adeno
sine receptor","Cytochrome P450 2D6","Cytochrome P450 2C19","CAMK protein kinase PKD family","Other protein kinase PLK family","CMGC protein kinase DYRK family","CMGC protein kinase Dyrk1 subfamily"}

> <pathway_chembl>
{Transporters,Enzymes,Receptors,"Ion channels","SLC superfamily of solute carriers","Cytochrome P450","Chromatin modifying enzymes","3.2.1.- Glycosidases","Eicosanoid turnover","Nuclear hormone recept
ors","Peptidases and proteinases","Ligand-gated ion channels","G protein-coupled receptors","1.-.-.- Oxidoreductases","Kinases (EC 2.7.x.x)","Catalytic receptors","Voltage-gated ion channels","Catecho
lamine turnover","SLC9 family of sodium/hydrogen exchangers","CYP1 family","1.14.11.- Histone demethylases","Prostaglandin synthases","1F. Retinoic acid-related orphans","PA: Serine (S) Peptidases","1
A. Thyroid hormone receptors","Acid-sensing (proton-gated) ion channels (ASICs)","Adenosine receptors","Epithelial sodium channel (ENaC)","CYP2 family: drug metabolising subset","Glycoprotein hormone 
receptors","CAMK: Calcium/calmodulin-dependent protein kinases","Receptor kinases","Voltage-gated sodium channels","CMGC: Containing CDK",MAPK,GSK3,"CLK families","SLC22 family of organic cation and a
nion transporters","Transient Receptor Potential channels","S1: Chymotrypsin","Protein kinase D (PKD) family","Other protein kinases","Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase (D
YRK) family","Organic cation transporters (OCT)","Polo-like kinase (PLK) family","Dyrk1 subfamily"}

> <pathway_reactome>
{"Transport of small molecules",Metabolism,Disease,"Cell Cycle","DNA Repair","Gene expression (Transcription)","Immune System","Metabolism of proteins","Signal Transduction","Developmental Biology","S
LC-mediated transmembrane transport","Biological oxidations","Diseases of metabolism",Mitotic,"Metabolism of amino acids and derivatives","DNA Double-Strand Break Repair","Metabolism of lipids","RNA P
olymerase II Transcription","Innate Immune System","Post-translational protein modification","Ion channel transport","Signaling by GPCR","Metabolism of carbohydrates","Metabolism of vitamins and cofac
tors","Infectious disease","Nervous system development","Transport of inorganic cations/anions and amino acids/oligopeptides","Phase I - Functionalization of compounds","Diseases of carbohydrate metab
olism","M Phase","Branched-chain amino acid catabolism","Nonhomologous End-Joining (NHEJ)","Biosynthesis of specialized proresolving mediators (SPMs)","Sphingolipid metabolism","Generic Transcription 
Pathway","Neutrophil degranulation",SUMOylation,"Stimuli-sensing channels","GPCR ligand binding","Glycosaminoglycan metabolism","Metabolism of water-soluble vitamins and cofactors","Leishmania infecti
on","Mitotic G2-G2/M phases","Axon guidance","Homology Directed Repair","Mitotic G1 phase and G1/S transition","Transport of bile salts and organic acids","metal ions and amine compounds","Sodium/Prot
on exchangers","Cytochrome P450 - arranged by substrate type","Glycogen storage diseases","Mitotic Metaphase and Anaphase","Ethanol oxidation","Biosynthesis of DHA-derived SPMs","Glycosphingolipid met
abolism","Transcriptional regulation by RUNX3","SUMO E3 ligases SUMOylate target proteins","Class A/1 (Rhodopsin-like receptors)","Hyaluronan metabolism","Cobalamin (Cbl","vitamin B12) transport and m
etabolism","Leishmania parasite growth and survival","Sphingolipid de novo biosynthesis","G2/M Transition","L1CAM interactions","HDR through Homologous Recombination (HRR) or Single Strand Annealing (
SSA)","Transcriptional Regulation by MECP2","G0 and Early G1","Amine Oxidase reactions","Organic cation/anion/zwitterion transport","Netrin-1 signaling","TRP channels",Xenobiotics,"Glycogen storage di
sease type II (GAA)","Mitotic Anaphase","Biosynthesis of D-series resolvins","RUNX3 Regulates Immune Response and Cell Migration","SUMOylation of intracellular receptors","Nucleotide-like (purinergic)
 receptors","Hyaluronan uptake and degradation","Anti-inflammatory response favouring Leishmania parasite infection","Centrosome maturation","Interaction between L1 and Ankyrins","HDR through Homologo
us Recombination (HRR)","Regulation of MECP2 expression and activity","Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB","Organic cation transport","Role of second messengers i
n netrin-1 signaling","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Nuclear Envelope (NE) Reassembly","Adenosine P1 receptors","CYP2E1 reactions","ADORA2B mediated anti-inflammat
ory cytokines production","Loss of proteins required for interphase microtubule organization from the centrosome","Homologous DNA Pairing and Strand Exchange","Initiation of Nuclear Envelope (NE) Refo
rmation","Loss of Nlp from mitotic centrosomes","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{AOC1,ASIC1,ASIC2,ASIC3,PKD2,PKD2L1,PLAU,SCNN1A,SCNN1B,SCNN1D,SCNN1G,SLC9A1,TRPC7,TRPV2}

> <broad_moa>
{"sodium channel blocker"}

> <synonyms>
{3,"5-DIAMINO-N-(AMINOIMINOMETHYL)-6-CHLORO- (CAS","5DIAMINON(AMINOIMINOMETHYL)6CHLORO (CAS","MK-870 hydrochloride","MK870 hydrochloride","Amiloride hydrochloride hydrate","Pyrazinecarboxamide, 3,5-di
amino-N-(aminoiminomethyl)-6-chloro- (CAS)","Pyrazinecarboxamide, 3,5diaminoN(aminoiminomethyl)6chloro (CAS)",SMR000449325,N-Amidino-3,NAmidino3,5-diamino-6-chloropyrazinecar,5diamino6chloropyrazineca
r,SAM001246996,CPD000449325}

> <pdid>
PD009902

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581809}

$$$$
NIHCC_2014
  SciTegic11012413002D

 32 34  0  0  1  0            999 V2000
    1.3000    2.2500    0.0000 O   0  0
    1.3000    0.7500    0.0000 C   0  0
    0.0007    0.0004    0.0000 O   0  0
    2.6000    0.0000    0.0000 C   0  0
    3.9000    0.7500    0.0000 C   0  0
    3.9014    2.2508    0.0000 C   0  0
    2.6028    3.0016    0.0000 O   0  0
    5.2007    3.0004    0.0000 O   0  0
   11.3064   -4.5066    0.0000 F   0  0
   12.6043   -3.7546    0.0000 C   0  0
   12.6019   -2.2546    0.0000 C   0  0
   13.8998   -1.5025    0.0000 C   0  0
   15.2001   -2.2504    0.0000 C   0  0
   15.2024   -3.7505    0.0000 C   0  0
   13.9045   -4.5025    0.0000 C   0  0
   16.4998   -1.5000    0.0000 C   0  0  2  0  0  0
   17.7988   -2.2501    0.0000 C   0  0
   19.0979   -1.5001    0.0000 C   0  0
   19.0979   -0.0001    0.0000 N   0  0
   17.7989    0.7499    0.0000 C   0  0
   16.4997    0.0000    0.0000 C   0  0  1  0  0  0
   15.2015    0.7531    0.0000 C   0  0
   15.2037    2.2539    0.0000 O   0  0
   13.9054    3.0070    0.0000 C   0  0
   13.9054    4.5070    0.0000 C   0  0
   12.6064    5.2570    0.0000 C   0  0
   11.3074    4.5070    0.0000 C   0  0
    9.8816    4.9705    0.0000 O   0  0
    9.0000    3.7570    0.0000 C   0  0
    9.8816    2.5434    0.0000 O   0  0
   11.3074    3.0070    0.0000 C   0  0
   12.6064    2.2570    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 16 13  1  1
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 16  1  0
 21 22  1  6
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 27  1  0
 31 32  2  0
 32 24  1  0
M  END
> <name>
NIHCC_2014

> <id>
5955

> <plate>
NGP-105-05

> <well>
B02

> <supplier_cmpd_name>
CPD000466269

> <ctcr_id>
3312

> <supplier_cmpd_id>
SAM001246991

> <smiles>
OC(=O)\C=C/C(O)=O.Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc3ccc4OCOc4c3

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Paroxetine maleate",64006-44-6,64006446,UNII-F726G2563Q,UNIIF726G2563Q,"Paroxetine maleate salt",CHEBI:64194,F726G2563Q,"FG 7051 maleate",SMR000466269,BRL-29060,BRL29060,FG-7051,FG7051,"GF 74",SR-01
000597775,SR01000597775,"Paroxetine  maleate",MLS000758308,MLS001076681,MLS001401441,SCHEMBL140608,SAM001246991,CPD000466269}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{6435921}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 22  0  0  0  0            999 V2000
    5.6484   -1.4334    0.0000 Br  0  0
    3.1476   -0.7184    0.0000 C   0  0
    1.6852   -0.3846    0.0000 N   0  0
    1.3514    1.0778    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -2.4523    2.0983    0.0000 C   0  0
   -3.8856    1.6561    0.0000 C   0  0
   -4.9852    2.6764    0.0000 Br  0  0
   -4.2194    0.1937    0.0000 C   0  0
   -5.6528   -0.2484    0.0000 O   0  0
   -3.1198   -0.8265    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
   -1.4011   -2.9095    0.0000 C   0  0
   -2.9046   -2.9463    0.0000 C   0  0
   -3.6237   -4.2627    0.0000 C   0  0
   -2.8432   -5.5436    0.0000 C   0  0
   -1.3436   -5.5082    0.0000 C   0  0
   -0.6245   -4.1918    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  8 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13  6  1  0
 13 14  1  0
 14 15  1  0
 15  3  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
M  END
> <name>
NIHCC_2014

> <id>
5956

> <plate>
NGP-105-05

> <well>
B03

> <supplier_cmpd_name>
CPD000449276

> <ctcr_id>
1639

> <supplier_cmpd_id>
SAM001247068

> <smiles>
Br.CN1CCc2cc(Br)c(O)cc2C(C1)c3ccccc3

> <pd_targets>
{MAPK1,LMNA,DRD5,DRD2,ADCY2,KCNJ6,NFO,KCNJ4,NFKB1,TSHR,THPO,CYP1A2,CYP2D6,CHRM1,HSD17B10,CYP3A4,ALOX15,HTR2A,KMT2A,MEN1,LEF,HTR2C,HTR2B,SIGMAR1,DRD3,CYP2C19}

> <pathway_gtopdb>
{Enzyme,"Other nuclear protein","Membrane receptor",Kinase,"Family A G protein-coupled receptor",Lyase,"Protein Kinase","Small molecule receptor (family A GPCR)","CMGC protein kinase group","Monoamine
 receptor","CMGC protein kinase MAPK family","Dopamine receptor","CMGC protein kinase ERK1","Ion channel","Voltage-gated ion channel",Hydrolase,"Potassium channels","Inwardly rectifying potassium chan
nel","Other cytosolic protein","Unclassified protein","Cytochrome P450",Oxidoreductase,"Peptide receptor (family A GPCR)","Cytochrome P450 family 1","Cytochrome P450 family 2","Cytochrome P450 family 
3","Glycohormone receptor","Cytochrome P450 family 1A","Cytochrome P450 family 2D","Cytochrome P450 family 3A","Cytochrome P450 1A1","Cytochrome P450 2D6","Acetylcholine receptor","Cytochrome P450 3A4
","Epigenetic regulator",Reader,Protease,Bromodomain,"Metallo protease","Metallo protease MAE clan","Serotonin receptor","Metallo protease M34 family","Cytochrome P450 family 2C","Cytochrome P450 2C19
"}

> <pathway_chembl>
{Enzymes,Receptors,"Kinases (EC 2.7.x.x)","G protein-coupled receptors","Cyclic nucleotide turnover/signalling","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Dopamine receptors","Adenylyl cyclases 
(ACs)","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily","Ion channels","Voltage-gated ion channels","Potassium channels","Inwardly rectifying potassium channels","Cytochrome P450","Gl
ycoprotein hormone receptors","CYP1 family","CYP2 family: drug metabolising subset","Acetylcholine receptors (muscarinic)","CYP3 family","Other protein targets","Eicosanoid turnover","Sigma receptors"
,Lipoxygenases,"5-Hydroxytryptamine receptors"}

> <pathway_reactome>
{"Immune System","Cell Cycle",Disease,"Signal Transduction","Neuronal System","Innate Immune System",Mitotic,"Infectious disease","Signaling by GPCR","Transmission across Chemical Synapses","Toll-like
 Receptor Cascades","M Phase","Leishmania infection","GPCR ligand binding","Neurotransmitter receptors and postsynaptic signal transmission","Toll Like Receptor 5 (TLR5) Cascade","Mitotic Metaphase an
d Anaphase","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","GABA receptor activation","MyD88 cascade initiated on plasma membrane","Mitotic Anaphase","Anti-inflammato
ry response favouring Leishmania parasite infection","Amine ligand-binding receptors","GABA B receptor activation","MAP kinase activation","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inf
lammatory cytokines production","Dopamine receptors","Activation of GABAB receptors","MAPK targets/ Nuclear events mediated by MAP kinases","Initiation of Nuclear Envelope (NE) Reformation","Adenylate
 cyclase inhibitory pathway","ERK/MAPK targets","ERKs are inactivated","Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits",Hemostasis,Metabolism,"Cytokine Signaling in Immune system"
,"Platelet activation","signaling and aggregation","Biological oxidations","Metabolism of amino acids and derivatives","Metabolism of lipids","Signaling by Interleukins","Platelet Aggregation (Plug Fo
rmation)","Phase I - Functionalization of compounds","Branched-chain amino acid catabolism","Biosynthesis of specialized proresolving mediators (SPMs)","Interleukin-1 family signaling","Cytochrome P45
0 - arranged by substrate type","Biosynthesis of DHA-derived SPMs","Interleukin-1 signaling",Xenobiotics,"Biosynthesis of maresins","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Aromatic amines can be
 N-hydroxylated or N-dealkylated by CYP1A2","CYP2E1 reactions","Muscarinic acetylcholine receptors","Biosynthesis of maresin-like SPMs","Uptake and actions of bacterial toxins","SARS-CoV Infections","
Biosynthesis of DPA-derived SPMs","Uptake and function of anthrax toxins","Potential therapeutics for SARS","Biosynthesis of DPAn-3 SPMs","Biosynthesis of DPAn-3-derived protectins and resolvins","Ser
otonin receptors"}

> <broad_targets>
{DRD1,DRD5}

> <broad_moa>
{"dopamine receptor antagonist"}

> <synonyms>
{"SKF 83566 hydrobromide",108179-91-5,108179915,"108179 91 5","SKF83566 hydrobromide","SKF 83566 (hydrobromide)","SKF-83566 (hydrobromide)","SKF83566 (hydrobromide)",SKF83566C,"Skf 83566","8-bromo-3-m
ethyl-5-phenyl-1,2,4,5-tetrahydro-3-benzazepin-7-ol;hydrobromide","8bromo3methyl5phenyl1,2,4,5tetrahydro3benzazepin7ol;hydrobromide","8 bromo 3 methyl 5 phenyl 1,2,4,5 tetrahydro 3 benzazepin 7 ol;hyd
robromide",C17H19Br2NO,SMR000449276,SK,T4369,SAM001247068,"SCH 23390 hydrochloride",CPD000449276}

> <pdid>
PD047114

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581817}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 23  0  0  1  0            999 V2000
   11.1800   -0.5178    0.0000 O   0  0
    8.6800   -0.5178    0.0000 Br  0  5
   -2.8159   -4.7248    0.0000 C   0  0
   -3.6016   -3.4471    0.0000 O   0  0
   -2.8900   -2.1300    0.0000 C   0  0
   -3.6900   -0.8600    0.0000 C   0  0
   -2.9600    0.3900    0.0000 C   0  0
   -1.4800    0.3900    0.0000 C   0  0
   -0.7800    1.6800    0.0000 C   0  0
    0.6500    1.7000    0.0000 C   0  0  1  0  0  0
    1.4200    0.4600    0.0000 C   0  0  1  0  0  0
    2.9000    0.5000    0.0000 C   0  0
    3.6800   -0.7900    0.0000 C   0  0
    2.9700   -2.0400    0.0000 C   0  0
    1.4800   -2.0400    0.0000 C   0  0
    0.7000   -0.8000    0.0000 C   0  0  2  0  0  0
   -0.1200    0.2700    0.0000 C   0  0
   -0.1900    2.9600    0.0000 C   0  0
    1.3400    2.9600    0.0000 N   0  0
    2.6455    3.6988    0.0000 C   0  0
   -0.6700   -0.8400    0.0000 C   0  0
   -1.4200   -2.1000    0.0000 C   0  0
    6.1800   -0.5178    0.0000 H   0  3
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
 10  9  1  6
 10 11  1  0
 11 12  1  1
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 11  1  0
 16 17  1  6
 17 18  1  0
 18 19  1  0
 19 10  1  0
 19 20  1  0
 16 21  1  0
 21  8  1  0
 21 22  2  0
 22  5  1  0
M  CHG  2   2  -1  23   1
M  END
> <name>
NIHCC_2014

> <id>
5957

> <plate>
NGP-105-05

> <well>
B04

> <supplier_cmpd_name>
CPD000326694

> <ctcr_id>
6721

> <supplier_cmpd_id>
SAM001247062

> <smiles>
O.[Br-].COc1ccc2C[C@H]3[C@H]4CCCC[C@@]4(CCN3C)c2c1.[H+]

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{CHRNA2,CHRNA3,CHRNA4,CHRNA7,CHRNB2,CHRNB4,CYBA,CYBB,GRIN3A,NCF1,NCF2,NCF4,OPRD1,OPRK1,OPRM1,PGRMC1,RAC1,RAC2,SIGMAR1,SLC6A2,SLC6A4}

> <broad_moa>
{"glutamate receptor antagonist","sigma receptor agonist"}

> <synonyms>
{RESTW35,"Dextromethorphan hydrobromide","Dextromethorphan hydrobromide monohydrate",6700-34-1,6700341,Methorate,"Drixoral Cough","PediaCare 1","Dextromethorphan hydrobromide hydrate",Hold,"Chlorasept
ic DM","Benylin DM","St. Joseph Cough Syrup",Romilar,Contac,SAM001247062,Prestw-359,CPD000326694}

> <pdid>
PD009985

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{57515976,5462351}

$$$$
NIHCC_2014
  SciTegic11012413002D

 12 12  0  0  0  0            999 V2000
    1.6317   -2.2458    0.0000 C   0  0
    0.7500   -1.0323    0.0000 C   0  0
    1.2135    0.3943    0.0000 N   0  0
    0.0000    1.2760    0.0000 C   0  0
   -1.2135    0.3943    0.0000 C   0  0
   -0.7500   -1.0323    0.0000 N   0  0
   -1.6281   -2.2462    0.0000 C   0  0
   -1.0157   -3.6164    0.0000 C   0  0
   -1.8949   -4.8318    0.0000 O   0  0
   -2.6375    0.8602    0.0000 N   0  3
   -3.7540   -0.1415    0.0000 O   0  5
   -2.9472    2.3279    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  2  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  5 10  1  0
 10 11  1  0
 10 12  2  0
M  CHG  2  10   1  11  -1
M  END
> <name>
NIHCC_2014

> <id>
5958

> <plate>
NGP-105-05

> <well>
B05

> <supplier_cmpd_name>
CPD000058175

> <ctcr_id>
2665

> <supplier_cmpd_id>
SAM001247010

> <smiles>
Cc1ncc(n1CCO)[N+]([O-])=O

> <pd_targets>
{LMNA,ALDH1A1,THRB,MAPK1,TSHR,RDXA}

> <pathway_gtopdb>
{"Other nuclear protein",Enzyme,"Transcription factor","Membrane receptor",Oxidoreductase,"Nuclear receptor",Kinase,"Family A G protein-coupled receptor","Nuclear hormone receptor subfamily 1","Protei
n Kinase","Peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1 group A","CMGC protein kinase group","Glycohormone receptor","Nuclear hormone receptor subfamily 1 group A member 2",
"CMGC protein kinase MAPK family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,"Nuclear hormone receptors","Kinases (EC 2.7.x.x)","G protein-coupled receptors","1A. Thyroid hormone receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Glycoprotein hormon
e receptors","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Cell Cycle",Metabolism,"Metabolism of proteins","Immune System",Disease,Mitotic,"Biological oxidations","Post-translational protein modification","Innate Immune System","Infectious disease","M Phase
","Phase I - Functionalization of compounds",SUMOylation,"Toll-like Receptor Cascades","Leishmania infection","Mitotic Metaphase and Anaphase","Ethanol oxidation","SUMO E3 ligases SUMOylate target pro
teins","Toll Like Receptor 5 (TLR5) Cascade","Leishmania parasite growth and survival","Mitotic Anaphase","SUMOylation of intracellular receptors","MyD88 cascade initiated on plasma membrane","Anti-in
flammatory response favouring Leishmania parasite infection","Nuclear Envelope (NE) Reassembly","MAP kinase activation","ADORA2B mediated anti-inflammatory cytokines production","Initiation of Nuclear
 Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{CYP2C9,CYP3A4}

> <broad_moa>
{"DNA inhibitor"}

> <synonyms>
{metronidazole,443-48-1,443481,Flagyl,Metronidazol,2-Methyl-5-nitroimidazole-1-ethanol,2Methyl5nitroimidazole1ethanol,Anagiardil,Trichazol,MetroGel,"Bayer 5360",Gineflavir,Meronidal,Metronidaz,Novonid
azol,Trichopol,Trivazol,Danizol,Mexibol,Vagilen,Clont,2-(2-Methyl-5-nitro-1H-imi,2(2Methyl5nitro1Himi,T1079,SAM001247010,1500412,Prestw-81,Metronidazole,CPD000058175,METRONIDAZOLE}

> <pdid>
PD001853

> <targets>
{Antibiotic,Apoptosis,Bacterial,Parasite}

> <classes>
{antiprotozoal,Anti-infection,Apoptosis}

> <pubchem_cids>
{4173}

$$$$
NIHCC_2014
  SciTegic11012413002D

 31 31  0  0  0  0            999 V2000
   11.3990    4.2667    0.0000 H   0  3
    8.8990    4.2667    0.0000 O   0  0
    6.3990    4.2667    0.0000 Cl  0  5
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 N   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 N   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3032   -3.7490    0.0000 C   0  0
   -1.2991    5.2507    0.0000 N   0  0
   -0.0012    6.0029    0.0000 C   0  0
   -0.0036    7.5029    0.0000 C   0  0
   -1.3039    8.2509    0.0000 N   0  0
   -2.6017    7.4988    0.0000 C   0  0
   -2.5993    5.9988    0.0000 C   0  0
   -1.3093    9.7517    0.0000 C   0  0
   -0.0128   10.5060    0.0000 O   0  0
   -2.6114   10.4982    0.0000 C   0  0
   -2.7567   11.9783    0.0000 C   0  0
   -4.2255   12.2827    0.0000 C   0  0
   -4.9689   10.9799    0.0000 C   0  0
   -3.9596    9.8703    0.0000 O   0  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14  8  1  0
 14 15  1  0
 15 16  2  0
 16  6  1  0
 16 17  1  0
 17 18  1  0
 10 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 19  1  0
 22 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 27  1  0
M  CHG  2   1   1   3  -1
M  END
> <name>
NIHCC_2014

> <id>
5959

> <plate>
NGP-105-05

> <well>
B06

> <supplier_cmpd_name>
CPD000449268

> <ctcr_id>
3992

> <supplier_cmpd_id>
SAM001247000

> <smiles>
[H+].O.[Cl-].COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4

> <pd_targets>
{ADRA1A,ADRA1D,ADRA2A,ADRA2C,NFO,KMT2A,MEN1,FFP,ADRA1B,ADRA2B,KDM4E,GLA,GAA,ALDH1A1,KCNH2,HPGD,HTT,SMN1,AMPC,LMNA,HSD17B10,MAPK1,ALD,SLC22A1,ABCC4,KCNH6,KCNH7,TGFB1,TSHR,LEF,TP53,CHRM1,RORC}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Epigenetic regulator","Ion channel","Unclassified protein","Other nuclear protein",Transporter,"Secreted protein","Transcription factor","Family A G protein-coupled recept
or",Hydrolase,Reader,Transferase,Eraser,Oxidoreductase,"Voltage-gated ion channel",Kinase,"Electrochemical transporter","Primary active transporter",Protease,"Small molecule receptor (family A GPCR)",
Bromodomain,"Lysine demethylase","Potassium channels","Methyl-lysine/arginine binding protein","Protein Kinase","SLC superfamily of solute carriers","ATP-binding cassette","Peptide receptor (family A 
GPCR)","Metallo protease","Monoamine receptor","Jumonji domain-containing","Voltage-gated potassium channel","Tudor domain","CMGC protein kinase group","SLC22 family of organic cation and anion transp
orters","ABCC subfamily","Glycohormone receptor","Metallo protease MAE clan","Adrenergic receptor","CMGC protein kinase MAPK family","Metallo protease M34 family","Acetylcholine receptor","CMGC protei
n kinase ERK1","Nuclear receptor","Nuclear hormone receptor subfamily 1","Nuclear hormone receptor subfamily 1 group F","Nuclear hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{Receptors,Enzymes,"Ion channels",Transporters,"G protein-coupled receptors","Chromatin modifying enzymes","3.2.1.- Glycosidases","Voltage-gated ion channels","Eicosanoid turnover","Kinases (EC 2.7.x.
x)","SLC superfamily of solute carriers","ATP-binding cassette transporter family",Adrenoceptors,"1.14.11.- Histone demethylases","Potassium channels","Prostaglandin synthases","CMGC: Containing CDK",
MAPK,GSK3,"CLK families","SLC22 family of organic cation and anion transporters","ABCC subfamily","Glycoprotein hormone receptors","Acetylcholine receptors (muscarinic)","Voltage-gated potassium chann
els","Mitogen-activated protein kinases (MAP kinases)","Organic cation transporters (OCT)","ERK subfamily","Nuclear hormone receptors","1F. Retinoic acid-related orphans"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,Disease,"Muscle contraction","Gene expression (Transcription)","Metabolism of RNA","Cell Cycle","Immune System","Transport of small molecules",Hemostasis,"Neuronal Sy
stem","Signaling by GPCR","Metabolism of lipids","Diseases of metabolism","Biological oxidations","Cardiac conduction","RNA Polymerase II Transcription","Metabolism of non-coding RNA",Mitotic,"Metabol
ism of amino acids and derivatives","Innate Immune System","SLC-mediated transmembrane transport","Platelet activation","signaling and aggregation","Potassium Channels","Diseases of signal transductio
n by growth factor receptors and second messengers","Infectious disease","Cell Cycle Checkpoints","GPCR ligand binding","Sphingolipid metabolism","Diseases of carbohydrate metabolism","Phase I - Funct
ionalization of compounds","Phase 3 - rapid repolarisation","Biosynthesis of specialized proresolving mediators (SPMs)","Generic Transcription Pathway","snRNP Assembly","M Phase","Branched-chain amino
 acid catabolism","Toll-like Receptor Cascades","Transport of bile salts and organic acids","metal ions and amine compounds","Response to elevated platelet cytosolic Ca2+","Voltage gated Potassium cha
nnels","Signaling by TGF-beta Receptor Complex in Cancer","Leishmania infection","Uptake and actions of bacterial toxins","G1/S DNA Damage Checkpoints","Class A/1 (Rhodopsin-like receptors)","Glycosph
ingolipid metabolism","Glycogen storage diseases","Ethanol oxidation","Biosynthesis of DHA-derived SPMs","Transcriptional Regulation by MECP2","Mitotic Metaphase and Anaphase","Toll Like Receptor 5 (T
LR5) Cascade","Organic cation/anion/zwitterion transport","Platelet degranulation","Loss of Function of SMAD2/3 in Cancer","Leishmania parasite growth and survival","Uptake and function of anthrax tox
ins","p53-Dependent G1/S DNA damage checkpoint","Amine ligand-binding receptors","Glycogen storage disease type II (GAA)","Biosynthesis of D-series resolvins","Regulation of MECP2 expression and activ
ity","Mitotic Anaphase","MyD88 cascade initiated on plasma membrane","Organic cation transport","SMAD2/3 Phosphorylation Motif Mutants in Cancer","Anti-inflammatory response favouring Leishmania paras
ite infection","p53-Dependent G1 DNA Damage Response",Adrenoceptors,"Nuclear Envelope (NE) Reassembly","MAP kinase activation","ADORA2B mediated anti-inflammatory cytokines production","Stabilization 
of p53","Muscarinic acetylcholine receptors","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","Autodegradation of the E3 ubiquitin ligase COP1",
"ERK/MAPK targets","ERKs are inactivated","Transcriptional regulation by RUNX3","RUNX3 Regulates Immune Response and Cell Migration"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{"Terazosin HCl",SCHEMBL8540346,CHEMBL1201091,C19H25N5O4.ClH.H2O,MLS000758297,"Terazosin hydrochloride monohydrate",2750AH,CCG-100778,NC00028,SMR000449268,SAM001247000,CPD000449268}

> <pdid>
PD002848

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{9803362}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 30  0  0  0  0            999 V2000
   10.0885   -4.5769    0.0000 C   0  0
    9.5757   -3.1673    0.0000 C   0  0
    8.0979   -2.9056    0.0000 O   0  0
    7.5847   -1.4952    0.0000 C   0  0
    8.5494   -0.3466    0.0000 O   0  0
    6.1069   -1.2335    0.0000 N   0  0
    5.5920    0.1754    0.0000 C   0  0
    4.1145    0.4339    0.0000 C   0  0
    3.1484   -0.7186    0.0000 C   0  0
    3.6667   -2.1252    0.0000 C   0  0
    5.1442   -2.3838    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.5913    1.9239    0.0000 C   0  0
    2.4792    3.4197    0.0000 C   0  0
    1.1278    4.0705    0.0000 C   0  0
    1.0157    5.5663    0.0000 Cl  0  0
   -0.1116    3.2255    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 N   0  0
    0.7500   -1.5574    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11  6  1  0
  9 12  2  3
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 19 13  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 12  1  0
 27 22  1  0
M  END
> <name>
NIHCC_2014

> <id>
5960

> <plate>
NGP-105-05

> <well>
B07

> <supplier_cmpd_name>
CPD000058255

> <ctcr_id>
2087

> <supplier_cmpd_id>
SAM001246987

> <smiles>
CCOC(=O)N1CCC(CC1)=C2c3ccc(Cl)cc3CCc4cccnc24

> <pd_targets>
{MAPK1,HRH1,CYP2C19,BLM,NPSR1,KCNH2,KMT2A,MEN1,LMNA,PMP22,TP53,CYP2C9,GMNN,CYP2C8,MAPT,ALOX15,THPO,TSHR,NR1H4,SLC6A15,CYP3A4,HIF1A,CHRM1,CYP2D6,RORC,NR1I2,ABCB1,MTOR,ABCB11,KCNK9,CACNA1C,CACNA1D,CACNA
1F,CACNA1S,HTR2B}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Ion channel","Epigenetic regulator","Other nuclear protein","Unclassified protein","Transcription factor","Other cytosolic protein",Transporter,Kinase,"Family A G protein-
coupled receptor",Protease,"Cytochrome P450","Voltage-gated ion channel",Reader,Oxidoreductase,"Nuclear receptor","Electrochemical transporter","Primary active transporter","Protein Kinase","Small mol
ecule receptor (family A GPCR)","Cysteine protease","Cytochrome P450 family 2","Peptide receptor (family A GPCR)","Potassium channels",Bromodomain,"Nuclear hormone receptor subfamily 1","SLC superfami
ly of solute carriers","Cytochrome P450 family 3","ATP-binding cassette","Voltage-gated calcium channel","CMGC protein kinase group","Monoamine receptor","Cysteine protease CA clan","Cytochrome P450 f
amily 2C","Short peptide receptor (family A GPCR)","Voltage-gated potassium channel","Glycohormone receptor","Nuclear hormone receptor subfamily 1 group H","SLC06 neurotransmitter transporter family",
"Cytochrome P450 family 3A","Cytochrome P450 family 2D","Nuclear hormone receptor subfamily 1 group F","Nuclear hormone receptor subfamily 1 group I","ABCB subfamily","Atypical protein kinase group","
Two-pore domain potassium channel","CMGC protein kinase MAPK family","Histamine receptor","Cysteine protease C1A family","Cytochrome P450 2C19","Neuropeptide receptor","Cytochrome P450 2C9","Cytochrom
e P450 2C8","Nuclear hormone receptor subfamily 1 group H member 4","Cytochrome P450 3A4","Acetylcholine receptor","Cytochrome P450 2D6","Nuclear hormone receptor subfamily 1 group F member 3","Nuclea
r hormone receptor subfamily 1 group I member 2","Atypical protein kinase PIKK family","Serotonin receptor","CMGC protein kinase ERK1","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Enzymes,Receptors,"Ion channels",Transporters,"Kinases (EC 2.7.x.x)","G protein-coupled receptors","Cytochrome P450","Voltage-gated ion channels","Eicosanoid turnover","Nuclear hormone receptors","SL
C superfamily of solute carriers","ATP-binding cassette transporter family","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Histamine receptors","CYP2 family: drug metabolising subset","Neuropeptide 
S receptor","Potassium channels",Lipoxygenases,"Glycoprotein hormone receptors","1H. Liver X receptor-like receptors","SLC6 neurotransmitter transporter family","CYP3 family","Acetylcholine receptors 
(muscarinic)","1F. Retinoic acid-related orphans","1I. Vitamin D receptor-like receptors","ABCB subfamily",Atypical,"5-Hydroxytryptamine receptors","Mitogen-activated protein kinases (MAP kinases)","V
oltage-gated potassium channels","Neutral amino acid transporter subfamily","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","Two P domain potassium channels","ERK subfamily","FRAP subf
amily"}

> <pathway_reactome>
{"Immune System","Signal Transduction",Metabolism,"DNA Repair",Disease,"Muscle contraction","Cell Cycle","Developmental Biology","Neuronal System",Hemostasis,"Transport of small molecules","Cellular r
esponses to external stimuli","Gene expression (Transcription)","Metabolism of proteins","Innate Immune System","Signaling by GPCR","Biological oxidations","DNA Double-Strand Break Repair","Infectious
 disease","Cardiac conduction",Mitotic,"Nervous system development","Cell Cycle Checkpoints","Transmission across Chemical Synapses","Metabolism of lipids","Platelet activation","signaling and aggrega
tion","SLC-mediated transmembrane transport","Cellular responses to stress","RNA Polymerase II Transcription","Post-translational protein modification","Abacavir transport and metabolism","Potassium C
hannels","Toll-like Receptor Cascades","GPCR ligand binding","Phase I - Functionalization of compounds","Homology Directed Repair","Leishmania infection","Phase 3 - rapid repolarisation","M Phase","EG
R2 and SOX10-mediated initiation of Schwann cell myelination","G1/S DNA Damage Checkpoints","Mitotic G1 phase and G1/S transition","Neurotransmitter receptors and postsynaptic signal transmission","Bi
osynthesis of specialized proresolving mediators (SPMs)","Platelet Aggregation (Plug Formation)","Metabolism of steroids","Transport of bile salts and organic acids","metal ions and amine compounds","
Cellular response to hypoxia","Generic Transcription Pathway",SUMOylation,"Abacavir transmembrane transport","Tandem pore domain potassium channels","Toll Like Receptor 5 (TLR5) Cascade","Class A/1 (R
hodopsin-like receptors)","Cytochrome P450 - arranged by substrate type","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Leishmania parasite growth and survival","Mitoti
c Metaphase and Anaphase","p53-Dependent G1/S DNA damage checkpoint","G1/S Transition","Activation of NMDA receptors and postsynaptic events","Biosynthesis of DPA-derived SPMs","Bile acid and bile sal
t metabolism","Na+/Cl- dependent neurotransmitter transporters","Biosynthesis of DHA-derived SPMs","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Transcriptional regulatio
n by RUNX3","SUMO E3 ligases SUMOylate target proteins","Transcriptional Regulation by TP53","TWIK-releated acid-sensitive K+ channel (TASK)","MyD88 cascade initiated on plasma membrane","Amine ligand
-binding receptors",Xenobiotics,"HDR through Homologous Recombination (HRR)","Anti-inflammatory response favouring Leishmania parasite infection","Mitotic Anaphase","p53-Dependent G1 DNA Damage Respon
se","Activation of the pre-replicative complex","Post NMDA receptor activation events","Biosynthesis of DPAn-3 SPMs","Synthesis of bile acids and bile salts","Biosynthesis of maresins","RUNX3 Regulate
s Immune Response and Cell Migration","SUMOylation of intracellular receptors","Regulation of TP53 Activity","MAP kinase activation","Histamine receptors","CYP2E1 reactions","Homologous DNA Pairing an
d Strand Exchange","ADORA2B mediated anti-inflammatory cytokines production","Nuclear Envelope (NE) Reassembly","Stabilization of p53","Activation of AMPK downstream of NMDARs","Biosynthesis of DPAn-3
-derived protectins and resolvins","Synthesis of bile acids and bile salts via 27-hydroxycholesterol","Biosynthesis of maresin-like SPMs","Muscarinic acetylcholine receptors","Regulation of TP53 Expre
ssion and Degradation","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Serotonin receptors","MAPK targets/ Nuclear events mediated by MAP kinases","Presynaptic phase of homolog
ous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation","Autodegradation of the E3 ubiquitin ligase COP1","Regulation of TP53 Degradation","ERK/MAPK targets","ERKs are i
nactivated"}

> <broad_targets>
{HRH1}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{loratadine,79794-75-5,79794755,Claritin,Loratidine,Alavert,Clarityn,Lisino,Clarityne,Loracert,Loradex,Bonalerg,Claritine,Fristamin,Histaloran,Lertamine,Lorastine,Civeran,Loranox,Versal,"Sch 29851",An
hissen,Sch-29851,Sch29851,UNII-7AJO3BO7QN,UNII7AJO3BO7QN,MFCD00672869,C22H23Cl,T1097,S1358,SAM001246987,1503712,Prestw-1432,Loratadine,CPD000058255,LORATADINE}

> <pdid>
PD000883

> <targets>
{Histamine Receptor,Influenza Virus}

> <classes>
{H1 antihistamine,Neuronal Signaling,Anti-infection,GPCR/G Protein,Immunology/Inflammation}

> <pubchem_cids>
{3957}

$$$$
NIHCC_2014
  SciTegic11012413002D

 33 34  0  0  1  0            999 V2000
    6.3990    1.1247    0.0000 O   0  0
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 N   0  0
   -0.0031    3.0008    0.0000 C   0  0
   -1.3039    3.7494    0.0000 C   0  0
   -1.3070    5.2502    0.0000 C   0  0
   -2.6078    5.9988    0.0000 O   0  0
   -2.6109    7.4996    0.0000 C   0  0
   -3.9100    8.2496    0.0000 C   0  0
   -3.9100    9.7496    0.0000 C   0  0
   -2.6110   10.4997    0.0000 C   0  0
   -2.6111   11.9997    0.0000 F   0  0
   -1.3119    9.7497    0.0000 C   0  0
   -1.3119    8.2497    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  1  0  0  0
   -0.0031   -3.0008    0.0000 N   0  0
   -1.3039   -3.7494    0.0000 C   0  0
   -2.6016   -2.9971    0.0000 O   0  0
   -1.3070   -5.2502    0.0000 C   0  0
   -0.0079   -6.0003    0.0000 C   0  0
   -0.0080   -7.5003    0.0000 C   0  0
    1.2910   -8.2504    0.0000 Cl  0  0
   -1.3070   -8.2503    0.0000 C   0  0
   -1.3071   -9.7503    0.0000 N   0  0
   -2.6060   -7.5003    0.0000 C   0  0
   -2.6060   -6.0003    0.0000 C   0  0
   -3.9073   -5.2526    0.0000 O   0  0
   -5.2053   -6.0044    0.0000 C   0  0
  2  3  1  0
  4  3  1  6
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 11  1  0
  6 18  1  0
 18 19  1  0
 19 20  1  0
 20  4  1  0
 20 21  1  6
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 26 28  2  0
 28 29  1  0
 28 30  1  0
 30 31  2  0
 31 24  1  0
 31 32  1  0
 32 33  1  0
M  END
> <name>
NIHCC_2014

> <id>
5961

> <plate>
NGP-105-05

> <well>
B08

> <supplier_cmpd_name>
CPD000449272

> <ctcr_id>
1666

> <supplier_cmpd_id>
SAM001246975

> <smiles>
O.CO[C@H]1CN(CCCOc2ccc(F)cc2)CC[C@H]1NC(=O)c3cc(Cl)c(N)cc3OC

> <pd_targets>
{MAPT,GSC2,KCNH2,HTR4,HTR3A,HTR2A,CYP2D6,CYP3A4,AMPC,RAD52,ADRA2A,ADRA1A,ADRA1B,HTR1A,HTR3B,HTR3C,HTR3D,HTR3E,HTR7,DRD2,HTR2B,HTR2C,ADRA1D,ADRA2B,ADRA2C,HTR1B,HTR1D,HTR1F,HMGCR,DRD3,CACNA1C,SLC6A4,SCN
5A,SIGMAR1,CACNA1D,CACNA1F,CACNA1S,ABCB11}

> <pathway_gtopdb>
{"Other cytosolic protein",Enzyme,"Ion channel","Membrane receptor","Other nuclear protein",Transporter,Transferase,"Voltage-gated ion channel","Family A G protein-coupled receptor","Ligand-gated ion 
channel","Cytochrome P450",Hydrolase,Oxidoreductase,"Electrochemical transporter","Primary active transporter","Potassium channels","Small molecule receptor (family A GPCR)","5HT3 receptor","Cytochrom
e P450 family 2","Cytochrome P450 family 3","Voltage-gated calcium channel","SLC superfamily of solute carriers","Voltage-gated sodium channel","ATP-binding cassette","Voltage-gated potassium channel"
,"Monoamine receptor","Cytochrome P450 family 2D","Cytochrome P450 family 3A","SLC06 neurotransmitter transporter family","ABCB subfamily","Serotonin receptor","Cytochrome P450 2D6","Cytochrome P450 3
A4","Adrenergic receptor","Dopamine receptor"}

> <pathway_chembl>
{"Ion channels",Receptors,Enzymes,Transporters,"Other protein targets","Voltage-gated ion channels","G protein-coupled receptors","Ligand-gated ion channels","Cytochrome P450","Lanosterol biosynthesis
 pathway","SLC superfamily of solute carriers","Sigma receptors","ATP-binding cassette transporter family","Potassium channels","5-Hydroxytryptamine receptors","5-HT<sub>3</sub> receptors","CYP2 famil
y: drug metabolising subset","CYP3 family",Adrenoceptors,"Dopamine receptors","Voltage-gated calcium channels","SLC6 neurotransmitter transporter family","Voltage-gated sodium channels","ABCB subfamil
y","Voltage-gated potassium channels","Monoamine transporter subfamily"}

> <pathway_reactome>
{"Neuronal System","Muscle contraction",Disease,"Signal Transduction",Metabolism,"DNA Repair","Developmental Biology","Transmission across Chemical Synapses","Cardiac conduction","Infectious disease",
"Signaling by GPCR","Biological oxidations","Metabolism of lipids","DNA Double-Strand Break Repair","Nervous system development","Neurotransmitter receptors and postsynaptic signal transmission","Phas
e 3 - rapid repolarisation","Leishmania infection","GPCR ligand binding","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","Homology Directed Repai
r","Metabolism of steroids","Axon guidance","Neurotransmitter clearance","SARS-CoV Infections","Activation of NMDA receptors and postsynaptic events","Leishmania parasite growth and survival","Class A
/1 (Rhodopsin-like receptors)","Cytochrome P450 - arranged by substrate type","Biosynthesis of DHA-derived SPMs","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Regulati
on of cholesterol biosynthesis by SREBP (SREBF)","NCAM signaling for neurite out-growth","Serotonin clearance from the synaptic cleft","L1CAM interactions","Potential therapeutics for SARS","Bile acid
 and bile salt metabolism","Post NMDA receptor activation events","Anti-inflammatory response favouring Leishmania parasite infection","Amine ligand-binding receptors",Xenobiotics,"Biosynthesis of mar
esins","HDR through Single Strand Annealing (SSA)","Activation of gene expression by SREBF (SREBP)","NCAM1 interactions","Interaction between L1 and Ankyrins","Synthesis of bile acids and bile salts",
"Activation of AMPK downstream of NMDARs","ADORA2B mediated anti-inflammatory cytokines production","Serotonin receptors","CYP2E1 reactions","Biosynthesis of maresin-like SPMs",Adrenoceptors,"Dopamine
 receptors","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"}

> <broad_targets>
{HTR2A,HTR3A,HTR4,KCNH2}

> <broad_moa>
{"serotonin receptor agonist"}

> <synonyms>
{"Cisapride monohydrate","Cisapride monohydrate (Orange Book)","Cisapride hydrate",260779-88-2,260779882,Risamol,Acenalin,Propulsin,Alimix,SMR000449272,CPD000449272,MLS000758247,MLS001423985,SCHEMBL46
7064,CHEMBL1546244,R-51619,R51619,HMS2051G13,(R,S)-CISAPRID,S)CISAPRID,T1291,SAM001246975,Cisapride}

> <pdid>
PD009896

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{6917697}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 23  0  0  0  0            999 V2000
   11.9554   -0.4782    0.0000 H   0  3
    9.4554   -0.4782    0.0000 Cl  0  5
    6.9546   -4.2653    0.0000 C   0  0
    5.4929   -3.9285    0.0000 N   0  0
    4.4707   -5.0263    0.0000 C   0  0
    5.0525   -2.4938    0.0000 C   0  0
    3.5900   -2.1568    0.0000 C   0  0
    3.1497   -0.7220    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.5913    1.9239    0.0000 C   0  0
    2.4792    3.4197    0.0000 C   0  0
    1.1278    4.0705    0.0000 C   0  0
   -0.1116    3.2255    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 O   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23  9  1  0
 23 18  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5962

> <plate>
NGP-105-05

> <well>
B09

> <supplier_cmpd_name>
CPD000449270

> <ctcr_id>
6207

> <supplier_cmpd_id>
SAM001246976

> <smiles>
[H+].[Cl-].CN(C)CC\C=C/1c2ccccc2COc3ccccc13

> <pd_targets>
{CHRM2,SLC6A4,CHRM5,SLC6A2,CHRM3,HRH1,HTR2A,ADRA2C,CHRM4,SLC6A3,CHRM1,HTR1A,ADRA1A,CYP2D6,ADRA2A,ADRA2B,ADRA1B,ADRA1D,RORC,TGR,HTR1B,HTR1D,HTR1F,HTR2B,HTR2C,HTR3A,HTR3B,HTR4,HTR5A,HTR5B,HTR6,HTR7,HRH2
,SIGMAR1,DRD3,SLC22A1,HRH4,KCNH2,NFKB1,PMP22,RECQL,KDM4E,ALDH1A1,TSHR,CYP1A2,KMT2A,MEN1,LMNA,DRD2}

> <pathway_gtopdb>
{"Membrane receptor",Transporter,Enzyme,"Family A G protein-coupled receptor","Electrochemical transporter","Cytochrome P450","Small molecule receptor (family A GPCR)","SLC superfamily of solute carri
ers","Cytochrome P450 family 2","Monoamine receptor","SLC06 neurotransmitter transporter family","Cytochrome P450 family 2D","Acetylcholine receptor","Histamine receptor","Serotonin receptor","Adrener
gic receptor","Cytochrome P450 2D6","Transcription factor","Ion channel","Other cytosolic protein","Unclassified protein","Epigenetic regulator","Other nuclear protein","Nuclear receptor","Voltage-gat
ed ion channel",Eraser,Oxidoreductase,Reader,"Nuclear hormone receptor subfamily 1","Potassium channels","Lysine demethylase","Peptide receptor (family A GPCR)","Cytochrome P450 family 1",Bromodomain,
"Nuclear hormone receptor subfamily 1 group F","SLC22 family of organic cation and anion transporters","Voltage-gated potassium channel","Jumonji domain-containing","Glycohormone receptor","Cytochrome
 P450 family 1A","Nuclear hormone receptor subfamily 1 group F member 3","Dopamine receptor","Cytochrome P450 1A1"}

> <pathway_chembl>
{Receptors,Transporters,Enzymes,"G protein-coupled receptors","SLC superfamily of solute carriers","Cytochrome P450","Acetylcholine receptors (muscarinic)","SLC6 neurotransmitter transporter family","
Histamine receptors","5-Hydroxytryptamine receptors",Adrenoceptors,"CYP2 family: drug metabolising subset","Monoamine transporter subfamily","Other protein targets","Ion channels","Nuclear hormone rec
eptors","Sigma receptors","Voltage-gated ion channels","Chromatin modifying enzymes","1F. Retinoic acid-related orphans","Dopamine receptors","SLC22 family of organic cation and anion transporters","P
otassium channels","1.14.11.- Histone demethylases","Glycoprotein hormone receptors","CYP1 family","Organic cation transporters (OCT)","Voltage-gated potassium channels"}

> <pathway_reactome>
{"Signal Transduction","Neuronal System",Disease,Metabolism,"Signaling by GPCR","Transmission across Chemical Synapses","Disorders of transmembrane transporters","Biological oxidations","GPCR ligand b
inding","Neurotransmitter clearance","SLC transporter disorders","Phase I - Functionalization of compounds","Class A/1 (Rhodopsin-like receptors)","Serotonin clearance from the synaptic cleft","Defect
ive SLC6A2 causes orthostatic intolerance (OI)","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Cytochrome P450 - arranged by substrate type","Amine ligand-binding receptors",Xenobi
otics,"Muscarinic acetylcholine receptors","Histamine receptors","Serotonin receptors",Adrenoceptors,"CYP2E1 reactions","Gene expression (Transcription)","Transport of small molecules","Muscle contrac
tion","Immune System","Developmental Biology","Cell Cycle","RNA Polymerase II Transcription","Infectious disease","SLC-mediated transmembrane transport","Cardiac conduction","Cytokine Signaling in Imm
une system","Nervous system development",Mitotic,"Generic Transcription Pathway","Leishmania infection","SARS-CoV Infections","Transport of bile salts and organic acids","metal ions and amine compound
s","Phase 3 - rapid repolarisation","Signaling by Interleukins","EGR2 and SOX10-mediated initiation of Schwann cell myelination","M Phase","Transcriptional regulation by RUNX3","Leishmania parasite gr
owth and survival","Potential therapeutics for SARS","Organic cation/anion/zwitterion transport","Interleukin-1 family signaling","Ethanol oxidation","Mitotic Metaphase and Anaphase","RUNX3 Regulates 
Immune Response and Cell Migration","Anti-inflammatory response favouring Leishmania parasite infection","Organic cation transport","Interleukin-1 signaling","Mitotic Anaphase","ADORA2B mediated anti-
inflammatory cytokines production","Dopamine receptors","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Nuclear Envelope (NE) Reassembl
y","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{HRH1,SLC6A2,SLC6A4}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{"Cidoxepin hydrochloride",UNII-XI27WMG8QK,UNIIXI27WMG8QK,"UNII XI27WMG8QK",1229-29-4,1229294,"1229 29 4",25127-31-5,25127315,"25127 31 5",P-4599,P4599,"P 4599",XI27WMG8QK,Curatin,Silenor,Adapin,"Cido
xepin hydrochloride (USAN)",Sinequan,"Doxepine h",T1540,SAM001246976,1500264,"Doxepin hydrochloride",CPD000449270,"DOXEPIN HYDROCHLORIDE"}

> <pdid>
PD009013

> <targets>
{}

> <classes>
{antidepressant}

> <pubchem_cids>
{5281088,92032367}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 20  0  0  0  0            999 V2000
   11.5023   -3.0060    0.0000 H   0  3
    9.0023   -3.0060    0.0000 Cl  0  5
    5.1884   -7.5113    0.0000 C   0  0
    5.1901   -6.0113    0.0000 N   0  0
    6.4902   -5.2631    0.0000 C   0  0
    3.8917   -5.2586    0.0000 C   0  0
    3.8934   -3.7577    0.0000 C   0  0
    2.5949   -3.0050    0.0000 O   0  0
    2.5966   -1.5042    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8990   -0.7582    0.0000 C   0  0
    3.9042    0.7419    0.0000 C   0  0
    5.2058    1.4875    0.0000 C   0  0
    6.5023    0.7331    0.0000 C   0  0
    6.4972   -0.7669    0.0000 C   0  0
    5.1956   -1.5125    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  9 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5963

> <plate>
NGP-105-05

> <well>
B10

> <supplier_cmpd_name>
CPD000058353

> <ctcr_id>
3701

> <supplier_cmpd_id>
SAM001247024

> <smiles>
[H+].[Cl-].CN(C)CCOC(c1ccccc1)c2ccccc2

> <pd_targets>
{PMP22,NFO,LMNA,MAPK1,KDM4E,KCNH2,HRH1,SLC22A2,CYP2D6,CHRM1,THPO,HRH4,ADRA1A,SCN1A,SCN2A,SCN3A,CYP1A2,CHRM4,CHRM3,HTT,CHRM5,TSHR,FFP,CHRM2,SLC6A2,HTR2B,HTR2A,SCN5A,HTR2C,SLC22A1}

> <pathway_gtopdb>
{"Unclassified protein",Enzyme,"Other nuclear protein","Epigenetic regulator","Ion channel","Membrane receptor",Transporter,Hydrolase,Kinase,Eraser,"Voltage-gated ion channel","Family A G protein-coup
led receptor","Electrochemical transporter","Cytochrome P450",Transferase,"Protein Kinase","Lysine demethylase","Potassium channels","Small molecule receptor (family A GPCR)","SLC superfamily of solut
e carriers","Cytochrome P450 family 2","Voltage-gated sodium channel","Cytochrome P450 family 1","Peptide receptor (family A GPCR)","CMGC protein kinase group","Jumonji domain-containing","Voltage-gat
ed potassium channel","Monoamine receptor","SLC22 family of organic cation and anion transporters","Cytochrome P450 family 2D","Cytochrome P450 family 1A","Glycohormone receptor","SLC06 neurotransmitt
er transporter family","CMGC protein kinase MAPK family","Histamine receptor","Cytochrome P450 2D6","Acetylcholine receptor","Adrenergic receptor","Cytochrome P450 1A1","Serotonin receptor","CMGC prot
ein kinase ERK1"}

> <pathway_chembl>
{Enzymes,"Ion channels",Receptors,Transporters,"Kinases (EC 2.7.x.x)","Chromatin modifying enzymes","Voltage-gated ion channels","G protein-coupled receptors","SLC superfamily of solute carriers","Cyt
ochrome P450","CMGC: Containing CDK",MAPK,GSK3,"CLK families","1.14.11.- Histone demethylases","Potassium channels","Histamine receptors","SLC22 family of organic cation and anion transporters","CYP2 
family: drug metabolising subset","Acetylcholine receptors (muscarinic)",Adrenoceptors,"CYP1 family","Glycoprotein hormone receptors","SLC6 neurotransmitter transporter family","5-Hydroxytryptamine re
ceptors","Voltage-gated sodium channels","Mitogen-activated protein kinases (MAP kinases)","Voltage-gated potassium channels","Organic cation transporters (OCT)","Monoamine transporter subfamily","ERK
 subfamily"}

> <pathway_reactome>
{"Developmental Biology","Cell Cycle","Immune System","Muscle contraction","Signal Transduction","Transport of small molecules",Metabolism,Hemostasis,"Gene expression (Transcription)",Disease,"Nervous
 system development",Mitotic,"Innate Immune System","Cardiac conduction","Signaling by GPCR","SLC-mediated transmembrane transport","Biological oxidations","Platelet activation","signaling and aggrega
tion","RNA Polymerase II Transcription","Infectious disease","Disorders of transmembrane transporters","EGR2 and SOX10-mediated initiation of Schwann cell myelination","M Phase","Toll-like Receptor Ca
scades","Phase 3 - rapid repolarisation","GPCR ligand binding","Transport of bile salts and organic acids","metal ions and amine compounds","Phase I - Functionalization of compounds","Platelet Aggrega
tion (Plug Formation)","Generic Transcription Pathway","Leishmania infection","SLC transporter disorders","Axon guidance","Mitotic Metaphase and Anaphase","Toll Like Receptor 5 (TLR5) Cascade","Class 
A/1 (Rhodopsin-like receptors)","Organic cation/anion/zwitterion transport","Cytochrome P450 - arranged by substrate type","Transcriptional Regulation by MECP2","Leishmania parasite growth and surviva
l","Defective SLC6A2 causes orthostatic intolerance (OI)","L1CAM interactions","Mitotic Anaphase","MyD88 cascade initiated on plasma membrane","Amine ligand-binding receptors","Organic cation transpor
t",Xenobiotics,"Regulation of MECP2 expression and activity","Anti-inflammatory response favouring Leishmania parasite infection","Interaction between L1 and Ankyrins","Nuclear Envelope (NE) Reassembl
y","MAP kinase activation","Histamine receptors","CYP2E1 reactions","Muscarinic acetylcholine receptors",Adrenoceptors,"Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","ADORA2B media
ted anti-inflammatory cytokines production","Serotonin receptors","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are 
inactivated"}

> <broad_targets>
{HRH1}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{CHEBI:4637,"(2-(diphenylmethoxy)ethyl)dimethylamine, chloride","(2(diphenylmethoxy)ethyl)dimethylamine, chloride","beta-Dimethylaminoethyl benzhydryl ether hydrochloride","betaDimethylaminoethyl benz
hydryl ether hydrochloride","alpha-Hydroxydiphenylmethane-beta-dimethylaminoethyl ether hydrochloride","alphaHydroxydiphenylmethanebetadimethylaminoethyl ether hydrochloride",SBB057437,AKOS025116949,2
-(,2(,SAM001247024,1500256,Prestw-65,CPD000058353,"DIPHENHYDRAMINE HYDROCHLORIDE","Diphenhydramine hydrochloride"}

> <pdid>
PD009823

> <targets>
{}

> <classes>
{antihistaminic}

> <pubchem_cids>
{43833360,657365,8980}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 17  0  0  0  0            999 V2000
    7.5987    0.0000    0.0000 H   0  3
    5.0987    0.0000    0.0000 Cl  0  5
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10  5  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17  4  1  0
 17 12  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5964

> <plate>
NGP-105-05

> <well>
B11

> <supplier_cmpd_name>
CPD000059105

> <ctcr_id>
1504

> <supplier_cmpd_id>
SAM001247002

> <smiles>
[H+].[Cl-].Nc1c2CCCCc2nc3ccccc13

> <pd_targets>
{THRB,CYP1A2,ACHE,CYP2D6,BCHE,AMPC,HSD17B10,LMNA,TSHR,LEF,MAPK1,ALDH1A1,NFKB1,CYP2C19,ALOX15,MAOA,OPRM1,SLC6A2,HNMT,CHRM2,CHRM1,CHRM3,CHRM4,CHRM5,CHRNE,SLC6A4,HTR2A,RORC,CHAT,ABCC4,KDM4E,CYP3A4,SLC6A3
,ADRA1A,APP,MAOB,FABP6,FABP1,SLC22A2,SLC22A1,GRIN1,GRIN2A,GRIN2B,SLC47A1}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Other nuclear protein","Membrane receptor","Other cytosolic protein",Transporter,"Ion channel","Epigenetic regulator","Unclassified protein","Auxiliary transport protei
n","Nuclear receptor","Cytochrome P450",Hydrolase,Oxidoreductase,"Family A G protein-coupled receptor",Protease,Kinase,"Electrochemical transporter",Transferase,"Ligand-gated ion channel","Primary act
ive transporter",Eraser,"Fatty acid binding protein family","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 1","Cytochrome P450 family 2","Peptide receptor (family A GPCR)","Metallo pro
tease","Protein Kinase","SLC superfamily of solute carriers","Small molecule receptor (family A GPCR)","Nicotinic acetylcholine receptor","ATP-binding cassette","Lysine demethylase","Cytochrome P450 f
amily 3","Ionotropic glutamate receptor","Nuclear hormone receptor subfamily 1 group A","Cytochrome P450 family 1A","Cytochrome P450 family 2D","Glycohormone receptor","Metallo protease MAE clan","CMG
C protein kinase group","Cytochrome P450 family 2C","Short peptide receptor (family A GPCR)","SLC06 neurotransmitter transporter family","Monoamine receptor","Nicotinic acetylcholine receptor epsilon 
subunit","Nuclear hormone receptor subfamily 1 group F","ABCC subfamily","Jumonji domain-containing","Cytochrome P450 family 3A","SLC22 family of organic cation and anion transporters","NMDA receptor"
,"SLC47 family of multidrug and toxin extrusion transporters","Nuclear hormone receptor subfamily 1 group A member 2","Cytochrome P450 1A1","Cytochrome P450 2D6","Metallo protease M34 family","CMGC pr
otein kinase MAPK family","Cytochrome P450 2C19","Opioid receptor","Acetylcholine receptor","Serotonin receptor","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 3A4","Adrenerg
ic receptor","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Ion channels","Other protein targets","Nuclear hormone receptors","Cytochrome P450","Acetylcholine turnover","G protein-coupled receptors","Kinases (EC 2.7.x.x)","Eico
sanoid turnover","Catecholamine turnover","SLC superfamily of solute carriers","Ligand-gated ion channels","ATP-binding cassette transporter family","Chromatin modifying enzymes","Fatty acid-binding p
roteins","1A. Thyroid hormone receptors","CYP1 family","CYP2 family: drug metabolising subset","Glycoprotein hormone receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK families",Lipoxygenases,"Opioid re
ceptors","SLC6 neurotransmitter transporter family","Acetylcholine receptors (muscarinic)","Nicotinic acetylcholine receptors","5-Hydroxytryptamine receptors","1F. Retinoic acid-related orphans","ABCC
 subfamily","1.14.11.- Histone demethylases","CYP3 family",Adrenoceptors,"SLC22 family of organic cation and anion transporters","SLC47 family of multidrug and toxin extrusion transporters","Mitogen-a
ctivated protein kinases (MAP kinases)","Monoamine transporter subfamily","Organic cation transporters (OCT)","ERK subfamily"}

> <pathway_reactome>
{"Metabolism of proteins",Metabolism,"Cell Cycle",Disease,"Immune System","Signal Transduction","Neuronal System","Gene expression (Transcription)",Hemostasis,"Transport of small molecules","Post-tran
slational protein modification","Biological oxidations","Metabolism of lipids","Metabolism of amino acids and derivatives",Mitotic,"Infectious disease","Innate Immune System","Cytokine Signaling in Im
mune system","Signaling by GPCR","Disorders of transmembrane transporters","Transmission across Chemical Synapses","RNA Polymerase II Transcription","Platelet activation","signaling and aggregation","
SLC-mediated transmembrane transport",SUMOylation,"Phase I - Functionalization of compounds","Phospholipid metabolism","Branched-chain amino acid catabolism","M Phase","Leishmania infection","Uptake a
nd actions of bacterial toxins","Toll-like Receptor Cascades","Signaling by Interleukins","Biosynthesis of specialized proresolving mediators (SPMs)","GPCR downstream signalling","SLC transporter diso
rders","Selenoamino acid metabolism","GPCR ligand binding","Neurotransmitter receptors and postsynaptic signal transmission","Neurotransmitter clearance","Generic Transcription Pathway","Response to e
levated platelet cytosolic Ca2+","Metabolism of steroids","Regulation of lipid metabolism by PPARalpha","Transport of bile salts and organic acids","metal ions and amine compounds","SUMO E3 ligases SU
MOylate target proteins","Cytochrome P450 - arranged by substrate type","Glycerophospholipid biosynthesis","Mitotic Metaphase and Anaphase","Leishmania parasite growth and survival","Uptake and functi
on of anthrax toxins","Toll Like Receptor 5 (TLR5) Cascade","Ethanol oxidation","Interleukin-1 family signaling","Biosynthesis of DPA-derived SPMs","Amine Oxidase reactions","G alpha (i) signalling ev
ents","Defective SLC6A2 causes orthostatic intolerance (OI)","Metabolism of ingested SeMet",Sec,"MeSec into H2Se","Class A/1 (Rhodopsin-like receptors)","Acetylcholine binding and downstream events","
Serotonin clearance from the synaptic cleft","Transcriptional regulation by RUNX3","Platelet degranulation","Biosynthesis of DHA-derived SPMs","Defective SLC6A3 causes Parkinsonism-dystonia infantile 
(PKDYS)","Bile acid and bile salt metabolism","PPARA activates gene expression","Organic cation/anion/zwitterion transport","SUMOylation of intracellular receptors",Xenobiotics,"Synthesis of PC","Mito
tic Anaphase","Anti-inflammatory response favouring Leishmania parasite infection","MyD88 cascade initiated on plasma membrane","Interleukin-1 signaling","Biosynthesis of DPAn-3 SPMs","Biogenic amines
 are oxidatively deaminated to aldehydes by MAOA and MAOB","Opioid Signalling","Amine ligand-binding receptors","Postsynaptic nicotinic acetylcholine receptors","RUNX3 Regulates Immune Response and Ce
ll Migration","Biosynthesis of maresins","Recycling of bile acids and salts","Organic cation transport","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","CYP2E1 reactions","Nuclear E
nvelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","MAP kinase activation","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Biosynthesis of DPAn-3-derived protectins and r
esolvins","G-protein activation","Muscarinic acetylcholine receptors","Highly sodium permeable postsynaptic acetylcholine nicotinic receptors","Serotonin receptors","Biosynthesis of maresin-like SPMs"
,Adrenoceptors,"TAK1 activates NFkB by phosphorylation and activation of IKKs complex","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAP
K targets","ERKs are inactivated"}

> <broad_targets>
{ACHE,BCHE}

> <broad_moa>
{"acetylcholinesterase inhibitor"}

> <synonyms>
{SPECTRUM2300104,"Tacrine hydrochloride",1684-40-8,1684408,"1,2,3,4-tetrahydroacridin-9-amine hydrochloride","1,2,3,4tetrahydroacridin9amine hydrochloride","Tacrine HCl",Hydroaminacrine,Romotal,Tenakr
in,"9-AMINO-1,2,3,4-TETRAHYDROACRIDINE HYDROCHLORIDE","9AMINO1,2,3,4TETRAHYDROACRIDINE HYDROCHLORIDE",UNII-4966RNG0BU,UNII4966RNG0BU,tacrine.HCl,"Tacrine (hydroc",T2191,SAM001247002,2300104,Prestw-329
,"Tacrine hydrochloride hydrate",CPD000059105,"TACRINE HYDROCHLORIDE"}

> <pdid>
PD009117

> <targets>
{}

> <classes>
{anticholinesterase,"K channel blocker","cognitive adjuvant"}

> <pubchem_cids>
{15517,2723754,67108391}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 27  0  0  1  0            999 V2000
   10.2985   -2.2535    0.0000 Cl  0  0
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0  1  0  0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -0.0031   -3.0008    0.0000 C   0  0
   -1.3039   -3.7494    0.0000 C   0  0
   -2.6016   -2.9971    0.0000 O   0  0
   -1.3070   -5.2502    0.0000 C   0  0
   -2.6060   -6.0003    0.0000 C   0  0
   -2.6060   -7.5003    0.0000 C   0  0
   -1.3070   -8.2503    0.0000 C   0  0
   -0.0080   -7.5003    0.0000 C   0  0
   -0.0079   -6.0003    0.0000 C   0  0
    2.6003    1.4978    0.0000 C   0  0
    3.8990    0.7455    0.0000 C   0  0  2  0  0  0
    3.8964   -0.7545    0.0000 O   0  0
    5.2003    1.4932    0.0000 C   0  0
    6.4994    0.7433    0.0000 C   0  0
    7.7985    1.4933    0.0000 C   0  0
    7.7985    2.9933    0.0000 C   0  0
    6.4995    3.7433    0.0000 C   0  0
    5.2004    2.9933    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  3  1  0
  8  9  1  1
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
  4 18  1  1
 18 19  1  0
 19 20  1  1
 19 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
M  END
> <name>
NIHCC_2014

> <id>
5965

> <plate>
NGP-105-05

> <well>
C02

> <supplier_cmpd_name>
CPD000058465

> <ctcr_id>
2286

> <supplier_cmpd_id>
SAM001247050

> <smiles>
Cl.CN1[C@@H](CCC[C@@H]1CC(=O)c2ccccc2)C[C@H](O)c3ccccc3

> <pd_targets>
{NFO,SLC18A2,CHRNA10,CHRNA2,CHRNA3,CHRNA4,CHRNA5,CHRNA6,CHRNA7,CHRNA9,CHRNB2,CHRNB3,CHRNB4,LMNA,HTR2A,CHRNA1,HRH1,CYP2D6,SLC6A4,NACHRALPHA5,SLC6A3}

> <pathway_gtopdb>
{Enzyme,Transporter,"Ion channel","Other nuclear protein","Membrane receptor","Unclassified protein",Hydrolase,"Electrochemical transporter","Ligand-gated ion channel","Family A G protein-coupled rece
ptor","Cytochrome P450","SLC superfamily of solute carriers","Nicotinic acetylcholine receptor","Small molecule receptor (family A GPCR)","Cytochrome P450 family 2","SLC18 family of vesicular amine tr
ansporters","Nicotinic acetylcholine receptor alpha subunit","Monoamine receptor","Cytochrome P450 family 2D","SLC06 neurotransmitter transporter family","Serotonin receptor","Histamine receptor","Cyt
ochrome P450 2D6"}

> <pathway_chembl>
{Transporters,"Ion channels",Receptors,Enzymes,"SLC superfamily of solute carriers","Ligand-gated ion channels","G protein-coupled receptors","Cytochrome P450","SLC18 family of vesicular amine transpo
rters","Nicotinic acetylcholine receptors","5-Hydroxytryptamine receptors","Histamine receptors","CYP2 family: drug metabolising subset","SLC6 neurotransmitter transporter family","Monoamine transport
er subfamily"}

> <pathway_reactome>
{"Neuronal System","Cell Cycle","Signal Transduction",Metabolism,Disease,"Transmission across Chemical Synapses",Mitotic,"Signaling by GPCR","Biological oxidations","Disorders of transmembrane transpo
rters","Neurotransmitter release cycle","Neurotransmitter receptors and postsynaptic signal transmission","M Phase","GPCR ligand binding","Phase I - Functionalization of compounds","Neurotransmitter c
learance","SLC transporter disorders","Dopamine Neurotransmitter Release Cycle","Acetylcholine binding and downstream events","Mitotic Metaphase and Anaphase","Class A/1 (Rhodopsin-like receptors)","C
ytochrome P450 - arranged by substrate type","Serotonin clearance from the synaptic cleft","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Postsynaptic nicotinic acetylcholine recep
tors","Mitotic Anaphase","Amine ligand-binding receptors",Xenobiotics,"Highly calcium permeable postsynaptic nicotinic acetylcholine receptors","Nuclear Envelope (NE) Reassembly","Serotonin receptors"
,"Histamine receptors","CYP2E1 reactions","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{CHRNA10,CHRNA9,SLC18A2}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{CCG-101032,CCG101032,"LOBELINE HYDROCHLORIDE","alpha-Lobeline hydrochloride","alphaLobeline hydrochloride",134-63-4,134634,"Lobeline HCl","(-)-Lobeline hydrochloride","()Lobeline hydrochloride","Lobe
line (hydrochloride)",UNII-96J834CB88,UNII96J834CB88,Zoolobelin,"Lobeline hydrochloride (JAN)",MLS000069392,MFCD00082455,96J834CB88,T0268,SAM001247050,"Lobeline hydrochloride",CPD000058465}

> <pdid>
PD008645

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{657330,101615}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 29  0  0  0  0            999 V2000
   15.1248  -23.7908    0.0000 C   0  0
   14.2598  -23.2891    0.0000 C   0  0
   14.2619  -21.7882    0.0000 C   0  0
   12.9637  -21.0352    0.0000 C   0  0
   12.9658  -19.5343    0.0000 C   0  0
   11.6676  -18.7813    0.0000 C   0  0
   11.6698  -17.2804    0.0000 C   0  0
   12.9701  -16.5310    0.0000 C   0  0
   12.9722  -15.0302    0.0000 C   0  0
   14.2726  -14.2808    0.0000 C   0  0
   15.5722  -15.0314    0.0000 C   0  0
   16.8726  -14.2821    0.0000 C   0  0
   18.1722  -15.0327    0.0000 C   0  0
   18.1729  -16.5335    0.0000 C   0  0
   19.4726  -17.2841    0.0000 C   0  0
   19.4733  -18.7849    0.0000 C   0  0
   18.1744  -19.5368    0.0000 C   0  0
   18.1751  -21.0376    0.0000 C   0  0
   16.8762  -21.7895    0.0000 C   0  0
   16.8769  -23.2903    0.0000 C   0  0
   18.1765  -24.0393    0.0000 O   0  0
   15.5780  -24.0422    0.0000 N   0  0
   15.5787  -25.5430    0.0000 C   0  0
   14.2816  -26.2963    0.0000 C   0  0
   14.2854  -27.7963    0.0000 C   0  0
   15.5863  -28.5430    0.0000 C   0  0
   15.5901  -30.0430    0.0000 O   0  0
   16.8834  -27.7897    0.0000 C   0  0
   16.8796  -26.2897    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 26 28  1  0
 28 29  2  0
 29 23  1  0
M  END
> <name>
NIHCC_2014

> <id>
5966

> <plate>
NGP-105-05

> <well>
C03

> <supplier_cmpd_name>
CPD000449274

> <ctcr_id>
3711

> <supplier_cmpd_id>
SAM001246965

> <smiles>
CCCCC/C=C\C\C=C/C/C=C\C\C=C/CCCC(=O)Nc1ccc(O)cc1

> <pd_targets>
{LEF,GAA,MAPT,CYP3A4,CYP2C19,TP53,CNR1,FAAH,HPGD,SKA,CYP1A2,FTL,TRPV1,CNR2,KMT2A,MEN1,MAPK1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMA8,PSMB1,PSMB10,PSMB11,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB7,PSMB
8,PSMB9,FABP1,TGR,NPSR1,CYP2C9,ALOX15,ALDH1A1}

> <pathway_gtopdb>
{Enzyme,"Other cytosolic protein","Transcription factor","Membrane receptor","Unclassified protein","Ion channel","Epigenetic regulator","Auxiliary transport protein",Protease,Hydrolase,"Cytochrome P4
50","Family A G protein-coupled receptor",Kinase,"Voltage-gated ion channel",Reader,"Fatty acid binding protein family",Oxidoreductase,"Metallo protease","Cytochrome P450 family 3","Cytochrome P450 fa
mily 2","Small molecule receptor (family A GPCR)","Cysteine protease","Cytochrome P450 family 1","Transient receptor potential channel",Bromodomain,"Protein Kinase","Threonine protease","Peptide recep
tor (family A GPCR)","Metallo protease MAE clan","Cytochrome P450 family 3A","Cytochrome P450 family 2C","Lipid-like ligand receptor (family A GPCR)","Cysteine protease CA clan","Cytochrome P450 famil
y 1A","CMGC protein kinase group","Threonine protease PBT clan","Short peptide receptor (family A GPCR)","Metallo protease M34 family","Cytochrome P450 3A4","Cytochrome P450 2C19","Cannabinoid recepto
r","Cysteine protease C1A family","Cytochrome P450 1A1","CMGC protein kinase MAPK family","Threonine protease T1A subfamily","Neuropeptide receptor","Cytochrome P450 2C9","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Receptors,"Ion channels","Other protein targets","3.2.1.- Glycosidases","Cytochrome P450","G protein-coupled receptors","Endocannabinoid turnover","Eicosanoid turnover","Voltage-gated ion cha
nnels","Kinases (EC 2.7.x.x)","Fatty acid-binding proteins","CYP3 family","CYP2 family: drug metabolising subset","Cannabinoid receptors","<i>N</i>-Acylethanolamine turnover","Prostaglandin synthases"
,"CYP1 family","Transient Receptor Potential channels","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Neuropeptide S receptor",Lipoxygenases,"Mitogen-activated protein kinases (MAP kinases)","ERK su
bfamily"}

> <pathway_reactome>
{Disease,"Neuronal System",Metabolism,"Cell Cycle","Signal Transduction","Vesicle-mediated transport","Transport of small molecules","Immune System","Infectious disease","Diseases of metabolism","Tran
smission across Chemical Synapses","Metabolism of lipids","Biological oxidations","Cell Cycle Checkpoints","Signaling by GPCR","Membrane Trafficking","Ion channel transport","Innate Immune System","Up
take and actions of bacterial toxins","Diseases of carbohydrate metabolism","Neurotransmitter receptors and postsynaptic signal transmission","Biosynthesis of specialized proresolving mediators (SPMs)
","Phase I - Functionalization of compounds","G1/S DNA Damage Checkpoints","GPCR downstream signalling","Fatty acid metabolism","trans-Golgi Network Vesicle Budding","Stimuli-sensing channels","Toll-l
ike Receptor Cascades","Regulation of lipid metabolism by PPARalpha","Leishmania infection","Uptake and function of anthrax toxins","Glycogen storage diseases","Activation of NMDA receptors and postsy
naptic events","Biosynthesis of DHA-derived SPMs","Cytochrome P450 - arranged by substrate type","p53-Dependent G1/S DNA damage checkpoint","G alpha (i) signalling events","Arachidonic acid metabolism
","Golgi Associated Vesicle Biogenesis","TRP channels","Toll Like Receptor 5 (TLR5) Cascade","PPARA activates gene expression","Leishmania parasite growth and survival","Biosynthesis of DPA-derived SP
Ms","Ethanol oxidation","Glycogen storage disease type II (GAA)","Post NMDA receptor activation events","Biosynthesis of maresins",Xenobiotics,"p53-Dependent G1 DNA Damage Response","Biosynthesis of D
-series resolvins","MyD88 cascade initiated on plasma membrane","Anti-inflammatory response favouring Leishmania parasite infection","Biosynthesis of DPAn-3 SPMs","Activation of AMPK downstream of NMD
ARs","Biosynthesis of maresin-like SPMs","CYP2E1 reactions","Stabilization of p53","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","MAP kinase activation","ADORA2B mediated anti-inf
lammatory cytokines production","Biosynthesis of DPAn-3-derived protectins and resolvins","Autodegradation of the E3 ubiquitin ligase COP1","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/
MAPK targets","ERKs are inactivated"}

> <broad_targets>
{CNR1,CNR2,FAAH,TRPV1}

> <broad_moa>
{"cyclooxygenase inhibitor","FAAH inhibitor","TRPV antagonist"}

> <synonyms>
{"AM 404",AM-404,AM404,183718-77-6,183718776,am404,198022-70-7,198022707,UNII-XVJ94H0U21,UNIIXVJ94H0U21,"(5Z,8Z,11Z,14Z)-N-(4-hydroxyphenyl)icosa-5,8,11,14-tetraenamide","(5Z,8Z,11Z,14Z)N(4hydroxyphen
yl)icosa5,8,11,14tetraenamide",CHEMBL39878,XVJ94H0U21,N-(4-Hydroxyphenyl)-arachidonylamide,N(4Hydroxyphenyl)arachidonylamide,"N-(4-Hydroxyphenyl)-5Z,8Z,11Z,14Z-eicosatetraenamide","N(4Hydroxyphenyl)5Z
,8Z,11Z,14Zeicosatetraenamide",SAM001246965,CPD000449274}

> <pdid>
PD003151

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{6604822}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 23  0  0  1  0            999 V2000
    1.2844    3.7485    0.0000 C   0  0
    2.5857    3.0025    0.0000 N   0  0
    2.5914    1.5017    0.0000 C   0  0
    3.8934    0.7553    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0  2  0  0  0
    2.6003   -1.4978    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    5.2003   -1.4933    0.0000 C   0  0
    5.3453   -2.9734    0.0000 S   0  0
    6.8141   -3.2782    0.0000 C   0  0
    7.5577   -1.9755    0.0000 C   0  0
    6.5486   -0.8657    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16  7  1  0
 16 11  1  0
  5 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 17  2  0
M  END
> <name>
NIHCC_2014

> <id>
5967

> <plate>
NGP-105-05

> <well>
C04

> <supplier_cmpd_name>
CPD000449282

> <ctcr_id>
1567

> <supplier_cmpd_id>
SAM001247059

> <smiles>
CNCC[C@H](Oc1cccc2ccccc12)c3sccc3

> <pd_targets>
{HTR2A,KMT2A,HTR6,CYP1A2,CYP3A4,SLC6A2,SLC6A3,SLC6A4,NET,HTT,GAA,CYP2C9,HTR2C,CYP2D6,SHMT2,CYP2C19,KCNH2,CACNA1C,CACNA1D,CACNA1F,CACNA1S,KCND3,SCN5A,KCNE1,KCNQ1}

> <pathway_gtopdb>
{"Membrane receptor","Epigenetic regulator",Enzyme,Transporter,"Unclassified protein","Ion channel","Family A G protein-coupled receptor",Reader,"Cytochrome P450","Electrochemical transporter",Hydrola
se,Transferase,"Voltage-gated ion channel","Small molecule receptor (family A GPCR)",Bromodomain,"Cytochrome P450 family 1","Cytochrome P450 family 3","SLC superfamily of solute carriers","Cytochrome 
P450 family 2","Potassium channels","Voltage-gated calcium channel","Voltage-gated sodium channel","Monoamine receptor","Cytochrome P450 family 1A","Cytochrome P450 family 3A","SLC06 neurotransmitter 
transporter family","Cytochrome P450 family 2C","Cytochrome P450 family 2D","Voltage-gated potassium channel","Serotonin receptor","Cytochrome P450 1A1","Cytochrome P450 3A4","Cytochrome P450 2C9","Cy
tochrome P450 2D6","Cytochrome P450 2C19"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Ion channels","G protein-coupled receptors","Chromatin modifying enzymes","Cytochrome P450","SLC superfamily of solute carriers","3.2.1.- Glycosidases","Voltage-gated 
ion channels","5-Hydroxytryptamine receptors","2.1.1.43 Histone methyltransferases (HMTs)","CYP1 family","CYP3 family","SLC6 neurotransmitter transporter family","CYP2 family: drug metabolising subset
","Potassium channels","Voltage-gated calcium channels","Voltage-gated sodium channels","Monoamine transporter subfamily","Voltage-gated potassium channels"}

> <pathway_reactome>
{"Signal Transduction","Gene expression (Transcription)",Disease,Metabolism,"Neuronal System","Muscle contraction","Developmental Biology","Signaling by GPCR","RNA Polymerase II Transcription","Infect
ious disease","Biological oxidations","Metabolism of lipids","Disorders of transmembrane transporters","Transmission across Chemical Synapses","Diseases of metabolism","Metabolism of vitamins and cofa
ctors","Cardiac conduction","Nervous system development","GPCR ligand binding","Generic Transcription Pathway","Leishmania infection","Phase I - Functionalization of compounds","Biosynthesis of specia
lized proresolving mediators (SPMs)","SLC transporter disorders","Neurotransmitter clearance","Diseases of carbohydrate metabolism","Metabolism of water-soluble vitamins and cofactors","Phase 3 - rapi
d repolarisation","Axon guidance","Phase 1 - inactivation of fast Na+ channels","Class A/1 (Rhodopsin-like receptors)","Transcriptional regulation by RUNX1","Leishmania parasite growth and survival","
Cytochrome P450 - arranged by substrate type","Biosynthesis of DHA-derived SPMs","Defective SLC6A2 causes orthostatic intolerance (OI)","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)
","Serotonin clearance from the synaptic cleft","Transcriptional Regulation by MECP2","Glycogen storage diseases","Metabolism of folate and pterines","NCAM signaling for neurite out-growth","L1CAM int
eractions","Amine ligand-binding receptors","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","Anti-inflammatory response favouring Leishmania parasite infection"
,Xenobiotics,"Biosynthesis of maresins","Regulation of MECP2 expression and activity","Glycogen storage disease type II (GAA)","NCAM1 interactions","Interaction between L1 and Ankyrins","Serotonin rec
eptors","ADORA2B mediated anti-inflammatory cytokines production","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Biosynthesis of maresin-like SPMs","CYP2E1 reactions"}

> <broad_targets>
{HTR2A,HTR2C,HTR6,SLC6A2,SLC6A3,SLC6A4}

> <broad_moa>
{"norepinephrine reuptake inhibitor","serotoninânorepinephrine reuptake inhibitor (SNRI)"}

> <synonyms>
{methyl((3S)-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl)amine,methyl((3S)3(naphthalen1yloxy)3(thiophen2yl)propyl)amine,duloxetine,116539-59-4,116539594,(S)-Duloxetine,(S)Duloxetine,Cymbalta,Yentre
ve,(S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine,(S)NMethyl3(naphthalen1yloxy)3(thiophen2yl)propan1amine,136434-34-9,136434349,"LY 248686",UNII-O5TNM5N07U,UNIIO5TNM5N07U,Ariclaim
,Xeri,T1471,SAM001247059,"Duloxetine hydrochloride",CPD000449282}

> <pdid>
PD003013

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{60835}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 25  0  0  1  0            999 V2000
    9.6093   -0.6796    0.0000 O   0  0
    7.1093   -0.6796    0.0000 Br  0  0
   -5.1750    2.4141    0.0000 C   0  0
   -3.7106    2.0893    0.0000 N   0  0
   -2.7244    3.5602    0.0000 C   0  0  2  0  0  0
   -1.3873    2.9083    0.0000 C   0  0
   -1.0864    1.5043    0.0000 C   0  0
   -1.9890    0.3677    0.0000 C   0  0
   -3.4432    0.3677    0.0000 C   0  0  1  0  0  0
   -4.3959    1.5043    0.0000 C   0  0  2  0  0  0
   -5.3820    2.3902    0.0000 O   0  0
   -4.0616    2.9083    0.0000 C   0  0  2  0  0  0
    0.3779    1.1636    0.0000 O   0  0
    0.8153   -0.2720    0.0000 C   0  0
   -0.2091   -1.3677    0.0000 O   0  0
    2.2771   -0.6120    0.0000 C   0  0  2  0  0  0
    3.2999    0.4864    0.0000 C   0  0
    2.8611    1.9208    0.0000 O   0  0
    2.7145   -2.0477    0.0000 C   0  0
    4.1751   -2.3896    0.0000 C   0  0
    4.6093   -3.8253    0.0000 C   0  0
    3.5830   -4.9193    0.0000 C   0  0
    2.1225   -4.5775    0.0000 C   0  0
    1.6883   -3.1417    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  1
  6  7  1  0
  7  8  1  0
  9  8  1  1
  9  4  1  0
  9 10  1  0
 10 11  1  6
 12 11  1  6
 12  5  1  0
 12 10  1  0
  7 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  6
 17 18  1  0
 16 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
M  END
> <name>
NIHCC_2014

> <id>
5968

> <plate>
NGP-105-05

> <well>
C05

> <supplier_cmpd_name>
CPD000449327

> <ctcr_id>
3824

> <supplier_cmpd_id>
SAM001246967

> <smiles>
O.Br.CN1[C@@H]2CC(C[C@H]1[C@@H]3O[C@H]23)OC(=O)[C@H](CO)c4ccccc4

> <pd_targets>
{MACHR-A,CHRM2,CHRM4,CHRM3,CHRM5,CHRM1,SI,RORC,NFO,KMT2A,MEN1}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Transcription factor","Epigenetic regulator","Family A G protein-coupled receptor","Nuclear receptor",Hydrolase,Reader,"Small molecule receptor (family A GPCR)","Nuclear h
ormone receptor subfamily 1",Bromodomain,"Monoamine receptor","Nuclear hormone receptor subfamily 1 group F","Acetylcholine receptor","Nuclear hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Nuclear hormone receptors","Acetylcholine receptors (muscarinic)","1F. Retinoic acid-related orphans"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Gene expression (Transcription)","Signaling by GPCR","Diseases of metabolism","RNA Polymerase II Transcription","GPCR ligand binding","Diseases of carbohydrate metaboli
sm","Generic Transcription Pathway","Class A/1 (Rhodopsin-like receptors)","Intestinal saccharidase deficiencies","Transcriptional regulation by RUNX3","Amine ligand-binding receptors","RUNX3 Regulate
s Immune Response and Cell Migration","Muscarinic acetylcholine receptors"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,SI}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{"Scopolamine hydrobromide hydrate","Scopolamine hydrobromide",SMR000449327,SMR000653471,MLS000758270,MLS001076136,MLS001401381,MLS002153276,MLS002207064,C17H21NO4.HBr.H2O,CHEMBL1877254,CHEMBL1895003,
SCHEMBL16892699,"Scopolamine hydrobromide n",SAM001246967,CPD000449327}

> <pdid>
PD008411

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581798}

$$$$
NIHCC_2014
  SciTegic11012413002D

 16 18  0  0  0  0            999 V2000
    3.2411   -4.2545    0.0000 O   0  0
    3.2676   -2.7548    0.0000 C   0  0
    4.0197   -1.4569    0.0000 C   0  0
    2.5987   -1.5004    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    5.3083   -0.6878    0.0000 C   0  0
    5.8327    0.6954    0.0000 C   0  0
    7.3130    0.9379    0.0000 C   0  0
    8.2631   -0.2228    0.0000 C   0  0
    7.7330   -1.6260    0.0000 C   0  0
    6.2527   -1.8685    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  2  3
  4  2  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  3 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
M  END
> <name>
NIHCC_2014

> <id>
5969

> <plate>
NGP-105-05

> <well>
C06

> <supplier_cmpd_name>
CPD000449319

> <ctcr_id>
861

> <supplier_cmpd_id>
SAM001247027

> <smiles>
O=C1C(=C1c2ccccc2)c3ccccc3

> <pd_targets>
{RORC,MAPT,HTT,TGR,LMNA}

> <pathway_gtopdb>
{"Transcription factor","Other cytosolic protein","Unclassified protein",Enzyme,"Other nuclear protein","Nuclear receptor","Nuclear hormone receptor subfamily 1","Nuclear hormone receptor subfamily 1 
group F","Nuclear hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{Receptors,"Nuclear hormone receptors","1F. Retinoic acid-related orphans"}

> <pathway_reactome>
{"Gene expression (Transcription)","Neuronal System","Cell Cycle","RNA Polymerase II Transcription","Transmission across Chemical Synapses",Mitotic,"Generic Transcription Pathway","Neurotransmitter re
ceptors and postsynaptic signal transmission","M Phase","Transcriptional regulation by RUNX3","Activation of NMDA receptors and postsynaptic events","Transcriptional Regulation by MECP2","Mitotic Meta
phase and Anaphase","RUNX3 Regulates Immune Response and Cell Migration","Post NMDA receptor activation events","Regulation of MECP2 expression and activity","Mitotic Anaphase","Activation of AMPK dow
nstream of NMDARs","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{}

> <broad_moa>
{immunostimulant}

> <synonyms>
{Diphenylcyclopropenone,886-38-4,886384,Diphencyprone,"2,3-Diphenylcycloprop-2-en-1-one","2,3Diphenylcycloprop2en1one","2,3-Diphenylcycloprop-2-enone","2,3Diphenylcycloprop2enone","2,3-Diphenylcyclopr
openone","2,3Diphenylcyclopropenone","1,2-Diphenylcyclopropen-3-one","1,2Diphenylcyclopropen3one","2-Cyclopropen-1-one, 2,3-diphenyl-","2Cyclopropen1one, 2,3diphenyl","Cyclopropenone, diphenyl-","Cycl
opropenone, diphenyl",DPC,SAM001247027,CPD000449319}

> <pdid>
PD003022

> <targets>
{Others}

> <classes>
{Others}

> <pubchem_cids>
{65057}

$$$$
NIHCC_2014
  SciTegic11012413002D

 15 14  0  0  0  0            999 V2000
    3.8912   -5.2570    0.0000 N   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    7.6933   -0.3789    0.0000 O   0  0
    7.6933   -1.8789    0.0000 S   0  0
    7.6933   -3.3789    0.0000 O   0  0
    6.3940   -2.6285    0.0000 O   0  0
    8.9926   -2.6285    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 12 15  2  0
M  END
> <name>
NIHCC_2014

> <id>
5970

> <plate>
NGP-105-05

> <well>
C07

> <supplier_cmpd_name>
CPD000058500

> <ctcr_id>
4779

> <supplier_cmpd_id>
SAM001247037

> <smiles>
NNCCc1ccccc1.O[S](O)(=O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Phenelzine sulfate",156-51-4,156514,"PHENELZINE SULFATE SALT","Phenelzine (sulfate)",Estinerval,Nardelzine,Kalgan,"Phenethylhydrazine sulfate",Phenethylhydrazin,Mao-Rem,MaoRem,"Phenelzine bisulfate"
,"Phenelzine acid sulfate","Phenelzine hydrogen sulfate",SAM001247037,1500476,Prestw-170,CPD000058500,"PHENELZINE SULFATE"}

> <pdid>

> <targets>
{}

> <classes>
{antidepressant}

> <pubchem_cids>
{61100,57417440}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 21  0  0  1  0            999 V2000
   10.8389   -2.0043    0.0000 Cl  0  5
   -0.2237   -5.5078    0.0000 C   0  0
   -0.6890   -4.0818    0.0000 N   0  3
    0.3114   -2.9665    0.0000 C   0  0  2  0  0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 C   0  0  1  0  0  0
    3.8813   -1.4408    0.0000 C   0  0
    4.4481   -0.0574    0.0000 C   0  0
    5.9346    0.1432    0.0000 C   0  0
    6.8516   -1.0438    0.0000 C   0  0
    8.3381   -0.8432    0.0000 Cl  0  0
    6.2821   -2.4315    0.0000 C   0  0
    7.1991   -3.6185    0.0000 Cl  0  0
    4.7956   -2.6321    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  3  1  0
  4  3  1  1
  4  5  1  0
  5  6  1  0
  6  7  1  6
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 12 14  2  0
 14  7  1  0
  6 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20  4  1  0
 20 15  1  0
M  CHG  2   1  -1   3   1
M  END
> <name>
NIHCC_2014

> <id>
5971

> <plate>
NGP-105-05

> <well>
C08

> <supplier_cmpd_name>
CPD000449273

> <ctcr_id>
3213

> <supplier_cmpd_id>
SAM001246981

> <smiles>
[Cl-].C[NH2+][C@@H]1C[C@@H](c2ccc(Cl)c(Cl)c2)c3ccccc13

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Indatraline hydrochloride","Indatraline HCl",96850-13-4,96850134,"96850 13 4",CPD000449273,NCGC00094042-01,NCGC0009404201,"NCGC00094042 01","Lu 19-005","Lu 19005","Lu 19 005",SMR000449273,SR-0100007
5409,SR01000075409,"SR 01000075409",MFCD000,SAM001246981}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{11163285,10314472}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 31  0  0  0  0            999 V2000
   10.1876   -3.0043    0.0000 H   0  3
    7.6876   -3.0043    0.0000 Cl  0  5
    3.8756   -9.7579    0.0000 C   0  0
    3.8808   -8.2579    0.0000 N   0  0
    5.1824   -7.5124    0.0000 C   0  0
    5.1876   -6.0124    0.0000 C   0  0
    3.8912   -5.2578    0.0000 N   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 S   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -1.2990   -5.2508    0.0000 C   0  0
   -2.5976   -6.0017    0.0000 F   0  0
    0.0003   -6.0004    0.0000 F   0  0
   -1.2983   -6.7508    0.0000 F   0  0
    2.5895   -6.0034    0.0000 C   0  0
    2.5844   -7.5034    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 11  1  0
 24 19  1  0
 22 25  1  0
 25 26  1  0
 25 27  1  0
 25 28  1  0
  7 29  1  0
 29 30  1  0
 30  4  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5972

> <plate>
NGP-105-05

> <well>
C09

> <supplier_cmpd_name>
CPD000059133

> <ctcr_id>
5986

> <supplier_cmpd_id>
SAM001247046

> <smiles>
[H+].[Cl-].CN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1

> <pd_targets>
{NS3,SIGMAR1,LMNA,MAPT,ALDH1A1,CHRM1,THPO,CYP2D6,CYP1A2,ADRA1A,ADRA1B,ADRA1D,NFKB1,FFP,CYP3A4,NFO,DRD2,HTR2C,CHRM2,HRH1,HTR2A,CHRM3,DRD4,HTR1A,CALM,POLB,GMNN,TPR,ADRA2A,HTR7,HTR6,ADRA2C,WDR48,GUSB,ATP
2A1,ERG2,LEF,ABCB1,EBP,CALM1,KMT2A,MEN1,CYP2C19,MAPK1,ALB,DRD3,EBPL,ALOX15,TP53,LYZ1,HTR2B,HSD17B10,PDR5,ADRA2B,TSHR,PRKCZ,USP1,RAD52,SCN1A,SCN2A,SCN3A,KDM4E,RORC,NPSR1,HTT,PMP22,MTOR,PRKDC,KCNH2,CALY
,S100A4}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Other nuclear protein","Other cytosolic protein","Unclassified protein",Transporter,"Epigenetic regulator","Secreted protein","Transcription factor","Ion channel",Protease
,Oxidoreductase,"Family A G protein-coupled receptor","Cytochrome P450",Transferase,Hydrolase,"Primary active transporter",Isomerase,Reader,Kinase,"Voltage-gated ion channel",Eraser,"Nuclear receptor"
,"Serine protease","Small molecule receptor (family A GPCR)","Cytochrome P450 family 2","Cytochrome P450 family 1","Cytochrome P450 family 3","P-type ATPase","Metallo protease","ATP-binding cassette",
Bromodomain,"Protein Kinase","Peptide receptor (family A GPCR)","Cysteine protease","Voltage-gated sodium channel","Lysine demethylase","Nuclear hormone receptor subfamily 1","Potassium channels","Ser
ine protease PA clan","Monoamine receptor","Cytochrome P450 family 2D","Cytochrome P450 family 1A","Cytochrome P450 family 3A","Calcium ATPase","Metallo protease MAE clan","ABCB subfamily","Cytochrome
 P450 family 2C","CMGC protein kinase group","Glycohormone receptor","AGC protein kinase group","Cysteine protease CA clan","Jumonji domain-containing","Nuclear hormone receptor subfamily 1 group F","
Short peptide receptor (family A GPCR)","Atypical protein kinase group","Voltage-gated potassium channel","Serine protease S29 family","Acetylcholine receptor","Cytochrome P450 2D6","Cytochrome P450 1
A1","Adrenergic receptor","Cytochrome P450 3A4","Dopamine receptor","Serotonin receptor","Histamine receptor","Metallo protease M34 family","Cytochrome P450 2C19","CMGC protein kinase MAPK family","AG
C protein kinase PKC family","Cysteine protease C19 family","Nuclear hormone receptor subfamily 1 group F member 3","Neuropeptide receptor","Atypical protein kinase PIKK family","CMGC protein kinase E
RK1","AGC protein kinase PKC iota subfamily","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{"Other protein targets",Receptors,Enzymes,Transporters,"Ion channels","Sigma receptors","G protein-coupled receptors","Cytochrome P450","P-type ATPases","ATP-binding cassette transporter family","Kin
ases (EC 2.7.x.x)","Eicosanoid turnover","Chromatin modifying enzymes","Nuclear hormone receptors","Voltage-gated ion channels","Acetylcholine receptors (muscarinic)","CYP2 family: drug metabolising s
ubset","CYP1 family","CYP3 family","Dopamine receptors","5-Hydroxytryptamine receptors","Histamine receptors",Adrenoceptors,"P2A P-type ATPases: Ca<sup>2+</sup>-ATPases","ABCB subfamily","CMGC: Contai
ning CDK",MAPK,GSK3,"CLK families",Lipoxygenases,"Glycoprotein hormone receptors","AGC: Containing PKA",PKG,"PKC families","1.14.11.- Histone demethylases","1F. Retinoic acid-related orphans","Neurope
ptide S receptor",Atypical,"Potassium channels","Mitogen-activated protein kinases (MAP kinases)","Protein kinase C (PKC) family","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","Volta
ge-gated potassium channels","ERK subfamily","Iota subfamily","FRAP subfamily","Other PIKK family kinases"}

> <pathway_reactome>
{Disease,"Cell Cycle","Neuronal System",Metabolism,"Signal Transduction",Hemostasis,"Immune System","DNA Repair","Gene expression (Transcription)","Developmental Biology","Muscle contraction","Infecti
ous disease",Mitotic,"Transmission across Chemical Synapses","Biological oxidations","Signaling by GPCR","Platelet activation","signaling and aggregation","Cytokine Signaling in Immune system","Metabo
lism of lipids","Base Excision Repair","Diseases of signal transduction by growth factor receptors and second messengers","Diseases of metabolism","Platelet homeostasis","Abacavir transport and metabo
lism","Innate Immune System","Cell Cycle Checkpoints","Metabolism of amino acids and derivatives","Signaling by Nuclear Receptors","DNA Double-Strand Break Repair","RNA Polymerase II Transcription","N
ervous system development","Cardiac conduction","SARS-CoV Infections","M Phase","Neurotransmitter receptors and postsynaptic signal transmission","Phase I - Functionalization of compounds","GPCR ligan
d binding","Platelet Aggregation (Plug Formation)","Signaling by Interleukins","Biosynthesis of specialized proresolving mediators (SPMs)","Resolution of Abasic Sites (AP sites)","Mitotic G1 phase and
 G1/S transition","Leishmania infection","Signaling by PDGFR in disease","Diseases of carbohydrate metabolism","Platelet calcium homeostasis","Uptake and actions of bacterial toxins","Abacavir transme
mbrane transport","Metabolism of steroids","Toll-like Receptor Cascades","G1/S DNA Damage Checkpoints","Branched-chain amino acid catabolism","ESR-mediated signaling","Homology Directed Repair","Gener
ic Transcription Pathway","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Cytosolic sensors of pathogen-associated DNA","Phase 3 - rapid repolarisation","Potential therapeutics for S
ARS","Mitotic Metaphase and Anaphase","Activation of NMDA receptors and postsynaptic events","Ethanol oxidation","Class A/1 (Rhodopsin-like receptors)","Cytochrome P450 - arranged by substrate type","
Interleukin-1 family signaling","Biosynthesis of DHA-derived SPMs","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","G1/S Transition","Leishmania parasite growth and surv
ival","Signaling by cytosolic PDGFRA and PDGFRB fusion proteins",Mucopolysaccharidoses,"Reduction of cytosolic Ca++ levels","Uptake and function of anthrax toxins","Cholesterol biosynthesis","Toll Lik
e Receptor 5 (TLR5) Cascade","Bile acid and bile salt metabolism","Biosynthesis of DPA-derived SPMs","p53-Dependent G1/S DNA damage checkpoint","Extra-nuclear estrogen signaling","HDR through Homologo
us Recombination (HRR) or Single Strand Annealing (SSA)","Transcriptional regulation by RUNX3","Transcriptional Regulation by MECP2","Transcriptional Regulation by TP53","STING mediated induction of h
ost immune responses","Mitotic Anaphase","Post NMDA receptor activation events","Amine ligand-binding receptors",Xenobiotics,"Interleukin-1 signaling","Biosynthesis of maresins","PCNA-Dependent Long P
atch Base Excision Repair","Activation of the pre-replicative complex","Anti-inflammatory response favouring Leishmania parasite infection","MPS VII - Sly syndrome","Cholesterol biosynthesis via desmo
sterol","MyD88 cascade initiated on plasma membrane","Recycling of bile acids and salts","Biosynthesis of DPAn-3 SPMs","p53-Dependent G1 DNA Damage Response","Estrogen-stimulated signaling through PRK
CZ","HDR through Single Strand Annealing (SSA)","RUNX3 Regulates Immune Response and Cell Migration","Regulation of MECP2 expression and activity","Regulation of TP53 Activity","IRF3-mediated inductio
n of type I IFN","Nuclear Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs","Muscarinic acetylcholine receptors","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealky
lated by CYP1A2","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Biosynthesis of maresin-like SPMs","Dopamine receptors","Serotonin receptors","Histamine receptors",Adrenoceptors,"ADORA2B mediated anti-
inflammatory cytokines production","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","MAP kinase activation","Biosynthesis of DPAn-3-derived protectins and resolvins",
"Stabilization of p53","Regulation of TP53 Expression and Degradation","Initiation of Nuclear Envelope (NE) Reformation","Ras activation upon Ca2+ influx through NMDA receptor","MAPK targets/ Nuclear 
events mediated by MAP kinases","Autodegradation of the E3 ubiquitin ligase COP1","Regulation of TP53 Degradation","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{ADRA1A,CALM1,CALY,DRD2,DRD4,HRH1,HTR2A,HTR2C,S100A4,TNNC1}

> <broad_moa>
{"dopamine receptor antagonist"}

> <synonyms>
{CPD000059133,MLS000069471,Fluoperazine,Calmazine,Eskazine,Stelazine,SMR000059133,"Stalazine hydrochloride","Stelazine dihydrochloride","Trifluperazine dihydrochloride",MLS001146870,MLS002702821,"Trif
luoroperazine dihydrochloride",NSC17474,SK,SAM001247046}

> <pdid>
PD003626

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{657206,2913535,5351676}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 24  0  0  1  0            999 V2000
    7.3178   -0.7831    0.0000 Br  0  5
    4.8170   -4.7955    0.0000 C   0  0
    3.3334   -4.5740    0.0000 O   0  0
    2.7822   -3.1780    0.0000 C   0  0
    3.7175   -2.0053    0.0000 C   0  0
    3.1695   -0.6090    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 C   0  0
    0.0000    1.7286    0.0000 N   0  3
    0.0000    3.2286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0  1  0  0  0
   -1.8100   -0.4996    0.0000 C   0  0
   -3.2620   -0.8758    0.0000 C   0  0
   -3.6623   -2.3214    0.0000 C   0  0  2  0  0  0
   -5.1144   -2.6975    0.0000 O   0  0
   -2.6105   -3.3908    0.0000 C   0  0
   -1.1558   -3.0222    0.0000 C   0  0  2  0  0  0
    0.0836   -3.8671    0.0000 O   0  0
    1.2990   -2.9545    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 13 12  1  6
 13 14  1  0
 14 15  2  3
 15 16  1  0
 16 17  1  1
 16 18  1  0
 19 18  1  1
 19 13  1  0
 19 20  1  0
 20 21  1  0
 21  4  1  0
 21 22  2  0
 22  7  1  0
 22 13  1  0
M  CHG  2   1  -1   9   1
M  END
> <name>
NIHCC_2014

> <id>
5973

> <plate>
NGP-105-05

> <well>
C10

> <supplier_cmpd_name>
CPD000449267

> <ctcr_id>
4310

> <supplier_cmpd_id>
SAM001246978

> <smiles>
[Br-].COc1ccc2C[NH+](C)CC[C@@]34C=C[C@H](O)C[C@@H]3Oc1c24

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Galanthamine hydrobromide",1953-04-4,Reminyl,"Galanthamine (hydrobromide)",Nivalin,MJ4PTD2VVW,UNII-MJ4PTD2VVW,C17H22BrNO3,MFCD00067672,"Razadyne ER","Reminyl (TN)",GALANTHAMINEHYDROBROMIDE,"1953-04-
4 (HBr); 1953-04-4 (free base).",SMR000449267,"Lycoremine hydrobromide",SR-01000597844,"Nivaline (pharmaceutical)",anti-Alzheimer,SR-05000001783,"Reminyl XL","Jilcon hydrobromide","Razadyne (TN)",Pres
twick_236,"EINECS 217-780-5","Galanthamine hydrobromide from Lycoris sp.",PubChem13654,CHEMBL1555,MLS000758283,MLS001401401,"Galanthamine Hydrobromide,(S)",SCHEMBL177993,SPECTRUM1501202,"(+/-)-Galanta
mine hydrobromide","(+/-)-Galanthamine hydrobromide","Galantamine hydrobromide (racemic)",HMS1569F18,HMS1921P21,"Galantamine hydrobromide, (+/-)-",HY-A0009,"Galantamine hydrobromide (JAN/USP)",AC-469,
CCG-38829,CG0027,"Galantamine hydrobromide (USAN:USP)",s1339,AKOS007930166,AKOS015960209,CS-0378,MCULE-7403371703,NC00061,193146-85-9,AS-12155,GP-37267,G0293,D02173,J10353,W-5061,953G044,R-113675,SR-0
1000597844-1,SR-01000597844-5,SR-05000001783-3,Q47495772,Z1558572528,"Galanthamine hydrobromide from Lycoris sp., >=94 (TLC)","UNII-5N4SA4KQX9 component QORVDGQLPPAFRS-XPSHAMGMSA-N",SAM001246978,15012
02,Prestw-588,CPD000449267,"GALANTHAMINE HYDROBROMIDE"}

> <pdid>

> <targets>
{}

> <classes>
{anticholinesterase,analgesic,antiAlzheimer}

> <pubchem_cids>
{121587,11760356,60206644,57904004}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 25  0  0  1  0            999 V2000
    2.2090   -0.3353    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0
   -6.4952    3.7500    0.0000 O   0  0
   -3.8971    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.3326   -2.9571    0.0000 C   0  0
    1.8253   -3.1044    0.0000 C   0  0
    2.4266   -1.7302    0.0000 C   0  0  2  0  0  0
    2.7105   -0.7713    0.0000 O   0  0
    3.4192   -2.8384    0.0000 C   0  0
    4.4371   -3.9401    0.0000 C   0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  6
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 13 14  1  0
 14 15  2  0
 15  5  1  0
 15  9  1  0
  6 16  1  0
 16  2  1  0
 16 17  1  1
 17 18  1  0
 18 19  1  0
 19  2  1  0
 19 20  1  1
 19 21  1  0
 21 22  3  0
M  END
> <name>
NIHCC_2014

> <id>
5974

> <plate>
NGP-105-05

> <well>
C11

> <supplier_cmpd_name>
CPD000058319

> <ctcr_id>
908

> <supplier_cmpd_id>
SAM001247008

> <smiles>
C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C

> <pd_targets>
{AR,ESR1,CYP2B6,ESR2,HTR4,SULT1A1,AOX1,CYP3A4,SHBG,PGR,ALOX15,CYP2B1,SLC6A3,ADORA3,SLC6A2,NR1I3,ADORA2A,OPRK1,UGT1A1,NR3C1,SLC6A4,ABCB11,OPRM1,SLC47A1,SLC22A2,SLC47A2,NR1I2}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Membrane receptor","Secreted protein",Transporter,"Nuclear receptor","Cytochrome P450","Family A G protein-coupled receptor",Transferase,Oxidoreductase,"Electrochemical
 transporter","Primary active transporter","Nuclear hormone receptor subfamily 3","Cytochrome P450 family 2","Small molecule receptor (family A GPCR)","Cytochrome P450 family 3","SLC superfamily of so
lute carriers","Nuclear hormone receptor subfamily 1","Peptide receptor (family A GPCR)","ATP-binding cassette","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 3 gro
up A","Cytochrome P450 family 2B","Monoamine receptor","Cytochrome P450 family 3A","SLC06 neurotransmitter transporter family","Nucleotide-like receptor (family A GPCR)","Nuclear hormone receptor subf
amily 1 group I","Short peptide receptor (family A GPCR)","ABCB subfamily","SLC47 family of multidrug and toxin extrusion transporters","SLC22 family of organic cation and anion transporters","Nuclear
 hormone receptor subfamily 3 group C member 4","Nuclear hormone receptor subfamily 3 group A member 1","Cytochrome P450 2B6","Nuclear hormone receptor subfamily 3 group A member 2","Serotonin recepto
r","Cytochrome P450 3A4","Nuclear hormone receptor subfamily 3 group C member 3","Cytochrome P450 2B1","Adenosine receptor","Nuclear hormone receptor subfamily 1 group I member 3","Opioid receptor","N
uclear hormone receptor subfamily 3 group C member 1","Nuclear hormone receptor subfamily 1 group I member 2"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Nuclear hormone receptors","Cytochrome P450","G protein-coupled receptors","Eicosanoid turnover","SLC superfamily of solute carriers","UDP glucuronosyltransferases (UG
T)","ATP-binding cassette transporter family","Steroid hormone receptors","CYP2 family: drug metabolising subset","5-Hydroxytryptamine receptors","CYP3 family",Lipoxygenases,"SLC6 neurotransmitter tra
nsporter family","Adenosine receptors","1I. Vitamin D receptor-like receptors","Opioid receptors","ABCB subfamily","SLC47 family of multidrug and toxin extrusion transporters","SLC22 family of organic
 cation and anion transporters","3C. 3-Ketosteroid receptors","3A. Estrogen receptors","Monoamine transporter subfamily","Organic cation transporters (OCT)"}

> <pathway_reactome>
{"Gene expression (Transcription)",Metabolism,"Signal Transduction",Disease,"Neuronal System","Transport of small molecules","Metabolism of proteins","RNA Polymerase II Transcription","Biological oxid
ations","Intracellular signaling by second messengers","Infectious disease","Metabolism of vitamins and cofactors","Metabolism of lipids","Disorders of transmembrane transporters","Signaling by GPCR",
"Diseases of metabolism","Transmission across Chemical Synapses","SLC-mediated transmembrane transport","Post-translational protein modification","Generic Transcription Pathway","Phase I - Functionali
zation of compounds","PIP3 activates AKT signaling","Leishmania infection","Phase II - Conjugation of compounds","Metabolism of water-soluble vitamins and cofactors","Biosynthesis of specialized prore
solving mediators (SPMs)","SLC transporter disorders","GPCR ligand binding","Metabolic disorders of biological oxidation enzymes","Neurotransmitter clearance","Metabolism of steroids","GPCR downstream
 signalling","Transport of bile salts and organic acids","metal ions and amine compounds",SUMOylation,"Transcriptional regulation by RUNX2","Transcriptional regulation by RUNX1","Cytochrome P450 - arr
anged by substrate type","Negative regulation of the PI3K/AKT network","Leishmania parasite growth and survival","Cytosolic sulfonation of small molecules","Vitamins B6 activation to pyridoxal phospha
te","Biosynthesis of DHA-derived SPMs","Biosynthesis of DPA-derived SPMs","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Class A/1 (Rhodopsin-like receptors)","Defective SLC6A2 cau
ses orthostatic intolerance (OI)","Nuclear Receptor transcription pathway","Transcriptional Regulation by MECP2","Defective UGT1A1 causes hyperbilirubinemia","FOXO-mediated transcription","Serotonin c
learance from the synaptic cleft","Bile acid and bile salt metabolism","G alpha (i) signalling events","Organic cation/anion/zwitterion transport","SUMO E3 ligases SUMOylate target proteins","RUNX2 re
gulates bone development","RUNX1 regulates estrogen receptor mediated transcription",Xenobiotics,PI5P,"PP2A and IER3 Regulate PI3K/AKT Signaling","Anti-inflammatory response favouring Leishmania paras
ite infection","Biosynthesis of maresins","Biosynthesis of DPAn-3 SPMs","Nucleotide-like (purinergic) receptors","MECP2 regulates neuronal receptors and channels","FOXO-mediated transcription of oxida
tive stress","metabolic and neuronal genes","Synthesis of bile acids and bile salts","Opioid Signalling","Organic cation transport","SUMOylation of intracellular receptors","RUNX2 regulates osteoblast
 differentiation","CYP2E1 reactions","ADORA2B mediated anti-inflammatory cytokines production","Biosynthesis of maresin-like SPMs","Biosynthesis of DPAn-3-derived protectins and resolvins","Adenosine 
P1 receptors","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","G-protein activation"}

> <broad_targets>
{ESR1,ESR2,NR1I2}

> <broad_moa>
{"estrogen receptor agonist","estrogenic hormone"}

> <synonyms>
{"ethinyl estradiol",Ethynylestradiol,ETHINYLESTRADIOL,57-63-6,"Ethynyl estradiol",Ethinyloestradiol,Ginestrene,Estinyl,17-Ethinylestradiol,17alpha-Ethynylestradiol,"Progynon C",Ethinoral,Eticyclin,Et
icyclol,Etinestrol,Etinestryl,Etinoestryl,Etistradiol,Follicoral,Novestrol,Orestralyn,Spanestrin,Amenoron,Dyloform,Ertonyl,Estigyn,Estoral,Estorals,Ethidol,Inestra,Linoral,Lynoral,Menolyn,Oradiol,Prim
ogyn,Esteed,Neo-Estrone,"Primogyn C","Primogyn M",Nogest-S,Eston-E,Feminone,Palonyl,Perovex,17-Ethynylestradiol,"Diogyn E",Chee-O-Genf,Chee-O-Gen,"17-Ethinyl-3,17-estradiol",Ethynyloestradiol,"17-Ethi
nyl-3,17-oestradiol",17alpha-Ethinylestradiol,17-Ethynyloestradiol,"Estoral (Orion)","17alpha-Ethinyl estradiol",Etivex,Diognat-E,Diogyn-E,Ethinylestriol,Eticylol,Kolpolyn,Orestrayln,Ylestrol,Anovlar,
"Progynon M","Estradiol, 17-ethynyl-",17a-Ethynylestradiol,NSC-10973,"Ethinyl Estradiol (USP)",ethynyl-estradiol,17.alpha.-Ethinylestradiol,17.alpha.-Ethynylestradiol,17.alpha.-Ethynyloestradiol,Micro
follin,17a-Ethinylestradiol,UNII-423D2T571U,"17 alpha-ethinyestradiol","Ethinyl estradiol (USP)",MFCD00003690,Diprol,EE,CHEMBL691,"17-alpha-ethynyl estradiol",17.alpha.-Ethinyl-17.beta.-estradiol,Ethi
nyl-oestranol,17.alpha.-Ethynyl-17.beta.-oestradiol,Norinyl,MLS000028479,Aethinyloestradiolum,CHEBI:4903,EE2,EO,Estopherol,Prosexol,"Ethinyl E2",17.alpha.-Ethynylestradiol-l7.beta.,423D2T571U,17.alpha
.-Ethynyloestradiol-17.beta.,"Estoral (VAN)","(17beta)-17-ethynylestra-1(10),2,4-triene-3,17-diol","Aethinyoestradiol (German)",NCGC00091533-04,Etinilestradiol,Certostat,"Ethinylestradiol, 98",SMR0000
58319,Etinilestradiolo,DSSTox_CID_576,Aethinyoestradiol,Ethinylestradiolum,"Etinilestradiol (INN-Spanish)","EE(sub 2)","Ethinylestradiolum (INN-Latin)","Etinilestradiolo (DCIT)",17alpha-Ethynyloestrad
iol,DSSTox_RID_75668,17-alpha-Ethynylestradiol,DSSTox_GSID_20576,"17alpha-Ethynylestra-1,3,5(10)-triene-3,17beta-diol","17alpha-ethinyl-estra-1,3,5(10)-triene-3,17beta-diol","17-Ethynyl-3,17-dihydroxy
-1,3,5-oestratriene","19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17a)-",17alpha-Ethinylestradiol-17beta,"Ethinylestradiol (INN:BAN:JAN)",ethinyl-estradiol,17-alpha-Ethynylestradiol-17-beta,CAS-57
-63-6,17-alpha-Ethinyl-17-beta-estradiol,17-alpha-Ethynyl-17-beta-oestradiol,"component of Oracon","component of Ortrel","CCRIS 286","Estinyl (TN)","component of Demulen","HSDB 3587","EINECS 200-342-2
",OVULEN-21,OVULEN-28,"Estra-1,5(10)-triene-3,17.beta.-diol, 17-ethynyl-","BRN 2419975","Ethinyloestradiol (Steroidal oestrogens)",Ylestol,"19-Nor-17.alpha.-pregna-1,5(10)-trien-20-yne-3,17-diol",AI3-
52941,"19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17.alpha.)-",17alpha-Ethinyl-17beta-estradiol,"19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17alpha)-","component of Ovral",3WF,"Levlen (Salt/
Mix)","Oracon (Salt/Mix)","Ortrel (Salt/Mix)","17-alpha-Ethynyl-1,3,5-oestratriene-3,17-beta-diol","Anovlar (Salt/Mix)","Desogen (Salt/Mix)",17a-Ethynyloestradiol,"Estoral ((Orion))","17alpha-ethinyle
stra-1,3,5(10)-triene-3,17beta-diol","17alpha-ethinyloestra-1,3,5(10)-triene-3,17beta-diol","Nordette (Salt/Mix)","Secrovin (Salt/Mix)","17-alpha-Ethinylestra-1,3,5(10)-triene-3,17-beta-diol","17-alph
a-Ethynyl-1,3,5(10)-estratriene-3,17-beta-diol","Seasonale (Salt/Mix)","Triphasil (Salt/Mix)","17-alpha-Ethinyloestra-1,3,5(10)-triene-3,17-beta-diol","17-alpha-Ethynyl-1,3,5(10)-oestratriene-3,17-bet
a-diol","17alpha-Ethinyl-3,17-dihydroxy-delta(sup1,3,5)-estratriene","17alpha-ethinyl-3,17-dihydroxy-delta(sup1,3,5)oestratriene","3,17beta-Dihydroxy-17alpha-ethynyl-1,3,5(10)-estratriene","3,17beta-D
ihydroxy-17alpha-ethynyl-1,3,5(10)-oestratriene","Estopherol (Salt/Mix)","Estra-1,3,5(10)-triene-3,17beta-diol, 17alpha-ethynyl-","Seasonique (Salt/Mix)","17-alpha-Ethinyl-3,17-dihydroxy-delta(sup 1,3
,5)-estratriene","17-Ethynylestradiol ram","19-Nor-17alpha-pregna-1,3,5(10)-trien-20-yne-3,17-diol","3,17-beta-Dihydroxy-17-alpha-ethynyl-1,3,5(10)-estratriene","3,17-beta-Dihydroxy-17-alpha-ethynyl-1
,3,5(10)-oestratriene","Estra-1,3,5(10)-triene-3,17-beta-diol, 17-alpha-ethynyl-","Ortho Evra (Salt/Mix)","Tri-Levlen (Salt/Mix)","(17-alpha)-19-Norpregna-1,3,5(10)-trien-20-yne-3,17,diol","17alpha-et
hinyl-delta(sup1,3,5(10))oestratriene-3,17-beta -diol","17alpha-Ethynyloestradiol-17beta; 17beta-Estradiol, 17-ethynyl-","19-Nor-17-alpha-pregna-1,3,5(10)-triene-20-yne-3,17-diol",Opera_ID_1808,17a-Et
hynylestradiol-l7b,"17-alpha-Ethinyl-delta(sup 1,3,5(10))oestratriene-3,17-beta-diol","19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol","Ortho-Cyclen (Salt/Mix)",17a-Ethynyloestradiol-17b,SCHEMBL4071,17
a-Ethinyl-17b-estradiol,17a-Ethynyl-17b-oestradiol,MLS000758274,MLS001424011,BIDD:ER0162,"Ethinylestradiol (JP17/INN)",GTPL7071,SGCUT00127,DTXSID5020576,"17alpha-Ethynylestradiol solution",HMS2051I19,
HMS2235J09,HMS3715J09,"17alpha-Ethynylestradiol, >=98","17.beta.-Estradiol, 17-ethynyl-","19-Nor-17-alpha-pregna-1,3,5(10)-trien-20-yne-3,17-diol",HY-B0216,NSC10973,to_000048,ZINC3812897,Tox21_111147,
Tox21_201291,Tox21_300413,BDBM50187243,LMST02010036,s1625,SBB066068,17|A-Ethynylestradiol;Ethynylestradiol,AKOS015894925,Tox21_111147_1,AC-2169,CCG-100819,DB00977,KS-5257,MCULE-5991854877,NC00069,"17.
alpha.-ethinyl-3,3,5)oestratriene","17.alpha.-Ethinyl-3,3,5)-estratriene",NCGC00091533-01,NCGC00091533-05,NCGC00091533-07,NCGC00091533-08,NCGC00091533-09,NCGC00091533-10,NCGC00254514-01,NCGC00258843-0
1,NCI60_000234,ST081364,392-EP2270017A1,392-EP2272846A1,392-EP2275422A1,392-EP2277622A1,392-EP2281816A1,392-EP2308866A1,392-EP2372017A1,392-EP2374791A1,"17-Ethynyl-3-17-dihydroxy-1,5-oestratriene","17
alpha-Ethynylestradiol, >=98.0 (HPLC)",C07534,D00554,"17-Ethynyl-3-17-dihydroxy-1,3,5-oestratriene",AB00441335-11,AB00441335_12,"WLN: L E5 B666TTT&J E1 FQ F1UU1 OQ",003E690,Q415563,SR-01000721903,"17-
Ethynylestra-1,3,5(10)-triene-3,17beta-diol","17a-Ethinylestradiol 100 microg/mL in Acetonitrile",Q-201076,SR-01000721903-3,"17-Ethynyloestra-1,5(10)-triene-3,17.beta.-diol","17.alpha.-Ethynyl-1,5-est
ratriene-3,17.beta.-diol","17.alpha.-Ethynyl-1,5-oestratriene-3,17.beta.-diol","17alpha-Ethinyl-1,3,5(10)-estratriene-3,17-diol",BRD-K48195008-001-19-9,"17-Ethynyloestra-1,3,5(10)-triene-3,17.beta.-di
ol","17.alpha.-Ethinyl-1,3,5(10)-estratriene-3,17-diol","17alpha-Ethynyl-1,3,5(10)-estratriene-3,17beta-diol",Z1541638513,"17.alpha.-ethinylestra-1,5(10)-triene-3,17.beta.-diol","17.alpha.-ethinyloest
ra-1,5(10)-triene-3,17.beta.-diol","17.alpha.-Ethynylestra-1,5(10)-triene-3,17.beta.-diol","17.alpha.-Ethynyloestra-1,5(10)-triene-3,17.beta.-diol","17.alpha.-ethinylestra-1,3,5(10)-triene-3,17.beta.-
diol","17.alpha.-ethinyloestra-1,3,5(10)-triene-3,17.beta.-diol","17.alpha.-Ethynyl-1,3,5(10)-estratriene-3,17.beta.-diol","17.alpha.-Ethynyl-1,3,5(10)-oestratriene-3,17.beta.-diol","17.alpha.-Ethynyl
estra-1,3,5(10)-triene-3,17.beta.-diol","17.alpha.-Ethynyloestra-1,3,5(10)-triene-3,17.beta.-diol","17alpha-Ethynylestradiol, VETRANAL(TM), analytical standard","19-Nor-1,3,5(10),17alpha-pregnatrien-2
0-yne-3,17-diol","19-nor-17.alpha.-Pregna-1,5(10)-trien-2-yne-3,17-diol","Estra-1,5(10)-triene-3,17.beta.-diol, 17.alpha.-ethynyl-","17.alpha.-Ethinyl-3,17-dihydroxy-.delta.(sup1,3,5)-estratriene","17
.alpha.-ethinyl-3,17-dihydroxy-.delta.(sup1,3,5)oestratriene","19-Nor-17.alpha.-pregna-1,3,5(10)-trien-20-yn-3,17-diol","19-Nor-17.alpha.-pregna-1,3,5(10)-trien-20-yne-3,17-diol","19-Norpregna-1,5(10)
-trien-20-yne-3,17-diol, (17.alpha.)-","3,17.beta.-Dihydroxy-17.alpha.-ethynyl-1,3,5(10)-estratriene","3,17.beta.-Dihydroxy-17.alpha.-ethynyl-1,3,5(10)-oestratriene","Estra-1,3,5(10)-triene-3,17.beta.
-diol, 17.alpha.-ethynyl-","Ethinylestradiol, European Pharmacopoeia (EP) Reference Standard","17.alpha.-ethinyl-.delta.(sup1,3,5(10))oestratriene-3,17-.beta. -diol","17.alpha.-ethinyl-.delta.(sup1,5(
10))oestratriene-3,17-.beta.-diol","19-Nor-17.alpha.-pregna-1,3,5(10)-trien-20-yne-3,17.beta.-diol","Ethinyl estradiol, United States Pharmacopeia (USP) Reference Standard","(9beta,13alpha,14beta,17al
pha)-17-ethynylestra-1(10),2,4-triene-3,17-diol",1050678-65-3,SAM001247008,Prestw-1405,CPD000058319,Ethinylestradiol}

> <pdid>
PD002336

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5991}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 15  0  0  1  0            999 V2000
    0.0007    0.0004    0.0000 C   0  0
    1.3000    0.7500    0.0000 N   0  0
    2.6000    0.0000    0.0000 C   0  0
    2.6000   -1.5000    0.0000 N   0  0
    3.9000    0.7500    0.0000 N   0  0
    5.2000    0.0000    0.0000 C   0  0
    6.5000    0.7500    0.0000 C   0  0
    7.7999    0.0000    0.0000 C   0  0
    9.0999    0.7500    0.0000 C   0  0  2  0  0  0
    9.0999    2.2500    0.0000 N   0  0
   10.3999    0.0000    0.0000 C   0  0
   10.3999   -1.5000    0.0000 O   0  0
   11.6992    0.7496    0.0000 O   0  0
   15.4999    1.4996    0.0000 C   0  0
   15.4999   -0.0004    0.0000 C   0  0
   14.2006   -0.7500    0.0000 O   0  0
   16.7992   -0.7500    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  6
  9 11  1  0
 11 12  1  0
 11 13  2  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
M  END
> <name>
NIHCC_2014

> <id>
5975

> <plate>
NGP-105-05

> <well>
D02

> <supplier_cmpd_name>
CPD000449329

> <ctcr_id>
1645

> <supplier_cmpd_id>
SAM001247049

> <smiles>
CNC(=N)NCCC[C@H](N)C(O)=O.CC(O)=O

> <pd_targets>
{NOS2,NOS3,NOS1,CYP1A2,CYP2C19,KMT2A,MEN1,AMPC}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Cytochrome P450",Reader,Hydrolase,"Cytochrome P450 family 1","Cytochrome P450 family 2",Bromodomain,"Cytochrome P450 family 1A","Cytochrome P450 family 2C","Cytochrome 
P450 1A1","Cytochrome P450 2C19"}

> <pathway_chembl>
{Enzymes,"L-Arginine turnover","Cytochrome P450","Nitric oxide synthases","CYP1 family","CYP2 family: drug metabolising subset"}

> <pathway_reactome>
{Disease,"Signal Transduction",Hemostasis,Metabolism,"Infectious disease","Signaling by Receptor Tyrosine Kinases","Platelet homeostasis","Biological oxidations","Infection with Mycobacterium tubercul
osis","Signaling by VEGF","Nitric oxide stimulates guanylate cyclase","Phase I - Functionalization of compounds","Response of Mtb to phagocytosis","VEGFA-VEGFR2 Pathway","Cytochrome P450 - arranged by
 substrate type","Suppression of phagosomal maturation","VEGFR2 mediated vascular permeability",Xenobiotics,"Inhibition of nitric oxide production","Aromatic amines can be N-hydroxylated or N-dealkyla
ted by CYP1A2","CYP2E1 reactions"}

> <broad_targets>
{NOS3}

> <broad_moa>
{"nitric oxide synthase inhibitor"}

> <synonyms>
{"Tilarginine Acetate",53308-83-1,53308831,"53308 83 1",L-NMMA,LNMMA,"L NMMA","L-NMMA acetate","LNMMA acetate","L NMMA acetate","NG-Monomethyl-L-arginine acetate","NGMonomethylLarginine acetate","NG M
onomethyl L arginine acetate",UNII-2FL3530A,UNII2FL3530A,SAM001247049,CPD000449329}

> <pdid>
PD013461

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{135242}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 31  0  0  1  0            999 V2000
    9.9725    0.2674    0.0000 Cl  0  0
   -2.6462   -3.3336    0.0000 O   0  0
   -1.3618   -2.5589    0.0000 C   0  0
    0.0000   -3.2772    0.0000 C   0  0
    1.0774   -2.5589    0.0000 C   0  0
    1.0774   -1.1373    0.0000 C   0  0  1  0  0  0
    2.3821   -1.8775    0.0000 O   0  0
    2.3045   -0.4040    0.0000 C   0  0  1  0  0  0
    2.3045    0.9727    0.0000 C   0  0
    1.0625    1.6760    0.0000 C   0  0
    1.0625    3.0827    0.0000 C   0  0
    0.0000    3.7710    0.0000 C   0  0
   -1.3618    3.0827    0.0000 C   0  0
   -2.6395    3.8685    0.0000 O   0  0
   -1.3618    1.6760    0.0000 C   0  0
   -2.5589    0.2394    0.0000 O   0  0
   -1.3618   -1.1223    0.0000 C   0  0
    0.0000   -0.4040    0.0000 C   0  0  1  0  0  0
    0.0000   -1.9005    0.0000 C   0  0
    3.2622   -1.9005    0.0000 C   0  0
    3.2622   -1.0625    0.0000 N   0  0
    4.6577   -0.4958    0.0000 C   0  0
    5.8415   -1.4184    0.0000 C   0  0
    7.2896   -1.2037    0.0000 C   0  0
    7.4725   -2.6925    0.0000 C   0  0
    5.9837   -2.8754    0.0000 C   0  0
    0.0000    0.9727    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  1
  6  8  1  0
  8  9  1  1
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17  3  1  0
 17 18  1  0
 18  6  1  0
 18 19  1  1
 19 20  1  0
 20 21  1  0
 21  8  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 23  1  0
 18 27  1  0
 27 10  1  0
 27 15  2  0
M  END
> <name>
NIHCC_2014

> <id>
5976

> <plate>
NGP-105-05

> <well>
D03

> <supplier_cmpd_name>
CPD000449281

> <ctcr_id>
419

> <supplier_cmpd_id>
SAM001247063

> <smiles>
Cl.OC1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC6CCC6)c45

> <pd_targets>
{OPRK1,OPRM1,OPRD1,AMPC}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Family A G protein-coupled receptor",Hydrolase,"Peptide receptor (family A GPCR)","Short peptide receptor (family A GPCR)","Opioid receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Opioid receptors"}

> <pathway_reactome>
{"Gene expression (Transcription)","Signal Transduction","RNA Polymerase II Transcription","Signaling by GPCR","Generic Transcription Pathway","GPCR downstream signalling","GPCR ligand binding","Trans
criptional Regulation by MECP2","G alpha (i) signalling events","Class A/1 (Rhodopsin-like receptors)","MECP2 regulates neuronal receptors and channels","Opioid Signalling","Peptide ligand-binding rec
eptors","G-protein activation"}

> <broad_targets>
{OPRD1,OPRK1,OPRM1}

> <broad_moa>
{"opioid receptor agonist","opioid receptor antagonist"}

> <synonyms>
{SMR000449281,MLS000758315,MLS001423945,SCHEMBL503570,CHEMBL4565116,CCG-100751,CCG100751,NC00001,SAM001247063,CPD000449281}

> <pdid>
PD009692

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581814}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 28  0  0  0  0            999 V2000
   -1.3127   -5.2403    0.0000 C   0  0
   -1.3074   -3.7403    0.0000 C   0  0
   -2.6041   -2.9862    0.0000 O   0  0
   -0.0048   -2.9949    0.0000 S   0  0
    1.2925   -3.7494    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    5.1937   -3.0093    0.0000 O   0  0
    3.8912   -5.2578    0.0000 N   0  0
    5.1894   -6.0109    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    3.8869   -8.2595    0.0000 O   0  0
    6.4855   -8.2648    0.0000 O   0  0
    6.4833   -9.7656    0.0000 C   0  0
    7.7815  -10.5187    0.0000 C   0  0
    7.7816  -12.0187    0.0000 C   0  0
    9.0806  -12.7688    0.0000 C   0  0
   10.3797  -12.0188    0.0000 C   0  0
   10.3797  -10.5188    0.0000 C   0  0
    9.0807   -9.7688    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  6 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
M  END
> <name>
NIHCC_2014

> <id>
5977

> <plate>
NGP-105-05

> <well>
D04

> <supplier_cmpd_name>
CPD000449320

> <ctcr_id>
1172

> <supplier_cmpd_id>
SAM001247060

> <smiles>
CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc2ccccc2

> <pd_targets>
{ABCB11,ABCC3,CYP2C9,CYP2C19,CYP2D6,CYP3A4,CYP1A2}

> <pathway_gtopdb>
{Transporter,"Primary active transporter","ATP-binding cassette","ABCB subfamily","ABCC subfamily",Enzyme,"Cytochrome P450","Cytochrome P450 family 2","Cytochrome P450 family 3","Cytochrome P450 famil
y 1","Cytochrome P450 family 2C","Cytochrome P450 family 2D","Cytochrome P450 family 3A","Cytochrome P450 family 1A","Cytochrome P450 2C9","Cytochrome P450 2C19","Cytochrome P450 2D6","Cytochrome P450
 3A4","Cytochrome P450 1A1"}

> <pathway_chembl>
{Transporters,"ATP-binding cassette transporter family","ABCB subfamily","ABCC subfamily",Enzymes,"Cytochrome P450","CYP2 family: drug metabolising subset","CYP3 family","CYP1 family"}

> <pathway_reactome>
{Metabolism,"Metabolism of lipids","Metabolism of steroids","Bile acid and bile salt metabolism","Synthesis of bile acids and bile salts","Recycling of bile acids and salts","Synthesis of bile acids a
nd bile salts via 7alpha-hydroxycholesterol","Biological oxidations","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","Cytochrome P450 - arranged 
by substrate type","Biosynthesis of DHA-derived SPMs",Xenobiotics,"Biosynthesis of maresins","CYP2E1 reactions","Biosynthesis of maresin-like SPMs","Aromatic amines can be N-hydroxylated or N-dealkyla
ted by CYP1A2"}

> <broad_targets>
{MME}

> <broad_moa>
{"enkephalinase inhibitor"}

> <synonyms>
{Racecadotril,81110-73-8,81110738,Acetorphan,"Benzyl 2-(3-(acetylthio)-2-benzylpropanamido)acetate","Benzyl 2(3(acetylthio)2benzylpropanamido)acetate","S049; Sinorphan","Racecadotril (Acetorphan)","be
nzyl (3-(acetylthio)-2-benzylpropanoyl)glycinate","benzyl (3(acetylthio)2benzylpropanoyl)glycinate",MFCD00865520,Tiorfan,"benzyl 2-((2-(acetylsulfanylmethyl)-3-","benzyl 2((2(acetylsulfanylmethyl)3",T
1176,S2503,SAM001247060,Prestw-626,Racecadotril,CPD000449320}

> <pdid>
PD001681

> <targets>
{"Opioid Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{107751}

$$$$
NIHCC_2014
  SciTegic11012413002D

 35 34  0  0  0  0            999 V2000
    8.8990   -0.0062    0.0000 O   0  0
    6.3990   -0.0062    0.0000 Cl  0  0
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 N   0  0
   -5.2029    2.9932    0.0000 C   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.8003    1.4887    0.0000 C   0  0
   -9.0990    0.7364    0.0000 C   0  0
  -10.4003    1.4841    0.0000 C   0  0
   -9.0763    2.2508    0.0000 C   0  0
   -7.7782    3.0025    0.0000 N   0  0
  -10.4029    2.9849    0.0000 C   0  0
  -11.7028    3.7334    0.0000 C   0  0
   -9.1049    3.7367    0.0000 C   0  0
  -11.6990    0.7318    0.0000 C   0  0
  -11.6968   -0.7682    0.0000 C   0  0
  -12.9948   -1.5200    0.0000 C   0  0
  -14.2949   -0.7719    0.0000 C   0  0
  -15.5920   -1.5268    0.0000 O   0  0
  -15.5878   -3.0268    0.0000 C   0  0
  -14.2970    0.7281    0.0000 C   0  0
  -15.5963    1.4794    0.0000 O   0  0
  -15.5963    2.9794    0.0000 C   0  0
  -12.9991    1.4800    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3032   -3.7490    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  3  0
 16 19  1  0
 19 20  1  0
 19 21  1  0
 16 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 25 28  1  0
 28 29  1  0
 29 30  1  0
 28 31  2  0
 31 22  1  0
  8 32  1  0
 32 33  2  0
 33  5  1  0
 33 34  1  0
 34 35  1  0
M  END
> <name>
NIHCC_2014

> <id>
5978

> <plate>
NGP-105-05

> <well>
D05

> <supplier_cmpd_name>
CPD000449323

> <ctcr_id>
2445

> <supplier_cmpd_id>
SAM001246968

> <smiles>
O.Cl.COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC

> <pd_targets>
{CYP3A4,MAPT,GAA,ABCB1,HTT,LMNA,ABCC1}

> <pathway_gtopdb>
{Enzyme,"Other cytosolic protein",Transporter,"Unclassified protein","Other nuclear protein","Cytochrome P450",Hydrolase,"Primary active transporter","Cytochrome P450 family 3","ATP-binding cassette",
"Cytochrome P450 family 3A","ABCB subfamily","ABCC subfamily","Cytochrome P450 3A4"}

> <pathway_chembl>
{Enzymes,Transporters,"Cytochrome P450","3.2.1.- Glycosidases","ATP-binding cassette transporter family","CYP3 family","ABCB subfamily","ABCC subfamily"}

> <pathway_reactome>
{Metabolism,"Neuronal System",Disease,"Gene expression (Transcription)","Cell Cycle","Metabolism of lipids","Transmission across Chemical Synapses","Diseases of metabolism","Abacavir transport and met
abolism","RNA Polymerase II Transcription",Mitotic,"Biosynthesis of specialized proresolving mediators (SPMs)","Neurotransmitter receptors and postsynaptic signal transmission","Diseases of carbohydra
te metabolism","Abacavir transmembrane transport","Generic Transcription Pathway","M Phase","Fatty acid metabolism","Biosynthesis of DHA-derived SPMs","Activation of NMDA receptors and postsynaptic ev
ents","Glycogen storage diseases","Transcriptional Regulation by MECP2","Mitotic Metaphase and Anaphase","Arachidonic acid metabolism","Biosynthesis of maresins","Post NMDA receptor activation events"
,"Glycogen storage disease type II (GAA)","Regulation of MECP2 expression and activity","Mitotic Anaphase","Synthesis of Leukotrienes (LT) and Eoxins (EX)","Biosynthesis of maresin-like SPMs","Activat
ion of AMPK downstream of NMDARs","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{CACNA1A,CACNA1B,CACNA1C,CACNA1D,CACNA1F,CACNA1G,CACNA1I,CACNA1S,CACNB1,CACNB2,CACNB3,CACNB4,CYP3A4,KCNA10,KCNA7,KCNH2,KCNJ11,NALCN,SCN5A,SLC29A4,SLC6A4}

> <broad_moa>
{"calcium channel blocker"}

> <synonyms>
{SMR000449323,MLS000758282,MLS001424030,SCHEMBL1869012,CHEMBL1707604,CCG-100772,NC00022,T1010,SAM001246968,"Verapamil hydrochloride",CPD000449323}

> <pdid>
PD009864

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581799}

$$$$
NIHCC_2014
  SciTegic11012413002D

  9  9  0  0  1  0            999 V2000
    3.1202   -2.0921    0.0000 O   0  0
    1.6281   -2.2462    0.0000 C   0  0
    1.0161   -3.6157    0.0000 O   0  0
    0.7500   -1.0323    0.0000 C   0  0  2  0  0  0
    1.2135    0.3943    0.0000 C   0  0
    0.0000    1.2760    0.0000 S   0  0
   -1.2135    0.3943    0.0000 C   0  0
   -2.6401    0.8578    0.0000 O   0  0
   -0.7500   -1.0323    0.0000 N   0  0
  1  2  1  0
  2  3  2  0
  4  2  1  1
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9  4  1  0
M  END
> <name>
NIHCC_2014

> <id>
5979

> <plate>
NGP-105-05

> <well>
D06

> <supplier_cmpd_name>
CPD000449326

> <ctcr_id>
1402

> <supplier_cmpd_id>
SAM001247016

> <smiles>
OC(=O)[C@@H]1CSC(=O)N1

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{}

> <broad_moa>
{"glutathione synthase stimulant"}

> <synonyms>
{19771-63-2,19771632,"19771 63 2","(R)-2-Oxothiazolidine-4-carboxylic acid","(R)2Oxothiazolidine4carboxylic acid","(R) 2 Oxothiazolidine 4 carboxylic acid","(4R)-2-oxo-1,3-thiazolidine-4-carboxylic ac
id","(4R)2oxo1,3thiazolidine4carboxylic acid","(4R) 2 oxo 1,3 thiazolidine 4 carboxylic acid","oxothiazolidinecarboxylic acid","4-Thiazolidinecarboxylic acid, 2-oxo-, (4R)-","4Thiazolidinecarboxylic a
cid, 2oxo, (4R)","4 Thiazolidinecarboxylic acid, 2 oxo , (4R)",L-2-Oxothiazolidine-4-carboxylate,L2Oxothiazolidine4carboxylate,"L 2 Oxothiazolidine 4 carboxylate",L-2-Oxo-4-thia,L2Oxo4thia,"L 2 Oxo 4 
thia",SAM001247016,CPD000449326}

> <pdid>
PD003170

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{72390}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 16  0  0  0  0            999 V2000
    7.5536    0.4136    0.0000 H   0  3
    5.0536    0.4136    0.0000 Cl  0  5
    2.5532   -4.4223    0.0000 N   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 S   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -0.0031    3.0008    0.0000 O   0  0
   -1.3039    3.7494    0.0000 C   0  0
   -1.3070    5.2494    0.0000 F   0  0
   -2.6017    2.9971    0.0000 F   0  0
   -2.6044    4.4969    0.0000 F   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 N   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 10 13  1  0
  8 14  2  0
 14 15  1  0
 15 16  2  0
 16  6  1  0
 16 17  1  0
 17  4  2  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5980

> <plate>
NGP-105-05

> <well>
D07

> <supplier_cmpd_name>
CPD000449311

> <ctcr_id>
4813

> <supplier_cmpd_id>
SAM001246997

> <smiles>
[H+].[Cl-].Nc1sc2cc(OC(F)(F)F)ccc2n1

> <pd_targets>
{KCNN3,RORC,CYP3A4,BLM,TP53,GMNN,TRPC5,LMNA,NFKB1,PTR1,KCNH2,KCNN4,CYP1A2,SCN2A,PKM,NPC1,GAA,PYK,SMN1,HTR1A,KCNN2,KCNN1,PMP22,RAB9A,ALOX15,HSD17B10,MAPK1,SLC6A2,SCN10A,SCN11A,SCN1A,SCN3A,SCN4A,SCN5A,S
CN7A,SCN8A,SCN9A,KCND3,KCND2,KCNK4,KCNK2,SLC7A11}

> <pathway_gtopdb>
{"Ion channel","Transcription factor",Enzyme,"Unclassified protein","Other nuclear protein","Other cytosolic protein",Transporter,"Epigenetic regulator","Membrane receptor","Voltage-gated ion channel"
,"Nuclear receptor","Cytochrome P450",Oxidoreductase,Hydrolase,Transferase,Reader,"Family A G protein-coupled receptor",Kinase,"Electrochemical transporter","Potassium channels","Nuclear hormone recep
tor subfamily 1","Cytochrome P450 family 3","Transient receptor potential channel","Cytochrome P450 family 1","Voltage-gated sodium channel","Methyl-lysine/arginine binding protein","Small molecule re
ceptor (family A GPCR)","Protein Kinase","SLC superfamily of solute carriers","Calcium-activated potassium channel","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family 3A","Voltage-
gated potassium channel","Cytochrome P450 family 1A","Tudor domain","Monoamine receptor","CMGC protein kinase group","SLC06 neurotransmitter transporter family","Two-pore domain potassium channel","SL
C03 and SLC07 families of heteromeric amino acid transporters (HATs)","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 3A4","Cytochrome P450 1A1","Serotonin receptor","CMGC pro
tein kinase MAPK family","SLC07 Cationic amino acid transporter/glycoprotein-associated family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{"Ion channels",Receptors,Enzymes,Transporters,"Voltage-gated ion channels","Nuclear hormone receptors","Cytochrome P450","2.7.1.40 Pyruvate kinases","SLC superfamily of solute carriers","3.2.1.- Glyc
osidases","G protein-coupled receptors","Eicosanoid turnover","Kinases (EC 2.7.x.x)","Potassium channels","1F. Retinoic acid-related orphans","CYP3 family","Transient Receptor Potential channels","CYP
1 family","Voltage-gated sodium channels","SLC65 NPC-type cholesterol transporters","5-Hydroxytryptamine receptors",Lipoxygenases,"CMGC: Containing CDK",MAPK,GSK3,"CLK families","SLC6 neurotransmitter
 transporter family","SLC3 and SLC7 families of heteromeric amino acid transporters (HATs)","Calcium- and sodium-activated potassium channels","Voltage-gated potassium channels","Mitogen-activated pro
tein kinases (MAP kinases)","Monoamine transporter subfamily","Two P domain potassium channels","SLC7 family","ERK subfamily"}

> <pathway_reactome>
{"Neuronal System","Gene expression (Transcription)",Metabolism,"DNA Repair","Cell Cycle","Developmental Biology","Immune System","Muscle contraction","Transport of small molecules",Disease,"Metabolis
m of RNA","Signal Transduction","Potassium Channels","RNA Polymerase II Transcription","Metabolism of lipids","DNA Double-Strand Break Repair","Cell Cycle Checkpoints",Mitotic,"Nervous system developm
ent","Cytokine Signaling in Immune system","Cardiac conduction","Biological oxidations","Metabolism of carbohydrates","Plasma lipoprotein assembly",remodeling,"and clearance","Diseases of metabolism",
"Metabolism of non-coding RNA","Signaling by GPCR","Signaling by Rho GTPases","Metabolism of amino acids and derivatives","Innate Immune System","Disorders of transmembrane transporters","SLC-mediated
 transmembrane transport","Ca2+ activated K+ channels","Generic Transcription Pathway","Biosynthesis of specialized proresolving mediators (SPMs)","Homology Directed Repair","G1/S DNA Damage Checkpoin
ts","Mitotic G1 phase and G1/S transition","Axon guidance","M Phase","Signaling by Interleukins","Phase 3 - rapid repolarisation","Phase I - Functionalization of compounds","Glucose metabolism","Plasm
a lipoprotein clearance","Diseases of carbohydrate metabolism","snRNP Assembly","GPCR ligand binding","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Rho GTPase cycle","Branched-chai
n amino acid catabolism","Toll-like Receptor Cascades","SLC transporter disorders","Phase 1 - inactivation of fast Na+ channels","Tandem pore domain potassium channels","Transport of inorganic cations
/anions and amino acids/oligopeptides","Transcriptional regulation by RUNX3","Biosynthesis of DHA-derived SPMs","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","p53-Depen
dent G1/S DNA damage checkpoint","G1/S Transition","Netrin-1 signaling","Mitotic Metaphase and Anaphase","Interleukin-1 family signaling","Cytochrome P450 - arranged by substrate type","L1CAM interact
ions",Glycolysis,"LDL clearance","Glycogen storage diseases","Class A/1 (Rhodopsin-like receptors)","RHOBTB GTPase Cycle","Biosynthesis of DPA-derived SPMs","Toll Like Receptor 5 (TLR5) Cascade","Defe
ctive SLC6A2 causes orthostatic intolerance (OI)","TWIK related potassium channel (TREK)","Amino acid transport across the plasma membrane","RUNX3 Regulates Immune Response and Cell Migration","Biosyn
thesis of maresins","HDR through Homologous Recombination (HRR)","p53-Dependent G1 DNA Damage Response","Activation of the pre-replicative complex","Role of second messengers in netrin-1 signaling","M
itotic Anaphase","Interleukin-1 signaling",Xenobiotics,"Interaction between L1 and Ankyrins","Glycogen storage disease type II (GAA)","Amine ligand-binding receptors","RHOBTB3 ATPase cycle","Biosynthe
sis of DPAn-3 SPMs","MyD88 cascade initiated on plasma membrane","Biosynthesis of maresin-like SPMs","Homologous DNA Pairing and Strand Exchange","Stabilization of p53","Nuclear Envelope (NE) Reassemb
ly","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Serotonin receptors","Biosynthesis of DPAn-3-derived protectins and resolvins","MAP
 kinase activation","Presynaptic phase of homologous DNA pairing and strand exchange","Autodegradation of the E3 ubiquitin ligase COP1","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/
 Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{KCNK10,KCNK2,KCNK4,KCNN4,SCN10A,SCN11A,SCN1A,SCN2A,SCN3A,SCN4A,SCN5A,SCN7A,SCN8A,SCN9A,SLC7A11}

> <broad_moa>
{"glutamate inhibitor"}

> <synonyms>
{"Riluzole hydrochloride",850608-87-6,850608876,"850608 87 6","2-Amino-6-trifluoromethoxybenzothiazole hydrochloride","2Amino6trifluoromethoxybenzothiazole hydrochloride","2 Amino 6 trifluoromethoxybe
nzothiazole hydrochloride",6-(trifluoromet,6(trifluoromet,SAM001246997,Prestw-167,CPD000449311}

> <pdid>
PD000919

> <targets>
{GABA Receptor,Sodium Channel}

> <classes>
{Membrane Transporter/Ion Channel,Neuronal Signaling}

> <pubchem_cids>
{6419992}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 29  0  0  0  0            999 V2000
   18.8107   -2.7548    0.0000 H   0  3
   16.3107   -2.7548    0.0000 Cl  0  5
   13.7975   -3.0842    0.0000 Cl  0  0
   13.0541   -4.3870    0.0000 C   0  0
   13.8107   -5.6823    0.0000 C   0  0
   13.0673   -6.9851    0.0000 C   0  0
   11.5673   -6.9927    0.0000 C   0  0
   10.8106   -5.6974    0.0000 C   0  0
   11.5542   -4.3946    0.0000 C   0  0
    9.3099   -5.7027    0.0000 N   0  0
    8.5644   -7.0043    0.0000 C   0  0
    7.0644   -7.0095    0.0000 C   0  0
    6.3098   -5.7131    0.0000 N   0  0
    4.8090   -5.7153    0.0000 C   0  0
    4.0559   -4.4171    0.0000 C   0  0
    2.5551   -4.4192    0.0000 C   0  0
    1.8032   -3.1233    0.0000 N   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
    0.3114   -2.9665    0.0000 C   0  0
   -0.6923   -4.0811    0.0000 O   0  0
    7.0554   -4.4114    0.0000 C   0  0
    8.5554   -4.4062    0.0000 C   0  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  3
 19 20  1  0
 20 21  2  3
 21 22  1  0
 22 23  2  3
 23 24  1  0
 24 19  1  0
 24 25  1  0
 25 17  1  0
 25 26  2  0
 13 27  1  0
 27 28  1  0
 28 10  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5981

> <plate>
NGP-105-05

> <well>
D08

> <supplier_cmpd_name>
CPD000058520

> <ctcr_id>
555

> <supplier_cmpd_id>
SAM001247045

> <smiles>
[H+].[Cl-].Clc1cccc(c1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2

> <pd_targets>
{KDM4E,ALDH1A1,HPGD,HSD17B10,HLA-A,HTR2A,ADRA2A,HRH1,HTR2B,HIF1A,ADRA1B,CYP2D6,ADRA1A,HTR1B,HTR2C,SLC6A4,HTR1A,SLC6A2,ADRA1D,ABCB11,SLC6A3,DRD2,ALB,LMNA,CHRM1,SIGMAR1,ADRA2B,DRD3,ADRA2C}

> <pathway_gtopdb>
{"Epigenetic regulator",Enzyme,"Surface antigen","Membrane receptor","Transcription factor",Transporter,"Secreted protein","Other nuclear protein",Eraser,Oxidoreductase,"Family A G protein-coupled rec
eptor","Cytochrome P450","Electrochemical transporter","Primary active transporter","Lysine demethylase","Small molecule receptor (family A GPCR)","Cytochrome P450 family 2","SLC superfamily of solute
 carriers","ATP-binding cassette","Jumonji domain-containing","Monoamine receptor","Cytochrome P450 family 2D","SLC06 neurotransmitter transporter family","ABCB subfamily","Serotonin receptor","Adrene
rgic receptor","Histamine receptor","Cytochrome P450 2D6","Dopamine receptor","Acetylcholine receptor"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Other protein targets","Chromatin modifying enzymes","Eicosanoid turnover","G protein-coupled receptors","Cytochrome P450","SLC superfamily of solute carriers","ATP-bi
nding cassette transporter family","Sigma receptors","1.14.11.- Histone demethylases","Prostaglandin synthases","5-Hydroxytryptamine receptors",Adrenoceptors,"Histamine receptors","CYP2 family: drug m
etabolising subset","SLC6 neurotransmitter transporter family","ABCB subfamily","Dopamine receptors","Acetylcholine receptors (muscarinic)","Monoamine transporter subfamily"}

> <pathway_reactome>
{Metabolism,"Immune System","Signal Transduction","Cellular responses to external stimuli","Neuronal System",Disease,"Cell Cycle","Biological oxidations","Metabolism of lipids","Metabolism of amino ac
ids and derivatives","Adaptive Immune System","Signaling by GPCR","Cellular responses to stress","Transmission across Chemical Synapses","Disorders of transmembrane transporters",Mitotic,"Infectious d
isease","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","Branched-chain amino acid catabolism","Class I MHC mediated antigen processing & present
ation","GPCR ligand binding","Cellular response to hypoxia","Neurotransmitter clearance","SLC transporter disorders","Metabolism of steroids","M Phase","SARS-CoV Infections","Ethanol oxidation","Biosy
nthesis of DHA-derived SPMs","Antigen processing-Cross presentation","Class A/1 (Rhodopsin-like receptors)","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Cytochrome P450 
- arranged by substrate type","Serotonin clearance from the synaptic cleft","Defective SLC6A2 causes orthostatic intolerance (OI)","Bile acid and bile salt metabolism","Defective SLC6A3 causes Parkins
onism-dystonia infantile (PKDYS)","Mitotic Metaphase and Anaphase","Potential therapeutics for SARS","Biosynthesis of D-series resolvins","Endosomal/Vacuolar pathway","Amine ligand-binding receptors",
Xenobiotics,"Synthesis of bile acids and bile salts","Recycling of bile acids and salts","Mitotic Anaphase","Serotonin receptors",Adrenoceptors,"Histamine receptors","CYP2E1 reactions","Synthesis of b
ile acids and bile salts via 7alpha-hydroxycholesterol","Dopamine receptors","Nuclear Envelope (NE) Reassembly","Muscarinic acetylcholine receptors","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ADRA1A,ADRA2A,HRH1,HTR1A,HTR2A,HTR2B,HTR2C,SLC6A4}

> <broad_moa>
{"adrenergic receptor antagonist","serotonin receptor antagonist","serotonin reuptake inhibitor"}

> <synonyms>
{AKOS026750159,"Trazodone hydrochloride",25332-39-2,25332392,"Trazodone Hcl",Desyrel,Molipaxin,Bimaran,Thombran,"Trazodone (hydrochloride)",AF-1161,AF1161,Trialodine,UNII-6E8ZO8LRNM,UNII6E8ZO8LRNM,Ole
ptro,6E8ZO8LRNM,19666-36-5,19666365,"AF-1161 (free base)","AF1161 (free base)",C19H23Cl2N5O,T1619,SAM001247045,1503121,Prestw-292,CPD000058520,"TRAZODONE HYDROCHLORIDE"}

> <pdid>
PD009868

> <targets>
{}

> <classes>
{antidepressant}

> <pubchem_cids>
{657357,62935}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 31  0  0  1  0            999 V2000
    2.6455    3.6988    0.0000 C   0  0
    1.3400    2.9600    0.0000 N   0  0
   -0.1900    2.9600    0.0000 C   0  0
   -0.1200    0.2700    0.0000 C   0  0
    0.7000   -0.8000    0.0000 C   0  0  1  0  0  0
    1.4800   -2.0400    0.0000 C   0  0
    2.9700   -2.0400    0.0000 C   0  0
    3.6800   -0.7900    0.0000 C   0  0
    2.9000    0.5000    0.0000 C   0  0
    1.4200    0.4600    0.0000 C   0  0  2  0  0  0
    0.6500    1.7000    0.0000 C   0  0  2  0  0  0
   -0.7800    1.6800    0.0000 C   0  0
   -1.4800    0.3900    0.0000 C   0  0
   -2.9600    0.3900    0.0000 C   0  0
   -3.6900   -0.8600    0.0000 C   0  0
   -2.8900   -2.1300    0.0000 C   0  0
   -3.6018   -3.4504    0.0000 O   0  0
   -1.4200   -2.1000    0.0000 C   0  0
   -0.6700   -0.8400    0.0000 C   0  0
   10.0800    2.0150    0.0000 O   0  0
   10.0800    0.5150    0.0000 C   0  0
    8.7800   -0.2350    0.0000 C   0  0
    8.7800   -1.7350    0.0000 O   0  0
    7.4800    0.5150    0.0000 C   0  0
    7.4800    2.0150    0.0000 O   0  0
    6.1807   -0.2346    0.0000 O   0  0
   11.3800   -0.2350    0.0000 C   0  0
   11.3800   -1.7350    0.0000 O   0  0
   12.6792    0.5146    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  5  4  1  6
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
 10  9  1  1
 10  5  1  0
 10 11  1  0
 11  2  1  0
 11 12  1  6
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 19  5  1  0
 19 13  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 24 26  2  0
 21 27  1  0
 27 28  1  0
 27 29  2  0
M  END
> <name>
NIHCC_2014

> <id>
5982

> <plate>
NGP-105-05

> <well>
D09

> <supplier_cmpd_name>
CPD000058908

> <ctcr_id>
6270

> <supplier_cmpd_id>
SAM001247023

> <smiles>
CN1CC[C@@]23CCCC[C@@H]2[C@@H]1Cc4ccc(O)cc34.OC(C(O)C(O)=O)C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{MLS000069430,"Dextrorphan D-tartrate","Dextrorphan Dtartrate",SMR000058908,"(+)-3-HYDROXY-N-METHYLMORPHINAN D-TARTRATE","(+)3HYDROXYNMETHYLMORPHINAN DTARTRATE",Opera_ID_574,OperaID574,Opera-ID-574,"O
pera ID 574",MLS000758204,MLS001074077,MLS001401402,MLS002153369,SCHEMBL1320608,CHEMBL1426948,HMS2051K15,HMS2234D21,AKOS032428353,CCG-100804,CCG100804,NC000,T4225,SAM001247023,"Dextrorphan tartrate",C
PD000058908}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5388990}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 27  0  0  0  0            999 V2000
    5.0973    0.1528    0.0000 O   0  0
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 C   0  0
   -3.1904   -2.6376    0.0000 C   0  0
   -4.6588   -2.9478    0.0000 C   0  0
   -5.1250   -4.3735    0.0000 O   0  0
   -5.6608   -1.8315    0.0000 O   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -5.1065    0.0000    0.0000 C   0  0
   -2.7248    1.2135    0.0000 N   0  0
   -3.1905    2.6376    0.0000 C   0  0
   -2.1885    3.7539    0.0000 O   0  0
   -4.6589    2.9478    0.0000 C   0  0
   -5.1272    4.3728    0.0000 C   0  0
   -6.5954    4.6799    0.0000 C   0  0
   -7.5954    3.5619    0.0000 C   0  0
   -9.0637    3.8689    0.0000 Cl  0  0
   -7.1272    2.1368    0.0000 C   0  0
   -5.6590    1.8298    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 10 15  2  0
 15 16  1  0
 15 17  1  0
 17  7  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 23 25  1  0
 25 26  2  0
 26 20  1  0
M  END
> <name>
NIHCC_2014

> <id>
5983

> <plate>
NGP-105-05

> <well>
D10

> <supplier_cmpd_name>
CPD000449290

> <ctcr_id>
2988

> <supplier_cmpd_id>
SAM001246982

> <smiles>
O.COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c3ccc(Cl)cc3

> <pd_targets>
{PTGDR2,PPARG,PTGS2,PTGS1,AKR1B1,DHRS9,PTGER2,LMNA,HIF1A,CYP2D6,CYP1A2,AKR1C3,ABCB11,CXCL8,ALB,NOS2,CYP2C9,ABCB1,MT-CO2,MAPT,PMP22,GLO1,ALOX5,TBXAS1,PTGDS,PTGER3,AKR1C2,AKR1C4,KDM4E,ALD,RORC,NPSR1,SLC
O1B1,PON1,SLC22A8,NAPRT,ABCC4,SLC22A6,PTGES,GPR17,ABCC1,AR,SLCO1B3,ABCC3,MTOR,SLC46A1,PLA2G2A,PTGR2,PPARA}

> <pathway_gtopdb>
{"Membrane receptor","Transcription factor",Enzyme,"Other nuclear protein",Transporter,"Secreted protein","Other cytosolic protein","Unclassified protein","Epigenetic regulator","Family A G protein-co
upled receptor","Nuclear receptor",Oxidoreductase,"Cytochrome P450","Primary active transporter",Protease,Lyase,Isomerase,Eraser,"Electrochemical transporter",Hydrolase,Ligase,Kinase,"Small molecule r
eceptor (family A GPCR)","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 2","Cytochrome P450 family 1","ATP-binding cassette","Cysteine protease","Oxidoreduction-driven transporters","C
ytochrome P450 family 5","Lysine demethylase","Peptide receptor (family A GPCR)","SLC superfamily of solute carriers","Nuclear hormone receptor subfamily 3","Protein Kinase","Lipid-like ligand recepto
r (family A GPCR)","Nuclear hormone receptor subfamily 1 group C","Cytochrome P450 family 2D","Cytochrome P450 family 1A","ABCB subfamily","Cysteine protease CA clan","Cytochrome P450 family 2C","Cyto
chrome P450 family 5A","Jumonji domain-containing","Nuclear hormone receptor subfamily 1 group F","Short peptide receptor (family A GPCR)","SLC21/SLCO family of organic anion transporting polypeptides
","SLC22 family of organic cation and anion transporters","ABCC subfamily","Nuclear hormone receptor subfamily 3 group C","Atypical protein kinase group","SLC46 family of folate transporters","Prostan
oid receptor","Nuclear hormone receptor subfamily 1 group C member 3","Cytochrome P450 2D6","Cytochrome P450 1A1","Cysteine protease C1A family","Cytochrome P450 2C9","Cytochrome P450 5A1","Nuclear ho
rmone receptor subfamily 1 group F member 3","Neuropeptide receptor","Leukotriene receptor","Nuclear hormone receptor subfamily 3 group C member 4","Atypical protein kinase PIKK family","Nuclear hormo
ne receptor subfamily 1 group C member 1","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"G protein-coupled receptors","Nuclear hormone receptors","Eicosanoid turnover","1.-.-.- Oxidoreductases","Cytochrome P450","ATP-binding cassette transporter family","L
-Arginine turnover","Chromatin modifying enzymes","SLC superfamily of solute carriers","Paraoxonase (PON) family","Kinases (EC 2.7.x.x)","Glycerophospholipid turnover","Prostanoid receptors","1C. Pero
xisome proliferator-activated receptors",Cyclooxygenase,"CYP2 family: drug metabolising subset","CYP1 family","Prostaglandin synthases","ABCB subfamily","Nitric oxide synthases",Lipoxygenases,CYP5,"CY
P7 and CYP8 families","1.14.11.- Histone demethylases","1F. Retinoic acid-related orphans","Neuropeptide S receptor","SLCO family of organic anion transporting polypeptides","SLC22 family of organic c
ation and anion transporters","ABCC subfamily","Orphan and other 7TM receptors","Steroid hormone receptors",Atypical,"SLC46 family of folate transporters","Phospholipase A<sub>2</sub>","Organic anion 
transporters (OATs)","Class A Orphans","3C. 3-Ketosteroid receptors","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","FRAP subfamily"}

> <pathway_reactome>
{"Signal Transduction","Gene expression (Transcription)",Metabolism,Disease,"Cell Cycle","Cellular responses to external stimuli","Neuronal System","Developmental Biology","Transport of small molecule
s",Hemostasis,"Signaling by GPCR","RNA Polymerase II Transcription","Metabolism of lipids","Infectious disease",Mitotic,"Cellular responses to stress","Biological oxidations","Abacavir transport and m
etabolism","Transmission across Chemical Synapses","Nervous system development","The citric acid (TCA) cycle and respiratory electron transport","SLC-mediated transmembrane transport","Metabolism of v
itamins and cofactors","Platelet activation","signaling and aggregation","GPCR ligand binding","Generic Transcription Pathway","Biosynthesis of specialized proresolving mediators (SPMs)","Fatty acid m
etabolism","Metabolism of steroids","GPCR downstream signalling","Leishmania infection","M Phase","Cellular response to hypoxia","Phase I - Functionalization of compounds","Infection with Mycobacteriu
m tuberculosis","Abacavir transmembrane transport","Neurotransmitter receptors and postsynaptic signal transmission","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Pyruvate metaboli
sm and Citric Acid (TCA) cycle","Transport of bile salts and organic acids","metal ions and amine compounds","Metabolism of water-soluble vitamins and cofactors","Response to elevated platelet cytosol
ic Ca2+","Phospholipid metabolism","Class A/1 (Rhodopsin-like receptors)","Transcriptional Regulation by MECP2","Biosynthesis of DPA-derived SPMs","Arachidonic acid metabolism","Metabolism of steroid 
hormones","G alpha (i) signalling events","Leishmania parasite growth and survival","Mitotic Metaphase and Anaphase","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Cytochr
ome P450 - arranged by substrate type","Bile acid and bile salt metabolism","Response of Mtb to phagocytosis","Transcriptional Regulation by TP53","Activation of NMDA receptors and postsynaptic events
","Pyruvate metabolism","Transcriptional regulation by RUNX3","Organic cation/anion/zwitterion transport","Nicotinate metabolism","Platelet degranulation","Transcriptional regulation by RUNX2","Metabo
lism of folate and pterines","Glycerophospholipid biosynthesis","Regulation of cholesterol biosynthesis by SREBP (SREBF)","Eicosanoid ligand-binding receptors","MECP2 regulates transcription factors",
"Biosynthesis of DPAn-3 SPMs","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","Pregnenolone biosynthesis","Visual phototransduction","Anti-inflammatory response favouring Leishmania parasite 
infection","Mitotic Anaphase",Xenobiotics,"Synthesis of bile acids and bile salts","Peptide ligand-binding receptors","Recycling of bile acids and salts","Suppression of phagosomal maturation","TP53 R
egulates Metabolic Genes","Post NMDA receptor activation events",Eicosanoids,"RUNX3 Regulates Immune Response and Cell Migration","Synthesis of 5-eicosatetraenoic acids","Organic anion transport","Nic
otinamide salvaging","Synthesis of Leukotrienes (LT) and Eoxins (EX)","RUNX2 regulates bone development","Regulation of TP53 Activity","Acyl chain remodelling of PC","Activation of gene expression by 
SREBF (SREBP)","Prostanoid ligand receptors","The canonical retinoid cycle in rods (twilight vision)","ADORA2B mediated anti-inflammatory cytokines production","Nuclear Envelope (NE) Reassembly","CYP2
E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Synthesis of bile acids and bile salts via 24-hydroxycholesterol","Synthesis of bile acids and bile salts via 7alpha-h
ydroxycholesterol","Chemokine receptors bind chemokines","Inhibition of nitric oxide production","Activation of AMPK downstream of NMDARs","Biosynthesis of DPAn-3-derived 13-series resolvins","Leukotr
iene receptors","RUNX2 regulates osteoblast differentiation","Regulation of TP53 Expression and Degradation","Initiation of Nuclear Envelope (NE) Reformation","Regulation of TP53 Degradation"}

> <broad_targets>
{GLO1,PLA2G2A,PPARA,PPARG,PTGDR2,PTGR2,PTGS1,PTGS2,SLC46A1}

> <broad_moa>
{"cyclooxygenase inhibitor"}

> <synonyms>
{SMR000449290,MLS000758212,MLS001423976,CHEMBL4590319,HMS2051E21,HMS3393E21,CCG-100825,CCG100825,NC00075,SAM001246982,CPD000449290}

> <pdid>
PD002292

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581802}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 18  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5987    1.5004    0.0000 C   0  0  2  0  0  0
   -3.9492    0.8772    0.0000 O   0  0
   -4.9546    1.9903    0.0000 C   0  0  2  0  0  0
   -6.4441    1.8282    0.0000 C   0  0
   -7.0500    0.4561    0.0000 O   0  0
   -4.2067    3.2905    0.0000 C   0  0  1  0  0  0
   -4.8190    4.6599    0.0000 O   0  0
   -2.7390    2.9810    0.0000 C   0  0  2  0  0  0
   -1.6199    3.9798    0.0000 O   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  3
  8  2  1  0
  9  6  1  6
  9 10  1  0
 10 11  1  0
 11 12  1  6
 12 13  1  0
 11 14  1  0
 14 15  1  1
 14 16  1  0
 16  9  1  0
 16 17  1  6
M  END
> <name>
NIHCC_2014

> <id>
5984

> <plate>
NGP-105-05

> <well>
D11

> <supplier_cmpd_name>
CPD000449317

> <ctcr_id>
4852

> <supplier_cmpd_id>
SAM001247012

> <smiles>
NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O

> <pd_targets>
{MAPT,NCOA3,FFP,POLB,KDM4E,GMNN,NFO,ALDH1A1,NPSR1,LMNA,PMP22,GLA,MDM2,FABI,LMP1,MTOR,POLA1,POLA2,POLD1,POLD2,POLD3,POLD4,POLE,POLE2,POLE3,PRIM1,PRIM2}

> <pathway_gtopdb>
{"Other cytosolic protein","Epigenetic regulator",Writer,"Histone acetyltransferase","SRC family",Enzyme,"Unclassified protein","Membrane receptor","Other nuclear protein",Transferase,Eraser,Hydrolase
,Oxidoreductase,"Family A G protein-coupled receptor",Ligase,Kinase,"Lysine demethylase","Peptide receptor (family A GPCR)","Protein Kinase","Jumonji domain-containing","Short peptide receptor (family
 A GPCR)","Atypical protein kinase group","Neuropeptide receptor","Atypical protein kinase PIKK family","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Enzymes,"Chromatin modifying enzymes","2.3.1.48 Histone acetyltransferases (HATs)",Receptors,"G protein-coupled receptors","E3 ubiquitin ligase components","Kinases (EC 2.7.x.x)","1.14.11.- Histone d
emethylases","Neuropeptide S receptor",Atypical,"Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","FRAP subfamily"}

> <pathway_reactome>
{"Neuronal System",Metabolism,"Transmission across Chemical Synapses","Metabolism of lipids","Neurotransmitter receptors and postsynaptic signal transmission","Regulation of lipid metabolism by PPARal
pha","Activation of NMDA receptors and postsynaptic events","PPARA activates gene expression","Post NMDA receptor activation events","Activation of AMPK downstream of NMDARs","DNA Repair","Cell Cycle"
,Disease,"Developmental Biology","Gene expression (Transcription)","Base Excision Repair",Mitotic,"Biological oxidations","Infectious disease","Nervous system development","RNA Polymerase II Transcrip
tion","Resolution of Abasic Sites (AP sites)","Mitotic G1 phase and G1/S transition","Phase I - Functionalization of compounds","Leishmania infection","M Phase","EGR2 and SOX10-mediated initiation of 
Schwann cell myelination","Sphingolipid metabolism","Generic Transcription Pathway","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","G1/S Transition","Ethanol oxidation"
,"Leishmania parasite growth and survival","Mitotic Metaphase and Anaphase","Glycosphingolipid metabolism","Transcriptional Regulation by TP53","PCNA-Dependent Long Patch Base Excision Repair","Activa
tion of the pre-replicative complex","Anti-inflammatory response favouring Leishmania parasite infection","Mitotic Anaphase","Regulation of TP53 Activity","ADORA2B mediated anti-inflammatory cytokines
 production","Nuclear Envelope (NE) Reassembly","Regulation of TP53 Expression and Degradation","Initiation of Nuclear Envelope (NE) Reformation","Regulation of TP53 Degradation"}

> <broad_targets>
{UCK2}

> <broad_moa>
{}

> <synonyms>
{cytarabine,147-94-4,147944,"Cytosine arabinoside",Ara-C,AraC,Arabinocytidine,Cytosar,Tarabine,Udicil,Cytosar-U,CytosarU,1-beta-D-Arabinofuranosylcytosine,1betaDArabinofuranosylcytosine,Arabinofuranos
ylcytosine,DepoCyte,Cytarabin,Arabinosylcytosine,Aracytidine,"Cytosine beta-D-arabinofuranoside","Cytosine betaDarabinofuranoside",S1648,SAM001247012,Prestw-1134,Cytarabine,CPD000449317}

> <pdid>
PD001475

> <targets>
{Apoptosis,Autophagy,DNA/RNA Synthesis,Endogenous Metabolite,HSV,Nucleoside Antimetabolite/Analog}

> <classes>
{Anti-infection,Apoptosis,Autophagy,Cell Cycle/DNA Damage,Metabolic Enzyme/Protease}

> <pubchem_cids>
{6253}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 28  0  0  0  0            999 V2000
    2.6000   -1.5000    0.0000 N   0  0
    2.6000    0.0000    0.0000 C   0  0
    1.3000    0.7500    0.0000 C   0  0
    0.0007    0.0004    0.0000 O   0  0
    3.9000    0.7500    0.0000 C   0  0
    5.1992    0.0004    0.0000 O   0  0
    1.2761   -0.7669    0.0000 C   0  0
    1.2773   -2.2669    0.0000 O   0  0
   16.7947   -4.0542    0.0000 O   0  0
   17.4024   -2.6828    0.0000 C   0  0
   18.8940   -2.5239    0.0000 O   0  0
   16.5192   -1.4725    0.0000 C   0  0
   16.9827   -0.0459    0.0000 C   0  0
   15.7692    0.8357    0.0000 C   0  0
   14.5557   -0.0459    0.0000 N   0  0
   15.0192   -1.4725    0.0000 C   0  0
   13.8077   -2.3536    0.0000 C   0  0
   12.5942   -1.4719    0.0000 C   0  0
   13.0577   -0.0453    0.0000 C   0  0
   12.1751    1.1654    0.0000 C   0  0
   12.7835    2.5365    0.0000 O   0  0
   10.6827    1.0071    0.0000 C   0  0
    9.7973    2.2180    0.0000 C   0  0
    8.3060    2.0567    0.0000 C   0  0
    7.7000    0.6846    0.0000 C   0  0
    8.5853   -0.5263    0.0000 C   0  0
   10.0766   -0.3650    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  2  5  1  0
  5  6  1  0
  2  7  1  0
  7  8  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 12  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 15  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
M  END
> <name>
NIHCC_2014

> <id>
5985

> <plate>
NGP-105-05

> <well>
E02

> <supplier_cmpd_name>
CPD000058461

> <ctcr_id>
4162

> <supplier_cmpd_id>
SAM001246596

> <smiles>
NC(CO)(CO)CO.OC(=O)C1CCn2c1ccc2C(=O)c3ccccc3

> <pd_targets>
{CDC42,RAC1}

> <pathway_gtopdb>
{Enzyme,Hydrolase}

> <pathway_chembl>
{}

> <pathway_reactome>
{}

> <broad_targets>
{PTGS1,PTGS2}

> <broad_moa>
{"cyclooxygenase inhibitor"}

> <synonyms>
{RESTW92,Lixidol,Acular,Dolac,CHEBI:6130,HMS3649A22,AKOS015961616,AC-23357,AC23357,A838010,"Ketorolac tromethamine","Ketorolac tris salt",74103-07-4,74103074,Toradol,"Ketorolac (tromethamine salt)","A
cular LS","Ketorolac tromethamine salt","Acular PF",Acuvail,Ketorolac,T1212,SAM001246596,1503925,Prestw-929,CPD000058461,"KETOROLAC TROMETHAMINE"}

> <pdid>
PD010012

> <targets>
{}

> <classes>
{antiinflammatory}

> <pubchem_cids>
{45357356,84003}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 16  0  0  1  0            999 V2000
   10.9509   -1.0370    0.0000 Cl  0  5
    1.0161   -3.6157    0.0000 C   0  0
    1.6281   -2.2462    0.0000 C   0  0
    0.7500   -1.0323    0.0000 C   0  0  1  0  0  0
    1.2135    0.3943    0.0000 C   0  0  2  0  0  0
    0.0000    1.2760    0.0000 C   0  0
   -1.2135    0.3943    0.0000 O   0  0
   -0.7500   -1.0323    0.0000 C   0  0
   -1.6317   -2.2458    0.0000 O   0  0
    2.6394    0.8543    0.0000 C   0  0
    3.7533   -0.1515    0.0000 C   0  0
    3.5751   -1.6281    0.0000 C   0  0
    4.9433   -2.2430    0.0000 N   0  0
    5.9509   -1.1317    0.0000 C   0  0
    5.2054    0.1699    0.0000 N   0  0
    5.8121    1.5417    0.0000 C   0  0
    8.4509   -1.0370    0.0000 H   0  3
  2  3  1  0
  4  3  1  6
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  4  1  0
  8  9  2  0
  5 10  1  6
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 11  1  0
 15 16  1  0
M  CHG  2   1  -1  17   1
M  END
> <name>
NIHCC_2014

> <id>
5986

> <plate>
NGP-105-05

> <well>
E03

> <supplier_cmpd_name>
CPD000059053

> <ctcr_id>
1532

> <supplier_cmpd_id>
SAM001246962

> <smiles>
[Cl-].CC[C@H]1[C@H](COC1=O)Cc2cncn2C.[H+]

> <pd_targets>
{CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,CYP3A4,LMNA,PMP22,MAPT,KDM4E,BLM,MACHR-A,CYP2A13,CYP2A6,CYP2C9}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Acetylcholine receptor",Enzyme,"Other nuclear protein","Unclassified protein"
,"Other cytosolic protein","Epigenetic regulator","Cytochrome P450",Eraser,"Cytochrome P450 family 3","Lysine demethylase","Cytochrome P450 family 2","Cytochrome P450 family 3A","Jumonji domain-contai
ning","Cytochrome P450 family 2A","Cytochrome P450 3A4","Cytochrome P450 2A6","Cytochrome P450 family 2C","Cytochrome P450 2C9"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Acetylcholine receptors (muscarinic)",Enzymes,"Cytochrome P450","Chromatin modifying enzymes","CYP3 family","1.14.11.- Histone demethylases","CYP2 family: dru
g metabolising subset"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Amine ligand-binding receptors","Muscarinic acetylcholine receptors",Metabolism,"Cell Cycle","D
evelopmental Biology","Neuronal System","DNA Repair","Metabolism of lipids",Mitotic,"Nervous system development","Transmission across Chemical Synapses","DNA Double-Strand Break Repair","Biological ox
idations","Biosynthesis of specialized proresolving mediators (SPMs)","M Phase","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Neurotransmitter receptors and postsynaptic signal tra
nsmission","Homology Directed Repair","Phase I - Functionalization of compounds","Biosynthesis of DHA-derived SPMs","Mitotic Metaphase and Anaphase","Activation of NMDA receptors and postsynaptic even
ts","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Cytochrome P450 - arranged by substrate type","Biosynthesis of maresins","Mitotic Anaphase","Post NMDA receptor activ
ation events","HDR through Homologous Recombination (HRR)",Xenobiotics,"Biosynthesis of maresin-like SPMs","Nuclear Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs","Homologous DNA 
Pairing and Strand Exchange","CYP2E1 reactions","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3,CHRM4,CHRM5}

> <broad_moa>
{"acetylcholine receptor agonist"}

> <synonyms>
{ST023894,"Pilocarpine monohydrochloride",MCULE-3540263793,MCULE3540263793,"MCULE 3540263793","Pilocarpine hydrochloride",54-71-7,54717,"54 71 7","(+)-Pilocarpine hydrochloride","(+)Pilocarpine hydroc
hloride","(+) Pilocarpine hydrochloride","Pilocarpine HCl",Almocarpine,Pilocarpal,Pilocar,Salagen,"Pilocar SMP",Pilomiotin,Pil,T0804,SAM001246962,CPD000059053}

> <pdid>
PD007685

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{24207492,657364,44656245,5909}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 20  0  0  0  0            999 V2000
    7.7003   -2.2522    0.0000 Na  0  3
    3.8964    0.7545    0.0000 O   0  5
    3.8990   -0.7455    0.0000 C   0  0
    5.1996   -1.4928    0.0000 O   0  0
    2.6003   -1.4977    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 N   0  0
   -1.3039   -3.7494    0.0000 C   0  0
   -1.3092   -5.2494    0.0000 C   0  0
   -0.0128   -6.0039    0.0000 Cl  0  0
   -2.6108   -5.9949    0.0000 C   0  0
   -3.9072   -5.2404    0.0000 C   0  0
   -3.9020   -3.7404    0.0000 C   0  0
   -2.6004   -2.9949    0.0000 C   0  0
   -2.5953   -1.4949    0.0000 Cl  0  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 13  1  0
 19 20  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
5987

> <plate>
NGP-105-05

> <well>
E04

> <supplier_cmpd_name>
CPD000449318

> <ctcr_id>
5514

> <supplier_cmpd_id>
SAM001247057

> <smiles>
[Na+].[O-]C(=O)Cc1ccccc1Nc2c(Cl)cccc2Cl

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Diclofenac sodium",15307-79-6,15307796,"Diclofenac sodium salt","Sodium diclofenac",Voltaren,"Diclofenac (Sodium)","GP 45840",Solaraze,Feloran,Orthophen,Voltarol,Voltaren-XR,VoltarenXR,Arthrotec,Olf
en,UNII-QTG126297Q,UNIIQTG126297Q,"Sodium (o-(2","Sodium (o(2",6-dichloroanilino)phenyl)aceta,6dichloroanilino)phenyl)aceta,SAM001247057,1500237,Prestw-594,CPD000449318,"DICLOFENAC SODIUM"}

> <pdid>

> <targets>
{}

> <classes>
{antiinflammatory}

> <pubchem_cids>
{5018304}

$$$$
NIHCC_2014
  SciTegic11012413002D

 16 14  0  0  1  0            999 V2000
   11.4876   -2.6320    0.0000 Cl  0  5
    1.2948   -3.7516    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0  2  0  0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    5.1937   -3.0093    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    5.1894   -6.0109    0.0000 C   0  0
    6.4869   -6.7636    0.0000 C   0  0
    8.9876   -2.6320    0.0000 H   0  3
  3  2  1  6
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  3 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  3  0
M  CHG  2   1  -1  16   1
M  END
> <name>
NIHCC_2014

> <id>
5988

> <plate>
NGP-105-05

> <well>
E05

> <supplier_cmpd_name>
CPD000449328

> <ctcr_id>
3456

> <supplier_cmpd_id>
SAM001246969

> <smiles>
[Cl-].C[C@H](Cc1ccccc1)N(C)CC#C.[H+]

> <pd_targets>
{FTL,KDM4E,MAOA,MAOB,ITGA4,CYP1A2,MAPK1,CYP2B1,ADRA2A,ADRA2B}

> <pathway_gtopdb>
{"Unclassified protein","Epigenetic regulator",Enzyme,"Membrane receptor",Eraser,Oxidoreductase,"Cytochrome P450","Lysine demethylase","Cytochrome P450 family 1","Jumonji domain-containing","Cytochrom
e P450 family 1A","Cytochrome P450 1A1",Kinase,"Family A G protein-coupled receptor","Protein Kinase","Cytochrome P450 family 2","Small molecule receptor (family A GPCR)","CMGC protein kinase group","
Cytochrome P450 family 2B","Monoamine receptor","CMGC protein kinase MAPK family","Cytochrome P450 2B1","Adrenergic receptor","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Receptors,"Chromatin modifying enzymes","Catecholamine turnover","Catalytic receptors","Cytochrome P450","1.14.11.- Histone demethylases",Integrins,"CYP1 family","Kinases (EC 2.7.x.x)","G pro
tein-coupled receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK families",Adrenoceptors,"Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Vesicle-mediated transport",Metabolism,"Gene expression (Transcription)","Membrane Trafficking","Biological oxidations","RNA Polymerase II Transcription","trans-Golgi Network Vesicle Budding","Phase
 I - Functionalization of compounds","Generic Transcription Pathway","Golgi Associated Vesicle Biogenesis","Amine Oxidase reactions","Transcriptional regulation by RUNX3","Cytochrome P450 - arranged b
y substrate type","Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB","RUNX3 Regulates Immune Response and Cell Migration",Xenobiotics,"Aromatic amines can be N-hydroxylated or 
N-dealkylated by CYP1A2","Immune System","Signal Transduction","Innate Immune System","Signaling by GPCR","Toll-like Receptor Cascades","GPCR ligand binding","Toll Like Receptor 5 (TLR5) Cascade","Cla
ss A/1 (Rhodopsin-like receptors)","MyD88 cascade initiated on plasma membrane","Amine ligand-binding receptors","MAP kinase activation",Adrenoceptors,"MAPK targets/ Nuclear events mediated by MAP kin
ases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{MAOA,MAOB}

> <broad_moa>
{"monoamine oxidase inhibitor"}

> <synonyms>
{"(-)-( R)- N,a-Dimethyl- N-2-propynylphenethylamine hydrochloride","Selegiline hydrochloride",14611-52-0,Eldepryl,Zelapar,"(-)-Deprenyl hydrochloride","l-Deprenyl hydrochloride","Selegiline Hcl","(R)
-N-Methyl-N-(1-phenylpropan-2-yl)prop-2-yn-1-amine hydrochloride",Jumex,UNII-6W731X367Q,"R-(-)-Deprenyl (hydrochloride)","(-)-selegiline hydrochloride","(R)-(-)-Deprenyl hydrochloride",(-)-Phenylisopr
opylmethylpropynylamine,Otrasel,"R-(-)-Deprenyl hydrochloride",6W731X367Q,DSSTox_CID_24584,DSSTox_RID_80331,"Jumex hydrochloride",DSSTox_GSID_44584,"Eldepryl hydrochloride","Zydis selegiline",CHEBI:90
87,"(-)-Deprenil hydrochloride","(-)-E-250 hydrochloride",SMR000449328,"HSDB 7183",FPF1100,SR-01000597928,Plurimen,Seledat,Vivapryl,Xilopar,Ensam,"CCRIS 8571","(R)-(-)-N,alpha-Dimethyl-N-(2-propynyl)p
henethylamine hydrochloride",MFCD00069299,"Eldepryl (TN)",Prestwick_846,"Selegiline hydrochloride (USAN:USP)",E-250,"(-)-(R)-N,alpha-Dimethyl-N-2-propynylphenethylamine hydrochloride","(-)-N,alpha-Dim
ethyl-N-2-propynylbenzeneethanamine hydrochloride",NCGC00016708-01,"(-)-(R)-N,alpha-Dimethyl-N-2-propynylphenethylamine monohydrochloride",CAS-14611-52-0,"R-(-)deprenyl hydrochloride",SCHEMBL41392,MLS
000758294,MLS001423947,MLS002153281,MLS002222269,CHEMBL1200904,DTXSID9044584,HMS1569P05,FPF-1100,"Selegiline hydrochloride (JAN/USP)",Tox21_110572,Tox21_301846,AKOS005166822,"Benzeneethanamine, N,alph
a-dimethyl-N-2-propynyl-, hydrochloride, (R)-",Tox21_110572_1,CCG-100773,KS-5098,NC00023,NC00605,NCGC00024994-06,NCGC00255797-01,AC-18759,HY-14199,D00785,K-4669,611S520,SR-01000597928-1,SR-01000597928
-5,SR-01000597928-6,Q27108267,"R-(-)-Deprenyl hydrochloride, powder, >=98 (HPLC)","UNII-63G7R4955A component IYETZZCWLLUHIJ-UTONKHPSSA-N","Selegiline Hydrochloride 1.0 mg/ml in Methanol (as free base)
","(R)-(-)-N-?-Dimethyl-N-2-propynylbenzeneethanamine hydrochloride","Benzeneethanamine, N,.alpha.-dimethyl-N-2-propynyl-, hydrochloride","Selegiline hydrochloride, European Pharmacopoeia (EP) Referen
ce Standard","N-methyl-N-((1R)-1-methyl-2-phenylethyl)prop-2-yn-1-aminium chloride",SAM002589926,SAM001246969,Prestw-552,CPD000449328}

> <pdid>
PD009583

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{57525649,26758,25058197}

$$$$
NIHCC_2014
  SciTegic11012413002D

 36 39  0  0  0  0            999 V2000
    2.5944   -6.0070    0.0000 C   0  0
    3.8934   -5.2570    0.0000 N   0  0
    5.1924   -6.0070    0.0000 C   0  0
    6.4915   -5.2571    0.0000 C   0  0
    6.4915   -3.7571    0.0000 C   0  0
    5.1925   -3.0070    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 S   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -1.2959   -5.2508    0.0000 S   0  0
   -2.5937   -6.0031    0.0000 C   0  0
    0.0042   -5.9990    0.0000 O   0  0
   12.8889   -3.3785    0.0000 O   0  0
   12.8893   -1.8785    0.0000 S   0  0
   14.1888   -1.1293    0.0000 O   0  0
   14.1880   -2.6291    0.0000 O   0  0
   11.5896   -1.1281    0.0000 C   0  0
   11.5896    0.3719    0.0000 C   0  0
   10.2905    1.1219    0.0000 C   0  0
    8.9915    0.3719    0.0000 C   0  0
    8.9915   -1.1281    0.0000 C   0  0
   10.2905   -1.8781    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  2  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 10  1  0
 23 18  1  0
 21 24  1  0
 24 25  1  0
 24 26  2  0
 27 28  1  0
 28 29  2  0
 28 30  2  0
 28 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 36 31  1  0
M  END
> <name>
NIHCC_2014

> <id>
5989

> <plate>
NGP-105-05

> <well>
E06

> <supplier_cmpd_name>
CPD000466274

> <ctcr_id>
630

> <supplier_cmpd_id>
SAM001247051

> <smiles>
CN1CCCCC1CCN2c3ccccc3Sc4ccc(cc24)[S](C)=O.O[S](=O)(=O)c5ccccc5

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"MESORIDAZINE BESYLATE",32672-69-8,32672698,"Mesoridazine benzenesulfonate","NC 123",UNII-T4G2I958J2,UNIIT4G2I958J2,"Mesoridazine (besylate)","Mesoridazine besylate (USP)",CHEBI:6781,"32672-69-8 (bes
ylate)","32672698 (besylate)",T4G2I958J2,"mesoridazine besilate","Lidanar; Lidanil; Mesor",SAM001247051,Prestw-529,CPD000466274,"Mesoridazine besylate"}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{36207}

$$$$
NIHCC_2014
  SciTegic11012413002D

 33 38  0  0  1  0            999 V2000
   11.3000    1.6099    0.0000 O   0  0
    8.8000    1.6099    0.0000 Cl  0  0
   -5.5469   -3.3830    0.0000 O   0  0
   -4.8400   -2.0600    0.0000 C   0  0
   -5.6600   -0.7600    0.0000 C   0  0
   -4.9100    0.5000    0.0000 C   0  0
   -3.4100    0.5000    0.0000 C   0  0
   -2.6900    1.8200    0.0000 C   0  0
   -1.2200    1.8400    0.0000 C   0  0
   -0.5200    3.1200    0.0000 N   0  0
    0.7595    3.8835    0.0000 C   0  0
    0.7395    5.3842    0.0000 C   0  0
    1.4703    6.6035    0.0000 C   0  0
   -0.0295    6.5798    0.0000 C   0  0
   -2.0900    3.1200    0.0000 C   0  0
   -2.0900    0.3800    0.0000 C   0  0
   -1.1700   -0.7500    0.0000 C   0  0  1  0  0  0
   -0.3700   -1.9700    0.0000 C   0  0  1  0  0  0
   -1.8000   -3.0200    0.0000 O   0  0
   -3.3400   -2.0200    0.0000 C   0  0
   -2.5800   -0.7500    0.0000 C   0  0
    1.1200   -1.9700    0.0000 C   0  0
    2.1500   -3.1800    0.0000 N   0  0
    3.6000   -2.4800    0.0000 C   0  0
    5.0500   -3.0400    0.0000 C   0  0
    6.3000   -2.0400    0.0000 C   0  0
    6.0600   -0.5200    0.0000 C   0  0
    4.5900    0.0400    0.0000 C   0  0
    3.3800   -0.9400    0.0000 C   0  0
    1.8500   -0.7000    0.0000 C   0  0
    1.0500    0.5600    0.0000 C   0  0
   -0.4300    0.5600    0.0000 C   0  0  1  0  0  0
    0.3008    1.8699    0.0000 O   0  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 12  1  0
 10 15  1  0
 15 16  1  0
 17 16  1  1
 17 18  1  0
 18 19  1  6
 19 20  1  0
 20  4  1  0
 20 21  2  0
 21  7  1  0
 21 17  1  0
 18 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 29 30  1  0
 30 22  2  0
 30 31  1  0
 31 32  1  0
 32  9  1  0
 32 17  1  0
 32 33  1  1
M  END
> <name>
NIHCC_2014

> <id>
5990

> <plate>
NGP-105-05

> <well>
E07

> <supplier_cmpd_name>
CPD000449312

> <ctcr_id>
709

> <supplier_cmpd_id>
SAM001247004

> <smiles>
O.Cl.Oc1ccc2CC3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)c7[nH]c8ccccc8c7C[C@@]36O

> <pd_targets>
{PMP22,NPSR1,MTOR,TGR,FFP,GAA,MAPT,OPRD1,OPRM1,OPRK1,AMPC,OPRL1}

> <pathway_gtopdb>
{"Unclassified protein","Membrane receptor",Enzyme,"Other cytosolic protein","Family A G protein-coupled receptor",Kinase,Transferase,Hydrolase,"Peptide receptor (family A GPCR)","Protein Kinase","Sho
rt peptide receptor (family A GPCR)","Atypical protein kinase group","Neuropeptide receptor","Atypical protein kinase PIKK family","Atypical protein kinase FRAP subfamily","Opioid receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Kinases (EC 2.7.x.x)","3.2.1.- Glycosidases","Neuropeptide S receptor",Atypical,"Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","FRAP 
subfamily","Opioid receptors"}

> <pathway_reactome>
{"Developmental Biology",Disease,"Gene expression (Transcription)","Neuronal System","Nervous system development","Infectious disease","RNA Polymerase II Transcription","Diseases of metabolism","Trans
mission across Chemical Synapses","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Leishmania infection","Generic Transcription Pathway","Diseases of carbohydrate metabolism","Neurotr
ansmitter receptors and postsynaptic signal transmission","Leishmania parasite growth and survival","Transcriptional Regulation by TP53","Glycogen storage diseases","Activation of NMDA receptors and p
ostsynaptic events","Anti-inflammatory response favouring Leishmania parasite infection","Regulation of TP53 Activity","Glycogen storage disease type II (GAA)","Post NMDA receptor activation events","
ADORA2B mediated anti-inflammatory cytokines production","Regulation of TP53 Expression and Degradation","Activation of AMPK downstream of NMDARs","Regulation of TP53 Degradation","Signal Transduction
","Signaling by GPCR","GPCR ligand binding","GPCR downstream signalling","Class A/1 (Rhodopsin-like receptors)","G alpha (i) signalling events","Transcriptional Regulation by MECP2","Peptide ligand-bi
nding receptors","Opioid Signalling","MECP2 regulates neuronal receptors and channels","G-protein activation"}

> <broad_targets>
{OPRD1,OPRK1,OPRM1}

> <broad_moa>
{"opioid receptor antagonist"}

> <synonyms>
{SMR000449312,MLS000758226,MLS001424020,CHEMBL1408911,CCG-100789,CCG100789,NC00039,SAM001247004,CPD000449312}

> <pdid>
PD008110

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581811}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 31  0  0  0  0            999 V2000
    8.8990    4.2667    0.0000 O   0  0
    6.3990    4.2667    0.0000 Cl  0  0
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 N   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 N   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3032   -3.7490    0.0000 C   0  0
   -1.2991    5.2507    0.0000 N   0  0
   -0.0012    6.0029    0.0000 C   0  0
   -0.0036    7.5029    0.0000 C   0  0
   -1.3039    8.2509    0.0000 N   0  0
   -2.6017    7.4988    0.0000 C   0  0
   -2.5993    5.9988    0.0000 C   0  0
   -1.3093    9.7517    0.0000 C   0  0
   -0.0128   10.5060    0.0000 O   0  0
   -2.6114   10.4982    0.0000 C   0  0
   -2.7567   11.9783    0.0000 O   0  0
   -4.2255   12.2827    0.0000 C   0  0
   -4.9689   10.9799    0.0000 C   0  0
   -3.9596    9.8703    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 13  7  1  0
 13 14  1  0
 14 15  2  0
 15  5  1  0
 15 16  1  0
 16 17  1  0
  9 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 18  1  0
 21 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 26  2  0
M  END
> <name>
NIHCC_2014

> <id>
5991

> <plate>
NGP-105-05

> <well>
E08

> <supplier_cmpd_name>
CPD000449301

> <ctcr_id>
6976

> <supplier_cmpd_id>
SAM001246995

> <smiles>
O.Cl.COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)c4occc4

> <pd_targets>
{SCN1A,SCN2A,SCN3A,GLA,ADRA2A,RORC,GAA,KDM4E,ADRA1D,ADRA1A,ADRA2B,ADRA2C,HTR7,HTR1B,HSD17B10,MAPK1,LEF,HPGD,ADRA1B,CSN2,CACNA1C,ALDH1A1,HIF1A,TP53,CYP3A4,CYP1A2,HTR1D,OPRM1,DRD2,KMT2A,MEN1,NFKB1,CHRM1
,THPO,MAPT,ADORA3,KCNH2,HTR1A,NQO2,SLC22A1,HTR2A,HTR2B,HTR2C,MMP1,LMNA,NFO,GMNN,TGR,PMP22,NS1,ALD,MTOR,SLC22A3,DRD4,MMP9,SLC47A2,SLC22A2,SLC47A1,ABCC4,LMP1}

> <pathway_gtopdb>
{"Ion channel",Enzyme,"Membrane receptor","Transcription factor","Epigenetic regulator","Secreted protein","Other cytosolic protein","Unclassified protein",Transporter,"Other nuclear protein","Voltage
-gated ion channel",Hydrolase,"Family A G protein-coupled receptor","Nuclear receptor",Eraser,Oxidoreductase,Kinase,Protease,"Cytochrome P450",Reader,"Electrochemical transporter","Primary active tran
sporter","Voltage-gated sodium channel","Small molecule receptor (family A GPCR)","Nuclear hormone receptor subfamily 1","Lysine demethylase","Protein Kinase","Metallo protease","Voltage-gated calcium
 channel","Cytochrome P450 family 3","Cytochrome P450 family 1","Peptide receptor (family A GPCR)",Bromodomain,"Potassium channels","SLC superfamily of solute carriers","ATP-binding cassette","Monoami
ne receptor","Nuclear hormone receptor subfamily 1 group F","Jumonji domain-containing","CMGC protein kinase group","Metallo protease MAE clan","Cytochrome P450 family 3A","Cytochrome P450 family 1A",
"Short peptide receptor (family A GPCR)","Nucleotide-like receptor (family A GPCR)","Voltage-gated potassium channel","SLC22 family of organic cation and anion transporters","Metallo protease MAM clan
","Atypical protein kinase group","SLC47 family of multidrug and toxin extrusion transporters","ABCC subfamily","Adrenergic receptor","Nuclear hormone receptor subfamily 1 group F member 3","Serotonin
 receptor","CMGC protein kinase MAPK family","Metallo protease M34 family","Cytochrome P450 3A4","Cytochrome P450 1A1","Opioid receptor","Dopamine receptor","Acetylcholine receptor","Adenosine recepto
r","Metallo protease M10A subfamily","Atypical protein kinase PIKK family","CMGC protein kinase ERK1","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Receptors,Enzymes,"Ion channels",Transporters,"G protein-coupled receptors","Nuclear hormone receptors","3.2.1.- Glycosidases","Chromatin modifying enzymes","Kinases (EC 2.7.x.x)","Eicosanoid turnove
r","Voltage-gated ion channels","Cytochrome P450","SLC superfamily of solute carriers","Peptidases and proteinases","ATP-binding cassette transporter family",Adrenoceptors,"1F. Retinoic acid-related o
rphans","1.14.11.- Histone demethylases","5-Hydroxytryptamine receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Prostaglandin synthases","Voltage-gated calcium channels","CYP3 family","CYP1 
family","Opioid receptors","Dopamine receptors","Acetylcholine receptors (muscarinic)","Adenosine receptors","Potassium channels","SLC22 family of organic cation and anion transporters","MA: Metallo (
M) Peptidases",Atypical,"SLC47 family of multidrug and toxin extrusion transporters","ABCC subfamily","Mitogen-activated protein kinases (MAP kinases)","Voltage-gated potassium channels","Organic cati
on transporters (OCT)","M10: Matrix metallopeptidase","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","ERK subfamily","FRAP subfamily"}

> <pathway_reactome>
{Metabolism,"Signal Transduction","Gene expression (Transcription)",Disease,"Immune System","Developmental Biology","Cellular responses to external stimuli","Cell Cycle",Hemostasis,"Neuronal System","
Muscle contraction","Transport of small molecules","Metabolism of lipids","Signaling by GPCR","RNA Polymerase II Transcription","Diseases of metabolism","Infectious disease","Metabolism of amino acids
 and derivatives","Innate Immune System","Nervous system development","Biological oxidations","Cellular responses to stress","Cell Cycle Checkpoints","Cytokine Signaling in Immune system","Platelet ac
tivation","signaling and aggregation","Transmission across Chemical Synapses","Cardiac conduction","SLC-mediated transmembrane transport",Mitotic,"Sphingolipid metabolism","GPCR ligand binding","Gener
ic Transcription Pathway","Diseases of carbohydrate metabolism","Leishmania infection","Branched-chain amino acid catabolism","Toll-like Receptor Cascades","Uptake and actions of bacterial toxins","Bi
osynthesis of specialized proresolving mediators (SPMs)","Axon guidance","Phase I - Functionalization of compounds","Cellular response to hypoxia","G1/S DNA Damage Checkpoints","GPCR downstream signal
ling","Signaling by Interleukins","Platelet Aggregation (Plug Formation)","Neurotransmitter receptors and postsynaptic signal transmission","Phase 3 - rapid repolarisation","Transport of bile salts an
d organic acids","metal ions and amine compounds","M Phase","Mitotic G1 phase and G1/S transition","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Response to elevated platelet cytos
olic Ca2+","Glycosphingolipid metabolism","Class A/1 (Rhodopsin-like receptors)","Transcriptional regulation by RUNX3","Glycogen storage diseases","Leishmania parasite growth and survival","Toll Like 
Receptor 5 (TLR5) Cascade","Uptake and function of anthrax toxins","Biosynthesis of DHA-derived SPMs","NCAM signaling for neurite out-growth","Ethanol oxidation","Oxygen-dependent proline hydroxylatio
n of Hypoxia-inducible Factor Alpha","p53-Dependent G1/S DNA damage checkpoint","Cytochrome P450 - arranged by substrate type","G alpha (i) signalling events","Interleukin-1 family signaling","Activat
ion of NMDA receptors and postsynaptic events","Organic cation/anion/zwitterion transport","Interleukin-4 and Interleukin-13 signaling","Mitotic Metaphase and Anaphase","G1/S Transition","Transcriptio
nal Regulation by TP53","EPH-Ephrin signaling","Platelet degranulation","Amine ligand-binding receptors","RUNX3 Regulates Immune Response and Cell Migration","Glycogen storage disease type II (GAA)","
Anti-inflammatory response favouring Leishmania parasite infection","MyD88 cascade initiated on plasma membrane","Biosynthesis of D-series resolvins","NCAM1 interactions","p53-Dependent G1 DNA Damage 
Response","Biosynthesis of maresins",Xenobiotics,"Opioid Signalling","Interleukin-1 signaling","Post NMDA receptor activation events","Nucleotide-like (purinergic) receptors","Organic cation transport
","Mitotic Anaphase","Activation of the pre-replicative complex","Regulation of TP53 Activity","EPH-ephrin mediated repulsion of cells",Adrenoceptors,"ADORA2B mediated anti-inflammatory cytokines prod
uction","Serotonin receptors","MAP kinase activation","Stabilization of p53","Biosynthesis of maresin-like SPMs","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","G-protein activatio
n","Dopamine receptors","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Muscarinic acetylcholine receptors","Activation of AMPK downstream of NMDARs","Adenosine P1 receptors","Nuclear Envelope (NE) Reas
sembly","Regulation of TP53 Expression and Degradation","MAPK targets/ Nuclear events mediated by MAP kinases","Autodegradation of the E3 ubiquitin ligase COP1","Initiation of Nuclear Envelope (NE) Re
formation","Regulation of TP53 Degradation","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,ADRA2A,ADRA2B,ADRA2C,KCNH2,KCNH6,KCNH7}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{SMR000449301,MLS000758237,MLS001424021,SCHEMBL9663302,CHEMBL1347191,CCG-100797,CCG100797,NC00047,T1050,SAM001246995,"Prazosin hydrochloride",CPD000449301}

> <pdid>
PD010017

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{19846442}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 24  0  0  0  0            999 V2000
    3.8926   -3.7566    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 O   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3039   -3.7494    0.0000 C   0  0
   -1.3070   -5.2502    0.0000 C   0  0
   -2.6078   -5.9988    0.0000 C   0  0
   -2.6109   -7.4996    0.0000 C   0  0
   -3.9117   -8.2482    0.0000 C   0  0
   -4.0547   -9.7285    0.0000 N   0  0
   -5.5230  -10.0353    0.0000 N   0  0
   -6.2685   -8.7337    0.0000 N   0  0
   -5.2609   -7.6224    0.0000 N   0  0
   -0.0031    3.0008    0.0000 C   0  0
    1.2946    3.7531    0.0000 C   0  0
   -1.3032    3.7490    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  4  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 16  2  0
  7 21  1  0
 21 22  1  0
 21 23  2  0
M  END
> <name>
NIHCC_2014

> <id>
5992

> <plate>
NGP-105-05

> <well>
E09

> <supplier_cmpd_name>
CPD000058555

> <ctcr_id>
2275

> <supplier_cmpd_id>
SAM001246988

> <smiles>
CCCc1c(O)c(ccc1OCCCCc2[nH]nnn2)C(C)=O

> <pd_targets>
{CYSLTR1,CYSLTR2,ALOX5,TSHR,TGR,KMT2A,MEN1,PTGS1,PTGS2,RORC,CYP3A4,ALOX15,GLA,LMNA,ALD}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Epigenetic regulator","Transcription factor","Other nuclear protein","Family A G protein-coupled receptor",Oxidoreductase,Reader,"Nuclear receptor","Cytochrome P450",Hydro
lase,"Small molecule receptor (family A GPCR)","Peptide receptor (family A GPCR)",Bromodomain,"Nuclear hormone receptor subfamily 1","Cytochrome P450 family 3","Lipid-like ligand receptor (family A GP
CR)","Glycohormone receptor","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family 3A","Leukotriene receptor","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 
3A4"}

> <pathway_chembl>
{Enzymes,Receptors,"Eicosanoid turnover","G protein-coupled receptors","Nuclear hormone receptors","Cytochrome P450",Lipoxygenases,"Glycoprotein hormone receptors","Leukotriene receptors","1F. Retinoi
c acid-related orphans","CYP3 family"}

> <pathway_reactome>
{Metabolism,Disease,"Gene expression (Transcription)","Cell Cycle","Metabolism of lipids","Infectious disease","RNA Polymerase II Transcription",Mitotic,"Biosynthesis of specialized proresolving media
tors (SPMs)","Leishmania infection","Generic Transcription Pathway","Sphingolipid metabolism","M Phase","Biosynthesis of DPA-derived SPMs","Leishmania parasite growth and survival","Transcriptional re
gulation by RUNX3","Biosynthesis of DHA-derived SPMs","Glycosphingolipid metabolism","Mitotic Metaphase and Anaphase","Biosynthesis of DPAn-3 SPMs","Anti-inflammatory response favouring Leishmania par
asite infection","RUNX3 Regulates Immune Response and Cell Migration","Biosynthesis of maresins","Mitotic Anaphase","Biosynthesis of DPAn-3-derived 13-series resolvins","ADORA2B mediated anti-inflamma
tory cytokines production","LTC4-CYSLTR mediated IL4 production","Biosynthesis of maresin-like SPMs","Biosynthesis of DPAn-3-derived protectins and resolvins","Nuclear Envelope (NE) Reassembly","Initi
ation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{Tomelukast,88107-10-2,88107102,"LY 171883",LY-171883,LY171883,Tomelukastum,"Tomelukastum (INN-Latin)","Tomelukastum (INNLatin)",UNII-59762X5CLS,UNII59762X5CLS,1-(2-Hydroxy-3-propyl-4-(4-(1H-tetrazol-
5-yl)butoxy)phenyl)ethanone,1(2Hydroxy3propyl4(4(1Htetrazol5yl)butoxy)phenyl)ethanone,ETHANONE,1-(2-HYDROXY-3-PROPYL-4-(4-(1H-TETRAZOL-5-YL)BUTOXY)PHE,1(2HYDROXY3PROPYL4(4(1HTETRAZOL5YL)BUTOXY)PHE,SAM
001246988,CPD000058555}

> <pdid>
PD003112

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{3969}

$$$$
NIHCC_2014
  SciTegic11012413002D

 16 15  0  0  0  0            999 V2000
    0.0007    0.0004    0.0000 C   0  0
    1.3000    0.7500    0.0000 C   0  0
    2.6000    0.0000    0.0000 N   0  0
    2.5969   -1.5008    0.0000 C   0  0
    1.2968   -2.2490    0.0000 C   0  0
    3.9000    0.7500    0.0000 C   0  0
    3.9000    2.2500    0.0000 S   0  0
    5.2000    0.0000    0.0000 S   0  0
    6.5000    0.7500    0.0000 S   0  0
    7.7999    0.0000    0.0000 C   0  0
    7.7999   -1.5000    0.0000 S   0  0
    9.0999    0.7500    0.0000 N   0  0
   10.3999    0.0000    0.0000 C   0  0
   11.6992    0.7496    0.0000 C   0  0
    9.1030    2.2508    0.0000 C   0  0
   10.4031    2.9990    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 12 15  1  0
 15 16  1  0
M  END
> <name>
NIHCC_2014

> <id>
5993

> <plate>
NGP-105-05

> <well>
E10

> <supplier_cmpd_name>
CPD000059171

> <ctcr_id>
91

> <supplier_cmpd_id>
SAM001247028

> <smiles>
CCN(CC)C(=S)SSC(=S)N(CC)CC

> <pd_targets>
{MGLL,ALDH1A1,NFKB1,PYK,FTL,EHMT2,CYP2C19,RORC,FFP,AGTR1,THPO,PTBP1,CYP2C9,GMNN,ALOX15,GSDMD,CCR4,ALDH2,KMT2A,MAPT,ALD,LEF,CHRM1,TP53,ABHD5,PLIN1,LMNA,APLNR,PMP22,HPGD,NPSR1,CYP3A4,REP,EHMT1,PKM,KDM5A
,CASP1,HSD17B10,HSP90AA1,HTR1B,HTT,ALOX12,MAPK3,AMPC,G6PD-6PGL,PLIN5,CYP1A2,LOX,GLMU,LOXL3,ADRA2A,DRD2,DRD4,ADORA3,CCR2,CCR5,DRD3,OPRK1,LOXL2,TRPA1,CXCR2,HTR2B,HTR6,MTOR,ADRA2B,SLC6A2,MAOA,OPRM1,LOXL4
,SLC6A3,DBH,FAAH}

> <pathway_gtopdb>
{Enzyme,"Other cytosolic protein","Unclassified protein","Epigenetic regulator","Transcription factor","Membrane receptor","Other nuclear protein","Ion channel",Transporter,Hydrolase,Oxidoreductase,Tr
ansferase,Protease,Writer,"Cytochrome P450","Nuclear receptor","Family A G protein-coupled receptor",Reader,Eraser,Kinase,"Voltage-gated ion channel","Electrochemical transporter","Cysteine protease",
"Protein methyltransferase","Cytochrome P450 family 2","Nuclear hormone receptor subfamily 1","Peptide receptor (family A GPCR)",Bromodomain,"Metallo protease","Small molecule receptor (family A GPCR)
","Cytochrome P450 family 3","Lysine demethylase","Protein Kinase","Cytochrome P450 family 1","Transient receptor potential channel","SLC superfamily of solute carriers","Cysteine protease CA clan","C
ytochrome P450 family 2C","Nuclear hormone receptor subfamily 1 group F","Short peptide receptor (family A GPCR)","Chemokine receptor","Metallo protease MAE clan","Monoamine receptor","Cytochrome P450
 family 3A","Jumonji domain-containing","Cysteine protease CD clan","CMGC protein kinase group","Cytochrome P450 family 1A","Nucleotide-like receptor (family A GPCR)","Atypical protein kinase group","
SLC06 neurotransmitter transporter family","Cysteine protease C1A family","Cytochrome P450 2C19","Nuclear hormone receptor subfamily 1 group F member 3","Angiotensin receptor","Cytochrome P450 2C9","C
C chemokine receptor","Metallo protease M34 family","Acetylcholine receptor","Neuropeptide receptor","Cytochrome P450 3A4","Cysteine protease C14 family","Serotonin receptor","CMGC protein kinase MAPK
 family","Cytochrome P450 1A1","Adrenergic receptor","Dopamine receptor","Adenosine receptor","Opioid receptor","CXC chemokine receptor","Atypical protein kinase PIKK family","CMGC protein kinase ERK1
","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Enzymes,Receptors,"Other protein targets","Ion channels",Transporters,"Peptidases and proteinases","Chromatin modifying enzymes","Cytochrome P450","Nuclear hormone receptors","G protein-coupled recep
tors","Eicosanoid turnover","1.-.-.- Oxidoreductases","Anti-infective targets","2.7.1.40 Pyruvate kinases","Heat shock proteins","Kinases (EC 2.7.x.x)","1.4.3.13 Lysyl oxidases","Voltage-gated ion cha
nnels","SLC superfamily of solute carriers","Catecholamine turnover","Endocannabinoid turnover","SC: Serine (S) Peptidases","2.1.1.43 Histone methyltransferases (HMTs)","CYP2 family: drug metabolising
 subset","1F. Retinoic acid-related orphans","Angiotensin receptors",Lipoxygenases,"Chemokine receptors","Acetylcholine receptors (muscarinic)","Apelin receptor","Prostaglandin synthases","Neuropeptid
e S receptor","CYP3 family","Viral protein targets","1.14.11.- Histone demethylases","CD: Cysteine (C) Peptidases","5-Hydroxytryptamine receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK families","CYP1
 family",Adrenoceptors,"Dopamine receptors","Adenosine receptors","Opioid receptors","Transient Receptor Potential channels",Atypical,"SLC6 neurotransmitter transporter family","<i>N</i>-Acylethanolam
ine turnover","S33: Prolyl aminopeptidase","Coronavirus (CoV) proteins","C14: Caspase","Mitogen-activated protein kinases (MAP kinases)","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family"
,"Monoamine transporter subfamily","ERK subfamily","FRAP subfamily"}

> <pathway_reactome>
{Metabolism,"Immune System","Vesicle-mediated transport","Gene expression (Transcription)","Signal Transduction",Hemostasis,"Cell Cycle","Neuronal System",Disease,"Developmental Biology","Chromatin or
ganization","Extracellular matrix organization","Transport of small molecules","Metabolism of lipids","Biological oxidations","Cytokine Signaling in Immune system","Membrane Trafficking","RNA Polymera
se II Transcription","Signaling by GPCR","Platelet activation","signaling and aggregation","Signaling by Receptor Tyrosine Kinases",Mitotic,"Innate Immune System","Transmission across Chemical Synapse
s","Infectious disease","Cell Cycle Checkpoints","Nervous system development","Metabolism of carbohydrates","Chromatin modifying enzymes","Metabolism of amino acids and derivatives","Collagen formatio
n","Ion channel transport","Disorders of transmembrane transporters","Phospholipid metabolism","Phase I - Functionalization of compounds","Signaling by Interleukins","trans-Golgi Network Vesicle Buddi
ng","Generic Transcription Pathway","GPCR ligand binding","Platelet Aggregation (Plug Formation)","Signaling by FGFR","Mitotic G1 phase and G1/S transition","Biosynthesis of specialized proresolving m
ediators (SPMs)","Neutrophil degranulation","Neurotransmitter clearance","Neurotransmitter receptors and postsynaptic signal transmission","Uptake and actions of bacterial toxins","G1/S DNA Damage Che
ckpoints","M Phase","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Leishmania infection","SARS-CoV Infections","Glucose metabolism","HDMs demethylate histones","Branched-chain amino
 acid catabolism","Mitotic G2-G2/M phases","Triglyceride metabolism","Toll-like Receptor Cascades","Assembly of collagen fibrils and other multimeric structures","HIV Infection","Stimuli-sensing chann
els","SLC transporter disorders","GPCR downstream signalling","Metabolism of amine-derived hormones","Fatty acid metabolism","Glycerophospholipid biosynthesis","Ethanol oxidation","Interleukin-1 famil
y signaling","Golgi Associated Vesicle Biogenesis","Transcriptional Regulation by TP53","Cytochrome P450 - arranged by substrate type","Transcriptional regulation by RUNX3","Class A/1 (Rhodopsin-like 
receptors)","Signaling by FGFR2","G1/S Transition","Biosynthesis of DPA-derived SPMs","Serotonin clearance from the synaptic cleft","Transcriptional regulation by RUNX1","Activation of NMDA receptors 
and postsynaptic events","Uptake and function of anthrax toxins","p53-Dependent G1/S DNA damage checkpoint","Mitotic Metaphase and Anaphase","Biosynthesis of DHA-derived SPMs","Leishmania parasite gro
wth and survival","SARS-CoV-2 Infection",Glycolysis,"G2/M Transition","Triglyceride catabolism","Transcriptional Regulation by MECP2","Toll Like Receptor 5 (TLR5) Cascade","Crosslinking of collagen fi
brils","HIV Life Cycle","TRP channels","Defective SLC6A2 causes orthostatic intolerance (OI)","Amine Oxidase reactions","G alpha (i) signalling events","Defective SLC6A3 causes Parkinsonism-dystonia i
nfantile (PKDYS)","Catecholamine biosynthesis","Arachidonic acid metabolism","Acyl chain remodeling of DAG and TAG","Interleukin-1 signaling","Regulation of TP53 Activity",Xenobiotics,"RUNX3 Regulates
 Immune Response and Cell Migration","Peptide ligand-binding receptors","FGFR2 alternative splicing","Activation of the pre-replicative complex","Biosynthesis of DPAn-3 SPMs","Metabolism of serotonin"
,"RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","Post NMDA receptor activation events","Amine ligand-binding receptors","p53-Dependent G1 DNA Damage Response",
"Mitotic Anaphase","Biosynthesis of D-series resolvins","Anti-inflammatory response favouring Leishmania parasite infection","Biosynthesis of maresins","SARS-CoV-2 Genome Replication and Transcription
","TP53 Regulates Transcription of Cell Death Genes","Centrosome maturation","Regulation of MECP2 expression and activity","MyD88 cascade initiated on plasma membrane","Nucleotide-like (purinergic) re
ceptors","Early Phase of HIV Life Cycle","MECP2 regulates neuronal receptors and channels","Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB","Opioid Signalling","MAP3K8 (TPL2)
-dependent MAPK1/3 activation","Regulation of TP53 Activity through Methylation","CYP2E1 reactions","Biosynthesis of DPAn-3-derived protectins and resolvins","Chemokine receptors bind chemokines","Act
ivation of AMPK downstream of NMDARs","Muscarinic acetylcholine receptors","Stabilization of p53","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Biosynth
esis of maresin-like SPMs","Replication of the SARS-CoV-2 genome","TP53 Regulates Transcription of Caspase Activators and Caspases","Loss of proteins required for interphase microtubule organization f
rom the centrosome","Serotonin receptors","Biosynthesis of DPAn-3-derived maresins","MAP kinase activation","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2",Adrenoceptors,"Dopamine r
eceptors","Adenosine P1 receptors","Binding and entry of HIV virion","Regulation of TP53 Expression and Degradation","G-protein activation","Autodegradation of the E3 ubiquitin ligase COP1","Initiatio
n of Nuclear Envelope (NE) Reformation","Loss of Nlp from mitotic centrosomes","MAPK targets/ Nuclear events mediated by MAP kinases","Regulation of TP53 Degradation","ERK/MAPK targets","ERKs are inac
tivated"}

> <broad_targets>
{ALDH2,DBH}

> <broad_moa>
{"aldehyde dehydrogenase inhibitor","DNA methyltransferase inhibitor","TRPV agonist"}

> <synonyms>
{disulfiram,"Tetraethylthiuram disulfide",97-77-8,97778,Antabuse,Antabus,"Bis(diethylthiocarbamoyl) disulfide",Alcophobin,Anticol,Esperal,Teturam,TETD,Dicupral,Exhorran,Hoca,Ethyldithiurame,Abstensil,
Antaethyl,Antietanol,Antivitium,Contralin,Tetradi,T0054,SAM001247028,1500262,Prestw-97,Disulfiram,CPD000059171,DISULFIRAM}

> <pdid>
PD002360

> <targets>
{Aldehyde Dehydrogenase (ALDH),Interleukin Related,Pyroptosis}

> <classes>
{alcohol antagonist,Apoptosis,Immunology/Inflammation,Metabolic Enzyme/Protease}

> <pubchem_cids>
{3117}

$$$$
NIHCC_2014
  SciTegic11012413002D

 34 35  0  0  1  0            999 V2000
   18.0927   -3.3779    0.0000 O   0  0
    1.2948   -3.7516    0.0000 C   0  0
    2.5951   -3.0039    0.0000 N   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 N   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 N   0  0
   -3.8971   -0.7500    0.0000 N   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
    3.8933   -3.7570    0.0000 C   0  0
    3.8934   -5.2570    0.0000 C   0  0
    5.1924   -6.0070    0.0000 C   0  0
    6.4915   -5.2571    0.0000 C   0  0
    6.4915   -3.7571    0.0000 C   0  0
    5.1925   -3.0070    0.0000 C   0  0
    7.7928   -6.0048    0.0000 C   0  0
    7.7953   -7.5048    0.0000 O   0  0
    9.0914   -5.2526    0.0000 N   0  0
   10.3927   -6.0004    0.0000 C   0  0  1  0  0  0
   11.6914   -5.2481    0.0000 C   0  0
   12.9927   -5.9959    0.0000 C   0  0
   14.2914   -5.2437    0.0000 C   0  0
   14.2888   -3.7437    0.0000 O   0  0
   15.5920   -5.9910    0.0000 O   0  0
   10.3984   -7.5012    0.0000 C   0  0
    9.1020   -8.2557    0.0000 O   0  0
   11.6998   -8.2471    0.0000 O   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15  8  1  0
 15 16  2  0
 16  5  1  0
  3 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 20 23  1  0
 23 24  2  0
 23 25  1  0
 26 25  1  1
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 29 31  2  0
 26 32  1  0
 32 33  1  0
 32 34  2  0
M  END
> <name>
NIHCC_2014

> <id>
5994

> <plate>
NGP-105-05

> <well>
E11

> <supplier_cmpd_name>
CPD000449324

> <ctcr_id>
2727

> <supplier_cmpd_id>
SAM001246985

> <smiles>
O.CN(Cc1cnc2nc(N)nc(N)c2n1)c3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O

> <pd_targets>
{SKA,DFRA17,CASP1,DFRA,DHFR,FOLA,THYA,APE1,PTR1,KDM4E,CASP7,MAPT,HMGB1,KMT2A,MEN1,HSD17B10,TDP1,ALDH1A1,TP53,TYMS,LMNA,FFP,APEX1,SLC19A1,BLM,GLA,ALOX15,POLB,HPGD,LMP1,NCOA3,FOLR2,FPGS,SLC46A1,ABCC3,FO
LR1,ATIC,GART}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Other cytosolic protein","Unclassified protein","Transcription factor","Other nuclear protein",Transporter,"Membrane receptor",Kinase,Oxidoreductase,Protease,Transferas
e,Eraser,Reader,Hydrolase,"Electrochemical transporter",Writer,Ligase,"Primary active transporter","Cysteine protease","Metallo protease","Lysine demethylase",Bromodomain,"SLC superfamily of solute ca
rriers","Histone acetyltransferase","ATP-binding cassette","Cysteine protease CD clan","Metallo protease MH clan","Jumonji domain-containing","SLC19 family of vitamin transporters","SRC family","SLC46
 family of folate transporters","ABCC subfamily","Cysteine protease C14 family","Metallo protease M18 family"}

> <pathway_chembl>
{Enzymes,Transporters,"Peptidases and proteinases","1.-.-.- Oxidoreductases","Chromatin modifying enzymes","2.1.1.- Methyltransferases","SLC superfamily of solute carriers","Eicosanoid turnover","ATP-
binding cassette transporter family","CD: Cysteine (C) Peptidases","1.14.11.- Histone demethylases","SLC19 family of vitamin transporters",Lipoxygenases,"Prostaglandin synthases","2.3.1.48 Histone ace
tyltransferases (HATs)","SLC46 family of folate transporters","ABCC subfamily","C14: Caspase"}

> <pathway_reactome>
{"Gene expression (Transcription)","Cell Cycle","Programmed Cell Death","Neuronal System","Immune System",Metabolism,"DNA Repair","Metabolism of proteins","RNA Polymerase II Transcription",Mitotic,Apo
ptosis,"Transmission across Chemical Synapses","Innate Immune System","Metabolism of amino acids and derivatives","DNA Double-Strand Break Repair","Biological oxidations","Cell Cycle Checkpoints","Bas
e Excision Repair","Metabolism of vitamins and cofactors","Metabolism of lipids","Post-translational protein modification","Metabolism of nucleotides","Generic Transcription Pathway","Mitotic G1 phase
 and G1/S transition","Intrinsic Pathway for Apoptosis","Neurotransmitter receptors and postsynaptic signal transmission","Toll-like Receptor Cascades","Branched-chain amino acid catabolism","Nonhomol
ogous End-Joining (NHEJ)","Phase I - Functionalization of compounds","G1/S DNA Damage Checkpoints","M Phase","Resolution of Abasic Sites (AP sites)","Metabolism of water-soluble vitamins and cofactors
","Homology Directed Repair","Sphingolipid metabolism","Biosynthesis of specialized proresolving mediators (SPMs)","Regulation of lipid metabolism by PPARalpha","Metabolism of steroids","Asparagine N-
linked glycosylation","Nucleobase biosynthesis","Transcriptional Regulation by TP53","G1/S Transition","Apoptotic factor-mediated response","Activation of NMDA receptors and postsynaptic events","Toll
 Like Receptor 5 (TLR5) Cascade","Ethanol oxidation","p53-Dependent G1/S DNA damage checkpoint","Mitotic Metaphase and Anaphase","Resolution of AP sites via the multiple-nucleotide patch replacement p
athway","Metabolism of folate and pterines","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Glycosphingolipid metabolism","Biosynthesis of DPA-derived SPMs","Biosynthesi
s of DHA-derived SPMs","PPARA activates gene expression","Bile acid and bile salt metabolism","Transport to the Golgi and subsequent modification","Purine ribonucleoside monophosphate biosynthesis","T
P53 Regulates Transcription of Cell Death Genes","G1/S-Specific Transcription","Cytochrome c-mediated apoptotic response","Post NMDA receptor activation events","MyD88 cascade initiated on plasma memb
rane","p53-Dependent G1 DNA Damage Response","Mitotic Anaphase","PCNA-Dependent Long Patch Base Excision Repair","HDR through Homologous Recombination (HRR)","Biosynthesis of DPAn-3 SPMs","Biosynthesi
s of D-series resolvins","Recycling of bile acids and salts","ER to Golgi Anterograde Transport","TP53 Regulates Transcription of Caspase Activators and Caspases","Activation of caspases through apopt
osome-mediated cleavage","Activation of AMPK downstream of NMDARs","TAK1 activates NFkB by phosphorylation and activation of IKKs complex","Stabilization of p53","Nuclear Envelope (NE) Reassembly","Ho
mologous DNA Pairing and Strand Exchange","Biosynthesis of DPAn-3-derived protectins and resolvins","Cargo concentration in the ER","Autodegradation of the E3 ubiquitin ligase COP1","Initiation of Nuc
lear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{DHFR}

> <broad_moa>
{"dihydrofolate reductase inhibitor"}

> <synonyms>
{"Methotrexate hydrate","Methotrexate monohydrate",133073-73-1,133073731,"Methotrexate hydrate(1:x)","Methotrexate xhydrate",6745-93-3,6745933,UNII-84DMZ3IHO0,UNII84DMZ3IHO0,84DMZ3IHO0,MLS001401431,MF
CD00150847,"L-Amethopterin hydrate","LAmethopterin hydrate",SMR000449324,Abitrexate(Methotrexate)/,M,T1485,SAM001246985,Methotrexate,CPD000449324}

> <pdid>
PD002823

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{165528}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 23  0  0  0  0            999 V2000
   11.6829   -9.7770    0.0000 C   0  0
   10.3821  -10.5239    0.0000 C   0  0
    9.0837   -9.7712    0.0000 O   0  0
    7.7821  -10.5185    0.0000 C   0  0
    7.7790  -12.0185    0.0000 O   0  0
    6.4833   -9.7656    0.0000 C   0  0
    6.4855   -8.2648    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    5.1894   -6.0109    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 Cl  0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    5.8467  -10.9971    0.0000 C   0  0
    5.0988   -9.6968    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  2  0
 20 14  1  0
  6 21  1  0
 21 22  1  0
 22  6  1  0
M  END
> <name>
NIHCC_2014

> <id>
5995

> <plate>
NGP-105-05

> <well>
F02

> <supplier_cmpd_name>
CPD000449321

> <ctcr_id>
1266

> <supplier_cmpd_id>
SAM001247025

> <smiles>
CCOC(=O)C1(CCCCCCOc2ccc(Cl)cc2)CO1

> <pd_targets>
{LMNA,MAPK1,RORC,MAPT,ABCB11}

> <pathway_gtopdb>
{"Other nuclear protein",Enzyme,"Transcription factor","Other cytosolic protein",Transporter,Kinase,"Nuclear receptor","Primary active transporter","Protein Kinase","Nuclear hormone receptor subfamily
 1","ATP-binding cassette","CMGC protein kinase group","Nuclear hormone receptor subfamily 1 group F","ABCB subfamily","CMGC protein kinase MAPK family","Nuclear hormone receptor subfamily 1 group F m
ember 3","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Kinases (EC 2.7.x.x)","Nuclear hormone receptors","ATP-binding cassette transporter family","CMGC: Containing CDK",MAPK,GSK3,"CLK families","1F. Retinoic acid-related 
orphans","ABCB subfamily","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Cell Cycle","Immune System","Gene expression (Transcription)","Neuronal System",Metabolism,Mitotic,"Innate Immune System","RNA Polymerase II Transcription","Transmission across Chemical Synapses","M
etabolism of lipids","M Phase","Toll-like Receptor Cascades","Generic Transcription Pathway","Neurotransmitter receptors and postsynaptic signal transmission","Metabolism of steroids","Mitotic Metapha
se and Anaphase","Toll Like Receptor 5 (TLR5) Cascade","Transcriptional regulation by RUNX3","Activation of NMDA receptors and postsynaptic events","Bile acid and bile salt metabolism","Mitotic Anapha
se","MyD88 cascade initiated on plasma membrane","RUNX3 Regulates Immune Response and Cell Migration","Post NMDA receptor activation events","Synthesis of bile acids and bile salts","Nuclear Envelope 
(NE) Reassembly","MAP kinase activation","Activation of AMPK downstream of NMDARs","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Initiation of Nuclear Envelope (NE) Reformati
on","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{CPT1A}

> <broad_moa>
{"carnitine palmitoyltransferase inhibitor"}

> <synonyms>
{82258-36-4,82258364,"Ethyl 2-(6-(4-chlorophenoxy)hexyl)oxirane-2-carboxylate","Ethyl 2(6(4chlorophenoxy)hexyl)oxirane2carboxylate","ethyl 2-(6-(4-chlorophenoxy)hexyl)oxirane-2-carboxylate","ethyl 2(6
(4chlorophenoxy)hexyl)oxirane2carboxylate","Oxiranecarboxylic acid, 2-(6-(4-chlorophenoxy)hexyl)-, ethyl ester","Oxiranecarboxylic acid, 2(6(4chlorophenoxy)hexyl), ethyl ester","rac- Etomoxir","rac Et
omoxir","Etomoxirum (Latin)",2-(6-(4-,2(6(4,SAM001247025,CPD000449321}

> <pdid>
PD002934

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{123823}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 26  0  0  0  0            999 V2000
    3.8926   -3.7566    0.0000 C   0  0
    2.5951   -3.0039    0.0000 O   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.2637    1.8997    0.0000 C   0  0
    1.7485    3.3085    0.0000 C   0  0
    2.7108    4.4591    0.0000 C   0  0
    4.1885    4.2009    0.0000 C   0  0
    4.7037    2.7922    0.0000 C   0  0
    3.7414    1.6416    0.0000 C   0  0
    3.7469    0.1408    0.0000 N   0  3
    2.4504   -0.6136    0.0000 O   0  5
    5.0483   -0.6052    0.0000 O   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
   -0.0031    3.0008    0.0000 C   0  0
    1.2946    3.7531    0.0000 O   0  0
   -1.3039    3.7494    0.0000 O   0  0
   -1.3070    5.2494    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
  6 16  1  0
 16 17  2  3
 17 18  1  0
 17 19  1  0
 19 20  2  3
 20  5  1  0
 20 21  1  0
 16 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
M  CHG  2  13   1  14  -1
M  END
> <name>
NIHCC_2014

> <id>
5996

> <plate>
NGP-105-05

> <well>
F03

> <supplier_cmpd_name>
CPD000058291

> <ctcr_id>
549

> <supplier_cmpd_id>
SAM001246963

> <smiles>
COC(/O)=C1/C(c2ccccc2[N+]([O-])=O)C(=C(C)N=C1C)C(=O)OC

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{nifedipine,21829-25-4,21829254,Adalat,Procardia,"Procardia XL","Adalat CC",Cordipin,Corinfar,Fenihidine,Citilat,Oxcord,Fenihidin,Bay-a-1040,Baya1040,Adalate,Nifediac,"Afeditab CR",Coracten,Hexadilat,
Introcar,Kordafen,Nifedical,Tibricol,Adapine,Anifed,Pidilat,S,SAM001246963,CPD000058291}

> <pdid>
PD003075

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{4485}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 26  0  0  1  0            999 V2000
   -2.1929   -3.7413    0.0000 C   0  0
   -0.7292   -4.0692    0.0000 C   0  0
   -0.2818   -5.5010    0.0000 O   0  0
    0.2851   -2.9666    0.0000 C   0  0  1  0  0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -1.2991    2.2500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -1.2212   -2.3711    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  4  2  1  6
  4  5  1  0
  5  6  1  0
  7  6  1  6
  7  8  1  0
  8  9  1  1
  9 10  1  0
 10 11  1  0
 11 12  2  3
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 11  1  0
 17 18  1  6
 17 19  1  0
 19  8  1  0
 19 20  1  6
 20 21  1  0
 21 22  1  0
 22  4  1  0
 22  7  1  0
 22 23  1  6
M  END
> <name>
NIHCC_2014

> <id>
5997

> <plate>
NGP-105-05

> <well>
F04

> <supplier_cmpd_name>
CPD000058345

> <ctcr_id>
6536

> <supplier_cmpd_id>
SAM001247039

> <smiles>
CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C

> <pd_targets>
{RORC,PGR,CATSPER1,NR3C1,SRD5A1,SRD5A2,SOAT1,FABP1,FABP2,CATSPER4,AR,TSHR,HIF1A,SIGMAR1,FTL,ALDH1A1,CYP3A4,CYP2C9,NR3C2,CATSPER3,LMNA,THPO,CATSPER2,TRPC5,ABCB1,MAPT,MAPK1,CHRM1,NPSR1,PMP22,KMT2A,MEN1,
KDM4E,ERG2,SHBG,SERPINA6,ESR1,ESR2,ABCB11,SLC22A2,SLC22A3,P2RX3,GPBAR1,SLC22A1,CYP17A1,OPRK1,ORM1}

> <pathway_gtopdb>
{"Transcription factor","Ion channel",Enzyme,"Auxiliary transport protein","Membrane receptor","Unclassified protein","Other nuclear protein",Transporter,"Other cytosolic protein","Epigenetic regulato
r","Secreted protein","Nuclear receptor","Voltage-gated ion channel",Oxidoreductase,Transferase,"Fatty acid binding protein family","Family A G protein-coupled receptor","Cytochrome P450","Primary act
ive transporter",Kinase,Reader,Eraser,Isomerase,"Electrochemical transporter","Ligand-gated ion channel","Nuclear hormone receptor subfamily 1","Nuclear hormone receptor subfamily 3","CatSper and Two-
Pore channels","Peptide receptor (family A GPCR)","Cytochrome P450 family 3","Cytochrome P450 family 2","Transient receptor potential channel","ATP-binding cassette","Protein Kinase","Small molecule r
eceptor (family A GPCR)",Bromodomain,"Lysine demethylase","SLC superfamily of solute carriers","P2X receptor","Cytochrome P450 family 17","Nuclear hormone receptor subfamily 1 group F","Nuclear hormon
e receptor subfamily 3 group C","Glycohormone receptor","Cytochrome P450 family 3A","Cytochrome P450 family 2C","ABCB subfamily","CMGC protein kinase group","Monoamine receptor","Short peptide recepto
r (family A GPCR)","Jumonji domain-containing","Nuclear hormone receptor subfamily 3 group A","SLC22 family of organic cation and anion transporters","Lipid-like ligand receptor (family A GPCR)","Cyto
chrome P450 family 17A","Nuclear hormone receptor subfamily 1 group F member 3","Nuclear hormone receptor subfamily 3 group C member 3","Nuclear hormone receptor subfamily 3 group C member 1","Nuclear
 hormone receptor subfamily 3 group C member 4","Cytochrome P450 3A4","Cytochrome P450 2C9","Nuclear hormone receptor subfamily 3 group C member 2","CMGC protein kinase MAPK family","Acetylcholine rec
eptor","Neuropeptide receptor","Nuclear hormone receptor subfamily 3 group A member 1","Steroid-like ligand receptor","Cytochrome P450 17A1","Opioid receptor","Nuclear hormone receptor subfamily 3 gro
up A member 2","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,"Ion channels","Other protein targets",Enzymes,Transporters,"Nuclear hormone receptors","Voltage-gated ion channels","Fatty acid-binding proteins","G protein-coupled receptors","Sigma recep
tors","Cytochrome P450","ATP-binding cassette transporter family","Kinases (EC 2.7.x.x)","Chromatin modifying enzymes","SLC superfamily of solute carriers","Ligand-gated ion channels","1F. Retinoic ac
id-related orphans","CatSper and Two-Pore channels","Steroid hormone receptors","Glycoprotein hormone receptors","CYP3 family","CYP2 family: drug metabolising subset","Transient Receptor Potential cha
nnels","ABCB subfamily","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Acetylcholine receptors (muscarinic)","Neuropeptide S receptor","1.14.11.- Histone demethylases","SLC22 family of organic catio
n and anion transporters","P2X receptors","Bile acid receptor",CYP11,CYP17,CYP19,"CYP20 and CYP21 families","Opioid receptors","3C. 3-Ketosteroid receptors","Mitogen-activated protein kinases (MAP kin
ases)","Organic cation transporters (OCT)","3A. Estrogen receptors","ERK subfamily"}

> <pathway_reactome>
{"Gene expression (Transcription)",Reproduction,"Metabolism of proteins","Transport of small molecules",Metabolism,Disease,"Cellular responses to external stimuli","Vesicle-mediated transport","Cell C
ycle",Hemostasis,"Developmental Biology","Neuronal System","Immune System","Signal Transduction","RNA Polymerase II Transcription",Fertilization,"Post-translational protein modification","Plasma lipop
rotein assembly",remodeling,"and clearance","Metabolism of lipids","Infectious disease","Cellular responses to stress","Membrane Trafficking","Biological oxidations",Mitotic,"Platelet activation","sig
naling and aggregation","Nervous system development","Abacavir transport and metabolism","Transmission across Chemical Synapses","Innate Immune System","Signaling by GPCR","SLC-mediated transmembrane 
transport","Platelet homeostasis","Intracellular signaling by second messengers","Generic Transcription Pathway","Sperm Motility And Taxes",SUMOylation,"Plasma lipoprotein clearance","Regulation of li
pid metabolism by PPARalpha","Triglyceride metabolism","Leishmania infection","Cellular response to hypoxia","SARS-CoV Infections","trans-Golgi Network Vesicle Budding","Phase I - Functionalization of
 compounds","Biosynthesis of specialized proresolving mediators (SPMs)","M Phase","Platelet Aggregation (Plug Formation)","Axon guidance","Abacavir transmembrane transport","Neurotransmitter receptors
 and postsynaptic signal transmission","Toll-like Receptor Cascades","GPCR ligand binding","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Metabolism of steroids","Transport of bile 
salts and organic acids","metal ions and amine compounds","Platelet calcium homeostasis","Response to elevated platelet cytosolic Ca2+","PIP3 activates AKT signaling","Transcriptional regulation by RU
NX3","SUMO E3 ligases SUMOylate target proteins","FOXO-mediated transcription","LDL clearance","PPARA activates gene expression","Triglyceride catabolism","Transcriptional regulation by RUNX2","Leishm
ania parasite growth and survival","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Potential therapeutics for SARS","Golgi Associated Vesicle Biogenesis","Ethanol oxidation
","Biosynthesis of DHA-derived SPMs","Cytochrome P450 - arranged by substrate type","Mitotic Metaphase and Anaphase","Netrin-1 signaling","Activation of NMDA receptors and postsynaptic events","Toll L
ike Receptor 5 (TLR5) Cascade","Class A/1 (Rhodopsin-like receptors)","Metabolism of steroid hormones","Bile acid and bile salt metabolism","Organic cation/anion/zwitterion transport","Elevation of cy
tosolic Ca2+ levels","Transcriptional regulation by RUNX1","Transcriptional Regulation by MECP2","Platelet degranulation","Negative regulation of the PI3K/AKT network","RUNX3 Regulates Immune Response
 and Cell Migration","SUMOylation of intracellular receptors","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","RUNX2 regulates bone development","Anti-inflammatory res
ponse favouring Leishmania parasite infection","Biosynthesis of maresins",Xenobiotics,"Mitotic Anaphase","Role of second messengers in netrin-1 signaling","Post NMDA receptor activation events","MyD88
 cascade initiated on plasma membrane","Amine ligand-binding receptors","Glucocorticoid biosynthesis","Synthesis of bile acids and bile salts","Organic cation transport","RUNX1 regulates estrogen rece
ptor mediated transcription","Androgen biosynthesis","MECP2 regulates neuronal receptors and channels",PI5P,"PP2A and IER3 Regulate PI3K/AKT Signaling","RUNX2 regulates osteoblast differentiation","AD
ORA2B mediated anti-inflammatory cytokines production","Biosynthesis of maresin-like SPMs","CYP2E1 reactions","Nuclear Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs","MAP kinase a
ctivation","Muscarinic acetylcholine receptors","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events m
ediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{CATSPER1,CATSPER2,CATSPER3,CATSPER4,CYP17A1,ESR1,NR3C2,OPRK1,PGR,TRPC5}

> <broad_moa>
{"progesterone receptor agonist"}

> <synonyms>
{progesterone,57-83-0,57830,"Pregn-4-ene-3,20-dione","Pregn4ene3,20dione",Agolutin,Luteohormone,Crinone,"4-Pregnene-3,20-dione","4Pregnene3,20dione","Corpus luteum hormone",Syngesterone,Utrogestan,Lut
eol,Glanducorpin,Pregnenedione,Progesterol,Syngestrets,Corlutin,Cyclogest,Gesterol,Gestone,SAM001247039,Prestw-477,CPD000058345,Progesterone}

> <pdid>
PD001781

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5994}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 22  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -0.0031    3.0008    0.0000 C   0  0
   -1.3039    3.7494    0.0000 N   0  0
   -1.3070    5.2502    0.0000 C   0  0
   -0.0093    6.0025    0.0000 O   0  0
   -2.6078    5.9988    0.0000 C   0  0
   -2.6109    7.4996    0.0000 C   0  0
   -3.9118    8.2481    0.0000 C   0  0
   -3.9149    9.7490    0.0000 C   0  0
   -5.2157   10.4975    0.0000 C   0  0
   -5.2188   11.9983    0.0000 C   0  0
   -3.9211   12.7522    0.0000 C   0  0
   -3.9242   14.2522    0.0000 C   0  0
   -2.6202   12.0053    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
  5 19  2  0
 19 20  1  0
 20 21  2  0
 21  3  1  0
 21 22  1  0
M  END
> <name>
NIHCC_2014

> <id>
5998

> <plate>
NGP-105-05

> <well>
F05

> <supplier_cmpd_name>
CPD000449294

> <ctcr_id>
1724

> <supplier_cmpd_id>
SAM001246970

> <smiles>
COc1cc(CNC(=O)CCCC\C=C/C(C)C)ccc1O

> <pd_targets>
{TRPV1,HSD17B10,ALDH1A1,KCNA1,TRPV2,TRPV4,LMNA,YARS1,MAPT,PTGS1,MAPK1,CYP3A4,ALOX15,MT-ND1,KCNA7,KCNA2,RORC,ALOX5,KMT2A,MEN1,TRPM8,CYP1A2,KCNC1,CFTR,TP53,CYP2D6,CYP2C19,CYP2C9,LEF,CASP1,KDM4E,GAA}

> <pathway_gtopdb>
{"Ion channel",Enzyme,"Other nuclear protein","Other cytosolic protein","Transcription factor","Epigenetic regulator","Voltage-gated ion channel",Oxidoreductase,Ligase,Kinase,"Cytochrome P450","Nuclea
r receptor",Reader,"Other ion channel","Transient receptor potential channel","Potassium channels","Protein Kinase","Cytochrome P450 family 3","Nuclear hormone receptor subfamily 1",Bromodomain,"Cytoc
hrome P450 family 1","Chloride channel","Voltage-gated potassium channel","CMGC protein kinase group","Cytochrome P450 family 3A","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family
 1A","Cystic fibrosis transmembrane conductance regulator","CMGC protein kinase MAPK family","Cytochrome P450 3A4","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 1A1","CMGC p
rotein kinase ERK1",Protease,Eraser,Hydrolase,"Cytochrome P450 family 2","Cysteine protease","Metallo protease","Lysine demethylase","Cytochrome P450 family 2D","Cytochrome P450 family 2C","Cysteine p
rotease CA clan","Metallo protease MAE clan","Cysteine protease CD clan","Jumonji domain-containing","Cytochrome P450 2D6","Cytochrome P450 2C19","Cysteine protease C1A family","Cytochrome P450 2C9","
Metallo protease M34 family","Cysteine protease C14 family"}

> <pathway_chembl>
{"Ion channels",Enzymes,Receptors,"Voltage-gated ion channels","Eicosanoid turnover","Kinases (EC 2.7.x.x)","Cytochrome P450","Nuclear hormone receptors","Other ion channels","Transient Receptor Poten
tial channels","Potassium channels",Cyclooxygenase,"CMGC: Containing CDK",MAPK,GSK3,"CLK families","CYP3 family",Lipoxygenases,"1F. Retinoic acid-related orphans","CYP1 family","Chloride channels","Vo
ltage-gated potassium channels","Mitogen-activated protein kinases (MAP kinases)",CFTR,"ERK subfamily","Peptidases and proteinases","Chromatin modifying enzymes","3.2.1.- Glycosidases","CYP2 family: d
rug metabolising subset","CD: Cysteine (C) Peptidases","1.14.11.- Histone demethylases","C14: Caspase"}

> <pathway_reactome>
{"Transport of small molecules",Metabolism,"Neuronal System","Cell Cycle","Metabolism of proteins","Immune System","Gene expression (Transcription)",Autophagy,"Ion channel transport","Metabolism of am
ino acids and derivatives","Biological oxidations","Potassium Channels",Mitotic,Translation,"Transmission across Chemical Synapses","Metabolism of lipids","Innate Immune System","The citric acid (TCA)
 cycle and respiratory electron transport","RNA Polymerase II Transcription",Macroautophagy,"Stimuli-sensing channels","Branched-chain amino acid catabolism","Phase I - Functionalization of compounds"
,"Voltage gated Potassium channels","M Phase","tRNA Aminoacylation","Neurotransmitter receptors and postsynaptic signal transmission","Fatty acid metabolism","Toll-like Receptor Cascades","Biosynthesi
s of specialized proresolving mediators (SPMs)","Respiratory electron transport","ATP synthesis by chemiosmotic coupling","and heat production by uncoupling proteins.","Generic Transcription Pathway",
"Selective autophagy","TRP channels","Ethanol oxidation","Mitotic Metaphase and Anaphase","Cytosolic tRNA aminoacylation","Activation of NMDA receptors and postsynaptic events","Arachidonic acid metab
olism","Toll Like Receptor 5 (TLR5) Cascade","Biosynthesis of DHA-derived SPMs","Biosynthesis of DPA-derived SPMs","Transcriptional regulation by RUNX3","Cytochrome P450 - arranged by substrate type",
Aggrephagy,"Mitotic Anaphase","Post NMDA receptor activation events","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","MyD88 cascade initiated on plasma membrane","Biosynthesis of maresins","B
iosynthesis of DPAn-3 SPMs","Complex I biogenesis","RUNX3 Regulates Immune Response and Cell Migration",Xenobiotics,"Nuclear Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs","MAP ki
nase activation","Biosynthesis of maresin-like SPMs","Biosynthesis of DPAn-3-derived protectins and resolvins","Biosynthesis of DPAn-3-derived 13-series resolvins","Aromatic amines can be N-hydroxylat
ed or N-dealkylated by CYP1A2","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated",Disease,"Cell Cycle Ch
eckpoints","Infectious disease","Diseases of metabolism","G1/S DNA Damage Checkpoints","Uptake and actions of bacterial toxins","Diseases of carbohydrate metabolism","p53-Dependent G1/S DNA damage che
ckpoint","Uptake and function of anthrax toxins","Transcriptional Regulation by TP53","Glycogen storage diseases","p53-Dependent G1 DNA Damage Response","TP53 Regulates Transcription of Cell Death Gen
es","Glycogen storage disease type II (GAA)","Stabilization of p53","CYP2E1 reactions","TP53 Regulates Transcription of Caspase Activators and Caspases","Autodegradation of the E3 ubiquitin ligase COP
1"}

> <broad_targets>
{CFTR,TRPV1}

> <broad_moa>
{"TRPV agonist"}

> <synonyms>
{Zucapsaicin,25775-90-0,25775900,Civamide,cis-Capsaicin,cisCapsaicin,(Z)-Capsaicin,(Z)Capsaicin,(Z)-N-(4-Hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide,(Z)N(4Hydroxy3methoxybenzyl)8methylnon6enamide,U
NII-15OX67P384,UNII15OX67P384,(Z)-N-((4-hydroxy-3-methoxyphenyl)methyl)-8-methylnon-6-enamide,(Z)N((4hydroxy3methoxyphenyl)methyl)8methylnon6enamide,15OX67P384,"BRN 4261852",Civanex,(6Z)-N-((4-hyd,(6Z
)N((4hyd,T1109,T1062,SAM001246970,Capsaicin,CPD000449294}

> <pdid>
PD001884

> <targets>
{HSV,TRP Channel}

> <classes>
{Anti-infection,Membrane Transporter/Ion Channel,Neuronal Signaling}

> <pubchem_cids>
{1548942}

$$$$
NIHCC_2014
  SciTegic11012413002D

 19 20  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3039   -3.7494    0.0000 C   0  0
   -1.3070   -5.2494    0.0000 F   0  0
   -2.6016   -2.9971    0.0000 F   0  0
    0.0000    3.0008    0.0000 C   0  0
    1.2978    3.7529    0.0000 N   0  0
    1.2954    5.2529    0.0000 N   0  0
   -0.0048    6.0009    0.0000 C   0  0
   -0.0072    7.5009    0.0000 O   0  0
   -1.3026    5.2488    0.0000 C   0  0
   -1.3002    3.7488    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
  5 13  1  0
 13 14  2  3
 14 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  2  3
 19 13  1  0
M  END
> <name>
NIHCC_2014

> <id>
5999

> <plate>
NGP-105-05

> <well>
F06

> <supplier_cmpd_name>
CPD000449313

> <ctcr_id>
6781

> <supplier_cmpd_id>
SAM001247053

> <smiles>
COc1cc(ccc1OC(F)F)C2=NNC(=O)C=C2

> <pd_targets>
{PDE4A,PDE4B,PDE4C,PDE4D,LMNA,SMN1,CHRM1,CYP2C9,CYP1A2,PDE3A,PDE3B,BLM,HPGD,CYP2C19,MAPK1,TP53,TSHR,PMP22,LEF}

> <pathway_gtopdb>
{Enzyme,"Other nuclear protein","Epigenetic regulator","Membrane receptor","Transcription factor","Unclassified protein",Phosphodiesterase,Reader,"Family A G protein-coupled receptor","Cytochrome P450
",Kinase,Protease,"Phosphodiesterase 4","Methyl-lysine/arginine binding protein","Small molecule receptor (family A GPCR)","Cytochrome P450 family 2","Cytochrome P450 family 1","Phosphodiesterase 3","
Protein Kinase","Peptide receptor (family A GPCR)","Metallo protease","Phosphodiesterase 4A","Phosphodiesterase 4D","Tudor domain","Monoamine receptor","Cytochrome P450 family 2C","Cytochrome P450 fam
ily 1A","Phosphodiesterase 3A","CMGC protein kinase group","Phosphodiesterase 4B","Glycohormone receptor","Metallo protease MAE clan","Acetylcholine receptor","Cytochrome P450 2C9","Cytochrome P450 1A
1","Cytochrome P450 2C19","CMGC protein kinase MAPK family","Metallo protease M34 family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Receptors,"Cyclic nucleotide turnover/signalling","G protein-coupled receptors","Cytochrome P450","Eicosanoid turnover","Kinases (EC 2.7.x.x)",Phosphodiesterases,3',"5'-cyclic nucleotide (PDE
s)","Acetylcholine receptors (muscarinic)","CYP2 family: drug metabolising subset","CYP1 family","Prostaglandin synthases","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Glycoprotein hormone recepto
rs","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Signal Transduction","Cell Cycle","Metabolism of RNA",Metabolism,"DNA Repair","Immune System",Disease,"Developmental Biology","Signaling by GPCR",Mitotic,"Metabolism of non-coding RNA","Biological o
xidations","DNA Double-Strand Break Repair","Metabolism of lipids","Innate Immune System","Cell Cycle Checkpoints","Infectious disease","Nervous system development","GPCR downstream signalling","M Pha
se","snRNP Assembly","GPCR ligand binding","Phase I - Functionalization of compounds","Homology Directed Repair","Biosynthesis of specialized proresolving mediators (SPMs)","Toll-like Receptor Cascade
s","G1/S DNA Damage Checkpoints","Leishmania infection","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Uptake and actions of bacterial toxins","G alpha (i) signalling events","Mitot
ic Metaphase and Anaphase","Class A/1 (Rhodopsin-like receptors)","Cytochrome P450 - arranged by substrate type","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Biosynth
esis of DHA-derived SPMs","Toll Like Receptor 5 (TLR5) Cascade","p53-Dependent G1/S DNA damage checkpoint","G alpha (s) signalling events","Leishmania parasite growth and survival","Uptake and functio
n of anthrax toxins","Opioid Signalling","Mitotic Anaphase","Amine ligand-binding receptors",Xenobiotics,"HDR through Homologous Recombination (HRR)","Biosynthesis of D-series resolvins","MyD88 cascad
e initiated on plasma membrane","p53-Dependent G1 DNA Damage Response","Anti-inflammatory response favouring Leishmania parasite infection","DARPP-32 events","Nuclear Envelope (NE) Reassembly","Muscar
inic acetylcholine receptors","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Homologous DNA Pairing and Strand Exchange","MAP kinase activation","Stabilization 
of p53","ADORA2B mediated anti-inflammatory cytokines production","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pairing and strand exchange","MAPK targets/ Nuc
lear events mediated by MAP kinases","Autodegradation of the E3 ubiquitin ligase COP1","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{PDE4D}

> <broad_moa>
{"phosphodiesterase inhibitor"}

> <synonyms>
{zardaverine,101975-10-4,101975104,"101975 10 4",Zardaverina,Zardaverinum,6-(4-(Difluoromethoxy)-3-methoxyphenyl)-3(2H)-pyridazinone,6(4(Difluoromethoxy)3methoxyphenyl)3(2H)pyridazinone,"6 (4 (Difluor
omethoxy) 3 methoxyphenyl) 3(2H) pyridazinon",SAM001247053,Prestw-977,CPD000449313,Zardaverine}

> <pdid>
PD002628

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5723}

$$$$
NIHCC_2014
  SciTegic11012413002D

 11 12  0  0  0  0            999 V2000
    4.2010   -3.2956    0.0000 C   0  0
    4.9531   -1.9978    0.0000 C   0  0
    3.9511   -0.8815    0.0000 N   0  0
    2.5987   -1.5004    0.0000 C   0  0
    2.7343   -2.9815    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  1  1  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
M  END
> <name>
NIHCC_2014

> <id>
6000

> <plate>
NGP-105-05

> <well>
F07

> <supplier_cmpd_name>
CPD000449277

> <ctcr_id>
3304

> <supplier_cmpd_id>
SAM001247026

> <smiles>
C1CNC(C1)c2cccnc2

> <pd_targets>
{CHRNA10,CHRNA2,CHRNA3,CHRNA4,CHRNA5,CHRNA6,CHRNA7,CHRNA9,CHRNB2,CHRNB3,CHRNB4,CHRNA1,CHRNB1,CHRND,CHRNG,NACHRALPHA5,CYP2C9,KMT2A,MEN1,CYP2C19,CYP2D6,SMN1,POLB,CYP2A6,CYP1A2}

> <pathway_gtopdb>
{"Ion channel","Ligand-gated ion channel","Nicotinic acetylcholine receptor","Nicotinic acetylcholine receptor alpha subunit",Enzyme,"Epigenetic regulator","Cytochrome P450",Reader,"Cytochrome P450 fa
mily 2",Bromodomain,"Methyl-lysine/arginine binding protein","Cytochrome P450 family 1","Cytochrome P450 family 2C","Cytochrome P450 family 2D","Tudor domain","Cytochrome P450 family 2A","Cytochrome P
450 family 1A","Cytochrome P450 2C9","Cytochrome P450 2C19","Cytochrome P450 2D6","Cytochrome P450 2A6","Cytochrome P450 1A1"}

> <pathway_chembl>
{"Ion channels","Ligand-gated ion channels","Nicotinic acetylcholine receptors",Enzymes,"Cytochrome P450","CYP2 family: drug metabolising subset","CYP1 family"}

> <pathway_reactome>
{"Neuronal System","Transmission across Chemical Synapses","Neurotransmitter receptors and postsynaptic signal transmission","Acetylcholine binding and downstream events","Postsynaptic nicotinic acety
lcholine receptors","Highly calcium permeable postsynaptic nicotinic acetylcholine receptors",Metabolism,"Metabolism of RNA","DNA Repair","Biological oxidations","Metabolism of non-coding RNA","Base E
xcision Repair","Phase I - Functionalization of compounds","snRNP Assembly","Resolution of Abasic Sites (AP sites)","Cytochrome P450 - arranged by substrate type","Resolution of AP sites via the multi
ple-nucleotide patch replacement pathway",Xenobiotics,"PCNA-Dependent Long Patch Base Excision Repair","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2"}

> <broad_targets>
{}

> <broad_moa>
{"acetylcholine receptor agonist"}

> <synonyms>
{3-(pyrrolidin-2-yl)pyridine,3(pyrrolidin2yl)pyridine,nornicotine,5746-86-1,5746861,3-(2-Pyrrolidinyl)pyridine,3(2Pyrrolidinyl)pyridine,3-pyrrolidin-2-ylpyridine,3pyrrolidin2ylpyridine,"(R,S)-Nornicot
ine","(R,S)Nornicotine",(+-)-Nornicotine,(+)Nornicotine,2-(3-Pyridyl)pyrrolidine,2(3Pyridyl)pyrrolidine,3-pyrrolidin-2-yl-pyridine,3-(2-Pyrrolidyl)pyridine,3(2Pyrrolidyl)pyridine,(+-)-1'-Demethylnicot
ine,(+)1'Demethylnicotine,SAM001247026,CPD000449277}

> <pdid>
PD003066

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{412}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 30  0  0  0  0            999 V2000
   10.2288   -7.4986    0.0000 H   0  3
    7.7288   -7.4986    0.0000 Cl  0  5
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0008    0.0000 N   0  0
   -1.2978   -3.7529    0.0000 C   0  0
   -1.2955   -5.2529    0.0000 C   0  0
    0.0048   -6.0009    0.0000 N   0  0
    0.0102   -7.5017    0.0000 C   0  0
    1.3123   -8.2482    0.0000 C   0  0
    1.3177   -9.7490    0.0000 C   0  0
    2.6197  -10.4955    0.0000 N   0  0
    2.6252  -11.9963    0.0000 C   0  0
    1.3274  -12.7485    0.0000 C   0  0
    1.3298  -14.2485    0.0000 C   0  0
    0.0320  -15.0006    0.0000 O   0  0
    2.6300  -14.9964    0.0000 N   0  0
    2.6325  -16.4964    0.0000 C   0  0
    3.9279  -14.2443    0.0000 C   0  0
    5.2281  -14.9922    0.0000 O   0  0
    3.9254  -12.7443    0.0000 N   0  0
    5.2233  -11.9922    0.0000 C   0  0
    1.3026   -5.2488    0.0000 C   0  0
    1.3002   -3.7488    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  3
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 23 25  1  0
 25 26  2  0
 25 27  1  0
 27 19  1  0
 27 28  1  0
 14 29  1  0
 29 30  1  0
 30 11  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6001

> <plate>
NGP-105-05

> <well>
F08

> <supplier_cmpd_name>
CPD000058525

> <ctcr_id>
2459

> <supplier_cmpd_id>
SAM001247001

> <smiles>
[H+].[Cl-].COc1ccccc1N2CCN(CCCNC3=CC(=O)N(C)C(=O)N3C)CC2

> <pd_targets>
{MAPT,HTR1A,CYP2C9,ADRA1A,ADRA1B,ADRA1D,CHRM1,TSHR,LMNA,CYP2C19,CYP3A4,BLM,PMP22}

> <pathway_gtopdb>
{"Other cytosolic protein","Membrane receptor",Enzyme,"Other nuclear protein","Unclassified protein","Family A G protein-coupled receptor","Cytochrome P450","Small molecule receptor (family A GPCR)","
Cytochrome P450 family 2","Peptide receptor (family A GPCR)","Cytochrome P450 family 3","Monoamine receptor","Cytochrome P450 family 2C","Glycohormone receptor","Cytochrome P450 family 3A","Serotonin 
receptor","Cytochrome P450 2C9","Adrenergic receptor","Acetylcholine receptor","Cytochrome P450 2C19","Cytochrome P450 3A4"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Cytochrome P450","5-Hydroxytryptamine receptors","CYP2 family: drug metabolising subset","Acetylcholine receptors (muscarinic)","Glycoprotein hormone 
receptors","CYP3 family"}

> <pathway_reactome>
{"Neuronal System","Signal Transduction",Metabolism,Disease,"Cell Cycle","DNA Repair","Developmental Biology","Transmission across Chemical Synapses","Signaling by GPCR","Biological oxidations","Infec
tious disease",Mitotic,"Metabolism of lipids","DNA Double-Strand Break Repair","Nervous system development","Neurotransmitter receptors and postsynaptic signal transmission","GPCR ligand binding","Pha
se I - Functionalization of compounds","Leishmania infection","M Phase","Biosynthesis of specialized proresolving mediators (SPMs)","Homology Directed Repair","EGR2 and SOX10-mediated initiation of Sc
hwann cell myelination","Activation of NMDA receptors and postsynaptic events","Class A/1 (Rhodopsin-like receptors)","Cytochrome P450 - arranged by substrate type","Leishmania parasite growth and sur
vival","Mitotic Metaphase and Anaphase","Biosynthesis of DHA-derived SPMs","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Post NMDA receptor activation events","Amine l
igand-binding receptors",Xenobiotics,"Anti-inflammatory response favouring Leishmania parasite infection","Mitotic Anaphase","Biosynthesis of maresins","HDR through Homologous Recombination (HRR)","Ac
tivation of AMPK downstream of NMDARs","Serotonin receptors","CYP2E1 reactions","Muscarinic acetylcholine receptors","ADORA2B mediated anti-inflammatory cytokines production","Nuclear Envelope (NE) Re
assembly","Biosynthesis of maresin-like SPMs","Homologous DNA Pairing and Strand Exchange","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pairing and strand exc
hange"}

> <broad_targets>
{HTR1A}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{AKOS026749783,"Urapidil hydrochloride","Urapidil HCl",64887-14-5,64887145,"Urapidil (hydrochloride)",UNII-PVU92PZO12,UNIIPVU92PZO12,PVU92PZO12,NCGC00094502-01,NCGC0009450201,"Ebrantil (TN)",DSSTox_CI
D_25812,DSSToxCID25812,DSSTox-CID-25812,"DSSTox CID 25812",DSSTox_RID_81149,DSSToxRID81149,DSSTox-RID-81149,"DSSTox RID 81149",DSSTox_GSID_45812,DSSToxGSID45812,DSSTox-GSID-45812,"DSSTox GSID 45812",S
MR000058525,SR-01000075295,SR01000075295,CAS-64887-1,CAS648871,S2025,SAM001247001,Prestw-905,CPD000058525}

> <pdid>
PD013272

> <targets>
{"5-HT Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{91981305,167980}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 24  0  0  0  0            999 V2000
    8.6400   -1.0822    0.0000 H   0  3
    6.1400   -1.0822    0.0000 Cl  0  5
   -2.9790   -5.5336    0.0000 C   0  0
   -2.9537   -4.0338    0.0000 N   0  0
   -1.6420   -3.3046    0.0000 C   0  0
   -1.6167   -1.8039    0.0000 C   0  0
   -0.3049   -1.0747    0.0000 C   0  0
   -0.2800    0.4200    0.0000 C   0  0
    0.0000    2.2500    0.0000 C   0  0
   -0.4900    3.3700    0.0000 C   0  0
   -0.5500    1.7600    0.0000 C   0  0
   -2.0000    1.1200    0.0000 C   0  0
   -3.4200    1.7700    0.0000 C   0  0
   -4.6300    0.8200    0.0000 C   0  0
   -4.4000   -0.6700    0.0000 C   0  0
   -2.9800   -1.2400    0.0000 C   0  0
   -1.7900   -0.2300    0.0000 C   0  0
    0.7800    1.1200    0.0000 C   0  0
    1.8800    2.2400    0.0000 C   0  0
    3.3200    1.7500    0.0000 C   0  0
    3.6400    0.2500    0.0000 C   0  0
    2.5000   -0.7300    0.0000 C   0  0
    1.0400   -0.2000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17  8  1  0
 17 12  1  0
 11 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23  8  1  0
 23 18  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6002

> <plate>
NGP-105-05

> <well>
F09

> <supplier_cmpd_name>
CPD000148117

> <ctcr_id>
3721

> <supplier_cmpd_id>
SAM001246989

> <smiles>
[H+].[Cl-].CNCCCC12CCC(c3ccccc13)c4ccccc24

> <pd_targets>
{CYP2D6,RORC,PMP22,AMPC,KMT2A,MEN1,CYP3A4,LMNA,GAA,CYP2C19,SMN1,FFP,TP53,HTT,MAPK1,SLC6A2,HTR2C,SLC6A3,KDM4E,TSHR,LEF,ADRA1A,HTR2A,SLC6A4,CHRM1,THPO,CYP1A2,ADRA1B,TRPM3,IMPA1,HRH1,KCNJ6,GRIN1,GRIN2A,G
RIN2B,GRIN2C,GRIN2D,GRIN3A,GRIN3B,ADRA2C,HTR2B,DRD3,MTOR,ADRA2B,CHRM4,CHRM5,HTR6,CACNA1C,DRD2,CHRM2,ADRA1D,DRD5,ADRA2A,HRH2,CHRM3,KCNJ5,HTR7,MBTD1,L3MBTL3,L3MBTL1}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Unclassified protein","Epigenetic regulator","Other nuclear protein",Transporter,"Membrane receptor","Ion channel","Cytochrome P450","Nuclear receptor",Hydrolase,Reader
,Transferase,Kinase,"Electrochemical transporter","Family A G protein-coupled receptor",Eraser,Protease,"Voltage-gated ion channel","Ligand-gated ion channel","Cytochrome P450 family 2","Nuclear hormo
ne receptor subfamily 1",Bromodomain,"Cytochrome P450 family 3","Methyl-lysine/arginine binding protein","Protein Kinase","SLC superfamily of solute carriers","Small molecule receptor (family A GPCR)"
,"Lysine demethylase","Peptide receptor (family A GPCR)","Metallo protease","Cytochrome P450 family 1","Potassium channels","Ionotropic glutamate receptor","Voltage-gated calcium channel","Cytochrome 
P450 family 2D","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family 3A","Cytochrome P450 family 2C","Tudor domain","CMGC protein kinase group","SLC06 neurotransmitter transporter fa
mily","Monoamine receptor","Jumonji domain-containing","Glycohormone receptor","Metallo protease MAE clan","Cytochrome P450 family 1A","Inwardly rectifying potassium channel","NMDA receptor","Atypical
 protein kinase group","MBT domain","Cytochrome P450 2D6","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 3A4","Cytochrome P450 2C19","CMGC protein kinase MAPK family","Seroto
nin receptor","Metallo protease M34 family","Adrenergic receptor","Acetylcholine receptor","Cytochrome P450 1A1","Histamine receptor","Dopamine receptor","Atypical protein kinase PIKK family","CMGC pr
otein kinase ERK1","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Ion channels","Other protein targets","Cytochrome P450","Nuclear hormone receptors","3.2.1.- Glycosidases","Kinases (EC 2.7.x.x)","SLC superfamily of solute carriers",
"G protein-coupled receptors","Chromatin modifying enzymes","Voltage-gated ion channels","Inositol phosphate turnover","Chromatin-interacting transcriptional repressors","CYP2 family: drug metabolisin
g subset","1F. Retinoic acid-related orphans","CYP3 family","CMGC: Containing CDK",MAPK,GSK3,"CLK families","SLC6 neurotransmitter transporter family","5-Hydroxytryptamine receptors","1.14.11.- Histon
e demethylases","Glycoprotein hormone receptors",Adrenoceptors,"Acetylcholine receptors (muscarinic)","CYP1 family","Transient Receptor Potential channels","Inositol monophosphatase","Histamine recept
ors","Potassium channels","Dopamine receptors",Atypical,"Voltage-gated calcium channels","Methyllysine reader proteins","Mitogen-activated protein kinases (MAP kinases)","Monoamine transporter subfami
ly","Inwardly rectifying potassium channels","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","ERK subfamily","FRAP subfamily"}

> <pathway_reactome>
{Metabolism,"Gene expression (Transcription)","Developmental Biology","Cell Cycle",Disease,"Metabolism of RNA","Immune System","Signal Transduction","Neuronal System",Hemostasis,"Transport of small mo
lecules","Biological oxidations","RNA Polymerase II Transcription","Nervous system development","Metabolism of lipids",Mitotic,"Diseases of metabolism","Metabolism of non-coding RNA","Cell Cycle Check
points","Innate Immune System","Disorders of transmembrane transporters","Signaling by GPCR","Infectious disease","Transmission across Chemical Synapses","Platelet activation","signaling and aggregati
on","Ion channel transport","Inositol phosphate metabolism","Phase I - Functionalization of compounds","Generic Transcription Pathway","EGR2 and SOX10-mediated initiation of Schwann cell myelination",
"Biosynthesis of specialized proresolving mediators (SPMs)","M Phase","Diseases of carbohydrate metabolism","snRNP Assembly","G1/S DNA Damage Checkpoints","Toll-like Receptor Cascades","SLC transporte
r disorders","GPCR ligand binding","Leishmania infection","Uptake and actions of bacterial toxins","Neurotransmitter clearance","Platelet Aggregation (Plug Formation)","Stimuli-sensing channels","Synt
hesis of IP2",IP,"and Ins in the cytosol","Neurotransmitter receptors and postsynaptic signal transmission","Axon guidance","Cytochrome P450 - arranged by substrate type","Transcriptional regulation b
y RUNX3","Biosynthesis of DHA-derived SPMs","Mitotic Metaphase and Anaphase","Glycogen storage diseases","p53-Dependent G1/S DNA damage checkpoint","Transcriptional Regulation by MECP2","Toll Like Rec
eptor 5 (TLR5) Cascade","Defective SLC6A2 causes orthostatic intolerance (OI)","Class A/1 (Rhodopsin-like receptors)","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Leishmania para
site growth and survival","Uptake and function of anthrax toxins","Serotonin clearance from the synaptic cleft","TRP channels","GABA receptor activation","Transcriptional Regulation by TP53","NCAM sig
naling for neurite out-growth",Xenobiotics,"RUNX3 Regulates Immune Response and Cell Migration","Biosynthesis of maresins","Mitotic Anaphase","Glycogen storage disease type II (GAA)","p53-Dependent G1
 DNA Damage Response","Regulation of MECP2 expression and activity","MyD88 cascade initiated on plasma membrane","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania paras
ite infection","GABA B receptor activation","Regulation of TP53 Activity","NCAM1 interactions","CYP2E1 reactions","Biosynthesis of maresin-like SPMs","Nuclear Envelope (NE) Reassembly","Stabilization 
of p53","MAP kinase activation","Serotonin receptors","ADORA2B mediated anti-inflammatory cytokines production",Adrenoceptors,"Muscarinic acetylcholine receptors","Aromatic amines can be N-hydroxylate
d or N-dealkylated by CYP1A2","Histamine receptors","Activation of GABAB receptors","Dopamine receptors","Regulation of TP53 Expression and Degradation","Regulation of TP53 Activity through Methylatio
n","Initiation of Nuclear Envelope (NE) Reformation","Autodegradation of the E3 ubiquitin ligase COP1","MAPK targets/ Nuclear events mediated by MAP kinases","Inhibition  of voltage gated Ca2+ channel
s via Gbeta/gamma subunits","Regulation of TP53 Degradation","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{SLC6A2}

> <broad_moa>
{"norepinephrine reputake inhibitor","tricyclic antidepressant"}

> <synonyms>
{"Maprotiline hydrochloride",10347-81-6,10347816,"Maprotiline Hcl",Ludiomil,Psymion,"Maprotilline HCl",UNII-7C8J54PVFI,UNII7C8J54PVFI,"Maprotiline (hydrochloride)","Maprotiline Hydrochlorine",7C8J54PV
FI,MLS000069552,MLS000557000,Deprilept,N-Methyl-9,NMethyl9,10-ethanoanthrac,10ethanoanthrac,S2517,SAM001246989,1500373,"Maprotiline HCl",CPD000148117,"MAPROTILINE HYDROCHLORIDE"}

> <pdid>
PD009633

> <targets>
{"Reuptake inhibitor"}

> <classes>
{antidepressant,"Neuronal Signaling"}

> <pubchem_cids>
{71478,657219}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 25  0  0  0  0            999 V2000
    8.8915   -4.5024    0.0000 O   0  0
    6.3915   -4.5024    0.0000 Cl  0  0
    2.5973   -1.5031    0.0000 C   0  0
    2.5951   -3.0039    0.0000 N   0  0
    3.8915   -3.7585    0.0000 C   0  0
    3.8864   -5.2585    0.0000 C   0  0
    2.5847   -6.0040    0.0000 N   0  0
    1.2883   -5.2495    0.0000 C   0  0
    1.2935   -3.7495    0.0000 C   0  0
    2.5795   -7.5047    0.0000 C   0  0
    3.8748   -8.2614    0.0000 N   0  0
    3.8672   -9.7614    0.0000 C   0  0
    2.5644  -10.5048    0.0000 C   0  0
    1.2692   -9.7483    0.0000 C   0  0
    1.2767   -8.2483    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 O   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  4  1  0
  7 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  3 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 19  1  0
 23 24  2  0
 24 16  1  0
M  END
> <name>
NIHCC_2014

> <id>
6003

> <plate>
NGP-105-05

> <well>
F10

> <supplier_cmpd_name>
CPD000449302

> <ctcr_id>
3217

> <supplier_cmpd_id>
SAM001246994

> <smiles>
O.Cl.C(N1CCN(CC1)c2ncccn2)c3ccc4OCOc4c3

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{ADRA1A,ADRA2A,ADRA2C,DRD2,DRD3,DRD4,HTR1A,HTR2B}

> <broad_moa>
{"dopamine receptor agonist"}

> <synonyms>
{SMR000449302,MLS000758225,MLS001423975,CHEMBL4594075,CCG-100814,CCG100814,NC00064,SAM001246994,CPD000449302}

> <pdid>
PD000220

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581808}

$$$$
NIHCC_2014
  SciTegic11012413002D

 18 17  0  0  0  0            999 V2000
    8.8990   -1.1263    0.0000 H   0  3
    6.3990   -1.1263    0.0000 Cl  0  5
    3.8983   -0.7512    0.0000 F   0  0
    2.5988   -1.5004    0.0000 C   0  0
    2.5983   -3.0004    0.0000 F   0  0
    3.8975   -2.2510    0.0000 F   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5987   -1.5004    0.0000 N   0  0
   -3.8991   -0.7525    0.0000 C   0  0
   -5.1969   -1.5046    0.0000 C   0  0
   -5.1945   -3.0046    0.0000 N   0  0
   -3.8943   -3.7525    0.0000 C   0  0
   -2.5964   -3.0004    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 13  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6004

> <plate>
NGP-105-05

> <well>
F11

> <supplier_cmpd_name>
CPD000449305

> <ctcr_id>
863

> <supplier_cmpd_id>
SAM001247043

> <smiles>
[H+].[Cl-].FC(F)(F)c1cccc(c1)N2CCNCC2

> <pd_targets>
{TGR,FFP,THRB,MAPT,HTR1E,HTR2C,HTR1D,HTR6,HTR5B,HTR2A,HTR1F,HTR2B,HTR1A,HTR1B,HTR7,DRD2,HTR5A,ADRA1A,ADRA1B,ADRA1D,SIGMAR1,ALDH1A1,HTR3A,HTR3B,HTR3C,HTR3D,HTR3E}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Other cytosolic protein","Membrane receptor","Ion channel",Transferase,"Nuclear receptor","Family A G protein-coupled receptor",Oxidoreductase,"Ligand-gated ion channel
","Nuclear hormone receptor subfamily 1","Small molecule receptor (family A GPCR)","5HT3 receptor","Nuclear hormone receptor subfamily 1 group A","Monoamine receptor","Nuclear hormone receptor subfami
ly 1 group A member 2","Serotonin receptor","Dopamine receptor","Adrenergic receptor"}

> <pathway_chembl>
{Receptors,"Other protein targets","Nuclear hormone receptors","G protein-coupled receptors","Sigma receptors","1A. Thyroid hormone receptors","5-Hydroxytryptamine receptors","Dopamine receptors"}

> <pathway_reactome>
{"Metabolism of proteins","Neuronal System","Signal Transduction",Disease,Metabolism,"Post-translational protein modification","Transmission across Chemical Synapses","Signaling by GPCR","Infectious d
isease","Biological oxidations",SUMOylation,"Neurotransmitter receptors and postsynaptic signal transmission","GPCR ligand binding","Leishmania infection","SARS-CoV Infections","Phase I - Functionaliz
ation of compounds","SUMO E3 ligases SUMOylate target proteins","Activation of NMDA receptors and postsynaptic events","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival",
"Potential therapeutics for SARS","Ethanol oxidation","SUMOylation of intracellular receptors","Post NMDA receptor activation events","Amine ligand-binding receptors","Anti-inflammatory response favou
ring Leishmania parasite infection","Activation of AMPK downstream of NMDARs","Serotonin receptors","ADORA2B mediated anti-inflammatory cytokines production","Dopamine receptors"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{16015-69-3,16015693,"1-(3-Trifluoromethylphenyl)piperazine hydrochloride","1(3Trifluoromethylphenyl)piperazine hydrochloride","TFMPP hydrochloride","1-(3-Trifluoromethylphenyl)piperazine monohydrochl
oride","1(3Trifluoromethylphenyl)piperazine monohydrochloride","1-(3-(trifluoromethyl)phenyl)piperazine hydrochloride","1(3(trifluoromethyl)phenyl)piperazine hydrochloride",UNII-41P8ENH29V,UNII41P8ENH
29V,41P8ENH29V,Piperazine,1,SAM001247043,CPD000449305}

> <pdid>
PD050704

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{2777675,74763994,3084246,44181810}

$$$$
NIHCC_2014
  SciTegic11012413002D

 33 36  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0  1  0  0  0
   -5.1953    1.5031    0.0000 O   0  0
   -5.1932    3.0039    0.0000 C   0  0
   -3.8929    3.7516    0.0000 O   0  0
   -6.4914    3.7570    0.0000 C   0  0
   -6.4915    5.2570    0.0000 C   0  0
   -7.7905    6.0070    0.0000 C   0  0
   -7.7905    7.5070    0.0000 O   0  0
   -9.0896    5.2570    0.0000 C   0  0
  -10.3886    6.0071    0.0000 O   0  0
   -9.0896    3.7570    0.0000 C   0  0
  -10.3886    3.0071    0.0000 O   0  0
   -7.7906    3.0070    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0  2  0  0  0
   -2.5981   -1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -5.1968   -1.5004    0.0000 C   0  0
   -5.1993   -3.0005    0.0000 C   0  0
   -6.4995   -3.7484    0.0000 C   0  0
   -6.5019   -5.2484    0.0000 O   0  0
   -7.7973   -2.9964    0.0000 C   0  0
   -9.0976   -3.7443    0.0000 O   0  0
   -7.7950   -1.4964    0.0000 C   0  0
   -9.0928   -0.7443    0.0000 O   0  0
   -6.4947   -0.7484    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  6
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 18 20  2  0
 20 12  1  0
  8 21  1  0
 21 22  1  0
 22 23  1  0
 23  6  1  0
 23 24  2  0
 24  2  1  0
 21 25  1  6
 25 26  2  0
 26 27  1  0
 27 28  1  0
 27 29  2  0
 29 30  1  0
 29 31  1  0
 31 32  1  0
 31 33  2  0
 33 25  1  0
M  END
> <name>
NIHCC_2014

> <id>
6005

> <plate>
NGP-105-05

> <well>
G02

> <supplier_cmpd_name>
CPD000449288

> <ctcr_id>
1029

> <supplier_cmpd_id>
SAM001247031

> <smiles>
Oc1cc(O)c2C[C@@H](OC(=O)c3cc(O)c(O)c(O)c3)[C@H](Oc2c1)c4cc(O)c(O)c(O)c4

> <pd_targets>
{PGD,CREBBP,HSPD1,HSPE1,RAD52,FABG,MET,MAPT,POS-1,DYRK1A,APP,KAT2B,REP,POL,FABI,BCL2,MMP14,POLB,ZWF1,RECQL,GAA,BACE1,TERT,PIN1,KAT5,TTR,GROES,GROL,STAT1,SQLE,MMP2,ELANE,TDP1,PKM,FASN,PTGES,CNR1,PSMB5,
FABZ,MEX-5,KMT2A,MEN1,EP300,TST,ATP2A1,CNR2,KDM4E,TGR,FFP,MAPK14,MMP7,ALD,DPP4,MAPKAPK5,ABCB1,NS3,DNMT1,PGAM1,HSP90AB1,APEX1,CYP3A4,HSD17B10,KCNH2,MAPK1,BLM,GALK1,ALDH1A1,ALOX15,USP2,HPGD}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Other cytosolic protein","Other nuclear protein","Transcription factor","Membrane receptor","Ion channel","Secreted protein","Unclassified protein",Transporter,Oxidored
uctase,Writer,Kinase,Transferase,Hydrolase,"Other ion channel",Protease,Isomerase,Reader,"Family A G protein-coupled receptor","Primary active transporter",Eraser,"Histone acetyltransferase","Protein 
Kinase","Miscellaneous ion channel","Metallo protease","Aspartic protease","Methyl-lysine/arginine binding protein","Serine protease","Small molecule receptor (family A GPCR)","Threonine protease",Bro
modomain,"P-type ATPase","Lysine demethylase","ATP-binding cassette","DNA methyltransferase","p300/CBP family","TK protein kinase group","CMGC protein kinase group","GNAT family","Bcl-2 family","Metal
lo protease MAM clan","Aspartic protease AA clan",Chromodomain,"Serine protease PA clan","Lipid-like ligand receptor (family A GPCR)","Threonine protease PBT clan","Calcium ATPase","Jumonji domain-con
taining","Serine protease SC clan","CAMK protein kinase group","ABCB subfamily","Tyrosine protein kinase Met family","CMGC protein kinase DYRK family","Metallo protease M10A subfamily","Aspartic prote
ase A1A subfamily","Serine protease S1A subfamily","Cannabinoid receptor","Threonine protease T1A subfamily","CMGC protein kinase MAPK family","Serine protease S9B subfamily","CAMK protein kinase MAPK
APK family","CMGC protein kinase Dyrk1 subfamily","CMGC protein kinase p38 subfamily","CAMK protein kinase MAPKAPK subfamily","Cytochrome P450","Voltage-gated ion channel","Cytochrome P450 family 3","
Potassium channels","Cysteine protease","Cytochrome P450 family 3A","Voltage-gated potassium channel","Cysteine protease CA clan","Cytochrome P450 3A4","Cysteine protease C19 family","CMGC protein kin
ase ERK1"}

> <pathway_chembl>
{"Other protein targets",Receptors,Enzymes,Transporters,"Bromodomain-containing proteins","Catalytic receptors","Kinases (EC 2.7.x.x)","Chromatin modifying enzymes","Anti-infective targets","B-cell ly
mphoma 2 (Bcl-2) protein family","Peptidases and proteinases","3.2.1.- Glycosidases","Peptidyl-prolyl cis/trans isomerases",Transthyretin,"Lanosterol biosynthesis pathway","2.7.1.40 Pyruvate kinases",
"2.3.1.-  Acyltransferases","Eicosanoid turnover","G protein-coupled receptors","P-type ATPases","ATP-binding cassette transporter family","2.1.1.- Methyltransferases","Non-enzymatic BRD containing pr
oteins","Receptor kinases","CMGC: Containing CDK",MAPK,GSK3,"CLK families","2.3.1.48 Histone acetyltransferases (HATs)","Viral protein targets","MA: Metallo (M) Peptidases","AA: Aspartic (A) Peptidase
s","PA: Serine (S) Peptidases","Prostaglandin synthases","Cannabinoid receptors","PB: Threonine (T) Peptidases","P2A P-type ATPases: Ca<sup>2+</sup>-ATPases","1.14.11.- Histone demethylases","SC: Seri
ne (S) Peptidases","CAMK: Calcium/calmodulin-dependent protein kinases","ABCB subfamily","TK: Tyrosine kinase","Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase (DYRK) family","Coronavir
us (CoV) proteins","M10: Matrix metallopeptidase","A1: Pepsin","S1: Chymotrypsin","T1: Proteasome","Mitogen-activated protein kinases (MAP kinases)","S9: Prolyl oligopeptidase","MAPK-Activated Protein
 Kinase (MAPKAPK) family","Receptor tyrosine kinases (RTKs)","Dyrk1 subfamily","p38 subfamily","MAPKAPK subfamily","Type X RTKs: HGF (hepatocyte growth factor) receptor family","Heat shock proteins","
Ion channels","Cytochrome P450","Voltage-gated ion channels","CYP3 family","Potassium channels",Lipoxygenases,"CA: Cysteine (C) Peptidases","Voltage-gated potassium channels","C19: Ubiquitin-specific 
protease","ERK subfamily"}

> <pathway_reactome>
{Metabolism,"Gene expression (Transcription)","DNA Repair","Developmental Biology","Neuronal System","Cell Cycle","Immune System",Disease,"Extracellular matrix organization","Metabolism of proteins","
Signal Transduction",Hemostasis,"Metabolism of carbohydrates","RNA Polymerase II Transcription","DNA Double-Strand Break Repair","Nervous system development","Transmission across Chemical Synapses",Mi
totic,"Innate Immune System","Diseases of signal transduction by growth factor receptors and second messengers","Infectious disease","Degradation of the extracellular matrix","Base Excision Repair","D
iseases of metabolism","Amyloid fiber formation","Chromosome Maintenance","Signaling by GPCR","Metabolism of lipids","Metabolism of amino acids and derivatives","Platelet homeostasis","Signaling by Nu
clear Receptors","Peptide hormone metabolism","Abacavir transport and metabolism","Post-translational protein modification","Pentose phosphate pathway","Generic Transcription Pathway","Homology Direct
ed Repair","Axon guidance","Neurotransmitter receptors and postsynaptic signal transmission","Mitotic G1 phase and G1/S transition","Toll-like Receptor Cascades","Signaling by NOTCH1 in Cancer","SARS-
CoV Infections","Nucleotide-binding domain","leucine rich repeat containing receptor (NLR) signaling pathways","Activation of Matrix Metalloproteinases","Resolution of Abasic Sites (AP sites)","Diseas
es of carbohydrate metabolism","Telomere Maintenance","GPCR downstream signalling","Signaling by FGFR in disease","Metabolism of steroids","Complement cascade","Nonhomologous End-Joining (NHEJ)","Gluc
ose metabolism","Fatty acid metabolism","Regulation of mitotic cell cycle","Sulfur amino acid metabolism","Platelet calcium homeostasis","ESR-mediated signaling","Incretin synthesis",secretion,"and in
activation","Abacavir transmembrane transport",SUMOylation,"Transcriptional Regulation by TP53","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Semaphorin interactions",
"Activation of NMDA receptors and postsynaptic events","G0 and Early G1","Toll Like Receptor 5 (TLR5) Cascade","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","SARS-CoV-2 Infection",Inflammasom
es,"Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Glycogen storage diseases","Extension of Telomeres","G alpha (i) signalling events","Signaling by FGFR1 in disease","
Regulation of cholesterol biosynthesis by SREBP (SREBF)","EPH-Ephrin signaling","Regulation of Complement cascade",Glycolysis,"Arachidonic acid metabolism","APC/C-mediated degradation of cell cycle pr
oteins","Degradation of cysteine and homocysteine","Reduction of cytosolic Ca++ levels","Extra-nuclear estrogen signaling",Synthesis,"and inactivation of Glucagon-like Peptide-1 (GLP-1)","SUMO E3 liga
ses SUMOylate target proteins",Gluconeogenesis,"TP53 Regulates Transcription of Cell Death Genes","HDR through Single Strand Annealing (SSA)","Sema4D in semaphorin signaling","Post NMDA receptor activ
ation events","MyD88 cascade initiated on plasma membrane","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","SARS-CoV-2 Genome Replication and Transcription","The NLRP1 inflammasome","PCNA-De
pendent Long Patch Base Excision Repair","Glycogen storage disease type II (GAA)","Telomere Extension By Telomerase","Regulation of TP53 Activity","HDR through Homologous Recombination (HRR)","Visual 
phototransduction","FGFR1 mutant receptor activation","Activation of gene expression by SREBF (SREBP)","EPH-ephrin mediated repulsion of cells","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"
,"Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins","Sulfide oxidation to sulfate","SUMOylation of DNA methylation proteins","TP53 Regulates Transcription of Genes Involved
 in Cytochrome C Release","Sema4D mediated inhibition of cell attachment and migration","Activation of AMPK downstream of NMDARs","TAK1 activates NFkB by phosphorylation and activation of IKKs complex
","Replication of the SARS-CoV-2 genome","Regulation of TP53 Activity through Acetylation","Homologous DNA Pairing and Strand Exchange","The canonical retinoid cycle in rods (twilight vision)","Signal
ing by cytosolic FGFR1 fusion mutants","APC/C:Cdc20 mediated degradation of mitotic proteins","MAP kinase activation","Regulation of TP53 Activity through Phosphorylation","PI5P Regulates TP53 Acetyla
tion","Presynaptic phase of homologous DNA pairing and strand exchange","APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint","MAPK targets/ Nuclear
 events mediated by MAP kinases","Cdc20:Phospho-APC/C mediated degradation of Cyclin A","Activation of the AP-1 family of transcription factors","Mitotic G2-G2/M phases","G2/M Transition","The role of
 GTSE1 in G2/M progression after G2 checkpoint","Muscle contraction","Cardiac conduction","Biological oxidations","Biosynthesis of specialized proresolving mediators (SPMs)","Branched-chain amino acid
 catabolism","Phase 3 - rapid repolarisation","Diseases of glycosylation","Phase I - Functionalization of compounds","Biosynthesis of DHA-derived SPMs","Diseases associated with glycosylation precurso
r biosynthesis","Ethanol oxidation","Biosynthesis of DPA-derived SPMs","Biosynthesis of maresins","Defective GALK1 can cause Galactosemia II (GALCT2)","Biosynthesis of DPAn-3 SPMs","Biosynthesis of D-
series resolvins","Biosynthesis of maresin-like SPMs","Biosynthesis of DPAn-3-derived protectins and resolvins","Regulation of TP53 Expression and Degradation","Regulation of TP53 Degradation","ERK/MA
PK targets","ERKs are inactivated"}

> <broad_targets>
{ELANE,EP300,FASN,KAT2B,MMP14,MMP2}

> <broad_moa>
{"bacterial DNA gyrase inhibitor"}

> <synonyms>
{"(-)-Epigallocatechin gallate","()Epigallocatechin gallate",EGCG,"Epigallocatechin gallate",989-51-5,989515,"Epigallocatechin 3-gallate","Epigallocatechin 3gallate",Epigallocatechin-3-gallate,Epigall
ocatechin3gallate,"Tea catechin",(-)-Epigallocatechin-3-o-gallate,()Epigallocatechin3ogallate,Epigallocatechin-3-monogallate,Epigallocatechin3monogallate,Teavigo,"(-)-Epigallocatechol galla","()Epigal
locatechol galla",T3807,T2988,S2250,SAM001247031,210239,"(-)-Gallocatechin gallate","(-)-Epigallocatechin Gallate","epigallocatechin-3-monogallate
((-)-Epigallocatechin Gallate)",CPD000449288,EPIGALLOCATECHIN-3-MONOGALLATE}

> <pdid>
PD002148

> <targets>
{"DNA Methyltransferase",HER2,Telomerase,EGFR,"Fatty Acid Synthase",Autophagy,"Endogenous Metabolite",Ferroptosis,HIV,"Mitochondrial Metabolism","Reactive Oxygen Species"}

> <classes>
{Anti-infection,Apoptosis,Autophagy,Immunology/Inflammation,Metabolic Enzyme/Protease,NF-ºB}

> <pubchem_cids>
{65064}

$$$$
NIHCC_2014
  SciTegic11012413002D

 18 19  0  0  0  0            999 V2000
    3.8976   -0.7553    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2948   -3.7516    0.0000 O   0  0
    3.8926   -3.7566    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 F   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5987    1.5004    0.0000 C   0  0
   -2.6012    3.0004    0.0000 C   0  0
   -3.9015    3.7484    0.0000 C   0  0
   -5.1993    2.9963    0.0000 C   0  0
   -5.1969    1.4963    0.0000 C   0  0
   -3.8967    0.7484    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  2  0
  2  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 10 12  2  0
 12  6  1  0
  9 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
M  END
> <name>
NIHCC_2014

> <id>
6006

> <plate>
NGP-105-05

> <well>
G03

> <supplier_cmpd_name>
CPD000042823

> <ctcr_id>
3366

> <supplier_cmpd_id>
SAM001246961

> <smiles>
CC(C(O)=O)c1ccc(c(F)c1)c2ccccc2

> <pd_targets>
{PTGS1,PTGS2,FABP2,FABP1,KMT2A,MEN1,TSHR,AKR1C2,AKR1C3,SLC22A6,ASIC1,CYP2C19,MAPT,HPGD,CYP1A2,APH1A,APH1B,NCSTN,PSEN1,PSEN2,PSENEN,CYP2C9,HIF1A,LMNA,ALD}

> <pathway_gtopdb>
{Enzyme,"Auxiliary transport protein","Epigenetic regulator","Membrane receptor",Transporter,"Ion channel",Oxidoreductase,"Fatty acid binding protein family",Reader,"Family A G protein-coupled recepto
r","Electrochemical transporter","Ligand-gated ion channel",Bromodomain,"Peptide receptor (family A GPCR)","SLC superfamily of solute carriers","Acid-sensing ion channel","Glycohormone receptor","SLC2
2 family of organic cation and anion transporters","Other cytosolic protein","Transcription factor","Other nuclear protein","Cytochrome P450",Protease,"Cytochrome P450 family 2","Cytochrome P450 famil
y 1","Aspartic protease","Cytochrome P450 family 2C","Cytochrome P450 family 1A","Aspartic protease AD clan","Cytochrome P450 2C19","Cytochrome P450 1A1","Aspartic protease A22A subfamily","Cytochrome
 P450 2C9","Aspartic protease A22A regulatory subfamily"}

> <pathway_chembl>
{Enzymes,"Other protein targets",Receptors,Transporters,"Ion channels","Eicosanoid turnover","Fatty acid-binding proteins","G protein-coupled receptors","SLC superfamily of solute carriers","Ligand-ga
ted ion channels",Cyclooxygenase,"Glycoprotein hormone receptors","Prostaglandin synthases","SLC22 family of organic cation and anion transporters","Acid-sensing (proton-gated) ion channels (ASICs)","
Organic anion transporters (OATs)","Cytochrome P450","CYP2 family: drug metabolising subset","CYP1 family"}

> <pathway_reactome>
{Metabolism,Disease,"Transport of small molecules","Metabolism of lipids","Infectious disease","SLC-mediated transmembrane transport","Ion channel transport","Fatty acid metabolism","Biosynthesis of s
pecialized proresolving mediators (SPMs)","Triglyceride metabolism","Regulation of lipid metabolism by PPARalpha","Leishmania infection","Metabolism of steroids","Transport of bile salts and organic a
cids","metal ions and amine compounds","Stimuli-sensing channels","Arachidonic acid metabolism","Biosynthesis of DPA-derived SPMs","Triglyceride catabolism","PPARA activates gene expression","Leishman
ia parasite growth and survival","Bile acid and bile salt metabolism","Organic cation/anion/zwitterion transport","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","Biosynthesis of DPAn-3 SPMs"
,"Anti-inflammatory response favouring Leishmania parasite infection","Synthesis of bile acids and bile salts","Organic anion transport","ADORA2B mediated anti-inflammatory cytokines production","Synt
hesis of bile acids and bile salts via 24-hydroxycholesterol","Neuronal System","Cellular responses to external stimuli","Cell Cycle","Biological oxidations","Transmission across Chemical Synapses","C
ellular responses to stress",Mitotic,"Phase I - Functionalization of compounds","Neurotransmitter receptors and postsynaptic signal transmission","Cellular response to hypoxia","M Phase","Cytochrome P
450 - arranged by substrate type","Activation of NMDA receptors and postsynaptic events","Biosynthesis of DHA-derived SPMs","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","
Mitotic Metaphase and Anaphase",Xenobiotics,"Post NMDA receptor activation events","Biosynthesis of D-series resolvins","Mitotic Anaphase","CYP2E1 reactions","Activation of AMPK downstream of NMDARs",
"Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{APH1B,BACE1,IKBKG,PSEN1,PSEN2,PTGS1,PTGS2}

> <broad_moa>
{"gamma secretase inhibitor"}

> <synonyms>
{5104-49-4,5104494,Ansaid,Froben,Antadys,"2-(2-fluorobiphenyl-4-yl)propanoic acid","2(2fluorobiphenyl4yl)propanoic acid",Cebutid,Flurofen,Anside,"3-Fluoro-4-phenylhydratropic acid","3Fluoro4phenylhydr
atropic acid",Ocufen,"2-(3-fluoro-4-phenylphenyl)propanoic acid","2(3fluoro4phenylphenyl)propanoic acid","Flurbiprofene (INN-French)","Flurbiprofene (INNFrench)",Flurbiprofenum,SAM002564209,SAM0012469
61,1500308,Prestw-917,S1679,CPD000042823,FLURBIPROFEN,Flurbiprofen}

> <pdid>
PD002326

> <targets>
{Others}

> <classes>
{analgesic,Others,antiinflammatory}

> <pubchem_cids>
{3394}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 20  0  0  0  0            999 V2000
    1.8949   -4.8318    0.0000 N   0  0
    1.0157   -3.6164    0.0000 C   0  0
   -0.4763   -3.7706    0.0000 N   0  0
    1.6281   -2.2462    0.0000 N   0  0
    0.7500   -1.0323    0.0000 C   0  0
    1.2135    0.3943    0.0000 S   0  0
    0.0000    1.2760    0.0000 C   0  0
   -1.2135    0.3943    0.0000 C   0  0
   -2.6394    0.8543    0.0000 C   0  0
   -3.7533   -0.1515    0.0000 S   0  0
   -5.1816    0.3093    0.0000 C   0  0
   -6.2955   -0.6966    0.0000 C   0  0
   -7.7238   -0.2358    0.0000 C   0  0
   -8.0383    1.2309    0.0000 N   0  0
   -8.8377   -1.2416    0.0000 N   0  0
  -10.2660   -0.7808    0.0000 S   0  0
  -11.6934   -0.3196    0.0000 N   0  0
  -11.3793   -1.7861    0.0000 O   0  0
  -10.5805    0.6858    0.0000 O   0  0
   -0.7500   -1.0323    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  2  4  2  3
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
 16 19  2  0
  8 20  1  0
 20  5  2  0
M  END
> <name>
NIHCC_2014

> <id>
6007

> <plate>
NGP-105-05

> <well>
G04

> <supplier_cmpd_name>
CPD000058961

> <ctcr_id>
6597

> <supplier_cmpd_id>
SAM001247033

> <smiles>
NC(N)=Nc1scc(CSCCC(=N)N[S](N)(=O)=O)n1

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{famotidine,76824-35-6,76824356,PEPCID,"Pepcid AC",Famodil,Gastridin,Pepcidine,Pepdine,Quamatel,Gaster,Pepdul,"Pepcid RPD",YM-11170,YM11170,"Famotidine (Pepcid)",MK-208,MK208,"MK 208",CHEBI:4975,"YM 1
1170",3-(2-Guanidinothiazol-4-ylmethylthio)-N1-sulfamoylpropionamide,3(2Guanidinothiazol4ylmethylthio)N1sulfamoylpropionamide,S2078,SAM001247033,1501003,Prestw-104,Famotidine,CPD000058961,FAMOTIDINE,F
amotidine}

> <pdid>

> <targets>
{"Histamine Receptor"}

> <classes>
{"H2 antihistamine","Neuronal Signaling"}

> <pubchem_cids>
{5702160,5353622,3325}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 21  0  0  0  0            999 V2000
    5.1887   -6.0105    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    2.5909   -6.0056    0.0000 C   0  0
    3.8883   -6.7578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 C   0  0
   -2.5951   -3.0031    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
    8.9894   -1.1291    0.0000 O   0  0
    8.9894   -2.6291    0.0000 S   0  0
    8.9894   -4.1291    0.0000 O   0  0
    7.6901   -3.3787    0.0000 O   0  0
   10.2887   -3.3787    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 14 17  2  0
 17  9  1  0
 18 19  1  0
 19 20  1  0
 19 21  2  0
 19 22  2  0
M  END
> <name>
NIHCC_2014

> <id>
6008

> <plate>
NGP-105-05

> <well>
G05

> <supplier_cmpd_name>
CPD000058513

> <ctcr_id>
3423

> <supplier_cmpd_id>
SAM001246971

> <smiles>
CC(C)(C)NCC(O)c1ccc(O)c(CO)c1.O[S](O)(=O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Salbutamol sulfate",51022-70-9,51022709,Ventolin,Asthavent,Ventorlin,Asthalin,39971-61-4,39971614,"4-(2-(tert-Butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol sulfate","4(2(tertButylamino)1hydrox
yethyl)2(hydroxymethyl)phenol sulfate",MFCD00055200,"Salbutamol hemisulfate, 98","Asmaven sulfate",SMR000058513,NSC-289928,NSC289928,Sal,SAM001246971,CPD000058513}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{9884233}

$$$$
NIHCC_2014
  SciTegic11012413002D

 33 35  0  0  0  0            999 V2000
    3.8756   -9.7579    0.0000 C   0  0
    3.8808   -8.2579    0.0000 N   0  0
    5.1824   -7.5124    0.0000 C   0  0
    5.1876   -6.0124    0.0000 C   0  0
    3.8912   -5.2578    0.0000 N   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 S   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -1.2990   -5.2500    0.0000 Cl  0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    2.5895   -6.0034    0.0000 C   0  0
    2.5844   -7.5034    0.0000 C   0  0
    8.9876   -1.1293    0.0000 O   0  0
    8.9876   -2.6293    0.0000 C   0  0
    7.6883   -3.3789    0.0000 O   0  0
   10.2876   -3.3793    0.0000 C   0  0
   11.5876   -2.6293    0.0000 C   0  0
   11.5890   -1.1285    0.0000 C   0  0
   10.2904   -0.3777    0.0000 O   0  0
   12.8883   -0.3789    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 20 22  1  0
 22 23  2  0
 23  9  1  0
 23 17  1  0
  5 24  1  0
 24 25  1  0
 25  2  1  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  1  0
 31 33  2  0
M  END
> <name>
NIHCC_2014

> <id>
6009

> <plate>
NGP-105-05

> <well>
G06

> <supplier_cmpd_name>
CPD000466275

> <ctcr_id>
4299

> <supplier_cmpd_id>
SAM001247054

> <smiles>
CN1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1.OC(=O)\C=C/C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"10H-Phenothiazine, 2-chloro-10-(3-(4-methyl-1-piperazinyl)propyl- (CAS)","10HPhenothiazine, 2chloro10(3(4methyl1piperazinyl)propyl (CAS)","Compazine maleate",SMR000466275,NSC167375,CPD000466275,MLS0
00758219,MLS001423948,SCHEMBL1806022,CHEMBL1200587,HMS2051A11,NSC748866,CCG-100783,CCG100783,NC00033,NSC-167375,NSC-74,NSC74,T0385,SAM001247054,"Prochlorperazine Maleate"}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{6436057}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 21  0  0  0  0            999 V2000
   12.9003   -2.2475    0.0000 Cl  0  5
   10.3996   -1.4837    0.0000 C   0  0
    9.0990   -0.7364    0.0000 N   0  3
    7.8003   -1.4887    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 C   0  0
   -1.3039   -3.7494    0.0000 C   0  0
   -1.3092   -5.2494    0.0000 C   0  0
   -2.6108   -5.9949    0.0000 C   0  0
   -3.9072   -5.2404    0.0000 C   0  0
   -3.9020   -3.7404    0.0000 C   0  0
   -2.6004   -2.9949    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
M  CHG  2   1  -1   3   1
M  END
> <name>
NIHCC_2014

> <id>
6010

> <plate>
NGP-105-05

> <well>
G07

> <supplier_cmpd_name>
CPD000449269

> <ctcr_id>
874

> <supplier_cmpd_id>
SAM001247052

> <smiles>
[Cl-].C[NH2+]CCCCOc1ccccc1Cc2ccccc2

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"bifemelane hydrochloride",62232-46-6,62232466,"Bifemelane HCl",Celeport,Alnert,"Bifemelane (hydrochloride)","4-(2-benzylphenoxy)-N-methylbutan-1-amine hydrochloride","4(2benzylphenoxy)Nmethylbutan1a
mine hydrochloride",UNII-2N52S01UFY,UNII2N52S01UFY,MCI-2016,MCI2016,E-0687,E0687,2N52S01UFY,SMR000449269,CPD000449269,MLS000758314,ML,SAM001247052}

> <pdid>

> <targets>
{Monoamine Oxidase}

> <classes>
{Neuronal Signaling}

> <pubchem_cids>
{6917789,43962}

$$$$
NIHCC_2014
  SciTegic11012413002D

 13 14  0  0  1  0            999 V2000
    4.2566    0.5871    0.0000 C   0  0
    3.9511   -0.8815    0.0000 N   0  0
    2.5987   -1.5004    0.0000 C   0  0  1  0  0  0
    2.7343   -2.9815    0.0000 C   0  0
    4.2010   -3.2956    0.0000 C   0  0
    4.9531   -1.9978    0.0000 C   0  0
    6.4451   -1.8434    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  2  1  0
  6  7  2  0
  3  8  1  1
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
M  END
> <name>
NIHCC_2014

> <id>
6011

> <plate>
NGP-105-05

> <well>
G08

> <supplier_cmpd_name>
CPD000449278

> <ctcr_id>
61

> <supplier_cmpd_id>
SAM001247007

> <smiles>
CN1[C@@H](CCC1=O)c2cccnc2

> <pd_targets>
{KMT2A,MEN1,KDM4E,NPSR1,CHRNA10,CHRNA2,CHRNA3,CHRNA4,CHRNA5,CHRNA6,CHRNA7,CHRNA9,CHRNB2,CHRNB3,CHRNB4}

> <pathway_gtopdb>
{"Epigenetic regulator","Membrane receptor","Ion channel",Reader,Eraser,"Family A G protein-coupled receptor","Ligand-gated ion channel",Bromodomain,"Lysine demethylase","Peptide receptor (family A GP
CR)","Nicotinic acetylcholine receptor","Jumonji domain-containing","Short peptide receptor (family A GPCR)","Nicotinic acetylcholine receptor alpha subunit","Neuropeptide receptor"}

> <pathway_chembl>
{Enzymes,Receptors,"Chromatin modifying enzymes","G protein-coupled receptors","1.14.11.- Histone demethylases","Neuropeptide S receptor"}

> <pathway_reactome>
{Disease,"Infectious disease","Leishmania infection","Leishmania parasite growth and survival","Anti-inflammatory response favouring Leishmania parasite infection","ADORA2B mediated anti-inflammatory 
cytokines production"}

> <broad_targets>
{}

> <broad_moa>
{"nicotine metabolite"}

> <synonyms>
{cotinine,(-)-Cotinine,486-56-6,(S)-Cotinine,Cotinina,Cotininum,(5S)-1-methyl-5-(pyridin-3-yl)pyrrolidin-2-one,(S)-(-)-Cotinine,"Cotinine (-)",(S)-1-methyl-5-(pyridin-3-yl)pyrrolidin-2-one,"2-Pyrrolid
inone, 1-methyl-5-(3-pyridinyl)-, (5S)-",UNII-K5161X06LL,(S)-1-Methyl-5-(3-pyridinyl)-2-pyrrolidinone,MFCD00077696,"NIH 10498","Nicotine related compound c",CHEBI:68641,(S)-1-Methyl-5-(3-pyridyl)-2-py
rrolidinone,(5S)-1-methyl-5-pyridin-3-ylpyrrolidin-2-one,K5161X06LL,S(-)-1-Methyl-5-(3-pyridyl)-2-pyrrolidone,(5S)-1-methyl-5-(3-pyridyl)pyrrolidin-2-one,DSSTox_CID_27576,DSSTox_RID_82428,DSSTox_GSID_
47576,BRD4010,BRD-4010,"Cotinine (INN)",SMR000449278,"Cotininum (INN-Latin)",SR-01000075768,"Cotinina (INN-Spanish)","CCRIS 7625","HSDB 7805",NCGC00093739-04,(5S)-1-methyl-5-(3-pyridinyl)-2-pyrrolidin
one,CAS-486-56-6,Prestwick_134,"EINECS 207-634-9","BRN 0083099",Spectrum_001984,"Nicotine EP Impurity C",Prestwick0_000082,Prestwick1_000082,Prestwick2_000082,Prestwick3_000082,Spectrum3_000700,Spectr
um4_001793,Spectrum5_000465,bmse000577,"(-)-Cotinine, 98",Lopac0_000285,SCHEMBL49060,BSPBio_000004,BSPBio_002459,KBioGR_002368,KBioSS_002550,"5-24-02-00504 (Beilstein Handbook Reference)",MLS000758262
,MLS001423950,DivK1c_000861,SPECTRUM1500208,SPBio_001943,"(-)-Cotinine, >=98",BPBio1_000006,CHEMBL578211,MEGxp0_001870,DTXSID1047576,ACon1_000202,KBio1_000861,KBio2_002541,KBio2_005109,KBio2_007677,KB
io3_001679,NINDS_000861,"US8609708, 91 Cotinine",HMS1568A06,HMS1920A14,HMS2051A15,HMS2091G22,HMS2095A06,HMS2232F15,HMS3260J12,Pharmakon1600-01500208,ZINC402766,"(-)-Cotinine, analytical standard",HY-B
1178,Tox21_111219,Tox21_300615,Tox21_500285,4205AE,BBL102262,BDBM50370573,NSC756704,s9339,STL556061,AKOS007930814,Tox21_111219_1,"(-)-Cotinine 1.0 mg/ml in Methanol",CCG-100799,CS-4787,LP00285,MCULE-8
421169764,NC00049,NSC-756704,PB32127,SB10317,SDCCGMLS-0066565.P001,SDCCGSBI-0050273.P004,IDI1_000861,NCGC00093739-08,NCGC00093739-13,NCGC00093739-20,NCGC00254396-01,NCGC00260970-01,AS-50387,ST057157,S
BI-0050273.P003,AM20061246,B7277,EU-0100285,"(-)-Cotinine 100 microg/mL in Acetonitrile","C 5923",Q-1537,AB00053721_08,(5S)-1-methyl-5-pyridin-3-yl-pyrrolidin-2-one,A827581,Q421177,(S)-(-)-1-Methyl-5-
(3-pyridyl)-2-pyrrolidinone,SR-01000075768-1,SR-01000075768-5,SR-01000075768-6,BRD-K94144010-001-04-8,BRD-K94144010-001-05-5,BRD-K94144010-001-09-7,"(-)-Cotinine solution, drug standard, 1.0 mg/mL in 
methanol","2-Pyrrolidinone, 1-methyl-5-(3-pyridinyl)-, (S)- (9CI)","(5S)-1-Methyl-5-(pyridin-3-yl)pyrrolidin-2-one ((-)-Cotinine)",T1202,SAM001247007,1500208,CPD000449278,COTININE}

> <pdid>
PD002405

> <targets>
{Endogenous Metabolite}

> <classes>
{antidepressant,Metabolic Enzyme/Protease}

> <pubchem_cids>
{854019}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 31  0  0  0  0            999 V2000
    7.5844   -1.4920    0.0000 C   0  0
    6.1069   -1.2335    0.0000 N   0  0
    5.5920    0.1754    0.0000 C   0  0
    4.1145    0.4339    0.0000 C   0  0
    3.1484   -0.7186    0.0000 C   0  0
    3.6667   -2.1252    0.0000 C   0  0
    5.1442   -2.3838    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.3882    2.1623    0.0000 C   0  0
    1.6774    3.4832    0.0000 C   0  0
    0.2015    3.2154    0.0000 S   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
   11.3852    1.5382    0.0000 O   0  0
   11.3852    0.0382    0.0000 C   0  0
   10.0859   -0.7113    0.0000 O   0  0
   12.6852   -0.7118    0.0000 C   0  0
   13.9852    0.0382    0.0000 C   0  0
   13.9866    1.5391    0.0000 C   0  0
   12.6880    2.2899    0.0000 O   0  0
   15.2859    2.2887    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  2  1  0
  5  8  2  3
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13  9  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21  8  1  0
 21 16  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  1  0
 27 29  2  0
M  END
> <name>
NIHCC_2014

> <id>
6012

> <plate>
NGP-105-05

> <well>
G09

> <supplier_cmpd_name>
CPD000466272

> <ctcr_id>
5302

> <supplier_cmpd_id>
SAM001247038

> <smiles>
CN1CCC(CC1)=C2c3ccsc3CCc4ccccc24.OC(=O)\C=C/C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Pizotifen maleate","Pizotyline maleate",CHEBI:50214,24359-22-6,24359226,UNII-2S5E7G70SZ,UNII2S5E7G70SZ,2S5E7G70SZ,SMR000466272,CPD000466272,"pizotifen hydrogen maleate",MLS000758265,MLS001424010,SCH
EMBL1000901,CHEMBL1326119,HMS2051A17,HMS2232E14,BCP9000202,CCG-1008,CCG1008,SAM001247038}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{11718531,6439699}

$$$$
NIHCC_2014
  SciTegic11012413002D

 36 40  0  0  1  0            999 V2000
    3.8976   -0.7553    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    2.5951   -3.0031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5987    1.5004    0.0000 C   0  0
   -2.6012    3.0004    0.0000 C   0  0
   -3.9015    3.7484    0.0000 C   0  0
   -5.1993    2.9963    0.0000 C   0  0
   -6.5018    3.7420    0.0000 O   0  0
   -7.7993    2.9876    0.0000 C   0  0
   -9.1017    3.7333    0.0000 C   0  0  1  0  0  0
  -10.4521    3.1101    0.0000 C   0  0
  -11.4576    4.2232    0.0000 O   0  0
  -10.7097    5.5235    0.0000 C   0  0  1  0  0  0
  -12.1915    5.6529    0.0000 C   0  0
  -13.0723    4.4376    0.0000 N   0  0
  -14.5587    4.4336    0.0000 C   0  0
  -15.0012    3.0003    0.0000 C   0  0
  -13.7748    2.1366    0.0000 N   0  0
  -12.5744    3.0360    0.0000 C   0  0
   -9.2420    5.2139    0.0000 O   0  0
   -9.8181    6.7146    0.0000 C   0  0
   -8.3287    6.5365    0.0000 C   0  0
   -7.4298    7.7374    0.0000 C   0  0
   -8.0203    9.1162    0.0000 C   0  0
   -7.1214   10.3171    0.0000 Cl  0  0
   -9.5097    9.2943    0.0000 C   0  0
  -10.4086    8.0934    0.0000 C   0  0
  -11.8980    8.2715    0.0000 Cl  0  0
   -5.1969    1.4963    0.0000 C   0  0
   -3.8967    0.7484    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  4  1  0
  7 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 16 15  1  1
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  1
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 21  1  0
 19 26  1  0
 26 16  1  0
 19 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 30 32  1  0
 32 33  2  0
 33 27  1  0
 33 34  1  0
 13 35  1  0
 35 36  2  0
 36 10  1  0
M  END
> <name>
NIHCC_2014

> <id>
6013

> <plate>
NGP-105-05

> <well>
G10

> <supplier_cmpd_name>
CPD000058460

> <ctcr_id>
5301

> <supplier_cmpd_id>
SAM001246983

> <smiles>
CC(=O)N1CCN(CC1)c2ccc(OC[C@H]3CO[C@@](Cn4ccnc4)(O3)c5ccc(Cl)cc5Cl)cc2

> <pd_targets>
{CYP3A4,CYP19A1,CYP2D6,CYP2C9,HMOX2,CYP2C19,CYP3A5,HMOX1,CYP17A1,CYP8B1,HIF1A,MAPK1,LEF,HSP90AA1,ABCB11,CYP11A1,CYP7A1,CYP51A1,KCNH2,LMNA,MAPT,ALDH1A1,CHRM1,ADRA1B,HTR1B,IDO1,CYP27B1,TSHR,CYP2C8,ABCB1
,CYP11B1,CYP2C11,CYP2A2,CYP11B2,CYP24A1,CYP1A2,GNRHR,CYP21A2,KMT2A,MEN1,BLM,THPO,NPSR1,NFKB1,PMP22,ADRA1A,ALOX15,RORC,GMNN,CYP4F2,KCNA10,ABCC4,ADRA2A,SLC6A4,CACNA1C,ABCB1A,ABCB1B,CYP26A1,CHRM2,TACR2,A
DRA2B,SLC6A2,UGT1A1,HRH2,SLC22A1,SLC6A3,OPRD1,TBXAS1,ERG11,AR,NR1I2}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Other cytosolic protein",Transporter,"Ion channel","Other nuclear protein","Membrane receptor","Unclassified protein","Epigenetic regulator","Cytochrome P450",Oxidoredu
ctase,Kinase,Protease,"Primary active transporter","Voltage-gated ion channel","Family A G protein-coupled receptor",Reader,"Nuclear receptor","Electrochemical transporter",Transferase,"Cytochrome P45
0 family 3","Cytochrome P450 family 19","Cytochrome P450 family 2","Cytochrome P450 family 17","Protein Kinase","Metallo protease","ATP-binding cassette","Cytochrome P450 family 11","Cytochrome P450 f
amily 7","Cytochrome P450 family 51","Potassium channels","Small molecule receptor (family A GPCR)","Cytochrome P450 family 27","Peptide receptor (family A GPCR)","Cytochrome P450 family 24","Cytochro
me P450 family 1","Cytochrome P450 family 21","Cysteine protease",Bromodomain,"Nuclear hormone receptor subfamily 1","Cytochrome P450 family 4","SLC superfamily of solute carriers","Voltage-gated calc
ium channel","Cytochrome P450 family 26","Cytochrome P450 family 5","Nuclear hormone receptor subfamily 3","Cytochrome P450 family 3A","Cytochrome P450 family 19A","Cytochrome P450 family 2D","Cytochr
ome P450 family 2C","Cytochrome P450 family 17A","CMGC protein kinase group","Metallo protease MAE clan","ABCB subfamily","Cytochrome P450 family 11A","Cytochrome P450 family 7A","Cytochrome P450 fami
ly 51A","Voltage-gated potassium channel","Monoamine receptor","Cytochrome P450 family 27B","Glycohormone receptor","Cytochrome P450 family 11B","Cytochrome P450 family 2A","Cytochrome P450 family 24A
","Cytochrome P450 family 1A","Short peptide receptor (family A GPCR)","Cytochrome P450 family 21A","Cysteine protease CA clan","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family 4
F","ABCC subfamily","SLC06 neurotransmitter transporter family","Cytochrome P450 family 26A","SLC22 family of organic cation and anion transporters","Cytochrome P450 family 5A","Nuclear hormone recept
or subfamily 3 group C","Nuclear hormone receptor subfamily 1 group I","Cytochrome P450 3A4","Cytochrome P450 19A1","Cytochrome P450 2D6","Cytochrome P450 2C9","Cytochrome P450 2C19","Cytochrome P450 
3A5","Cytochrome P450 17A1","CMGC protein kinase MAPK family","Metallo protease M34 family","Cytochrome P450 11A1","Cytochrome P450 7A1","Cytochrome P450 51A1","Acetylcholine receptor","Adrenergic rec
eptor","Serotonin receptor","Cytochrome P450 27B1","Cytochrome P450 2C8","Cytochrome P450 11B1","Cytochrome P450 2C11","Cytochrome P450 2A2","Cytochrome P450 11B2","Cytochrome P450 24A1","Cytochrome P
450 1A1","GnRH receptor","Cytochrome P450 21A2","Cysteine protease C1A family","Neuropeptide receptor","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 4F2","Cytochrome P450 26
A1","Neurokinin receptor","Histamine receptor","Opioid receptor","Cytochrome P450 5A1","Nuclear hormone receptor subfamily 3 group C member 4","Nuclear hormone receptor subfamily 1 group I member 2","
CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,"Other protein targets",Transporters,"Ion channels",Receptors,"Cytochrome P450","Haem oxygenase","Kinases (EC 2.7.x.x)","Heat shock proteins","ATP-binding cassette transporter family","Voltag
e-gated ion channels","G protein-coupled receptors","1.13.11.- Dioxygenases","Eicosanoid turnover","Nuclear hormone receptors","SLC superfamily of solute carriers","UDP glucuronosyltransferases (UGT)"
,"CYP3 family",CYP11,CYP17,CYP19,"CYP20 and CYP21 families","CYP2 family: drug metabolising subset",CYP5,"CYP7 and CYP8 families","CMGC: Containing CDK",MAPK,GSK3,"CLK families","ABCB subfamily",CYP39
,"CYP46 and CYP51 families","Potassium channels","Acetylcholine receptors (muscarinic)",Adrenoceptors,"5-Hydroxytryptamine receptors",CYP24,"CYP26 and CYP27 families","Glycoprotein hormone receptors",
"CYP1 family","Gonadotrophin-releasing hormone receptors","Neuropeptide S receptor",Lipoxygenases,"1F. Retinoic acid-related orphans","CYP4 family","ABCC subfamily","SLC6 neurotransmitter transporter 
family","Voltage-gated calcium channels","Tachykinin receptors","Histamine receptors","SLC22 family of organic cation and anion transporters","Opioid receptors","Steroid hormone receptors","1I. Vitami
n D receptor-like receptors","Mitogen-activated protein kinases (MAP kinases)","Voltage-gated potassium channels","Monoamine transporter subfamily","Organic cation transporters (OCT)","3C. 3-Ketostero
id receptors","ERK subfamily"}

> <pathway_reactome>
{Metabolism,"Immune System","Cellular responses to external stimuli",Disease,"Cell Cycle","Muscle contraction","Neuronal System","Signal Transduction","DNA Repair",Hemostasis,"Developmental Biology","
Gene expression (Transcription)","Transport of small molecules","Metabolism of proteins","Metabolism of lipids","Biological oxidations","Innate Immune System","Cytokine Signaling in Immune system","Ce
llular responses to stress","Infectious disease",Mitotic,"Cardiac conduction","Transmission across Chemical Synapses","Signaling by GPCR","Metabolism of amino acids and derivatives","Abacavir transpor
t and metabolism","DNA Double-Strand Break Repair","Platelet activation","signaling and aggregation","Nervous system development","RNA Polymerase II Transcription","Potassium Channels","Disorders of t
ransmembrane transporters","Diseases of metabolism","SLC-mediated transmembrane transport","Post-translational protein modification","Biosynthesis of specialized proresolving mediators (SPMs)","Phase 
I - Functionalization of compounds","Neutrophil degranulation","Signaling by Interleukins","Metabolism of steroids","Cellular response to hypoxia","Toll-like Receptor Cascades","Uptake and actions of 
bacterial toxins","Mitotic G2-G2/M phases","Phase 3 - rapid repolarisation","M Phase","Neurotransmitter receptors and postsynaptic signal transmission","GPCR ligand binding","Tryptophan catabolism","L
eishmania infection","Abacavir transmembrane transport","Homology Directed Repair","Platelet Aggregation (Plug Formation)","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Generic Tra
nscription Pathway","Mitotic G1 phase and G1/S transition","Voltage gated Potassium channels","Response to elevated platelet cytosolic Ca2+","Neurotransmitter clearance","Axon guidance","SLC transport
er disorders","Metabolic disorders of biological oxidation enzymes","Transport of bile salts and organic acids","metal ions and amine compounds",SUMOylation,"Biosynthesis of DHA-derived SPMs","Cytochr
ome P450 - arranged by substrate type","Interleukin-4 and Interleukin-13 signaling","Metabolism of steroid hormones","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Toll Li
ke Receptor 5 (TLR5) Cascade","Uptake and function of anthrax toxins","G2/M Transition","Bile acid and bile salt metabolism","Mitotic Metaphase and Anaphase","Activation of NMDA receptors and postsyna
ptic events","Ethanol oxidation","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Interle
ukin-1 family signaling","Biosynthesis of DPA-derived SPMs","Transcriptional regulation by RUNX3","G1/S Transition","Platelet degranulation","Serotonin clearance from the synaptic cleft","NCAM signali
ng for neurite out-growth","Defective SLC6A2 causes orthostatic intolerance (OI)","Defective UGT1A1 causes hyperbilirubinemia","Organic cation/anion/zwitterion transport","Defective SLC6A3 causes Park
insonism-dystonia infantile (PKDYS)","Transcriptional regulation by RUNX2","SUMO E3 ligases SUMOylate target proteins","Biosynthesis of maresins","Endogenous sterols",Xenobiotics,"Androgen biosynthesi
s","MyD88 cascade initiated on plasma membrane","Centrosome maturation","Synthesis of bile acids and bile salts","Mitotic Anaphase","Post NMDA receptor activation events","Amine ligand-binding recepto
rs",Vitamins,"Anti-inflammatory response favouring Leishmania parasite infection","Hormone ligand-binding receptors","HDR through Homologous Recombination (HRR)","Interleukin-1 signaling","Biosynthesi
s of DPAn-3 SPMs","RUNX3 Regulates Immune Response and Cell Migration","Activation of the pre-replicative complex",Eicosanoids,"NCAM1 interactions","Peptide ligand-binding receptors","Organic cation t
ransport","RUNX2 regulates bone development","SUMOylation of intracellular receptors","Biosynthesis of maresin-like SPMs","CYP2E1 reactions","Sterols are 12-hydroxylated by CYP8B1","MAP kinase activat
ion","Loss of proteins required for interphase microtubule organization from the centrosome","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Synthesis of bile acids and bile sa
lts via 27-hydroxycholesterol","Nuclear Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs","Muscarinic acetylcholine receptors",Adrenoceptors,"Serotonin receptors","ADORA2B mediated a
nti-inflammatory cytokines production","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Homologous DNA Pairing and Strand Exchange","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Bio
synthesis of DPAn-3-derived protectins and resolvins","Tachykinin receptors bind tachykinins","RUNX2 regulates osteoblast differentiation","MAPK targets/ Nuclear events mediated by MAP kinases","Loss 
of Nlp from mitotic centrosomes","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pairing and strand exchange","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{KCNA10}

> <broad_moa>
{"sterol demethylase inhibitor"}

> <synonyms>
{EI-107,EI107,s1353,AKOS007930650,"Ketoconazole - CAS 65277-42-1","Ketoconazole  CAS 65277421",AB02344,CCG-100815,CCG100815,CS-1846,CS1846,ketoconazole,65277-42-1,65277421,(+)-Ketoconazole,(+)Ketocona
zole,"(2R,4S)-ketoconazole","(2R,4S)ketoconazole",Xolegel,Kuric,Ketocanazole,CPD000058460,CHEMBL75,MFCD00058579,C26H28Cl2N4O4,SMR000058460,MLS,T0679,SAM001246983,Prestw-389,Ketoconazole}

> <pdid>
PD001920

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{456201}

$$$$
NIHCC_2014
  SciTegic11012413002D

 14 15  0  0  1  0            999 V2000
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 N   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -5.1065    0.0000    0.0000 N   0  0
   -2.7248   -1.2135    0.0000 S   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  5  4  1  6
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 13  8  2  0
 13 14  1  0
 14  5  1  0
M  END
> <name>
NIHCC_2014

> <id>
6014

> <plate>
NGP-105-05

> <well>
G11

> <supplier_cmpd_name>
CPD000449298

> <ctcr_id>
6377

> <supplier_cmpd_id>
SAM001247006

> <smiles>
CCCN[C@H]1CCc2nc(N)sc2C1

> <pd_targets>
{DRD3,DRD2,SIGMAR1,DRD4,DRD1,DRD5,HTR1A,ADRA2A,HTR2A,HTR7,ADRA2C,HRH2,ADRB2,HTR1B,ADRA2B}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Dopamine receptor","Serotonin receptor","Adrenergic receptor","Histamine rece
ptor"}

> <pathway_chembl>
{Receptors,"Other protein targets","G protein-coupled receptors","Sigma receptors","Dopamine receptors","5-Hydroxytryptamine receptors",Adrenoceptors,"Histamine receptors"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Signaling by GPCR","Infectious disease","GPCR ligand binding","SARS-CoV Infections","Leishmania infection","Class A/1 (Rhodopsin-like receptors)","Potential therapeutic
s for SARS","Leishmania parasite growth and survival","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Dopamine receptors","Serotonin receptors",A
drenoceptors,"ADORA2B mediated anti-inflammatory cytokines production"}

> <broad_targets>
{ADRA2A,ADRA2B,ADRA2C,DRD1,DRD2,DRD3,DRD4,DRD5,HTR1A,HTR1B,HTR1D,HTR2A,HTR2B,HTR2C}

> <broad_moa>
{"dopamine receptor agonist"}

> <synonyms>
{pramipexole,104632-26-0,104632260,(-)-Pramipexole,()Pramipexole,Sifrol,Mirapexin,Pramipexol,"(S)-N6-Propyl-4,5,6,7-tetrahydrobenzo(d)thiazole-2,6-diamine","(S)N6Propyl4,5,6,7tetrahydrobenzo(d)thiazol
e2,6diamine",Pramipexolum,(S)-Pramipexole,(S)Pramipexole,Mirapex,SUD919CL2Y,U-98528E,U98528E,(S)-2-Amino-4,(S)2Amino4,5,6,7-tetrahydro-6-(propylamino)benzoth,7tetrahydro6(propylamino)benzoth,T1476,S24
60,SAM001247006,Prestw-1316,Pramipexole,CPD000449298}

> <pdid>
PD002907

> <targets>
{"Dopamine Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{119570}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 23  0  0  1  0            999 V2000
    7.6431   -6.6564    0.0000 C   0  0
    6.5256   -5.6559    0.0000 C   0  0
    5.1017   -6.1218    0.0000 N   0  0
    4.6332   -7.5468    0.0000 C   0  0
    3.1332   -7.5416    0.0000 C   0  0
    2.6747   -6.1134    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0  1  0  0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 N   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 O   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 Cl  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 Cl  0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0031   -3.0008    0.0000 O   0  0
    1.3032   -3.7490    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  3  1  0
  7  8  1  1
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 15 17  2  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 20 12  1  0
 20 21  1  0
 21 22  1  0
M  END
> <name>
NIHCC_2014

> <id>
6015

> <plate>
NGP-105-05

> <well>
H02

> <supplier_cmpd_name>
CPD000449275

> <ctcr_id>
5299

> <supplier_cmpd_id>
SAM001247072

> <smiles>
CCN1CCC[C@H]1CNC(=O)c2c(O)c(Cl)cc(Cl)c2OC

> <pd_targets>
{CYP2C19,HTR2C,HTR6,KDM4E,DRD2,KMT2A,HTR2A,ALD,DRD1,DRD3,DRD4,DRD5,CYP2D6,CYP2C9,HRH1,HTR7,HSD17B10,HTR1A,LEF,CYP1A2}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Epigenetic regulator","Cytochrome P450","Family A G protein-coupled receptor",Eraser,Reader,Oxidoreductase,Protease,"Cytochrome P450 family 2","Small molecule receptor (fa
mily A GPCR)","Lysine demethylase",Bromodomain,"Metallo protease","Cytochrome P450 family 1","Cytochrome P450 family 2C","Monoamine receptor","Jumonji domain-containing","Cytochrome P450 family 2D","M
etallo protease MAE clan","Cytochrome P450 family 1A","Cytochrome P450 2C19","Serotonin receptor","Dopamine receptor","Cytochrome P450 2D6","Cytochrome P450 2C9","Histamine receptor","Metallo protease
 M34 family","Cytochrome P450 1A1"}

> <pathway_chembl>
{Enzymes,Receptors,"Cytochrome P450","G protein-coupled receptors","Chromatin modifying enzymes","CYP2 family: drug metabolising subset","5-Hydroxytryptamine receptors","1.14.11.- Histone demethylases
","Dopamine receptors","2.1.1.43 Histone methyltransferases (HMTs)","Histamine receptors","CYP1 family"}

> <pathway_reactome>
{Metabolism,"Signal Transduction",Disease,"Gene expression (Transcription)","Biological oxidations","Signaling by GPCR","Infectious disease","RNA Polymerase II Transcription","Metabolism of amino acid
s and derivatives","Phase I - Functionalization of compounds","GPCR ligand binding","Leishmania infection","Generic Transcription Pathway","Branched-chain amino acid catabolism","Uptake and actions of
 bacterial toxins","Cytochrome P450 - arranged by substrate type","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","Transcriptional regulation by RUNX1","Uptake and fun
ction of anthrax toxins",Xenobiotics,"Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection","RUNX1 regulates genes involved in megakaryocyte differentiat
ion and platelet function","CYP2E1 reactions","Serotonin receptors","ADORA2B mediated anti-inflammatory cytokines production","Dopamine receptors","Histamine receptors","Aromatic amines can be N-hydro
xylated or N-dealkylated by CYP1A2"}

> <broad_targets>
{DRD2,DRD3,HTR1A}

> <broad_moa>
{"dopamine receptor antagonist"}

> <synonyms>
{RACLOPRIDE,84225-95-6,84225956,UNII-430K3SOZ7G,UNII430K3SOZ7G,CHEMBL8809,430K3SOZ7G,NCGC00025303-03,NCGC0002530303,DSSTox_CID_25687,DSSToxCID25687,DSSTox-CID-25687,"DSSTox CID 25687",DSSTox_RID_81059
,DSSToxRID81059,DSSTox-RID-81059,"DSSTox RID 81059",DSSTox_GSID_45687,DSSToxGSID45687,DSSTox-GSID-45687,"DSSTox GSID 45687",Racloprida,Raclopridum,(3H)raclopride,(3H)-raclopride,SMR000449275,CAS-84225
-95-6,CAS84225956,"Raclopridum (Latin)",S-(-)-racl,S()racl,SAM001247072,Prestw-1325,CPD000449275,Raclopride}

> <pdid>
PD002893

> <targets>
{Dopamine Receptor}

> <classes>
{GPCR/G Protein,Neuronal Signaling}

> <pubchem_cids>
{3033769}

$$$$
NIHCC_2014
  SciTegic11012413002D

 10 10  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  3
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  3
  8  2  1  0
  8  9  1  0
  7 10  1  0
M  END
> <name>
NIHCC_2014

> <id>
6016

> <plate>
NGP-105-05

> <well>
H03

> <supplier_cmpd_name>
CPD000059136

> <ctcr_id>
2846

> <supplier_cmpd_id>
SAM001247015

> <smiles>
CN1C=CC(=O)C(=C1C)O

> <pd_targets>
{KDM4E,DOHH,FFP,ALD}

> <pathway_gtopdb>
{"Epigenetic regulator",Enzyme,Eraser,Oxidoreductase,Transferase,"Lysine demethylase","Jumonji domain-containing"}

> <pathway_chembl>
{Enzymes,"Chromatin modifying enzymes","1.14.11.- Histone demethylases"}

> <pathway_reactome>
{"Metabolism of proteins","Post-translational protein modification","Gamma carboxylation","hypusine formation and arylsulfatase activation","Hypusine synthesis from eIF5A-lysine"}

> <broad_targets>
{UGT1A6}

> <broad_moa>
{"chelating agent"}

> <synonyms>
{deferiprone,30652-11-0,30652110,"3-Hydroxy-1,2-dimethyl-4(1H)-pyridone","3Hydroxy1,2dimethyl4(1H)pyridone",Ferriprox,"3-hydroxy-1,2-dimethylpyridin-4(1H)-one","3hydroxy1,2dimethylpyridin4(1H)one",CP2
0,"1,2-dimethyl-3-hydroxy-4-pyridone","1,2dimethyl3hydroxy4pyridone","1,2-Dimethyl-3-hydroxypyrid-4-one","1,2Dimethyl3hydroxypyrid4one","1,2-Dimethyl-3-hydroxypyridine-4-one","1,2Dimethyl3hydroxypyrid
ine4one",4(1H)-Pyri,4(1H)Pyri,T1565,SAM001247015,Deferidone,CPD000059136}

> <pdid>
PD001143

> <targets>
{Ferroptosis,HCV}

> <classes>
{Anti-infection,Apoptosis}

> <pubchem_cids>
{2972}

$$$$
NIHCC_2014
  SciTegic11012413002D

 16 15  0  0  0  0            999 V2000
    7.5987    1.1240    0.0000 H   0  3
    5.0987    1.1240    0.0000 Cl  0  5
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5987    1.5004    0.0000 C   0  0
   -2.6012    3.0004    0.0000 C   0  0
   -3.9015    3.7484    0.0000 C   0  0
   -5.1993    2.9963    0.0000 C   0  0
   -5.1969    1.4963    0.0000 C   0  0
   -6.4947    0.7442    0.0000 Cl  0  0
   -3.8967    0.7484    0.0000 N   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  4  1  0
  7 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 16 10  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6017

> <plate>
NGP-105-05

> <well>
H04

> <supplier_cmpd_name>
CPD000449299

> <ctcr_id>
689

> <supplier_cmpd_id>
SAM001246999

> <smiles>
[H+].[Cl-].NC1CCN(CC1)c2cccc(Cl)n2

> <pd_targets>
{LEF,NFKB1,TSHR,ALOX15,CYP2D6,HTR3A,HTR3B,HTR3C,HTR3D,HTR3E,CYP1A2,KMT2A,MEN1,CHRM1}

> <pathway_gtopdb>
{Enzyme,"Other cytosolic protein","Membrane receptor","Ion channel","Epigenetic regulator",Protease,"Family A G protein-coupled receptor",Oxidoreductase,"Cytochrome P450","Ligand-gated ion channel",Re
ader,"Metallo protease","Peptide receptor (family A GPCR)","Cytochrome P450 family 2","5HT3 receptor","Cytochrome P450 family 1",Bromodomain,"Small molecule receptor (family A GPCR)","Metallo protease
 MAE clan","Glycohormone receptor","Cytochrome P450 family 2D","Cytochrome P450 family 1A","Monoamine receptor","Metallo protease M34 family","Cytochrome P450 2D6","Cytochrome P450 1A1","Acetylcholine
 receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"Ion channels","G protein-coupled receptors","Eicosanoid turnover","Cytochrome P450","Ligand-gated ion channels","Glycoprotein hormone receptors",Lipoxygenases,"CYP2 family: drug me
tabolising subset","5-HT<sub>3</sub> receptors","CYP1 family","Acetylcholine receptors (muscarinic)"}

> <pathway_reactome>
{Disease,"Immune System",Metabolism,"Neuronal System","Signal Transduction","Infectious disease","Cytokine Signaling in Immune system","Metabolism of lipids","Biological oxidations","Transmission acro
ss Chemical Synapses","Signaling by GPCR","Uptake and actions of bacterial toxins","Signaling by Interleukins","Leishmania infection","Biosynthesis of specialized proresolving mediators (SPMs)","Phase
 I - Functionalization of compounds","Neurotransmitter receptors and postsynaptic signal transmission","GPCR ligand binding","Uptake and function of anthrax toxins","Interleukin-1 family signaling","L
eishmania parasite growth and survival","Biosynthesis of DPA-derived SPMs","Cytochrome P450 - arranged by substrate type","Class A/1 (Rhodopsin-like receptors)","Interleukin-1 signaling","Anti-inflamm
atory response favouring Leishmania parasite infection","Biosynthesis of DPAn-3 SPMs",Xenobiotics,"Amine ligand-binding receptors","MAP3K8 (TPL2)-dependent MAPK1/3 activation","ADORA2B mediated anti-i
nflammatory cytokines production","Biosynthesis of DPAn-3-derived protectins and resolvins","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Muscarinic acetylchol
ine receptors"}

> <broad_targets>
{HTR3A}

> <broad_moa>
{"serotonin receptor agonist"}

> <synonyms>
{"SR 57227A",77145-61-0,77145610,"SR 57227 HYDROCHLORIDE","SR 57227A hydrochloride","4-amino-1-(6-chloro-2-pyridyl)-piperidine hydrochloride","4amino1(6chloro2pyridyl)piperidine hydrochloride",UNII-OW
45B79UZD,UNIIOW45B79UZD,OW45B79UZD,"sr-57227 hydrochloride","sr57227 hydrochloride",SR-57227A,SR57227A,"SR 57,227A",1-(6-chloro-2-pyridinyl)-4-piperidi,1(6chloro2pyridinyl)4piperidi,SAM001246999,CPD00
0449299}

> <pdid>
PD014014

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{131746,50986999}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 21  0  0  1  0            999 V2000
    7.5987   -4.5009    0.0000 Cl  0  5
    2.5981   -1.5000    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  1  0  0  0
    0.0000   -3.0008    0.0000 N   0  0
    1.2979   -3.7529    0.0000 C   0  0
    1.2955   -5.2529    0.0000 C   0  0
   -0.0047   -6.0009    0.0000 C   0  0
   -1.3026   -5.2488    0.0000 C   0  0
   -1.3002   -3.7488    0.0000 C   0  0
   -0.0071   -7.5016    0.0000 C   0  0
    1.2895   -8.2558    0.0000 C   0  0
    1.2848   -9.7558    0.0000 C   0  0
   -0.0166  -10.5017    0.0000 C   0  0
   -1.3133   -9.7476    0.0000 C   0  0
   -1.3085   -8.2476    0.0000 C   0  0
    5.0987   -4.5009    0.0000 H   0  3
  3  2  1  1
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  3  1  0
  8  9  1  6
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14  9  1  0
 12 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
M  CHG  2   1  -1  21   1
M  END
> <name>
NIHCC_2014

> <id>
6018

> <plate>
NGP-105-05

> <well>
H05

> <supplier_cmpd_name>
CPD000057879

> <ctcr_id>
4817

> <supplier_cmpd_id>
SAM001246972

> <smiles>
[Cl-].O[C@@H]1CCCC[C@H]1N2CCC(CC2)c3ccccc3.[H+]

> <pd_targets>
{SIGMAR1,CHRM1,CYP2D6,SLC18A3,TSHR,AMPC,TMEM97,ALDH1A1,APEX1,BLM,CYP1A2,LEF}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,Transporter,"Unclassified protein","Family A G protein-coupled receptor","Cytochrome P450","Electrochemical transporter",Hydrolase,Oxidoreductase,"Small molecule receptor (
family A GPCR)","Cytochrome P450 family 2","SLC superfamily of solute carriers","Peptide receptor (family A GPCR)","Monoamine receptor","Cytochrome P450 family 2D","SLC18 family of vesicular amine tra
nsporters","Glycohormone receptor","Acetylcholine receptor","Cytochrome P450 2D6",Protease,"Cytochrome P450 family 1","Metallo protease","Cytochrome P450 family 1A","Metallo protease MAE clan","Cytoch
rome P450 1A1","Metallo protease M34 family"}

> <pathway_chembl>
{"Other protein targets",Receptors,Enzymes,Transporters,"Sigma receptors","G protein-coupled receptors","Cytochrome P450","SLC superfamily of solute carriers","Acetylcholine receptors (muscarinic)","C
YP2 family: drug metabolising subset","SLC18 family of vesicular amine transporters","Glycoprotein hormone receptors","CYP1 family"}

> <pathway_reactome>
{Disease,"Signal Transduction",Metabolism,"Neuronal System","DNA Repair","Infectious disease","Signaling by GPCR","Biological oxidations","Transmission across Chemical Synapses","Base Excision Repair"
,"DNA Double-Strand Break Repair","SARS-CoV Infections","GPCR ligand binding","Phase I - Functionalization of compounds","Neurotransmitter release cycle","Leishmania infection","Resolution of Abasic S
ites (AP sites)","Homology Directed Repair","Potential therapeutics for SARS","Class A/1 (Rhodopsin-like receptors)","Cytochrome P450 - arranged by substrate type","Acetylcholine Neurotransmitter Rele
ase Cycle","Leishmania parasite growth and survival","Ethanol oxidation","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","HDR through Homologous Recombination (HRR) or S
ingle Strand Annealing (SSA)","Amine ligand-binding receptors",Xenobiotics,"Anti-inflammatory response favouring Leishmania parasite infection","PCNA-Dependent Long Patch Base Excision Repair","HDR th
rough Homologous Recombination (HRR)","Muscarinic acetylcholine receptors","CYP2E1 reactions","ADORA2B mediated anti-inflammatory cytokines production","Homologous DNA Pairing and Strand Exchange","Pr
esynaptic phase of homologous DNA pairing and strand exchange","Uptake and actions of bacterial toxins","Uptake and function of anthrax toxins","Aromatic amines can be N-hydroxylated or N-dealkylated 
by CYP1A2"}

> <broad_targets>
{SLC18A3}

> <broad_moa>
{"acetylcholinesterase inhibitor"}

> <synonyms>
{"+/)VESAMICOL HYDROCHLORID","(+/-)-Vesamicol hydrochloride","(+/)Vesamicol hydrochloride","Vesamicol hydrochloride, (+/-)-","Vesamicol hydrochloride, (+/)","AH 5183",120447-62-3,120447623,"AH-5183 hy
drochloride","AH5183 hydrochloride","Cyclohexanol, 2-(4-phenyl-1-piperidinyl)-, hydrochloride, trans-(+/-)-","Cyclohexanol, 2(4phenyl1piperidinyl), hydrochloride, trans(+/)","L-(-)-Vesamicol hydrochlo
ride","L()Vesamicol hydrochloride",SMR000,SAM001246972,Prestw-920,CPD000057879,"L(-)-vesamicol hydrochloride"}

> <pdid>
PD013275

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{659839,6603219}

$$$$
NIHCC_2014
  SciTegic11012413002D

 14 16  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.4133   -1.7530    0.0000 C   0  0
   -1.8032   -3.1233    0.0000 C   0  0
   -0.3114   -2.9665    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  3  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14  2  1  0
 14 10  2  0
M  END
> <name>
NIHCC_2014

> <id>
6019

> <plate>
NGP-105-05

> <well>
H06

> <supplier_cmpd_name>
CPD000449322

> <ctcr_id>
6928

> <supplier_cmpd_id>
SAM001247055

> <smiles>
Nc1c2CCCCc2nc3CCCc13

> <pd_targets>
{BCHE,ACHE,MAPK1}

> <pathway_gtopdb>
{Enzyme,Hydrolase,Kinase,"Protein Kinase","CMGC protein kinase group","CMGC protein kinase MAPK family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,"Acetylcholine turnover","Kinases (EC 2.7.x.x)","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{Metabolism,"Immune System","Metabolism of lipids","Innate Immune System","Phospholipid metabolism","Toll-like Receptor Cascades","Glycerophospholipid biosynthesis","Toll Like Receptor 5 (TLR5) Cascad
e","Synthesis of PC","MyD88 cascade initiated on plasma membrane","MAP kinase activation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{ACHE}

> <broad_moa>
{"acetylcholinesterase inhibitor"}

> <synonyms>
{Ipidacrine,62732-44-9,62732449,Amiridine,"2,3,5,6,7,8-Hexahydro-1H-cyclopenta(b)quinolin-9-ylamine","2,3,5,6,7,8Hexahydro1Hcyclopenta(b)quinolin9ylamine","2,3,5,6,7,8-hexahydro-1H-cyclopenta(b)quinol
in-9-amine","2,3,5,6,7,8hexahydro1Hcyclopenta(b)quinolin9amine",UNII-CV71VTP0VN,UNIICV71VTP0VN,CV71VTP0VN,"9-Amino-2,3,5,6,7,8-hexahydro-1H-cyclopenta(b)quinoline","9Amino2,3,5,6,7,8hexahydro1Hcyclope
nta(b)quinoline",1H-Cyclo,1HCyclo,SAM001247055,CPD000449322}

> <pdid>
PD003184

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{604519}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 23  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -3.8971    3.7500    0.0000 Cl  0  0
   -2.5981    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.4133   -1.7530    0.0000 N   0  0
   -1.8032   -3.1233    0.0000 C   0  0
   -0.3114   -2.9665    0.0000 N   0  0
    0.0000   -1.5000    0.0000 N   0  0
   -2.5536   -4.4230    0.0000 C   0  0
   -4.0145   -4.6748    0.0000 O   0  0
   -4.2107   -6.1619    0.0000 C   0  0
   -2.8569   -6.8080    0.0000 C   0  0
   -1.8241   -5.7201    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
 10  4  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15  2  1  0
 15 11  1  0
 13 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 16  2  0
M  END
> <name>
NIHCC_2014

> <id>
6020

> <plate>
NGP-105-05

> <well>
H07

> <supplier_cmpd_name>
CPD000449284

> <ctcr_id>
409

> <supplier_cmpd_id>
SAM001246973

> <smiles>
Nc1nc2ccc(Cl)cc2c3nc(nn13)c4occc4

> <pd_targets>
{ADORA2A,ADORA3,ADORA1,ADORA2B,KDM4E,CYP2D6,CYP1A2,MAPT,GMNN,HIF1A,RORC,MAPK1,LEF,CREBBP,THPO,CYP2C9,LMNA,NS1,CYP3A4,PMP22,MTOR}

> <pathway_gtopdb>
{"Membrane receptor","Epigenetic regulator",Enzyme,"Other cytosolic protein","Unclassified protein","Transcription factor","Other nuclear protein","Family A G protein-coupled receptor",Eraser,"Cytochr
ome P450","Nuclear receptor",Kinase,Protease,Writer,"Small molecule receptor (family A GPCR)","Lysine demethylase","Cytochrome P450 family 2","Cytochrome P450 family 1","Nuclear hormone receptor subfa
mily 1","Protein Kinase","Metallo protease","Histone acetyltransferase","Cytochrome P450 family 3","Nucleotide-like receptor (family A GPCR)","Jumonji domain-containing","Cytochrome P450 family 2D","C
ytochrome P450 family 1A","Nuclear hormone receptor subfamily 1 group F","CMGC protein kinase group","Metallo protease MAE clan","p300/CBP family","Cytochrome P450 family 2C","Cytochrome P450 family 3
A","Atypical protein kinase group","Adenosine receptor","Cytochrome P450 2D6","Cytochrome P450 1A1","Nuclear hormone receptor subfamily 1 group F member 3","CMGC protein kinase MAPK family","Metallo p
rotease M34 family","Cytochrome P450 2C9","Cytochrome P450 3A4","Atypical protein kinase PIKK family","CMGC protein kinase ERK1","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Receptors,Enzymes,"Other protein targets","G protein-coupled receptors","Chromatin modifying enzymes","Cytochrome P450","Nuclear hormone receptors","Kinases (EC 2.7.x.x)","Bromodomain-containing prot
eins","Adenosine receptors","1.14.11.- Histone demethylases","CYP2 family: drug metabolising subset","CYP1 family","1F. Retinoic acid-related orphans","CMGC: Containing CDK",MAPK,GSK3,"CLK families","
Non-enzymatic BRD containing proteins","CYP3 family",Atypical,"Mitogen-activated protein kinases (MAP kinases)","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","ERK subfamily","FRAP su
bfamily"}

> <pathway_reactome>
{Disease,"Signal Transduction",Metabolism,"Neuronal System","Cell Cycle","Cellular responses to external stimuli","Gene expression (Transcription)","Immune System",Hemostasis,"Developmental Biology","
Infectious disease","Signaling by GPCR","Biological oxidations","Transmission across Chemical Synapses",Mitotic,"Cellular responses to stress","RNA Polymerase II Transcription","Innate Immune System",
"Platelet activation","signaling and aggregation","Metabolism of lipids","Nervous system development","Leishmania infection","GPCR ligand binding","Phase I - Functionalization of compounds","Neurotran
smitter receptors and postsynaptic signal transmission","Mitotic G1 phase and G1/S transition","Cellular response to hypoxia","Generic Transcription Pathway","Toll-like Receptor Cascades","Uptake and 
actions of bacterial toxins","Platelet Aggregation (Plug Formation)","M Phase","Biosynthesis of specialized proresolving mediators (SPMs)","EGR2 and SOX10-mediated initiation of Schwann cell myelinati
on","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Cytochrome P450 - arranged by substrate type","Activation of NMDA receptors and postsynaptic events","G1/S Transit
ion","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Transcriptional regulation by RUNX3","Toll Like Receptor 5 (TLR5) Cascade","Uptake and function of anthrax toxins","Tra
nscriptional Regulation by TP53","Mitotic Metaphase and Anaphase","Biosynthesis of DHA-derived SPMs","Anti-inflammatory response favouring Leishmania parasite infection","Nucleotide-like (purinergic) 
receptors",Xenobiotics,"Post NMDA receptor activation events","Activation of the pre-replicative complex","RUNX3 Regulates Immune Response and Cell Migration","MyD88 cascade initiated on plasma membra
ne","TP53 Regulates Transcription of Cell Death Genes","Mitotic Anaphase","Biosynthesis of maresins","Regulation of TP53 Activity","ADORA2B mediated anti-inflammatory cytokines production","Adenosine 
P1 receptors","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Activation of AMPK downstream of NMDARs","MAP kinase activation","TP53 Regulates Transcription of G
enes Involved in Cytochrome C Release","Nuclear Envelope (NE) Reassembly","Biosynthesis of maresin-like SPMs","Regulation of TP53 Expression and Degradation","MAPK targets/ Nuclear events mediated by 
MAP kinases","Initiation of Nuclear Envelope (NE) Reformation","Regulation of TP53 Degradation","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{ADORA1,ADORA2A,ADORA2B,ADORA3}

> <broad_moa>
{"adenosine receptor antagonist"}

> <synonyms>
{"Cgs 15943",104615-18-1,104615181,CGS-15943,CGS15943,"CGS 15943A","9-chloro-2-(furan-2-yl)-(1,2,4)triazolo(1,5-c)quinazolin-5-amine","9chloro2(furan2yl)(1,2,4)triazolo(1,5c)quinazolin5amine","9-chlor
o-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine","9chloro2(2furyl)(1,2,4)triazolo(1,5c)quinazolin5imine",UNII-Y5A5D5E2AQ,UNIIY5A5D5E2AQ,Y5A5D5E2AQ,CHEMBL16687,9-chloro-2-(2-f,9chloro2(2f,SAM001
246973,CPD000449284}

> <pdid>
PD002809

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{2690}

$$$$
NIHCC_2014
  SciTegic11012413002D

  7  7  0  0  1  0            999 V2000
    1.6317   -2.2458    0.0000 N   0  0
    0.7500   -1.0323    0.0000 C   0  0  2  0  0  0
    1.2135    0.3943    0.0000 C   0  0
    0.0000    1.2760    0.0000 O   0  0
   -1.2135    0.3943    0.0000 N   0  0
   -0.7500   -1.0323    0.0000 C   0  0
   -1.6317   -2.2458    0.0000 O   0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  2  1  0
  6  7  2  0
M  END
> <name>
NIHCC_2014

> <id>
6021

> <plate>
NGP-105-05

> <well>
H08

> <supplier_cmpd_name>
CPD000058313

> <ctcr_id>
1288

> <supplier_cmpd_id>
SAM001247014

> <smiles>
N[C@@H]1CONC1=O

> <pd_targets>
{BLM,NFO,SMN1,GRIN2C,CYP3A4,LMNA,HIF1A,GRIN1,GRIN2A,GRIN2B,GRIN2D,GRIN3A,GRIN3B,KMT2A,MEN1,MAPK1,TSHR,HSD17B10,ALR,DDL,DDLA}

> <pathway_gtopdb>
{Enzyme,Hydrolase,"Epigenetic regulator","Ion channel","Other nuclear protein","Transcription factor","Membrane receptor",Reader,"Ligand-gated ion channel","Cytochrome P450",Kinase,"Family A G protein
-coupled receptor",Oxidoreductase,Isomerase,Ligase,"Methyl-lysine/arginine binding protein","Ionotropic glutamate receptor","Cytochrome P450 family 3",Bromodomain,"Protein Kinase","Peptide receptor (f
amily A GPCR)","Tudor domain","NMDA receptor","Cytochrome P450 family 3A","CMGC protein kinase group","Glycohormone receptor","Cytochrome P450 3A4","CMGC protein kinase MAPK family","CMGC protein kina
se ERK1"}

> <pathway_chembl>
{"Ion channels",Enzymes,Receptors,"Ligand-gated ion channels","Cytochrome P450","Kinases (EC 2.7.x.x)","G protein-coupled receptors","Ionotropic glutamate receptors","CYP3 family","CMGC: Containing CD
K",MAPK,GSK3,"CLK families","Glycoprotein hormone receptors","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"DNA Repair","DNA Double-Strand Break Repair","Homology Directed Repair","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","HDR through Homologous Recombination (HRR)","Ho
mologous DNA Pairing and Strand Exchange","Presynaptic phase of homologous DNA pairing and strand exchange","Metabolism of RNA","Neuronal System",Metabolism,"Cell Cycle","Cellular responses to externa
l stimuli","Immune System",Disease,"Metabolism of non-coding RNA","Transmission across Chemical Synapses","Metabolism of lipids",Mitotic,"Cellular responses to stress","Innate Immune System","Infectio
us disease","Metabolism of amino acids and derivatives","snRNP Assembly","Neurotransmitter receptors and postsynaptic signal transmission","Biosynthesis of specialized proresolving mediators (SPMs)","
M Phase","Cellular response to hypoxia","Toll-like Receptor Cascades","Leishmania infection","Branched-chain amino acid catabolism","Activation of NMDA receptors and postsynaptic events","Biosynthesis
 of DHA-derived SPMs","Mitotic Metaphase and Anaphase","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Toll Like Receptor 5 (TLR5) Cascade","Leishmania parasite growth and 
survival","Post NMDA receptor activation events","Biosynthesis of maresins","Mitotic Anaphase","MyD88 cascade initiated on plasma membrane","Anti-inflammatory response favouring Leishmania parasite in
fection","Long-term potentiation","Biosynthesis of maresin-like SPMs","Nuclear Envelope (NE) Reassembly","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","MAP kinase 
activation","ADORA2B mediated anti-inflammatory cytokines production","Initiation of Nuclear Envelope (NE) Reformation","Ras activation upon Ca2+ influx through NMDA receptor","MAPK targets/ Nuclear e
vents mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{GRIN1}

> <broad_moa>
{"bacterial cell wall synthesis inhibitor"}

> <synonyms>
{CYCLOSERIN,D-cycloserine,Dcycloserine,cycloserine,68-41-7,68417,Seromycin,orientomycin,Oxamycin,Cyclo-D-serine,CycloDserine,Cyclorin,D-4-amino-3-isoxazolidinone,D4amino3isoxazolidinone,Cicloserina,Fa
rmiserina,Miroseryn,Tisomycin,Wasserina,Closina,D-4-amino-3-isoxazolidone,D4amino3isoxazolidone,alpha-Cycloserine,alphaCycloserine,(+)-4-Amino-3-iso,(+)4Amino3iso,T0710,T1589,SAM002264599,SAM001247014
,1500215,Prestw-1089,L-Cycloserine,D-Cycloserine,CPD000058313,CYCLOSERINE,(S)-(-)-Cycloserine}

> <pdid>
PD000159

> <targets>
{}

> <classes>
{"antibacterial (tuberculostatic)"}

> <pubchem_cids>
{6234,51670069}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 23  0  0  1  0            999 V2000
    2.6640   -0.1280    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0
   -6.4952    3.7500    0.0000 O   0  0
   -3.8971    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.3326   -2.9571    0.0000 C   0  0
    1.8253   -3.1044    0.0000 C   0  0
    2.4266   -1.7302    0.0000 C   0  0  2  0  0  0
    3.8900   -1.4008    0.0000 O   0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  6
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 13 14  1  0
 14 15  2  0
 15  5  1  0
 15  9  1  0
  6 16  1  0
 16  2  1  0
 16 17  1  1
 17 18  1  0
 18 19  1  0
 19  2  1  0
 19 20  1  1
M  END
> <name>
NIHCC_2014

> <id>
6022

> <plate>
NGP-105-05

> <well>
H09

> <supplier_cmpd_name>
CPD000059126

> <ctcr_id>
390

> <supplier_cmpd_id>
SAM001247032

> <smiles>
C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O

> <pd_targets>
{ESR1,ESR2,AR,AOX1,SHBG,GPER1,LMNA,MAPT,PMP22,ALOX15,SULT1A1,TSHR,ESRRA,KCNMA1,CYP3A4,BLM,PGR,SERPINA6,HSD17B10,ALDH1A1,CYP1B1,RECQL,ESRRB,SMN1,SLC22A1,SLC6A4,SLC22A3,CACNA1C,GPBAR1,NR3C1,CYP2B6,STS,S
LC6A3,SLCO1A1,SLC22A2,NR1I2,CHRNA4,MT-ATP6,BECN1}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Secreted protein","Membrane receptor","Other nuclear protein","Other cytosolic protein","Unclassified protein","Ion channel","Epigenetic regulator",Transporter,"Nuclear
 receptor",Oxidoreductase,"Family A G protein-coupled receptor",Transferase,"Voltage-gated ion channel","Cytochrome P450",Reader,"Electrochemical transporter",Hydrolase,"Ligand-gated ion channel","Nuc
lear hormone receptor subfamily 3","Small molecule receptor (family A GPCR)","Peptide receptor (family A GPCR)","Potassium channels","Cytochrome P450 family 3","Cytochrome P450 family 1","Methyl-lysin
e/arginine binding protein","SLC superfamily of solute carriers","Voltage-gated calcium channel","Cytochrome P450 family 2","Nuclear hormone receptor subfamily 1","Nicotinic acetylcholine receptor","N
uclear hormone receptor subfamily 3 group A","Nuclear hormone receptor subfamily 3 group C","Lipid-like ligand receptor (family A GPCR)","Glycohormone receptor","Nuclear hormone receptor subfamily 3 g
roup B","Calcium-activated potassium channel","Cytochrome P450 family 3A","Cytochrome P450 family 1B","Tudor domain","SLC22 family of organic cation and anion transporters","SLC06 neurotransmitter tra
nsporter family","Cytochrome P450 family 2B","SLC21/SLCO family of organic anion transporting polypeptides","Nuclear hormone receptor subfamily 1 group I","Nicotinic acetylcholine receptor alpha subun
it","Nuclear hormone receptor subfamily 3 group A member 1","Nuclear hormone receptor subfamily 3 group A member 2","Nuclear hormone receptor subfamily 3 group C member 4","Steroid-like ligand recepto
r","Nuclear hormone receptor subfamily 3 group B member 1","Cytochrome P450 3A4","Nuclear hormone receptor subfamily 3 group C member 3","Cytochrome P450 1B1","Nuclear hormone receptor subfamily 3 gro
up B member 2","Nuclear hormone receptor subfamily 3 group C member 1","Cytochrome P450 2B6","Nuclear hormone receptor subfamily 1 group I member 2"}

> <pathway_chembl>
{Receptors,Enzymes,"Ion channels",Transporters,"Nuclear hormone receptors","G protein-coupled receptors","Eicosanoid turnover","Voltage-gated ion channels","Cytochrome P450","SLC superfamily of solute
 carriers","Ligand-gated ion channels","F-type and V-type ATPases","Steroid hormone receptors","G protein-coupled estrogen receptor",Lipoxygenases,"Glycoprotein hormone receptors","3B. Estrogen-relate
d receptors","Potassium channels","CYP3 family","CYP1 family","SLC22 family of organic cation and anion transporters","SLC6 neurotransmitter transporter family","Voltage-gated calcium channels","Bile 
acid receptor","CYP2 family: drug metabolising subset","1I. Vitamin D receptor-like receptors","Nicotinic acetylcholine receptors","F-type ATPase","3A. Estrogen receptors","3C. 3-Ketosteroid receptors
","Calcium- and sodium-activated potassium channels","Organic cation transporters (OCT)","Monoamine transporter subfamily"}

> <pathway_reactome>
{"Gene expression (Transcription)","Signal Transduction",Metabolism,"Cell Cycle","Neuronal System","Developmental Biology",Disease,Hemostasis,"DNA Repair","Metabolism of RNA","Transport of small molec
ules","Metabolism of proteins","RNA Polymerase II Transcription","Intracellular signaling by second messengers","Metabolism of vitamins and cofactors","Signaling by GPCR",Mitotic,"Transmission across 
Chemical Synapses","Nervous system development","Metabolism of lipids","Biological oxidations","Infectious disease","Platelet homeostasis","DNA Double-Strand Break Repair","Metabolism of amino acids a
nd derivatives","Metabolism of non-coding RNA","SLC-mediated transmembrane transport","Disorders of transmembrane transporters","Post-translational protein modification","The citric acid (TCA) cycle a
nd respiratory electron transport","Generic Transcription Pathway","PIP3 activates AKT signaling","Metabolism of water-soluble vitamins and cofactors","GPCR ligand binding","M Phase","Neurotransmitter
 receptors and postsynaptic signal transmission","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Biosynthesis of specialized proresolving mediators (SPMs)","Phase II - Conjugation of
 compounds","Leishmania infection","Nitric oxide stimulates guanylate cyclase","Homology Directed Repair","Metabolism of steroids","Branched-chain amino acid catabolism","Phase I - Functionalization o
f compounds","snRNP Assembly","Transport of bile salts and organic acids","metal ions and amine compounds","Neurotransmitter clearance","Axon guidance","Sphingolipid metabolism","SLC transporter disor
ders",SUMOylation,"Respiratory electron transport","ATP synthesis by chemiosmotic coupling","and heat production by uncoupling proteins.","SARS-CoV Infections","Transcriptional regulation by RUNX1","N
egative regulation of the PI3K/AKT network","Transcriptional regulation by RUNX2","Vitamins B6 activation to pyridoxal phosphate","Class A/1 (Rhodopsin-like receptors)","Mitotic Metaphase and Anaphase
","Activation of NMDA receptors and postsynaptic events","Biosynthesis of DPA-derived SPMs","Cytosolic sulfonation of small molecules","Leishmania parasite growth and survival","cGMP effects","Biosynt
hesis of DHA-derived SPMs","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Metabolism of steroid hormones","Ethanol oxidation","Cytochrome P450 - arranged by substrate t
ype","Nuclear Receptor transcription pathway","Organic cation/anion/zwitterion transport","Serotonin clearance from the synaptic cleft","NCAM signaling for neurite out-growth","FOXO-mediated transcrip
tion","Glycosphingolipid metabolism","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","SUMO E3 ligases SUMOylate target proteins","Acetylcholine binding and downstream events","Format
ion of ATP by chemiosmotic coupling","SARS-CoV-1 Infection","RUNX1 regulates estrogen receptor mediated transcription",PI5P,"PP2A and IER3 Regulate PI3K/AKT Signaling","RUNX2 regulates bone developmen
t","Peptide ligand-binding receptors","Mitotic Anaphase","Post NMDA receptor activation events","Biosynthesis of DPAn-3 SPMs","Anti-inflammatory response favouring Leishmania parasite infection","Regu
lation of RUNX2 expression and activity","Biosynthesis of maresins","HDR through Homologous Recombination (HRR)","Glucocorticoid biosynthesis","Endogenous sterols","Organic cation transport","NCAM1 in
teractions","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes",Xenobiotics,"SUMOylation of intracellular receptors","Postsynaptic nicotinic acetylcholine receptors","Tran
slation of Replicase and Assembly of the Replication Transcription Complex","RUNX2 regulates osteoblast differentiation","Nuclear Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs","B
iosynthesis of DPAn-3-derived protectins and resolvins","ADORA2B mediated anti-inflammatory cytokines production","Biosynthesis of maresin-like SPMs","Homologous DNA Pairing and Strand Exchange","CYP2
E1 reactions","Highly calcium permeable postsynaptic nicotinic acetylcholine receptors","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pairing and strand exchan
ge"}

> <broad_targets>
{ESR1,ESR2,GPER1,KCNMA1,NR1I2}

> <broad_moa>
{"estrogen receptor agonist"}

> <synonyms>
{RESTW44,estradiol,beta-Estradiol,betaEstradiol,17beta-Estradiol,17betaEstradiol,50-28-2,50282,Oestradiol,Dihydrofolliculin,Estrace,Ovocyclin,Vivelle,progynon,Dihydrotheelin,Dihydroxyestrin,Aquadiol,D
iogynets,Gynergon,Gynoestryl,Diogyn,Oestroglandol,Aerodiol,Corpagen,Dimenformon,Estrovite,T3378,T1048,SAM001247032,Prestw-441,17±-Estradiol,Estradiol,CPD000059126,"Estradiol-17 beta"}

> <pdid>
PD002343

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5757}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 20  0  0  0  0            999 V2000
   11.4915   -2.2566    0.0000 H   0  3
    8.9915   -2.2566    0.0000 Cl  0  5
   -2.6041   -2.9866    0.0000 C   0  0
   -1.3074   -3.7406    0.0000 N   0  0
   -1.3125   -5.2406    0.0000 C   0  0
   -0.0048   -2.9950    0.0000 C   0  0
    1.2926   -3.7495    0.0000 C   0  0
    2.5951   -3.0039    0.0000 N   0  0
    2.5973   -1.5030    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8934   -3.7569    0.0000 C   0  0
    5.1961   -3.0132    0.0000 C   0  0
    6.4915   -3.7695    0.0000 C   0  0
    6.4843   -5.2694    0.0000 C   0  0
    5.1817   -6.0132    0.0000 C   0  0
    3.8862   -5.2570    0.0000 N   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  8 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6023

> <plate>
NGP-105-05

> <well>
H10

> <supplier_cmpd_name>
CPD000058623

> <ctcr_id>
2401

> <supplier_cmpd_id>
SAM001247047

> <smiles>
[H+].[Cl-].CN(C)CCN(Cc1ccccc1)c2ccccn2

> <pd_targets>
{LMNA,KDM4E,MAPK1,HRH1}

> <pathway_gtopdb>
{"Other nuclear protein","Epigenetic regulator",Enzyme,"Membrane receptor",Eraser,Kinase,"Family A G protein-coupled receptor","Lysine demethylase","Protein Kinase","Small molecule receptor (family A 
GPCR)","Jumonji domain-containing","CMGC protein kinase group","Monoamine receptor","CMGC protein kinase MAPK family","Histamine receptor","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Receptors,"Chromatin modifying enzymes","Kinases (EC 2.7.x.x)","G protein-coupled receptors","1.14.11.- Histone demethylases","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Histamine recept
ors","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Cell Cycle","Immune System","Signal Transduction",Mitotic,"Innate Immune System","Signaling by GPCR","M Phase","Toll-like Receptor Cascades","GPCR ligand binding","Mitotic Metaphase and Anaphase","T
oll Like Receptor 5 (TLR5) Cascade","Class A/1 (Rhodopsin-like receptors)","Mitotic Anaphase","MyD88 cascade initiated on plasma membrane","Amine ligand-binding receptors","Nuclear Envelope (NE) Reass
embly","MAP kinase activation","Histamine receptors","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{HRH1}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{"Tripelennamine hydrochloride",154-69-8,154698,"Tripelennamine Hcl",Ahistamin,Piristin,Pyrinamine,Stanzamine,"Tripelennamine (hydrochloride)","Pyribenzamine hydrochloride","AntiAllergicum Medivet","D
ehistin monohydrochloride",Dehis,T1269,SAM001247047,Prestw-1199,CPD000058623}

> <pdid>
PD009718

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{9066,43833334,657216}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 17  0  0  0  0            999 V2000
    5.1873   -7.5109    0.0000 C   0  0
    5.1894   -6.0109    0.0000 C   0  0
    3.8912   -5.2578    0.0000 N   0  0
    2.5886   -6.0033    0.0000 C   0  0
    1.2919   -5.2492    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2948   -3.7516    0.0000 O   0  0
    2.5973   -1.5031    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 10  1  0
 16 17  1  0
M  END
> <name>
NIHCC_2014

> <id>
6024

> <plate>
NGP-105-05

> <well>
H11

> <supplier_cmpd_name>
CPD000058189

> <ctcr_id>
4905

> <supplier_cmpd_id>
SAM001247018

> <smiles>
CCN(CC)CC(=O)Nc1c(C)cccc1C

> <pd_targets>
{SCN2A,AMPC,SCN1A,SCN3A,MAPK1,SCN9A,SCN5A,MAPT,LMNA,CHRM1,SCN4A,SCN10A,ALDH1A1,CYP3A4,GAA,BLM,SCN11A,SCN7A,SCN8A,EGFR}

> <pathway_gtopdb>
{"Ion channel",Enzyme,"Other cytosolic protein","Other nuclear protein","Membrane receptor","Voltage-gated ion channel",Hydrolase,Kinase,"Family A G protein-coupled receptor",Oxidoreductase,"Cytochrom
e P450","Voltage-gated sodium channel","Protein Kinase","Small molecule receptor (family A GPCR)","Cytochrome P450 family 3","CMGC protein kinase group","Monoamine receptor","Cytochrome P450 family 3A
","TK protein kinase group","CMGC protein kinase MAPK family","Acetylcholine receptor","Cytochrome P450 3A4","Tyrosine protein kinase EGFR family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{"Ion channels",Enzymes,Receptors,"Voltage-gated ion channels","Kinases (EC 2.7.x.x)","G protein-coupled receptors","Cytochrome P450","3.2.1.- Glycosidases","Catalytic receptors","Voltage-gated sodium
 channels","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Acetylcholine receptors (muscarinic)","CYP3 family","Receptor kinases","Mitogen-activated protein kinases (MAP kinases)","TK: Tyrosine kinas
e","ERK subfamily","Receptor tyrosine kinases (RTKs)","Type I RTKs: ErbB (epidermal growth factor) receptor family"}

> <pathway_reactome>
{"Developmental Biology","Immune System","Neuronal System","Cell Cycle","Signal Transduction",Metabolism,Disease,"DNA Repair","Nervous system development","Innate Immune System","Transmission across C
hemical Synapses",Mitotic,"Signaling by GPCR","Biological oxidations","Metabolism of lipids","Diseases of metabolism","DNA Double-Strand Break Repair","Axon guidance","Toll-like Receptor Cascades","Ne
urotransmitter receptors and postsynaptic signal transmission","M Phase","GPCR ligand binding","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","D
iseases of carbohydrate metabolism","Homology Directed Repair","GPCR downstream signalling","L1CAM interactions","Toll Like Receptor 5 (TLR5) Cascade","Activation of NMDA receptors and postsynaptic ev
ents","Mitotic Metaphase and Anaphase","Class A/1 (Rhodopsin-like receptors)","Ethanol oxidation","Biosynthesis of DHA-derived SPMs","Glycogen storage diseases","HDR through Homologous Recombination (
HRR) or Single Strand Annealing (SSA)","G alpha (q) signalling events","Interaction between L1 and Ankyrins","MyD88 cascade initiated on plasma membrane","Post NMDA receptor activation events","Mitoti
c Anaphase","Amine ligand-binding receptors","Biosynthesis of maresins","Glycogen storage disease type II (GAA)","HDR through Homologous Recombination (HRR)","Gastrin-CREB signalling pathway via PKC a
nd MAPK","MAP kinase activation","Activation of AMPK downstream of NMDARs","Nuclear Envelope (NE) Reassembly","Muscarinic acetylcholine receptors","Biosynthesis of maresin-like SPMs","Homologous DNA P
airing and Strand Exchange","EGFR Transactivation by Gastrin","MAPK targets/ Nuclear events mediated by MAP kinases","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous 
DNA pairing and strand exchange","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{EGFR,SCN10A,SCN5A,SCN9A}

> <broad_moa>
{"histamine receptor agonist"}

> <synonyms>
{lidocaine,137-58-6,137586,Lignocaine,Xylocaine,"2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide","2(Diethylamino)N(2,6dimethylphenyl)acetamide",Lidoderm,Anestacon,Esracaine,Duncaine,Alphacaine,Cappi
caine,Gravocain,Isicaina,L-Caine,LCaine,Leostesin,Maricaine,Xylocain,Xylocitin,Solcain,Isicaine,Xylestes,T0468,S1357,SAM001247018,Lidocaine,CPD000058189}

> <pdid>
PD003120

> <targets>
{"Histamine Receptor",Apoptosis,ERK,MEK,NF-ºB,"Sodium Channel"}

> <classes>
{Neuronal Signaling,Apoptosis,MAPK/ERK Pathway,Membrane Transporter/Ion Channel,NF-ºB,Stem Cell/Wnt}

> <pubchem_cids>
{3676}

$$$$
NIHCC_2014
  SciTegic11012413002D

 33 37  0  0  1  0            999 V2000
   11.3000    1.3845    0.0000 O   0  0
    8.8000    1.3845    0.0000 Cl  0  0
   -0.5697    6.1163    0.0000 C   0  0
    0.7395    5.3842    0.0000 C   0  0
    2.0279    6.1523    0.0000 C   0  0
    0.7595    3.8835    0.0000 C   0  0
   -0.5200    3.1200    0.0000 N   0  0
   -2.0900    3.1200    0.0000 C   0  0
   -2.0900    0.3800    0.0000 C   0  0
   -1.1700   -0.7500    0.0000 C   0  0  2  0  0  0
   -0.3700   -1.9700    0.0000 C   0  0  1  0  0  0
   -1.8000   -3.0200    0.0000 O   0  0
   -3.3400   -2.0200    0.0000 C   0  0
   -4.8400   -2.0600    0.0000 C   0  0
   -5.5469   -3.3830    0.0000 O   0  0
   -5.6600   -0.7600    0.0000 C   0  0
   -4.9100    0.5000    0.0000 C   0  0
   -3.4100    0.5000    0.0000 C   0  0
   -2.6900    1.8200    0.0000 C   0  0
   -1.2200    1.8400    0.0000 C   0  0
   -0.4300    0.5600    0.0000 C   0  0  1  0  0  0
    0.3008    1.8699    0.0000 O   0  0
    1.0500    0.5600    0.0000 C   0  0
    1.8500   -0.7000    0.0000 C   0  0
    1.1200   -1.9700    0.0000 C   0  0
    2.1500   -3.1800    0.0000 N   0  0
    3.6000   -2.4800    0.0000 C   0  0
    5.0500   -3.0400    0.0000 C   0  0
    6.3000   -2.0400    0.0000 C   0  0
    6.0600   -0.5200    0.0000 C   0  0
    4.5900    0.0400    0.0000 C   0  0
    3.3800   -0.9400    0.0000 C   0  0
   -2.5800   -0.7500    0.0000 C   0  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
 10  9  1  1
 10 11  1  0
 11 12  1  6
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20  7  1  0
 20 21  1  0
 21 10  1  0
 21 22  1  1
 21 23  1  0
 23 24  1  0
 24 25  2  0
 25 11  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 24  1  0
 32 27  1  0
 18 33  2  0
 33 10  1  0
 33 13  1  0
M  END
> <name>
NIHCC_2014

> <id>
6025

> <plate>
NGP-105-06

> <well>
A02

> <supplier_cmpd_name>
CPD000466297

> <ctcr_id>
3472

> <supplier_cmpd_id>
SAM001247099

> <smiles>
O.Cl.CC(=C)CN1CC[C@]23[C@H]4Oc5c(O)ccc(CC1[C@]2(O)Cc6c4[nH]c7ccccc67)c35

> <pd_targets>
{MAPT,POLB,MAPK1}

> <pathway_gtopdb>
{"Other cytosolic protein",Enzyme,Kinase,"Protein Kinase","CMGC protein kinase group","CMGC protein kinase MAPK family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,"Kinases (EC 2.7.x.x)","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Neuronal System","DNA Repair","Immune System","Transmission across Chemical Synapses","Base Excision Repair","Innate Immune System","Neurotransmitter receptors and postsynaptic signal transmission",
"Resolution of Abasic Sites (AP sites)","Toll-like Receptor Cascades","Activation of NMDA receptors and postsynaptic events","Resolution of AP sites via the multiple-nucleotide patch replacement pathw
ay","Toll Like Receptor 5 (TLR5) Cascade","Post NMDA receptor activation events","PCNA-Dependent Long Patch Base Excision Repair","MyD88 cascade initiated on plasma membrane","Activation of AMPK downs
tream of NMDARs","MAP kinase activation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{OPRD1}

> <broad_moa>
{"opioid receptor antagonist"}

> <synonyms>
{SDM25N,SMR000466297,MLS000758917,MLS001424286,CHEMBL1324873,CCG-101191,CCG101191,NC00441,SAM001247099,CPD000466297}

> <pdid>
PD062171

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581824}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 25  0  0  0  0            999 V2000
    2.5983   -3.0004    0.0000 C   0  0
    2.5988   -1.5004    0.0000 S   0  0
    3.8983   -0.7512    0.0000 O   0  0
    3.8975   -2.2510    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5987    1.5004    0.0000 C   0  0
   -3.9492    0.8772    0.0000 C   0  0
   -4.9546    1.9903    0.0000 C   0  0
   -6.4462    1.8312    0.0000 Br  0  0
   -4.2067    3.2905    0.0000 S   0  0
   -2.7390    2.9810    0.0000 C   0  0
   -1.6193    3.9803    0.0000 C   0  0
   -0.1673    3.6256    0.0000 C   0  0
    0.8689    4.7101    0.0000 C   0  0
    0.4478    6.1498    0.0000 C   0  0
    1.4840    7.2343    0.0000 F   0  0
   -1.0096    6.5049    0.0000 C   0  0
   -2.0458    5.4204    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  8 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 11  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 20 22  1  0
 22 23  2  0
 23 17  1  0
M  END
> <name>
NIHCC_2014

> <id>
6026

> <plate>
NGP-105-06

> <well>
A03

> <supplier_cmpd_name>
CPD000466299

> <ctcr_id>
3292

> <supplier_cmpd_id>
SAM001247101

> <smiles>
C[S](=O)(=O)c1ccc(cc1)c2cc(Br)sc2c3ccc(F)cc3

> <pd_targets>
{PTGS2,PTGS1,HSD17B10,LEF,CYP2C19,HPGD,CYP3A4,TSHR,CYP1A2,KDM4E,CYP2C9}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Epigenetic regulator",Oxidoreductase,Protease,"Cytochrome P450","Family A G protein-coupled receptor",Eraser,"Metallo protease","Cytochrome P450 family 2","Cytochrome P450
 family 3","Peptide receptor (family A GPCR)","Cytochrome P450 family 1","Lysine demethylase","Metallo protease MAE clan","Cytochrome P450 family 2C","Cytochrome P450 family 3A","Glycohormone receptor
","Cytochrome P450 family 1A","Jumonji domain-containing","Metallo protease M34 family","Cytochrome P450 2C19","Cytochrome P450 3A4","Cytochrome P450 1A1","Cytochrome P450 2C9"}

> <pathway_chembl>
{Enzymes,Receptors,"Eicosanoid turnover","Cytochrome P450","G protein-coupled receptors","Chromatin modifying enzymes",Cyclooxygenase,"CYP2 family: drug metabolising subset","Prostaglandin synthases",
"CYP3 family","Glycoprotein hormone receptors","CYP1 family","1.14.11.- Histone demethylases"}

> <pathway_reactome>
{Metabolism,Disease,"Metabolism of lipids","Metabolism of amino acids and derivatives","Infectious disease","Biological oxidations","Biosynthesis of specialized proresolving mediators (SPMs)","Fatty a
cid metabolism","Branched-chain amino acid catabolism","Uptake and actions of bacterial toxins","Phase I - Functionalization of compounds","Leishmania infection","Biosynthesis of DPA-derived SPMs","Ar
achidonic acid metabolism","Uptake and function of anthrax toxins","Cytochrome P450 - arranged by substrate type","Biosynthesis of DHA-derived SPMs","Leishmania parasite growth and survival","Biosynth
esis of DPAn-3 SPMs","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)",Xenobiotics,"Biosynthesis of D-series resolvins","Biosynthesis of maresins","Anti-inflammatory response favouring Leishman
ia parasite infection","CYP2E1 reactions","Biosynthesis of maresin-like SPMs","ADORA2B mediated anti-inflammatory cytokines production","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A
2"}

> <broad_targets>
{PTGS2}

> <broad_moa>
{"cyclooxygenase inhibitor"}

> <synonyms>
{"5-BROMO-2-(4-FLUOROPHENYL)-3-(4-(METHYLSULFONYL)PHENYL)- (CAS","5BROMO2(4FLUOROPHENYL)3(4(METHYLSULFONYL)PHENYL) (CAS",dup-697,dup697,"Dup 697",88149-94-4,88149944,MRWLZPOFPA,UNII-MRWLZPOFPA,UNIIMRW
LZPOFPA,5-bromo-2-(4-fluorophenyl)-3-(4-methylsulfonylphenyl)thiophene,5bromo2(4fluorophenyl)3(4methylsulfonylphenyl)thiophene,CHEMBL42485,CHEBI:4720,5-Bromo-2-(4-fluorophenyl)-3-(4-(methy,5Bromo2(4fl
uorophenyl)3(4(methy,SAM001247101,CPD000466299}

> <pdid>
PD002843

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{3177}

$$$$
NIHCC_2014
  SciTegic11012413002D

 60 67  0  0  1  0            999 V2000
    2.3980    5.1974    0.0000 C   0  0
    1.0617    4.5159    0.0000 C   0  0
   -0.2000    5.2900    0.0000 C   0  0  2  0  0  0
   -0.2341    6.7896    0.0000 O   0  0
   -0.2000    4.0900    0.0000 C   0  0
   -1.2300    3.5100    0.0000 C   0  0  1  0  0  0
   -2.2500    4.0900    0.0000 C   0  0
   -2.2500    5.2900    0.0000 N   0  0
   -3.9200    5.5000    0.0000 C   0  0
   -5.4100    4.7800    0.0000 C   0  0
   -5.7000    3.1300    0.0000 C   0  0
   -4.9700    1.7900    0.0000 C   0  0
   -6.0100    0.6800    0.0000 N   0  0
   -7.4000    1.3200    0.0000 C   0  0
   -8.8100    0.7400    0.0000 C   0  0
  -10.0200    1.6700    0.0000 C   0  0
   -9.8300    3.1800    0.0000 C   0  0
   -8.4200    3.7700    0.0000 C   0  0
   -7.2000    2.8400    0.0000 C   0  0
   -3.3800    1.2800    0.0000 C   0  0  1  0  0  0
   -1.8700    1.9700    0.0000 C   0  0
   -4.3011    0.1350    0.0000 C   0  0
   -5.7734    0.4218    0.0000 O   0  0
   -3.8135   -1.2844    0.0000 O   0  0
   -4.7977   -2.4164    0.0000 C   0  0
   -2.3301    0.2513    0.0000 C   0  0
   -2.7110   -1.1720    0.0000 C   0  0
   -1.6165   -2.2180    0.0000 C   0  0
   -0.2693   -1.8150    0.0000 C   0  0
    0.1414   -0.3694    0.0000 C   0  0
   -0.9061    0.6597    0.0000 C   0  0
   -0.5303    2.1129    0.0000 O   0  0
    0.4332    2.3808    0.0000 C   0  0
    0.6269   -3.0200    0.0000 N   0  0
    2.1267   -3.0420    0.0000 C   0  0
   -0.2779   -4.1651    0.0000 C   0  0  1  0  0  0
   -0.0140   -5.6041    0.0000 C   0  0  2  0  0  0
    1.0936   -4.5926    0.0000 O   0  0
   -1.1529   -6.6124    0.0000 C   0  0  2  0  0  0
   -0.9635   -7.5943    0.0000 O   0  0
   -2.5335   -6.1188    0.0000 C   0  0  2  0  0  0
   -2.2630   -7.5946    0.0000 C   0  0
   -3.0242   -8.2431    0.0000 C   0  0
   -3.6287   -7.0542    0.0000 C   0  0
   -5.0406   -6.5494    0.0000 C   0  0
   -5.3459   -4.5824    0.0000 C   0  0
   -4.0445   -3.8623    0.0000 N   0  0
   -3.7291   -2.4358    0.0000 C   0  0
   -2.2452   -2.2939    0.0000 C   0  0
   -1.6741   -3.6659    0.0000 C   0  0  2  0  0  0
   -2.8019   -4.6427    0.0000 C   0  0  2  0  0  0
    0.7146   -6.8921    0.0000 C   0  0
    2.2144   -6.8669    0.0000 N   0  0
    0.2295   -7.7666    0.0000 O   0  0
   -1.2300    5.8900    0.0000 C   0  0
    8.1667    1.5465    0.0000 O   0  0
    8.1667    0.0465    0.0000 S   0  0
    8.1667   -1.4535    0.0000 O   0  0
    6.8674   -0.7031    0.0000 O   0  0
    9.4660   -0.7031    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  1
  3  5  1  0
  6  5  1  6
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 11  1  0
 19 14  1  0
 12 20  1  0
 20 21  1  0
 21  6  1  0
 20 22  1  1
 22 23  2  0
 22 24  1  0
 24 25  1  0
 20 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
 31 32  1  0
 32 33  1  0
 29 34  1  0
 34 35  1  0
 36 34  1  1
 36 37  1  0
 37 38  1  6
 37 39  1  0
 39 40  1  6
 39 41  1  0
 41 42  1  1
 42 43  1  0
 41 44  1  0
 44 45  2  3
 45 46  1  0
 46 47  1  0
 47 48  1  0
 48 49  1  0
 50 49  1  6
 50 28  1  0
 50 36  1  0
 50 51  1  0
 51 41  1  0
 51 47  1  6
 37 52  1  0
 52 53  1  0
 52 54  2  0
  8 55  1  0
 55  3  1  0
 56 57  1  0
 57 58  1  0
 57 59  2  0
 57 60  2  0
M  END
> <name>
NIHCC_2014

> <id>
6027

> <plate>
NGP-105-06

> <well>
A04

> <supplier_cmpd_name>
CPD000469153

> <ctcr_id>
4735

> <supplier_cmpd_id>
SAM001246568

> <smiles>
CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@H]7[C@](O)([C@H](O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(N)=O)C1.O[S](O)(=O)=O

> <pd_targets>
{TUBB1}

> <pathway_gtopdb>
{"Structural protein"}

> <pathway_chembl>
{}

> <pathway_reactome>
{"Cell Cycle",Mitotic,"M Phase","Mitotic Metaphase and Anaphase","Mitotic Anaphase","Nuclear Envelope (NE) Reassembly","Sealing of the nuclear envelope (NE) by ESCRT-III"}

> <broad_targets>
{TUBB,TUBB1}

> <broad_moa>
{"tubulin polymerization inhibitor"}

> <synonyms>
{33860-EP2295416A2,33860EP2295416A2,"vindesine sulfate","Vindesine sulfate salt",59917-39-4,59917394,"Fildesin (TN)",Eldesine,Eldisine,"Desacetylvinblastine amide sulfate",CHEBI:32295,"3-carbamoyl-O(4
)-deacetyl-3-de(methoxycarbonyl)vincaleukoblastine sulfate","3carbamoylO(4)deacetyl3de(methoxycarbonyl)vincaleukoblastine sulfate",SCHEMBL42,SAM001246568,CPD000469153}

> <pdid>
PD010109

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{43116}

$$$$
NIHCC_2014
  SciTegic11012413002D

 33 37  0  0  0  0            999 V2000
    5.1996   -1.4928    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    3.8964    0.7545    0.0000 C   0  0
    2.6003   -1.4977    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 N   0  0
    1.2997    3.7504    0.0000 C   0  0
    2.6000    3.0025    0.0000 C   0  0
    3.8978    3.7546    0.0000 C   0  0
    3.8954    5.2546    0.0000 C   0  0
    5.1933    6.0067    0.0000 Cl  0  0
    2.5952    6.0025    0.0000 C   0  0
    1.2974    5.2504    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -2.5981    6.0000    0.0000 C   0  0
   -3.8972    5.2500    0.0000 C   0  0
   -3.8971    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 N   0  0
   -1.3039   -3.7494    0.0000 C   0  0
   -1.3092   -5.2494    0.0000 C   0  0
   -2.6108   -5.9949    0.0000 C   0  0
   -3.9072   -5.2404    0.0000 C   0  0
   -5.2089   -5.9859    0.0000 Cl  0  0
   -3.9020   -3.7404    0.0000 C   0  0
   -2.6004   -2.9949    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  3
  5  6  1  0
  6  7  2  3
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
 15  9  1  0
  8 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 21 22  1  0
 22 23  2  3
 23  7  1  0
 23 24  1  0
 24 25  2  3
 25  5  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 30 32  1  0
 32 33  2  0
 33 27  1  0
M  END
> <name>
NIHCC_2014

> <id>
6028

> <plate>
NGP-105-06

> <well>
A05

> <supplier_cmpd_name>
CPD000058704

> <ctcr_id>
4460

> <supplier_cmpd_id>
SAM001246878

> <smiles>
CC(C)N=C1C=C2N(c3ccc(Cl)cc3)c4ccccc4N=C2C=C1Nc5ccc(Cl)cc5

> <pd_targets>
{HIF1A,CYP2D6,ABCB11,FFP,SKA,MAPK1,KMT2A,MEN1,LMNA,ABCB1,ABCC2,ABCC3,ABCC4,PPARG,KCNA3}

> <pathway_gtopdb>
{Enzyme,"Transcription factor",Transporter,"Epigenetic regulator","Other nuclear protein","Ion channel",Protease,"Cytochrome P450","Primary active transporter",Transferase,Kinase,Reader,"Nuclear recep
tor","Voltage-gated ion channel","Cysteine protease","Cytochrome P450 family 2","ATP-binding cassette","Protein Kinase",Bromodomain,"Nuclear hormone receptor subfamily 1","Potassium channels","Cystein
e protease CA clan","Cytochrome P450 family 2D","ABCB subfamily","CMGC protein kinase group","ABCC subfamily","Nuclear hormone receptor subfamily 1 group C","Voltage-gated potassium channel","Cysteine
 protease C1A family","Cytochrome P450 2D6","CMGC protein kinase MAPK family","Nuclear hormone receptor subfamily 1 group C member 3","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Transporters,Receptors,"Ion channels","Cytochrome P450","ATP-binding cassette transporter family","Kinases (EC 2.7.x.x)","Nuclear hormone receptors","Voltage-gated ion channels","CYP2 family:
 drug metabolising subset","ABCB subfamily","CMGC: Containing CDK",MAPK,GSK3,"CLK families","ABCC subfamily","1C. Peroxisome proliferator-activated receptors","Potassium channels","Mitogen-activated p
rotein kinases (MAP kinases)","Voltage-gated potassium channels","ERK subfamily"}

> <pathway_reactome>
{"Cellular responses to external stimuli",Metabolism,"Immune System","Cell Cycle",Disease,Hemostasis,"Gene expression (Transcription)","Neuronal System","Cellular responses to stress","Biological oxid
ations","Metabolism of lipids","Innate Immune System",Mitotic,"Abacavir transport and metabolism","Disorders of transmembrane transporters","Platelet activation","signaling and aggregation","RNA Polym
erase II Transcription","Potassium Channels","Cellular response to hypoxia","Phase I - Functionalization of compounds","Metabolism of steroids","Toll-like Receptor Cascades","M Phase","Abacavir transm
embrane transport","ABC transporter disorders","Response to elevated platelet cytosolic Ca2+","Generic Transcription Pathway","Voltage gated Potassium channels","Oxygen-dependent proline hydroxylation
 of Hypoxia-inducible Factor Alpha","Cytochrome P450 - arranged by substrate type","Bile acid and bile salt metabolism","Toll Like Receptor 5 (TLR5) Cascade","Mitotic Metaphase and Anaphase","Defectiv
e ABCC2 causes DJS","Platelet degranulation","Transcriptional Regulation by MECP2",Xenobiotics,"Synthesis of bile acids and bile salts","MyD88 cascade initiated on plasma membrane","Mitotic Anaphase",
"Recycling of bile acids and salts","MECP2 regulates transcription factors","CYP2E1 reactions","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","MAP kinase activation","Nuclear E
nvelope (NE) Reassembly","MAPK targets/ Nuclear events mediated by MAP kinases","Initiation of Nuclear Envelope (NE) Reformation","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{}

> <broad_moa>
{"GK0582 inhibitor"}

> <synonyms>
{clofazimine,2030-63-9,2030639,Lamprene,Lampren,Chlofazimine,Clofazimina,Clofaziminum,"B 663 (Pharmaceutical)","Clofaziminum (INN-Latin)","Clofaziminum (INNLatin)","Clofazimina (INN-Spanish)","Clofazi
mina (INNSpanish)",NSC-141046,NSC141046,"G 30320",B-663,B663,N,5-bis(4-chlorophenyl)-3-propan-2-yliminophenazin-2-amine,5bis(4chlorophenyl)3propan2yliminophenazin2amine,T0377,SAM001246878,Clofazimine,
CPD000058704}

> <pdid>
PD000250

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{2794}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 21  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 Cl  0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 N   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -5.2029    2.9932    0.0000 N   0  0
   -6.4990    0.7409    0.0000 S   0  0
   -7.8003    1.4887    0.0000 C   0  0
   -9.0990    0.7364    0.0000 C   0  0
  -10.4003    1.4841    0.0000 C   0  0
  -11.6990    0.7318    0.0000 C   0  0
  -13.0525    1.3482    0.0000 N   0  0
  -14.0523    0.2300    0.0000 C   0  0
  -13.2978   -1.0665    0.0000 N   0  0
  -11.8317   -0.7495    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 14  2  0
  5 19  1  0
 19 20  2  0
 20  2  1  0
M  END
> <name>
NIHCC_2014

> <id>
6029

> <plate>
NGP-105-06

> <well>
A06

> <supplier_cmpd_name>
CPD000469632

> <ctcr_id>
5369

> <supplier_cmpd_id>
SAM001247107

> <smiles>
Clc1ccc(CNC(=N)SCCCc2[nH]cnc2)cc1

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{HRH1,HRH2,HRH3,HRH4}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{clobenpropit,145231-45-4,145231454,"Vuf 9153",Vuf-9153,Vuf9153,UNII-RKU631JF4H,UNIIRKU631JF4H,S-(3-(4(5)-Imidazolyl))propyl-N-(4-chlorobenzyl)isothiourea,S(3(4(5)Imidazolyl))propylN(4chlorobenzyl)iso
thiourea,CHEBI:64177,RKU631JF4H,"3-(1H-imidazol-4-yl)propyl N-(4-chlorobenzyl)carbamimidothioate","3(1Himidazol4yl)propyl N(4chlorobenzyl)carbamimidothioate",VUF9153,Tocris-0752,Tocris0752,3-(1h-imida
,3(1himida,SAM001247107,CPD000469632}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{2790}

$$$$
NIHCC_2014
  SciTegic11012413002D

 42 45  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2007    1.4909    0.0000 C   0  0
   -6.4972    0.7364    0.0000 C   0  0
   -6.4920   -0.7636    0.0000 C   0  0
   -5.1903   -1.5091    0.0000 C   0  0
   -3.8939   -0.7546    0.0000 C   0  0
   -7.7876   -1.5212    0.0000 C   0  0
   -9.0905   -0.7779    0.0000 O   0  0
   -7.7802   -3.0220    0.0000 N   0  0
   -9.0758   -3.7796    0.0000 C   0  0
   -9.0707   -5.2796    0.0000 C   0  0
  -10.3671   -6.0341    0.0000 C   0  0
  -11.6687   -5.2886    0.0000 C   0  0
  -12.9652   -6.0432    0.0000 C   0  0
  -11.6740   -3.7886    0.0000 C   0  0
  -12.9748   -3.0401    0.0000 N   0  0
  -12.9779   -1.5393    0.0000 C   0  0
  -14.2769   -0.7892    0.0000 N   0  0
  -14.2770    0.7108    0.0000 C   0  0
  -12.9780    1.4608    0.0000 C   0  0
  -11.6789    0.7109    0.0000 C   0  0
  -11.6789   -0.7891    0.0000 N   0  0
  -10.3792    1.4613    0.0000 C   0  0
  -10.3768    2.9613    0.0000 C   0  0
   -9.0766    3.7093    0.0000 C   0  0
   -7.7787    2.9573    0.0000 C   0  0
   -7.7811    1.4573    0.0000 N   0  0
   -9.0813    0.7093    0.0000 C   0  0
  -10.3776   -3.0341    0.0000 C   0  0
    6.3987    0.3329    0.0000 C   0  0
    6.3987   -1.1671    0.0000 S   0  0
    6.3987   -2.6671    0.0000 O   0  0
    5.0994   -1.9167    0.0000 O   0  0
    7.6980   -1.9167    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  2  1  0
  5  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 12 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
 29 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 36 31  1  0
 23 37  2  0
 37 18  1  0
 38 39  1  0
 39 40  1  0
 39 41  2  0
 39 42  2  0
M  END
> <name>
NIHCC_2014

> <id>
6030

> <plate>
NGP-105-06

> <well>
A07

> <supplier_cmpd_name>
CPD000469175

> <ctcr_id>
4225

> <supplier_cmpd_id>
SAM001246622

> <smiles>
CN1CCN(CC1)Cc2ccc(cc2)C(=O)Nc3ccc(C)c(Nc4nccc(n4)c5cccnc5)c3.C[S](O)(=O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{ABL1,CSF1R,DDR1,KIT,NTRK1,PDGFRA,PDGFRB,RET}

> <broad_moa>
{"Bcr-Abl kinase inhibitor","KIT inhibitor","PDGFR tyrosine kinase receptor inhibitor"}

> <synonyms>
{"Imatinib mesylate",220127-57-1,220127571,Gleevec,Glivec,"Imatinib mesilate","imatinib methanesulfonate","Imatinib Mesylate (STI571)",sti-571,sti571,"Imatinib (mesylate)",CGP-57148B,CGP57148B,"imatin
ib monomesylate","CGP 57148B","220127-57-1 (mesylate)","220127571 (mesylate)","STI 571",T1621,S1026,SAM001246622,"Imatinib Mesylate",CPD000469175}

> <pdid>
PD001319

> <targets>
{c-Kit,Autophagy,Bcr-Abl,PDGFR}

> <classes>
{Autophagy,Protein Tyrosine Kinase/RTK}

> <pubchem_cids>
{123596,90091706}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 23  0  0  0  0            999 V2000
   10.2815   -5.2598    0.0000 Cl  0  0
    7.7794  -12.0187    0.0000 C   0  0
    7.7815  -10.5187    0.0000 C   0  0
    6.4833   -9.7656    0.0000 C   0  0
    6.4855   -8.2648    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    5.1894   -6.0109    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 N   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 C   0  0
   -3.1904   -2.6376    0.0000 C   0  0
   -4.6588   -2.9478    0.0000 C   0  0
   -5.1250   -4.3735    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 18 22  1  0
 22 15  1  0
 22 23  2  0
 23 12  1  0
M  END
> <name>
NIHCC_2014

> <id>
6031

> <plate>
NGP-105-06

> <well>
B02

> <supplier_cmpd_name>
CPD000466300

> <ctcr_id>
1472

> <supplier_cmpd_id>
SAM001247103

> <smiles>
Cl.CCCCCCCCCOc1ccc2[nH]cc(CCN)c2c1

> <pd_targets>
{NPSR1,MAPT,MAPK1,KMT2A,MEN1,FFP,FTL,RORC,HTR1B,CYP2C19,LEF,CYP3A4,KDM4E,TP53,CYP2C9,HTR2A,CYP2D6,CYP1A2,HTR1D,HTR2C,HTR1A}

> <pathway_gtopdb>
{"Membrane receptor","Other cytosolic protein",Enzyme,"Epigenetic regulator","Unclassified protein","Transcription factor","Family A G protein-coupled receptor",Kinase,Reader,Transferase,"Nuclear rece
ptor","Cytochrome P450",Protease,Eraser,"Peptide receptor (family A GPCR)","Protein Kinase",Bromodomain,"Nuclear hormone receptor subfamily 1","Small molecule receptor (family A GPCR)","Cytochrome P45
0 family 2","Metallo protease","Cytochrome P450 family 3","Lysine demethylase","Cytochrome P450 family 1","Short peptide receptor (family A GPCR)","CMGC protein kinase group","Nuclear hormone receptor
 subfamily 1 group F","Monoamine receptor","Cytochrome P450 family 2C","Metallo protease MAE clan","Cytochrome P450 family 3A","Jumonji domain-containing","Cytochrome P450 family 2D","Cytochrome P450 
family 1A","Neuropeptide receptor","CMGC protein kinase MAPK family","Nuclear hormone receptor subfamily 1 group F member 3","Serotonin receptor","Cytochrome P450 2C19","Metallo protease M34 family","
Cytochrome P450 3A4","Cytochrome P450 2C9","Cytochrome P450 2D6","Cytochrome P450 1A1","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Kinases (EC 2.7.x.x)","Nuclear hormone receptors","Cytochrome P450","Chromatin modifying enzymes","Neuropeptide S receptor","CMGC: Containing CDK",MAP
K,GSK3,"CLK families","1F. Retinoic acid-related orphans","5-Hydroxytryptamine receptors","CYP2 family: drug metabolising subset","CYP3 family","1.14.11.- Histone demethylases","CYP1 family","Mitogen-
activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{Disease,"Neuronal System","Immune System","Vesicle-mediated transport","Gene expression (Transcription)","Signal Transduction",Metabolism,"Cell Cycle","Infectious disease","Transmission across Chemic
al Synapses","Innate Immune System","Membrane Trafficking","RNA Polymerase II Transcription","Signaling by GPCR","Biological oxidations","Metabolism of lipids","Cell Cycle Checkpoints","Leishmania inf
ection","Neurotransmitter receptors and postsynaptic signal transmission","Toll-like Receptor Cascades","trans-Golgi Network Vesicle Budding","Generic Transcription Pathway","GPCR ligand binding","Pha
se I - Functionalization of compounds","Uptake and actions of bacterial toxins","Biosynthesis of specialized proresolving mediators (SPMs)","G1/S DNA Damage Checkpoints","Leishmania parasite growth an
d survival","Activation of NMDA receptors and postsynaptic events","Toll Like Receptor 5 (TLR5) Cascade","Golgi Associated Vesicle Biogenesis","Transcriptional regulation by RUNX3","Class A/1 (Rhodops
in-like receptors)","Cytochrome P450 - arranged by substrate type","Uptake and function of anthrax toxins","Biosynthesis of DHA-derived SPMs","p53-Dependent G1/S DNA damage checkpoint","Anti-inflammat
ory response favouring Leishmania parasite infection","Post NMDA receptor activation events","MyD88 cascade initiated on plasma membrane","RUNX3 Regulates Immune Response and Cell Migration","Amine li
gand-binding receptors",Xenobiotics,"Biosynthesis of maresins","p53-Dependent G1 DNA Damage Response","ADORA2B mediated anti-inflammatory cytokines production","Activation of AMPK downstream of NMDARs
","MAP kinase activation","Serotonin receptors","CYP2E1 reactions","Biosynthesis of maresin-like SPMs","Stabilization of p53","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","MAPK t
argets/ Nuclear events mediated by MAP kinases","Autodegradation of the E3 ubiquitin ligase COP1","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{CPD000466300,SMR000466300,MLS000758953,MLS001424310,CHEMBL1359181,SCHEMBL21523192,CCG-101193,CCG101193,NC00443,SAM001247103}

> <pdid>
PD047537

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581825}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 31  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 O   0  0
    2.6003   -1.4977    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
   -0.0031    3.0008    0.0000 C   0  0
    1.2946    3.7531    0.0000 O   0  0
   -1.3039    3.7494    0.0000 C   0  0
   -1.3070    5.2502    0.0000 N   0  0
   -2.6078    5.9988    0.0000 C   0  0
   -2.6109    7.4996    0.0000 C   0  0
   -3.9118    8.2481    0.0000 C   0  0
   -3.9149    9.7490    0.0000 C   0  0
   -5.2157   10.4975    0.0000 C   0  0
   -5.2188   11.9983    0.0000 C   0  0
   -6.5196   12.7469    0.0000 O   0  0
   -6.5227   14.2477    0.0000 C   0  0
   -7.8235   14.9963    0.0000 C   0  0
   -7.8266   16.4971    0.0000 C   0  0
   -9.1274   17.2456    0.0000 C   0  0
   -9.1305   18.7465    0.0000 C   0  0
  -10.4296   19.4965    0.0000 C   0  0
  -10.4296   20.9965    0.0000 C   0  0
   -9.1306   21.7466    0.0000 C   0  0
   -7.8316   20.9966    0.0000 C   0  0
   -7.8315   19.4966    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  8  9  1  0
  5 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
M  END
> <name>
NIHCC_2014

> <id>
6032

> <plate>
NGP-105-06

> <well>
B03

> <supplier_cmpd_name>
CPD000466295

> <ctcr_id>
6566

> <supplier_cmpd_id>
SAM001247096

> <smiles>
OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc2ccccc2

> <pd_targets>
{ADRB1,ADRB2,RORC,FFP,KDM4E,FTL,TP53,CYP3A4,THPO,LMNA,HSD17B10,HPGD,PMP22,MAPK1,BLM,ALDH1A1,CHRM1,NFKB1,KMT2A,MEN1,GMNN,ADRB3,DRD3,DRD2,MTOR,LMP1,TSHR,ALOX15,CYP2D6,LEF,CYP2C9,CYP1A2}

> <pathway_gtopdb>
{"Membrane receptor","Transcription factor",Enzyme,"Epigenetic regulator","Unclassified protein","Other nuclear protein","Other cytosolic protein","Family A G protein-coupled receptor","Nuclear recept
or",Transferase,Eraser,"Cytochrome P450",Oxidoreductase,Kinase,Reader,Protease,"Small molecule receptor (family A GPCR)","Nuclear hormone receptor subfamily 1","Lysine demethylase","Cytochrome P450 fa
mily 3","Protein Kinase",Bromodomain,"Peptide receptor (family A GPCR)","Cytochrome P450 family 2","Metallo protease","Cysteine protease","Cytochrome P450 family 1","Monoamine receptor","Nuclear hormo
ne receptor subfamily 1 group F","Jumonji domain-containing","Cytochrome P450 family 3A","CMGC protein kinase group","Atypical protein kinase group","Glycohormone receptor","Cytochrome P450 family 2D"
,"Metallo protease MAE clan","Cysteine protease CA clan","Cytochrome P450 family 2C","Cytochrome P450 family 1A","Adrenergic receptor","Nuclear hormone receptor subfamily 1 group F member 3","Cytochro
me P450 3A4","CMGC protein kinase MAPK family","Acetylcholine receptor","Dopamine receptor","Atypical protein kinase PIKK family","Cytochrome P450 2D6","Metallo protease M34 family","Cysteine protease
 C1A family","Cytochrome P450 2C9","Cytochrome P450 1A1","CMGC protein kinase ERK1","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Nuclear hormone receptors","Chromatin modifying enzymes","Cytochrome P450","Eicosanoid turnover","Kinases (EC 2.7.x.x)",Adrenoceptors,"1F. Retinoic ac
id-related orphans","1.14.11.- Histone demethylases","CYP3 family","Prostaglandin synthases","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Acetylcholine receptors (muscarinic)","Dopamine receptors"
,Atypical,"Glycoprotein hormone receptors",Lipoxygenases,"CYP2 family: drug metabolising subset","CYP1 family","Mitogen-activated protein kinases (MAP kinases)","Phosphatidyl inositol 3' kinase-relate
d kinases (PIKK) family","ERK subfamily","FRAP subfamily"}

> <pathway_reactome>
{Disease,"Gene expression (Transcription)","Vesicle-mediated transport","Cell Cycle",Metabolism,Hemostasis,"Developmental Biology","Immune System","DNA Repair","Signal Transduction","Infectious diseas
e","RNA Polymerase II Transcription","Membrane Trafficking","Cell Cycle Checkpoints","Metabolism of lipids","Platelet activation","signaling and aggregation",Mitotic,"Metabolism of amino acids and der
ivatives","Nervous system development","Innate Immune System","DNA Double-Strand Break Repair","Biological oxidations","Signaling by GPCR","Cytokine Signaling in Immune system","Leishmania infection",
"Generic Transcription Pathway","trans-Golgi Network Vesicle Budding","G1/S DNA Damage Checkpoints","Biosynthesis of specialized proresolving mediators (SPMs)","Platelet Aggregation (Plug Formation)",
"M Phase","Branched-chain amino acid catabolism","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Toll-like Receptor Cascades","Homology Directed Repair","Phase I - Functionalization 
of compounds","GPCR ligand binding","Signaling by Interleukins","Mitotic G1 phase and G1/S transition","Uptake and actions of bacterial toxins","Leishmania parasite growth and survival","Transcription
al regulation by RUNX3","Golgi Associated Vesicle Biogenesis","p53-Dependent G1/S DNA damage checkpoint","Biosynthesis of DHA-derived SPMs","Mitotic Metaphase and Anaphase","Toll Like Receptor 5 (TLR5
) Cascade","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Ethanol oxidation","Class A/1 (Rhodopsin-like receptors)","Interleukin-1 family signaling","G1/S Transition","
Transcriptional Regulation by TP53","Biosynthesis of DPA-derived SPMs","Cytochrome P450 - arranged by substrate type","Uptake and function of anthrax toxins","Anti-inflammatory response favouring Leis
hmania parasite infection","RUNX3 Regulates Immune Response and Cell Migration","p53-Dependent G1 DNA Damage Response","Biosynthesis of maresins","Mitotic Anaphase","Biosynthesis of D-series resolvins
","MyD88 cascade initiated on plasma membrane","HDR through Homologous Recombination (HRR)","Amine ligand-binding receptors","Interleukin-1 signaling","Activation of the pre-replicative complex","Regu
lation of TP53 Activity","Biosynthesis of DPAn-3 SPMs",Xenobiotics,"ADORA2B mediated anti-inflammatory cytokines production","Stabilization of p53","Biosynthesis of maresin-like SPMs","Nuclear Envelop
e (NE) Reassembly","MAP kinase activation","Homologous DNA Pairing and Strand Exchange","Muscarinic acetylcholine receptors","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Dopamine receptors","Regulati
on of TP53 Expression and Degradation","Biosynthesis of DPAn-3-derived protectins and resolvins","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Autodegradation 
of the E3 ubiquitin ligase COP1","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","Presynaptic phase of homologous DNA pairing and strand exchan
ge","Regulation of TP53 Degradation","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{ADRB2}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{Salmeterol,89365-50-4,89365504,Serevent,Aeromax,"Salmeterolum (Latin)","GR 33343X",SALMATEROL,2-(hydroxymethyl)-4-(1-hydroxy-2-(6-(4-phenylbutoxy)hexylamino)ethyl)phenol,2(hydroxymethyl)4(1hydroxy2(6
(4phenylbutoxy)hexylamino)ethyl)phenol,"Salmeterol free base",SN408D,Astmerole,CHEBI:64064,"18910-65-1 (free base)","18910651 (free base)",GR,SAM001247096,Prestw-945,CPD000466295}

> <pdid>
PD002869

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5152}

$$$$
NIHCC_2014
  SciTegic11012413002D

 65 72  0  0  1  0            999 V2000
    2.3980    5.1974    0.0000 C   0  0
    1.0617    4.5159    0.0000 C   0  0
   -0.2000    5.2900    0.0000 C   0  0  2  0  0  0
   -0.2341    6.7896    0.0000 O   0  0
   -0.2000    4.0900    0.0000 C   0  0
   -1.2300    3.5100    0.0000 C   0  0  2  0  0  0
   -2.2500    4.0900    0.0000 C   0  0
   -2.2500    5.2900    0.0000 N   0  0
   -3.9200    5.5000    0.0000 C   0  0
   -5.4100    4.7800    0.0000 C   0  0
   -5.7000    3.1300    0.0000 C   0  0
   -4.9700    1.7900    0.0000 C   0  0
   -6.0100    0.6800    0.0000 N   0  0
   -7.4000    1.3200    0.0000 C   0  0
   -8.8100    0.7400    0.0000 C   0  0
  -10.0200    1.6700    0.0000 C   0  0
   -9.8300    3.1800    0.0000 C   0  0
   -8.4200    3.7700    0.0000 C   0  0
   -7.2000    2.8400    0.0000 C   0  0
   -3.3800    1.2800    0.0000 C   0  0  1  0  0  0
   -1.8700    1.9700    0.0000 C   0  0
   -4.3011    0.1350    0.0000 C   0  0
   -5.7734    0.4218    0.0000 O   0  0
   -3.8135   -1.2844    0.0000 O   0  0
   -4.7977   -2.4164    0.0000 C   0  0
   -2.3301    0.2513    0.0000 C   0  0
   -2.7110   -1.1720    0.0000 C   0  0
   -1.6165   -2.2180    0.0000 C   0  0
   -0.2693   -1.8150    0.0000 C   0  0
    0.1414   -0.3694    0.0000 C   0  0
   -0.9061    0.6597    0.0000 C   0  0
   -0.5303    2.1129    0.0000 O   0  0
    0.4332    2.3808    0.0000 C   0  0
    0.6269   -3.0200    0.0000 N   0  0
    2.1244   -3.0533    0.0000 C   0  0
    2.8460   -4.3683    0.0000 O   0  0
   -0.2779   -4.1651    0.0000 C   0  0  1  0  0  0
   -0.0140   -5.6041    0.0000 C   0  0  2  0  0  0
    1.0936   -4.5926    0.0000 O   0  0
   -1.1529   -6.6124    0.0000 C   0  0  2  0  0  0
   -0.8799   -8.0880    0.0000 O   0  0
    0.5342   -8.5906    0.0000 C   0  0
    1.2952   -7.9418    0.0000 C   0  0
    0.8068  -10.0656    0.0000 O   0  0
   -2.5335   -6.1188    0.0000 C   0  0  2  0  0  0
   -2.2630   -7.5946    0.0000 C   0  0
   -3.0242   -8.2431    0.0000 C   0  0
   -3.6287   -7.0542    0.0000 C   0  0
   -5.0406   -6.5494    0.0000 C   0  0
   -5.3459   -4.5824    0.0000 C   0  0
   -4.0445   -3.8623    0.0000 N   0  0
   -3.7291   -2.4358    0.0000 C   0  0
   -2.2452   -2.2939    0.0000 C   0  0
   -1.6741   -3.6659    0.0000 C   0  0  2  0  0  0
   -2.8019   -4.6427    0.0000 C   0  0  2  0  0  0
    0.2302   -7.0636    0.0000 C   0  0
    1.1755   -7.3898    0.0000 O   0  0
   -0.9029   -8.0479    0.0000 O   0  0
   -0.6181   -9.5206    0.0000 C   0  0
   -1.2300    5.8900    0.0000 C   0  0
    8.2352    0.9101    0.0000 O   0  0
    8.2352   -0.5899    0.0000 S   0  0
    8.2352   -2.0899    0.0000 O   0  0
    6.9359   -1.3395    0.0000 O   0  0
    9.5344   -1.3395    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  1
  3  5  1  0
  6  5  1  1
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 11  1  0
 19 14  1  0
 12 20  1  0
 20 21  1  0
 21  6  1  0
 20 22  1  1
 22 23  2  0
 22 24  1  0
 24 25  1  0
 20 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
 31 32  1  0
 32 33  1  0
 29 34  1  0
 34 35  1  0
 35 36  2  0
 37 34  1  1
 37 38  1  0
 38 39  1  6
 38 40  1  0
 40 41  1  6
 41 42  1  0
 42 43  1  0
 42 44  2  0
 40 45  1  0
 45 46  1  1
 46 47  1  0
 45 48  1  0
 48 49  2  3
 49 50  1  0
 50 51  1  0
 51 52  1  0
 52 53  1  0
 54 53  1  6
 54 28  1  0
 54 37  1  0
 54 55  1  0
 55 45  1  0
 55 51  1  6
 38 56  1  0
 56 57  2  0
 56 58  1  0
 58 59  1  0
  8 60  1  0
 60  3  1  0
 61 62  1  0
 62 63  1  0
 62 64  2  0
 62 65  2  0
M  END
> <name>
NIHCC_2014

> <id>
6033

> <plate>
NGP-105-06

> <well>
B04

> <supplier_cmpd_name>
CPD000058540

> <ctcr_id>
4962

> <supplier_cmpd_id>
SAM001246570

> <smiles>
CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(C)=O)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1.O[S](O)(=O)=O

> <pd_targets>
{NR5A1,NR0B1,TUBB5,TUBA4A,MAPT,HIF1A,RORC,GAA,LMNA,TUBB2B,TUBA1A,SLCO1B3,TUBA1B,TUBA1C,TUBA3C,TUBA3E,TUBB,TUBB1,TUBB2A,TUBB3,TUBB4A,TUBB4B,TUBB6,TUBB8,HTT,SLCO1B1,ABCC1,ALDH1A1,KMT2A,MEN1,BLM,NPSR1,NF
O,PMP22,NS1,GMNN,MTOR}

> <pathway_gtopdb>
{"Transcription factor","Structural protein","Other cytosolic protein",Enzyme,"Other nuclear protein",Transporter,"Unclassified protein","Nuclear receptor",Hydrolase,"Electrochemical transporter","Pri
mary active transporter","Nuclear hormone receptor subfamily 5","Nuclear hormone receptor subfamily 0","Nuclear hormone receptor subfamily 1","SLC superfamily of solute carriers","ATP-binding cassette
","Nuclear hormone receptor subfamily 5 group A","Nuclear hormone receptor subfamily 0 group B","Nuclear hormone receptor subfamily 1 group F","SLC21/SLCO family of organic anion transporting polypept
ides","ABCC subfamily","Nuclear hormone receptor subfamily 5 group A member 1","Nuclear hormone receptor subfamily 0 group B member 1","Nuclear hormone receptor subfamily 1 group F member 3","Epigenet
ic regulator","Membrane receptor",Oxidoreductase,Reader,"Family A G protein-coupled receptor",Protease,Kinase,Bromodomain,"Peptide receptor (family A GPCR)","Cysteine protease","Protein Kinase","Short
 peptide receptor (family A GPCR)","Cysteine protease CA clan","Atypical protein kinase group","Neuropeptide receptor","Cysteine protease C1A family","Atypical protein kinase PIKK family","Atypical pr
otein kinase FRAP subfamily"}

> <pathway_chembl>
{Receptors,"Other protein targets",Enzymes,Transporters,"Nuclear hormone receptors",Tubulins,"3.2.1.- Glycosidases","SLC superfamily of solute carriers","ATP-binding cassette transporter family","5A. 
Fushi tarazu F1-like receptors","0B. DAX-like receptors","1F. Retinoic acid-related orphans","SLCO family of organic anion transporting polypeptides","ABCC subfamily","G protein-coupled receptors","Ki
nases (EC 2.7.x.x)","Neuropeptide S receptor",Atypical,"Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","FRAP subfamily"}

> <pathway_reactome>
{"Metabolism of proteins","Gene expression (Transcription)","Cell Cycle","Neuronal System","Cellular responses to external stimuli",Disease,Metabolism,"Post-translational protein modification","RNA Po
lymerase II Transcription",Mitotic,"Transmission across Chemical Synapses","Cellular responses to stress","Diseases of metabolism","Metabolism of lipids",SUMOylation,"Generic Transcription Pathway","M
itotic G2-G2/M phases","Neurotransmitter receptors and postsynaptic signal transmission","Cellular response to hypoxia","Diseases of carbohydrate metabolism","M Phase","Metabolism of steroids","Fatty 
acid metabolism","SUMO E3 ligases SUMOylate target proteins","Nuclear Receptor transcription pathway","G2/M Transition","Activation of NMDA receptors and postsynaptic events","Oxygen-dependent proline
 hydroxylation of Hypoxia-inducible Factor Alpha","Transcriptional regulation by RUNX3","Glycogen storage diseases","Mitotic Metaphase and Anaphase","Bile acid and bile salt metabolism","Transcription
al Regulation by MECP2","Arachidonic acid metabolism","SUMOylation of intracellular receptors","Centrosome maturation","Post NMDA receptor activation events","RUNX3 Regulates Immune Response and Cell 
Migration","Glycogen storage disease type II (GAA)","Mitotic Anaphase","Recycling of bile acids and salts","Regulation of MECP2 expression and activity","Synthesis of Leukotrienes (LT) and Eoxins (EX)
","Loss of proteins required for interphase microtubule organization from the centrosome","Activation of AMPK downstream of NMDARs","Nuclear Envelope (NE) Reassembly","Loss of Nlp from mitotic centros
omes","Initiation of Nuclear Envelope (NE) Reformation","DNA Repair","Developmental Biology","Biological oxidations","DNA Double-Strand Break Repair","Infectious disease","Nervous system development",
"Phase I - Functionalization of compounds","Homology Directed Repair","Leishmania infection","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Mitotic G1 phase and G1/S transition","Et
hanol oxidation","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Leishmania parasite growth and survival","G1/S Transition","Transcriptional Regulation by TP53","HDR thr
ough Homologous Recombination (HRR)","Anti-inflammatory response favouring Leishmania parasite infection","Activation of the pre-replicative complex","Regulation of TP53 Activity","Homologous DNA Pair
ing and Strand Exchange","ADORA2B mediated anti-inflammatory cytokines production","Regulation of TP53 Expression and Degradation","Presynaptic phase of homologous DNA pairing and strand exchange","Re
gulation of TP53 Degradation"}

> <broad_targets>
{TUBA4A,TUBB}

> <broad_moa>
{"tubulin polymerization inhibitor"}

> <synonyms>
{"Vincristine sulfate",Oncovin,"Vincristine sulfate salt",2068-78-2,2068782,"Vincristine sulphate","Vincristine (sulfate)",UNII-T5IRO3534A,UNIIT5IRO3534A,C46H58N4O14S,Vincrex,Onkovin,Vincrisul,MLS0008
63277,T5IRO3534A,"VCR sulfate",Marqibo,SMR000058540,Lill,SAM001246570,CPD000058540}

> <pdid>
PD003310

> <targets>
{Apoptosis,Microtubule/Tubulin}

> <classes>
{Apoptosis,Cell Cycle/DNA Damage,Cytoskeleton}

> <pubchem_cids>
{5388992}

$$$$
NIHCC_2014
  SciTegic11012413002D

 45 49  0  0  1  0            999 V2000
    8.9060   -2.8271    0.0000 O   0  0
    6.4060   -2.8271    0.0000 Cl  0  0
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.4133    1.7530    0.0000 C   0  0
    1.8032    3.1233    0.0000 N   0  0
    2.4134    4.4924    0.0000 C   0  0
    3.9053    4.6489    0.0000 O   0  0
    1.5317    5.7059    0.0000 C   0  0
    0.0400    5.5491    0.0000 C   0  0
   -0.5701    4.1788    0.0000 C   0  0
    0.3114    2.9665    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -1.2959   -5.2508    0.0000 O   0  0
    0.0049   -5.9994    0.0000 C   0  0
    1.3026   -5.2471    0.0000 O   0  0
    0.0080   -7.5002    0.0000 N   0  0
    1.3070   -8.2503    0.0000 C   0  0
    1.3071   -9.7503    0.0000 C   0  0
    0.0081  -10.5003    0.0000 C   0  0
   -1.2910   -9.7503    0.0000 C   0  0
   -1.2910   -8.2503    0.0000 C   0  0
    0.0081  -12.0011    0.0000 N   0  0
    1.3060  -12.7532    0.0000 C   0  0
    1.3036  -14.2532    0.0000 C   0  0
    0.0034  -15.0012    0.0000 C   0  0
   -1.2944  -14.2491    0.0000 C   0  0
   -1.2921  -12.7491    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.8417    6.7626    0.0000 C   0  0  1  0  0  0
   -1.6934    7.9974    0.0000 O   0  0
   -1.4104    5.3957    0.0000 C   0  0
   -2.8925    5.1650    0.0000 C   0  0
   -0.2316    8.1329    0.0000 C   0  0
   -1.1133    9.3464    0.0000 O   0  0
    1.2601    8.2897    0.0000 O   0  0
    2.1418    7.0762    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  3
 12 13  1  0
 13 14  2  3
 14  8  1  0
 14 15  1  0
 15  6  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 24  1  0
 27 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 30  1  0
 20 36  1  0
 36 37  2  0
 37  5  1  0
 37 17  1  0
 12 38  1  0
 38 39  1  6
 38 40  1  0
 40 41  1  0
 38 42  1  0
 42 43  2  0
 42 44  1  0
 44 45  1  0
 45 11  1  0
M  END
> <name>
NIHCC_2014

> <id>
6034

> <plate>
NGP-105-06

> <well>
B05

> <supplier_cmpd_name>
CPD000469166

> <ctcr_id>
3943

> <supplier_cmpd_id>
SAM001246598

> <smiles>
O.Cl.CCc1c2CN3C(=O)C4=C(C=C3c2nc5ccc(OC(=O)N6CCC(CC6)N7CCCCC7)cc15)[C@@](O)(CC)C(=O)OC4

> <pd_targets>
{RMLC,NCOA1,NCOA3,HPGD,ALDH1A1,GLA,LMNA,KDM4E,HSD17B10,GAA,ACHE,MMP1,CYP3A4,PAX8,ADRA2C,SLC47A1,SLC22A3,SLC47A2,SLC22A1,CHRM4,SLC22A2,TOP1,TOP1MT}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Other nuclear protein","Unclassified protein","Membrane receptor",Transporter,Isomerase,Writer,Oxidoreductase,Hydrolase,Eraser,Protease,"Cytochrome P450","Family A G pr
otein-coupled receptor","Electrochemical transporter","Histone acetyltransferase","Lysine demethylase","Cysteine protease","Metallo protease","Cytochrome P450 family 3","Small molecule receptor (famil
y A GPCR)","SLC superfamily of solute carriers","SRC family","Jumonji domain-containing","Cysteine protease CA clan","Metallo protease MAM clan","Cytochrome P450 family 3A","Monoamine receptor","SLC47
 family of multidrug and toxin extrusion transporters","SLC22 family of organic cation and anion transporters","Cysteine protease C1A family","Metallo protease M10A subfamily","Cytochrome P450 3A4","A
drenergic receptor","Acetylcholine receptor"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Chromatin modifying enzymes","Eicosanoid turnover","3.2.1.- Glycosidases","Acetylcholine turnover","Peptidases and proteinases","Cytochrome P450","G protein-coupled re
ceptors","SLC superfamily of solute carriers","DNA topoisomerases","2.3.1.48 Histone acetyltransferases (HATs)","Prostaglandin synthases","1.14.11.- Histone demethylases","MA: Metallo (M) Peptidases",
"CYP3 family",Adrenoceptors,"SLC47 family of multidrug and toxin extrusion transporters","SLC22 family of organic cation and anion transporters","Acetylcholine receptors (muscarinic)","M10: Matrix met
allopeptidase","Organic cation transporters (OCT)"}

> <pathway_reactome>
{Metabolism,"Cell Cycle",Disease,"Immune System","Signal Transduction","Transport of small molecules","Metabolism of proteins","Metabolism of lipids","Biological oxidations",Mitotic,"Metabolism of ami
no acids and derivatives","Diseases of metabolism","Cytokine Signaling in Immune system","Signaling by GPCR","SLC-mediated transmembrane transport","Post-translational protein modification","Metabolis
m of steroids","Regulation of lipid metabolism by PPARalpha","Biosynthesis of specialized proresolving mediators (SPMs)","Phase I - Functionalization of compounds","Sphingolipid metabolism","M Phase",
"Branched-chain amino acid catabolism","Diseases of carbohydrate metabolism","Phospholipid metabolism","Signaling by Interleukins","GPCR ligand binding","Transport of bile salts and organic acids","me
tal ions and amine compounds",SUMOylation,"Bile acid and bile salt metabolism","PPARA activates gene expression","Biosynthesis of DHA-derived SPMs","Ethanol oxidation","Glycosphingolipid metabolism","
Mitotic Metaphase and Anaphase","Glycogen storage diseases","Glycerophospholipid biosynthesis","Interleukin-4 and Interleukin-13 signaling","Class A/1 (Rhodopsin-like receptors)","Organic cation/anion
/zwitterion transport","SUMO E3 ligases SUMOylate target proteins","Synthesis of bile acids and bile salts","Biosynthesis of D-series resolvins","Mitotic Anaphase","Glycogen storage disease type II (G
AA)","Synthesis of PC","Biosynthesis of maresins","Amine ligand-binding receptors","Organic cation transport","SUMOylation of DNA replication proteins","Synthesis of bile acids and bile salts via 27-h
ydroxycholesterol","Nuclear Envelope (NE) Reassembly","Biosynthesis of maresin-like SPMs",Adrenoceptors,"Muscarinic acetylcholine receptors","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{TOP1,TOP1MT}

> <broad_moa>
{"topoisomerase inhibitor"}

> <synonyms>
{"IRINOTECAN HCl )trihydrate)",MLS001401366,SMR000469166,SCHEMBL572716,CHEMBL1200512,BDBM51762,cid_23581792,cid23581792,cid-23581792,"cid 23581792",AKOS025149074,CCG-101160,CCG101160,NC00410,T0486,SAM
001246598,"Irinotecan hydrochloride trihydrate",CPD000469166}

> <pdid>
PD009733

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581792}

$$$$
NIHCC_2014
  SciTegic11012413002D

 18 20  0  0  1  0            999 V2000
    3.5435   -3.9479    0.0000 C   0  0
    2.2164   -3.2486    0.0000 C   0  0
    2.1581   -1.7535    0.0000 C   0  0
    0.6777   -0.8641    0.0000 C   0  0  2  0  0  0
    1.4812   -0.5114    0.0000 C   0  0
    3.3185    0.4632    0.0000 C   0  0
    4.1596    0.3357    0.0000 C   0  0
    6.1079    1.1257    0.0000 C   0  0
    6.7836    2.1256    0.0000 C   0  0
    5.7282    2.2751    0.0000 C   0  0
    5.4895    3.7559    0.0000 O   0  0
    4.0164    1.4262    0.0000 N   0  0
    3.6007   -0.6744    0.0000 C   0  0  2  0  0  0
    4.4673   -1.1733    0.0000 N   0  0
    2.8587    0.6592    0.0000 C   0  0
    1.3470    1.7008    0.0000 C   0  0
    0.2662    0.9399    0.0000 C   0  0
    1.3395    3.2008    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  6
  5  6  1  0
  6  7  2  3
  7  8  1  0
  8  9  2  3
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12  6  1  0
 13  7  1  6
 13  3  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  2  3
 17  4  1  0
 16 18  1  0
M  END
> <name>
NIHCC_2014

> <id>
6035

> <plate>
NGP-105-06

> <well>
B06

> <supplier_cmpd_name>
CPD000469231

> <ctcr_id>
2258

> <supplier_cmpd_id>
SAM001246851

> <smiles>
C\C=C/1[C@@H]2CC3=C(C=CC(=O)N3)[C@@]1(N)CC(=C2)C

> <pd_targets>
{BCHE,ACHE}

> <pathway_gtopdb>
{Enzyme,Hydrolase}

> <pathway_chembl>
{Enzymes,"Acetylcholine turnover"}

> <pathway_reactome>
{Metabolism,"Metabolism of lipids","Phospholipid metabolism","Glycerophospholipid biosynthesis","Synthesis of PC"}

> <broad_targets>
{ACHE}

> <broad_moa>
{"acetylcholinesterase inhibitor"}

> <synonyms>
{"(-)-huperzine A","()huperzine A","Huperzine A",102518-79-6,102518796,"(-)-Huperzine A (HupA)","()Huperzine A (HupA)",MFCD01714949,"(-)- HUPPERZINE A","() HUPPERZINE A","(-)huperzine A",SCHEMBL136369
,HMS3887I17,"HUPERZINE A (naturally extracted)",ZINC2094254,CH0011,s2251,"(-)-Huperzine A","()Huperzine A","analytical standard",S2251,SAM001246851,CPD000469231}

> <pdid>
PD000542

> <targets>
{AChE,Apoptosis,iGluR}

> <classes>
{Apoptosis,Membrane Transporter/Ion Channel,Neuronal Signaling}

> <pubchem_cids>
{907504}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 20  0  0  0  0            999 V2000
    5.0987    1.1193    0.0000 Cl  0  0
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -6.4964   -0.7591    0.0000 O   0  0
   -7.8003    1.4887    0.0000 C   0  0
   -9.0994    0.7387    0.0000 C   0  0
  -10.3984    1.4886    0.0000 C   0  0
  -10.3985    2.9886    0.0000 C   0  0
  -11.6975    3.7386    0.0000 F   0  0
   -9.0995    3.7387    0.0000 C   0  0
   -7.8004    2.9887    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 12  1  0
  6 19  1  0
 19 20  1  0
 20  3  1  0
M  END
> <name>
NIHCC_2014

> <id>
6036

> <plate>
NGP-105-06

> <well>
B07

> <supplier_cmpd_name>
CPD000468736

> <ctcr_id>
1518

> <supplier_cmpd_id>
SAM001247102

> <smiles>
Cl.CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1

> <pd_targets>
{HRH1,CHRM4,HTR2C,HTR7,DRD2,KMT2A,MEN1,HTR2A,HTR1D,HTR1A,CHRM2,DRD4,DRD3,HTR6,ADRA2A,ADRA1A}

> <pathway_gtopdb>
{"Membrane receptor","Epigenetic regulator","Family A G protein-coupled receptor",Reader,"Small molecule receptor (family A GPCR)",Bromodomain,"Monoamine receptor","Histamine receptor","Acetylcholine 
receptor","Serotonin receptor","Dopamine receptor","Adrenergic receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Histamine receptors","Acetylcholine receptors (muscarinic)","5-Hydroxytryptamine receptors","Dopamine receptors",Adrenoceptors}

> <pathway_reactome>
{"Signal Transduction",Disease,"Signaling by GPCR","Infectious disease","GPCR ligand binding","Leishmania infection","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","A
mine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Histamine receptors","Muscarinic acetylcholine receptors","Serotonin receptors","ADORA2B mediated a
nti-inflammatory cytokines production","Dopamine receptors",Adrenoceptors}

> <broad_targets>
{DRD2,HTR2A}

> <broad_moa>
{"dopamine receptor antagonist","serotonin receptor antagonist"}

> <synonyms>
{"Melperone hydrochloride",1622-79-3,"1-(4-Fluorophenyl)-4-(4-methylpiperidin-1-yl)butan-1-one hydrochloride",Metylperon,UNII-88G640374K,1-(4-fluorophenyl)-4-(4-methylpiperidin-1-yl)butan-1-one;hydroc
hloride,88G640374K,"Buronil (TN)",C16H23ClFNO,MLS001424296,CHEMBL4551527,1-(3-(p-fluorobenzoyl)propyl)-4-methylpiperaziniumchloride,DTXSID10936649,Pharmakon1600-01502266,8232AA,ANW-71962,MFCD00270922,
NSC760102,AKOS016007345,CCG-101176,NC00426,NSC-760102,SMR000468736,B7078,D08172,J-009916,Q27269931,"1-(4-Fluorophenyl)-4-(4-methyl-1-piperidinyl)-1-butanone hydrochloride","1-(4-fluorophenyl)-4-(4-met
hyl-piperidin-1-yl)butan-1-one hydrochloride",Buronil,Eunerpan,"Methylperone chloride","Methylperone hydrochloride","Melperone HCl","EINECS 216-599-9",SCHEMBL1649537,"1-(3-(p-Fluorobenzoyl)propyl)-4-m
ethylpiperazinium chloride","4'-Fluoro-4-(4-methylpiperidino)butyrophenone hydrochloride","gamma-(4-Methylpiperidine)-p-fluorobutyrophenone hydrochloride","1-Butanone, 1-(4-fluorophenyl)-4-(4-methyl-1
-piperidinyl)-, hydrochloride","BUTYROPHENONE, 4'-FLUORO-4-(4-METHYLPIPERIDINO)-, HYDROCHLORIDE",1-(4-fluorophenyl)-4-(4-methylpiperidin-1-ium-1-yl)butan-1-one;chloride,SAM001247102,CPD000468736}

> <pdid>
PD008997

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{9926325,15386}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 30  0  0  1  0            999 V2000
    7.5987    1.8754    0.0000 O   0  0
    5.0987    1.8754    0.0000 Br  0  0
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  2  0  0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 N   0  0
   -6.4952    0.7500    0.0000 C   0  0
   -7.7943    1.4999    0.0000 C   0  0
   -9.0933    0.7499    0.0000 C   0  0
   -9.0933   -0.7501    0.0000 C   0  0
   -7.7942   -1.5001    0.0000 C   0  0
   -6.4952   -0.7500    0.0000 C   0  0
   -5.1961   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    0.0000   -1.5000    0.0000 C   0  0
   -1.2991    2.2507    0.0000 C   0  0
   -2.5981    3.0007    0.0000 C   0  0
   -2.5981    4.5007    0.0000 C   0  0
   -1.2991    5.2507    0.0000 C   0  0
    0.0000    4.5008    0.0000 C   0  0
    1.2990    5.2508    0.0000 O   0  0
    0.0000    3.0008    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 16 17  1  0
 17 18  2  0
 18  9  1  0
 18 19  1  0
 20 19  1  6
 20  7  1  0
 20 21  1  0
 21  4  1  0
  7 22  1  6
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 26 28  2  0
 28 22  1  0
M  END
> <name>
NIHCC_2014

> <id>
6037

> <plate>
NGP-105-06

> <well>
C02

> <supplier_cmpd_name>
CPD000466296

> <ctcr_id>
5841

> <supplier_cmpd_id>
SAM001247097

> <smiles>
O.Br.CN1CC[C@@]2(Cc3nc4ccccc4cc3C[C@H]2C1)c5cccc(O)c5

> <pd_targets>
{OPRK1,MRGPRX2,OPRD1,OPRM1,KMT2A,MEN1,MAPT}

> <pathway_gtopdb>
{"Membrane receptor","Epigenetic regulator","Other cytosolic protein","Family A G protein-coupled receptor",Reader,"Peptide receptor (family A GPCR)",Bromodomain,"Short peptide receptor (family A GPCR
)","Opioid receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Opioid receptors","Orphan and other 7TM receptors","Class A Orphans"}

> <pathway_reactome>
{"Gene expression (Transcription)","Signal Transduction","Neuronal System","RNA Polymerase II Transcription","Signaling by GPCR","Transmission across Chemical Synapses","Generic Transcription Pathway"
,"GPCR ligand binding","GPCR downstream signalling","Neurotransmitter receptors and postsynaptic signal transmission","Transcriptional Regulation by MECP2","Class A/1 (Rhodopsin-like receptors)","G al
pha (i) signalling events","Activation of NMDA receptors and postsynaptic events","MECP2 regulates neuronal receptors and channels","Peptide ligand-binding receptors","Opioid Signalling","Post NMDA re
ceptor activation events","G-protein activation","Activation of AMPK downstream of NMDARs"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"SB 205607",SMR000466296,MLS000759012,MLS001424239,CHEMBL1339124,CCG-101195,CCG101195,NC00445,SAM001247097,CPD000466296}

> <pdid>
PD071062

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581823}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 22  0  0  1  0            999 V2000
    8.1484   -1.5012    0.0000 Cl  0  5
    3.1476   -0.7184    0.0000 C   0  0
    1.6852   -0.3846    0.0000 N   0  0
    1.3514    1.0778    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -2.4523    2.0983    0.0000 C   0  0
   -3.8856    1.6561    0.0000 C   0  0
   -4.9852    2.6764    0.0000 Cl  0  0
   -4.2194    0.1937    0.0000 C   0  0
   -5.6528   -0.2484    0.0000 O   0  0
   -3.1198   -0.8265    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0  2  0  0  0
    0.7500   -1.5574    0.0000 C   0  0
   -1.4011   -2.9095    0.0000 C   0  0
   -0.4925   -4.1079    0.0000 C   0  0
   -1.0733   -5.4909    0.0000 C   0  0
   -2.5615   -5.6793    0.0000 C   0  0
   -3.4687   -4.4848    0.0000 C   0  0
   -2.8879   -3.1018    0.0000 C   0  0
    5.6484   -1.5012    0.0000 H   0  3
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  8 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13  6  1  0
 13 14  1  0
 14 15  1  0
 15  3  1  0
 14 16  1  6
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
M  CHG  2   1  -1  22   1
M  END
> <name>
NIHCC_2014

> <id>
6038

> <plate>
NGP-105-06

> <well>
C03

> <supplier_cmpd_name>
CPD000326935

> <ctcr_id>
4429

> <supplier_cmpd_id>
SAM001247098

> <smiles>
[Cl-].CN1CCc2cc(Cl)c(O)cc2[C@H](C1)c3ccccc3.[H+]

> <pd_targets>
{MAPK1,LMNA,DRD5,DRD2,ADCY2,KCNJ6,NFO,KCNJ4,NFKB1,TSHR,THPO,CYP1A2,CYP2D6,CHRM1,HSD17B10,CYP3A4,ALOX15,HTR2A,KMT2A,MEN1,LEF,HTR2C,HTR2B,SIGMAR1,DRD3,CYP2C19}

> <pathway_gtopdb>
{Enzyme,"Other nuclear protein","Membrane receptor",Kinase,"Family A G protein-coupled receptor",Lyase,"Protein Kinase","Small molecule receptor (family A GPCR)","CMGC protein kinase group","Monoamine
 receptor","CMGC protein kinase MAPK family","Dopamine receptor","CMGC protein kinase ERK1","Ion channel","Voltage-gated ion channel",Hydrolase,"Potassium channels","Inwardly rectifying potassium chan
nel","Other cytosolic protein","Unclassified protein","Cytochrome P450",Oxidoreductase,"Peptide receptor (family A GPCR)","Cytochrome P450 family 1","Cytochrome P450 family 2","Cytochrome P450 family 
3","Glycohormone receptor","Cytochrome P450 family 1A","Cytochrome P450 family 2D","Cytochrome P450 family 3A","Cytochrome P450 1A1","Cytochrome P450 2D6","Acetylcholine receptor","Cytochrome P450 3A4
","Epigenetic regulator",Reader,Protease,Bromodomain,"Metallo protease","Metallo protease MAE clan","Serotonin receptor","Metallo protease M34 family","Cytochrome P450 family 2C","Cytochrome P450 2C19
"}

> <pathway_chembl>
{Enzymes,Receptors,"Kinases (EC 2.7.x.x)","G protein-coupled receptors","Cyclic nucleotide turnover/signalling","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Dopamine receptors","Adenylyl cyclases 
(ACs)","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily","Ion channels","Voltage-gated ion channels","Potassium channels","Inwardly rectifying potassium channels","Cytochrome P450","Gl
ycoprotein hormone receptors","CYP1 family","CYP2 family: drug metabolising subset","Acetylcholine receptors (muscarinic)","CYP3 family","Other protein targets","Eicosanoid turnover","Sigma receptors"
,Lipoxygenases,"5-Hydroxytryptamine receptors"}

> <pathway_reactome>
{"Immune System","Cell Cycle",Disease,"Signal Transduction","Neuronal System","Innate Immune System",Mitotic,"Infectious disease","Signaling by GPCR","Transmission across Chemical Synapses","Toll-like
 Receptor Cascades","M Phase","Leishmania infection","GPCR ligand binding","Neurotransmitter receptors and postsynaptic signal transmission","Toll Like Receptor 5 (TLR5) Cascade","Mitotic Metaphase an
d Anaphase","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","GABA receptor activation","MyD88 cascade initiated on plasma membrane","Mitotic Anaphase","Anti-inflammato
ry response favouring Leishmania parasite infection","Amine ligand-binding receptors","GABA B receptor activation","MAP kinase activation","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inf
lammatory cytokines production","Dopamine receptors","Activation of GABAB receptors","MAPK targets/ Nuclear events mediated by MAP kinases","Initiation of Nuclear Envelope (NE) Reformation","Adenylate
 cyclase inhibitory pathway","ERK/MAPK targets","ERKs are inactivated","Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits",Hemostasis,Metabolism,"Cytokine Signaling in Immune system"
,"Platelet activation","signaling and aggregation","Biological oxidations","Metabolism of amino acids and derivatives","Metabolism of lipids","Signaling by Interleukins","Platelet Aggregation (Plug Fo
rmation)","Phase I - Functionalization of compounds","Branched-chain amino acid catabolism","Biosynthesis of specialized proresolving mediators (SPMs)","Interleukin-1 family signaling","Cytochrome P45
0 - arranged by substrate type","Biosynthesis of DHA-derived SPMs","Interleukin-1 signaling",Xenobiotics,"Biosynthesis of maresins","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Aromatic amines can be
 N-hydroxylated or N-dealkylated by CYP1A2","CYP2E1 reactions","Muscarinic acetylcholine receptors","Biosynthesis of maresin-like SPMs","Uptake and actions of bacterial toxins","SARS-CoV Infections","
Biosynthesis of DPA-derived SPMs","Uptake and function of anthrax toxins","Potential therapeutics for SARS","Biosynthesis of DPAn-3 SPMs","Biosynthesis of DPAn-3-derived protectins and resolvins","Ser
otonin receptors"}

> <broad_targets>
{DRD1,DRD5}

> <broad_moa>
{"dopamine receptor antagonist"}

> <synonyms>
{125941-87-9,125941879,"SCH 23390 HYDROCHLORIDE","SCH-23390 hydrochloride","SCH23390 hydrochloride","R(+)-SCH-23390 hydrochloride","R(+)SCH23390 hydrochloride",UNII-4S8T3E2F4Z,UNII4S8T3E2F4Z,"(R)-(+)-
Sch 23390 Hydrochloride","(R)(+)Sch 23390 Hydrochloride","SCH23390 HCl",4S8T3E2F4Z,"125941-87-9 (HCl)","125941879 (HCl)","SCH-23390 (hydrochlor","SCH23390 (hydrochlor",SAM001247098,CPD000326935}

> <pdid>
PD047114

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{11957535}

$$$$
NIHCC_2014
  SciTegic11012413002D

 33 34  0  0  0  0            999 V2000
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 O   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.4642   -1.0046    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5987    1.5004    0.0000 C   0  0
    2.5964    3.0005    0.0000 C   0  0
    3.8943    3.7525    0.0000 C   0  0
    5.1945    3.0046    0.0000 C   0  0
    5.1969    1.5046    0.0000 C   0  0
    3.8990    0.7525    0.0000 C   0  0
    3.9046   -0.7483    0.0000 C   0  0
    5.2066   -1.4947    0.0000 C   0  0
    5.2122   -2.9956    0.0000 C   0  0
    4.3478   -3.4985    0.0000 O   0  0
    6.5142   -3.7420    0.0000 O   0  0
    6.5198   -5.2428    0.0000 C   0  0
    7.8211   -5.9888    0.0000 C   0  0
    6.5246   -6.7428    0.0000 C   0  0
    5.2233   -5.9972    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
   -0.0031    3.0008    0.0000 C   0  0
    1.2946    3.7531    0.0000 O   0  0
   -1.3039    3.7494    0.0000 O   0  0
   -1.3070    5.2502    0.0000 C   0  0
   -2.6071    5.9984    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 19 22  1  0
  7 23  1  0
 23 24  2  3
 24 25  1  0
 24 26  1  0
 26 27  2  3
 27  6  1  0
 27 28  1  0
 23 29  1  0
 29 30  2  0
 29 31  1  0
 31 32  1  0
 32 33  1  0
M  END
> <name>
NIHCC_2014

> <id>
6039

> <plate>
NGP-105-06

> <well>
C04

> <supplier_cmpd_name>
CPD000466342

> <ctcr_id>
120

> <supplier_cmpd_id>
SAM001246648

> <smiles>
CCOC(/O)=C1/C(c2ccccc2\C=C\C(=O)OC(C)(C)C)C(=C(C)N=C1C)C(=O)OCC

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{ZINC33130652,MCULE-2822570363,MCULE2822570363,SAM001246648,CPD000466342}

> <pdid>
PD002941

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{46386664}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 27  0  0  0  0            999 V2000
    0.2951   -8.3214    0.0000 C   0  0
    1.7951   -8.3214    0.0000 C   0  0
    2.5451   -7.0223    0.0000 C   0  0
    1.7974   -5.7210    0.0000 C   0  0
    2.5497   -4.4224    0.0000 S   0  0
    4.0497   -4.4250    0.0000 O   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 N   0  0
    4.0452   -7.0225    0.0000 N   0  0
    4.7951   -8.3215    0.0000 C   0  0
    4.0450   -9.6205    0.0000 C   0  0
    2.5450   -9.6205    0.0000 C   0  0
    1.7973  -10.9218    0.0000 O   0  0
    2.5495  -12.2205    0.0000 C   0  0
    1.8017  -13.5217    0.0000 C   0  0
    2.5535  -14.8197    0.0000 F   0  0
    0.3017  -13.5243    0.0000 F   0  0
    1.0537  -14.8219    0.0000 F   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 14 15  1  0
 15  7  2  0
  3 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19  2  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 22 25  1  0
M  END
> <name>
NIHCC_2014

> <id>
6040

> <plate>
NGP-105-06

> <well>
C05

> <supplier_cmpd_name>
CPD000058469

> <ctcr_id>
459

> <supplier_cmpd_id>
SAM001246544

> <smiles>
Cc1c(C[S](=O)c2[nH]c3ccccc3n2)nccc1OCC(F)(F)F

> <pd_targets>
{AMPC,LMNA,GLA,ALDH1A1,FFP,CYP2D6,CYP3A4,CYP2C9,FASN,REP,RAB9A,TSHR,MAPT,CYP2C19,RORC,ALOX15,KDM4E,HIF1A,ALD,NPC1,PHOSPHO1,CYP1A2,CYP2C8,DDAH1,HSD17B10,PMP22,HPGD,GAA,ATP4A,ATP4B,ATP1A1,ATP1A2,ATP1A3,
ATP1A4,ATP1B1,ATP1B2,ATP1B3,FXYD2,CHRM1,IDO2,IDO1,ENGASE,ABCB1,SARM1}

> <pathway_gtopdb>
{Enzyme,"Other nuclear protein","Membrane receptor","Other cytosolic protein","Transcription factor","Epigenetic regulator",Transporter,"Unclassified protein",Hydrolase,Oxidoreductase,Transferase,"Cyt
ochrome P450","Family A G protein-coupled receptor","Nuclear receptor",Eraser,Phosphatase,"Primary active transporter","Cytochrome P450 family 2","Cytochrome P450 family 3","Peptide receptor (family A
 GPCR)","Nuclear hormone receptor subfamily 1","Lysine demethylase","Cytochrome P450 family 1","P-type ATPase","Small molecule receptor (family A GPCR)","ATP-binding cassette","Cytochrome P450 family 
2D","Cytochrome P450 family 3A","Cytochrome P450 family 2C","Glycohormone receptor","Nuclear hormone receptor subfamily 1 group F","Jumonji domain-containing","Cytochrome P450 family 1A","Hydrogen pot
assium ATPase","Sodium potassium ATPase","Monoamine receptor","ABCB subfamily","Cytochrome P450 2D6","Cytochrome P450 3A4","Cytochrome P450 2C9","Cytochrome P450 2C19","Nuclear hormone receptor subfam
ily 1 group F member 3","Cytochrome P450 1A1","Cytochrome P450 2C8","Acetylcholine receptor"}

> <pathway_chembl>
{Enzymes,"Other protein targets",Receptors,Transporters,"Cytochrome P450","2.3.1.-  Acyltransferases","Anti-infective targets","G protein-coupled receptors","Nuclear hormone receptors","Eicosanoid tur
nover","Chromatin modifying enzymes","SLC superfamily of solute carriers","L-Arginine turnover","3.2.1.- Glycosidases","1.13.11.- Dioxygenases","ATP-binding cassette transporter family","P-type ATPase
s","CYP2 family: drug metabolising subset","CYP3 family","Viral protein targets","Glycoprotein hormone receptors","1F. Retinoic acid-related orphans",Lipoxygenases,"1.14.11.- Histone demethylases","SL
C65 NPC-type cholesterol transporters","CYP1 family","Dimethylarginine dimethylaminohydrolases","Prostaglandin synthases","Acetylcholine receptors (muscarinic)","ABCB subfamily","P2C P-type ATPases","
Coronavirus (CoV) proteins",H<sup>+</sup>/K<sup>+</sup>-ATPases}

> <pathway_reactome>
{"Cell Cycle",Metabolism,Disease,"Signal Transduction","Neuronal System","Gene expression (Transcription)","Cellular responses to external stimuli","Transport of small molecules","Developmental Biolog
y","Metabolism of proteins",Mitotic,"Metabolism of lipids","Biological oxidations","Infectious disease","Signaling by Rho GTPases","Transmission across Chemical Synapses","RNA Polymerase II Transcript
ion","Cellular responses to stress","Plasma lipoprotein assembly",remodeling,"and clearance","Metabolism of nitric oxide: NOS3 activation and regulation","Metabolism of amino acids and derivatives","N
ervous system development","Diseases of metabolism","Signaling by GPCR","Post-translational protein modification","Abacavir transport and metabolism","Ion channel transport","M Phase","Sphingolipid me
tabolism","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","Metabolism of steroids","SARS-CoV Infections","Rho GTPase cycle","Leishmania infection
","Neurotransmitter receptors and postsynaptic signal transmission","Generic Transcription Pathway","Cellular response to hypoxia","Plasma lipoprotein clearance","Phospholipid metabolism","eNOS activa
tion","Branched-chain amino acid catabolism","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Diseases of carbohydrate metabolism","GPCR ligand binding","Tryptophan catabolism","Aspar
agine N-linked glycosylation","Abacavir transmembrane transport","Ion transport by P-type ATPases","Mitotic Metaphase and Anaphase","Glycosphingolipid metabolism","Ethanol oxidation","Cytochrome P450 
- arranged by substrate type","Biosynthesis of DHA-derived SPMs","Regulation of cholesterol biosynthesis by SREBP (SREBF)","SARS-CoV-2 Infection","RHOBTB GTPase Cycle","Leishmania parasite growth and 
survival","Activation of NMDA receptors and postsynaptic events","Transcriptional regulation by RUNX3","Biosynthesis of DPA-derived SPMs","Oxygen-dependent proline hydroxylation of Hypoxia-inducible F
actor Alpha","LDL clearance","Glycerophospholipid biosynthesis","Glycogen storage diseases","Class A/1 (Rhodopsin-like receptors)","N-glycan trimming in the ER and Calnexin/Calreticulin cycle","Mitoti
c Anaphase",Xenobiotics,"Biosynthesis of maresins","Activation of gene expression by SREBF (SREBP)","SARS-CoV-2 Genome Replication and Transcription","RHOBTB3 ATPase cycle","Anti-inflammatory response
 favouring Leishmania parasite infection","Post NMDA receptor activation events","RUNX3 Regulates Immune Response and Cell Migration","Biosynthesis of DPAn-3 SPMs","Synthesis of PC","Biosynthesis of D
-series resolvins","Glycogen storage disease type II (GAA)","Amine ligand-binding receptors","Nuclear Envelope (NE) Reassembly","CYP2E1 reactions","Biosynthesis of maresin-like SPMs","Replication of t
he SARS-CoV-2 genome","ADORA2B mediated anti-inflammatory cytokines production","Activation of AMPK downstream of NMDARs","Biosynthesis of DPAn-3-derived protectins and resolvins","Aromatic amines can
 be N-hydroxylated or N-dealkylated by CYP1A2","Muscarinic acetylcholine receptors","Initiation of Nuclear Envelope (NE) Reformation","Immune System","Innate Immune System","Toll-like Receptor Cascade
s","Toll Like Receptor 4 (TLR4) Cascade","MyD88-independent TLR4 cascade","TRIF(TICAM1)-mediated TLR4 signaling","Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon"}

> <broad_targets>
{ATP4A,ATP4B}

> <broad_moa>
{"ATPase inhibitor"}

> <synonyms>
{lansoprazole,103577-45-3,103577453,Prevacid,Bamalite,Monolitum,Ogastro,Lansoprazol,Agopton,Limpidex,Lanzor,Opiren,"Prevacid SoluTab",Lanzopral,Takepron,Zoton,Lanproton,Lansopep,Lasoprol,Mesactol,Apra
zol,Blason,Ketian,Lancid,Lanston,Lanz,AG-1749,AG1749,Lansoprazolum,SAM001246544,1503926,Prestw-1072,S4099,CPD000058469,LANSOPRAZOLE,Lansoprazole,Dexlansoprazole}

> <pdid>
PD000804

> <targets>
{Others}

> <classes>
{Others,antiulcer}

> <pubchem_cids>
{3883}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 20  0  0  0  0            999 V2000
   12.6896   -2.2553    0.0000 H   0  3
   10.1896   -2.2553    0.0000 O   0  0
    7.6896   -2.2553    0.0000 Cl  0  5
    5.1889   -6.0106    0.0000 C   0  0
    3.8914   -5.2578    0.0000 C   0  0
    2.5910   -6.0055    0.0000 C   0  0
    3.8937   -3.7570    0.0000 C   0  0
    2.5955   -3.0038    0.0000 C   0  0
    1.2959   -3.7545    0.0000 N   0  0
    1.2954   -5.2545    0.0000 C   0  0
   -0.0030   -3.0044    0.0000 C   0  0
    2.5978   -1.5030    0.0000 C   0  0
    2.9074   -0.1013    0.0000 C   0  0
    4.3556   -0.4920    0.0000 C   0  0
    3.9650   -1.9402    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 Cl  0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
  8 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 12  1  0
 12 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 19 21  1  0
 21 22  2  0
 22 16  1  0
M  CHG  2   1   1   3  -1
M  END
> <name>
NIHCC_2014

> <id>
6041

> <plate>
NGP-105-06

> <well>
C06

> <supplier_cmpd_name>
CPD000472527

> <ctcr_id>
348

> <supplier_cmpd_id>
SAM001246592

> <smiles>
[H+].O.[Cl-].CC(C)CC(N(C)C)C1(CCC1)c2ccc(Cl)cc2

> <pd_targets>
{TSHR,ALDH1A1,LMNA,RORC,MAPK1,CYP3A4,MAPT,LEF,ALOX15,KCND3,SLC6A2,SLC6A3,SLC6A4,CYP2B6,ADRA2B}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Other nuclear protein","Transcription factor","Other cytosolic protein","Ion channel",Transporter,"Family A G protein-coupled receptor",Oxidoreductase,"Nuclear receptor",K
inase,"Cytochrome P450",Protease,"Voltage-gated ion channel","Electrochemical transporter","Peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1","Protein Kinase","Cytochrome P450 f
amily 3","Metallo protease","Potassium channels","SLC superfamily of solute carriers","Cytochrome P450 family 2","Small molecule receptor (family A GPCR)","Glycohormone receptor","Nuclear hormone rece
ptor subfamily 1 group F","CMGC protein kinase group","Cytochrome P450 family 3A","Metallo protease MAE clan","Voltage-gated potassium channel","SLC06 neurotransmitter transporter family","Cytochrome 
P450 family 2B","Monoamine receptor","Nuclear hormone receptor subfamily 1 group F member 3","CMGC protein kinase MAPK family","Cytochrome P450 3A4","Metallo protease M34 family","Cytochrome P450 2B6"
,"Adrenergic receptor","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,"Ion channels",Transporters,"G protein-coupled receptors","Nuclear hormone receptors","Kinases (EC 2.7.x.x)","Cytochrome P450","Eicosanoid turnover","Voltage-gated ion channels","SL
C superfamily of solute carriers","Glycoprotein hormone receptors","1F. Retinoic acid-related orphans","CMGC: Containing CDK",MAPK,GSK3,"CLK families","CYP3 family",Lipoxygenases,"Potassium channels",
"SLC6 neurotransmitter transporter family","CYP2 family: drug metabolising subset",Adrenoceptors,"Mitogen-activated protein kinases (MAP kinases)","Voltage-gated potassium channels","Monoamine transpo
rter subfamily","ERK subfamily"}

> <pathway_reactome>
{Disease,Metabolism,"Cell Cycle","Gene expression (Transcription)","Immune System","Neuronal System","Muscle contraction","Signal Transduction","Infectious disease","Biological oxidations",Mitotic,"RN
A Polymerase II Transcription","Innate Immune System","Metabolism of lipids","Transmission across Chemical Synapses","Cardiac conduction","Disorders of transmembrane transporters","Signaling by GPCR",
"Leishmania infection","Phase I - Functionalization of compounds","M Phase","Generic Transcription Pathway","Toll-like Receptor Cascades","Biosynthesis of specialized proresolving mediators (SPMs)","N
eurotransmitter receptors and postsynaptic signal transmission","Uptake and actions of bacterial toxins","Phase 1 - inactivation of fast Na+ channels","SLC transporter disorders","Neurotransmitter cle
arance","GPCR ligand binding","Leishmania parasite growth and survival","Ethanol oxidation","Mitotic Metaphase and Anaphase","Transcriptional regulation by RUNX3","Toll Like Receptor 5 (TLR5) Cascade"
,"Biosynthesis of DHA-derived SPMs","Activation of NMDA receptors and postsynaptic events","Uptake and function of anthrax toxins","Biosynthesis of DPA-derived SPMs","Defective SLC6A2 causes orthostat
ic intolerance (OI)","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Serotonin clearance from the synaptic cleft","Cytochrome P450 - arranged by substrate type","Class A/1 (Rhodopsi
n-like receptors)","Anti-inflammatory response favouring Leishmania parasite infection","Mitotic Anaphase","RUNX3 Regulates Immune Response and Cell Migration","MyD88 cascade initiated on plasma membr
ane","Biosynthesis of maresins","Post NMDA receptor activation events","Biosynthesis of DPAn-3 SPMs",Xenobiotics,"Amine ligand-binding receptors","ADORA2B mediated anti-inflammatory cytokines producti
on","Nuclear Envelope (NE) Reassembly","MAP kinase activation","Biosynthesis of maresin-like SPMs","Activation of AMPK downstream of NMDARs","Biosynthesis of DPAn-3-derived protectins and resolvins","
CYP2E1 reactions",Adrenoceptors,"Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{AKOS026749801,Meridia,"Sibutramine hydrochloride monohydrate",125494-59-9,Reductil,"Sibutramine hydrochloride hydrate","Sibutramine (hydrochloride monohydrate)","BTS 54524",BTS-54524,"Sibutramine hyd
rochloride (USAN)","Meridia (TN)","Sibutramine HCl H2O",CPD000472527,"Sibutramine hydrochloride civ",SCHEMBL42301,MLS001424319,"Sibutramine Hydrochloride,(S)",CHEMBL3989830,"Sibutramine hydrochloride 
(USP)",DTXSID00925148,KES-524,BCP07236,MFCD04039806,"106650-56-0 (base)",AKOS015855356,AC-4218,CCG-101169,KS-1192,"Sibutramine hydrochloride hydrate (JAN)",HY-14470,SMR000472527,"1-(1-(4-chlorophenyl)
cyclobutyl)-N,N,3",AB0106331,DB-049918,"trimethylbutan-1-amine hydrochloride hydrate","1-(1-(4-chlorophenyl)cyclobutyl)-N,N,3-",FT-0651268,D02571,485S007,A805388,Q27285644,"Sibutramine hydrochloride m
onohydrate, >=98 (HPLC), solid",SAM001246592}

> <pdid>
PD002864

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{69649162,64765}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 28  0  0  0  0            999 V2000
    7.7002   -1.0113    0.0000 Na  0  3
    5.1995   -6.0025    0.0000 C   0  0
    3.9005   -5.2525    0.0000 C   0  0
    3.8995   -3.7516    0.0000 C   0  0
    5.1983   -3.0012    0.0000 O   0  0
    2.5997   -3.0012    0.0000 N   0  5
    2.5988   -1.5004    0.0000 S   0  0
    3.8982   -2.2498    0.0000 O   0  0
    3.8976   -0.7500    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5987    1.5004    0.0000 C   0  0
   -2.7390    2.9810    0.0000 C   0  0
   -1.6199    3.9799    0.0000 C   0  0
   -4.2067    3.2905    0.0000 O   0  0
   -4.9546    1.9903    0.0000 N   0  0
   -3.9492    0.8772    0.0000 C   0  0
   -4.2501   -0.5931    0.0000 C   0  0
   -3.2134   -1.6699    0.0000 C   0  0
   -3.6300   -3.1109    0.0000 C   0  0
   -5.0862   -3.4707    0.0000 C   0  0
   -6.1259   -2.3894    0.0000 C   0  0
   -5.7093   -0.9484    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  2  0
  7 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 13 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
M  CHG  2   1   1   6  -1
M  END
> <name>
NIHCC_2014

> <id>
6042

> <plate>
NGP-105-06

> <well>
C07

> <supplier_cmpd_name>
CPD000469594

> <ctcr_id>
2499

> <supplier_cmpd_id>
SAM001246773

> <smiles>
[Na+].CCC(=O)[N-][S](=O)(=O)c1ccc(cc1)c2c(C)onc2c3ccccc3

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{NC00427,"Parecoxib sodium",198470-85-8,198470858,Rayzon,"Parecoxib (Sodium)",Dynastat,"SC 69124A","Parecoxib sodium salt","PARECOXIB Na",SC-69124A,SC69124A,"Parecoxib sodium (USAN)",UNII-EB87433V6F,U
NIIEB87433V6F,"sodium ((4-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfon","sodium ((4(5methyl3phenylisoxazol4yl)phenyl)sulfon",SAM001246773,CPD000469594}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23715649,15895902,74089340}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 24  0  0  1  0            999 V2000
    2.6640   -0.1280    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0
   -6.4952    3.7500    0.0000 O   0  0
   -3.8971    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0  2  0  0  0
   -1.2990    2.2500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.3326   -2.9571    0.0000 C   0  0
    1.8253   -3.1044    0.0000 C   0  0
    2.4266   -1.7302    0.0000 C   0  0  2  0  0  0
    3.8900   -1.4008    0.0000 O   0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  6
  7  8  1  0
  8  9  1  0
  9 10  2  3
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15  5  1  0
 15  9  1  0
 15 16  1  1
  6 17  1  0
 17  2  1  0
 17 18  1  1
 18 19  1  0
 19 20  1  0
 20  2  1  0
 20 21  1  1
M  END
> <name>
NIHCC_2014

> <id>
6043

> <plate>
NGP-105-06

> <well>
D02

> <supplier_cmpd_name>
CPD000058344

> <ctcr_id>
2572

> <supplier_cmpd_id>
SAM001246921

> <smiles>
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O

> <pd_targets>
{HSD17B10,ERG2,AR,SHBG,SRD5A1,SRD5A2,CYP3A4,TSHR,PGR,NR1I3,LMNA,SERPINA6,SIGMAR1,CYP19A1,CACNA1C,GPBAR1,CYP51A1,NR3C1,SLCO1A1,ESR1,OR51E2}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Secreted protein","Membrane receptor","Other nuclear protein","Ion channel",Transporter,Oxidoreductase,Isomerase,"Nuclear receptor","Cytochrome P450","Family A G protei
n-coupled receptor","Voltage-gated ion channel","Electrochemical transporter","Nuclear hormone receptor subfamily 3","Cytochrome P450 family 3","Peptide receptor (family A GPCR)","Nuclear hormone rece
ptor subfamily 1","Cytochrome P450 family 19","Voltage-gated calcium channel","Small molecule receptor (family A GPCR)","Cytochrome P450 family 51","SLC superfamily of solute carriers","Nuclear hormon
e receptor subfamily 3 group C","Cytochrome P450 family 3A","Glycohormone receptor","Nuclear hormone receptor subfamily 1 group I","Cytochrome P450 family 19A","Lipid-like ligand receptor (family A GP
CR)","Cytochrome P450 family 51A","SLC21/SLCO family of organic anion transporting polypeptides","Nuclear hormone receptor subfamily 3 group A","Nuclear hormone receptor subfamily 3 group C member 4",
"Cytochrome P450 3A4","Nuclear hormone receptor subfamily 3 group C member 3","Nuclear hormone receptor subfamily 1 group I member 3","Cytochrome P450 19A1","Steroid-like ligand receptor","Cytochrome 
P450 51A1","Nuclear hormone receptor subfamily 3 group C member 1","Nuclear hormone receptor subfamily 3 group A member 1","Unclassified protein"}

> <pathway_chembl>
{Receptors,Enzymes,"Other protein targets","Ion channels","Nuclear hormone receptors","Cytochrome P450","G protein-coupled receptors","Sigma receptors","Voltage-gated ion channels","Steroid hormone re
ceptors","CYP3 family","Glycoprotein hormone receptors","1I. Vitamin D receptor-like receptors",CYP11,CYP17,CYP19,"CYP20 and CYP21 families","Voltage-gated calcium channels","Bile acid receptor",CYP39
,"CYP46 and CYP51 families","3C. 3-Ketosteroid receptors","3A. Estrogen receptors"}

> <pathway_reactome>
{Metabolism,"Gene expression (Transcription)",Disease,"Cell Cycle","Developmental Biology","Metabolism of amino acids and derivatives","RNA Polymerase II Transcription","Metabolism of lipids","Infecti
ous disease",Mitotic,"Biological oxidations","Nervous system development","Branched-chain amino acid catabolism","Generic Transcription Pathway","Biosynthesis of specialized proresolving mediators (SP
Ms)","Leishmania infection","M Phase","Metabolism of steroids","SARS-CoV Infections","Phase I - Functionalization of compounds","Axon guidance","Transcriptional regulation by RUNX2","Biosynthesis of D
HA-derived SPMs","Leishmania parasite growth and survival","Nuclear Receptor transcription pathway","Mitotic Metaphase and Anaphase","Metabolism of steroid hormones","Potential therapeutics for SARS",
"Cytochrome P450 - arranged by substrate type","NCAM signaling for neurite out-growth","FOXO-mediated transcription","Transcriptional regulation by RUNX1","RUNX2 regulates bone development","Biosynthe
sis of maresins","Anti-inflammatory response favouring Leishmania parasite infection","Mitotic Anaphase","Glucocorticoid biosynthesis","Endogenous sterols","NCAM1 interactions","FOXO-mediated transcri
ption of oxidative stress","metabolic and neuronal genes","RUNX1 regulates estrogen receptor mediated transcription","RUNX2 regulates osteoblast differentiation","Biosynthesis of maresin-like SPMs","A
DORA2B mediated anti-inflammatory cytokines production","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation","Signal Transduction","Signaling by GPCR","GPCR downstream 
signalling","G alpha (s) signalling events","Olfactory Signaling Pathway"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{testosterone,58-22-0,58220,Testosteron,Androderm,Testim,Testoderm,Mertestate,Virosterone,Androlin,Oreton,AndroGel,"Synandrol F",Testostosterone,Andropatch,Malerone,Testogel,Testoviron,trans-Testoster
one,transTestosterone,Relibra,"Cristerone T",LibiGel,17beta-Hydroxy,17betaHydroxy,SAM001246921,CPD000058344}

> <pdid>
PD001987

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{6013}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 24  0  0  1  0            999 V2000
    2.6640   -0.1280    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0  1  0  0  0
   -6.4952    3.7500    0.0000 O   0  0
   -3.8971    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0  2  0  0  0
   -1.2990    2.2500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.3326   -2.9571    0.0000 C   0  0
    1.8253   -3.1044    0.0000 C   0  0
    2.4266   -1.7302    0.0000 C   0  0
    3.8900   -1.4008    0.0000 O   0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  6
  7  8  1  0
  8  9  2  3
  9 10  1  0
 10 11  1  0
 11 12  1  1
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15  5  1  0
 15  9  1  0
 15 16  1  1
  6 17  1  0
 17  2  1  0
 17 18  1  1
 18 19  1  0
 19 20  1  0
 20  2  1  0
 20 21  2  0
M  END
> <name>
NIHCC_2014

> <id>
6044

> <plate>
NGP-105-06

> <well>
D03

> <supplier_cmpd_name>
CPD000059075

> <ctcr_id>
5622

> <supplier_cmpd_id>
SAM001246922

> <smiles>
C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CCC2=O

> <pd_targets>
{G6PD,SHBG,KMT2A,MEN1,PMP22,SERPINA6,LMNA,CYP3A4,GPBAR1,ESR2,ESR1,GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG3,GABRP,GABRQ,GRIN1,GRIN2A,GRIN2B,GRIN2C
,GRIN2D,GRIN3A,GRIN3B,AR,PPARA,SIGMAR1,NR1I2,NR1I3}

> <pathway_gtopdb>
{Enzyme,"Secreted protein","Epigenetic regulator","Unclassified protein","Other nuclear protein","Membrane receptor","Transcription factor","Ion channel",Oxidoreductase,Reader,"Cytochrome P450","Famil
y A G protein-coupled receptor","Nuclear receptor","Ligand-gated ion channel",Bromodomain,"Cytochrome P450 family 3","Small molecule receptor (family A GPCR)","Nuclear hormone receptor subfamily 3","G
ABA-A receptor","Ionotropic glutamate receptor","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 3A","Lipid-like ligand receptor (family A GPCR)","Nuclear hormone receptor subfamily 3 gr
oup A","NMDA receptor","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 1 group C","Nuclear hormone receptor subfamily 1 group I","Cytochrome P450 3A4","Steroid-like 
ligand receptor","Nuclear hormone receptor subfamily 3 group A member 2","Nuclear hormone receptor subfamily 3 group A member 1","Nuclear hormone receptor subfamily 3 group C member 4","Nuclear hormon
e receptor subfamily 1 group C member 1","Nuclear hormone receptor subfamily 1 group I member 2","Nuclear hormone receptor subfamily 1 group I member 3"}

> <pathway_chembl>
{Enzymes,Receptors,"Other protein targets","Cytochrome P450","G protein-coupled receptors","Nuclear hormone receptors","Sigma receptors","CYP3 family","Bile acid receptor","Steroid hormone receptors",
"1C. Peroxisome proliferator-activated receptors","1I. Vitamin D receptor-like receptors","3A. Estrogen receptors","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"Gene expression (Transcription)","Developmental Biology",Metabolism,"Cell Cycle",Disease,"Signal Transduction","Metabolism of proteins","RNA Polymerase II Transcription","Nervous system development"
,"Metabolism of lipids",Mitotic,"Infectious disease","Intracellular signaling by second messengers","Post-translational protein modification","Generic Transcription Pathway","EGR2 and SOX10-mediated i
nitiation of Schwann cell myelination","Metabolism of steroids","M Phase","Biosynthesis of specialized proresolving mediators (SPMs)","Leishmania infection","PIP3 activates AKT signaling","SARS-CoV In
fections",SUMOylation,"Transcriptional Regulation by TP53","Metabolism of steroid hormones","Mitotic Metaphase and Anaphase","Biosynthesis of DHA-derived SPMs","Leishmania parasite growth and survival
","Negative regulation of the PI3K/AKT network","Transcriptional regulation by RUNX1","Transcriptional regulation by RUNX2","Regulation of cholesterol biosynthesis by SREBP (SREBF)","Potential therape
utics for SARS","SUMO E3 ligases SUMOylate target proteins","Nuclear Receptor transcription pathway","TP53 Regulates Metabolic Genes","Glucocorticoid biosynthesis","Mitotic Anaphase","Biosynthesis of 
maresins","Anti-inflammatory response favouring Leishmania parasite infection",PI5P,"PP2A and IER3 Regulate PI3K/AKT Signaling","RUNX1 regulates estrogen receptor mediated transcription","RUNX2 regula
tes bone development","Activation of gene expression by SREBF (SREBP)","SUMOylation of intracellular receptors","Nuclear Envelope (NE) Reassembly","Biosynthesis of maresin-like SPMs","ADORA2B mediated
 anti-inflammatory cytokines production","RUNX2 regulates osteoblast differentiation","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ESR1,ESR2,G6PD,GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG3,GABRP,GABRQ,GRIN1,GRIN2A,GRIN2B,GRIN2C,GRIN2D,GRIN3A,GRIN3B,HSD17B1,NR1I2,NR1I3,PPARA,SI
GMAR1,SULT2A1,SULT2B1}

> <broad_moa>
{"protein synthesis stimulant"}

> <synonyms>
{Dehydroepiandrosterone,DHEA,PRASTERONE,53-43-0,53430,Dehydroisoandrosterone,Androstenolone,trans-Dehydroandrosterone,transDehydroandrosterone,Psicosterone,Diandron,Diandrone,3beta-hydroxyandrost-5-en
-17-one,3betahydroxyandrost5en17one,17-Hormoforin,17Hormoforin,Prestara,17-Chetovis,17Chetovis,Andrestenol,5-Dehydro,5Dehydro,T0856L,SAM001246922,CPD000059075}

> <pdid>
PD000630

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5881}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 23  0  0  0  0            999 V2000
    4.9852    2.6764    0.0000 C   0  0
    3.8856    1.6562    0.0000 N   0  0
    4.2194    0.1938    0.0000 C   0  0
    3.1198   -0.8265    0.0000 C   0  0
    1.6852   -0.3846    0.0000 N   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.4522    2.0983    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
    0.1115    3.2255    0.0000 C   0  0
   -1.1278    4.0705    0.0000 C   0  0
   -2.4793    3.4196    0.0000 C   0  0
   -2.5914    1.9238    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 N   0  0
    0.7500   -1.5574    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  2  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20  5  1  0
 20 15  1  0
M  END
> <name>
NIHCC_2014

> <id>
6045

> <plate>
NGP-105-06

> <well>
D04

> <supplier_cmpd_name>
CPD000466347

> <ctcr_id>
2914

> <supplier_cmpd_id>
SAM001246659

> <smiles>
CN1CCN2C(C1)c3ccccc3Cc4cccnc24

> <pd_targets>
{ADRA2A,HTR2A,DRD2,HTR2C,HTR7,CYP2C19,CYP2D6,ADRA2C,HTR1A,SLC6A2,TSHR,CYP2C9,ADRA2B,ADRA1A,ADRA1B,ADRA1D,HRH1,CYP1A2,DRD3,HTR3A,OPRK1,AMPC,HTR2B}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,Transporter,"Ion channel","Family A G protein-coupled receptor","Cytochrome P450","Electrochemical transporter","Ligand-gated ion channel",Hydrolase,"Small molecule recepto
r (family A GPCR)","Cytochrome P450 family 2","SLC superfamily of solute carriers","Peptide receptor (family A GPCR)","Cytochrome P450 family 1","5HT3 receptor","Monoamine receptor","Cytochrome P450 f
amily 2C","Cytochrome P450 family 2D","SLC06 neurotransmitter transporter family","Glycohormone receptor","Cytochrome P450 family 1A","Short peptide receptor (family A GPCR)","Adrenergic receptor","Se
rotonin receptor","Dopamine receptor","Cytochrome P450 2C19","Cytochrome P450 2D6","Cytochrome P450 2C9","Histamine receptor","Cytochrome P450 1A1","Opioid receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"Ion channels","G protein-coupled receptors","Cytochrome P450","Ligand-gated ion channels",Adrenoceptors,"5-Hydroxytryptamine receptors","Dopamine receptors","CYP2 family: drug meta
bolising subset","Glycoprotein hormone receptors","Histamine receptors","CYP1 family","5-HT<sub>3</sub> receptors","Opioid receptors"}

> <pathway_reactome>
{"Signal Transduction",Disease,Metabolism,"Neuronal System","Gene expression (Transcription)","Signaling by GPCR","Infectious disease","Biological oxidations","Transmission across Chemical Synapses","
RNA Polymerase II Transcription","GPCR ligand binding","Leishmania infection","Phase I - Functionalization of compounds","Neurotransmitter receptors and postsynaptic signal transmission","Generic Tran
scription Pathway","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","Cytochrome P450 - arranged by substrate type","Transcriptional Regulation by MECP2","Amine ligand-b
inding receptors","Anti-inflammatory response favouring Leishmania parasite infection",Xenobiotics,"MECP2 regulates neuronal receptors and channels",Adrenoceptors,"Serotonin receptors","Dopamine recep
tors","ADORA2B mediated anti-inflammatory cytokines production","CYP2E1 reactions","Histamine receptors","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2"}

> <broad_targets>
{ADRA2A,ADRA2B,ADRA2C,HTR2A,HTR2C}

> <broad_moa>
{"adrenergic receptor antagonist","serotonin receptor antagonist"}

> <synonyms>
{mirtazapine,85650-52-8,85650528,Remeron,61337-67-5,61337675,Mepirzepine,Remergil,Zispin,Remergon,Mirtazepine,Rexer,6-Azamianserin,6Azamianserin,"Remeron SolTab",Mepirzapin,Mirtazipine,Promyrtil,Norse
t,"ORG 3770",Mirtazapina,Avanza,Mirtazapinum,"Mirtazapinum (INN-Latin)","Mirtazapinum (INNLatin)",Mi,T0137,SAM001246659,Prestw-1144,Mirtazapine,CPD000466347}

> <pdid>
PD000124

> <targets>
{5-HT Receptor,Adrenergic Receptor,Histamine Receptor}

> <classes>
{GPCR/G Protein,Immunology/Inflammation,Neuronal Signaling}

> <pubchem_cids>
{4205}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 25  0  0  0  0            999 V2000
    4.9852    2.6764    0.0000 Cl  0  0
    3.8856    1.6562    0.0000 C   0  0
    4.2194    0.1938    0.0000 C   0  0
    3.1198   -0.8265    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -3.1695   -0.6090    0.0000 C   0  0
   -3.7175   -2.0053    0.0000 C   0  0
   -2.7822   -3.1781    0.0000 C   0  0
   -1.2990   -2.9545    0.0000 N   0  0
   -0.7500   -1.5574    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
    1.4012   -2.9095    0.0000 C   0  0
    0.4925   -4.1079    0.0000 C   0  0
    1.0734   -5.4909    0.0000 C   0  0
    2.5615   -5.6793    0.0000 N   0  0
    3.4687   -4.4848    0.0000 C   0  0
    2.8879   -3.1018    0.0000 C   0  0
    2.4522    2.0983    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 14 15  1  0
 15  5  1  0
 15 16  2  3
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 16  1  0
  6 22  2  0
 22  2  1  0
M  END
> <name>
NIHCC_2014

> <id>
6046

> <plate>
NGP-105-06

> <well>
D05

> <supplier_cmpd_name>
CPD000149358

> <ctcr_id>
6488

> <supplier_cmpd_id>
SAM001246545

> <smiles>
Clc1ccc2c(CCc3cccnc3C2=C4CCNCC4)c1

> <pd_targets>
{KMT2A,MEN1,GLRA1,GLRA2,GLRA3,GLRB,HRH1,HRH4,ADRA1B,LMNA,AMPC,TGR,SLC6A2,CHRM2,HTR2A,HRH2,CHRM4,CHRM5,SLC6A4,ABCB1,DRD3,CHRM3,HTR2C,ADRA2B,HTR2B,SLC6A3,CHRM1,HTR6}

> <pathway_gtopdb>
{"Epigenetic regulator","Ion channel","Membrane receptor","Other nuclear protein",Enzyme,Transporter,Reader,"Ligand-gated ion channel","Family A G protein-coupled receptor",Hydrolase,"Electrochemical 
transporter","Primary active transporter",Bromodomain,"Glycine receptor","Small molecule receptor (family A GPCR)","SLC superfamily of solute carriers","ATP-binding cassette","Monoamine receptor","SLC
06 neurotransmitter transporter family","ABCB subfamily","Histamine receptor","Adrenergic receptor","Acetylcholine receptor","Serotonin receptor","Dopamine receptor"}

> <pathway_chembl>
{Receptors,Transporters,"G protein-coupled receptors","SLC superfamily of solute carriers","ATP-binding cassette transporter family","Histamine receptors",Adrenoceptors,"SLC6 neurotransmitter transpor
ter family","Acetylcholine receptors (muscarinic)","5-Hydroxytryptamine receptors","ABCB subfamily","Dopamine receptors","Monoamine transporter subfamily"}

> <pathway_reactome>
{"Signal Transduction","Cell Cycle",Disease,"Neuronal System",Metabolism,"Signaling by GPCR",Mitotic,"Disorders of transmembrane transporters","Infectious disease","Transmission across Chemical Synaps
es","Abacavir transport and metabolism","GPCR ligand binding","M Phase","SLC transporter disorders","Leishmania infection","Neurotransmitter clearance","Abacavir transmembrane transport","Class A/1 (R
hodopsin-like receptors)","Mitotic Metaphase and Anaphase","Defective SLC6A2 causes orthostatic intolerance (OI)","Leishmania parasite growth and survival","Serotonin clearance from the synaptic cleft
","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Amine ligand-binding receptors","Mitotic Anaphase","Anti-inflammatory response favouring Leishmania parasite infection","Histamine 
receptors",Adrenoceptors,"Nuclear Envelope (NE) Reassembly","Muscarinic acetylcholine receptors","Serotonin receptors","ADORA2B mediated anti-inflammatory cytokines production","Dopamine receptors","I
nitiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{HRH1}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{Desloratadine,100643-71-8,100643718,Clarinex,Descarboethoxyloratadine,Desloratidine,Neoclarityn,Sch-34117,Sch34117,Aerius,Azomyr,Denosin,"Sch 34117",Descarboethoxyoratidine,UNII-FVF865388R,UNIIFVF865
388R,MFCD00871949,CHEMBL1172,"Loratadine related compound a",C19H19ClN2,MLS000559042,S4012,SAM001246545,1505393,Prestw-1390,CPD000149358,DESLORATIDINE}

> <pdid>
PD000515

> <targets>
{"Histamine Receptor"}

> <classes>
{H1-antihistamine,"Neuronal Signaling"}

> <pubchem_cids>
{124087}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 23  0  0  0  0            999 V2000
    3.1476   -0.7184    0.0000 O   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 N   0  0
    0.0000    1.7286    0.0000 C   0  0
    0.0000    3.2293    0.0000 C   0  0
   -1.2561    4.0476    0.0000 C   0  0
   -1.1794    5.5457    0.0000 C   0  0
    0.1563    6.2283    0.0000 C   0  0
    1.4153    5.4128    0.0000 C   0  0
    1.3386    3.9148    0.0000 C   0  0
    2.5979    3.0998    0.0000 Cl  0  0
   -1.3515    1.0777    0.0000 C   0  0
   -2.4523    2.0983    0.0000 C   0  0
   -3.8856    1.6561    0.0000 C   0  0
   -4.9852    2.6764    0.0000 Cl  0  0
   -4.2194    0.1937    0.0000 C   0  0
   -3.1198   -0.8265    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 N   0  0
    0.7500   -1.5574    0.0000 C   0  0
    1.4008   -2.9088    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  3
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 10 11  1  0
  4 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 16 17  1  0
 17 18  2  0
 18 12  1  0
 18 19  1  0
 19 20  1  0
 20  2  1  0
 20 21  2  0
M  END
> <name>
NIHCC_2014

> <id>
6047

> <plate>
NGP-105-06

> <well>
D06

> <supplier_cmpd_name>
CPD000058410

> <ctcr_id>
6828

> <supplier_cmpd_id>
SAM001246833

> <smiles>
OC1N=C(c2ccccc2Cl)c3cc(Cl)ccc3NC1=O

> <pd_targets>
{FABP1,LMNA,GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG3,GABRP,GABRQ,ADRA1B,GPR68,AMPC,ALD}

> <pathway_gtopdb>
{"Auxiliary transport protein","Other nuclear protein","Ion channel","Membrane receptor","Fatty acid binding protein family","Ligand-gated ion channel","Family A G protein-coupled receptor","GABA-A re
ceptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Adrenergic receptor",Enzyme,Hydrolase}

> <pathway_chembl>
{"Other protein targets",Receptors,"Fatty acid-binding proteins","G protein-coupled receptors",Adrenoceptors,"Orphan and other 7TM receptors","Class A Orphans"}

> <pathway_reactome>
{Metabolism,"Cell Cycle","Signal Transduction","Metabolism of lipids",Mitotic,"Signaling by GPCR","Regulation of lipid metabolism by PPARalpha","M Phase","GPCR ligand binding","GPCR downstream signall
ing","PPARA activates gene expression","Mitotic Metaphase and Anaphase","Class A/1 (Rhodopsin-like receptors)","G alpha (q) signalling events","Mitotic Anaphase","Amine ligand-binding receptors","Nucl
ear Envelope (NE) Reassembly",Adrenoceptors,"Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{lorazepam,Ativan,846-49-1,846491,o-Chloroxazepam,oChloroxazepam,o-Chlorooxazepam,oChlorooxazepam,Temesta,Tavor,Delormetazepam,Almazine,Anxiedin,Bonatranquan,Duralozam,Emotival,Lorabenz,Sedatival,Laub
eel,Orfidal,Punktyl,Lorax,Loraz,Quait,Wypax,Apo-Lorazepam,ApoLorazepam,"Lorazepam Intensol",No,SAM001246833,CPD000058410}

> <pdid>
PD003117

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{3958}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 29  0  0  1  0            999 V2000
    5.1996   -1.4928    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
    0.0031    3.0008    0.0000 C   0  0
    1.3039    3.7494    0.0000 S   0  0
    1.3070    5.2494    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    0.0000   -1.5000    0.0000 C   0  0  1  0  0  0
    0.0000   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -1.8481   -5.2205    0.0000 C   0  0
   -3.3481   -5.2205    0.0000 N   0  0
   -3.8971   -3.7500    0.0000 C   0  0
   -5.1961   -3.0000    0.0000 C   0  0
   -5.1962   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
    9.0003    1.5149    0.0000 C   0  0
    9.0003    0.0149    0.0000 S   0  0
    9.0003   -1.4851    0.0000 O   0  0
    7.7010   -0.7347    0.0000 O   0  0
   10.2996   -0.7347    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  1
  7  8  1  0
  8  9  1  0
  6 10  1  0
 11 10  1  1
 11 12  1  0
 12  4  1  0
 12 13  1  6
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 11  1  0
 21 22  2  0
 22 14  1  0
 22 17  1  0
 23 24  1  0
 24 25  1  0
 24 26  2  0
 24 27  2  0
M  END
> <name>
NIHCC_2014

> <id>
6048

> <plate>
NGP-105-06

> <well>
D07

> <supplier_cmpd_name>
CPD000058504

> <ctcr_id>
4632

> <supplier_cmpd_id>
SAM001247070

> <smiles>
CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc3c[nH]c4cccc2c34.C[S](O)(=O)=O

> <pd_targets>
{DRD2,HTR1B,DRD3,HTR7,HTR1A,ADRA1B,ADRA2A,DRD1,ADRA2B,ADRA2C,ADRA1A,KCNH2,DRD5,HTR2A,HTR2B,HTR6,ADRA1D,DRD4,HTR2C,FFP,CYP3A4,HTR1D,HTR1F,HTR3A,HTR3B,HTR4,HTR5A,HTR5B,HRH1,BLM,CYP2D6}

> <pathway_gtopdb>
{"Membrane receptor","Ion channel",Enzyme,"Family A G protein-coupled receptor","Voltage-gated ion channel",Transferase,"Cytochrome P450","Small molecule receptor (family A GPCR)","Potassium channels"
,"Cytochrome P450 family 3","Cytochrome P450 family 2","Monoamine receptor","Voltage-gated potassium channel","Cytochrome P450 family 3A","Cytochrome P450 family 2D","Dopamine receptor","Serotonin rec
eptor","Adrenergic receptor","Cytochrome P450 3A4","Histamine receptor","Cytochrome P450 2D6"}

> <pathway_chembl>
{Receptors,"Ion channels",Enzymes,"G protein-coupled receptors","Voltage-gated ion channels","Cytochrome P450","Dopamine receptors","5-Hydroxytryptamine receptors",Adrenoceptors,"Potassium channels","
CYP3 family","Histamine receptors","CYP2 family: drug metabolising subset","Voltage-gated potassium channels"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Muscle contraction",Metabolism,"DNA Repair","Signaling by GPCR","Infectious disease","Cardiac conduction","Metabolism of lipids","DNA Double-Strand Break Repair","Biolo
gical oxidations","GPCR ligand binding","Leishmania infection","Phase 3 - rapid repolarisation","Biosynthesis of specialized proresolving mediators (SPMs)","Homology Directed Repair","Phase I - Functi
onalization of compounds","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","Biosynthesis of DHA-derived SPMs","HDR through Homologous Recombination (HRR) or Single Stra
nd Annealing (SSA)","Cytochrome P450 - arranged by substrate type","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Biosynthesis of maresins","HDR
 through Homologous Recombination (HRR)",Xenobiotics,"Dopamine receptors","Serotonin receptors","ADORA2B mediated anti-inflammatory cytokines production",Adrenoceptors,"Biosynthesis of maresin-like SP
Ms","Histamine receptors","Homologous DNA Pairing and Strand Exchange","CYP2E1 reactions","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,ADRA2A,ADRA2B,ADRA2C,DRD1,DRD2,DRD3,DRD4,DRD5,HTR1A,HTR1B,HTR1D,HTR2A,HTR2B,HTR2C}

> <broad_moa>
{"dopamine receptor agonist"}

> <synonyms>
{"PERGOLIDE MESYLATE",66104-23-2,66104232,"Pergolide Methanesulfonate","PERGOLIDE MESYLATE SALT","Pergolide (mesylate)","Pergolide mesilate",LY127809,UNII-55B9HQY616,UNII55B9HQY616,"8-beta-((Methylthi
o)methyl)-6-propylergoline methanesulfonate","8beta((Methylthio)methyl)6propylergoline methanesulfonate",MLS000069837,CHEBI:8021,55B9H,S4000,SAM001247070,1503269,Prestw-295,"Pergolide mesylate",CPD000
058504}

> <pdid>
PD009755

> <targets>
{"Dopamine Receptor"}

> <classes>
{"dopamine receptor agonist","Neuronal Signaling"}

> <pubchem_cids>
{47812,11292791}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 25  0  0  0  0            999 V2000
    5.1774   -7.5107    0.0000 C   0  0
    5.1845   -6.0107    0.0000 C   0  0
    3.8888   -5.2533    0.0000 N   0  0
    2.5868   -5.9998    0.0000 C   0  0
    1.2903   -5.2455    0.0000 C   0  0
    2.5814   -7.4998    0.0000 O   0  0
    3.8943   -3.7525    0.0000 C   0  0
    5.1945   -3.0045    0.0000 C   0  0
    5.1969   -1.5045    0.0000 C   0  0
    3.8991   -0.7525    0.0000 C   0  0
    2.5987   -1.5004    0.0000 C   0  0
    2.5965   -3.0004    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
   -0.3114   -2.9665    0.0000 N   0  0
   -1.8032   -3.1233    0.0000 C   0  0
   -2.4133   -1.7530    0.0000 C   0  0
   -3.8788   -1.4412    0.0000 C   0  0
   -5.3459   -1.1290    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  3  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 13  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 17  2  0
 21 22  1  0
 22 23  3  0
M  END
> <name>
NIHCC_2014

> <id>
6049

> <plate>
NGP-105-06

> <well>
E02

> <supplier_cmpd_name>
CPD000238180

> <ctcr_id>
3430

> <supplier_cmpd_id>
SAM001246641

> <smiles>
CCN(C(C)=O)c1cccc(c1)c2ccnc3n2ncc3C#N

> <pd_targets>
{KDM4E,GABRA1,MAPK1,AOX1,GABRB2,GABRG2,GABRA2,GABRB3,GABRB1}

> <pathway_gtopdb>
{"Epigenetic regulator","Ion channel",Enzyme,Eraser,"Ligand-gated ion channel",Kinase,Oxidoreductase,"Lysine demethylase","GABA-A receptor","Protein Kinase","Jumonji domain-containing","CMGC protein k
inase group","CMGC protein kinase MAPK family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,"Ion channels","Chromatin modifying enzymes","Ligand-gated ion channels","Kinases (EC 2.7.x.x)","1.14.11.- Histone demethylases","GABA<sub>A</sub> receptors","CMGC: Containing CDK",MAPK,GSK3,
"CLK families","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Neuronal System","Immune System",Metabolism,"Transmission across Chemical Synapses","Innate Immune System","Metabolism of vitamins and cofactors","Neurotransmitter receptors and postsynaptic signal 
transmission","Toll-like Receptor Cascades","Metabolism of water-soluble vitamins and cofactors","GABA receptor activation","Toll Like Receptor 5 (TLR5) Cascade","Vitamins B6 activation to pyridoxal p
hosphate","MyD88 cascade initiated on plasma membrane","MAP kinase activation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{zaleplon,151319-34-5,151319345,"151319 34 5",Sonata,Zerene,"N-(3-(3-cyanopyrazolo(1,5-a)pyrimidin-7-yl)phenyl)-N-ethylacetamide","N(3(3cyanopyrazolo(1,5a)pyrimidin7yl)phenyl)Nethylacetamide","N (3 (3
 cyanopyrazolo(1","5 a)pyrimidin 7 yl)phenyl) N e",SAM001246641,1505925,Prestw-1369,CPD000238180,ZALEPLON,Zaleplon}

> <pdid>
PD000263

> <targets>
{}

> <classes>
{sedative,hypnotic}

> <pubchem_cids>
{5719}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 25  0  0  1  0            999 V2000
    1.8177  -11.3743    0.0000 C   0  0
    2.4298  -10.0049    0.0000 C   0  0
    1.5502   -8.7888    0.0000 C   0  0
    2.1626   -7.4186    0.0000 C   0  0
    1.2830   -6.2026    0.0000 C   0  0
    1.8954   -4.8324    0.0000 C   0  0  2  0  0  0
    3.3874   -4.6783    0.0000 O   0  0
    1.0157   -3.6164    0.0000 C   0  0
    1.6281   -2.2462    0.0000 C   0  0
    0.7500   -1.0323    0.0000 C   0  0  1  0  0  0
    1.2135    0.3943    0.0000 C   0  0  2  0  0  0
    2.6401    0.8578    0.0000 O   0  0
    0.0000    1.2760    0.0000 C   0  0
   -1.2135    0.3943    0.0000 C   0  0
   -2.6401    0.8578    0.0000 O   0  0
   -0.7500   -1.0323    0.0000 C   0  0  2  0  0  0
   -1.6332   -2.2426    0.0000 C   0  0
   -3.1255   -2.0835    0.0000 C   0  0
   -4.0102   -3.2959    0.0000 C   0  0
   -5.5026   -3.1369    0.0000 C   0  0
   -6.3873   -4.3492    0.0000 C   0  0
   -7.8796   -4.1902    0.0000 C   0  0
   -8.7643   -5.4026    0.0000 C   0  0
   -8.1566   -6.7740    0.0000 O   0  0
  -10.2559   -5.2436    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  1
  6  8  1  0
  8  9  2  0
 10  9  1  6
 10 11  1  0
 11 12  1  1
 11 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 10  1  0
 16 17  1  1
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  2  0
M  END
> <name>
NIHCC_2014

> <id>
6050

> <plate>
NGP-105-06

> <well>
E03

> <supplier_cmpd_name>
CPD000112594

> <ctcr_id>
4125

> <supplier_cmpd_id>
SAM001246840

> <smiles>
CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O

> <pd_targets>
{PTGIR,PTGER2,PTGER3,CATSPER1,CATSPER4,PTGER1,PTGER4,CATSPER3,PTGDR,CATSPER2,ABCC3,SLCO2B1,ABCC4,PTGDR2}

> <pathway_gtopdb>
{"Membrane receptor","Ion channel",Transporter,"Family A G protein-coupled receptor","Voltage-gated ion channel","Primary active transporter","Electrochemical transporter","Small molecule receptor (fa
mily A GPCR)","CatSper and Two-Pore channels","ATP-binding cassette","SLC superfamily of solute carriers","Lipid-like ligand receptor (family A GPCR)","ABCC subfamily","SLC21/SLCO family of organic an
ion transporting polypeptides","Prostanoid receptor"}

> <pathway_chembl>
{Receptors,"Ion channels",Transporters,"G protein-coupled receptors","Voltage-gated ion channels","ATP-binding cassette transporter family","SLC superfamily of solute carriers","Prostanoid receptors",
"CatSper and Two-Pore channels","ABCC subfamily","SLCO family of organic anion transporting polypeptides"}

> <pathway_reactome>
{Disease,"Signal Transduction",Reproduction,Metabolism,"Transport of small molecules",Hemostasis,"Infectious disease","Signaling by GPCR",Fertilization,"Metabolism of lipids","SLC-mediated transmembra
ne transport","Platelet activation","signaling and aggregation","Leishmania infection","GPCR ligand binding","Sperm Motility And Taxes","Metabolism of steroids","Transport of vitamins",nucleosides,"an
d related molecules","Response to elevated platelet cytosolic Ca2+","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Bile acid and bile salt metabolism","Transport of 
organic anions","Platelet degranulation","Anti-inflammatory response favouring Leishmania parasite infection","Eicosanoid ligand-binding receptors","Recycling of bile acids and salts","ADORA2B mediate
d anti-inflammatory cytokines production","Prostanoid ligand receptors"}

> <broad_targets>
{CATSPER1,CATSPER2,CATSPER3,CATSPER4,PTGDR,PTGER1,PTGER2,PTGER4,PTGIR}

> <broad_moa>
{"prostanoid receptor agonist"}

> <synonyms>
{alprostadil,"Prostaglandin E1",745-65-3,745653,PGE1,Edex,Caverject,Muse,"Prostin VR",Alprostadilum,Femprox,Befar,Alprox-TD,AlproxTD,"l-Prostaglandin E1","lProstaglandin E1",Liprostin,Prostandin,Vitar
os,PGE-1,Topiglan,Alprostadil(Caverject),(11alpha,13E,15S)-11,15S)11,15-dihydro,15dihydro,SAM001246840,Prestw-1018,CPD000112594,Alprostadil}

> <pdid>
PD002898

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5280723}

$$$$
NIHCC_2014
  SciTegic11012413002D

 31 33  0  0  0  0            999 V2000
   10.3996   -1.4837    0.0000 C   0  0
    9.0990   -0.7364    0.0000 C   0  0
    7.8003   -1.4887    0.0000 O   0  0
    6.4990   -0.7409    0.0000 C   0  0
    6.4964    0.7591    0.0000 O   0  0
    5.2003   -1.4932    0.0000 O   0  0
    3.8990   -0.7455    0.0000 C   0  0
    3.8973    0.2545    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 N   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 S   0  0
   -2.5800   -0.0305    0.0000 O   0  0
   -1.2638    2.2496    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    2.5972    1.5031    0.0000 C   0  0
    3.4641    1.0046    0.0000 O   0  0
    2.5951    3.0039    0.0000 N   0  0
    3.8933    3.7570    0.0000 C   0  0
    3.8933    5.2571    0.0000 C   0  0
    5.1924    6.0071    0.0000 C   0  0
    6.4914    5.2571    0.0000 C   0  0
    6.4915    3.7571    0.0000 C   0  0
    5.1925    3.0071    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  2  3
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  2  0
 14 16  2  0
 14 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 10  1  0
 22 17  1  0
 11 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
M  END
> <name>
NIHCC_2014

> <id>
6051

> <plate>
NGP-105-06

> <well>
E04

> <supplier_cmpd_name>
CPD000469285

> <ctcr_id>
6318

> <supplier_cmpd_id>
SAM001246707

> <smiles>
CCOC(=O)OC(C)OC1=C(N(C)[S](=O)(=O)c2ccccc12)C(=O)Nc3ccccn3

> <pd_targets>
{LMNA}

> <pathway_gtopdb>
{"Other nuclear protein"}

> <pathway_chembl>
{}

> <pathway_reactome>
{"Cell Cycle",Mitotic,"M Phase","Mitotic Metaphase and Anaphase","Mitotic Anaphase","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{PTGS1,PTGS2}

> <broad_moa>
{"cyclooxygenase inhibitor"}

> <synonyms>
{ampiroxicam,99464-64-9,99464649,Flucam,"CP 65703",Ampiroxicamum,CP-65703,CP65703,C20H21N3O7S,CHEBI:31210,NCGC00164605-01,NCGC0016460501,DSSTox_CID_26474,DSSToxCID26474,DSSTox-CID-26474,"DSSTox CID 26
474",DSSTox_RID_81645,DSSToxRID81645,DSSTox-RID-81645,"DSSTox RID 81645",DSSTox_GSID_46474,DSSToxGSID46474,DSSTox-GSID-46474,"DSSTox GSID 46474","Ampiroxicamum (Latin)",Nacyl,CAS-99464-64-9,CAS9946464
9,"BRN 5184713","Ampiroxicam (INN:BAN:JAN)",SAM001246707,CPD000469285}

> <pdid>
PD000728

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{2176}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 27  0  0  1  0            999 V2000
    6.3908    1.8251    0.0000 Na  0  3
    2.6640   -0.1280    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0
   -6.4944    3.7531    0.0000 O   0  0
   -6.4922    5.2539    0.0000 S   0  0
   -5.1919    6.0016    0.0000 O   0  5
   -7.7897    6.0066    0.0000 O   0  0
   -6.4894    6.7539    0.0000 O   0  0
   -3.8971    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.3326   -2.9571    0.0000 C   0  0
    1.8253   -3.1044    0.0000 C   0  0
    2.4266   -1.7302    0.0000 C   0  0
    3.8900   -1.4008    0.0000 O   0  0
  3  2  1  1
  3  4  1  0
  4  5  1  0
  6  5  1  1
  6  7  1  0
  7  8  1  6
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 14 17  2  0
 12 18  2  0
 18 19  1  0
 19 20  2  0
 20  6  1  0
 20 10  1  0
  7 21  1  0
 21  3  1  0
 21 22  1  1
 22 23  1  0
 23 24  1  0
 24  3  1  0
 24 25  2  0
M  CHG  2   1   1  15  -1
M  END
> <name>
NIHCC_2014

> <id>
6052

> <plate>
NGP-105-06

> <well>
E05

> <supplier_cmpd_name>
CPD000058772

> <ctcr_id>
6625

> <supplier_cmpd_id>
SAM001246904

> <smiles>
[Na+].C[C@]12CC[C@H]3[C@@H](CCc4cc(O[S]([O-])(=O)=O)ccc34)[C@@H]1CCC2=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Sodium estrone sulfate","ESTRONE SODIUM SULFATE",438-67-5,Conestoral,Hyhorin,Morestin,"Estrone sulfate sodium","Par Estro","Estrone-3-sulfate sodium salt","Sodium estrone 3-sulfate","Oestrone-3-sulp
hate sodium salt","Estrogenic substances (conjugated)",UNII-6K6FDA543A,"Estrone 3-sulfate sodium salt","Conjugated estrogens",6K6FDA543A,CHEBI:8389,"Estrone sodium sulphate","17-Oxoestra-1,3,5(10)-tri
en-3-yl sodium sulfate","Sodium estrone-3-sulfate","1,3,5(10)-ESTRATRIEN-3-OL-17-ONE SULPHATE, SODIUM SALT","Estrone sulfate sodium salt",SMR000058772,"EINECS 207-120-4","NSC 18313","Conjugated estrog
ens: sodium estrone sulfate","Estra-1,3,5(10)-trien-17-one,3-(sulfooxy)-, sodium salt (1:1)",ESTRONE3-SULFATESODIUMSALT,"sodium 17-oxoestra-1(10),2,4-trien-3-yl sulfate","Estrone, hydrogen sulfate, so
dium salt","Sodium Estrone sulphate",SCHEMBL4616,MLS000069757,MLS001424259,CHEMBL2106240,DTXSID00860005,DTXSID70881181,HMS2052J05,HMS2232J23,MFCD00070035,AKOS015967195,CCG-101163,NC00413,"1,3,5(10)-Es
tratrien-17-one 3-sulfate",D00312,Q4118295,"UNII-3ASP8Q3768 component VUCAHVBMSFIGAI-ZFINNJDLSA-M","UNII-8L6LAK9BTR component VUCAHVBMSFIGAI-ZFINNJDLSA-M","UNII-IU5QR144QX component VUCAHVBMSFIGAI-ZFI
NNJDLSA-M","UNII-JM2621P2LS component VUCAHVBMSFIGAI-ZFINNJDLSA-M","Estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, sodium salt (9CI)",SAM001246904,CPD000058772}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23667301}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 29  0  0  0  0            999 V2000
   13.7496   -0.6561    0.0000 Br  0  0
   -0.0060   -2.5971    0.0000 O   0  0
   -0.7540   -1.2970    0.0000 C   0  0
   -2.2621   -1.2970    0.0000 C   0  0
   -3.0162    0.0000    0.0000 C   0  0
   -3.8909    1.2065    0.0000 C   0  0
   -5.3236    0.7390    0.0000 C   0  0
   -5.3236   -0.7540    0.0000 C   0  0
   -3.8909   -1.2065    0.0000 C   0  0
   -2.2621    1.2970    0.0000 C   0  0
   -0.7540    1.2970    0.0000 C   0  0
   -0.0060    2.5971    0.0000 O   0  0
    0.0000    0.0000    0.0000 N   0  0
    1.5008   -0.0031    0.0000 C   0  0
    2.2493   -1.3039    0.0000 C   0  0
    3.7501   -1.3070    0.0000 N   0  0
    4.4987   -2.6078    0.0000 C   0  0
    5.9995   -2.6109    0.0000 C   0  0
    6.7496   -3.9099    0.0000 C   0  0
    8.2496   -3.9100    0.0000 O   0  0
    8.9996   -2.6110    0.0000 C   0  0
   10.4996   -2.6110    0.0000 C   0  0
   11.2496   -1.3120    0.0000 C   0  0
   10.4997   -0.0129    0.0000 C   0  0
    8.9997   -0.0129    0.0000 C   0  0
    8.2496   -1.3119    0.0000 C   0  0
    6.7496   -1.3119    0.0000 O   0  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  5  1  0
  5 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13  3  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 26 27  1  0
 27 18  1  0
M  END
> <name>
NIHCC_2014

> <id>
6053

> <plate>
NGP-105-06

> <well>
E06

> <supplier_cmpd_name>
CPD000469633

> <ctcr_id>
236

> <supplier_cmpd_id>
SAM001247108

> <smiles>
Br.O=C1CC2(CCCC2)CC(=O)N1CCNCC3COc4ccccc4O3

> <pd_targets>
{ALDH1A1,LEF,CYP3A4,CYP2D6,CYP1A2}

> <pathway_gtopdb>
{Enzyme,Oxidoreductase,Protease,"Cytochrome P450","Metallo protease","Cytochrome P450 family 3","Cytochrome P450 family 2","Cytochrome P450 family 1","Metallo protease MAE clan","Cytochrome P450 famil
y 3A","Cytochrome P450 family 2D","Cytochrome P450 family 1A","Metallo protease M34 family","Cytochrome P450 3A4","Cytochrome P450 2D6","Cytochrome P450 1A1"}

> <pathway_chembl>
{Enzymes,"Cytochrome P450","CYP3 family","CYP2 family: drug metabolising subset","CYP1 family"}

> <pathway_reactome>
{Metabolism,"Biological oxidations","Phase I - Functionalization of compounds","Ethanol oxidation",Disease,"Infectious disease","Metabolism of lipids","Uptake and actions of bacterial toxins","Biosynt
hesis of specialized proresolving mediators (SPMs)","Uptake and function of anthrax toxins","Biosynthesis of DHA-derived SPMs","Cytochrome P450 - arranged by substrate type","Biosynthesis of maresins"
,Xenobiotics,"Biosynthesis of maresin-like SPMs","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2"}

> <broad_targets>
{HTR1A}

> <broad_moa>
{"serotonin receptor antagonist"}

> <synonyms>
{MLS001424248,CCG-101171,CCG101171,NC00421,SMR000469633,SAM001247108,CPD000469633}

> <pdid>
PD013927

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581829}

$$$$
NIHCC_2014
  SciTegic11012413002D

 77 82  0  0  0  0            999 V2000
    9.0912    0.7685    0.0000 C   0  0
    7.7907    1.5158    0.0000 O   0  0
    6.4920    0.7636    0.0000 C   0  0
    6.4972   -0.7364    0.0000 C   0  0
    5.2007   -1.4909    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 C   0  0
    2.6015   -2.9986    0.0000 C   0  0
    3.9027   -3.7449    0.0000 C   0  0
    5.1996   -2.9912    0.0000 C   0  0
    6.5008   -3.7375    0.0000 C   0  0
    7.7968   -2.9807    0.0000 O   0  0
    7.7904   -1.4807    0.0000 C   0  0
    6.5050   -5.2375    0.0000 C   0  0
    7.8054   -5.9869    0.0000 O   0  0
    7.8075   -7.4869    0.0000 C   0  0
    5.2081   -5.9912    0.0000 C   0  0
    3.9070   -5.2449    0.0000 C   0  0
    2.6101   -5.9986    0.0000 C   0  0
    1.3089   -5.2523    0.0000 C   0  0
    1.3046   -3.7523    0.0000 N   0  3
    1.3371   -2.2526    0.0000 C   0  0
    0.0434   -4.5274    0.0000 C   0  0
    0.0470   -6.0283    0.0000 C   0  0
   -1.2504   -6.7826    0.0000 C   0  0
   -2.5515   -6.0362    0.0000 O   0  0
   -1.2468   -8.2835    0.0000 O   0  0
   -2.5443   -9.0378    0.0000 C   0  0
   -2.5406  -10.5387    0.0000 C   0  0
   -3.8381  -11.2930    0.0000 C   0  0
   -3.8344  -12.7939    0.0000 C   0  0
   -5.1319  -13.5482    0.0000 C   0  0
   -5.1282  -15.0491    0.0000 O   0  0
   -6.4257  -15.8035    0.0000 C   0  0
   -7.7268  -15.0570    0.0000 O   0  0
   -6.4221  -17.3043    0.0000 C   0  0
   -7.7195  -18.0587    0.0000 C   0  0
   -7.7159  -19.5595    0.0000 N   0  3
   -9.0128  -20.3130    0.0000 C   0  0
   -6.4549  -18.7854    0.0000 C   0  0
   -5.1540  -19.5320    0.0000 C   0  0
   -5.1501  -21.0320    0.0000 C   0  0
   -3.8491  -21.7787    0.0000 C   0  0
   -3.8452  -23.2787    0.0000 C   0  0
   -2.5420  -24.0230    0.0000 O   0  0
   -1.2460  -23.2678    0.0000 C   0  0
   -5.1423  -24.0320    0.0000 C   0  0
   -5.1415  -25.5328    0.0000 O   0  0
   -3.8426  -26.2830    0.0000 C   0  0
   -6.4433  -23.2854    0.0000 C   0  0
   -6.4472  -21.7854    0.0000 C   0  0
   -7.7481  -21.0387    0.0000 C   0  0
   -9.0560  -21.7745    0.0000 C   0  0
  -10.3479  -21.0106    0.0000 C   0  0
  -11.6563  -21.7441    0.0000 C   0  0
  -12.9458  -20.9779    0.0000 C   0  0
  -12.9270  -19.4780    0.0000 C   0  0
  -14.2188  -18.7141    0.0000 O   0  0
  -15.5261  -19.4496    0.0000 C   0  0
  -11.6187  -18.7444    0.0000 C   0  0
  -11.5968  -17.2437    0.0000 O   0  0
  -10.2874  -16.5119    0.0000 C   0  0
  -10.3291  -19.5106    0.0000 C   0  0
    3.8939    0.7546    0.0000 C   0  0
    5.1903    1.5091    0.0000 C   0  0
    5.1821    3.0099    0.0000 O   0  0
    3.8794    3.7535    0.0000 C   0  0
   15.4893   -1.1054    0.0000 O   0  5
   15.4898    0.3946    0.0000 S   0  0
   16.7893    1.1437    0.0000 O   0  0
   16.7885   -0.3561    0.0000 O   0  0
   14.1900    1.1450    0.0000 C   0  0
   14.1900    2.6450    0.0000 C   0  0
   12.8910    3.3950    0.0000 C   0  0
   11.5920    2.6450    0.0000 C   0  0
   11.5920    1.1450    0.0000 C   0  0
   12.8910    0.3950    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 11 14  2  0
 14 15  1  0
 15 16  1  0
 14 17  1  0
 17 18  2  0
 18  9  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21  8  1  0
 21 22  1  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  2  0
 34 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
 38 40  1  0
 40 41  1  0
 41 42  1  0
 42 43  2  0
 43 44  1  0
 44 45  1  0
 45 46  1  0
 44 47  2  0
 47 48  1  0
 48 49  1  0
 47 50  1  0
 50 51  2  0
 51 42  1  0
 51 52  1  0
 52 38  1  0
 52 53  1  0
 53 54  1  0
 54 55  2  0
 55 56  1  0
 56 57  2  0
 57 58  1  0
 58 59  1  0
 57 60  1  0
 60 61  1  0
 61 62  1  0
 60 63  2  0
 63 54  1  0
  6 64  1  0
 64 65  2  0
 65  3  1  0
 65 66  1  0
 66 67  1  0
 68 69  1  0
 69 70  2  0
 69 71  2  0
 69 72  1  0
 72 73  2  0
 73 74  1  0
 74 75  2  0
 75 76  1  0
 76 77  2  0
 77 72  1  0
M  CHG  3  21   1  38   1  68  -1
M  END
> <name>
NIHCC_2014

> <id>
6054

> <plate>
NGP-105-06

> <well>
E07

> <supplier_cmpd_name>
CPD000471626

> <ctcr_id>
4416

> <supplier_cmpd_id>
SAM001246793

> <smiles>
COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]4(C)CCc5cc(OC)c(OC)cc5C4Cc6ccc(OC)c(OC)c6)cc1OC.[O-][S](=O)(=O)c7ccccc7

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{CHRNA2}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{SMR000471626,MLS001333139,MLS001333140,MLS001424237,CHEMBL4584552,HMS2052J09,HMS2233O03,HMS3370E14,HMS3394J09,CCG-101179,CCG101179,NCGC00180990-01,NCGC0018099001,SAM001246793,CPD000471626}

> <pdid>
PD013187

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23641207}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 21  0  0  0  0            999 V2000
    0.9513   -6.4982    0.0000 C   0  0
    1.8372   -5.2877    0.0000 C   0  0
    3.3372   -5.2929    0.0000 S   0  0
    3.8056   -3.8679    0.0000 C   0  0
    5.2311   -3.4009    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.3786   -3.8595    0.0000 C   0  0
   -0.0436   -3.3826    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5988   -1.5004    0.0000 C   0  0
   -3.8983   -0.7513    0.0000 F   0  0
   -2.5983   -3.0004    0.0000 F   0  0
   -3.8975   -2.2510    0.0000 F   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  7  2  2  0
  7  8  1  0
  6  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 15 17  1  0
 17 18  1  0
 17 19  1  0
 17 20  1  0
M  END
> <name>
NIHCC_2014

> <id>
6055

> <plate>
NGP-105-06

> <well>
F02

> <supplier_cmpd_name>
CPD000468734

> <ctcr_id>
3356

> <supplier_cmpd_id>
SAM001247067

> <smiles>
Cc1sc(N)c(c1C)C(=O)c2cccc(c2)C(F)(F)F

> <pd_targets>
{MAPT,RORC,ALD,ADORA1,HSD17B10,KMT2A,MEN1,FFP,LEF,CYP3A4,CYP1A2,ALDH1A1}

> <pathway_gtopdb>
{"Other cytosolic protein","Transcription factor",Enzyme,"Membrane receptor","Epigenetic regulator","Nuclear receptor","Family A G protein-coupled receptor",Oxidoreductase,Reader,Transferase,Protease,
"Cytochrome P450","Nuclear hormone receptor subfamily 1","Small molecule receptor (family A GPCR)",Bromodomain,"Metallo protease","Cytochrome P450 family 3","Cytochrome P450 family 1","Nuclear hormone
 receptor subfamily 1 group F","Nucleotide-like receptor (family A GPCR)","Metallo protease MAE clan","Cytochrome P450 family 3A","Cytochrome P450 family 1A","Nuclear hormone receptor subfamily 1 grou
p F member 3","Adenosine receptor","Metallo protease M34 family","Cytochrome P450 3A4","Cytochrome P450 1A1"}

> <pathway_chembl>
{Receptors,Enzymes,"Nuclear hormone receptors","G protein-coupled receptors","Cytochrome P450","1F. Retinoic acid-related orphans","Adenosine receptors","CYP3 family","CYP1 family"}

> <pathway_reactome>
{"Neuronal System","Gene expression (Transcription)","Signal Transduction",Metabolism,Disease,"Transmission across Chemical Synapses","RNA Polymerase II Transcription","Signaling by GPCR","Metabolism 
of amino acids and derivatives","Infectious disease","Metabolism of lipids","Biological oxidations","Neurotransmitter receptors and postsynaptic signal transmission","Generic Transcription Pathway","G
PCR ligand binding","Branched-chain amino acid catabolism","Uptake and actions of bacterial toxins","Biosynthesis of specialized proresolving mediators (SPMs)","Phase I - Functionalization of compound
s","Activation of NMDA receptors and postsynaptic events","Transcriptional regulation by RUNX3","Class A/1 (Rhodopsin-like receptors)","Uptake and function of anthrax toxins","Biosynthesis of DHA-deri
ved SPMs","Cytochrome P450 - arranged by substrate type","Ethanol oxidation","Post NMDA receptor activation events","RUNX3 Regulates Immune Response and Cell Migration","Nucleotide-like (purinergic) r
eceptors","Biosynthesis of maresins",Xenobiotics,"Activation of AMPK downstream of NMDARs","Adenosine P1 receptors","Biosynthesis of maresin-like SPMs","Aromatic amines can be N-hydroxylated or N-deal
kylated by CYP1A2"}

> <broad_targets>
{ADORA1}

> <broad_moa>
{"adenosine receptor agonist"}

> <synonyms>
{"(2-Amino-4,5-dimethyl-thiophen-3-yl)-(3-trifluoromethyl-phenyl)-methanone","(2Amino4,5dimethylthiophen3yl)(3trifluoromethylphenyl)methanone","(2-amino-4,5-dimethylthien-3-yl)-(3-(trifluoromethyl)phe
nyl)-methanone","(2amino4,5dimethylthien3yl)(3(trifluoromethyl)phenyl)methanone",132861-87-1,132861871,"PD 81723",(2-amino-4,(2amino4,5-dimethylthiophen-3-yl)(3-(trifluoromethyl)phenyl)methanone,5dime
thylthiophen3yl)(3(trifluoromethyl)phenyl)methanone,SAM001247067,CPD000468734}

> <pdid>
PD002923

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{122028}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 28  0  0  1  0            999 V2000
   -0.6872   -2.7329    0.0000 C   0  0
    0.2851   -2.9666    0.0000 C   0  0  2  0  0  0
    0.7521   -4.3921    0.0000 O   0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0  1  0  0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.3115    7.4665    0.0000 N   0  0
   -1.8033    7.6233    0.0000 N   0  0
   -2.4134    6.2529    0.0000 C   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -1.2991    2.2500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -0.8141   -2.0807    0.0000 C   0  0
  2  1  1  1
  2  3  1  0
  2  4  1  0
  4  5  1  0
  6  5  1  6
  6  7  1  0
  7  8  1  1
  8  9  1  0
 10  9  1  6
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 12  2  0
 16 17  1  0
 17 18  1  0
 18 10  1  0
 18 19  1  6
 18 20  1  0
 20  7  1  0
 20 21  1  6
 21 22  1  0
 22 23  1  0
 23  2  1  0
 23  6  1  0
 23 24  1  6
M  END
> <name>
NIHCC_2014

> <id>
6056

> <plate>
NGP-105-06

> <well>
F03

> <supplier_cmpd_name>
CPD000058878

> <ctcr_id>
6960

> <supplier_cmpd_id>
SAM001246590

> <smiles>
C[C@]1(O)CC[C@H]2[C@@H]3CC[C@H]4Cc5[nH]ncc5C[C@]4(C)[C@H]3CC[C@]12C

> <pd_targets>
{AR,ESR1,PGR,ADORA3,CYP2D6,CYP2C19,CYP2C9}

> <pathway_gtopdb>
{"Transcription factor","Membrane receptor",Enzyme,"Nuclear receptor","Family A G protein-coupled receptor","Cytochrome P450","Nuclear hormone receptor subfamily 3","Small molecule receptor (family A 
GPCR)","Cytochrome P450 family 2","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 3 group A","Nucleotide-like receptor (family A GPCR)","Cytochrome P450 family 2D","
Cytochrome P450 family 2C","Nuclear hormone receptor subfamily 3 group C member 4","Nuclear hormone receptor subfamily 3 group A member 1","Nuclear hormone receptor subfamily 3 group C member 3","Aden
osine receptor","Cytochrome P450 2D6","Cytochrome P450 2C19","Cytochrome P450 2C9"}

> <pathway_chembl>
{Receptors,Enzymes,"Nuclear hormone receptors","G protein-coupled receptors","Cytochrome P450","Steroid hormone receptors","Adenosine receptors","CYP2 family: drug metabolising subset","3C. 3-Ketoster
oid receptors","3A. Estrogen receptors"}

> <pathway_reactome>
{"Gene expression (Transcription)","Signal Transduction",Metabolism,"RNA Polymerase II Transcription","Signaling by GPCR","Biological oxidations","Generic Transcription Pathway","GPCR ligand binding",
"Phase I - Functionalization of compounds","Transcriptional regulation by RUNX2","Transcriptional regulation by RUNX1","Class A/1 (Rhodopsin-like receptors)","Cytochrome P450 - arranged by substrate t
ype","RUNX2 regulates bone development","RUNX1 regulates estrogen receptor mediated transcription","Nucleotide-like (purinergic) receptors",Xenobiotics,"RUNX2 regulates osteoblast differentiation","Ad
enosine P1 receptors","CYP2E1 reactions"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{stanozolol,Winstrol,Androstanazole,10418-03-8,10418038,"10418 03 8",Androstanazol,Stromba,Stanazolol,Tevabolin,"Winstrol Depot",Strombaject,Estazol,Winstroid,"Winstrol V",Estanozolol,Stanozololum,"WI
N 14833",Anabol,UNII-4R1VB9P8V3,UNII4R1VB9P8V3,UNII4R1VB9P,SAM001246590,Prestw-1161,CPD000058878,Stanozolol}

> <pdid>
PD002859

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{25249}

$$$$
NIHCC_2014
  SciTegic11012413002D

 34 36  0  0  1  0            999 V2000
    6.5176  -10.3859    0.0000 C   0  0
    7.4010   -9.1736    0.0000 C   0  0
    6.7945   -7.8036    0.0000 C   0  0
    7.5445   -6.5046    0.0000 C   0  0
    9.0363   -6.3478    0.0000 C   0  0
    6.5408   -5.3899    0.0000 C   0  0
    5.1894   -6.0109    0.0000 N   0  0
    3.8912   -5.2578    0.0000 C   0  0
    2.5909   -6.0056    0.0000 O   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5988    1.5004    0.0000 S   0  0
   -3.8976    0.7500    0.0000 O   0  0
   -3.8982    2.2498    0.0000 O   0  0
   -2.5998    3.0012    0.0000 N   0  0
   -3.8995    3.7516    0.0000 C   0  0
   -5.1983    3.0012    0.0000 O   0  0
   -3.9005    5.2525    0.0000 N   0  0
   -5.2002    6.0029    0.0000 C   0  0  1  0  0  0
   -5.2034    7.5029    0.0000 C   0  0
   -6.5039    8.2502    0.0000 C   0  0
   -7.8014    7.4976    0.0000 C   0  0  2  0  0  0
   -9.1020    8.2449    0.0000 C   0  0
   -7.7984    5.9976    0.0000 C   0  0
   -6.4978    5.2502    0.0000 C   0  0
    5.3273   -7.4917    0.0000 C   0  0
    4.2066   -8.4888    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  3
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 16 19  1  0
 19 20  2  0
 19 21  2  0
 19 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 26 25  1  6
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  1
 29 31  1  0
 31 32  1  0
 32 26  1  0
  7 33  1  0
 33  3  1  0
 33 34  2  0
M  END
> <name>
NIHCC_2014

> <id>
6057

> <plate>
NGP-105-06

> <well>
F04

> <supplier_cmpd_name>
CPD000466368

> <ctcr_id>
4237

> <supplier_cmpd_id>
SAM001246710

> <smiles>
CCC1=C(C)CN(C(=O)NCCc2ccc(cc2)[S](=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)C1=O

> <pd_targets>
{ABCB11,ALD,RORC,ABCC3,ABCC4,ABCC8,KCNJ11,KCNJ1,HIF1A,CYP2C9}

> <pathway_gtopdb>
{Transporter,Enzyme,"Transcription factor","Ion channel","Primary active transporter","Nuclear receptor","Voltage-gated ion channel","Cytochrome P450","ATP-binding cassette","Nuclear hormone receptor 
subfamily 1","Potassium channels","Cytochrome P450 family 2","ABCB subfamily","Nuclear hormone receptor subfamily 1 group F","ABCC subfamily","Inwardly rectifying potassium channel","Cytochrome P450 f
amily 2C","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 2C9"}

> <pathway_chembl>
{Transporters,Receptors,"Ion channels",Enzymes,"ATP-binding cassette transporter family","Nuclear hormone receptors","Voltage-gated ion channels","Cytochrome P450","ABCB subfamily","1F. Retinoic acid-
related orphans","ABCC subfamily","Potassium channels","CYP2 family: drug metabolising subset","Inwardly rectifying potassium channels"}

> <pathway_reactome>
{Metabolism,"Gene expression (Transcription)",Hemostasis,Disease,"Neuronal System","Cellular responses to external stimuli","Metabolism of lipids","RNA Polymerase II Transcription","Platelet activatio
n","signaling and aggregation","Disorders of transmembrane transporters","Potassium Channels","Cellular responses to stress","Biological oxidations","Metabolism of steroids","Generic Transcription Pat
hway","Response to elevated platelet cytosolic Ca2+","ABC transporter disorders","Inwardly rectifying K+ channels","Cellular response to hypoxia","Phase I - Functionalization of compounds","Bile acid 
and bile salt metabolism","Transcriptional regulation by RUNX3","Platelet degranulation","Defective ABCC8 can cause hypo- and hyper-glycemias","Potassium transport channels","Oxygen-dependent proline 
hydroxylation of Hypoxia-inducible Factor Alpha","Cytochrome P450 - arranged by substrate type","Synthesis of bile acids and bile salts","RUNX3 Regulates Immune Response and Cell Migration","Recycling
 of bile acids and salts",Xenobiotics,"Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","CYP2E1 reactions"}

> <broad_targets>
{ABCC8,KCNJ1,KCNJ11}

> <broad_moa>
{"insulin secretagogue"}

> <synonyms>
{AB00513874_11,AB0051387411,AB00513874-11,"AB00513874 11",glimepiride,93479-97-1,93479971,Amaryl,Glimepirid,Amarel,Glimepirida,Glimepiridum,Hoe-490,Hoe490,Glimepride,cis-Glimepiride,cisGlimepiride,"HO
E 490",UNII-24T6XIR2MZ,UNII24T6XIR2MZ,684286-46-2,684286462,CHEBI:5383,UNII-6KY687524K,UNII6KY687524K,Endial,24T6XIR2MZ,MFCD00878417,6KY687524K,NCGC00016960-,NCGC00016960,T0127,SAM001246710,Prestw-651
,Glimepiride,CPD000466368}

> <pdid>
PD000671

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{3476}

$$$$
NIHCC_2014
  SciTegic11012413002D

 32 36  0  0  1  0            999 V2000
    1.6391   -7.2459    0.0000 C   0  0
    1.1939   -5.8135    0.0000 C   0  0
    0.7485   -4.3803    0.0000 C   0  0
    0.2851   -2.9666    0.0000 C   0  0  2  0  0  0
   -0.6873   -2.7330    0.0000 O   0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  2  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -0.8141   -2.0807    0.0000 C   0  0
   -2.5987    1.5004    0.0000 C   0  0
   -3.8991    0.7525    0.0000 C   0  0
   -5.1969    1.5045    0.0000 C   0  0
   -5.1945    3.0045    0.0000 C   0  0
   -3.8943    3.7525    0.0000 C   0  0
   -2.5965    3.0004    0.0000 C   0  0
   -6.4916    3.7597    0.0000 N   0  0
   -6.4870    5.2597    0.0000 C   0  0
   -7.7931    3.0140    0.0000 C   0  0
  1  2  1  0
  2  3  3  0
  3  4  1  0
  4  5  1  6
  4  6  1  0
  6  7  1  0
  8  7  1  6
  8  9  1  0
  9 10  1  1
 10 11  1  0
 11 12  1  0
 12 13  2  3
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 12  1  0
 18 19  2  3
 19  9  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22  4  1  0
 22  8  1  0
 22 23  1  6
 20 24  1  6
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 27 30  1  0
 30 31  1  0
 30 32  1  0
M  END
> <name>
NIHCC_2014

> <id>
6058

> <plate>
NGP-105-06

> <well>
F05

> <supplier_cmpd_name>
CPD000058481

> <ctcr_id>
4858

> <supplier_cmpd_id>
SAM001246881

> <smiles>
CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@]12C)c5ccc(cc5)N(C)C

> <pd_targets>
{NR3C1,PGR,AR,NR3C2,ABCB1A,ESR1,FTL,BLM,GMNN,LMNA,MAPK1,RORC,NPSR1,CYP3A4,CYP2C8,HTT,NFO,MAPK14,PMP22,ESR2,ALOX15,CYP2C9,NR1I2,MTOR,ADRA2B,ABCB11,OPRM1,OPRK1,FYN,SIGMAR1}

> <pathway_gtopdb>
{"Transcription factor",Transporter,"Other nuclear protein","Unclassified protein",Enzyme,"Membrane receptor","Nuclear receptor","Primary active transporter",Kinase,Protease,"Family A G protein-couple
d receptor","Cytochrome P450",Hydrolase,Oxidoreductase,"Nuclear hormone receptor subfamily 3","ATP-binding cassette","Protein Kinase","Nuclear hormone receptor subfamily 1","Cysteine protease","Peptid
e receptor (family A GPCR)","Cytochrome P450 family 3","Cytochrome P450 family 2","Small molecule receptor (family A GPCR)","Nuclear hormone receptor subfamily 3 group C","ABCB subfamily","Nuclear hor
mone receptor subfamily 3 group A","CMGC protein kinase group","Nuclear hormone receptor subfamily 1 group F","Cysteine protease CA clan","Short peptide receptor (family A GPCR)","Cytochrome P450 fami
ly 3A","Cytochrome P450 family 2C","Nuclear hormone receptor subfamily 1 group I","Atypical protein kinase group","Monoamine receptor","TK protein kinase group","Nuclear hormone receptor subfamily 3 g
roup C member 1","Nuclear hormone receptor subfamily 3 group C member 3","Nuclear hormone receptor subfamily 3 group C member 4","Nuclear hormone receptor subfamily 3 group C member 2","Nuclear hormon
e receptor subfamily 3 group A member 1","CMGC protein kinase MAPK family","Nuclear hormone receptor subfamily 1 group F member 3","Cysteine protease C1A family","Neuropeptide receptor","Cytochrome P4
50 3A4","Cytochrome P450 2C8","Nuclear hormone receptor subfamily 3 group A member 2","Cytochrome P450 2C9","Nuclear hormone receptor subfamily 1 group I member 2","Atypical protein kinase PIKK family
","Adrenergic receptor","Opioid receptor","Tyrosine protein kinase Src family","CMGC protein kinase ERK1","CMGC protein kinase p38 subfamily","Atypical protein kinase FRAP subfamily","Tyrosine protein
 kinase SrcA"}

> <pathway_chembl>
{Receptors,Transporters,Enzymes,"Other protein targets","Nuclear hormone receptors","ATP-binding cassette transporter family","Kinases (EC 2.7.x.x)","G protein-coupled receptors","Cytochrome P450","Ei
cosanoid turnover","Catalytic receptors","Sigma receptors","Steroid hormone receptors","ABCB subfamily","CMGC: Containing CDK",MAPK,GSK3,"CLK families","1F. Retinoic acid-related orphans","Neuropeptid
e S receptor","CYP3 family","CYP2 family: drug metabolising subset",Lipoxygenases,"1I. Vitamin D receptor-like receptors",Atypical,Adrenoceptors,"Opioid receptors","Receptor kinases","3C. 3-Ketosteroi
d receptors","3A. Estrogen receptors","Mitogen-activated protein kinases (MAP kinases)","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","TK: Tyrosine kinase","ERK subfamily","p38 subfa
mily","FRAP subfamily","Non-receptor tyrosine kinases (nRTKs)","Src family"}

> <pathway_reactome>
{"Gene expression (Transcription)","Metabolism of proteins","Vesicle-mediated transport","DNA Repair","Cell Cycle","Immune System",Disease,Metabolism,"Developmental Biology","Signal Transduction","RNA
 Polymerase II Transcription","Post-translational protein modification","Membrane Trafficking","DNA Double-Strand Break Repair",Mitotic,"Innate Immune System","Infectious disease","Metabolism of lipid
s","Biological oxidations","Nervous system development","Intracellular signaling by second messengers","Signaling by GPCR","Generic Transcription Pathway",SUMOylation,"trans-Golgi Network Vesicle Budd
ing","Homology Directed Repair","Mitotic G1 phase and G1/S transition","M Phase","Toll-like Receptor Cascades","Leishmania infection","Biosynthesis of specialized proresolving mediators (SPMs)","Phase
 I - Functionalization of compounds","EGR2 and SOX10-mediated initiation of Schwann cell myelination","PIP3 activates AKT signaling","GPCR ligand binding","Metabolism of steroids","GPCR downstream sig
nalling","HIV Infection","SARS-CoV Infections","FOXO-mediated transcription","SUMO E3 ligases SUMOylate target proteins","Transcriptional regulation by RUNX2","Transcriptional regulation by RUNX1","Go
lgi Associated Vesicle Biogenesis","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","G1/S Transition","Mitotic Metaphase and Anaphase","Toll Like Receptor 5 (TLR5) Cascade
","Transcriptional regulation by RUNX3","Leishmania parasite growth and survival","Biosynthesis of DHA-derived SPMs","Cytochrome P450 - arranged by substrate type","Transcriptional Regulation by MECP2
","Negative regulation of the PI3K/AKT network","Biosynthesis of DPA-derived SPMs","Transcriptional Regulation by TP53","Class A/1 (Rhodopsin-like receptors)","Bile acid and bile salt metabolism","G a
lpha (i) signalling events","Host Interactions of HIV factors","Potential therapeutics for SARS","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","SUMOylation of intrac
ellular receptors","RUNX2 regulates bone development","RUNX1 regulates estrogen receptor mediated transcription","HDR through Homologous Recombination (HRR)","Activation of the pre-replicative complex
","Mitotic Anaphase","MyD88 cascade initiated on plasma membrane","RUNX3 Regulates Immune Response and Cell Migration","Anti-inflammatory response favouring Leishmania parasite infection","Biosynthesi
s of maresins",Xenobiotics,"Regulation of MECP2 expression and activity",PI5P,"PP2A and IER3 Regulate PI3K/AKT Signaling","Biosynthesis of DPAn-3 SPMs","Regulation of TP53 Activity","Amine ligand-bind
ing receptors","Synthesis of bile acids and bile salts","Opioid Signalling","MECP2 regulates neuronal receptors and channels","The role of Nef in HIV-1 replication and disease pathogenesis","RUNX2 reg
ulates osteoblast differentiation","Homologous DNA Pairing and Strand Exchange","Nuclear Envelope (NE) Reassembly","MAP kinase activation","ADORA2B mediated anti-inflammatory cytokines production","Bi
osynthesis of maresin-like SPMs","CYP2E1 reactions","Biosynthesis of DPAn-3-derived protectins and resolvins","Regulation of TP53 Expression and Degradation",Adrenoceptors,"Synthesis of bile acids and
 bile salts via 7alpha-hydroxycholesterol","G-protein activation","Nef and signal transduction","Presynaptic phase of homologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) R
eformation","MAPK targets/ Nuclear events mediated by MAP kinases","Regulation of TP53 Degradation","ERK/MAPK targets","Activation of the AP-1 family of transcription factors","ERKs are inactivated"}

> <broad_targets>
{AR,NR1I2,NR3C1,PGR}

> <broad_moa>
{"glucocorticoid receptor antagonist","progesterone receptor antagonist"}

> <synonyms>
{mifepristone,84371-65-3,84371653,Mifegyne,Mifeprex,RU-486,RU486,Corlux,Korlym,"RU 486","RU 38486",Mifepriston,RU-38486,RU38486,UNII-320T6RNW1F,UNII320T6RNW1F,MLS000069785,320T6RNW1F,VGX-410C,VGX410C,
CHEBI:50692,VGX-410,VGX410,"Mifepristone, 98",NCGC00025179-05,NCGC0002517905,SMR000058481,Mifepristonum,S2606,SAM001246881,Prestw-299,Mifepristone,CPD000058481}

> <pdid>
PD000351

> <targets>
{Estrogen/progestogen Receptor,Autophagy,Glucocorticoid Receptor,NO Synthase,Progesterone Receptor}

> <classes>
{Endocrinology & Hormones,Autophagy,GPCR/G Protein,Immunology/Inflammation,Others}

> <pubchem_cids>
{55245}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 28  0  0  1  0            999 V2000
   10.2318   -1.1888    0.0000 O   0  0
    7.7318   -1.1888    0.0000 Cl  0  0
   -5.2649   -4.1084    0.0000 O   0  0
   -4.3533   -5.2996    0.0000 C   0  0
   -2.8675   -5.1069    0.0000 C   0  0  1  0  0  0
   -2.1519   -3.7886    0.0000 O   0  0
   -0.6928   -4.0817    0.0000 C   0  0  2  0  0  0
   -0.4810   -5.5489    0.0000 C   0  0  1  0  0  0
    0.8417   -6.2564    0.0000 O   0  0
   -1.8348   -6.1949    0.0000 C   0  0
   -2.1080   -7.6698    0.0000 O   0  0
    0.3114   -2.9665    0.0000 N   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5972    1.5031    0.0000 N   0  0
    2.5951    3.0039    0.0000 C   0  0  1  0  0  0
    1.3786    3.8595    0.0000 C   0  0
    1.8371    5.2877    0.0000 C   0  0
    3.3371    5.2929    0.0000 C   0  0
    3.8056    3.8680    0.0000 C   0  0  2  0  0  0
    5.2310    3.4009    0.0000 O   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  1
  8 10  1  0
 10  5  1  0
 10 11  1  0
  7 12  1  1
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 18 17  1  1
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 18  1  0
 22 23  1  6
 16 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 12  1  0
 27 15  1  0
M  END
> <name>
NIHCC_2014

> <id>
6059

> <plate>
NGP-105-06

> <well>
F06

> <supplier_cmpd_name>
CPD000469631

> <ctcr_id>
4302

> <supplier_cmpd_id>
SAM001247106

> <smiles>
O.Cl.OC[C@H]1O[C@H]([C@@H](O)C1O)n2cnc3c(N[C@H]4CCC[C@@H]4O)ncnc23

> <pd_targets>
{ADORA2A,ADORA1,ADORA2B,ADORA3}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Nucleotide-like receptor (family A GPCR)","Adenosine receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Adenosine receptors"}

> <pathway_reactome>
{Disease,"Signal Transduction","Infectious disease","Signaling by GPCR","Leishmania infection","GPCR ligand binding","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","A
nti-inflammatory response favouring Leishmania parasite infection","Nucleotide-like (purinergic) receptors","ADORA2B mediated anti-inflammatory cytokines production","Adenosine P1 receptors"}

> <broad_targets>
{ADORA1,ADORA2A}

> <broad_moa>
{"adenosine receptor agonist"}

> <synonyms>
{"Adenosine, N-(2-hydroxycyclopentyl)-, (1S-trans)- (CAS)","Adenosine, N(2hydroxycyclopentyl), (1Strans) (CAS)",N-2-Hydroxycyclopentyladenosine,N2Hydroxycyclopentyladenosine,MLS001424260,CHEMBL4586755
,CCG-101172,CCG101172,NC00422,SMR000469631,SAM001247106,CPD000469631}

> <pdid>
PD012271

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581827}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 24  0  0  1  0            999 V2000
    1.8305   -5.4177    0.0000 C   0  0
    2.5846   -4.1210    0.0000 O   0  0
    1.8400   -2.8200    0.0000 C   0  0  1  0  0  0
    0.1500   -2.8200    0.0000 O   0  0
   -0.6900   -1.3600    0.0000 C   0  0  2  0  0  0
   -1.9100   -1.3600    0.0000 O   0  0
   -2.7600   -0.5000    0.0000 C   0  0  1  0  0  0
   -1.3725    0.0700    0.0000 C   0  0
   -2.7600    0.7100    0.0000 C   0  0
   -1.9100    1.5700    0.0000 C   0  0
   -0.6900    1.5700    0.0000 C   0  0  1  0  0  0
    0.1500    3.0300    0.0000 C   0  0  2  0  0  0
   -0.6010    4.3285    0.0000 C   0  0
    1.8400    3.0300    0.0000 C   0  0
    2.6900    1.5700    0.0000 C   0  0
    1.8400    0.1000    0.0000 C   0  0  1  0  0  0
    2.6900   -1.3600    0.0000 C   0  0  1  0  0  0
    4.1900   -1.3600    0.0000 C   0  0
    0.1500    0.1000    0.0000 C   0  0  1  0  0  0
   -1.1700    0.6900    0.0000 O   0  0
   -2.1000    0.1500    0.0000 O   0  0
  1  2  1  0
  3  2  1  1
  3  4  1  0
  5  4  1  6
  5  6  1  0
  6  7  1  0
  7  8  1  6
  7  9  1  0
  9 10  1  0
 11 10  1  1
 11 12  1  0
 12 13  1  6
 12 14  1  0
 14 15  1  0
 16 15  1  1
 16 17  1  0
 17  3  1  0
 17 18  1  1
 16 19  1  0
 19  5  1  0
 19 11  1  0
 19 20  1  6
 20 21  1  0
 21  7  1  0
M  END
> <name>
NIHCC_2014

> <id>
6060

> <plate>
NGP-105-06

> <well>
F07

> <supplier_cmpd_name>
CPD000469218

> <ctcr_id>
6678

> <supplier_cmpd_id>
SAM001246799

> <smiles>
CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@@]24OO3

> <pd_targets>
{LMNA}

> <pathway_gtopdb>
{"Other nuclear protein"}

> <pathway_chembl>
{}

> <pathway_reactome>
{"Cell Cycle",Mitotic,"M Phase","Mitotic Metaphase and Anaphase","Mitotic Anaphase","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ATP1A1}

> <broad_moa>
{"antimalarial agent"}

> <synonyms>
{Artemether,beta-Artemether,betaArtemether,71963-77-4,71963774,"Dihydroartemisinin methyl ether","Artemisininelactol methyl ether",Methyl-dihydroartemisinine,Methyldihydroartemisinine,Artemetherum,Art
emetero,"beta-Dihydroartemisinin methyl ether","betaDihydroartemisinin methyl ether","SM 224",Artemetheri,CHEBI:195280,Artenam,Arte,T1323,SAM001246799,CPD000469218}

> <pdid>
PD000643

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{68911}

$$$$
NIHCC_2014
  SciTegic11012413002D

 58 62  0  0  1  0            999 V2000
    8.5136   -7.3779    0.0000 C   0  0
    8.2450   -6.4147    0.0000 C   0  0
    6.7900   -6.0400    0.0000 C   0  0  1  0  0  0
    6.4900   -4.6600    0.0000 O   0  0
    7.8900   -3.9900    0.0000 C   0  0
    8.7233   -4.5428    0.0000 O   0  0
    7.9600   -2.5000    0.0000 C   0  0  2  0  0  0
    8.8480   -2.0402    0.0000 C   0  0
    6.6600   -1.6700    0.0000 C   0  0
    6.6243   -0.1704    0.0000 O   0  0
    5.3600   -2.5900    0.0000 C   0  0  2  0  0  0
    4.0089   -1.9384    0.0000 C   0  0
    5.4500   -4.1900    0.0000 C   0  0  1  0  0  0
    6.3944   -5.3527    0.0000 O   0  0
    7.8766   -5.1166    0.0000 C   0  0  2  0  0  0
    8.4101   -3.7146    0.0000 O   0  0
    9.8910   -3.4757    0.0000 C   0  0  2  0  0  0
   10.4245   -2.0738    0.0000 C   0  0
   10.8383   -4.6387    0.0000 C   0  0
   10.3049   -6.0406    0.0000 C   0  0  1  0  0  0
    8.8240   -6.2795    0.0000 C   0  0  1  0  0  0
    8.2906   -7.6815    0.0000 O   0  0
   11.2504   -7.2062    0.0000 N   0  0
   10.7149   -8.6073    0.0000 C   0  0
   12.7316   -6.9698    0.0000 C   0  0
    4.0000   -4.8600    0.0000 C   0  0  1  0  0  0
    4.0337   -3.3604    0.0000 C   0  0
    4.1300   -6.4700    0.0000 C   0  0
    2.6900   -7.1900    0.0000 C   0  0  1  0  0  0
    1.3765   -6.4655    0.0000 C   0  0
    2.8500   -8.8000    0.0000 C   0  0
    1.6253   -9.6661    0.0000 O   0  0
    4.1500   -9.4100    0.0000 C   0  0  2  0  0  0
    4.2036  -10.9090    0.0000 C   0  0
    5.4900   -8.6600    0.0000 C   0  0  2  0  0  0
    6.7300   -9.4400    0.0000 N   0  0
    6.8087  -10.9379    0.0000 C   0  0
    8.1458  -11.6195    0.0000 C   0  0
    8.2251  -13.1182    0.0000 C   0  0
    9.5623  -13.7997    0.0000 C   0  0
    9.6416  -15.2985    0.0000 N   0  0
   10.8972  -16.0955    0.0000 C   0  0
   10.5068  -17.5438    0.0000 N   0  0
    9.0087  -17.6200    0.0000 C   0  0
    8.4733  -16.2188    0.0000 C   0  0
    8.1894  -18.8774    0.0000 C   0  0
    8.7646  -20.2573    0.0000 C   0  0
    7.8535  -21.4489    0.0000 C   0  0
    6.3660  -21.2556    0.0000 C   0  0
    5.7897  -19.8707    0.0000 N   0  0
    6.7008  -18.6792    0.0000 C   0  0
    7.8300   -8.6400    0.0000 C   0  0
    9.2489   -9.1266    0.0000 O   0  0
    7.4400   -7.2900    0.0000 O   0  0
    5.7900   -7.1200    0.0000 C   0  0  2  0  0  0
    7.1935   -6.5908    0.0000 C   0  0
    2.7222   -5.6191    0.0000 O   0  0
    2.7167   -6.6190    0.0000 C   0  0
  1  2  1  0
  3  2  1  6
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  1
  7  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  1
 11 13  1  0
 13 14  1  1
 15 14  1  6
 15 16  1  0
 16 17  1  0
 17 18  1  6
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 15  1  0
 21 22  1  1
 20 23  1  6
 23 24  1  0
 23 25  1  0
 13 26  1  0
 26 27  1  6
 26 28  1  0
 28 29  1  0
 29 30  1  6
 29 31  1  0
 31 32  2  0
 31 33  1  0
 33 34  1  1
 33 35  1  0
 35 36  1  1
 36 37  1  0
 37 38  1  0
 38 39  1  0
 39 40  1  0
 40 41  1  0
 41 42  1  0
 42 43  2  0
 43 44  1  0
 44 45  2  0
 45 41  1  0
 44 46  1  0
 46 47  2  0
 47 48  1  0
 48 49  2  0
 49 50  1  0
 50 51  2  0
 51 46  1  0
 36 52  1  0
 52 53  2  0
 52 54  1  0
 54 55  1  0
 55  3  1  0
 55 35  1  0
 55 56  1  6
 26 57  1  0
 57 58  1  0
M  END
> <name>
NIHCC_2014

> <id>
6061

> <plate>
NGP-105-06

> <well>
G02

> <supplier_cmpd_name>
CPD000469222

> <ctcr_id>
5141

> <supplier_cmpd_id>
SAM001246805

> <smiles>
CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H]3N(CCCCn4cnc(c4)c5cccnc5)C(=O)O[C@]13C)OC

> <pd_targets>
{ABCB11,CYP3A4,KCNH2,CYP3A43,CYP3A5,CYP3A7,SLCO1B3,SLCO1B1,ABCC4}

> <pathway_gtopdb>
{Transporter,Enzyme,"Ion channel","Primary active transporter","Cytochrome P450","Voltage-gated ion channel","Electrochemical transporter","ATP-binding cassette","Cytochrome P450 family 3","Potassium 
channels","SLC superfamily of solute carriers","ABCB subfamily","Cytochrome P450 family 3A","Voltage-gated potassium channel","SLC21/SLCO family of organic anion transporting polypeptides","ABCC subfa
mily","Cytochrome P450 3A4"}

> <pathway_chembl>
{Transporters,Enzymes,"Ion channels","ATP-binding cassette transporter family","Cytochrome P450","Voltage-gated ion channels","SLC superfamily of solute carriers","ABCB subfamily","CYP3 family","Potas
sium channels","SLCO family of organic anion transporting polypeptides","ABCC subfamily","Voltage-gated potassium channels"}

> <pathway_reactome>
{Metabolism,"Muscle contraction",Hemostasis,"Metabolism of lipids","Cardiac conduction","Platelet activation","signaling and aggregation","Metabolism of steroids","Biosynthesis of specialized proresol
ving mediators (SPMs)","Phase 3 - rapid repolarisation","Response to elevated platelet cytosolic Ca2+","Bile acid and bile salt metabolism","Biosynthesis of DHA-derived SPMs","Platelet degranulation",
"Synthesis of bile acids and bile salts","Biosynthesis of maresins","Recycling of bile acids and salts","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Biosynthesis of maresin-
like SPMs"}

> <broad_targets>
{CYP1A2,CYP2D6,CYP3A4,CYP3A5,CYP3A7}

> <broad_moa>
{"bacterial 30S ribosomal subunit inhibitor","bacterial 50S ribosomal subunit inhibitor"}

> <synonyms>
{Telithromycin,Levviax,Ketek,191114-48-4,191114484,HMR-3647,HMR3647,RU-66647,RU66647,MLS001424285,CHEMBL1215848,GTPL10878,HMS2052B11,MFCD00943561,ZINC91302264,AKOS016339661,CCG-101183,CCG101183,NC0043
3,MRF-0000457,MRF0000457,SMR000469222,114T484,SAM001246805,CPD000469222}

> <pdid>
PD000534

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{11693521}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 28  0  0  1  0            999 V2000
    6.3056   -1.1888    0.0000 O   0  0
   -5.2649   -4.1084    0.0000 O   0  0
   -4.3533   -5.2996    0.0000 C   0  0
   -2.8675   -5.1069    0.0000 C   0  0  1  0  0  0
   -2.1519   -3.7886    0.0000 O   0  0
   -0.6928   -4.0817    0.0000 C   0  0  2  0  0  0
   -0.4810   -5.5489    0.0000 C   0  0  1  0  0  0
    0.8417   -6.2564    0.0000 O   0  0
   -1.8348   -6.1949    0.0000 C   0  0
   -2.1080   -7.6698    0.0000 O   0  0
    0.3114   -2.9665    0.0000 N   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5972    1.5031    0.0000 N   0  0
    2.5951    3.0039    0.0000 C   0  0
    3.8056    3.8680    0.0000 C   0  0
    3.3371    5.2929    0.0000 C   0  0
    1.8371    5.2877    0.0000 C   0  0
    1.3786    3.8595    0.0000 C   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 Cl  0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  3  1  0
  4  3  1  1
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  1
  7  9  1  0
  9  4  1  0
  9 10  1  0
  6 11  1  1
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 17  1  0
 15 22  1  0
 22 23  2  0
 23 24  1  0
 23 25  1  0
 25 26  2  0
 26 11  1  0
 26 14  1  0
M  END
> <name>
NIHCC_2014

> <id>
6062

> <plate>
NGP-105-06

> <well>
G03

> <supplier_cmpd_name>
CPD000468732

> <ctcr_id>
3069

> <supplier_cmpd_id>
SAM001247065

> <smiles>
O.OC[C@H]1O[C@H]([C@@H](O)C1O)n2cnc3c(NC4CCCC4)nc(Cl)nc23

> <pd_targets>
{ADORA1,ADORA2A,ADORA3,ADORA2B}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Nucleotide-like receptor (family A GPCR)","Adenosine receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Adenosine receptors"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Signaling by GPCR","Infectious disease","GPCR ligand binding","Leishmania infection","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","N
ucleotide-like (purinergic) receptors","Anti-inflammatory response favouring Leishmania parasite infection","Adenosine P1 receptors","ADORA2B mediated anti-inflammatory cytokines production"}

> <broad_targets>
{ADORA1,ADORA2A,ADORA2B,ADORA3}

> <broad_moa>
{"adenosine receptor agonist"}

> <synonyms>
{MLS001424297,CHEMBL4532702,HMS2052D11,CCG-101184,CCG101184,NC00434,SMR000468732,SAM001247065,CPD000468732}

> <pdid>
PD021806

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23581815}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 29  0  0  0  0            999 V2000
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 O   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.5133   -2.9102    0.0000 C   0  0
    1.9910   -3.1685    0.0000 C   0  0
    2.5062   -4.5772    0.0000 C   0  0
    1.5439   -5.7278    0.0000 C   0  0
    0.0662   -5.4697    0.0000 C   0  0
   -0.4490   -4.0609    0.0000 C   0  0
   -1.9267   -3.8029    0.0000 Cl  0  0
   -2.5972   -1.5031    0.0000 C   0  0
   -3.8976   -0.7554    0.0000 O   0  0
   -2.5951   -3.0039    0.0000 O   0  0
   -3.8926   -3.7566    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
    2.5972    1.5031    0.0000 C   0  0
    2.5951    3.0039    0.0000 O   0  0
    3.8933    3.7570    0.0000 C   0  0
    3.8912    5.2578    0.0000 C   0  0
    5.1886    6.0105    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  2  3
  7  8  1  0
  8  9  1  0
  9 10  2  3
 10 11  1  0
 11  6  1  0
 11 12  1  0
 12 13  2  3
 13 14  1  0
 14 15  2  3
 15 16  1  0
 16 17  2  3
 17 12  1  0
 17 18  1  0
 10 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
  9 23  1  0
  7 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
M  END
> <name>
NIHCC_2014

> <id>
6063

> <plate>
NGP-105-06

> <well>
G04

> <supplier_cmpd_name>
CPD000469198

> <ctcr_id>
4377

> <supplier_cmpd_id>
SAM001246705

> <smiles>
CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN

> <pd_targets>
{CACNA1C,CACNA1D,CACNA1F,CACNA1S,NOS3,NOS2,FFP,NR1I2,RORC,CYP3A4,KCNK2,ABCB11,ADRA1B,ADRA1D,ADRA1A,ADRA2A,ADRA2C,HTR6,SLC6A3,ABCB1,CACNA1B,CACNB1,CACNA2D3,CA1,SMPD1,CACNA1I}

> <pathway_gtopdb>
{"Ion channel",Enzyme,"Voltage-gated ion channel","Voltage-gated calcium channel","Transcription factor",Transporter,"Membrane receptor",Transferase,"Nuclear receptor","Cytochrome P450","Primary activ
e transporter","Family A G protein-coupled receptor","Electrochemical transporter",Lyase,Hydrolase,"Nuclear hormone receptor subfamily 1","Cytochrome P450 family 3","Potassium channels","ATP-binding c
assette","Small molecule receptor (family A GPCR)","SLC superfamily of solute carriers","Nuclear hormone receptor subfamily 1 group I","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 f
amily 3A","Two-pore domain potassium channel","ABCB subfamily","Monoamine receptor","SLC06 neurotransmitter transporter family","Nuclear hormone receptor subfamily 1 group I member 2","Nuclear hormone
 receptor subfamily 1 group F member 3","Cytochrome P450 3A4","Adrenergic receptor","Serotonin receptor"}

> <pathway_chembl>
{"Ion channels",Enzymes,"Voltage-gated ion channels","L-Arginine turnover","Voltage-gated calcium channels","Nitric oxide synthases",Receptors,Transporters,"Nuclear hormone receptors","Cytochrome P450
","ATP-binding cassette transporter family","G protein-coupled receptors","SLC superfamily of solute carriers","Carbonic anhydrases","Ceramide turnover","1I. Vitamin D receptor-like receptors","1F. Re
tinoic acid-related orphans","CYP3 family","Potassium channels","ABCB subfamily",Adrenoceptors,"5-Hydroxytryptamine receptors","SLC6 neurotransmitter transporter family","Sphingomyelin phosphodiestera
se","Two P domain potassium channels","Monoamine transporter subfamily"}

> <pathway_reactome>
{"Developmental Biology","Signal Transduction",Disease,"Nervous system development","Signaling by Receptor Tyrosine Kinases","Infectious disease","Axon guidance","Signaling by VEGF","Infection with My
cobacterium tuberculosis","NCAM signaling for neurite out-growth","VEGFA-VEGFR2 Pathway","Response of Mtb to phagocytosis","NCAM1 interactions","VEGFR2 mediated vascular permeability","Suppression of 
phagosomal maturation","Inhibition of nitric oxide production","Metabolism of proteins","Gene expression (Transcription)",Metabolism,"Neuronal System","Immune System","Post-translational protein modif
ication","RNA Polymerase II Transcription","Metabolism of lipids","Potassium Channels","Signaling by GPCR","Disorders of transmembrane transporters","Abacavir transport and metabolism","Transmission a
cross Chemical Synapses","Cytokine Signaling in Immune system",SUMOylation,"Generic Transcription Pathway","Biosynthesis of specialized proresolving mediators (SPMs)","Tandem pore domain potassium cha
nnels","Metabolism of steroids","GPCR ligand binding","Leishmania infection","SLC transporter disorders","Abacavir transmembrane transport","Presynaptic depolarization and calcium channel opening","Si
gnaling by Interleukins","Sphingolipid metabolism","SUMO E3 ligases SUMOylate target proteins","Transcriptional regulation by RUNX3","Biosynthesis of DHA-derived SPMs","TWIK related potassium channel 
(TREK)","Bile acid and bile salt metabolism","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Interle
ukin-12 family signaling","Glycosphingolipid metabolism","SUMOylation of intracellular receptors","RUNX3 Regulates Immune Response and Cell Migration","Biosynthesis of maresins","Synthesis of bile aci
ds and bile salts","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Interleukin-12 signaling","Biosynthesis of maresin-like SPMs","Synthesis of bi
le acids and bile salts via 7alpha-hydroxycholesterol",Adrenoceptors,"ADORA2B mediated anti-inflammatory cytokines production","Gene and protein expression by JAK-STAT signaling after Interleukin-12 s
timulation"}

> <broad_targets>
{}

> <broad_moa>
{"calcium channel blocker"}

> <synonyms>
{amlodipine,88150-42-9,88150429,Norvasc,"AMLODIPINE BASE",Amlodipino,Amlodipinum,Caduet,Istin,"Amlodipine Free Base","Amlodipine besilate",Amvaz,Amlodis,CHEBI:2668,"Norvasc (TN)",Amlocard,Coroval,Lipi
nox,UK-4834011,UK4834011,Amlor,"Amlodipinum (Latin)",Amlodipi,SAM001246705,CPD000469198}

> <pdid>
PD008989

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{2162}

$$$$
NIHCC_2014
  SciTegic11012413002D

 42 48  0  0  1  0            999 V2000
    2.6018   -5.9994    0.0000 C   0  0
    3.9008   -5.2492    0.0000 O   0  0
    3.9014   -3.7484    0.0000 C   0  0
    2.6012   -3.0004    0.0000 C   0  0
    2.5987   -1.5004    0.0000 C   0  0
    3.8967   -0.7484    0.0000 C   0  0
    5.1969   -1.4963    0.0000 C   0  0
    6.4939   -0.7411    0.0000 O   0  0
    6.4894    0.7589    0.0000 C   0  0
    5.1993   -2.9963    0.0000 C   0  0
    6.4995   -3.7442    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
    0.3114    2.9665    0.0000 C   0  0
    1.8032    3.1233    0.0000 O   0  0
    2.4133    1.7530    0.0000 C   0  0
    3.8805    1.4410    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0  2  0  0  0
   -2.5973    1.5031    0.0000 O   0  0
   -2.5951    3.0039    0.0000 C   0  0  2  0  0  0
   -1.2935    3.7495    0.0000 O   0  0
   -1.2883    5.2495    0.0000 C   0  0  2  0  0  0
    0.0133    5.9950    0.0000 C   0  0
    0.0185    7.4950    0.0000 O   0  0
   -1.2780    8.2495    0.0000 C   0  0  1  0  0  0
   -1.2728    9.7495    0.0000 C   0  0
   -2.5796    7.5040    0.0000 O   0  0
   -2.5848    6.0040    0.0000 C   0  0  1  0  0  0
   -3.8864    5.2585    0.0000 C   0  0  2  0  0  0
   -5.1828    6.0129    0.0000 O   0  0
   -3.8915    3.7585    0.0000 C   0  0  1  0  0  0
   -5.1932    3.0130    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -3.7124   -4.0030    0.0000 O   0  0
   -3.1022   -5.3733    0.0000 C   0  0
   -1.6105   -5.2165    0.0000 O   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  7 10  2  0
 10  3  1  0
 10 11  1  0
 12  5  1  6
 12 13  1  0
 13 14  1  0
 14 15  1  1
 15 16  1  0
 16 17  1  0
 13 17  1  6
 17 18  2  0
 14 19  1  0
 19 20  1  1
 21 20  1  1
 21 22  1  0
 23 22  1  1
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  6
 26 28  1  0
 29 28  1  6
 29 23  1  0
 29 30  1  0
 30 31  1  1
 30 32  1  0
 32 21  1  0
 32 33  1  6
 19 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
 39 40  1  0
 40 36  2  0
 40 41  1  0
 41 42  2  0
 42 12  1  0
 42 34  1  0
M  END
> <name>
NIHCC_2014

> <id>
6064

> <plate>
NGP-105-06

> <well>
G05

> <supplier_cmpd_name>
CPD000112002

> <ctcr_id>
4511

> <supplier_cmpd_id>
SAM001246880

> <smiles>
COc1cc(cc(OC)c1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)c6cc7OCOc7cc26

> <pd_targets>
{TOP2A,ALOX15,TOP2B,SLCO1B3,NCOA1,LMP1,NCOA3,BLM,LMNA,GAA,RECQL,PMP22,POLB,GMNN,APEX1,NPSR1,NFO,MTOR,KMT2A,MEN1,RORC}

> <pathway_gtopdb>
{Enzyme,Transporter,"Epigenetic regulator","Unclassified protein","Other nuclear protein","Membrane receptor","Transcription factor",Isomerase,Oxidoreductase,"Electrochemical transporter",Writer,Hydro
lase,"Family A G protein-coupled receptor",Kinase,Reader,"Nuclear receptor","SLC superfamily of solute carriers","Histone acetyltransferase","Peptide receptor (family A GPCR)","Protein Kinase",Bromodo
main,"Nuclear hormone receptor subfamily 1","SLC21/SLCO family of organic anion transporting polypeptides","SRC family","Short peptide receptor (family A GPCR)","Atypical protein kinase group","Nuclea
r hormone receptor subfamily 1 group F","Neuropeptide receptor","Atypical protein kinase PIKK family","Nuclear hormone receptor subfamily 1 group F member 3","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Enzymes,Transporters,Receptors,"DNA topoisomerases","Eicosanoid turnover","SLC superfamily of solute carriers","Chromatin modifying enzymes","3.2.1.- Glycosidases","G protein-coupled receptors","Kina
ses (EC 2.7.x.x)","Nuclear hormone receptors",Lipoxygenases,"SLCO family of organic anion transporting polypeptides","2.3.1.48 Histone acetyltransferases (HATs)","Neuropeptide S receptor",Atypical,"1F
. Retinoic acid-related orphans","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","FRAP subfamily"}

> <pathway_reactome>
{"Cell Cycle",Metabolism,"Metabolism of proteins","DNA Repair",Disease,"Developmental Biology","Gene expression (Transcription)",Mitotic,"Metabolism of lipids","Post-translational protein modification
","DNA Double-Strand Break Repair","Diseases of metabolism","Nervous system development","Base Excision Repair","Infectious disease","RNA Polymerase II Transcription","Mitotic G1 phase and G1/S transi
tion","Biosynthesis of specialized proresolving mediators (SPMs)",SUMOylation,"Metabolism of steroids","Regulation of lipid metabolism by PPARalpha","Homology Directed Repair","M Phase","Diseases of c
arbohydrate metabolism","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Resolution of Abasic Sites (AP sites)","Leishmania infection","Generic Transcription Pathway","G0 and Early G1
","Biosynthesis of DPA-derived SPMs","SUMO E3 ligases SUMOylate target proteins","Bile acid and bile salt metabolism","PPARA activates gene expression","HDR through Homologous Recombination (HRR) or S
ingle Strand Annealing (SSA)","Mitotic Metaphase and Anaphase","Glycogen storage diseases","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","G1/S Transition","Leishmania 
parasite growth and survival","Transcriptional Regulation by TP53","Transcriptional regulation by RUNX3","Transcription of E2F targets under negative control by DREAM complex","Biosynthesis of DPAn-3 
SPMs","SUMOylation of DNA replication proteins","Recycling of bile acids and salts","Synthesis of bile acids and bile salts","HDR through Homologous Recombination (HRR)","Mitotic Anaphase","Glycogen s
torage disease type II (GAA)","PCNA-Dependent Long Patch Base Excision Repair","Activation of the pre-replicative complex","Anti-inflammatory response favouring Leishmania parasite infection","Regulat
ion of TP53 Activity","RUNX3 Regulates Immune Response and Cell Migration","Biosynthesis of DPAn-3-derived protectins and resolvins","Synthesis of bile acids and bile salts via 27-hydroxycholesterol",
"Homologous DNA Pairing and Strand Exchange","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Regulation of TP53 Expression and Degradation","Presynaptic p
hase of homologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation","Regulation of TP53 Degradation"}

> <broad_targets>
{TOP2A,TOP2B}

> <broad_moa>
{"topoisomerase inhibitor"}

> <synonyms>
{etoposide,33419-42-0,33419420,"33419 42 0",VePesid,Toposar,trans-Etoposide,transEtoposide,"trans Etoposide",Lastet,(-)-Etoposide,()Etoposide,"( ) Etoposide",Zuyeyidal,Etoposido,Etoposidum,"Etoposidum
 (INN-Latin)","Etoposidum (INNLatin)",Etop,S1225,SAM001246880,Prestw-396,CPD000112002,Etoposide}

> <pdid>
PD001532

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{36462}

$$$$
NIHCC_2014
  SciTegic11012413002D

 33 33  0  0  0  0            999 V2000
   12.0649   -6.0244    0.0000 H   0  3
    9.5649   -6.0244    0.0000 Cl  0  5
    6.3090   -5.7131    0.0000 C   0  0
    4.8090   -5.7153    0.0000 C   0  0
    4.0559   -4.4171    0.0000 C   0  0
    2.5551   -4.4192    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
   -0.6890   -4.0818    0.0000 C   0  0
   -2.1567   -3.7722    0.0000 O   0  0
   -0.2234   -5.5086    0.0000 C   0  0
   -1.2234   -6.6267    0.0000 C   0  0
   -0.7552   -8.0517    0.0000 C   0  0
   -1.7552   -9.1697    0.0000 I   0  0
    0.7130   -8.3588    0.0000 C   0  0
    1.1844   -9.7837    0.0000 O   0  0
    2.6539  -10.0888    0.0000 C   0  0
    3.1253  -11.5137    0.0000 C   0  0
    4.5948  -11.8188    0.0000 N   0  0
    5.0662  -13.2437    0.0000 C   0  0
    6.5348  -13.5486    0.0000 C   0  0
    5.5957  -10.7005    0.0000 C   0  0
    7.0640  -11.0071    0.0000 C   0  0
    1.7131   -7.2408    0.0000 C   0  0
    3.1813   -7.5478    0.0000 I   0  0
    1.2449   -5.8157    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 14 15  1  0
 15  7  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 20 22  2  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 26 29  1  0
 29 30  1  0
 22 31  1  0
 31 32  1  0
 31 33  2  0
 33 18  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6065

> <plate>
NGP-105-06

> <well>
G06

> <supplier_cmpd_name>
CPD000058296

> <ctcr_id>
2099

> <supplier_cmpd_id>
SAM001246646

> <smiles>
[H+].[Cl-].CCCCc1oc2ccccc2c1C(=O)c3cc(I)c(OCCN(CC)CC)c(I)c3

> <pd_targets>
{SIGMAR1,TSHR,HIF1A,CHRM1,SCN7A,PHF2,SLCO1A4,CYP1A2,CCR4,CYP2C9,AR,SCN10A,SCN11A,SCN1A,SCN2A,SCN3A,SCN4A,SCN5A,SCN8A,SCN9A,ABCB11,FDFT1,KCNH2,ABCB1,RORC,ALDH1A1,SQLE,KDM7A,KCNA7,THPO,TP53,CACNA1C,CACN
A1D,CACNA1F,CACNA1S,BDKRB2,HTR1B,MAPK1,EBP,CYP2D6,CYP2C8,ERG2,HTT,CHRM5,CYP3A4,NFKB1,FFP,THRB,LEF,NPSR1,PMP22,NS1,BLM,LMNA,NFO,KMT2A,MEN1,FTL,MAPT,ATM,GMNN,ABCB1A,DRD4,CHRM2,OPRD1,OPRK1,SLC6A4,ADORA3,
SLC6A3,HTR6,ABCB1B,MTOR,THRA,ADRA2B,ADRB3,SLC6A2,HRH2,MC3R,FYN,ERBB2,HTR2B,KDM5A,ADRB1,DRD2,CHRM3,HTR2C,DRD3,MC4R,OPRM1,HTR2A,TACR2,ADRA2A,CCR2,EDNRA,MC5R,CHRM4,KCNH6,KCNH7,ADRB2,CACNA1I,CACNB1,CACNB2
,CACNB3,CACNB4,PPARG,PPARA,PPARGC1B}

> <pathway_gtopdb>
{"Membrane receptor","Transcription factor","Ion channel",Enzyme,Transporter,"Epigenetic regulator","Unclassified protein","Other cytosolic protein","Other nuclear protein","Family A G protein-coupled
 receptor","Voltage-gated ion channel",Oxidoreductase,"Electrochemical transporter","Cytochrome P450","Nuclear receptor","Primary active transporter",Eraser,Kinase,Protease,Isomerase,Transferase,Hydro
lase,Reader,"Peptide receptor (family A GPCR)","Small molecule receptor (family A GPCR)","Voltage-gated sodium channel","SLC superfamily of solute carriers","Cytochrome P450 family 1","Cytochrome P450
 family 2","Nuclear hormone receptor subfamily 3","ATP-binding cassette","Potassium channels","Nuclear hormone receptor subfamily 1","Lysine demethylase","Voltage-gated calcium channel","Protein Kinas
e","Cysteine protease","Cytochrome P450 family 3","Metallo protease",Bromodomain,"Glycohormone receptor","Monoamine receptor","SLC21/SLCO family of organic anion transporting polypeptides","Cytochrome
 P450 family 1A","Chemokine receptor","Cytochrome P450 family 2C","Nuclear hormone receptor subfamily 3 group C","ABCB subfamily","Voltage-gated potassium channel","Nuclear hormone receptor subfamily 
1 group F","Jumonji domain-containing","Short peptide receptor (family A GPCR)","CMGC protein kinase group","Cysteine protease CA clan","Cytochrome P450 family 2D","Cytochrome P450 family 3A","Nuclear
 hormone receptor subfamily 1 group A","Metallo protease MAE clan","Atypical protein kinase group","SLC06 neurotransmitter transporter family","Nucleotide-like receptor (family A GPCR)","TK protein ki
nase group","Nuclear hormone receptor subfamily 1 group C","Acetylcholine receptor","Cytochrome P450 1A1","CC chemokine receptor","Cytochrome P450 2C9","Nuclear hormone receptor subfamily 3 group C me
mber 4","Nuclear hormone receptor subfamily 1 group F member 3","Bradykinin receptor","Serotonin receptor","CMGC protein kinase MAPK family","Cysteine protease C1A family","Cytochrome P450 2D6","Cytoc
hrome P450 2C8","Cytochrome P450 3A4","Nuclear hormone receptor subfamily 1 group A member 2","Metallo protease M34 family","Neuropeptide receptor","Atypical protein kinase PIKK family","Dopamine rece
ptor","Opioid receptor","Adenosine receptor","Nuclear hormone receptor subfamily 1 group A member 1","Adrenergic receptor","Histamine receptor","Melanocortin receptor","Tyrosine protein kinase Src fam
ily","Tyrosine protein kinase EGFR family","Neurokinin receptor","Endothelin receptor","Nuclear hormone receptor subfamily 1 group C member 3","Nuclear hormone receptor subfamily 1 group C member 1","
CMGC protein kinase ERK1","Atypical protein kinase FRAP subfamily","Tyrosine protein kinase SrcA"}

> <pathway_chembl>
{"Other protein targets",Receptors,Enzymes,Transporters,"Ion channels","Sigma receptors","G protein-coupled receptors","Chromatin modifying enzymes","Cytochrome P450","Nuclear hormone receptors","ATP-
binding cassette transporter family","Lanosterol biosynthesis pathway","Voltage-gated ion channels","Kinases (EC 2.7.x.x)","SLC superfamily of solute carriers","Catalytic receptors","Glycoprotein horm
one receptors","Acetylcholine receptors (muscarinic)","1.14.11.- Histone demethylases","CYP1 family","Chemokine receptors","CYP2 family: drug metabolising subset","Steroid hormone receptors","ABCB sub
family","Potassium channels","1F. Retinoic acid-related orphans","Bradykinin receptors","5-Hydroxytryptamine receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK families","CYP3 family","Voltage-gated sod
ium channels","1A. Thyroid hormone receptors","Neuropeptide S receptor",Atypical,"Dopamine receptors","Opioid receptors","SLC6 neurotransmitter transporter family","Adenosine receptors",Adrenoceptors,
"Histamine receptors","Melanocortin receptors","Receptor kinases","Tachykinin receptors","Endothelin receptors","Voltage-gated calcium channels","1C. Peroxisome proliferator-activated receptors","3C. 
3-Ketosteroid receptors","Voltage-gated potassium channels","Mitogen-activated protein kinases (MAP kinases)","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","Monoamine transporter sub
family","TK: Tyrosine kinase","ERK subfamily","Other PIKK family kinases","FRAP subfamily","Non-receptor tyrosine kinases (nRTKs)","Receptor tyrosine kinases (RTKs)","Src family","Type I RTKs: ErbB (e
pidermal growth factor) receptor family"}

> <pathway_reactome>
{Disease,"Cellular responses to external stimuli","Signal Transduction","Developmental Biology","Chromatin organization",Metabolism,"Gene expression (Transcription)","Muscle contraction","Neuronal Sys
tem",Hemostasis,"Cell Cycle","Immune System","Metabolism of proteins","DNA Repair","Vesicle-mediated transport","Infectious disease","Cellular responses to stress","Signaling by GPCR","Nervous system 
development","Chromatin modifying enzymes","Biological oxidations","RNA Polymerase II Transcription","Metabolism of lipids","Cardiac conduction","Abacavir transport and metabolism","Diseases of signal
 transduction by growth factor receptors and second messengers","Potassium Channels","Platelet activation","signaling and aggregation","Cell Cycle Checkpoints","Innate Immune System","Cytokine Signali
ng in Immune system","Post-translational protein modification","DNA Double-Strand Break Repair",Mitotic,"Membrane Trafficking","Transmission across Chemical Synapses","Disorders of transmembrane trans
porters","SARS-CoV Infections","Leishmania infection","Cellular response to hypoxia","GPCR ligand binding","Axon guidance","HDMs demethylate histones","Phase I - Functionalization of compounds","Gener
ic Transcription Pathway","Metabolism of steroids","Phase 3 - rapid repolarisation","Abacavir transmembrane transport","Oncogenic MAPK signaling","Voltage gated Potassium channels","Platelet Aggregati
on (Plug Formation)","G1/S DNA Damage Checkpoints","Toll-like Receptor Cascades","Biosynthesis of specialized proresolving mediators (SPMs)","Signaling by Interleukins",SUMOylation,"Uptake and actions
 of bacterial toxins","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Homology Directed Repair","M Phase","trans-Golgi Network Vesicle Budding","Neurotransmitter receptors and postsy
naptic signal transmission","Mitotic G1 phase and G1/S transition","Neurotransmitter clearance","SLC transporter disorders","HIV Infection","GPCR downstream signalling","Potential therapeutics for SAR
S","Leishmania parasite growth and survival","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Class A/1 (Rhodopsin-like receptors)","L1CAM interactions","Cytochrome P450 - a
rranged by substrate type","Transcriptional regulation by RUNX2","Bile acid and bile salt metabolism","Regulation of cholesterol biosynthesis by SREBP (SREBF)","Transcriptional regulation by RUNX3","E
thanol oxidation","Signaling by BRAF and RAF fusions","p53-Dependent G1/S DNA damage checkpoint","Toll Like Receptor 5 (TLR5) Cascade","Cholesterol biosynthesis","Transcriptional Regulation by MECP2",
"Biosynthesis of DHA-derived SPMs","Interleukin-1 family signaling","SUMO E3 ligases SUMOylate target proteins","Uptake and function of anthrax toxins","HDR through Homologous Recombination (HRR) or S
ingle Strand Annealing (SSA)","Mitotic Metaphase and Anaphase","Golgi Associated Vesicle Biogenesis","Activation of NMDA receptors and postsynaptic events","G1/S Transition","Serotonin clearance from 
the synaptic cleft","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Transcriptional Regulation by TP53","Defective SLC6A2 causes orthostatic intolerance (OI)","Host Interactions of 
HIV factors","Semaphorin interactions","G alpha (i) signalling events","NCAM signaling for neurite out-growth","Anti-inflammatory response favouring Leishmania parasite infection","Amine ligand-bindin
g receptors","Interaction between L1 and Ankyrins",Xenobiotics,"Peptide ligand-binding receptors","RUNX2 regulates bone development","Synthesis of bile acids and bile salts","Activation of gene expres
sion by SREBF (SREBP)","RUNX3 Regulates Immune Response and Cell Migration","p53-Dependent G1 DNA Damage Response","MyD88 cascade initiated on plasma membrane","Cholesterol biosynthesis via desmostero
l","Regulation of MECP2 expression and activity","Biosynthesis of maresins","Interleukin-1 signaling","SUMOylation of intracellular receptors","HDR through Homologous Recombination (HRR)","Mitotic Ana
phase","Post NMDA receptor activation events","Activation of the pre-replicative complex","MECP2 regulates neuronal receptors and channels","Nucleotide-like (purinergic) receptors","Regulation of TP53
 Activity","The role of Nef in HIV-1 replication and disease pathogenesis","Sema4D in semaphorin signaling","Opioid Signalling","NCAM1 interactions","MECP2 regulates transcription factors","Regulation
 of RUNX2 expression and activity","ADORA2B mediated anti-inflammatory cytokines production","Muscarinic acetylcholine receptors","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Ch
emokine receptors bind chemokines","CYP2E1 reactions","RUNX2 regulates osteoblast differentiation","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Stabilization of p53","Seroto
nin receptors","MAP kinase activation","Biosynthesis of maresin-like SPMs","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Homologous DNA Pairing and Strand Exchange","Nuclear Envelope (NE) Reassembly",
"Activation of AMPK downstream of NMDARs","Dopamine receptors","Adenosine P1 receptors","Regulation of TP53 Expression and Degradation",Adrenoceptors,"Nef and signal transduction","Sema4D induced cell
 migration and growth-cone collapse","G-protein activation","Tachykinin receptors bind tachykinins","Autodegradation of the E3 ubiquitin ligase COP1","MAPK targets/ Nuclear events mediated by MAP kina
ses","Presynaptic phase of homologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation","Regulation of TP53 Degradation","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{ADRB1,CACNA1H,CACNA2D2,KCNA7,KCNH2}

> <broad_moa>
{"potassium channel blocker"}

> <synonyms>
{RESTW40,MCULE-1243290270,MCULE1243290270,AKOS026750123,FT-0651477,FT0651477,"Amiodarone hydrochloride",19774-82-4,19774824,"Amiodarone HCL",Nexterone,Amiodar,Pacerone,Uro-Septra,UroSeptra,"Amiodarone
 (hydrochloride)",UNII-976728SY6Z,UNII976728SY6Z,"51087 N HCl",MLS000028520,"SKF 33134-A","SKF 33134A",MFCD00069204,NSC-85442,NSC85442,T1496,SAM001246646,2300165,Prestw-409,CPD000058296,"AMIODARONE HY
DROCHLORIDE"}

> <pdid>
PD009796

> <targets>
{}

> <classes>
{"adrenergic agonist","Ca channel blocker","coronary vasodilator"}

> <pubchem_cids>
{29770,657191,441325}

$$$$
NIHCC_2014
  SciTegic11012413002D

 16 18  0  0  0  0            999 V2000
   -0.6923   -4.0811    0.0000 O   0  0
    0.3114   -2.9665    0.0000 C   0  0
    1.8032   -3.1233    0.0000 N   0  0
    2.4133   -1.7530    0.0000 Se  0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    2.5536   -4.4230    0.0000 C   0  0
    1.9048   -5.7699    0.0000 C   0  0
    2.7505   -7.0088    0.0000 C   0  0
    4.2462   -6.8959    0.0000 C   0  0
    4.8963   -5.5441    0.0000 C   0  0
    4.0507   -4.3052    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  2  1  0
 10  5  1  0
  3 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
M  END
> <name>
NIHCC_2014

> <id>
6066

> <plate>
NGP-105-06

> <well>
H02

> <supplier_cmpd_name>
CPD000058445

> <ctcr_id>
116

> <supplier_cmpd_id>
SAM001247071

> <smiles>
O=C1N([Se]c2ccccc12)c3ccccc3

> <pd_targets>
{GALE,HK1,HSD17B10,PLIN5,PKM,RORC,HIF1A,GNAI1,RGS12,POLB,SKA,NPSR1,G6PD-6PGL,MAPT,ALDH1A1,FFP,ALOX12,ALD,HPGD,THPO,TP53,GMNN,EPHX2,BBOX1,HDAC6,MPI,PHOSPHO1,TIM23,ACHE,UREA,UREB,REP,MAP2,BCHE,LMNA,PYK,
ALOX15,TIM10,PTGS1,KDM4E,TGR,KMT2A,MEN1,PMM2,ABHD5,PLIN1,ARRB1,IDO1,TCDB,TRXB,NFKB1,EHMT2,GLA,LEF,CYP3A4,EIF4G1,MIF,EHMT1,HDAC9,HDAC5,PANC,RMLC,MURA,CASP1,CYP2C19,PMP22,AMPC,CYP2C9,G6PD,HTT,FTL,METAP2
,ALDOA,CYP2D6,MTOR,NCF1,IDE,QSOX1}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Membrane receptor","Other cytosolic protein","Unclassified protein","Epigenetic regulator","Other nuclear protein",Isomerase,Oxidoreductase,"Nuclear receptor",Kinase,"F
amily A G protein-coupled receptor",Transferase,Protease,Eraser,Phosphatase,Hydrolase,Reader,Writer,"Cytochrome P450",Ligase,Lyase,"Nuclear hormone receptor subfamily 1","Peptide receptor (family A GP
CR)","Serine protease","Histone deacetylase","Cysteine protease","Lysine demethylase",Bromodomain,"Protein methyltransferase","Metallo protease","Cytochrome P450 family 3","Cytochrome P450 family 2","
Protein Kinase","Nuclear hormone receptor subfamily 1 group F","Short peptide receptor (family A GPCR)","Serine protease SC clan","HDAC class IIb","Cysteine protease CA clan","Jumonji domain-containin
g","Metallo protease MAE clan","Cytochrome P450 family 3A","HDAC class IIa","Cysteine protease CD clan","Cytochrome P450 family 2C","Metallo protease MG clan","Cytochrome P450 family 2D","Atypical pro
tein kinase group","Nuclear hormone receptor subfamily 1 group F member 3","Neuropeptide receptor","Serine protease S33 family","Cysteine protease C1A family","Metallo protease M34 family","Cytochrome
 P450 3A4","Cysteine protease C14 family","Cytochrome P450 2C19","Cytochrome P450 2C9","Metallo protease M24A subfamily","Cytochrome P450 2D6","Atypical protein kinase PIKK family","Atypical protein k
inase FRAP subfamily"}

> <pathway_chembl>
{Enzymes,Receptors,"Other protein targets","2.7.1.40 Pyruvate kinases","Nuclear hormone receptors","G protein-coupled receptors","Eicosanoid turnover",Hydrolases,"Chromatin modifying enzymes","Acetylc
holine turnover","Anti-infective targets","1.13.11.- Dioxygenases","Cytochrome P450","Peptidases and proteinases","Kinases (EC 2.7.x.x)","1F. Retinoic acid-related orphans","Neuropeptide S receptor",L
ipoxygenases,"Prostaglandin synthases","3.5.1.- Histone deacetylases (HDACs)","Viral protein targets",Cyclooxygenase,"1.14.11.- Histone demethylases","2.1.1.43 Histone methyltransferases (HMTs)","CYP3
 family","CD: Cysteine (C) Peptidases","CYP2 family: drug metabolising subset","MG: Metallo (M) Peptidases",Atypical,"ME: Metallo (M) Peptidases","Coronavirus (CoV) proteins","C14: Caspase","M24: Meth
ionyl aminopeptidase","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","M16: Pitrilysin","FRAP subfamily"}

> <pathway_reactome>
{Disease,Metabolism,"Gene expression (Transcription)","Cellular responses to external stimuli","DNA Repair","Neuronal System",Hemostasis,"Cell Cycle","Metabolism of proteins","Immune System","Developm
ental Biology","Vesicle-mediated transport","Signal Transduction","Diseases of metabolism","Disorders of transmembrane transporters","Metabolism of amino acids and derivatives","Metabolism of carbohyd
rates","RNA Polymerase II Transcription","Cellular responses to stress","Base Excision Repair","Infectious disease","Transmission across Chemical Synapses","Biological oxidations","Metabolism of lipid
s","Platelet activation","signaling and aggregation","Cell Cycle Checkpoints",Mitotic,"Post-translational protein modification","Diseases of signal transduction by growth factor receptors and second m
essengers","Cytokine Signaling in Immune system",Translation,"Nervous system development","Membrane Trafficking","Signaling by GPCR","Adaptive Immune System","Diseases of glycosylation","SLC transport
er disorders","Branched-chain amino acid catabolism","Glucose metabolism","Generic Transcription Pathway","Cellular response to hypoxia","Resolution of Abasic Sites (AP sites)","Leishmania infection",
"Neurotransmitter receptors and postsynaptic signal transmission","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","Platelet Aggregation (Plug For
mation)","G1/S DNA Damage Checkpoints","Mitotic G1 phase and G1/S transition","Carnitine synthesis","Asparagine N-linked glycosylation","Phospholipid metabolism","SARS-CoV Infections","M Phase","Fatty
 acid metabolism","Oncogenic MAPK signaling","Tryptophan catabolism","Signaling by Interleukins","Sphingolipid metabolism","Uptake and actions of bacterial toxins","Eukaryotic Translation Initiation",
"Signaling by NOTCH1 in Cancer","EGR2 and SOX10-mediated initiation of Schwann cell myelination","trans-Golgi Network Vesicle Budding","GPCR downstream signalling","Triglyceride metabolism","Response 
to elevated platelet cytosolic Ca2+","Class I MHC mediated antigen processing & presentation",Deubiquitination,"Diseases associated with glycosylation precursor biosynthesis","Defective HK1 causes hex
okinase deficiency (HK deficiency)",Glycolysis,"Transcriptional regulation by RUNX3","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Resolution of AP sites via the multiple
-nucleotide patch replacement pathway","Leishmania parasite growth and survival","Activation of NMDA receptors and postsynaptic events","Ethanol oxidation","Biosynthesis of DPA-derived SPMs","Biosynth
esis of DHA-derived SPMs","p53-Dependent G1/S DNA damage checkpoint","G1/S Transition","Transcriptional regulation by RUNX2","Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosacchar
ide","LLO) and transfer to a nascent protein","Glycerophospholipid biosynthesis","SARS-CoV-2 Infection","Mitotic Metaphase and Anaphase","Arachidonic acid metabolism","Signaling by RAS mutants","Inter
leukin-1 family signaling","Transcriptional Regulation by TP53","Glycosphingolipid metabolism","Uptake and function of anthrax toxins","Cap-dependent Translation Initiation","Interleukin-12 family sig
naling","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","Cytochrome P450 - arranged by substrate type","Transcriptional Regulation by MECP2","Golgi Associated Vesicle Biogenesis","G alpha (i) s
ignalling events","Triglyceride catabolism","Platelet degranulation","Antigen processing-Cross presentation","Ub-specific processing proteases","Defective GALE can cause Epimerase-deficiency galactose
mia (EDG)","RUNX3 Regulates Immune Response and Cell Migration","PCNA-Dependent Long Patch Base Excision Repair","Anti-inflammatory response favouring Leishmania parasite infection","Post NMDA recepto
r activation events","Biosynthesis of DPAn-3 SPMs","Biosynthesis of D-series resolvins","p53-Dependent G1 DNA Damage Response","Activation of the pre-replicative complex","Biosynthesis of maresins","R
UNX2 regulates bone development","Synthesis of substrates in N-glycan biosythesis","Synthesis of PC","SARS-CoV-2 Genome Replication and Transcription","Mitotic Anaphase","Synthesis of Prostaglandins (
PG) and Thromboxanes (TX)","Signaling downstream of RAS mutants","Interleukin-1 signaling","Regulation of TP53 Activity","Activation of the mRNA upon binding of the cap-binding complex and eIFs","and 
subsequent binding to 43S","Interleukin-12 signaling","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","TP53 Regulates Transcription of Cell Death Genes",Xenobiotics,"TP53 Regulates Metabolic
 Genes","Regulation of MECP2 expression and activity","Visual phototransduction","Cross-presentation of particulate exogenous antigens (phagosomes)","ADORA2B mediated anti-inflammatory cytokines produ
ction","Activation of AMPK downstream of NMDARs","Biosynthesis of DPAn-3-derived maresins","Stabilization of p53","RUNX2 regulates osteoblast differentiation","Synthesis of GDP-mannose","Replication o
f the SARS-CoV-2 genome","Nuclear Envelope (NE) Reassembly","Biosynthesis of DPAn-3-derived protectins and resolvins","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Regulation of TP53 Activity through 
Methylation","Biosynthesis of maresin-like SPMs","Translation initiation complex formation","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","TP53 Regulates Transcr
iption of Caspase Activators and Caspases","CYP2E1 reactions","The phototransduction cascade","Regulation of TP53 Expression and Degradation","Autodegradation of the E3 ubiquitin ligase COP1","Initiat
ion of Nuclear Envelope (NE) Reformation",Inactivation,"recovery and regulation of the phototransduction cascade","Regulation of TP53 Degradation"}

> <broad_targets>
{ALB}

> <broad_moa>
{"cyclooxygenase inhibitor","glutathione peroxidase agonist","H+/K+-ATPase inhibitor","nitric oxide synthase inhibitor"}

> <synonyms>
{ebselen,60940-34-3,60940343,"2-Phenyl-1,2-benzisoselenazol-3(2H)-one","2Phenyl1,2benzisoselenazol3(2H)one",Ebselenum,"2-phenyl-1,2-benzoselenazol-3-one","2phenyl1,2benzoselenazol3one",Ebselene,Ebsele
no,"2-phenylbenzo(d)(1,2)selenazol-3(2H)-one","2phenylbenzo(d)(1,2)selenazol3(2H)one",SPI-1005,SPI1005,"Ebselene (French)","Ebselenum (Latin)","Ebselen (INN)",T0825,SAM001247071,Prestw-740,Ebselen,CPD
000058445}

> <pdid>
PD002767

> <targets>
{Calcium Channel,HIV,Phosphatase,Virus Protease}

> <classes>
{Anti-infection,Membrane Transporter/Ion Channel,Metabolic Enzyme/Protease,Neuronal Signaling}

> <pubchem_cids>
{3194}

$$$$
NIHCC_2014
  SciTegic11012413002D

 32 34  0  0  0  0            999 V2000
    6.4924   -3.7566    0.0000 C   0  0
    5.1945   -3.0045    0.0000 N   0  0
    5.1969   -1.5045    0.0000 C   0  0
    3.8991   -0.7525    0.0000 C   0  0
    2.5987   -1.5004    0.0000 N   0  0
    2.5965   -3.0004    0.0000 C   0  0
    3.8943   -3.7525    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
   -2.4133   -1.7530    0.0000 C   0  0
   -1.8032   -3.1233    0.0000 C   0  0
   -0.3114   -2.9665    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -1.2991    5.2508    0.0000 C   0  0
   -0.0005    6.0017    0.0000 F   0  0
   -2.5984    6.0004    0.0000 F   0  0
   -1.2998    6.7508    0.0000 F   0  0
   10.2930    3.3723    0.0000 O   0  0
   10.2930    1.8723    0.0000 C   0  0
    8.9937    1.1227    0.0000 O   0  0
   11.5930    1.1223    0.0000 C   0  0
   12.8930    1.8723    0.0000 C   0  0
   12.8944    3.3731    0.0000 C   0  0
   11.5959    4.1239    0.0000 O   0  0
   14.1937    4.1227    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  2  1  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20  8  1  0
 20 16  1  0
 12 21  1  0
 21 22  1  0
 21 23  1  0
 21 24  1  0
 25 26  1  0
 26 27  2  0
 26 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  1  0
 30 32  2  0
M  END
> <name>
NIHCC_2014

> <id>
6067

> <plate>
NGP-105-06

> <well>
H03

> <supplier_cmpd_name>
CPD000468733

> <ctcr_id>
5237

> <supplier_cmpd_id>
SAM001247066

> <smiles>
CN1CCN(CC1)c2nc3cc(ccc3n4cccc24)C(F)(F)F.OC(=O)\C=C/C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"CGS 12066B","CGS-12066 maleate salt","CGS12066 maleate salt","CGS-12066A maleate","CGS12066A maleate","CGS-12066A maleate salt","CGS12066A maleate salt",CPD000468733,"CGS 12066B dimaleate","1350965-
83-1 (maleate)","1350965831 (maleate)",SR-01000075259,SR01000075259,1350965-83-1,1350965831,MLS000860007,MLS001424273,SCHEMBL7746196,CHEMBL1256689,"CGS-12066 ma","CGS12066 ma",SAM001247066}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{6438352}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 27  0  0  0  0            999 V2000
    2.5579  -17.4197    0.0000 C   0  0
    1.8061  -16.1217    0.0000 O   0  0
    2.5539  -14.8204    0.0000 C   0  0
    1.8016  -13.5217    0.0000 C   0  0
    2.5494  -12.2205    0.0000 C   0  0
    1.7972  -10.9218    0.0000 O   0  0
    2.5450   -9.6205    0.0000 C   0  0
    4.0450   -9.6205    0.0000 C   0  0
    4.7951   -8.3215    0.0000 C   0  0
    4.0452   -7.0225    0.0000 N   0  0
    2.5451   -7.0223    0.0000 C   0  0
    1.7974   -5.7210    0.0000 C   0  0
    2.5497   -4.4224    0.0000 S   0  0
    4.0497   -4.4250    0.0000 O   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 N   0  0
    1.7951   -8.3214    0.0000 C   0  0
    0.2951   -8.3214    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 22 23  1  0
 23 15  2  0
 11 24  2  0
 24  7  1  0
 24 25  1  0
M  END
> <name>
NIHCC_2014

> <id>
6068

> <plate>
NGP-105-06

> <well>
H04

> <supplier_cmpd_name>
CPD000469174

> <ctcr_id>
560

> <supplier_cmpd_id>
SAM001246619

> <smiles>
COCCCOc1ccnc(C[S](=O)c2[nH]c3ccccc3n2)c1C

> <pd_targets>
{LMNA,AMPC,GAA,ALD,NPC1,FFP,PKM,RAB9A,REP,HPGD,MAPT,DDAH1,UREA,UREB,ALDH1A1,FASN,ABCB11,DRD3,ENGASE,IDE,SARM1,ADORA3,ADRA2B,ATP4A,ATP4B,CYP2C9}

> <pathway_gtopdb>
{"Other nuclear protein",Enzyme,Transporter,"Other cytosolic protein","Membrane receptor",Hydrolase,Transferase,Oxidoreductase,"Primary active transporter","Family A G protein-coupled receptor","ATP-b
inding cassette","Small molecule receptor (family A GPCR)","P-type ATPase","ABCB subfamily","Monoamine receptor","Nucleotide-like receptor (family A GPCR)","Hydrogen potassium ATPase","Dopamine recept
or","Adenosine receptor","Adrenergic receptor","Cytochrome P450","Cytochrome P450 family 2","Cytochrome P450 family 2C","Cytochrome P450 2C9"}

> <pathway_chembl>
{Enzymes,Transporters,"Other protein targets",Receptors,"3.2.1.- Glycosidases","SLC superfamily of solute carriers","2.7.1.40 Pyruvate kinases","Anti-infective targets","Eicosanoid turnover","L-Argini
ne turnover","2.3.1.-  Acyltransferases","ATP-binding cassette transporter family","G protein-coupled receptors","Peptidases and proteinases","P-type ATPases","SLC65 NPC-type cholesterol transporters"
,"Viral protein targets","Prostaglandin synthases","Dimethylarginine dimethylaminohydrolases","ABCB subfamily","Dopamine receptors","ME: Metallo (M) Peptidases","Adenosine receptors",Adrenoceptors,"P2
C P-type ATPases","Coronavirus (CoV) proteins","M16: Pitrilysin",H<sup>+</sup>/K<sup>+</sup>-ATPases,"Cytochrome P450","CYP2 family: drug metabolising subset"}

> <pathway_reactome>
{"Cell Cycle",Disease,"Transport of small molecules",Metabolism,"Signal Transduction","Neuronal System","Metabolism of proteins","Immune System",Mitotic,"Diseases of metabolism","Plasma lipoprotein as
sembly",remodeling,"and clearance","Metabolism of carbohydrates","Signaling by Rho GTPases","Infectious disease","Metabolism of lipids","Transmission across Chemical Synapses","Metabolism of nitric ox
ide: NOS3 activation and regulation","Biological oxidations","Signaling by GPCR","Post-translational protein modification","Innate Immune System","Ion channel transport","M Phase","Diseases of carbohy
drate metabolism","Plasma lipoprotein clearance","Glucose metabolism","Rho GTPase cycle","SARS-CoV Infections","Biosynthesis of specialized proresolving mediators (SPMs)","Neurotransmitter receptors a
nd postsynaptic signal transmission","eNOS activation","Phase I - Functionalization of compounds","Metabolism of steroids","GPCR ligand binding","Asparagine N-linked glycosylation",Deubiquitination,"T
oll-like Receptor Cascades","Ion transport by P-type ATPases","Mitotic Metaphase and Anaphase","Glycogen storage diseases","LDL clearance",Glycolysis,"RHOBTB GTPase Cycle","SARS-CoV-2 Infection","Bios
ynthesis of DHA-derived SPMs","Activation of NMDA receptors and postsynaptic events","Ethanol oxidation","Regulation of cholesterol biosynthesis by SREBP (SREBF)","Bile acid and bile salt metabolism",
"Class A/1 (Rhodopsin-like receptors)","N-glycan trimming in the ER and Calnexin/Calreticulin cycle","Ub-specific processing proteases","Toll Like Receptor 4 (TLR4) Cascade","Mitotic Anaphase","Glycog
en storage disease type II (GAA)","RHOBTB3 ATPase cycle","SARS-CoV-2 Genome Replication and Transcription","Biosynthesis of D-series resolvins","Post NMDA receptor activation events","Activation of ge
ne expression by SREBF (SREBP)","Synthesis of bile acids and bile salts","Amine ligand-binding receptors","MyD88-independent TLR4 cascade","Nucleotide-like (purinergic) receptors","Nuclear Envelope (N
E) Reassembly","Replication of the SARS-CoV-2 genome","Activation of AMPK downstream of NMDARs","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Dopamine receptors","TRIF(TICAM1
)-mediated TLR4 signaling","Adenosine P1 receptors",Adrenoceptors,"Initiation of Nuclear Envelope (NE) Reformation","Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon","Cytochrome P450 - arranged b
y substrate type",Xenobiotics,"CYP2E1 reactions"}

> <broad_targets>
{ATP4A}

> <broad_moa>
{"ATPase inhibitor","gastrin inhibitor"}

> <synonyms>
{rabeprazole,117976-89-3,117976893,Aciphex,Habeprazole,Pariets,CHEBI:8768,LY307640,"Sodium rabeprazole","Rabeprazole (INN:BAN)",rabeprazol,Rabeloc,"Rabeprazole (INN)","Eraloc (TN)","HSDB 7321",2--1H-b
enzimidazole,21Hbenzimidazole,"LY 307640",CHEMBL1219,SCHEMBL23336,MLS00,SAM001246619,CPD000469174}

> <pdid>
PD002894

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5029}

$$$$
NIHCC_2014
  SciTegic11012413002D

 19 20  0  0  0  0            999 V2000
    5.1889   -6.0106    0.0000 C   0  0
    3.8914   -5.2578    0.0000 C   0  0
    2.5910   -6.0055    0.0000 C   0  0
    3.8937   -3.7570    0.0000 C   0  0
    2.5955   -3.0038    0.0000 C   0  0
    1.2959   -3.7545    0.0000 N   0  0
    1.2954   -5.2545    0.0000 C   0  0
   -0.0030   -3.0044    0.0000 C   0  0
    2.5978   -1.5030    0.0000 C   0  0
    2.9074   -0.1013    0.0000 C   0  0
    4.3556   -0.4920    0.0000 C   0  0
    3.9650   -1.9402    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 Cl  0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  5  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12  9  1  0
  9 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 19 13  1  0
M  END
> <name>
NIHCC_2014

> <id>
6069

> <plate>
NGP-105-06

> <well>
H05

> <supplier_cmpd_name>
CPD000238156

> <ctcr_id>
1136

> <supplier_cmpd_id>
SAM001247105

> <smiles>
CC(C)CC(N(C)C)C1(CCC1)c2ccc(Cl)cc2

> <pd_targets>
{TSHR,ALDH1A1,LMNA,RORC,MAPK1,CYP3A4,MAPT,LEF,ALOX15,KCND3,SLC6A2,SLC6A3,SLC6A4,CYP2B6,ADRA2B}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Other nuclear protein","Transcription factor","Other cytosolic protein","Ion channel",Transporter,"Family A G protein-coupled receptor",Oxidoreductase,"Nuclear receptor",K
inase,"Cytochrome P450",Protease,"Voltage-gated ion channel","Electrochemical transporter","Peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1","Protein Kinase","Cytochrome P450 f
amily 3","Metallo protease","Potassium channels","SLC superfamily of solute carriers","Cytochrome P450 family 2","Small molecule receptor (family A GPCR)","Glycohormone receptor","Nuclear hormone rece
ptor subfamily 1 group F","CMGC protein kinase group","Cytochrome P450 family 3A","Metallo protease MAE clan","Voltage-gated potassium channel","SLC06 neurotransmitter transporter family","Cytochrome 
P450 family 2B","Monoamine receptor","Nuclear hormone receptor subfamily 1 group F member 3","CMGC protein kinase MAPK family","Cytochrome P450 3A4","Metallo protease M34 family","Cytochrome P450 2B6"
,"Adrenergic receptor","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,"Ion channels",Transporters,"G protein-coupled receptors","Nuclear hormone receptors","Kinases (EC 2.7.x.x)","Cytochrome P450","Eicosanoid turnover","Voltage-gated ion channels","SL
C superfamily of solute carriers","Glycoprotein hormone receptors","1F. Retinoic acid-related orphans","CMGC: Containing CDK",MAPK,GSK3,"CLK families","CYP3 family",Lipoxygenases,"Potassium channels",
"SLC6 neurotransmitter transporter family","CYP2 family: drug metabolising subset",Adrenoceptors,"Mitogen-activated protein kinases (MAP kinases)","Voltage-gated potassium channels","Monoamine transpo
rter subfamily","ERK subfamily"}

> <pathway_reactome>
{Disease,Metabolism,"Cell Cycle","Gene expression (Transcription)","Immune System","Neuronal System","Muscle contraction","Signal Transduction","Infectious disease","Biological oxidations",Mitotic,"RN
A Polymerase II Transcription","Innate Immune System","Metabolism of lipids","Transmission across Chemical Synapses","Cardiac conduction","Disorders of transmembrane transporters","Signaling by GPCR",
"Leishmania infection","Phase I - Functionalization of compounds","M Phase","Generic Transcription Pathway","Toll-like Receptor Cascades","Biosynthesis of specialized proresolving mediators (SPMs)","N
eurotransmitter receptors and postsynaptic signal transmission","Uptake and actions of bacterial toxins","Phase 1 - inactivation of fast Na+ channels","SLC transporter disorders","Neurotransmitter cle
arance","GPCR ligand binding","Leishmania parasite growth and survival","Ethanol oxidation","Mitotic Metaphase and Anaphase","Transcriptional regulation by RUNX3","Toll Like Receptor 5 (TLR5) Cascade"
,"Biosynthesis of DHA-derived SPMs","Activation of NMDA receptors and postsynaptic events","Uptake and function of anthrax toxins","Biosynthesis of DPA-derived SPMs","Defective SLC6A2 causes orthostat
ic intolerance (OI)","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Serotonin clearance from the synaptic cleft","Cytochrome P450 - arranged by substrate type","Class A/1 (Rhodopsi
n-like receptors)","Anti-inflammatory response favouring Leishmania parasite infection","Mitotic Anaphase","RUNX3 Regulates Immune Response and Cell Migration","MyD88 cascade initiated on plasma membr
ane","Biosynthesis of maresins","Post NMDA receptor activation events","Biosynthesis of DPAn-3 SPMs",Xenobiotics,"Amine ligand-binding receptors","ADORA2B mediated anti-inflammatory cytokines producti
on","Nuclear Envelope (NE) Reassembly","MAP kinase activation","Biosynthesis of maresin-like SPMs","Activation of AMPK downstream of NMDARs","Biosynthesis of DPAn-3-derived protectins and resolvins","
CYP2E1 reactions",Adrenoceptors,"Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{sibutramine,106650-56-0,106650560,"Sibutraminum (Latin)","Sibutramina (Spanish)","1-(1-(4-chlorophenyl)cyclobutyl)-N,N,3-trimethylbutan-1-amine","1(1(4chlorophenyl)cyclobutyl)N,N,3trimethylbutan1amin
e",CHEBI:9137,Sibutramina,Sibutraminum,"Sibutramine (INN:BAN)","Butramin (TN)",SMR000238156,"Sibutramine (INN)",SAM001247105,CPD000238156}

> <pdid>
PD002864

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5210}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 30  0  0  1  0            999 V2000
    7.7996   -1.4883    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0  2  0  0  0
    5.2029   -2.9932    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    3.8964    0.7545    0.0000 O   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0  2  0  0  0
   -1.2990   -5.2500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0  2  0  0  0
    1.2982   -3.7531    0.0000 C   0  0
    1.2961   -5.2539    0.0000 C   0  0
    2.5943   -6.0070    0.0000 C   0  0  2  0  0  0
    2.5944   -7.5070    0.0000 C   0  0
    3.8934   -8.2570    0.0000 C   0  0  1  0  0  0
    3.8934   -9.7570    0.0000 O   0  0
    5.1924   -7.5071    0.0000 C   0  0
    5.1925   -6.0071    0.0000 C   0  0
    6.4915   -5.2571    0.0000 O   0  0
    3.8935   -5.2570    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0  1  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  6
  3  5  1  0
  5  6  2  0
  5  7  1  0
  8  7  1  6
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  3
 12 13  1  0
 13 14  2  3
 14 15  1  0
 15 16  1  1
 15 17  1  0
 17 18  1  1
 18 19  1  0
 20 19  1  1
 20 21  1  0
 21 22  1  0
 22 23  1  6
 22 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27 20  1  0
 17 28  1  0
 28  8  1  0
 28 12  1  6
M  END
> <name>
NIHCC_2014

> <id>
6070

> <plate>
NGP-105-06

> <well>
H06

> <supplier_cmpd_name>
CPD000336944

> <ctcr_id>
1199

> <supplier_cmpd_id>
SAM001246644

> <smiles>
CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12

> <pd_targets>
{HMGCR,MAPK1,NPSR1,SMN1,KMT2A,MEN1,ALDH1A1,FTL,RORC,HTT,MTOR,ABCB11}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Epigenetic regulator","Unclassified protein","Transcription factor",Transporter,Oxidoreductase,Kinase,"Family A G protein-coupled receptor",Reader,"Nuclear receptor","Prim
ary active transporter","Protein Kinase","Peptide receptor (family A GPCR)","Methyl-lysine/arginine binding protein",Bromodomain,"Nuclear hormone receptor subfamily 1","ATP-binding cassette","CMGC pro
tein kinase group","Short peptide receptor (family A GPCR)","Tudor domain","Nuclear hormone receptor subfamily 1 group F","Atypical protein kinase group","ABCB subfamily","CMGC protein kinase MAPK fam
ily","Neuropeptide receptor","Nuclear hormone receptor subfamily 1 group F member 3","Atypical protein kinase PIKK family","CMGC protein kinase ERK1","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Lanosterol biosynthesis pathway","Kinases (EC 2.7.x.x)","G protein-coupled receptors","Nuclear hormone receptors","ATP-binding cassette transporter family","CMGC: Cont
aining CDK",MAPK,GSK3,"CLK families","Neuropeptide S receptor","1F. Retinoic acid-related orphans",Atypical,"ABCB subfamily","Mitogen-activated protein kinases (MAP kinases)","Phosphatidyl inositol 3'
 kinase-related kinases (PIKK) family","ERK subfamily","FRAP subfamily"}

> <pathway_reactome>
{Metabolism,"Immune System",Disease,"Metabolism of RNA","Vesicle-mediated transport","Gene expression (Transcription)","Metabolism of lipids","Innate Immune System","Infectious disease","Metabolism of
 non-coding RNA","Biological oxidations","Membrane Trafficking","RNA Polymerase II Transcription","Metabolism of steroids","Toll-like Receptor Cascades","Leishmania infection","snRNP Assembly","Phase 
I - Functionalization of compounds","trans-Golgi Network Vesicle Budding","Generic Transcription Pathway","Regulation of cholesterol biosynthesis by SREBP (SREBF)","Toll Like Receptor 5 (TLR5) Cascade
","Leishmania parasite growth and survival","Ethanol oxidation","Golgi Associated Vesicle Biogenesis","Transcriptional regulation by RUNX3","Transcriptional Regulation by MECP2","Transcriptional Regul
ation by TP53","Bile acid and bile salt metabolism","Activation of gene expression by SREBF (SREBP)","MyD88 cascade initiated on plasma membrane","Anti-inflammatory response favouring Leishmania paras
ite infection","RUNX3 Regulates Immune Response and Cell Migration","Regulation of MECP2 expression and activity","Regulation of TP53 Activity","Synthesis of bile acids and bile salts","MAP kinase act
ivation","ADORA2B mediated anti-inflammatory cytokines production","Regulation of TP53 Expression and Degradation","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","MAPK targets/
 Nuclear events mediated by MAP kinases","Regulation of TP53 Degradation","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{HMGCR}

> <broad_moa>
{"HMGCR inhibitor"}

> <synonyms>
{RESTW144,Mevastatin,compactin,73573-88-3,73573883,ML-236B,ML236B,Mevastatina,Mevastatine,Mevastatinum,"Mevastatinum (INN-Latin)","Mevastatinum (INNLatin)","Antibiotic ML 236B","CS 500",UNII-1UQM1K0W9
X,UNII1UQM1K0W9X,"ML 236 B",1UQM1K0W9X,CHEMBL54440,CHEBI:34848,MFCD05662341,"Mevastatin (Compactin)",Mevastat,SAM001246644,Prestw-1441,CPD000336944}

> <pdid>
PD000447

> <targets>
{Antibiotic,Apoptosis,Autophagy,Bacterial,HMG-CoA Reductase (HMGCR)}

> <classes>
{Anti-infection,Apoptosis,Autophagy,Metabolic Enzyme/Protease}

> <pubchem_cids>
{64715}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 23  0  0  0  0            999 V2000
   11.9554   -0.4782    0.0000 H   0  3
    9.4554   -0.4782    0.0000 Cl  0  5
    6.9546   -4.2653    0.0000 C   0  0
    5.4929   -3.9285    0.0000 N   0  0
    4.4707   -5.0263    0.0000 C   0  0
    5.0525   -2.4938    0.0000 C   0  0
    3.5900   -2.1568    0.0000 C   0  0
    3.1497   -0.7220    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    0.7452   -1.5536    0.0000 C   0  0
    1.4899   -2.8569    0.0000 C   0  0
    0.7346   -4.1529    0.0000 C   0  0
   -0.7654   -4.1467    0.0000 C   0  0
   -1.5101   -2.8447    0.0000 C   0  0
   -0.7548   -1.5474    0.0000 C   0  0
   -1.6852   -0.3709    0.0000 C   0  0
   -1.3455    1.0901    0.0000 O   0  0
    0.0086    1.7354    0.0000 C   0  0
   -0.0968    3.2328    0.0000 C   0  0
    1.1460    4.0727    0.0000 C   0  0
    2.4948    3.4164    0.0000 C   0  0
    2.6008    1.9201    0.0000 C   0  0
    1.3574    1.0791    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23  9  1  0
 23 18  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6071

> <plate>
NGP-202-01

> <well>
A02

> <supplier_cmpd_name>
CPD000058230

> <ctcr_id>
5831

> <supplier_cmpd_id>
SAM002264608

> <smiles>
[H+].[Cl-].CN(C)CC\C=C1/c2ccccc2COc3ccccc13

> <pd_targets>
{CHRM2,SLC6A4,CHRM5,SLC6A2,CHRM3,HRH1,HTR2A,ADRA2C,CHRM4,SLC6A3,CHRM1,HTR1A,ADRA1A,CYP2D6,ADRA2A,ADRA2B,ADRA1B,ADRA1D,RORC,TGR,HTR1B,HTR1D,HTR1F,HTR2B,HTR2C,HTR3A,HTR3B,HTR4,HTR5A,HTR5B,HTR6,HTR7,HRH2
,SIGMAR1,DRD3,SLC22A1,HRH4,KCNH2,NFKB1,PMP22,RECQL,KDM4E,ALDH1A1,TSHR,CYP1A2,KMT2A,MEN1,LMNA,DRD2}

> <pathway_gtopdb>
{"Membrane receptor",Transporter,Enzyme,"Family A G protein-coupled receptor","Electrochemical transporter","Cytochrome P450","Small molecule receptor (family A GPCR)","SLC superfamily of solute carri
ers","Cytochrome P450 family 2","Monoamine receptor","SLC06 neurotransmitter transporter family","Cytochrome P450 family 2D","Acetylcholine receptor","Histamine receptor","Serotonin receptor","Adrener
gic receptor","Cytochrome P450 2D6","Transcription factor","Ion channel","Other cytosolic protein","Unclassified protein","Epigenetic regulator","Other nuclear protein","Nuclear receptor","Voltage-gat
ed ion channel",Eraser,Oxidoreductase,Reader,"Nuclear hormone receptor subfamily 1","Potassium channels","Lysine demethylase","Peptide receptor (family A GPCR)","Cytochrome P450 family 1",Bromodomain,
"Nuclear hormone receptor subfamily 1 group F","SLC22 family of organic cation and anion transporters","Voltage-gated potassium channel","Jumonji domain-containing","Glycohormone receptor","Cytochrome
 P450 family 1A","Nuclear hormone receptor subfamily 1 group F member 3","Dopamine receptor","Cytochrome P450 1A1"}

> <pathway_chembl>
{Receptors,Transporters,Enzymes,"G protein-coupled receptors","SLC superfamily of solute carriers","Cytochrome P450","Acetylcholine receptors (muscarinic)","SLC6 neurotransmitter transporter family","
Histamine receptors","5-Hydroxytryptamine receptors",Adrenoceptors,"CYP2 family: drug metabolising subset","Monoamine transporter subfamily","Other protein targets","Ion channels","Nuclear hormone rec
eptors","Sigma receptors","Voltage-gated ion channels","Chromatin modifying enzymes","1F. Retinoic acid-related orphans","Dopamine receptors","SLC22 family of organic cation and anion transporters","P
otassium channels","1.14.11.- Histone demethylases","Glycoprotein hormone receptors","CYP1 family","Organic cation transporters (OCT)","Voltage-gated potassium channels"}

> <pathway_reactome>
{"Signal Transduction","Neuronal System",Disease,Metabolism,"Signaling by GPCR","Transmission across Chemical Synapses","Disorders of transmembrane transporters","Biological oxidations","GPCR ligand b
inding","Neurotransmitter clearance","SLC transporter disorders","Phase I - Functionalization of compounds","Class A/1 (Rhodopsin-like receptors)","Serotonin clearance from the synaptic cleft","Defect
ive SLC6A2 causes orthostatic intolerance (OI)","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Cytochrome P450 - arranged by substrate type","Amine ligand-binding receptors",Xenobi
otics,"Muscarinic acetylcholine receptors","Histamine receptors","Serotonin receptors",Adrenoceptors,"CYP2E1 reactions","Gene expression (Transcription)","Transport of small molecules","Muscle contrac
tion","Immune System","Developmental Biology","Cell Cycle","RNA Polymerase II Transcription","Infectious disease","SLC-mediated transmembrane transport","Cardiac conduction","Cytokine Signaling in Imm
une system","Nervous system development",Mitotic,"Generic Transcription Pathway","Leishmania infection","SARS-CoV Infections","Transport of bile salts and organic acids","metal ions and amine compound
s","Phase 3 - rapid repolarisation","Signaling by Interleukins","EGR2 and SOX10-mediated initiation of Schwann cell myelination","M Phase","Transcriptional regulation by RUNX3","Leishmania parasite gr
owth and survival","Potential therapeutics for SARS","Organic cation/anion/zwitterion transport","Interleukin-1 family signaling","Ethanol oxidation","Mitotic Metaphase and Anaphase","RUNX3 Regulates 
Immune Response and Cell Migration","Anti-inflammatory response favouring Leishmania parasite infection","Organic cation transport","Interleukin-1 signaling","Mitotic Anaphase","ADORA2B mediated anti-
inflammatory cytokines production","Dopamine receptors","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Nuclear Envelope (NE) Reassembl
y","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{HRH1,SLC6A2,SLC6A4}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{AKOS024386983,"Doxepine HCI",AKOS026750141,"Dibenz(b,e)oxepin-delta (sup 11 (6H),gamma)-propylamine, N,N-dimethyl- HCl","Dibenz(b,e)oxepindelta (sup 11 (6H),gamma)propylamine, N,Ndimethyl HCl",Dibenz
(b,"e)oxepin delta (sup 11 (6H)","gamma) prop",SAM002264608,Prestw-263,CPD000058230,"Doxepin hydrochloride"}

> <pdid>
PD009013

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{43835204,67329943,6419921}

$$$$
NIHCC_2014
  SciTegic11012413002D

 32 34  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 N   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1984    1.4977    0.0000 C   0  0
   -6.4971    0.7454    0.0000 N   0  0
   -7.7984    1.4932    0.0000 C   0  0
   -9.0975    0.7432    0.0000 C   0  0
  -10.3966    1.4932    0.0000 C   0  0
  -10.3966    2.9932    0.0000 C   0  0
   -9.0976    3.7432    0.0000 C   0  0
   -7.7985    2.9932    0.0000 C   0  0
  -11.6948    3.7462    0.0000 C   0  0
  -12.9952    2.9984    0.0000 O   0  0
  -11.6927    5.2470    0.0000 N   0  0
  -12.9910    6.0001    0.0000 C   0  0  1  0  0  0
  -12.9889    7.5009    0.0000 C   0  0
  -14.2871    8.2539    0.0000 C   0  0
  -14.2850    9.7548    0.0000 C   0  0
  -12.9847   10.5025    0.0000 O   0  0
  -15.5825   10.5074    0.0000 O   0  0
  -14.2936    5.2546    0.0000 C   0  0
  -14.2987    3.7546    0.0000 O   0  0
  -15.5902    6.0086    0.0000 O   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 14 17  1  0
 17 18  2  0
 17 19  1  0
 20 19  1  6
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  2  0
 20 26  1  0
 26 27  1  0
 26 28  2  0
  8 29  2  0
 29 30  1  0
 30 31  2  0
 31  6  1  0
 31 32  1  0
 32  2  1  0
M  END
> <name>
NIHCC_2014

> <id>
6072

> <plate>
NGP-202-01

> <well>
A03

> <supplier_cmpd_name>
CPD000471860

> <ctcr_id>
1200

> <supplier_cmpd_id>
SAM002264616

> <smiles>
NC1=NC(=O)c2nc(CNc3ccc(cc3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)cnc2N1

> <pd_targets>
{GAA,TSHR,DFRA17,KDM4E,ALDH1A1,ALD,POLB,KMT2A,MEN1,HSD17B10,HPGD,TDP1,SLCO1A3,TYMS,FOLR3,FOLR2,GLA}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Epigenetic regulator",Transporter,Hydrolase,"Family A G protein-coupled receptor",Oxidoreductase,Eraser,Reader,"Electrochemical transporter",Transferase,"Peptide receptor 
(family A GPCR)","Lysine demethylase",Bromodomain,"SLC superfamily of solute carriers","Glycohormone receptor","Jumonji domain-containing","SLC21/SLCO family of organic anion transporting polypeptides
"}

> <pathway_chembl>
{Enzymes,Receptors,"3.2.1.- Glycosidases","G protein-coupled receptors","Chromatin modifying enzymes","Eicosanoid turnover","2.1.1.- Methyltransferases","Glycoprotein hormone receptors","1.14.11.- His
tone demethylases","Prostaglandin synthases"}

> <pathway_reactome>
{Disease,Metabolism,"DNA Repair","Cell Cycle","Immune System","Diseases of metabolism","Infectious disease","Biological oxidations","Base Excision Repair","Metabolism of amino acids and derivatives","
Metabolism of lipids","DNA Double-Strand Break Repair",Mitotic,"Innate Immune System","Metabolism of vitamins and cofactors","Diseases of carbohydrate metabolism","Leishmania infection","Phase I - Fun
ctionalization of compounds","Resolution of Abasic Sites (AP sites)","Branched-chain amino acid catabolism","Biosynthesis of specialized proresolving mediators (SPMs)","Nonhomologous End-Joining (NHEJ
)","Mitotic G1 phase and G1/S transition","Neutrophil degranulation","Metabolism of water-soluble vitamins and cofactors","Sphingolipid metabolism","Glycogen storage diseases","Leishmania parasite gro
wth and survival","Ethanol oxidation","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Biosynthesis of DHA-derived SPMs","G1/S Transition","Metabolism of folate and pter
ines","Glycosphingolipid metabolism","Glycogen storage disease type II (GAA)","Anti-inflammatory response favouring Leishmania parasite infection","PCNA-Dependent Long Patch Base Excision Repair","Bio
synthesis of D-series resolvins","G1/S-Specific Transcription","ADORA2B mediated anti-inflammatory cytokines production"}

> <broad_targets>
{FOLR2,FOLR3,SLC19A1,SLC46A1}

> <broad_moa>
{"folate receptor ligand"}

> <synonyms>
{Prestw-627,Prestw627,"Folic acid","FOLIC ACID",SAM002264616,T0062,1502020,CPD000471860}

> <pdid>
PD001427

> <targets>
{DNA/RNA Synthesis,Endogenous Metabolite}

> <classes>
{hematopoietic vitamin,Cell Cycle/DNA Damage,Metabolic Enzyme/Protease}

> <pubchem_cids>
{6037}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 23  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -3.8963   -3.7531    0.0000 N   0  0
   -3.8941   -5.2539    0.0000 C   0  0
   -2.5938   -6.0017    0.0000 O   0  0
   -5.1923   -6.0070    0.0000 C   0  0
   -5.3302   -7.4879    0.0000 C   0  0
   -6.7974   -7.7998    0.0000 C   0  0
   -7.5474   -6.5007    0.0000 C   0  0
   -9.0392   -6.3440    0.0000 O   0  0
   -6.5437   -5.3860    0.0000 N   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 13  1  0
  9 19  2  0
 19 20  1  0
 20 21  2  0
 21  2  1  0
 21  7  1  0
M  END
> <name>
NIHCC_2014

> <id>
6073

> <plate>
NGP-202-01

> <well>
A04

> <supplier_cmpd_name>
CPD001317860

> <ctcr_id>
7004

> <supplier_cmpd_id>
SAM002264625

> <smiles>
CC1=CC(=O)Oc2cc(NC(=O)C3CCC(=O)N3)ccc12

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{045896,Pyr-AMC,PyrAMC,CPD001317860,H-L-Pyr-AMC,HLPyrAMC,SCHEMBL18659350,DTXSID50408335,HMS3259A07,N-(4-methyl-2-oxochromen-7-yl)-5-oxopyrrolidine-2-carboxamide,N(4methyl2oxochromen7yl)5oxopyrrolidine
2carboxamide,AKOS027661788,MCULE-6598397592,MCULE6598397592,NC00463,FT-0628009,FT0628009,(2S)-N-(4-methyl-2-oxochromen-7-yl)-5-oxopyrrolidine-2-ca,(2S)N(4methyl2oxochromen7yl)5oxopyrrolidine2ca,SAM002
264625}

> <pdid>
PD003161

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5102257}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 22  0  0  0  0            999 V2000
    7.6943   -0.7539    0.0000 Cl  0  5
    1.2948   -3.7516    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 S   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  3
    3.8912   -5.2570    0.0000 C   0  0
    5.1937   -3.0093    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18  5  1  0
 18 13  1  0
  3 19  1  0
 19 20  1  0
 19 21  1  0
M  CHG  2   1  -1  19   1
M  END
> <name>
NIHCC_2014

> <id>
6074

> <plate>
NGP-202-01

> <well>
A05

> <supplier_cmpd_name>
CPD000058379

> <ctcr_id>
2343

> <supplier_cmpd_id>
SAM002264636

> <smiles>
[Cl-].CC(CN1c2ccccc2Sc3ccccc13)[NH+](C)C

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Promethazine HCI",AKOS015914197,"(+/-)-10-(2-(Dimethylamino)propyl)phenothiazine HCl","(+/)10(2(Dimethylamino)propyl)phenothiazine HCl",SCHEMBL13257618,"PROMETHAZINE HYDROCHLORIDE",58-33-3,58333,"Pr
omethazine Hcl",Phenergan,"N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine hydrochloride","N,Ndimethyl1(10Hphenothiazin10yl)propan2amine hydrochloride",Fenerg,SAM002264636,1500510,Prestw-888,CPD
000058379,"Promethazine hydrochloride"}

> <pdid>

> <targets>
{}

> <classes>
{antihistaminic}

> <pubchem_cids>
{517306,657263,89044377,6014}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 21  0  0  0  0            999 V2000
    7.6971   -3.7837    0.0000 H   0  3
    5.1971   -3.7837    0.0000 Cl  0  5
   -0.5529  -10.3163    0.0000 C   0  0
    0.0576   -8.9462    0.0000 N   0  0
    1.5502   -8.7888    0.0000 C   0  0
    2.1626   -7.4186    0.0000 N   0  0
    1.2830   -6.2026    0.0000 C   0  0
    1.8954   -4.8324    0.0000 C   0  0
    1.0157   -3.6164    0.0000 S   0  0
    1.6281   -2.2462    0.0000 C   0  0
    0.7500   -1.0323    0.0000 C   0  0
    1.2135    0.3943    0.0000 O   0  0
    0.0000    1.2760    0.0000 C   0  0
   -0.0031    2.7742    0.0000 C   0  0
   -1.3040    3.5228    0.0000 N   0  0
   -1.3071    5.0228    0.0000 C   0  0
   -2.6017    2.7705    0.0000 C   0  0
   -1.2135    0.3943    0.0000 C   0  0
   -0.7500   -1.0323    0.0000 C   0  0
    2.4298  -10.0049    0.0000 C   0  0
    1.8174  -11.3750    0.0000 N   0  3
    0.3254  -11.5292    0.0000 O   0  5
    2.6966  -12.5904    0.0000 O   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 13 18  2  0
 18 19  1  0
 19 11  2  0
  5 20  2  0
 20 21  1  0
 21 22  1  0
 21 23  2  0
M  CHG  4   1   1   2  -1  21   1  22  -1
M  END
> <name>
NIHCC_2014

> <id>
6075

> <plate>
NGP-202-01

> <well>
A06

> <supplier_cmpd_name>
CPD000653467

> <ctcr_id>
7007

> <supplier_cmpd_id>
SAM002264645

> <smiles>
[H+].[Cl-].CNC(/NCCSCc1oc(CN(C)C)cc1)=C\[N+]([O-])=O

> <pd_targets>
{CA2,CA1,HRH2,RAD52,BLM,MAPT,AMPC,NFKB1,TSHR,ATP4A,ATP4B,HIF1A,KMT2A,MEN1,LMNA,CHRM1,ACHE,HSD17B10,SLC47A1}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Other nuclear protein","Other cytosolic protein",Transporter,"Transcription factor","Epigenetic regulator",Lyase,"Family A G protein-coupled receptor",Hydrolase,"Primary a
ctive transporter",Reader,Oxidoreductase,"Electrochemical transporter","Small molecule receptor (family A GPCR)","Peptide receptor (family A GPCR)","P-type ATPase",Bromodomain,"SLC superfamily of solu
te carriers","Monoamine receptor","Glycohormone receptor","Hydrogen potassium ATPase","SLC47 family of multidrug and toxin extrusion transporters","Histamine receptor","Acetylcholine receptor"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Carbonic anhydrases","G protein-coupled receptors","Acetylcholine turnover","SLC superfamily of solute carriers","Histamine receptors","Glycoprotein hormone receptors"
,"Acetylcholine receptors (muscarinic)","SLC47 family of multidrug and toxin extrusion transporters"}

> <pathway_reactome>
{"Transport of small molecules","Immune System",Disease,"DNA Repair","Neuronal System","Cellular responses to external stimuli","Cell Cycle","Signal Transduction",Metabolism,"O2/CO2 exchange in erythr
ocytes","Cytokine Signaling in Immune system","Infectious disease","DNA Double-Strand Break Repair","Transmission across Chemical Synapses","Cellular responses to stress",Mitotic,"Signaling by GPCR","
Metabolism of lipids","Metabolism of amino acids and derivatives","SLC-mediated transmembrane transport","Erythrocytes take up carbon dioxide and release oxygen","Signaling by Interleukins","Leishmani
a infection","Homology Directed Repair","Neurotransmitter receptors and postsynaptic signal transmission","Cellular response to hypoxia","M Phase","GPCR ligand binding","Phospholipid metabolism","Bran
ched-chain amino acid catabolism","Transport of bile salts and organic acids","metal ions and amine compounds","Interleukin-12 family signaling","Leishmania parasite growth and survival","HDR through 
Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Activation of NMDA receptors and postsynaptic events","Interleukin-1 family signaling","Oxygen-dependent proline hydroxylation of Hypo
xia-inducible Factor Alpha","Mitotic Metaphase and Anaphase","Class A/1 (Rhodopsin-like receptors)","Glycerophospholipid biosynthesis","Interleukin-12 signaling","Anti-inflammatory response favouring 
Leishmania parasite infection","HDR through Single Strand Annealing (SSA)","HDR through Homologous Recombination (HRR)","Post NMDA receptor activation events","Interleukin-1 signaling","Mitotic Anapha
se","Amine ligand-binding receptors","Synthesis of PC","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","ADORA2B mediated anti-inflammatory cytokines production","H
omologous DNA Pairing and Strand Exchange","Activation of AMPK downstream of NMDARs","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Nuclear Envelope (NE) Reassembly","Muscarinic acetylcholine receptors
","Presynaptic phase of homologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"ranitidine hydrochloride","Ranitidine HCL",66357-59-3,66357593,ZANTAC,Fendibina,Gastridina,Gastrolav,Kuracid,Raniberl,Ranibloc,Alquen,Rani-nerton,Raninerton,Nu-Ranit,NuRanit,Rani-Q,RaniQ,"Ranitidine
 (hydrochloride)",71130-06-8,71130068,Santanol,Tanidina,Toriol,Coralen,Quantor,Radin,Noctone,S1801,SAM002264645,Ranitidine,CPD000653467}

> <pdid>
PD009680

> <targets>
{Bacterial,Cytochrome P450,Histamine Receptor}

> <classes>
{Neuronal Signaling,Anti-infection,GPCR/G Protein,Immunology/Inflammation,Metabolic Enzyme/Protease}

> <pubchem_cids>
{3033332,24883424,43835200}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 31  0  0  1  0            999 V2000
   -0.2823   -5.5001    0.0000 C   0  0
   -0.7300   -4.0685    0.0000 C   0  0  2  0  0  0
   -2.1946   -3.7406    0.0000 C   0  0
   -3.2115   -4.8444    0.0000 C   0  0
   -4.6761   -4.5166    0.0000 C   0  0
   -5.1237   -3.0850    0.0000 O   0  0
   -5.6924   -5.6198    0.0000 O   0  0
    0.2851   -2.9666    0.0000 C   0  0  1  0  0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0  1  0  0  0
    3.8971    0.7500    0.0000 O   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0  2  0  0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0  2  0  0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -1.2991    2.2500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -1.2212   -2.3711    0.0000 C   0  0
  2  1  1  6
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  2  0
  2  8  1  0
  8  9  1  6
  9 10  1  0
 11 10  1  6
 12 11  1  1
 12 13  1  0
 13 14  1  6
 13 15  1  0
 16 15  1  1
 16 17  1  0
 17 18  1  0
 18 19  1  1
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 16  1  0
 22 23  1  6
 22 24  1  0
 24 12  1  0
 24 25  1  6
 25 26  1  0
 26 27  1  0
 27  8  1  0
 27 11  1  0
 27 28  1  6
M  END
> <name>
NIHCC_2014

> <id>
6076

> <plate>
NGP-202-01

> <well>
A07

> <supplier_cmpd_name>
CPD000058403

> <ctcr_id>
2169

> <supplier_cmpd_id>
SAM002264653

> <smiles>
C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

> <pd_targets>
{CISD1,SLC10A2,GPBAR1,SLC10A1,NR1H4,AKR1C2,FPR1,KMT2A,MEN1,ABCB11,RXRA}

> <pathway_gtopdb>
{Enzyme,"Unclassified protein",Transporter,"Membrane receptor","Transcription factor",Protease,"Electrochemical transporter","Family A G protein-coupled receptor","Nuclear receptor",Oxidoreductase,"Me
tallo protease","SLC superfamily of solute carriers","Small molecule receptor (family A GPCR)","Nuclear hormone receptor subfamily 1","Metallo protease MAE clan","SLC10 family of sodium-bile acid co-t
ransporters","Lipid-like ligand receptor (family A GPCR)","Nuclear hormone receptor subfamily 1 group H","Metallo protease M1 family","Steroid-like ligand receptor","Nuclear hormone receptor subfamily
 1 group H member 4","Epigenetic regulator",Reader,"Primary active transporter","Peptide receptor (family A GPCR)",Bromodomain,"ATP-binding cassette","N-formyl methionyl peptide receptor","ABCB subfam
ily"}

> <pathway_chembl>
{Transporters,Receptors,"SLC superfamily of solute carriers","G protein-coupled receptors","Nuclear hormone receptors","SLC10 family of sodium-bile acid co-transporters","Bile acid receptor","1H. Live
r X receptor-like receptors","ATP-binding cassette transporter family","Formylpeptide receptors","ABCB subfamily"}

> <pathway_reactome>
{Metabolism,Disease,"Metabolism of lipids","Infectious disease","Metabolism of steroids","Leishmania infection","Bile acid and bile salt metabolism","Leishmania parasite growth and survival","Recyclin
g of bile acids and salts","Anti-inflammatory response favouring Leishmania parasite infection","Synthesis of bile acids and bile salts","ADORA2B mediated anti-inflammatory cytokines production","Synt
hesis of bile acids and bile salts via 27-hydroxycholesterol","Synthesis of bile acids and bile salts via 24-hydroxycholesterol","Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class 
A/1 (Rhodopsin-like receptors)","Peptide ligand-binding receptors","Formyl peptide receptors bind formyl peptides and many other ligands","Synthesis of bile acids and bile salts via 7alpha-hydroxychol
esterol"}

> <broad_targets>
{AKR1C2,NR1H4}

> <broad_moa>
{"nuclear factor erythroid derived","like (NRF2) activator"}

> <synonyms>
{ursodiol,"URSODEOXYCHOLIC ACID",128-13-2,128132,Actigall,ursodeoxycholate,UDCA,Ursofalk,Ursolvan,Delursan,UrSO,"Urso Forte","Ursodesoxycholic acid",Destolit,Ursochol,Cholit-ursan,Cholitursan,Litursol
,Solutrat,Ursobilin,Ursodamor,Arsacol,Deursil,Lyeton,Ursacol,Urso,SAM002264653,Prestw-958,CPD000058403,Urosiol}

> <pdid>
PD001561

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{31401}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 24  0  0  0  0            999 V2000
    1.2948   -3.7516    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 I   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 O   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2007    1.4909    0.0000 C   0  0
   -6.4972    0.7364    0.0000 C   0  0
   -6.4920   -0.7636    0.0000 C   0  0
   -7.7884   -1.5181    0.0000 O   0  0
   -5.1903   -1.5091    0.0000 C   0  0
   -5.1851   -3.0091    0.0000 I   0  0
   -3.8939   -0.7546    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 I   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    5.1937   -3.0093    0.0000 O   0  0
    3.8912   -5.2570    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 15 17  2  0
 17 10  1  0
  8 18  1  0
 18 19  1  0
 18 20  2  0
 20  4  1  0
  2 21  1  0
 21 22  1  0
 21 23  2  0
M  END
> <name>
NIHCC_2014

> <id>
6077

> <plate>
NGP-202-01

> <well>
A08

> <supplier_cmpd_name>
CPD001567029

> <ctcr_id>
7011

> <supplier_cmpd_id>
SAM003107539

> <smiles>
NC(Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(O)=O

> <pd_targets>
{THRA,CYP2D6,GRIN1,GRIN2A,GRIN2B,GRIN2C,GRIN2D,GRIN3A,GRIN3B,TSHR,THRB,LMNA,LEF,HIF1A,USP2,TGR,ALDH1A1,GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG3,G
ABRP,GABRQ,NPSR1,ABCB11,PCNA,KMT2A,MEN1,MAPT,ALOX12,POLB,BLM,MCL1,RORC,HPGD,L3MBTL1,AMPC,SLCO1A4,SLCO1C1,ADORA1,HSD17B10}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Ion channel","Membrane receptor","Other nuclear protein",Transporter,"Epigenetic regulator","Other cytosolic protein","Nuclear receptor","Cytochrome P450","Ligand-gated
 ion channel","Family A G protein-coupled receptor",Protease,Oxidoreductase,"Primary active transporter",Reader,Hydrolase,"Electrochemical transporter","Nuclear hormone receptor subfamily 1","Cytochro
me P450 family 2","Ionotropic glutamate receptor","Peptide receptor (family A GPCR)","Metallo protease","Cysteine protease","GABA-A receptor","ATP-binding cassette",Bromodomain,"Methyl-lysine/arginine
 binding protein","SLC superfamily of solute carriers","Small molecule receptor (family A GPCR)","Nuclear hormone receptor subfamily 1 group A","Cytochrome P450 family 2D","NMDA receptor","Glycohormon
e receptor","Metallo protease MAE clan","Cysteine protease CA clan","Short peptide receptor (family A GPCR)","ABCB subfamily","Nuclear hormone receptor subfamily 1 group F","MBT domain","SLC21/SLCO fa
mily of organic anion transporting polypeptides","Nucleotide-like receptor (family A GPCR)","Nuclear hormone receptor subfamily 1 group A member 1","Cytochrome P450 2D6","Nuclear hormone receptor subf
amily 1 group A member 2","Metallo protease M34 family","Cysteine protease C19 family","Cysteine protease C1A family","Neuropeptide receptor","Nuclear hormone receptor subfamily 1 group F member 3","A
denosine receptor"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Other protein targets","Nuclear hormone receptors","Cytochrome P450","G protein-coupled receptors","Peptidases and proteinases","ATP-binding cassette transporter famil
y","Eicosanoid turnover","B-cell lymphoma 2 (Bcl-2) protein family","SLC superfamily of solute carriers","1A. Thyroid hormone receptors","CYP2 family: drug metabolising subset","Glycoprotein hormone r
eceptors","CA: Cysteine (C) Peptidases","Neuropeptide S receptor","ABCB subfamily",Lipoxygenases,"1F. Retinoic acid-related orphans","Prostaglandin synthases","SLCO family of organic anion transportin
g polypeptides","Adenosine receptors","C19: Ubiquitin-specific protease"}

> <pathway_reactome>
{"Metabolism of proteins",Metabolism,Disease,"Cell Cycle","Cellular responses to external stimuli","Gene expression (Transcription)","Neuronal System","DNA Repair","Immune System","Transport of small 
molecules","Signal Transduction","Post-translational protein modification","Biological oxidations","Infectious disease",Mitotic,"Cellular responses to stress","RNA Polymerase II Transcription","Metabo
lism of lipids","Chromosome Maintenance","Transmission across Chemical Synapses","Base Excision Repair","DNA Double-Strand Break Repair","Cytokine Signaling in Immune system","SLC-mediated transmembra
ne transport","Signaling by GPCR",SUMOylation,"Phase I - Functionalization of compounds","Leishmania infection","M Phase","Uptake and actions of bacterial toxins","Cellular response to hypoxia","Gener
ic Transcription Pathway","Metabolism of steroids","Telomere Maintenance","Neurotransmitter receptors and postsynaptic signal transmission","Biosynthesis of specialized proresolving mediators (SPMs)",
"Resolution of Abasic Sites (AP sites)","Homology Directed Repair","Signaling by Interleukins","Transport of vitamins",nucleosides,"and related molecules","GPCR ligand binding","SUMO E3 ligases SUMOyl
ate target proteins","Cytochrome P450 - arranged by substrate type","Leishmania parasite growth and survival","Mitotic Metaphase and Anaphase","Uptake and function of anthrax toxins","Oxygen-dependent
 proline hydroxylation of Hypoxia-inducible Factor Alpha","Transcriptional Regulation by TP53","Ethanol oxidation","Bile acid and bile salt metabolism","Extension of Telomeres","Activation of NMDA rec
eptors and postsynaptic events","Biosynthesis of DPA-derived SPMs","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","HDR through Homologous Recombination (HRR) or Single 
Strand Annealing (SSA)","Interleukin-4 and Interleukin-13 signaling","Transcriptional regulation by RUNX3","Biosynthesis of DHA-derived SPMs","Transport of organic anions","Class A/1 (Rhodopsin-like r
eceptors)","SUMOylation of intracellular receptors",Xenobiotics,"Anti-inflammatory response favouring Leishmania parasite infection","Mitotic Anaphase","Regulation of TP53 Activity","Synthesis of bile
 acids and bile salts","Telomere C-strand (Lagging Strand) Synthesis","Post NMDA receptor activation events","Biosynthesis of DPAn-3 SPMs","PCNA-Dependent Long Patch Base Excision Repair","HDR through
 Homologous Recombination (HRR)","RUNX3 Regulates Immune Response and Cell Migration","Biosynthesis of D-series resolvins","Nucleotide-like (purinergic) receptors","CYP2E1 reactions","ADORA2B mediated
 anti-inflammatory cytokines production","Nuclear Envelope (NE) Reassembly","Regulation of TP53 Expression and Degradation","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Proc
essive synthesis on the C-strand of the telomere","Activation of AMPK downstream of NMDARs","Biosynthesis of DPAn-3-derived maresins","Homologous DNA Pairing and Strand Exchange","Regulation of TP53 A
ctivity through Methylation","Adenosine P1 receptors","Initiation of Nuclear Envelope (NE) Reformation","Regulation of TP53 Degradation","Removal of the Flap Intermediate from the C-strand","Presynapt
ic phase of homologous DNA pairing and strand exchange","Metabolism of amino acids and derivatives","Branched-chain amino acid catabolism"}

> <broad_targets>
{}

> <broad_moa>
{}

> <synonyms>
{Rathyronine,dl-triiodothyronine,dltriiodothyronine,3130-96-9,3130969,NSC46046,"2-amino-3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)propanoic acid","2amino3(4(4hydroxy3iodophenoxy)3,5diiodophenyl)
propanoic acid","O-(4-hydroxy-3-iodophenyl)-3,5-diiodotyrosine","O(4hydroxy3iodophenyl)3,5diiodotyrosine",Detrothyronin,"Triiodothyronine;3,3',5-Triiodo-L-thyronine;T3","Triiodothyronine;3,3',5Triiodo
Lthyronine;T3",5714-08,571408,SAM003107539,CPD001567029}

> <pdid>
PD001582

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{861,44367053}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 17  0  0  0  0            999 V2000
    6.5002   -8.2537    0.0000 C   0  0
    5.2012   -7.5037    0.0000 C   0  0
    5.2002   -6.0029    0.0000 C   0  0
    3.9005   -5.2525    0.0000 N   0  0
    3.8995   -3.7516    0.0000 C   0  0
    5.1983   -3.0012    0.0000 O   0  0
    2.5997   -3.0012    0.0000 N   0  0
    2.5988   -1.5004    0.0000 S   0  0
    3.8982   -2.2498    0.0000 O   0  0
    3.8976   -0.7500    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 Cl  0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  2  0
  8 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 11  1  0
M  END
> <name>
NIHCC_2014

> <id>
6078

> <plate>
NGP-202-01

> <well>
A09

> <supplier_cmpd_name>
CPD000058364

> <ctcr_id>
5029

> <supplier_cmpd_id>
SAM002554890

> <smiles>
CCCNC(=O)N[S](=O)(=O)c1ccc(Cl)cc1

> <pd_targets>
{TSHR,THRB,LMNA,NFKB1,NPSR1,CYP3A4,SLC22A6,ABCC8,KCNJ11}

> <pathway_gtopdb>
{"Membrane receptor","Transcription factor","Other nuclear protein","Other cytosolic protein",Enzyme,Transporter,"Ion channel","Family A G protein-coupled receptor","Nuclear receptor","Cytochrome P450
","Electrochemical transporter","Primary active transporter","Voltage-gated ion channel","Peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 3","SLC super
family of solute carriers","ATP-binding cassette","Potassium channels","Glycohormone receptor","Nuclear hormone receptor subfamily 1 group A","Short peptide receptor (family A GPCR)","Cytochrome P450 
family 3A","SLC22 family of organic cation and anion transporters","ABCC subfamily","Inwardly rectifying potassium channel","Nuclear hormone receptor subfamily 1 group A member 2","Neuropeptide recept
or","Cytochrome P450 3A4"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"G protein-coupled receptors","Nuclear hormone receptors","Cytochrome P450","SLC superfamily of solute carriers","ATP-binding cassette transporter family","Glycoprotein
 hormone receptors","1A. Thyroid hormone receptors","Neuropeptide S receptor","CYP3 family","SLC22 family of organic cation and anion transporters","ABCC subfamily","Organic anion transporters (OATs)"
}

> <pathway_reactome>
{Disease,"Metabolism of proteins","Cell Cycle","Immune System",Metabolism,"Transport of small molecules","Infectious disease","Post-translational protein modification",Mitotic,"Cytokine Signaling in I
mmune system","Metabolism of lipids","SLC-mediated transmembrane transport","Disorders of transmembrane transporters","Leishmania infection",SUMOylation,"M Phase","Signaling by Interleukins","Biosynth
esis of specialized proresolving mediators (SPMs)","Transport of bile salts and organic acids","metal ions and amine compounds","ABC transporter disorders","Leishmania parasite growth and survival","S
UMO E3 ligases SUMOylate target proteins","Mitotic Metaphase and Anaphase","Interleukin-1 family signaling","Biosynthesis of DHA-derived SPMs","Organic cation/anion/zwitterion transport","Defective AB
CC8 can cause hypo- and hyper-glycemias","Anti-inflammatory response favouring Leishmania parasite infection","SUMOylation of intracellular receptors","Mitotic Anaphase","Interleukin-1 signaling","Bio
synthesis of maresins","Organic anion transport","ADORA2B mediated anti-inflammatory cytokines production","Nuclear Envelope (NE) Reassembly","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Biosynthesis
 of maresin-like SPMs","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ABCC8,KCNJ10}

> <broad_moa>
{"ATP channel blocker"}

> <synonyms>
{94-20-2,94202,Chloropropamide,Diabinese,Chlorpropamid,Diabenese,Glucamide,Meldian,Chlorodiabina,Chloronase,Diabeneza,Diabetoral,Adiaben,Catanil,Diabaril,Dynalase,Insulase,Melitase,Diabechlor,Diabenal
,Mellinese,Millinese,Asucrol,Glise,T0490,SAM002554890,1500185,Prestw-323,Chlorpropamide,CPD000058364,CHLORPROPAMIDE}

> <pdid>
PD002423

> <targets>
{Na+/K+ ATPase}

> <classes>
{antidiabetic,Membrane Transporter/Ion Channel}

> <pubchem_cids>
{2727}

$$$$
NIHCC_2014
  SciTegic11012413002D

 55 60  0  0  0  0            999 V2000
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
    0.0031   -3.0008    0.0000 C   0  0
    1.3039   -3.7494    0.0000 C   0  0
    1.3070   -5.2502    0.0000 O   0  0
    2.6078   -5.9988    0.0000 C   0  0
    2.6109   -7.4996    0.0000 C   0  0
    3.9110   -8.2477    0.0000 O   0  0
   -0.0020    3.0008    0.0000 C   0  0
   -1.3030    3.7490    0.0000 C   0  0
   -2.6024    2.9995    0.0000 C   0  0
   -3.9012    3.7500    0.0000 C   0  0
   -3.9006    5.2500    0.0000 C   0  0
   -2.6013    5.9995    0.0000 C   0  0
   -1.3026    5.2491    0.0000 C   0  0
    1.2969    3.7525    0.0000 C   0  0
    2.5983    3.0066    0.0000 C   0  0
    3.8951    3.7606    0.0000 C   0  0
    3.8905    5.2606    0.0000 C   0  0
    2.5891    6.0066    0.0000 C   0  0
    1.2924    5.2526    0.0000 C   0  0
    5.1872    6.0146    0.0000 Cl  0  0
   18.0870   -4.4893    0.0000 C   0  0
   18.0870   -2.9893    0.0000 C   0  0
   16.7880   -2.2393    0.0000 C   0  0
   15.4889   -2.9893    0.0000 C   0  0
   15.4889   -4.4893    0.0000 C   0  0
   16.7880   -5.2393    0.0000 C   0  0
   14.1899   -5.2393    0.0000 C   0  0
   12.8909   -4.4893    0.0000 C   0  0
   12.8909   -2.9893    0.0000 C   0  0
   14.1899   -2.2393    0.0000 C   0  0
   14.1868   -0.7385    0.0000 C   0  0
   12.8860    0.0100    0.0000 C   0  0
   11.5894   -0.7444    0.0000 C   0  0
   10.2878    0.0011    0.0000 C   0  0
   10.2826    1.5011    0.0000 C   0  0
   11.5791    2.2556    0.0000 C   0  0
   11.5739    3.7556    0.0000 C   0  0
   12.8703    4.5100    0.0000 C   0  0
   14.1719    3.7645    0.0000 C   0  0
   14.1771    2.2646    0.0000 C   0  0
   12.8807    1.5101    0.0000 C   0  0
    8.9891   -0.7512    0.0000 C   0  0
    7.6885   -0.0038    0.0000 O   0  0
    8.9917   -2.2512    0.0000 O   0  0
   11.5929   -1.7444    0.0000 O   0  5
   12.0248   -2.4894    0.0000 O   0  0
   11.5926   -5.2424    0.0000 C   0  0
   11.5948   -6.7424    0.0000 O   0  0
   10.2923   -4.4947    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  1  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  3 13  1  0
 13 14  1  0
 14 15  2  3
 15 16  1  0
 16 17  2  3
 17 18  1  0
 18 19  2  3
 19 14  1  0
 13 20  1  0
 20 21  2  3
 21 22  1  0
 22 23  2  3
 23 24  1  0
 24 25  2  3
 25 20  1  0
 23 26  1  0
 27 28  2  3
 28 29  1  0
 29 30  2  3
 30 31  1  0
 31 32  2  3
 32 27  1  0
 31 33  1  0
 33 34  2  3
 34 35  1  0
 35 36  2  3
 36 30  1  0
 36 37  1  0
 37 38  1  0
 38 39  2  3
 39 40  1  0
 40 41  2  3
 41 42  1  0
 42 43  2  3
 43 44  1  0
 44 45  2  3
 45 46  1  0
 46 47  2  3
 47 42  1  0
 47 38  1  0
 40 48  1  0
 48 49  2  0
 48 50  1  0
 39 51  1  0
 35 52  1  0
 34 53  1  0
 53 54  2  0
 53 55  1  0
M  CHG  1  51  -1
M  END
> <name>
NIHCC_2014

> <id>
6079

> <plate>
NGP-202-01

> <well>
A10

> <supplier_cmpd_name>
CPD001370751

> <ctcr_id>
7013

> <supplier_cmpd_id>
SAM002554902

> <smiles>
C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)[O-])O)C(=O)O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{HMS3259A19,NC00511,SAM002554902,CPD001370751}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{54732907}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 20  0  0  0  0            999 V2000
   12.9003   -0.3743    0.0000 Cl  0  0
   10.3996   -1.4837    0.0000 C   0  0
    9.0990   -0.7364    0.0000 C   0  0
    7.8003   -1.4887    0.0000 N   0  0
    7.7998   -2.9895    0.0000 C   0  0
    6.5010   -3.7399    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    3.8990   -0.7455    0.0000 N   0  0
    2.6003   -1.4977    0.0000 C   0  0
    2.6030   -2.9977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 Cl  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3032   -3.7490    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 19 12  1  0
 19 20  1  0
 20 21  1  0
M  END
> <name>
NIHCC_2014

> <id>
6080

> <plate>
NGP-202-01

> <well>
A11

> <supplier_cmpd_name>
CPD000058471

> <ctcr_id>
6171

> <supplier_cmpd_id>
SAM002554911

> <smiles>
Cl.CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC

> <pd_targets>
{CYP2D6,AMPC,CYP1A2,DRD2,RAB9A,HTR4,HTR3A,HTR3B,HTR2A,ADRA1A,ADRA1B,ADRA1D,DRD3,HTR2B,HTR2C,HTR3C,HTR3D,HTR3E,LMNA,ADRA2C,CHRM1,HTR6,ESR2,HTR1A,HTR1B,HTR1D,HTR1F,ADRA2A,ADRA2B,ALB,MPO,ALDH1A1,SLC22A1}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Cytochrome P450",Hydrolase,"Family A G protein-coupled receptor","Cytochrome P450 family 2","Cytochrome P450 family 1","Small molecule receptor (family A GPCR)","Cytochrom
e P450 family 2D","Cytochrome P450 family 1A","Monoamine receptor","Cytochrome P450 2D6","Cytochrome P450 1A1","Dopamine receptor","Ion channel","Other nuclear protein","Transcription factor","Secrete
d protein",Transporter,"Ligand-gated ion channel","Nuclear receptor",Oxidoreductase,"Electrochemical transporter","5HT3 receptor","Nuclear hormone receptor subfamily 3","SLC superfamily of solute carr
iers","Nuclear hormone receptor subfamily 3 group A","SLC22 family of organic cation and anion transporters","Serotonin receptor","Adrenergic receptor","Acetylcholine receptor","Nuclear hormone recept
or subfamily 3 group A member 2"}

> <pathway_chembl>
{Enzymes,Receptors,"Cytochrome P450","G protein-coupled receptors","CYP2 family: drug metabolising subset","CYP1 family","Dopamine receptors","Ion channels",Transporters,"Ligand-gated ion channels","N
uclear hormone receptors","1.-.-.- Oxidoreductases","SLC superfamily of solute carriers","5-Hydroxytryptamine receptors","5-HT<sub>3</sub> receptors",Adrenoceptors,"Acetylcholine receptors (muscarinic
)","Steroid hormone receptors","SLC22 family of organic cation and anion transporters","3A. Estrogen receptors","Organic cation transporters (OCT)"}

> <pathway_reactome>
{Metabolism,"Signal Transduction","Biological oxidations","Signaling by GPCR","Phase I - Functionalization of compounds","GPCR ligand binding","Cytochrome P450 - arranged by substrate type","Class A/1
 (Rhodopsin-like receptors)",Xenobiotics,"Amine ligand-binding receptors","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Dopamine receptors",Disease,"Cell Cycle
","Neuronal System","Immune System","Transport of small molecules","Signaling by Rho GTPases","Infectious disease",Mitotic,"Transmission across Chemical Synapses","Intracellular signaling by second me
ssengers","Metabolism of lipids","Innate Immune System","SLC-mediated transmembrane transport","Rho GTPase cycle","Leishmania infection","M Phase","Neurotransmitter receptors and postsynaptic signal t
ransmission","PIP3 activates AKT signaling","Metabolism of steroids","ROS and RNS production in phagocytes","Transport of bile salts and organic acids","metal ions and amine compounds","RHOBTB GTPase 
Cycle","Leishmania parasite growth and survival","Mitotic Metaphase and Anaphase","Negative regulation of the PI3K/AKT network","Bile acid and bile salt metabolism","Events associated with phagocytoly
tic activity of PMN cells","Ethanol oxidation","Organic cation/anion/zwitterion transport","RHOBTB3 ATPase cycle","Anti-inflammatory response favouring Leishmania parasite infection","Mitotic Anaphase
",PI5P,"PP2A and IER3 Regulate PI3K/AKT Signaling","Recycling of bile acids and salts","Organic cation transport","ADORA2B mediated anti-inflammatory cytokines production","Serotonin receptors","Nucle
ar Envelope (NE) Reassembly",Adrenoceptors,"Muscarinic acetylcholine receptors","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{CHRM1,DRD2,HTR3A,HTR3B,HTR4}

> <broad_moa>
{"dopamine receptor antagonist","serotonin receptor antagonist"}

> <synonyms>
{"Metoclopramide Base","2-Methoxy-4-amino-5-chloro-N,N-dimethylaminoethyl)benzamide","2Methoxy4amino5chloroN,Ndimethylaminoethyl)benzamide",AKOS015890642,A823256,4-amino-5-chloro-N-(2-diethylaminoethy
l)-2-methoxy-benzamide,4amino5chloroN(2diethylaminoethyl)2methoxybenzamide,"Metoclopramide hydrochloride",7232-21-5,7232215,Maxolon,"METOCLOPRAMIDE HCL",Meto,S4289,SAM002554911,1500410,Prestw-209,"Met
oclopraMide HCl",CPD000058471,"METOCLOPRAMIDE HYDROCHLORIDE","Metoclopramide monohydrochloride"}

> <pdid>
PD001072

> <targets>
{"Dopamine Receptor"}

> <classes>
{antiemetic,"Neuronal Signaling"}

> <pubchem_cids>
{657384,23659}

$$$$
NIHCC_2014
  SciTegic11012413002D

 36 39  0  0  0  0            999 V2000
    3.8912   -5.2570    0.0000 O   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 N   0  0
    3.8999   -0.7576    0.0000 C   0  0
    5.1972   -1.5121    0.0000 C   0  0
    6.4991   -0.7671    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0008    0.0000 N   0  0
    1.2978    3.7529    0.0000 C   0  0
    1.2954    5.2529    0.0000 C   0  0
   -0.0048    6.0009    0.0000 C   0  0
   -1.3026    5.2488    0.0000 C   0  0
   -1.3002    3.7488    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 N   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 N   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0008    0.0000 N   0  0
   -3.8959   -3.7529    0.0000 C   0  0
   -3.8935   -5.2529    0.0000 C   0  0
   -2.5933   -6.0009    0.0000 C   0  0
   -1.2954   -5.2488    0.0000 C   0  0
   -1.2978   -3.7488    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
   -5.1984    1.4977    0.0000 N   0  0
   -6.4971    0.7454    0.0000 C   0  0
   -7.7984    1.4932    0.0000 C   0  0
   -9.0964    0.7413    0.0000 O   0  0
   -5.2041    2.9985    0.0000 C   0  0
   -6.5063    3.7448    0.0000 C   0  0
   -6.5120    5.2448    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  4  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 11  1  0
 10 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 22  1  0
 21 28  1  0
 28 17  1  0
 28 29  2  0
 29  8  1  0
 19 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 30 34  1  0
 34 35  1  0
 35 36  1  0
M  END
> <name>
NIHCC_2014

> <id>
6081

> <plate>
NGP-202-01

> <well>
B02

> <supplier_cmpd_name>
CPD000058382

> <ctcr_id>
6477

> <supplier_cmpd_id>
SAM002264609

> <smiles>
OCCN(CCO)c1nc(N2CCCCC2)c3nc(nc(N4CCCCC4)c3n1)N(CCO)CCO

> <pd_targets>
{BLM,HPGD,THPO,PDE5A,PDE2A,PDE7A,PDE7B,KMT2A,MEN1,KDM4E,NPSR1,MAPT,HIF1A,LEF,CASP1,CYP2D6,PDE3A,PDE3B,PDE6A,PDE6B,PDE6C,PDE6D,PDE6G,PDE6H,USP2,BRCA1,HSD17B10,CASP7,ALDH1A1,GABRA1,PDE11A,ABCB1,PDE10A,I
MPA1,GNAI1,RGS12,GMNN,GAA,CYP3A4,PRUNE1,PDE4A,THRB,TSHR,CYP2C19,PMP22,ALOX15,PDE8A,PDE8B,SLC29A4,PDE1A,PDE1B,PDE1C,LMNA,NFKB1,HSP90AA1,HSP90AB1,RORC,SLC47A1,SLC22A2,SLC29A1,APEX1,CYP2C9,KEAP1,NFE2L2,P
DE4B,PDE4C,PDE4D,ATM,ABCC5,ABCC4,SLC47A2,SLC22A1,ABCB11,PDE9A,ADA}

> <pathway_gtopdb>
{Enzyme,"Unclassified protein","Epigenetic regulator","Membrane receptor","Other cytosolic protein","Transcription factor","Ion channel",Transporter,"Other nuclear protein",Phosphodiesterase,Reader,Er
aser,"Family A G protein-coupled receptor",Protease,"Cytochrome P450",Oxidoreductase,"Ligand-gated ion channel","Primary active transporter",Hydrolase,"Nuclear receptor","Electrochemical transporter",
Kinase,"Phosphodiesterase 5","Phosphodiesterase 2","Phosphodiesterase 7",Bromodomain,"Lysine demethylase","Peptide receptor (family A GPCR)","Metallo protease","Cysteine protease","Cytochrome P450 fam
ily 2","Phosphodiesterase 3","Phosphodiesterase 6","GABA-A receptor","Phosphodiesterase 11","ATP-binding cassette","Phosphodiesterase 10","Cytochrome P450 family 3","Phosphodiesterase 4","Nuclear horm
one receptor subfamily 1","Phosphodiesterase 8","SLC superfamily of solute carriers","Phosphodiesterase 1","Protein Kinase","Phosphodiesterase 5A","Phosphodiesterase 2A","Phosphodiesterase 7A","Jumonj
i domain-containing","Short peptide receptor (family A GPCR)","Metallo protease MAE clan","Cysteine protease CD clan","Cytochrome P450 family 2D","Phosphodiesterase 3A","Phosphodiesterase 6A","Cystein
e protease CA clan","Phosphodiesterase 11A","ABCB subfamily","Phosphodiesterase 10A","Cytochrome P450 family 3A","Phosphodiesterase 4A","Nuclear hormone receptor subfamily 1 group A","Glycohormone rec
eptor","Phosphodiesterase 7B","Cytochrome P450 family 2C","Phosphodiesterase 8A","Phosphodiesterase 8B","SLC28 and SLC29 families of nucleoside transporters","Phosphodiesterase 1A","Nuclear hormone re
ceptor subfamily 1 group F","SLC47 family of multidrug and toxin extrusion transporters","SLC22 family of organic cation and anion transporters","Atypical protein kinase group","ABCC subfamily","Neuro
peptide receptor","Metallo protease M34 family","Cysteine protease C14 family","Cytochrome P450 2D6","Cysteine protease C19 family","Cytochrome P450 3A4","Nuclear hormone receptor subfamily 1 group A 
member 2","Cytochrome P450 2C19","SLC29 Facilitative nucleoside transporter family","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 2C9","Atypical protein kinase PIKK family"}

> <pathway_chembl>
{Enzymes,Receptors,"Ion channels",Transporters,"Other protein targets","Eicosanoid turnover","Cyclic nucleotide turnover/signalling","Chromatin modifying enzymes","G protein-coupled receptors","Peptid
ases and proteinases","Cytochrome P450","Ligand-gated ion channels","ATP-binding cassette transporter family","Inositol phosphate turnover","3.2.1.- Glycosidases","Nuclear hormone receptors","SLC supe
rfamily of solute carriers","Heat shock proteins","Kinases (EC 2.7.x.x)","Adenosine turnover","Prostaglandin synthases",Phosphodiesterases,3',"5'-cyclic nucleotide (PDEs)","1.14.11.- Histone demethyla
ses","2.1.1.43 Histone methyltransferases (HMTs)","Neuropeptide S receptor","CD: Cysteine (C) Peptidases","CYP2 family: drug metabolising subset","CA: Cysteine (C) Peptidases","GABA<sub>A</sub> recept
ors","ABCB subfamily","Inositol monophosphatase","CYP3 family","1A. Thyroid hormone receptors","Glycoprotein hormone receptors",Lipoxygenases,"SLC28 and SLC29 families of nucleoside transporters","1F.
 Retinoic acid-related orphans","SLC47 family of multidrug and toxin extrusion transporters","SLC22 family of organic cation and anion transporters",Atypical,"ABCC subfamily","C14: Caspase","C19: Ubiq
uitin-specific protease","SLC29 family","Organic cation transporters (OCT)","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","Other PIKK family kinases"}

> <pathway_reactome>
{"DNA Repair",Metabolism,Hemostasis,"Gene expression (Transcription)",Disease,"Neuronal System","Cellular responses to external stimuli","Programmed Cell Death","Cell Cycle","Metabolism of proteins","
Signal Transduction","Developmental Biology","Transport of small molecules","Immune System","DNA Double-Strand Break Repair","Metabolism of lipids","Platelet activation","signaling and aggregation","P
latelet homeostasis","RNA Polymerase II Transcription","Infectious disease","Transmission across Chemical Synapses","Cellular responses to stress","Biological oxidations","Metabolism of amino acids an
d derivatives",Apoptosis,"Abacavir transport and metabolism","Inositol phosphate metabolism",Mitotic,"Diseases of metabolism","Post-translational protein modification","Signaling by GPCR","Nervous sys
tem development","SLC-mediated transmembrane transport","Cytokine Signaling in Immune system","Base Excision Repair","Cell Cycle Checkpoints","Metabolism of carbohydrates","Metabolism of nucleotides",
"Homology Directed Repair","Biosynthesis of specialized proresolving mediators (SPMs)","Platelet Aggregation (Plug Formation)","Nitric oxide stimulates guanylate cyclase","Generic Transcription Pathwa
y","Leishmania infection","Neurotransmitter receptors and postsynaptic signal transmission","Cellular response to hypoxia","Uptake and actions of bacterial toxins","Phase I - Functionalization of comp
ounds","Branched-chain amino acid catabolism","Intrinsic Pathway for Apoptosis","Abacavir transmembrane transport","Synthesis of IP2",IP,"and Ins in the cytosol","Mitotic G1 phase and G1/S transition"
,"Diseases of carbohydrate metabolism",SUMOylation,"GPCR downstream signalling","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Transport of vitamins",nucleosides,"and related molecu
les","M Phase","Signaling by Interleukins","Transport of bile salts and organic acids","metal ions and amine compounds","Resolution of Abasic Sites (AP sites)","Mitotic G2-G2/M phases","G1/S DNA Damag
e Checkpoints","Glycosaminoglycan metabolism","Response to elevated platelet cytosolic Ca2+","Metabolism of steroids","Nucleotide salvage","HDR through Homologous Recombination (HRR) or Single Strand 
Annealing (SSA)","Biosynthesis of DHA-derived SPMs","cGMP effects","Transcriptional regulation by RUNX1","Leishmania parasite growth and survival","Activation of NMDA receptors and postsynaptic events
","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Uptake and function of anthrax toxins","Transcriptional Regulation by TP53","Cytochrome P450 - arranged by substrate type"
,"Apoptotic factor-mediated response","Ethanol oxidation","GABA receptor activation","G1/S Transition","Glycogen storage diseases","SUMO E3 ligases SUMOylate target proteins","G alpha (s) signalling e
vents","Biosynthesis of DPA-derived SPMs","Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane","Mitotic Metaphase and Anaphase","Interleukin-1 family signaling","
Transcriptional regulation by RUNX3","Organic cation/anion/zwitterion transport","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","G2/M Transition","p53-Dependent G1/S DN
A damage checkpoint","Hyaluronan metabolism","Platelet degranulation","Bile acid and bile salt metabolism","Purine salvage","G alpha (i) signalling events","HDR through Homologous Recombination (HRR)"
,"Biosynthesis of D-series resolvins","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","Anti-inflammatory response favouring Leishmania parasite infection","Post
 NMDA receptor activation events","TP53 Regulates Transcription of Cell Death Genes",Xenobiotics,"Regulation of TP53 Activity","Cytochrome c-mediated apoptotic response","Activation of the pre-replica
tive complex","Glycogen storage disease type II (GAA)","Biosynthesis of maresins","SUMOylation of intracellular receptors","Biosynthesis of DPAn-3 SPMs","Mitotic Anaphase","Interleukin-1 signaling","R
UNX3 Regulates Immune Response and Cell Migration","Organic cation transport","PCNA-Dependent Long Patch Base Excision Repair","Centrosome maturation","p53-Dependent G1 DNA Damage Response","Hyalurona
n biosynthesis and export","Synthesis of bile acids and bile salts","Opioid Signalling","Homologous DNA Pairing and Strand Exchange","ADORA2B mediated anti-inflammatory cytokines production","Activati
on of AMPK downstream of NMDARs","TP53 Regulates Transcription of Caspase Activators and Caspases","CYP2E1 reactions","Regulation of TP53 Expression and Degradation","Activation of caspases through ap
optosome-mediated cleavage","Biosynthesis of maresin-like SPMs","Biosynthesis of DPAn-3-derived protectins and resolvins","Nuclear Envelope (NE) Reassembly","MAP3K8 (TPL2)-dependent MAPK1/3 activation
","Loss of proteins required for interphase microtubule organization from the centrosome","Stabilization of p53","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","DARPP-32 events
","Presynaptic phase of homologous DNA pairing and strand exchange","Regulation of TP53 Degradation","Initiation of Nuclear Envelope (NE) Reformation","Loss of Nlp from mitotic centrosomes","Autodegra
dation of the E3 ubiquitin ligase COP1"}

> <broad_targets>
{ADA,PDE10A,PDE1A,PDE1B,PDE1C,PDE2A,PDE3A,PDE3B,PDE4A,PDE4B,PDE4C,PDE4D,PDE5A,PDE6A,PDE6B,PDE6C,PDE6D,PDE6G,PDE6H,PDE7A,PDE7B,PDE8A,PDE8B,PDE9A,SLC29A1}

> <broad_moa>
{"phosphodiesterase inhibitor"}

> <synonyms>
{58-32-2,58322,Dipyridamol,Dipyridamine,Persantin,Dipyudamine,Persantine,Curantyl,Stimolcardio,Cardoxin,Kurantil,Stenocardil,Cardioflux,Dipiridamol,Dipyridan,Peridamol,Anginal,Apricor,Coribon,Corosan,
Coroxin,Stenocardiol,Agilease,Chilco,T1618,SAM002264609,1500259,Prestw-142,Dypyridamole,CPD000058382,DIPYRIDAMOLE,Dipyridamole}

> <pdid>
PD002363

> <targets>
{}

> <classes>
{"coronary vasodilator"}

> <pubchem_cids>
{3108}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 29  0  0  1  0            999 V2000
    2.5981    0.0000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    1.2990   -3.7500    0.0000 C   0  0
    2.5981   -3.0000    0.0000 C   0  0  1  0  0  0
    3.8971   -3.7500    0.0000 C   0  0  2  0  0  0
    4.2297   -5.2071    0.0000 C   0  0
    5.7224   -5.3544    0.0000 C   0  0
    6.3238   -3.9802    0.0000 C   0  0  2  0  0  0
    6.6067   -3.0210    0.0000 O   0  0
    7.3153   -5.0895    0.0000 C   0  0
    8.7787   -4.7600    0.0000 O   0  0
    6.8692   -6.5225    0.0000 C   0  0
    7.8858   -7.6254    0.0000 O   0  0
    5.1962   -3.0000    0.0000 C   0  0  2  0  0  0
    6.1061   -2.5853    0.0000 C   0  0
    5.1962   -1.5000    0.0000 C   0  0
    3.8971   -0.7500    0.0000 C   0  0  2  0  0  0
    3.8971    0.7500    0.0000 O   0  0
    2.5981   -1.5000    0.0000 C   0  0  2  0  0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  3
  8  2  1  0
  8  9  1  0
  9 10  1  0
 11 10  1  6
 11 12  1  0
 12 13  1  1
 13 14  1  0
 14 15  1  0
 15 16  1  6
 15 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 15 21  1  0
 21 12  1  0
 21 22  1  1
 21 23  1  0
 23 24  1  0
 24 25  1  1
 26 24  1  1
 26  2  1  0
 26 11  1  0
M  END
> <name>
NIHCC_2014

> <id>
6082

> <plate>
NGP-202-01

> <well>
B03

> <supplier_cmpd_name>
CPD000653523

> <ctcr_id>
6634

> <supplier_cmpd_id>
SAM002264617

> <smiles>
C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)CO)[C@@]4(C)C[C@H](O)[C@H]23

> <pd_targets>
{SHBG,HIF1A,HSD17B10,CHRM1,NR3C2,NR3C1,SERPINA6,ARHGAP35,NFKB1,MAPT,CYP3A4,ANXA1}

> <pathway_gtopdb>
{"Secreted protein",Enzyme,"Transcription factor","Membrane receptor","Other cytosolic protein","Ion channel",Protease,Oxidoreductase,"Family A G protein-coupled receptor","Nuclear receptor","Cytochro
me P450","Other ion channel","Cysteine protease","Small molecule receptor (family A GPCR)","Nuclear hormone receptor subfamily 3","Cytochrome P450 family 3",Annexin,"Cysteine protease CA clan","Monoam
ine receptor","Nuclear hormone receptor subfamily 3 group C","Cytochrome P450 family 3A","Cysteine protease C1A family","Acetylcholine receptor","Nuclear hormone receptor subfamily 3 group C member 2"
,"Nuclear hormone receptor subfamily 3 group C member 1","Cytochrome P450 3A4"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Nuclear hormone receptors","Cytochrome P450","Acetylcholine receptors (muscarinic)","Steroid hormone receptors","CYP3 family","3C. 3-Ketosteroid recep
tors"}

> <pathway_reactome>
{"Cellular responses to external stimuli",Metabolism,"Signal Transduction","Metabolism of proteins","Gene expression (Transcription)","Developmental Biology","Immune System","Neuronal System","Cellula
r responses to stress","Metabolism of amino acids and derivatives","Signaling by GPCR","Post-translational protein modification","RNA Polymerase II Transcription","Metabolism of lipids","Nervous syste
m development","Cytokine Signaling in Immune system","Transmission across Chemical Synapses","Cellular response to hypoxia","Branched-chain amino acid catabolism","GPCR ligand binding",SUMOylation,"Ge
neric Transcription Pathway","Metabolism of steroids","Axon guidance","Signaling by Interleukins","Neurotransmitter receptors and postsynaptic signal transmission","Biosynthesis of specialized proreso
lving mediators (SPMs)","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Class A/1 (Rhodopsin-like receptors)","SUMO E3 ligases SUMOylate target proteins","FOXO-mediated tra
nscription","Metabolism of steroid hormones","Semaphorin interactions","Interleukin-1 family signaling","Activation of NMDA receptors and postsynaptic events","Biosynthesis of DHA-derived SPMs","Amine
 ligand-binding receptors","SUMOylation of intracellular receptors","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","Glucocorticoid biosynthesis","Sema4D in semaphorin
 signaling","Interleukin-1 signaling","Post NMDA receptor activation events","Biosynthesis of maresins","Peptide ligand-binding receptors","Muscarinic acetylcholine receptors","Sema4D mediated inhibit
ion of cell attachment and migration","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Activation of AMPK downstream of NMDARs","Biosynthesis of maresin-like SPMs","Formyl peptide receptors bind formyl p
eptides and many other ligands"}

> <broad_targets>
{ANXA1,NOS2,NR3C1,NR3C2}

> <broad_moa>
{"glucocorticoid receptor agonist"}

> <synonyms>
{hydrocortisone,Cortisol,50-23-7,50237,"50 23 7",Acticort,Cetacort,Hydrasson,Hydrocortisyl,Cobadex,Hydrocortone,Cortef,Hycort,Hytone,Signef,17-Hydroxycorticosterone,17Hydroxycorticosterone,"17 Hydroxy
corticosterone",Optef,"Kendall's compound",SAM002264617,Prestw-447,CPD000653523,"Hydrocortisone base"}

> <pdid>
PD002049

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5754}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 23  0  0  1  0            999 V2000
   10.3996   -1.4837    0.0000 C   0  0
    9.0990   -0.7364    0.0000 C   0  0
    9.0964    0.7636    0.0000 C   0  0
   10.3966    0.0161    0.0000 C   0  0
    7.8003   -1.4887    0.0000 N   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    5.2029   -2.9932    0.0000 O   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0  1  0  0  0
   -3.8971   -3.7500    0.0000 O   0  0
   -1.2990   -3.7500    0.0000 C   0  0  1  0  0  0
   -1.2990   -5.2500    0.0000 O   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  6
 17 19  1  0
 19 20  1  6
 19 21  1  0
 21 22  1  0
 22 11  1  0
 22 15  2  0
M  END
> <name>
NIHCC_2014

> <id>
6083

> <plate>
NGP-202-01

> <well>
B04

> <supplier_cmpd_name>
CPD000058975

> <ctcr_id>
2346

> <supplier_cmpd_id>
SAM002264627

> <smiles>
CC(C)(C)NCC(O)COc1cccc2C[C@@H](O)[C@@H](O)Cc12

> <pd_targets>
{ADRB3,RECQL,ADRB2,ADRB1}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Adrenergic receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors",Adrenoceptors}

> <pathway_reactome>
{Disease,"Infectious disease","Leishmania infection","Leishmania parasite growth and survival","Anti-inflammatory response favouring Leishmania parasite infection","ADORA2B mediated anti-inflammatory 
cytokines production"}

> <broad_targets>
{ADRB1,ADRB2,ADRB3}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{GTPL554,KBioGR_000765,KBioGR000765,KBioGR-000765,"KBioGR 000765",nadolol,42200-33-9,42200339,Corgard,Solgol,SQ-11725,SQ11725,CHEMBL649,MLS000028580,SMR000058975,DSSTox_CID_3342,DSSToxCID3342,DSSTox-C
ID-3342,"DSSTox CID 3342",DSSTox_RID_76983,DSSToxRID76983,DSSTox-RID-76983,"DSSTox RID 76983",DSSTox_GSID_23342,DSSToxGSID23342,DSSTox-GSID-23342,"DSSTox GSID 23342",SR-01000000251,SR01000000251,NCGC0
0016851-01,NCGC0001685101,Prestwick_108,Prestwick108,Prestwick-108,"Prestwick 108","Nadolol (EP)","Nadolol (HSDB)","Nadolol (INN",T1203,SAM002264627,1503260,Prestw-818,Nadolol,CPD000058975,NADOLOL}

> <pdid>
PD001017

> <targets>
{}

> <classes>
{"betaadrenergic blocker"}

> <pubchem_cids>
{39147}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 30  0  0  0  0            999 V2000
    2.5608  -12.0027    0.0000 O   0  0
    2.5691  -10.5028    0.0000 C   0  0
    3.8725   -9.7587    0.0000 C   0  0
    3.8808   -8.2579    0.0000 N   0  0
    5.1824   -7.5124    0.0000 C   0  0
    5.1876   -6.0124    0.0000 C   0  0
    3.8912   -5.2578    0.0000 N   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 S   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -1.2990   -5.2500    0.0000 Cl  0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    2.5895   -6.0034    0.0000 C   0  0
    2.5844   -7.5034    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 22 24  1  0
 24 25  2  0
 25 11  1  0
 25 19  1  0
  7 26  1  0
 26 27  1  0
 27  4  1  0
M  END
> <name>
NIHCC_2014

> <id>
6084

> <plate>
NGP-202-01

> <well>
B05

> <supplier_cmpd_name>
CPD000058180

> <ctcr_id>
2071

> <supplier_cmpd_id>
SAM002264637

> <smiles>
OCCN1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1

> <pd_targets>
{TSHR,MAPT,FFP,CHRM1,THPO,CYP3A4,AOX1,UBE2N,ADRA2A,DRD2,PDR5,SIGMAR1,HTR1A,HTR2A,ADRA2C,CHRM2,HTR6,ABCB11,HTR7,TP53,NPSR1,CYP2D6,GMNN,RORC,CYP1A2,RAD52,CYP2J2,LMNA,HRH1,HTR2C,ADRA1A,NFKB1,CYP2C19,ALB,
KMT2A,MEN1,CYP2C9,MAPK1,LEF,CHRM3,PMP22,NFO,RECQL,DRD3,ADRA2B,MTOR,KCNH2,CALM1}

> <pathway_gtopdb>
{"Membrane receptor","Other cytosolic protein",Enzyme,"Unclassified protein",Transporter,"Transcription factor","Other nuclear protein","Secreted protein","Epigenetic regulator","Ion channel","Family 
A G protein-coupled receptor",Transferase,"Cytochrome P450",Oxidoreductase,Aminoacyltransferase,"Primary active transporter","Nuclear receptor",Reader,Kinase,Protease,Hydrolase,"Voltage-gated ion chan
nel","Peptide receptor (family A GPCR)","Small molecule receptor (family A GPCR)","Cytochrome P450 family 3","ATP-binding cassette","Cytochrome P450 family 2","Nuclear hormone receptor subfamily 1","C
ytochrome P450 family 1",Bromodomain,"Protein Kinase","Metallo protease","Potassium channels","Glycohormone receptor","Monoamine receptor","Cytochrome P450 family 3A","ABCB subfamily","Short peptide r
eceptor (family A GPCR)","Cytochrome P450 family 2D","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family 1A","Cytochrome P450 family 2C","CMGC protein kinase group","Metallo proteas
e MAE clan","Atypical protein kinase group","Voltage-gated potassium channel","Acetylcholine receptor","Cytochrome P450 3A4","Dopamine receptor","Adrenergic receptor","Serotonin receptor","Neuropeptid
e receptor","Cytochrome P450 2D6","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 1A1","Histamine receptor","Cytochrome P450 2C19","Cytochrome P450 2C9","CMGC protein kinase M
APK family","Metallo protease M34 family","Atypical protein kinase PIKK family","CMGC protein kinase ERK1","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Receptors,Enzymes,"Other protein targets",Transporters,"Ion channels","G protein-coupled receptors","Cytochrome P450","Sigma receptors","ATP-binding cassette transporter family","Nuclear hormone rece
ptors","Kinases (EC 2.7.x.x)","Voltage-gated ion channels","Glycoprotein hormone receptors","Acetylcholine receptors (muscarinic)","CYP3 family","Dopamine receptors",Adrenoceptors,"5-Hydroxytryptamine
 receptors","ABCB subfamily","Neuropeptide S receptor","CYP2 family: drug metabolising subset","1F. Retinoic acid-related orphans","CYP1 family","Histamine receptors","CMGC: Containing CDK",MAPK,GSK3,
"CLK families",Atypical,"Potassium channels","Mitogen-activated protein kinases (MAP kinases)","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","Voltage-gated potassium channels","ERK s
ubfamily","FRAP subfamily"}

> <pathway_reactome>
{Disease,"Neuronal System","Signal Transduction",Hemostasis,Metabolism,"Immune System","Cell Cycle","Gene expression (Transcription)","DNA Repair","Developmental Biology","Muscle contraction","Infecti
ous disease","Transmission across Chemical Synapses","Signaling by GPCR","Platelet activation","signaling and aggregation","Metabolism of lipids","Metabolism of vitamins and cofactors","Innate Immune 
System","Cell Cycle Checkpoints","Biological oxidations",Mitotic,"RNA Polymerase II Transcription","DNA Double-Strand Break Repair","Cytokine Signaling in Immune system","Nervous system development","
Cardiac conduction","Leishmania infection","Neurotransmitter receptors and postsynaptic signal transmission","GPCR ligand binding","Platelet Aggregation (Plug Formation)","Biosynthesis of specialized 
proresolving mediators (SPMs)","Metabolism of water-soluble vitamins and cofactors","Toll-like Receptor Cascades","SARS-CoV Infections","Metabolism of steroids","G1/S DNA Damage Checkpoints","Phase I 
- Functionalization of compounds","Mitotic G1 phase and G1/S transition","Generic Transcription Pathway","Homology Directed Repair","M Phase","Signaling by Interleukins","Uptake and actions of bacteri
al toxins","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Phase 3 - rapid repolarisation","Leishmania parasite growth and survival","Activation of NMDA receptors and postsynaptic ev
ents","Class A/1 (Rhodopsin-like receptors)","Biosynthesis of DHA-derived SPMs","Vitamins B6 activation to pyridoxal phosphate","Toll Like Receptor 4 (TLR4) Cascade","Potential therapeutics for SARS",
"Bile acid and bile salt metabolism","p53-Dependent G1/S DNA damage checkpoint","Cytochrome P450 - arranged by substrate type","G1/S Transition","Transcriptional regulation by RUNX3","HDR through Homo
logous Recombination (HRR) or Single Strand Annealing (SSA)","Mitotic Metaphase and Anaphase","Interleukin-1 family signaling","Toll Like Receptor 5 (TLR5) Cascade","Uptake and function of anthrax tox
ins","Transcriptional Regulation by TP53","Anti-inflammatory response favouring Leishmania parasite infection","Post NMDA receptor activation events","Amine ligand-binding receptors","Biosynthesis of 
maresins","MyD88-independent TLR4 cascade","Synthesis of bile acids and bile salts","p53-Dependent G1 DNA Damage Response",Xenobiotics,"Activation of the pre-replicative complex","RUNX3 Regulates Immu
ne Response and Cell Migration","HDR through Single Strand Annealing (SSA)","Fatty acids","Mitotic Anaphase","Interleukin-1 signaling","Recycling of bile acids and salts","MyD88 cascade initiated on p
lasma membrane","Regulation of TP53 Activity","ADORA2B mediated anti-inflammatory cytokines production","Activation of AMPK downstream of NMDARs","Muscarinic acetylcholine receptors","Biosynthesis of 
maresin-like SPMs","TRIF(TICAM1)-mediated TLR4 signaling",Adrenoceptors,"Dopamine receptors","Serotonin receptors","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Stabilization
 of p53","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Nuclear Envelope (NE) Reassembly","Histamine receptors","MAP3K8 (TPL2)-dependent MAPK1/3 activation","MA
P kinase activation","Regulation of TP53 Expression and Degradation","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","IKK complex recruitment mediated by RIP1","Auto
degradation of the E3 ubiquitin ligase COP1","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","Regulation of TP53 Degradation","Ras activation u
pon Ca2+ influx through NMDA receptor","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{CALM1,DRD1,DRD2,HRH1,HTR2A,HTR2C,HTR6,HTR7}

> <broad_moa>
{"dopamine receptor antagonist"}

> <synonyms>
{58-39-9,58399,Trilafon,Perphenazin,Etaperazine,Perfenazine,Ethaperazine,Etaperazin,Fentazin,Chlorpiprazine,Perphenan,Thilatazin,Tranquisan,Decentan,Chlorperphenazine,Emesinal,Perfenazina,Trifaron,Tri
lifan,Triphenot,F-mon,Fmon,Perphenazinum,T1090,SAM002264637,1503934,Prestw-125,Perphenazine,CPD000058180,PERPHENAZINE}

> <pdid>
PD000799

> <targets>
{}

> <classes>
{antipsychotic}

> <pubchem_cids>
{4748}

$$$$
NIHCC_2014
  SciTegic11012413002D

 59 63  0  0  1  0            999 V2000
   -7.4552   -3.5838    0.0000 C   0  0
   -6.0104   -3.9870    0.0000 O   0  0
   -4.9400   -2.9400    0.0000 C   0  0  1  0  0  0
   -3.3500   -3.2400    0.0000 C   0  0
   -3.1000   -4.8300    0.0000 C   0  0
   -1.5200   -5.1200    0.0000 O   0  0
   -0.7000   -3.7400    0.0000 C   0  0  1  0  0  0
   -2.1973   -3.6507    0.0000 C   0  0
   -1.3600   -2.2500    0.0000 O   0  0
   -0.1600   -1.1700    0.0000 C   0  0
   -0.1600    0.4200    0.0000 C   0  0
   -1.0286    0.9155    0.0000 C   0  0
    1.2100    1.2300    0.0000 C   0  0
    1.2029    2.7300    0.0000 O   0  0
    2.6100    0.4200    0.0000 C   0  0
    4.0000    1.2300    0.0000 C   0  0
    3.9954    2.7300    0.0000 O   0  0
    5.4100    0.4200    0.0000 C   0  0
    6.8200    1.2300    0.0000 N   0  0
    6.4200    3.1700    0.0000 C   0  0
    7.6031    4.0921    0.0000 O   0  0
    5.2400    3.7400    0.0000 C   0  0
    3.6200    3.7900    0.0000 C   0  0
    2.3600    2.7300    0.0000 C   0  0
    1.1200    3.8200    0.0000 C   0  0
   -0.2200    3.0400    0.0000 C   0  0  2  0  0  0
   -0.3675    1.5473    0.0000 C   0  0
   -1.4300    4.1100    0.0000 C   0  0  2  0  0  0
   -1.2537    5.5996    0.0000 O   0  0
   -2.8600    3.3500    0.0000 C   0  0  1  0  0  0
   -4.2023    4.0195    0.0000 C   0  0
   -2.6100    1.7700    0.0000 C   0  0  1  0  0  0
   -1.7116    1.3309    0.0000 O   0  0
   -4.0400    0.9800    0.0000 C   0  0  1  0  0  0
   -5.3935    1.6266    0.0000 C   0  0
   -3.7700   -0.5500    0.0000 C   0  0  2  0  0  0
   -2.4087   -1.1738    0.0000 O   0  0
   -2.2675   -2.6680    0.0000 C   0  0
   -3.0828   -3.2470    0.0000 C   0  0
   -1.3585   -3.0848    0.0000 O   0  0
   -5.2000   -1.3500    0.0000 C   0  0  2  0  0  0
   -6.5511   -0.6985    0.0000 C   0  0
    5.5972    5.1969    0.0000 C   0  0
    5.4100   -1.1700    0.0000 C   0  0
    6.7110   -1.9161    0.0000 C   0  0
    6.7165   -3.4169    0.0000 N   0  0
    8.0185   -4.1634    0.0000 N   0  0
    8.0262   -5.6634    0.0000 C   0  0
    9.3291   -6.4068    0.0000 C   0  0
   10.6243   -5.6502    0.0000 N   0  0
   11.9271   -6.3936    0.0000 C   0  0
   10.6167   -4.1502    0.0000 C   0  0
    9.3138   -3.4068    0.0000 C   0  0
    4.0000   -1.9800    0.0000 C   0  0
    3.9954   -3.4800    0.0000 O   0  0
    2.6100   -1.1700    0.0000 C   0  0
    1.2100   -1.9800    0.0000 C   0  0
    0.8800   -3.5500    0.0000 C   0  0
    1.8933   -4.6560    0.0000 O   0  0
  1  2  1  0
  3  2  1  6
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  6
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 13 15  2  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  6
 26 28  1  0
 28 29  1  1
 28 30  1  0
 30 31  1  6
 30 32  1  0
 32 33  1  1
 32 34  1  0
 34 35  1  6
 34 36  1  0
 36 37  1  6
 37 38  1  0
 38 39  1  0
 38 40  2  0
 36 41  1  0
 41  3  1  0
 41 42  1  1
 22 43  1  0
 18 44  1  0
 44 45  1  0
 45 46  2  3
 46 47  1  0
 47 48  1  0
 48 49  1  0
 49 50  1  0
 50 51  1  0
 50 52  1  0
 52 53  1  0
 53 47  1  0
 44 54  2  0
 54 55  1  0
 54 56  1  0
 56 15  1  0
 56 57  2  0
 57 10  1  0
 57 58  1  0
 58  7  1  0
 58 59  2  0
M  END
> <name>
NIHCC_2014

> <id>
6085

> <plate>
NGP-202-01

> <well>
B06

> <supplier_cmpd_name>
CPD001906767

> <ctcr_id>
7008

> <supplier_cmpd_id>
SAM002264646

> <smiles>
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(NC(=O)C(=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)/C)c(C=NN5CCN(C)CC5)c(O)c4c3C2=O

> <pd_targets>
{NR1I2,SLCO1B3,INHA,ALB,ALOX15,ABCB11,SLCO1B1,SLCO1A2,GSTO1,CASP1,SLCO2B1,SLCO1A4,SLCO1A1,ABCC3,CYP51A1,ABCC2,ABCC4,CYP2B6,RPOA,RPOB,RPOC,RPOZ,GAA,KMT2A,MEN1,MAPK1,MAPT,ALDH1A1,HPGD,PYK,FFP,KDM4E,ALD,
TSHR,USP2,UCHL1,UCHL3,UCHL5,USP15}

> <pathway_gtopdb>
{"Transcription factor",Transporter,Enzyme,"Secreted protein","Epigenetic regulator","Other cytosolic protein","Nuclear receptor","Electrochemical transporter",Oxidoreductase,"Primary active transport
er",Protease,"Cytochrome P450",Transferase,Hydrolase,Reader,Kinase,Eraser,"Nuclear hormone receptor subfamily 1","SLC superfamily of solute carriers","ATP-binding cassette","Cysteine protease","Cytoch
rome P450 family 51","Cytochrome P450 family 2",Bromodomain,"Protein Kinase","Lysine demethylase","Nuclear hormone receptor subfamily 1 group I","SLC21/SLCO family of organic anion transporting polype
ptides","ABCB subfamily","Cysteine protease CD clan","ABCC subfamily","Cytochrome P450 family 51A","Cytochrome P450 family 2B","Cysteine protease CA clan","CMGC protein kinase group","Jumonji domain-c
ontaining","Nuclear hormone receptor subfamily 1 group I member 2","Cysteine protease C14 family","Cytochrome P450 51A1","Cytochrome P450 2B6","Cysteine protease C1A family","CMGC protein kinase MAPK 
family","CMGC protein kinase ERK1","Membrane receptor","Family A G protein-coupled receptor","Peptide receptor (family A GPCR)","Glycohormone receptor","Cysteine protease C19 family","Cysteine proteas
e C12 family"}

> <pathway_chembl>
{Receptors,Transporters,Enzymes,"Nuclear hormone receptors","SLC superfamily of solute carriers","Eicosanoid turnover","ATP-binding cassette transporter family","2.5.1.18 Glutathione transferases","Pe
ptidases and proteinases","Cytochrome P450","3.2.1.- Glycosidases","Kinases (EC 2.7.x.x)","Chromatin modifying enzymes","1I. Vitamin D receptor-like receptors","SLCO family of organic anion transporti
ng polypeptides",Lipoxygenases,"ABCB subfamily","CD: Cysteine (C) Peptidases","ABCC subfamily",CYP39,"CYP46 and CYP51 families","CYP2 family: drug metabolising subset","CMGC: Containing CDK",MAPK,GSK3
,"CLK families","Prostaglandin synthases","1.14.11.- Histone demethylases","C14: Caspase","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily","G protein-coupled receptors","Glycoprotein 
hormone receptors","CA: Cysteine (C) Peptidases","C19: Ubiquitin-specific protease","C12: Ubiquitin C-terminal hydrolase"}

> <pathway_reactome>
{"Metabolism of proteins",Metabolism,"Immune System","Gene expression (Transcription)","Transport of small molecules",Disease,Hemostasis,"Neuronal System","Post-translational protein modification","Me
tabolism of lipids","Cytokine Signaling in Immune system","RNA Polymerase II Transcription","SLC-mediated transmembrane transport","Biological oxidations","Disorders of transmembrane transporters","Pl
atelet activation","signaling and aggregation","Diseases of metabolism","Innate Immune System","Transmission across Chemical Synapses",SUMOylation,"Metabolism of steroids","Biosynthesis of specialized
 proresolving mediators (SPMs)","Signaling by Interleukins","Generic Transcription Pathway","Transport of vitamins",nucleosides,"and related molecules","Phase I - Functionalization of compounds","ABC 
transporter disorders","Response to elevated platelet cytosolic Ca2+","Diseases of carbohydrate metabolism","Toll-like Receptor Cascades","Neurotransmitter receptors and postsynaptic signal transmissi
on","SUMO E3 ligases SUMOylate target proteins","Bile acid and bile salt metabolism","Biosynthesis of DPA-derived SPMs","Interleukin-12 family signaling","Transcriptional Regulation by TP53","Transpor
t of organic anions","Cytochrome P450 - arranged by substrate type","Defective ABCC2 causes DJS","Platelet degranulation","Glycogen storage diseases","Toll Like Receptor 5 (TLR5) Cascade","Activation 
of NMDA receptors and postsynaptic events","Ethanol oxidation","Biosynthesis of DHA-derived SPMs","SUMOylation of intracellular receptors","Recycling of bile acids and salts","Biosynthesis of DPAn-3 S
PMs","Synthesis of bile acids and bile salts","Interleukin-12 signaling","TP53 Regulates Transcription of Cell Death Genes","Endogenous sterols",Xenobiotics,"Glycogen storage disease type II (GAA)","M
yD88 cascade initiated on plasma membrane","Post NMDA receptor activation events","Biosynthesis of D-series resolvins","Biosynthesis of DPAn-3-derived protectins and resolvins","Synthesis of bile acid
s and bile salts via 7alpha-hydroxycholesterol","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","TP53 Regulates Transcription of Caspase Activators and Caspases","
CYP2E1 reactions","MAP kinase activation","Activation of AMPK downstream of NMDARs","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated","Signal Transductio
n","Infectious disease","Signaling by TGFB family members","Leishmania infection",Deubiquitination,"Signaling by TGF-beta Receptor Complex","Leishmania parasite growth and survival","UCH proteinases",
"TGF-beta receptor signaling activates SMADs","Anti-inflammatory response favouring Leishmania parasite infection","Regulation of TP53 Activity","Downregulation of TGF-beta receptor signaling","ADORA2
B mediated anti-inflammatory cytokines production","Regulation of TP53 Expression and Degradation","Regulation of TP53 Degradation"}

> <broad_targets>
{NR1I2,SLCO1A2,SLCO1B1,SLCO1B3}

> <broad_moa>
{"RNA polymerase inhibitor"}

> <synonyms>
{Rifampicin,rifampin,MLS001148237,MLS002548867,CHEMBL4565586,HMS2230H07,HMS3259C11,ZINC169722578,NC00480,SMR000653525,SMR001906767,SAM002264646,CPD001906767}

> <pdid>
PD002886

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{135900090}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 18  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5988    1.5004    0.0000 S   0  0
   -3.8976    0.7500    0.0000 O   0  0
   -2.5986    0.0004    0.0000 O   0  0
   -2.5998    3.0012    0.0000 C   0  0
   -3.8993    3.7504    0.0000 C   0  0
   -3.9002    5.2504    0.0000 C   0  0
   -2.6017    6.0012    0.0000 C   0  0
   -2.6026    7.5012    0.0000 N   0  0
   -1.3022    5.2521    0.0000 C   0  0
   -1.3012    3.7521    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  5  8  1  0
  8  9  2  0
  8 10  2  0
  8 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 11  1  0
M  END
> <name>
NIHCC_2014

> <id>
6086

> <plate>
NGP-202-01

> <well>
B07

> <supplier_cmpd_name>
CPD000059064

> <ctcr_id>
3747

> <supplier_cmpd_id>
SAM002554879

> <smiles>
Nc1ccc(cc1)[S](=O)(=O)c2ccc(N)cc2

> <pd_targets>
{LMNA,CYP3A4,TSHR,MPO,PPPK-DHPS,HTR6,FOLP1,FOLP2}

> <pathway_gtopdb>
{"Other nuclear protein",Enzyme,"Membrane receptor","Unclassified protein","Cytochrome P450","Family A G protein-coupled receptor",Oxidoreductase,Transferase,"Cytochrome P450 family 3","Peptide recept
or (family A GPCR)","Small molecule receptor (family A GPCR)","Cytochrome P450 family 3A","Glycohormone receptor","Monoamine receptor","Cytochrome P450 3A4","Serotonin receptor"}

> <pathway_chembl>
{Enzymes,Receptors,"Cytochrome P450","G protein-coupled receptors","1.-.-.- Oxidoreductases","CYP3 family","Glycoprotein hormone receptors","5-Hydroxytryptamine receptors"}

> <pathway_reactome>
{"Cell Cycle",Metabolism,Disease,"Immune System",Mitotic,"Metabolism of lipids","Infectious disease","Innate Immune System","M Phase","Biosynthesis of specialized proresolving mediators (SPMs)","Leish
mania infection","ROS and RNS production in phagocytes","Mitotic Metaphase and Anaphase","Biosynthesis of DHA-derived SPMs","Leishmania parasite growth and survival","Events associated with phagocytol
ytic activity of PMN cells","Mitotic Anaphase","Biosynthesis of maresins","Anti-inflammatory response favouring Leishmania parasite infection","Nuclear Envelope (NE) Reassembly","Biosynthesis of mares
in-like SPMs","ADORA2B mediated anti-inflammatory cytokines production","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{DHFR}

> <broad_moa>
{"bacterial antifolate"}

> <synonyms>
{80-08-0,80080,"4,4'-Sulfonyldianiline","4,4'Sulfonyldianiline","4,4'-Diaminodiphenyl sulfone","4,4'Diaminodiphenyl sulfone",Diaphenylsulfone,"4-Aminophenyl sulfone","4Aminophenyl sulfone",Dapson,"4,4
'-Diaminodiphenylsulfone","4,4'Diaminodiphenylsulfone",Diaphenylsulfon,Sulfona,DADPS,"Bis(4-aminophenyl) sulfone","Bis(4aminophenyl) sulfone",Avlosulfone,Diphenasone,Sulfadion,T0891,SAM002554879,15002
22,Prestw-35,Sulphadione,CPD000059064,DAPSONE,Dapsone}

> <pdid>
PD002394

> <targets>
{Antibiotic,Bacterial,Parasite,Reactive Oxygen Species}

> <classes>
{leprostatic,dermatitis herpetiformis suppressant,antibacterial,Anti-infection,Immunology/Inflammation,Metabolic Enzyme/Protease,NF-ºB}

> <pubchem_cids>
{2955}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 21  0  0  0  0            999 V2000
    2.5983   -3.0004    0.0000 N   0  0
    2.5988   -1.5004    0.0000 S   0  0
    3.8983   -0.7512    0.0000 O   0  0
    3.8975   -2.2510    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 N   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -1.2991    3.7500    0.0000 N   0  0
    0.0000    3.0000    0.0000 S   0  0
    1.2810    2.2196    0.0000 O   0  0
   -0.0353    4.4996    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0008    0.0000 C   0  0
   -1.2986   -3.7517    0.0000 F   0  0
    1.2993   -3.7504    0.0000 F   0  0
    0.0007   -4.5008    0.0000 F   0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12  7  1  0
 12 13  2  0
 12 14  2  0
  8 15  1  0
 15 16  2  0
 16  5  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 17 20  1  0
M  END
> <name>
NIHCC_2014

> <id>
6087

> <plate>
NGP-202-01

> <well>
B08

> <supplier_cmpd_name>
CPD000058284

> <ctcr_id>
3375

> <supplier_cmpd_id>
SAM002703134

> <smiles>
N[S](=O)(=O)c1cc2c(NCN[S]2(=O)=O)cc1C(F)(F)F

> <pd_targets>
{KDM4E,CA5B,CA6,CA7,CA2,CA1,CA5A,CA14,ALDH1A1,CA12,CA4,CA13,CA9,LMNA,FFP,PTPN7,SLC12A3,SLC12A1,ATP1A1,KCNMA1}

> <pathway_gtopdb>
{"Epigenetic regulator",Enzyme,"Other nuclear protein",Transporter,"Ion channel",Eraser,Lyase,Oxidoreductase,Transferase,Phosphatase,"Electrochemical transporter","Primary active transporter","Voltage
-gated ion channel","Lysine demethylase","Protein Phosphatase","SLC superfamily of solute carriers","P-type ATPase","Potassium channels","Jumonji domain-containing","Tyrosine protein phosphatase","SLC
12 family of cation-coupled chloride transporters","Sodium potassium ATPase","Calcium-activated potassium channel"}

> <pathway_chembl>
{Enzymes,Transporters,"Ion channels","Chromatin modifying enzymes","Carbonic anhydrases","SLC superfamily of solute carriers","P-type ATPases","Voltage-gated ion channels","1.14.11.- Histone demethyla
ses","SLC12 family of cation-coupled chloride transporters","P2C P-type ATPases","Potassium channels",Na<sup>+</sup>/K<sup>+</sup>-ATPases,"Calcium- and sodium-activated potassium channels"}

> <pathway_reactome>
{Metabolism,"Transport of small molecules","Immune System","Cellular responses to external stimuli","Cell Cycle",Disease,Hemostasis,"Reversible hydration of carbon dioxide","O2/CO2 exchange in erythro
cytes","Cytokine Signaling in Immune system","Biological oxidations","Cellular responses to stress",Mitotic,"Disorders of transmembrane transporters","Infectious disease","Platelet homeostasis","Eryth
rocytes take up carbon dioxide and release oxygen","Signaling by Interleukins","Phase I - Functionalization of compounds","Cellular response to hypoxia","M Phase","SLC transporter disorders","SARS-CoV
 Infections","Nitric oxide stimulates guanylate cyclase","Interleukin-12 family signaling","Ethanol oxidation","Regulation of gene expression by Hypoxia-inducible Factor","Mitotic Metaphase and Anapha
se","Interleukin-1 family signaling","Defective SLC12A3 causes Gitelman syndrome (GS)","Defective SLC12A1 causes Bartter syndrome 1 (BS1)","Potential therapeutics for SARS","cGMP effects","Interleukin
-12 signaling","Mitotic Anaphase","Interleukin-37 signaling","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","Nuclear Envelope (NE) Reassembly","Initiation of Nucl
ear Envelope (NE) Reformation"}

> <broad_targets>
{ATP1A1,CA1,CA12,CA2,CA4,CA9,KCNMA1,SLC12A1,SLC12A3}

> <broad_moa>
{"sodium/potassium/chloride transporter inhibitor"}

> <synonyms>
{135-09-1,135091,Diuredemina,Glomerulin,Hidroflumetiazid,Hydroflumethizide,Diucardin,Diurometon,Flutizide,Hidroalogen,Spandiuril,Robezon,Saluron,Enjit,Trifluoromethylhydrothiazide,Bristurin,Elodrine,H
ydrenox,Leodrine,Olmagran,Rodiu,SAM002703134,1500341,Prestw-13,CPD000058284,HYDROFLUMETHIAZIDE,Hydroflumethiazide}

> <pdid>
PD002300

> <targets>
{}

> <classes>
{antihypertensive,diuretic}

> <pubchem_cids>
{3647}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 23  0  0  0  0            999 V2000
   11.4632    0.7733    0.0000 H   0  3
    8.9632    0.7733    0.0000 Cl  0  5
    6.4625    6.7757    0.0000 C   0  0
    5.1636    6.0254    0.0000 C   0  0
    5.1630    4.5246    0.0000 N   0  0
    6.4611    3.7714    0.0000 C   0  0
    6.4588    2.2714    0.0000 C   0  0
    3.8634    3.7739    0.0000 C   0  0
    3.8627    2.2731    0.0000 C   0  0
    2.5631    1.5224    0.0000 O   0  0
    2.5625    0.0216    0.0000 C   0  0
    3.8615   -0.7286    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    1.2628   -2.2303    0.0000 C   0  0
    2.5430   -3.0120    0.0000 C   0  0
    2.5063   -4.5115    0.0000 C   0  0
    1.1893   -5.2294    0.0000 C   0  0
   -0.0910   -4.4478    0.0000 C   0  0
   -0.0543   -2.9483    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 13  1  0
 13 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 19  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6088

> <plate>
NGP-202-01

> <well>
B09

> <supplier_cmpd_name>
CPD000058440

> <ctcr_id>
3502

> <supplier_cmpd_id>
SAM002554894

> <smiles>
[H+].[Cl-].CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2

> <pd_targets>
{TSHR,THPO,CYP3A4,MAPK1,KMT2A,MEN1,NPSR1,CHRM2,CHRM1,CHRM3,LMNA,CYP1A2,CHRM4,CYP2D6,SCN1A,SCN2A,SCN3A,ABCB11,HSD17B10,TDP1,PMP22,DRD3,HTR2A,HTR2C,HTR6,SIGMAR1,KCNH2,HRH2,CHRM5,HTR2B}

> <pathway_gtopdb>
{"Membrane receptor","Unclassified protein",Enzyme,"Epigenetic regulator","Other nuclear protein","Ion channel",Transporter,"Family A G protein-coupled receptor","Cytochrome P450",Kinase,Reader,"Volta
ge-gated ion channel","Primary active transporter",Oxidoreductase,Hydrolase,"Peptide receptor (family A GPCR)","Cytochrome P450 family 3","Protein Kinase",Bromodomain,"Small molecule receptor (family 
A GPCR)","Cytochrome P450 family 1","Cytochrome P450 family 2","Voltage-gated sodium channel","ATP-binding cassette","Potassium channels","Glycohormone receptor","Cytochrome P450 family 3A","CMGC prot
ein kinase group","Short peptide receptor (family A GPCR)","Monoamine receptor","Cytochrome P450 family 1A","Cytochrome P450 family 2D","ABCB subfamily","Voltage-gated potassium channel","Cytochrome P
450 3A4","CMGC protein kinase MAPK family","Neuropeptide receptor","Acetylcholine receptor","Cytochrome P450 1A1","Cytochrome P450 2D6","Dopamine receptor","Serotonin receptor","Histamine receptor","C
MGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Other protein targets","Ion channels","G protein-coupled receptors","Cytochrome P450","Kinases (EC 2.7.x.x)","ATP-binding cassette transporter family","Sigma receptors
","Voltage-gated ion channels","Glycoprotein hormone receptors","CYP3 family","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Neuropeptide S receptor","Acetylcholine receptors (muscarinic)","CYP1 fam
ily","CYP2 family: drug metabolising subset","ABCB subfamily","Dopamine receptors","5-Hydroxytryptamine receptors","Potassium channels","Histamine receptors","Mitogen-activated protein kinases (MAP ki
nases)","Voltage-gated potassium channels","ERK subfamily"}

> <pathway_reactome>
{Disease,Hemostasis,Metabolism,"Immune System","Signal Transduction","Cell Cycle","DNA Repair","Developmental Biology","Muscle contraction","Infectious disease","Platelet activation","signaling and ag
gregation","Metabolism of lipids","Innate Immune System","Signaling by GPCR",Mitotic,"Biological oxidations","Metabolism of amino acids and derivatives","DNA Double-Strand Break Repair","Nervous syste
m development","Cardiac conduction","Leishmania infection","Platelet Aggregation (Plug Formation)","Biosynthesis of specialized proresolving mediators (SPMs)","Toll-like Receptor Cascades","GPCR ligan
d binding","M Phase","Phase I - Functionalization of compounds","Metabolism of steroids","Branched-chain amino acid catabolism","Nonhomologous End-Joining (NHEJ)","EGR2 and SOX10-mediated initiation o
f Schwann cell myelination","SARS-CoV Infections","Phase 3 - rapid repolarisation","Leishmania parasite growth and survival","Biosynthesis of DHA-derived SPMs","Toll Like Receptor 5 (TLR5) Cascade","C
lass A/1 (Rhodopsin-like receptors)","Mitotic Metaphase and Anaphase","Cytochrome P450 - arranged by substrate type","Bile acid and bile salt metabolism","Potential therapeutics for SARS","Anti-inflam
matory response favouring Leishmania parasite infection","Biosynthesis of maresins","MyD88 cascade initiated on plasma membrane","Amine ligand-binding receptors","Mitotic Anaphase",Xenobiotics,"Synthe
sis of bile acids and bile salts","ADORA2B mediated anti-inflammatory cytokines production","Biosynthesis of maresin-like SPMs","MAP kinase activation","Muscarinic acetylcholine receptors","Nuclear En
velope (NE) Reassembly","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","CYP2E1 reactions","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Dopamine receptors
","Serotonin receptors","MAPK targets/ Nuclear events mediated by MAP kinases","Initiation of Nuclear Envelope (NE) Reformation","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{RESTW4,"Dicyclomine HCI",AKOS026750112,"2-Diethylaminoethyl bicyclohexyl-1-carboxylate HCl","2Diethylaminoethyl bicyclohexyl1carboxylate HCl","Dicyclomine hydrochloride","Dicyclomine Hcl",67-92-5,679
25,"Dicycloverine hydrochloride",Procyclomin,Bentomine,"Dicyclomine (hydrochloride)",Mamiesan,Merbentyl,Sawam,SAM002554894,1500240,Prestw-48,CPD000058440,"DICYCLOMINE HYDROCHLORIDE"}

> <pdid>
PD009709

> <targets>
{}

> <classes>
{anticholinergic}

> <pubchem_cids>
{657341,441344,46878358}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 22  0  0  0  0            999 V2000
    2.1651   -1.2500    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 Cl  0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 Cl  0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 Cl  0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0031   -3.0008    0.0000 C   0  0
    1.3039   -3.7494    0.0000 C   0  0
    1.3092   -5.2494    0.0000 C   0  0
    0.0128   -6.0039    0.0000 O   0  0
    2.6108   -5.9949    0.0000 C   0  0
    2.6160   -7.4949    0.0000 Cl  0  0
    3.9073   -5.2404    0.0000 C   0  0
    3.9021   -3.7404    0.0000 C   0  0
    5.1985   -2.9859    0.0000 Cl  0  0
    2.6004   -2.9949    0.0000 C   0  0
    2.5970   -1.9949    0.0000 Cl  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  8 10  2  0
 10  2  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 15 17  2  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 20 12  1  0
 20 21  1  0
M  END
> <name>
NIHCC_2014

> <id>
6089

> <plate>
NGP-202-01

> <well>
B10

> <supplier_cmpd_name>
CPD000058356

> <ctcr_id>
2687

> <supplier_cmpd_id>
SAM002554903

> <smiles>
Oc1c(Cl)cc(Cl)c(Cl)c1Cc2c(O)c(Cl)cc(Cl)c2Cl

> <pd_targets>
{AR,USP2,SERPINE1,THRB,HSD17B10,HSPA1A,KMT2A,MEN1,MCL1,ISPE,BLM,MEX-5,MIF,GROES,GROL,HSPD1,HSPE1,HTT,HIF1A,ALOX12,LMNA,RECQL,RORC,DNAB,ESR1,TSHR,MAPT,EIF4G1,RECD,REP,GALK1,CASP7,POS-1,HSPA8,NPY1R,MAPK
3,MAPK1,CAPN2,VCP,HPGD,CYP3A4,RECA,NAPEPLD,SKA,POLB,ENV,ALOX15,FTL,LEF,HSP90AA1,ESR2,MAPK14,TST,CYP1A2,HTR2B,SLC6A4,TACR2,HSPA5,PTGS2,EGFR,LCK,PAX8,ADRA2C,ACHE,ADORA2A,HTR2C,ERBB2,ADRA2A,CYP2C19,ADORA
3,FYN,TBXAS1,FABI,DLD,SDHD,GLUD1}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Secreted protein","Other cytosolic protein","Epigenetic regulator","Unclassified protein","Other nuclear protein","Membrane receptor",Transporter,"Surface antigen","Nuc
lear receptor",Protease,Oxidoreductase,Reader,Transferase,Isomerase,"Family A G protein-coupled receptor",Kinase,"Primary active transporter","Cytochrome P450",Phosphodiesterase,"Electrochemical trans
porter",Hydrolase,"Nuclear hormone receptor subfamily 3","Cysteine protease","Nuclear hormone receptor subfamily 1",Bromodomain,"Metallo protease","Peptide receptor (family A GPCR)","Protein Kinase","
Endoplasmic reticular retrotranslocon family","Cytochrome P450 family 3","Cytochrome P450 family 1","Small molecule receptor (family A GPCR)","SLC superfamily of solute carriers","Cytochrome P450 fami
ly 2","Cytochrome P450 family 5","Nuclear hormone receptor subfamily 3 group C","Cysteine protease CA clan","Nuclear hormone receptor subfamily 1 group A","Metallo protease MAE clan","Nuclear hormone 
receptor subfamily 1 group F","Nuclear hormone receptor subfamily 3 group A","Glycohormone receptor","Cysteine protease CD clan","Short peptide receptor (family A GPCR)","CMGC protein kinase group","C
ytochrome P450 family 3A","Cytochrome P450 family 1A","Monoamine receptor","SLC06 neurotransmitter transporter family","TK protein kinase group","Nucleotide-like receptor (family A GPCR)","Cytochrome 
P450 family 2C","Cytochrome P450 family 5A","Nuclear hormone receptor subfamily 3 group C member 4","Cysteine protease C19 family","Nuclear hormone receptor subfamily 1 group A member 2","Cysteine pro
tease C1A family","Metallo protease M1 family","Nuclear hormone receptor subfamily 1 group F member 3","Nuclear hormone receptor subfamily 3 group A member 1","Cysteine protease C14 family","Neuropept
ide Y receptor","CMGC protein kinase MAPK family","Cysteine protease C2 family","Cytochrome P450 3A4","Metallo protease M34 family","Nuclear hormone receptor subfamily 3 group A member 2","Cytochrome 
P450 1A1","Serotonin receptor","Neurokinin receptor","Tyrosine protein kinase EGFR family","Tyrosine protein kinase Src family","Adrenergic receptor","Adenosine receptor","Cytochrome P450 2C19","Cytoc
hrome P450 5A1","CMGC protein kinase ERK1","CMGC protein kinase p38 subfamily","Tyrosine protein kinase SrcA"}

> <pathway_chembl>
{Receptors,Enzymes,"Other protein targets",Transporters,"Nuclear hormone receptors","Peptidases and proteinases","Heat shock proteins","B-cell lymphoma 2 (Bcl-2) protein family","Eicosanoid turnover",
"G protein-coupled receptors","Anti-infective targets","Kinases (EC 2.7.x.x)","Cytochrome P450","Endocannabinoid turnover","SLC superfamily of solute carriers","Catalytic receptors","Acetylcholine tur
nover","Steroid hormone receptors","CA: Cysteine (C) Peptidases","1A. Thyroid hormone receptors",Lipoxygenases,"1F. Retinoic acid-related orphans","Glycoprotein hormone receptors","Viral protein targe
ts","CD: Cysteine (C) Peptidases","Neuropeptide Y receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Prostaglandin synthases","CYP3 family","<i>N</i>-Acylethanolamine turnover","CYP1 family",
"5-Hydroxytryptamine receptors","SLC6 neurotransmitter transporter family","Tachykinin receptors",Cyclooxygenase,"Receptor kinases",Adrenoceptors,"Adenosine receptors","CYP2 family: drug metabolising 
subset",CYP5,"CYP7 and CYP8 families","3C. 3-Ketosteroid receptors","C19: Ubiquitin-specific protease","3A. Estrogen receptors","Coronavirus (CoV) proteins","C14: Caspase","Mitogen-activated protein k
inases (MAP kinases)","C2: Calpain","Monoamine transporter subfamily","TK: Tyrosine kinase","ERK subfamily","p38 subfamily","Receptor tyrosine kinases (RTKs)","Non-receptor tyrosine kinases (nRTKs)","
Type I RTKs: ErbB (epidermal growth factor) receptor family","Src family"}

> <pathway_reactome>
{"Gene expression (Transcription)","Metabolism of proteins",Metabolism,"Cellular responses to external stimuli","Immune System","DNA Repair","Cell Cycle",Disease,"Neuronal System","Programmed Cell Dea
th","Signal Transduction","Vesicle-mediated transport","Developmental Biology","RNA Polymerase II Transcription","Post-translational protein modification","Metabolism of amino acids and derivatives","
Cellular responses to stress","Cytokine Signaling in Immune system","DNA Double-Strand Break Repair","Metabolism of lipids",Mitotic,"Infectious disease","Transmission across Chemical Synapses",Transla
tion,"Diseases of metabolism",Apoptosis,"Signaling by GPCR","Innate Immune System","Diseases of programmed cell death","Base Excision Repair","Membrane Trafficking","Intracellular signaling by second 
messengers","Biological oxidations","Nervous system development","The citric acid (TCA) cycle and respiratory electron transport","Generic Transcription Pathway",SUMOylation,"Branched-chain amino acid
 catabolism","Cellular response to heat stress","Signaling by Interleukins","Homology Directed Repair","Cellular response to hypoxia","Biosynthesis of specialized proresolving mediators (SPMs)","M Pha
se","Leishmania infection","Neurotransmitter receptors and postsynaptic signal transmission","Eukaryotic Translation Initiation","SARS-CoV Infections","Diseases of glycosylation","Intrinsic Pathway fo
r Apoptosis","GPCR ligand binding","Toll-like Receptor Cascades","Neurodegenerative Diseases","GPCR downstream signalling","Resolution of Abasic Sites (AP sites)","trans-Golgi Network Vesicle Budding"
,"Uptake and actions of bacterial toxins","Mitotic G2-G2/M phases","PIP3 activates AKT signaling","Sulfur amino acid metabolism","Phase I - Functionalization of compounds","Neurotransmitter clearance"
,"HIV Infection","Phospholipid metabolism","Axon guidance","Pyruvate metabolism and Citric Acid (TCA) cycle","Glutamate and glutamine metabolism","Transcriptional regulation by RUNX2","Transcriptional
 Regulation by TP53","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","SUMO E3 ligases SUMOylate target proteins","HSF1-dependent transactivation","Interleukin-4 and Interleukin-13 signali
ng","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Interleukin-12 family signaling","Transcriptional Regulation by MECP2","Oxygen-dependent proline hydroxylation of Hyp
oxia-inducible Factor Alpha","Biosynthesis of DPA-derived SPMs","Mitotic Metaphase and Anaphase","Transcriptional regulation by RUNX3","Transcriptional regulation by RUNX1","Leishmania parasite growth
 and survival","Activation of NMDA receptors and postsynaptic events","Cap-dependent Translation Initiation","SARS-CoV-2 Infection","Diseases associated with glycosylation precursor biosynthesis","Apo
ptotic factor-mediated response","Class A/1 (Rhodopsin-like receptors)","SARS-CoV-1 Infection","Toll Like Receptor 5 (TLR5) Cascade","Deregulated CDK5 triggers multiple neurodegenerative pathways in A
lzheimer's disease models","Biosynthesis of DHA-derived SPMs","G alpha (i) signalling events","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Golgi Associated Vesicle B
iogenesis","Uptake and function of anthrax toxins","G2/M Transition","Negative regulation of the PI3K/AKT network","Degradation of cysteine and homocysteine","Cytochrome P450 - arranged by substrate t
ype","Serotonin clearance from the synaptic cleft","Regulation of HSF1-mediated heat shock response","G alpha (q) signalling events","Host Interactions of HIV factors","Glycerophospholipid biosynthesi
s","Semaphorin interactions","Citric acid cycle (TCA cycle)","RUNX2 regulates bone development","Regulation of TP53 Activity","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","SUMOylation of i
ntracellular receptors","Attenuation phase","HDR through Homologous Recombination (HRR)","Interleukin-12 signaling","Regulation of MECP2 expression and activity","Biosynthesis of DPAn-3 SPMs","Mitotic
 Anaphase","RUNX3 Regulates Immune Response and Cell Migration","RUNX1 regulates estrogen receptor mediated transcription","Anti-inflammatory response favouring Leishmania parasite infection","Post NM
DA receptor activation events","Activation of the mRNA upon binding of the cap-binding complex and eIFs","and subsequent binding to 43S","SARS-CoV-2 Genome Replication and Transcription","Defective GA
LK1 can cause Galactosemia II (GALCT2)","Cytochrome c-mediated apoptotic response","Peptide ligand-binding receptors","SARS-CoV-1 Genome Replication and Transcription","MyD88 cascade initiated on plas
ma membrane","Attachment and Entry","Biosynthesis of D-series resolvins","Biosynthesis of maresins","Visual phototransduction","PCNA-Dependent Long Patch Base Excision Repair","Centrosome maturation",
PI5P,"PP2A and IER3 Regulate PI3K/AKT Signaling","Sulfide oxidation to sulfate",Xenobiotics,"Amine ligand-binding receptors","Gastrin-CREB signalling pathway via PKC and MAPK","The role of Nef in HIV-
1 replication and disease pathogenesis","Synthesis of PC","Sema4D in semaphorin signaling","Nucleotide-like (purinergic) receptors",Eicosanoids,"RUNX2 regulates osteoblast differentiation","Regulation
 of TP53 Expression and Degradation","Homologous DNA Pairing and Strand Exchange","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","Biosynthesis of DPAn-3-derived m
aresins","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Activation of AMPK downstream of NMDARs","Translation initiation complex formation","Replication 
of the SARS-CoV-2 genome","Activation of caspases through apoptosome-mediated cleavage","Replication of the SARS-CoV-1 genome","MAP kinase activation","Biosynthesis of maresin-like SPMs","The canonica
l retinoid cycle in rods (twilight vision)","Biosynthesis of DPAn-3-derived protectins and resolvins","Loss of proteins required for interphase microtubule organization from the centrosome","Aromatic 
amines can be N-hydroxylated or N-dealkylated by CYP1A2","Serotonin receptors","Tachykinin receptors bind tachykinins","EGFR Transactivation by Gastrin","Nef-mediates down modulation of cell surface r
eceptors by recruiting them to clathrin adapters",Adrenoceptors,"Sema4D induced cell migration and growth-cone collapse","CYP2E1 reactions","Adenosine P1 receptors","Nef and signal transduction","Regu
lation of TP53 Degradation","Presynaptic phase of homologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","
Biosynthesis of A2E","implicated in retinal degradation","Loss of Nlp from mitotic centrosomes","Nef Mediated CD4 Down-regulation","ERK/MAPK targets","Activation of the AP-1 family of transcription fa
ctors","ERKs are inactivated"}

> <broad_targets>
{GLUD1,SDHD}

> <broad_moa>
{"potassium channel activator"}

> <synonyms>
{"Bis(3,5,6-trichloro-2-hydroxyphenyl)-methane","Bis(3,5,6trichloro2hydroxyphenyl)methane",hexachlorophene,70-30-4,70304,Hexachlorofen,Hexachlorophen,Nabac,pHisoHex,Almederm,Exofene,Fostril,Gamophene,
Hexophene,Steraskin,Tersaseptic,Acigena,Dermadex,Distodin,Gamophen,Hexabalm,Hexafen,Phiso,T1019,SAM002554903,1500328,Prestw-1472,Hexachlorophene,CPD000058356,HEXACHLOROPHENE}

> <pdid>
PD002310

> <targets>
{}

> <classes>
{"antiinfective (topical)"}

> <pubchem_cids>
{3598}

$$$$
NIHCC_2014
  SciTegic11012413002D

 15 15  0  0  0  0            999 V2000
    1.2948   -3.7516    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2973   -2.2519    0.0000 N   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    5.1937   -3.0093    0.0000 O   0  0
    3.8912   -5.2570    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 10 12  2  0
 12  5  1  0
  2 13  1  0
 13 14  1  0
 13 15  2  0
M  END
> <name>
NIHCC_2014

> <id>
6090

> <plate>
NGP-202-01

> <well>
B11

> <supplier_cmpd_name>
CPD001370753

> <ctcr_id>
7014

> <supplier_cmpd_id>
SAM002554912

> <smiles>
CC(N)(Cc1ccc(O)c(O)c1)C(O)=O

> <pd_targets>
{KDM4E,MAPT,AMPC,HPGD,CYP3A4,CASP6,ABCC2,TDP1,ALD,BLM,GAA,ABCC4,RECQL,PMP22,ALOX15,POLB,PYK,RORC,ALDH1A1,TGR,FFP,ESR2,USP2,KMT2A,MEN1,LEF,APEX1,HSD17B10,ABCC3,CYP1A2,LMNA,MTOR,FYN,EGFR,DDC,ADRA2A,ADRA
2B,ADRA2C}

> <pathway_gtopdb>
{"Epigenetic regulator","Other cytosolic protein",Enzyme,Transporter,"Unclassified protein","Transcription factor","Other nuclear protein","Membrane receptor",Eraser,Hydrolase,"Cytochrome P450",Protea
se,"Primary active transporter",Oxidoreductase,Transferase,"Nuclear receptor",Reader,Kinase,Lyase,"Family A G protein-coupled receptor","Lysine demethylase","Cytochrome P450 family 3","Cysteine protea
se","ATP-binding cassette","Nuclear hormone receptor subfamily 1","Nuclear hormone receptor subfamily 3",Bromodomain,"Metallo protease","Cytochrome P450 family 1","Protein Kinase","Small molecule rece
ptor (family A GPCR)","Jumonji domain-containing","Cytochrome P450 family 3A","Cysteine protease CD clan","ABCC subfamily","Nuclear hormone receptor subfamily 1 group F","Nuclear hormone receptor subf
amily 3 group A","Cysteine protease CA clan","Metallo protease MAE clan","Cytochrome P450 family 1A","Atypical protein kinase group","TK protein kinase group","Monoamine receptor","Cytochrome P450 3A4
","Cysteine protease C14 family","Nuclear hormone receptor subfamily 1 group F member 3","Nuclear hormone receptor subfamily 3 group A member 2","Cysteine protease C19 family","Metallo protease M34 fa
mily","Cytochrome P450 1A1","Atypical protein kinase PIKK family","Tyrosine protein kinase Src family","Tyrosine protein kinase EGFR family","Adrenergic receptor","Atypical protein kinase FRAP subfami
ly","Tyrosine protein kinase SrcA"}

> <pathway_chembl>
{Enzymes,Transporters,Receptors,"Chromatin modifying enzymes","Eicosanoid turnover","Cytochrome P450","Peptidases and proteinases","ATP-binding cassette transporter family","3.2.1.- Glycosidases","Nuc
lear hormone receptors","Kinases (EC 2.7.x.x)","Catalytic receptors","Carboxylases and decarboxylases","1.14.11.- Histone demethylases","Prostaglandin synthases","CYP3 family","CD: Cysteine (C) Peptid
ases","ABCC subfamily",Lipoxygenases,"1F. Retinoic acid-related orphans","Steroid hormone receptors","CA: Cysteine (C) Peptidases","CYP1 family",Atypical,"Receptor kinases",Decarboxylases,"C14: Caspas
e","3A. Estrogen receptors","C19: Ubiquitin-specific protease","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","TK: Tyrosine kinase","FRAP subfamily","Non-receptor tyrosine kinases (nR
TKs)","Receptor tyrosine kinases (RTKs)","Src family","Type I RTKs: ErbB (epidermal growth factor) receptor family"}

> <pathway_reactome>
{"Neuronal System",Metabolism,"Gene expression (Transcription)",Disease,"DNA Repair",Hemostasis,"Developmental Biology","Signal Transduction","Cell Cycle","Transmission across Chemical Synapses","Meta
bolism of lipids","RNA Polymerase II Transcription","Disorders of transmembrane transporters","DNA Double-Strand Break Repair","Diseases of metabolism","Platelet activation","signaling and aggregation
","Nervous system development","Base Excision Repair","Biological oxidations","Intracellular signaling by second messengers","Infectious disease","Metabolism of amino acids and derivatives",Mitotic,"S
ignaling by GPCR","Neurotransmitter receptors and postsynaptic signal transmission","Biosynthesis of specialized proresolving mediators (SPMs)","Generic Transcription Pathway","ABC transporter disorde
rs","Nonhomologous End-Joining (NHEJ)","Homology Directed Repair","Diseases of carbohydrate metabolism","Response to elevated platelet cytosolic Ca2+","EGR2 and SOX10-mediated initiation of Schwann ce
ll myelination","Resolution of Abasic Sites (AP sites)","Phase I - Functionalization of compounds","PIP3 activates AKT signaling","Uptake and actions of bacterial toxins","Branched-chain amino acid ca
tabolism","Metabolism of steroids","M Phase","HIV Infection","GPCR downstream signalling","Metabolism of amine-derived hormones","Activation of NMDA receptors and postsynaptic events","Biosynthesis of
 DHA-derived SPMs","Transcriptional Regulation by TP53","Defective ABCC2 causes DJS","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Glycogen storage diseases","Platelet
 degranulation","Biosynthesis of DPA-derived SPMs","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Transcriptional regulation by RUNX3","Ethanol oxidation","Negative re
gulation of the PI3K/AKT network","Uptake and function of anthrax toxins","Bile acid and bile salt metabolism","Cytochrome P450 - arranged by substrate type","Mitotic Metaphase and Anaphase","Host Int
eractions of HIV factors","G alpha (q) signalling events","Catecholamine biosynthesis","Post NMDA receptor activation events","Biosynthesis of D-series resolvins","Biosynthesis of maresins","TP53 Regu
lates Transcription of Cell Death Genes","HDR through Homologous Recombination (HRR)","Glycogen storage disease type II (GAA)","Biosynthesis of DPAn-3 SPMs","PCNA-Dependent Long Patch Base Excision Re
pair","RUNX3 Regulates Immune Response and Cell Migration",PI5P,"PP2A and IER3 Regulate PI3K/AKT Signaling","Regulation of TP53 Activity","Recycling of bile acids and salts",Xenobiotics,"Mitotic Anaph
ase","The role of Nef in HIV-1 replication and disease pathogenesis","Gastrin-CREB signalling pathway via PKC and MAPK","Activation of AMPK downstream of NMDARs","Biosynthesis of maresin-like SPMs","T
P53 Regulates Transcription of Caspase Activators and Caspases","Homologous DNA Pairing and Strand Exchange","Biosynthesis of DPAn-3-derived protectins and resolvins","Regulation of TP53 Expression an
d Degradation","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Nuclear Envelope (NE) Reassembly","Nef and signal transduction","EGFR Transactivation by Gastrin","Presynaptic phase 
of homologous DNA pairing and strand exchange","Regulation of TP53 Degradation","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ADRA2A,ADRA2B,ADRA2C,DDC}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{3-Hydroxy-alpha-methyl-DL-tyrosine,3HydroxyalphamethylDLtyrosine,"3 Hydroxy alpha methyl DL tyrosine",DL-Methyldopa,DLMethyldopa,"DL Methyldopa",55-40-3,55403,"55 40 3",555-29-3,555293,"555 29 3","DL
-alpha-Methyl DOPA","DLalphaMethyl DOPA",D,SAM002554912,CPD001370753}

> <pdid>
PD001858

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{4138,25202646}

$$$$
NIHCC_2014
  SciTegic11012413002D

 13 13  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 C   0  0
    2.6030   -2.9977    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.6003   -1.4978    0.0000 C   0  0
   -3.8983   -0.7459    0.0000 C   0  0
   -2.6029   -2.9978    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
  8 12  2  0
 12  4  1  0
 12 13  1  0
M  END
> <name>
NIHCC_2014

> <id>
6091

> <plate>
NGP-202-01

> <well>
C02

> <supplier_cmpd_name>
CPD000059151

> <ctcr_id>
6555

> <supplier_cmpd_id>
SAM002264610

> <smiles>
CC(C)c1cccc(C(C)C)c1O

> <pd_targets>
{GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG3,GABRP,GABRQ,LMNA,HCN1,FAAH,HIF1A,CYP1A2,CA2,FTL,CYP3A4,CA1,ALOX15,TSHR,CHRM1,HPGD,HTR2B,PTGS1,HTR2C,SLC
6A2,SCN4A,SCN2A}

> <pathway_gtopdb>
{"Ion channel","Other nuclear protein",Enzyme,"Transcription factor","Unclassified protein","Membrane receptor",Transporter,"Ligand-gated ion channel","Voltage-gated ion channel",Hydrolase,"Cytochrome
 P450",Lyase,Oxidoreductase,"Family A G protein-coupled receptor","Electrochemical transporter","GABA-A receptor","Cyclic nucleotide-regulated channel","Cytochrome P450 family 1","Cytochrome P450 fami
ly 3","Peptide receptor (family A GPCR)","Small molecule receptor (family A GPCR)","SLC superfamily of solute carriers","Voltage-gated sodium channel","Cytochrome P450 family 1A","Cytochrome P450 fami
ly 3A","Glycohormone receptor","Monoamine receptor","SLC06 neurotransmitter transporter family","Cytochrome P450 1A1","Cytochrome P450 3A4","Acetylcholine receptor","Serotonin receptor"}

> <pathway_chembl>
{"Ion channels",Enzymes,Receptors,Transporters,"Voltage-gated ion channels","Endocannabinoid turnover","Cytochrome P450","Carbonic anhydrases","Eicosanoid turnover","G protein-coupled receptors","SLC 
superfamily of solute carriers","Ligand-gated ion channels","Cyclic nucleotide-regulated channels","<i>N</i>-Acylethanolamine turnover","CYP1 family","CYP3 family",Lipoxygenases,"Glycoprotein hormone 
receptors","Acetylcholine receptors (muscarinic)","Prostaglandin synthases","5-Hydroxytryptamine receptors",Cyclooxygenase,"SLC6 neurotransmitter transporter family","GABA<sub>A</sub> receptors","Volt
age-gated sodium channels","Monoamine transporter subfamily"}

> <pathway_reactome>
{"Cell Cycle","Neuronal System",Metabolism,"Cellular responses to external stimuli","Transport of small molecules","Vesicle-mediated transport","Immune System",Disease,"Signal Transduction","Developme
ntal Biology",Mitotic,"Potassium Channels","Metabolism of lipids","Cellular responses to stress","Biological oxidations","O2/CO2 exchange in erythrocytes","Membrane Trafficking","Cytokine Signaling in
 Immune system","Infectious disease","Signaling by GPCR","Disorders of transmembrane transporters","Transmission across Chemical Synapses","Nervous system development","M Phase","HCN channels","Fatty 
acid metabolism","Cellular response to hypoxia","Phase I - Functionalization of compounds","Erythrocytes take up carbon dioxide and release oxygen","trans-Golgi Network Vesicle Budding","Biosynthesis 
of specialized proresolving mediators (SPMs)","Signaling by Interleukins","Leishmania infection","GPCR ligand binding","SLC transporter disorders","Neurotransmitter receptors and postsynaptic signal t
ransmission","Axon guidance","Mitotic Metaphase and Anaphase","Arachidonic acid metabolism","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Cytochrome P450 - arranged by su
bstrate type","Golgi Associated Vesicle Biogenesis","Biosynthesis of DHA-derived SPMs","Interleukin-12 family signaling","Biosynthesis of DPA-derived SPMs","Leishmania parasite growth and survival","C
lass A/1 (Rhodopsin-like receptors)","Defective SLC6A2 causes orthostatic intolerance (OI)","GABA receptor activation","L1CAM interactions","Mitotic Anaphase",Xenobiotics,"Biosynthesis of maresins","I
nterleukin-12 signaling","Biosynthesis of DPAn-3 SPMs","Anti-inflammatory response favouring Leishmania parasite infection","Amine ligand-binding receptors","Biosynthesis of D-series resolvins","Synth
esis of Prostaglandins (PG) and Thromboxanes (TX)","Interaction between L1 and Ankyrins","Nuclear Envelope (NE) Reassembly","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Biosynth
esis of maresin-like SPMs","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","Biosynthesis of DPAn-3-derived protectins and resolvins","ADORA2B mediated anti-inflamm
atory cytokines production","Muscarinic acetylcholine receptors","Serotonin receptors","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{FAAH,GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG3,GABRP,GABRQ,SCN2A,SCN4A}

> <broad_moa>
{"benzodiazepine receptor agonist"}

> <synonyms>
{propofol,"2,6-DIISOPROPYLPHENOL","2,6DIISOPROPYLPHENOL",2078-54-8,2078548,Diprivan,Disoprofol,Disoprivan,Diisopropylphenol,"2,6-Bis(1-methylethyl)phenol","2,6Bis(1methylethyl)phenol",Fresofol,Ampofol
,"Phenol, 2,6-bis(1-methylethyl)-","Phenol, 2,6bis(1methylethyl)",Rapinovet,Propofolum,Recofol,Ivofol,Propofol-Lipuro,PropofolLipuro,2,6-di(propan-2-yl),6di(propan2yl),T1300,SAM002264610,1505022,Prest
w-931,Propofol,CPD000059151,PROPOFOL}

> <pdid>
PD000647

> <targets>
{Endogenous Metabolite,GABA Receptor}

> <classes>
{anesthetic,Membrane Transporter/Ion Channel,Metabolic Enzyme/Protease,Neuronal Signaling}

> <pubchem_cids>
{4943}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 32  0  0  1  0            999 V2000
    5.1422   -5.3703    0.0000 C   0  0
    4.1252   -6.4729    0.0000 C   0  0
    4.5720   -7.9048    0.0000 O   0  0
    2.6611   -6.1428    0.0000 O   0  0
    2.2141   -4.7101    0.0000 C   0  0
    0.7500   -4.3800    0.0000 C   0  0
   -0.2670   -5.4825    0.0000 O   0  0
    0.2851   -2.9666    0.0000 C   0  0  1  0  0  0
   -0.6870   -2.7320    0.0000 O   0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -1.2991    2.2500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -0.8141   -2.0807    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  1
  8 10  1  0
 10 11  1  0
 12 11  1  6
 12 13  1  0
 13 14  1  1
 14 15  1  0
 15 16  1  0
 16 17  2  3
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 16  1  0
 22 23  1  6
 24 22  1  6
 24 13  1  0
 24 25  1  0
 25 26  1  6
 25 27  1  0
 27 28  1  0
 28  8  1  0
 28 12  1  0
 28 29  1  6
M  END
> <name>
NIHCC_2014

> <id>
6092

> <plate>
NGP-202-01

> <well>
C03

> <supplier_cmpd_name>
CPD000653536

> <ctcr_id>
196

> <supplier_cmpd_id>
SAM002264618

> <smiles>
CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@]12C

> <pd_targets>
{HIF1A,SERPINA6,LMNA,AMPC,NR3C1}

> <pathway_gtopdb>
{"Transcription factor","Secreted protein","Other nuclear protein",Enzyme,Hydrolase,"Nuclear receptor","Nuclear hormone receptor subfamily 3","Nuclear hormone receptor subfamily 3 group C","Nuclear ho
rmone receptor subfamily 3 group C member 1"}

> <pathway_chembl>
{Receptors,"Nuclear hormone receptors","Steroid hormone receptors","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"Cellular responses to external stimuli",Metabolism,"Cell Cycle","Gene expression (Transcription)","Cellular responses to stress","Metabolism of lipids",Mitotic,"RNA Polymerase II Transcription","Cel
lular response to hypoxia","Metabolism of steroids","M Phase","Generic Transcription Pathway","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Metabolism of steroid hormones
","Mitotic Metaphase and Anaphase","FOXO-mediated transcription","Glucocorticoid biosynthesis","Mitotic Anaphase","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","Nucl
ear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{NR3C1}

> <broad_moa>
{"glucocorticoid receptor agonist"}

> <synonyms>
{"hydrocortisone acetate",50-03-3,50033,"Cortisol 21-acetate","Cortisol 21acetate",Cortell,"Hydrocortisone 21-acetate","Hydrocortisone 21acetate",Cortifoam,"Cortisol acetate",Lanacort,"Cortef acetate"
,Cortacream,Hydrocortisat,Abbocort,Bambicort,Biocortar,Chemysone,Cortaid,Epifoam,Hydrosone,Pabrac,T1243,SAM002264618,Prestw-1486,"Hydrocortisone acetate",CPD000653536}

> <pdid>
PD002303

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5744}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 21  0  0  0  0            999 V2000
   11.5023   -3.0060    0.0000 H   0  3
    9.0023   -3.0060    0.0000 Cl  0  5
    5.1884   -7.5113    0.0000 C   0  0
    5.1901   -6.0113    0.0000 N   0  0
    6.4902   -5.2631    0.0000 C   0  0
    3.8917   -5.2586    0.0000 C   0  0
    3.8934   -3.7577    0.0000 C   0  0
    2.5949   -3.0050    0.0000 O   0  0
    2.5966   -1.5042    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8990   -0.7582    0.0000 C   0  0
    5.1956   -1.5125    0.0000 C   0  0
    6.4972   -0.7669    0.0000 C   0  0
    6.5023    0.7331    0.0000 C   0  0
    5.2058    1.4875    0.0000 C   0  0
    3.9042    0.7419    0.0000 C   0  0
    2.6078    1.4964    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  9 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 21 22  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6093

> <plate>
NGP-202-01

> <well>
C04

> <supplier_cmpd_name>
CPD000058999

> <ctcr_id>
28

> <supplier_cmpd_id>
SAM002264628

> <smiles>
[H+].[Cl-].CN(C)CCOC(c1ccccc1)c2ccccc2C

> <pd_targets>
{KCNH2,NPSR1,LMNA,PMP22,KDM4E,AMPC,HRH1,GRIN1,GRIN2A,GRIN2B,GRIN2C,GRIN2D,GRIN3A,GRIN3B,CYP2C19,CYP2D6,HRH2,CHRM1,CHRM3,HTR2A,HTR2B,HTR2C,SLC6A4,SLC22A2,SLC47A1,CHRM4,CHRM5,ADRA2A,SLC22A1,CHRM2,ADRA2B
,SLC6A2,HTR6,SCN10A,SCN11A,SCN1A,SCN2A,SCN3A,SCN4A,SCN5A,SCN7A,SCN8A,SCN9A,CYP3A4}

> <pathway_gtopdb>
{"Ion channel","Membrane receptor","Other nuclear protein","Unclassified protein","Epigenetic regulator",Enzyme,Transporter,"Voltage-gated ion channel","Family A G protein-coupled receptor",Eraser,Hyd
rolase,"Ligand-gated ion channel","Cytochrome P450","Electrochemical transporter","Potassium channels","Peptide receptor (family A GPCR)","Lysine demethylase","Small molecule receptor (family A GPCR)"
,"Ionotropic glutamate receptor","Cytochrome P450 family 2","SLC superfamily of solute carriers","Voltage-gated sodium channel","Cytochrome P450 family 3","Voltage-gated potassium channel","Short pept
ide receptor (family A GPCR)","Jumonji domain-containing","Monoamine receptor","NMDA receptor","Cytochrome P450 family 2C","Cytochrome P450 family 2D","SLC06 neurotransmitter transporter family","SLC2
2 family of organic cation and anion transporters","SLC47 family of multidrug and toxin extrusion transporters","Cytochrome P450 family 3A","Neuropeptide receptor","Histamine receptor","Cytochrome P45
0 2C19","Cytochrome P450 2D6","Acetylcholine receptor","Serotonin receptor","Adrenergic receptor","Cytochrome P450 3A4"}

> <pathway_chembl>
{"Ion channels",Receptors,Enzymes,Transporters,"Voltage-gated ion channels","G protein-coupled receptors","Chromatin modifying enzymes","Cytochrome P450","SLC superfamily of solute carriers","Ligand-g
ated ion channels","Potassium channels","Neuropeptide S receptor","1.14.11.- Histone demethylases","Histamine receptors","CYP2 family: drug metabolising subset","Acetylcholine receptors (muscarinic)",
"5-Hydroxytryptamine receptors","SLC6 neurotransmitter transporter family","SLC22 family of organic cation and anion transporters","SLC47 family of multidrug and toxin extrusion transporters",Adrenoce
ptors,"Ionotropic glutamate receptors","Voltage-gated sodium channels","CYP3 family","Voltage-gated potassium channels","Monoamine transporter subfamily","Organic cation transporters (OCT)"}

> <pathway_reactome>
{"Muscle contraction",Disease,"Cell Cycle","Developmental Biology","Signal Transduction",Metabolism,"Neuronal System","Transport of small molecules","Cardiac conduction","Infectious disease",Mitotic,"
Nervous system development","Signaling by GPCR","Biological oxidations","Transmission across Chemical Synapses","SLC-mediated transmembrane transport","Disorders of transmembrane transporters","Metabo
lism of lipids","Phase 3 - rapid repolarisation","Leishmania infection","M Phase","EGR2 and SOX10-mediated initiation of Schwann cell myelination","GPCR ligand binding","Phase I - Functionalization of
 compounds","Neurotransmitter clearance","Transport of bile salts and organic acids","metal ions and amine compounds","SLC transporter disorders","Neurotransmitter receptors and postsynaptic signal tr
ansmission","Axon guidance","Biosynthesis of specialized proresolving mediators (SPMs)","Leishmania parasite growth and survival","Mitotic Metaphase and Anaphase","Class A/1 (Rhodopsin-like receptors)
","Cytochrome P450 - arranged by substrate type","Serotonin clearance from the synaptic cleft","Organic cation/anion/zwitterion transport","Defective SLC6A2 causes orthostatic intolerance (OI)","Activ
ation of NMDA receptors and postsynaptic events","L1CAM interactions","Biosynthesis of DHA-derived SPMs","Anti-inflammatory response favouring Leishmania parasite infection","Mitotic Anaphase","Amine 
ligand-binding receptors",Xenobiotics,"Organic cation transport","Post NMDA receptor activation events","Assembly and cell surface presentation of NMDA receptors","Interaction between L1 and Ankyrins"
,"Biosynthesis of maresins","ADORA2B mediated anti-inflammatory cytokines production","Nuclear Envelope (NE) Reassembly","Histamine receptors","CYP2E1 reactions","Muscarinic acetylcholine receptors","
Serotonin receptors",Adrenoceptors,"CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","Biosynthesis of maresin-like SPMs","Initiation of Nuclear Envelope (NE) Reformati
on","Ras activation upon Ca2+ influx through NMDA receptor"}

> <broad_targets>
{}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{AKOS015909563,"Orphenadrine hydrochloride",341-69-5,341695,"Orphenadrine HCl",Disipal,Mephenamin,Mebedrol,Mephenamine,"Orphenadrine (hydrochloride)",Brocadisipal,"Mephenamin hydrochloride","Orfenadri
n hydrochloride","Mephenamine hydrochloride",Mefe,SAM002264628,Prestw-239,CPD000058999}

> <pdid>
PD009762

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{657244,9568,49852363}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 29  0  0  1  0            999 V2000
    2.2090   -0.3353    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0
   -6.4952    3.7500    0.0000 O   0  0
   -3.8971    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0  2  0  0  0
   -1.2990    2.2500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.3326   -2.9571    0.0000 C   0  0
    1.8253   -3.1044    0.0000 C   0  0
    2.4266   -1.7302    0.0000 C   0  0  1  0  0  0
    2.7095   -0.7710    0.0000 O   0  0
    3.4182   -2.8395    0.0000 C   0  0
    4.8815   -2.5100    0.0000 O   0  0
    2.9720   -4.2725    0.0000 C   0  0
    3.9887   -5.3754    0.0000 O   0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  1  1
  6  4  1  1
  6  7  1  0
  7  8  1  6
  8  9  1  0
  9 10  1  0
 10 11  2  3
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  3
 15 16  1  0
 16  6  1  0
 16 10  1  0
 16 17  1  1
  7 18  1  0
 18  2  1  0
 18 19  1  1
 19 20  1  0
 20 21  1  0
 21  2  1  0
 21 22  1  6
 21 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
M  END
> <name>
NIHCC_2014

> <id>
6094

> <plate>
NGP-202-01

> <well>
C05

> <supplier_cmpd_name>
CPD000718761

> <ctcr_id>
6578

> <supplier_cmpd_id>
SAM002264639

> <smiles>
C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO

> <pd_targets>
{NR3C1,AR,NR3C2,ADAM17,GPBAR1,PGR,SERPINA6,ABCB11,FABP1,IL6,GLUL}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Membrane receptor","Secreted protein",Transporter,"Auxiliary transport protein","Nuclear receptor",Protease,"Family A G protein-coupled receptor","Primary active transp
orter","Fatty acid binding protein family",Ligase,"Nuclear hormone receptor subfamily 3","Metallo protease","Small molecule receptor (family A GPCR)","ATP-binding cassette","Nuclear hormone receptor s
ubfamily 3 group C","Metallo protease MAM clan","Lipid-like ligand receptor (family A GPCR)","ABCB subfamily","Nuclear hormone receptor subfamily 3 group C member 1","Nuclear hormone receptor subfamil
y 3 group C member 4","Nuclear hormone receptor subfamily 3 group C member 2","Metallo protease M12B subfamily","Steroid-like ligand receptor","Nuclear hormone receptor subfamily 3 group C member 3"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Other protein targets","Nuclear hormone receptors","Peptidases and proteinases","G protein-coupled receptors","ATP-binding cassette transporter family","Fatty acid-bin
ding proteins","Steroid hormone receptors","MA: Metallo (M) Peptidases","Bile acid receptor","ABCB subfamily","3C. 3-Ketosteroid receptors","M12: Astacin/Adamalysin"}

> <pathway_reactome>
{"Gene expression (Transcription)","Metabolism of proteins",Disease,Metabolism,"Neuronal System","RNA Polymerase II Transcription","Post-translational protein modification","Infectious disease","Metab
olism of lipids","Transmission across Chemical Synapses","Generic Transcription Pathway",SUMOylation,"Leishmania infection","Metabolism of steroids","Regulation of lipid metabolism by PPARalpha","Neur
otransmitter uptake and metabolism In glial cells","FOXO-mediated transcription","Transcriptional regulation by RUNX2","SUMO E3 ligases SUMOylate target proteins","Leishmania parasite growth and survi
val","Metabolism of steroid hormones","Bile acid and bile salt metabolism","PPARA activates gene expression","Astrocytic Glutamate-Glutamine Uptake And Metabolism","FOXO-mediated transcription of oxid
ative stress","metabolic and neuronal genes","RUNX2 regulates bone development","SUMOylation of intracellular receptors","Anti-inflammatory response favouring Leishmania parasite infection","Glucocort
icoid biosynthesis","Synthesis of bile acids and bile salts","RUNX2 regulates osteoblast differentiation","CD163 mediating an anti-inflammatory response","ADORA2B mediated anti-inflammatory cytokines 
production","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"}

> <broad_targets>
{NR3C1,NR3C2,SERPINA6}

> <broad_moa>
{"glucocorticoid receptor agonist"}

> <synonyms>
{RESTW27,prednisolone,50-24-8,50248,Metacortandralone,Hydroretrocortine,Predonine,Delta-Cortef,DeltaCortef,Deltacortril,Meticortelone,Deltahydrocortisone,Prenolone,Hydroretrocortin,PRDL,Deltacortenol,
Hydrodeltalone,Hydrodeltisone,Codelcortone,Cortalone,Cotogesic,Decapred,SAM002264639,Prestw-274,CPD000718761,Prednisolone}

> <pdid>
PD001791

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5755}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 22  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.6003    1.4978    0.0000 C   0  0
    3.8990    0.7455    0.0000 C   0  0
    5.2003    1.4932    0.0000 C   0  0
    5.2029    2.9932    0.0000 C   0  0
    6.4990    0.7410    0.0000 C   0  0
    7.8003    1.4887    0.0000 C   0  0
    9.0990    0.7365    0.0000 C   0  0
   10.4003    1.4842    0.0000 C   0  0
   10.4029    2.9842    0.0000 C   0  0
   11.6989    0.7320    0.0000 C   0  0
   13.0002    1.4797    0.0000 C   0  0
   13.0028    2.9797    0.0000 O   0  0
   14.2982    0.7279    0.0000 O   0  0
    0.0000    1.5000    0.0000 C   0  0
    1.3164    2.2191    0.0000 C   0  0
   -1.3163    2.2193    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
  3 17  1  0
 17 18  1  0
 17 19  1  0
 17 20  1  0
 20 21  1  0
 21 22  1  0
 22  2  1  0
M  END
> <name>
NIHCC_2014

> <id>
6095

> <plate>
NGP-202-01

> <well>
C06

> <supplier_cmpd_name>
CPD000058245

> <ctcr_id>
4916

> <supplier_cmpd_id>
SAM002264647

> <smiles>
CC1=C(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)C(C)(C)CCC1

> <pd_targets>
{RARB,RARG,PPARD,NR2E1,RARA,RXRA,RXRB,FFP,RXRG,ALDH1A1,TGR,RORC,CYP3A4,CRABP1,RORB,PIN1,S1PR1,CRABP2,GROES,GROL,HIF1A,KDM4E,FTL,MAPT,MAPK1,RORA,TST,DUSP1,GMNN,NR2C2,KMT2A,MEN1,HSPD1,HSPE1,BLM,RECQL,AD
ORA3,HTR2B,IDO2,RARRES1,THRB,ABCB11,MAPK14,PMP22,ADRA2B,MTOR,OR51E2,NR1H2,NR1H3,NR4A1,VKORC1}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Auxiliary transport protein","Membrane receptor","Unclassified protein","Epigenetic regulator","Other cytosolic protein","Nuclear receptor",Transferase,Oxidoreductase,"
Cytochrome P450","Fatty acid binding protein family",Isomerase,"Family A G protein-coupled receptor",Eraser,Protease,Kinase,Phosphatase,Reader,"Nuclear hormone receptor subfamily 1","Nuclear hormone r
eceptor subfamily 2","Cytochrome P450 family 3","Small molecule receptor (family A GPCR)","Lysine demethylase","Cysteine protease","Protein Kinase","Protein Phosphatase",Bromodomain,"Nuclear hormone r
eceptor subfamily 1 group B","Nuclear hormone receptor subfamily 1 group C","Nuclear hormone receptor subfamily 2 group E","Nuclear hormone receptor subfamily 2 group B","Nuclear hormone receptor subf
amily 1 group F","Cytochrome P450 family 3A","Lipid-like ligand receptor (family A GPCR)","Jumonji domain-containing","Cysteine protease CA clan","CMGC protein kinase group","Serine/threonine/tyrosine
 protein phosphatase","Nuclear hormone receptor subfamily 2 group C","Nucleotide-like receptor (family A GPCR)","Monoamine receptor","Nuclear hormone receptor subfamily 1 group B member 2","Nuclear ho
rmone receptor subfamily 1 group B member 3","Nuclear hormone receptor subfamily 1 group C member 2","Nuclear hormone receptor subfamily 2 group E member 1","Nuclear hormone receptor subfamily 1 group
 B member 1","Nuclear hormone receptor subfamily 2 group B member 1","Nuclear hormone receptor subfamily 2 group B member 2","Nuclear hormone receptor subfamily 2 group B member 3","Nuclear hormone re
ceptor subfamily 1 group F member 3","Cytochrome P450 3A4","EDG receptor","Cysteine protease C1A family","CMGC protein kinase MAPK family","Nuclear hormone receptor subfamily 1 group F member 1","Nucl
ear hormone receptor subfamily 2 group C member 2","Adenosine receptor","Serotonin receptor","CMGC protein kinase ERK1",Transporter,"Primary active transporter","ATP-binding cassette","Nuclear hormone
 receptor subfamily 1 group A","ABCB subfamily","Atypical protein kinase group","Nuclear hormone receptor subfamily 1 group A member 2","Adrenergic receptor","Atypical protein kinase PIKK family","CMG
C protein kinase p38 subfamily","Atypical protein kinase FRAP subfamily","Nuclear hormone receptor subfamily 4","Nuclear hormone receptor subfamily 1 group H","Nuclear hormone receptor subfamily 4 gro
up A","Nuclear hormone receptor subfamily 1 group H member 3","Nuclear hormone receptor subfamily 4 group A member 1"}

> <pathway_chembl>
{Receptors,Enzymes,"Other protein targets","Nuclear hormone receptors","Cytochrome P450","Fatty acid-binding proteins","Peptidyl-prolyl cis/trans isomerases","G protein-coupled receptors","Chromatin m
odifying enzymes","Kinases (EC 2.7.x.x)","1.13.11.- Dioxygenases","1B. Retinoic acid receptors","1C. Peroxisome proliferator-activated receptors","2E. Tailless-like receptors","2B. Retinoid X receptor
s","1F. Retinoic acid-related orphans","CYP3 family","Lysophospholipid (S1P) receptors","1.14.11.- Histone demethylases","CMGC: Containing CDK",MAPK,GSK3,"CLK families","2C. Testicular receptors","Ade
nosine receptors","5-Hydroxytryptamine receptors","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily",Transporters,"ATP-binding cassette transporter family","1A. Thyroid hormone receptor
s","ABCB subfamily",Adrenoceptors,Atypical,"Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","p38 subfamily","FRAP subfamily","1.-.-.- Oxidoreductases","1H. Liver X receptor-like recepto
rs","4A. Nerve growth factor IB-like receptors"}

> <pathway_reactome>
{"Gene expression (Transcription)",Metabolism,"Signal Transduction","Metabolism of proteins","Cellular responses to external stimuli","Vesicle-mediated transport","Neuronal System","Immune System","Ce
ll Cycle","DNA Repair","RNA Polymerase II Transcription","The citric acid (TCA) cycle and respiratory electron transport","Intracellular signaling by second messengers","Post-translational protein mod
ification","Metabolism of lipids","Biological oxidations","Signaling by Nuclear Receptors","Signaling by GPCR","Cellular responses to stress","Membrane Trafficking","Transmission across Chemical Synap
ses","Innate Immune System","Metabolism of amino acids and derivatives","MAPK family signaling cascades",Mitotic,"DNA Double-Strand Break Repair","Generic Transcription Pathway","Pyruvate metabolism a
nd Citric Acid (TCA) cycle","PIP3 activates AKT signaling",SUMOylation,"Metabolism of steroids","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","
Signaling by Retinoic Acid","GPCR ligand binding","Cellular response to hypoxia","trans-Golgi Network Vesicle Budding","Neurotransmitter receptors and postsynaptic signal transmission","Toll-like Rece
ptor Cascades","Sulfur amino acid metabolism","MAPK1/MAPK3 signaling","Mitotic G1 phase and G1/S transition","Homology Directed Repair","Tryptophan catabolism","Nuclear Receptor transcription pathway"
,"Pyruvate metabolism","PTEN Regulation","SUMO E3 ligases SUMOylate target proteins","Bile acid and bile salt metabolism","Ethanol oxidation","Transcriptional regulation by RUNX3","Biosynthesis of DHA
-derived SPMs","RA biosynthesis pathway","Transcriptional Regulation by TP53","Class A/1 (Rhodopsin-like receptors)","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Golgi A
ssociated Vesicle Biogenesis","Activation of NMDA receptors and postsynaptic events","Toll Like Receptor 5 (TLR5) Cascade","Degradation of cysteine and homocysteine","RAF/MAP kinase cascade","G1/S Tra
nsition","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Regulation of pyruvate dehydrogenase (PDH) complex","Regulation of PTEN gene transcription","SUMOylation of intr
acellular receptors","Synthesis of bile acids and bile salts","RUNX3 Regulates Immune Response and Cell Migration","Biosynthesis of maresins","Regulation of TP53 Activity","Lysosphingolipid and LPA re
ceptors","Post NMDA receptor activation events","MyD88 cascade initiated on plasma membrane","Sulfide oxidation to sulfate","Negative regulation of MAPK pathway","Activation of the pre-replicative com
plex","HDR through Homologous Recombination (HRR)","Nucleotide-like (purinergic) receptors","Amine ligand-binding receptors","Synthesis of bile acids and bile salts via 27-hydroxycholesterol","Biosynt
hesis of maresin-like SPMs","Regulation of TP53 Activity through Acetylation","Activation of AMPK downstream of NMDARs","MAP kinase activation","Homologous DNA Pairing and Strand Exchange","Adenosine 
P1 receptors","Serotonin receptors","PI5P Regulates TP53 Acetylation","MAPK targets/ Nuclear events mediated by MAP kinases","Presynaptic phase of homologous DNA pairing and strand exchange","ERK/MAPK
 targets","ERKs are inactivated","Developmental Biology","Nervous system development","EGR2 and SOX10-mediated initiation of Schwann cell myelination","GPCR downstream signalling","G alpha (s) signall
ing events","Olfactory Signaling Pathway","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol",Adrenoceptors,"Regulation of TP53 Expression and Degradation","Regulation of TP53 Degra
dation","Activation of the AP-1 family of transcription factors",Disease,"Diseases of signal transduction by growth factor receptors and second messengers","Metabolism of vitamins and cofactors","PI3K
/AKT Signaling in Cancer","Metabolism of fat-soluble vitamins","Constitutive Signaling by AKT1 E17K in Cancer","Metabolism of vitamin K"}

> <broad_targets>
{ALDH1A1,ALDH1A2,GPRC5A,NR0B1,NR2C2,PPARD,RARA,RARB,RARG,RARRES1,RORB,RORC,RXRB,RXRG}

> <broad_moa>
{"retinoid receptor agonist","retinoid receptor ligand"}

> <synonyms>
{"Retinoic acid",tretinoin,302-79-4,302794,"Vitamin A acid","all-trans-Retinoic acid","alltransRetinoic acid","trans-Retinoic acid","transRetinoic acid",ATRA,Airol,Retin-A,RetinA,Vesanoid,Renova,"All-
trans Retinoic Acid","Alltrans Retinoic Acid","all-trans-Vitamin A acid","alltransVitamin A acid",Dermairol,Aknoten,Aberel,Eudyna,Aknefug,"Cordes vas",Epi-a,Epia,122758,R2625,SAM002264647,1502016,Pres
tw-257,"NSC 122758",Tretinoin,CPD000058245,TRETINON}

> <pdid>
PD001430

> <targets>
{Autophagy,Endogenous Metabolite,PPAR,RAR/RXR}

> <classes>
{Retinoid,keratolytic,Autophagy,Cell Cycle/DNA Damage,Metabolic Enzyme/Protease}

> <pubchem_cids>
{444795}

$$$$
NIHCC_2014
  SciTegic11012413002D

 12 13  0  0  0  0            999 V2000
    4.2790    0.1284    0.0000 Cl  0  5
   -2.3282    0.4544    0.0000 N   0  3
   -0.8987    0.0000    0.0000 C   0  0
   -2.0541   -1.3755    0.0000 C   0  0
   -0.6052   -0.9721    0.0000 C   0  0
   -0.6052    0.5686    0.0000 C   0  0
    0.4035    1.7790    0.0000 C   0  0
    1.7790    1.2105    0.0000 C   0  0
    1.7607   -0.2751    0.0000 C   0  0
    0.7703   -1.5223    0.0000 C   0  0
    0.3852   -0.6052    0.0000 C   0  0
   -0.8987    1.3205    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10  5  1  0
  9 11  1  0
 11  3  1  0
  7 12  1  0
 12  3  1  0
M  CHG  2   1  -1   2   1
M  END
> <name>
NIHCC_2014

> <id>
6096

> <plate>
NGP-202-01

> <well>
C07

> <supplier_cmpd_name>
CPD001370746

> <ctcr_id>
4634

> <supplier_cmpd_id>
SAM002554881

> <smiles>
[Cl-].[NH3+]C12CC3CC(CC(C3)C1)C2

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{SCHEMBL8907194,AKOS026750102,Symmetrel,"adamantan-1-aminium chloride","adamantan1aminium chloride","adamantan 1 aminium chloride",CHEBI:2619,"1-adamantylammonium chloride","1adamantylammonium chlorid
e","1 adamantylammonium chloride",1-Aminoa,1Aminoa,S2451,SAM002554881,1500110,"Amantadine HCl",CPD001370746,"AMANTADINE HYDROCHLORIDE"}

> <pdid>

> <targets>
{"Dopamine Receptor"}

> <classes>
{"antiparkinsonian; treatment of drug-induced extrapyrimidal reactions",antiviral,"Neuronal Signaling"}

> <pubchem_cids>
{19031614,517422,64150}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 23  0  0  0  0            999 V2000
   11.9554   -0.4782    0.0000 H   0  3
    9.4554   -0.4782    0.0000 Cl  0  5
    6.9546   -4.2653    0.0000 C   0  0
    5.4929   -3.9285    0.0000 N   0  0
    4.4707   -5.0263    0.0000 C   0  0
    5.0525   -2.4938    0.0000 C   0  0
    3.5900   -2.1568    0.0000 C   0  0
    3.1497   -0.7220    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.5913    1.9239    0.0000 C   0  0
    2.4792    3.4197    0.0000 C   0  0
    1.1278    4.0705    0.0000 C   0  0
   -0.1116    3.2255    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  3
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23  9  1  0
 23 18  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6097

> <plate>
NGP-202-01

> <well>
C08

> <supplier_cmpd_name>
CPD000058368

> <ctcr_id>
3305

> <supplier_cmpd_id>
SAM002554886

> <smiles>
[H+].[Cl-].CN(C)CCC=C1c2ccccc2CCc3ccccc13

> <pd_targets>
{MAPT,ALDH1A1,TP53,LEF,LMNA,PMP22,FFP,KMT2A,MEN1,NFO,TGR,ALD,KDM4E,CYP3A4,HTR2C,LPAR1,NFKB1,CYP2D6,ADRA1B,ADRA1A,CHRM2,HTR6,ADRA2A,HTR7,SLC6A2,SLC6A3,CACNA1C,CACNA1D,CACNA1F,CACNA1S,ADRA2C,HRH1,CHRM1,
SIGMAR1,CHRM3,HTR2A,SLC6A4,KCNH2,HRH2,SCN7A,CYP1A2,RET,DRD2,CHRM4,CHRM5,HTR1B,SCN10A,SCN11A,SCN1A,SCN2A,SCN3A,SCN4A,SCN5A,SCN8A,SCN9A,ALB,KCNJ6,HSD17B10,HRH4,HTR1A,GSC2,HTR1D,HTR1F,HTR2B,HTR3A,HTR3B,H
TR4,HTR5A,HTR5B,DRD3,MTOR,DRD5,ADRA1D,ADRA2B,NTRK1,SLC22A1,KCNJ5,OPRD1,OPRK1,NTRK2,KCNQ2,KCNA1,OPRM1,KCNQ3,KCNH6,KCNH7}

> <pathway_gtopdb>
{"Other cytosolic protein",Enzyme,"Transcription factor","Other nuclear protein","Unclassified protein","Epigenetic regulator","Membrane receptor",Transporter,"Ion channel","Secreted protein",Oxidored
uctase,Protease,Transferase,Reader,Hydrolase,Eraser,"Cytochrome P450","Family A G protein-coupled receptor","Electrochemical transporter","Voltage-gated ion channel",Kinase,"Metallo protease",Bromodom
ain,"Lysine demethylase","Cytochrome P450 family 3","Small molecule receptor (family A GPCR)","Cytochrome P450 family 2","SLC superfamily of solute carriers","Voltage-gated calcium channel","Potassium
 channels","Voltage-gated sodium channel","Cytochrome P450 family 1","Protein Kinase","Peptide receptor (family A GPCR)","Metallo protease MAE clan","Jumonji domain-containing","Cytochrome P450 family
 3A","Monoamine receptor","Lipid-like ligand receptor (family A GPCR)","Cytochrome P450 family 2D","SLC06 neurotransmitter transporter family","Voltage-gated potassium channel","Cytochrome P450 family
 1A","TK protein kinase group","Inwardly rectifying potassium channel","Atypical protein kinase group","SLC22 family of organic cation and anion transporters","Short peptide receptor (family A GPCR)",
"Metallo protease M34 family","Cytochrome P450 3A4","Serotonin receptor","EDG receptor","Cytochrome P450 2D6","Adrenergic receptor","Acetylcholine receptor","Histamine receptor","Cytochrome P450 1A1",
"Tyrosine protein kinase Ret family","Dopamine receptor","Atypical protein kinase PIKK family","Tyrosine protein kinase Trk family","Opioid receptor","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Other protein targets","Ion channels","Chromatin modifying enzymes","Cytochrome P450","G protein-coupled receptors","SLC superfamily of solute carriers","Sigma recepto
rs","Voltage-gated ion channels","Catalytic receptors","Kinases (EC 2.7.x.x)","1.14.11.- Histone demethylases","CYP3 family","5-Hydroxytryptamine receptors","Lysophospholipid (LPA) receptors","CYP2 fa
mily: drug metabolising subset",Adrenoceptors,"Acetylcholine receptors (muscarinic)","SLC6 neurotransmitter transporter family","Histamine receptors","Potassium channels","CYP1 family","Receptor kinas
es","Dopamine receptors","Voltage-gated sodium channels",Atypical,"Voltage-gated calcium channels","SLC22 family of organic cation and anion transporters","Opioid receptors","Monoamine transporter sub
family","Voltage-gated potassium channels","TK: Tyrosine kinase","Inwardly rectifying potassium channels","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","Organic cation transporters (
OCT)","Receptor tyrosine kinases (RTKs)","FRAP subfamily","Type XIV RTKs: RET","Type VII RTKs: Neurotrophin receptor/Trk family"}

> <pathway_reactome>
{"Neuronal System",Metabolism,"Cell Cycle",Disease,"Developmental Biology","Signal Transduction","Immune System","Muscle contraction","Gene expression (Transcription)","Transport of small molecules","
Transmission across Chemical Synapses","Biological oxidations","Cell Cycle Checkpoints","Infectious disease",Mitotic,"Nervous system development","Metabolism of lipids","Signaling by GPCR","Cytokine S
ignaling in Immune system","Disorders of transmembrane transporters","Cardiac conduction","Metabolism of amino acids and derivatives","RNA Polymerase II Transcription","Signaling by Receptor Tyrosine 
Kinases","SLC-mediated transmembrane transport","Potassium Channels","Neurotransmitter receptors and postsynaptic signal transmission","Phase I - Functionalization of compounds","G1/S DNA Damage Check
points","Uptake and actions of bacterial toxins","M Phase","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Biosynthesis of specialized proresolving mediators (SPMs)","GPCR ligand bin
ding","Signaling by Interleukins","Leishmania infection","SLC transporter disorders","SARS-CoV Infections","Neurotransmitter clearance","Phase 3 - rapid repolarisation","Axon guidance","Metabolism of 
steroids","Branched-chain amino acid catabolism","Generic Transcription Pathway","Signaling by NTRKs","Transport of bile salts and organic acids","metal ions and amine compounds","Voltage gated Potass
ium channels","GPCR downstream signalling","Activation of NMDA receptors and postsynaptic events","Ethanol oxidation","p53-Dependent G1/S DNA damage checkpoint","Uptake and function of anthrax toxins"
,"Mitotic Metaphase and Anaphase","Biosynthesis of DHA-derived SPMs","Class A/1 (Rhodopsin-like receptors)","Interleukin-1 family signaling","Cytochrome P450 - arranged by substrate type","Leishmania 
parasite growth and survival","Defective SLC6A2 causes orthostatic intolerance (OI)","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Potential therapeutics for SARS","Serotonin clea
rance from the synaptic cleft","L1CAM interactions","RET signaling","Bile acid and bile salt metabolism","GABA receptor activation","Transcriptional Regulation by TP53","NCAM signaling for neurite out
-growth","Signaling by NTRK1 (TRKA)","Organic cation/anion/zwitterion transport","Transcriptional Regulation by MECP2","G alpha (i) signalling events","Post NMDA receptor activation events","p53-Depen
dent G1 DNA Damage Response","Mitotic Anaphase","Biosynthesis of maresins","Amine ligand-binding receptors","Lysosphingolipid and LPA receptors","Interleukin-1 signaling",Xenobiotics,"Anti-inflammator
y response favouring Leishmania parasite infection","Interaction between L1 and Ankyrins","Recycling of bile acids and salts","GABA B receptor activation","Regulation of TP53 Activity","NCAM1 interact
ions","Signalling to ERKs","Organic cation transport","Peptide ligand-binding receptors","MECP2 regulates neuronal receptors and channels","Activation of TRKA receptors","Opioid Signalling","Activatio
n of AMPK downstream of NMDARs","Stabilization of p53","Nuclear Envelope (NE) Reassembly","Biosynthesis of maresin-like SPMs","Serotonin receptors","MAP3K8 (TPL2)-dependent MAPK1/3 activation","CYP2E1
 reactions",Adrenoceptors,"Muscarinic acetylcholine receptors","ADORA2B mediated anti-inflammatory cytokines production","Histamine receptors","Aromatic amines can be N-hydroxylated or N-dealkylated b
y CYP1A2","Dopamine receptors","Activation of GABAB receptors","Regulation of TP53 Expression and Degradation","Prolonged ERK activation events","NGF-independant TRKA activation","G-protein activation
","Autodegradation of the E3 ubiquitin ligase COP1","Initiation of Nuclear Envelope (NE) Reformation","Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits","Regulation of TP53 Degradat
ion","ARMS-mediated activation"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,ADRA2A,ADRB1,ADRB2,ADRB3,CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,HRH1,HRH2,HRH4,HTR1A,HTR1B,HTR1D,HTR2A,HTR2C,HTR6,HTR7,KCNA1,KCND2,KCND3,KCNQ2,KCNQ3,NTRK1,NTRK2,OPRD1,OPRK1,OPRM1,SIGMAR1,
SLC6A2,SLC6A4}

> <broad_moa>
{"norepinephrine inhibitor","norepinephrine reuptake inhibitor","serotonin receptor antagonist","serotoninânorepinephrine reuptake inhibitor (SNRI)"}

> <synonyms>
{RESTW7,AKOS015917367,SBB057420,AKOS024366256,MCULE-6119641097,MCULE6119641097,"Amitriptyline Amitriptyline hydrochloride",ST50999679,"Amitriptyline hydrochloride",549-18-8,549188,"Amitriptyline HCl",
Annoyltin,Tryptizol,Domical,Lentizol,Saroten,Endep,"Elavil hydrochloride",Am,S3183,SAM002554886,1500117,Prestw-74,"Amitriptyline HCl",CPD000058368,"AMITRIPTYLINE HYDROCHLORIDE","Amitryptiline hydrochl
oride"}

> <pdid>
PD010103

> <targets>
{"5-HT Receptor"}

> <classes>
{antidepressant,"Neuronal Signaling"}

> <pubchem_cids>
{657376,43833356,11065}

$$$$
NIHCC_2014
  SciTegic11012413002D

 13 14  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 Cl  0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 Cl  0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  2  1  0
 13  8  1  0
M  END
> <name>
NIHCC_2014

> <id>
6098

> <plate>
NGP-202-01

> <well>
C09

> <supplier_cmpd_name>
CPD000312779

> <ctcr_id>
5975

> <supplier_cmpd_id>
SAM002554895

> <smiles>
Oc1c(Cl)cc(Cl)c2cccnc12

> <pd_targets>
{CYP1A2,LMNA,HIF1A,RORC,ALOX15,COMT,HDAC8,HDAC7,MAPT,KMT2A,MEN1,HPGD,TP53,OPRK1,BOTA,HDAC2,HDAC5,CA15,KDM4E,HTT,HSP90AA1,APE1,HDAC9,ALDH1A1,CYP3A4,APP,TGR,FFP,ALOX12,MAPK1,HDAC4,ALOX5,ALOX15B,ALD,SKA,
NR1I2,STAT6,MAPK14,ACE,AMPC,HSD17B10,MAPK3,ERBB2,PAX8,ADORA3,EGFR,LCK,FYN}

> <pathway_gtopdb>
{Enzyme,"Other nuclear protein","Transcription factor","Unclassified protein","Epigenetic regulator","Other cytosolic protein","Membrane receptor","Cytochrome P450",Protease,"Nuclear receptor",Oxidore
ductase,Transferase,Eraser,Reader,"Family A G protein-coupled receptor",Lyase,Kinase,"Cytochrome P450 family 1","Cysteine protease","Nuclear hormone receptor subfamily 1","Histone deacetylase",Bromodo
main,"Peptide receptor (family A GPCR)","Metallo protease","Lysine demethylase","Cytochrome P450 family 3","Protein Kinase","Cytochrome P450 family 1A","Cysteine protease CA clan","Nuclear hormone rec
eptor subfamily 1 group F","HDAC class I","HDAC class IIa","Short peptide receptor (family A GPCR)","Metallo protease MAE clan","Jumonji domain-containing","Metallo protease MH clan","Cytochrome P450 
family 3A","CMGC protein kinase group","Cytochrome P450 1A1","Cysteine protease C1A family","Nuclear hormone receptor subfamily 1 group F member 3","Opioid receptor","Metallo protease M27 family","Met
allo protease M18 family","Cytochrome P450 3A4","CMGC protein kinase MAPK family","CMGC protein kinase ERK1","Nuclear hormone receptor subfamily 1 group I","Nuclear hormone receptor subfamily 1 group 
I member 2",Hydrolase,"Small molecule receptor (family A GPCR)","TK protein kinase group","Nucleotide-like receptor (family A GPCR)","Metallo protease M2 family","Tyrosine protein kinase EGFR family",
"Adenosine receptor","Tyrosine protein kinase Src family","CMGC protein kinase p38 subfamily","Tyrosine protein kinase SrcA"}

> <pathway_chembl>
{Enzymes,Receptors,"Other protein targets","Cytochrome P450","Nuclear hormone receptors","Eicosanoid turnover","Catecholamine turnover","Chromatin modifying enzymes","G protein-coupled receptors","Hea
t shock proteins","Kinases (EC 2.7.x.x)","CYP1 family","1F. Retinoic acid-related orphans",Lipoxygenases,"3.5.1.- Histone deacetylases (HDACs)","Prostaglandin synthases","Opioid receptors","1.14.11.- 
Histone demethylases","CYP3 family","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily","1I. Vitamin D receptor-like receptors","Transcrip
tion factors","Peptidases and proteinases","Catalytic receptors","STAT transcription factors","MA: Metallo (M) Peptidases","Receptor kinases","Adenosine receptors","M2: Angiotensin-converting  (ACE an
d ACE2)","TK: Tyrosine kinase","p38 subfamily","Receptor tyrosine kinases (RTKs)","Non-receptor tyrosine kinases (nRTKs)","Type I RTKs: ErbB (epidermal growth factor) receptor family","Src family"}

> <pathway_reactome>
{Metabolism,"Cell Cycle","Cellular responses to external stimuli","Gene expression (Transcription)","Neuronal System",Disease,"Immune System","Biological oxidations",Mitotic,"Cellular responses to str
ess","RNA Polymerase II Transcription","Metabolism of lipids","Transmission across Chemical Synapses","Diseases of signal transduction by growth factor receptors and second messengers","Cell Cycle Che
ckpoints","Infectious disease","Innate Immune System","Phase I - Functionalization of compounds","M Phase","Cellular response to hypoxia","Generic Transcription Pathway","Biosynthesis of specialized p
roresolving mediators (SPMs)","Neurotransmitter clearance","Signaling by NOTCH1 in Cancer","Neurotransmitter receptors and postsynaptic signal transmission","G1/S DNA Damage Checkpoints","Uptake and a
ctions of bacterial toxins","Mitotic G2-G2/M phases","Toll-like Receptor Cascades","Cytochrome P450 - arranged by substrate type","Mitotic Metaphase and Anaphase","Oxygen-dependent proline hydroxylati
on of Hypoxia-inducible Factor Alpha","Transcriptional regulation by RUNX3","Biosynthesis of DPA-derived SPMs","Dopamine clearance from the synaptic cleft","Signaling by NOTCH1 HD+PEST Domain Mutants 
in Cancer","Activation of NMDA receptors and postsynaptic events","Biosynthesis of DHA-derived SPMs","p53-Dependent G1/S DNA damage checkpoint","Transcriptional Regulation by MECP2","Neurotoxicity of 
clostridium toxins","Transcriptional Regulation by TP53","G2/M Transition","Ethanol oxidation","Toll Like Receptor 5 (TLR5) Cascade","Transcriptional regulation by RUNX2",Xenobiotics,"Mitotic Anaphase
","RUNX3 Regulates Immune Response and Cell Migration","Biosynthesis of DPAn-3 SPMs","Enzymatic degradation of dopamine by COMT","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","Post NMDA re
ceptor activation events","Biosynthesis of D-series resolvins","p53-Dependent G1 DNA Damage Response","MECP2 regulates neuronal receptors and channels","Toxicity of botulinum toxin type A (botA)","Reg
ulation of TP53 Activity","Regulation of MECP2 expression and activity","Centrosome maturation","Biosynthesis of maresins","MyD88 cascade initiated on plasma membrane","RUNX2 regulates bone developmen
t","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Nuclear Envelope (NE) Reassembly","Biosynthesis of DPAn-3-derived protectins and resolvins","Separation of Sister Chromatids","Ac
tivation of AMPK downstream of NMDARs","Stabilization of p53","Regulation of TP53 Activity through Acetylation","Loss of proteins required for interphase microtubule organization from the centrosome",
"Biosynthesis of maresin-like SPMs","TAK1 activates NFkB by phosphorylation and activation of IKKs complex","Biosynthesis of DPAn-3-derived maresins","MAP kinase activation","RUNX2 regulates chondrocy
te maturation","Initiation of Nuclear Envelope (NE) Reformation","Autodegradation of the E3 ubiquitin ligase COP1","Loss of Nlp from mitotic centrosomes","MAPK targets/ Nuclear events mediated by MAP 
kinases","ERK/MAPK targets","ERKs are inactivated","Metabolism of proteins","Post-translational protein modification","Fatty acid metabolism",SUMOylation,"Arachidonic acid metabolism","SUMO E3 ligases
 SUMOylate target proteins","Synthesis of 15-eicosatetraenoic acid derivatives","SUMOylation of intracellular receptors","Biosynthesis of DPAn-3-derived 13-series resolvins","Developmental Biology","S
ignal Transduction","Peptide hormone metabolism","Metabolism of amino acids and derivatives","Nervous system development","Signaling by GPCR","Cytosolic sensors of pathogen-associated DNA","Metabolism
 of Angiotensinogen to Angiotensins","Branched-chain amino acid catabolism","Axon guidance","GPCR ligand binding","GPCR downstream signalling","HIV Infection","STING mediated induction of host immune 
responses","Semaphorin interactions","Class A/1 (Rhodopsin-like receptors)","G alpha (q) signalling events","Host Interactions of HIV factors","STAT6-mediated induction of chemokines","Sema4D in semap
horin signaling","Nucleotide-like (purinergic) receptors","Gastrin-CREB signalling pathway via PKC and MAPK","The role of Nef in HIV-1 replication and disease pathogenesis","Sema4D induced cell migrat
ion and growth-cone collapse","Adenosine P1 receptors","EGFR Transactivation by Gastrin","Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters","Nef and signa
l transduction","Nef Mediated CD4 Down-regulation","Activation of the AP-1 family of transcription factors"}

> <broad_targets>
{}

> <broad_moa>
{antiseptic}

> <synonyms>
{chloroxine,"5,7-Dichloroquinolin-8-ol","5,7Dichloroquinolin8ol",773-76-2,773762,"5,7-Dichloro-8-hydroxyquinoline","5,7Dichloro8hydroxyquinoline","5,7-Dichloro-8-quinolinol","5,7Dichloro8quinolinol",C
apitrol,Chlorquinol,Dichloroxin,Quixalin,Chloroxyquinoline,Dichloroquinolinol,Dikhloroskin,Clofuzid,Endiaron,Quinolor,Dichlorohydro,SAM002554895,1503202,Prestw-1474,CPD000312779,CHLOROXINE,Chloroxine}

> <pdid>
PD000622

> <targets>
{Antibiotic,Bacterial}

> <classes>
{chelating agent,Anti-infection}

> <pubchem_cids>
{2722}

$$$$
NIHCC_2014
  SciTegic11012413002D

 10 10  0  0  0  0            999 V2000
    3.8926   -3.7566    0.0000 N   0  0
    2.5951   -3.0039    0.0000 N   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
M  END
> <name>
NIHCC_2014

> <id>
6099

> <plate>
NGP-202-01

> <well>
C10

> <supplier_cmpd_name>
CPD000059082

> <ctcr_id>
2919

> <supplier_cmpd_id>
SAM002554904

> <smiles>
NNC(=O)c1ccncc1

> <pd_targets>
{FOLA,CYP3A4,CYP2D6,CYP1A2,MPO,CYP2C19,MYMA,FFP,CYP2A6,RORC,INHA,KATG}

> <pathway_gtopdb>
{Enzyme,"Transcription factor",Oxidoreductase,"Cytochrome P450",Transferase,"Nuclear receptor","Cytochrome P450 family 3","Cytochrome P450 family 2","Cytochrome P450 family 1","Nuclear hormone recepto
r subfamily 1","Cytochrome P450 family 3A","Cytochrome P450 family 2D","Cytochrome P450 family 1A","Cytochrome P450 family 2C","Cytochrome P450 family 2A","Nuclear hormone receptor subfamily 1 group F
","Cytochrome P450 3A4","Cytochrome P450 2D6","Cytochrome P450 1A1","Cytochrome P450 2C19","Cytochrome P450 2A6","Nuclear hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{Enzymes,Receptors,"Cytochrome P450","1.-.-.- Oxidoreductases","Nuclear hormone receptors","CYP3 family","CYP2 family: drug metabolising subset","CYP1 family","1F. Retinoic acid-related orphans"}

> <pathway_reactome>
{Metabolism,"Immune System","Gene expression (Transcription)",Disease,"Metabolism of lipids","Biological oxidations","Innate Immune System","RNA Polymerase II Transcription","Infectious disease","Bios
ynthesis of specialized proresolving mediators (SPMs)","Phase I - Functionalization of compounds","ROS and RNS production in phagocytes","Generic Transcription Pathway","Infection with Mycobacterium t
uberculosis","Biosynthesis of DHA-derived SPMs","Cytochrome P450 - arranged by substrate type","Events associated with phagocytolytic activity of PMN cells","Transcriptional regulation by RUNX3","Late
nt infection - Other responses of Mtb to phagocytosis","Biosynthesis of maresins",Xenobiotics,"RUNX3 Regulates Immune Response and Cell Migration","Tolerance of reactive oxygen produced by macrophages
","Biosynthesis of maresin-like SPMs","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2"}

> <broad_targets>
{CYP1A2,CYP2C19,CYP2C8,CYP2E1,CYP3A4}

> <broad_moa>
{"FABI inhibitor"}

> <synonyms>
{54-85-3,54853,"Isonicotinic acid hydrazide",Isonicotinohydrazide,pyridine-4-carbohydrazide,pyridine4carbohydrazide,Isoniazide,Nydrazid,Rimifon,"Isonicotinic hydrazide",Laniazid,Isonicotinylhydrazine,
Andrazide,Cotinazin,Dinacrin,Hydrazid,Neoteben,Nicizina,Nicotibina,T0972,SAM002554904,1500355,Prestw-161,Isoniazid,CPD000059082,ISONIAZID}

> <pdid>
PD001926

> <targets>
{Antibiotic,Autophagy,Bacterial,Mitophagy}

> <classes>
{tuberculostatic,antibacterial,Anti-infection,Autophagy}

> <pubchem_cids>
{3767}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 18  0  0  0  0            999 V2000
    3.1202   -2.0921    0.0000 O   0  5
    1.6281   -2.2462    0.0000 N   0  3
    1.0161   -3.6157    0.0000 O   0  0
    0.7500   -1.0323    0.0000 C   0  0
    1.2135    0.3943    0.0000 O   0  0
    0.0000    1.2760    0.0000 C   0  0
   -1.2135    0.3943    0.0000 C   0  0
   -0.7500   -1.0323    0.0000 C   0  0
   -0.0031    2.7742    0.0000 C   0  0
   -1.3040    3.5228    0.0000 N   0  0
   -1.3071    5.0236    0.0000 N   0  0
   -0.0936    5.8834    0.0000 C   0  0
   -0.5571    7.3100    0.0000 C   0  0
    0.3245    8.5236    0.0000 O   0  0
   -2.0571    7.3100    0.0000 N   0  0
   -2.5206    5.8834    0.0000 C   0  0
   -3.9444    5.4113    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  4  2  0
  6  9  1  0
  9 10  2  3
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 11  1  0
 16 17  2  0
M  CHG  2   1  -1   2   1
M  END
> <name>
NIHCC_2014

> <id>
6100

> <plate>
NGP-202-01

> <well>
C11

> <supplier_cmpd_name>
CPD000058271

> <ctcr_id>
7015

> <supplier_cmpd_id>
SAM002554913

> <smiles>
[O-][N+](=O)c1oc(cc1)C=NN2CC(=O)NC2=O

> <pd_targets>
{KDM4E,TSHR,MAPT,CISD1,CASP7,TDP1,FFP,ALD,LEF,SKA,LMNA,CYP3A4,TGR,ABCC4,YDBK,NFSA,RPSJ}

> <pathway_gtopdb>
{"Epigenetic regulator","Membrane receptor","Other cytosolic protein","Unclassified protein",Enzyme,"Other nuclear protein",Transporter,Eraser,"Family A G protein-coupled receptor",Protease,Hydrolase,
Transferase,Kinase,"Cytochrome P450","Primary active transporter","Lysine demethylase","Peptide receptor (family A GPCR)","Cysteine protease","Metallo protease","Cytochrome P450 family 3","ATP-binding
 cassette","Jumonji domain-containing","Glycohormone receptor","Cysteine protease CD clan","Metallo protease MAE clan","Cytochrome P450 family 3A","ABCC subfamily","Cysteine protease C14 family","Meta
llo protease M34 family","Cytochrome P450 3A4"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Chromatin modifying enzymes","G protein-coupled receptors","Peptidases and proteinases","Cytochrome P450","ATP-binding cassette transporter family","1.14.11.- Histone 
demethylases","Glycoprotein hormone receptors","CD: Cysteine (C) Peptidases","CYP3 family","ABCC subfamily","C14: Caspase"}

> <pathway_reactome>
{Disease,"Neuronal System","Programmed Cell Death","DNA Repair","Cell Cycle",Metabolism,Hemostasis,"Infectious disease","Transmission across Chemical Synapses",Apoptosis,"DNA Double-Strand Break Repai
r",Mitotic,"Metabolism of lipids","Platelet activation","signaling and aggregation","Leishmania infection","Neurotransmitter receptors and postsynaptic signal transmission","Intrinsic Pathway for Apop
tosis","Nonhomologous End-Joining (NHEJ)","Uptake and actions of bacterial toxins","M Phase","Biosynthesis of specialized proresolving mediators (SPMs)","Response to elevated platelet cytosolic Ca2+",
"Leishmania parasite growth and survival","Activation of NMDA receptors and postsynaptic events","Apoptotic factor-mediated response","Uptake and function of anthrax toxins","Mitotic Metaphase and Ana
phase","Biosynthesis of DHA-derived SPMs","Platelet degranulation","Anti-inflammatory response favouring Leishmania parasite infection","Post NMDA receptor activation events","Cytochrome c-mediated ap
optotic response","Mitotic Anaphase","Biosynthesis of maresins","ADORA2B mediated anti-inflammatory cytokines production","Activation of AMPK downstream of NMDARs","Activation of caspases through apop
tosome-mediated cleavage","Nuclear Envelope (NE) Reassembly","Biosynthesis of maresin-like SPMs","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{}

> <broad_moa>
{"DNA inhibitor"}

> <synonyms>
{DSSTox_CID_972,DSSToxCID972,DSSTox-CID-972,"DSSTox CID 972",DSSTox_RID_75899,DSSToxRID75899,DSSTox-RID-75899,"DSSTox RID 75899",DSSTox_GSID_20972,DSSToxGSID20972,DSSTox-GSID-20972,"DSSTox GSID 20972"
,1-((5-nitro-2-furanyl)methylideneamino),1((5nitro2furanyl)methylideneamino),SAM002554913,CPD000058271}

> <pdid>
PD001838

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{4509}

$$$$
NIHCC_2014
  SciTegic11012413002D

 19 19  0  0  0  0            999 V2000
    6.4983   -0.7414    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    3.8964    0.7545    0.0000 C   0  0
    2.6003   -1.4977    0.0000 C   0  0
    2.6030   -2.9977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5973    1.5031    0.0000 O   0  0
   -2.5951    3.0039    0.0000 C   0  0
   -3.8933    3.7570    0.0000 C   0  0
   -5.1937    3.0092    0.0000 O   0  0
   -3.8912    5.2570    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 Cl  0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 Cl  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 10 16  1  0
 16 17  1  0
 16 18  2  0
 18  7  1  0
 18 19  1  0
M  END
> <name>
NIHCC_2014

> <id>
6101

> <plate>
NGP-202-01

> <well>
D02

> <supplier_cmpd_name>
CPD000058600

> <ctcr_id>
3094

> <supplier_cmpd_id>
SAM002264611

> <smiles>
CCC(=C)C(=O)c1ccc(OCC(O)=O)c(Cl)c1Cl

> <pd_targets>
{RECQL,RORC,FFP,PLIN1,GSTP1,GROES,GROL,LMNA,HIF1A,CYP2C9,ABCC2,HSPD1,HSPE1,ALDH1A1,TGR,NPSR1,ABHD5,PLIN5,TSHR,MAPT,LEF,GSTO1,GSTA1,MAP2K6,ATM,GALE,AKR1B1,ALD,HTT,ABCC3,SLC12A1,ATP1A1}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Unclassified protein","Other nuclear protein",Transporter,"Other cytosolic protein","Membrane receptor","Nuclear receptor",Transferase,"Cytochrome P450","Primary active
 transporter",Oxidoreductase,"Family A G protein-coupled receptor",Protease,Kinase,Isomerase,"Electrochemical transporter","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 2","ATP-bindin
g cassette","Peptide receptor (family A GPCR)","Metallo protease","Protein Kinase","SLC superfamily of solute carriers","P-type ATPase","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 
family 2C","ABCC subfamily","Short peptide receptor (family A GPCR)","Glycohormone receptor","Metallo protease MAE clan","STE protein kinase group","Atypical protein kinase group","SLC12 family of cat
ion-coupled chloride transporters","Sodium potassium ATPase","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 2C9","Neuropeptide receptor","Metallo protease M34 family","STE pr
otein kinase STE7 family","Atypical protein kinase PIKK family"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Nuclear hormone receptors","Cytochrome P450","ATP-binding cassette transporter family","G protein-coupled receptors","2.5.1.18 Glutathione transferases","Kinases (EC 2
.7.x.x)","1.-.-.- Oxidoreductases","SLC superfamily of solute carriers","P-type ATPases","1F. Retinoic acid-related orphans","CYP2 family: drug metabolising subset","ABCC subfamily","Neuropeptide S re
ceptor","Glycoprotein hormone receptors","STE: Homologs of yeast Sterile 7","Sterile 11","Sterile 20 kinases",Atypical,"SLC12 family of cation-coupled chloride transporters","P2C P-type ATPases","STE7
 family","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family",Na<sup>+</sup>/K<sup>+</sup>-ATPases,"Other PIKK family kinases"}

> <pathway_reactome>
{"Gene expression (Transcription)",Metabolism,"Cell Cycle","Cellular responses to external stimuli",Disease,"Neuronal System","Immune System","RNA Polymerase II Transcription","Metabolism of lipids","
Biological oxidations",Mitotic,"Cellular responses to stress","Disorders of transmembrane transporters","Infectious disease","Transmission across Chemical Synapses","Cytokine Signaling in Immune syste
m","Cell Cycle Checkpoints","Diseases of metabolism","Generic Transcription Pathway","Triglyceride metabolism","Phase II - Conjugation of compounds","M Phase","Cellular response to hypoxia","Phase I -
 Functionalization of compounds","ABC transporter disorders","Leishmania infection","Neurotransmitter receptors and postsynaptic signal transmission","Uptake and actions of bacterial toxins","Signalin
g by Interleukins","G1/S DNA Damage Checkpoints","Diseases of glycosylation","Metabolism of steroids","SLC transporter disorders","SARS-CoV Infections","Transcriptional regulation by RUNX3","Triglycer
ide catabolism","Glutathione conjugation","Mitotic Metaphase and Anaphase","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Cytochrome P450 - arranged by substrate type","De
fective ABCC2 causes DJS","Ethanol oxidation","Leishmania parasite growth and survival","Activation of NMDA receptors and postsynaptic events","Uptake and function of anthrax toxins","Interleukin-12 f
amily signaling","Transcriptional Regulation by TP53","p53-Dependent G1/S DNA damage checkpoint","Diseases associated with glycosylation precursor biosynthesis","Metabolism of steroid hormones","Trans
criptional Regulation by MECP2","Bile acid and bile salt metabolism","Defective SLC12A1 causes Bartter syndrome 1 (BS1)","Potential therapeutics for SARS","RUNX3 Regulates Immune Response and Cell Mig
ration","Mitotic Anaphase",Xenobiotics,"Anti-inflammatory response favouring Leishmania parasite infection","Post NMDA receptor activation events","Interleukin-12 signaling","Regulation of TP53 Activi
ty","p53-Dependent G1 DNA Damage Response","Defective GALE can cause Epimerase-deficiency galactosemia (EDG)","Pregnenolone biosynthesis","Regulation of MECP2 expression and activity","Recycling of bi
le acids and salts","Nuclear Envelope (NE) Reassembly","CYP2E1 reactions","ADORA2B mediated anti-inflammatory cytokines production","Activation of AMPK downstream of NMDARs","Gene and protein expressi
on by JAK-STAT signaling after Interleukin-12 stimulation","Regulation of TP53 Activity through Acetylation","Stabilization of p53","Initiation of Nuclear Envelope (NE) Reformation","PI5P Regulates TP
53 Acetylation","Autodegradation of the E3 ubiquitin ligase COP1"}

> <broad_targets>
{ATP1A1,SLC12A1}

> <broad_moa>
{"sodium/potassium/chloride transporter inhibitor"}

> <synonyms>
{"ETHACRYNIC ACID","Etacrynic Acid",58-54-8,58548,ethacrynate,"Etacrinic acid",Edecrin,Hydromedin,Crinuryl,Edecril,Edecrina,Endecril,Hidromedin,Otacril,Taladren,Mingit,Reomax,Uregit,"Etakrinic acid","
Methylenebutyrylphenoxyacetic acid",MK-595,MK595,T4564,SAM002264611,1500287,Prestw-259,"Ethacrynic acid",CPD000058600}

> <pdid>
PD002338

> <targets>
{Calcium Channel,Gutathione S-transferase,NF-ºB}

> <classes>
{diuretic,Membrane Transporter/Ion Channel,Metabolic Enzyme/Protease,Neuronal Signaling,NF-ºB}

> <pubchem_cids>
{3278}

$$$$
NIHCC_2014
  SciTegic11012413002D

 15 15  0  0  0  0            999 V2000
    3.8926   -3.7566    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2948   -3.7516    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -2.6030    2.9977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -3.8964   -0.7545    0.0000 O   0  0
   -5.1996    1.4928    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  8 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 13 15  2  0
M  END
> <name>
NIHCC_2014

> <id>
6102

> <plate>
NGP-202-01

> <well>
D03

> <supplier_cmpd_name>
CPD000058184

> <ctcr_id>
304

> <supplier_cmpd_id>
SAM002264619

> <smiles>
CC(C)Cc1ccc(cc1)C(C)C(O)=O

> <pd_targets>
{PTGS1,CYP2C9,BLM,CXCR1,CXCR2,NFO,PTGS2,TSHR,PMP22,LMNA,AKR1C3,AKR1C2,BCL2,THBD,PLAT,FABP2,PPARG,CFTR,SLC5A8,NFKB1,ALB,ALOX5,DHRS9,PTGDS,FABP1,SLC22A20,SLC22A6,ASIC1,PPARA,GP1BA,S100A7,CXCL8}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Unclassified protein","Other nuclear protein","Ion channel","Auxiliary transport protein","Transcription factor",Oxidoreductase,"Cytochrome P450","Family A G protein-coupl
ed receptor",Hydrolase,"Other ion channel",Protease,"Fatty acid binding protein family","Nuclear receptor","Cytochrome P450 family 2","Peptide receptor (family A GPCR)","Miscellaneous ion channel","Se
rine protease","Nuclear hormone receptor subfamily 1","Chloride channel","Cytochrome P450 family 2C","Chemokine receptor","Glycohormone receptor","Bcl-2 family","Serine protease PA clan","Nuclear horm
one receptor subfamily 1 group C","Cystic fibrosis transmembrane conductance regulator","Cytochrome P450 2C9","CXC chemokine receptor","Serine protease S1A subfamily","Nuclear hormone receptor subfami
ly 1 group C member 3","Other cytosolic protein","Secreted protein",Transporter,Isomerase,"Electrochemical transporter","Ligand-gated ion channel","SLC superfamily of solute carriers","Acid-sensing io
n channel","SLC22 family of organic cation and anion transporters","Nuclear hormone receptor subfamily 1 group C member 1"}

> <pathway_chembl>
{Enzymes,Receptors,"Other protein targets","Ion channels","Eicosanoid turnover","Cytochrome P450","G protein-coupled receptors","B-cell lymphoma 2 (Bcl-2) protein family","Peptidases and proteinases",
"Fatty acid-binding proteins","Nuclear hormone receptors","Other ion channels",Cyclooxygenase,"CYP2 family: drug metabolising subset","Glycoprotein hormone receptors","Prostaglandin synthases","PA: Se
rine (S) Peptidases","1C. Peroxisome proliferator-activated receptors","Chloride channels","S1: Chymotrypsin",CFTR,Transporters,"SLC superfamily of solute carriers","Ligand-gated ion channels","SLC5 f
amily of sodium-dependent glucose transporters",Lipoxygenases,"SLC22 family of organic cation and anion transporters","Acid-sensing (proton-gated) ion channels (ASICs)","Sodium iodide symporter","sodi
um-dependent multivitamin transporter and sodium-coupled monocarboxylate transporters","Orphan or poorly characterized SLC22 family members","Organic anion transporters (OATs)"}

> <pathway_reactome>
{Metabolism,"DNA Repair",Disease,"Developmental Biology","Cell Cycle","Immune System",Hemostasis,"Signal Transduction","Gene expression (Transcription)",Autophagy,"Metabolism of lipids","Biological ox
idations","DNA Double-Strand Break Repair","Infectious disease","Nervous system development",Mitotic,"Innate Immune System","Formation of Fibrin Clot (Clotting Cascade)","Signaling by Receptor Tyrosin
e Kinases","RNA Polymerase II Transcription",Macroautophagy,"Fatty acid metabolism","Phase I - Functionalization of compounds","Homology Directed Repair","Biosynthesis of specialized proresolving medi
ators (SPMs)","Leishmania infection","EGR2 and SOX10-mediated initiation of Schwann cell myelination","M Phase","Metabolism of steroids","Nucleotide-binding domain","leucine rich repeat containing rec
eptor (NLR) signaling pathways","Common Pathway of Fibrin Clot Formation","Signaling by PDGF","Triglyceride metabolism","Generic Transcription Pathway","Selective autophagy","Arachidonic acid metaboli
sm","Cytochrome P450 - arranged by substrate type","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Biosynthesis of DPA-derived SPMs","Leishmania parasite growth and surv
ival","Mitotic Metaphase and Anaphase","Bile acid and bile salt metabolism",Inflammasomes,"Triglyceride catabolism","Transcriptional Regulation by MECP2",Aggrephagy,"Synthesis of Prostaglandins (PG) a
nd Thromboxanes (TX)",Xenobiotics,"HDR through Homologous Recombination (HRR)","Biosynthesis of DPAn-3 SPMs","Anti-inflammatory response favouring Leishmania parasite infection","Mitotic Anaphase","Sy
nthesis of bile acids and bile salts","The NLRP1 inflammasome","MECP2 regulates transcription factors","CYP2E1 reactions","Homologous DNA Pairing and Strand Exchange","ADORA2B mediated anti-inflammato
ry cytokines production","Nuclear Envelope (NE) Reassembly","Synthesis of bile acids and bile salts via 24-hydroxycholesterol","Presynaptic phase of homologous DNA pairing and strand exchange","Initia
tion of Nuclear Envelope (NE) Reformation","Transport of small molecules","Metabolism of vitamins and cofactors","Cytokine Signaling in Immune system","Signaling by GPCR","SLC-mediated transmembrane t
ransport","Ion channel transport","Diseases of hemostasis","Metabolism of water-soluble vitamins and cofactors","Signaling by Interleukins","GPCR downstream signalling","Regulation of lipid metabolism
 by PPARalpha","Transport of bile salts and organic acids","metal ions and amine compounds","Stimuli-sensing channels","Defects of contact activation system (CAS) and kallikrein/kinin system (KKS)","A
ntimicrobial peptides","GPCR ligand binding","Nicotinate metabolism","Interleukin-1 family signaling","G alpha (i) signalling events","PPARA activates gene expression","Organic cation/anion/zwitterion
 transport","Regulation of cholesterol biosynthesis by SREBP (SREBF)","Defective factor IX causes hemophilia B","Metal sequestration by antimicrobial proteins","Class A/1 (Rhodopsin-like receptors)","
Nicotinamide salvaging","Interleukin-1 signaling","Recycling of bile acids and salts","Visual phototransduction","Organic anion transport","Activation of gene expression by SREBF (SREBP)","Defective F
9 activation","Peptide ligand-binding receptors","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Biosynthesis of DPAn-3-derived 13-series resolvins","The canonical retinoid cycle in rods (twilight visio
n)","Chemokine receptors bind chemokines"}

> <broad_targets>
{ASIC1,PTGS1,PTGS2,SLC5A8}

> <broad_moa>
{"cyclooxygenase inhibitor"}

> <synonyms>
{ibuprofen,Nobgen,PediaProfen,Rufen,Nobfelon,Brufort,Inabrin,Pantrop,Rebugen,Suspren,Tabalon,(RS)-Ibuprofen,(RS)Ibuprofen,Anco,Urem,Ibu-slo,Ibuslo,Brufanic,Ibuprohm,Napacetin,Ibufen,Ibren,"4-Isobutylh
ydratropic acid","4Isobutylhydratropic acid","p-Isobutylhydratropic acid","pIsobutylhydratropic acid",Proartinal,Dibufen,T1394,T0448,SAM002264619,1500347,Ibuprofen,Dexibuprofen,CPD000058184,IBUPROFEN}

> <pdid>
PD001306

> <targets>
{}

> <classes>
{antiinflammatory}

> <pubchem_cids>
{3672}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 29  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -2.5981    3.0007    0.0000 N   0  0
   -1.3003    3.7529    0.0000 C   0  0
   -1.3026    5.2529    0.0000 C   0  0
   -2.6029    6.0009    0.0000 N   0  0
   -2.6053    7.5009    0.0000 C   0  0
   -3.9007    5.2488    0.0000 C   0  0
   -3.8983    3.7488    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 F   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -3.8971   -3.7500    0.0000 O   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -1.2959   -5.2508    0.0000 C   0  0
   -2.5936   -6.0031    0.0000 O   0  0
    0.0042   -5.9990    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  1  0
 13  7  1  0
  6 14  1  0
 14 15  1  0
 14 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  2  3
 21 22  1  0
 22  2  1  0
 22 23  1  0
 23  5  1  0
 23 17  2  0
 20 24  1  0
 24 25  1  0
 24 26  2  0
M  END
> <name>
NIHCC_2014

> <id>
6103

> <plate>
NGP-202-01

> <well>
D04

> <supplier_cmpd_name>
CPD000058192

> <ctcr_id>
6437

> <supplier_cmpd_id>
SAM002264629

> <smiles>
CC1COc2c(N3CCN(C)CC3)c(F)cc4C(=O)C(=CN1c24)C(O)=O

> <pd_targets>
{GYRA,POLB,SKA,KDM4E,RCE1,SLC47A1,PARC,PARE,GYRB,HSD17B10,ALDH1A1,HPGD,ALB,STE24,GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG3,GABRP,GABRQ,TOP2A,CHRM1
}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator",Transporter,Isomerase,Kinase,Eraser,Protease,"Electrochemical transporter","Lysine demethylase","Metallo protease","SLC superfamily of solute carriers","Jumonji domain-c
ontaining","Metallo protease unclassified clan","SLC47 family of multidrug and toxin extrusion transporters","Metallo protease M79 family","Secreted protein","Ion channel",Oxidoreductase,"Ligand-gated
 ion channel","GABA-A receptor","Serine protease","Metallo protease MAE clan","Serine protease PA clan","Metallo protease M48A subfamily","Serine protease S1A subfamily","Membrane receptor","Family A 
G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Acetylcholine receptor"}

> <pathway_chembl>
{Enzymes,Transporters,"Chromatin modifying enzymes","Peptidases and proteinases","SLC superfamily of solute carriers","1.14.11.- Histone demethylases","M-: Metallo (M) Peptidases","SLC47 family of mul
tidrug and toxin extrusion transporters","M79: Prenyl protease 2","Eicosanoid turnover","DNA topoisomerases","Prostaglandin synthases",Receptors,"G protein-coupled receptors","Acetylcholine receptors 
(muscarinic)"}

> <pathway_reactome>
{"DNA Repair","Signal Transduction","Transport of small molecules","Base Excision Repair","MAPK family signaling cascades","SLC-mediated transmembrane transport","Resolution of Abasic Sites (AP sites)
","MAPK1/MAPK3 signaling","Transport of bile salts and organic acids","metal ions and amine compounds","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","RAF/MAP kinase ca
scade","PCNA-Dependent Long Patch Base Excision Repair","RAS processing",Metabolism,"Cell Cycle","Metabolism of amino acids and derivatives","Biological oxidations","Metabolism of lipids",Mitotic,"Bra
nched-chain amino acid catabolism","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","Metabolism of steroids","Mitotic G1 phase and G1/S transition
","Ethanol oxidation","Biosynthesis of DHA-derived SPMs","Bile acid and bile salt metabolism","G0 and Early G1","Biosynthesis of D-series resolvins","Recycling of bile acids and salts","Transcription 
of E2F targets under negative control by DREAM complex","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Amine ligand-binding receptors","Muscarinic acetylcholine rece
ptors"}

> <broad_targets>
{}

> <broad_moa>
{"bacterial DNA gyrase inhibitor"}

> <synonyms>
{ofloxacin,82419-36-1,82419361,Floxin,Ofloxacine,Tarivid,Ocuflox,OFLX,Ofloxacino,Ofloxacinum,Exocin,Hoe-280,Hoe280,DL-8280,DL8280,"Floxin otic","HOE 280",Oxaldin,Dextrofloxacin,DL-ofloxacin,DLofloxaci
n,CHEBI:7731,Oflocet,Visiren,CHEMBL4,MFCD00226105,MLS000028749,Ofloxacina,Ofl,SAM002264629,1502044,Prestw-237,CPD000058192,OFLOXACIN,Ofloxacin}

> <pdid>
PD001207

> <targets>
{}

> <classes>
{antibacterial}

> <pubchem_cids>
{4583,3288597}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 16  0  0  0  0            999 V2000
   12.9003   -0.7504    0.0000 Cl  0  0
   10.3996   -1.4837    0.0000 C   0  0
    9.0990   -0.7364    0.0000 C   0  0
    7.8003   -1.4887    0.0000 C   0  0
    6.4990   -0.7409    0.0000 N   0  0
    5.2003   -1.4932    0.0000 C   0  0
    5.2029   -2.9932    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    3.8964    0.7545    0.0000 O   0  0
    2.6003   -1.4977    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 16 17  1  0
M  END
> <name>
NIHCC_2014

> <id>
6104

> <plate>
NGP-202-01

> <well>
D05

> <supplier_cmpd_name>
CPD000058506

> <ctcr_id>
2267

> <supplier_cmpd_id>
SAM002264640

> <smiles>
Cl.CCCNC(C)C(=O)Nc1ccccc1C

> <pd_targets>
{LMNA,GAA,HPGD,MAPT,SCN1A,SCN2A,SCN3A,SCN10A,SCN11A,SCN4A,SCN5A,SCN7A,SCN8A,SCN9A,CYP1A2,CHRM1}

> <pathway_gtopdb>
{"Other nuclear protein",Enzyme,"Other cytosolic protein","Ion channel","Membrane receptor",Hydrolase,"Voltage-gated ion channel","Cytochrome P450","Family A G protein-coupled receptor","Voltage-gated
 sodium channel","Cytochrome P450 family 1","Small molecule receptor (family A GPCR)","Cytochrome P450 family 1A","Monoamine receptor","Cytochrome P450 1A1","Acetylcholine receptor"}

> <pathway_chembl>
{Enzymes,"Ion channels",Receptors,"3.2.1.- Glycosidases","Eicosanoid turnover","Voltage-gated ion channels","Cytochrome P450","G protein-coupled receptors","Prostaglandin synthases","Voltage-gated sod
ium channels","CYP1 family","Acetylcholine receptors (muscarinic)"}

> <pathway_reactome>
{"Cell Cycle",Disease,Metabolism,"Neuronal System","Developmental Biology","Signal Transduction",Mitotic,"Diseases of metabolism","Metabolism of lipids","Transmission across Chemical Synapses","Nervou
s system development","Biological oxidations","Signaling by GPCR","M Phase","Diseases of carbohydrate metabolism","Biosynthesis of specialized proresolving mediators (SPMs)","Neurotransmitter receptor
s and postsynaptic signal transmission","Axon guidance","Phase I - Functionalization of compounds","GPCR ligand binding","Mitotic Metaphase and Anaphase","Glycogen storage diseases","Biosynthesis of D
HA-derived SPMs","Activation of NMDA receptors and postsynaptic events","L1CAM interactions","Cytochrome P450 - arranged by substrate type","Class A/1 (Rhodopsin-like receptors)","Mitotic Anaphase","G
lycogen storage disease type II (GAA)","Biosynthesis of D-series resolvins","Post NMDA receptor activation events","Interaction between L1 and Ankyrins",Xenobiotics,"Amine ligand-binding receptors","N
uclear Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Muscarinic acetylcholine receptors","Initiation of Nuclea
r Envelope (NE) Reformation"}

> <broad_targets>
{SCN5A}

> <broad_moa>
{"local anesthetic"}

> <synonyms>
{2-(Propylamino)-O-Propionotoluididmonohydrochloride,2(Propylamino)OPropionotoluididmonohydrochloride,AKOS026749949,Xylonest,CHEBI:32053,"2-(Propylamino)-o-propionotoluidide hydrochloride","2(Propylam
ino)opropionotoluidide hydrochloride","2-(Propylamino)-o-propionotoluidide monohydrochloride","2(Propylamino)opropionotoluidide monohydrochloride","alpha-Propylamine-2-methyl-propionanilide hydr","alp
haPropylamine2methylpropionanilide hydr",T0796,SAM002264640,1503270,Prestw-199,"Propitocaine hydrochloride",CPD000058506,"PRILOCAINE HYDROCHLORIDE","Prilocaine hydrochloride"}

> <pdid>
PD009832

> <targets>
{}

> <classes>
{"anesthetic (local)"}

> <pubchem_cids>
{68805528,53262280,92163}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 33  0  0  1  0            999 V2000
    3.8964    0.7545    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    5.1996   -1.4928    0.0000 O   0  0
    2.6003   -1.4977    0.0000 S   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -1.2991    5.2500    0.0000 O   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    0.0000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0  1  0  0  0
   -2.5202   -4.6211    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0  1  0  0  0
    1.0957   -4.0166    0.0000 C   0  0
    0.4768   -5.3829    0.0000 C   0  0
   -1.0139   -5.2166    0.0000 C   0  0  1  0  0  0
   -2.3873   -5.9129    0.0000 C   0  0
   -2.2072   -7.4020    0.0000 C   0  0
   -0.7352   -7.6909    0.0000 C   0  0
   -0.1038   -9.0515    0.0000 O   0  0
   -0.0057   -6.3803    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  0
  7  8  2  3
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13  7  1  0
 13 14  1  6
 13 15  1  0
 15 16  1  6
 16 17  1  0
 17 18  1  0
 18 19  1  6
 18 20  1  0
 20 21  1  6
 21 22  1  0
 23 22  1  1
 23 18  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  2  0
 26 28  1  0
 28 23  1  0
 29 20  1  1
 29  5  1  0
 29 15  1  0
M  END
> <name>
NIHCC_2014

> <id>
6105

> <plate>
NGP-202-01

> <well>
D06

> <supplier_cmpd_name>
CPD000471892

> <ctcr_id>
6845

> <supplier_cmpd_id>
SAM002264648

> <smiles>
CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]45CCC(=O)O5)[C@H]13

> <pd_targets>
{NR3C2,PGR,AR,NR3C1,ESR1,ESR2,CYP2C19,ABCB1,SLC47A1,CYP11B2,CYP17A1,SRD5A1,SRD5A2,SRD5A3,SHBG,CACNA1A,CACNA1B,CACNA1C,CACNA1D,CACNA1E,CACNA1F,CACNA1G,CACNA1H,CACNA1I,CACNA1S,CACNA2D1,CACNA2D2,CACNA2D3
,CACNA2D4,CACNB1,CACNB2,CACNB3,CACNB4,CACNG1,CACNG2,CACNG3,CACNG4,CACNG5,CACNG6,CACNG7,CACNG8,MAPT,LMNA}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,Transporter,"Secreted protein","Ion channel","Nuclear receptor","Cytochrome P450","Primary active transporter","Electrochemical transporter",Oxidoreductase,"Voltage-gate
d ion channel","Nuclear hormone receptor subfamily 3","Cytochrome P450 family 2","ATP-binding cassette","SLC superfamily of solute carriers","Cytochrome P450 family 11","Cytochrome P450 family 17","Vo
ltage-gated calcium channel","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 3 group A","Cytochrome P450 family 2C","ABCB subfamily","SLC47 family of multidrug and t
oxin extrusion transporters","Cytochrome P450 family 11B","Cytochrome P450 family 17A","Nuclear hormone receptor subfamily 3 group C member 2","Nuclear hormone receptor subfamily 3 group C member 3","
Nuclear hormone receptor subfamily 3 group C member 4","Nuclear hormone receptor subfamily 3 group C member 1","Nuclear hormone receptor subfamily 3 group A member 1","Nuclear hormone receptor subfami
ly 3 group A member 2","Cytochrome P450 2C19","Cytochrome P450 11B2","Cytochrome P450 17A1","Other cytosolic protein","Other nuclear protein"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Nuclear hormone receptors","Cytochrome P450","ATP-binding cassette transporter family","SLC superfamily of solute carriers","Steroid hormone receptors","CYP2 family: d
rug metabolising subset","ABCB subfamily","SLC47 family of multidrug and toxin extrusion transporters",CYP11,CYP17,CYP19,"CYP20 and CYP21 families","3C. 3-Ketosteroid receptors","3A. Estrogen receptor
s"}

> <pathway_reactome>
{"Metabolism of proteins","Gene expression (Transcription)","Signal Transduction",Metabolism,"Transport of small molecules","Post-translational protein modification","RNA Polymerase II Transcription",
"Intracellular signaling by second messengers","Biological oxidations","Abacavir transport and metabolism","SLC-mediated transmembrane transport","Metabolism of lipids",SUMOylation,"Generic Transcript
ion Pathway","PIP3 activates AKT signaling","Phase I - Functionalization of compounds","Abacavir transmembrane transport","Transport of bile salts and organic acids","metal ions and amine compounds","
Metabolism of steroids","SUMO E3 ligases SUMOylate target proteins","Transcriptional regulation by RUNX2","FOXO-mediated transcription","Transcriptional regulation by RUNX1","Negative regulation of th
e PI3K/AKT network","Cytochrome P450 - arranged by substrate type","Metabolism of steroid hormones","SUMOylation of intracellular receptors","RUNX2 regulates bone development","FOXO-mediated transcrip
tion of oxidative stress","metabolic and neuronal genes","RUNX1 regulates estrogen receptor mediated transcription",PI5P,"PP2A and IER3 Regulate PI3K/AKT Signaling",Xenobiotics,"Endogenous sterols","A
ndrogen biosynthesis","RUNX2 regulates osteoblast differentiation","CYP2E1 reactions","Neuronal System","Cell Cycle","Transmission across Chemical Synapses",Mitotic,"Neurotransmitter receptors and pos
tsynaptic signal transmission","M Phase","Activation of NMDA receptors and postsynaptic events","Mitotic Metaphase and Anaphase","Post NMDA receptor activation events","Mitotic Anaphase","Activation o
f AMPK downstream of NMDARs","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{AR,CACNA1A,CACNA1B,CACNA1C,CACNA1D,CACNA1F,CACNA1G,CACNA1H,CACNA1I,CACNA1S,CACNA2D1,CACNA2D2,CACNA2D3,CACNB1,CACNB2,CACNB3,CACNB4,CACNG1,CYP11B2,NR3C1,NR3C2,PGR,SHBG}

> <broad_moa>
{"mineralocorticoid receptor antagonist"}

> <synonyms>
{spironolactone,52-01-7,52017,"52 01 7",Aldactone,Spirolactone,Verospiron,Euteberol,Spirolang,Verospirone,Spiroctan,Acelat,"Aldactone A",Spironocompren,Melarcon,Spiresis,Spiridon,Uractone,Urusonin,Ald
eron,Spirone,Xenalon,Dira,Spiro-Tablinen,SpiroTablinen,Sp,SAM002264648,Prestw-128,CPD000471892,Spironolactone}

> <pdid>
PD001755

> <targets>
{Androgen Receptor,Autophagy,Mineralocorticoid Receptor}

> <classes>
{Autophagy,Metabolic Enzyme/Protease,Others}

> <pubchem_cids>
{5833}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 25  0  0  0  0            999 V2000
    9.0023   -0.7543    0.0000 Na  0  3
    5.1935   -3.0096    0.0000 C   0  0
    3.8934   -3.7577    0.0000 C   0  0
    3.8917   -5.2577    0.0000 O   0  0
    2.5949   -3.0050    0.0000 C   0  0
    2.5966   -1.5042    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 O   0  5
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
    3.8990   -0.7582    0.0000 C   0  0
    3.9042    0.7419    0.0000 C   0  0
    5.2058    1.4875    0.0000 C   0  0
    6.5023    0.7331    0.0000 C   0  0
    6.4972   -0.7669    0.0000 C   0  0
    5.1956   -1.5125    0.0000 C   0  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  3
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 15 16  1  0
 16 17  1  0
 17  7  1  0
 17 18  2  0
  6 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
M  CHG  2   1   1   9  -1
M  END
> <name>
NIHCC_2014

> <id>
6106

> <plate>
NGP-202-01

> <well>
D07

> <supplier_cmpd_name>
CPD000058849

> <ctcr_id>
7009

> <supplier_cmpd_id>
SAM002554882

> <smiles>
[Na+].CC(=O)CC(C1=C([O-])c2ccccc2OC1=O)c3ccccc3

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Warfarin sodium",129-06-6,129066,"Sodium warfarin",Jantoven,Marevan,Athrombin,"Warfarin sodium salt","Warfarin (sodium)","Sodium 2-oxo-3-(3-oxo-1-phenylbutyl)-2H-chromen-4-olate","Sodium 2oxo3(3oxo1
phenylbutyl)2Hchromen4olate","3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin sodium salt","3(alphaAcetonylbenzyl)4hydroxycoumarin sodium salt","Warfarin so",SAM002554882,CPD000058849}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{16204922}

$$$$
NIHCC_2014
  SciTegic11012413002D

 14 13  0  0  0  0            999 V2000
    1.3000    2.2500    0.0000 C   0  0
    1.3000    0.7500    0.0000 S   0  0
    0.0007    0.0004    0.0000 O   0  0
    0.0011    1.5002    0.0000 O   0  0
    2.6000    0.0000    0.0000 O   0  0
    3.9000    0.7500    0.0000 C   0  0
    5.2000    0.0000    0.0000 C   0  0
    6.5000    0.7500    0.0000 C   0  0
    7.7999    0.0000    0.0000 C   0  0
    9.0999    0.7500    0.0000 O   0  0
   10.3999    0.0000    0.0000 S   0  0
   10.3999   -1.5000    0.0000 C   0  0
   11.6992    0.7496    0.0000 O   0  0
   11.6988   -0.7502    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 11 14  2  0
M  END
> <name>
NIHCC_2014

> <id>
6107

> <plate>
NGP-202-01

> <well>
D08

> <supplier_cmpd_name>
CPD000058613

> <ctcr_id>
2614

> <supplier_cmpd_id>
SAM002554887

> <smiles>
C[S](=O)(=O)OCCCCO[S](C)(=O)=O

> <pd_targets>
{TSHR,ALDH1A1,KDM4E,LEF,LMNA,ALOX15,MMP9}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Epigenetic regulator","Other nuclear protein","Family A G protein-coupled receptor",Oxidoreductase,Eraser,Protease,"Peptide receptor (family A GPCR)","Lysine demethylase",
"Metallo protease","Glycohormone receptor","Jumonji domain-containing","Metallo protease MAE clan","Metallo protease MAM clan","Metallo protease M34 family","Metallo protease M10A subfamily"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Chromatin modifying enzymes","Eicosanoid turnover","Peptidases and proteinases","Glycoprotein hormone receptors","1.14.11.- Histone demethylases",Lipo
xygenases,"MA: Metallo (M) Peptidases","M10: Matrix metallopeptidase"}

> <pathway_reactome>
{Disease,Metabolism,"Cell Cycle","Developmental Biology","Infectious disease","Biological oxidations",Mitotic,"Metabolism of lipids","Nervous system development","Leishmania infection","Phase I - Func
tionalization of compounds","Uptake and actions of bacterial toxins","M Phase","Biosynthesis of specialized proresolving mediators (SPMs)","Axon guidance","Leishmania parasite growth and survival","Et
hanol oxidation","Uptake and function of anthrax toxins","Mitotic Metaphase and Anaphase","Biosynthesis of DPA-derived SPMs","EPH-Ephrin signaling","Anti-inflammatory response favouring Leishmania par
asite infection","Mitotic Anaphase","Biosynthesis of DPAn-3 SPMs","EPH-ephrin mediated repulsion of cells","ADORA2B mediated anti-inflammatory cytokines production","Nuclear Envelope (NE) Reassembly",
"Biosynthesis of DPAn-3-derived protectins and resolvins","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{}

> <broad_moa>
{"DNA inhibitor"}

> <synonyms>
{busulfan,55-98-1,55981,Myleran,Busulphan,Sulphabutin,Myelosan,Leucosulfan,Busulfex,Citosulfan,Mielucin,Misulban,Mitostan,Myeloleukon,Mylecytan,Sulfabutin,Mablin,Mielevcin,Milecitan,Mielosan,Mileran,"
butane-1,4-diyl dimethanesulfonate","butane1,4diyl dimethanesulfonate",Buzulfan,1,4-Di,4Di,T0923,750,NSC750,SAM002554887,1500152,Prestw-1179,"NSC 750
NSC 750",Busulfan,CPD000058613,BUSULFAN}

> <pdid>
PD002449

> <targets>
{Apoptosis,DNA Alkylator/Crosslinker}

> <classes>
{antineoplastic,alkylating agent,Alkylating agent,Apoptosis,Cell Cycle/DNA Damage}

> <pubchem_cids>
{2478}

$$$$
NIHCC_2014
  SciTegic11012413002D

 18 19  0  0  0  0            999 V2000
    2.6030   -2.9977    0.0000 O   0  0
    2.6003   -1.4977    0.0000 C   0  0
    3.8983   -0.7459    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
    0.0000    3.0008    0.0000 C   0  0
   -1.3002    3.7488    0.0000 C   0  0
   -1.3026    5.2488    0.0000 C   0  0
   -0.0048    6.0009    0.0000 C   0  0
   -0.0072    7.5009    0.0000 F   0  0
    1.2954    5.2529    0.0000 C   0  0
    1.2978    3.7529    0.0000 C   0  0
    2.5981    3.0050    0.0000 F   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  9 10  1  0
  6 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 11  1  0
 17 18  1  0
M  END
> <name>
NIHCC_2014

> <id>
6108

> <plate>
NGP-202-01

> <well>
D09

> <supplier_cmpd_name>
CPD000058723

> <ctcr_id>
4014

> <supplier_cmpd_id>
SAM002554896

> <smiles>
OC(=O)c1cc(ccc1O)c2ccc(F)cc2F

> <pd_targets>
{DHFR,LMNA,KDM4E,ALDH1A1,CA2,HSD17B10,KMT2A,MEN1,SLC12A5,TTR,CA1,ALB,HIF1A,ALD,HPGD,PTGS2,RORC,SLC22A6,PTGS1}

> <pathway_gtopdb>
{Enzyme,"Other nuclear protein","Epigenetic regulator",Transporter,"Secreted protein","Transcription factor",Oxidoreductase,Eraser,Lyase,Reader,"Electrochemical transporter","Nuclear receptor","Lysine
 demethylase",Bromodomain,"SLC superfamily of solute carriers","Nuclear hormone receptor subfamily 1","Jumonji domain-containing","SLC12 family of cation-coupled chloride transporters","Nuclear hormon
e receptor subfamily 1 group F","SLC22 family of organic cation and anion transporters","Nuclear hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{Enzymes,Transporters,"Other protein targets",Receptors,"1.-.-.- Oxidoreductases","Chromatin modifying enzymes","Carbonic anhydrases","SLC superfamily of solute carriers",Transthyretin,"Eicosanoid tur
nover","Nuclear hormone receptors","1.14.11.- Histone demethylases","SLC12 family of cation-coupled chloride transporters","Prostaglandin synthases",Cyclooxygenase,"1F. Retinoic acid-related orphans",
"SLC22 family of organic cation and anion transporters","Organic anion transporters (OATs)"}

> <pathway_reactome>
{"Cell Cycle",Metabolism,"Transport of small molecules","Signal Transduction","Immune System","Cellular responses to external stimuli","Gene expression (Transcription)",Mitotic,"Biological oxidations"
,"O2/CO2 exchange in erythrocytes","Metabolism of amino acids and derivatives","SLC-mediated transmembrane transport","Signaling by GPCR","Cytokine Signaling in Immune system","Metabolism of lipids","
Cellular responses to stress","RNA Polymerase II Transcription","Mitotic G1 phase and G1/S transition","M Phase","Phase I - Functionalization of compounds","Erythrocytes take up carbon dioxide and rel
ease oxygen","Branched-chain amino acid catabolism","Transport of inorganic cations/anions and amino acids/oligopeptides","GPCR downstream signalling","Signaling by Interleukins","Metabolism of steroi
ds","Cellular response to hypoxia","Biosynthesis of specialized proresolving mediators (SPMs)","Generic Transcription Pathway","Transport of bile salts and organic acids","metal ions and amine compoun
ds","Fatty acid metabolism","G1/S Transition","Mitotic Metaphase and Anaphase","Ethanol oxidation","Cation-coupled Chloride cotransporters","G alpha (i) signalling events","Interleukin-12 family signa
ling","Bile acid and bile salt metabolism","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Biosynthesis of DHA-derived SPMs","Biosynthesis of DPA-derived SPMs","Transcripti
onal regulation by RUNX3","Organic cation/anion/zwitterion transport","Arachidonic acid metabolism","G1/S-Specific Transcription","Mitotic Anaphase","Visual phototransduction","Interleukin-12 signalin
g","Recycling of bile acids and salts","Biosynthesis of D-series resolvins","Biosynthesis of DPAn-3 SPMs","RUNX3 Regulates Immune Response and Cell Migration","Organic anion transport","Synthesis of P
rostaglandins (PG) and Thromboxanes (TX)","Nuclear Envelope (NE) Reassembly","The canonical retinoid cycle in rods (twilight vision)","Gene and protein expression by JAK-STAT signaling after Interleuk
in-12 stimulation","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{PTGS1,PTGS2}

> <broad_moa>
{"prostanoid receptor antagonist"}

> <synonyms>
{22494-42-4,22494424,Dolobid,Dolobis,Fluniget,Flovacil,Fluodonil,Adomal,Flustar,"5-(2,4-Difluorophenyl)salicylic acid","5(2,4Difluorophenyl)salicylic acid",MK-647,MK647,"5-(2,4-difluorophenyl)-2-hydro
xybenzoic acid","5(2,4difluorophenyl)2hydroxybenzoic acid",Diflusinal,"MK 647","2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid","2(Hydroxy)5(2,4difluorophenyl)benzoic acid",T0808,SAM002554896,1500245,
Prestw-39,Diflunisal,CPD000058723,DIFLUNISAL}

> <pdid>
PD002374

> <targets>
{}

> <classes>
{analgesic,antiinflammatory}

> <pubchem_cids>
{3059}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 23  0  0  0  0            999 V2000
   15.3833   -4.5076    0.0000 H   0  3
   12.8833   -4.5076    0.0000 Cl  0  5
    5.1937   -3.0093    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8912   -5.2578    0.0000 N   0  0
    5.1894   -6.0109    0.0000 C   0  0
    6.4897   -5.2632    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    3.8869   -8.2595    0.0000 O   0  0
    6.4855   -8.2648    0.0000 C   0  0
    6.4855   -9.7648    0.0000 C   0  0
    7.7846  -10.5149    0.0000 C   0  0
    9.0836   -9.7649    0.0000 C   0  0
   10.3826  -10.5149    0.0000 O   0  0
    9.0836   -8.2649    0.0000 C   0  0
    7.7846   -7.5149    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  4 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 23  1  0
 23 24  2  0
 24 18  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6109

> <plate>
NGP-202-01

> <well>
D10

> <supplier_cmpd_name>
CPD000058729

> <ctcr_id>
6202

> <supplier_cmpd_id>
SAM002554905

> <smiles>
[H+].[Cl-].CC(COc1ccccc1)NC(C)C(O)c2ccc(O)cc2

> <pd_targets>
{CYP2C19,CYP1A2,HIF1A,CYP2D6,KMT2A,MEN1,MAPK1,ADRA1A,ADRA1B,ADRA1D,ADRB2}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Epigenetic regulator","Membrane receptor","Cytochrome P450",Reader,Kinase,"Family A G protein-coupled receptor","Cytochrome P450 family 2","Cytochrome P450 family 1",Br
omodomain,"Protein Kinase","Small molecule receptor (family A GPCR)","Cytochrome P450 family 2C","Cytochrome P450 family 1A","Cytochrome P450 family 2D","CMGC protein kinase group","Monoamine receptor
","Cytochrome P450 2C19","Cytochrome P450 1A1","Cytochrome P450 2D6","CMGC protein kinase MAPK family","Adrenergic receptor","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Receptors,"Cytochrome P450","Kinases (EC 2.7.x.x)","G protein-coupled receptors","CYP2 family: drug metabolising subset","CYP1 family","CMGC: Containing CDK",MAPK,GSK3,"CLK families",Adrenoce
ptors,"Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{Metabolism,"Cellular responses to external stimuli","Immune System",Disease,"Biological oxidations","Cellular responses to stress","Innate Immune System","Infectious disease","Phase I - Functionaliza
tion of compounds","Cellular response to hypoxia","Toll-like Receptor Cascades","Leishmania infection","Cytochrome P450 - arranged by substrate type","Oxygen-dependent proline hydroxylation of Hypoxia
-inducible Factor Alpha","Toll Like Receptor 5 (TLR5) Cascade","Leishmania parasite growth and survival",Xenobiotics,"MyD88 cascade initiated on plasma membrane","Anti-inflammatory response favouring 
Leishmania parasite infection","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","MAP kinase activation","ADORA2B mediated anti-inflammatory cytokines production","
MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{ADRB2}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{AKOS024362797,MCULE-3637060810,MCULE3637060810,ST50993910,"1-(4-hydroxyphenyl)-2-((1-methyl-2-phenoxyethyl)amino)propan-1-ol, chloride","1(4hydroxyphenyl)2((1methyl2phenoxyethyl)amino)propan1ol, chlo
ride","Isoxsuprine hydrochloride",579-56-6,579566,Duvadilan,"Isoxsuprine HCl",MLS000028704,4-(1-Hydroxy-2-((1-phenoxypropan-2-yl)amino,4(1Hydroxy2((1phenoxypropan2yl)amino,SAM002554905,Prestw-68,CPD00
0058729}

> <pdid>
PD005906

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{43834308,11368,657230}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 22  0  0  0  0            999 V2000
   11.9554   -0.0975    0.0000 H   0  3
    9.4554   -0.0975    0.0000 Cl  0  5
    6.9546   -4.2653    0.0000 C   0  0
    5.4929   -3.9285    0.0000 N   0  0
    5.0525   -2.4938    0.0000 C   0  0
    3.5900   -2.1568    0.0000 C   0  0
    3.1497   -0.7220    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.5913    1.9239    0.0000 C   0  0
    2.4792    3.4197    0.0000 C   0  0
    1.1278    4.0705    0.0000 C   0  0
   -0.1116    3.2255    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  3
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22  8  1  0
 22 17  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6110

> <plate>
NGP-202-01

> <well>
D11

> <supplier_cmpd_name>
CPD000058486

> <ctcr_id>
5327

> <supplier_cmpd_id>
SAM002554915

> <smiles>
[H+].[Cl-].CNCCC=C1c2ccccc2CCc3ccccc13

> <pd_targets>
{CYP3A4,ADRA2A,CHRM2,DRD2,SLC6A4,KCNJ10,CYP2D4,CYP2D6,HRH2,CYP2D3,ADRA1A,CYP1A2,HTR6,TSHR,CYP2C19,THPO,HTR1A,HTR2C,SLC6A2,SLC6A3,RET,CHRM5,HRH1,HTR1B,HTR1D,HTR1F,HTR2A,HTR2B,HTR3A,HTR3B,HTR4,HTR5A,HTR
5B,HTR7,LMNA,HTT,CHRM1,CYP2D26,CYP2C8,ADRA1B,SIGMAR1,CHRM3,TP53,CHRM4,AMPC,PMP22,MAPT,FTL,KMT2A,MEN1,NPSR1,MTOR,DRD3,ADRA2B,ADRA1D,ADRA2C,KCNJ5,KCNJ6,ADRB1,ADRB2,ADRB3,PGRMC1}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor",Transporter,"Ion channel","Unclassified protein","Other nuclear protein","Transcription factor","Other cytosolic protein","Epigenetic regulator","Cytochrome P450","Family A
 G protein-coupled receptor","Electrochemical transporter","Voltage-gated ion channel",Kinase,Hydrolase,Reader,"Cytochrome P450 family 3","Small molecule receptor (family A GPCR)","SLC superfamily of 
solute carriers","Potassium channels","Cytochrome P450 family 2","Cytochrome P450 family 1","Peptide receptor (family A GPCR)","Protein Kinase",Bromodomain,"Cytochrome P450 family 3A","Monoamine recep
tor","SLC06 neurotransmitter transporter family","Inwardly rectifying potassium channel","Cytochrome P450 family 2D","Cytochrome P450 family 1A","Glycohormone receptor","Cytochrome P450 family 2C","TK
 protein kinase group","Short peptide receptor (family A GPCR)","Atypical protein kinase group","Cytochrome P450 3A4","Adrenergic receptor","Acetylcholine receptor","Dopamine receptor","Cytochrome P45
0 2D18","Cytochrome P450 2D6","Histamine receptor","Cytochrome P450 2D3","Cytochrome P450 1A1","Serotonin receptor","Cytochrome P450 2C19","Tyrosine protein kinase Ret family","Cytochrome P450 2D2","C
ytochrome P450 2C8","Neuropeptide receptor","Atypical protein kinase PIKK family","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Ion channels","Other protein targets","Cytochrome P450","G protein-coupled receptors","SLC superfamily of solute carriers","Voltage-gated ion channels","Catalytic rece
ptors","Sigma receptors","Kinases (EC 2.7.x.x)","CYP3 family",Adrenoceptors,"Acetylcholine receptors (muscarinic)","Dopamine receptors","SLC6 neurotransmitter transporter family","Potassium channels",
"CYP2 family: drug metabolising subset","Histamine receptors","CYP1 family","5-Hydroxytryptamine receptors","Glycoprotein hormone receptors","Receptor kinases","Neuropeptide S receptor",Atypical,"Mono
amine transporter subfamily","Inwardly rectifying potassium channels","TK: Tyrosine kinase","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","Receptor tyrosine kinases (RTKs)","FRAP sub
family","Type XIV RTKs: RET"}

> <pathway_reactome>
{Metabolism,"Signal Transduction","Neuronal System",Disease,Hemostasis,"Developmental Biology","Cell Cycle","Gene expression (Transcription)","Vesicle-mediated transport","Metabolism of lipids","Signa
ling by GPCR","Transmission across Chemical Synapses","Biological oxidations","Infectious disease","Platelet activation","signaling and aggregation","Disorders of transmembrane transporters","Nervous 
system development",Mitotic,"RNA Polymerase II Transcription","Cell Cycle Checkpoints","Membrane Trafficking","Biosynthesis of specialized proresolving mediators (SPMs)","GPCR ligand binding","Neurotr
ansmitter clearance","Neurotransmitter receptors and postsynaptic signal transmission","Phase I - Functionalization of compounds","Leishmania infection","Platelet Aggregation (Plug Formation)","SLC tr
ansporter disorders","Axon guidance","M Phase","Generic Transcription Pathway","SARS-CoV Infections","G1/S DNA Damage Checkpoints","EGR2 and SOX10-mediated initiation of Schwann cell myelination","tra
ns-Golgi Network Vesicle Budding","Biosynthesis of DHA-derived SPMs","Class A/1 (Rhodopsin-like receptors)","Serotonin clearance from the synaptic cleft","GABA receptor activation","Cytochrome P450 - 
arranged by substrate type","Leishmania parasite growth and survival","Defective SLC6A2 causes orthostatic intolerance (OI)","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","RET sign
aling","Mitotic Metaphase and Anaphase","Transcriptional Regulation by MECP2","Potential therapeutics for SARS","p53-Dependent G1/S DNA damage checkpoint","Activation of NMDA receptors and postsynapti
c events","Golgi Associated Vesicle Biogenesis","Transcriptional Regulation by TP53","Biosynthesis of maresins","Amine ligand-binding receptors","GABA B receptor activation",Xenobiotics,"Anti-inflamma
tory response favouring Leishmania parasite infection","Mitotic Anaphase","Regulation of MECP2 expression and activity","p53-Dependent G1 DNA Damage Response","Post NMDA receptor activation events","R
egulation of TP53 Activity","Biosynthesis of maresin-like SPMs",Adrenoceptors,"Muscarinic acetylcholine receptors","Dopamine receptors","Activation of GABAB receptors","CYP2E1 reactions","ADORA2B medi
ated anti-inflammatory cytokines production","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Serotonin receptors","Histamine receptors","Nuclear Envelope (NE) Reassembly","Stabiliz
ation of p53","Activation of AMPK downstream of NMDARs","Regulation of TP53 Expression and Degradation","Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits","Initiation of Nuclear Env
elope (NE) Reformation","Autodegradation of the E3 ubiquitin ligase COP1","Regulation of TP53 Degradation"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,ADRA2A,ADRA2B,ADRA2C,ADRB1,ADRB2,ADRB3,CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,DRD2,HRH1,HTR1A,HTR2A,HTR2C,HTR6,KCNJ10,PGRMC1,SIGMAR1,SLC6A2,SLC6A4}

> <broad_moa>
{"tricyclic antidepressant"}

> <synonyms>
{"Nortriptyline hydrochloride",894-71-3,894713,"894 71 3",Pamelor,"Desmethylamitriptyline hydrochloride",Allegron,Nortrilen,Altilev,"Nortriptyline Hcl","Nortriptyline (hydrochloride)",Acetexa,Sensival
,Vividyl,"Aventyl allegron","Ateben hydroch",SAM002554915,Prestw-254,CPD000058486}

> <pdid>
PD009970

> <targets>
{Apoptosis,Autophagy,Drug Metabolite}

> <classes>
{Apoptosis,Autophagy,Metabolic Enzyme/Protease}

> <pubchem_cids>
{441358,657214,13468}

$$$$
NIHCC_2014
  SciTegic11012413002D

 19 19  0  0  0  0            999 V2000
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    5.1937   -3.0093    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2948   -3.7516    0.0000 O   0  0
    2.5973   -1.5031    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5988   -1.5004    0.0000 C   0  0
   -3.8983   -0.7513    0.0000 F   0  0
   -2.5983   -3.0004    0.0000 F   0  0
   -3.8975   -2.2510    0.0000 F   0  0
   -2.5973    1.5031    0.0000 N   0  3
   -3.8976    0.7553    0.0000 O   0  5
   -2.5951    3.0031    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 11 13  1  0
 13 14  1  0
 13 15  1  0
 13 16  1  0
 10 17  1  0
 17 18  1  0
 17 19  2  0
M  CHG  2  17   1  18  -1
M  END
> <name>
NIHCC_2014

> <id>
6111

> <plate>
NGP-202-01

> <well>
E02

> <supplier_cmpd_name>
CPD000058187

> <ctcr_id>
1718

> <supplier_cmpd_id>
SAM002264612

> <smiles>
CC(C)C(=O)Nc1ccc(c(c1)C(F)(F)F)[N+]([O-])=O

> <pd_targets>
{HTT,CYP1A2,HTR4,AADAC,ABCB11,LMNA,ALOX15,CHRM1,AR,CYP3A4,CYP2C9,RORC,ALDH1A1,FTL,CYP2C19,MAPK1,GLA,NFO,CES2,AMPC,PMP22,HTR6,AHR}

> <pathway_gtopdb>
{"Unclassified protein",Enzyme,"Membrane receptor",Transporter,"Other nuclear protein","Transcription factor","Cytochrome P450","Family A G protein-coupled receptor",Hydrolase,"Primary active transpor
ter",Oxidoreductase,"Nuclear receptor",Kinase,"Cytochrome P450 family 1","Small molecule receptor (family A GPCR)","ATP-binding cassette","Nuclear hormone receptor subfamily 3","Cytochrome P450 family
 3","Cytochrome P450 family 2","Nuclear hormone receptor subfamily 1","Protein Kinase","Cytochrome P450 family 1A","Monoamine receptor","ABCB subfamily","Nuclear hormone receptor subfamily 3 group C",
"Cytochrome P450 family 3A","Cytochrome P450 family 2C","Nuclear hormone receptor subfamily 1 group F","CMGC protein kinase group","Cytochrome P450 1A1","Serotonin receptor","Acetylcholine receptor","
Nuclear hormone receptor subfamily 3 group C member 4","Cytochrome P450 3A4","Cytochrome P450 2C9","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 2C19","CMGC protein kinase M
APK family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Other protein targets","Cytochrome P450","G protein-coupled receptors","ATP-binding cassette transporter family","Eicosanoid turnover","Nuclear hormone receptors","Kin
ases (EC 2.7.x.x)","Aryl hydrocarbon receptor","CYP1 family","5-Hydroxytryptamine receptors","ABCB subfamily",Lipoxygenases,"Acetylcholine receptors (muscarinic)","Steroid hormone receptors","CYP3 fam
ily","CYP2 family: drug metabolising subset","1F. Retinoic acid-related orphans","CMGC: Containing CDK",MAPK,GSK3,"CLK families","3C. 3-Ketosteroid receptors","Mitogen-activated protein kinases (MAP k
inases)","ERK subfamily"}

> <pathway_reactome>
{"Gene expression (Transcription)",Metabolism,Disease,"Cell Cycle","Signal Transduction","Vesicle-mediated transport","Immune System","Developmental Biology","RNA Polymerase II Transcription","Biologi
cal oxidations","Infectious disease","Metabolism of lipids",Mitotic,"Signaling by GPCR","Membrane Trafficking","Innate Immune System","Nervous system development","Generic Transcription Pathway","Phas
e I - Functionalization of compounds","Leishmania infection","Metabolism of steroids","M Phase","Biosynthesis of specialized proresolving mediators (SPMs)","GPCR ligand binding","trans-Golgi Network V
esicle Budding","Toll-like Receptor Cascades","Sphingolipid metabolism","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Transcriptional Regulation by MECP2","Cytochrome P450 - arrang
ed by substrate type","Leishmania parasite growth and survival","Bile acid and bile salt metabolism","Mitotic Metaphase and Anaphase","Biosynthesis of DPA-derived SPMs","Class A/1 (Rhodopsin-like rece
ptors)","Transcriptional regulation by RUNX2","Biosynthesis of DHA-derived SPMs","Transcriptional regulation by RUNX3","Ethanol oxidation","Golgi Associated Vesicle Biogenesis","Toll Like Receptor 5 (
TLR5) Cascade","Glycosphingolipid metabolism","Regulation of MECP2 expression and activity",Xenobiotics,"Anti-inflammatory response favouring Leishmania parasite infection","Synthesis of bile acids an
d bile salts","Mitotic Anaphase","Biosynthesis of DPAn-3 SPMs","Amine ligand-binding receptors","RUNX2 regulates bone development","Biosynthesis of maresins","RUNX3 Regulates Immune Response and Cell 
Migration","MyD88 cascade initiated on plasma membrane","Endogenous sterols","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","ADORA2B mediated anti-inflammatory cytokines production
","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Nuclear Envelope (NE) Reassembly","Biosynthesis of DPAn-3-derived protectins and resolvins","Muscarinic acetylcholine receptor
s","RUNX2 regulates osteoblast differentiation","Biosynthesis of maresin-like SPMs","CYP2E1 reactions","MAP kinase activation","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear 
events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{AHR,AR}

> <broad_moa>
{"androgen receptor antagonist"}

> <synonyms>
{flutamide,13311-84-7,13311847,Eulexin,Niftolide,Niftholide,2-Methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)propanamide,2MethylN(4nitro3(trifluoromethyl)phenyl)propanamide,NFBA,niftolid,Drogenil,"Sch 13
521",Flutamin,"Cebatrol, veterinary",Flutamida,Flutamidum,Sch-13521,Sch13521,4'-Nitro-3'-trifluoromethylisobutyra,4'Nitro3'trifluoromethylisobutyra,T0489,SAM002264612,1500995,Prestw-180,Flutamide,CPD0
00058187,FLUTAMIDE}

> <pdid>
PD001517

> <targets>
{}

> <classes>
{antiandrogen}

> <pubchem_cids>
{3397}

$$$$
NIHCC_2014
  SciTegic11012413002D

 19 20  0  0  0  0            999 V2000
    3.8976   -0.7553    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2948   -3.7516    0.0000 O   0  0
    3.8926   -3.7566    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 C   0  0
   -3.8976   -0.7554    0.0000 O   0  0
   -2.5951   -3.0039    0.0000 C   0  0
   -3.8915   -3.7585    0.0000 C   0  0
   -3.8863   -5.2585    0.0000 C   0  0
   -2.5847   -6.0040    0.0000 C   0  0
   -1.2883   -5.2495    0.0000 C   0  0
   -1.2935   -3.7495    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  2  0
  2  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
 10 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
M  END
> <name>
NIHCC_2014

> <id>
6112

> <plate>
NGP-202-01

> <well>
E03

> <supplier_cmpd_name>
CPD000040181

> <ctcr_id>
5066

> <supplier_cmpd_id>
SAM002264620

> <smiles>
CC(C(O)=O)c1cccc(c1)C(=O)c2ccccc2

> <pd_targets>
{AMPC,PMP22,KDM4E,HPGD,PTGS2,SMN1,CYP3A4,PTGS1,LMNA,ALDH1A1,HSD17B10,MAPK1,MAPT,SLC22A7,SLC22A6,SLC5A8,CXCR1,CXCL8,CXCR2,THPO,HIF1A,RECQL,RORC,ALD}

> <pathway_gtopdb>
{Enzyme,"Unclassified protein","Epigenetic regulator","Other nuclear protein","Other cytosolic protein",Transporter,"Membrane receptor","Secreted protein","Transcription factor",Hydrolase,Eraser,Oxido
reductase,Reader,"Cytochrome P450",Kinase,"Electrochemical transporter","Family A G protein-coupled receptor","Lysine demethylase","Methyl-lysine/arginine binding protein","Cytochrome P450 family 3","
Protein Kinase","SLC superfamily of solute carriers","Peptide receptor (family A GPCR)","Jumonji domain-containing","Tudor domain","Cytochrome P450 family 3A","CMGC protein kinase group","SLC22 family
 of organic cation and anion transporters","Chemokine receptor","Cytochrome P450 3A4","CMGC protein kinase MAPK family","CXC chemokine receptor","CMGC protein kinase ERK1","Nuclear receptor","Nuclear 
hormone receptor subfamily 1","Nuclear hormone receptor subfamily 1 group F","Nuclear hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{Enzymes,Transporters,Receptors,"Chromatin modifying enzymes","Eicosanoid turnover","Cytochrome P450","Kinases (EC 2.7.x.x)","SLC superfamily of solute carriers","G protein-coupled receptors","1.14.11
.- Histone demethylases","Prostaglandin synthases",Cyclooxygenase,"CYP3 family","CMGC: Containing CDK",MAPK,GSK3,"CLK families","SLC22 family of organic cation and anion transporters","SLC5 family of 
sodium-dependent glucose transporters","Chemokine receptors","Mitogen-activated protein kinases (MAP kinases)","Organic anion transporters (OATs)","Sodium iodide symporter","sodium-dependent multivita
min transporter and sodium-coupled monocarboxylate transporters","ERK subfamily","Nuclear hormone receptors","1F. Retinoic acid-related orphans"}

> <pathway_reactome>
{"Developmental Biology",Metabolism,"Metabolism of RNA","Cell Cycle","Immune System","Neuronal System","Transport of small molecules","Signal Transduction",Hemostasis,"Cellular responses to external s
timuli","Nervous system development","Metabolism of lipids","Metabolism of non-coding RNA",Mitotic,"Biological oxidations","Metabolism of amino acids and derivatives","Innate Immune System","Transmiss
ion across Chemical Synapses","SLC-mediated transmembrane transport","Metabolism of vitamins and cofactors","Signaling by GPCR","Platelet activation","signaling and aggregation","Cellular responses to
 stress","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Biosynthesis of specialized proresolving mediators (SPMs)","snRNP Assembly","Fatty acid metabolism","M Phase","Phase I - Func
tionalization of compounds","Branched-chain amino acid catabolism","Toll-like Receptor Cascades","Neurotransmitter receptors and postsynaptic signal transmission","Transport of bile salts and organic 
acids","metal ions and amine compounds","Metabolism of water-soluble vitamins and cofactors","GPCR ligand binding","Platelet Aggregation (Plug Formation)","Cellular response to hypoxia","Biosynthesis 
of DHA-derived SPMs","Biosynthesis of DPA-derived SPMs","Arachidonic acid metabolism","Mitotic Metaphase and Anaphase","Ethanol oxidation","Toll Like Receptor 5 (TLR5) Cascade","Activation of NMDA rec
eptors and postsynaptic events","Organic cation/anion/zwitterion transport","Nicotinate metabolism","Class A/1 (Rhodopsin-like receptors)","Oxygen-dependent proline hydroxylation of Hypoxia-inducible 
Factor Alpha","Biosynthesis of D-series resolvins","Biosynthesis of DPAn-3 SPMs","Biosynthesis of maresins","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","Mitotic Anaphase","MyD88 cascade i
nitiated on plasma membrane","Post NMDA receptor activation events","Organic anion transport","Nicotinamide salvaging","Peptide ligand-binding receptors","Biosynthesis of maresin-like SPMs","Nuclear E
nvelope (NE) Reassembly","MAP kinase activation","Activation of AMPK downstream of NMDARs","Chemokine receptors bind chemokines","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclea
r events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated","Gene expression (Transcription)","RNA Polymerase II Transcription","Generic Transcription Pathway","Transcriptional regulat
ion by RUNX3","RUNX3 Regulates Immune Response and Cell Migration"}

> <broad_targets>
{PTGS1,PTGS2,SLC5A8}

> <broad_moa>
{"cyclooxygenase inhibitor"}

> <synonyms>
{ketoprofen,22071-15-4,22071154,"2-(3-Benzoylphenyl)propanoic acid","2(3Benzoylphenyl)propanoic acid","2-(3-Benzoylphenyl)propionic acid","2(3Benzoylphenyl)propionic acid",Orudis,"m-Benzoylhydratropic
 acid","mBenzoylhydratropic acid",Ketoprofene,Profenid,Oruvail,Actron,"3-Benzoylhydratropic acid","3Benzoylhydratropic acid",Alrheumun,Capisten,Epatec,Aneol,"Orudis (TN)",Ket,T0839,T0839L,SAM002264620
,1501215,Prestw-219,Ketoprofen,(S)-(+)-Ketoprofen,CPD000040181,KETOPROFEN}

> <pdid>
PD001443

> <targets>
{Apoptosis,COX}

> <classes>
{antiinflammatory,Apoptosis,Immunology/Inflammation}

> <pubchem_cids>
{3825}

$$$$
NIHCC_2014
  SciTegic11012413002D

 18 19  0  0  0  0            999 V2000
   10.3996   -1.4837    0.0000 C   0  0
    9.0990   -0.7364    0.0000 C   0  0
    9.0964    0.7636    0.0000 C   0  0
    7.8003   -1.4887    0.0000 N   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    5.2029   -2.9932    0.0000 O   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.4133   -1.7530    0.0000 N   0  0
   -1.8032   -3.1233    0.0000 C   0  0
   -0.3114   -2.9665    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 10  1  0
 18 14  2  0
M  END
> <name>
NIHCC_2014

> <id>
6113

> <plate>
NGP-202-01

> <well>
E04

> <supplier_cmpd_name>
CPD000059120

> <ctcr_id>
672

> <supplier_cmpd_id>
SAM002264631

> <smiles>
CC(C)NCC(O)COc1cccc2[nH]ccc12

> <pd_targets>
{HTR2A,ADRB1,HTR1A,LMNA,CHRM1,CYP3A4,HTR1B,HTR1D,HTR1F,NFKB1,ALOX15,GLA,NFO,TP53,HTR2C,HTR2B,NS1,ADRB2,ADRB3,TSHR,CYP2D6,CYP1A2,THRB,BLM,KMT2A,MEN1,ALDH1A1}

> <pathway_gtopdb>
{"Membrane receptor","Other nuclear protein",Enzyme,"Other cytosolic protein","Transcription factor","Unclassified protein","Family A G protein-coupled receptor","Cytochrome P450",Oxidoreductase,Hydro
lase,"Nuclear receptor","Small molecule receptor (family A GPCR)","Cytochrome P450 family 3","Peptide receptor (family A GPCR)","Cytochrome P450 family 2","Cytochrome P450 family 1","Nuclear hormone r
eceptor subfamily 1","Monoamine receptor","Cytochrome P450 family 3A","Glycohormone receptor","Cytochrome P450 family 2D","Cytochrome P450 family 1A","Nuclear hormone receptor subfamily 1 group A","Se
rotonin receptor","Adrenergic receptor","Acetylcholine receptor","Cytochrome P450 3A4","Cytochrome P450 2D6","Cytochrome P450 1A1","Nuclear hormone receptor subfamily 1 group A member 2","Epigenetic r
egulator",Reader,Bromodomain}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Cytochrome P450","Eicosanoid turnover","Nuclear hormone receptors","5-Hydroxytryptamine receptors",Adrenoceptors,"Acetylcholine receptors (muscarinic)
","CYP3 family",Lipoxygenases,"Glycoprotein hormone receptors","CYP2 family: drug metabolising subset","CYP1 family","1A. Thyroid hormone receptors"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Cell Cycle",Metabolism,"Immune System","Metabolism of proteins","Signaling by GPCR","Infectious disease",Mitotic,"Metabolism of lipids","Cytokine Signaling in Immune sy
stem","Cell Cycle Checkpoints","Biological oxidations","Post-translational protein modification","GPCR ligand binding","Leishmania infection","M Phase","Biosynthesis of specialized proresolving mediat
ors (SPMs)","Signaling by Interleukins","Sphingolipid metabolism","G1/S DNA Damage Checkpoints","Phase I - Functionalization of compounds",SUMOylation,"Class A/1 (Rhodopsin-like receptors)","Leishmani
a parasite growth and survival","Mitotic Metaphase and Anaphase","Biosynthesis of DHA-derived SPMs","Interleukin-1 family signaling","Biosynthesis of DPA-derived SPMs","Glycosphingolipid metabolism","
p53-Dependent G1/S DNA damage checkpoint","Cytochrome P450 - arranged by substrate type","SUMO E3 ligases SUMOylate target proteins","Amine ligand-binding receptors","Anti-inflammatory response favour
ing Leishmania parasite infection","Mitotic Anaphase","Biosynthesis of maresins","Interleukin-1 signaling","Biosynthesis of DPAn-3 SPMs","p53-Dependent G1 DNA Damage Response",Xenobiotics,"SUMOylation
 of intracellular receptors","Serotonin receptors","ADORA2B mediated anti-inflammatory cytokines production","Nuclear Envelope (NE) Reassembly","Muscarinic acetylcholine receptors","Biosynthesis of ma
resin-like SPMs","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Biosynthesis of DPAn-3-derived protectins and resolvins","Stabilization of p53","CYP2E1 reactions","Aromatic amines can be N-hydroxylated
 or N-dealkylated by CYP1A2","Initiation of Nuclear Envelope (NE) Reformation","Autodegradation of the E3 ubiquitin ligase COP1","DNA Repair","DNA Double-Strand Break Repair","Homology Directed Repair
","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Ethanol oxidation","HDR through Homologous Recombination (HRR)","Homologous DNA Pairing and Strand Exchange","Presynapt
ic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{HTR1A}

> <broad_moa>
{"adrenergic receptor antagonist","serotonin receptor antagonist"}

> <synonyms>
{pindolol,13523-86-9,13523869,Visken,Prinodolol,Betapindol,Carvisken,Durapindol,Pinbetol,Calvisken,Decreten,Pectobloc,Pynastin,"Blocklin L",LB-46,LB46,Pindololum,Glauco-visken,Glaucovisken,"Blockin L"
,"LB 46",Blocklin-L,BlocklinL,4-(2-Hydroxy-3-isopropylaminopropoxy)-indole,4(2Hydroxy3isopropylaminopropoxy)indole,1-(1H,1(1H,T0735,SAM002264631,1500488,Prestw-90,Pindolol,CPD000059120,PINDOLOL}

> <pdid>
PD001798

> <targets>
{5-HT Receptor,Adrenergic Receptor}

> <classes>
{antihypertensive,antiarrhythmic,antiglaucoma agent,antianginal,GPCR/G Protein,Neuronal Signaling}

> <pubchem_cids>
{4828}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 29  0  0  1  0            999 V2000
    2.2090   -0.3353    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0
   -6.4952    3.7500    0.0000 O   0  0
   -3.8971    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0  2  0  0  0
   -1.2990    2.2500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.3326   -2.9571    0.0000 C   0  0
    1.8253   -3.1044    0.0000 C   0  0
    2.4266   -1.7302    0.0000 C   0  0  1  0  0  0
    2.7095   -0.7710    0.0000 O   0  0
    3.4182   -2.8395    0.0000 C   0  0
    4.8815   -2.5100    0.0000 O   0  0
    2.9720   -4.2725    0.0000 C   0  0
    3.9887   -5.3754    0.0000 O   0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  2  0
  6  4  1  1
  6  7  1  0
  7  8  1  6
  8  9  1  0
  9 10  1  0
 10 11  2  3
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  3
 15 16  1  0
 16  6  1  0
 16 10  1  0
 16 17  1  1
  7 18  1  0
 18  2  1  0
 18 19  1  1
 19 20  1  0
 20 21  1  0
 21  2  1  0
 21 22  1  6
 21 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
M  END
> <name>
NIHCC_2014

> <id>
6114

> <plate>
NGP-202-01

> <well>
E05

> <supplier_cmpd_name>
CPD001227202

> <ctcr_id>
4035

> <supplier_cmpd_id>
SAM002264641

> <smiles>
C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO

> <pd_targets>
{HIF1A,HSD17B10,NR3C1,KMT2A,MEN1,RORC,ALDH1A1}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Epigenetic regulator",Oxidoreductase,"Nuclear receptor",Reader,"Nuclear hormone receptor subfamily 3",Bromodomain,"Nuclear hormone receptor subfamily 1","Nuclear hormon
e receptor subfamily 3 group C","Nuclear hormone receptor subfamily 1 group F","Nuclear hormone receptor subfamily 3 group C member 1","Nuclear hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{Receptors,"Nuclear hormone receptors","Steroid hormone receptors","1F. Retinoic acid-related orphans","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"Cellular responses to external stimuli",Metabolism,"Gene expression (Transcription)","Cellular responses to stress","Metabolism of amino acids and derivatives","RNA Polymerase II Transcription","Bio
logical oxidations","Cellular response to hypoxia","Branched-chain amino acid catabolism","Generic Transcription Pathway","Phase I - Functionalization of compounds","Oxygen-dependent proline hydroxyla
tion of Hypoxia-inducible Factor Alpha","FOXO-mediated transcription","Transcriptional regulation by RUNX3","Ethanol oxidation","FOXO-mediated transcription of oxidative stress","metabolic and neurona
l genes","RUNX3 Regulates Immune Response and Cell Migration"}

> <broad_targets>
{HSD11B1,NR3C1}

> <broad_moa>
{"glucocorticoid receptor agonist"}

> <synonyms>
{prednisone,53-03-2,53032,Dehydrocortisone,Decortin,Deltasone,Meticorten,Orasone,Rectodelt,Ultracorten,Dacortin,Encorton,"1,2-Dehydrocortisone","1,2Dehydrocortisone",Deltacortisone,Deltacortone,Ancort
one,Colisone,Decortancyl,Decortisyl,Deltison,Encortone,Paracort,Prednilon,SAM002264641,Prestw-77,CPD001227202,Prednisone}

> <pdid>
PD001789

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5865}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 22  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -0.0031    3.0008    0.0000 C   0  0
   -1.3039    3.7494    0.0000 C   0  0
   -2.6005    2.9949    0.0000 C   0  0
   -3.9021    3.7404    0.0000 N   0  0
   -3.9073    5.2404    0.0000 C   0  0
   -5.2089    5.9859    0.0000 N   0  0
   -2.6108    5.9949    0.0000 N   0  0
   -1.3092    5.2494    0.0000 C   0  0
   -0.0128    6.0039    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.6003   -1.4978    0.0000 O   0  0
   -3.8983   -0.7459    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0031   -3.0008    0.0000 O   0  0
    1.3032   -3.7490    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13  7  1  0
 13 14  1  0
  5 15  2  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 16 19  2  0
 19  3  1  0
 19 20  1  0
 20 21  1  0
M  END
> <name>
NIHCC_2014

> <id>
6115

> <plate>
NGP-202-01

> <well>
E06

> <supplier_cmpd_name>
CPD000035999

> <ctcr_id>
2280

> <supplier_cmpd_id>
SAM002264649

> <smiles>
COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC

> <pd_targets>
{DHFR,BLM,KMT2A,MEN1,FOLA,DFRA17,NFKB1,DFR1,SLC22A1,LEF,DFRA,HSD17B10,CYP3A4,DHFRI,TSHR,CHRM1}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Other cytosolic protein",Transporter,"Membrane receptor",Oxidoreductase,Reader,"Electrochemical transporter",Protease,"Cytochrome P450","Family A G protein-coupled rece
ptor",Bromodomain,"SLC superfamily of solute carriers","Metallo protease","Cytochrome P450 family 3","Peptide receptor (family A GPCR)","Small molecule receptor (family A GPCR)","SLC22 family of organ
ic cation and anion transporters","Metallo protease MAE clan","Cytochrome P450 family 3A","Glycohormone receptor","Monoamine receptor","Metallo protease M34 family","Cytochrome P450 3A4","Acetylcholin
e receptor"}

> <pathway_chembl>
{Enzymes,Transporters,Receptors,"1.-.-.- Oxidoreductases","SLC superfamily of solute carriers","Cytochrome P450","G protein-coupled receptors","SLC22 family of organic cation and anion transporters","
CYP3 family","Glycoprotein hormone receptors","Acetylcholine receptors (muscarinic)","Organic cation transporters (OCT)"}

> <pathway_reactome>
{"Cell Cycle","DNA Repair","Immune System","Transport of small molecules",Disease,Metabolism,"Signal Transduction",Mitotic,"DNA Double-Strand Break Repair","Cytokine Signaling in Immune system","SLC-m
ediated transmembrane transport","Infectious disease","Metabolism of amino acids and derivatives","Metabolism of lipids","Signaling by GPCR","Mitotic G1 phase and G1/S transition","Homology Directed R
epair","Signaling by Interleukins","Transport of bile salts and organic acids","metal ions and amine compounds","Uptake and actions of bacterial toxins","Branched-chain amino acid catabolism","Biosynt
hesis of specialized proresolving mediators (SPMs)","Leishmania infection","GPCR ligand binding","G1/S Transition","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Interl
eukin-1 family signaling","Organic cation/anion/zwitterion transport","Uptake and function of anthrax toxins","Biosynthesis of DHA-derived SPMs","Leishmania parasite growth and survival","Class A/1 (R
hodopsin-like receptors)","G1/S-Specific Transcription","HDR through Homologous Recombination (HRR)","Interleukin-1 signaling","Organic cation transport","Biosynthesis of maresins","Anti-inflammatory 
response favouring Leishmania parasite infection","Amine ligand-binding receptors","Homologous DNA Pairing and Strand Exchange","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Biosynthesis of maresin-li
ke SPMs","ADORA2B mediated anti-inflammatory cytokines production","Muscarinic acetylcholine receptors","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{DHFR,TYMS}

> <broad_moa>
{"dihydrofolate reductase inhibitor"}

> <synonyms>
{trimethoprim,738-70-5,738705,Proloprim,Trimpex,Trimetoprim,Bactramin,Monotrim,Monotrimin,Trimopan,"2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine","2,4Diamino5(3,4,5trimethoxybenzyl)pyrimidine",Mon
oprim,Syraprim,Trimanyl,Wellcoprim,Triprim,Uretrim,5-(3,5(3,4,5-trimethoxybenzyl)pyrimidine-2,5trimethoxybenzyl)pyrimidine2,4-diam,4diam,T1153,SAM002264649,1500595,Prestw-208,Trimethoprim,CPD000035999
,TRIMETHOPRIM}

> <pdid>
PD002101

> <targets>
{}

> <classes>
{antibacterial}

> <pubchem_cids>
{5578}

$$$$
NIHCC_2014
  SciTegic11012413002D

 13 13  0  0  0  0            999 V2000
   -0.4763   -3.7706    0.0000 C   0  0
    1.0157   -3.6164    0.0000 C   0  0
    1.8949   -4.8318    0.0000 O   0  0
    1.6281   -2.2462    0.0000 N   0  0
    0.7500   -1.0323    0.0000 C   0  0
    1.2135    0.3943    0.0000 S   0  0
    0.0000    1.2760    0.0000 C   0  0
   -1.2135    0.3943    0.0000 N   0  0
   -0.7500   -1.0323    0.0000 N   0  0
    0.0000    2.7742    0.0000 S   0  0
   -1.2993    3.5238    0.0000 N   0  0
    1.2985    3.5251    0.0000 O   0  0
   -0.0007    4.2742    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  2  0
  7 10  1  0
 10 11  1  0
 10 12  2  0
 10 13  2  0
M  END
> <name>
NIHCC_2014

> <id>
6116

> <plate>
NGP-202-01

> <well>
E07

> <supplier_cmpd_name>
CPD000058394

> <ctcr_id>
5697

> <supplier_cmpd_id>
SAM002554883

> <smiles>
CC(=O)Nc1sc(nn1)[S](N)(=O)=O

> <pd_targets>
{CA1,CA2,CA9,CA12,CA14,CA3,CA7,CA4,CA15,NCE103,MTCA1,CA13,THRB,CAH1,CA11,CA6,CA5A,MTCA2,CA5B,AMPC,BLM,CAH2,CYNT,CTS1,KMT2A,MEN1,1272966,AQP1}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Unclassified protein","Epigenetic regulator",Lyase,"Nuclear receptor",Hydrolase,Reader,"Nuclear hormone receptor subfamily 1",Bromodomain,"Nuclear hormone receptor subf
amily 1 group A","Nuclear hormone receptor subfamily 1 group A member 2"}

> <pathway_chembl>
{Enzymes,Receptors,"Ion channels","Carbonic anhydrases","Nuclear hormone receptors","Other ion channels","1A. Thyroid hormone receptors",Aquaporins}

> <pathway_reactome>
{"Immune System","Transport of small molecules","Cellular responses to external stimuli",Metabolism,"Metabolism of proteins","DNA Repair","Cytokine Signaling in Immune system","O2/CO2 exchange in eryt
hrocytes","Cellular responses to stress","Reversible hydration of carbon dioxide","Post-translational protein modification","DNA Double-Strand Break Repair","Aquaporin-mediated transport","Signaling b
y Interleukins","Erythrocytes take up carbon dioxide and release oxygen","Cellular response to hypoxia",SUMOylation,"Homology Directed Repair","Passive transport by Aquaporins","Interleukin-12 family 
signaling","Regulation of gene expression by Hypoxia-inducible Factor","SUMO E3 ligases SUMOylate target proteins","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Interl
eukin-12 signaling","SUMOylation of intracellular receptors","HDR through Homologous Recombination (HRR)","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","Homologo
us DNA Pairing and Strand Exchange","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{AQP1,CA1,CA12,CA14,CA2,CA3,CA4,CA7}

> <broad_moa>
{"carbonic anhydrase inhibitor"}

> <synonyms>
{RESTW,acetazolamide,59-66-5,59665,Diamox,"N-(5-Sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide","N(5Sulfamoyl1,3,4thiadiazol2yl)acetamide",Acetazolamid,Acetamox,Diacarb,Glaupax,Defiltran,Nephramide,Cidamex
,Diluran,Edemox,Dehydratin,Diuramid,Diutazol,Duiramid,Eumicton,Natrionex,Nephramid,Phonurit,Diakarb,Do,T0813,SAM002554883,1500102,Prestw-3,Acetazolamide,CPD000058394,ACETAZOLAMIDE}

> <pdid>
PD002491

> <targets>
{Autophagy,Carbonic Anhydrase}

> <classes>
{carbonic anhydrase inhibitor,antiglaucoma,diuretic,Autophagy,Metabolic Enzyme/Protease}

> <pubchem_cids>
{1986}

$$$$
NIHCC_2014
  SciTegic11012413002D

 11 12  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 Cl  0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 O   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -5.1065    0.0000    0.0000 O   0  0
   -2.7248   -1.2135    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 10  5  1  0
 10 11  2  0
 11  2  1  0
M  END
> <name>
NIHCC_2014

> <id>
6117

> <plate>
NGP-202-01

> <well>
E08

> <supplier_cmpd_name>
CPD000058269

> <ctcr_id>
1449

> <supplier_cmpd_id>
SAM002554888

> <smiles>
Clc1ccc2OC(=O)Nc2c1

> <pd_targets>
{LMNA,TSHR,NOS2,THPO,CYP1A2,NOS1,KCNN2,KCNN4,NOS3,NPSR1,CMA1}

> <pathway_gtopdb>
{"Other nuclear protein","Membrane receptor",Enzyme,"Unclassified protein","Ion channel","Family A G protein-coupled receptor","Cytochrome P450","Voltage-gated ion channel","Peptide receptor (family A
 GPCR)","Cytochrome P450 family 1","Potassium channels","Glycohormone receptor","Cytochrome P450 family 1A","Calcium-activated potassium channel","Short peptide receptor (family A GPCR)","Cytochrome P
450 1A1","Neuropeptide receptor",Protease,"Serine protease","Serine protease PA clan","Serine protease S1A subfamily"}

> <pathway_chembl>
{Receptors,Enzymes,"Ion channels","G protein-coupled receptors","L-Arginine turnover","Cytochrome P450","Voltage-gated ion channels","Glycoprotein hormone receptors","Nitric oxide synthases","CYP1 fam
ily","Potassium channels","Neuropeptide S receptor","Calcium- and sodium-activated potassium channels","Peptidases and proteinases","PA: Serine (S) Peptidases","S1: Chymotrypsin"}

> <pathway_reactome>
{"Cell Cycle",Disease,Hemostasis,Metabolism,"Neuronal System","Signal Transduction",Mitotic,"Infectious disease","Platelet activation","signaling and aggregation","Biological oxidations","Platelet hom
eostasis","Potassium Channels","Signaling by Receptor Tyrosine Kinases","M Phase","Leishmania infection","Infection with Mycobacterium tuberculosis","Platelet Aggregation (Plug Formation)","Phase I - 
Functionalization of compounds","Nitric oxide stimulates guanylate cyclase","Ca2+ activated K+ channels","Signaling by VEGF","Mitotic Metaphase and Anaphase","Leishmania parasite growth and survival",
"Response of Mtb to phagocytosis","Cytochrome P450 - arranged by substrate type","VEGFA-VEGFR2 Pathway","Mitotic Anaphase","Anti-inflammatory response favouring Leishmania parasite infection","Suppres
sion of phagosomal maturation",Xenobiotics,"VEGFR2 mediated vascular permeability","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Inhibition of nitric ox
ide production","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Initiation of Nuclear Envelope (NE) Reformation","Extracellular matrix organization","Degradation of the extracellul
ar matrix","Activation of Matrix Metalloproteinases"}

> <broad_targets>
{KCNMA1,KCNN4}

> <broad_moa>
{"bacterial 30S ribosomal subunit inhibitor"}

> <synonyms>
{chlorzoxazone,95-25-0,95250,Paraflex,Chloroxazone,Chlorzoxazon,5-Chloro-2-benzoxazolone,5Chloro2benzoxazolone,5-Chloro-2-benzoxazolinone,5Chloro2benzoxazolinone,"2(3H)-Benzoxazolone, 5-chloro-","2(3H
)Benzoxazolone, 5chloro",Biomioran,Escoflex,Myoflexin,Myoflexine,Pathorysin,5-Chloro-2-hydroxybenzoxazole,5Chloro2hydroxybenzoxazole,Mioran,Miotran,Neo,T0577,T1650,SAM002554888,1500188,Prestw-163,Chlo
robenzothiazolinone,Chlorzoxazone,CPD000058269,CHLORZOXAZONE}

> <pdid>
PD002420

> <targets>
{Cytochrome P450}

> <classes>
{muscle relaxant (skeletal),Metabolic Enzyme/Protease}

> <pubchem_cids>
{2733}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 29  0  0  0  0            999 V2000
    0.0007    0.0004    0.0000 O   0  5
    1.3000    0.7500    0.0000 N   0  3
    1.3000    2.2500    0.0000 O   0  5
    2.5993    0.0004    0.0000 O   0  0
   17.8534   -3.3718    0.0000 Cl  0  0
   16.5544   -2.6218    0.0000 C   0  0
   16.5544   -1.1218    0.0000 C   0  0
   15.2554   -0.3718    0.0000 C   0  0
   13.9563   -1.1219    0.0000 C   0  0
   12.6550   -0.3741    0.0000 C   0  0
   11.3563   -1.1264    0.0000 O   0  0
   10.0550   -0.3787    0.0000 C   0  0
    8.7564   -1.1309    0.0000 C   0  0
    7.4551   -0.3832    0.0000 N   0  0
    6.1037   -1.0042    0.0000 C   0  0
    5.1000    0.1105    0.0000 C   0  0
    5.8500    1.4095    0.0000 N   0  0
    7.3172    1.0977    0.0000 C   0  0
   10.0524    1.1221    0.0000 C   0  0
   11.3512    1.8727    0.0000 C   0  0
   11.3506    3.3727    0.0000 C   0  0
   10.0513    4.1222    0.0000 C   0  0
   10.0507    5.6222    0.0000 Cl  0  0
    8.7525    3.3717    0.0000 C   0  0
    8.7531    1.8717    0.0000 C   0  0
    7.8872    1.3714    0.0000 Cl  0  0
   13.9563   -2.6219    0.0000 C   0  0
   15.2554   -3.3719    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 14  1  0
 12 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 22 24  1  0
 24 25  2  0
 25 19  1  0
 25 26  1  0
  9 27  1  0
 27 28  2  0
 28  6  1  0
M  CHG  3   1  -1   2   1   3  -1
M  END
> <name>
NIHCC_2014

> <id>
6118

> <plate>
NGP-202-01

> <well>
E09

> <supplier_cmpd_name>
CPD001370749

> <ctcr_id>
7012

> <supplier_cmpd_id>
SAM002554898

> <smiles>
[O-][N+]([O-])=O.Clc1ccc(COC(Cn2ccnc2)c3ccc(Cl)cc3Cl)cc1

> <pd_targets>
{AR,AMPC,NPY2R,PGR,BCHE,CYP8B1,CYP51,CYP17A1,HTR1B,IDO1,ABCB11,ACHE,CYP3A4,ADRA1A,CNR1,CYP121,MDH1,HIF1A,DNAB,LMNA,RORC,FFP,TP53,GAA,NPY1R,TSHR,MAPK1,HTT,ALDH1A1,KMT2A,MEN1,LEF,RECA,USP2,NPSR1,RECQL,M
APT,HSP90AA1,IDO2,OPRM1,HTR1A,HTR6,TACR2,ORAI1,CYP1A2,DRD2,ADORA3,CYP2C19,SLC6A3,MC3R,CHRM1,CHRM3,OPRD1,OPRK1,MMP9,EGFR,HTR2A,HTR2C,ADORA2A,ADRA2B,ADRB3,SLC6A2,DRD4,ADORA1,ADRB1,CYP2D6,CHRM2,CYP2C9,MC
5R,CHRM4,HTR2B,SIGMAR1,TACR1,DRD3,ERBB2,CYP51A1,HRH2,FYN,SLC6A4,TBXAS1,ADRA1D,ADRA2A,TRPM2,TRPV5,ERG11,NR1I2,ULK1}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Membrane receptor",Transporter,"Other nuclear protein","Unclassified protein","Epigenetic regulator","Other cytosolic protein","Ion channel","Nuclear receptor",Hydrolas
e,"Family A G protein-coupled receptor",Oxidoreductase,"Cytochrome P450","Primary active transporter",Transferase,Kinase,Reader,Protease,"Other ion channel","Electrochemical transporter","Voltage-gate
d ion channel","Nuclear hormone receptor subfamily 3","Peptide receptor (family A GPCR)","Cytochrome P450 family 51","Cytochrome P450 family 17","Small molecule receptor (family A GPCR)","ATP-binding 
cassette","Cytochrome P450 family 3","Nuclear hormone receptor subfamily 1","Protein Kinase",Bromodomain,"Metallo protease","Cysteine protease","Miscellaneous ion channel","Cytochrome P450 family 1","
Cytochrome P450 family 2","SLC superfamily of solute carriers","Cytochrome P450 family 5","Transient receptor potential channel","Nuclear hormone receptor subfamily 3 group C","Short peptide receptor 
(family A GPCR)","Cytochrome P450 family 51A","Cytochrome P450 family 17A","Monoamine receptor","ABCB subfamily","Cytochrome P450 family 3A","Lipid-like ligand receptor (family A GPCR)","Nuclear hormo
ne receptor subfamily 1 group F","Glycohormone receptor","CMGC protein kinase group","Metallo protease MAE clan","Cysteine protease CA clan","Ca2+ release-activated Ca2+ channel family","Cytochrome P4
50 family 1A","Nucleotide-like receptor (family A GPCR)","Cytochrome P450 family 2C","SLC06 neurotransmitter transporter family","Metallo protease MAM clan","TK protein kinase group","Cytochrome P450 
family 2D","Cytochrome P450 family 5A","Nuclear hormone receptor subfamily 1 group I","Other protein kinase group","Nuclear hormone receptor subfamily 3 group C member 4","Neuropeptide Y receptor","Nu
clear hormone receptor subfamily 3 group C member 3","Cytochrome P450 51A1","Cytochrome P450 17A1","Serotonin receptor","Cytochrome P450 3A4","Adrenergic receptor","Cannabinoid receptor","Nuclear horm
one receptor subfamily 1 group F member 3","CMGC protein kinase MAPK family","Metallo protease M34 family","Cysteine protease C19 family","Neuropeptide receptor","Opioid receptor","Neurokinin receptor
","Cytochrome P450 1A1","Dopamine receptor","Adenosine receptor","Cytochrome P450 2C19","Melanocortin receptor","Acetylcholine receptor","Metallo protease M10A subfamily","Tyrosine protein kinase EGFR
 family","Cytochrome P450 2D6","Cytochrome P450 2C9","Histamine receptor","Tyrosine protein kinase Src family","Cytochrome P450 5A1","Nuclear hormone receptor subfamily 1 group I member 2","Other prot
ein kinase ULK family","CMGC protein kinase ERK1","Tyrosine protein kinase SrcA"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Other protein targets","Ion channels","Nuclear hormone receptors","G protein-coupled receptors","Acetylcholine turnover","Cytochrome P450","1.13.11.- Dioxygenases","AT
P-binding cassette transporter family","3.2.1.- Glycosidases","Kinases (EC 2.7.x.x)","Peptidases and proteinases","Heat shock proteins","Other ion channels","SLC superfamily of solute carriers","Catal
ytic receptors","Sigma receptors","Voltage-gated ion channels","Steroid hormone receptors","Neuropeptide Y receptors",CYP5,"CYP7 and CYP8 families",CYP11,CYP17,CYP19,"CYP20 and CYP21 families","5-Hydr
oxytryptamine receptors","ABCB subfamily","CYP3 family",Adrenoceptors,"Cannabinoid receptors","1F. Retinoic acid-related orphans","Glycoprotein hormone receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK
 families","CA: Cysteine (C) Peptidases","Neuropeptide S receptor","Opioid receptors","Tachykinin receptors","Store-operated ion channels","CYP1 family","Dopamine receptors","Adenosine receptors","CYP
2 family: drug metabolising subset","SLC6 neurotransmitter transporter family","Melanocortin receptors","Acetylcholine receptors (muscarinic)","MA: Metallo (M) Peptidases","Receptor kinases",CYP39,"CY
P46 and CYP51 families","Histamine receptors","Transient Receptor Potential channels","1I. Vitamin D receptor-like receptors","3C. 3-Ketosteroid receptors","Mitogen-activated protein kinases (MAP kina
ses)","C19: Ubiquitin-specific protease","Orai channels","Monoamine transporter subfamily","M10: Matrix metallopeptidase","TK: Tyrosine kinase","Other protein kinases","ERK subfamily","Receptor tyrosi
ne kinases (RTKs)","Non-receptor tyrosine kinases (nRTKs)","Unc-51-like kinase (ULK) family","Type I RTKs: ErbB (epidermal growth factor) receptor family","Src family"}

> <pathway_reactome>
{"Gene expression (Transcription)","Signal Transduction",Metabolism,"Cellular responses to external stimuli","Cell Cycle",Disease,"Immune System","Neuronal System",Hemostasis,"Developmental Biology","
Transport of small molecules","Metabolism of proteins",Autophagy,"RNA Polymerase II Transcription","Signaling by GPCR","Metabolism of lipids","Biological oxidations","Metabolism of amino acids and der
ivatives","Metabolism of carbohydrates","Cellular responses to stress",Mitotic,"Cell Cycle Checkpoints","Diseases of metabolism","Infectious disease","Innate Immune System","Transmission across Chemic
al Synapses","Platelet homeostasis","Disorders of transmembrane transporters","Nervous system development","Ion channel transport","Post-translational protein modification",Macroautophagy,"Generic Tra
nscription Pathway","GPCR ligand binding","Phospholipid metabolism","Phase I - Functionalization of compounds","Metabolism of steroids","Tryptophan catabolism","Biosynthesis of specialized proresolvin
g mediators (SPMs)","GPCR downstream signalling","Glucose metabolism","Cellular response to hypoxia","M Phase","G1/S DNA Damage Checkpoints","Diseases of carbohydrate metabolism","Leishmania infection
","Toll-like Receptor Cascades","Uptake and actions of bacterial toxins","Neurotransmitter receptors and postsynaptic signal transmission","Mitotic G2-G2/M phases","Platelet calcium homeostasis","SLC 
transporter disorders","Axon guidance","SARS-CoV Infections","HIV Infection","Neurotransmitter clearance","Stimuli-sensing channels",SUMOylation,"Selective autophagy","Transcriptional regulation by RU
NX2","Class A/1 (Rhodopsin-like receptors)","Glycerophospholipid biosynthesis","Cytochrome P450 - arranged by substrate type","Metabolism of steroid hormones","Bile acid and bile salt metabolism","Bio
synthesis of DHA-derived SPMs","G alpha (i) signalling events",Gluconeogenesis,"Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Mitotic Metaphase and Anaphase","Transcriptio
nal regulation by RUNX3","p53-Dependent G1/S DNA damage checkpoint","Glycogen storage diseases","Leishmania parasite growth and survival","Toll Like Receptor 5 (TLR5) Cascade","Transcriptional Regulat
ion by MECP2","Ethanol oxidation","Uptake and function of anthrax toxins","Transcriptional Regulation by TP53","Activation of NMDA receptors and postsynaptic events","G2/M Transition","Elevation of cy
tosolic Ca2+ levels","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","EPH-Ephrin signaling","G alpha (q) signalling events","Defective SLC6A2 causes orthostatic intolerance (OI)","Po
tential therapeutics for SARS","Semaphorin interactions","Host Interactions of HIV factors","Serotonin clearance from the synaptic cleft","TRP channels","SUMO E3 ligases SUMOylate target proteins",Mit
ophagy,"RUNX2 regulates bone development","Peptide ligand-binding receptors","Synthesis of PC","Endogenous sterols","Androgen biosynthesis","Amine ligand-binding receptors","Synthesis of bile acids an
d bile salts","Biosynthesis of maresins","Mitotic Anaphase","RUNX3 Regulates Immune Response and Cell Migration","p53-Dependent G1 DNA Damage Response","Glycogen storage disease type II (GAA)","Anti-i
nflammatory response favouring Leishmania parasite infection","MyD88 cascade initiated on plasma membrane","Regulation of MECP2 expression and activity","Regulation of TP53 Activity","Post NMDA recept
or activation events","Centrosome maturation","Opioid Signalling",Xenobiotics,"Nucleotide-like (purinergic) receptors","MECP2 regulates neuronal receptors and channels","EPH-ephrin mediated repulsion 
of cells","Gastrin-CREB signalling pathway via PKC and MAPK","Sema4D in semaphorin signaling","The role of Nef in HIV-1 replication and disease pathogenesis",Eicosanoids,"SUMOylation of intracellular 
receptors","Receptor Mediated Mitophagy","RUNX2 regulates osteoblast differentiation","Sterols are 12-hydroxylated by CYP8B1","Serotonin receptors","Synthesis of bile acids and bile salts via 7alpha-h
ydroxycholesterol","Biosynthesis of maresin-like SPMs",Adrenoceptors,"Nuclear Envelope (NE) Reassembly","Stabilization of p53","ADORA2B mediated anti-inflammatory cytokines production","MAP kinase act
ivation","Regulation of TP53 Expression and Degradation","Activation of AMPK downstream of NMDARs","Loss of proteins required for interphase microtubule organization from the centrosome","G-protein ac
tivation","Tachykinin receptors bind tachykinins","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Dopamine receptors","Adenosine P1 receptors","CYP2E1 reactions","Muscarinic acetyl
choline receptors","EGFR Transactivation by Gastrin","Sema4D induced cell migration and growth-cone collapse","Nef and signal transduction","Initiation of Nuclear Envelope (NE) Reformation","Autodegra
dation of the E3 ubiquitin ligase COP1","MAPK targets/ Nuclear events mediated by MAP kinases","Regulation of TP53 Degradation","Loss of Nlp from mitotic centrosomes","ERK/MAPK targets","ERKs are inac
tivated"}

> <broad_targets>
{}

> <broad_moa>
{"sterol demethylase inhibitor"}

> <synonyms>
{MLS006010626,HMS3259I17,NC00507,CPD001370749,SMR001370749,A817124,SAM002554898}

> <pdid>
PD005536

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{20512667}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 15  0  0  0  0            999 V2000
   10.1894   -2.2553    0.0000 H   0  3
    7.6894   -2.2553    0.0000 Cl  0  5
    5.1887   -6.0105    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    2.5909   -6.0056    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 15 17  2  0
 17 10  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6119

> <plate>
NGP-202-01

> <well>
E10

> <supplier_cmpd_name>
CPD000058267

> <ctcr_id>
33

> <supplier_cmpd_id>
SAM002554906

> <smiles>
[H+].[Cl-].CC(C)NCC(O)c1ccc(O)c(O)c1

> <pd_targets>
{TSHR,ALDOA,ADRB3,ADRB1,ADRB2,FFP,ADRA1A,ADRA1B,ADRA1D,ADRA2A,ADRA2B,ADRA2C,MAPT,ALOX15,ALD,HSD17B10,KDM4E,TDP1,PMP22,RXFP1,MAPK1,AMPC,BLM,POLB,NS1,GAA,TAS2R46,TAS2R31,TAS2R50,TAS2R10,TAS2R41,DRD3,TAS
2R45,MTOR,DRD4,TAS2R14,TAS2R4,DRD2,TAS2R3,TAS2R40,TAS2R39,TAS2R9,TAS2R8,TAS2R13,TAS2R43,TAS2R16,TAS2R19,TAS2R7,TAS2R42,TAS2R60,TAS2R38,TAS2R30,TAS2R1,TAS2R5,TAS2R20,PIK3R1,PIK3R2,PIK3R3,PDE4,MPI,TGR,N
FKB1,HIF1A,CYP3A4,CYP1A2,KMT2A,MEN1,HPGD,LMNA,CYP2C19,ALDH1A1}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Other cytosolic protein","Epigenetic regulator","Unclassified protein","Family A G protein-coupled receptor",Lyase,Transferase,Oxidoreductase,Eraser,Hydrolase,Kinase,"Tast
e family G protein-coupled receptor",Isomerase,"Peptide receptor (family A GPCR)","Small molecule receptor (family A GPCR)","Lysine demethylase","Protein Kinase","Taste receptor (taste family GPCR)","
Glycohormone receptor","Monoamine receptor","Jumonji domain-containing","Relaxin-like peptide receptor (family A GPCR)","CMGC protein kinase group","Atypical protein kinase group","Adrenergic receptor
","Relaxin receptor","CMGC protein kinase MAPK family","Dopamine receptor","Atypical protein kinase PIKK family","CMGC protein kinase ERK1","Atypical protein kinase FRAP subfamily","Transcription fact
or","Other nuclear protein","Cytochrome P450",Reader,"Cytochrome P450 family 3","Cytochrome P450 family 1",Bromodomain,"Cytochrome P450 family 2","Cytochrome P450 family 3A","Cytochrome P450 family 1A
","Cytochrome P450 family 2C","Cytochrome P450 3A4","Cytochrome P450 1A1","Cytochrome P450 2C19"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Eicosanoid turnover","Chromatin modifying enzymes","Kinases (EC 2.7.x.x)","3.2.1.- Glycosidases","Glycerophospholipid turnover","Glycoprotein hormone 
receptors",Adrenoceptors,Lipoxygenases,"1.14.11.- Histone demethylases","Relaxin family peptide receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Orphan and other 7TM receptors","Dopamine re
ceptors",Atypical,"Phosphatidylinositol kinases","Mitogen-activated protein kinases (MAP kinases)","Taste 2 receptors","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","ERK subfamily","
FRAP subfamily","Cytochrome P450","CYP3 family","CYP1 family","Prostaglandin synthases","CYP2 family: drug metabolising subset"}

> <pathway_reactome>
{Disease,Hemostasis,"Neuronal System",Metabolism,"DNA Repair","Developmental Biology","Immune System","Signal Transduction","Gene expression (Transcription)","Metabolism of proteins","Infectious disea
se","Platelet activation","signaling and aggregation","Transmission across Chemical Synapses","Metabolism of lipids","Metabolism of amino acids and derivatives","DNA Double-Strand Break Repair","Nervo
us system development","Innate Immune System","Base Excision Repair","Diseases of metabolism","Signaling by GPCR","RNA Polymerase II Transcription","Diseases of signal transduction by growth factor re
ceptors and second messengers","Signaling by Receptor Tyrosine Kinases","Adaptive Immune System","Post-translational protein modification","Leishmania infection","Response to elevated platelet cytosol
ic Ca2+","Neurotransmitter receptors and postsynaptic signal transmission","Biosynthesis of specialized proresolving mediators (SPMs)","Branched-chain amino acid catabolism","Nonhomologous End-Joining
 (NHEJ)","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Toll-like Receptor Cascades","Homology Directed Repair","Resolution of Abasic Sites (AP sites)","Diseases of carbohydrate met
abolism","GPCR downstream signalling","GPCR ligand binding","Generic Transcription Pathway","Signaling by FGFR in disease","Signaling by Insulin receptor","Costimulation by the CD28 family","Asparagin
e N-linked glycosylation","Leishmania parasite growth and survival","Platelet degranulation","Activation of NMDA receptors and postsynaptic events","Biosynthesis of DPA-derived SPMs","Toll Like Recept
or 5 (TLR5) Cascade","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Glycogen storage dise
ases","G alpha (i) signalling events","Class A/1 (Rhodopsin-like receptors)","Transcriptional Regulation by TP53","Signaling by FGFR1 in disease","Insulin receptor signalling cascade","CD28 co-stimula
tion","Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide","LLO) and transfer to a nascent protein","Anti-inflammatory response favouring Leishmania parasite infection","Pos
t NMDA receptor activation events","Biosynthesis of DPAn-3 SPMs","MyD88 cascade initiated on plasma membrane","HDR through Homologous Recombination (HRR)","PCNA-Dependent Long Patch Base Excision Repa
ir","Glycogen storage disease type II (GAA)","Amine ligand-binding receptors","Regulation of TP53 Activity","FGFR1 mutant receptor activation","IRS-mediated signalling","CD28 dependent PI3K/Akt signal
ing","Synthesis of substrates in N-glycan biosythesis","ADORA2B mediated anti-inflammatory cytokines production","Activation of AMPK downstream of NMDARs","Biosynthesis of DPAn-3-derived protectins an
d resolvins","MAP kinase activation","Homologous DNA Pairing and Strand Exchange","Dopamine receptors","Regulation of TP53 Expression and Degradation","Signaling by cytosolic FGFR1 fusion mutants","PI
3K Cascade",Adrenoceptors,"Synthesis of GDP-mannose","MAPK targets/ Nuclear events mediated by MAP kinases","Presynaptic phase of homologous DNA pairing and strand exchange","Regulation of TP53 Degrad
ation","ERK/MAPK targets","ERKs are inactivated","Cellular responses to external stimuli","Cell Cycle","Cytokine Signaling in Immune system","Cellular responses to stress","Biological oxidations",Mito
tic,"Signaling by Interleukins","Cellular response to hypoxia","Phase I - Functionalization of compounds","M Phase","Interleukin-1 family signaling","Oxygen-dependent proline hydroxylation of Hypoxia-
inducible Factor Alpha","Biosynthesis of DHA-derived SPMs","Cytochrome P450 - arranged by substrate type","Mitotic Metaphase and Anaphase","Ethanol oxidation","Interleukin-1 signaling","Biosynthesis o
f maresins",Xenobiotics,"Biosynthesis of D-series resolvins","Mitotic Anaphase","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Biosynthesis of maresin-like SPMs","Aromatic amines can be N-hydroxylated 
or N-dealkylated by CYP1A2","Nuclear Envelope (NE) Reassembly","CYP2E1 reactions","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ADRB1,ADRB2,ADRB3}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{AKOS026750017,"l-Isoprenaline hydrochloride","lIsoprenaline hydrochloride",MCULE-1456958404,MCULE1456958404,"(2-(3,4-dihydroxyphenyl)-2-hydroxyethyl)-propan-2-ylazanium;chloride","(2(3,4dihydroxyphen
yl)2hydroxyethyl)propan2ylazanium;chloride","Isoprenaline hydrochloride","ISOPROTERENOL HYDROCHLORIDE",51-30-9,51309,Isuprel,"Isoprenaline HCl",Euspiran,Aerolo,S2566,SAM002554906,1500357,CPD000058267}

> <pdid>
PD009570

> <targets>
{"Adrenergic Receptor"}

> <classes>
{bronchodilator,"Neuronal Signaling"}

> <pubchem_cids>
{57513594,13701,5807}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 18  0  0  0  0            999 V2000
    8.7524   -1.1250    0.0000 Cl  0  0
    5.4979    1.0528    0.0000 C   0  0
    6.2524   -0.2436    0.0000 C   0  0
    5.2526   -1.3618    0.0000 N   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    4.0317    0.7359    0.0000 N   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  3
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16  7  1  0
 16 11  1  0
  5 17  1  0
 17  2  1  0
M  END
> <name>
NIHCC_2014

> <id>
6120

> <plate>
NGP-202-01

> <well>
E11

> <supplier_cmpd_name>
CPD000058292

> <ctcr_id>
5249

> <supplier_cmpd_id>
SAM002554916

> <smiles>
Cl.C1CN=C(Cc2cccc3ccccc23)N1

> <pd_targets>
{LMNA,ADRA1A,MAPK1,HTR7,ADRA2A,NISCH,MAPT,TAAR1,ADRA2B,ADRA2C,CYP2D6,ADRA1B,ADRA1D,TAAR4}

> <pathway_gtopdb>
{"Other nuclear protein","Membrane receptor",Enzyme,"Other cytosolic protein","Family A G protein-coupled receptor",Kinase,"Cytochrome P450","Small molecule receptor (family A GPCR)","Protein Kinase",
"Cytochrome P450 family 2","Monoamine receptor","CMGC protein kinase group","Cytochrome P450 family 2D","Adrenergic receptor","CMGC protein kinase MAPK family","Serotonin receptor","Trace amine recept
or","Cytochrome P450 2D6","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Kinases (EC 2.7.x.x)","Cytochrome P450",Adrenoceptors,"CMGC: Containing CDK",MAPK,GSK3,"CLK families","5-Hydroxytryptamine receptors","Trace amine rec
eptor","CYP2 family: drug metabolising subset","Orphan and other 7TM receptors","Mitogen-activated protein kinases (MAP kinases)","Class A Orphans","ERK subfamily"}

> <pathway_reactome>
{"Cell Cycle","Signal Transduction","Immune System",Disease,"Neuronal System",Metabolism,Mitotic,"Signaling by GPCR","Innate Immune System","Infectious disease","Transmission across Chemical Synapses"
,"Biological oxidations","M Phase","GPCR ligand binding","Toll-like Receptor Cascades","Leishmania infection","Neurotransmitter receptors and postsynaptic signal transmission","Phase I - Functionaliza
tion of compounds","Mitotic Metaphase and Anaphase","Class A/1 (Rhodopsin-like receptors)","Toll Like Receptor 5 (TLR5) Cascade","Leishmania parasite growth and survival","Activation of NMDA receptors
 and postsynaptic events","Cytochrome P450 - arranged by substrate type","Mitotic Anaphase","Amine ligand-binding receptors","MyD88 cascade initiated on plasma membrane","Anti-inflammatory response fa
vouring Leishmania parasite infection","Post NMDA receptor activation events",Xenobiotics,"Nuclear Envelope (NE) Reassembly",Adrenoceptors,"MAP kinase activation","ADORA2B mediated anti-inflammatory c
ytokines production","Activation of AMPK downstream of NMDARs","CYP2E1 reactions","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK tar
gets","ERKs are inactivated"}

> <broad_targets>
{ADRA1A,ADRA2A}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{MCULE-8346078401,MCULE8346078401,"NAPHAZOLINE HYDROCHLORIDE",550-99-2,550992,"NAPHAZOLINE HCL",Albalon,"Albalon Liquifilm",Rhinantin,Rhinoperd,Stricylon,Naphcon,Niazol,Rinofug,Vasocon,Opcon,"Clera hy
drochloride","2-(1-Naphthylmethyl)-2-imidazoline hy","2(1Naphthylmethyl)2imidazoline hy",T0446,S2519,SAM002554916,1500424,Prestw-46,"Naphazoline hydrochloride","Naphazoline HCl",CPD000058292}

> <pdid>
PD009276

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"adrenergic agonist","nasal decongestant","Neuronal Signaling"}

> <pubchem_cids>
{43834266,11079,657295,43834388}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 26  0  0  0  0            999 V2000
    5.1873   -7.5109    0.0000 C   0  0
    5.1894   -6.0109    0.0000 C   0  0
    6.4897   -5.2632    0.0000 C   0  0
    3.8912   -5.2578    0.0000 O   0  0
    3.8933   -3.7570    0.0000 C   0  0
    5.1937   -3.0093    0.0000 O   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2948   -3.7516    0.0000 C   0  0
    1.2973   -2.2519    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -2.6030    2.9977    0.0000 O   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2007    1.4909    0.0000 C   0  0
   -6.4972    0.7364    0.0000 C   0  0
   -6.4920   -0.7636    0.0000 C   0  0
   -7.7884   -1.5181    0.0000 Cl  0  0
   -5.1903   -1.5091    0.0000 C   0  0
   -3.8939   -0.7546    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  7  9  1  0
  7 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 14 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 22 24  1  0
 24 25  2  0
 25 19  1  0
M  END
> <name>
NIHCC_2014

> <id>
6121

> <plate>
NGP-202-01

> <well>
F02

> <supplier_cmpd_name>
CPD000058299

> <ctcr_id>
979

> <supplier_cmpd_id>
SAM002264613

> <smiles>
CC(C)OC(=O)C(C)(C)Oc1ccc(cc1)C(=O)c2ccc(Cl)cc2

> <pd_targets>
{FABP1,LMNA,TSHR,MAPK1,CYP2C9,NFO,KMT2A,MEN1,BLM,CYP3A4,PPARA,PPARG,FTL,CYP2C19,ABCB11,FABP2,TDP1,FFP,MAPT,CHRM1,ATM,PMP22,RORC,HPGD,USP2,NPSR1,CYP1A2,ADRB3,MTOR,HTR2C,SLC6A3,HTR2A,ADORA3,SLC6A2,DRD3,
ACHE,MMP25,NR1I2}

> <pathway_gtopdb>
{"Auxiliary transport protein",Enzyme,"Other nuclear protein","Membrane receptor","Epigenetic regulator","Transcription factor","Unclassified protein",Transporter,"Other cytosolic protein","Fatty acid
 binding protein family",Protease,"Family A G protein-coupled receptor",Kinase,"Cytochrome P450",Hydrolase,Reader,"Nuclear receptor","Primary active transporter",Transferase,"Electrochemical transport
er","Cysteine protease","Peptide receptor (family A GPCR)","Protein Kinase","Cytochrome P450 family 2",Bromodomain,"Cytochrome P450 family 3","Nuclear hormone receptor subfamily 1","ATP-binding casset
te","Small molecule receptor (family A GPCR)","Cytochrome P450 family 1","SLC superfamily of solute carriers","Metallo protease","Cysteine protease CA clan","Glycohormone receptor","CMGC protein kinas
e group","Cytochrome P450 family 2C","Cytochrome P450 family 3A","Nuclear hormone receptor subfamily 1 group C","ABCB subfamily","Monoamine receptor","Atypical protein kinase group","Nuclear hormone r
eceptor subfamily 1 group F","Short peptide receptor (family A GPCR)","Cytochrome P450 family 1A","SLC06 neurotransmitter transporter family","Nucleotide-like receptor (family A GPCR)","Metallo protea
se MAM clan","Nuclear hormone receptor subfamily 1 group I","Cysteine protease C1A family","CMGC protein kinase MAPK family","Cytochrome P450 2C9","Cytochrome P450 3A4","Nuclear hormone receptor subfa
mily 1 group C member 1","Nuclear hormone receptor subfamily 1 group C member 3","Cytochrome P450 2C19","Acetylcholine receptor","Atypical protein kinase PIKK family","Nuclear hormone receptor subfami
ly 1 group F member 3","Cysteine protease C19 family","Neuropeptide receptor","Cytochrome P450 1A1","Adrenergic receptor","Serotonin receptor","Adenosine receptor","Dopamine receptor","Metallo proteas
e M10A subfamily","Nuclear hormone receptor subfamily 1 group I member 2","CMGC protein kinase ERK1","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{"Other protein targets",Receptors,Enzymes,Transporters,"Fatty acid-binding proteins","G protein-coupled receptors","Kinases (EC 2.7.x.x)","Cytochrome P450","Nuclear hormone receptors","ATP-binding ca
ssette transporter family","Eicosanoid turnover","Peptidases and proteinases","SLC superfamily of solute carriers","Acetylcholine turnover","Glycoprotein hormone receptors","CMGC: Containing CDK",MAPK
,GSK3,"CLK families","CYP2 family: drug metabolising subset","CYP3 family","1C. Peroxisome proliferator-activated receptors","ABCB subfamily","Acetylcholine receptors (muscarinic)",Atypical,"1F. Retin
oic acid-related orphans","Prostaglandin synthases","CA: Cysteine (C) Peptidases","Neuropeptide S receptor","CYP1 family",Adrenoceptors,"5-Hydroxytryptamine receptors","SLC6 neurotransmitter transport
er family","Adenosine receptors","Dopamine receptors","MA: Metallo (M) Peptidases","1I. Vitamin D receptor-like receptors","Mitogen-activated protein kinases (MAP kinases)","Phosphatidyl inositol 3' k
inase-related kinases (PIKK) family","C19: Ubiquitin-specific protease","Monoamine transporter subfamily","M10: Matrix metallopeptidase","ERK subfamily","Other PIKK family kinases","FRAP subfamily"}

> <pathway_reactome>
{Metabolism,"Cell Cycle",Disease,"Immune System","DNA Repair","Gene expression (Transcription)","Vesicle-mediated transport","Neuronal System","Signal Transduction","Developmental Biology","Extracellu
lar matrix organization","Metabolism of proteins","Metabolism of lipids",Mitotic,"Infectious disease","Innate Immune System","Biological oxidations","DNA Double-Strand Break Repair","RNA Polymerase II
 Transcription","Membrane Trafficking","Transmission across Chemical Synapses","Signaling by GPCR","Cell Cycle Checkpoints","Nervous system development","Disorders of transmembrane transporters","Degr
adation of the extracellular matrix","Post-translational protein modification","Regulation of lipid metabolism by PPARalpha","M Phase","Leishmania infection","Toll-like Receptor Cascades","Phase I - F
unctionalization of compounds","Homology Directed Repair","Biosynthesis of specialized proresolving mediators (SPMs)","Metabolism of steroids","Generic Transcription Pathway","trans-Golgi Network Vesi
cle Budding","Triglyceride metabolism","Nonhomologous End-Joining (NHEJ)","Neurotransmitter receptors and postsynaptic signal transmission","GPCR ligand binding","G1/S DNA Damage Checkpoints","EGR2 an
d SOX10-mediated initiation of Schwann cell myelination","SLC transporter disorders","Phospholipid metabolism","Activation of Matrix Metalloproteinases",SUMOylation,"PPARA activates gene expression","
Mitotic Metaphase and Anaphase","Leishmania parasite growth and survival","Toll Like Receptor 5 (TLR5) Cascade","Cytochrome P450 - arranged by substrate type","HDR through Homologous Recombination (HR
R) or Single Strand Annealing (SSA)","Biosynthesis of DHA-derived SPMs","Regulation of cholesterol biosynthesis by SREBP (SREBF)","Transcriptional Regulation by MECP2","Golgi Associated Vesicle Biogen
esis","Bile acid and bile salt metabolism","Triglyceride catabolism","Activation of NMDA receptors and postsynaptic events","Class A/1 (Rhodopsin-like receptors)","p53-Dependent G1/S DNA damage checkp
oint","Transcriptional regulation by RUNX3","Transcriptional Regulation by TP53","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Defective SLC6A2 causes orthostatic intolerance (OI)
","Glycerophospholipid biosynthesis","SUMO E3 ligases SUMOylate target proteins","Mitotic Anaphase","Anti-inflammatory response favouring Leishmania parasite infection","MyD88 cascade initiated on pla
sma membrane",Xenobiotics,"HDR through Homologous Recombination (HRR)","Biosynthesis of maresins","Activation of gene expression by SREBF (SREBP)","MECP2 regulates transcription factors","Synthesis of
 bile acids and bile salts","Post NMDA receptor activation events","Amine ligand-binding receptors","p53-Dependent G1 DNA Damage Response","RUNX3 Regulates Immune Response and Cell Migration","Biosynt
hesis of D-series resolvins","Regulation of TP53 Activity","Nucleotide-like (purinergic) receptors","Synthesis of PC","SUMOylation of intracellular receptors","Nuclear Envelope (NE) Reassembly","ADORA
2B mediated anti-inflammatory cytokines production","MAP kinase activation","CYP2E1 reactions","Homologous DNA Pairing and Strand Exchange","Biosynthesis of maresin-like SPMs","Synthesis of bile acids
 and bile salts via 7alpha-hydroxycholesterol","Activation of AMPK downstream of NMDARs","Muscarinic acetylcholine receptors","Stabilization of p53","Regulation of TP53 Expression and Degradation","Ar
omatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Serotonin receptors","Adenosine P1 receptors","Dopamine receptors","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuc
lear events mediated by MAP kinases","Presynaptic phase of homologous DNA pairing and strand exchange","Autodegradation of the E3 ubiquitin ligase COP1","Regulation of TP53 Degradation","ERK/MAPK targ
ets","ERKs are inactivated"}

> <broad_targets>
{MMP25,PPARA}

> <broad_moa>
{"PPAR receptor agonist"}

> <synonyms>
{fenofibrate,49562-28-9,49562289,Procetofen,Lipantil,Tricor,Lipanthyl,Fenobrate,Lipidil,Secalip,Antara,Finofibrate,Lipoclar,Lipofene,Proctofene,Triglide,Fenogal,Lipirex,Sedufen,Elasterin,Fenoglide,Fen
otard,Protolipan,Ankebin,Lipidex,Lipifen,Lipofen,Lip,T1149,SAM002264613,1501010,Prestw-275,Fenofibrate,CPD000058299,FENOFIBRATE}

> <pdid>
PD001506

> <targets>
{}

> <classes>
{antihyperlipidemic}

> <pubchem_cids>
{3339}

$$$$
NIHCC_2014
  SciTegic11012413002D

 34 36  0  0  1  0            999 V2000
   10.2961    2.6232    0.0000 Cl  0  0
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 N   0  0
    3.8976   -0.7553    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    3.8971    3.7500    0.0000 C   0  0
    3.8971    5.2500    0.0000 C   0  0
    5.1961    6.0001    0.0000 C   0  0
    5.1961    7.5001    0.0000 C   0  0
    3.8970    8.2500    0.0000 C   0  0
    2.5980    7.5000    0.0000 C   0  0
    1.2990    8.2500    0.0000 O   0  0
    2.5980    6.0000    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2991    3.7500    0.0000 O   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
   -1.2991    2.2500    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 C   0  0
   -2.5951   -3.0031    0.0000 O   0  0
   -3.8976   -0.7554    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
   -2.5981    1.5000    0.0000 O   0  0
    0.0000    6.0000    0.0000 O   0  0
    6.4974    5.2523    0.0000 N   0  0
    7.7954    6.0042    0.0000 C   0  0
    6.5001    3.7523    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  5  3  1  6
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 16 10  1  0
 16 17  1  0
 17 18  2  3
 18  8  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21  6  1  0
 21 22  1  6
 21 23  1  0
 23 24  2  3
 24 25  1  0
 25 26  2  0
 25 27  1  0
 24 28  1  0
 28  5  1  0
 28 29  2  0
 23 30  1  0
 17 31  1  0
 11 32  1  0
 32 33  1  0
 32 34  1  0
M  END
> <name>
NIHCC_2014

> <id>
6122

> <plate>
NGP-202-01

> <well>
F03

> <supplier_cmpd_name>
CPD001906766

> <ctcr_id>
7003

> <supplier_cmpd_id>
SAM002264621

> <smiles>
Cl.CN(C)[C@H]1C2CC3Cc4c(ccc(O)c4C(=C3C(=O)[C@]2(O)C(=C(C(=O)N)C1=O)O)O)N(C)C

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{Minocin,Minomycin,CHEBI:50697,SCHEMBL11297721,SCHEMBL22117619,"MINOCYCLINE HYDROCHLORIDE",13614-98-7,"Minocycline HCl",Arestin,Solodyn,Periocline,"Minocycline (hydrochloride)",Vectrin,Minomax,UNII-00
20414E5U,"Mynocine hydrochloride",C23H28ClN3O7,0020414E5U,"Minocycline, Hydrochloride",Tri-mino,DSSTox_CID_24545,DSSTox_RID_80306,DSSTox_GSID_44545,Lederderm,Mynocine,Acnez,Ximino,"Minomycin chloride"
,NSC-141993,"EINECS 237-099-7","Minocycline hydrochloride (internal use)",C23H27N3O7.HCl,MFCD00083669,"Minocycline, HCl",NCGC00096006-01,Prestwick_626,"Arestin (TN)","Dynacin (TN)","Minocin (TN)","Sol
odyn (TN)","Minocycline hydrochloride (USP:JAN)",Minocyclinhydrochlorid,"minomycin hydrochloride",SCHEMBL2537,CAS-13614-98-7,MLS002548863,SPECTRUM1500414,"7-Dimethylamino-6-demethyl-6-deoxytetracyclin
e, HCl",FXFM-244,"Minocycline hydrochloride, 97",CHEMBL1200881,CHEMBL4576719,DTXSID8044545,HMS1568P12,Pharmakon1600-01500414,BCP06597,Tox21_111250,Tox21_113183,Tox21_301590,"10118-90-8 (base)",CCG-401
07,NSC757120,s4226,"Minocycline hydrochloride, crystalline",AKOS015951312,"Minocycline hydrochloride (JP17/USP)",Tox21_111250_1,CS-1256,NC00460,NSC-757120,NCGC00178854-03,NCGC00255988-01,AC-22362,AS-7
5306,HY-17412,S051,SMR001906766,M2288,D00850,J10198,W-5076,"Minocycline, Hydrochloride - CAS 13614-98-7",614M987,SR-01000075625,Q-201407,SR-01000075625-1,Q27104777,"Minocycline hydrochloride, Antibiot
ic for Culture Media Use Only","Minocycline hydrochloride, European Pharmacopoeia (EP) Reference Standard",SAM002264621,CPD001906766}

> <pdid>
PD033041

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{54751657,54685925}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 26  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
    0.0000   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -3.8971   -3.7500    0.0000 C   0  0
   -5.1961   -3.0000    0.0000 C   0  0
   -5.1962   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -0.0031    3.0008    0.0000 C   0  0
    1.2946    3.7531    0.0000 O   0  0
   -1.3039    3.7494    0.0000 C   0  0
   -1.3092    5.2494    0.0000 C   0  0
   -2.6108    5.9949    0.0000 C   0  0
   -3.9073    5.2404    0.0000 C   0  0
   -3.9021    3.7404    0.0000 C   0  0
   -2.6005    2.9949    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  2  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15  6  1  0
 15 10  1  0
  4 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 18  1  0
M  END
> <name>
NIHCC_2014

> <id>
6123

> <plate>
NGP-202-01

> <well>
F04

> <supplier_cmpd_name>
CPD000037139

> <ctcr_id>
6337

> <supplier_cmpd_id>
SAM002264632

> <smiles>
O=C1CN(CC2N1CCc3ccccc23)C(=O)C4CCCCC4

> <pd_targets>
{BLM,TP53,ABCB11,LMNA,ALDH1A1,MAPK1,CHRM1,CYP3A4,NPSR1,TSHR,CYP2C19,CYP1A2}

> <pathway_gtopdb>
{Enzyme,"Transcription factor",Transporter,"Other nuclear protein","Membrane receptor","Auxiliary transport protein","Primary active transporter",Oxidoreductase,Kinase,"Family A G protein-coupled rece
ptor","Cytochrome P450","Calcium channel auxiliary subunit beta family","ATP-binding cassette","Protein Kinase","Small molecule receptor (family A GPCR)","Cytochrome P450 family 3","Peptide receptor (
family A GPCR)","ABCB subfamily","CMGC protein kinase group","Monoamine receptor","Cytochrome P450 family 3A","Short peptide receptor (family A GPCR)","CMGC protein kinase MAPK family","Acetylcholine 
receptor","Cytochrome P450 3A4","Neuropeptide receptor","CMGC protein kinase ERK1","Cytochrome P450 family 2","Cytochrome P450 family 1","Glycohormone receptor","Cytochrome P450 family 2C","Cytochrome
 P450 family 1A","Cytochrome P450 2C19","Cytochrome P450 1A1"}

> <pathway_chembl>
{Transporters,Enzymes,Receptors,"ATP-binding cassette transporter family","Kinases (EC 2.7.x.x)","G protein-coupled receptors","Cytochrome P450","ABCB subfamily","CMGC: Containing CDK",MAPK,GSK3,"CLK 
families","Acetylcholine receptors (muscarinic)","CYP3 family","Neuropeptide S receptor","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily","Glycoprotein hormone receptors","CYP2 family
: drug metabolising subset","CYP1 family"}

> <pathway_reactome>
{"DNA Repair","Cell Cycle",Metabolism,"Immune System","Signal Transduction",Disease,"DNA Double-Strand Break Repair","Cell Cycle Checkpoints","Metabolism of lipids",Mitotic,"Biological oxidations","In
nate Immune System","Signaling by GPCR","Infectious disease","Homology Directed Repair","G1/S DNA Damage Checkpoints","Metabolism of steroids","M Phase","Phase I - Functionalization of compounds","Tol
l-like Receptor Cascades","GPCR ligand binding","Biosynthesis of specialized proresolving mediators (SPMs)","Leishmania infection","HDR through Homologous Recombination (HRR) or Single Strand Annealin
g (SSA)","p53-Dependent G1/S DNA damage checkpoint","Bile acid and bile salt metabolism","Mitotic Metaphase and Anaphase","Ethanol oxidation","Toll Like Receptor 5 (TLR5) Cascade","Class A/1 (Rhodopsi
n-like receptors)","Biosynthesis of DHA-derived SPMs","Leishmania parasite growth and survival","HDR through Homologous Recombination (HRR)","p53-Dependent G1 DNA Damage Response","Synthesis of bile a
cids and bile salts","Mitotic Anaphase","MyD88 cascade initiated on plasma membrane","Amine ligand-binding receptors","Biosynthesis of maresins","Anti-inflammatory response favouring Leishmania parasi
te infection","Homologous DNA Pairing and Strand Exchange","Stabilization of p53","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Nuclear Envelope (NE) Reassembly","MAP kinase 
activation","Muscarinic acetylcholine receptors","Biosynthesis of maresin-like SPMs","ADORA2B mediated anti-inflammatory cytokines production","Presynaptic phase of homologous DNA pairing and strand e
xchange","Autodegradation of the E3 ubiquitin ligase COP1","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactiv
ated","Cytochrome P450 - arranged by substrate type",Xenobiotics,"CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2"}

> <broad_targets>
{}

> <broad_moa>
{"anthelmintic agent"}

> <synonyms>
{RESTW26,cid_4891,cid4891,cid-4891,"cid 4891",Lopac0_000909,Lopac0000909,Lopac0-000909,"Lopac0 000909",Oprea1_163497,Oprea1163497,Oprea1-163497,"Oprea1 163497",praziquantel,55268-74-1,55268741,Biltric
ide,Droncit,Pyquiton,Cesol,"Embay 8440",Azinox,MLS000038419,"Praziquantel (Biltricide)",MFCD00058531,SMR000037139,"Cutter Tape Tabs",Praziquantelum,Distocide,Prazinon,DSSTox_CI,DSSToxCI,DSSTox-CI,"DSS
Tox CI",T1435,SAM002264632,1500494,Prestw-260,Praziquantel,CPD000037139,PRAZIQUANTEL}

> <pdid>
PD001793

> <targets>
{}

> <classes>
{anthelmintic}

> <pubchem_cids>
{4891}

$$$$
NIHCC_2014
  SciTegic11012413002D

  9  8  0  0  0  0            999 V2000
    1.3000    2.2500    0.0000 C   0  0
    1.3000    0.7500    0.0000 C   0  0
    0.0011    1.5002    0.0000 C   0  0
    0.0007    0.0004    0.0000 S   0  0
    2.6000    0.0000    0.0000 C   0  0
    2.6000   -1.5000    0.0000 N   0  0
    3.9000    0.7500    0.0000 C   0  0
    3.9000    2.2500    0.0000 O   0  0
    5.1992    0.0004    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  7  9  2  0
M  END
> <name>
NIHCC_2014

> <id>
6124

> <plate>
NGP-202-01

> <well>
F05

> <supplier_cmpd_name>
CPD000059161

> <ctcr_id>
4139

> <supplier_cmpd_id>
SAM002264642

> <smiles>
CC(C)(S)C(N)C(O)=O

> <pd_targets>
{DAPE,ALDH1A1,CYP1A2,FFP,MAPT,ALD}

> <pathway_gtopdb>
{Enzyme,"Other cytosolic protein",Hydrolase,Oxidoreductase,"Cytochrome P450",Transferase,"Cytochrome P450 family 1","Cytochrome P450 family 1A","Cytochrome P450 1A1"}

> <pathway_chembl>
{Enzymes,"Cytochrome P450","CYP1 family"}

> <pathway_reactome>
{Metabolism,"Neuronal System","Biological oxidations","Transmission across Chemical Synapses","Phase I - Functionalization of compounds","Neurotransmitter receptors and postsynaptic signal transmissio
n","Ethanol oxidation","Cytochrome P450 - arranged by substrate type","Activation of NMDA receptors and postsynaptic events",Xenobiotics,"Post NMDA receptor activation events","Aromatic amines can be 
N-hydroxylated or N-dealkylated by CYP1A2","Activation of AMPK downstream of NMDARs"}

> <broad_targets>
{}

> <broad_moa>
{}

> <synonyms>
{DLPenicillamine,52-66-4,52664,"2-Amino-3-mercapto-3-methylbutanoic acid","2Amino3mercapto3methylbutanoic acid","3,3-Dimethyl-DL-cysteine","3,3DimethylDLcysteine",3-Sulfanylvaline,3Sulfanylvaline,DL-b
eta-Mercaptovaline,DLbetaMercaptovaline,beta-Mercaptovaline,betaMercaptovaline,"D,L-Penicillamine","D,LPenicillamine","2-amino-3-methyl-3-sulfanylbutanoic acid","2amino3methyl3sulfanylbutanoic acid",D
L-3-Mercaptovaline,DL3Mercaptovaline,(+-),(+),SAM002264642,1500464,CPD000059161,PENICILLAMINE}

> <pdid>
PD001813

> <targets>
{}

> <classes>
{antirheumatic,"chelating agent (Cu)"}

> <pubchem_cids>
{3799362,4727,4871804,4303221}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 17  0  0  0  0            999 V2000
    6.2990    1.8942    0.0000 H   0  3
    3.7990    1.8942    0.0000 Cl  0  5
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0008    0.0000 C   0  0
    1.2121    3.8625    0.0000 N   0  0
    0.7463    5.2884    0.0000 C   0  0
   -0.7537    5.2860    0.0000 C   0  0
   -1.2149    3.8587    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  3
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10  6  1  0
  5 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 16 17  1  0
 17  3  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6125

> <plate>
NGP-202-01

> <well>
F06

> <supplier_cmpd_name>
CPD000058219

> <ctcr_id>
2105

> <supplier_cmpd_id>
SAM002264650

> <smiles>
[H+].[Cl-].C1CC(C2=NCCN2)c3ccccc3C1

> <pd_targets>
{AMPC,BLM,ADRA2A,ADRA2B,ADRA2C,ADRA1A,ADRA1B,ADRA1D,TAAR1,CYP2D6}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor",Hydrolase,"Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Adrenergic receptor","Trace amine receptor","Cytochrome P450
","Cytochrome P450 family 2","Cytochrome P450 family 2D","Cytochrome P450 2D6"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Trace amine receptor",Adrenoceptors,Enzymes,"Cytochrome P450","CYP2 family: drug metabolising subset"}

> <pathway_reactome>
{"DNA Repair",Disease,"Signal Transduction","DNA Double-Strand Break Repair","Infectious disease","Signaling by GPCR","Homology Directed Repair","Leishmania infection","GPCR ligand binding","HDR throu
gh Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","HDR through Homologous Recombination (HRR)","Anti-
inflammatory response favouring Leishmania parasite infection","Amine ligand-binding receptors","Homologous DNA Pairing and Strand Exchange","ADORA2B mediated anti-inflammatory cytokines production",A
drenoceptors,"Presynaptic phase of homologous DNA pairing and strand exchange",Metabolism,"Biological oxidations","Phase I - Functionalization of compounds","Cytochrome P450 - arranged by substrate ty
pe",Xenobiotics,"CYP2E1 reactions"}

> <broad_targets>
{}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{"Tetrahydrozoline hydrochloride",522-48-5,522485,"Tetrahydrozoline HCl","Tetryzoline hydrochloride",Tyzine,Visine,"Murine Plus",Vasopos,"Tyzanol hydrochloride","Tetrahydrozoline (hydrochloride)",MLS0
00069739,2-(1,2(1,2,3,4-Tetrahydr,4Tetrahydr,T0397,S4043,SAM002264650,1500567,Prestw-698,Tetryzoline,CPD000058219,"TETRAHYDROZOLINE HYDROCHLORIDE"}

> <pdid>
PD009236

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"adrenergic agonist","nasal decongestant","Neuronal Signaling"}

> <pubchem_cids>
{10648,657258,57506628}

$$$$
NIHCC_2014
  SciTegic11012413002D

 10 11  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.4133   -1.7530    0.0000 N   0  0
   -1.8032   -3.1233    0.0000 N   0  0
   -0.3114   -2.9665    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  3
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10  2  1  0
 10  6  2  0
M  END
> <name>
NIHCC_2014

> <id>
6126

> <plate>
NGP-202-01

> <well>
F07

> <supplier_cmpd_name>
CPD000059083

> <ctcr_id>
6943

> <supplier_cmpd_id>
SAM002554884

> <smiles>
O=C1NC=Nc2[nH]ncc12

> <pd_targets>
{XDH,RAB9A,BLM,LMNA,TSHR,STXA}

> <pathway_gtopdb>
{Enzyme,"Other nuclear protein","Membrane receptor",Oxidoreductase,Hydrolase,"Family A G protein-coupled receptor","Peptide receptor (family A GPCR)","Glycohormone receptor"}

> <pathway_chembl>
{Enzymes,Receptors,"1.-.-.- Oxidoreductases","G protein-coupled receptors","Glycoprotein hormone receptors"}

> <pathway_reactome>
{Metabolism,"Signal Transduction","DNA Repair","Cell Cycle",Disease,"Metabolism of nucleotides","Signaling by Rho GTPases","DNA Double-Strand Break Repair",Mitotic,"Infectious disease","Nucleobase cat
abolism","Rho GTPase cycle","Homology Directed Repair","M Phase","Leishmania infection","Purine catabolism","RHOBTB GTPase Cycle","HDR through Homologous Recombination (HRR) or Single Strand Annealing
 (SSA)","Mitotic Metaphase and Anaphase","Leishmania parasite growth and survival","RHOBTB3 ATPase cycle","HDR through Homologous Recombination (HRR)","Mitotic Anaphase","Anti-inflammatory response fa
vouring Leishmania parasite infection","Homologous DNA Pairing and Strand Exchange","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Presynaptic phase of h
omologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{Aloprim,Allopurinol,Prestw-1213,Prestw1213,ALLOPURINOL,CPD000059083,S1630,SAM002554884,1390,1500108,"NSC 1390",Allopurinol}

> <pdid>
PD002486

> <targets>
{Others,OX Receptor,Xanthine Oxidase}

> <classes>
{antihyperuricemia,Xanthine Oxidase Inhibitor,antiurolithic,antigout,GPCR & G Protein,Metabolic Enzyme/Protease}

> <pubchem_cids>
{2094}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 18  0  0  0  0            999 V2000
    2.5983   -3.0004    0.0000 N   0  0
    2.5988   -1.5004    0.0000 S   0  0
    3.8983   -0.7512    0.0000 O   0  0
    3.8975   -2.2510    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 Cl  0  0
   -2.5981    1.5000    0.0000 N   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -1.2991    3.7500    0.0000 N   0  0
    0.0000    3.0000    0.0000 S   0  0
    1.2810    2.2196    0.0000 O   0  0
   -0.0353    4.4996    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 10 11  1  0
  8 12  1  0
 12 13  2  3
 13 14  1  0
 14 15  1  0
 15  7  1  0
 15 16  2  0
 15 17  2  0
M  END
> <name>
NIHCC_2014

> <id>
6127

> <plate>
NGP-202-01

> <well>
F08

> <supplier_cmpd_name>
CPD000058429

> <ctcr_id>
2463

> <supplier_cmpd_id>
SAM002554891

> <smiles>
N[S](=O)(=O)c1cc2c(cc1Cl)N=CN[S]2(=O)=O

> <pd_targets>
{AMPC,CHRM1,NFKB1,TSHR,CA1,CYP3A4,LMNA,NS1,SLC12A3,CA2}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Other cytosolic protein","Other nuclear protein","Unclassified protein",Transporter,Hydrolase,"Family A G protein-coupled receptor",Lyase,"Cytochrome P450","Electrochemica
l transporter","Small molecule receptor (family A GPCR)","Peptide receptor (family A GPCR)","Cytochrome P450 family 3","SLC superfamily of solute carriers","Monoamine receptor","Glycohormone receptor"
,"Cytochrome P450 family 3A","SLC12 family of cation-coupled chloride transporters","Acetylcholine receptor","Cytochrome P450 3A4"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"G protein-coupled receptors","Carbonic anhydrases","Cytochrome P450","SLC superfamily of solute carriers","Acetylcholine receptors (muscarinic)","Glycoprotein hormone 
receptors","CYP3 family","SLC12 family of cation-coupled chloride transporters"}

> <pathway_reactome>
{"Signal Transduction","Immune System",Disease,Metabolism,"Cell Cycle","Transport of small molecules","Signaling by GPCR","Cytokine Signaling in Immune system","Infectious disease","Metabolism of lipi
ds",Mitotic,"Disorders of transmembrane transporters","O2/CO2 exchange in erythrocytes","GPCR ligand binding","Signaling by Interleukins","Leishmania infection","Biosynthesis of specialized proresolvi
ng mediators (SPMs)","M Phase","SLC transporter disorders","Erythrocytes take up carbon dioxide and release oxygen","Class A/1 (Rhodopsin-like receptors)","Interleukin-1 family signaling","Leishmania 
parasite growth and survival","Interleukin-12 family signaling","Biosynthesis of DHA-derived SPMs","Mitotic Metaphase and Anaphase","Defective SLC12A3 causes Gitelman syndrome (GS)","Amine ligand-bind
ing receptors","Interleukin-1 signaling","Anti-inflammatory response favouring Leishmania parasite infection","Interleukin-12 signaling","Biosynthesis of maresins","Mitotic Anaphase","Muscarinic acety
lcholine receptors","MAP3K8 (TPL2)-dependent MAPK1/3 activation","ADORA2B mediated anti-inflammatory cytokines production","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimu
lation","Biosynthesis of maresin-like SPMs","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{CA1,CA2,CA4,SLC12A3}

> <broad_moa>
{diuretic}

> <synonyms>
{chlorothiazide,58-94-6,58946,"58 94 6",Diuril,Chlorothiazid,Chlorthiazide,Chlotride,Thiazide,Chlortiazid,Chlorosal,Chlorurit,Saluretil,Warduzide,Alurene,Clotride,Diuresal,Diurilix,Diurite,Diutrid,Sal
isan,Salunil,Saluric,Yadalan,Flumen,Minzi,SAM002554891,1500180,Prestw-251,CPD000058429,CHLOROTHIAZIDE,Chlorothiazide}

> <pdid>
PD002427

> <targets>
{Others}

> <classes>
{antihypertensive,diuretic,Others}

> <pubchem_cids>
{2720}

$$$$
NIHCC_2014
  SciTegic11012413002D

 11 11  0  0  0  0            999 V2000
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
   -0.0031    3.0008    0.0000 C   0  0
    1.2946    3.7531    0.0000 N   0  0
   -1.3032    3.7490    0.0000 S   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  5  9  1  0
  9 10  1  0
  9 11  2  0
M  END
> <name>
NIHCC_2014

> <id>
6128

> <plate>
NGP-202-01

> <well>
F09

> <supplier_cmpd_name>
CPD001370750

> <ctcr_id>
4730

> <supplier_cmpd_id>
SAM002554899

> <smiles>
CCc1cc(ccn1)C(N)=S

> <pd_targets>
{POLB,CYP1A2,INHA,KATG}

> <pathway_gtopdb>
{Enzyme,"Cytochrome P450",Oxidoreductase,"Cytochrome P450 family 1","Cytochrome P450 family 1A","Cytochrome P450 1A1"}

> <pathway_chembl>
{Enzymes,"Cytochrome P450","CYP1 family"}

> <pathway_reactome>
{"DNA Repair",Metabolism,Disease,"Base Excision Repair","Biological oxidations","Infectious disease","Resolution of Abasic Sites (AP sites)","Phase I - Functionalization of compounds","Infection with 
Mycobacterium tuberculosis","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Cytochrome P450 - arranged by substrate type","Latent infection - Other responses of Mtb to 
phagocytosis","PCNA-Dependent Long Patch Base Excision Repair",Xenobiotics,"Tolerance of reactive oxygen produced by macrophages","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2"}

> <broad_targets>
{}

> <broad_moa>
{"mycolic synthesis inhibitor"}

> <synonyms>
{536-33-4,536334,2-ethylpyridine-4-carbothioamide,2ethylpyridine4carbothioamide,Ethioniamide,Ethyonomide,Amidazine,Ethinamide,Etionamid,Etioniamid,Thioamide,Trecator,Ethylisothiamide,2-Ethylthioisonic
otinamide,2Ethylthioisonicotinamide,Trecator-SC,TrecatorSC,"4-Pyridinecarbothioamide, 2-ethyl-","4Pyridinecarbothioamide, 2ethyl",Amidazin,T1165,SAM002554899,1500292,Prestw-526,CPD001370750,ETHIONAMID
E,Ethionamide}

> <pdid>
PD002335

> <targets>
{Antibiotic,Bacterial}

> <classes>
{tuberculostatic,antibacterial,Anti-infection}

> <pubchem_cids>
{2761171}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 18  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 Cl  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3039   -3.7494    0.0000 C   0  0
   -2.6004   -2.9949    0.0000 C   0  0
   -3.9021   -3.7405    0.0000 C   0  0
   -3.9072   -5.2404    0.0000 C   0  0
   -5.2088   -5.9860    0.0000 Cl  0  0
   -2.6108   -5.9949    0.0000 C   0  0
   -1.3092   -5.2494    0.0000 C   0  0
   -0.0127   -6.0039    0.0000 Cl  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  7  8  2  0
  8  2  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 16 10  1  0
 16 17  1  0
M  END
> <name>
NIHCC_2014

> <id>
6129

> <plate>
NGP-202-01

> <well>
F10

> <supplier_cmpd_name>
CPD000471847

> <ctcr_id>
2380

> <supplier_cmpd_id>
SAM002554907

> <smiles>
Oc1cc(Cl)ccc1Oc2ccc(Cl)cc2Cl

> <pd_targets>
{ENR,HPGD,FABI,TTR,INHA,LMNA,MAPT,HSP90AA1,CBR1,FTL,HSPA5,NR1I3}

> <pathway_gtopdb>
{Enzyme,"Secreted protein","Other nuclear protein","Other cytosolic protein","Unclassified protein","Transcription factor",Oxidoreductase,"Nuclear receptor","Nuclear hormone receptor subfamily 1","Nuc
lear hormone receptor subfamily 1 group I","Nuclear hormone receptor subfamily 1 group I member 3"}

> <pathway_chembl>
{Enzymes,"Other protein targets",Receptors,"Eicosanoid turnover",Transthyretin,"Heat shock proteins","Nuclear hormone receptors","Prostaglandin synthases","1I. Vitamin D receptor-like receptors"}

> <pathway_reactome>
{Metabolism,"Signal Transduction","Cell Cycle","Neuronal System","Vesicle-mediated transport","Cellular responses to external stimuli","Gene expression (Transcription)","Metabolism of lipids","Signali
ng by GPCR",Mitotic,"Transmission across Chemical Synapses","Membrane Trafficking","Cellular responses to stress","RNA Polymerase II Transcription","Biosynthesis of specialized proresolving mediators 
(SPMs)","GPCR downstream signalling","M Phase","Neurotransmitter receptors and postsynaptic signal transmission","Mitotic G2-G2/M phases","Fatty acid metabolism","trans-Golgi Network Vesicle Budding",
"Cellular response to heat stress","Generic Transcription Pathway","Biosynthesis of DHA-derived SPMs","G alpha (i) signalling events","Mitotic Metaphase and Anaphase","Activation of NMDA receptors and
 postsynaptic events","G2/M Transition","Arachidonic acid metabolism","Golgi Associated Vesicle Biogenesis","Regulation of HSF1-mediated heat shock response","Nuclear Receptor transcription pathway","
Biosynthesis of D-series resolvins","Visual phototransduction","Mitotic Anaphase","Post NMDA receptor activation events","Centrosome maturation","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)
","The canonical retinoid cycle in rods (twilight vision)","Nuclear Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs","Loss of proteins required for interphase microtubule organizati
on from the centrosome","Initiation of Nuclear Envelope (NE) Reformation","Loss of Nlp from mitotic centrosomes"}

> <broad_targets>
{DNMT1}

> <broad_moa>
{"antibacterial agent"}

> <synonyms>
{triclosan,3380-34-5,3380345,"5-CHLORO-2-(2,4-DICHLOROPHENOXY)PHENOL","5CHLORO2(2,4DICHLOROPHENOXY)PHENOL","2,4,4'-Trichloro-2'-hydroxydiphenyl ether","2,4,4'Trichloro2'hydroxydiphenyl ether",Irgasan,
Cloxifenolum,Triclosanum,"Irgasan DP300","Phenol, 5-chloro-2-(2,4-dichlorophenoxy)-","Phenol, 5chloro2(2,4dichlorophenoxy)","CH 3565",5-Chloro-2-(2,5Chloro2(2,4-dichloro-phenoxy),4dichlorophenoxy),T13
14,SAM002554907,1505465,Prestw-1479,Triclosan,CPD000471847,TRICLOSAN}

> <pdid>
PD000390

> <targets>
{Antibiotic,Autophagy,Bacterial,Fungal}

> <classes>
{antiinfective,Anti-infection,Autophagy}

> <pubchem_cids>
{5564}

$$$$
NIHCC_2014
  SciTegic11012413002D

  9  9  0  0  0  0            999 V2000
    3.8976   -0.7553    0.0000 O   0  0
    2.5973   -1.5031    0.0000 C   0  0
    2.5951   -3.0031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
M  END
> <name>
NIHCC_2014

> <id>
6130

> <plate>
NGP-202-01

> <well>
F11

> <supplier_cmpd_name>
CPD000059024

> <ctcr_id>
3573

> <supplier_cmpd_id>
SAM002554917

> <smiles>
OC(=O)c1cccnc1

> <pd_targets>
{HCAR2,ALDH1A1,GAA,APP,HCAR3,HCAR1,QPRT,NNMT}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Family A G protein-coupled receptor",Oxidoreductase,Hydrolase,Transferase,"Small molecule receptor (family A GPCR)","Carboxylic acid receptor","Hydroxycarboxylic acid rece
ptor"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","3.2.1.- Glycosidases","Hydroxycarboxylic acid receptors"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,Disease,"Immune System","Signaling by GPCR","Biological oxidations","Diseases of metabolism","Innate Immune System","Metabolism of vitamins and cofactors","GPCR ligan
d binding","Phase I - Functionalization of compounds","Diseases of carbohydrate metabolism","Toll-like Receptor Cascades","Metabolism of water-soluble vitamins and cofactors","Class A/1 (Rhodopsin-lik
e receptors)","Ethanol oxidation","Glycogen storage diseases","Toll Like Receptor 5 (TLR5) Cascade","Nicotinate metabolism","Hydroxycarboxylic acid-binding receptors","Glycogen storage disease type II
 (GAA)","MyD88 cascade initiated on plasma membrane","Nicotinamide salvaging","TAK1 activates NFkB by phosphorylation and activation of IKKs complex"}

> <broad_targets>
{DGAT2,HCAR1,HCAR2,HCAR3,NNMT,QPRT}

> <broad_moa>
{"NAD precursor","vitamin B"}

> <synonyms>
{"nicotinic acid",niacin,59-67-6,59676,"Pyridine-3-carboxylic acid","Pyridine3carboxylic acid","3-pyridinecarboxylic acid","3pyridinecarboxylic acid",3-Carboxypyridine,3Carboxypyridine,wampocap,Niaspa
n,Apelagrin,Pellagrin,Akotin,Daskil,Efacin,Pelonin,"Acidum nicotinicum",Linic,nicamin,nicobid,nicoca,T0879,SAM002554917,1500430,Prestw-881,"Nicotinic acid",CPD000059024,NIACIN,Niacin}

> <pdid>
PD001840

> <targets>
{}

> <classes>
{"vitamin (enzyme cofactor)",antihyperlipidemic}

> <pubchem_cids>
{117629482,938}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 22  0  0  0  0            999 V2000
    2.5983   -3.0004    0.0000 N   0  0
    2.5988   -1.5004    0.0000 S   0  0
    3.8983   -0.7512    0.0000 O   0  0
    3.8975   -2.2510    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0031    3.0008    0.0000 C   0  0
   -1.2947    3.7531    0.0000 O   0  0
    1.3032    3.7490    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 N   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.5517    0.8722    0.0000 O   0  0
   -7.5554    1.9869    0.0000 C   0  0
   -6.8054    3.2859    0.0000 C   0  0
   -5.3382    2.9741    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 Cl  0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  2  0
  7 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 14  2  0
 11 19  1  0
 19 20  2  0
 20  5  1  0
 20 21  1  0
M  END
> <name>
NIHCC_2014

> <id>
6131

> <plate>
NGP-202-01

> <well>
G02

> <supplier_cmpd_name>
CPD000058202

> <ctcr_id>
3070

> <supplier_cmpd_id>
SAM002264614

> <smiles>
N[S](=O)(=O)c1cc(C(O)=O)c(NCc2occc2)cc1Cl

> <pd_targets>
{CA5B,CA13,ALDH1A1,CISD1,GPR35,CA5A,CA4,CA1,CA2,CA9,CA14,CA12,CA7,ACPS,CA6,SLC12A1,SLC12A2,HSD11B1,SLC10A1,SLCO2A1,SLC22A6}

> <pathway_gtopdb>
{Enzyme,"Unclassified protein","Membrane receptor",Transporter,Lyase,Oxidoreductase,"Family A G protein-coupled receptor",Transferase,"Electrochemical transporter","Small molecule receptor (family A G
PCR)","SLC superfamily of solute carriers","Carboxylic acid receptor","SLC12 family of cation-coupled chloride transporters","SLC10 family of sodium-bile acid co-transporters","SLC21/SLCO family of or
ganic anion transporting polypeptides","SLC22 family of organic cation and anion transporters","Kynurenic acid receptor"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Carbonic anhydrases","G protein-coupled receptors","SLC superfamily of solute carriers","1.-.-.- Oxidoreductases","Orphan and other 7TM receptors","SLC12 family of cat
ion-coupled chloride transporters","SLC10 family of sodium-bile acid co-transporters","SLCO family of organic anion transporting polypeptides","SLC22 family of organic cation and anion transporters","
Class A Orphans","Organic anion transporters (OATs)"}

> <pathway_reactome>
{Metabolism,"Signal Transduction","Transport of small molecules","Immune System","Cellular responses to external stimuli",Disease,"Reversible hydration of carbon dioxide","Biological oxidations","Sign
aling by GPCR","O2/CO2 exchange in erythrocytes","Cytokine Signaling in Immune system","Cellular responses to stress","Disorders of transmembrane transporters","SLC-mediated transmembrane transport","
Metabolism of lipids","Phase I - Functionalization of compounds","GPCR ligand binding","Erythrocytes take up carbon dioxide and release oxygen","Signaling by Interleukins","Cellular response to hypoxi
a","SLC transporter disorders","Transport of inorganic cations/anions and amino acids/oligopeptides","Metabolism of steroids","Transport of bile salts and organic acids","metal ions and amine compound
s","Ethanol oxidation","Class A/1 (Rhodopsin-like receptors)","Interleukin-12 family signaling","Regulation of gene expression by Hypoxia-inducible Factor","Defective SLC12A1 causes Bartter syndrome 1
 (BS1)","Cation-coupled Chloride cotransporters","Metabolism of steroid hormones","Bile acid and bile salt metabolism","Defective SLCO2A1 causes primary","autosomal recessive hypertrophic osteoarthrop
athy 2 (PHOAR2)","Organic cation/anion/zwitterion transport","Interleukin-12 signaling","Glucocorticoid biosynthesis","Recycling of bile acids and salts","Organic anion transport","Gene and protein ex
pression by JAK-STAT signaling after Interleukin-12 stimulation"}

> <broad_targets>
{CA2,GPR35,SLC12A1,SLC12A2}

> <broad_moa>
{diuretic}

> <synonyms>
{furosemide,54-31-9,54319,Frusemide,Lasix,Furosemid,Furanthril,Errolon,Fusid,Aisemide,Beronald,Desdemin,Frusemin,Fuluvamide,Furanthryl,Furantril,Fursemide,Lowpstron,Macasirool,Prefemin,Rosemide,Trofur
it,Fulsix,Furesis,Katlex,Lasilix,Radonna,Seguril,T0837,SAM002264614,1500310,Prestw-341,Furosemide,CPD000058202,FUROSEMIDE}

> <pdid>
PD002324

> <targets>
{}

> <classes>
{antihypertensive,diuretic}

> <pubchem_cids>
{3440,118985385}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 30  0  0  0  0            999 V2000
    1.3000    2.2500    0.0000 O   0  0
    1.3000    0.7500    0.0000 N   0  3
    0.0007    0.0004    0.0000 O   0  5
    2.5993    0.0004    0.0000 O   0  0
   16.7911   -3.5262    0.0000 Cl  0  0
   15.4921   -2.7762    0.0000 C   0  0
   15.4921   -1.2762    0.0000 C   0  0
   14.1930   -0.5262    0.0000 C   0  0
   12.8940   -1.2762    0.0000 C   0  0
   11.5958   -0.5232    0.0000 C   0  0
   11.5979    0.9777    0.0000 O   0  0
   10.2997    1.7308    0.0000 C   0  0
   10.3018    3.2316    0.0000 C   0  0
    9.0036    3.9847    0.0000 N   0  0
    8.8657    5.4655    0.0000 C   0  0
    7.3985    5.7774    0.0000 C   0  0
    6.6485    4.4783    0.0000 N   0  0
    7.6522    3.3636    0.0000 C   0  0
    8.9987    0.9826    0.0000 C   0  0
    8.9980   -0.5174    0.0000 C   0  0
    7.6987   -1.2669    0.0000 C   0  0
    6.3999   -0.5164    0.0000 C   0  0
    5.1006   -1.2660    0.0000 Cl  0  0
    6.4005    0.9836    0.0000 C   0  0
    7.6998    1.7331    0.0000 C   0  0
    7.7002    2.7331    0.0000 Cl  0  0
   12.8940   -2.7762    0.0000 C   0  0
   11.5950   -3.5262    0.0000 Cl  0  0
   14.1930   -3.5262    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 14  1  0
 12 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 22 24  1  0
 24 25  2  0
 25 19  1  0
 25 26  1  0
  9 27  1  0
 27 28  1  0
 27 29  2  0
 29  6  1  0
M  CHG  2   2   1   3  -1
M  END
> <name>
NIHCC_2014

> <id>
6132

> <plate>
NGP-202-01

> <well>
G03

> <supplier_cmpd_name>
CPD000058733

> <ctcr_id>
6047

> <supplier_cmpd_id>
SAM002264623

> <smiles>
O[N+]([O-])=O.Clc1ccc(COC(Cn2ccnc2)c3ccc(Cl)cc3Cl)c(Cl)c1

> <pd_targets>
{MDH1,HIF1A,RECA,RECQL,CYP19A1,MAPT,CYP3A4,CYP2D6,CNR1,HTR1B,CYP51,PGR,CYP2J2,IDO1,ABCB1,AMPC,CYP1A2,AR,BCHE,CYP17A1,CYP2C19,CYP2C9,RORC,CYP121,HPL,ACHE,CYP8B1,LMNA,DNAB,KMT2A,MEN1,MAPK1,FFP,NPSR1,HTT
,USP2,TP53,GAA,GRM6,PTGS2,ABCB1B,ADORA1,ADORA3,ADRA2B,AGTR2,DRD2,MC3R,MC5R,OPRK1,FYN,SLC6A4,ABCB1A,CYP51A1,ADRA1D,DRD4,SLC6A3,CHRM1,HTR2A,ORAI1,CHRM4,HTR2B,ADRA2A,ADRB1,HRH2,CHRM2,CHRM3,OPRD1,EGFR,HTR
1A,HTR6,TBXAS1,IDO2,SLC6A2,MC4R,TACR2,ADRB3,OPRM1,DRD3,TACR1,CACNA1C,ADORA2A,ERBB2,HTR2C,TRPM2,TRPV5,ERG11,NOS3,NOS2,NR1I2,KCNMA1,KCNMB1,KCNMB2,KCNMB3,KCNMB4,KCNN1,KCNN2,KCNN3,KCNN4,KCNA1,KCNA10,KCNA2
,KCNA3,KCNA4,KCNA5,KCNA6,KCNAB1,KCNAB2,KCNB1,KCNB2,KCNC1,KCNC2,KCNC3,KCNC4,KCND1,KCND2,KCND3,KCNE1,KCNE2,KCNE3,KCNE4,KCNE5,KCNF1,KCNG1,KCNG2,KCNG3,KCNG4,KCNH1,KCNH2,KCNH3,KCNH4,KCNH5,KCNH6,KCNH7,KCNH8
,KCNQ1,KCNQ2,KCNQ3,KCNQ4,KCNQ5,KCNS1,KCNS3,KCNV1,KCNV2,KCNJ12,KCNJ14,KCNJ2,KCNJ4,CACNA1D,CACNA1F,CACNA1S,CACNB1,CACNB2,CACNB3,CACNB4}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Other cytosolic protein","Membrane receptor",Transporter,"Unclassified protein","Other nuclear protein","Epigenetic regulator","Ion channel",Oxidoreductase,"Cytochrome 
P450","Family A G protein-coupled receptor","Nuclear receptor","Primary active transporter",Hydrolase,Reader,Kinase,Transferase,Protease,"Family C G protein-coupled receptor","Electrochemical transpor
ter","Other ion channel","Voltage-gated ion channel","Cytochrome P450 family 19","Cytochrome P450 family 3","Cytochrome P450 family 2","Small molecule receptor (family A GPCR)","Cytochrome P450 family
 51","Nuclear hormone receptor subfamily 3","ATP-binding cassette","Cytochrome P450 family 1","Cytochrome P450 family 17","Nuclear hormone receptor subfamily 1",Bromodomain,"Protein Kinase","Peptide r
eceptor (family A GPCR)","Cysteine protease","Small molecule receptor (family C GPCR)","SLC superfamily of solute carriers","Miscellaneous ion channel","Cytochrome P450 family 5","Voltage-gated calciu
m channel","Transient receptor potential channel","Cytochrome P450 family 19A","Cytochrome P450 family 3A","Cytochrome P450 family 2D","Lipid-like ligand receptor (family A GPCR)","Monoamine receptor"
,"Cytochrome P450 family 51A","Nuclear hormone receptor subfamily 3 group C","ABCB subfamily","Cytochrome P450 family 1A","Cytochrome P450 family 17A","Cytochrome P450 family 2C","Nuclear hormone rece
ptor subfamily 1 group F","CMGC protein kinase group","Short peptide receptor (family A GPCR)","Cysteine protease CA clan","Neurotransmitter receptor (family C GPCR)","Nucleotide-like receptor (family
 A GPCR)","TK protein kinase group","SLC06 neurotransmitter transporter family","Ca2+ release-activated Ca2+ channel family","Cytochrome P450 family 5A","Nuclear hormone receptor subfamily 1 group I",
"Cytochrome P450 19A1","Cytochrome P450 3A4","Cytochrome P450 2D6","Cannabinoid receptor","Serotonin receptor","Cytochrome P450 51A1","Nuclear hormone receptor subfamily 3 group C member 3","Cytochrom
e P450 1A1","Nuclear hormone receptor subfamily 3 group C member 4","Cytochrome P450 17A1","Cytochrome P450 2C19","Cytochrome P450 2C9","Nuclear hormone receptor subfamily 1 group F member 3","CMGC pr
otein kinase MAPK family","Neuropeptide receptor","Cysteine protease C19 family","Metabotropic glutamate receptor","Adenosine receptor","Adrenergic receptor","Angiotensin receptor","Dopamine receptor"
,"Melanocortin receptor","Opioid receptor","Tyrosine protein kinase Src family","Acetylcholine receptor","Histamine receptor","Tyrosine protein kinase EGFR family","Cytochrome P450 5A1","Neurokinin re
ceptor","Nuclear hormone receptor subfamily 1 group I member 2","CMGC protein kinase ERK1","Tyrosine protein kinase SrcA"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Ion channels","Cytochrome P450","G protein-coupled receptors","1.13.11.- Dioxygenases","ATP-binding cassette transporter family","Nuclear hormone receptors","Acetylcho
line turnover","Kinases (EC 2.7.x.x)","Peptidases and proteinases","3.2.1.- Glycosidases","Eicosanoid turnover","Catalytic receptors","SLC superfamily of solute carriers","Other ion channels","Voltage
-gated ion channels","L-Arginine turnover",CYP11,CYP17,CYP19,"CYP20 and CYP21 families","CYP3 family","CYP2 family: drug metabolising subset","Cannabinoid receptors","5-Hydroxytryptamine receptors","A
BCB subfamily","CYP1 family","Steroid hormone receptors","1F. Retinoic acid-related orphans",CYP5,"CYP7 and CYP8 families","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Neuropeptide S receptor","CA
: Cysteine (C) Peptidases","Metabotropic glutamate receptors",Cyclooxygenase,"Adenosine receptors",Adrenoceptors,"Angiotensin receptors","Dopamine receptors","Melanocortin receptors","Opioid receptors
","Receptor kinases","SLC6 neurotransmitter transporter family",CYP39,"CYP46 and CYP51 families","Acetylcholine receptors (muscarinic)","Store-operated ion channels","Histamine receptors","Tachykinin 
receptors","Voltage-gated calcium channels","Transient Receptor Potential channels","Nitric oxide synthases","1I. Vitamin D receptor-like receptors","3C. 3-Ketosteroid receptors","Mitogen-activated pr
otein kinases (MAP kinases)","C19: Ubiquitin-specific protease","TK: Tyrosine kinase","Monoamine transporter subfamily","Orai channels","ERK subfamily","Non-receptor tyrosine kinases (nRTKs)","Recepto
r tyrosine kinases (RTKs)","Src family","Type I RTKs: ErbB (epidermal growth factor) receptor family"}

> <pathway_reactome>
{Metabolism,"Cellular responses to external stimuli","Neuronal System","Signal Transduction","Gene expression (Transcription)","Cell Cycle","Immune System",Disease,Hemostasis,"Developmental Biology","
Transport of small molecules","Metabolism of proteins","Metabolism of carbohydrates","Cellular responses to stress","Biological oxidations","Transmission across Chemical Synapses","Metabolism of lipid
s","Signaling by GPCR","Metabolism of amino acids and derivatives","Abacavir transport and metabolism","RNA Polymerase II Transcription",Mitotic,"Innate Immune System","Infectious disease","Cell Cycle
 Checkpoints","Diseases of metabolism","Disorders of transmembrane transporters","Platelet homeostasis","Nervous system development","Ion channel transport","Signaling by Receptor Tyrosine Kinases","P
ost-translational protein modification","Glucose metabolism","Cellular response to hypoxia","Phase I - Functionalization of compounds","Neurotransmitter receptors and postsynaptic signal transmission"
,"Biosynthesis of specialized proresolving mediators (SPMs)","GPCR downstream signalling","GPCR ligand binding","Tryptophan catabolism","Abacavir transmembrane transport","Generic Transcription Pathwa
y","Phospholipid metabolism","Metabolism of steroids","M Phase","Toll-like Receptor Cascades","Leishmania infection","G1/S DNA Damage Checkpoints","Diseases of carbohydrate metabolism","HIV Infection"
,"Neurotransmitter clearance","SLC transporter disorders","Platelet calcium homeostasis","Axon guidance","Stimuli-sensing channels","Signaling by VEGF","Infection with Mycobacterium tuberculosis",SUMO
ylation,Gluconeogenesis,"Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Cytochrome P450 - arranged by substrate type","Activation of NMDA receptors and postsynaptic events"
,"Biosynthesis of DHA-derived SPMs","G alpha (i) signalling events","Class A/1 (Rhodopsin-like receptors)","Transcriptional regulation by RUNX2","Glycerophospholipid biosynthesis","Metabolism of stero
id hormones","Transcriptional regulation by RUNX3","Mitotic Metaphase and Anaphase","Toll Like Receptor 5 (TLR5) Cascade","Leishmania parasite growth and survival","Transcriptional Regulation by MECP2
","Transcriptional Regulation by TP53","p53-Dependent G1/S DNA damage checkpoint","Glycogen storage diseases","Biosynthesis of DPA-derived SPMs","Host Interactions of HIV factors","Serotonin clearance
 from the synaptic cleft","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Elevation of cytosolic Ca2+ levels","G alpha (q) signalling events","Defective SLC6A2 causes orthostatic in
tolerance (OI)","NCAM signaling for neurite out-growth","Semaphorin interactions","TRP channels","VEGFA-VEGFR2 Pathway","Response of Mtb to phagocytosis","SUMO E3 ligases SUMOylate target proteins","E
ndogenous sterols","Post NMDA receptor activation events","Biosynthesis of maresins",Xenobiotics,"Amine ligand-binding receptors","Fatty acids","RUNX2 regulates bone development","Synthesis of PC","An
drogen biosynthesis","RUNX3 Regulates Immune Response and Cell Migration","Mitotic Anaphase","MyD88 cascade initiated on plasma membrane","Anti-inflammatory response favouring Leishmania parasite infe
ction","Regulation of MECP2 expression and activity","Regulation of TP53 Activity","p53-Dependent G1 DNA Damage Response","Glycogen storage disease type II (GAA)","Biosynthesis of DPAn-3 SPMs","Nucleo
tide-like (purinergic) receptors","Peptide ligand-binding receptors","MECP2 regulates neuronal receptors and channels","The role of Nef in HIV-1 replication and disease pathogenesis","Gastrin-CREB sig
nalling pathway via PKC and MAPK",Eicosanoids,"Opioid Signalling","NCAM1 interactions","Sema4D in semaphorin signaling","VEGFR2 mediated vascular permeability","Suppression of phagosomal maturation","
SUMOylation of intracellular receptors","Activation of AMPK downstream of NMDARs","Biosynthesis of maresin-like SPMs","CYP2E1 reactions","Serotonin receptors","Aromatic amines can be N-hydroxylated or
 N-dealkylated by CYP1A2","RUNX2 regulates osteoblast differentiation","Sterols are 12-hydroxylated by CYP8B1","Nuclear Envelope (NE) Reassembly","MAP kinase activation","ADORA2B mediated anti-inflamm
atory cytokines production","Regulation of TP53 Expression and Degradation","Stabilization of p53","Adenosine P1 receptors",Adrenoceptors,"Dopamine receptors","Nef and signal transduction","Muscarinic
 acetylcholine receptors","EGFR Transactivation by Gastrin","Tachykinin receptors bind tachykinins","G-protein activation","Sema4D induced cell migration and growth-cone collapse","Inhibition of nitri
c oxide production","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","Regulation of TP53 Degradation","Autodegradation of the E3 ubiquitin ligas
e COP1","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{TRPM2,TRPV5}

> <broad_moa>
{"bacterial cell wall synthesis inhibitor"}

> <synonyms>
{"Miconazole nitrate",22832-87-7,22832877,Andergin,Albistat,Aflorix,Conofite,Florid,Micatin,Gyno-Monistat,GynoMonistat,Epi-Monistat,EpiMonistat,Gyno-Daktar,GynoDaktar,"Miconazole (nitrate)",Brentan,Da
ktarin,Vusion,"Miconazole 7","Monistat 3","Monistat 5","Monistat 7","(+/-)-Miconazole ni","(+/)Miconazole ni",T0344L,SAM002264623,1500413,CPD000058733,"MICONAZOLE NITRATE"}

> <pdid>
PD009802

> <targets>
{Antibiotic,Bacterial,Fungal}

> <classes>
{antifungal (topical),Anti-infection}

> <pubchem_cids>
{68553}

$$$$
NIHCC_2014
  SciTegic11012413002D

 12 12  0  0  0  0            999 V2000
    2.5909   -6.0056    0.0000 O   0  0
    3.8912   -5.2578    0.0000 C   0  0
    5.1887   -6.0105    0.0000 O   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
M  END
> <name>
NIHCC_2014

> <id>
6133

> <plate>
NGP-202-01

> <well>
G04

> <supplier_cmpd_name>
CPD000059104

> <ctcr_id>
4891

> <supplier_cmpd_id>
SAM002264634

> <smiles>
OC(=O)CCCc1ccccc1

> <pd_targets>
{HDAC1,MAPK1,HDAC2,HDAC8,HDAC10,HDAC11,HDAC3,HDAC4,HDAC5,HDAC6,HDAC7,HDAC9}

> <pathway_gtopdb>
{"Epigenetic regulator",Enzyme,Eraser,Kinase,"Histone deacetylase","Protein Kinase","HDAC class I","CMGC protein kinase group","CMGC protein kinase MAPK family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,"Chromatin modifying enzymes","Kinases (EC 2.7.x.x)","3.5.1.- Histone deacetylases (HDACs)","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Mitogen-activated protein kinases (MAP kinases)","
ERK subfamily"}

> <pathway_reactome>
{Disease,"Immune System","Gene expression (Transcription)","Cell Cycle","Disorders of Developmental Biology","Innate Immune System","RNA Polymerase II Transcription",Mitotic,"Disorders of Nervous Syst
em Development","Toll-like Receptor Cascades","Generic Transcription Pathway","M Phase","Pervasive developmental disorders","Toll Like Receptor 5 (TLR5) Cascade","Transcriptional Regulation by TP53","
Mitotic Metaphase and Anaphase","Loss of function of MECP2 in Rett syndrome","MyD88 cascade initiated on plasma membrane","Regulation of TP53 Activity","Mitotic Anaphase","Loss of MECP2 binding abilit
y to 5mC-DNA","MAP kinase activation","Regulation of TP53 Activity through Acetylation","Separation of Sister Chromatids","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERK
s are inactivated"}

> <broad_targets>
{HDAC1}

> <broad_moa>
{"HDAC inhibitor"}

> <synonyms>
{"4PHENYLBUTYRIC ACID","4-Phenylbutanoic acid","4Phenylbutanoic acid",1821-12-1,1821121,"Benzenebutanoic acid","Benzenebutyric acid",Phenylbutyrate,"Phenylbutyric acid","gamma-Phenylbutyric acid","gam
maPhenylbutyric acid","omega-Phenylbutanoic acid","omegaPhenylbutanoic acid","Butyric acid, 4-phenyl-","Butyric acid, 4phenyl","4-PHENYL-BUTANOIC ACID","4PHENYLBUTANOIC ACID",SAM002264634,306001,CPD00
0059104,"PHENYLBUTYRIC ACID"}

> <pdid>
PD001992

> <targets>
{}

> <classes>
{"antihyperammonemic (Na salt)",antiinflammatory}

> <pubchem_cids>
{4775}

$$$$
NIHCC_2014
  SciTegic11012413002D

 37 39  0  0  1  0            999 V2000
    9.3245   -6.2288    0.0000 Na  0  3
    0.1208  -14.7861    0.0000 C   0  0
    1.5715  -14.4045    0.0000 C   0  0
    1.9675  -12.9569    0.0000 N   0  0
    0.9103  -11.8929    0.0000 C   0  0
    1.3031  -10.4452    0.0000 C   0  0
    2.7533  -10.0615    0.0000 N   0  0
    3.1434   -8.6123    0.0000 C   0  0
    4.5929   -8.2262    0.0000 O   0  0
    2.0841   -7.5492    0.0000 N   0  0
    2.4742   -6.0999    0.0000 C   0  0  1  0  0  0
    1.4149   -5.0368    0.0000 C   0  0
   -0.0346   -5.4229    0.0000 O   0  0
    1.8050   -3.5876    0.0000 N   0  0
    0.7500   -2.5287    0.0000 C   0  0  1  0  0  0
    0.7500   -1.0323    0.0000 C   0  0  1  0  0  0
    1.2135    0.3943    0.0000 S   0  0
    0.0000    1.2760    0.0000 C   0  0
   -1.3101    2.0064    0.0000 C   0  0
    1.3100    2.0066    0.0000 C   0  0
   -1.2135    0.3943    0.0000 C   0  0  1  0  0  0
   -0.7500   -1.0323    0.0000 N   0  0
   -0.7500   -2.5287    0.0000 C   0  0
   -1.8107   -3.5893    0.0000 O   0  0
   -2.6375    0.8602    0.0000 C   0  0
   -3.7540   -0.1415    0.0000 O   0  5
   -2.9472    2.3279    0.0000 O   0  0
    3.9244   -5.7137    0.0000 C   0  0
    4.3169   -4.2658    0.0000 C   0  0
    5.7669   -3.8817    0.0000 C   0  0
    6.8245   -4.9454    0.0000 C   0  0
    6.4322   -6.3932    0.0000 C   0  0
    4.9822   -6.7773    0.0000 C   0  0
    3.8105  -11.1257    0.0000 C   0  0
    5.2607  -10.7421    0.0000 O   0  0
    3.4177  -12.5733    0.0000 C   0  0
    4.4749  -13.6374    0.0000 O   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 11 10  1  1
 11 12  1  0
 12 13  2  0
 12 14  1  0
 15 14  1  6
 15 16  1  0
 16 17  1  6
 17 18  1  0
 18 19  1  0
 18 20  1  0
 18 21  1  0
 21 22  1  0
 22 16  1  0
 22 23  1  0
 23 15  1  0
 23 24  2  0
 21 25  1  1
 25 26  1  0
 25 27  2  0
 11 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 28  1  0
  7 34  1  0
 34 35  2  0
 34 36  1  0
 36  4  1  0
 36 37  2  0
M  CHG  2   1   1  26  -1
M  END
> <name>
NIHCC_2014

> <id>
6134

> <plate>
NGP-202-01

> <well>
G05

> <supplier_cmpd_name>
CPD000058579

> <ctcr_id>
5878

> <supplier_cmpd_id>
SAM002264643

> <smiles>
[Na+].CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C([O-])=O)c4ccccc4)C(=O)C1=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"PIPERACILLIN SODIUM",59703-84-3,59703843,"PIPERACILLIN SODIUM SALT","Sodium piperacillin","Piperacillin (sodium)",UNII-M98T69Q7HP,UNIIM98T69Q7HP,MLS000069533,CHEBI:8233,M98T69Q7HP,SMR000058579,"CL 2
27,193",T-1220,T1220,Pentcillin,"Pipracil Sterile",Cl-227193,Cl227193,1-carboxami,1carboxami,SAM002264643,Prestw-755,CPD000058579,"Piperacillin sodium salt"}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23666879}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 25  0  0  1  0            999 V2000
    1.2948   -3.7516    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0  1  0  0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 I   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 O   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2007    1.4909    0.0000 C   0  0
   -6.4972    0.7364    0.0000 C   0  0
   -7.7988    1.4819    0.0000 I   0  0
   -6.4920   -0.7636    0.0000 C   0  0
   -7.7884   -1.5181    0.0000 O   0  0
   -5.1903   -1.5091    0.0000 C   0  0
   -5.1851   -3.0091    0.0000 I   0  0
   -3.8939   -0.7546    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 I   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    5.1937   -3.0093    0.0000 O   0  0
    3.8912   -5.2570    0.0000 O   0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 16 18  2  0
 18 10  1  0
  8 19  1  0
 19 20  1  0
 19 21  2  0
 21  4  1  0
  2 22  1  0
 22 23  1  0
 22 24  2  0
M  END
> <name>
NIHCC_2014

> <id>
6135

> <plate>
NGP-202-01

> <well>
G06

> <supplier_cmpd_name>
CPD000059176

> <ctcr_id>
1496

> <supplier_cmpd_id>
SAM002264651

> <smiles>
N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(O)=O

> <pd_targets>
{LMNA,THRB,KMT2A,MEN1,TTR,MDH2,NR1I2,NR1H4,SLCO4C1,UGT1A1,THRA,CYP1A2,HSD17B10,ALD,CYP2C9,GRIN1,GRIN2A,GRIN2B,GRIN2C,GRIN2D,GRIN3A,GRIN3B,SLCO1C1,MAPT,ALOX15,CYP3A4,ALDH1A1,USP2,MIF}

> <pathway_gtopdb>
{"Other nuclear protein","Transcription factor","Epigenetic regulator","Secreted protein",Enzyme,Transporter,"Nuclear receptor",Reader,Oxidoreductase,"Electrochemical transporter",Transferase,"Nuclear
 hormone receptor subfamily 1",Bromodomain,"SLC superfamily of solute carriers","Nuclear hormone receptor subfamily 1 group A","Nuclear hormone receptor subfamily 1 group I","Nuclear hormone receptor 
subfamily 1 group H","SLC21/SLCO family of organic anion transporting polypeptides","Nuclear hormone receptor subfamily 1 group A member 2","Nuclear hormone receptor subfamily 1 group I member 2","Nuc
lear hormone receptor subfamily 1 group H member 4","Nuclear hormone receptor subfamily 1 group A member 1","Ion channel","Cytochrome P450","Ligand-gated ion channel","Cytochrome P450 family 1","Cytoc
hrome P450 family 2","Ionotropic glutamate receptor","Cytochrome P450 family 1A","Cytochrome P450 family 2C","NMDA receptor","Cytochrome P450 1A1","Cytochrome P450 2C9","Other cytosolic protein",Prote
ase,Isomerase,"Cytochrome P450 family 3","Cysteine protease","Cytochrome P450 family 3A","Cysteine protease CA clan","Cytochrome P450 3A4","Cysteine protease C19 family"}

> <pathway_chembl>
{Receptors,"Other protein targets",Transporters,Enzymes,"Nuclear hormone receptors",Transthyretin,"SLC superfamily of solute carriers","UDP glucuronosyltransferases (UGT)","1A. Thyroid hormone recepto
rs","1I. Vitamin D receptor-like receptors","1H. Liver X receptor-like receptors","SLCO family of organic anion transporting polypeptides","Cytochrome P450","CYP1 family","CYP2 family: drug metabolisi
ng subset","Eicosanoid turnover","Peptidases and proteinases",Lipoxygenases,"CYP3 family","CA: Cysteine (C) Peptidases","C19: Ubiquitin-specific protease"}

> <pathway_reactome>
{"Cell Cycle","Metabolism of proteins","Signal Transduction",Metabolism,"Transport of small molecules",Disease,Mitotic,"Post-translational protein modification","Signaling by GPCR","Metabolism of carb
ohydrates","Metabolism of lipids","SLC-mediated transmembrane transport","Diseases of metabolism","M Phase",SUMOylation,"GPCR downstream signalling","Glucose metabolism","Metabolism of steroids","Tran
sport of vitamins",nucleosides,"and related molecules","Metabolic disorders of biological oxidation enzymes","Mitotic Metaphase and Anaphase","SUMO E3 ligases SUMOylate target proteins","G alpha (i) s
ignalling events",Gluconeogenesis,"Bile acid and bile salt metabolism","Transport of organic anions","Defective UGT1A1 causes hyperbilirubinemia","Mitotic Anaphase","SUMOylation of intracellular recep
tors","Visual phototransduction","Synthesis of bile acids and bile salts","Nuclear Envelope (NE) Reassembly","The canonical retinoid cycle in rods (twilight vision)","Synthesis of bile acids and bile 
salts via 27-hydroxycholesterol","Initiation of Nuclear Envelope (NE) Reformation","Biological oxidations","Metabolism of amino acids and derivatives","Phase I - Functionalization of compounds","Branc
hed-chain amino acid catabolism","Cytochrome P450 - arranged by substrate type",Xenobiotics,"Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","CYP2E1 reactions","Neuronal System","Gen
e expression (Transcription)","Immune System","Transmission across Chemical Synapses","RNA Polymerase II Transcription","Cytokine Signaling in Immune system","Neurotransmitter receptors and postsynapt
ic signal transmission","Biosynthesis of specialized proresolving mediators (SPMs)","Generic Transcription Pathway","Signaling by Interleukins","Activation of NMDA receptors and postsynaptic events","
Biosynthesis of DPA-derived SPMs","Biosynthesis of DHA-derived SPMs","Ethanol oxidation","Transcriptional Regulation by TP53","Interleukin-12 family signaling","Post NMDA receptor activation events","
Biosynthesis of DPAn-3 SPMs","Biosynthesis of maresins","Regulation of TP53 Activity","Interleukin-12 signaling","Activation of AMPK downstream of NMDARs","Biosynthesis of DPAn-3-derived protectins an
d resolvins","Biosynthesis of maresin-like SPMs","Regulation of TP53 Expression and Degradation","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","Regulation of TP5
3 Degradation"}

> <broad_targets>
{THRA,THRB}

> <broad_moa>
{"thyroid hormone stimulant"}

> <synonyms>
{"L-thyroxine zwitterion","Lthyroxine zwitterion",CHEBI:58448,BDBM408980,"US10377729, T4",L-thyroxine,Lthyroxine,levothyroxine,51-48-9,51489,thyroxine,thyroxin,Tetraiodothyronine,Thyrax,"3,3',5,5'-Tet
raiodo-L-thyronine","3,3',5,5'TetraiodoLthyronine",synthroid,Thyratabs,Thyreoideum,Thyroxinal,"Thyroxine iodine",Le,T0864,SAM002264651,1500774,Prestw-403,L-Thyroxine,CPD000059176,LEVOTHYROXINE,"Thyrox
ine (L)"}

> <pdid>
PD001584

> <targets>
{}

> <classes>
{antihypercholesterimic,thyromimetic}

> <pubchem_cids>
{25201348,5819}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 23  0  0  0  0            999 V2000
   -1.8778    2.7573    0.0000 C   0  0
   -1.0947    1.4779    0.0000 N   0  0
    0.0000    0.6568    0.0000 C   0  0
   -0.6568   -0.6386    0.0000 C   0  0
   -1.8063   -1.3319    0.0000 C   0  0
   -0.8393    0.0000    0.0000 C   0  0
    0.9488    0.0000    0.0000 C   0  0
    1.8975   -0.8028    0.0000 C   0  0
    1.6421    0.6933    0.0000 C   0  0
    2.6654   -2.0798    0.0000 O   0  0
    4.1661   -2.0555    0.0000 C   0  0
    4.8945   -0.7443    0.0000 O   0  0
    4.9382   -3.3425    0.0000 C   0  0
    4.2067   -4.6529    0.0000 C   0  0
    2.7069   -4.6756    0.0000 O   0  0
    6.4389   -3.3181    0.0000 C   0  0
    7.2125   -4.6033    0.0000 C   0  0
    8.7123   -4.5759    0.0000 C   0  0
    9.4385   -3.2634    0.0000 C   0  0
    8.6649   -1.9783    0.0000 C   0  0
    7.1652   -2.0056    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  2  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  3  1  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 13 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
M  END
> <name>
NIHCC_2014

> <id>
6136

> <plate>
NGP-202-01

> <well>
G07

> <supplier_cmpd_name>
CPD001906768

> <ctcr_id>
7010

> <supplier_cmpd_id>
SAM002554885

> <smiles>
CN1C2CCC1CC(C2)OC(=O)C(CO)c3ccccc3

> <pd_targets>
{CFTR,CHRM3,CHRM2,GPM3,CHRM4,CHRM1,CHRM5,MAPT,ACHE,ADRA2A,NACHRALPHA5,ADRA1D,HTR2C,SLC22A1,GLRA1,AMPC,LMNA,KDM4E,BLM,POLB}

> <pathway_gtopdb>
{"Ion channel","Membrane receptor","Other ion channel","Family A G protein-coupled receptor","Chloride channel","Small molecule receptor (family A GPCR)","Cystic fibrosis transmembrane conductance reg
ulator","Monoamine receptor","Acetylcholine receptor","Other cytosolic protein",Enzyme,Transporter,Hydrolase,"Ligand-gated ion channel","Electrochemical transporter","Nicotinic acetylcholine receptor"
,"SLC superfamily of solute carriers","Glycine receptor","SLC22 family of organic cation and anion transporters","Adrenergic receptor","Serotonin receptor","Other nuclear protein","Epigenetic regulato
r",Eraser,"Lysine demethylase","Jumonji domain-containing"}

> <pathway_chembl>
{"Ion channels",Receptors,"Other ion channels","G protein-coupled receptors","Chloride channels","Acetylcholine receptors (muscarinic)",CFTR,Enzymes,Transporters,"Acetylcholine turnover","SLC superfam
ily of solute carriers","Ligand-gated ion channels",Adrenoceptors,"5-Hydroxytryptamine receptors","SLC22 family of organic cation and anion transporters","Glycine receptors","Organic cation transporte
rs (OCT)","Chromatin modifying enzymes","1.14.11.- Histone demethylases"}

> <pathway_reactome>
{Autophagy,"Signal Transduction",Macroautophagy,"Signaling by GPCR","Selective autophagy","GPCR ligand binding",Aggrephagy,"Class A/1 (Rhodopsin-like receptors)","Amine ligand-binding receptors","Musc
arinic acetylcholine receptors","Neuronal System",Metabolism,"Transport of small molecules","Transmission across Chemical Synapses","Metabolism of lipids","SLC-mediated transmembrane transport","Neuro
transmitter receptors and postsynaptic signal transmission","Phospholipid metabolism","Transport of bile salts and organic acids","metal ions and amine compounds","Activation of NMDA receptors and pos
tsynaptic events","Glycerophospholipid biosynthesis","Organic cation/anion/zwitterion transport","Post NMDA receptor activation events","Synthesis of PC","Organic cation transport","Activation of AMPK
 downstream of NMDARs",Adrenoceptors,"Serotonin receptors","Cell Cycle","DNA Repair",Mitotic,"DNA Double-Strand Break Repair","Base Excision Repair","M Phase","Homology Directed Repair","Resolution of
 Abasic Sites (AP sites)","Mitotic Metaphase and Anaphase","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Resolution of AP sites via the multiple-nucleotide patch repla
cement pathway","Mitotic Anaphase","HDR through Homologous Recombination (HRR)","PCNA-Dependent Long Patch Base Excision Repair","Nuclear Envelope (NE) Reassembly","Homologous DNA Pairing and Strand E
xchange","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3,CHRM4}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{ATROPINE,dl-Hyoscyamine,dlHyoscyamine,"dl Hyoscyamine","Tropine tropate",Atropin,Atropen,dl-Tropyltropate,dlTropyltropate,"dl Tropyltropate",Atropinol,Eyesules,Isopto-atropine,Isoptoatropine,"Isopto 
atropine","Troyl tropate",51-55-8,51558,"51 55",SAM002554885,CPD001906768}

> <pdid>
PD002296

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{174174}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 17  0  0  0  0            999 V2000
    7.5993   -1.6061    0.0000 C   0  0
    8.4849   -2.8168    0.0000 N   0  0
    7.8797   -4.1902    0.0000 C   0  0
    8.7644   -5.4025    0.0000 N   0  0
   10.2567   -5.2435    0.0000 C   0  0
   11.7483   -5.0845    0.0000 N   0  0
    6.3873   -4.3492    0.0000 N   0  0
    5.5026   -3.1368    0.0000 C   0  0
    4.0102   -3.2959    0.0000 C   0  0
    3.1255   -2.0835    0.0000 S   0  0
    1.6332   -2.2426    0.0000 C   0  0
    0.7500   -1.0323    0.0000 C   0  0
    1.2135    0.3943    0.0000 N   0  0
    0.0000    1.2760    0.0000 C   0  0
   -1.2135    0.3943    0.0000 N   0  0
   -0.7500   -1.0323    0.0000 C   0  0
   -1.6317   -2.2458    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  3  0
  3  7  2  3
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 12  2  0
 16 17  1  0
M  END
> <name>
NIHCC_2014

> <id>
6137

> <plate>
NGP-202-01

> <well>
G08

> <supplier_cmpd_name>
CPD001370748

> <ctcr_id>
3832

> <supplier_cmpd_id>
SAM002554892

> <smiles>
CNC(NC#N)=NCCSCc1nc[nH]c1C

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{cimetidine,51481-61-9,51481619,Tagamet,Eureceptor,Tametin,Dyspamet,Ulcedine,Acinil,Cimetag,Tratul,Ulcedin,Acibilin,Gastromet,Cimetum,Edalene,Ulcimet,Ulcomet,Cimal,Ulhys,"Tagamet Hb","Cimetidine Hcl",
"Tagamet Hb 200",SKF-92334,SKF92334,Cimetidina,Ulcomedina,Val,902,S1845,SAM002554892,1500684,Prestw-26,Cimetidine,Cimetidine,CPD001370748,CIMETIDINE}

> <pdid>

> <targets>
{""}

> <classes>
{antiulcer,"Neuronal Signaling"}

> <pubchem_cids>
{2756}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 17  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3039   -3.7494    0.0000 C   0  0
   -1.3070   -5.2502    0.0000 C   0  0
   -0.0092   -6.0025    0.0000 O   0  0
   -2.6078   -5.9988    0.0000 C   0  0
   -2.6109   -7.4996    0.0000 O   0  0
   -3.9117   -8.2482    0.0000 C   0  0
   -5.2094   -7.4959    0.0000 N   0  0
   -3.9148   -9.7482    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
M  END
> <name>
NIHCC_2014

> <id>
6138

> <plate>
NGP-202-01

> <well>
G09

> <supplier_cmpd_name>
CPD000058719

> <ctcr_id>
365

> <supplier_cmpd_id>
SAM002554900

> <smiles>
COc1ccccc1OCC(O)COC(N)=O

> <pd_targets>
{CA1}

> <pathway_gtopdb>
{Enzyme,Lyase}

> <pathway_chembl>
{Enzymes,"Carbonic anhydrases"}

> <pathway_reactome>
{"Immune System","Cytokine Signaling in Immune system","Signaling by Interleukins","Interleukin-12 family signaling","Interleukin-12 signaling","Gene and protein expression by JAK-STAT signaling after
 Interleukin-12 stimulation"}

> <broad_targets>
{CA1}

> <broad_moa>
{"muscle relaxant"}

> <synonyms>
{Traumacut,DSSTox_CID_3286,DSSToxCID3286,DSSTox-CID-3286,"DSSTox CID 3286",methocarbamol,532-03-6,532036,Robaxin,Lumirelax,Parabaxin,Metocarbamolo,Etroflex,Methocal,Metocarbamol,Metofenia,Miolaxene,Mi
orilas,Myolaxene,Neuraxin,Reflexyn,Relestrid,Romethocarb,Surquetil,Tresortil,Avetil,Delaxin,Miowas,P,T1409,SAM002554900,1500397,Prestw-184,Methocarbamol,CPD000058719,METHOCARBAMOL}

> <pdid>
PD001863

> <targets>
{}

> <classes>
{"muscle relaxant (skeletal)"}

> <pubchem_cids>
{4107}

$$$$
NIHCC_2014
  SciTegic11012413002D

 18 19  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.6003   -1.4978    0.0000 N   0  0
   -3.8990   -0.7455    0.0000 C   0  0
   -3.8939    0.7546    0.0000 C   0  0
   -5.1904    1.5090    0.0000 C   0  0
   -6.4920    0.7635    0.0000 C   0  0
   -6.4971   -0.7365    0.0000 C   0  0
   -5.2007   -1.4909    0.0000 C   0  0
   -5.2090   -2.9918    0.0000 C   0  0
   -3.9139   -3.7485    0.0000 O   0  0
   -6.5117   -3.7354    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
  6 17  2  0
 17  2  1  0
 17 18  1  0
M  END
> <name>
NIHCC_2014

> <id>
6139

> <plate>
NGP-202-01

> <well>
G10

> <supplier_cmpd_name>
CPD000058188

> <ctcr_id>
4285

> <supplier_cmpd_id>
SAM002554908

> <smiles>
Cc1cccc(Nc2ccccc2C(O)=O)c1C

> <pd_targets>
{HIF1A,CYP3A4,RORC,AKR1C1,NLRP3,PTGS2,ABCB11,AKR1C2,PTGS1,AKR1B10,AKR1B1,AKR1C3,MPO,TDP1,CYP1A2,NAPRT,KMT2A,MEN1,ACHE,LMNA,CYP2C9,TRPA1,KCNQ1,TRPM3}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Unclassified protein",Transporter,"Epigenetic regulator","Other nuclear protein","Ion channel","Cytochrome P450","Nuclear receptor",Oxidoreductase,"Primary active trans
porter",Hydrolase,Ligase,Reader,"Voltage-gated ion channel","Cytochrome P450 family 3","Nuclear hormone receptor subfamily 1","ATP-binding cassette","Cytochrome P450 family 1",Bromodomain,"Cytochrome 
P450 family 2","Transient receptor potential channel","Potassium channels","Cytochrome P450 family 3A","Nuclear hormone receptor subfamily 1 group F","ABCB subfamily","Cytochrome P450 family 1A","Cyto
chrome P450 family 2C","Voltage-gated potassium channel","Cytochrome P450 3A4","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 1A1","Cytochrome P450 2C9"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Ion channels","Cytochrome P450","Nuclear hormone receptors","Catalytic receptors","Eicosanoid turnover","ATP-binding cassette transporter family","1.-.-.- Oxidoreducta
ses","Acetylcholine turnover","Voltage-gated ion channels","CYP3 family","1F. Retinoic acid-related orphans","Pattern recognition receptors",Cyclooxygenase,"ABCB subfamily","Prostaglandin synthases","
CYP1 family","CYP2 family: drug metabolising subset","Transient Receptor Potential channels","Potassium channels","NOD-like receptor family","Voltage-gated potassium channels"}

> <pathway_reactome>
{"Cellular responses to external stimuli",Metabolism,"Gene expression (Transcription)",Disease,"Immune System","DNA Repair","Cell Cycle","Transport of small molecules","Muscle contraction","Cellular r
esponses to stress","Metabolism of lipids","RNA Polymerase II Transcription","Infectious disease","Metabolism of vitamins and cofactors","Innate Immune System","DNA Double-Strand Break Repair","Biolog
ical oxidations",Mitotic,"Ion channel transport","Cardiac conduction","Cellular response to hypoxia","Biosynthesis of specialized proresolving mediators (SPMs)","Generic Transcription Pathway","Metabo
lism of steroids","Leishmania infection","Fatty acid metabolism","Metabolism of fat-soluble vitamins","ROS and RNS production in phagocytes","Nonhomologous End-Joining (NHEJ)","Phase I - Functionaliza
tion of compounds","Metabolism of water-soluble vitamins and cofactors","Phospholipid metabolism","M Phase","Stimuli-sensing channels","Phase 2 - plateau phase","Oxygen-dependent proline hydroxylation
 of Hypoxia-inducible Factor Alpha","Biosynthesis of DHA-derived SPMs","Transcriptional regulation by RUNX3","Bile acid and bile salt metabolism","Cell recruitment (pro-inflammatory response)","Biosyn
thesis of DPA-derived SPMs","Arachidonic acid metabolism","Retinoid metabolism and transport","Metabolism of steroid hormones","Events associated with phagocytolytic activity of PMN cells","Cytochrome
 P450 - arranged by substrate type","Nicotinate metabolism","Glycerophospholipid biosynthesis","Mitotic Metaphase and Anaphase","TRP channels","Biosynthesis of maresins","RUNX3 Regulates Immune Respon
se and Cell Migration","Synthesis of bile acids and bile salts","Purinergic signaling in leishmaniasis infection","Biosynthesis of DPAn-3 SPMs","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)"
,"Pregnenolone biosynthesis",Xenobiotics,"Nicotinamide salvaging","Synthesis of PC","Mitotic Anaphase","Biosynthesis of maresin-like SPMs","Synthesis of bile acids and bile salts via 24-hydroxycholest
erol","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Nuclear Envelope (NE) Reassembly","CYP2E1 reactions","I
nitiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{KCNQ1,PTGS1,PTGS2,TRPM3}

> <broad_moa>
{"cyclooxygenase inhibitor"}

> <synonyms>
{61-68-7,61687,Ponstel,"2-((2,3-dimethylphenyl)amino)benzoic acid","2((2,3dimethylphenyl)amino)benzoic acid",Ponstan,"Mephenamic acid","2-((2,3-Dimethylphenyl)amino)benzoic acid","2((2,3Dimethylphenyl
)amino)benzoic acid",Parkemed,Coslan,Mefacit,Ponalar,"Methenamic acid","Mephenaminic acid",Mefenaminsaeure,Bonab,T0890,SAM002554908,1501103,Prestw-54,"Mefenamic acid",CPD000058188,"MEFENAMIC ACID"}

> <pdid>
PD001903

> <targets>
{}

> <classes>
{analgesic,antiinflammatory}

> <pubchem_cids>
{4044}

$$$$
NIHCC_2014
  SciTegic11012413002D

 33 33  0  0  0  0            999 V2000
    5.1884   -7.5113    0.0000 C   0  0
    5.1901   -6.0113    0.0000 N   0  0
    6.4902   -5.2631    0.0000 C   0  0
    3.8917   -5.2586    0.0000 C   0  0
    3.8934   -3.7577    0.0000 C   0  0
    2.5949   -3.0050    0.0000 O   0  0
    2.5966   -1.5042    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8990   -0.7582    0.0000 C   0  0
    5.1956   -1.5125    0.0000 C   0  0
    6.4972   -0.7669    0.0000 C   0  0
    6.5023    0.7331    0.0000 C   0  0
    5.2058    1.4875    0.0000 C   0  0
    3.9042    0.7419    0.0000 C   0  0
    2.6078    1.4964    0.0000 C   0  0
   10.3023   -2.2649    0.0000 O   0  0
   10.3023   -3.7649    0.0000 C   0  0
    9.0030   -4.5145    0.0000 O   0  0
   11.6023   -4.5149    0.0000 C   0  0
   12.9023   -3.7649    0.0000 C   0  0
   14.2008   -4.5157    0.0000 O   0  0
   12.9037   -2.2641    0.0000 C   0  0
   14.2037   -1.5141    0.0000 C   0  0
   15.5023   -2.2649    0.0000 O   0  0
   14.2051   -0.0141    0.0000 O   0  0
   12.9035   -5.2948    0.0000 C   0  0
   11.6048   -6.0455    0.0000 O   0  0
   14.2026   -6.0446    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  7 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 19 20  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 28 30  2  0
 25 31  1  0
 31 32  1  0
 31 33  2  0
M  END
> <name>
NIHCC_2014

> <id>
6140

> <plate>
NGP-202-01

> <well>
G11

> <supplier_cmpd_name>
CPD000058817

> <ctcr_id>
287

> <supplier_cmpd_id>
SAM002554918

> <smiles>
CN(C)CCOC(c1ccccc1)c2ccccc2C.OC(=O)CC(O)(CC(O)=O)C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"N,N-Dimethyl-2-((o-methyl-alpha-phenyl-benzyl)oxy)-ethylamine citrate","ETHYLAMINE, N,N-DIMETHYL-2-((o-METHYL-alpha-PHENYLBENZYL)OXY)-, CITRATE",4724-58-7,"N,N-Dimethyl-2-(o-methyl-alpha-phenylbenzy
loxy)ethylamine citrate","Orphenadrine citrate",4682-36-4,Banflex,Flexon,"Orphenadrine (Citrate)","Orphenadrine dihydrogen citrate",X-Otag,"Orphenadrine citrate salt","Orphenadrine citrate (USP)","Orp
henadrine citrate (Norflex)",CHEBI:7790,Flexoject,C24H31NO8,4596-23-0,NCGC00094745-01,Plenactol,Euflex,Flexor,Tega-Flex,DSSTox_CID_24678,DSSTox_RID_80390,DSSTox_GSID_44678,"Norflex (pharmaceutical)",O
rphenadrinecitrate,CAS-4682-36-4,"EINECS 225-137-5","Norflex (TN)","ORPHENADINE CITRATE","N,N-Dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)ethylamine citrate (1:1)",MLS000069549,SCHEMBL119470,SPECTRUM
1500447,CHEMBL1200395,DTXSID8044678,HMS502K15,HY-B0369A,HMS1920D10,HMS2091L10,HMS2231J06,HMS3259M21,HMS3370M12,HMS3651A10,HMS3884M22,Pharmakon1600-01500447,Tox21_111323,Tox21_113543,Tox21_301079,CCG-4
0242,NSC757238,AKOS008132385,Tox21_111323_1,MCULE-5864907407,NC00525,NE62567,NSC-757238,NCGC00015771-13,NCGC00094745-02,NCGC00094745-03,NCGC00254980-01,AK117797,AS-74807,SMR000058817,FT-0655842,FT-067
3305,S2054,SW102176-4,EN300-53019,D00774,A826945,SR-01000002975-5,Q27107584,"N,N-dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)ethylamine citrate","(+-)-N,N-dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy
)ethylamine citrate",SAM002554918,1500447,"Orphenadrine Citrate",CPD000058817,"ORPHENADRINE CITRATE","Orphenadrine Citrate"}

> <pdid>

> <targets>
{AChR,iGluR}

> <classes>
{antihistaminic,muscle relaxant (skeletal),Neuronal Signaling,Membrane Transporter/Ion Channel}

> <pubchem_cids>
{20846,83823}

$$$$
NIHCC_2014
  SciTegic11012413002D

  9  9  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 F   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 N   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  7  9  2  0
  9  2  1  0
M  END
> <name>
NIHCC_2014

> <id>
6141

> <plate>
NGP-202-01

> <well>
H02

> <supplier_cmpd_name>
CPD000038082

> <ctcr_id>
604

> <supplier_cmpd_id>
SAM002264615

> <smiles>
Oc1ncc(F)c(O)n1

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{5-Fluorouracil,5Fluorouracil,fluorouracil,51-21-8,51218,5-FU,5FU,Fluoroplex,Efudex,Adrucil,Carac,"5-fluoropyrimidine-2,4(1H,3H)-dione","5fluoropyrimidine2,4(1H,3H)dione",Fluracil,Fluoroblastin,Kecime
ton,Carzonal,Timazin,Arumel,Efudix,Fluril,5-Fluoracil,5Fluoracil,Fluracilum,Queroplex,Ulup,Phthoruracil,5-fluoro-,5fluoro,19893,S1209,SAM002264615,1500305,Prestw-1203,"NSC 19893",Fluorouracil,CPD00003
8082,FLUOROURACIL,5-fluorouracil}

> <pdid>

> <targets>
{}

> <classes>
{"pyrimidine antimetabolite",antineoplastic,Anti-metabolite}

> <pubchem_cids>
{3385}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 18  0  0  0  0            999 V2000
    2.5983   -3.0004    0.0000 C   0  0
    2.5988   -1.5004    0.0000 C   0  0
    3.8975   -2.2510    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8990   -0.7508    0.0000 C   0  0
    3.8995    0.7492    0.0000 O   0  0
    5.1988   -1.5012    0.0000 C   0  0
    6.4994   -0.7539    0.0000 C   0  0
    7.7969   -1.5066    0.0000 C   0  0
    7.7939   -3.0066    0.0000 C   0  0
    6.4933   -3.7539    0.0000 N   0  0
    5.1958   -3.0013    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  2 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
M  END
> <name>
NIHCC_2014

> <id>
6142

> <plate>
NGP-202-01

> <well>
H03

> <supplier_cmpd_name>
CPD000059134

> <ctcr_id>
5078

> <supplier_cmpd_id>
SAM002297829

> <smiles>
CC(C)(c1cccnc1)C(=O)c2cccnc2

> <pd_targets>
{CYP11B1,CYP3A4,CYP11B2,LMNA,CYP1A2,CAMC}

> <pathway_gtopdb>
{Enzyme,"Other nuclear protein","Cytochrome P450","Cytochrome P450 family 11","Cytochrome P450 family 3","Cytochrome P450 family 1","Cytochrome P450 CAM family","Cytochrome P450 family 11B","Cytochrom
e P450 family 3A","Cytochrome P450 family 1A","Cytochrome P450 11B1","Cytochrome P450 3A4","Cytochrome P450 11B2","Cytochrome P450 1A1"}

> <pathway_chembl>
{Enzymes,"Cytochrome P450",CYP11,CYP17,CYP19,"CYP20 and CYP21 families","CYP3 family","CYP1 family"}

> <pathway_reactome>
{Metabolism,"Cell Cycle","Biological oxidations","Metabolism of lipids",Mitotic,"Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","M Phase","Cytoch
rome P450 - arranged by substrate type","Biosynthesis of DHA-derived SPMs","Mitotic Metaphase and Anaphase","Endogenous sterols","Biosynthesis of maresins","Mitotic Anaphase",Xenobiotics,"Biosynthesis
 of maresin-like SPMs","Nuclear Envelope (NE) Reassembly","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{CYP11B1}

> <broad_moa>
{"cytochrome P450 inhibitor"}

> <synonyms>
{54-36-4,54364,"2-Methyl-1,2-di-3-pyridyl-1-propanone","2Methyl1,2di3pyridyl1propanone",Metopirone,Methopyrapone,Metopiron,Methapyrapone,Methopirapone,Methopyrinine,Methopyrone,Metyrapon,Methbipyranon
e,Metopyrone,Mepyrapone,Metroprione,Metapirone,Metapyron,Metirapona,Met,T0293,SAM002297829,Prestw-904,Metyrapone,CPD000059134}

> <pdid>
PD000227

> <targets>
{Autophagy,Cytochrome P450}

> <classes>
{Autophagy,Metabolic Enzyme/Protease}

> <pubchem_cids>
{4174}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 32  0  0  1  0            999 V2000
    5.1422   -5.3703    0.0000 C   0  0
    4.1252   -6.4729    0.0000 C   0  0
    4.5720   -7.9048    0.0000 O   0  0
    2.6611   -6.1428    0.0000 O   0  0
    2.2141   -4.7101    0.0000 C   0  0
    0.7500   -4.3800    0.0000 C   0  0
   -0.2670   -5.4825    0.0000 O   0  0
    0.2851   -2.9666    0.0000 C   0  0  1  0  0  0
   -0.6870   -2.7320    0.0000 O   0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -1.2991    2.2500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -0.8141   -2.0807    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  1
  8 10  1  0
 10 11  1  0
 12 11  1  6
 12 13  1  0
 13 14  1  1
 14 15  1  0
 15 16  1  0
 16 17  2  3
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  2  3
 21 22  1  0
 22 16  1  0
 22 23  1  6
 24 22  1  6
 24 13  1  0
 24 25  1  0
 25 26  1  6
 25 27  1  0
 27 28  1  0
 28  8  1  0
 28 12  1  0
 28 29  1  6
M  END
> <name>
NIHCC_2014

> <id>
6143

> <plate>
NGP-202-01

> <well>
H04

> <supplier_cmpd_name>
CPD000058326

> <ctcr_id>
7005

> <supplier_cmpd_id>
SAM002264635

> <smiles>
CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]12C

> <pd_targets>
{HIF1A,NR3C1}

> <pathway_gtopdb>
{"Transcription factor","Nuclear receptor","Nuclear hormone receptor subfamily 3","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 3 group C member 1"}

> <pathway_chembl>
{Receptors,"Nuclear hormone receptors","Steroid hormone receptors","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"Cellular responses to external stimuli","Gene expression (Transcription)","Cellular responses to stress","RNA Polymerase II Transcription","Cellular response to hypoxia","Generic Transcription Pathw
ay","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","FOXO-mediated transcription","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes"}

> <broad_targets>
{NR3C1}

> <broad_moa>
{"glucocorticoid receptor agonist"}

> <synonyms>
{"prednisolone acetate",52-21-1,52211,Omnipred,Pricortin,Cormalone,Cortipred,Deltilen,Durapred,Econopred,Predicort,Prednidoren,Supercortyl,"Prednisolone 21-acetate","Prednisolone 21acetate",Prenema,"M
eticortelone acetate",Prednelan-N,PrednelanN,Delcort-E,DelcortE,"Pred Mild","Pred Fo",S2570,SAM002264635,"Prednisolone Acetate",CPD000058326}

> <pdid>
PD001790

> <targets>
{Others}

> <classes>
{}

> <pubchem_cids>
{5834}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 27  0  0  1  0            999 V2000
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 N   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.6001   -3.0008    0.0000 C   0  0  2  0  0  0
   -3.9004   -3.7487    0.0000 O   0  0
   -1.3018   -3.7538    0.0000 C   0  0  1  0  0  0
    0.0504   -3.7772    0.0000 C   0  0
    0.7490   -4.8836    0.0000 C   0  0  2  0  0  0
    0.4079   -6.4955    0.0000 C   0  0
   -1.0295   -6.5002    0.0000 C   0  0
   -0.5882   -4.9489    0.0000 N   0  0
    1.1725   -4.4592    0.0000 C   0  0
    2.3256   -4.6763    0.0000 C   0  0  2  0  0  0
    3.8088   -4.8069    0.0000 C   0  0
    4.6688   -3.5780    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  1
 11 13  1  0
 13 14  1  1
 15 14  1  1
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 13  1  0
 18 19  1  0
 19 20  1  0
 20 15  1  0
 20 21  1  6
 21 22  2  0
 10 23  1  0
 23  6  1  0
 23 24  2  0
 24  3  1  0
M  END
> <name>
NIHCC_2014

> <id>
6144

> <plate>
NGP-202-01

> <well>
H05

> <supplier_cmpd_name>
CPD000857275

> <ctcr_id>
7006

> <supplier_cmpd_id>
SAM002264644

> <smiles>
COc1ccc2nccc([C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C)c2c1

> <pd_targets>
{AMPC,CYP2D6,KCNT1,SCN5A,CYP3A4,ABCB1,TSHR,BCHE,SCN1A,SCN2A,SCN3A,CYP2D1,KCND2,CYP2D26,KCNA5,SLC29A4,KCNH2,CYP2C9,CYP2D3,ALDH1A1,KCNH1,CYP2D4,TDP1,KCNA7,ABCC4,ABCB1B,SLC22A1,CACNA1C,SLCO1A1,SLC22A2,SL
C47A1,ABCB1A,CACNA1D,CACNA1F,CACNA1S,KCNK5,KCNT2,KCNK10,KCNH5,KCNU1,KCNK16,KCNA4,KCNK1,KCNK6,ADRA1A,ADRA1B,ADRA1D,SCN10A,SCN11A,SCN4A,SCN7A,SCN8A,SCN9A,HSD17B10,CHRM1,KCNB2,KCNK2,ABCB11,SLCO1A4,GP9,KC
NN4,KDM4E,THRB}

> <pathway_gtopdb>
{Enzyme,"Ion channel",Transporter,"Membrane receptor","Unclassified protein",Hydrolase,"Cytochrome P450","Voltage-gated ion channel","Primary active transporter","Family A G protein-coupled receptor",
"Electrochemical transporter",Oxidoreductase,"Cytochrome P450 family 2","Voltage-gated sodium channel","Cytochrome P450 family 3","ATP-binding cassette","Peptide receptor (family A GPCR)","Potassium c
hannels","SLC superfamily of solute carriers","Voltage-gated calcium channel","Small molecule receptor (family A GPCR)","Cytochrome P450 family 2D","Cytochrome P450 family 3A","ABCB subfamily","Glycoh
ormone receptor","Voltage-gated potassium channel","SLC28 and SLC29 families of nucleoside transporters","Cytochrome P450 family 2C","ABCC subfamily","SLC22 family of organic cation and anion transpor
ters","SLC21/SLCO family of organic anion transporting polypeptides","SLC47 family of multidrug and toxin extrusion transporters","Two-pore domain potassium channel","Monoamine receptor","Cytochrome P
450 2D6","Cytochrome P450 3A4","Cytochrome P450 2D1","Cytochrome P450 2D2","SLC29 Facilitative nucleoside transporter family","Cytochrome P450 2C9","Cytochrome P450 2D3","Cytochrome P450 2D18","Adrene
rgic receptor","Acetylcholine receptor","Epigenetic regulator",Eraser,"Lysine demethylase","Calcium-activated potassium channel","Jumonji domain-containing","Transcription factor","Nuclear receptor","
Nuclear hormone receptor subfamily 1","Nuclear hormone receptor subfamily 1 group A","Nuclear hormone receptor subfamily 1 group A member 2"}

> <pathway_chembl>
{Enzymes,"Ion channels",Transporters,Receptors,"Cytochrome P450","Voltage-gated ion channels","ATP-binding cassette transporter family","G protein-coupled receptors","Acetylcholine turnover","SLC supe
rfamily of solute carriers","CYP2 family: drug metabolising subset","Potassium channels","Voltage-gated sodium channels","CYP3 family","ABCB subfamily","Glycoprotein hormone receptors","SLC28 and SLC2
9 families of nucleoside transporters","ABCC subfamily","SLC22 family of organic cation and anion transporters","Voltage-gated calcium channels","SLC47 family of multidrug and toxin extrusion transpor
ters",Adrenoceptors,"Acetylcholine receptors (muscarinic)","Calcium- and sodium-activated potassium channels","Voltage-gated potassium channels","SLC29 family","Organic cation transporters (OCT)","Two
 P domain potassium channels","Chromatin modifying enzymes","1.14.11.- Histone demethylases","Nuclear hormone receptors","1A. Thyroid hormone receptors"}

> <pathway_reactome>
{Metabolism,"Developmental Biology",Disease,"Muscle contraction","Neuronal System","Transport of small molecules","DNA Repair",Hemostasis,Reproduction,"Signal Transduction","Biological oxidations","Ne
rvous system development","Metabolism of lipids","Abacavir transport and metabolism","Infectious disease","Cardiac conduction","Potassium Channels","SLC-mediated transmembrane transport","DNA Double-S
trand Break Repair","Platelet activation","signaling and aggregation",Fertilization,"Signaling by GPCR","Metabolism of amino acids and derivatives","Phase I - Functionalization of compounds","Axon gui
dance","Biosynthesis of specialized proresolving mediators (SPMs)","Abacavir transmembrane transport","Leishmania infection","Phospholipid metabolism","Phase 1 - inactivation of fast Na+ channels","Vo
ltage gated Potassium channels","Transport of vitamins",nucleosides,"and related molecules","Phase 3 - rapid repolarisation","Nonhomologous End-Joining (NHEJ)","Response to elevated platelet cytosolic
 Ca2+","Transport of bile salts and organic acids","metal ions and amine compounds","Phase 4 - resting membrane potential","Tandem pore domain potassium channels","Sperm Motility And Taxes","GPCR liga
nd binding","Branched-chain amino acid catabolism","Cytochrome P450 - arranged by substrate type","L1CAM interactions","Biosynthesis of DHA-derived SPMs","Leishmania parasite growth and survival","Gly
cerophospholipid biosynthesis","Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane","Ethanol oxidation","Platelet degranulation","Organic cation/anion/zwitterion 
transport","NCAM signaling for neurite out-growth","TWIK related potassium channel (TREK)","TWIK-related alkaline pH activated K+ channel (TALK)","Tandem of pore domain in a weak inwardly rectifying K
+ channels (TWIK)","Class A/1 (Rhodopsin-like receptors)",Xenobiotics,"Interaction between L1 and Ankyrins","Biosynthesis of maresins","Anti-inflammatory response favouring Leishmania parasite infecti
on","Synthesis of PC","Organic cation transport","NCAM1 interactions","Amine ligand-binding receptors","CYP2E1 reactions","Biosynthesis of maresin-like SPMs","ADORA2B mediated anti-inflammatory cytoki
nes production",Adrenoceptors,"Muscarinic acetylcholine receptors","Diseases of hemostasis","Metabolism of steroids","Defects of contact activation system (CAS) and kallikrein/kinin system (KKS)","Ca2
+ activated K+ channels","Bile acid and bile salt metabolism","Defective factor IX causes hemophilia B","Synthesis of bile acids and bile salts","Defective F9 activation","Synthesis of bile acids and 
bile salts via 7alpha-hydroxycholesterol","Metabolism of proteins","Post-translational protein modification",SUMOylation,"SUMO E3 ligases SUMOylate target proteins","SUMOylation of intracellular recep
tors"}

> <broad_targets>
{GP9,KCNB2,KCNN4,SLC29A4}

> <broad_moa>
{"hemozoin biocrystallization inhibitor"}

> <synonyms>
{quinidine,56-54-2,56542,(+)-Quinidine,(+)Quinidine,Conchinin,Chinidin,Pitayine,Quinidex,beta-Quinine,betaQuinine,"(8R,9S)-Quinidine","(8R,9S)Quinidine",(9S)-6'-Methoxycinchonan-9-ol,(9S)6'Methoxycinc
honan9ol,Cin-Quin,CinQuin,Conquinine,Kinidin,Conchinine,chinidinum,quinidina,Quiniduran,Chinidine,Cinchonan-9-ol,Cinchonan9ol,6'-methoxy-,6'methoxy,T0690,SAM002264644,Quinine,CPD000857275}

> <pdid>
PD001767

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{441074}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 24  0  0  0  0            999 V2000
   10.1995   -3.3789    0.0000 H   0  3
    7.6995   -3.3789    0.0000 Cl  0  5
    5.1937   -3.0093    0.0000 O   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2934   -3.7508    0.0000 C   0  0
   -0.0049   -2.9977    0.0000 N   0  0
   -1.3070   -3.7424    0.0000 C   0  0
   -2.6029   -2.9870    0.0000 C   0  0
   -2.5967   -1.4870    0.0000 C   0  0
   -1.2946   -0.7424    0.0000 C   0  0
    0.0013   -1.4977    0.0000 C   0  0
    3.8962   -2.2562    0.0000 C   0  0
    5.1966   -1.5087    0.0000 C   0  0
    5.1995   -0.0087    0.0000 C   0  0
    3.9019    0.7438    0.0000 C   0  0
    2.6014   -0.0038    0.0000 C   0  0
    2.5986   -1.5038    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    5.1892   -6.0097    0.0000 C   0  0
    5.1870   -7.5097    0.0000 C   0  0
    3.8869   -8.2578    0.0000 C   0  0
    2.5890   -7.5060    0.0000 C   0  0
    2.5911   -6.0060    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12  7  1  0
  4 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 13  1  0
  4 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6145

> <plate>
NGP-202-01

> <well>
H06

> <supplier_cmpd_name>
CPD000058515

> <ctcr_id>
5266

> <supplier_cmpd_id>
SAM002264652

> <smiles>
[H+].[Cl-].OC(CCN1CCCCC1)(C2CCCCC2)c3ccccc3

> <pd_targets>
{CHRM1,HRH1,GRIN1,GRIN2A,GRIN2B,GRIN2C,GRIN2D,GRIN3A,GRIN3B,CHRM2,CHRM4,CHRM3,PMP22,AMPC,BLM,MAPT,CHRM5,SIGMAR1,CYP2D6,TDP1,NFKB1,CYP3A4,TSHR}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Acetylcholine receptor","Ion channel","Ligand-gated ion channel","Ionotropic 
glutamate receptor","NMDA receptor","Histamine receptor","Unclassified protein",Enzyme,"Other cytosolic protein",Hydrolase,"Cytochrome P450","Cytochrome P450 family 2","Cytochrome P450 family 2D","Cyt
ochrome P450 2D6","Cytochrome P450 family 3","Peptide receptor (family A GPCR)","Cytochrome P450 family 3A","Glycohormone receptor","Cytochrome P450 3A4"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Acetylcholine receptors (muscarinic)","Histamine receptors","Other protein targets",Enzymes,"Sigma receptors","Cytochrome P450","CYP2 family: drug metabolisin
g subset","CYP3 family","Glycoprotein hormone receptors"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Amine ligand-binding receptors","Muscarinic acetylcholine receptors","Histamine receptors","Dev
elopmental Biology","DNA Repair","Neuronal System",Disease,Metabolism,"Nervous system development","DNA Double-Strand Break Repair","Transmission across Chemical Synapses","Infectious disease","Biolog
ical oxidations","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Homology Directed Repair","Neurotransmitter receptors and postsynaptic signal transmission","SARS-CoV Infections","Ph
ase I - Functionalization of compounds","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Activation of NMDA receptors and postsynaptic events","Potential therapeutics for
 SARS","Cytochrome P450 - arranged by substrate type","HDR through Homologous Recombination (HRR)","Post NMDA receptor activation events",Xenobiotics,"Homologous DNA Pairing and Strand Exchange","Acti
vation of AMPK downstream of NMDARs","CYP2E1 reactions","Presynaptic phase of homologous DNA pairing and strand exchange","Immune System","Cytokine Signaling in Immune system","Metabolism of lipids","
Nonhomologous End-Joining (NHEJ)","Signaling by Interleukins","Biosynthesis of specialized proresolving mediators (SPMs)","Leishmania infection","Interleukin-1 family signaling","Biosynthesis of DHA-d
erived SPMs","Leishmania parasite growth and survival","Interleukin-1 signaling","Biosynthesis of maresins","Anti-inflammatory response favouring Leishmania parasite infection","MAP3K8 (TPL2)-dependen
t MAPK1/3 activation","Biosynthesis of maresin-like SPMs","ADORA2B mediated anti-inflammatory cytokines production"}

> <broad_targets>
{CHRM1}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{"Trihexyphenidyl hydrochloride","Benzhexol hydrochloride",52-49-3,52493,Artane,"Trihexyphenidyl HCl","Benzhexol HCL","Artane hydrochloride","Trihexyphenidyl (hydrochloride)",58947-95-8,58947958,"1-Cy
clohexyl-1-phenyl-3-(piperidin-1-yl)propan-1-ol hydrochlor","1Cyclohexyl1phenyl3(piperidin1yl)propan1ol hydrochlor",T1328,SAM002264652,1500592,Prestw-701,"DL-trihexyphenidyl hydrochloride",CPD00005851
5,"TRIHEXYPHENIDYL HYDROCHLORIDE","Trihexyphenidyl-D,L Hydrochloride"}

> <pdid>
PD009627

> <targets>
{}

> <classes>
{anticholinergic,antiparkinsonian}

> <pubchem_cids>
{66007,517300,657317}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 18  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0031    3.0008    0.0000 C   0  0
   -1.2947    3.7531    0.0000 O   0  0
    1.3032    3.7490    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -1.2990   -5.2500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  3
  5  6  1  0
  6  7  1  0
  6  8  2  0
  5  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17  3  1  0
 17 11  1  0
M  END
> <name>
NIHCC_2014

> <id>
6146

> <plate>
NGP-202-01

> <well>
H07

> <supplier_cmpd_name>
CPD000058264

> <ctcr_id>
705

> <supplier_cmpd_id>
SAM002554914

> <smiles>
CCN1C=C(C(O)=O)C(=O)c2ccc(C)nc12

> <pd_targets>
{CYP1A2,LMNA,GYRA,GYRB,RORC,NFKB1,HSD17B10,BLM,KDM4E,ABCC4}

> <pathway_gtopdb>
{Enzyme,"Other nuclear protein","Transcription factor","Other cytosolic protein","Epigenetic regulator",Transporter,"Cytochrome P450",Isomerase,"Nuclear receptor",Oxidoreductase,Eraser,"Primary active
 transporter","Cytochrome P450 family 1","Nuclear hormone receptor subfamily 1","Lysine demethylase","ATP-binding cassette","Cytochrome P450 family 1A","Nuclear hormone receptor subfamily 1 group F","
Jumonji domain-containing","ABCC subfamily","Cytochrome P450 1A1","Nuclear hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Cytochrome P450","Nuclear hormone receptors","Chromatin modifying enzymes","ATP-binding cassette transporter family","CYP1 family","1F. Retinoic acid-related orphans",
"1.14.11.- Histone demethylases","ABCC subfamily"}

> <pathway_reactome>
{Metabolism,"Cell Cycle","Gene expression (Transcription)","Immune System","DNA Repair",Hemostasis,"Biological oxidations",Mitotic,"RNA Polymerase II Transcription","Cytokine Signaling in Immune syste
m","Metabolism of amino acids and derivatives","DNA Double-Strand Break Repair","Platelet activation","signaling and aggregation","Phase I - Functionalization of compounds","M Phase","Generic Transcri
ption Pathway","Signaling by Interleukins","Branched-chain amino acid catabolism","Homology Directed Repair","Response to elevated platelet cytosolic Ca2+","Cytochrome P450 - arranged by substrate typ
e","Mitotic Metaphase and Anaphase","Transcriptional regulation by RUNX3","Interleukin-1 family signaling","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Platelet degra
nulation",Xenobiotics,"Mitotic Anaphase","RUNX3 Regulates Immune Response and Cell Migration","Interleukin-1 signaling","HDR through Homologous Recombination (HRR)","Aromatic amines can be N-hydroxyla
ted or N-dealkylated by CYP1A2","Nuclear Envelope (NE) Reassembly","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Homologous DNA Pairing and Strand Exchange","Initiation of Nuclear Envelope (NE) Reform
ation","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{}

> <broad_moa>
{"bacterial DNA gyrase inhibitor"}

> <synonyms>
{"nalidixic acid",389-08-2,389082,Nalidixate,Nalidixin,Nevigramon,Uronidix,NegGram,Innoxalon,Nalidixan,Nalitucsan,Sicmylon,Unaserus,"Nalidic acid","Nalidixinic acid",Wintomylon,Dixiben,Dixinal,Jicsron
,Nalurin,Naxuril,Nogram,Urisal,Cybis,Nalix,1-,1,T0909,SAM002554914,1500756,"Nalidixic acid",CPD000058264,"NALIDIXIC ACID"}

> <pdid>
PD001597

> <targets>
{}

> <classes>
{antibacterial}

> <pubchem_cids>
{4421}

$$$$
NIHCC_2014
  SciTegic11012413002D

 18 17  0  0  0  0            999 V2000
    3.9007   -3.7520    0.0000 C   0  0
    3.9007   -2.2520    0.0000 C   0  0
    5.2000   -1.5007    0.0000 C   0  0
    5.2000    0.0000    0.0000 C   0  0
    5.2000    1.5000    0.0000 C   0  0
    3.9000    0.7500    0.0000 C   0  0
    2.6000    0.0000    0.0000 O   0  0
    1.3000    0.7500    0.0000 C   0  0
    1.3000    2.2500    0.0000 N   0  0
    0.0007    0.0004    0.0000 O   0  0
    6.5000    0.7500    0.0000 C   0  0
    7.7999    0.0000    0.0000 O   0  0
    9.0999    0.7500    0.0000 C   0  0
    9.0999    2.2500    0.0000 O   0  0
   10.3999    0.0000    0.0000 N   0  0
   11.6999    0.7500    0.0000 C   0  0
   12.9992    0.0004    0.0000 C   0  0
   11.6999    2.2500    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  2  0
  4 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
M  END
> <name>
NIHCC_2014

> <id>
6147

> <plate>
NGP-202-01

> <well>
H08

> <supplier_cmpd_name>
CPD000058433

> <ctcr_id>
4514

> <supplier_cmpd_id>
SAM002554889

> <smiles>
CCCC(C)(COC(N)=O)COC(=O)NC(C)C

> <pd_targets>
{NFKB1,LMNA,TSHR,CHRM1,TDP1,CYP3A4,GABRA1,GABRB2,GABRA5,GABRA3}

> <pathway_gtopdb>
{"Other cytosolic protein","Other nuclear protein","Membrane receptor",Enzyme,"Ion channel","Family A G protein-coupled receptor",Hydrolase,"Cytochrome P450","Ligand-gated ion channel","Peptide recept
or (family A GPCR)","Small molecule receptor (family A GPCR)","Cytochrome P450 family 3","GABA-A receptor","Glycohormone receptor","Monoamine receptor","Cytochrome P450 family 3A","Acetylcholine recep
tor","Cytochrome P450 3A4"}

> <pathway_chembl>
{Receptors,Enzymes,"Ion channels","G protein-coupled receptors","Cytochrome P450","Ligand-gated ion channels","Glycoprotein hormone receptors","Acetylcholine receptors (muscarinic)","CYP3 family","GAB
A<sub>A</sub> receptors"}

> <pathway_reactome>
{"Immune System","Cell Cycle",Disease,"Signal Transduction","DNA Repair",Metabolism,"Neuronal System","Cytokine Signaling in Immune system",Mitotic,"Infectious disease","Signaling by GPCR","DNA Double
-Strand Break Repair","Metabolism of lipids","Transmission across Chemical Synapses","Signaling by Interleukins","M Phase","Leishmania infection","GPCR ligand binding","Nonhomologous End-Joining (NHEJ
)","Biosynthesis of specialized proresolving mediators (SPMs)","Neurotransmitter receptors and postsynaptic signal transmission","Interleukin-1 family signaling","Mitotic Metaphase and Anaphase","Leis
hmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Biosynthesis of DHA-derived SPMs","GABA receptor activation","Interleukin-1 signaling","Mitotic Anaphase","Anti-inflammator
y response favouring Leishmania parasite infection","Amine ligand-binding receptors","Biosynthesis of maresins","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Nuclear Envelope (NE) Reassembly","ADORA2B
 mediated anti-inflammatory cytokines production","Muscarinic acetylcholine receptors","Biosynthesis of maresin-like SPMs","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{78-44-4,78444,Isomeprobamate,Carisoprodate,Carisoprodatum,Carisoma,Isobamate,Isoprotane,Isoprothane,SOMA,Sanoma,"Isopropyl meprobamate",Atonalyt,Flexartal,Miolisodal,Mioratrina,Skutamil,Somalgit,Apes
an,Arusal,Flexal,Mioril,Nospasm,Rela,SAM002554889,1500162,Prestw-423,CPD000058433,CARISOPRODOL,Carisoprodol}

> <pdid>
PD002442

> <targets>
{}

> <classes>
{"muscle relaxant (skeletal)"}

> <pubchem_cids>
{2576}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 18  0  0  0  0            999 V2000
    2.5983   -3.0004    0.0000 N   0  0
    2.5988   -1.5004    0.0000 S   0  0
    3.8983   -0.7512    0.0000 O   0  0
    3.8975   -2.2510    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 N   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -1.2991    3.7500    0.0000 N   0  0
    0.0000    3.0000    0.0000 S   0  0
    1.2810    2.2196    0.0000 O   0  0
   -0.0353    4.4996    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 Cl  0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12  7  1  0
 12 13  2  0
 12 14  2  0
  8 15  1  0
 15 16  2  0
 16  5  1  0
 16 17  1  0
M  END
> <name>
NIHCC_2014

> <id>
6148

> <plate>
NGP-202-01

> <well>
H09

> <supplier_cmpd_name>
CPD000035778

> <ctcr_id>
3072

> <supplier_cmpd_id>
SAM002554901

> <smiles>
N[S](=O)(=O)c1cc2c(NCN[S]2(=O)=O)cc1Cl

> <pd_targets>
{CA14,CA4,CA13,CA7,CA5A,CA2,CA1,THRB,LMNA,CA12,1272966,CA9,CA5B,CA6,PMP22,APEX1,SLC12A3,KCNMA1}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Other nuclear protein","Unclassified protein",Transporter,"Ion channel",Lyase,"Nuclear receptor","Electrochemical transporter","Voltage-gated ion channel","Nuclear horm
one receptor subfamily 1","SLC superfamily of solute carriers","Potassium channels","Nuclear hormone receptor subfamily 1 group A","SLC12 family of cation-coupled chloride transporters","Calcium-activ
ated potassium channel","Nuclear hormone receptor subfamily 1 group A member 2"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Ion channels","Carbonic anhydrases","Nuclear hormone receptors","SLC superfamily of solute carriers","Voltage-gated ion channels","1A. Thyroid hormone receptors","SLC1
2 family of cation-coupled chloride transporters","Potassium channels","Calcium- and sodium-activated potassium channels"}

> <pathway_reactome>
{Metabolism,"Transport of small molecules","Immune System","Metabolism of proteins","Cell Cycle","Cellular responses to external stimuli","Developmental Biology","DNA Repair",Disease,Hemostasis,"Rever
sible hydration of carbon dioxide","O2/CO2 exchange in erythrocytes","Cytokine Signaling in Immune system","Post-translational protein modification",Mitotic,"Cellular responses to stress","Nervous sys
tem development","Base Excision Repair","Disorders of transmembrane transporters","Platelet homeostasis","Erythrocytes take up carbon dioxide and release oxygen","Signaling by Interleukins",SUMOylatio
n,"M Phase","Cellular response to hypoxia","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Resolution of Abasic Sites (AP sites)","SLC transporter disorders","Nitric oxide stimulates
 guanylate cyclase","Interleukin-12 family signaling","SUMO E3 ligases SUMOylate target proteins","Mitotic Metaphase and Anaphase","Regulation of gene expression by Hypoxia-inducible Factor","Resoluti
on of AP sites via the multiple-nucleotide patch replacement pathway","Defective SLC12A3 causes Gitelman syndrome (GS)","cGMP effects","Interleukin-12 signaling","SUMOylation of intracellular receptor
s","Mitotic Anaphase","PCNA-Dependent Long Patch Base Excision Repair","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","Nuclear Envelope (NE) Reassembly","Initiati
on of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{CA1,CA12,CA2,CA4,CA9,KCNMA1,SLC12A3}

> <broad_moa>
{"thiazide diuretic"}

> <synonyms>
{hydrochlorothiazide,58-93-5,58935,HCTZ,Esidrix,Hypothiazide,Oretic,Dichlotiazid,Hidrotiazida,Hydrochlorothiazid,Hydrochlorthiazide,Hydrodiuretic,Hydrosaluric,Servithiazid,Aquarills,Aquarius,Dichlotri
de,Diclotride,Disalunil,Hypothiazid,Idrotiazide,M,T1449,SAM002554901,1500335,Prestw-9,Hydrochlorothiazide,CPD000035778,HYDROCHLOROTHIAZIDE}

> <pdid>
PD002304

> <targets>
{Potassium Channel,TGF-beta/Smad}

> <classes>
{diuretic,Membrane Transporter/Ion Channel,Stem Cell/Wnt,TGF-beta/Smad}

> <pubchem_cids>
{3639}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 27  0  0  0  0            999 V2000
    5.0632   -3.3789    0.0000 Br  0  5
    2.5800    0.0305    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  3
    1.2638   -2.2496    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 O   0  0
   -2.5951   -3.0039    0.0000 C   0  0
   -1.2948   -3.7517    0.0000 O   0  0
   -3.8933   -3.7570    0.0000 C   0  0
   -2.5930   -4.5047    0.0000 O   0  0
   -3.8912   -5.2578    0.0000 C   0  0
   -5.1891   -6.0097    0.0000 C   0  0
   -5.1870   -7.5097    0.0000 C   0  0
   -3.8869   -8.2578    0.0000 C   0  0
   -2.5889   -7.5060    0.0000 C   0  0
   -2.5911   -6.0060    0.0000 C   0  0
   -5.1943   -3.0089    0.0000 C   0  0
   -6.4920   -3.7612    0.0000 C   0  0
   -7.7924   -3.0134    0.0000 C   0  0
   -7.7950   -1.5134    0.0000 C   0  0
   -6.4973   -0.7612    0.0000 C   0  0
   -5.1969   -1.5089    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  3  1  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 13 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
M  CHG  2   1  -1   3   1
M  END
> <name>
NIHCC_2014

> <id>
6149

> <plate>
NGP-202-01

> <well>
H10

> <supplier_cmpd_name>
CPD000058832

> <ctcr_id>
2332

> <supplier_cmpd_id>
SAM002554910

> <smiles>
[Br-].C[N+]1(C)CCCC(C1)OC(=O)C(O)(c2ccccc2)c3ccccc3

> <pd_targets>
{CHRM2,CHRM4,CHRM3,SLC22A1,CHRM1}

> <pathway_gtopdb>
{"Membrane receptor",Transporter,"Family A G protein-coupled receptor","Electrochemical transporter","Small molecule receptor (family A GPCR)","SLC superfamily of solute carriers","Monoamine receptor"
,"SLC22 family of organic cation and anion transporters","Acetylcholine receptor"}

> <pathway_chembl>
{Receptors,Transporters,"G protein-coupled receptors","SLC superfamily of solute carriers","Acetylcholine receptors (muscarinic)","SLC22 family of organic cation and anion transporters","Organic catio
n transporters (OCT)"}

> <pathway_reactome>
{"Signal Transduction","Transport of small molecules","Signaling by GPCR","SLC-mediated transmembrane transport","GPCR ligand binding","Transport of bile salts and organic acids","metal ions and amine
 compounds","Class A/1 (Rhodopsin-like receptors)","Organic cation/anion/zwitterion transport","Amine ligand-binding receptors","Organic cation transport","Muscarinic acetylcholine receptors"}

> <broad_targets>
{}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{"MEPENZOLATE BROMIDE",76-90-4,76904,Cantil,Cantilaque,Colibantil,Gastropidil,Cantilon,Colopiril,Delevil,Eftoron,Tralanta,Trancolon,Colum,"3-(2-Hydroxy-2,2-diphenylacetoxy)-1,1-dimethylpiperidin-1-ium
 bromide","3(2Hydroxy2,2diphenylacetoxy)1,1dimethylpiperidin1ium bromide","Mepenzolate (Bromide)","JB 340",N-Met,NMet,T0794,SAM002554910,1500383,Prestw-653,"Mepenzolate Bromide",CPD000058832,"Mepenzol
ate bromide"}

> <pdid>
PD009364

> <targets>
{}

> <classes>
{anticholinergic}

> <pubchem_cids>
{6461}

$$$$
NIHCC_2014
  SciTegic11012413002D

 34 36  0  0  0  0            999 V2000
    2.5800    0.0305    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    3.8971    3.7500    0.0000 C   0  0
    3.8971    5.2500    0.0000 C   0  0
    5.1961    6.0001    0.0000 O   0  0
    2.5980    6.0000    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2991    3.7500    0.0000 O   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 O   0  0
   -2.5981    1.5000    0.0000 O   0  0
    0.0000    4.5000    0.0000 O   0  0
    0.0000    6.0000    0.0000 O   0  0
    2.5949    7.5009    0.0000 C   0  0
    1.2948    8.2490    0.0000 O   0  0
    3.8927    8.2531    0.0000 N   0  0
    5.1984    3.0023    0.0000 N   0  0
    6.4964    3.7542    0.0000 C   0  0
    5.2010    1.5023    0.0000 C   0  0
    3.8971    0.7500    0.0000 O   0  0
    1.2638   -2.2496    0.0000 O   0  0
    8.9971    2.2518    0.0000 Cl  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  2  3
 10 11  1  0
 11  5  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14  3  1  0
 14 15  2  3
 15 16  1  0
 16 17  2  3
 17  2  1  0
 17 18  1  0
 18 19  2  3
 19 20  1  0
 20 21  2  3
 21 16  1  0
 21 22  1  0
 15 23  1  0
 11 24  1  0
 10 25  1  0
  9 26  1  0
 26 27  2  0
 26 28  1  0
  6 29  1  0
 29 30  1  0
 29 31  1  0
  4 32  1  0
  2 33  1  0
M  END
> <name>
NIHCC_2014

> <id>
6150

> <plate>
NGP-202-01

> <well>
H11

> <supplier_cmpd_name>
CPD001614498

> <ctcr_id>
7016

> <supplier_cmpd_id>
SAM002554919

> <smiles>
CC1(C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O.Cl

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"CCRIS 200",CAS-2058-46-0,CAS2058460,"OXYTETRACYCLINE HYDROCHLORIDE","Oxytetracycline HCl",2058-46-0,2058460,"Terramycin hydrochloride",Bisolvomycin,Dalimycin,Unimycin,Imperacin,Mepatar,Oxacycline,Ox
ymykoin,Oxysteclin,Vendarcin,Alamycin,Dalinmycin,Engemycin,Oxa,SAM002554919,CPD001614498}

> <pdid>
PD055520

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{54680782}

$$$$
NIHCC_2014
  SciTegic11012413002D

 19 17  0  0  0  0            999 V2000
   11.4894   -3.3822    0.0000 H   0  3
    8.9894   -3.3822    0.0000 Cl  0  5
    6.4848   -8.2644    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    5.1894   -6.0109    0.0000 N   0  0
    6.4889   -5.2601    0.0000 C   0  0
    6.4894   -3.7601    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 O   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 16 18  1  0
 18 19  2  0
 19 13  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6151

> <plate>
NGP-202-02

> <well>
A02

> <supplier_cmpd_name>
CPD000718771

> <ctcr_id>
3911

> <supplier_cmpd_id>
SAM002554920

> <smiles>
[H+].[Cl-].CCN(CC)CCOC(=O)c1ccc(N)cc1

> <pd_targets>
{ALD,NFO,BLM,NPSR1,CYP2D6,CHRM1,TSHR,SCN10A,SCN11A,SCN1A,SCN2A,SCN3A,SCN4A,SCN5A,SCN7A,SCN8A,SCN9A,RYR2,RYR1,GRIN3A,HTR3A,SLC6A3,CHRNA2,KCNMA1,KCNMB1,KCNMB2,KCNMB3,KCNMB4,KCNN1,KCNN2,KCNN3,KCNN4,PLA2G
4A,ASPG,MAOA,MAOB,DNMT1,DNMT3A}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Ion channel",Transporter,"Epigenetic regulator",Hydrolase,"Family A G protein-coupled receptor","Cytochrome P450","Voltage-gated ion channel","Ligand-gated ion channel","E
lectrochemical transporter",Oxidoreductase,Writer,Reader,"Peptide receptor (family A GPCR)","Cytochrome P450 family 2","Small molecule receptor (family A GPCR)","Voltage-gated sodium channel","Ryanodi
ne receptor","Ionotropic glutamate receptor","5HT3 receptor","SLC superfamily of solute carriers","Nicotinic acetylcholine receptor","DNA methyltransferase","Methyl-lysine/arginine binding protein","S
hort peptide receptor (family A GPCR)","Cytochrome P450 family 2D","Monoamine receptor","Glycohormone receptor","NMDA receptor","SLC06 neurotransmitter transporter family","Nicotinic acetylcholine rec
eptor alpha subunit","PWWP domain","Neuropeptide receptor","Cytochrome P450 2D6","Acetylcholine receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"Ion channels",Transporters,"G protein-coupled receptors","Cytochrome P450","Voltage-gated ion channels","Ligand-gated ion channels","SLC superfamily of solute carriers","Glyceropho
spholipid turnover","3.1.1.- Carboxylic Ester Hydrolases","2.1.1.- Methyltransferases","Neuropeptide S receptor","CYP2 family: drug metabolising subset","Acetylcholine receptors (muscarinic)","Glycopr
otein hormone receptors","Ryanodine receptors","Voltage-gated sodium channels","Ionotropic glutamate receptors","5-HT<sub>3</sub> receptors","SLC6 neurotransmitter transporter family","Nicotinic acety
lcholine receptors","Phospholipase A<sub>2</sub>","Monoamine transporter subfamily"}

> <pathway_reactome>
{"DNA Repair",Disease,Metabolism,"Signal Transduction","Muscle contraction","Developmental Biology","Neuronal System","Metabolism of proteins","DNA Double-Strand Break Repair","Infectious disease","Bi
ological oxidations","Signaling by GPCR","Cardiac conduction","Nervous system development","Transmission across Chemical Synapses","Disorders of transmembrane transporters","Metabolism of amino acids 
and derivatives","Post-translational protein modification","Homology Directed Repair","Leishmania infection","Phase I - Functionalization of compounds","GPCR ligand binding","Ion homeostasis","Axon gu
idance","Neurotransmitter receptors and postsynaptic signal transmission","SLC transporter disorders","GPCR downstream signalling","Aspartate and asparagine metabolism",SUMOylation,"HDR through Homolo
gous Recombination (HRR) or Single Strand Annealing (SSA)","Leishmania parasite growth and survival","Cytochrome P450 - arranged by substrate type","Class A/1 (Rhodopsin-like receptors)","L1CAM intera
ctions","Activation of NMDA receptors and postsynaptic events","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Acetylcholine binding and downstream events","G alpha (i) signalling e
vents","SUMO E3 ligases SUMOylate target proteins","HDR through Homologous Recombination (HRR)","Anti-inflammatory response favouring Leishmania parasite infection",Xenobiotics,"Amine ligand-binding r
eceptors","Interaction between L1 and Ankyrins","Assembly and cell surface presentation of NMDA receptors","Postsynaptic nicotinic acetylcholine receptors","Opioid Signalling","SUMOylation of DNA meth
ylation proteins","Homologous DNA Pairing and Strand Exchange","ADORA2B mediated anti-inflammatory cytokines production","CYP2E1 reactions","Muscarinic acetylcholine receptors","Highly calcium permeab
le postsynaptic nicotinic acetylcholine receptors","G-protein mediated events","Presynaptic phase of homologous DNA pairing and strand exchange","PLC beta mediated events","Ca-dependent events","phosp
ho-PLA2 pathway"}

> <broad_targets>
{CHRNA2,GRIN3A,HTR3A,KCNMA1,KCNMB1,KCNMB2,KCNMB3,KCNMB4,KCNN1,KCNN2,KCNN3,KCNN4,MAOA,MAOB,RYR1,RYR2,SCN10A,SLC6A3}

> <broad_moa>
{"HMGCR inhibitor"}

> <synonyms>
{"PROCAINE HYDROCHLORIDE",51-05-8,51058,"Procaine Hcl","2-(diethylamino)ethyl 4-aminobenzoate hydrochloride","2(diethylamino)ethyl 4aminobenzoate hydrochloride","Procaine (hydrochloride)",Allocaine,Sc
urocaine,"Novocaine hydrochloride",UNII-95URV01IDQ,UNII95URV01IDQ,"Benzoic acid",4-amino-,4amino,"2-(diethylamino)ethyl est","2(diethylamino)ethyl est",T0029,SAM002554920,1500504,Prestw-41,Procaine,CP
D000718771,"Procaine hydrochloride"}

> <pdid>
PD010059

> <targets>
{DNA/RNA Synthesis,Histone Demethylase}

> <classes>
{anesthetic (local),Cell Cycle/DNA Damage,Epigenetics}

> <pubchem_cids>
{5795,15939510,43833393,16057736,45489743}

$$$$
NIHCC_2014
  SciTegic11012413002D

 18 17  0  0  0  0            999 V2000
    8.9894   -3.3822    0.0000 Cl  0  5
    6.4848   -8.2644    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    5.1894   -6.0109    0.0000 N   0  0
    6.4889   -5.2601    0.0000 C   0  0
    6.4894   -3.7601    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 N   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 N   0  3
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 12  1  0
M  CHG  2   1  -1  16   1
M  END
> <name>
NIHCC_2014

> <id>
6152

> <plate>
NGP-202-02

> <well>
A03

> <supplier_cmpd_name>
CPD000059079

> <ctcr_id>
787

> <supplier_cmpd_id>
SAM002554928

> <smiles>
[Cl-].CCN(CC)CCNC(=O)c1ccc([NH3+])cc1

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"procainamide hydrochloride","Procainamide Hcl",614-39-1,614391,"614 39 1",Pronestyl,Procanbid,Procapan,Procan,"Procainamide (hydrochloride)","4-amino-N-(2-(diethylamino)ethyl)benzamide hydrochloride
","4aminoN(2(diethylamino)ethyl)benzamide hydrochloride","4aminoN(2(diethylamino)ethyl)benzamide hydr",SAM002554928,1500503,Prestw-337,CPD000059079,"PROCAINAMIDE HYDROCHLORIDE","Procainamide hydrochlo
ride"}

> <pdid>

> <targets>
{}

> <classes>
{antiarrhythmic}

> <pubchem_cids>
{43833392,66068,44272299,657275}

$$$$
NIHCC_2014
  SciTegic11012413002D

 18 18  0  0  0  0            999 V2000
   11.6982   -0.7537    0.0000 C   0  0
   10.3987   -1.5029    0.0000 C   0  0
    9.0990   -0.7525    0.0000 C   0  0
    7.7988   -1.5020    0.0000 C   0  0
    6.4990   -0.7516    0.0000 N   0  0
    5.1988   -1.5012    0.0000 C   0  0
    5.1983   -3.0012    0.0000 O   0  0
    3.8990   -0.7508    0.0000 N   0  0
    2.5988   -1.5004    0.0000 S   0  0
    3.8975   -2.2510    0.0000 O   0  0
    2.5983   -3.0004    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  2  0
  9 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 12  1  0
M  END
> <name>
NIHCC_2014

> <id>
6153

> <plate>
NGP-202-02

> <well>
A04

> <supplier_cmpd_name>
CPD000058363

> <ctcr_id>
1355

> <supplier_cmpd_id>
SAM002554936

> <smiles>
CCCCNC(=O)N[S](=O)(=O)c1ccc(C)cc1

> <pd_targets>
{ALB,TSHR,LEF,CHRM1,KCNJ11,CYP2C9,LMNA,ALDH1A1,SLC22A6,ABCC8,KCNJ8,KCNJ1}

> <pathway_gtopdb>
{"Secreted protein","Membrane receptor",Enzyme,"Ion channel","Other nuclear protein",Transporter,"Family A G protein-coupled receptor",Protease,"Voltage-gated ion channel","Cytochrome P450",Oxidoreduc
tase,"Electrochemical transporter","Primary active transporter","Peptide receptor (family A GPCR)","Metallo protease","Small molecule receptor (family A GPCR)","Potassium channels","Cytochrome P450 fa
mily 2","SLC superfamily of solute carriers","ATP-binding cassette","Glycohormone receptor","Metallo protease MAE clan","Monoamine receptor","Inwardly rectifying potassium channel","Cytochrome P450 fa
mily 2C","SLC22 family of organic cation and anion transporters","ABCC subfamily","Metallo protease M34 family","Acetylcholine receptor","Cytochrome P450 2C9"}

> <pathway_chembl>
{Receptors,"Ion channels",Enzymes,Transporters,"G protein-coupled receptors","Voltage-gated ion channels","Cytochrome P450","SLC superfamily of solute carriers","ATP-binding cassette transporter famil
y","Glycoprotein hormone receptors","Acetylcholine receptors (muscarinic)","Potassium channels","CYP2 family: drug metabolising subset","SLC22 family of organic cation and anion transporters","ABCC su
bfamily","Inwardly rectifying potassium channels","Organic anion transporters (OATs)"}

> <pathway_reactome>
{Metabolism,Disease,"Signal Transduction","Cell Cycle","Transport of small molecules","Neuronal System","Metabolism of lipids","Infectious disease","Signaling by GPCR","Disorders of transmembrane tran
sporters","Biological oxidations",Mitotic,"SLC-mediated transmembrane transport","Potassium Channels","Metabolism of steroids","Leishmania infection","Uptake and actions of bacterial toxins","GPCR lig
and binding","ABC transporter disorders","Phase I - Functionalization of compounds","M Phase","Transport of bile salts and organic acids","metal ions and amine compounds","Inwardly rectifying K+ chann
els","Bile acid and bile salt metabolism","Leishmania parasite growth and survival","Uptake and function of anthrax toxins","Class A/1 (Rhodopsin-like receptors)","Defective ABCC8 can cause hypo- and 
hyper-glycemias","Cytochrome P450 - arranged by substrate type","Mitotic Metaphase and Anaphase","Ethanol oxidation","Organic cation/anion/zwitterion transport","ATP sensitive Potassium channels","Pot
assium transport channels","Recycling of bile acids and salts","Anti-inflammatory response favouring Leishmania parasite infection","Amine ligand-binding receptors",Xenobiotics,"Mitotic Anaphase","Org
anic anion transport","ADORA2B mediated anti-inflammatory cytokines production","Muscarinic acetylcholine receptors","CYP2E1 reactions","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelo
pe (NE) Reformation"}

> <broad_targets>
{ABCC8,KCNJ1,KCNJ11,KCNJ8}

> <broad_moa>
{"ATP channel blocker"}

> <synonyms>
{RESTW19,tolbutamide,64-77-7,64777,Orinase,Artosin,1-Butyl-3-tosylurea,1Butyl3tosylurea,Tolbutamid,Aglicid,Arkozal,Diabetol,Dolipol,Rastinon,Tolumid,Diaben,Orabet,Tolylsulfonylbutylurea,Willbutamide,B
utamide,Diabetamid,Diabuton,Diasulfon,Dirastan,Glyconon,Ipoglicone,Pramidex,T1054,SAM002554936,1500581,Prestw-190,Tolbutamide,CPD000058363,TOLBUTAMIDE}

> <pdid>
PD001726

> <targets>
{Autophagy,Potassium Channel}

> <classes>
{antidiabetic,Autophagy,Membrane Transporter/Ion Channel}

> <pubchem_cids>
{5505}

$$$$
NIHCC_2014
  SciTegic11012413002D

 32 35  0  0  1  0            999 V2000
   -4.7175   -4.3834    0.0000 C   0  0
   -3.6663   -3.3134    0.0000 C   0  0
   -2.2130   -3.6880    0.0000 C   0  0
   -1.8114   -5.1333    0.0000 O   0  0
   -1.1612   -2.6174    0.0000 O   0  0
    0.2851   -2.9666    0.0000 C   0  0  2  0  0  0
    1.7758   -3.1329    0.0000 C   0  0  1  0  0  0
    2.2703   -4.0021    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -0.8660    2.5000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
    0.0000    0.5000    0.0000 F   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -0.8141   -2.0807    0.0000 C   0  0
    0.7499   -4.3804    0.0000 C   0  0
    1.7256   -4.5995    0.0000 O   0  0
   -0.2668   -5.4844    0.0000 C   0  0
    0.1798   -6.9164    0.0000 Cl  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  6  5  1  1
  6  7  1  0
  7  8  1  6
  7  9  1  0
 10  9  1  6
 10 11  1  0
 11 12  1  1
 12 13  1  0
 13 14  1  0
 14 15  2  3
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  2  3
 19 20  1  0
 20 14  1  0
 20 21  1  6
 20 22  1  0
 22 11  1  0
 22 23  1  1
 22 24  1  0
 24 25  1  6
 24 26  1  0
 26 27  1  0
 27  6  1  0
 27 10  1  0
 27 28  1  6
  6 29  1  0
 29 30  2  0
 29 31  1  0
 31 32  1  0
M  END
> <name>
NIHCC_2014

> <id>
6154

> <plate>
NGP-202-02

> <well>
A05

> <supplier_cmpd_name>
CPD000058745

> <ctcr_id>
6451

> <supplier_cmpd_id>
SAM002564250

> <smiles>
CCC(=O)O[C@@]1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C)C(=O)CCl

> <pd_targets>
{MAPT,NPSR1,RORC,CYP3A5,AMPC,AR,NR3C1,PGR,ABCB11,LMNA,CYP3A4,ANXA1,NR3C2}

> <pathway_gtopdb>
{"Other cytosolic protein","Membrane receptor","Transcription factor",Enzyme,Transporter,"Other nuclear protein","Ion channel","Family A G protein-coupled receptor","Nuclear receptor","Cytochrome P450
",Hydrolase,"Primary active transporter",Protease,"Other ion channel","Peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 3","Nuclear hormone receptor sub
family 3","ATP-binding cassette","Cysteine protease",Annexin,"Short peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family 3A","Nuclear hormone recept
or subfamily 3 group C","ABCB subfamily","Cysteine protease CA clan","Neuropeptide receptor","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 3A5","Nuclear hormone receptor sub
family 3 group C member 4","Nuclear hormone receptor subfamily 3 group C member 1","Nuclear hormone receptor subfamily 3 group C member 3","Cysteine protease C1A family","Cytochrome P450 3A4","Nuclear
 hormone receptor subfamily 3 group C member 2"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"G protein-coupled receptors","Nuclear hormone receptors","Cytochrome P450","ATP-binding cassette transporter family","Neuropeptide S receptor","1F. Retinoic acid-relat
ed orphans","CYP3 family","Steroid hormone receptors","ABCB subfamily","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"Neuronal System",Disease,"Gene expression (Transcription)",Metabolism,"Cell Cycle","Signal Transduction","Metabolism of proteins","Transmission across Chemical Synapses","Infectious disease","RNA Po
lymerase II Transcription","Biological oxidations","Metabolism of lipids",Mitotic,"Signaling by GPCR","Post-translational protein modification","Neurotransmitter receptors and postsynaptic signal tran
smission","Leishmania infection","Generic Transcription Pathway","Phase I - Functionalization of compounds","Metabolism of steroids","M Phase","Biosynthesis of specialized proresolving mediators (SPMs
)","GPCR ligand binding",SUMOylation,"Activation of NMDA receptors and postsynaptic events","Leishmania parasite growth and survival","Transcriptional regulation by RUNX3","Cytochrome P450 - arranged 
by substrate type","Transcriptional regulation by RUNX2","FOXO-mediated transcription","Bile acid and bile salt metabolism","Mitotic Metaphase and Anaphase","Biosynthesis of DHA-derived SPMs","Class A
/1 (Rhodopsin-like receptors)","SUMO E3 ligases SUMOylate target proteins","Post NMDA receptor activation events","Anti-inflammatory response favouring Leishmania parasite infection","RUNX3 Regulates 
Immune Response and Cell Migration",Xenobiotics,"RUNX2 regulates bone development","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","Synthesis of bile acids and bile sa
lts","Mitotic Anaphase","Biosynthesis of maresins","Peptide ligand-binding receptors","SUMOylation of intracellular receptors","Activation of AMPK downstream of NMDARs","ADORA2B mediated anti-inflamma
tory cytokines production","RUNX2 regulates osteoblast differentiation","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Nuclear Envelope (NE) Reassembly","Biosynthesis of mares
in-like SPMs","Formyl peptide receptors bind formyl peptides and many other ligands","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{NR3C1,PLA2G1B}

> <broad_moa>
{"glucocorticoid receptor agonist"}

> <synonyms>
{RESTW78,"CLOBETASOL PROPIONATE",25122-46-7,25122467,"Clobetasol 17-propionate","Clobetasol 17propionate",Clobex,Dermovate,Temovate,"Clobestasol propionate","clobetasol 17-propanoate","clobetasol 17pr
opanoate","GR 2/925","CCI 4725",MLS000028708,Embeline,UNII-779619577M,UNII779619577M,"Embeline E",SMR000058745,Clobesol,CHEBI:314,SAM002564250,Prestw-781,CPD000058745,"Clobetasol propionate"}

> <pdid>
PD000810

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{32798}

$$$$
NIHCC_2014
  SciTegic11012413002D

 55 62  0  0  1  0            999 V2000
    5.1667  -15.0029    0.0000 C   0  0
    6.4683  -14.2574    0.0000 C   0  0  1  0  0  0
    6.4735  -12.7574    0.0000 O   0  0
    7.7751  -12.0118    0.0000 C   0  0  2  0  0  0
    9.0715  -12.7664    0.0000 C   0  0
    9.0664  -14.2664    0.0000 C   0  0  2  0  0  0
   10.3628  -15.0208    0.0000 O   0  0
    7.7647  -15.0119    0.0000 C   0  0  2  0  0  0
    7.7596  -16.5119    0.0000 O   0  0
    7.7773  -10.5110    0.0000 O   0  0
    6.4790   -9.7579    0.0000 C   0  0  1  0  0  0
    6.4790   -8.2579    0.0000 C   0  0  1  0  0  0
    7.7781   -7.5079    0.0000 O   0  0
    5.1800   -7.5079    0.0000 C   0  0
    3.8809   -8.2579    0.0000 C   0  0  1  0  0  0
    3.8810   -9.7579    0.0000 O   0  0
    5.1800  -10.5079    0.0000 C   0  0  2  0  0  0
    5.1800  -12.0079    0.0000 C   0  0
    2.5826   -7.5048    0.0000 O   0  0
    2.5847   -6.0040    0.0000 C   0  0  1  0  0  0
    1.2883   -5.2495    0.0000 C   0  0  1  0  0  0
   -0.0133   -5.9950    0.0000 O   0  0
    1.2935   -3.7495    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0  1  0  0  0
    3.8915   -3.7585    0.0000 O   0  0
    3.8864   -5.2585    0.0000 C   0  0  2  0  0  0
    5.1828   -6.0130    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -1.2990    2.2500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0  2  0  0  0
   -2.5981    1.5000    0.0000 C   0  0  2  0  0  0
   -2.5981    3.0000    0.0000 C   0  0
   -3.8971    3.7500    0.0000 C   0  0  1  0  0  0
   -3.8971    5.2500    0.0000 O   0  0
   -5.1962    3.0000    0.0000 C   0  0  2  0  0  0
   -5.3512    4.4919    0.0000 C   0  0
   -6.6112    3.4635    0.0000 C   0  0
   -7.4928    2.2500    0.0000 C   0  0
   -6.6111    1.0364    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0  2  0  0  0
   -5.3512    0.0080    0.0000 O   0  0
   -7.0732    4.8913    0.0000 C   0  0
   -6.2824    6.1452    0.0000 C   0  0
   -7.2559    7.2864    0.0000 C   0  0
   -6.9049    8.7447    0.0000 O   0  0
   -8.6421    6.7131    0.0000 O   0  0
   -8.5252    5.2177    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  6
  6  8  1  0
  8  2  1  0
  8  9  1  6
  4 10  1  1
 11 10  1  6
 11 12  1  0
 12 13  1  6
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 11  1  0
 17 18  1  1
 15 19  1  1
 20 19  1  1
 20 21  1  0
 21 22  1  1
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 20  1  0
 26 27  1  6
 24 28  1  6
 29 28  1  6
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  6
 32 34  1  0
 34 35  1  1
 35 36  1  0
 37 36  1  1
 37 38  1  0
 38 32  1  0
 38 39  1  6
 39 40  1  0
 40 41  1  6
 40 42  1  0
 42 43  1  6
 42 44  1  0
 44 45  1  0
 45 46  1  0
 46 47  1  0
 47 37  1  0
 47 42  1  0
 47 48  1  6
 44 49  1  0
 49 50  2  3
 50 51  1  0
 51 52  2  0
 51 53  1  0
 53 54  1  0
 54 49  1  0
 34 55  1  0
 55 29  1  0
M  END
> <name>
NIHCC_2014

> <id>
6155

> <plate>
NGP-202-02

> <well>
A06

> <supplier_cmpd_name>
CPD001906774

> <ctcr_id>
7021

> <supplier_cmpd_id>
SAM002564205

> <smiles>
C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@H]2[C@@H](O)C[C@@H](O[C@@H]2C)O[C@H]3[C@@H](O)C[C@@H](O[C@@H]3C)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)C(CC[C@]67O)C8=CC(=O)OC8)C4

> <pd_targets>
{GLA,ATP1A2,ATP1A3,RORC,ATP1A1,LMNA,TP53,REP,ATP1A4,ATP1B1,ATP1B2,ATP1B3,FXYD2,RECQL,LEF,SLCO1A4,SLCO1B1,STAT3,PAX8,SLCO1B3}

> <pathway_gtopdb>
{Enzyme,Transporter,"Transcription factor","Other nuclear protein","Unclassified protein",Hydrolase,"Primary active transporter","Nuclear receptor",Protease,Transferase,"Electrochemical transporter","
P-type ATPase","Nuclear hormone receptor subfamily 1","Cysteine protease","Metallo protease","SLC superfamily of solute carriers","Sodium potassium ATPase","Nuclear hormone receptor subfamily 1 group 
F","Cysteine protease CA clan","Metallo protease MAE clan","SLC21/SLCO family of organic anion transporting polypeptides","Nuclear hormone receptor subfamily 1 group F member 3","Cysteine protease C1A
 family","Metallo protease M34 family"}

> <pathway_chembl>
{Receptors,Transporters,"Other protein targets","Nuclear hormone receptors","P-type ATPases","Anti-infective targets","SLC superfamily of solute carriers","Transcription factors","1F. Retinoic acid-re
lated orphans","P2C P-type ATPases","Viral protein targets","SLCO family of organic anion transporting polypeptides","STAT transcription factors",Na<sup>+</sup>/K<sup>+</sup>-ATPases,"Coronavirus (CoV
) proteins"}

> <pathway_reactome>
{Metabolism,"Gene expression (Transcription)",Disease,"Cell Cycle","Metabolism of lipids","RNA Polymerase II Transcription","Infectious disease",Mitotic,"Cell Cycle Checkpoints","Diseases of signal tr
ansduction by growth factor receptors and second messengers","Sphingolipid metabolism","Generic Transcription Pathway","SARS-CoV Infections","M Phase","G1/S DNA Damage Checkpoints","Uptake and actions
 of bacterial toxins","Metabolism of steroids","Signaling by FGFR in disease","Glycosphingolipid metabolism","Transcriptional regulation by RUNX3","Potential therapeutics for SARS","Mitotic Metaphase 
and Anaphase","p53-Dependent G1/S DNA damage checkpoint","SARS-CoV-2 Infection","Uptake and function of anthrax toxins","Bile acid and bile salt metabolism","Signaling by FGFR1 in disease","RUNX3 Regu
lates Immune Response and Cell Migration","Mitotic Anaphase","p53-Dependent G1 DNA Damage Response","SARS-CoV-2 Genome Replication and Transcription","Recycling of bile acids and salts","FGFR1 mutant 
receptor activation","Nuclear Envelope (NE) Reassembly","Stabilization of p53","Replication of the SARS-CoV-2 genome","Signaling by cytosolic FGFR1 fusion mutants","Initiation of Nuclear Envelope (NE)
 Reformation","Autodegradation of the E3 ubiquitin ligase COP1"}

> <broad_targets>
{ATP1A1}

> <broad_moa>
{"ATPase inhibitor"}

> <synonyms>
{CHEMBL49693,SCHEMBL18947799,HMS3259A12,NC00559,NCGC00247770-01,NCGC0024777001,BRD-A75144621-001-01-0,BRDA75144621001010,SAM002564205,CPD001906774}

> <pdid>
PD002372

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{30322}

$$$$
NIHCC_2014
  SciTegic11012413002D

 33 36  0  0  1  0            999 V2000
    2.5981    0.0000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    1.2990   -3.7500    0.0000 C   0  0
    2.5981   -3.0000    0.0000 C   0  0  1  0  0  0
    3.8971   -3.7500    0.0000 C   0  0  2  0  0  0
    4.2297   -5.2071    0.0000 C   0  0
    5.7224   -5.3544    0.0000 C   0  0
    6.3238   -3.9802    0.0000 C   0  0  2  0  0  0
    6.6067   -3.0210    0.0000 O   0  0
    7.3153   -5.0895    0.0000 C   0  0
    8.7787   -4.7600    0.0000 O   0  0
    6.8692   -6.5225    0.0000 C   0  0
    7.8864   -7.6260    0.0000 O   0  0
    7.4403   -9.0589    0.0000 C   0  0
    5.9769   -9.3884    0.0000 O   0  0
    8.4575  -10.1624    0.0000 C   0  0
    8.0114  -11.5954    0.0000 C   0  0
    9.0286  -12.6989    0.0000 C   0  0
   10.4920  -12.3694    0.0000 O   0  0
    8.5827  -14.1311    0.0000 O   0  0
    5.1962   -3.0000    0.0000 C   0  0  2  0  0  0
    6.1061   -2.5853    0.0000 C   0  0
    5.1962   -1.5000    0.0000 C   0  0
    3.8971   -0.7500    0.0000 C   0  0  2  0  0  0
    3.8971    0.7500    0.0000 O   0  0
    2.5981   -1.5000    0.0000 C   0  0  2  0  0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  2  3
  8  2  1  0
  8  9  1  0
  9 10  1  0
 11 10  1  6
 11 12  1  0
 12 13  1  1
 13 14  1  0
 14 15  1  0
 15 16  1  6
 15 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  2  0
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 25 27  2  0
 15 28  1  0
 28 12  1  0
 28 29  1  1
 28 30  1  0
 30 31  1  0
 31 32  1  1
 33 31  1  1
 33  2  1  0
 33 11  1  0
M  END
> <name>
NIHCC_2014

> <id>
6156

> <plate>
NGP-202-02

> <well>
A07

> <supplier_cmpd_name>
CPD000058328

> <ctcr_id>
7022

> <supplier_cmpd_id>
SAM002564213

> <smiles>
C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@](O)(C(=O)COC(=O)CCC(O)=O)[C@@]4(C)C[C@H](O)[C@H]23

> <pd_targets>
{HIF1A,AMPC,PMP22,RORC,NR3C1}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Unclassified protein",Hydrolase,"Nuclear receptor","Nuclear hormone receptor subfamily 1","Nuclear hormone receptor subfamily 3","Nuclear hormone receptor subfamily 1 g
roup F","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 1 group F member 3","Nuclear hormone receptor subfamily 3 group C member 1"}

> <pathway_chembl>
{Receptors,"Nuclear hormone receptors","1F. Retinoic acid-related orphans","Steroid hormone receptors","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"Cellular responses to external stimuli","Developmental Biology","Gene expression (Transcription)","Cellular responses to stress","Nervous system development","RNA Polymerase II Transcription","Cellu
lar response to hypoxia","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Generic Transcription Pathway","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Tr
anscriptional regulation by RUNX3","FOXO-mediated transcription","RUNX3 Regulates Immune Response and Cell Migration","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes"}

> <broad_targets>
{}

> <broad_moa>
{}

> <synonyms>
{"hydrocortisone hemisuccinate","Hydrocortisone succinate","Cortisol succinate","Hydrocortisone 21-hemisuccinate","Hydrocortisone 21hemisuccinate",2203-97-6,2203976,"Cortisol hemisuccinate","Cortisol 
21-hemisuccinate","Cortisol 21hemisuccinate",Solu-Cortef,SoluCortef,"Hydrocortisone hydrogen succinate",CHEBI:31677,UNII-I,UNIII,SAM002564213,CPD000058328}

> <pdid>
PD002302

> <targets>
{Glucocorticoid Receptor,Interleukin Related}

> <classes>
{GPCR/G Protein,Immunology/Inflammation}

> <pubchem_cids>
{16623}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 28  0  0  1  0            999 V2000
   -1.8114   -5.1333    0.0000 C   0  0
   -2.2130   -3.6880    0.0000 C   0  0
   -3.6655   -3.3136    0.0000 O   0  0
   -1.1612   -2.6174    0.0000 O   0  0
    0.2851   -2.9666    0.0000 C   0  0  1  0  0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  2  0  0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -0.8141   -2.0807    0.0000 C   0  0
    0.7499   -4.3804    0.0000 C   0  0
    1.1965   -5.8123    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  5  4  1  6
  5  6  1  0
  6  7  1  0
  8  7  1  6
  8  9  1  0
  9 10  1  1
 10 11  1  0
 11 12  1  0
 12 13  2  3
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 18 17  1  1
 18 12  1  0
 18 19  1  0
 19  9  1  0
 19 20  1  6
 20 21  1  0
 21 22  1  0
 22  5  1  0
 22  8  1  0
 22 23  1  6
  5 24  1  0
 24 25  3  0
M  END
> <name>
NIHCC_2014

> <id>
6157

> <plate>
NGP-202-02

> <well>
A08

> <supplier_cmpd_name>
CPD001906776

> <ctcr_id>
7025

> <supplier_cmpd_id>
SAM002564222

> <smiles>
CC(=O)O[C@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C)C#C

> <pd_targets>
{FTL,PGR,AR,MAPT,RORC,CYP2C19,NR3C1}

> <pathway_gtopdb>
{"Unclassified protein","Transcription factor","Other cytosolic protein",Enzyme,"Nuclear receptor","Cytochrome P450","Nuclear hormone receptor subfamily 3","Nuclear hormone receptor subfamily 1","Cyto
chrome P450 family 2","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family 2C","Nuclear hormone receptor subfamily 3 group C member 3",
"Nuclear hormone receptor subfamily 3 group C member 4","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 2C19","Nuclear hormone receptor subfamily 3 group C member 1"}

> <pathway_chembl>
{Receptors,Enzymes,"Nuclear hormone receptors","Cytochrome P450","Steroid hormone receptors","1F. Retinoic acid-related orphans","CYP2 family: drug metabolising subset","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"Vesicle-mediated transport","Gene expression (Transcription)","Neuronal System",Metabolism,"Metabolism of proteins","Membrane Trafficking","RNA Polymerase II Transcription","Transmission across Chem
ical Synapses","Biological oxidations","Post-translational protein modification","trans-Golgi Network Vesicle Budding","Generic Transcription Pathway","Neurotransmitter receptors and postsynaptic sign
al transmission","Phase I - Functionalization of compounds",SUMOylation,"Golgi Associated Vesicle Biogenesis","Transcriptional regulation by RUNX2","Activation of NMDA receptors and postsynaptic event
s","Transcriptional regulation by RUNX3","Cytochrome P450 - arranged by substrate type","FOXO-mediated transcription","SUMO E3 ligases SUMOylate target proteins","RUNX2 regulates bone development","Po
st NMDA receptor activation events","RUNX3 Regulates Immune Response and Cell Migration",Xenobiotics,"FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","SUMOylation of in
tracellular receptors","RUNX2 regulates osteoblast differentiation","Activation of AMPK downstream of NMDARs","CYP2E1 reactions"}

> <broad_targets>
{PGR}

> <broad_moa>
{"progesterone receptor agonist"}

> <synonyms>
{"Norethindrone acetate","19-Norethindrone acetate","19Norethindrone acetate","Norethisterone acetate",51-98-9,51989,Orlutate,"Norlutin acetate",ENTA,Aygestin,Norlutate,"19-Norethisterone acetate","19
Norethisterone acetate",Primolut-Nor,PrimolutNor,"Norethindrone 17-acetate","Norethindrone 17acetate","Norethisteron acetate",SAM002564222,CPD001906776}

> <pdid>
PD001833

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5832}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 25  0  0  0  0            999 V2000
    4.7271    3.0702    0.0000 K   0  3
    0.1194   -2.3933    0.0000 C   0  0
    0.7500   -1.0323    0.0000 C   0  0
    2.2393   -0.8534    0.0000 C   0  0
    1.2135    0.3943    0.0000 S   0  0
    0.0000    1.2760    0.0000 C   0  0
   -0.8796    2.4866    0.0000 C   0  0
   -0.6484    3.9634    0.0000 N   0  0
   -1.8159    4.9065    0.0000 C   0  0
   -3.2155    4.3669    0.0000 O   0  0
   -1.5838    6.3893    0.0000 C   0  0
   -2.7513    7.3324    0.0000 C   0  0
   -2.5215    8.8147    0.0000 C   0  0
   -3.6902    9.7549    0.0000 C   0  0
   -5.0888    9.2129    0.0000 C   0  0
   -5.3187    7.7306    0.0000 C   0  0
   -4.1500    6.7904    0.0000 C   0  0
   -2.0931    1.6049    0.0000 C   0  0
   -3.5746    1.8395    0.0000 O   0  0
   -1.2135    0.3943    0.0000 N   0  0
   -0.7500   -1.0323    0.0000 C   0  0
   -1.6332   -2.2426    0.0000 C   0  0
   -1.0255   -3.6140    0.0000 O   0  5
   -3.1247   -2.0836    0.0000 O   0  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
  7 18  1  0
 18 19  2  0
 18 20  1  0
 20  6  1  0
 20 21  1  0
 21  3  1  0
 21 22  1  0
 22 23  1  0
 22 24  2  0
M  CHG  2   1   1  23  -1
M  END
> <name>
NIHCC_2014

> <id>
6158

> <plate>
NGP-202-02

> <well>
A09

> <supplier_cmpd_name>
CPD001491654

> <ctcr_id>
7028

> <supplier_cmpd_id>
SAM002564229

> <smiles>
[K+].CC1(C)SC2C(NC(=O)Cc3ccccc3)C(=O)N2C1C([O-])=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Penicillin G, potassium salt",SCHEMBL6054109,"Benzylpenicillin, potassium salt",CHEMBL1434858,HMS3259A18,HMS3370F17,"Benzyl Penicillinate Potassium Salt",MCULE-3955575945,MCULE3955575945,NC00583,NCG
C00094752-01,NCGC0009475201,NCGC00094752-02,NCGC0009475202,"Benzyl Penicillinate-(d7) Potass","Benzyl Penicillinate(d7) Potass",SAM002564229,CPD001491654}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{101828753,517573}

$$$$
NIHCC_2014
  SciTegic11012413002D

 31 35  0  0  1  0            999 V2000
    1.9438   -6.2113    0.0000 C   0  0
    0.7315   -5.3280    0.0000 C   0  0
   -0.6572   -5.8951    0.0000 C   0  0
    2.0426   -4.5993    0.0000 O   0  0
    1.7758   -3.1329    0.0000 C   0  0  2  0  0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -0.8660    2.5000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
    0.0000    0.5000    0.0000 F   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  1  0  0  0
   -0.8141   -2.0807    0.0000 C   0  0
    0.2851   -2.9666    0.0000 C   0  0  2  0  0  0
   -0.3667   -4.3062    0.0000 O   0  0
   -1.1988   -2.7813    0.0000 C   0  0
   -1.7813   -1.3990    0.0000 O   0  0
   -2.1056   -3.9772    0.0000 C   0  0
   -3.5939   -3.7910    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  5  4  1  1
  5  6  1  0
  7  6  1  6
  7  8  1  0
  8  9  1  1
  9 10  1  0
 10 11  1  0
 11 12  2  3
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  2  3
 16 17  1  0
 17 11  1  0
 17 18  1  6
 17 19  1  0
 19  8  1  0
 19 20  1  1
 19 21  1  0
 21 22  1  6
 21 23  1  0
 23 24  1  0
 24  7  1  0
 24 25  1  6
 24 26  1  0
 26  5  1  0
 26 27  1  0
 27  2  1  0
 26 28  1  6
 28 29  2  0
 28 30  1  0
 30 31  1  0
M  END
> <name>
NIHCC_2014

> <id>
6159

> <plate>
NGP-202-02

> <well>
A10

> <supplier_cmpd_name>
CPD000058335

> <ctcr_id>
7030

> <supplier_cmpd_id>
SAM002564237

> <smiles>
CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO

> <pd_targets>
{RORC,HIF1A,PGR,NR3C1,LMNA,AMPC}

> <pathway_gtopdb>
{"Transcription factor","Other nuclear protein",Enzyme,"Nuclear receptor",Hydrolase,"Nuclear hormone receptor subfamily 1","Nuclear hormone receptor subfamily 3","Nuclear hormone receptor subfamily 1 
group F","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 1 group F member 3","Nuclear hormone receptor subfamily 3 group C member 3","Nuclear hormone receptor subfam
ily 3 group C member 1"}

> <pathway_chembl>
{Receptors,"Nuclear hormone receptors","1F. Retinoic acid-related orphans","Steroid hormone receptors","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"Gene expression (Transcription)","Cellular responses to external stimuli","Cell Cycle","RNA Polymerase II Transcription","Cellular responses to stress",Mitotic,"Generic Transcription Pathway","Cellu
lar response to hypoxia","M Phase","Transcriptional regulation by RUNX3","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","FOXO-mediated transcription","Mitotic Metaphase and
 Anaphase","RUNX3 Regulates Immune Response and Cell Migration","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","Mitotic Anaphase","Nuclear Envelope (NE) Reassembly","
Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{NR3C1,SERPINA6}

> <broad_moa>
{"glucocorticoid receptor agonist",immunosuppressant}

> <synonyms>
{"TRIAMCINOLONE ACETONIDE",76-25-5,76255,Azmacort,Aristogel,Aristoderm,Kenalog,"Nasacort AQ",Solodelf,Tramacin,Triaceton,Triacort,Tricinolon,Zilretta,Flutex,Flutone,Oracort,Oralone,Rineton,Triacet,Tri
atex,Triderm,Trymex,AllerNaze,"Aristocort A",Triam-In,TriamIn,S1628,SAM002564237,"Triamcinolone Acetonide",CPD000058335}

> <pdid>
PD002109

> <targets>
{Others}

> <classes>
{}

> <pubchem_cids>
{6436}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 28  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
    0.0000    3.0000    0.0000 C   0  0  2  0  0  0
    1.0956    4.0166    0.0000 C   0  0
    0.4767    5.3830    0.0000 C   0  0
   -1.0140    5.2166    0.0000 C   0  0  2  0  0  0
   -2.0283    6.3192    0.0000 C   0  0
   -3.4920    5.9912    0.0000 C   0  0
   -1.5809    7.7510    0.0000 O   0  0
   -1.2991    3.7500    0.0000 C   0  0  2  0  0  0
   -2.5202    4.6210    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0  2  0  0  0
   -3.8971    0.7500    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0  2  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    0.0000    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -1.2990   -5.2500    0.0000 O   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  1  1  6
  2  3  1  0
  4  3  1  6
  4  5  1  0
  5  6  1  1
  6  7  1  0
  7  8  1  0
  8  9  1  1
  9 10  1  0
  9 11  2  0
  8 12  1  0
 12  5  1  0
 12 13  1  1
 12 14  1  0
 14 15  1  0
 15 16  1  1
 17 15  1  1
 17  4  1  0
 17 18  1  0
 18 19  1  1
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  2  3
 25  2  1  0
 25 18  1  0
M  END
> <name>
NIHCC_2014

> <id>
6160

> <plate>
NGP-202-02

> <well>
A11

> <supplier_cmpd_name>
CPD000058693

> <ctcr_id>
5684

> <supplier_cmpd_id>
SAM002564258

> <smiles>
C[C@H]1C[C@H]2[C@@H]3CC[C@H](C(C)=O)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]4(C)CCC(=O)C=C14

> <pd_targets>
{NR3C1}

> <pathway_gtopdb>
{Enzyme,"Transcription factor",Protease,"Nuclear receptor","Cysteine protease","Nuclear hormone receptor subfamily 3","Cysteine protease CA clan","Nuclear hormone receptor subfamily 3 group C","Cystei
ne protease C1A family","Nuclear hormone receptor subfamily 3 group C member 1"}

> <pathway_chembl>
{Receptors,"Nuclear hormone receptors","Steroid hormone receptors","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"Gene expression (Transcription)","RNA Polymerase II Transcription","Generic Transcription Pathway","FOXO-mediated transcription","FOXO-mediated transcription of oxidative stress","metabolic and neur
onal genes"}

> <broad_targets>
{NR3C1}

> <broad_moa>
{"glucocorticoid receptor agonist"}

> <synonyms>
{medrysone,Hydroxymesterone,2668-66-8,2668668,Medrifar,Medrocort,Medritonic,Visudrisone,"HMS Liquifilm",6alpha-Methyl-11beta-hydroxyprogesterone,6alphaMethyl11betahydroxyprogesterone,U-8471,U8471,UNII
-D2UFC189XF,UNIID2UFC189XF,HMS,"11beta-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione","11betaHydroxy6alphamethylpregn4ene3,20dione","GSH 1043",NSC-63278,NSC63278,D2UFC,T0977,SAM002564258,Prestw-743,Medr
ysone,CPD000058693}

> <pdid>
PD001873

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{247839}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 18  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0008    0.0000 C   0  0
   -1.2978   -3.7529    0.0000 C   0  0
   -1.2955   -5.2529    0.0000 C   0  0
    0.0048   -6.0009    0.0000 C   0  0
    0.0072   -7.5009    0.0000 Cl  0  0
    1.3026   -5.2488    0.0000 C   0  0
    1.3002   -3.7488    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  5  7  2  0
  7  8  1  0
  8  9  1  0
  8 10  2  0
 10  3  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 11  1  0
M  END
> <name>
NIHCC_2014

> <id>
6161

> <plate>
NGP-202-02

> <well>
B02

> <supplier_cmpd_name>
CPD000058714

> <ctcr_id>
258

> <supplier_cmpd_id>
SAM002554921

> <smiles>
CCc1nc(N)nc(N)c1c2ccc(Cl)cc2

> <pd_targets>
{DHFR,DFR1,KMT2A,MEN1,CYP3A4,CYP2D6,HEXA,HEXB,ACP1,DFRA17,CYP1A2,LMNA,ALDH1A1,TP53,SLC47A1,SKA,SLC47A2,CYP2C9,PTR1,SLC22A1}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Unclassified protein","Other nuclear protein","Transcription factor",Transporter,Oxidoreductase,Reader,"Cytochrome P450",Hydrolase,Phosphatase,"Electrochemical transpor
ter",Kinase,Bromodomain,"Cytochrome P450 family 3","Cytochrome P450 family 2","Protein Phosphatase","Cytochrome P450 family 1","SLC superfamily of solute carriers","Cytochrome P450 family 3A","Cytochr
ome P450 family 2D","Tyrosine protein phosphatase","Cytochrome P450 family 1A","SLC47 family of multidrug and toxin extrusion transporters","Cytochrome P450 family 2C","SLC22 family of organic cation 
and anion transporters","Cytochrome P450 3A4","Cytochrome P450 2D6","Cytochrome P450 1A1","Cytochrome P450 2C9"}

> <pathway_chembl>
{Enzymes,"Other protein targets",Transporters,"1.-.-.- Oxidoreductases","Cytochrome P450","Anti-infective targets","SLC superfamily of solute carriers","CYP3 family","CYP2 family: drug metabolising su
bset","Antimalarial targets","CYP1 family","SLC47 family of multidrug and toxin extrusion transporters","SLC22 family of organic cation and anion transporters","Folate biosynthesis enzymes","Organic c
ation transporters (OCT)"}

> <pathway_reactome>
{"Cell Cycle",Metabolism,Disease,"Transport of small molecules",Mitotic,"Metabolism of lipids","Biological oxidations","Diseases of metabolism","Cell Cycle Checkpoints","SLC-mediated transmembrane tra
nsport","Mitotic G1 phase and G1/S transition","Biosynthesis of specialized proresolving mediators (SPMs)","Phase I - Functionalization of compounds","Diseases of glycosylation","M Phase","G1/S DNA Da
mage Checkpoints","Transport of bile salts and organic acids","metal ions and amine compounds","G1/S Transition","Biosynthesis of DHA-derived SPMs","Cytochrome P450 - arranged by substrate type","Dise
ases associated with glycosaminoglycan metabolism","Mitotic Metaphase and Anaphase","Ethanol oxidation","p53-Dependent G1/S DNA damage checkpoint","Organic cation/anion/zwitterion transport","G1/S-Spe
cific Transcription","Biosynthesis of maresins",Xenobiotics,"Defective HEXA causes GM2G1","Mitotic Anaphase","Defective HEXB causes GM2G2","p53-Dependent G1 DNA Damage Response","Organic cation transp
ort","Biosynthesis of maresin-like SPMs","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Nuclear Envelope (NE) Reassembly","Stabilization of p53","Initiation of 
Nuclear Envelope (NE) Reformation","Autodegradation of the E3 ubiquitin ligase COP1"}

> <broad_targets>
{DHFR,SLC47A1}

> <broad_moa>
{"dihydrofolate reductase inhibitor"}

> <synonyms>
{pyrimethamine,58-14-0,58140,Daraprim,"5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine","5(4chlorophenyl)6ethylpyrimidine2,4diamine",Chloridine,Diaminopyritamin,Ethylpyrimidine,Pirimetamin,Chloridin,
Chloridyn,Pirimecidan,Pirimetamina,Pyrimethamin,Malocide,Primethamine,Darachlor,Erbaprelina,Kh,T0849,SAM002554921,1500520,Prestw-37,Pyrimethamine,CPD000058714,PYRIMETHAMINE}

> <pdid>
PD001771

> <targets>
{}

> <classes>
{antimalarial}

> <pubchem_cids>
{4993}

$$$$
NIHCC_2014
  SciTegic11012413002D

 18 19  0  0  0  0            999 V2000
    6.1212   -6.9101    0.0000 C   0  0
    5.5083   -5.5411    0.0000 C   0  0
    6.2556   -4.2405    0.0000 N   0  0
    5.2496   -3.1278    0.0000 O   0  0
    3.8995   -3.7516    0.0000 C   0  0
    2.5997   -3.0012    0.0000 N   0  0
    2.5988   -1.5004    0.0000 S   0  0
    3.8976   -0.7500    0.0000 O   0  0
    3.8982   -2.2498    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    4.0404   -5.2322    0.0000 C   0  0
    2.9218   -6.2315    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  2  0
  7 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 16 10  1  0
  5 17  2  0
 17  2  1  0
 17 18  1  0
M  END
> <name>
NIHCC_2014

> <id>
6162

> <plate>
NGP-202-02

> <well>
B03

> <supplier_cmpd_name>
CPD000037657

> <ctcr_id>
4568

> <supplier_cmpd_id>
SAM002554929

> <smiles>
Cc1noc(N[S](=O)(=O)c2ccc(N)cc2)c1C

> <pd_targets>
{KMT2A,MEN1,TSHR,EDNRA,CYP2C19,EDNRB,FOLP}

> <pathway_gtopdb>
{"Epigenetic regulator","Membrane receptor",Enzyme,Reader,"Family A G protein-coupled receptor","Cytochrome P450",Transferase,Bromodomain,"Peptide receptor (family A GPCR)","Cytochrome P450 family 2",
"Glycohormone receptor","Short peptide receptor (family A GPCR)","Cytochrome P450 family 2C","Endothelin receptor","Cytochrome P450 2C19"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Cytochrome P450","Glycoprotein hormone receptors","Endothelin receptors","CYP2 family: drug metabolising subset"}

> <pathway_reactome>
{Disease,"Signal Transduction",Metabolism,"Infectious disease","Signaling by GPCR","Biological oxidations","Leishmania infection","GPCR ligand binding","Phase I - Functionalization of compounds","Leis
hmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Cytochrome P450 - arranged by substrate type","Anti-inflammatory response favouring Leishmania parasite infection","Peptide
 ligand-binding receptors",Xenobiotics,"ADORA2B mediated anti-inflammatory cytokines production","CYP2E1 reactions"}

> <broad_targets>
{}

> <broad_moa>
{"bacterial antifolate"}

> <synonyms>
{NSC-38588,NSC38588,NSC757343,sulfisoxazole,Sulfafurazole,127-69-5,127695,Sulphafurazole,Sulfisoxazol,Sulfafurazol,Sulfaisoxazole,Sulfofurazole,Sulfisoxasole,Sulphaisoxazole,Gantrisin,Sulfadimethyliso
xazole,Alphazole,Amidoxal,Sulfalar,Sulfoxol,Sulfisoxazole,T0750,SAM002554929,1500555,Prestw-334,CPD000037657,SULFISOXAZOLE}

> <pdid>
PD001741

> <targets>
{}

> <classes>
{antibacterial}

> <pubchem_cids>
{5344}

$$$$
NIHCC_2014
  SciTegic11012413002D

 19 21  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 N   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1968    1.5003    0.0000 C   0  0
   -5.1993    3.0004    0.0000 C   0  0
   -6.4995    3.7483    0.0000 C   0  0
   -7.7974    2.9963    0.0000 C   0  0
   -7.7950    1.4963    0.0000 C   0  0
   -6.4948    0.7483    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -5.1961   -1.5000    0.0000 N   0  0
   -2.5981   -1.5000    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
  8 15  1  0
 15 16  1  0
 15 17  2  0
 17 18  1  0
 18  6  1  0
 18 19  2  0
 19  2  1  0
M  END
> <name>
NIHCC_2014

> <id>
6163

> <plate>
NGP-202-02

> <well>
B04

> <supplier_cmpd_name>
CPD000059118

> <ctcr_id>
1840

> <supplier_cmpd_id>
SAM002554937

> <smiles>
Nc1nc(N)c2nc(c3ccccc3)c(N)nc2n1

> <pd_targets>
{GAA,ALOX12,SMN1,APEX1,HPGD,CHRM1,NS1,CASP1,CYP3A4,HSD17B10,KDM4E,NFO,RORC,ALDH1A1,PYK,NFKB1,CASP7,GLA,PMP22,TP53,LMNA,HIF1A,TSHR,CSNK1A1,IMPA1,GMNN,RMLC,CSNK1D,SCNN1A,SCNN1B,SCNN1G,PKM,JAK2,CSNK1E,LE
F,CYP1A2,PTR1,CTSG,MTOR,CYP2D6,SCNN1D}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Membrane receptor","Unclassified protein","Transcription factor","Other cytosolic protein","Other nuclear protein","Ion channel",Hydrolase,Reader,"Family A G protein-co
upled receptor",Protease,"Cytochrome P450",Oxidoreductase,Eraser,"Nuclear receptor",Transferase,Kinase,Isomerase,"Ligand-gated ion channel","Methyl-lysine/arginine binding protein","Small molecule rec
eptor (family A GPCR)","Cysteine protease","Cytochrome P450 family 3","Lysine demethylase","Nuclear hormone receptor subfamily 1","Peptide receptor (family A GPCR)","Protein Kinase","Epithelial sodium
 channel","Metallo protease","Cytochrome P450 family 1","Serine protease","Cytochrome P450 family 2","Tudor domain","Monoamine receptor","Cysteine protease CD clan","Cytochrome P450 family 3A","Jumonj
i domain-containing","Nuclear hormone receptor subfamily 1 group F","Cysteine protease CA clan","Glycohormone receptor","CK1 protein kinase group","TK protein kinase group","Metallo protease MAE clan"
,"Cytochrome P450 family 1A","Serine protease PA clan","Atypical protein kinase group","Cytochrome P450 family 2D","Acetylcholine receptor","Cysteine protease C14 family","Cytochrome P450 3A4","Nuclea
r hormone receptor subfamily 1 group F member 3","Cysteine protease C1A family","CK1 protein kinase CK1 family","Tyrosine protein kinase JakA family","Metallo protease M34 family","Cytochrome P450 1A1
","Serine protease S1A subfamily","Atypical protein kinase PIKK family","Cytochrome P450 2D6","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Enzymes,Receptors,"Ion channels","3.2.1.- Glycosidases","Eicosanoid turnover","G protein-coupled receptors","Peptidases and proteinases","Cytochrome P450","Chromatin modifying enzymes","Nuclear hormo
ne receptors","Kinases (EC 2.7.x.x)","Inositol phosphate turnover","Ligand-gated ion channels","2.7.1.40 Pyruvate kinases","Catalytic receptors",Lipoxygenases,"Prostaglandin synthases","Acetylcholine 
receptors (muscarinic)","CD: Cysteine (C) Peptidases","CYP3 family","1.14.11.- Histone demethylases","1F. Retinoic acid-related orphans","Glycoprotein hormone receptors","CK1: Casein kinase 1","Inosit
ol monophosphatase","Epithelial sodium channel (ENaC)","Receptor kinases","CYP1 family","PA: Serine (S) Peptidases",Atypical,"CYP2 family: drug metabolising subset","C14: Caspase","Casein kinase 1 (CK
1) family","TK: Tyrosine kinase","S1: Chymotrypsin","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","Non-receptor tyrosine kinases (nRTKs)","FRAP subfamily","Janus kinase (JakA) family
"}

> <pathway_reactome>
{Disease,Metabolism,"Metabolism of RNA","DNA Repair","Signal Transduction","Gene expression (Transcription)","Immune System","Programmed Cell Death","Developmental Biology","Cell Cycle","Cellular resp
onses to external stimuli","Transport of small molecules","Diseases of metabolism","Metabolism of lipids","Metabolism of non-coding RNA","Base Excision Repair","Signaling by GPCR","RNA Polymerase II T
ranscription","Metabolism of amino acids and derivatives","Biological oxidations","Cytokine Signaling in Immune system",Apoptosis,"Nervous system development","Cell Cycle Checkpoints",Mitotic,"Cellula
r responses to stress","Infectious disease","Diseases of signal transduction by growth factor receptors and second messengers","Inositol phosphate metabolism","Metabolism of carbohydrates","Ion channe
l transport","Diseases of carbohydrate metabolism","Biosynthesis of specialized proresolving mediators (SPMs)","snRNP Assembly","Resolution of Abasic Sites (AP sites)","GPCR ligand binding","Generic T
ranscription Pathway","Branched-chain amino acid catabolism","Phase I - Functionalization of compounds","Signaling by Interleukins","Intrinsic Pathway for Apoptosis","Sphingolipid metabolism","EGR2 an
d SOX10-mediated initiation of Schwann cell myelination","G1/S DNA Damage Checkpoints","M Phase","Cellular response to hypoxia","Leishmania infection","Signaling by WNT in cancer","Synthesis of IP2",I
P,"and Ins in the cytosol","Mitotic G1 phase and G1/S transition","Mitotic G2-G2/M phases","Glucose metabolism","Uptake and actions of bacterial toxins","Infection with Mycobacterium tuberculosis","St
imuli-sensing channels","Glycogen storage diseases","Biosynthesis of DPA-derived SPMs","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Biosynthesis of DHA-derived SPMs"
,"Class A/1 (Rhodopsin-like receptors)","Transcriptional Regulation by TP53","Transcriptional regulation by RUNX3","Ethanol oxidation","Interleukin-1 family signaling","Apoptotic factor-mediated respo
nse","Glycosphingolipid metabolism","p53-Dependent G1/S DNA damage checkpoint","Mitotic Metaphase and Anaphase","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Leishmania p
arasite growth and survival","Signaling by AMER1 mutants","G1/S Transition","G2/M Transition",Glycolysis,"G1 Phase","Uptake and function of anthrax toxins","Cytochrome P450 - arranged by substrate typ
e","Response of Mtb to phagocytosis","Glycogen storage disease type II (GAA)","Biosynthesis of DPAn-3 SPMs","PCNA-Dependent Long Patch Base Excision Repair","Biosynthesis of D-series resolvins","Amine
 ligand-binding receptors","TP53 Regulates Transcription of Cell Death Genes","Biosynthesis of maresins","RUNX3 Regulates Immune Response and Cell Migration","Interleukin-1 signaling","Cytochrome c-me
diated apoptotic response","p53-Dependent G1 DNA Damage Response","Mitotic Anaphase","Anti-inflammatory response favouring Leishmania parasite infection","Truncations of AMER1 destabilize the destruct
ion complex","Activation of the pre-replicative complex","Centrosome maturation","Cyclin D associated events in G1",Xenobiotics,"Suppression of apoptosis","Regulation of TP53 Activity","Biosynthesis o
f DPAn-3-derived maresins","Muscarinic acetylcholine receptors","TP53 Regulates Transcription of Caspase Activators and Caspases","Biosynthesis of maresin-like SPMs","MAP3K8 (TPL2)-dependent MAPK1/3 a
ctivation","Activation of caspases through apoptosome-mediated cleavage","Stabilization of p53","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Loss of pr
oteins required for interphase microtubule organization from the centrosome","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Regulation of TP53 Expression and Degradation","CYP2E1 
reactions","Autodegradation of the E3 ubiquitin ligase COP1","Initiation of Nuclear Envelope (NE) Reformation","Loss of Nlp from mitotic centrosomes","Regulation of TP53 Degradation"}

> <broad_targets>
{SCNN1A,SCNN1B,SCNN1D,SCNN1G}

> <broad_moa>
{"sodium channel blocker"}

> <synonyms>
{triamterene,396-01-0,396010,"6-phenylpteridine-2,4,7-triamine","6phenylpteridine2,4,7triamine","2,4,7-Triamino-6-phenylpteridine","2,4,7Triamino6phenylpteridine",Dyrenium,Dytac,Pterofen,Pterophene,Tr
iamteren,Triamteril,Triteren,Ademin,Ademine,Diurene,Noridil,Taturil,Teridin,Urocaudal,Jatropur,Noridyl,Triampur,Dir,T0843,SAM002554937,1500589,Prestw-34,CPD000059118,TRIAMTERENE,Triamterene}

> <pdid>
PD002107

> <targets>
{GPCR19,Sodium Channel}

> <classes>
{diuretic,GPCR/G Protein,Membrane Transporter/Ion Channel}

> <pubchem_cids>
{5546}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 23  0  0  0  0            999 V2000
    7.6894   -1.1304    0.0000 Cl  0  5
    5.1887   -6.0105    0.0000 C   0  0
    3.8912   -5.2578    0.0000 N   0  3
    2.5909   -6.0056    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 S   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -1.2990   -5.2500    0.0000 Cl  0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 19 21  1  0
 21 22  2  0
 22  8  1  0
 22 16  1  0
M  CHG  2   1  -1   3   1
M  END
> <name>
NIHCC_2014

> <id>
6164

> <plate>
NGP-202-02

> <well>
B05

> <supplier_cmpd_name>
CPD000058254

> <ctcr_id>
4361

> <supplier_cmpd_id>
SAM002564196

> <smiles>
[Cl-].C[NH+](C)CCCN1c2ccccc2Sc3ccc(Cl)cc13

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{MLS000595399,SMR000149922,Opera_ID_1263,OperaID1263,Opera-ID-1263,"Opera ID 1263",HMS2234H07,HMS3370H01,(3-(2-Chloro-phenothiazin-10-yl)-propyl)-dimethyl-ammonium,(3(2Chlorophenothiazin10yl)propyl)di
methylammonium,Plegomazin,Propaphenin,Hibernal,"Chlorpromazinium chloride",2-Chloro-10-(3-(dimethylamino)propyl)pheno,2Chloro10(3(dimethylamino)propyl)pheno,SAM002564196,Prestw-64,CPD000058254,"Chlorp
romazine hydrochloride"}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{522335,25010312,657361,6240}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 29  0  0  1  0            999 V2000
   -1.4188  -10.5751    0.0000 C   0  0
   -1.8661   -9.1434    0.0000 C   0  0
   -0.8500   -8.0388    0.0000 C   0  0
   -1.2977   -6.6063    0.0000 C   0  0
   -0.2816   -5.5018    0.0000 C   0  0
    1.1821   -5.8297    0.0000 O   0  0
   -0.7292   -4.0692    0.0000 O   0  0
    0.2851   -2.9666    0.0000 C   0  0  1  0  0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -1.2212   -2.3711    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  8  7  1  6
  8  9  1  0
  9 10  1  0
 11 10  1  6
 11 12  1  0
 12 13  1  1
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 19 20  1  0
 20 21  2  0
 21 15  1  0
 21 22  1  0
 22 12  1  0
 22 23  1  6
 23 24  1  0
 24 25  1  0
 25  8  1  0
 25 11  1  0
 25 26  1  6
M  END
> <name>
NIHCC_2014

> <id>
6165

> <plate>
NGP-202-02

> <well>
B06

> <supplier_cmpd_name>
CPD000058346

> <ctcr_id>
5879

> <supplier_cmpd_id>
SAM002564206

> <smiles>
CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C

> <pd_targets>
{RORC,POLB,SKA,MAPT,LMNA,KMT2A,ATM,ESR1,ESR2}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Other cytosolic protein","Other nuclear protein","Epigenetic regulator","Nuclear receptor",Kinase,Reader,"Nuclear hormone receptor subfamily 1",Bromodomain,"Protein Kin
ase","Nuclear hormone receptor subfamily 3","Nuclear hormone receptor subfamily 1 group F","Atypical protein kinase group","Nuclear hormone receptor subfamily 3 group A","Nuclear hormone receptor subf
amily 1 group F member 3","Atypical protein kinase PIKK family","Nuclear hormone receptor subfamily 3 group A member 1","Nuclear hormone receptor subfamily 3 group A member 2"}

> <pathway_chembl>
{Receptors,Enzymes,"Nuclear hormone receptors","Chromatin modifying enzymes","Kinases (EC 2.7.x.x)","1F. Retinoic acid-related orphans","2.1.1.43 Histone methyltransferases (HMTs)",Atypical,"Steroid h
ormone receptors","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","3A. Estrogen receptors","Other PIKK family kinases"}

> <pathway_reactome>
{"Gene expression (Transcription)","DNA Repair","Neuronal System","Cell Cycle","Signal Transduction","RNA Polymerase II Transcription","Base Excision Repair","Transmission across Chemical Synapses",Mi
totic,"Cell Cycle Checkpoints","Intracellular signaling by second messengers","Generic Transcription Pathway","Resolution of Abasic Sites (AP sites)","Neurotransmitter receptors and postsynaptic signa
l transmission","M Phase","G1/S DNA Damage Checkpoints","PIP3 activates AKT signaling","Transcriptional regulation by RUNX3","Resolution of AP sites via the multiple-nucleotide patch replacement pathw
ay","Activation of NMDA receptors and postsynaptic events","Mitotic Metaphase and Anaphase","Transcriptional regulation by RUNX1","p53-Dependent G1/S DNA damage checkpoint","Negative regulation of the
 PI3K/AKT network","RUNX3 Regulates Immune Response and Cell Migration","PCNA-Dependent Long Patch Base Excision Repair","Post NMDA receptor activation events","Mitotic Anaphase","RUNX1 regulates gene
s involved in megakaryocyte differentiation and platelet function","p53-Dependent G1 DNA Damage Response","RUNX1 regulates estrogen receptor mediated transcription",PI5P,"PP2A and IER3 Regulate PI3K/A
KT Signaling","Activation of AMPK downstream of NMDARs","Nuclear Envelope (NE) Reassembly","Stabilization of p53","Initiation of Nuclear Envelope (NE) Reformation","Autodegradation of the E3 ubiquitin
 ligase COP1"}

> <broad_targets>
{ESR1}

> <broad_moa>
{"estrogen receptor agonist"}

> <synonyms>
{"estradiol valerate",979-32-8,Delestrogen,"Estradiol 17-valerate","Estradiol valerianate",Estraval,Neofollin,Progynova,Femogex,Progynon-Depot,"Oestradiol valerate",Atladiol,Climaval,Deladiol,Duratrad
,Pharlon,Estate,Dura-estradiol,"Exten strone","Depo estro med",Repo-Estra,"Delestrogen 4X","Estraval PA","Estraval 2X",Estroval-10,"Delahormone unimatic",Depo-Estro-Med,Femogen-L.A.,"Gynogen L.A. 20",
"Gynogen L.A. 40","ESTRADIOL, 17-VALERATE","component of Ditate",UNII-OKG364O896,NSC-17590,"component of Deluteval 2X","17-BETA-ESTRADIOL 17-VALERATE","Estradiol 17.beta.-valerate","component of Mal-O
-Fem L.A",MLS000028449,CHEBI:31561,OKG364O896,MFCD00056541,Cyclocur,Gynokadin,Merimono,Nuvelle,Pelanin,Postoval,Primogyna,Ronfase,SMR000058346,ST075188,"Estradiol Depot",Primogyn-Depot,"beta-Estradiol
 17-valerate","3-Hydroxy-17beta-valeroyloxyestra-1,3,5(10)-trien","17-pentanoyl-estra-1,3,5(10)-triene-3,17beta-diol","Gynogen L.A. 10","(17beta)-3-hydroxyestra-1,3,5(10)-trien-17-yl valerate",Valerge
n,"Estradiol 17beta-valerate","Estradiol valerate (VAN)","Estradiol-17-valerate; 1,3,5(10)-Estratriene-3,17b-diol 17-pentanote",estradiol-valerate,"Estradioli valeras","Valerate d'estradiol","CCRIS 55
71","Valerato de estradiol","Estradioli valeras (INN-Latin)",Oestradiol-17b-valerate,"Valerate d'estradiol (INN-French)","EINECS 213-559-2","NSC 17590","Valerato de estradiol (INN-Spanish)",Altadiol,"
Pelanin depot","Gynogen LA","Deladumone (TN)",NCGC00094673-01,"3-Hydroxy-17beta-valeroyloxyestra-1,3,5(10)-triene","Gynogen L.A.10","Estradiol valerate (USP:INN:BAN:JAN)",Opera_ID_444,"Estradiol 17?-v
alerate","B-Estradiol 17-valerate",DSSTox_CID_3004,CHEMBL1511,DSSTox_RID_76827,DSSTox_GSID_23004,SCHEMBL40563,MLS001146931,ARONIS24416,GTPL7655,DTXSID8023004,HMS2232L17,HMS3259C12,HMS3715B21,BCP11918,
EBD28143,"Estra-1,3,5(10)-triene-3,17-diol (17-beta)-, 17-pentanoate","Estra-1,3,5(10)-triene-3,17-diol(17beta)-, 17-pentanoate","Estradiol valerate (JAN/USP/INN)",HY-B0672,NSC17590,ZINC3881556,Tox21_
111312,"Estra-1,3,5(10)-triene-3,17-diol (17.beta.)-, 17-pentanoate",LMST02010039,s3149,SBB080821,AKOS005267158,CCG-221130,DB13956,KS-5213,MCULE-6732064308,NC00560,NCGC00018166-02,NCGC00018166-14,CAS-
979-32-8,CPD000058346,AB0106305,B1506,E0876,C12859,D01413,AB00382980_15,124683-EP2295426A1,124683-EP2295427A1,979E328,A845765,SR-01000003061,Q-201506,Q5401768,SR-01000003061-3,"1,3,5(10)-Estratriene-3
,17beta-diol 17-pentanote",BRD-K66766661-001-19-2,"(17.beta.)-Estra-1,3,5(10)-triene-3,17-diol 17-valerate","(17beta)-3-hydroxyestra-1(10),2,4-trien-17-yl pentanoate","Estra-1,5(10)-triene-3,17-diol (
17.beta.)-, 17-pentanoate",S3149,SAM002564206,Prestw-1473,"Estradiol valerate","Estradiol Valerate"}

> <pdid>
PD002341

> <targets>
{"Estrogen/progestogen Receptor"}

> <classes>
{"Endocrinology & Hormones"}

> <pubchem_cids>
{13791}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 26  0  0  0  0            999 V2000
    2.5532   -4.4223    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 N   0  0
   -0.6890   -4.0818    0.0000 N   0  0
   -0.2234   -5.5086    0.0000 C   0  0
    1.2443   -5.8182    0.0000 O   0  0
   -1.2256   -6.6258    0.0000 C   0  0
   -0.7624   -8.0525    0.0000 C   0  0
   -1.7662   -9.1671    0.0000 C   0  0
   -3.2334   -8.8550    0.0000 C   0  0
   -4.2373   -9.9695    0.0000 Cl  0  0
   -3.6967   -7.4283    0.0000 C   0  0
   -2.6928   -6.3138    0.0000 C   0  0
   -5.1647   -7.1160    0.0000 S   0  0
   -5.6275   -5.6892    0.0000 N   0  0
   -6.1693   -8.2300    0.0000 O   0  0
   -6.6317   -6.8032    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  9 10  1  0
 10  2  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 17 19  1  0
 19 20  2  0
 20 14  1  0
 19 21  1  0
 21 22  1  0
 21 23  2  0
 21 24  2  0
M  END
> <name>
NIHCC_2014

> <id>
6166

> <plate>
NGP-202-02

> <well>
B07

> <supplier_cmpd_name>
CPD000058829

> <ctcr_id>
3898

> <supplier_cmpd_id>
SAM002564214

> <smiles>
CC1Cc2ccccc2N1NC(=O)c3ccc(Cl)c(c3)[S](N)(=O)=O

> <pd_targets>
{CA2,CA3,CA4,CA5A,CA5B,CA9,CA13,CA1,CA7,CA12,ALDH1A1,CA6,CA14,GAA,ALOX15,SLC12A3}

> <pathway_gtopdb>
{Enzyme,Transporter,Lyase,Oxidoreductase,Hydrolase,"Electrochemical transporter","SLC superfamily of solute carriers","SLC12 family of cation-coupled chloride transporters"}

> <pathway_chembl>
{Enzymes,Transporters,"Carbonic anhydrases","3.2.1.- Glycosidases","Eicosanoid turnover","SLC superfamily of solute carriers",Lipoxygenases,"SLC12 family of cation-coupled chloride transporters"}

> <pathway_reactome>
{"Transport of small molecules",Metabolism,"Cellular responses to external stimuli","Immune System",Disease,"O2/CO2 exchange in erythrocytes","Reversible hydration of carbon dioxide","Cellular respons
es to stress","Cytokine Signaling in Immune system","Biological oxidations","Diseases of metabolism","Metabolism of lipids","Disorders of transmembrane transporters","Erythrocytes take up carbon dioxi
de and release oxygen","Cellular response to hypoxia","Signaling by Interleukins","Phase I - Functionalization of compounds","Diseases of carbohydrate metabolism","Biosynthesis of specialized proresol
ving mediators (SPMs)","SLC transporter disorders","Regulation of gene expression by Hypoxia-inducible Factor","Interleukin-12 family signaling","Ethanol oxidation","Glycogen storage diseases","Biosyn
thesis of DPA-derived SPMs","Defective SLC12A3 causes Gitelman syndrome (GS)","Interleukin-12 signaling","Glycogen storage disease type II (GAA)","Biosynthesis of DPAn-3 SPMs","Gene and protein expres
sion by JAK-STAT signaling after Interleukin-12 stimulation","Biosynthesis of DPAn-3-derived protectins and resolvins"}

> <broad_targets>
{CA2,HTR3A,KCNQ1}

> <broad_moa>
{"thiazide diuretic"}

> <synonyms>
{680765,indapamide,26807-65-8,26807658,Noranat,Lozol,Tertensif,Veroxil,Indaflex,Arifon,Fludex,Indamol,Natrilix,Pressurai,Bajaten,Ipamix,Tandix,Indapamida,Damide,Indapamidum,"Indapamidum (INN-Latin)","
Indapamidum (INNLatin)","Indapamida (INN-Spanish)","Indapamida (INNSpanish)",SE-1520,SE1520,1-(4-Chloro-3-sulfamoylbenz,1(4Chloro3sulfamoylbenz,T1498,SAM002564214,1500349,Prestw-220,Indapamide,CPD0000
58829,INDAPAMIDE}

> <pdid>
PD002293

> <targets>
{}

> <classes>
{antihypertensive,diuretic}

> <pubchem_cids>
{3702}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 25  0  0  1  0            999 V2000
    2.2090   -0.3353    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0
   -6.4952    3.7500    0.0000 O   0  0
   -3.8971    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0  2  0  0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.3326   -2.9571    0.0000 C   0  0
    1.8253   -3.1044    0.0000 C   0  0
    2.4266   -1.7302    0.0000 C   0  0  2  0  0  0
    2.7105   -0.7713    0.0000 O   0  0
    3.4192   -2.8384    0.0000 C   0  0
    4.4371   -3.9401    0.0000 C   0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  6
  7  8  1  0
  8  9  1  0
  9 10  2  3
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 15 14  1  6
 15  5  1  0
 15  9  1  0
  6 16  1  0
 16  2  1  0
 16 17  1  1
 17 18  1  0
 18 19  1  0
 19  2  1  0
 19 20  1  1
 19 21  1  0
 21 22  3  0
M  END
> <name>
NIHCC_2014

> <id>
6167

> <plate>
NGP-202-02

> <well>
B08

> <supplier_cmpd_name>
CPD000499579

> <ctcr_id>
3039

> <supplier_cmpd_id>
SAM002564223

> <smiles>
C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]1CC[C@@]2(O)C#C

> <pd_targets>
{PGR,ABCB11,SHBG,AR,ESR1,ESR2,SLC6A4,NR3C1}

> <pathway_gtopdb>
{"Transcription factor",Transporter,"Secreted protein","Nuclear receptor","Primary active transporter","Electrochemical transporter","Nuclear hormone receptor subfamily 3","ATP-binding cassette","SLC 
superfamily of solute carriers","Nuclear hormone receptor subfamily 3 group C","ABCB subfamily","Nuclear hormone receptor subfamily 3 group A","SLC06 neurotransmitter transporter family","Nuclear horm
one receptor subfamily 3 group C member 3","Nuclear hormone receptor subfamily 3 group C member 4","Nuclear hormone receptor subfamily 3 group A member 1","Nuclear hormone receptor subfamily 3 group C
 member 1"}

> <pathway_chembl>
{Receptors,Transporters,"Nuclear hormone receptors","ATP-binding cassette transporter family","SLC superfamily of solute carriers","Steroid hormone receptors","ABCB subfamily","SLC6 neurotransmitter t
ransporter family","3C. 3-Ketosteroid receptors","Monoamine transporter subfamily","3A. Estrogen receptors"}

> <pathway_reactome>
{"Metabolism of proteins",Metabolism,"Gene expression (Transcription)","Neuronal System","Post-translational protein modification","Metabolism of lipids","RNA Polymerase II Transcription","Transmissio
n across Chemical Synapses",SUMOylation,"Metabolism of steroids","Generic Transcription Pathway","Neurotransmitter clearance","SUMO E3 ligases SUMOylate target proteins","Bile acid and bile salt metab
olism","Transcriptional regulation by RUNX2","Serotonin clearance from the synaptic cleft","Transcriptional regulation by RUNX1","FOXO-mediated transcription","SUMOylation of intracellular receptors",
"Synthesis of bile acids and bile salts","RUNX2 regulates bone development","RUNX1 regulates estrogen receptor mediated transcription","FOXO-mediated transcription of oxidative stress","metabolic and 
neuronal genes","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","RUNX2 regulates osteoblast differentiation"}

> <broad_targets>
{PGR}

> <broad_moa>
{"progesterone receptor agonist"}

> <synonyms>
{norethindrone,Norethisterone,68-22-4,68224,Micronor,19-Norethisterone,19Norethisterone,Norethisteron,Norcolut,Noriday,Norlutin,Primolut-N,PrimolutN,Norethynodrone,Conludag,Micronovum,Norluten,Camila,
Utovlan,Mini-pill,Minipill,Mini-Pe,MiniPe,Noresthisterone,Conludaf,Micronett,Noralutin,Noret,T1514,SAM002564223,Prestw-253,Norethindrone,CPD000499579}

> <pdid>
PD001834

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{6230}

$$$$
NIHCC_2014
  SciTegic11012413002D

 10  9  0  0  0  0            999 V2000
    0.0007    0.0004    0.0000 C   0  0
    1.3000    0.7500    0.0000 C   0  0
    2.6000    0.0000    0.0000 C   0  0
    3.9000    0.7500    0.0000 C   0  0
    5.2000    0.0000    0.0000 C   0  0
    6.5000    0.7500    0.0000 C   0  0
    7.7992    0.0004    0.0000 C   0  0
    3.9031    2.2508    0.0000 C   0  0
    2.6053    3.0031    0.0000 O   0  0
    5.2032    2.9990    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  4  8  1  0
  8  9  1  0
  8 10  2  0
M  END
> <name>
NIHCC_2014

> <id>
6168

> <plate>
NGP-202-02

> <well>
B09

> <supplier_cmpd_name>
CPD000499581

> <ctcr_id>
5832

> <supplier_cmpd_id>
SAM002564230

> <smiles>
CCCC(CCC)C(O)=O

> <pd_targets>
{AKR1B1,AKR1A1,HDAC2,HDAC1,AKR1B7,TSHR,NPSR1,CHRM1,CYP3A4,NFKB1,ALDH5A1,ACADSB,HDAC9,OGDH,SCN10A,SCN11A,SCN1A,SCN1B,SCN2A,SCN2B,SCN3A,SCN3B,SCN4A,SCN4B,SCN5A,SCN7A,SCN8A,SCN9A}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Membrane receptor","Other cytosolic protein",Oxidoreductase,Eraser,"Family A G protein-coupled receptor","Cytochrome P450","Histone deacetylase","Peptide receptor (fami
ly A GPCR)","Small molecule receptor (family A GPCR)","Cytochrome P450 family 3","HDAC class I","Glycohormone receptor","Short peptide receptor (family A GPCR)","Monoamine receptor","Cytochrome P450 f
amily 3A","HDAC class IIa","Neuropeptide receptor","Acetylcholine receptor","Cytochrome P450 3A4"}

> <pathway_chembl>
{Enzymes,Receptors,"1.-.-.- Oxidoreductases","Chromatin modifying enzymes","G protein-coupled receptors","Cytochrome P450","GABA turnover","3.5.1.- Histone deacetylases (HDACs)","Glycoprotein hormone 
receptors","Neuropeptide S receptor","Acetylcholine receptors (muscarinic)","CYP3 family"}

> <pathway_reactome>
{Metabolism,"Gene expression (Transcription)",Disease,"Signal Transduction","Immune System","Neuronal System","Metabolism of lipids","Biological oxidations","RNA Polymerase II Transcription","Disorder
s of Developmental Biology","Infectious disease","Signaling by GPCR","Cytokine Signaling in Immune system","Transmission across Chemical Synapses","Metabolism of amino acids and derivatives","Diseases
 of signal transduction by growth factor receptors and second messengers","The citric acid (TCA) cycle and respiratory electron transport","Metabolism of steroids","Phase II - Conjugation of compounds
","Generic Transcription Pathway","Disorders of Nervous System Development","Leishmania infection","GPCR ligand binding","Biosynthesis of specialized proresolving mediators (SPMs)","Signaling by Inter
leukins","Neurotransmitter release cycle","Branched-chain amino acid catabolism","Signaling by NOTCH1 in Cancer","Pyruvate metabolism and Citric Acid (TCA) cycle","Metabolism of steroid hormones","Glu
tathione conjugation","Transcriptional Regulation by TP53","Pervasive developmental disorders","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Biosynthesis of DHA-der
ived SPMs","Interleukin-1 family signaling","GABA synthesis",release,"reuptake and degradation","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","Citric acid cycle (TCA cycle)","Pregnenolone bio
synthesis","Regulation of TP53 Activity","Loss of function of MECP2 in Rett syndrome","Anti-inflammatory response favouring Leishmania parasite infection","Amine ligand-binding receptors","Biosynthesi
s of maresins","Interleukin-1 signaling","Degradation of GABA","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","Regulation of TP53 Activity through Acetylation","Loss of MECP2 binding abilit
y to 5mC-DNA","ADORA2B mediated anti-inflammatory cytokines production","Muscarinic acetylcholine receptors","Biosynthesis of maresin-like SPMs","MAP3K8 (TPL2)-dependent MAPK1/3 activation"}

> <broad_targets>
{ABAT,ACADSB,ALDH5A1,HDAC1,HDAC2,HDAC9,OGDH,SCN10A,SCN11A,SCN1A,SCN1B,SCN2A,SCN2B,SCN3A,SCN3B,SCN4A,SCN4B,SCN5A,SCN7A,SCN8A,SCN9A}

> <broad_moa>
{"benzodiazepine receptor agonist","HDAC inhibitor"}

> <synonyms>
{"VALPROIC ACID","2-Propylpentanoic acid","2Propylpentanoic acid",99-66-1,99661,"2-Propylvaleric acid","2Propylvaleric acid","Dipropylacetic acid",Depakine,Depakene,Valproate,Ergenyl,"Di-n-propylaceti
c acid","Dinpropylacetic acid",Mylproin,"Pentanoic acid, 2-propyl-","Pentanoic acid, 2propyl","4-Heptanecarboxylic acid","4Heptanecarboxylic acid","n-Dipropylacetic ac","nDipropylacetic ac",T7064,SAM0
02564230,Prestw-1482,"Valproic Acid",CPD000499581,"Valproic acid"}

> <pdid>
PD003158

> <targets>
{Autophagy,HDAC,HIV,Mitophagy,Notch}

> <classes>
{Anti-infection,Autophagy,Cell Cycle/DNA Damage,Epigenetics,Neuronal Signaling,Stem Cell/Wnt}

> <pubchem_cids>
{3121}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 22  0  0  1  0            999 V2000
    9.4504    6.4036    0.0000 C   0  0
    9.1445    4.9351    0.0000 C   0  0
   10.2636    3.9363    0.0000 C   0  0
   10.5691    5.4047    0.0000 C   0  0
    7.7193    4.4647    0.0000 N   0  0
    7.4132    2.9954    0.0000 C   0  0
    5.9880    2.5249    0.0000 C   0  0  2  0  0  0
    4.8689    3.5238    0.0000 O   0  0
    5.6819    1.0557    0.0000 C   0  0
    4.2567    0.5852    0.0000 O   0  0
    3.9511   -0.8815    0.0000 C   0  0
    4.9531   -1.9978    0.0000 N   0  0
    4.2010   -3.2956    0.0000 S   0  0
    2.7343   -2.9815    0.0000 N   0  0
    2.5987   -1.5004    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  1
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 11  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 16  1  0
M  END
> <name>
NIHCC_2014

> <id>
6169

> <plate>
NGP-202-02

> <well>
B10

> <supplier_cmpd_name>
CPD001456519

> <ctcr_id>
7031

> <supplier_cmpd_id>
SAM002564238

> <smiles>
CC(C)(C)NC[C@H](O)COc1nsnc1N2CCOCC2

> <pd_targets>
{AMPC,ADRB2,ADRB1,CYP2D6,CYP3A4,NFKB1,HTR1A,CHRM1,CYP1A2,ADRB3}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Other cytosolic protein",Hydrolase,"Family A G protein-coupled receptor","Cytochrome P450","Small molecule receptor (family A GPCR)","Cytochrome P450 family 2","Cytochrome
 P450 family 3","Cytochrome P450 family 1","Monoamine receptor","Cytochrome P450 family 2D","Cytochrome P450 family 3A","Cytochrome P450 family 1A","Adrenergic receptor","Cytochrome P450 2D6","Cytochr
ome P450 3A4","Serotonin receptor","Acetylcholine receptor","Cytochrome P450 1A1"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Cytochrome P450",Adrenoceptors,"CYP2 family: drug metabolising subset","CYP3 family","5-Hydroxytryptamine receptors","Acetylcholine receptors (muscari
nic)","CYP1 family"}

> <pathway_reactome>
{Disease,Metabolism,"Immune System","Signal Transduction","Infectious disease","Biological oxidations","Metabolism of lipids","Cytokine Signaling in Immune system","Signaling by GPCR","Leishmania infe
ction","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","Signaling by Interleukins","GPCR ligand binding","Leishmania parasite growth and survival
","Cytochrome P450 - arranged by substrate type","Biosynthesis of DHA-derived SPMs","Interleukin-1 family signaling","Class A/1 (Rhodopsin-like receptors)","Anti-inflammatory response favouring Leishm
ania parasite infection",Xenobiotics,"Biosynthesis of maresins","Interleukin-1 signaling","Amine ligand-binding receptors","ADORA2B mediated anti-inflammatory cytokines production","CYP2E1 reactions",
"Biosynthesis of maresin-like SPMs","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Serotonin receptors","Muscarinic acetylcholine receptors","Aromatic amines can be N-hydroxylated or N-dealkylated by C
YP1A2"}

> <broad_targets>
{ADRB1,ADRB2}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{Tox21_110614_1,Tox211106141,Tox21-110614-1,"Tox21 110614 1",DB00373,NC00592,timolol,(S)-timolol,(S)timolol,26839-75-8,26839758,Istalol,Blocadren,Betimol,Timoptic,Timoptic-XE,TimopticXE,"(S)-timolol (
anhydrous)","(S)timolol (anhydrous)","Timololum (INN-Latin)","Timololum (INNLatin)",UNII-5JKY92S7BR,UNII5JKY92S7BR,(-)-3-Morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,()3Morpholino4(3tertbutylam
ino2hydroxypropoxy)1,2,5-thia,5thia,SAM002564238,CPD001456519}

> <pdid>
PD002871

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{33624}

$$$$
NIHCC_2014
  SciTegic11012413002D

 19 21  0  0  0  0            999 V2000
    4.4991   -8.4771    0.0000 O   0  0
    3.8490   -7.1253    0.0000 C   0  0
    2.3532   -7.0124    0.0000 C   0  0
    1.7031   -5.6606    0.0000 C   0  0
    2.5536   -4.4230    0.0000 C   0  0
    1.8032   -3.1233    0.0000 N   0  0
    2.4133   -1.7530    0.0000 C   0  0
    3.8805   -1.4410    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
   -0.6923   -4.0811    0.0000 O   0  0
    4.0445   -4.5346    0.0000 C   0  0
    4.8897   -3.2954    0.0000 O   0  0
    4.6946   -5.8864    0.0000 N   0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 14 15  1  0
 15  6  1  0
 15 16  2  0
  5 17  1  0
 17 18  2  0
 17 19  1  0
 19  2  1  0
M  END
> <name>
NIHCC_2014

> <id>
6170

> <plate>
NGP-202-02

> <well>
B11

> <supplier_cmpd_name>
CPD000058524

> <ctcr_id>
857

> <supplier_cmpd_id>
SAM002564245

> <smiles>
O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1

> <pd_targets>
{CRBN,PTGS1,PTGS2,ALDH1A1,CUL4A,DDB1,RBX1,TNF,NFKB1,FGFR2,ORM1,ORM2,TSHR,TDP1,CYP1A2,AMPC}

> <pathway_gtopdb>
{"Unclassified protein",Enzyme,"Secreted protein","Other cytosolic protein","Membrane receptor",Oxidoreductase,Kinase,"Family A G protein-coupled receptor",Hydrolase,"Cytochrome P450","Protein Kinase"
,"Peptide receptor (family A GPCR)","Cytochrome P450 family 1","TK protein kinase group","Glycohormone receptor","Cytochrome P450 family 1A","Tyrosine protein kinase FGFR family","Cytochrome P450 1A1"
}

> <pathway_chembl>
{Enzymes,Receptors,"E3 ubiquitin ligase components","Eicosanoid turnover","Catalytic receptors","G protein-coupled receptors","Cytochrome P450",Cyclooxygenase,"Receptor kinases","Glycoprotein hormone 
receptors","CYP1 family","TK: Tyrosine kinase","Receptor tyrosine kinases (RTKs)","Type V RTKs: FGF (fibroblast growth factor) receptor family"}

> <pathway_reactome>
{Disease,Metabolism,"Immune System","DNA Repair","Infectious disease","Metabolism of lipids","Biological oxidations","Cytokine Signaling in Immune system","Diseases of signal transduction by growth fa
ctor receptors and second messengers","DNA Double-Strand Break Repair","SARS-CoV Infections","Fatty acid metabolism","Biosynthesis of specialized proresolving mediators (SPMs)","Phase I - Functionaliz
ation of compounds","Signaling by Interleukins","Signaling by FGFR in disease","Leishmania infection","Nonhomologous End-Joining (NHEJ)","Potential therapeutics for SARS","Arachidonic acid metabolism"
,"Biosynthesis of DPA-derived SPMs","Ethanol oxidation","Interleukin-10 signaling","Interleukin-1 family signaling","Signaling by FGFR2 in disease","Leishmania parasite growth and survival","Cytochrom
e P450 - arranged by substrate type","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","Biosynthesis of DPAn-3 SPMs","Interleukin-1 signaling","FGFR2 mutant receptor activation","Anti-inflammat
ory response favouring Leishmania parasite infection",Xenobiotics,"MAP3K8 (TPL2)-dependent MAPK1/3 activation","Activated point mutants of FGFR2","ADORA2B mediated anti-inflammatory cytokines producti
on","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2"}

> <broad_targets>
{TNF}

> <broad_moa>
{"tumor necrosis factor production inhibitor"}

> <synonyms>
{thalidomide,50-35-1,50351,Thalomid,"2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione","2(2,6dioxopiperidin3yl)isoindoline1,3dione",Sedoval,(+/-)-THALIDOMIDE,(+/)THALIDOMIDE,Corronarobetin,Psycholiqui
d,Psychotablets,Theophilcholine,Algosediv,Asmadion,Bonbrain,Calmorex,Contergan,Distaval,Ectiluran,Enterosediv,T0213,66847,S1193,SAM002564245,1503607,Prestw-192,"NSC 66847",Thalidomide,CPD000058524,THA
LIDOMIDE}

> <pdid>
PD000977

> <targets>
{Apoptosis,Autophagy,Ligand for E3 Ligase}

> <classes>
{hypnotic,immunomodulatory agent,Apoptosis,Autophagy,PROTAC}

> <pubchem_cids>
{5426}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 29  0  0  0  0            999 V2000
   10.3146   -2.2635    0.0000 Br  0  5
    6.0523   -8.0135    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    3.8869   -8.2595    0.0000 C   0  0
    5.1894   -6.0109    0.0000 N   0  3
    6.4897   -5.2632    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 O   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    6.5141   -6.7763    0.0000 C   0  0
    7.8139   -6.0275    0.0000 C   0  0
    6.5135   -7.7763    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 12  1  0
 25 20  1  0
  5 26  1  0
 26 27  1  0
 26 28  1  0
M  CHG  2   1  -1   5   1
M  END
> <name>
NIHCC_2014

> <id>
6171

> <plate>
NGP-202-02

> <well>
C02

> <supplier_cmpd_name>
CPD000058661

> <ctcr_id>
4149

> <supplier_cmpd_id>
SAM002554922

> <smiles>
[Br-].CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc3ccccc13)C(C)C

> <pd_targets>
{PMP22,LMNA,APEX1,RECQL,MAPT,TDP1,CHRM4,NFKB1,TSHR,CHRM1,CYP3A4,CYP1A2,CYP2D6,CHRM2,CHRM3}

> <pathway_gtopdb>
{"Unclassified protein","Other nuclear protein",Enzyme,"Other cytosolic protein","Membrane receptor",Hydrolase,"Family A G protein-coupled receptor","Cytochrome P450","Small molecule receptor (family 
A GPCR)","Peptide receptor (family A GPCR)","Cytochrome P450 family 3","Cytochrome P450 family 1","Cytochrome P450 family 2","Monoamine receptor","Glycohormone receptor","Cytochrome P450 family 3A","C
ytochrome P450 family 1A","Cytochrome P450 family 2D","Acetylcholine receptor","Cytochrome P450 3A4","Cytochrome P450 1A1","Cytochrome P450 2D6"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Cytochrome P450","Acetylcholine receptors (muscarinic)","Glycoprotein hormone receptors","CYP3 family","CYP1 family","CYP2 family: drug metabolising s
ubset"}

> <pathway_reactome>
{"Developmental Biology","Cell Cycle","DNA Repair","Neuronal System","Signal Transduction","Immune System",Disease,Metabolism,"Nervous system development",Mitotic,"Base Excision Repair","Transmission 
across Chemical Synapses","DNA Double-Strand Break Repair","Signaling by GPCR","Cytokine Signaling in Immune system","Infectious disease","Metabolism of lipids","Biological oxidations","EGR2 and SOX10
-mediated initiation of Schwann cell myelination","M Phase","Resolution of Abasic Sites (AP sites)","Neurotransmitter receptors and postsynaptic signal transmission","Nonhomologous End-Joining (NHEJ)"
,"GPCR ligand binding","Signaling by Interleukins","Leishmania infection","Biosynthesis of specialized proresolving mediators (SPMs)","Phase I - Functionalization of compounds","Mitotic Metaphase and 
Anaphase","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Activation of NMDA receptors and postsynaptic events","Class A/1 (Rhodopsin-like receptors)","Interleukin-1 fa
mily signaling","Leishmania parasite growth and survival","Biosynthesis of DHA-derived SPMs","Cytochrome P450 - arranged by substrate type","Mitotic Anaphase","PCNA-Dependent Long Patch Base Excision 
Repair","Post NMDA receptor activation events","Amine ligand-binding receptors","Interleukin-1 signaling","Anti-inflammatory response favouring Leishmania parasite infection","Biosynthesis of maresins
",Xenobiotics,"Nuclear Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs","Muscarinic acetylcholine receptors","MAP3K8 (TPL2)-dependent MAPK1/3 activation","ADORA2B mediated anti-infl
ammatory cytokines production","Biosynthesis of maresin-like SPMs","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","CYP2E1 reactions","Initiation of Nuclear Envelope (NE) Reformatio
n"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3,CHRM4}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{"PROPANTHELINE BROMIDE",50-34-0,50340,Pro-Banthine,ProBanthine,"Propantheline (bromide)",UNII-UX9Z118X9F,UNIIUX9Z118X9F,"(2-Hydroxyethyl)diisopropylmethylammonium bromide xanthene-9-carboxylate","(2H
ydroxyethyl)diisopropylmethylammonium bromide xanthene9carboxylate",MLS000028703,UX9Z118X9F,methyl-di(propan-2-yl)-(2-(9H-xanthene-9-carbonyloxy)eth,methyldi(propan2yl)(2(9Hxanthene9carbonyloxy)eth,T1
006,SAM002554922,1500511,Prestw-827,"Propantheline bromide",CPD000058661}

> <pdid>
PD009722

> <targets>
{}

> <classes>
{anticholinergic}

> <pubchem_cids>
{9279,521275}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 18  0  0  0  0            999 V2000
    7.7471   -4.0806    0.0000 C   0  0
    6.2556   -4.2405    0.0000 C   0  0
    5.5083   -5.5411    0.0000 O   0  0
    4.0404   -5.2322    0.0000 N   0  0
    3.8995   -3.7516    0.0000 C   0  0
    2.5997   -3.0012    0.0000 N   0  0
    2.5988   -1.5004    0.0000 S   0  0
    3.8976   -0.7500    0.0000 O   0  0
    3.8982   -2.2498    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    5.2496   -3.1278    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  2  0
  7 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 13 15  1  0
 15 16  2  0
 16 10  1  0
  5 17  1  0
 17  2  2  0
M  END
> <name>
NIHCC_2014

> <id>
6172

> <plate>
NGP-202-02

> <well>
C03

> <supplier_cmpd_name>
CPD000058223

> <ctcr_id>
2756

> <supplier_cmpd_id>
SAM002554930

> <smiles>
Cc1onc(N[S](=O)(=O)c2ccc(N)cc2)c1

> <pd_targets>
{RECD,EDNRA,POL,FOLP,ALDH1A1,MAPT}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Other cytosolic protein",Oxidoreductase,"Family A G protein-coupled receptor",Protease,Transferase,"Peptide receptor (family A GPCR)","Aspartic protease","Short peptide re
ceptor (family A GPCR)","Aspartic protease AA clan","Endothelin receptor","Aspartic protease A2A subfamily"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Endothelin receptors"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,"Neuronal System","Signaling by GPCR","Biological oxidations","Transmission across Chemical Synapses","GPCR ligand binding","Phase I - Functionalization of compounds"
,"Neurotransmitter receptors and postsynaptic signal transmission","Class A/1 (Rhodopsin-like receptors)","Ethanol oxidation","Activation of NMDA receptors and postsynaptic events","Peptide ligand-bin
ding receptors","Post NMDA receptor activation events","Activation of AMPK downstream of NMDARs"}

> <broad_targets>
{}

> <broad_moa>
{"PABA antagonist"}

> <synonyms>
{Sulpha-methoxizole,Sulphamethoxizole,Bactrim,Sulfamethalazole,sulfamethoxazole,723-46-6,723466,Sulphamethoxazole,Gantanol,Sulfisomezole,Sulfamethoxazol,Metoxal,4-Amino-N-(5-methyl-3-isoxazolyl)benzen
esulfonamide,4AminoN(5methyl3isoxazolyl)benzenesulfonamide,Sulfamethylisoxazole,Simsinomin,Radonil,Sinomin,Sul,T0885,SAM002554930,1500550,Prestw-177,Sulfamethoxazole,CPD000058223,SULFAMETHOXAZOLE}

> <pdid>
PD001746

> <targets>
{}

> <classes>
{antipneumocystis,antibacterial}

> <pubchem_cids>
{5329}

$$$$
NIHCC_2014
  SciTegic11012413002D

 13 11  0  0  0  0            999 V2000
    8.8933   -1.1283    0.0000 H   0  3
    6.3933   -1.1283    0.0000 Cl  0  5
    3.8926   -3.7566    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 11 13  2  0
 13  6  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6173

> <plate>
NGP-202-02

> <well>
C04

> <supplier_cmpd_name>
CPD000059081

> <ctcr_id>
5016

> <supplier_cmpd_id>
SAM002554938

> <smiles>
[H+].[Cl-].NCCc1ccc(O)c(O)c1

> <pd_targets>
{ALOX5}

> <pathway_gtopdb>
{Enzyme,Oxidoreductase}

> <pathway_chembl>
{Enzymes,"Eicosanoid turnover",Lipoxygenases}

> <pathway_reactome>
{Metabolism,"Metabolism of lipids","Biosynthesis of specialized proresolving mediators (SPMs)","Biosynthesis of DPA-derived SPMs","Biosynthesis of DPAn-3 SPMs","Biosynthesis of DPAn-3-derived 13-serie
s resolvins"}

> <broad_targets>
{DBH,DRD1,DRD2,DRD3,DRD4,DRD5,HTR1A,HTR7,SLC6A2,SLC6A3,SLC6A4}

> <broad_moa>
{"dopamine receptor agonist"}

> <synonyms>
{"Dopamine hydrochloride",62-31-7,62317,"62 31 7","3-Hydroxytyramine hydrochloride","3Hydroxytyramine hydrochloride","3 Hydroxytyramine hydrochloride","Dopamine HCl","4-(2-aminoethyl)benzene-1,2-diol 
hydrochloride","4(2aminoethyl)benzene1,2diol hydrochloride",4(2aminoethyl)benzene1,2d,S2529,SAM002554938,1500263,Prestw-1398,"Dopamine HCl",CPD000059081,"DOPAMINE HYDROCHLORIDE"}

> <pdid>
PD000596

> <targets>
{"Dopamine Receptor"}

> <classes>
{"Neuronal Signaling",cardiotonic,antihypotensive}

> <pubchem_cids>
{65340,46911794,517540}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 32  0  0  0  0            999 V2000
    8.7484    0.6048    0.0000 Na  0  3
    6.1085   -6.9200    0.0000 C   0  0
    5.4984   -5.5497    0.0000 C   0  0
    4.0312   -5.2378    0.0000 S   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 S   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 S   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.0479    2.0470    0.0000 C   0  0
   -3.4910    2.4366    0.0000 N   0  0
   -3.8776    3.8868    0.0000 C   0  0
   -2.8152    4.9458    0.0000 O   0  0
   -5.3265    4.2780    0.0000 C   0  0
   -5.7131    5.7282    0.0000 N   0  0
   -7.1061    6.2492    0.0000 C   0  0
   -7.0226    7.7469    0.0000 N   0  0
   -5.5724    8.1303    0.0000 N   0  0
   -4.7597    6.8696    0.0000 N   0  0
   -0.7488    2.7970    0.0000 C   0  0
   -0.3606    4.2459    0.0000 O   0  0
    2.6003    1.4978    0.0000 C   0  0
    2.6029    2.9978    0.0000 O   0  5
    3.8983    0.7459    0.0000 O   0  0
    5.2447   -3.1359    0.0000 N   0  0
    6.2484   -4.2507    0.0000 N   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  3
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13  8  1  0
 11 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 19  1  0
 14 24  1  0
 24 10  1  0
 24 25  2  0
  9 26  1  0
 26 27  1  0
 26 28  2  0
  5 29  2  0
 29 30  1  0
 30  3  2  0
M  CHG  2   1   1  27  -1
M  END
> <name>
NIHCC_2014

> <id>
6174

> <plate>
NGP-202-02

> <well>
C05

> <supplier_cmpd_name>
CPD001491644

> <ctcr_id>
7020

> <supplier_cmpd_id>
SAM002564200

> <smiles>
[Na+].Cc1sc(SCC2=C(N3C(SC2)C(NC(=O)Cn4cnnn4)C3=O)C([O-])=O)nn1

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Sodium cefazolin;Sodium cephazolin",SCHEMBL720701,CHEMBL4526291,HMS3259E10,ANW-43350,ANW43350,AKOS000489774,AKOS003261853,AKOS024290203,MCULE-3206261439,MCULE3206261439,NC00553,ST055251,FT-0623529,F
T0623529,FT-0623530,FT0623530,A-8996,A8996,F1443-7605,F14437605,T0953,SAM002564200,"Cefazolin sodium salt",CPD001491644}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{4214199}

$$$$
NIHCC_2014
  SciTegic11012413002D

 13 12  0  0  0  0            999 V2000
    6.3995   -1.1258    0.0000 Cl  0  5
    3.8988   -3.7512    0.0000 C   0  0
    2.5997   -3.0012    0.0000 C   0  0
    2.5988   -1.5004    0.0000 N   0  3
    3.8976   -0.7500    0.0000 C   0  0
    3.8982   -2.2498    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 13  7  1  0
M  CHG  2   1  -1   4   1
M  END
> <name>
NIHCC_2014

> <id>
6175

> <plate>
NGP-202-02

> <well>
C06

> <supplier_cmpd_name>
CPD000058672

> <ctcr_id>
404

> <supplier_cmpd_id>
SAM002564207

> <smiles>
[Cl-].CC[N+](C)(C)c1cccc(O)c1

> <pd_targets>
{ACHE,BLM,SMN1,TSHR,CHRM1,BCHE}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Membrane receptor",Hydrolase,Reader,"Family A G protein-coupled receptor","Methyl-lysine/arginine binding protein","Peptide receptor (family A GPCR)","Small molecule re
ceptor (family A GPCR)","Tudor domain","Glycohormone receptor","Monoamine receptor","Acetylcholine receptor"}

> <pathway_chembl>
{Enzymes,Receptors,"Acetylcholine turnover","G protein-coupled receptors","Glycoprotein hormone receptors","Acetylcholine receptors (muscarinic)"}

> <pathway_reactome>
{Metabolism,"DNA Repair","Metabolism of RNA",Disease,"Signal Transduction","Metabolism of lipids","DNA Double-Strand Break Repair","Metabolism of non-coding RNA","Infectious disease","Signaling by GPC
R","Phospholipid metabolism","Homology Directed Repair","snRNP Assembly","Leishmania infection","GPCR ligand binding","Glycerophospholipid biosynthesis","HDR through Homologous Recombination (HRR) or 
Single Strand Annealing (SSA)","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Synthesis of PC","HDR through Homologous Recombination (HRR)","Anti-inflammatory respon
se favouring Leishmania parasite infection","Amine ligand-binding receptors","Homologous DNA Pairing and Strand Exchange","ADORA2B mediated anti-inflammatory cytokines production","Muscarinic acetylch
oline receptors","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{ACHE,BCHE}

> <broad_moa>
{"acetylcholinesterase inhibitor"}

> <synonyms>
{"Edrophonium chloride",116-38-1,116381,"N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium chloride","Nethyl3hydroxyN,Ndimethylbenzenaminium chloride","Edrophonii chloridum","Ethyl(m-hydroxyphenyl)dimethyla
mmonium chloride","Ethyl(mhydroxyphenyl)dimethylammonium chloride",Reversol,"Cloruro de edrofonio","Chlorure d'edrophonium","Edrophonium (c",SAM002564207,2300219,Prestw-83,CPD000058672,"EDROPHONIUM CH
LORIDE"}

> <pdid>
PD009595

> <targets>
{}

> <classes>
{"acetylcholinesterase inhibitor"}

> <pubchem_cids>
{60204238,8307}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 26  0  0  0  0            999 V2000
    1.1065    2.8606    0.0000 C   0  0
   -0.3930    2.8217    0.0000 C   0  0
   -1.1760    4.1011    0.0000 C   0  0
   -1.0947    1.4779    0.0000 N   0  3
   -2.5947    1.4650    0.0000 C   0  0
    0.0000    0.6568    0.0000 C   0  0
   -0.6568   -0.6386    0.0000 C   0  0
   -1.8063   -1.3319    0.0000 C   0  0
   -0.8393    0.0000    0.0000 C   0  0
    0.9488    0.0000    0.0000 C   0  0
    1.8975   -0.8028    0.0000 C   0  0
    1.6421    0.6933    0.0000 C   0  0
    2.6654   -2.0798    0.0000 O   0  0
    4.1661   -2.0555    0.0000 C   0  0
    4.8945   -0.7443    0.0000 O   0  0
    4.9382   -3.3425    0.0000 C   0  0
    4.2067   -4.6529    0.0000 C   0  0
    2.7069   -4.6756    0.0000 O   0  0
    6.4389   -3.3181    0.0000 C   0  0
    7.2125   -4.6033    0.0000 C   0  0
    8.7123   -4.5759    0.0000 C   0  0
    9.4385   -3.2634    0.0000 C   0  0
    8.6649   -1.9783    0.0000 C   0  0
    7.1652   -2.0056    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  4  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12  6  1  0
 11 13  1  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 16 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
M  CHG  1   4   1
M  END
> <name>
NIHCC_2014

> <id>
6176

> <plate>
NGP-202-02

> <well>
C07

> <supplier_cmpd_name>
CPD001906775

> <ctcr_id>
7023

> <supplier_cmpd_id>
SAM002564215

> <smiles>
CC(C)[N+]1(C)C2CCC1CC(C2)OC(=O)C(CO)c3ccccc3

> <pd_targets>
{CHRM1,CHRM3,CHRM2,CHRM5,CHRM4,KMT2A,MEN1,FFP}

> <pathway_gtopdb>
{"Membrane receptor","Epigenetic regulator",Enzyme,"Family A G protein-coupled receptor",Reader,Transferase,"Small molecule receptor (family A GPCR)",Bromodomain,"Monoamine receptor","Acetylcholine re
ceptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Acetylcholine receptors (muscarinic)"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Amine ligand-binding receptors","Muscarinic acetylcholine receptors"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3,CHRM4,CHRM5}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{ipratropium,Atrovent,60205-81-4,60205814,"60205 81 4","Atrovent Hfa","Ipratropium bromide monohydrate",CHEMBL1237108,Ipraxa,Prestwick0_000575,Prestwick0000575,Prestwick0-000575,"Prestwick0 000575",Pr
estwick1_000575,Prestwick1000575,Prestwick1-000575,"Prestwick1 000575",Prestwick1,SAM002564215,CPD001906775}

> <pdid>
PD002966

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{3746}

$$$$
NIHCC_2014
  SciTegic11012413002D

 12 13  0  0  1  0            999 V2000
    4.2566    0.5871    0.0000 C   0  0
    3.9511   -0.8815    0.0000 N   0  0
    4.9531   -1.9978    0.0000 C   0  0
    4.2010   -3.2956    0.0000 C   0  0
    2.7343   -2.9815    0.0000 C   0  0
    2.5987   -1.5004    0.0000 C   0  0  1  0  0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  2  1  0
  6  7  1  1
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
M  END
> <name>
NIHCC_2014

> <id>
6177

> <plate>
NGP-202-02

> <well>
C08

> <supplier_cmpd_name>
CPD000059074

> <ctcr_id>
7026

> <supplier_cmpd_id>
SAM002564224

> <smiles>
CN1CCC[C@H]1c2cccnc2

> <pd_targets>
{CHRNA4,CHRNB2,CHRNA7,CHRNA3,CHRNB4,CHRNA10,CHRNA2,CHRNA5,CHRNA6,CHRNA9,CHRNB3,MAPT,NACHRBETA2,CHRNA1,ALDH1A1,CHRNB1,CHRND,CHRNG,CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,HTR3A,HTR3B,HTR3C,HTR3D,HTR3E,CHRNE,NACHR
ALPHA5,TRPA1,CYP2A6,IMPA1,CYP2A13,KCND3,BLM,KDM4E,SLC22A2,SLC22A1,CYP19A1,CHAT}

> <pathway_gtopdb>
{"Ion channel","Other cytosolic protein",Enzyme,"Membrane receptor","Epigenetic regulator",Transporter,"Ligand-gated ion channel",Oxidoreductase,"Family A G protein-coupled receptor","Voltage-gated io
n channel","Cytochrome P450",Hydrolase,Eraser,"Electrochemical transporter",Transferase,"Nicotinic acetylcholine receptor","Small molecule receptor (family A GPCR)","5HT3 receptor","Transient receptor
 potential channel","Cytochrome P450 family 2","Potassium channels","Lysine demethylase","SLC superfamily of solute carriers","Cytochrome P450 family 19","Nicotinic acetylcholine receptor alpha subuni
t","Nicotinic acetylcholine receptor beta subunit","Monoamine receptor","Cytochrome P450 family 2A","Voltage-gated potassium channel","Jumonji domain-containing","SLC22 family of organic cation and an
ion transporters","Cytochrome P450 family 19A","Acetylcholine receptor","Cytochrome P450 2A6","Cytochrome P450 19A1"}

> <pathway_chembl>
{"Ion channels",Enzymes,Transporters,"Ligand-gated ion channels","Voltage-gated ion channels","Cytochrome P450","Inositol phosphate turnover","Chromatin modifying enzymes","SLC superfamily of solute c
arriers","Acetylcholine turnover","Nicotinic acetylcholine receptors","Transient Receptor Potential channels","CYP2 family: drug metabolising subset","Inositol monophosphatase","Potassium channels","1
.14.11.- Histone demethylases","SLC22 family of organic cation and anion transporters",CYP11,CYP17,CYP19,"CYP20 and CYP21 families","Voltage-gated potassium channels","Organic cation transporters (OCT
)"}

> <pathway_reactome>
{"Neuronal System",Metabolism,"Transport of small molecules","Muscle contraction","DNA Repair","Transmission across Chemical Synapses","Biological oxidations","Ion channel transport","Inositol phospha
te metabolism","Cardiac conduction","DNA Double-Strand Break Repair","SLC-mediated transmembrane transport","Metabolism of lipids","Neurotransmitter receptors and postsynaptic signal transmission","Ph
ase I - Functionalization of compounds","Stimuli-sensing channels","Synthesis of IP2",IP,"and Ins in the cytosol","Phase 1 - inactivation of fast Na+ channels","Homology Directed Repair","Transport of
 bile salts and organic acids","metal ions and amine compounds","Phospholipid metabolism","Acetylcholine binding and downstream events","Activation of NMDA receptors and postsynaptic events","Ethanol 
oxidation","TRP channels","Cytochrome P450 - arranged by substrate type","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Organic cation/anion/zwitterion transport","Glyc
erophospholipid biosynthesis","Postsynaptic nicotinic acetylcholine receptors","Post NMDA receptor activation events",Xenobiotics,"HDR through Homologous Recombination (HRR)","Organic cation transport
","Endogenous sterols","Synthesis of PC","Highly calcium permeable postsynaptic nicotinic acetylcholine receptors","Activation of AMPK downstream of NMDARs","CYP2E1 reactions","Homologous DNA Pairing 
and Strand Exchange","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{CHAT,CHRNA10,CHRNA2,CHRNA3,CHRNA4,CHRNA5,CHRNA6,CHRNA7,CHRNA9,CHRNB2,CHRNB3,CHRNB4,CYP19A1,TBXAS1,TRPA1}

> <broad_moa>
{"acetylcholine receptor agonist"}

> <synonyms>
{nicotine,L-Nicotine,LNicotine,54-11-5,54115,(-)-Nicotine,()Nicotine,(S)-Nicotine,(S)Nicotine,(S)-3-(1-methylpyrrolidin-2-yl)pyridine,(S)3(1methylpyrrolidin2yl)pyridine,Habitrol,3-((2S)-1-methylpyrrol
idin-2-yl)pyridine,3((2S)1methylpyrrolidin2yl)pyridine,(S)-(-)-Nicotine,(S)()Nicotine,Nicoderm,Nicotrol,Fumetobac,"Nicotine polacrilex","Flux MAAG","Ortho N-4 dust","Ortho N4 dust",O,T2892,SAM00256422
4,Nicotine,CPD000059074}

> <pdid>
PD003076

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{89594}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 23  0  0  0  0            999 V2000
   11.4962    0.0191    0.0000 H   0  3
    8.9962    0.0191    0.0000 Cl  0  5
    1.2996   -2.2502    0.0000 O   0  0
    2.5987   -1.5004    0.0000 C   0  0
    2.5985    0.0005    0.0000 C   0  0
    3.8976    0.7519    0.0000 C   0  0
    3.8974    2.2527    0.0000 N   0  0
    5.1090    3.1152    0.0000 C   0  0
    4.6423    4.5408    0.0000 C   0  0
    3.1423    4.5375    0.0000 C   0  0
    2.6820    3.1099    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8981   -2.2514    0.0000 C   0  0
    3.8974   -3.7514    0.0000 C   0  0
    5.1961   -4.5020    0.0000 C   0  0
    6.4955   -3.7526    0.0000 C   0  0
    6.4962   -2.2526    0.0000 C   0  0
    5.1975   -1.5020    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11  7  1  0
  4 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 12  1  0
  4 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6178

> <plate>
NGP-202-02

> <well>
C09

> <supplier_cmpd_name>
CPD000058821

> <ctcr_id>
3003

> <supplier_cmpd_id>
SAM002564231

> <smiles>
[H+].[Cl-].OC(CCN1CCCC1)(C2CCCCC2)c3ccccc3

> <pd_targets>
{CHRM1,HRH1,GRIN1,GRIN2A,GRIN2B,GRIN2C,GRIN2D,GRIN3A,GRIN3B,CHRM2,CHRM4,CHRM3,PMP22,AMPC,BLM,MAPT,CHRM5,SIGMAR1,CYP2D6,TDP1,NFKB1,CYP3A4,TSHR}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Acetylcholine receptor","Ion channel","Ligand-gated ion channel","Ionotropic 
glutamate receptor","NMDA receptor","Histamine receptor","Unclassified protein",Enzyme,"Other cytosolic protein",Hydrolase,"Cytochrome P450","Cytochrome P450 family 2","Cytochrome P450 family 2D","Cyt
ochrome P450 2D6","Cytochrome P450 family 3","Peptide receptor (family A GPCR)","Cytochrome P450 family 3A","Glycohormone receptor","Cytochrome P450 3A4"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Acetylcholine receptors (muscarinic)","Histamine receptors","Other protein targets",Enzymes,"Sigma receptors","Cytochrome P450","CYP2 family: drug metabolisin
g subset","CYP3 family","Glycoprotein hormone receptors"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Amine ligand-binding receptors","Muscarinic acetylcholine receptors","Histamine receptors","Dev
elopmental Biology","DNA Repair","Neuronal System",Disease,Metabolism,"Nervous system development","DNA Double-Strand Break Repair","Transmission across Chemical Synapses","Infectious disease","Biolog
ical oxidations","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Homology Directed Repair","Neurotransmitter receptors and postsynaptic signal transmission","SARS-CoV Infections","Ph
ase I - Functionalization of compounds","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Activation of NMDA receptors and postsynaptic events","Potential therapeutics for
 SARS","Cytochrome P450 - arranged by substrate type","HDR through Homologous Recombination (HRR)","Post NMDA receptor activation events",Xenobiotics,"Homologous DNA Pairing and Strand Exchange","Acti
vation of AMPK downstream of NMDARs","CYP2E1 reactions","Presynaptic phase of homologous DNA pairing and strand exchange","Immune System","Cytokine Signaling in Immune system","Metabolism of lipids","
Nonhomologous End-Joining (NHEJ)","Signaling by Interleukins","Biosynthesis of specialized proresolving mediators (SPMs)","Leishmania infection","Interleukin-1 family signaling","Biosynthesis of DHA-d
erived SPMs","Leishmania parasite growth and survival","Interleukin-1 signaling","Biosynthesis of maresins","Anti-inflammatory response favouring Leishmania parasite infection","MAP3K8 (TPL2)-dependen
t MAPK1/3 activation","Biosynthesis of maresin-like SPMs","ADORA2B mediated anti-inflammatory cytokines production"}

> <broad_targets>
{CHRM1}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{"Tricyclamol hydrochloride","(+-)-Procyclidine hydrochloride","(+)Procyclidine hydrochloride","(+ ) Procyclidine hydrochloride",CHEBI:8449,"1-cyclohexyl-1-phenyl-3-pyrrolidin-1-ylpropan-1-ol hydrochl
oride","1cyclohexyl1phenyl3pyrrolidin1ylpropan1ol hydrochloride",1cyclohexyl1phenyl3,SAM002564231,1500507,Prestw-844,CPD000058821,"PROCYCLIDINE HYDROCHLORIDE","Procyclidine hydrochloride"}

> <pdid>
PD009627

> <targets>
{}

> <classes>
{anticholinergic}

> <pubchem_cids>
{657394,207841}

$$$$
NIHCC_2014
  SciTegic11012413002D

 14 16  0  0  0  0            999 V2000
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 N   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.5536   -4.4230    0.0000 C   0  0
    2.0412   -5.8141    0.0000 C   0  0
    3.2310   -6.7275    0.0000 S   0  0
    4.4674   -5.8782    0.0000 C   0  0
    4.0417   -4.4399    0.0000 N   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  7  8  1  0
  8  9  2  0
  9  1  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 10  1  0
M  END
> <name>
NIHCC_2014

> <id>
6179

> <plate>
NGP-202-02

> <well>
C10

> <supplier_cmpd_name>
CPD000058170

> <ctcr_id>
3544

> <supplier_cmpd_id>
SAM002564239

> <smiles>
[nH]1c2ccccc2nc1c3cscn3

> <pd_targets>
{RAB9A,TSHR,FKBP1A,SMN1,CYP2D6,MAP,POL,HIF1A,METAP1,TP53,CYP2C19,NPC1,PYK,CYP3A4,CYP1A2,KDM4E,METAP2,FRDA}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Epigenetic regulator","Transcription factor",Transporter,Hydrolase,"Family A G protein-coupled receptor",Isomerase,Reader,"Cytochrome P450",Protease,Transferase,Eraser,"Pe
ptide receptor (family A GPCR)","Methyl-lysine/arginine binding protein","Cytochrome P450 family 2","Metallo protease","Cytochrome P450 family 3","Cytochrome P450 family 1","Lysine demethylase","Small
 molecule receptor (family A GPCR)","Glycohormone receptor","Tudor domain","Cytochrome P450 family 2D","Metallo protease MG clan","Cytochrome P450 family 2C","Cytochrome P450 family 3A","Cytochrome P4
50 family 1A","Jumonji domain-containing","Monoamine-derivative receptor (family A GPCR)","Cytochrome P450 2D6","Metallo protease M24A subfamily","Cytochrome P450 2C19","Cytochrome P450 3A4","Cytochro
me P450 1A1","Melatonin receptor"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"G protein-coupled receptors","Peptidyl-prolyl cis/trans isomerases","Cytochrome P450","Peptidases and proteinases","SLC superfamily of solute carriers","Chromatin modi
fying enzymes","Catalytic receptors","Glycoprotein hormone receptors","CYP2 family: drug metabolising subset","MG: Metallo (M) Peptidases","SLC65 NPC-type cholesterol transporters","CYP3 family","CYP1
 family","1.14.11.- Histone demethylases","Receptor guanylyl cyclase (RGC) family","M24: Methionyl aminopeptidase","Nitric oxide (NO)-sensitive (soluble) guanylyl cyclase"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Metabolism of RNA",Metabolism,"Cellular responses to external stimuli","Cell Cycle","Transport of small molecules","Signaling by Rho GTPases","Infectious disease","Dise
ases of signal transduction by growth factor receptors and second messengers","Metabolism of non-coding RNA","Biological oxidations","Cellular responses to stress","Signaling by GPCR","Cell Cycle Chec
kpoints","Plasma lipoprotein assembly",remodeling,"and clearance","Metabolism of lipids","Rho GTPase cycle","Leishmania infection","Signaling by TGF-beta Receptor Complex in Cancer","snRNP Assembly","
Phase I - Functionalization of compounds","Cellular response to hypoxia","GPCR downstream signalling","G1/S DNA Damage Checkpoints","Plasma lipoprotein clearance","Biosynthesis of specialized proresol
ving mediators (SPMs)","RHOBTB GTPase Cycle","Leishmania parasite growth and survival","Loss of Function of TGFBR1 in Cancer","Cytochrome P450 - arranged by substrate type","Oxygen-dependent proline h
ydroxylation of Hypoxia-inducible Factor Alpha","G alpha (i) signalling events","p53-Dependent G1/S DNA damage checkpoint","LDL clearance","Biosynthesis of DHA-derived SPMs","RHOBTB3 ATPase cycle","An
ti-inflammatory response favouring Leishmania parasite infection","TGFBR1 LBD Mutants in Cancer",Xenobiotics,"Visual phototransduction","p53-Dependent G1 DNA Damage Response","Biosynthesis of maresins
","ADORA2B mediated anti-inflammatory cytokines production","CYP2E1 reactions","The phototransduction cascade","Stabilization of p53","Biosynthesis of maresin-like SPMs","Aromatic amines can be N-hydr
oxylated or N-dealkylated by CYP1A2",Inactivation,"recovery and regulation of the phototransduction cascade","Autodegradation of the E3 ubiquitin ligase COP1"}

> <broad_targets>
{}

> <broad_moa>
{"angiogenesis inhibitor"}

> <synonyms>
{thiabendazole,148-79-8,148798,Tiabendazole,Mintezol,2-(4-Thiazolyl)benzimidazole,2(4Thiazolyl)benzimidazole,Equizole,Thiabendazol,Tiabendazol,Mintesol,Omnizole,Thibenzole,Bovizole,Minzolum,Thiabenzol
e,Thibenzol,Thiaben,Testo,Lombristop,Bioguard,Eprofil,Mertect,Mycozol,Nemapan,T0938,SAM002564239,1500570,Prestw-524,Thiabendazole,CPD000058170,THIABENDAZOLE}

> <pdid>
PD001733

> <targets>
{Mitochondrial Metabolism,Parasite}

> <classes>
{anthelmintic,Anti-infection,Metabolic Enzyme/Protease}

> <pubchem_cids>
{5430}

$$$$
NIHCC_2014
  SciTegic11012413002D

  9  8  0  0  0  0            999 V2000
    0.0007    0.0004    0.0000 N   0  0
    1.3000    0.7500    0.0000 C   0  0
    2.6000    0.0000    0.0000 C   0  0
    2.6000   -1.5000    0.0000 O   0  0
    3.9000    0.7500    0.0000 C   0  0
    5.2000    0.0000    0.0000 C   0  0
    6.5000    0.7500    0.0000 C   0  0
    6.5000    2.2500    0.0000 O   0  0
    7.7992    0.0004    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  2  0
M  END
> <name>
NIHCC_2014

> <id>
6180

> <plate>
NGP-202-02

> <well>
C11

> <supplier_cmpd_name>
CPD000857229

> <ctcr_id>
7034

> <supplier_cmpd_id>
SAM002589919

> <smiles>
NCC(=O)CCC(O)=O

> <pd_targets>
{AMPC,GABRR1,ALAD}

> <pathway_gtopdb>
{Enzyme,"Ion channel",Hydrolase,"Ligand-gated ion channel",Lyase,"GABA-A receptor"}

> <pathway_chembl>
{"Ion channels","Ligand-gated ion channels","GABA<sub>A</sub> receptors"}

> <pathway_reactome>
{"Neuronal System","Immune System","Transmission across Chemical Synapses","Innate Immune System","Neurotransmitter receptors and postsynaptic signal transmission","Neutrophil degranulation","GABA rec
eptor activation"}

> <broad_targets>
{ALAD}

> <broad_moa>
{"oxidizing agent"}

> <synonyms>
{"5-Aminolevulinic acid","5Aminolevulinic acid","5 Aminolevulinic acid","Aminolevulinic acid",106-60-5,106605,"106 60 5","5-Amino-4-oxopentanoic acid","5Amino4oxopentanoic acid","5 Amino 4 oxopentanoi
c acid",5-Aminolevulinate,5Aminolevulinate,SAM002589919,CPD000857229}

> <pdid>
PD003147

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{137,7048523}

$$$$
NIHCC_2014
  SciTegic11012413002D

 19 19  0  0  0  0            999 V2000
    5.1995   -6.0025    0.0000 C   0  0
    3.9005   -5.2525    0.0000 C   0  0
    3.8995   -3.7516    0.0000 C   0  0
    2.5997   -3.0012    0.0000 N   0  0
    1.3018   -3.7547    0.0000 C   0  0
    1.3044   -5.2556    0.0000 C   0  0
    0.0071   -6.0086    0.0000 C   0  0
    2.5988   -1.5004    0.0000 S   0  0
    3.8982   -2.2498    0.0000 O   0  0
    3.8976   -0.7500    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -2.6030    2.9977    0.0000 O   0  0
   -3.8983    0.7459    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  4  8  1  0
  8  9  2  0
  8 10  2  0
  8 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 14 17  1  0
 17 18  1  0
 17 19  2  0
M  END
> <name>
NIHCC_2014

> <id>
6181

> <plate>
NGP-202-02

> <well>
D02

> <supplier_cmpd_name>
CPD000058280

> <ctcr_id>
4702

> <supplier_cmpd_id>
SAM002554923

> <smiles>
CCCN(CCC)[S](=O)(=O)c1ccc(cc1)C(O)=O

> <pd_targets>
{SLC22A6,UGT1A7,CA12,CA2,CA9,SLC22A11,ABCC2,TRPV2,SLC22A12,ALD,SLC22A8,SLCO1A1,SLC22A20,SLCO1A4,SLCO1C1,PANX1}

> <pathway_gtopdb>
{Transporter,Enzyme,"Ion channel","Electrochemical transporter",Transferase,Lyase,"Primary active transporter","Voltage-gated ion channel","Other ion channel","SLC superfamily of solute carriers","ATP
-binding cassette","Transient receptor potential channel","SLC22 family of organic cation and anion transporters","ABCC subfamily","SLC21/SLCO family of organic anion transporting polypeptides"}

> <pathway_chembl>
{Transporters,Enzymes,"Ion channels","SLC superfamily of solute carriers","Carbonic anhydrases","ATP-binding cassette transporter family","Voltage-gated ion channels","Other ion channels","SLC22 famil
y of organic cation and anion transporters","ABCC subfamily","Transient Receptor Potential channels","SLCO family of organic anion transporting polypeptides","Connexins and Pannexins","Organic anion t
ransporters (OATs)","Urate transporter","Orphan or poorly characterized SLC22 family members"}

> <pathway_reactome>
{"Transport of small molecules",Metabolism,"Cellular responses to external stimuli",Disease,"Immune System","SLC-mediated transmembrane transport","Biological oxidations","Reversible hydration of carb
on dioxide","O2/CO2 exchange in erythrocytes","Cellular responses to stress","Disorders of transmembrane transporters","Ion channel transport","Innate Immune System","Transport of bile salts and organ
ic acids","metal ions and amine compounds","Phase II - Conjugation of compounds","Erythrocytes take up carbon dioxide and release oxygen","Cellular response to hypoxia","ABC transporter disorders","St
imuli-sensing channels","Transport of vitamins",nucleosides,"and related molecules","Nucleotide-binding domain","leucine rich repeat containing receptor (NLR) signaling pathways","Organic cation/anion
/zwitterion transport",Glucuronidation,"Regulation of gene expression by Hypoxia-inducible Factor","Defective ABCC2 causes DJS","TRP channels","Transport of organic anions",Inflammasomes,"Organic anio
n transport","The NLRP3 inflammasome"}

> <broad_targets>
{PANX1,SLC22A11,SLC22A6,SLC22A8,SLCO1C1}

> <broad_moa>
{"uricosuric blocker"}

> <synonyms>
{probenecid,57-66-9,57669,"4-(Dipropylsulfamoyl)benzoic acid","4(Dipropylsulfamoyl)benzoic acid","Probenecid acid",Benemid,Probecid,Benecid,Probenemid,Benuryl,Probalan,Probexin,Prolongine,Tubophan,Uri
cosid,Apurina,Proben,"Synergid R","p-(Dipropylsulfamoyl)benzoic acid","p(Dipropylsulfamoyl)benzoic acid",4-((dipropylami,4((dipropylami,T0457,SAM002554923,1500502,Prestw-542,Probenecid,CPD000058280,PR
OBENECID}

> <pdid>
PD001786

> <targets>
{Bacterial,HIV,TRP Channel}

> <classes>
{uricosuric,Anti-infection,Membrane Transporter/Ion Channel,Neuronal Signaling}

> <pubchem_cids>
{4911}

$$$$
NIHCC_2014
  SciTegic11012413002D

 14 14  0  0  0  0            999 V2000
    5.1983   -3.0012    0.0000 C   0  0
    5.1988   -1.5012    0.0000 C   0  0
    6.4983   -0.7520    0.0000 O   0  0
    3.8990   -0.7508    0.0000 N   0  0
    2.5988   -1.5004    0.0000 S   0  0
    3.8975   -2.2510    0.0000 O   0  0
    2.5983   -3.0004    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  2  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14  8  1  0
M  END
> <name>
NIHCC_2014

> <id>
6182

> <plate>
NGP-202-02

> <well>
D03

> <supplier_cmpd_name>
CPD000058173

> <ctcr_id>
2218

> <supplier_cmpd_id>
SAM002554931

> <smiles>
CC(=O)N[S](=O)(=O)c1ccc(N)cc1

> <pd_targets>
{PON1,DHFR,NS1,TSHR,FOLP,SULI,FOL1}

> <pathway_gtopdb>
{Enzyme,"Unclassified protein","Membrane receptor",Hydrolase,Oxidoreductase,"Family A G protein-coupled receptor",Transferase,"Peptide receptor (family A GPCR)","Glycohormone receptor"}

> <pathway_chembl>
{Enzymes,Receptors,"Paraoxonase (PON) family","1.-.-.- Oxidoreductases","G protein-coupled receptors","Glycoprotein hormone receptors"}

> <pathway_reactome>
{Metabolism,"Cell Cycle",Disease,"Metabolism of lipids",Mitotic,"Infectious disease","Fatty acid metabolism","Mitotic G1 phase and G1/S transition","Leishmania infection","Arachidonic acid metabolism"
,"G1/S Transition","Leishmania parasite growth and survival","Synthesis of 5-eicosatetraenoic acids","G1/S-Specific Transcription","Anti-inflammatory response favouring Leishmania parasite infection",
"ADORA2B mediated anti-inflammatory cytokines production"}

> <broad_targets>
{}

> <broad_moa>
{"PABA antagonist"}

> <synonyms>
{sulfacetamide,144-80-9,144809,"144 80 9",Sulphacetamide,Acetosulfamine,N-((4-Aminophenyl)sulfonyl)acetamide,N((4Aminophenyl)sulfonyl)acetamide,"N ((4 Aminophenyl)sulfonyl)acetamide",N-Acetylsulfanila
mide,NAcetylsulfanilamide,"N Acetylsulfani",SAM002554931,1500545,CPD000058173,SULFACETAMIDE}

> <pdid>
PD001751

> <targets>
{}

> <classes>
{antibacterial}

> <pubchem_cids>
{5320}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 25  0  0  0  0            999 V2000
    3.3303   -4.5744    0.0000 Cl  0  0
    2.7822   -3.1780    0.0000 C   0  0
    3.7175   -2.0053    0.0000 C   0  0
    3.1695   -0.6090    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 O   0  0
    0.0000    1.7286    0.0000 C   0  0
    0.1115    3.2255    0.0000 C   0  0
   -1.1278    4.0705    0.0000 C   0  0
   -2.4793    3.4196    0.0000 C   0  0
   -2.5914    1.9238    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 N   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.4011   -2.9095    0.0000 N   0  0
   -2.9046   -2.9463    0.0000 C   0  0
   -3.6237   -4.2627    0.0000 C   0  0
   -2.8432   -5.5436    0.0000 N   0  0
   -1.3436   -5.5082    0.0000 C   0  0
   -0.6245   -4.1918    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
    1.2990   -2.9545    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 12 13  1  0
 13 14  2  3
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 15  1  0
 14 21  1  0
 21  5  1  0
 21 22  2  0
 22  2  1  0
M  END
> <name>
NIHCC_2014

> <id>
6183

> <plate>
NGP-202-02

> <well>
D04

> <supplier_cmpd_name>
CPD000058416

> <ctcr_id>
251

> <supplier_cmpd_id>
SAM002564189

> <smiles>
Clc1ccc2Oc3ccccc3N=C(N4CCNCC4)c2c1

> <pd_targets>
{HTR6,HTR2A,SMN1,TSHR,HIF1A,ALDH1A1,ADRA1A,HTR2C,SLC6A2,SLC6A4,HTR7,DRD2,DRD3,SULT1A1,DRD4,NFO,THPO,CYP3A4,ADRA1B,HRH4,THRB,NPSR1,CYP1A2,SLC6A3,CHRM1,CYP2D6,KDM4E,TDP1,LMNA,KMT2A,MEN1,TP53,PMP22,NFKB1
,FTL,ADRA1D,ADRA2C,HRH1,CHRM2,MTOR,CHRM4,HTR2B,ADRA2B,ADRA2A,CHRM5,HTR1A,CHRM3,DRD1,DRD5,GABRA1,HTR3A,HTR1B,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG3,GAB
RP,GABRQ}

> <pathway_gtopdb>
{"Membrane receptor","Epigenetic regulator","Transcription factor",Enzyme,Transporter,"Unclassified protein","Other nuclear protein","Other cytosolic protein","Ion channel","Family A G protein-coupled
 receptor",Reader,Oxidoreductase,"Electrochemical transporter",Transferase,Hydrolase,"Cytochrome P450","Nuclear receptor",Eraser,Kinase,"Ligand-gated ion channel","Small molecule receptor (family A GP
CR)","Methyl-lysine/arginine binding protein","Peptide receptor (family A GPCR)","SLC superfamily of solute carriers","Cytochrome P450 family 3","Nuclear hormone receptor subfamily 1","Cytochrome P450
 family 1","Cytochrome P450 family 2","Lysine demethylase",Bromodomain,"Protein Kinase","GABA-A receptor","5HT3 receptor","Monoamine receptor","Tudor domain","Glycohormone receptor","SLC06 neurotransm
itter transporter family","Cytochrome P450 family 3A","Nuclear hormone receptor subfamily 1 group A","Short peptide receptor (family A GPCR)","Cytochrome P450 family 1A","Cytochrome P450 family 2D","J
umonji domain-containing","Atypical protein kinase group","Serotonin receptor","Adrenergic receptor","Dopamine receptor","Cytochrome P450 3A4","Histamine receptor","Nuclear hormone receptor subfamily 
1 group A member 2","Neuropeptide receptor","Cytochrome P450 1A1","Acetylcholine receptor","Cytochrome P450 2D6","Atypical protein kinase PIKK family","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Receptors,Transporters,Enzymes,"Ion channels","G protein-coupled receptors","SLC superfamily of solute carriers","Cytochrome P450","Nuclear hormone receptors","Chromatin modifying enzymes","Kinases (
EC 2.7.x.x)","Ligand-gated ion channels","5-Hydroxytryptamine receptors","Glycoprotein hormone receptors",Adrenoceptors,"SLC6 neurotransmitter transporter family","Dopamine receptors","CYP3 family","H
istamine receptors","1A. Thyroid hormone receptors","Neuropeptide S receptor","CYP1 family","Acetylcholine receptors (muscarinic)","CYP2 family: drug metabolising subset","1.14.11.- Histone demethylas
es",Atypical,"GABA<sub>A</sub> receptors","5-HT<sub>3</sub> receptors","Monoamine transporter subfamily","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","FRAP subfamily"}

> <pathway_reactome>
{Disease,"Signal Transduction","Metabolism of RNA","Cellular responses to external stimuli",Metabolism,"Neuronal System",Hemostasis,"Metabolism of proteins","DNA Repair","Cell Cycle","Developmental Bi
ology","Immune System","Vesicle-mediated transport","Gene expression (Transcription)","Infectious disease","Signaling by GPCR","Metabolism of non-coding RNA","Cellular responses to stress","Biological
 oxidations","Disorders of transmembrane transporters","Transmission across Chemical Synapses","Platelet activation","signaling and aggregation","Metabolism of lipids","Post-translational protein modi
fication","DNA Double-Strand Break Repair",Mitotic,"Cell Cycle Checkpoints","Nervous system development","Cytokine Signaling in Immune system","Membrane Trafficking","RNA Polymerase II Transcription",
"Leishmania infection","GPCR ligand binding","snRNP Assembly","Cellular response to hypoxia","Phase I - Functionalization of compounds","SLC transporter disorders","Neurotransmitter clearance","Phase 
II - Conjugation of compounds","Platelet Aggregation (Plug Formation)","Biosynthesis of specialized proresolving mediators (SPMs)",SUMOylation,"Nonhomologous End-Joining (NHEJ)","M Phase","G1/S DNA Da
mage Checkpoints","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Signaling by Interleukins","trans-Golgi Network Vesicle Budding","Generic Transcription Pathway","Neurotransmitter r
eceptors and postsynaptic signal transmission","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alph
a","Ethanol oxidation","Defective SLC6A2 causes orthostatic intolerance (OI)","Serotonin clearance from the synaptic cleft","Cytosolic sulfonation of small molecules","Biosynthesis of DHA-derived SPMs
","SUMO E3 ligases SUMOylate target proteins","Cytochrome P450 - arranged by substrate type","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Mitotic Metaphase and Anaphase","p53-Dep
endent G1/S DNA damage checkpoint","Interleukin-1 family signaling","Golgi Associated Vesicle Biogenesis","Transcriptional Regulation by TP53","GABA receptor activation","Anti-inflammatory response fa
vouring Leishmania parasite infection","Amine ligand-binding receptors","Biosynthesis of maresins","SUMOylation of intracellular receptors",Xenobiotics,"Mitotic Anaphase","p53-Dependent G1 DNA Damage 
Response","Interleukin-1 signaling","Regulation of TP53 Activity","ADORA2B mediated anti-inflammatory cytokines production","Serotonin receptors",Adrenoceptors,"Dopamine receptors","Biosynthesis of ma
resin-like SPMs","Histamine receptors","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Muscarinic acetylcholine receptors","CYP2E1 reactions","Nuclear Envelope (NE) Reassembly","St
abilization of p53","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Regulation of TP53 Expression and Degradation","Initiation of Nuclear Envelope (NE) Reformation","Autodegradation of the E3 ubiquitin 
ligase COP1","Regulation of TP53 Degradation"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,ADRA2A,ADRA2B,ADRA2C,CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,DRD1,DRD2,DRD3,DRD4,DRD5,GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG3,GABRP,
GABRQ,HRH1,HRH4,HTR1A,HTR1B,HTR2A,HTR2B,HTR2C,HTR3A,HTR6,HTR7,SLC6A2,SLC6A3,SLC6A4}

> <broad_moa>
{"norepinephrine reputake inhibitor"}

> <synonyms>
{amoxapine,14028-44-5,14028445,Asendin,Demolox,Moxadil,Amoxan,Desmethylloxapin,Amoxapina,Amoxapinum,Amoxepine,"Dibenz(b,f)(1,4)oxazepine, 2-chloro-11-(1-piperazinyl)-","Dibenz(b,f)(1,4)oxazepine, 2chl
oro11(1piperazinyl)","2-Chloro-11-(1-piperazinyl)dibenz(b,f)(1,4)oxazepine","2Chloro11(1piperazinyl)dibenz(b,f)(1,4)oxazepine","CL 67772",CL-67772,CL67772,8-chloro-6-,8chloro6,T1568,SAM002564189,23001
61,Prestw-102,Amoxapine,CPD000058416,AMOXAPINE}

> <pdid>
PD000076

> <targets>
{Others}

> <classes>
{antidepressant,inhibits norepinephrine uptake,Others}

> <pubchem_cids>
{2170}

$$$$
NIHCC_2014
  SciTegic11012413002D

 14 14  0  0  1  0            999 V2000
    3.7332   -0.7121    0.0000 C   0  0
    3.1255   -2.0835    0.0000 C   0  0  2  0  0  0
    4.0102   -3.2959    0.0000 C   0  0
    5.5018   -3.1369    0.0000 S   0  0
    1.6332   -2.2426    0.0000 C   0  0
    1.0255   -3.6140    0.0000 O   0  0
    0.7500   -1.0323    0.0000 N   0  0
    1.2135    0.3943    0.0000 C   0  0
    0.0000    1.2760    0.0000 C   0  0
   -1.2135    0.3943    0.0000 C   0  0
   -0.7500   -1.0323    0.0000 C   0  0  1  0  0  0
   -1.6281   -2.2462    0.0000 C   0  0
   -3.1202   -2.0921    0.0000 O   0  0
   -1.0160   -3.6157    0.0000 O   0  0
  2  1  1  6
  2  3  1  0
  3  4  1  0
  2  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11  7  1  0
 11 12  1  6
 12 13  1  0
 12 14  2  0
M  END
> <name>
NIHCC_2014

> <id>
6184

> <plate>
NGP-202-02

> <well>
D05

> <supplier_cmpd_name>
CPD000059061

> <ctcr_id>
6792

> <supplier_cmpd_id>
SAM002564201

> <smiles>
C[C@H](CS)C(=O)N1CCC[C@H]1C(O)=O

> <pd_targets>
{ACE,F2,KDM4E,PMP22,THPO,PTGS1,LTA4H,MAPT,TGR,ALOX15,BLAIMP-1,PTGS2,DAPE,HSD17B10,REN,FFP,BLA2,BLAVIM-2,LMNA,ACE2,BLANDM-1,MMP2,MMP9}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Unclassified protein","Other cytosolic protein","Other nuclear protein",Protease,Eraser,Oxidoreductase,Hydrolase,Transferase,"Metallo protease","Serine protease","Lysin
e demethylase","Aspartic protease","Metallo protease MAE clan","Serine protease PA clan","Jumonji domain-containing","Aspartic protease AA clan","Metallo protease MAM clan","Metallo protease M2 family
","Serine protease S1A subfamily","Metallo protease M1 family","Aspartic protease A1A subfamily","Metallo protease M10A subfamily"}

> <pathway_chembl>
{Enzymes,"Peptidases and proteinases","Chromatin modifying enzymes","Eicosanoid turnover","MA: Metallo (M) Peptidases","PA: Serine (S) Peptidases","1.14.11.- Histone demethylases",Cyclooxygenase,Lipox
ygenases,"AA: Aspartic (A) Peptidases","M2: Angiotensin-converting  (ACE and ACE2)","S1: Chymotrypsin","M1: Aminopeptidase N","A1: Pepsin","M10: Matrix metallopeptidase"}

> <pathway_reactome>
{"Metabolism of proteins",Disease,"Developmental Biology",Hemostasis,Metabolism,"Neuronal System","Cell Cycle","Peptide hormone metabolism","Diseases of hemostasis","Nervous system development","Plate
let activation","signaling and aggregation","Metabolism of lipids","Transmission across Chemical Synapses","Metabolism of amino acids and derivatives",Mitotic,"Metabolism of Angiotensinogen to Angiote
nsins","Defects of contact activation system (CAS) and kallikrein/kinin system (KKS)","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Platelet Aggregation (Plug Formation)","Fatty ac
id metabolism","Biosynthesis of specialized proresolving mediators (SPMs)","Neurotransmitter receptors and postsynaptic signal transmission","Branched-chain amino acid catabolism","M Phase","Axon guid
ance","Defective factor VIII causes hemophilia A","Arachidonic acid metabolism","Biosynthesis of DHA-derived SPMs","Activation of NMDA receptors and postsynaptic events","Biosynthesis of DPA-derived S
PMs","Mitotic Metaphase and Anaphase","EPH-Ephrin signaling","Defective F8 cleavage by thrombin","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","Biosynthesis of aspirin-triggered D-series re
solvins","Post NMDA receptor activation events","Biosynthesis of DPAn-3 SPMs","Mitotic Anaphase","EPH-ephrin mediated repulsion of cells","Activation of AMPK downstream of NMDARs","Biosynthesis of DPA
n-3-derived protectins and resolvins","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ACE,LTA4H,MMP2,MMP9}

> <broad_moa>
{"angiotensin converting enzyme inhibitor"}

> <synonyms>
{62571-86-2,62571862,Capoten,L-Captopril,LCaptopril,Lopirin,Captopryl,Cesplon,Captolane,Tensoprel,Acepress,Captoril,Dilabar,Garranil,Hypertil,Tenosbon,Alopresin,Acepril,Lopril,Captoprilum,Acediur,Acep
lus,(2S)-1-((2S)-2-methyl-3-sulfanylpropanoyl)pyrrol,(2S)1((2S)2methyl3sulfanylpropanoyl)pyrrol,T1462,SAM002564201,1500682,Prestw-19,Captopril,CPD000059061,CAPTOPRIL}

> <pdid>
PD001635

> <targets>
{}

> <classes>
{antihypertensive}

> <pubchem_cids>
{44093}

$$$$
NIHCC_2014
  SciTegic11012413002D

 32 36  0  0  1  0            999 V2000
    1.9438   -6.2113    0.0000 C   0  0
    0.7315   -5.3280    0.0000 C   0  0
   -0.6572   -5.8951    0.0000 C   0  0
    2.0426   -4.5993    0.0000 O   0  0
    1.7758   -3.1329    0.0000 C   0  0  2  0  0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0  2  0  0  0
    3.8971    3.7500    0.0000 F   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -0.8660    2.5000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
    0.0000    0.5000    0.0000 F   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  1  0  0  0
   -0.8141   -2.0807    0.0000 C   0  0
    0.2851   -2.9666    0.0000 C   0  0  2  0  0  0
   -0.3667   -4.3062    0.0000 O   0  0
   -1.1988   -2.7813    0.0000 C   0  0
   -1.7813   -1.3990    0.0000 O   0  0
   -2.1056   -3.9772    0.0000 C   0  0
   -3.5939   -3.7910    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  5  4  1  1
  5  6  1  0
  7  6  1  6
  7  8  1  0
  8  9  1  1
  9 10  1  0
 10 11  1  1
 10 12  1  0
 12 13  2  3
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  2  3
 17 18  1  0
 18 12  1  0
 18 19  1  6
 18 20  1  0
 20  8  1  0
 20 21  1  1
 20 22  1  0
 22 23  1  6
 22 24  1  0
 24 25  1  0
 25  7  1  0
 25 26  1  6
 25 27  1  0
 27  5  1  0
 27 28  1  0
 28  2  1  0
 27 29  1  6
 29 30  2  0
 29 31  1  0
 31 32  1  0
M  END
> <name>
NIHCC_2014

> <id>
6185

> <plate>
NGP-202-02

> <well>
D06

> <supplier_cmpd_name>
CPD000058329

> <ctcr_id>
6992

> <supplier_cmpd_id>
SAM002564208

> <smiles>
CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO

> <pd_targets>
{LMNA,PGR,NR3C1,HIF1A,KDM4E,MAPK1,ANXA1,ANXA2,ANXA3,ANXA4,ANXA5}

> <pathway_gtopdb>
{"Other nuclear protein","Transcription factor","Epigenetic regulator",Enzyme,"Ion channel","Nuclear receptor",Eraser,Kinase,"Other ion channel","Nuclear hormone receptor subfamily 3","Lysine demethyl
ase","Protein Kinase",Annexin,"Nuclear hormone receptor subfamily 3 group C","Jumonji domain-containing","CMGC protein kinase group","Nuclear hormone receptor subfamily 3 group C member 3","Nuclear ho
rmone receptor subfamily 3 group C member 1","CMGC protein kinase MAPK family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,"Nuclear hormone receptors","Chromatin modifying enzymes","Kinases (EC 2.7.x.x)","Steroid hormone receptors","1.14.11.- Histone demethylases","CMGC: Containing CDK",MAPK,GSK3,"CLK f
amilies","3C. 3-Ketosteroid receptors","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Cell Cycle","Gene expression (Transcription)","Cellular responses to external stimuli","Immune System","Signal Transduction",Hemostasis,Mitotic,"RNA Polymerase II Transcription","Cellular responses 
to stress","Innate Immune System","Signaling by GPCR","Cytokine Signaling in Immune system","Platelet activation","signaling and aggregation","M Phase","Generic Transcription Pathway","Cellular respon
se to hypoxia","Toll-like Receptor Cascades","GPCR ligand binding","Signaling by Interleukins","Response to elevated platelet cytosolic Ca2+","Mitotic Metaphase and Anaphase","FOXO-mediated transcript
ion","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Toll Like Receptor 5 (TLR5) Cascade","Class A/1 (Rhodopsin-like receptors)","Interleukin-12 family signaling","Platelet
 degranulation","Mitotic Anaphase","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","MyD88 cascade initiated on plasma membrane","Peptide ligand-binding receptors","Int
erleukin-12 signaling","Nuclear Envelope (NE) Reassembly","MAP kinase activation","Formyl peptide receptors bind formyl peptides and many other ligands","Gene and protein expression by JAK-STAT signal
ing after Interleukin-12 stimulation","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{NR3C1,SERPINA6}

> <broad_moa>
{"glucocorticoid receptor agonist"}

> <synonyms>
{"FLUOCINOLONE ACETONIDE",67-73-2,67732,Synalar,Flucinar,Synandone,Fluonid,Jellin,Synamol,Synemol,Coriphate,Fluovitif,Flupollon,Percutina,Synandrone,Dermalar,Localyn,Omniderm,Radiocin,Sinalar,Synotic,
Tefunote,Synsac,Fluotrex,Retisert,Syn,SAM002564208,Prestw-1419,CPD000058329,"Fluocinolone acetonide"}

> <pdid>
PD002329

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{6215}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 23  0  0  0  0            999 V2000
   11.9554   -0.4782    0.0000 H   0  3
    9.4554   -0.4782    0.0000 Cl  0  5
    6.9546   -4.2653    0.0000 C   0  0
    5.4929   -3.9285    0.0000 N   0  0
    4.4707   -5.0263    0.0000 C   0  0
    5.0525   -2.4938    0.0000 C   0  0
    3.5900   -2.1568    0.0000 C   0  0
    3.1497   -0.7220    0.0000 C   0  0
    1.6852   -0.3846    0.0000 N   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.5913    1.9239    0.0000 C   0  0
    2.4792    3.4197    0.0000 C   0  0
    1.1278    4.0705    0.0000 C   0  0
   -0.1116    3.2255    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23  9  1  0
 23 18  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6186

> <plate>
NGP-202-02

> <well>
D07

> <supplier_cmpd_name>
CPD000058388

> <ctcr_id>
6765

> <supplier_cmpd_id>
SAM002564216

> <smiles>
[H+].[Cl-].CN(C)CCCN1c2ccccc2CCc3ccccc13

> <pd_targets>
{SLC6A2,SLC6A4,KDM4E,MAPT,PMP22,LMNA,KCNH1,CHRM1,CYP2D6,HTR2C,HRH1,HTR6,ADRA1A,CHRM2,CHRM5,HTR7,ADORA3,HTR2A,DRD2,ADRA2C,KCNJ6,ADRA1B,ADRA1D,CHRM3,CHRM4,DRD1,DRD3,DRD4,DRD5,ALDH1A1,ADRA2A,ADRA2B,HTR3A
,KCNH2,SLC6A3,HRH2,KCNJ5,GRIN1,GRIN2A,GRIN2B,GRIN2C,GRIN2D,GRIN3A,GRIN3B,PDR5,HTR1A,HTR1B,HTR1D,HTR1F,HTR2B,HTR3B,HTR4,HTR5A,HTR5B,CACNA1C,CACNA1D,CACNA1F,CACNA1S,SCN7A,SCN10A,SCN11A,SCN1A,SCN2A,SCN3A
,SCN4A,SCN5A,SCN8A,SCN9A,SMPD1,SIGMAR1,PRNP,MTOR,SLC22A2,SLC47A1,SLC22A1,SLC22A3,KCND2,KCND3}

> <pathway_gtopdb>
{Transporter,"Epigenetic regulator","Other cytosolic protein","Unclassified protein","Other nuclear protein","Ion channel","Membrane receptor",Enzyme,"Surface antigen","Electrochemical transporter",Er
aser,"Voltage-gated ion channel","Family A G protein-coupled receptor","Cytochrome P450",Oxidoreductase,"Ligand-gated ion channel",Hydrolase,Kinase,"SLC superfamily of solute carriers","Lysine demethy
lase","Potassium channels","Small molecule receptor (family A GPCR)","Cytochrome P450 family 2","5HT3 receptor","Ionotropic glutamate receptor","Voltage-gated calcium channel","Voltage-gated sodium ch
annel","Protein Kinase","SLC06 neurotransmitter transporter family","Jumonji domain-containing","Voltage-gated potassium channel","Monoamine receptor","Cytochrome P450 family 2D","Nucleotide-like rece
ptor (family A GPCR)","Inwardly rectifying potassium channel","NMDA receptor","Atypical protein kinase group","SLC22 family of organic cation and anion transporters","SLC47 family of multidrug and tox
in extrusion transporters","Acetylcholine receptor","Cytochrome P450 2D6","Serotonin receptor","Histamine receptor","Adrenergic receptor","Adenosine receptor","Dopamine receptor","Atypical protein kin
ase PIKK family","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Transporters,Enzymes,"Ion channels",Receptors,"Other protein targets","SLC superfamily of solute carriers","Chromatin modifying enzymes","Voltage-gated ion channels","G protein-coupled receptors","Cy
tochrome P450","Ligand-gated ion channels","Ceramide turnover","Sigma receptors","Kinases (EC 2.7.x.x)","SLC6 neurotransmitter transporter family","1.14.11.- Histone demethylases","Potassium channels"
,"Acetylcholine receptors (muscarinic)","CYP2 family: drug metabolising subset","5-Hydroxytryptamine receptors","Histamine receptors",Adrenoceptors,"Adenosine receptors","Dopamine receptors","5-HT<sub
>3</sub> receptors","Sphingomyelin phosphodiesterase",Atypical,"SLC22 family of organic cation and anion transporters","SLC47 family of multidrug and toxin extrusion transporters","Voltage-gated calci
um channels","Monoamine transporter subfamily","Voltage-gated potassium channels","Inwardly rectifying potassium channels","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","Organic cati
on transporters (OCT)","FRAP subfamily"}

> <pathway_reactome>
{"Neuronal System","Developmental Biology","Cell Cycle",Disease,"Signal Transduction",Metabolism,"Muscle contraction","Gene expression (Transcription)","Transport of small molecules","Transmission acr
oss Chemical Synapses","Nervous system development",Mitotic,"Potassium Channels","Disorders of transmembrane transporters","Signaling by GPCR","Biological oxidations","Infectious disease","Cardiac con
duction","Metabolism of lipids","RNA Polymerase II Transcription","SLC-mediated transmembrane transport","Neurotransmitter clearance","Neurotransmitter receptors and postsynaptic signal transmission",
"EGR2 and SOX10-mediated initiation of Schwann cell myelination","M Phase","Voltage gated Potassium channels","SLC transporter disorders","GPCR ligand binding","Phase I - Functionalization of compound
s","Leishmania infection","Phase 3 - rapid repolarisation","Axon guidance","Sphingolipid metabolism","SARS-CoV Infections","Generic Transcription Pathway","Transport of bile salts and organic acids","
metal ions and amine compounds","Phase 1 - inactivation of fast Na+ channels","Serotonin clearance from the synaptic cleft","Activation of NMDA receptors and postsynaptic events","Mitotic Metaphase an
d Anaphase","Defective SLC6A2 causes orthostatic intolerance (OI)","Class A/1 (Rhodopsin-like receptors)","Cytochrome P450 - arranged by substrate type","Leishmania parasite growth and survival","GABA
 receptor activation","Ethanol oxidation","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","L1CAM interactions","Glycosphingolipid metabolism","Potential therapeutics for SARS","NCAM 
signaling for neurite out-growth","Transcriptional Regulation by TP53","Organic cation/anion/zwitterion transport","Post NMDA receptor activation events","Mitotic Anaphase","Amine ligand-binding recep
tors",Xenobiotics,"Anti-inflammatory response favouring Leishmania parasite infection","Nucleotide-like (purinergic) receptors","GABA B receptor activation","Interaction between L1 and Ankyrins","NCAM
1 interactions","Regulation of TP53 Activity","Organic cation transport","Activation of AMPK downstream of NMDARs","Nuclear Envelope (NE) Reassembly","Muscarinic acetylcholine receptors","CYP2E1 react
ions","Serotonin receptors","Histamine receptors","ADORA2B mediated anti-inflammatory cytokines production",Adrenoceptors,"Adenosine P1 receptors","Dopamine receptors","Activation of GABAB receptors",
"Regulation of TP53 Expression and Degradation","Initiation of Nuclear Envelope (NE) Reformation","Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits","Regulation of TP53 Degradation"
}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,DRD1,DRD2,DRD5,HRH1,HTR1A,HTR2A,HTR2C,HTR6,HTR7,KCND2,KCND3,KCNH1,KCNH2,SLC6A2,SLC6A3,SLC6A4}

> <broad_moa>
{"norepinephrine reputake inhibitor","serotonin reuptake inhibitor"}

> <synonyms>
{Tofranil,ST50985122,"(3-(10H,11H-dibenzo(b,f)azepin-5-yl)propyl)dimethylamine, chloride","(3(10H,11Hdibenzo(b,f)azepin5yl)propyl)dimethylamine, chloride",AKOS024356992,"Imipramine hydrochloride",113-
52-0,113520,"Imipramine Hcl",Chimoreptin,Feinalmin,Imilanyle,Persamine,Pertofram,Presamine,Pryleugan,Teperine,Tofra,SAM002564216,1500348,Prestw-72,CPD000058388,"IMIPRAMINE HYDROCHLORIDE"}

> <pdid>
PD010016

> <targets>
{}

> <classes>
{antidepressant}

> <pubchem_cids>
{657207,15893898,8228}

$$$$
NIHCC_2014
  SciTegic11012413002D

 36 37  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -2.6030    2.9977    0.0000 O   0  0
   -3.8990    0.7455    0.0000 O   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.8003    1.4887    0.0000 N   0  0
   -7.8029    2.9887    0.0000 C   0  0
   -9.0990    0.7364    0.0000 C   0  0
  -10.4003    1.4841    0.0000 C   0  0
  -11.6994    0.7341    0.0000 C   0  0
  -12.9984    1.4841    0.0000 C   0  0
  -12.9985    2.9841    0.0000 C   0  0
  -11.6994    3.7341    0.0000 C   0  0
  -10.4004    2.9842    0.0000 C   0  0
    0.0000    3.0008    0.0000 C   0  0
    1.2978    3.7529    0.0000 C   0  0
    1.2954    5.2529    0.0000 C   0  0
   -0.0048    6.0009    0.0000 C   0  0
   -1.3026    5.2488    0.0000 C   0  0
   -1.3002    3.7488    0.0000 C   0  0
    2.5925    6.0081    0.0000 N   0  3
    2.5879    7.5081    0.0000 O   0  0
    3.8940    5.2624    0.0000 O   0  5
    2.5972    1.5031    0.0000 C   0  0
    3.8976    0.7554    0.0000 O   0  0
    2.5951    3.0039    0.0000 O   0  0
    3.8926    3.7566    0.0000 C   0  0
    6.3982    3.0043    0.0000 Cl  0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  1  0
  5  6  2  3
  6  7  1  0
  7  2  1  0
  6  8  1  0
  5  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 17 18  2  3
 18 19  1  0
 19 20  2  3
 20 21  1  0
 21 22  2  3
 22 17  1  0
  4 23  1  0
 23 24  2  3
 24 25  1  0
 25 26  2  3
 26 27  1  0
 27 28  2  3
 28 23  1  0
 25 29  1  0
 29 30  2  0
 29 31  1  0
  3 32  1  0
 32 33  2  0
 32 34  1  0
 34 35  1  0
M  CHG  2  29   1  31  -1
M  END
> <name>
NIHCC_2014

> <id>
6187

> <plate>
NGP-202-02

> <well>
D08

> <supplier_cmpd_name>
CPD001456372

> <ctcr_id>
7027

> <supplier_cmpd_id>
SAM002564254

> <smiles>
CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC.Cl

> <pd_targets>
{BLM,CYP3A4,GMNN,FTL,MAPT,PMP22,MAPK1,NPSR1,NFO,LMNA,MDH1,CYP2C9,ADORA2A,CYP2J2,SLC29A1,ADRA1A,ADRA1B,ADRA1D,CYP2C8,KCNA4,ADORA1,ABCB11,AMPC,ABCB1,NORA,CYP2C19,CYP1A2,CYP2D6,CACNA1C,CACNA1D,CACNA1S,AD
RA2A,ADRA2B,ADRA2C,ADORA3,ABCB1A,ABCB1B,MTOR,ABCG2,TRPA1,ABCC4,CACNA1F,CACNB2,CACNA2D1,PDE1A,PDE1B,CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,CALM1,NFKB1,HIF1A,THPO,TP53,TSHR}

> <pathway_gtopdb>
{Enzyme,"Unclassified protein","Other cytosolic protein","Membrane receptor","Other nuclear protein",Transporter,"Ion channel","Auxiliary transport protein","Transcription factor","Cytochrome P450",Ki
nase,"Family A G protein-coupled receptor",Hydrolase,Oxidoreductase,"Electrochemical transporter","Voltage-gated ion channel","Primary active transporter","Calcium channel auxiliary subunit beta famil
y","Calcium channel auxiliary subunit alpha2delta family",Phosphodiesterase,"Cytochrome P450 family 3","Protein Kinase","Peptide receptor (family A GPCR)","Cytochrome P450 family 2","Small molecule re
ceptor (family A GPCR)","SLC superfamily of solute carriers","Potassium channels","ATP-binding cassette","Cytochrome P450 family 1","Voltage-gated calcium channel","Transient receptor potential channe
l","Phosphodiesterase 1","Cytochrome P450 family 3A","CMGC protein kinase group","Short peptide receptor (family A GPCR)","Cytochrome P450 family 2C","Nucleotide-like receptor (family A GPCR)","SLC28 
and SLC29 families of nucleoside transporters","Monoamine receptor","Voltage-gated potassium channel","ABCB subfamily","Cytochrome P450 family 1A","Cytochrome P450 family 2D","Atypical protein kinase 
group","ABCG subfamily","ABCC subfamily","Phosphodiesterase 1A","Phosphodiesterase 1B","Cytochrome P450 3A4","CMGC protein kinase MAPK family","Neuropeptide receptor","Cytochrome P450 2C9","Adenosine 
receptor","SLC29 Facilitative nucleoside transporter family","Adrenergic receptor","Cytochrome P450 2C8","Cytochrome P450 2C19","Cytochrome P450 1A1","Cytochrome P450 2D6","Atypical protein kinase PIK
K family","Acetylcholine receptor","CMGC protein kinase ERK1","Atypical protein kinase FRAP subfamily","Glycohormone receptor"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Ion channels","Cytochrome P450","Kinases (EC 2.7.x.x)","G protein-coupled receptors","SLC superfamily of solute carriers","Voltage-gated ion channels","ATP-binding cas
sette transporter family","Cyclic nucleotide turnover/signalling","CYP3 family","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Neuropeptide S receptor","CYP2 family: drug metabolising subset","Adeno
sine receptors","SLC28 and SLC29 families of nucleoside transporters","Potassium channels","ABCB subfamily","CYP1 family",Atypical,"Voltage-gated calcium channels","ABCG subfamily","Transient Receptor
 Potential channels","ABCC subfamily",Phosphodiesterases,3',"5'-cyclic nucleotide (PDEs)",Adrenoceptors,"Acetylcholine receptors (muscarinic)","Mitogen-activated protein kinases (MAP kinases)","SLC29 
family","Voltage-gated potassium channels","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","ERK subfamily","FRAP subfamily","Glycoprotein hormone receptors"}

> <pathway_reactome>
{"DNA Repair",Metabolism,"Cell Cycle","Vesicle-mediated transport","Neuronal System","Developmental Biology","Immune System",Disease,"Transport of small molecules","Signal Transduction","Gene expressi
on (Transcription)",Hemostasis,"Cellular responses to external stimuli","DNA Double-Strand Break Repair","Metabolism of lipids",Mitotic,"Membrane Trafficking","Transmission across Chemical Synapses","
Nervous system development","Innate Immune System","Infectious disease","Metabolism of carbohydrates","Biological oxidations","SLC-mediated transmembrane transport","Potassium Channels","Signaling by 
GPCR","Abacavir transport and metabolism","RNA Polymerase II Transcription","Ion channel transport","Platelet activation","signaling and aggregation","Intracellular signaling by second messengers","Cy
tokine Signaling in Immune system","Cellular responses to stress","Cell Cycle Checkpoints","Homology Directed Repair","Biosynthesis of specialized proresolving mediators (SPMs)","Mitotic G1 phase and 
G1/S transition","trans-Golgi Network Vesicle Budding","Neurotransmitter receptors and postsynaptic signal transmission","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Toll-like Rec
eptor Cascades","Leishmania infection","M Phase","Glucose metabolism","Phase I - Functionalization of compounds","Transport of vitamins",nucleosides,"and related molecules","Voltage gated Potassium ch
annels","GPCR ligand binding","Metabolism of steroids","Abacavir transmembrane transport","Generic Transcription Pathway","Axon guidance","Stimuli-sensing channels","Response to elevated platelet cyto
solic Ca2+","DAG and IP3 signaling","Signaling by Interleukins","Cellular response to hypoxia","Platelet Aggregation (Plug Formation)","G1/S DNA Damage Checkpoints","HDR through Homologous Recombinati
on (HRR) or Single Strand Annealing (SSA)","Biosynthesis of DHA-derived SPMs","G1/S Transition","Golgi Associated Vesicle Biogenesis","Activation of NMDA receptors and postsynaptic events","Toll Like 
Receptor 5 (TLR5) Cascade","Leishmania parasite growth and survival","Mitotic Metaphase and Anaphase",Gluconeogenesis,"Cytochrome P450 - arranged by substrate type","Transport of nucleosides and free 
purine and pyrimidine bases across the plasma membrane","Class A/1 (Rhodopsin-like receptors)","Bile acid and bile salt metabolism","Transcriptional Regulation by TP53","NCAM signaling for neurite out
-growth","TRP channels","Platelet degranulation","CaM pathway","Interleukin-1 family signaling","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","p53-Dependent G1/S DNA damag
e checkpoint","HDR through Homologous Recombination (HRR)","Biosynthesis of maresins","Activation of the pre-replicative complex","Post NMDA receptor activation events","MyD88 cascade initiated on pla
sma membrane","Anti-inflammatory response favouring Leishmania parasite infection","Mitotic Anaphase",Xenobiotics,"Fatty acids","Nucleotide-like (purinergic) receptors","Synthesis of bile acids and bi
le salts","Regulation of TP53 Activity","NCAM1 interactions","Calmodulin induced events","Amine ligand-binding receptors","Interleukin-1 signaling","p53-Dependent G1 DNA Damage Response","Homologous D
NA Pairing and Strand Exchange","Biosynthesis of maresin-like SPMs","Activation of AMPK downstream of NMDARs","MAP kinase activation","ADORA2B mediated anti-inflammatory cytokines production","Nuclear
 Envelope (NE) Reassembly","CYP2E1 reactions","Adenosine P1 receptors","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Aromatic amines can be N-hydroxylated or N-dealkylated by
 CYP1A2","Regulation of TP53 Expression and Degradation","Cam-PDE 1 activation",Adrenoceptors,"Muscarinic acetylcholine receptors","CREB1 phosphorylation through NMDA receptor-mediated activation of R
AS signaling","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Stabilization of p53","Presynaptic phase of homologous DNA pairing and strand exchange","MAPK targets/ Nuclear events mediated by MAP kinase
s","Initiation of Nuclear Envelope (NE) Reformation","Regulation of TP53 Degradation","Ras activation upon Ca2+ influx through NMDA receptor","Autodegradation of the E3 ubiquitin ligase COP1","ERK/MAP
K targets","ERKs are inactivated"}

> <broad_targets>
{ADORA3}

> <broad_moa>
{"calcium channel blocker"}

> <synonyms>
{"NICARDIPINE HYDROCHLORIDE",54527-84-3,54527843,"Nicardipine HCl",Perdipine,Loxen,Nicodel,YC-93,YC93,"Nicardipine (Hydrochloride)","YC-93 hydrochloride","YC93 hydrochloride",RS-69216,RS69216,RS-69216
-XX-07-0,RS69216XX070,MLS000069782,Lincil,Dagan,"Cardene SR",MFCD00057327,Angioglebil,Bionicard,Nic,SAM002564254,CPD001456372}

> <pdid>
PD009884

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{41114}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 21  0  0  0  0            999 V2000
    8.9990    0.3675    0.0000 Cl  0  5
    6.4983   -0.7414    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 N   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -2.6030    2.9977    0.0000 O   0  0
   -3.8990    0.7455    0.0000 O   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.8003    1.4887    0.0000 N   0  3
   -9.0990    0.7364    0.0000 C   0  0
  -10.3996    1.4837    0.0000 C   0  0
   -7.8060    2.9895    0.0000 C   0  0
   -9.1074    3.7354    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
 11 12  1  0
  9 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 18 21  1  0
 21 22  1  0
M  CHG  2   1  -1  18   1
M  END
> <name>
NIHCC_2014

> <id>
6188

> <plate>
NGP-202-02

> <well>
D09

> <supplier_cmpd_name>
CPD000875264

> <ctcr_id>
6833

> <supplier_cmpd_id>
SAM002564232

> <smiles>
[Cl-].CCCOc1ccc(cc1N)C(=O)OCC[NH+](CC)CC

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{AKOS026749832,MCULE-8418206804,MCULE8418206804,"MCULE 8418206804","Proparacaine hydrochloride",5875-06-9,5875069,"5875 06 9","Proparacaine Hcl","Proxymetacaine hydrochloride","2-(Diethylamino)ethyl 3
-Amino-4-propoxybenzoate Hydrochloride","2(Diethylamino)ethyl 3Amino4propoxybenzoate Hydrochloride",2(,SAM002564232,1505688,Prestw-959,CPD000875264,"PROPARACAINE HYDROCHLORIDE"}

> <pdid>

> <targets>
{}

> <classes>
{"local anesthetic"}

> <pubchem_cids>
{22169,517321}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 28  0  0  0  0            999 V2000
    7.5973   -3.3752    0.0000 H   0  3
    5.0973   -3.3752    0.0000 Cl  0  5
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 S   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 S   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -6.4952    0.7500    0.0000 C   0  0
   -6.4952   -0.7500    0.0000 C   0  0
   -5.1961   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 N   0  0
   -2.5950   -3.0008    0.0000 C   0  0
   -1.2942   -3.7494    0.0000 C   0  0
   -1.2911   -5.2502    0.0000 C   0  0
   -2.5901   -6.0004    0.0000 C   0  0
   -2.5900   -7.5004    0.0000 C   0  0
   -1.2910   -8.2503    0.0000 C   0  0
    0.0080   -7.5003    0.0000 C   0  0
    0.0080   -6.0003    0.0000 N   0  0
    1.3070   -5.2503    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 19  1  0
 24 25  1  0
 16 26  1  0
 26  8  1  0
 26 27  2  0
 27  5  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6189

> <plate>
NGP-202-02

> <well>
D10

> <supplier_cmpd_name>
CPD000058380

> <ctcr_id>
103

> <supplier_cmpd_id>
SAM002564240

> <smiles>
[H+].[Cl-].CSc1ccc2Sc3ccccc3N(CCC4CCCCN4C)c2c1

> <pd_targets>
{GMNN,ALDH1A1,STAT6,MAPT,LMNA,KMT2A,PIM1,MEN1,NPSR1,CYP3A4,RORC,KDM4E,PMP22,NFO,FFP,MAPK1,TP53,RAD52,ADRA1A,HTR2A,DRD5,HTR7,DRD2,PDR5,KCNH2,ADRA1B,ADRA1D,ADRA2A,ADRA2B,ADRA2C,HTT,ALB,CHRM2,SCN1A,SCN2A
,SCN3A,CHRM5,HTR2C,DRD4,REP,CHRM4,CACNA1C,HRH1,CHRM1,DRD3,HTR6,KCNJ6,HTR1A,CHRM3,HTR2B,ABCB11,HTR1B,HTR1D,HTR1F,SIGMAR1,DRD1,PSMA6,EGFR,CYP2C19,SLC6A3,HRH2,OPRK1,SLC6A2,CYP1A2,CYP2D6,SLC6A4,SCN5A,MTOR
,FYN,CACNA1D,CACNA1F,CACNA1S}

> <pathway_gtopdb>
{"Unclassified protein",Enzyme,"Transcription factor","Other cytosolic protein","Other nuclear protein","Epigenetic regulator","Membrane receptor",Transporter,"Ion channel","Secreted protein",Oxidored
uctase,Reader,Kinase,"Family A G protein-coupled receptor","Cytochrome P450","Nuclear receptor",Eraser,Hydrolase,Transferase,"Voltage-gated ion channel","Primary active transporter","Electrochemical t
ransporter",Bromodomain,"Protein Kinase","Peptide receptor (family A GPCR)","Cytochrome P450 family 3","Nuclear hormone receptor subfamily 1","Lysine demethylase","Small molecule receptor (family A GP
CR)","Potassium channels","Voltage-gated sodium channel","Voltage-gated calcium channel","ATP-binding cassette","Cytochrome P450 family 2","SLC superfamily of solute carriers","Cytochrome P450 family 
1","CAMK protein kinase group","Short peptide receptor (family A GPCR)","Cytochrome P450 family 3A","Nuclear hormone receptor subfamily 1 group F","Jumonji domain-containing","CMGC protein kinase grou
p","Monoamine receptor","Voltage-gated potassium channel","Inwardly rectifying potassium channel","ABCB subfamily","TK protein kinase group","Cytochrome P450 family 2C","SLC06 neurotransmitter transpo
rter family","Cytochrome P450 family 1A","Cytochrome P450 family 2D","Atypical protein kinase group","CAMK protein kinase PIM family","Neuropeptide receptor","Cytochrome P450 3A4","Nuclear hormone rec
eptor subfamily 1 group F member 3","CMGC protein kinase MAPK family","Adrenergic receptor","Dopamine receptor","Serotonin receptor","Acetylcholine receptor","Histamine receptor","Tyrosine protein kin
ase EGFR family","Cytochrome P450 2C19","Opioid receptor","Cytochrome P450 1A1","Cytochrome P450 2D6","Atypical protein kinase PIKK family","Tyrosine protein kinase Src family","CMGC protein kinase ER
K1","Atypical protein kinase FRAP subfamily","Tyrosine protein kinase SrcA"}

> <pathway_chembl>
{"Other protein targets",Enzymes,Receptors,"Ion channels",Transporters,"Transcription factors","Chromatin modifying enzymes","Kinases (EC 2.7.x.x)","G protein-coupled receptors","Cytochrome P450","Nuc
lear hormone receptors","Voltage-gated ion channels","Anti-infective targets","ATP-binding cassette transporter family","Sigma receptors","Catalytic receptors","SLC superfamily of solute carriers","ST
AT transcription factors","2.1.1.43 Histone methyltransferases (HMTs)","CAMK: Calcium/calmodulin-dependent protein kinases","Neuropeptide S receptor","CYP3 family","1F. Retinoic acid-related orphans",
"1.14.11.- Histone demethylases","CMGC: Containing CDK",MAPK,GSK3,"CLK families",Adrenoceptors,"Dopamine receptors","5-Hydroxytryptamine receptors","Potassium channels","Acetylcholine receptors (musca
rinic)","Viral protein targets","Voltage-gated calcium channels","Histamine receptors","ABCB subfamily","Receptor kinases","CYP2 family: drug metabolising subset","SLC6 neurotransmitter transporter fa
mily","Opioid receptors","CYP1 family","Voltage-gated sodium channels",Atypical,"PIM family","Mitogen-activated protein kinases (MAP kinases)","Voltage-gated potassium channels","Coronavirus (CoV) pro
teins","Inwardly rectifying potassium channels","TK: Tyrosine kinase","Monoamine transporter subfamily","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","ERK subfamily","Receptor tyrosi
ne kinases (RTKs)","FRAP subfamily","Non-receptor tyrosine kinases (nRTKs)","Type I RTKs: ErbB (epidermal growth factor) receptor family","Src family"}

> <pathway_reactome>
{"Cell Cycle",Metabolism,"Immune System","Neuronal System","Gene expression (Transcription)",Disease,"Developmental Biology","DNA Repair","Signal Transduction","Muscle contraction",Mitotic,"Biological
 oxidations","Innate Immune System","Transmission across Chemical Synapses","RNA Polymerase II Transcription","Diseases of signal transduction by growth factor receptors and second messengers","Infect
ious disease","Metabolism of lipids","Nervous system development","Cell Cycle Checkpoints","DNA Double-Strand Break Repair","Signaling by GPCR","Cardiac conduction","Disorders of transmembrane transpo
rters","Mitotic G1 phase and G1/S transition","Phase I - Functionalization of compounds","Cytosolic sensors of pathogen-associated DNA","Neurotransmitter receptors and postsynaptic signal transmission
","M Phase","Generic Transcription Pathway","FLT3 signaling in disease","Leishmania infection","Biosynthesis of specialized proresolving mediators (SPMs)","EGR2 and SOX10-mediated initiation of Schwan
n cell myelination","Toll-like Receptor Cascades","G1/S DNA Damage Checkpoints","Homology Directed Repair","GPCR ligand binding","Phase 3 - rapid repolarisation","Metabolism of steroids","SARS-CoV Inf
ections","Axon guidance","Regulation of mitotic cell cycle","GPCR downstream signalling","SLC transporter disorders","Neurotransmitter clearance","HIV Infection","G1/S Transition","Ethanol oxidation",
"STING mediated induction of host immune responses","Activation of NMDA receptors and postsynaptic events","Mitotic Metaphase and Anaphase","Transcriptional regulation by RUNX1","Signaling by FLT3 ITD
 and TKD mutants","Leishmania parasite growth and survival","Biosynthesis of DHA-derived SPMs","Transcriptional regulation by RUNX3","Toll Like Receptor 5 (TLR5) Cascade","p53-Dependent G1/S DNA damag
e checkpoint","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Class A/1 (Rhodopsin-like receptors)","Transcriptional Regulation by MECP2","Bile acid and bile salt metabo
lism","SARS-CoV-2 Infection","NCAM signaling for neurite out-growth","GABA receptor activation","Potential therapeutics for SARS","APC/C-mediated degradation of cell cycle proteins","G alpha (q) signa
lling events","Cytochrome P450 - arranged by substrate type","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Defective SLC6A2 causes orthostatic intolerance (OI)","Serotonin clearan
ce from the synaptic cleft","L1CAM interactions","Transcriptional Regulation by TP53","Host Interactions of HIV factors","Activation of the pre-replicative complex","STAT6-mediated induction of chemok
ines","Post NMDA receptor activation events","Mitotic Anaphase","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","STAT5 activation downstream of FLT3 ITD mutants
","Anti-inflammatory response favouring Leishmania parasite infection","Biosynthesis of maresins","RUNX3 Regulates Immune Response and Cell Migration","MyD88 cascade initiated on plasma membrane","p53
-Dependent G1 DNA Damage Response","HDR through Single Strand Annealing (SSA)","Amine ligand-binding receptors","Regulation of MECP2 expression and activity","Recycling of bile acids and salts","SARS-
CoV-2 Genome Replication and Transcription","NCAM1 interactions","GABA B receptor activation","Synthesis of bile acids and bile salts","Activation of APC/C and APC/C:Cdc20 mediated degradation of mito
tic proteins","Gastrin-CREB signalling pathway via PKC and MAPK",Xenobiotics,"MECP2 regulates neuronal receptors and channels","Interaction between L1 and Ankyrins","Regulation of TP53 Activity","The 
role of Nef in HIV-1 replication and disease pathogenesis","Activation of AMPK downstream of NMDARs","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Biosy
nthesis of maresin-like SPMs","MAP kinase activation","Stabilization of p53",Adrenoceptors,"Serotonin receptors","Dopamine receptors","Muscarinic acetylcholine receptors","Replication of the SARS-CoV-
2 genome","Histamine receptors","Activation of GABAB receptors","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","APC/C:Cdc20 mediated degradation of mitotic proteins","EGFR Tran
sactivation by Gastrin","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Regulation of TP53 Expression and Degradation","Nef and signal transduction","Initiation 
of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","Autodegradation of the E3 ubiquitin ligase COP1","Inhibition  of voltage gated Ca2+ channels via Gbeta/gam
ma subunits","APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint","Regulation of TP53 Degradation","ERK/MAPK targets","Cdc20:Phospho-APC/C mediated
 degradation of Cyclin A","ERKs are inactivated"}

> <broad_targets>
{DRD1,DRD2,DRD3,DRD4,DRD5,HRH1,HTR1A,HTR2A,HTR2C,HTR6,HTR7}

> <broad_moa>
{"dopamine receptor antagonist"}

> <synonyms>
{RESTW7,"Thioridazine hydrochloride",130-61-0,130610,"Thioridazine Hcl","Sonapax hydrochloride","Thioridazine chloride","Mellaril hydrochloride",Thioridazine.HCl,Aldazine,"USAF SZ-B","USAF SZB","USAF 
SZ-3","USAF SZ3","Thioridazine (hydrochloride)","Thioridazine-d3 Hydrochloride","Thioridazined3 Hydrochloride",ML,T0365,SAM002564240,1500575,Prestw-78,CPD000058380,"THIORIDAZINE HYDROCHLORIDE"}

> <pdid>
PD009853

> <targets>
{5-HT Receptor,Apoptosis,Autophagy,Bacterial,Dopamine Receptor}

> <classes>
{antipsychotic,Anti-infection,Apoptosis,Autophagy,GPCR/G Protein,Neuronal Signaling}

> <pubchem_cids>
{66062,657213}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 28  0  0  0  0            999 V2000
    5.1884   -7.5113    0.0000 C   0  0
    5.1901   -6.0113    0.0000 N   0  0
    6.4902   -5.2631    0.0000 C   0  0
    3.8917   -5.2586    0.0000 C   0  0
    3.8934   -3.7577    0.0000 C   0  0
    2.5949   -3.0050    0.0000 O   0  0
    2.5966   -1.5042    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 Cl  0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8990   -0.7582    0.0000 C   0  0
    3.9042    0.7419    0.0000 C   0  0
    5.2058    1.4875    0.0000 C   0  0
    6.5023    0.7331    0.0000 C   0  0
    6.4972   -0.7669    0.0000 C   0  0
    5.1956   -1.5125    0.0000 N   0  0
   10.3023   -1.1309    0.0000 O   0  0
   10.3023   -2.6309    0.0000 C   0  0
    9.0030   -3.3804    0.0000 O   0  0
   11.6023   -3.3809    0.0000 C   0  0
   12.9023   -2.6309    0.0000 C   0  0
   12.9037   -1.1300    0.0000 C   0  0
   11.6051   -0.3792    0.0000 O   0  0
   14.2030   -0.3804    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14  8  1  0
  7 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 26 28  2  0
M  END
> <name>
NIHCC_2014

> <id>
6190

> <plate>
NGP-202-02

> <well>
D11

> <supplier_cmpd_name>
CPD001496929

> <ctcr_id>
1839

> <supplier_cmpd_id>
SAM002589920

> <smiles>
CN(C)CCOC(c1ccc(Cl)cc1)c2ccccn2.OC(=O)\C=C/C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{3505-38-2,3505382,"3505 38 2","Carbinoxamine maleate salt",Lergefin,Ciberon,Clistin,Cliston,"p-Carbinoxamine maleate","pCarbinoxamine maleate","p Carbinoxamine maleate","Allergefon maleate","Paracarb
inoxamine maleate","Carbinoxamine hydrogen maleate",C20H23ClN2O5,CHEBI:31353,2,T2222,SAM002589920,1500161,Prestw-801,"Carbinoxamine Maleate Salt",CPD001496929,"CARBINOXAMINE MALEATE"}

> <pdid>

> <targets>
{}

> <classes>
{antihistaminic}

> <pubchem_cids>
{5282409}

$$$$
NIHCC_2014
  SciTegic11012413002D

 11 10  0  0  0  0            999 V2000
    5.0987   -1.8751    0.0000 Cl  0  0
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 C   0  0
   -1.3039   -3.7494    0.0000 N   0  3
   -1.3070   -5.2494    0.0000 O   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  3
  5  6  1  0
  6  7  2  3
  7  8  1  0
  8  3  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
M  CHG  1  10   1
M  END
> <name>
NIHCC_2014

> <id>
6191

> <plate>
NGP-202-02

> <well>
E02

> <supplier_cmpd_name>
CPD001906769

> <ctcr_id>
7017

> <supplier_cmpd_id>
SAM002554924

> <smiles>
Cl.CN1C=CC=C/C/1=C\[NH+]=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{SAM002554924,CPD001906769}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{16219909}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 32  0  0  0  0            999 V2000
    6.5271   -5.6548    0.0000 O   0  0
    5.1017   -6.1219    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 S   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    2.6747   -6.1134    0.0000 C   0  0
    1.2525   -5.6365    0.0000 O   0  0
    3.1332   -7.5416    0.0000 N   0  0
    4.6332   -7.5468    0.0000 N   0  0
    5.5111   -8.7640    0.0000 C   0  0
    5.0018  -10.1696    0.0000 C   0  0
    5.9683  -11.3167    0.0000 C   0  0
    7.4450  -11.0533    0.0000 C   0  0
    7.9552   -9.6427    0.0000 C   0  0
    6.9887   -8.4956    0.0000 C   0  0
    2.2469   -8.7527    0.0000 C   0  0
    0.7527   -8.7026    0.0000 C   0  0
   -0.0396   -9.9763    0.0000 C   0  0
    0.6673  -11.2993    0.0000 C   0  0
    2.1665  -11.3486    0.0000 C   0  0
    2.9588  -10.0749    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  3 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17  2  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 16 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
M  END
> <name>
NIHCC_2014

> <id>
6192

> <plate>
NGP-202-02

> <well>
E03

> <supplier_cmpd_name>
CPD000058991

> <ctcr_id>
6186

> <supplier_cmpd_id>
SAM002554932

> <smiles>
O=C1C(CC[S](=O)c2ccccc2)C(=O)N(N1c3ccccc3)c4ccccc4

> <pd_targets>
{FPR1,HPGD,KDM4E,LMNA,FFP,ALOX12,CYP3A4,RORC,ABCB11,HSD17B10,SLC22A12,ALDH1A1,CYP2C9,MAPT,KMT2A,MEN1,TGR,NAPRT,ABCC2,ABCC1,NR1I2}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Epigenetic regulator","Other nuclear protein","Transcription factor",Transporter,"Other cytosolic protein","Family A G protein-coupled receptor",Eraser,Transferase,"Cytoch
rome P450","Nuclear receptor","Primary active transporter",Oxidoreductase,"Electrochemical transporter",Reader,Ligase,"Peptide receptor (family A GPCR)","Lysine demethylase","Cytochrome P450 family 3"
,"Nuclear hormone receptor subfamily 1","ATP-binding cassette","SLC superfamily of solute carriers","Cytochrome P450 family 2",Bromodomain,"N-formyl methionyl peptide receptor","Jumonji domain-contain
ing","Cytochrome P450 family 3A","Nuclear hormone receptor subfamily 1 group F","ABCB subfamily","SLC22 family of organic cation and anion transporters","Cytochrome P450 family 2C","ABCC subfamily","N
uclear hormone receptor subfamily 1 group I","Cytochrome P450 3A4","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 2C9","Nuclear hormone receptor subfamily 1 group I member 2"
}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"G protein-coupled receptors","Eicosanoid turnover","Chromatin modifying enzymes","Cytochrome P450","Nuclear hormone receptors","ATP-binding cassette transporter family
","SLC superfamily of solute carriers","Formylpeptide receptors","Prostaglandin synthases","1.14.11.- Histone demethylases",Lipoxygenases,"CYP3 family","1F. Retinoic acid-related orphans","ABCB subfam
ily","SLC22 family of organic cation and anion transporters","CYP2 family: drug metabolising subset","ABCC subfamily","1I. Vitamin D receptor-like receptors","Urate transporter"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,"Cell Cycle","Gene expression (Transcription)","Transport of small molecules","Neuronal System",Disease,"Metabolism of proteins","Signaling by GPCR","Metabolism of li
pids",Mitotic,"RNA Polymerase II Transcription","Metabolism of amino acids and derivatives","SLC-mediated transmembrane transport","Biological oxidations","Transmission across Chemical Synapses","Meta
bolism of vitamins and cofactors","Disorders of transmembrane transporters","Post-translational protein modification","GPCR ligand binding","Biosynthesis of specialized proresolving mediators (SPMs)",
"M Phase","Generic Transcription Pathway","Metabolism of steroids","Branched-chain amino acid catabolism","Transport of bile salts and organic acids","metal ions and amine compounds","Phase I - Functi
onalization of compounds","Neurotransmitter receptors and postsynaptic signal transmission","Metabolism of water-soluble vitamins and cofactors","ABC transporter disorders","Fatty acid metabolism",SUM
Oylation,"Class A/1 (Rhodopsin-like receptors)","Biosynthesis of DHA-derived SPMs","Mitotic Metaphase and Anaphase","Biosynthesis of DPA-derived SPMs","Transcriptional regulation by RUNX3","Bile acid 
and bile salt metabolism","Organic cation/anion/zwitterion transport","Ethanol oxidation","Cytochrome P450 - arranged by substrate type","Activation of NMDA receptors and postsynaptic events","Nicotin
ate metabolism","Defective ABCC2 causes DJS","Arachidonic acid metabolism","SUMO E3 ligases SUMOylate target proteins","Peptide ligand-binding receptors","Biosynthesis of D-series resolvins","Mitotic 
Anaphase","Biosynthesis of DPAn-3 SPMs","Biosynthesis of maresins","RUNX3 Regulates Immune Response and Cell Migration","Synthesis of bile acids and bile salts","Organic anion transport",Xenobiotics,"
Post NMDA receptor activation events","Nicotinamide salvaging","Synthesis of Leukotrienes (LT) and Eoxins (EX)","SUMOylation of intracellular receptors","Formyl peptide receptors bind formyl peptides 
and many other ligands","Nuclear Envelope (NE) Reassembly","Biosynthesis of DPAn-3-derived maresins","Biosynthesis of maresin-like SPMs","Synthesis of bile acids and bile salts via 7alpha-hydroxychole
sterol","CYP2E1 reactions","Activation of AMPK downstream of NMDARs","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ABCC1,FPR1,SLC22A12}

> <broad_moa>
{"uricosuric blocker"}

> <synonyms>
{sulfinpyrazone,57-96-5,57965,Sulphinpyrazone,(+/-)-SULFINPYRAZONE,(+/)SULFINPYRAZONE,Anturane,Sulfinpyrazon,Anturan,Diphenylpyrazone,Sulfoxyphenylpyrazolidine,Anturanil,Anturidin,Enturen,Anturano,"1,
2-Diphenyl-4-(2-(phenylsulfinyl)ethyl)pyrazolidine-3,5-dione","1,2Diphenyl4(2(phenylsulfinyl)ethyl)pyrazolidine3,5dione",Sulfinpy,T0435,SAM002554932,1500554,Prestw-290,Sulfinpyrazone,CPD000058991,SULF
INPYRAZONE}

> <pdid>
PD001742

> <targets>
{}

> <classes>
{uricosuric}

> <pubchem_cids>
{5342}

$$$$
NIHCC_2014
  SciTegic11012413002D

 19 21  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.4133   -1.7530    0.0000 N   0  0
   -1.8032   -3.1233    0.0000 C   0  0
   -0.3114   -2.9665    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -3.8813   -1.4408    0.0000 C   0  0  2  0  0  0
   -4.8896   -2.5354    0.0000 O   0  0
   -6.2433   -1.8893    0.0000 C   0  0  2  0  0  0
   -7.5587   -2.6066    0.0000 C   0  0
   -7.5961   -4.1061    0.0000 O   0  0
   -6.0471   -0.4022    0.0000 C   0  0  1  0  0  0
   -7.1349    0.6307    0.0000 O   0  0
   -4.5721   -0.1292    0.0000 C   0  0  2  0  0  0
   -3.9177    1.2205    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10  2  1  0
 10  6  2  0
 11  7  1  6
 11 12  1  0
 12 13  1  0
 13 14  1  6
 14 15  1  0
 13 16  1  0
 16 17  1  1
 16 18  1  0
 18 11  1  0
 18 19  1  6
M  END
> <name>
NIHCC_2014

> <id>
6193

> <plate>
NGP-202-02

> <well>
E04

> <supplier_cmpd_name>
CPD000471872

> <ctcr_id>
1871

> <supplier_cmpd_id>
SAM002564191

> <smiles>
Nc1ncnc2n(cnc12)[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3O

> <pd_targets>
{AHCY,NS5B,ADCY5,DPP4,TK,KMT2A,MEN1,RXFP1,HIF1A,AMPC,HTT,MAPK1,RORC,CYP3A4,LMNA,ADORA2A,ADORA2B,SLC28A1,ADORA1,ADORA3,GAPDH,AK,SLC28A2,SLC29A1,PI4K2A,PI4K2B,STAT6,DOT1L,PI4KA,PI4KB,SLC28A3,PRKACA,PRKA
CB,PRKAR2A,PRKAR2B,MAP3K7,TRPM4,MAPT,ADK,ADOK}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Membrane receptor","Transcription factor","Unclassified protein","Other nuclear protein",Hydrolase,Transferase,Lyase,Protease,Reader,"Family A G protein-coupled recepto
r",Kinase,"Nuclear receptor","Cytochrome P450","Serine protease",Bromodomain,"Peptide receptor (family A GPCR)","Protein Kinase","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 3","Seri
ne protease SC clan","Relaxin-like peptide receptor (family A GPCR)","CMGC protein kinase group","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family 3A","Serine protease S9B subfami
ly","Relaxin receptor","CMGC protein kinase MAPK family","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 3A4","CMGC protein kinase ERK1",Transporter,"Ion channel","Electrochem
ical transporter",Oxidoreductase,Writer,"Voltage-gated ion channel","Small molecule receptor (family A GPCR)","SLC superfamily of solute carriers","Protein methyltransferase","Transient receptor poten
tial channel","Nucleotide-like receptor (family A GPCR)","SLC28 and SLC29 families of nucleoside transporters","AGC protein kinase group","TKL protein kinase group","Adenosine receptor","SLC28 Na+-cou
pled nucleoside transport family","SLC29 Facilitative nucleoside transporter family","AGC protein kinase PKA family","TKL protein kinase MLK family","TKL protein kinase TAK1 subfamily","Other cytosoli
c protein"}

> <pathway_chembl>
{Enzymes,Receptors,"Adenosine turnover","Cyclic nucleotide turnover/signalling","Peptidases and proteinases","G protein-coupled receptors","Kinases (EC 2.7.x.x)","Nuclear hormone receptors","Cytochrom
e P450","Adenylyl cyclases (ACs)","SC: Serine (S) Peptidases","Relaxin family peptide receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK families","1F. Retinoic acid-related orphans","CYP3 family","S9: 
Prolyl oligopeptidase","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily",Transporters,"Other protein targets","Ion channels","SLC superfamily of solute carriers","Glycerophospholipid t
urnover","Transcription factors","Chromatin modifying enzymes","Catalytic receptors","Voltage-gated ion channels","SLC28 and SLC29 families of nucleoside transporters","Adenosine receptors","Phosphati
dylinositol kinases","STAT transcription factors","2.1.1.43 Histone methyltransferases (HMTs)","Receptor kinases","Transient Receptor Potential channels","SLC28 family","SLC29 family","TKL: Tyrosine k
inase-like","Mixed Lineage Kinase (MLK) family","TAK1 subfamily"}

> <pathway_reactome>
{Disease,"Neuronal System","Metabolism of proteins","Cellular responses to external stimuli","Gene expression (Transcription)","Immune System",Metabolism,"Cell Cycle","Diseases of metabolism","Infecti
ous disease","Transmission across Chemical Synapses","Peptide hormone metabolism","Cellular responses to stress","RNA Polymerase II Transcription","Innate Immune System","Metabolism of lipids",Mitotic
,"Metabolic disorders of biological oxidation enzymes","SARS-CoV Infections","Neurotransmitter receptors and postsynaptic signal transmission","Incretin synthesis",secretion,"and inactivation","Leishm
ania infection","Cellular response to hypoxia","Generic Transcription Pathway","Toll-like Receptor Cascades","Biosynthesis of specialized proresolving mediators (SPMs)","M Phase","Defective AHCY cause
s Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD)","Potential therapeutics for SARS","GABA receptor activation",Synthesis,"and inactivation of Glucagon-like Peptide-1 (GL
P-1)","Leishmania parasite growth and survival","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Transcriptional Regulation by MECP2","Toll Like Receptor 5 (TLR5) Cascade","
Transcriptional regulation by RUNX3","Biosynthesis of DHA-derived SPMs","Mitotic Metaphase and Anaphase","GABA B receptor activation","Anti-inflammatory response favouring Leishmania parasite infectio
n","Regulation of MECP2 expression and activity","MyD88 cascade initiated on plasma membrane","RUNX3 Regulates Immune Response and Cell Migration","Biosynthesis of maresins","Mitotic Anaphase","Activa
tion of GABAB receptors","ADORA2B mediated anti-inflammatory cytokines production","MAP kinase activation","Biosynthesis of maresin-like SPMs","Nuclear Envelope (NE) Reassembly","Adenylate cyclase inh
ibitory pathway","MAPK targets/ Nuclear events mediated by MAP kinases","Initiation of Nuclear Envelope (NE) Reformation","ERK/MAPK targets","ERKs are inactivated","Transport of small molecules","Sign
al Transduction","Chromatin organization","SLC-mediated transmembrane transport","Signaling by GPCR","Metabolism of carbohydrates","Chromatin modifying enzymes","Ion channel transport","Transport of v
itamins",nucleosides,"and related molecules","GPCR ligand binding","Glucose metabolism","Phospholipid metabolism","Cytosolic sensors of pathogen-associated DNA","PKMTs methylate histone lysines","Stim
uli-sensing channels","Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane","Class A/1 (Rhodopsin-like receptors)",Gluconeogenesis,"PI Metabolism","STING mediated 
induction of host immune responses","Toll Like Receptor 4 (TLR4) Cascade","TRP channels","Nucleotide-like (purinergic) receptors","Synthesis of PIPs at the early endosome membrane","STAT6-mediated ind
uction of chemokines","MyD88-independent TLR4 cascade","Adenosine P1 receptors","TRIF(TICAM1)-mediated TLR4 signaling","TRAF6-mediated induction of TAK1 complex within TLR4 complex","Activation of NMD
A receptors and postsynaptic events","Post NMDA receptor activation events","Activation of AMPK downstream of NMDARs","Metabolism of nucleotides","Nucleotide salvage","Purine salvage"}

> <broad_targets>
{ADA}

> <broad_moa>
{antiviral}

> <synonyms>
{Vidarabine,"Adenine arabinoside",Ara-A,AraA,5536-17-4,5536174,Arabinosyladenine,Vira-A,ViraA,Spongoadenosine,Araadenosine,"Arabinosyl adenine",9-beta-D-Arabinofuranosyladenine,9betaDArabinofuranosyla
denine,"Arabinoside adenine","Vidarabine anhydrous",Vidarabin,9-BETA-D-ARABINOFURANOSYL-ADENIN,9BETADARABINOFURANOSYLADENIN,T1506,T0853,SAM002564191,1500609,Prestw-768,Adenosine,CPD000471872,VIDARABIN
E}

> <pdid>
PD002089

> <targets>
{Apoptosis,Autophagy,Endogenous Metabolite,Nucleoside Antimetabolite/Analog,Antibiotic,HSV}

> <classes>
{antiviral,Apoptosis,Autophagy,Cell Cycle/DNA Damage,Metabolic Enzyme/Protease,Anti-infection}

> <pubchem_cids>
{21704}

$$$$
NIHCC_2014
  SciTegic11012413002D

 19 19  0  0  0  0            999 V2000
    2.5909   -6.0056    0.0000 O   0  0
    3.8912   -5.2578    0.0000 C   0  0
    5.1887   -6.0105    0.0000 O   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 N   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.4983    0.7413    0.0000 Cl  0  0
   -2.6061    2.9986    0.0000 C   0  0
   -3.9082    3.7448    0.0000 C   0  0
   -3.9139    5.2448    0.0000 Cl  0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 10 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 13 17  1  0
 17 18  1  0
 18 19  1  0
M  END
> <name>
NIHCC_2014

> <id>
6194

> <plate>
NGP-202-02

> <well>
E05

> <supplier_cmpd_name>
CPD000058372

> <ctcr_id>
2305

> <supplier_cmpd_id>
SAM002564202

> <smiles>
OC(=O)CCCc1ccc(cc1)N(CCCl)CCCl

> <pd_targets>
{SLCO1B3,PMP22,HIF1A,TSHR,MAPT,CYP2D6,CHRM1,THPO,GMNN,NFKB1,LMNA,AKR1B1,TGR}

> <pathway_gtopdb>
{Transporter,"Unclassified protein","Transcription factor","Membrane receptor","Other cytosolic protein",Enzyme,"Other nuclear protein","Electrochemical transporter","Family A G protein-coupled recept
or","Cytochrome P450",Oxidoreductase,"SLC superfamily of solute carriers","Peptide receptor (family A GPCR)","Cytochrome P450 family 2","Small molecule receptor (family A GPCR)","SLC21/SLCO family of 
organic anion transporting polypeptides","Glycohormone receptor","Cytochrome P450 family 2D","Monoamine receptor","Cytochrome P450 2D6","Acetylcholine receptor"}

> <pathway_chembl>
{Transporters,Receptors,Enzymes,"SLC superfamily of solute carriers","G protein-coupled receptors","Cytochrome P450","1.-.-.- Oxidoreductases","SLCO family of organic anion transporting polypeptides",
"Glycoprotein hormone receptors","CYP2 family: drug metabolising subset","Acetylcholine receptors (muscarinic)"}

> <pathway_reactome>
{Metabolism,"Developmental Biology","Cellular responses to external stimuli",Disease,"Neuronal System","Signal Transduction",Hemostasis,"Cell Cycle","Immune System","Metabolism of lipids","Nervous sys
tem development","Cellular responses to stress","Infectious disease","Transmission across Chemical Synapses","Biological oxidations","Signaling by GPCR","Platelet activation","signaling and aggregatio
n",Mitotic,"Cytokine Signaling in Immune system","Metabolism of steroids","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Cellular response to hypoxia","Leishmania infection","Neurot
ransmitter receptors and postsynaptic signal transmission","Phase I - Functionalization of compounds","GPCR ligand binding","Platelet Aggregation (Plug Formation)","Mitotic G1 phase and G1/S transitio
n","Signaling by Interleukins","M Phase","Bile acid and bile salt metabolism","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Leishmania parasite growth and survival","Acti
vation of NMDA receptors and postsynaptic events","Cytochrome P450 - arranged by substrate type","Class A/1 (Rhodopsin-like receptors)","G1/S Transition","Interleukin-1 family signaling","Mitotic Meta
phase and Anaphase","Metabolism of steroid hormones","Recycling of bile acids and salts","Anti-inflammatory response favouring Leishmania parasite infection","Post NMDA receptor activation events",Xen
obiotics,"Amine ligand-binding receptors","Activation of the pre-replicative complex","Interleukin-1 signaling","Mitotic Anaphase","Pregnenolone biosynthesis","ADORA2B mediated anti-inflammatory cytok
ines production","Activation of AMPK downstream of NMDARs","CYP2E1 reactions","Muscarinic acetylcholine receptors","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Nuclear Envelope (NE) Reassembly","Init
iation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{}

> <broad_moa>
{"DNA inhibitor"}

> <synonyms>
{RESTW107,chlorambucil,305-03-3,305033,Ambochlorin,Chloroambucil,Leukeran,Chloraminophen,Chlorbutin,Chloraminophene,Chlorobutine,Amboclorin,Chlorbutine,Chlorobutin,Linfolizin,Linfolysin,Ecloril,Elcori
l,"Phenylbutyric acid nitrogen mustard",Chlocambucil,Lymphol,T0975,3088,C0253,SAM002564202,1500171,Prestw-1079,"NSC 3088",Chlorambucil,CPD000058372,CHLORAMBUCIL}

> <pdid>
PD002434

> <targets>
{}

> <classes>
{antineoplastic,"alkylating agent","Alkylating agent"}

> <pubchem_cids>
{2708}

$$$$
NIHCC_2014
  SciTegic11012413002D

 18 19  0  0  0  0            999 V2000
    3.8976   -0.7553    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2948   -3.7516    0.0000 O   0  0
    3.8926   -3.7566    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 F   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5987    1.5004    0.0000 C   0  0
   -2.6012    3.0004    0.0000 C   0  0
   -3.9015    3.7484    0.0000 C   0  0
   -5.1993    2.9963    0.0000 C   0  0
   -5.1969    1.4963    0.0000 C   0  0
   -3.8967    0.7484    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  2  0
  2  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 10 12  2  0
 12  6  1  0
  9 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
M  END
> <name>
NIHCC_2014

> <id>
6195

> <plate>
NGP-202-02

> <well>
E06

> <supplier_cmpd_name>
CPD000042823

> <ctcr_id>
3366

> <supplier_cmpd_id>
SAM002564209

> <smiles>
CC(C(O)=O)c1ccc(c(F)c1)c2ccccc2

> <pd_targets>
{PTGS1,PTGS2,FABP2,FABP1,KMT2A,MEN1,TSHR,AKR1C2,AKR1C3,SLC22A6,ASIC1,CYP2C19,MAPT,HPGD,CYP1A2,APH1A,APH1B,NCSTN,PSEN1,PSEN2,PSENEN,CYP2C9,HIF1A,LMNA,ALD}

> <pathway_gtopdb>
{Enzyme,"Auxiliary transport protein","Epigenetic regulator","Membrane receptor",Transporter,"Ion channel",Oxidoreductase,"Fatty acid binding protein family",Reader,"Family A G protein-coupled recepto
r","Electrochemical transporter","Ligand-gated ion channel",Bromodomain,"Peptide receptor (family A GPCR)","SLC superfamily of solute carriers","Acid-sensing ion channel","Glycohormone receptor","SLC2
2 family of organic cation and anion transporters","Other cytosolic protein","Transcription factor","Other nuclear protein","Cytochrome P450",Protease,"Cytochrome P450 family 2","Cytochrome P450 famil
y 1","Aspartic protease","Cytochrome P450 family 2C","Cytochrome P450 family 1A","Aspartic protease AD clan","Cytochrome P450 2C19","Cytochrome P450 1A1","Aspartic protease A22A subfamily","Cytochrome
 P450 2C9","Aspartic protease A22A regulatory subfamily"}

> <pathway_chembl>
{Enzymes,"Other protein targets",Receptors,Transporters,"Ion channels","Eicosanoid turnover","Fatty acid-binding proteins","G protein-coupled receptors","SLC superfamily of solute carriers","Ligand-ga
ted ion channels",Cyclooxygenase,"Glycoprotein hormone receptors","Prostaglandin synthases","SLC22 family of organic cation and anion transporters","Acid-sensing (proton-gated) ion channels (ASICs)","
Organic anion transporters (OATs)","Cytochrome P450","CYP2 family: drug metabolising subset","CYP1 family"}

> <pathway_reactome>
{Metabolism,Disease,"Transport of small molecules","Metabolism of lipids","Infectious disease","SLC-mediated transmembrane transport","Ion channel transport","Fatty acid metabolism","Biosynthesis of s
pecialized proresolving mediators (SPMs)","Triglyceride metabolism","Regulation of lipid metabolism by PPARalpha","Leishmania infection","Metabolism of steroids","Transport of bile salts and organic a
cids","metal ions and amine compounds","Stimuli-sensing channels","Arachidonic acid metabolism","Biosynthesis of DPA-derived SPMs","Triglyceride catabolism","PPARA activates gene expression","Leishman
ia parasite growth and survival","Bile acid and bile salt metabolism","Organic cation/anion/zwitterion transport","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","Biosynthesis of DPAn-3 SPMs"
,"Anti-inflammatory response favouring Leishmania parasite infection","Synthesis of bile acids and bile salts","Organic anion transport","ADORA2B mediated anti-inflammatory cytokines production","Synt
hesis of bile acids and bile salts via 24-hydroxycholesterol","Neuronal System","Cellular responses to external stimuli","Cell Cycle","Biological oxidations","Transmission across Chemical Synapses","C
ellular responses to stress",Mitotic,"Phase I - Functionalization of compounds","Neurotransmitter receptors and postsynaptic signal transmission","Cellular response to hypoxia","M Phase","Cytochrome P
450 - arranged by substrate type","Activation of NMDA receptors and postsynaptic events","Biosynthesis of DHA-derived SPMs","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","
Mitotic Metaphase and Anaphase",Xenobiotics,"Post NMDA receptor activation events","Biosynthesis of D-series resolvins","Mitotic Anaphase","CYP2E1 reactions","Activation of AMPK downstream of NMDARs",
"Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{APH1B,BACE1,IKBKG,PSEN1,PSEN2,PTGS1,PTGS2}

> <broad_moa>
{"gamma secretase inhibitor"}

> <synonyms>
{5104-49-4,5104494,Ansaid,Froben,Antadys,"2-(2-fluorobiphenyl-4-yl)propanoic acid","2(2fluorobiphenyl4yl)propanoic acid",Cebutid,Flurofen,Anside,"3-Fluoro-4-phenylhydratropic acid","3Fluoro4phenylhydr
atropic acid",Ocufen,"2-(3-fluoro-4-phenylphenyl)propanoic acid","2(3fluoro4phenylphenyl)propanoic acid","Flurbiprofene (INN-French)","Flurbiprofene (INNFrench)",Flurbiprofenum,SAM002564209,SAM0012469
61,1500308,Prestw-917,S1679,CPD000042823,FLURBIPROFEN,Flurbiprofen}

> <pdid>
PD002326

> <targets>
{Others}

> <classes>
{analgesic,Others,antiinflammatory}

> <pubchem_cids>
{3394}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 25  0  0  0  0            999 V2000
   14.1828   -4.5076    0.0000 Cl  0  0
    5.1937   -3.0093    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8912   -5.2578    0.0000 N   0  0
    5.1894   -6.0109    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    3.8869   -8.2595    0.0000 O   0  0
    6.4855   -8.2648    0.0000 C   0  0
    6.4855   -9.7648    0.0000 C   0  0
    7.7846  -10.5149    0.0000 C   0  0
    9.0836   -9.7649    0.0000 C   0  0
   10.3826  -10.5149    0.0000 O   0  0
    9.0836   -8.2649    0.0000 C   0  0
    7.7846   -7.5149    0.0000 C   0  0
   10.3819   -7.5118    0.0000 C   0  0
   11.6822   -8.2596    0.0000 N   0  0
   10.3798   -6.0118    0.0000 O   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
  3 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 19 21  1  0
 21 22  2  0
 22 16  1  0
 21 23  1  0
 23 24  1  0
 23 25  2  0
M  END
> <name>
NIHCC_2014

> <id>
6196

> <plate>
NGP-202-02

> <well>
E07

> <supplier_cmpd_name>
CPD000058463

> <ctcr_id>
6569

> <supplier_cmpd_id>
SAM002564217

> <smiles>
Cl.CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(N)=O

> <pd_targets>
{ALDH1A1,HPGD,KDM4E,GAA,ADRA1A,ADRA1B,ADRA1D,ADRA2A,ADRA2B,ADRA2C,RCE1,STE24,LMNA,SMN1,ADRB1,ADRB2,ADRB3,HSD17B10,CYP2D6,SLC6A3,SIGMAR1,HTR1A,HTR2B,SLC6A2}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Membrane receptor","Other nuclear protein",Transporter,Oxidoreductase,Eraser,Hydrolase,"Family A G protein-coupled receptor",Protease,Reader,"Cytochrome P450","Electroc
hemical transporter","Lysine demethylase","Small molecule receptor (family A GPCR)","Metallo protease","Methyl-lysine/arginine binding protein","Cytochrome P450 family 2","SLC superfamily of solute ca
rriers","Jumonji domain-containing","Monoamine receptor","Metallo protease MAE clan","Tudor domain","Cytochrome P450 family 2D","SLC06 neurotransmitter transporter family","Adrenergic receptor","Metal
lo protease M48A subfamily","Cytochrome P450 2D6","Serotonin receptor"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Other protein targets","Eicosanoid turnover","Chromatin modifying enzymes","3.2.1.- Glycosidases","G protein-coupled receptors","Cytochrome P450","SLC superfamily of s
olute carriers","Sigma receptors","Prostaglandin synthases","1.14.11.- Histone demethylases",Adrenoceptors,"CYP2 family: drug metabolising subset","SLC6 neurotransmitter transporter family","5-Hydroxy
tryptamine receptors","Monoamine transporter subfamily"}

> <pathway_reactome>
{Metabolism,Disease,"Cell Cycle","Metabolism of RNA","Signal Transduction","Biological oxidations","Metabolism of lipids","Diseases of metabolism",Mitotic,"Metabolism of non-coding RNA","Metabolism of
 amino acids and derivatives","Signaling by GPCR","Infectious disease","Disorders of transmembrane transporters","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving me
diators (SPMs)","Diseases of carbohydrate metabolism","M Phase","snRNP Assembly","Branched-chain amino acid catabolism","GPCR ligand binding","Leishmania infection","SLC transporter disorders","SARS-C
oV Infections","Ethanol oxidation","Biosynthesis of DHA-derived SPMs","Glycogen storage diseases","Mitotic Metaphase and Anaphase","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth an
d survival","Cytochrome P450 - arranged by substrate type","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Potential therapeutics for SARS","Defective SLC6A2 causes orthostatic into
lerance (OI)","Biosynthesis of D-series resolvins","Glycogen storage disease type II (GAA)","Mitotic Anaphase","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasit
e infection",Xenobiotics,"Nuclear Envelope (NE) Reassembly",Adrenoceptors,"ADORA2B mediated anti-inflammatory cytokines production","CYP2E1 reactions","Serotonin receptors","Initiation of Nuclear Enve
lope (NE) Reformation"}

> <broad_targets>
{ADRA1D,ADRB1,ADRB2}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{AKOS026749871,"Labetalol hydrochloride",32780-64-6,32780646,"32780 64 6","Labetalol HCL",Amipress,Presdate,"Labetalol (hydrochloride)",Trandate,"ScH 15719W","AH 5158A",UNII-1GEV3BAW9J,UNII1GEV3BAW9J,
"UNII 1GEV3BAW9J",Sch-15719W,Sch15719W,Sch,T0348,S4291,SAM002564217,1503243,Prestw-277,"Labetalol HCl",CPD000058463,"LABETALOL HYDROCHLORIDE"}

> <pdid>
PD009899

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"adrenergic blocker","GPCR & G Protein"}

> <pubchem_cids>
{657196,71412}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 18  0  0  0  0            999 V2000
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1984    1.4977    0.0000 C   0  0
   -6.4971    0.7454    0.0000 C   0  0
   -7.7984    1.4932    0.0000 C   0  0
   -7.8010    2.9932    0.0000 C   0  0
   -9.0964    0.7413    0.0000 O   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
  8 14  1  0
 14 15  2  0
 15 16  1  0
 16  6  1  0
 16 17  2  0
 17  3  1  0
M  END
> <name>
NIHCC_2014

> <id>
6197

> <plate>
NGP-202-02

> <well>
E08

> <supplier_cmpd_name>
CPD000058835

> <ctcr_id>
4397

> <supplier_cmpd_id>
SAM002564225

> <smiles>
COc1ccc2cc(CCC(C)=O)ccc2c1

> <pd_targets>
{SMN1,MAPT,RORC,CYP3A4,LMNA,RAB9A,NPC1,TP53,KDM4E,CYP1A2,SLC6A2,MAOA,PTGS2,PTGS1}

> <pathway_gtopdb>
{"Epigenetic regulator","Other cytosolic protein","Transcription factor",Enzyme,"Other nuclear protein",Transporter,Reader,"Nuclear receptor","Cytochrome P450",Hydrolase,Eraser,"Electrochemical transp
orter",Oxidoreductase,"Methyl-lysine/arginine binding protein","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 3","Lysine demethylase","Cytochrome P450 family 1","SLC superfamily of sol
ute carriers","Tudor domain","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family 3A","Jumonji domain-containing","Cytochrome P450 family 1A","SLC06 neurotransmitter transporter fami
ly","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 3A4","Cytochrome P450 1A1"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Nuclear hormone receptors","Cytochrome P450","SLC superfamily of solute carriers","Chromatin modifying enzymes","Catecholamine turnover","Eicosanoid turnover","1F. Ret
inoic acid-related orphans","CYP3 family","SLC65 NPC-type cholesterol transporters","1.14.11.- Histone demethylases","CYP1 family","SLC6 neurotransmitter transporter family",Cyclooxygenase,"Monoamine 
transporter subfamily"}

> <pathway_reactome>
{"Metabolism of RNA","Neuronal System","Gene expression (Transcription)",Metabolism,"Cell Cycle","Signal Transduction","Transport of small molecules",Disease,"Metabolism of non-coding RNA","Transmissi
on across Chemical Synapses","RNA Polymerase II Transcription","Metabolism of lipids",Mitotic,"Signaling by Rho GTPases","Plasma lipoprotein assembly",remodeling,"and clearance","Cell Cycle Checkpoint
s","Biological oxidations","Disorders of transmembrane transporters","snRNP Assembly","Neurotransmitter receptors and postsynaptic signal transmission","Generic Transcription Pathway","Biosynthesis of
 specialized proresolving mediators (SPMs)","M Phase","Rho GTPase cycle","Plasma lipoprotein clearance","G1/S DNA Damage Checkpoints","Phase I - Functionalization of compounds","SLC transporter disord
ers","Fatty acid metabolism","Activation of NMDA receptors and postsynaptic events","Transcriptional regulation by RUNX3","Biosynthesis of DHA-derived SPMs","Mitotic Metaphase and Anaphase","RHOBTB GT
Pase Cycle","LDL clearance","p53-Dependent G1/S DNA damage checkpoint","Cytochrome P450 - arranged by substrate type","Defective SLC6A2 causes orthostatic intolerance (OI)","Amine Oxidase reactions","
Biosynthesis of DPA-derived SPMs","Arachidonic acid metabolism","Post NMDA receptor activation events","RUNX3 Regulates Immune Response and Cell Migration","Biosynthesis of maresins","Mitotic Anaphase
","RHOBTB3 ATPase cycle","p53-Dependent G1 DNA Damage Response",Xenobiotics,"Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB","Biosynthesis of DPAn-3 SPMs","Synthesis of Prost
aglandins (PG) and Thromboxanes (TX)","Activation of AMPK downstream of NMDARs","Biosynthesis of maresin-like SPMs","Nuclear Envelope (NE) Reassembly","Stabilization of p53","Aromatic amines can be N-
hydroxylated or N-dealkylated by CYP1A2","Initiation of Nuclear Envelope (NE) Reformation","Autodegradation of the E3 ubiquitin ligase COP1"}

> <broad_targets>
{PTGS1,PTGS2}

> <broad_moa>
{"cyclooxygenase inhibitor"}

> <synonyms>
{nabumetone,42924-53-8,42924538,Relafen,4-(6-methoxynaphthalen-2-yl)butan-2-one,4(6methoxynaphthalen2yl)butan2one,Arthaxan,Nabumetona,Relifex,nabumeton,Listran,Relifen,4-(6-Methoxy-2-naphthyl)-2-butan
one,4(6Methoxy2naphthyl)2butanone,Consolan,Balmox,"Nabumetonum (INN-Latin)","Nabumetonum (INNLatin)",Nabumetonum,Nabuser,4-(6-Methoxy-2-napht,4(6Methoxy2napht,T1258,SAM002564225,1503650,Prestw-909,Nab
umetone,CPD000058835,NABUMETONE}

> <pdid>
PD000963

> <targets>
{}

> <classes>
{antiinflammatory}

> <pubchem_cids>
{4409}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 28  0  0  1  0            999 V2000
   12.2327    0.2674    0.0000 Cl  0  5
   -2.6395    3.8685    0.0000 O   0  0
   -1.3618    3.0827    0.0000 C   0  0
    0.0000    3.7710    0.0000 C   0  0
    1.0625    3.0827    0.0000 C   0  0
    1.0625    1.6760    0.0000 C   0  0
    2.3045    0.9727    0.0000 C   0  0
    2.3045   -0.4040    0.0000 C   0  0  1  0  0  0
    3.2622   -1.0625    0.0000 N   0  0
    3.2622   -1.9005    0.0000 C   0  0
    0.0000   -1.9005    0.0000 C   0  0
    0.0000   -0.4040    0.0000 C   0  0  1  0  0  0
   -1.3618   -1.1223    0.0000 C   0  0  1  0  0  0
   -2.5589    0.2394    0.0000 O   0  0
   -1.3618    1.6760    0.0000 C   0  0
    0.0000    0.9727    0.0000 C   0  0
   -1.3618   -2.5589    0.0000 C   0  0
   -2.6462   -3.3336    0.0000 O   0  0
    0.0000   -3.2772    0.0000 C   0  0
    1.0774   -2.5589    0.0000 C   0  0
    1.0774   -1.1373    0.0000 C   0  0  1  0  0  0
    2.3821   -1.8775    0.0000 O   0  0
    4.6577   -0.4958    0.0000 C   0  0
    5.8415   -1.4184    0.0000 C   0  0
    7.2320   -0.8558    0.0000 C   0  0
    9.7327    0.2674    0.0000 H   0  3
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  8  7  1  1
  8  9  1  0
  9 10  1  0
 10 11  1  0
 12 11  1  1
 12 13  1  0
 13 14  1  6
 14 15  1  0
 15  3  1  0
 15 16  2  0
 16  6  1  0
 16 12  1  0
 13 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21  8  1  0
 21 12  1  0
 21 22  1  1
  9 23  1  0
 23 24  1  0
 24 25  2  0
M  CHG  2   1  -1  26   1
M  END
> <name>
NIHCC_2014

> <id>
6198

> <plate>
NGP-202-02

> <well>
E09

> <supplier_cmpd_name>
CPD000058766

> <ctcr_id>
4880

> <supplier_cmpd_id>
SAM002703137

> <smiles>
[Cl-].Oc1ccc2C[C@H]3N(CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O)CC=C.[H+]

> <pd_targets>
{LMNA,MAPT,BLM,OPRK1,OPRD1,OPRM1,CCR5,TGR,CYP2D6,CREB1,ESR1,TLR4}

> <pathway_gtopdb>
{"Other nuclear protein","Other cytosolic protein",Enzyme,"Membrane receptor","Unclassified protein","Transcription factor","Family A G protein-coupled receptor","Cytochrome P450","Nuclear receptor",H
ydrolase,"Peptide receptor (family A GPCR)","Cytochrome P450 family 2","Nuclear hormone receptor subfamily 3","Short peptide receptor (family A GPCR)","Chemokine receptor","Cytochrome P450 family 2D",
"Nuclear hormone receptor subfamily 3 group A","Opioid receptor","CC chemokine receptor","Cytochrome P450 2D6","Nuclear hormone receptor subfamily 3 group A member 1"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Cytochrome P450","Nuclear hormone receptors","Catalytic receptors","Opioid receptors","Chemokine receptors","CYP2 family: drug metabolising subset","S
teroid hormone receptors","Pattern recognition receptors","3A. Estrogen receptors","Toll-like receptor family"}

> <pathway_reactome>
{"Cell Cycle","Neuronal System","DNA Repair",Mitotic,"Transmission across Chemical Synapses","DNA Double-Strand Break Repair","M Phase","Neurotransmitter receptors and postsynaptic signal transmission
","Homology Directed Repair","Mitotic Metaphase and Anaphase","Activation of NMDA receptors and postsynaptic events","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Mito
tic Anaphase","Post NMDA receptor activation events","HDR through Homologous Recombination (HRR)","Nuclear Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs","Homologous DNA Pairing a
nd Strand Exchange","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pairing and strand exchange","Gene expression (Transcription)","Signal Transduction",Disease,
Metabolism,"Immune System","RNA Polymerase II Transcription","Signaling by GPCR","Infectious disease","Biological oxidations","Innate Immune System","Generic Transcription Pathway","GPCR ligand bindin
g","GPCR downstream signalling","HIV Infection","Phase I - Functionalization of compounds","Toll-like Receptor Cascades","Transcriptional Regulation by MECP2","Class A/1 (Rhodopsin-like receptors)","G
 alpha (i) signalling events","HIV Life Cycle","Cytochrome P450 - arranged by substrate type","Toll Like Receptor 5 (TLR5) Cascade","Transcriptional regulation by RUNX1","Toll Like Receptor 4 (TLR4) C
ascade","MECP2 regulates neuronal receptors and channels","Peptide ligand-binding receptors","Opioid Signalling","Early Phase of HIV Life Cycle",Xenobiotics,"MyD88 cascade initiated on plasma membrane
","RUNX1 regulates estrogen receptor mediated transcription","MyD88-independent TLR4 cascade","G-protein activation","Binding and entry of HIV virion","CYP2E1 reactions","MAP kinase activation","TRIF(
TICAM1)-mediated TLR4 signaling","MAPK targets/ Nuclear events mediated by MAP kinases","Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon","CREB phosphorylation"}

> <broad_targets>
{CREB1,ESR1,OPRD1,OPRK1,OPRM1,TLR4}

> <broad_moa>
{"opioid receptor antagonist"}

> <synonyms>
{RESTW11,"Naloxone hydrochloride","Naloxone HCl",357-08-4,357084,Narcan,"Naloxone (hydrochloride)","NIH 7890",UNII-F850569PQR,UNIIF850569PQR,EN-15304,EN15304,CHEBI:31892,F850569PQR,MFCD00069322,"357-0
8-4 (HCl)","357084 (HCl)",Narcanti,17-Allyl-4,17Allyl4,5alpha-epoxy-3,5alphaepoxy3,"14-dihydroxymorphinan-6-one hydrochl","14dihydroxymorphinan6one hydrochl",S3066,SAM002703137,Prestw-111,CPD000058766
}

> <pdid>
PD007525

> <targets>
{"Opioid Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{44666320,5464092,46911858}

$$$$
NIHCC_2014
  SciTegic11012413002D

 15 15  0  0  0  0            999 V2000
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 N   0  0
    3.8976   -0.7553    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
   -2.5972   -1.5031    0.0000 N   0  0
   -2.5951   -3.0031    0.0000 C   0  0
   -3.8976   -0.7554    0.0000 C   0  0
   -0.0031    3.0008    0.0000 N   0  0
   -1.3032    3.7490    0.0000 C   0  0
    1.2946    3.7531    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  8 10  1  0
 10 11  1  0
 10 12  1  0
  6 13  1  0
 13 14  1  0
 13 15  1  0
M  END
> <name>
NIHCC_2014

> <id>
6199

> <plate>
NGP-202-02

> <well>
E10

> <supplier_cmpd_name>
CPD000058181

> <ctcr_id>
2557

> <supplier_cmpd_id>
SAM002564241

> <smiles>
CN(C)c1nc(nc(n1)N(C)C)N(C)C

> <pd_targets>
{THRB,CHRM1,CYP1A2,NS1,LMNA,CREBBP,HSD17B10}

> <pathway_gtopdb>
{"Transcription factor","Membrane receptor",Enzyme,"Unclassified protein","Other nuclear protein","Epigenetic regulator","Nuclear receptor","Family A G protein-coupled receptor","Cytochrome P450",Writ
er,Oxidoreductase,"Nuclear hormone receptor subfamily 1","Small molecule receptor (family A GPCR)","Cytochrome P450 family 1","Histone acetyltransferase","Nuclear hormone receptor subfamily 1 group A"
,"Monoamine receptor","Cytochrome P450 family 1A","p300/CBP family","Nuclear hormone receptor subfamily 1 group A member 2","Acetylcholine receptor","Cytochrome P450 1A1"}

> <pathway_chembl>
{Receptors,Enzymes,"Other protein targets","Nuclear hormone receptors","G protein-coupled receptors","Cytochrome P450","Bromodomain-containing proteins","1A. Thyroid hormone receptors","Acetylcholine 
receptors (muscarinic)","CYP1 family","Non-enzymatic BRD containing proteins"}

> <pathway_reactome>
{"Metabolism of proteins","Signal Transduction",Metabolism,"Cell Cycle","Gene expression (Transcription)","Post-translational protein modification","Signaling by GPCR","Biological oxidations",Mitotic,
"RNA Polymerase II Transcription","Metabolism of amino acids and derivatives",SUMOylation,"GPCR ligand binding","Phase I - Functionalization of compounds","M Phase","Generic Transcription Pathway","Br
anched-chain amino acid catabolism","SUMO E3 ligases SUMOylate target proteins","Class A/1 (Rhodopsin-like receptors)","Cytochrome P450 - arranged by substrate type","Mitotic Metaphase and Anaphase","
Transcriptional Regulation by TP53","SUMOylation of intracellular receptors","Amine ligand-binding receptors",Xenobiotics,"Mitotic Anaphase","TP53 Regulates Transcription of Cell Death Genes","Muscari
nic acetylcholine receptors","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Nuclear Envelope (NE) Reassembly","TP53 Regulates Transcription of Genes Involved in Cytochrome C Relea
se","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{}

> <broad_moa>
{"DNA synthesis inhibitor"}

> <synonyms>
{"Altretamine (USP/INN)",altretamine,645-05-6,645056,HEXAMETHYLMELAMINE,Hexalen,Hexastat,Hemel,"2,4,6-Tris(dimethylamino)-1,3,5-triazine","2,4,6Tris(dimethylamino)1,3,5triazine","Melamine, hexamethyl-
","Melamine, hexamethyl",Altretaminum,Altretamina,"Altretaminum (INN-Latin)","Altretaminum (INNLatin)",N2,N4,N6,N6-hexamethyl-1,N6hexamethyl1,3,5-t,5t,T1241,13875,SAM002564241,1503065,Prestw-946,"NSC 
13875",Altretamine,CPD000058181,ALTRETAMINE}

> <pdid>
PD001093

> <targets>
{DNA Alkylator/Crosslinker}

> <classes>
{antineoplastic,Alkylating agent,Cell Cycle/DNA Damage}

> <pubchem_cids>
{2123}

$$$$
NIHCC_2014
  SciTegic11012413002D

 32 35  0  0  0  0            999 V2000
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 N   0  0
    3.8976   -0.7553    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    3.8971    3.7500    0.0000 C   0  0
    5.1961    3.0001    0.0000 O   0  0
    3.8971    5.2500    0.0000 C   0  0
    5.1961    6.0001    0.0000 C   0  0
    6.4952    5.2501    0.0000 Cl  0  0
    5.1961    7.5001    0.0000 C   0  0
    3.8970    8.2500    0.0000 C   0  0
    2.5980    7.5000    0.0000 C   0  0
    1.2990    8.2500    0.0000 O   0  0
    2.5980    6.0000    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2991    3.7500    0.0000 O   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2991    2.2500    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 C   0  0
   -2.5951   -3.0031    0.0000 O   0  0
   -3.8976   -0.7554    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
   -2.5981    1.5000    0.0000 O   0  0
    0.0000    6.0000    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 17 10  1  0
 17 18  1  0
 18 19  2  3
 19  7  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22  5  1  0
 22 23  1  0
 22 24  1  0
 24 25  2  3
 25 26  1  0
 26 27  2  0
 26 28  1  0
 25 29  1  0
 29  4  1  0
 29 30  2  0
 24 31  1  0
 18 32  1  0
M  END
> <name>
NIHCC_2014

> <id>
6200

> <plate>
NGP-202-02

> <well>
E11

> <supplier_cmpd_name>
CPD001496930

> <ctcr_id>
7035

> <supplier_cmpd_id>
SAM002589921

> <smiles>
CN(C)C1C2CC3C(O)c4c(Cl)ccc(O)c4C(=C3C(=O)C2(O)C(=C(C(=O)N)C1=O)O)O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{Bioterciclin,Demetraclin,Novotriclina,Perciclina,Deganol,Demeclor,Diuciclin,Sumaclina,"DMCT (antibiotic)",6-Demethylchlortetracycline,6Demethylchlortetracycline,"Demethylchlortetracycline base",6-Dem
ethyl-7-chlortetracycline,6Demethyl7chlortetracycline,Elkamicina,4-epi-Demeclocycline,4epiDemeclocycline,"RP 10192",SAM002589921,CPD001496930}

> <pdid>
PD003031

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{54680103}

$$$$
NIHCC_2014
  SciTegic11012413002D

 16 17  0  0  0  0            999 V2000
    3.4523   -0.4348    0.0000 C   0  0
    2.5625    0.0216    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.1651    1.2500    0.0000 O   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -2.5000    0.0000 O   0  0
    1.7713   -2.1535    0.0000 C   0  0
    3.2417   -2.4501    0.0000 C   0  0
    3.7200   -3.8718    0.0000 C   0  0
    2.7279   -4.9969    0.0000 C   0  0
    1.2576   -4.7003    0.0000 C   0  0
    0.7792   -3.2786    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  3  1  0
  9 10  2  0
  3 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
M  END
> <name>
NIHCC_2014

> <id>
6201

> <plate>
NGP-202-02

> <well>
F02

> <supplier_cmpd_name>
CPD000058501

> <ctcr_id>
4168

> <supplier_cmpd_id>
SAM002554925

> <smiles>
CCC1(C(=O)NCNC1=O)c2ccccc2

> <pd_targets>
{KMT2A,MEN1,APEX1,POLB,CYP1A2,TRPM3,TSHR,SCN10A,SCN11A,SCN1A,SCN2A,SCN3A,SCN4A,SCN5A,SCN7A,SCN8A,SCN9A,GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG3,G
ABRP,GABRQ,CHRNA4,CHRNA7,GRIA2,GRIK2}

> <pathway_gtopdb>
{"Epigenetic regulator",Enzyme,"Unclassified protein","Membrane receptor","Ion channel",Reader,"Cytochrome P450","Family A G protein-coupled receptor","Voltage-gated ion channel","Ligand-gated ion cha
nnel",Bromodomain,"Cytochrome P450 family 1","Peptide receptor (family A GPCR)","Voltage-gated sodium channel","GABA-A receptor","Nicotinic acetylcholine receptor","Ionotropic glutamate receptor","Cyt
ochrome P450 family 1A","Glycohormone receptor","Nicotinic acetylcholine receptor alpha subunit","AMPA receptor","Kainate receptor","Cytochrome P450 1A1"}

> <pathway_chembl>
{Enzymes,"Ion channels",Receptors,"Cytochrome P450","Voltage-gated ion channels","G protein-coupled receptors","Ligand-gated ion channels","CYP1 family","Transient Receptor Potential channels","Glycop
rotein hormone receptors","GABA<sub>A</sub> receptors","Nicotinic acetylcholine receptors","Ionotropic glutamate receptors"}

> <pathway_reactome>
{"DNA Repair",Metabolism,"Transport of small molecules",Disease,"Neuronal System","Base Excision Repair","Biological oxidations","Ion channel transport","Infectious disease","Transmission across Chemi
cal Synapses","Resolution of Abasic Sites (AP sites)","Phase I - Functionalization of compounds","Stimuli-sensing channels","Leishmania infection","Neurotransmitter receptors and postsynaptic signal t
ransmission","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Cytochrome P450 - arranged by substrate type","TRP channels","Leishmania parasite growth and survival","GAB
A receptor activation","Acetylcholine binding and downstream events","Activation of NMDA receptors and postsynaptic events","Activation of kainate receptors upon glutamate binding","PCNA-Dependent Lon
g Patch Base Excision Repair",Xenobiotics,"Anti-inflammatory response favouring Leishmania parasite infection","Postsynaptic nicotinic acetylcholine receptors","Post NMDA receptor activation events","
Ionotropic activity of kainate receptors","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","ADORA2B mediated anti-inflammatory cytokines production","Highly calcium permeable postsyn
aptic nicotinic acetylcholine receptors","Long-term potentiation","Activation of Ca-permeable Kainate Receptor"}

> <broad_targets>
{CHRNA4,CHRNA7,GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG3,GABRP,GABRQ,GRIA2,GRIK2,SCN10A,SCN11A,SCN1A,SCN2A,SCN3A,SCN4A,SCN5A,SCN7A,SCN8A,SCN9A}

> <broad_moa>
{"GABA receptor antagonist"}

> <synonyms>
{primidone,125-33-7,125337,Primaclone,Mysoline,2-Deoxyphenobarbital,2Deoxyphenobarbital,Lepimidin,Liskantin,Mylepsinum,Lepsiral,Misodine,Mizodin,Mylepsin,Neurosyn,Primidon,Sertan,2-Desoxyphenobarbital
,2Desoxyphenobarbital,Hexadiona,Majsolin,Milepsin,Misolyne,Prilepsin,Primakton,Primoline,Pryso,T0024,SAM002554925,1500501,Prestw-933,Primidone,CPD000058501,PRIMIDONE}

> <pdid>
PD001787

> <targets>
{Sodium Channel}

> <classes>
{anticonvulsant,Membrane Transporter/Ion Channel}

> <pubchem_cids>
{4909}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 27  0  0  0  0            999 V2000
    2.5532   -4.4223    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 C   0  0
    3.8794   -1.4442    0.0000 C   0  0
    4.8823   -2.5608    0.0000 C   0  0
    4.4166   -3.9866    0.0000 O   0  0
    6.3501   -2.2517    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 F   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
   -0.6890   -4.0818    0.0000 C   0  0
   -2.1578   -3.7735    0.0000 C   0  0
   -3.1610   -4.8886    0.0000 C   0  0
   -4.6284   -4.5775    0.0000 C   0  0
   -5.0926   -3.1511    0.0000 C   0  0
   -4.0895   -2.0359    0.0000 C   0  0
   -2.6221   -2.3471    0.0000 C   0  0
   -6.5602   -2.8368    0.0000 S   0  0
   -7.5653   -3.9502    0.0000 C   0  0
   -7.0224   -1.4097    0.0000 O   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  2  0
  3  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 10 12  2  0
 12 13  1  0
 13 14  2  0
 14  8  1  0
 14 15  1  0
 15  2  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 20 23  1  0
 23 24  1  0
 23 25  2  0
M  END
> <name>
NIHCC_2014

> <id>
6202

> <plate>
NGP-202-02

> <well>
F03

> <supplier_cmpd_name>
CPD000326718

> <ctcr_id>
4819

> <supplier_cmpd_id>
SAM002554933

> <smiles>
CC\1=C(CC(O)=O)c2cc(F)ccc2C1=C\c3ccc(cc3)[S](C)=O

> <pd_targets>
{PMP22,CYP2C19,RORC,GLO1,RXRA,PTGS2,MAPK1,CYP3A4,CYP2C9,PTGS1,KDM4E,MAPT,CYP1A2,LMNA,ALDH1A1,ABCB11,NPSR1,AKR1B1,C5,FFP,PTGES,GLRA1,MAPK3,PPARD,PTGDR2,AKR1B10,KMT2A,TGR}

> <pathway_gtopdb>
{"Unclassified protein",Enzyme,"Transcription factor","Epigenetic regulator","Other cytosolic protein","Other nuclear protein",Transporter,"Membrane receptor","Secreted protein","Ion channel","Cytochr
ome P450","Nuclear receptor",Lyase,Oxidoreductase,Kinase,Eraser,"Primary active transporter","Family A G protein-coupled receptor",Transferase,Isomerase,"Ligand-gated ion channel",Reader,"Cytochrome P
450 family 2","Nuclear hormone receptor subfamily 1","Nuclear hormone receptor subfamily 2","Protein Kinase","Cytochrome P450 family 3","Lysine demethylase","Cytochrome P450 family 1","ATP-binding cas
sette","Peptide receptor (family A GPCR)","Glycine receptor","Small molecule receptor (family A GPCR)",Bromodomain,"Cytochrome P450 family 2C","Nuclear hormone receptor subfamily 1 group F","Nuclear h
ormone receptor subfamily 2 group B","CMGC protein kinase group","Cytochrome P450 family 3A","Jumonji domain-containing","Cytochrome P450 family 1A","ABCB subfamily","Short peptide receptor (family A 
GPCR)","Nuclear hormone receptor subfamily 1 group C","Lipid-like ligand receptor (family A GPCR)","Cytochrome P450 2C19","Nuclear hormone receptor subfamily 1 group F member 3","Nuclear hormone recep
tor subfamily 2 group B member 1","CMGC protein kinase MAPK family","Cytochrome P450 3A4","Cytochrome P450 2C9","Cytochrome P450 1A1","Neuropeptide receptor","Nuclear hormone receptor subfamily 1 grou
p C member 2","Prostanoid receptor","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Ion channels","Cytochrome P450","Nuclear hormone receptors","Eicosanoid turnover","Kinases (EC 2.7.x.x)","Chromatin modifying enzymes","ATP-binding cassette transporte
r family","G protein-coupled receptors","1.-.-.- Oxidoreductases","Ligand-gated ion channels","CYP2 family: drug metabolising subset","1F. Retinoic acid-related orphans","2B. Retinoid X receptors",Cyc
looxygenase,"CMGC: Containing CDK",MAPK,GSK3,"CLK families","CYP3 family","1.14.11.- Histone demethylases","CYP1 family","ABCB subfamily","Neuropeptide S receptor","Prostaglandin synthases","Glycine r
eceptors","1C. Peroxisome proliferator-activated receptors","Prostanoid receptors","2.1.1.43 Histone methyltransferases (HMTs)","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Developmental Biology",Metabolism,"Gene expression (Transcription)","Immune System","Neuronal System","Cell Cycle",Disease,"Signal Transduction","Nervous system development","Biological oxidations",
"RNA Polymerase II Transcription","The citric acid (TCA) cycle and respiratory electron transport","Metabolism of lipids","Innate Immune System","Transmission across Chemical Synapses",Mitotic,"Infect
ious disease","Signaling by GPCR","Metabolism of vitamins and cofactors","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Phase I - Functionalization of compounds","Generic Transcript
ion Pathway","Pyruvate metabolism and Citric Acid (TCA) cycle","Metabolism of steroids","Biosynthesis of specialized proresolving mediators (SPMs)","Toll-like Receptor Cascades","Fatty acid metabolism
","Neurotransmitter receptors and postsynaptic signal transmission","M Phase","Leishmania infection","GPCR ligand binding","Metabolism of fat-soluble vitamins","Cytochrome P450 - arranged by substrate
 type","Transcriptional regulation by RUNX3","Pyruvate metabolism","Bile acid and bile salt metabolism","Biosynthesis of DPA-derived SPMs","Toll Like Receptor 5 (TLR5) Cascade","Biosynthesis of DHA-de
rived SPMs","Arachidonic acid metabolism","Activation of NMDA receptors and postsynaptic events","Mitotic Metaphase and Anaphase","Ethanol oxidation","Leishmania parasite growth and survival","Metabol
ism of steroid hormones","Class A/1 (Rhodopsin-like receptors)","Retinoid metabolism and transport","Transcriptional regulation by RUNX1",Xenobiotics,"RUNX3 Regulates Immune Response and Cell Migratio
n","Synthesis of bile acids and bile salts","Biosynthesis of DPAn-3 SPMs","MyD88 cascade initiated on plasma membrane","Biosynthesis of maresins","Synthesis of Prostaglandins (PG) and Thromboxanes (TX
)","Post NMDA receptor activation events","Mitotic Anaphase","Anti-inflammatory response favouring Leishmania parasite infection","Pregnenolone biosynthesis","Peptide ligand-binding receptors","Regula
tion of pyruvate dehydrogenase (PDH) complex","Eicosanoid ligand-binding receptors","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","CYP2E1 reactions","Synthesi
s of bile acids and bile salts via 27-hydroxycholesterol","MAP kinase activation","Biosynthesis of maresin-like SPMs","Activation of AMPK downstream of NMDARs","Aromatic amines can be N-hydroxylated o
r N-dealkylated by CYP1A2","Nuclear Envelope (NE) Reassembly","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","ADORA2B mediated anti-inflammatory cytokines production","Prostano
id ligand receptors","MAPK targets/ Nuclear events mediated by MAP kinases","Initiation of Nuclear Envelope (NE) Reformation","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{AKR1B1}

> <broad_moa>
{"cyclooxygenase inhibitor"}

> <synonyms>
{J012337,SR-01000075237-2,SR010000752372,sulindac,Clinoril,38194-50-2,38194502,Arthrocine,Sulindaco,Sulindacum,Aflodac,"Sulindac sulfoxide",Sulreuma,Mobilin,"cis-5-Fluoro-2-methyl-1-((p-methylsulfinyl
)benzylidene)indene-3-acetic acid","cis5Fluoro2methyl1((pmethylsulfinyl)benzylidene)indene3acetic acid",CHEBI:9352,"MK 231",Algocetil,A,T0459,SAM002554933,1500556,Prestw-73,Sulindac,CPD000326718,SULIN
DAC}

> <pdid>
PD001740

> <targets>
{}

> <classes>
{antiinflammatory}

> <pubchem_cids>
{1548887}

$$$$
NIHCC_2014
  SciTegic11012413002D

 19 19  0  0  0  0            999 V2000
    6.4848   -8.2644    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    3.8869   -8.2595    0.0000 C   0  0
    5.1894   -6.0109    0.0000 N   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    5.1937   -3.0093    0.0000 O   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -3.8964   -0.7545    0.0000 N   0  0
   -5.1996    1.4928    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 13 18  1  0
 18 19  2  0
 19 10  1  0
M  END
> <name>
NIHCC_2014

> <id>
6203

> <plate>
NGP-202-02

> <well>
F04

> <supplier_cmpd_name>
CPD000036768

> <ctcr_id>
920

> <supplier_cmpd_id>
SAM002564193

> <smiles>
CC(C)NCC(O)COc1ccc(CC(N)=O)cc1

> <pd_targets>
{ADRB1,HTR1A,ADRA1A,ADRA1B,ADRA1D,ADRB2,LMNA,GLA,LEF,BLM,THPO,CHRM1,PMP22,TSHR,NFKB1,CYP3A4,CYP1A2,TDP1}

> <pathway_gtopdb>
{"Membrane receptor","Other nuclear protein","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Adrenergic receptor","Serotonin receptor",Enzyme,"Unc
lassified protein","Other cytosolic protein",Hydrolase,Protease,"Cytochrome P450","Metallo protease","Peptide receptor (family A GPCR)","Cytochrome P450 family 3","Cytochrome P450 family 1","Metallo p
rotease MAE clan","Glycohormone receptor","Cytochrome P450 family 3A","Cytochrome P450 family 1A","Metallo protease M34 family","Acetylcholine receptor","Cytochrome P450 3A4","Cytochrome P450 1A1"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors",Adrenoceptors,"5-Hydroxytryptamine receptors",Enzymes,"Cytochrome P450","Acetylcholine receptors (muscarinic)","Glycoprotein hormone receptors","CYP3 family","
CYP1 family"}

> <pathway_reactome>
{Disease,"Signal Transduction","Cell Cycle","Infectious disease","Signaling by GPCR",Mitotic,"Leishmania infection","GPCR ligand binding","M Phase","Leishmania parasite growth and survival","Class A/1
 (Rhodopsin-like receptors)","Mitotic Metaphase and Anaphase","Anti-inflammatory response favouring Leishmania parasite infection","Amine ligand-binding receptors","Mitotic Anaphase","ADORA2B mediated
 anti-inflammatory cytokines production","Serotonin receptors","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation",Metabolism,"DNA Repair",Hemostasis,"Developmental Bi
ology","Immune System","Metabolism of lipids","DNA Double-Strand Break Repair","Platelet activation","signaling and aggregation","Nervous system development","Cytokine Signaling in Immune system","Bio
logical oxidations","Sphingolipid metabolism","Uptake and actions of bacterial toxins","Homology Directed Repair","Platelet Aggregation (Plug Formation)","EGR2 and SOX10-mediated initiation of Schwann
 cell myelination","Signaling by Interleukins","Biosynthesis of specialized proresolving mediators (SPMs)","Phase I - Functionalization of compounds","Nonhomologous End-Joining (NHEJ)","Glycosphingoli
pid metabolism","Uptake and function of anthrax toxins","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Interleukin-1 family signaling","Biosynthesis of DHA-derived SPMs
","Cytochrome P450 - arranged by substrate type","HDR through Homologous Recombination (HRR)","Interleukin-1 signaling","Biosynthesis of maresins",Xenobiotics,"Homologous DNA Pairing and Strand Exchan
ge","Muscarinic acetylcholine receptors","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Biosynthesis of maresin-like SPMs","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Presynapti
c phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{atenolol,29122-68-7,29122687,Tenormin,Blokium,Normiten,Tenormine,Prenormine,Tenoblock,Atehexal,Betablok,Cuxanorm,Myocord,Selobloc,(RS)-Atenolol,(RS)Atenolol,Duraatenolol,Antipressan,Atcardil,Atenbloc
k,Betacard,Corotenol,Evitocor,Farnormin,Internolol,Normalol,Premo,T0007,SAM002564193,1501127,Atenolol,CPD000036768,ATENOLOL}

> <pdid>
PD001885

> <targets>
{}

> <classes>
{"beta adrenergic blocker"}

> <pubchem_cids>
{2249}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 30  0  0  1  0            999 V2000
    6.8348    0.5669    0.0000 Na  0  3
    3.8780   -3.8845    0.0000 C   0  0
    2.4294   -3.4952    0.0000 O   0  0
    2.0479   -2.0470    0.0000 C   0  0  2  0  0  0
    3.1019   -0.9836    0.0000 N   0  0
    4.5551   -1.3587    0.0000 C   0  0
    4.9562   -2.8040    0.0000 O   0  0
    5.6072   -0.2883    0.0000 C   0  0
    7.0604   -0.6634    0.0000 C   0  0
    8.1982    0.2944    0.0000 S   0  0
    9.4620   -0.5135    0.0000 C   0  0
    9.0842   -1.9651    0.0000 C   0  0
    7.5868   -2.0544    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 S   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
    0.7488   -2.7970    0.0000 C   0  0
    0.3606   -4.2459    0.0000 O   0  0
   -2.6003   -1.4978    0.0000 C   0  0
   -2.6029   -2.9978    0.0000 O   0  5
   -3.8983   -0.7459    0.0000 O   0  0
   -2.5973    1.5031    0.0000 C   0  0
   -2.5951    3.0039    0.0000 O   0  0
   -3.8933    3.7570    0.0000 C   0  0
   -5.1937    3.0092    0.0000 N   0  0
   -3.8912    5.2570    0.0000 O   0  0
  2  3  1  0
  4  3  1  1
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13  9  2  0
  4 14  1  0
 14 15  1  6
 15 16  1  0
 16 17  1  0
 17 18  2  3
 18 19  1  0
 19 14  1  0
 19 20  1  0
 20  4  1  0
 20 21  2  0
 18 22  1  0
 22 23  1  0
 22 24  2  0
 17 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 27 29  2  0
M  CHG  2   1   1  23  -1
M  END
> <name>
NIHCC_2014

> <id>
6204

> <plate>
NGP-202-02

> <well>
F05

> <supplier_cmpd_name>
CPD000058809

> <ctcr_id>
2116

> <supplier_cmpd_id>
SAM002564251

> <smiles>
[Na+].CO[C@]1(NC(=O)Cc2sccc2)[C@H]3SCC(=C(N3C1=O)C([O-])=O)COC(N)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{AKOS015951242,"CEFOXITIN SODIUM","Cefoxitin sodium salt",33564-30-6,33564306,Cenomycin,"Cefoxitin (sodium)",Mefoxitin,UNII-Q68050H03T,UNIIQ68050H03T,MLS000028557,CHEBI:3501,Betacef,Merxin,Q68050H03T,
SMR000058809,"Cefoxitin sodium salt, 94","Monosodium cefoxiti",T1023,SAM002564251,1502031,Prestw-832,"Cefoxitin sodium",CPD000058809}

> <pdid>

> <targets>
{}

> <classes>
{antibacterial}

> <pubchem_cids>
{78759335,23667300}

$$$$
NIHCC_2014
  SciTegic11012413002D

 31 33  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -2.6030    2.9977    0.0000 O   0  0
   -3.8990    0.7455    0.0000 N   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.8003    1.4887    0.0000 C   0  0
   -9.0994    0.7387    0.0000 C   0  0
  -10.3984    1.4886    0.0000 C   0  0
  -10.3985    2.9886    0.0000 C   0  0
   -9.0995    3.7387    0.0000 C   0  0
   -7.8004    2.9887    0.0000 C   0  0
  -11.6983    3.7390    0.0000 S   0  0
  -11.6978    5.2390    0.0000 O   0  0
  -12.9970    4.4896    0.0000 O   0  0
  -12.9985    2.9894    0.0000 N   0  0
  -14.2982    3.7398    0.0000 C   0  0
  -14.2978    5.2398    0.0000 O   0  0
  -15.5984    2.9902    0.0000 N   0  0
  -16.8982    3.7405    0.0000 C   0  0
  -18.1988    2.9932    0.0000 C   0  0
  -19.4964    3.7458    0.0000 C   0  0
  -19.4934    5.2458    0.0000 C   0  0
  -18.1928    5.9932    0.0000 C   0  0
  -16.8953    5.2406    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  5  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 16 19  1  0
 19 20  2  0
 19 21  2  0
 19 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 26  1  0
M  END
> <name>
NIHCC_2014

> <id>
6205

> <plate>
NGP-202-02

> <well>
F06

> <supplier_cmpd_name>
CPD000058455

> <ctcr_id>
1879

> <supplier_cmpd_id>
SAM002564210

> <smiles>
Cc1cnc(cn1)C(=O)NCCc2ccc(cc2)[S](=O)(=O)NC(=O)NC3CCCCC3

> <pd_targets>
{CYP3A4,MAPT,BLM,CYP2C9,NFKB1,TSHR,LMNA,AMPC,ABCC8,KCNJ11,PPARG}

> <pathway_gtopdb>
{Enzyme,"Other cytosolic protein","Membrane receptor","Other nuclear protein","Ion channel",Transporter,"Transcription factor","Cytochrome P450","Family A G protein-coupled receptor",Hydrolase,"Voltag
e-gated ion channel","Primary active transporter","Nuclear receptor","Cytochrome P450 family 3","Cytochrome P450 family 2","Peptide receptor (family A GPCR)","Potassium channels","ATP-binding cassette
","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 3A","Cytochrome P450 family 2C","Glycohormone receptor","Inwardly rectifying potassium channel","ABCC subfamily","Nuclear hormone recep
tor subfamily 1 group C","Cytochrome P450 3A4","Cytochrome P450 2C9","Nuclear hormone receptor subfamily 1 group C member 3"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Cytochrome P450","G protein-coupled receptors","ATP-binding cassette transporter family","Nuclear hormone receptors","CYP3 family","CYP2 family: drug metabolising subs
et","Glycoprotein hormone receptors","ABCC subfamily","1C. Peroxisome proliferator-activated receptors"}

> <pathway_reactome>
{Metabolism,"Neuronal System","DNA Repair","Immune System",Disease,"Cell Cycle","Gene expression (Transcription)","Metabolism of lipids","Transmission across Chemical Synapses","DNA Double-Strand Brea
k Repair","Biological oxidations","Cytokine Signaling in Immune system","Infectious disease",Mitotic,"Disorders of transmembrane transporters","RNA Polymerase II Transcription","Biosynthesis of specia
lized proresolving mediators (SPMs)","Neurotransmitter receptors and postsynaptic signal transmission","Homology Directed Repair","Phase I - Functionalization of compounds","Signaling by Interleukins"
,"Leishmania infection","M Phase","ABC transporter disorders","Generic Transcription Pathway","Biosynthesis of DHA-derived SPMs","Activation of NMDA receptors and postsynaptic events","HDR through Hom
ologous Recombination (HRR) or Single Strand Annealing (SSA)","Cytochrome P450 - arranged by substrate type","Interleukin-1 family signaling","Leishmania parasite growth and survival","Mitotic Metapha
se and Anaphase","Defective ABCC8 can cause hypo- and hyper-glycemias","Transcriptional Regulation by MECP2","Biosynthesis of maresins","Post NMDA receptor activation events","HDR through Homologous R
ecombination (HRR)",Xenobiotics,"Interleukin-1 signaling","Anti-inflammatory response favouring Leishmania parasite infection","Mitotic Anaphase","MECP2 regulates transcription factors","Biosynthesis 
of maresin-like SPMs","Activation of AMPK downstream of NMDARs","Homologous DNA Pairing and Strand Exchange","CYP2E1 reactions","MAP3K8 (TPL2)-dependent MAPK1/3 activation","ADORA2B mediated anti-infl
ammatory cytokines production","Nuclear Envelope (NE) Reassembly","Presynaptic phase of homologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ABCC8,KCNJ10,KCNJ11,PPARG}

> <broad_moa>
{sulfonylurea}

> <synonyms>
{909461,glipizide,29094-61-9,29094619,Glucotrol,Glydiazinamide,Melizide,Glibenese,Glucozide,Glupizide,Sucrazide,Dipazide,Glupitel,Mindiab,Minidiab,Minodiab,Napizide,Ozidia,"Glucotrol XL",Glibetin,Gluc
olip,Aldiab,Digrin,Glican,Glidiab,Glipid,Minidab,Glyde,Gluco-,Gluco,T1603,SAM002564210,Prestw-131,Glipizide,CPD000058455}

> <pdid>
PD000414

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{3478}

$$$$
NIHCC_2014
  SciTegic11012413002D

 36 37  0  0  0  0            999 V2000
   12.7943   -3.0140    0.0000 H   0  3
   10.2943   -3.0140    0.0000 Cl  0  5
    6.4876   -5.2643    0.0000 C   0  0
    6.4912   -3.7643    0.0000 N   0  0
    7.7922   -3.0178    0.0000 C   0  0
    5.1937   -3.0100    0.0000 C   0  0
    4.3263   -3.5077    0.0000 O   0  0
    5.1972   -1.5092    0.0000 C   0  0
    3.8990   -0.7562    0.0000 C   0  0
    3.9012    0.7447    0.0000 C   0  0
    2.6029    1.4977    0.0000 N   0  0
    1.3008    0.7531    0.0000 C   0  0
    0.0049    1.5084    0.0000 C   0  0
    0.0110    3.0084    0.0000 C   0  0
   -1.2731    2.2332    0.0000 O   0  0
    1.3132    3.7531    0.0000 C   0  0
    2.6091    2.9977    0.0000 C   0  0
    0.0519    4.4885    0.0000 C   0  0
    1.3711    5.2023    0.0000 C   0  0
    1.4125    6.7018    0.0000 C   0  0
    0.1347    7.4873    0.0000 C   0  0
    0.1761    8.9868    0.0000 Cl  0  0
   -1.1846    6.7735    0.0000 C   0  0
   -1.2259    5.2740    0.0000 C   0  0
    6.4990   -0.7623    0.0000 C   0  0
    7.7960   -1.5158    0.0000 C   0  0
    9.0971   -0.7693    0.0000 C   0  0
    9.1011    0.7307    0.0000 C   0  0
    7.8041    1.4842    0.0000 C   0  0
    6.5030    0.7377    0.0000 C   0  0
    3.8959   -2.2567    0.0000 C   0  0
    3.8926   -3.7567    0.0000 C   0  0
    2.5919   -4.5039    0.0000 C   0  0
    1.2945   -3.7510    0.0000 C   0  0
    1.2978   -2.2510    0.0000 C   0  0
    2.5985   -1.5039    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 17 11  1  0
 14 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 23  1  0
 23 24  2  0
 24 18  1  0
  8 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
  8 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  2  0
 36 31  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6206

> <plate>
NGP-202-02

> <well>
F07

> <supplier_cmpd_name>
CPD000058466

> <ctcr_id>
1861

> <supplier_cmpd_id>
SAM002564218

> <smiles>
[H+].[Cl-].CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4

> <pd_targets>
{TSHR,THPO,ADRA1B,ABCB11,CES2,KMT2A,MEN1,HTT,ALOX15,CYP2D6,ALOX12,CHRM1,ADRA1A,OPRD1,CALM,CYP3A4,OPRM1,SLC22A1,TEK,LMNA,REP,OPRK1,CYP1A2,CACNA1C,SCN1A,SCN2A,SCN3A,RORC,TP53,FTL,PMP22,BLM,NPSR1,NFO,GMN
N,ADRB2,DRD3,MTOR,SIGMAR1,SCN5A,HTR2B,KCNH2,SLC6A4,HRH2,ABCB1,POMC,CALM1}

> <pathway_gtopdb>
{"Membrane receptor","Unclassified protein",Transporter,Enzyme,"Epigenetic regulator","Other nuclear protein","Ion channel","Transcription factor","Family A G protein-coupled receptor","Primary active
 transporter",Hydrolase,Reader,Oxidoreductase,"Cytochrome P450","Electrochemical transporter",Kinase,Transferase,"Voltage-gated ion channel","Nuclear receptor","Peptide receptor (family A GPCR)","Smal
l molecule receptor (family A GPCR)","ATP-binding cassette",Bromodomain,"Cytochrome P450 family 2","Cytochrome P450 family 3","SLC superfamily of solute carriers","Protein Kinase","Cytochrome P450 fam
ily 1","Voltage-gated calcium channel","Voltage-gated sodium channel","Nuclear hormone receptor subfamily 1","Potassium channels","Glycohormone receptor","Monoamine receptor","ABCB subfamily","Cytochr
ome P450 family 2D","Short peptide receptor (family A GPCR)","Cytochrome P450 family 3A","SLC22 family of organic cation and anion transporters","TK protein kinase group","Cytochrome P450 family 1A","
Nuclear hormone receptor subfamily 1 group F","Atypical protein kinase group","Voltage-gated potassium channel","SLC06 neurotransmitter transporter family","Adrenergic receptor","Cytochrome P450 2D6",
"Acetylcholine receptor","Opioid receptor","Cytochrome P450 3A4","Tyrosine protein kinase Tie family","Cytochrome P450 1A1","Nuclear hormone receptor subfamily 1 group F member 3","Neuropeptide recept
or","Dopamine receptor","Atypical protein kinase PIKK family","Serotonin receptor","Histamine receptor","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Receptors,Transporters,Enzymes,"Other protein targets","Ion channels","G protein-coupled receptors","ATP-binding cassette transporter family","Eicosanoid turnover","Cytochrome P450","SLC superfamily 
of solute carriers","Catalytic receptors","Anti-infective targets","Voltage-gated ion channels","Nuclear hormone receptors","Kinases (EC 2.7.x.x)","Sigma receptors","Glycoprotein hormone receptors",Ad
renoceptors,"ABCB subfamily",Lipoxygenases,"CYP2 family: drug metabolising subset","Acetylcholine receptors (muscarinic)","Opioid receptors","CYP3 family","SLC22 family of organic cation and anion tra
nsporters","Receptor kinases","Viral protein targets","CYP1 family","Voltage-gated calcium channels","1F. Retinoic acid-related orphans","Neuropeptide S receptor","Dopamine receptors",Atypical,"Voltag
e-gated sodium channels","5-Hydroxytryptamine receptors","Potassium channels","SLC6 neurotransmitter transporter family","Histamine receptors","Organic cation transporters (OCT)","TK: Tyrosine kinase"
,"Coronavirus (CoV) proteins","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","Voltage-gated potassium channels","Monoamine transporter subfamily","Receptor tyrosine kinases (RTKs)","F
RAP subfamily","Type XII RTKs: TIE family of angiopoietin receptors"}

> <pathway_reactome>
{Disease,Hemostasis,"Signal Transduction",Metabolism,"Gene expression (Transcription)","Transport of small molecules","Cell Cycle","Developmental Biology","Vesicle-mediated transport","DNA Repair","Mu
scle contraction","Neuronal System","Infectious disease","Platelet activation","signaling and aggregation","Signaling by GPCR","Metabolism of lipids","Biological oxidations","RNA Polymerase II Transcr
iption","SLC-mediated transmembrane transport","MAPK family signaling cascades",Mitotic,"Nervous system development","Cell Cycle Checkpoints","Membrane Trafficking","DNA Double-Strand Break Repair","C
ardiac conduction","Transmission across Chemical Synapses","Abacavir transport and metabolism","Leishmania infection","Platelet Aggregation (Plug Formation)","GPCR ligand binding","Metabolism of stero
ids","Phase I - Functionalization of compounds","Generic Transcription Pathway","Biosynthesis of specialized proresolving mediators (SPMs)","GPCR downstream signalling","Transport of bile salts and or
ganic acids","metal ions and amine compounds","MAPK1/MAPK3 signaling","M Phase","SARS-CoV Infections","Axon guidance","G1/S DNA Damage Checkpoints","trans-Golgi Network Vesicle Budding","EGR2 and SOX1
0-mediated initiation of Schwann cell myelination","Homology Directed Repair","Mitotic G1 phase and G1/S transition","Phase 3 - rapid repolarisation","Neurotransmitter clearance","Abacavir transmembra
ne transport","Neurotransmitter receptors and postsynaptic signal transmission","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Bile acid and bile salt metabolism","T
ranscriptional Regulation by MECP2","Biosynthesis of DPA-derived SPMs","Cytochrome P450 - arranged by substrate type","Biosynthesis of DHA-derived SPMs","G alpha (i) signalling events","Organic cation
/anion/zwitterion transport","RAF/MAP kinase cascade","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","Mitotic Metaphase and Anaphase","SARS-CoV-2 Infection","NCAM signaling for neurite o
ut-growth","SARS-CoV-1 Infection","Transcriptional regulation by RUNX3","p53-Dependent G1/S DNA damage checkpoint","Golgi Associated Vesicle Biogenesis","HDR through Homologous Recombination (HRR) or 
Single Strand Annealing (SSA)","G1/S Transition","Transcriptional Regulation by TP53","Potential therapeutics for SARS","L1CAM interactions","Serotonin clearance from the synaptic cleft","Activation o
f NMDA receptors and postsynaptic events","Anti-inflammatory response favouring Leishmania parasite infection","Amine ligand-binding receptors","Synthesis of bile acids and bile salts","Regulation of 
MECP2 expression and activity","Biosynthesis of DPAn-3 SPMs",Xenobiotics,"Peptide ligand-binding receptors","Biosynthesis of maresins","Opioid Signalling","Organic cation transport","SMAD2/SMAD3:SMAD4
 heterotrimer regulates transcription","Mitotic Anaphase","SARS-CoV-2 Genome Replication and Transcription","MECP2 regulates neuronal receptors and channels","NCAM1 interactions","SARS-CoV-1 Genome Re
plication and Transcription","RUNX3 Regulates Immune Response and Cell Migration","p53-Dependent G1 DNA Damage Response","HDR through Homologous Recombination (HRR)","Activation of the pre-replicative
 complex","Regulation of TP53 Activity","Interaction between L1 and Ankyrins","Post NMDA receptor activation events","ADORA2B mediated anti-inflammatory cytokines production",Adrenoceptors,"Synthesis 
of bile acids and bile salts via 7alpha-hydroxycholesterol","Biosynthesis of DPAn-3-derived protectins and resolvins","CYP2E1 reactions","Biosynthesis of DPAn-3-derived maresins","Muscarinic acetylcho
line receptors","Biosynthesis of maresin-like SPMs","G-protein activation","Nuclear Envelope (NE) Reassembly","Replication of the SARS-CoV-2 genome","Aromatic amines can be N-hydroxylated or N-dealkyl
ated by CYP1A2","Replication of the SARS-CoV-1 genome","Stabilization of p53","Homologous DNA Pairing and Strand Exchange","Dopamine receptors","Regulation of TP53 Expression and Degradation","Seroton
in receptors","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","Initiation of Nuclear Envelope (NE) Reformation","Autodegradation of the E3 ubiquitin ligase COP1","Pr
esynaptic phase of homologous DNA pairing and strand exchange","Regulation of TP53 Degradation","Ras activation upon Ca2+ influx through NMDA receptor"}

> <broad_targets>
{CACNA1A,CALM1,OPRD1,OPRK1,OPRM1,POMC}

> <broad_moa>
{"opioid receptor agonist"}

> <synonyms>
{"Loperamide hydrochloride",34552-83-5,34552835,"Loperamide HCl",Imodium,Suprasec,Fortasec,"Imodium A-D","Imodium AD","Loperamide (hydrochloride)",UNII-77TI35393C,UNII77TI35393C,"Maalox Anti-Diarrheal
","Maalox AntiDiarrheal",MLS000069779,CHEBI:6533,MFCD00058581,77TI35393C,NSC-696356,NSC696356,Dissenten,Lopemid,Lopemin,T0209,S2480,SAM002564218,Prestw-144,CPD000058466}

> <pdid>
PD009698

> <targets>
{"Opioid Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{71420,57516049,43833345}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 27  0  0  0  0            999 V2000
   19.2976   -2.2507    0.0000 H   0  3
   16.7976   -2.2507    0.0000 Cl  0  5
   14.2969   -2.2679    0.0000 C   0  0
   12.9965   -3.0156    0.0000 C   0  0
   11.6976   -2.2637    0.0000 N   0  0
   11.6967   -0.7629    0.0000 C   0  0
   10.3977   -0.0128    0.0000 C   0  0
   10.3966   -3.0118    0.0000 C   0  0
    9.0977   -2.2599    0.0000 C   0  0
    7.7988   -1.5080    0.0000 C   0  0
    6.4999   -0.7561    0.0000 C   0  0
    5.1988   -1.5042    0.0000 O   0  0
    3.8999   -0.7523    0.0000 C   0  0
    3.9021    0.7477    0.0000 O   0  0
    2.5988   -1.5004    0.0000 C   0  0
    2.6001   -0.0004    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    2.5996   -3.0013    0.0000 C   0  0
    1.3010   -3.7520    0.0000 C   0  0
    1.3018   -5.2520    0.0000 C   0  0
    2.6012   -6.0013    0.0000 C   0  0
    3.8998   -5.2506    0.0000 C   0  0
    3.8990   -3.7506    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  1  0
  8  9  1  0
  9 10  3  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 17  1  0
 15 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6207

> <plate>
NGP-202-02

> <well>
F08

> <supplier_cmpd_name>
CPD000058490

> <ctcr_id>
2504

> <supplier_cmpd_id>
SAM002564226

> <smiles>
[H+].[Cl-].CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c2ccccc2

> <pd_targets>
{KMT2A,MEN1,PMP22,NPSR1,RECQL,CHRM1,GPM3,CHRM2,CHRM5,CHRM4,ABCB11,CHRM3,DRD3,SLC6A3,SLC6A2,SIGMAR1,CYP2C19,HTR2B,CACNA1C,NFKB1,CYP3A4,CYP2C9,CYP1A2,THPO,CYP2D6,PKM,KCNH2}

> <pathway_gtopdb>
{"Epigenetic regulator","Unclassified protein","Membrane receptor",Enzyme,Transporter,"Ion channel","Other cytosolic protein",Reader,"Family A G protein-coupled receptor","Primary active transporter",
"Electrochemical transporter","Cytochrome P450","Voltage-gated ion channel",Bromodomain,"Peptide receptor (family A GPCR)","Small molecule receptor (family A GPCR)","ATP-binding cassette","SLC superfa
mily of solute carriers","Cytochrome P450 family 2","Voltage-gated calcium channel","Cytochrome P450 family 3","Cytochrome P450 family 1","Potassium channels","Short peptide receptor (family A GPCR)",
"Monoamine receptor","ABCB subfamily","SLC06 neurotransmitter transporter family","Cytochrome P450 family 2C","Cytochrome P450 family 3A","Cytochrome P450 family 1A","Cytochrome P450 family 2D","Volta
ge-gated potassium channel","Neuropeptide receptor","Acetylcholine receptor","Dopamine receptor","Cytochrome P450 2C19","Serotonin receptor","Cytochrome P450 3A4","Cytochrome P450 2C9","Cytochrome P45
0 1A1","Cytochrome P450 2D6"}

> <pathway_chembl>
{Receptors,Transporters,"Other protein targets",Enzymes,"Ion channels","G protein-coupled receptors","ATP-binding cassette transporter family","SLC superfamily of solute carriers","Sigma receptors","C
ytochrome P450","Voltage-gated ion channels","2.7.1.40 Pyruvate kinases","Neuropeptide S receptor","Acetylcholine receptors (muscarinic)","ABCB subfamily","Dopamine receptors","SLC6 neurotransmitter t
ransporter family","CYP2 family: drug metabolising subset","5-Hydroxytryptamine receptors","Voltage-gated calcium channels","CYP3 family","CYP1 family","Potassium channels","Monoamine transporter subf
amily","Voltage-gated potassium channels"}

> <pathway_reactome>
{"Developmental Biology",Disease,"Signal Transduction",Metabolism,"Immune System",Hemostasis,"Muscle contraction","Nervous system development","Infectious disease","Signaling by GPCR","Metabolism of l
ipids","Disorders of transmembrane transporters","Biological oxidations","Cytokine Signaling in Immune system","Platelet activation","signaling and aggregation","Metabolism of carbohydrates","Cardiac 
conduction","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Leishmania infection","GPCR ligand binding","Metabolism of steroids","SLC transporter disorders","SARS-CoV Infections","Ph
ase I - Functionalization of compounds","Axon guidance","Signaling by Interleukins","Biosynthesis of specialized proresolving mediators (SPMs)","Platelet Aggregation (Plug Formation)","Glucose metabol
ism","Phase 3 - rapid repolarisation","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Bile acid and bile salt metabolism","Defective SLC6A3 causes Parkinsonism-dyston
ia infantile (PKDYS)","Defective SLC6A2 causes orthostatic intolerance (OI)","Potential therapeutics for SARS","Cytochrome P450 - arranged by substrate type","NCAM signaling for neurite out-growth","I
nterleukin-1 family signaling","Biosynthesis of DHA-derived SPMs",Glycolysis,"Anti-inflammatory response favouring Leishmania parasite infection","Amine ligand-binding receptors","Synthesis of bile ac
ids and bile salts",Xenobiotics,"NCAM1 interactions","Interleukin-1 signaling","Biosynthesis of maresins","ADORA2B mediated anti-inflammatory cytokines production","Muscarinic acetylcholine receptors"
,"Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Dopamine receptors","CYP2E1 reactions","Serotonin receptors","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Biosynthesis of mare
sin-like SPMs","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{"Oxybutynin chloride","Oxybutynin hydrochloride",1508-65-2,1508652,"Oxybutynin HCl","Oxybutynin (chloride)","Ditropan Xl","MJ 4309-1","MJ 43091",C22H32ClNO3,MLS000069688,MFCD00072150,Dridase,SMR00005
8490,Tropax,"(R)-Oxybutynin Chloride","(R)Oxybutynin Chloride",4-Diethylamino-2-butyny,4Diethylamino2butyny,S3117,SAM002564226,1505399,Prestw-287,CPD000058490,"OXYBUTYNIN CHLORIDE"}

> <pdid>
PD009572

> <targets>
{AChR}

> <classes>
{anticholinergic,"Neuronal Signaling"}

> <pubchem_cids>
{91505,43835207,657224}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 25  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    0.0000   -1.5000    0.0000 O   0  0
   -2.5981   -1.5000    0.0000 O   0  0
   -3.8971   -0.7500    0.0000 C   0  0  2  0  0  0
   -5.1962   -1.5000    0.0000 C   0  0  2  0  0  0
   -6.4952   -0.7500    0.0000 C   0  0  1  0  0  0
   -6.4952    0.7500    0.0000 C   0  0  1  0  0  0
   -5.1962    1.5000    0.0000 C   0  0  1  0  0  0
   -3.8971    0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    1.5000    0.0000 O   0  0
   -5.1993    3.0008    0.0000 N   0  0
   -6.4994    3.7490    0.0000 C   0  0
   -7.7942    1.5000    0.0000 O   0  0
   -7.7934   -1.5031    0.0000 N   0  0
   -7.7913   -3.0031    0.0000 C   0  0
   -5.1962   -3.0000    0.0000 O   0  0
   -1.2990    2.2500    0.0000 O   0  0
    5.0987    0.3727    0.0000 O   0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  1
  8  2  1  0
  7  9  1  0
 10  9  1  6
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 10  1  0
 15 16  1  1
 16  6  1  0
 14 17  1  6
 17 18  1  0
 13 19  1  6
 12 20  1  6
 20 21  1  0
 11 22  1  1
  6 23  1  6
M  END
> <name>
NIHCC_2014

> <id>
6208

> <plate>
NGP-202-02

> <well>
F09

> <supplier_cmpd_name>
CPD001906777

> <ctcr_id>
7029

> <supplier_cmpd_id>
SAM002564233

> <smiles>
C[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)NC)O)NC)O)O.O

> <pd_targets>
{RPSL}

> <pathway_gtopdb>
{}

> <pathway_chembl>
{}

> <pathway_reactome>
{}

> <broad_targets>
{}

> <broad_moa>
{"bacterial 30S ribosomal subunit inhibitor"}

> <synonyms>
{"spectinomycin hydrate","Spectinomycin dihydrochloride pentahydrate",HMS3259K18,NC00588,SAM002564233,CPD001906777}

> <pdid>
PD009642

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{49842936}

$$$$
NIHCC_2014
  SciTegic11012413002D

 33 34  0  0  0  0            999 V2000
   11.6676  -18.7804    0.0000 C   0  0
   11.6698  -17.2804    0.0000 C   0  0
   12.9701  -16.5327    0.0000 C   0  0
   10.3716  -16.5273    0.0000 C   0  0
   10.3737  -15.0265    0.0000 C   0  0
    9.0755  -14.2734    0.0000 C   0  0
    9.0776  -12.7726    0.0000 C   0  0
   10.3780  -12.0249    0.0000 C   0  0
    7.7794  -12.0195    0.0000 C   0  0
    7.7815  -10.5187    0.0000 C   0  0
    6.4833   -9.7656    0.0000 C   0  0
    6.4855   -8.2648    0.0000 C   0  0
    7.7858   -7.5171    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    5.1894   -6.0109    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    5.1937   -3.0093    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  2  3
 19 20  1  0
 20 21  1  0
 21 22  2  3
 22 23  1  0
 22 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 26  1  0
 31 32  1  0
 32 21  1  0
 32 33  2  0
M  END
> <name>
NIHCC_2014

> <id>
6209

> <plate>
NGP-202-02

> <well>
F10

> <supplier_cmpd_name>
CPD001491672

> <ctcr_id>
7032

> <supplier_cmpd_id>
SAM002564257

> <smiles>
CC(C)CCCC(C)CCCC(C)CCCC(C)=CCC1=C(C)C(=O)c2ccccc2C1=O

> <pd_targets>
{GGCX,BGLAP,AMPC,FTL,TGR}

> <pathway_gtopdb>
{Enzyme,Lyase,"Unclassified protein",Hydrolase}

> <pathway_chembl>
{Enzymes,"Carboxylases and decarboxylases",Carboxylases}

> <pathway_reactome>
{Disease,"Gene expression (Transcription)","Diseases of hemostasis","RNA Polymerase II Transcription","Defects of contact activation system (CAS) and kallikrein/kinin system (KKS)","Generic Transcript
ion Pathway","Defective factor IX causes hemophilia B","Transcriptional regulation by RUNX2","Defective gamma-carboxylation of F9","RUNX2 regulates bone development","RUNX2 regulates osteoblast differ
entiation","Vesicle-mediated transport","Membrane Trafficking","trans-Golgi Network Vesicle Budding","Golgi Associated Vesicle Biogenesis"}

> <broad_targets>
{BGLAP,GGCX}

> <broad_moa>
{}

> <synonyms>
{"2-methyl-3-(3,7,11,15-tetramethylhexadec-2-enyl)naphthalene-1,4-dione","2methyl3(3,7,11,15tetramethylhexadec2enyl)naphthalene1,4dione","phylloquinone;2-METHYL-3-PHYTYL-1,4-NAPHTHOQUINONE","phylloqui
none;2METHYL3PHYTYL1,4NAPHTHOQUINONE",SCHEMBL351364,"Vitamin K1 (E-Phytonadione)","Vitamin K1 (EPhytonadione)",CHEMBL4549212,DTXSID80859134,"cis-Vitamin K1 (Z-Phytonadione)","cisVitamin K1 (ZPhytonadi
one)",HMS3259K20,SAM002564257,CPD001491672}

> <pdid>
PD000381

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{4812}

$$$$
NIHCC_2014
  SciTegic11012413002D

 32 35  0  0  0  0            999 V2000
   -7.2226   -5.0795    0.0000 C   0  0
   -6.1714   -4.0094    0.0000 C   0  0
   -4.7181   -4.3840    0.0000 C   0  0
   -3.6663   -3.3134    0.0000 C   0  0
   -2.2130   -3.6880    0.0000 C   0  0
   -1.8114   -5.1333    0.0000 O   0  0
   -1.1612   -2.6174    0.0000 O   0  0
    0.2851   -2.9666    0.0000 C   0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2991    2.2500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.8141   -2.0807    0.0000 C   0  0
    0.7499   -4.3804    0.0000 C   0  0
    2.2134   -4.7091    0.0000 O   0  0
   -0.2668   -5.4844    0.0000 C   0  0
    0.1798   -6.9164    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  3
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 15  1  0
 21 22  1  0
 21 23  1  0
 23 12  1  0
 23 24  1  0
 24 25  1  0
 24 26  1  0
 26 27  1  0
 27  8  1  0
 27 11  1  0
 27 28  1  0
  8 29  1  0
 29 30  2  0
 29 31  1  0
 31 32  1  0
M  END
> <name>
NIHCC_2014

> <id>
6210

> <plate>
NGP-202-02

> <well>
F11

> <supplier_cmpd_name>
CPD001496932

> <ctcr_id>
7036

> <supplier_cmpd_id>
SAM002589925

> <smiles>
CCCCC(=O)OC1(CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC12C)C(=O)CO

> <pd_targets>
{HIF1A,KMT2A,NR3C1}

> <pathway_gtopdb>
{"Transcription factor","Epigenetic regulator",Enzyme,Reader,Protease,"Nuclear receptor",Bromodomain,"Cysteine protease","Nuclear hormone receptor subfamily 3","Cysteine protease CA clan","Nuclear hor
mone receptor subfamily 3 group C","Cysteine protease C1A family","Nuclear hormone receptor subfamily 3 group C member 1"}

> <pathway_chembl>
{Enzymes,Receptors,"Chromatin modifying enzymes","Nuclear hormone receptors","2.1.1.43 Histone methyltransferases (HMTs)","Steroid hormone receptors","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"Cellular responses to external stimuli","Gene expression (Transcription)","Cellular responses to stress","RNA Polymerase II Transcription","Cellular response to hypoxia","Generic Transcription Pathw
ay","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Transcriptional regulation by RUNX1","FOXO-mediated transcription","RUNX1 regulates genes involved in megakaryocyte diff
erentiation and platelet function","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes"}

> <broad_targets>
{NR3C1}

> <broad_moa>
{"glucocorticoid receptor agonist"}

> <synonyms>
{Westcort,CPD001496932,CHEMBL4538138,CHEBI:94344,HMS3259K22,MCULE-3492234187,MCULE3492234187,NC00604,FT-0771452,FT0771452,BRD-A23290232-001-01-5,BRDA23290232001015,Q27166172,SAM002589925}

> <pdid>
PD000409

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5225092}

$$$$
NIHCC_2014
  SciTegic11012413002D

 11 11  0  0  0  0            999 V2000
    3.8926   -3.7566    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 S   0  0
    0.0000   -1.5000    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  3
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11  4  1  0
M  END
> <name>
NIHCC_2014

> <id>
6211

> <plate>
NGP-202-02

> <well>
G02

> <supplier_cmpd_name>
CPD000058275

> <ctcr_id>
2404

> <supplier_cmpd_id>
SAM002554926

> <smiles>
CCCC1=CC(=O)NC(=S)N1

> <pd_targets>
{TSHR,FFP,TPO,MPO,ALD,TAS2R38,DIO1}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Unclassified protein","Family A G protein-coupled receptor",Transferase,Oxidoreductase,"Peptide receptor (family A GPCR)","Glycohormone receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Thyroid hormone turnover","1.-.-.- Oxidoreductases","Glycoprotein hormone receptors","Orphan and other 7TM receptors","Taste 2 receptors"}

> <pathway_reactome>
{Disease,Metabolism,"Immune System","Signal Transduction","Infectious disease","Metabolism of amino acids and derivatives","Innate Immune System","Signaling by GPCR","Leishmania infection","Metabolism
 of amine-derived hormones","ROS and RNS production in phagocytes","GPCR downstream signalling","Leishmania parasite growth and survival","Thyroxine biosynthesis","Events associated with phagocytolyti
c activity of PMN cells","G alpha (i) signalling events","Anti-inflammatory response favouring Leishmania parasite infection","Regulation of thyroid hormone activity","ADORA2B mediated anti-inflammato
ry cytokines production"}

> <broad_targets>
{DIO1,TPO}

> <broad_moa>
{"thyroid peroxidase inhibitor"}

> <synonyms>
{RESTW49,"CCRIS 544","HSDB 3390","Propylthiouracil (TN)",SR-05000001706,SR05000001706,propylthiouracil,51-52-5,51525,6-Propyl-2-thiouracil,6Propyl2thiouracil,Propacil,Procasil,Prothiurone,Prothyran,2-
Mercapto-6-propylpyrimidin-4-ol,2Mercapto6propylpyrimidin4ol,Propycil,Prothiucil,Protiural,Thiuragyl,Prothycil,Propyl-Thi,PropylThi,T1309,SAM002554926,1500515,Prestw-494,Propylthiouracil,CPD000058275,
PROPYLTHIOURACIL}

> <pdid>
PD001776

> <targets>
{}

> <classes>
{antihyperthyroid}

> <pubchem_cids>
{657298}

$$$$
NIHCC_2014
  SciTegic11012413002D

 31 34  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  0  0  0  3
    1.2990    0.7500    0.0000 C   0  0  1  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0  1  0  0  0
    3.8971    3.7500    0.0000 C   0  0  1  0  0  0
    3.8971    5.2500    0.0000 C   0  0
    5.1961    6.0001    0.0000 O   0  0
    2.5980    6.0000    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0  1  0  0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2991    3.7500    0.0000 O   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 O   0  0
   -2.5981    1.5000    0.0000 O   0  0
    0.0000    4.5000    0.0000 O   0  0
    0.0000    6.0000    0.0000 O   0  0
    2.5949    7.5009    0.0000 C   0  0
    1.2948    8.2490    0.0000 O   0  0
    3.8927    8.2531    0.0000 N   0  0
    5.1953    2.9970    0.0000 N   0  0
    5.1932    1.4970    0.0000 C   0  0
    6.4957    3.7447    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  6
  5  4  1  6
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  2  3
 10 11  1  0
 11  5  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14  3  1  0
 14 15  2  3
 15 16  1  0
 16 17  2  3
 17  2  1  0
 17 18  1  0
 18 19  2  3
 19 20  1  0
 20 21  2  3
 21 16  1  0
 21 22  1  0
 15 23  1  0
 11 24  1  1
 10 25  1  0
  9 26  1  0
 26 27  2  0
 26 28  1  0
  6 29  1  1
 29 30  1  0
 29 31  1  0
M  END
> <name>
NIHCC_2014

> <id>
6212

> <plate>
NGP-202-02

> <well>
G03

> <supplier_cmpd_name>
CPD001906770

> <ctcr_id>
7018

> <supplier_cmpd_id>
SAM002554934

> <smiles>
C[C]1[C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{CPD001906770,SAM002554934}

> <pdid>
PD002845

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{73951549}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 30  0  0  0  0            999 V2000
    5.1965   -1.5117    0.0000 C   0  0
    3.8999   -0.7576    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    3.8934   -5.2570    0.0000 C   0  0
    5.1924   -6.0070    0.0000 C   0  0
    6.4915   -5.2571    0.0000 C   0  0
    6.4915   -3.7571    0.0000 C   0  0
    5.1925   -3.0070    0.0000 C   0  0
    1.2941   -3.7520    0.0000 C   0  0
    1.2894   -5.2521    0.0000 C   0  0
   -0.0120   -5.9981    0.0000 C   0  0
   -1.3087   -5.2440    0.0000 C   0  0
   -2.6123   -5.9877    0.0000 O   0  0
   -3.9086   -5.2314    0.0000 C   0  0
   -5.2123   -5.9751    0.0000 C   0  0
   -6.5086   -5.2188    0.0000 N   0  0
   -7.8115   -5.9621    0.0000 C   0  0
   -6.5013   -3.7189    0.0000 C   0  0
   -1.3040   -3.7440    0.0000 C   0  0
   -0.0027   -2.9981    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  3 10  2  3
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 10 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 24 26  1  0
 20 27  1  0
 27 28  2  0
 28 17  1  0
M  END
> <name>
NIHCC_2014

> <id>
6213

> <plate>
NGP-202-02

> <well>
G04

> <supplier_cmpd_name>
CPD001491671

> <ctcr_id>
7019

> <supplier_cmpd_id>
SAM002703133

> <smiles>
CCC(c1ccccc1)=C(c2ccccc2)c3ccc(OCCN(C)C)cc3

> <pd_targets>
{KDM4E,RORC,TP53,CYP3A4,ESR2,NFKB1,HIF1A,CYP2C19,CYP2D6,GMNN,CYP1A2,TSHR,ALDH1A1,LEF,BLM,ESR1,HTT,THPO,NFO,PMP22,MAPK1,LMNA,HSD17B10,FFP,KMT2A,MEN1,L3MBTL1,CYP2C9,SKA,ADRA1A,ABCB1,CYP2B6,SIGMAR1,REP,G
PER1,EBP,AR,LUXR,MAPT,FTL,BDKRB2,EBPL,DHCR7,AMPC,KCNH2,PGR,ESRRG,PRKCA,PRKCB,PRKCD,PRKCE,PRKCG,PRKCH,PRKCQ,PRKCZ,PRKCI,PRKD1,PRKD3,ERG2,PPP3CA,AOX1,CYP2C8,TBXAS1,HTR1A,MTOR,ADORA1,ADORA3,MC3R,MC5R,CHR
M3,OPRK1,HTR6,ABCB11,SLC6A3,CHRM1,FYN,ERBB2,LCK,ADRA1D,ADRB3,PTGS1,CHRM2,CHRM5,OPRM1,SLC6A4,TACR2,ADORA2A,DRD3,DRD4,CHRM4,OPRD1,HTR2C,TACR1,ADRA2B,HTR2A,ADRA2A,ADRB1,HRH2,HTR2B,SLC6A2,MC4R,ESRRA,DRD2,
EGFR,SHBG,MAPK8}

> <pathway_gtopdb>
{"Epigenetic regulator","Transcription factor",Enzyme,"Other cytosolic protein","Unclassified protein","Membrane receptor","Other nuclear protein",Transporter,"Ion channel","Secreted protein",Eraser,"
Nuclear receptor","Cytochrome P450","Family A G protein-coupled receptor",Oxidoreductase,Protease,Hydrolase,Kinase,Transferase,Reader,"Primary active transporter",Isomerase,"Voltage-gated ion channel"
,Phosphatase,"Electrochemical transporter","Lysine demethylase","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 3","Nuclear hormone receptor subfamily 3","Cytochrome P450 family 2","Cyt
ochrome P450 family 1","Peptide receptor (family A GPCR)","Metallo protease","Protein Kinase","Cysteine protease",Bromodomain,"Methyl-lysine/arginine binding protein","Small molecule receptor (family 
A GPCR)","ATP-binding cassette","Potassium channels","Protein Phosphatase","Cytochrome P450 family 5","SLC superfamily of solute carriers","Jumonji domain-containing","Nuclear hormone receptor subfami
ly 1 group F","Cytochrome P450 family 3A","Nuclear hormone receptor subfamily 3 group A","Cytochrome P450 family 2C","Cytochrome P450 family 2D","Cytochrome P450 family 1A","Glycohormone receptor","Me
tallo protease MAE clan","CMGC protein kinase group","Cysteine protease CA clan","MBT domain","Monoamine receptor","ABCB subfamily","Cytochrome P450 family 2B","Lipid-like ligand receptor (family A GP
CR)","Nuclear hormone receptor subfamily 3 group C","Short peptide receptor (family A GPCR)","Voltage-gated potassium channel","Nuclear hormone receptor subfamily 3 group B","AGC protein kinase group"
,"Serine/threonine protein phosphatase","Cytochrome P450 family 5A","Atypical protein kinase group","Nucleotide-like receptor (family A GPCR)","SLC06 neurotransmitter transporter family","TK protein k
inase group","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 3A4","Nuclear hormone receptor subfamily 3 group A member 2","Cytochrome P450 2C19","Cytochrome P450 2D6","Cytochr
ome P450 1A1","Metallo protease M34 family","Nuclear hormone receptor subfamily 3 group A member 1","CMGC protein kinase MAPK family","Cysteine protease C1A family","Cytochrome P450 2C9","Adrenergic r
eceptor","Cytochrome P450 2B6","Steroid-like ligand receptor","Nuclear hormone receptor subfamily 3 group C member 4","Bradykinin receptor","Nuclear hormone receptor subfamily 3 group C member 3","Nuc
lear hormone receptor subfamily 3 group B member 3","AGC protein kinase PKC family","Cytochrome P450 2C8","Cytochrome P450 5A1","Serotonin receptor","Atypical protein kinase PIKK family","Adenosine re
ceptor","Melanocortin receptor","Acetylcholine receptor","Opioid receptor","Tyrosine protein kinase Src family","Tyrosine protein kinase EGFR family","Neurokinin receptor","Dopamine receptor","Histami
ne receptor","Nuclear hormone receptor subfamily 3 group B member 1","CMGC protein kinase ERK1","AGC protein kinase PKC alpha subfamily","Atypical protein kinase FRAP subfamily","Tyrosine protein kina
se SrcA","CMGC protein kinase JNK subfamily"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Other protein targets","Ion channels","Chromatin modifying enzymes","Nuclear hormone receptors","Cytochrome P450","G protein-coupled receptors","Kinases (EC 2.7.x.x)",
"ATP-binding cassette transporter family","Sigma receptors","Anti-infective targets","Voltage-gated ion channels","SLC superfamily of solute carriers","Catalytic receptors","Eicosanoid turnover","1.14
.11.- Histone demethylases","1F. Retinoic acid-related orphans","CYP3 family","Steroid hormone receptors","CYP2 family: drug metabolising subset","CYP1 family","Glycoprotein hormone receptors","CMGC: 
Containing CDK",MAPK,GSK3,"CLK families",Adrenoceptors,"ABCB subfamily","Viral protein targets","G protein-coupled estrogen receptor","Bradykinin receptors","Potassium channels","3B. Estrogen-related 
receptors",CYP5,"CYP7 and CYP8 families","5-Hydroxytryptamine receptors",Atypical,"Adenosine receptors","Melanocortin receptors","Acetylcholine receptors (muscarinic)","Opioid receptors","SLC6 neurotr
ansmitter transporter family","Receptor kinases",Cyclooxygenase,"Tachykinin receptors","Dopamine receptors","Histamine receptors","3A. Estrogen receptors","Mitogen-activated protein kinases (MAP kinas
es)","Coronavirus (CoV) proteins","3C. 3-Ketosteroid receptors","Voltage-gated potassium channels","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","Monoamine transporter subfamily","TK
: Tyrosine kinase","ERK subfamily","FRAP subfamily","Non-receptor tyrosine kinases (nRTKs)","Receptor tyrosine kinases (RTKs)","JNK subfamily","Src family","Type I RTKs: ErbB (epidermal growth factor)
 receptor family"}

> <pathway_reactome>
{"Gene expression (Transcription)","Cell Cycle",Metabolism,"Signal Transduction","Immune System","Cellular responses to external stimuli",Disease,"DNA Repair",Hemostasis,"Developmental Biology","Neuro
nal System","Vesicle-mediated transport","Muscle contraction","Metabolism of proteins","RNA Polymerase II Transcription","Cell Cycle Checkpoints","Metabolism of lipids","Intracellular signaling by sec
ond messengers","Cytokine Signaling in Immune system","Cellular responses to stress","Biological oxidations",Mitotic,"Infectious disease","DNA Double-Strand Break Repair","Platelet activation","signal
ing and aggregation","Nervous system development","Innate Immune System","Metabolism of amino acids and derivatives","Signaling by GPCR","Abacavir transport and metabolism","Transmission across Chemic
al Synapses","Membrane Trafficking","Cardiac conduction","Metabolism of vitamins and cofactors","Disorders of transmembrane transporters","Post-translational protein modification","Generic Transcripti
on Pathway","G1/S DNA Damage Checkpoints","Biosynthesis of specialized proresolving mediators (SPMs)","PIP3 activates AKT signaling","Signaling by Interleukins","Cellular response to hypoxia","Phase I
 - Functionalization of compounds","Mitotic G1 phase and G1/S transition","Leishmania infection","Uptake and actions of bacterial toxins","Homology Directed Repair","Platelet Aggregation (Plug Formati
on)","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Toll-like Receptor Cascades","M Phase","Branched-chain amino acid catabolism","GPCR ligand binding","Abacavir transmembrane trans
port","SARS-CoV Infections","Metabolism of steroids","Neurotransmitter receptors and postsynaptic signal transmission","trans-Golgi Network Vesicle Budding","Phase 3 - rapid repolarisation","GPCR down
stream signalling","Metabolism of water-soluble vitamins and cofactors","SLC transporter disorders","HIV Infection","Axon guidance","Fatty acid metabolism","Neurotransmitter clearance",SUMOylation,"Tr
anscriptional regulation by RUNX3","p53-Dependent G1/S DNA damage checkpoint","Biosynthesis of DHA-derived SPMs","Negative regulation of the PI3K/AKT network","Interleukin-1 family signaling","Oxygen-
dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Cytochrome P450 - arranged by substrate type","G1/S Transition","Leishmania parasite growth and survival","Ethanol oxidation","Uptak
e and function of anthrax toxins","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Transcriptional regulation by RUNX1","Transcriptional Regulation by MECP2","Toll Like R
eceptor 5 (TLR5) Cascade","Mitotic Metaphase and Anaphase","Transcriptional Regulation by TP53","Class A/1 (Rhodopsin-like receptors)","Potential therapeutics for SARS","SARS-CoV-1 Infection","Cholest
erol biosynthesis","Transcriptional regulation by RUNX2","Activation of NMDA receptors and postsynaptic events","Golgi Associated Vesicle Biogenesis","Nuclear Receptor transcription pathway","G alpha 
(i) signalling events","Vitamins B6 activation to pyridoxal phosphate","Bile acid and bile salt metabolism","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Host Interactions of HIV 
factors","Semaphorin interactions","Arachidonic acid metabolism","Serotonin clearance from the synaptic cleft","SUMO E3 ligases SUMOylate target proteins","Defective SLC6A2 causes orthostatic intolera
nce (OI)","G alpha (q) signalling events","RUNX3 Regulates Immune Response and Cell Migration","p53-Dependent G1 DNA Damage Response","Biosynthesis of maresins",PI5P,"PP2A and IER3 Regulate PI3K/AKT S
ignaling","Interleukin-1 signaling",Xenobiotics,"Activation of the pre-replicative complex","Anti-inflammatory response favouring Leishmania parasite infection","HDR through Homologous Recombination (
HRR)","RUNX1 regulates estrogen receptor mediated transcription","Regulation of MECP2 expression and activity","MyD88 cascade initiated on plasma membrane","Mitotic Anaphase","Regulation of TP53 Activ
ity","Amine ligand-binding receptors","SARS-CoV-1 Genome Replication and Transcription","Peptide ligand-binding receptors","Cholesterol biosynthesis via desmosterol","RUNX2 regulates bone development"
,"Post NMDA receptor activation events","Opioid Signalling",Eicosanoids,"Nucleotide-like (purinergic) receptors","MECP2 regulates neuronal receptors and channels","Synthesis of bile acids and bile sal
ts","The role of Nef in HIV-1 replication and disease pathogenesis","Sema4D in semaphorin signaling","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","SUMOylation of intracellular receptors","
Regulation of RUNX2 expression and activity","Gastrin-CREB signalling pathway via PKC and MAPK","Stabilization of p53","Biosynthesis of maresin-like SPMs","MAP3K8 (TPL2)-dependent MAPK1/3 activation",
"CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","ADORA2B mediated anti-inflammatory cytokines production","Homologous DNA Pairing and Strand Exchange","MAP kinase
 activation","Nuclear Envelope (NE) Reassembly","Regulation of TP53 Activity through Methylation",Adrenoceptors,"Replication of the SARS-CoV-1 genome","RUNX2 regulates osteoblast differentiation","Act
ivation of AMPK downstream of NMDARs","DARPP-32 events","Serotonin receptors","Regulation of TP53 Expression and Degradation","Adenosine P1 receptors","Muscarinic acetylcholine receptors","Synthesis o
f bile acids and bile salts via 7alpha-hydroxycholesterol","Nef and signal transduction","Sema4D induced cell migration and growth-cone collapse","Nef-mediates down modulation of cell surface receptor
s by recruiting them to clathrin adapters","G-protein activation","Tachykinin receptors bind tachykinins","Dopamine receptors","EGFR Transactivation by Gastrin","Autodegradation of the E3 ubiquitin li
gase COP1","Presynaptic phase of homologous DNA pairing and strand exchange","MAPK targets/ Nuclear events mediated by MAP kinases","Initiation of Nuclear Envelope (NE) Reformation","Regulation of TP5
3 Degradation","Nef Mediated CD4 Down-regulation","ERK/MAPK targets","Activation of the AP-1 family of transcription factors","ERKs are inactivated"}

> <broad_targets>
{EBP,ESR1,ESR2,GPER1,PRKCA,PRKCB,PRKCD,PRKCE,PRKCG,PRKCI,PRKCQ,PRKCZ}

> <broad_moa>
{"estrogen receptor antagonist","selective estrogen receptor modulator (SERM)"}

> <synonyms>
{"2-(4-(1,2-diphenylbut-1-enyl)phenoxy)-N,N-dimethylethanamine","2(4(1,2diphenylbut1enyl)phenoxy)N,Ndimethylethanamine","ICI 46474;(Z)-Tamoxifen (Citrate);trans-Tamoxifen (Citrate)","ICI 46474;(Z)Tamo
xifen (Citrate);transTamoxifen (Citrate)",7728-73-6,7728736,157698-32-3,157698323,"Tamoxifen Impurity E",Spectrum_001028,Spectrum001028,Spectrum-001028,"Spectrum 001028",Prestwick0_000146,Prestwick000
0146,Prestwick0-000146,"Prestwick0 000146",Prestwick1_000146,Prestwick1000146,Prestwick1-000146,"Prestwick1 000146",Spectrum2_000889,Spectrum2000889,Spectrum2-000889,"Spectrum2 000889",Spectr,SAM00270
3133,CPD001491671}

> <pdid>
PD002854

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5376}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 29  0  0  1  0            999 V2000
    2.5981    0.0000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -0.3115    2.9665    0.0000 C   0  0
   -1.8032    3.1233    0.0000 N   0  0
   -2.4133    1.7530    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    1.2990   -3.7500    0.0000 C   0  0
    2.5981   -3.0000    0.0000 C   0  0  2  0  0  0
    2.5981   -1.5000    0.0000 C   0  0  2  0  0  0
    3.8971   -0.7500    0.0000 C   0  0
    5.1962   -1.5000    0.0000 C   0  0
    5.1962   -3.0000    0.0000 C   0  0  1  0  0  0
    6.1061   -2.5853    0.0000 C   0  0
    3.8971   -3.7500    0.0000 C   0  0  1  0  0  0
    4.2297   -5.2071    0.0000 C   0  0
    5.7224   -5.3544    0.0000 C   0  0
    6.3238   -3.9802    0.0000 C   0  0  2  0  0  0
    6.6076   -3.0213    0.0000 O   0  0
    7.3163   -5.0884    0.0000 C   0  0
    8.3343   -6.1901    0.0000 C   0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  4  2  0
  8  9  1  0
  9 10  2  3
 10  2  1  0
 10 11  1  0
 11 12  1  0
 13 12  1  6
 13 14  1  0
 14  2  1  0
 14 15  1  1
 15 16  1  0
 16 17  1  0
 17 18  1  1
 17 19  1  0
 19 13  1  0
 19 20  1  1
 20 21  1  0
 21 22  1  0
 22 17  1  0
 22 23  1  1
 22 24  1  0
 24 25  3  0
M  END
> <name>
NIHCC_2014

> <id>
6214

> <plate>
NGP-202-02

> <well>
G05

> <supplier_cmpd_name>
CPD000058321

> <ctcr_id>
1968

> <supplier_cmpd_id>
SAM002564203

> <smiles>
C[C@]12Cc3cnoc3C=C1CC[C@@H]4[C@@H]2CC[C@@]5(C)[C@H]4CC[C@@]5(O)C#C

> <pd_targets>
{PGR,AR,CYP2C8,CYP2J2,ABCB11,CYP2D6,SHBG,CYP2C9,ADRA2A,OPRM1,SLC6A4,ADORA3,ADRA2C,OPRK1,ADRA2B,DRD3,SLC6A3,NR3C1,HTR2A,SLC6A2,ESR1,ADRB3,CHRM3,TACR2,GNRHR,GNRHR2,CCL2,LMNA,MAPT,BLM,NPSR1,GMNN,FTL,PMP2
2}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,Transporter,"Secreted protein","Membrane receptor","Other nuclear protein","Other cytosolic protein","Unclassified protein","Nuclear receptor","Cytochrome P450","Primary
 active transporter","Family A G protein-coupled receptor","Electrochemical transporter","Nuclear hormone receptor subfamily 3","Cytochrome P450 family 2","ATP-binding cassette","Small molecule recept
or (family A GPCR)","Peptide receptor (family A GPCR)","SLC superfamily of solute carriers","Nuclear hormone receptor subfamily 3 group C","Cytochrome P450 family 2C","ABCB subfamily","Cytochrome P450
 family 2D","Monoamine receptor","Short peptide receptor (family A GPCR)","SLC06 neurotransmitter transporter family","Nucleotide-like receptor (family A GPCR)","Nuclear hormone receptor subfamily 3 g
roup A","Chemokine receptor","Nuclear hormone receptor subfamily 3 group C member 3","Nuclear hormone receptor subfamily 3 group C member 4","Cytochrome P450 2C8","Cytochrome P450 2D6","Cytochrome P45
0 2C9","Adrenergic receptor","Opioid receptor","Adenosine receptor","Dopamine receptor","Nuclear hormone receptor subfamily 3 group C member 1","Serotonin receptor","Nuclear hormone receptor subfamily
 3 group A member 1","Acetylcholine receptor","Neurokinin receptor","GnRH receptor","CC chemokine receptor","Neuropeptide receptor"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Nuclear hormone receptors","Cytochrome P450","ATP-binding cassette transporter family","G protein-coupled receptors","SLC superfamily of solute carriers","Steroid horm
one receptors","CYP2 family: drug metabolising subset","ABCB subfamily",Adrenoceptors,"Opioid receptors","SLC6 neurotransmitter transporter family","Adenosine receptors","Dopamine receptors","5-Hydrox
ytryptamine receptors","Acetylcholine receptors (muscarinic)","Tachykinin receptors","Gonadotrophin-releasing hormone receptors","Neuropeptide S receptor","3C. 3-Ketosteroid receptors","Monoamine tran
sporter subfamily","3A. Estrogen receptors"}

> <pathway_reactome>
{"Gene expression (Transcription)",Metabolism,"Signal Transduction","Neuronal System",Disease,"Metabolism of proteins","Cell Cycle","DNA Repair","Vesicle-mediated transport","Developmental Biology","R
NA Polymerase II Transcription","Biological oxidations","Metabolism of lipids","Signaling by GPCR","Transmission across Chemical Synapses","Disorders of transmembrane transporters","Infectious disease
","Post-translational protein modification",Mitotic,"DNA Double-Strand Break Repair","Membrane Trafficking","Nervous system development","Generic Transcription Pathway","Phase I - Functionalization of
 compounds","Metabolism of steroids","GPCR ligand binding","GPCR downstream signalling","Neurotransmitter clearance","SLC transporter disorders","Leishmania infection",SUMOylation,"M Phase","Neurotran
smitter receptors and postsynaptic signal transmission","Homology Directed Repair","Mitotic G1 phase and G1/S transition","trans-Golgi Network Vesicle Budding","EGR2 and SOX10-mediated initiation of S
chwann cell myelination","Transcriptional regulation by RUNX2","Cytochrome P450 - arranged by substrate type","Bile acid and bile salt metabolism","Class A/1 (Rhodopsin-like receptors)","G alpha (i) s
ignalling events","Serotonin clearance from the synaptic cleft","Transcriptional Regulation by MECP2","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","FOXO-mediated transcription","D
efective SLC6A2 causes orthostatic intolerance (OI)","Transcriptional regulation by RUNX1","Leishmania parasite growth and survival","SUMO E3 ligases SUMOylate target proteins","Mitotic Metaphase and 
Anaphase","Activation of NMDA receptors and postsynaptic events","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","G1/S Transition","Golgi Associated Vesicle Biogenesis","
RUNX2 regulates bone development",Xenobiotics,"Fatty acids","Synthesis of bile acids and bile salts","Amine ligand-binding receptors","Opioid Signalling","Nucleotide-like (purinergic) receptors","MECP
2 regulates neuronal receptors and channels","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","RUNX1 regulates estrogen receptor mediated transcription","Anti-inflammat
ory response favouring Leishmania parasite infection","Peptide ligand-binding receptors","SUMOylation of intracellular receptors","Hormone ligand-binding receptors","Mitotic Anaphase","Post NMDA recep
tor activation events","HDR through Homologous Recombination (HRR)","Activation of the pre-replicative complex","RUNX2 regulates osteoblast differentiation","CYP2E1 reactions","Synthesis of bile acids
 and bile salts via 7alpha-hydroxycholesterol",Adrenoceptors,"G-protein activation","Adenosine P1 receptors","Dopamine receptors","Serotonin receptors","ADORA2B mediated anti-inflammatory cytokines pr
oduction","Muscarinic acetylcholine receptors","Tachykinin receptors bind tachykinins","Chemokine receptors bind chemokines","Nuclear Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs
","Homologous DNA Pairing and Strand Exchange","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{AR,CCL2,ESR1,GNRHR,GNRHR2,PGR}

> <broad_moa>
{"estrogen receptor antagonist","progesterone receptor agonist"}

> <synonyms>
{RESTW10,danazol,Danocrine,17230-88-5,17230885,Chronogyn,Danol,Winobanin,Cyclomen,Danazolum,Ladogal,Danzol,UNII-N29QWW3BUO,UNIIN29QWW3BUO,WIN-17757,WIN17757,"WIN 17,757",Danazole,N29QWW3BUO,"WIN 17757
",Danovaol,CHEBI:4315,Danokrin,NCGC00164400-01,NCGC0016440001,Danogen,DSSTox_CID_2880,DSSToxCID2880,DSSTox-CID-2880,"DSSTox CID 2880","Danazolum (INN",T1480,SAM002564203,Prestw-105,Danazol,CPD00005832
1}

> <pdid>
PD002395

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{28417}

$$$$
NIHCC_2014
  SciTegic11012413002D

 18 18  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 O   0  0
   -2.5951   -3.0039    0.0000 C   0  0
   -3.8933   -3.7570    0.0000 C   0  0
   -3.8912   -5.2578    0.0000 C   0  0
   -5.1894   -6.0109    0.0000 C   0  0
   -6.4897   -5.2632    0.0000 C   0  0
   -5.1922   -4.5109    0.0000 C   0  0
   -5.1872   -7.5117    0.0000 C   0  0
   -3.8869   -8.2595    0.0000 O   0  0
   -6.4847   -8.2644    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 12 15  1  0
 15 16  1  0
 15 17  2  0
  7 18  2  0
 18  2  1  0
M  END
> <name>
NIHCC_2014

> <id>
6215

> <plate>
NGP-202-02

> <well>
G06

> <supplier_cmpd_name>
CPD000058393

> <ctcr_id>
1112

> <supplier_cmpd_id>
SAM002564211

> <smiles>
Cc1ccc(C)c(OCCCC(C)(C)C(O)=O)c1

> <pd_targets>
{CYP2C9,CYP2C8,FABP1,RORC,PPARA,TTR,CISD1,TSHR,SMN1,CYP1A2,SLCO1B1,SLCO1B3,SLCO2B1,SLC22A8}

> <pathway_gtopdb>
{Enzyme,"Auxiliary transport protein","Transcription factor","Secreted protein","Unclassified protein","Membrane receptor","Epigenetic regulator",Transporter,"Cytochrome P450","Fatty acid binding prot
ein family","Nuclear receptor","Family A G protein-coupled receptor",Reader,"Electrochemical transporter","Cytochrome P450 family 2","Nuclear hormone receptor subfamily 1","Peptide receptor (family A 
GPCR)","Methyl-lysine/arginine binding protein","Cytochrome P450 family 1","SLC superfamily of solute carriers","Cytochrome P450 family 2C","Nuclear hormone receptor subfamily 1 group F","Nuclear horm
one receptor subfamily 1 group C","Glycohormone receptor","Tudor domain","Cytochrome P450 family 1A","SLC21/SLCO family of organic anion transporting polypeptides","SLC22 family of organic cation and 
anion transporters","Cytochrome P450 2C9","Cytochrome P450 2C8","Nuclear hormone receptor subfamily 1 group F member 3","Nuclear hormone receptor subfamily 1 group C member 1","Cytochrome P450 1A1"}

> <pathway_chembl>
{Enzymes,"Other protein targets",Receptors,Transporters,"Cytochrome P450","Fatty acid-binding proteins","Nuclear hormone receptors",Transthyretin,"G protein-coupled receptors","SLC superfamily of solu
te carriers","CYP2 family: drug metabolising subset","1F. Retinoic acid-related orphans","1C. Peroxisome proliferator-activated receptors","Glycoprotein hormone receptors","CYP1 family","SLCO family o
f organic anion transporting polypeptides","SLC22 family of organic cation and anion transporters","Organic anion transporters (OATs)"}

> <pathway_reactome>
{Metabolism,"Gene expression (Transcription)","Signal Transduction",Disease,"Metabolism of RNA","Transport of small molecules","Biological oxidations","Metabolism of lipids","RNA Polymerase II Transcr
iption","Signaling by GPCR","Infectious disease","Metabolism of non-coding RNA","SLC-mediated transmembrane transport","Phase I - Functionalization of compounds","Regulation of lipid metabolism by PPA
Ralpha","Generic Transcription Pathway","Metabolism of steroids","GPCR downstream signalling","Leishmania infection","snRNP Assembly","Transport of vitamins",nucleosides,"and related molecules","Trans
port of bile salts and organic acids","metal ions and amine compounds","Cytochrome P450 - arranged by substrate type","PPARA activates gene expression","Transcriptional regulation by RUNX3","Regulatio
n of cholesterol biosynthesis by SREBP (SREBF)","G alpha (i) signalling events","Leishmania parasite growth and survival","Bile acid and bile salt metabolism","Transport of organic anions","Organic ca
tion/anion/zwitterion transport",Xenobiotics,"RUNX3 Regulates Immune Response and Cell Migration","Activation of gene expression by SREBF (SREBP)","Visual phototransduction","Anti-inflammatory respons
e favouring Leishmania parasite infection","Recycling of bile acids and salts","Organic anion transport","CYP2E1 reactions","The canonical retinoid cycle in rods (twilight vision)","ADORA2B mediated a
nti-inflammatory cytokines production","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2"}

> <broad_targets>
{LPL,PPARA,SLCO1B1,SLCO1B3,SLCO2B1}

> <broad_moa>
{"lipoprotein lipase activator"}

> <synonyms>
{RESTW21,gemfibrozil,25812-30-0,25812300,"5-(2,5-Dimethylphenoxy)-2,2-dimethylpentanoic acid","5(2,5Dimethylphenoxy)2,2dimethylpentanoic acid",Lopid,Jezil,Lipur,CI-719,CI719,Clearol,Gemfibrozilo,Gemfi
brozilum,Gen-Fibro,GenFibro,"2,2-Dimethyl-5-(2,5-xylyloxy)valeric acid","2,2Dimethyl5(2,5xylyloxy)valeric acid","Pentanoic acid",5-(2,5(2,5-dimethylphenoxy)-2,5dimethylphenoxy)2,2-dimethyl-,2dimethyl,
T1415,SAM002564211,1500313,Prestw-214,Gemfibrozil,CPD000058393,GEMFIBROZIL}

> <pdid>
PD002321

> <targets>
{Cytochrome P450,PPAR}

> <classes>
{antihyperlipoproteinemic,Cell Cycle/DNA Damage,Metabolic Enzyme/Protease}

> <pubchem_cids>
{3463}

$$$$
NIHCC_2014
  SciTegic11012413002D

 19 18  0  0  0  0            999 V2000
    5.0973   -2.2539    0.0000 Cl  0  0
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5973    1.5031    0.0000 O   0  0
   -2.5951    3.0031    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 C   0  0
   -3.8976   -0.7554    0.0000 O   0  0
   -2.5951   -3.0039    0.0000 C   0  0
   -3.8933   -3.7570    0.0000 N   0  0
   -3.8912   -5.2578    0.0000 C   0  0
   -2.5908   -6.0056    0.0000 O   0  0
   -5.1894   -6.0109    0.0000 C   0  0
   -5.1872   -7.5109    0.0000 N   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  7 10  1  0
 10 11  2  0
 11  4  1  0
 10 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
M  END
> <name>
NIHCC_2014

> <id>
6216

> <plate>
NGP-202-02

> <well>
G07

> <supplier_cmpd_name>
CPD000058833

> <ctcr_id>
590

> <supplier_cmpd_id>
SAM002564219

> <smiles>
Cl.COc1ccc(OC)c(c1)C(O)CNC(=O)CN

> <pd_targets>
{AMPC,ADRA1A,ADRA1B,ADRA1D}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor",Hydrolase,"Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Adrenergic receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors",Adrenoceptors}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Amine ligand-binding receptors",Adrenoceptors}

> <broad_targets>
{}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{AKOS026750147,"MIDODRINE HYDROCHLORIDE",3092-17-9,3092179,Pro-Amatine,ProAmatine,"Midodrine HCL",43218-56-0,43218560,"Midodrine (hydrochloride)","(+-)-Midodrine hydrochloride","(+)Midodrine hydrochlo
ride","St. Peter 224",(+/-)-Midodrin,(+/)Midodrin,"A-4020 Linz","A4020 Linz","St 1085 (as the base)",(+/-)-Midodri,(+/)Midodri,T1577,SAM002564219,1503257,Prestw-191,"Midodrine hydrochloride",CPD000058
833}

> <pdid>
PD010170

> <targets>
{}

> <classes>
{antihypertensive,vasoconstrictor}

> <pubchem_cids>
{11426313,25137866,18340}

$$$$
NIHCC_2014
  SciTegic11012413002D

 14 13  0  0  0  0            999 V2000
    7.6943   -1.8789    0.0000 Br  0  5
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    5.1937   -3.0093    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2948   -3.7516    0.0000 O   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  3
   -2.5981   -1.5000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14  8  1  0
M  CHG  2   1  -1  12   1
M  END
> <name>
NIHCC_2014

> <id>
6217

> <plate>
NGP-202-02

> <well>
G08

> <supplier_cmpd_name>
CPD000058605

> <ctcr_id>
2588

> <supplier_cmpd_id>
SAM002564227

> <smiles>
[Br-].CN(C)C(=O)Oc1ccc[n+](C)c1

> <pd_targets>
{BCHE,ACHE,TSHR,CHRM1,IMPA1,GLA,NFO,RORC,LMNA}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Transcription factor","Other nuclear protein",Hydrolase,"Family A G protein-coupled receptor","Nuclear receptor","Peptide receptor (family A GPCR)","Small molecule recepto
r (family A GPCR)","Nuclear hormone receptor subfamily 1","Glycohormone receptor","Monoamine receptor","Nuclear hormone receptor subfamily 1 group F","Acetylcholine receptor","Nuclear hormone receptor
 subfamily 1 group F member 3"}

> <pathway_chembl>
{Enzymes,Receptors,"Acetylcholine turnover","G protein-coupled receptors","Inositol phosphate turnover","Nuclear hormone receptors","Glycoprotein hormone receptors","Acetylcholine receptors (muscarini
c)","Inositol monophosphatase","1F. Retinoic acid-related orphans"}

> <pathway_reactome>
{Metabolism,Disease,"Signal Transduction","Gene expression (Transcription)","Cell Cycle","Metabolism of lipids","Infectious disease","Signaling by GPCR","Inositol phosphate metabolism","RNA Polymerase
 II Transcription",Mitotic,"Phospholipid metabolism","Leishmania infection","GPCR ligand binding","Synthesis of IP2",IP,"and Ins in the cytosol","Sphingolipid metabolism","Generic Transcription Pathwa
y","M Phase","Glycerophospholipid biosynthesis","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Glycosphingolipid metabolism","Transcriptional regulation by RUNX3","M
itotic Metaphase and Anaphase","Synthesis of PC","Anti-inflammatory response favouring Leishmania parasite infection","Amine ligand-binding receptors","RUNX3 Regulates Immune Response and Cell Migrati
on","Mitotic Anaphase","ADORA2B mediated anti-inflammatory cytokines production","Muscarinic acetylcholine receptors","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformatio
n"}

> <broad_targets>
{ACHE,BCHE}

> <broad_moa>
{"cholinesterase inhibitor"}

> <synonyms>
{Kalimin,Kalymin,Mestinon,Regonal,"Mestinon bromide","Ro 1-5130","Ro 15130","3-(Dimethylcarbamyloxy)-1-methylpyridinium bromide","3(Dimethylcarbamyloxy)1methylpyridinium bromide","1-Methyl-3-hydroxypy
ridinium bromide dimethylcarbamate","1Methyl3hydroxypyridinium bromide dimethylcarbamate","3-Hydroxy-1-methylpyridinium bromide dimethylcarbamate","3Hydroxy1methylpyridinium bromide dimethylcarbamate"
,Dimethylca,S1608,SAM002564227,1503240,"Pyridostigmine Bromide",CPD000058605,"PYRIDOSTIGMINE BROMIDE"}

> <pdid>
PD010140

> <targets>
{Others}

> <classes>
{cholinergic,"Neuronal Signaling"}

> <pubchem_cids>
{91696191,7550}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 22  0  0  0  0            999 V2000
   -0.0041   -2.9953    0.0000 C   0  0
    1.2925   -3.7494    0.0000 C   0  0
    2.5951   -3.0039    0.0000 N   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    5.1937   -3.0093    0.0000 O   0  0
    3.8912   -5.2578    0.0000 C   0  0
    2.5886   -6.0033    0.0000 C   0  0
    1.2919   -5.2492    0.0000 O   0  0
    5.1894   -6.0109    0.0000 C   0  0
    5.1895   -7.5109    0.0000 C   0  0
    6.4885   -8.2610    0.0000 C   0  0
    7.7875   -7.5110    0.0000 C   0  0
    7.7876   -6.0110    0.0000 C   0  0
    6.4885   -5.2610    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  3 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 13 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
M  END
> <name>
NIHCC_2014

> <id>
6218

> <plate>
NGP-202-02

> <well>
G09

> <supplier_cmpd_name>
CPD000058523

> <ctcr_id>
1400

> <supplier_cmpd_id>
SAM002564235

> <smiles>
CCN(Cc1ccncc1)C(=O)C(CO)c2ccccc2

> <pd_targets>
{CHRM5,MAPT,BLM,CHRM4,CHRM2,CHRM3,NFO,CYP2C19,CYP2C9,CHRM1,TSHR,HSD17B10,CYP3A4,NFKB1,CYP1A2,LEF,LMNA}

> <pathway_gtopdb>
{"Membrane receptor","Other cytosolic protein",Enzyme,"Other nuclear protein","Family A G protein-coupled receptor",Hydrolase,"Cytochrome P450",Oxidoreductase,Protease,"Small molecule receptor (family
 A GPCR)","Cytochrome P450 family 2","Peptide receptor (family A GPCR)","Cytochrome P450 family 3","Cytochrome P450 family 1","Metallo protease","Monoamine receptor","Cytochrome P450 family 2C","Glyco
hormone receptor","Cytochrome P450 family 3A","Cytochrome P450 family 1A","Metallo protease MAE clan","Acetylcholine receptor","Cytochrome P450 2C19","Cytochrome P450 2C9","Cytochrome P450 3A4","Cytoc
hrome P450 1A1","Metallo protease M34 family"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Cytochrome P450","Acetylcholine receptors (muscarinic)","CYP2 family: drug metabolising subset","Glycoprotein hormone receptors","CYP3 family","CYP1 f
amily"}

> <pathway_reactome>
{"Signal Transduction","Neuronal System","DNA Repair",Metabolism,Disease,"Immune System","Cell Cycle","Signaling by GPCR","Transmission across Chemical Synapses","DNA Double-Strand Break Repair","Biol
ogical oxidations","Infectious disease","Metabolism of amino acids and derivatives","Metabolism of lipids","Cytokine Signaling in Immune system",Mitotic,"GPCR ligand binding","Neurotransmitter recepto
rs and postsynaptic signal transmission","Homology Directed Repair","Phase I - Functionalization of compounds","Leishmania infection","Branched-chain amino acid catabolism","Biosynthesis of specialize
d proresolving mediators (SPMs)","Signaling by Interleukins","Uptake and actions of bacterial toxins","M Phase","Class A/1 (Rhodopsin-like receptors)","Activation of NMDA receptors and postsynaptic ev
ents","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Cytochrome P450 - arranged by substrate type","Leishmania parasite growth and survival","Biosynthesis of DHA-derive
d SPMs","Interleukin-1 family signaling","Uptake and function of anthrax toxins","Mitotic Metaphase and Anaphase","Amine ligand-binding receptors","Post NMDA receptor activation events","HDR through H
omologous Recombination (HRR)",Xenobiotics,"Anti-inflammatory response favouring Leishmania parasite infection","Biosynthesis of maresins","Interleukin-1 signaling","Mitotic Anaphase","Muscarinic acet
ylcholine receptors","Activation of AMPK downstream of NMDARs","Homologous DNA Pairing and Strand Exchange","CYP2E1 reactions","ADORA2B mediated anti-inflammatory cytokines production","Biosynthesis o
f maresin-like SPMs","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Nuclear Envelope (NE) Reassembly","Presynaptic phase of homologous
 DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{CHRM3,CHRM4}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{1508-75-4,1508754,Mydriacyl,Mydriaticum,N-ethyl-3-hydroxy-2-phenyl-N-(pyridin-4-ylmethyl)propanamide,Nethyl3hydroxy2phenylN(pyridin4ylmethyl)propanamide,Tropicamidum,"Ro 1-7683","Ro 17683",N-Ethyl-2-
phenyl-N-(4-pyridylmethyl)hydracrylamide,NEthyl2phenylN(4pyridylmethyl)hydracrylamide,Mydriafair,Tropicacyl,"Minims tropicamide",Bistropamide,Epitro,T1281,S1913,SAM002564235,1500599,Prestw-228,Tropica
mide,CPD000058523,TROPICAMIDE}

> <pdid>
PD002097

> <targets>
{AChR}

> <classes>
{"anticholinergic (opthalmic)","Neuronal Signaling"}

> <pubchem_cids>
{5593}

$$$$
NIHCC_2014
  SciTegic11012413002D

 60 62  0  0  0  0            999 V2000
   -7.7836   -6.0202    0.0000 C   0  0
   -7.7866   -4.5202    0.0000 C   0  0
   -6.4889   -3.7663    0.0000 O   0  0
   -6.4919   -2.2655    0.0000 C   0  0
   -7.7927   -1.5185    0.0000 O   0  0
   -5.1942   -1.5116    0.0000 C   0  0
   -5.1972   -0.0108    0.0000 C   0  0
   -3.8995    0.7431    0.0000 C   0  0
   -2.5987   -0.0038    0.0000 O   0  0
   -3.9026    2.2439    0.0000 O   0  0
   -2.6048    2.9978    0.0000 C   0  0
   -2.6058    4.4978    0.0000 C   0  0
   -1.3072    5.2487    0.0000 C   0  0
   -0.0077    4.4995    0.0000 C   0  0
    1.2909    5.2503    0.0000 C   0  0
   -0.0067    2.9995    0.0000 O   0  0
   -1.3053    2.2486    0.0000 C   0  0
   -1.3013    0.7478    0.0000 O   0  0
    0.0000    0.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -1.2989   -2.2502    0.0000 C   0  0
    1.3000   -2.2500    0.0000 C   0  0
    1.3031   -3.7508    0.0000 O   0  0
    0.0054   -4.5047    0.0000 C   0  0
    0.0062   -6.0048    0.0000 C   0  0
   -1.2923   -6.7556    0.0000 C   0  0
   -2.6089   -7.4744    0.0000 C   0  0
    0.0081   -7.4632    0.0000 O   0  0
    0.0836   -8.9613    0.0000 C   0  0
   -2.5918   -6.0065    0.0000 C   0  0
   -3.8904   -6.7573    0.0000 O   0  0
   -2.5928   -4.5065    0.0000 C   0  0
   -3.8923   -3.7573    0.0000 C   0  0
   -1.2943   -3.7556    0.0000 O   0  0
    2.6000   -1.5000    0.0000 C   0  0
    2.6000    0.0000    0.0000 C   0  0
    3.9000   -2.2500    0.0000 C   0  0
    3.9000   -3.7500    0.0000 O   0  0
    5.2000   -1.5000    0.0000 O   0  0
    6.5000   -2.2500    0.0000 C   0  0
    6.4969   -3.7508    0.0000 C   0  0
    5.1968   -4.4990    0.0000 C   0  0
    7.8000   -1.5000    0.0000 C   0  0
    7.7644   -2.9996    0.0000 C   0  0
    9.0812   -0.7199    0.0000 O   0  0
    7.8000    0.0000    0.0000 C   0  0
    9.0989    0.7502    0.0000 O   0  0
    6.5000    0.7500    0.0000 C   0  0
    6.5000    2.2500    0.0000 C   0  0
    5.2000    0.0000    0.0000 C   0  0
    5.2000   -1.5000    0.0000 O   0  0
    3.9000    0.7500    0.0000 C   0  0
    3.9000    2.2500    0.0000 C   0  0
    2.6000    0.0000    0.0000 C   0  0
    1.3000    0.7500    0.0000 C   0  0
   -0.0164    1.4691    0.0000 C   0  0
    2.6163    1.4692    0.0000 O   0  0
   -3.9045    5.2501    0.0000 N   0  0
   -3.9033    6.7501    0.0000 C   0  0
   -5.2043    4.5015    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 17 11  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 26 28  1  0
 28 29  1  0
 26 30  1  0
 30 31  1  0
 30 32  1  0
 32 33  1  0
 32 34  1  0
 34 24  1  0
 22 35  1  0
 35 36  1  0
 35 37  1  0
 37 38  2  0
 37 39  1  0
 39 40  1  0
 40 41  1  0
 41 42  1  0
 40 43  1  0
 43 44  1  0
 43 45  1  0
 43 46  1  0
 46 47  1  0
 46 48  1  0
 48 49  1  0
 48 50  1  0
 50 51  2  0
 50 52  1  0
 52 53  1  0
 52 54  1  0
 54 55  1  0
 55 19  1  0
 55 56  1  0
 55 57  1  0
 12 58  1  0
 58 59  1  0
 58 60  1  0
M  END
> <name>
NIHCC_2014

> <id>
6219

> <plate>
NGP-202-02

> <well>
G10

> <supplier_cmpd_name>
CPD001491659

> <ctcr_id>
7033

> <supplier_cmpd_id>
SAM002564242

> <smiles>
CCOC(=O)CCC(=O)OC1C(CC(C)OC1OC2C(C)C(OC3CC(C)(OC)C(O)C(C)O3)C(C)C(=O)OC(CC)C(C)(O)C(O)C(C)C(=O)C(C)CC2(C)O)N(C)C

> <pd_targets>
{AMPC,RECD,SLCO1B3,SLCO1B1}

> <pathway_gtopdb>
{Enzyme,Transporter,Hydrolase,"Electrochemical transporter","SLC superfamily of solute carriers","SLC21/SLCO family of organic anion transporting polypeptides"}

> <pathway_chembl>
{Transporters,"SLC superfamily of solute carriers","SLCO family of organic anion transporting polypeptides"}

> <pathway_reactome>
{Metabolism,"Metabolism of lipids","Metabolism of steroids","Bile acid and bile salt metabolism","Recycling of bile acids and salts"}

> <broad_targets>
{ABCB1,ALB,CYP3A4,CYP51A1,KCNH2,MLNR,SLC47A1}

> <broad_moa>
{"cytochrome P450 inhibitor","protein synthesis inhibitor"}

> <synonyms>
{"Erythromycin ethyl succinate",1264-62-6,1264626,"Erythromycin, 2'-(ethyl butanedioate)","Erythromycin, 2'(ethyl butanedioate)",ST075191,NCGC00183038-01,NCGC0018303801,CPD001491659,CHEMBL4550869,CHEB
I:94382,HMS3259M20,STK177309,AKOS005410741,MCULE-7434719386,MCULE7434719386,NC00597,SMP2_000005,SMP2000005,SMP2-000005,"SMP2 000005",FT-0625701,FT0625701,5,6-tetrahydr,6tetrahydr,T0474,SAM002564242,"E
rythromycin ethylsuccinate"}

> <pdid>
PD002346

> <targets>
{Antibiotic,Autophagy,Bacterial,HIV}

> <classes>
{Anti-infection,Autophagy}

> <pubchem_cids>
{3256}

$$$$
NIHCC_2014
  SciTegic11012413002D

 16 14  0  0  1  0            999 V2000
   11.4876   -2.6320    0.0000 Cl  0  5
    1.2948   -3.7516    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0  2  0  0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    5.1937   -3.0093    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    5.1894   -6.0109    0.0000 C   0  0
    6.4869   -6.7636    0.0000 C   0  0
    8.9876   -2.6320    0.0000 H   0  3
  3  2  1  6
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  3 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  3  0
M  CHG  2   1  -1  16   1
M  END
> <name>
NIHCC_2014

> <id>
6220

> <plate>
NGP-202-02

> <well>
G11

> <supplier_cmpd_name>
CPD000449328

> <ctcr_id>
3456

> <supplier_cmpd_id>
SAM002589926

> <smiles>
[Cl-].C[C@H](Cc1ccccc1)N(C)CC#C.[H+]

> <pd_targets>
{FTL,KDM4E,MAOA,MAOB,ITGA4,CYP1A2,MAPK1,CYP2B1,ADRA2A,ADRA2B}

> <pathway_gtopdb>
{"Unclassified protein","Epigenetic regulator",Enzyme,"Membrane receptor",Eraser,Oxidoreductase,"Cytochrome P450","Lysine demethylase","Cytochrome P450 family 1","Jumonji domain-containing","Cytochrom
e P450 family 1A","Cytochrome P450 1A1",Kinase,"Family A G protein-coupled receptor","Protein Kinase","Cytochrome P450 family 2","Small molecule receptor (family A GPCR)","CMGC protein kinase group","
Cytochrome P450 family 2B","Monoamine receptor","CMGC protein kinase MAPK family","Cytochrome P450 2B1","Adrenergic receptor","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Receptors,"Chromatin modifying enzymes","Catecholamine turnover","Catalytic receptors","Cytochrome P450","1.14.11.- Histone demethylases",Integrins,"CYP1 family","Kinases (EC 2.7.x.x)","G pro
tein-coupled receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK families",Adrenoceptors,"Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Vesicle-mediated transport",Metabolism,"Gene expression (Transcription)","Membrane Trafficking","Biological oxidations","RNA Polymerase II Transcription","trans-Golgi Network Vesicle Budding","Phase
 I - Functionalization of compounds","Generic Transcription Pathway","Golgi Associated Vesicle Biogenesis","Amine Oxidase reactions","Transcriptional regulation by RUNX3","Cytochrome P450 - arranged b
y substrate type","Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB","RUNX3 Regulates Immune Response and Cell Migration",Xenobiotics,"Aromatic amines can be N-hydroxylated or 
N-dealkylated by CYP1A2","Immune System","Signal Transduction","Innate Immune System","Signaling by GPCR","Toll-like Receptor Cascades","GPCR ligand binding","Toll Like Receptor 5 (TLR5) Cascade","Cla
ss A/1 (Rhodopsin-like receptors)","MyD88 cascade initiated on plasma membrane","Amine ligand-binding receptors","MAP kinase activation",Adrenoceptors,"MAPK targets/ Nuclear events mediated by MAP kin
ases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{MAOA,MAOB}

> <broad_moa>
{"monoamine oxidase inhibitor"}

> <synonyms>
{"(-)-( R)- N,a-Dimethyl- N-2-propynylphenethylamine hydrochloride","Selegiline hydrochloride",14611-52-0,Eldepryl,Zelapar,"(-)-Deprenyl hydrochloride","l-Deprenyl hydrochloride","Selegiline Hcl","(R)
-N-Methyl-N-(1-phenylpropan-2-yl)prop-2-yn-1-amine hydrochloride",Jumex,UNII-6W731X367Q,"R-(-)-Deprenyl (hydrochloride)","(-)-selegiline hydrochloride","(R)-(-)-Deprenyl hydrochloride",(-)-Phenylisopr
opylmethylpropynylamine,Otrasel,"R-(-)-Deprenyl hydrochloride",6W731X367Q,DSSTox_CID_24584,DSSTox_RID_80331,"Jumex hydrochloride",DSSTox_GSID_44584,"Eldepryl hydrochloride","Zydis selegiline",CHEBI:90
87,"(-)-Deprenil hydrochloride","(-)-E-250 hydrochloride",SMR000449328,"HSDB 7183",FPF1100,SR-01000597928,Plurimen,Seledat,Vivapryl,Xilopar,Ensam,"CCRIS 8571","(R)-(-)-N,alpha-Dimethyl-N-(2-propynyl)p
henethylamine hydrochloride",MFCD00069299,"Eldepryl (TN)",Prestwick_846,"Selegiline hydrochloride (USAN:USP)",E-250,"(-)-(R)-N,alpha-Dimethyl-N-2-propynylphenethylamine hydrochloride","(-)-N,alpha-Dim
ethyl-N-2-propynylbenzeneethanamine hydrochloride",NCGC00016708-01,"(-)-(R)-N,alpha-Dimethyl-N-2-propynylphenethylamine monohydrochloride",CAS-14611-52-0,"R-(-)deprenyl hydrochloride",SCHEMBL41392,MLS
000758294,MLS001423947,MLS002153281,MLS002222269,CHEMBL1200904,DTXSID9044584,HMS1569P05,FPF-1100,"Selegiline hydrochloride (JAN/USP)",Tox21_110572,Tox21_301846,AKOS005166822,"Benzeneethanamine, N,alph
a-dimethyl-N-2-propynyl-, hydrochloride, (R)-",Tox21_110572_1,CCG-100773,KS-5098,NC00023,NC00605,NCGC00024994-06,NCGC00255797-01,AC-18759,HY-14199,D00785,K-4669,611S520,SR-01000597928-1,SR-01000597928
-5,SR-01000597928-6,Q27108267,"R-(-)-Deprenyl hydrochloride, powder, >=98 (HPLC)","UNII-63G7R4955A component IYETZZCWLLUHIJ-UTONKHPSSA-N","Selegiline Hydrochloride 1.0 mg/ml in Methanol (as free base)
","(R)-(-)-N-?-Dimethyl-N-2-propynylbenzeneethanamine hydrochloride","Benzeneethanamine, N,.alpha.-dimethyl-N-2-propynyl-, hydrochloride","Selegiline hydrochloride, European Pharmacopoeia (EP) Referen
ce Standard","N-methyl-N-((1R)-1-methyl-2-phenylethyl)prop-2-yn-1-aminium chloride",SAM002589926,SAM001246969,Prestw-552,CPD000449328}

> <pdid>
PD009583

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{57525649,26758,25058197}

$$$$
NIHCC_2014
  SciTegic11012413002D

  9  9  0  0  0  0            999 V2000
    3.8976   -0.7553    0.0000 N   0  0
    2.5973   -1.5031    0.0000 C   0  0
    2.5951   -3.0031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
M  END
> <name>
NIHCC_2014

> <id>
6221

> <plate>
NGP-202-02

> <well>
H02

> <supplier_cmpd_name>
CPD000036662

> <ctcr_id>
6821

> <supplier_cmpd_id>
SAM002554927

> <smiles>
NC(=O)c1cnccn1

> <pd_targets>
{TSHR,FAS}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Family A G protein-coupled receptor",Transferase,"Peptide receptor (family A GPCR)","Glycohormone receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Glycoprotein hormone receptors"}

> <pathway_reactome>
{Disease,"Infectious disease","Leishmania infection","Leishmania parasite growth and survival","Anti-inflammatory response favouring Leishmania parasite infection","ADORA2B mediated anti-inflammatory 
cytokines production"}

> <broad_targets>
{FASN}

> <broad_moa>
{"fatty acid synthase inhibitor"}

> <synonyms>
{pyrazinamide,pyrazinecarboxamide,98-96-4,98964,pyrazine-2-carboxamide,pyrazine2carboxamide,"pyrazinoic acid amide",2-Pyrazinecarboxamide,2Pyrazinecarboxamide,Zinamide,Aldinamide,Tebrazid,Aldinamid,Pi
razinamid,Pyrazineamide,Pyrafat,Unipyranamide,Farmizina,Pirazimida,"pyrazine carboxylamide",T1426,SAM002554927,1500518,Prestw-514,Pyrazinamide,CPD000036662,PYRAZINAMIDE}

> <pdid>
PD001773

> <targets>
{Antibiotic,Autophagy,Bacterial}

> <classes>
{tuberculostatic,antibacterial,Anti-infection,Autophagy}

> <pubchem_cids>
{1046}

$$$$
NIHCC_2014
  SciTegic11012413002D

 13 14  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 O   0  0
    0.0000    1.5000    0.0000 N   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 N   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11  7  2  0
 11 12  1  0
 12  2  1  0
 12 13  2  0
M  END
> <name>
NIHCC_2014

> <id>
6222

> <plate>
NGP-202-02

> <well>
H03

> <supplier_cmpd_name>
CPD000058537

> <ctcr_id>
5893

> <supplier_cmpd_id>
SAM002554935

> <smiles>
CN1C(=O)N(C)c2[nH]cnc2C1=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{theophylline,58-55-9,58559,"1,3-Dimethylxanthine","1,3Dimethylxanthine",Theophyllin,Elixophyllin,Theolair,Nuelin,"Theophylline anhydrous",Respbid,Theocin,Theo-dur,Theodur,Elixophylline,Pseudotheophyl
line,Lanophyllin,Theovent,Uniphyl,Slo-phyllin,Slophyllin,Accurbron,Armophylline,Bronkodyl,SAM002554935,1500568,CPD000058537,THEOPHYLLINE}

> <pdid>

> <targets>
{}

> <classes>
{bronchodilator}

> <pubchem_cids>
{2153}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 26  0  0  0  0            999 V2000
    7.7996   -1.4883    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0031   -3.0008    0.0000 O   0  0
    1.3039   -3.7494    0.0000 C   0  0
    1.3092   -5.2494    0.0000 C   0  0
    2.6108   -5.9949    0.0000 C   0  0
    3.9073   -5.2404    0.0000 C   0  0
    3.9021   -3.7404    0.0000 C   0  0
    2.6004   -2.9949    0.0000 C   0  0
   -2.5988   -1.5004    0.0000 S   0  0
   -2.5983   -3.0004    0.0000 N   0  0
   -3.8983   -0.7513    0.0000 O   0  0
   -3.8975   -2.2510    0.0000 O   0  0
   -0.0031    3.0008    0.0000 C   0  0
    1.2946    3.7531    0.0000 O   0  0
   -1.3032    3.7490    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 10 19  1  0
 19 20  1  0
 19 21  2  0
 19 22  2  0
  8 23  1  0
 23 24  1  0
 23 25  2  0
M  END
> <name>
NIHCC_2014

> <id>
6223

> <plate>
NGP-202-02

> <well>
H04

> <supplier_cmpd_name>
CPD000058418

> <ctcr_id>
6574

> <supplier_cmpd_id>
SAM002564195

> <smiles>
CCCCNc1cc(cc(c1Oc2ccccc2)[S](N)(=O)=O)C(O)=O

> <pd_targets>
{GPR35,HSD17B10,CA5B,LMNA,ALDH1A1,CA6,CA14,SLC12A5,TSHR,HIF1A,CA7,SLC12A1,CA1,USP2,HPGD,CA9,CA12,KDM4E,BLM,NPSR1,CA2,CA4,CA13,CA5A,SLC12A2,SLC22A6,SLC12A4,CFTR}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Other nuclear protein",Transporter,"Transcription factor","Epigenetic regulator","Ion channel","Family A G protein-coupled receptor",Oxidoreductase,Lyase,"Electrochemical 
transporter",Protease,Eraser,"Other ion channel","Small molecule receptor (family A GPCR)","SLC superfamily of solute carriers","Peptide receptor (family A GPCR)","Cysteine protease","Lysine demethyla
se","Chloride channel","Carboxylic acid receptor","SLC12 family of cation-coupled chloride transporters","Glycohormone receptor","Cysteine protease CA clan","Jumonji domain-containing","Short peptide 
receptor (family A GPCR)","SLC22 family of organic cation and anion transporters","Cystic fibrosis transmembrane conductance regulator","Kynurenic acid receptor","Cysteine protease C19 family","Neurop
eptide receptor"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Ion channels","G protein-coupled receptors","Carbonic anhydrases","SLC superfamily of solute carriers","Peptidases and proteinases","Eicosanoid turnover","Chromatin mo
difying enzymes","Other ion channels","Orphan and other 7TM receptors","SLC12 family of cation-coupled chloride transporters","Glycoprotein hormone receptors","CA: Cysteine (C) Peptidases","Prostaglan
din synthases","1.14.11.- Histone demethylases","Neuropeptide S receptor","SLC22 family of organic cation and anion transporters","Chloride channels","Class A Orphans","C19: Ubiquitin-specific proteas
e","Organic anion transporters (OATs)",CFTR}

> <pathway_reactome>
{"Signal Transduction",Metabolism,"Cell Cycle","Transport of small molecules",Disease,"Cellular responses to external stimuli","Immune System","Gene expression (Transcription)","DNA Repair",Autophagy,
"Signaling by GPCR","Metabolism of amino acids and derivatives","Reversible hydration of carbon dioxide",Mitotic,"Biological oxidations","SLC-mediated transmembrane transport","Infectious disease","Ce
llular responses to stress","Disorders of transmembrane transporters","Cytokine Signaling in Immune system","RNA Polymerase II Transcription","Metabolism of lipids","DNA Double-Strand Break Repair","O
2/CO2 exchange in erythrocytes",Macroautophagy,"GPCR ligand binding","Branched-chain amino acid catabolism","M Phase","Phase I - Functionalization of compounds","Transport of inorganic cations/anions 
and amino acids/oligopeptides","Leishmania infection","Cellular response to hypoxia","SLC transporter disorders","Signaling by Interleukins","Generic Transcription Pathway","Biosynthesis of specialize
d proresolving mediators (SPMs)","Homology Directed Repair","Erythrocytes take up carbon dioxide and release oxygen","Transport of bile salts and organic acids","metal ions and amine compounds","Selec
tive autophagy","Class A/1 (Rhodopsin-like receptors)","Mitotic Metaphase and Anaphase","Ethanol oxidation","Cation-coupled Chloride cotransporters","Leishmania parasite growth and survival","Oxygen-d
ependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Defective SLC12A1 causes Bartter syndrome 1 (BS1)","Interleukin-12 family signaling","Transcriptional Regulation by TP53","Biosynthes
is of DHA-derived SPMs","Regulation of gene expression by Hypoxia-inducible Factor","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Organic cation/anion/zwitterion trans
port",Aggrephagy,"Mitotic Anaphase","Anti-inflammatory response favouring Leishmania parasite infection","Interleukin-12 signaling","Regulation of TP53 Activity","Biosynthesis of D-series resolvins","
HDR through Homologous Recombination (HRR)","Organic anion transport","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Gene and protein expression by JAK-S
TAT signaling after Interleukin-12 stimulation","Regulation of TP53 Expression and Degradation","Homologous DNA Pairing and Strand Exchange","Initiation of Nuclear Envelope (NE) Reformation","Regulati
on of TP53 Degradation","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{CFTR,GPR35,SLC12A1,SLC12A2,SLC12A4,SLC12A5}

> <broad_moa>
{"solute carrier family member inhibitor"}

> <synonyms>
{RESTW27,bumetanide,28395-03-1,28395031,"3-(Butylamino)-4-phenoxy-5-sulfamoylbenzoic acid","3(Butylamino)4phenoxy5sulfamoylbenzoic acid",Bumex,Burinex,Fordiuran,Lunetoron,Fontego,Segurex,"Ro 10-6338",
"Ro 106338",Bumetanida,Bumetanidum,"Bumetanidum (INN-Latin)","Bumetanidum (INNLatin)","3-(Aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid","3(Aminosulfonyl)5(butylamino)4phenoxybenzoic acid",B,T01
08,SAM002564195,1502004,Prestw-276,Bumetanide,CPD000058418,BUMETANIDE}

> <pdid>
PD001439

> <targets>
{NKCC}

> <classes>
{diuretic,Membrane Transporter/Ion Channel}

> <pubchem_cids>
{2471}

$$$$
NIHCC_2014
  SciTegic11012413002D

 31 31  0  0  1  0            999 V2000
   13.5566   -0.7173    0.0000 Cl  0  5
    8.5560   -0.8962    0.0000 C   0  0
    7.4824   -1.9437    0.0000 O   0  0
    6.0373   -1.5383    0.0000 C   0  0
    4.9622   -2.5843    0.0000 C   0  0
    3.5188   -2.1762    0.0000 C   0  0
    3.1484   -0.7186    0.0000 C   0  0
    4.2257    0.3239    0.0000 C   0  0
    5.6691   -0.0842    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0  2  0  0  0
    1.3514    1.0778    0.0000 S   0  0
    0.0000    1.7286    0.0000 C   0  0
    0.1115    3.2255    0.0000 C   0  0
   -1.1278    4.0705    0.0000 C   0  0
   -2.4793    3.4196    0.0000 C   0  0
   -2.5914    1.9238    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 N   0  0
   -3.1497   -0.7220    0.0000 C   0  0
   -3.5900   -2.1568    0.0000 C   0  0
   -5.0525   -2.4938    0.0000 N   0  0
   -5.4926   -3.9278    0.0000 C   0  0
   -6.0747   -1.3960    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.4008   -2.9088    0.0000 O   0  0
    0.7500   -1.5574    0.0000 C   0  0  2  0  0  0
    1.3993   -2.9127    0.0000 O   0  0
    0.5521   -4.1515    0.0000 C   0  0
   -0.9435   -4.0368    0.0000 C   0  0
    1.2002   -5.5043    0.0000 O   0  0
   11.0566   -0.7173    0.0000 H   0  3
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
 10  7  1  1
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 18 24  1  0
 24 25  2  0
 24 26  1  0
 26 10  1  0
 26 27  1  1
 27 28  1  0
 28 29  1  0
 28 30  2  0
M  CHG  2   1  -1  31   1
M  END
> <name>
NIHCC_2014

> <id>
6224

> <plate>
NGP-202-02

> <well>
H05

> <supplier_cmpd_name>
CPD000058375

> <ctcr_id>
3390

> <supplier_cmpd_id>
SAM002564204

> <smiles>
[Cl-].COc1ccc(cc1)[C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O.[H+]

> <pd_targets>
{KCNH2,CACNA1C,CACNA1D,CACNA1S,CYP3A4,KCNC1,TSHR,CACNA1F,KCNA7,ABCB1,HTR3A,SCN1A,SCN2A,SCN3A,LMNA,HTT,SCN10A,SCN11A,SCN4A,SCN5A,SCN7A,SCN8A,SCN9A,NS1,FFP,BLM,KMT2A,MEN1,SLC22A1,KCNA1,KCNA2,KCNA5,CACNG
1,ABCB11,CNGA1,CHRM1,CNGB3,CNGA2,CNGA3}

> <pathway_gtopdb>
{"Ion channel",Enzyme,"Membrane receptor",Transporter,"Other nuclear protein","Unclassified protein","Epigenetic regulator","Voltage-gated ion channel","Cytochrome P450","Family A G protein-coupled re
ceptor","Primary active transporter",Transferase,Reader,"Electrochemical transporter","Potassium channels","Voltage-gated calcium channel","Cytochrome P450 family 3","Peptide receptor (family A GPCR)"
,"ATP-binding cassette","Voltage-gated sodium channel",Bromodomain,"SLC superfamily of solute carriers","Voltage-gated potassium channel","Cytochrome P450 family 3A","Glycohormone receptor","ABCB subf
amily","SLC22 family of organic cation and anion transporters","Cytochrome P450 3A4","Cyclic nucleotide-regulated channel","Small molecule receptor (family A GPCR)","Monoamine receptor","Acetylcholine
 receptor"}

> <pathway_chembl>
{"Ion channels",Enzymes,Receptors,Transporters,"Voltage-gated ion channels","Cytochrome P450","G protein-coupled receptors","ATP-binding cassette transporter family","Ligand-gated ion channels","SLC s
uperfamily of solute carriers","Potassium channels","CYP3 family","Voltage-gated calcium channels","Glycoprotein hormone receptors","ABCB subfamily","5-HT<sub>3</sub> receptors","SLC22 family of organ
ic cation and anion transporters","Voltage-gated potassium channels","Organic cation transporters (OCT)","Cyclic nucleotide-regulated channels","Acetylcholine receptors (muscarinic)"}

> <pathway_reactome>
{"Muscle contraction",Metabolism,"Neuronal System","Developmental Biology",Disease,"Cell Cycle","Gene expression (Transcription)","DNA Repair","Transport of small molecules","Cardiac conduction","Meta
bolism of lipids","Potassium Channels","Nervous system development","Infectious disease","Abacavir transport and metabolism","Transmission across Chemical Synapses",Mitotic,"RNA Polymerase II Transcri
ption","DNA Double-Strand Break Repair","SLC-mediated transmembrane transport","Phase 3 - rapid repolarisation","Biosynthesis of specialized proresolving mediators (SPMs)","Voltage gated Potassium cha
nnels","Axon guidance","Leishmania infection","Abacavir transmembrane transport","Neurotransmitter receptors and postsynaptic signal transmission","M Phase","Generic Transcription Pathway","Homology D
irected Repair","Transport of bile salts and organic acids","metal ions and amine compounds","Metabolism of steroids","Biosynthesis of DHA-derived SPMs","NCAM signaling for neurite out-growth","Leishm
ania parasite growth and survival","Mitotic Metaphase and Anaphase","Transcriptional Regulation by MECP2","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Organic cation/
anion/zwitterion transport","Bile acid and bile salt metabolism","Biosynthesis of maresins","NCAM1 interactions","Anti-inflammatory response favouring Leishmania parasite infection","Mitotic Anaphase"
,"Regulation of MECP2 expression and activity","HDR through Homologous Recombination (HRR)","Organic cation transport","Synthesis of bile acids and bile salts","Biosynthesis of maresin-like SPMs","ADO
RA2B mediated anti-inflammatory cytokines production","Nuclear Envelope (NE) Reassembly","Homologous DNA Pairing and Strand Exchange","Synthesis of bile acids and bile salts via 7alpha-hydroxycholeste
rol","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pairing and strand exchange","Signal Transduction","Organelle biogenesis and maintenance","Signaling by GPCR
","Cilium Assembly","GPCR downstream signalling","GPCR ligand binding","Cargo trafficking to the periciliary membrane","G alpha (i) signalling events","Class A/1 (Rhodopsin-like receptors)","VxPx carg
o-targeting to cilium","Visual phototransduction","Amine ligand-binding receptors","The phototransduction cascade","Muscarinic acetylcholine receptors","Activation of the phototransduction cascade"}

> <broad_targets>
{CACNA1C,CACNA1S,CACNA2D1,CACNG1,HTR3A,KCNA5}

> <broad_moa>
{"calcium channel blocker"}

> <synonyms>
{SCHEMBL20394103,MCULE-4757300773,MCULE4757300773,"Diltiazem hydrochloride","Diltiazem HCl",33286-22-5,33286225,"(+)-cis-Diltiazem hydrochloride","(+)cisDiltiazem hydrochloride",Dilzem,Tiazac,Herbesse
r,Dilzene,Lacerol,Masdil,Tildiem,Mono-Tildiem,MonoTildiem,Bi-Tildiem,BiTildiem,CRD-401,CRD401,"Cardizem CD",Cardize,SAM002564204,Prestw-134,CPD000058375}

> <pdid>
PD010090

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{44659717,657259,62920}

$$$$
NIHCC_2014
  SciTegic11012413002D

 33 35  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 Cl  0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 C   0  0
    1.2947   -3.7531    0.0000 O   0  0
   -1.3039   -3.7494    0.0000 N   0  0
   -1.3070   -5.2502    0.0000 C   0  0
   -2.6078   -5.9988    0.0000 C   0  0
   -2.6109   -7.4996    0.0000 C   0  0
   -3.9099   -8.2497    0.0000 C   0  0
   -3.9099   -9.7497    0.0000 C   0  0
   -2.6109  -10.4997    0.0000 C   0  0
   -1.3119   -9.7497    0.0000 C   0  0
   -1.3118   -8.2497    0.0000 C   0  0
   -2.6110  -12.0005    0.0000 S   0  0
   -1.3117  -12.7501    0.0000 O   0  0
   -2.6103  -13.5005    0.0000 O   0  0
   -3.9102  -12.7517    0.0000 N   0  0
   -3.9103  -14.2526    0.0000 C   0  0
   -2.6110  -15.0022    0.0000 O   0  0
   -5.2096  -15.0038    0.0000 N   0  0
   -5.2096  -16.5046    0.0000 C   0  0
   -6.5071  -17.2573    0.0000 C   0  0
   -6.5041  -18.7573    0.0000 C   0  0
   -5.2035  -19.5047    0.0000 C   0  0
   -3.9060  -18.7521    0.0000 C   0  0
   -3.9090  -17.2521    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9  3  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 18 21  1  0
 21 22  2  0
 21 23  2  0
 21 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 28  1  0
M  END
> <name>
NIHCC_2014

> <id>
6225

> <plate>
NGP-202-02

> <well>
H06

> <supplier_cmpd_name>
CPD000058229

> <ctcr_id>
6831

> <supplier_cmpd_id>
SAM002564212

> <smiles>
COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)[S](=O)(=O)NC(=O)NC3CCCCC3

> <pd_targets>
{CYP2C19,BLM,RORC,CYP2C9,ABCB11,CISD1,KCNH2,LMNA,TSHR,HIF1A,PMP22,NS1,ALD,CYP3A4,PPARG,KCNK2,MAPT,KCNJ11,ABCC9,ALDH1A1,CYP2D6,NLRP3,CHRM1,CFTR,CYP1A2,SLC22A7,SLCO1B1,SLC22A6,ABCC3,ABCC8,SLC15A1,SLC15A
2,ABCC4,SLCO2B1,KCNJ8,ABCA1,CPT1A,TRPM4}

> <pathway_gtopdb>
{Enzyme,"Transcription factor",Transporter,"Unclassified protein","Ion channel","Other nuclear protein","Membrane receptor","Other cytosolic protein","Cytochrome P450","Nuclear receptor","Primary acti
ve transporter","Voltage-gated ion channel","Family A G protein-coupled receptor",Oxidoreductase,"Other ion channel","Electrochemical transporter",Transferase,"Cytochrome P450 family 2","Nuclear hormo
ne receptor subfamily 1","ATP-binding cassette","Potassium channels","Peptide receptor (family A GPCR)","Cytochrome P450 family 3","Small molecule receptor (family A GPCR)","Chloride channel","Cytochr
ome P450 family 1","SLC superfamily of solute carriers","Transient receptor potential channel","Cytochrome P450 family 2C","Nuclear hormone receptor subfamily 1 group F","ABCB subfamily","Voltage-gate
d potassium channel","Glycohormone receptor","Cytochrome P450 family 3A","Nuclear hormone receptor subfamily 1 group C","Two-pore domain potassium channel","Inwardly rectifying potassium channel","Cyt
ochrome P450 family 2D","Monoamine receptor","Cystic fibrosis transmembrane conductance regulator","Cytochrome P450 family 1A","SLC22 family of organic cation and anion transporters","SLC21/SLCO famil
y of organic anion transporting polypeptides","ABCC subfamily","SLC15 family of peptide transporters","ABCA subfamily","Cytochrome P450 2C19","Nuclear hormone receptor subfamily 1 group F member 3","C
ytochrome P450 2C9","Cytochrome P450 3A4","Nuclear hormone receptor subfamily 1 group C member 3","Cytochrome P450 2D6","Acetylcholine receptor","Cytochrome P450 1A1"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Ion channels","Cytochrome P450","Nuclear hormone receptors","ATP-binding cassette transporter family","Voltage-gated ion channels","G protein-coupled receptors","Catal
ytic receptors","Other ion channels","SLC superfamily of solute carriers","CYP2 family: drug metabolising subset","1F. Retinoic acid-related orphans","ABCB subfamily","Potassium channels","Glycoprotei
n hormone receptors","CYP3 family","1C. Peroxisome proliferator-activated receptors","Pattern recognition receptors","Acetylcholine receptors (muscarinic)","Chloride channels","CYP1 family","SLC22 fam
ily of organic cation and anion transporters","SLCO family of organic anion transporting polypeptides","ABCC subfamily","SLC15 family of peptide transporters","ABCA subfamily","Transient Receptor Pote
ntial channels","Voltage-gated potassium channels","Two P domain potassium channels","Inwardly rectifying potassium channels","NOD-like receptor family",CFTR,"Organic anion transporters (OATs)"}

> <pathway_reactome>
{Metabolism,"DNA Repair","Gene expression (Transcription)","Muscle contraction","Cell Cycle",Disease,"Cellular responses to external stimuli","Developmental Biology","Neuronal System","Signal Transduc
tion",Autophagy,"Transport of small molecules",Hemostasis,"Biological oxidations","DNA Double-Strand Break Repair","RNA Polymerase II Transcription","Metabolism of lipids","Cardiac conduction",Mitotic
,"Infectious disease","Cellular responses to stress","Nervous system development","Potassium Channels","Transmission across Chemical Synapses","Disorders of transmembrane transporters","Signaling by G
PCR",Macroautophagy,"SLC-mediated transmembrane transport","Platelet activation","signaling and aggregation","Ion channel transport","Phase I - Functionalization of compounds","Homology Directed Repai
r","Generic Transcription Pathway","Metabolism of steroids","Phase 3 - rapid repolarisation","M Phase","Leishmania infection","Cellular response to hypoxia","EGR2 and SOX10-mediated initiation of Schw
ann cell myelination","Biosynthesis of specialized proresolving mediators (SPMs)","Tandem pore domain potassium channels","Neurotransmitter receptors and postsynaptic signal transmission","ABC transpo
rter disorders","GPCR ligand binding","Selective autophagy","Transport of bile salts and organic acids","metal ions and amine compounds","Transport of inorganic cations/anions and amino acids/oligopep
tides","Response to elevated platelet cytosolic Ca2+","Transport of vitamins",nucleosides,"and related molecules","Inwardly rectifying K+ channels","Fatty acid metabolism","Stimuli-sensing channels","
Cytochrome P450 - arranged by substrate type","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Transcriptional regulation by RUNX3","Bile acid and bile salt metabolism","
Mitotic Metaphase and Anaphase","Leishmania parasite growth and survival","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Biosynthesis of DHA-derived SPMs","Transcriptional
 Regulation by MECP2","TWIK related potassium channel (TREK)","Activation of NMDA receptors and postsynaptic events","Defective ABCC8 can cause hypo- and hyper-glycemias","Ethanol oxidation","Cell rec
ruitment (pro-inflammatory response)","Class A/1 (Rhodopsin-like receptors)",Aggrephagy,"Organic cation/anion/zwitterion transport","Proton/oligopeptide cotransporters","Platelet degranulation","Trans
port of organic anions","ATP sensitive Potassium channels","Defective ABCC9 causes CMD10","ATFB12 and Cantu syndrome","Defective ABCA1 causes TGD","Carnitine metabolism","TRP channels",Xenobiotics,"HD
R through Homologous Recombination (HRR)","RUNX3 Regulates Immune Response and Cell Migration","Synthesis of bile acids and bile salts","Mitotic Anaphase","Anti-inflammatory response favouring Leishma
nia parasite infection","Biosynthesis of maresins","MECP2 regulates transcription factors","Post NMDA receptor activation events","Purinergic signaling in leishmaniasis infection","Amine ligand-bindin
g receptors","Organic anion transport","Recycling of bile acids and salts","CYP2E1 reactions","Homologous DNA Pairing and Strand Exchange","Synthesis of bile acids and bile salts via 7alpha-hydroxycho
lesterol","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Biosynthesis of maresin-like SPMs","Activation of AMPK downstream of NMDARs","Muscarinic acetylc
holine receptors","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Presynaptic phase of homologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation"
}

> <broad_targets>
{ABCA1,ABCB11,ABCC8,ABCC9,CFTR,CPT1A,KCNJ1,KCNJ11,KCNJ5,KCNJ8,SLCO2B1}

> <broad_moa>
{"ATP channel blocker","insulin secretagogue",sulfonylurea}

> <synonyms>
{glyburide,Glibenclamide,10238-21-8,10238218,Glybenclamide,Glynase,Micronase,Diabeta,Daonil,Euglucon,Maninil,Semi-daonil,Semidaonil,Apo-Glibenclamide,ApoGlibenclamide,"Euglucon 5",Azuglucon,Bastiverit
,Benclamin,Betanase,Duraglucon,Euglucan,Euglykon,Glibenil,Glucolon,Orabetic,Prodiab,T1634,SAM002564212,2300229,Prestw-316,Glyburide,CPD000058229,GLYBURIDE}

> <pdid>
PD000061

> <targets>
{Autophagy,CFTR,P-glycoprotein,Potassium Channel}

> <classes>
{antihyperglycemic,Autophagy,Membrane Transporter/Ion Channel}

> <pubchem_cids>
{3488}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 31  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
   -1.2990    0.7500    0.0000 C   0  0  2  0  0  0
   -2.5981    1.5000    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0  1  0  0  0
   -2.1132    4.3307    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
    1.0956    4.0166    0.0000 C   0  0
    0.4768    5.3830    0.0000 C   0  0
   -1.0140    5.2166    0.0000 C   0  0  1  0  0  0
   -2.4603    4.8674    0.0000 O   0  0
   -3.5120    5.9380    0.0000 C   0  0
   -3.1105    7.3833    0.0000 C   0  0
   -4.9646    5.5636    0.0000 O   0  0
   -0.5492    6.6304    0.0000 C   0  0
    0.9144    6.9591    0.0000 C   0  0
   -1.5653    7.7338    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    0.0000    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -1.2990   -5.2500    0.0000 O   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  1  1  6
  2  3  1  0
  4  3  1  6
  4  5  1  0
  5  6  1  1
  6  7  1  0
  7  8  1  0
  8  9  1  1
  8 10  1  0
 10  4  1  0
 10 11  1  1
 11 12  1  0
 12 13  1  0
 13  8  1  0
 13 14  1  6
 14 15  1  0
 15 16  1  0
 15 17  2  0
 13 18  1  0
 18 19  1  0
 18 20  2  0
  5 21  1  0
 21 22  1  1
 21 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  2  3
 28  2  1  0
 28 21  1  0
M  END
> <name>
NIHCC_2014

> <id>
6226

> <plate>
NGP-202-02

> <well>
H07

> <supplier_cmpd_name>
CPD000653524

> <ctcr_id>
7024

> <supplier_cmpd_id>
SAM002564220

> <smiles>
C[C@H]1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(OC(C)=O)C(C)=O)[C@@]4(C)CCC(=O)C=C14

> <pd_targets>
{NR3C2,PGR,SHBG,AKR1C2,AR,NR3C1,ALDH1A1,ESR1,ESR2,AKR1C3,AKR1C1,LMNA,NPSR1,CYP3A4,ABCC4,ABCB11,HRH2,ABCB1,GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG
3,GABRP,GABRQ}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Secreted protein","Other nuclear protein","Membrane receptor",Transporter,"Ion channel","Nuclear receptor",Protease,Oxidoreductase,"Family A G protein-coupled receptor"
,"Cytochrome P450","Primary active transporter","Ligand-gated ion channel","Nuclear hormone receptor subfamily 3","Cysteine protease","Peptide receptor (family A GPCR)","Cytochrome P450 family 3","ATP
-binding cassette","Small molecule receptor (family A GPCR)","GABA-A receptor","Nuclear hormone receptor subfamily 3 group C","Cysteine protease CA clan","Nuclear hormone receptor subfamily 3 group A"
,"Short peptide receptor (family A GPCR)","Cytochrome P450 family 3A","ABCC subfamily","ABCB subfamily","Monoamine receptor","Nuclear hormone receptor subfamily 3 group C member 2","Cysteine protease 
C1A family","Nuclear hormone receptor subfamily 3 group C member 3","Nuclear hormone receptor subfamily 3 group C member 4","Nuclear hormone receptor subfamily 3 group C member 1","Nuclear hormone rec
eptor subfamily 3 group A member 1","Neuropeptide receptor","Cytochrome P450 3A4","Histamine receptor"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Nuclear hormone receptors","Eicosanoid turnover","G protein-coupled receptors","Cytochrome P450","ATP-binding cassette transporter family","Steroid hormone receptors",
"Prostaglandin synthases","Neuropeptide S receptor","CYP3 family","ABCC subfamily","ABCB subfamily","Histamine receptors","3C. 3-Ketosteroid receptors","3A. Estrogen receptors"}

> <pathway_reactome>
{"Metabolism of proteins",Metabolism,"Gene expression (Transcription)","Cell Cycle",Disease,Hemostasis,"Post-translational protein modification","Metabolism of lipids","RNA Polymerase II Transcription
","Biological oxidations",Mitotic,"Infectious disease","Platelet activation","signaling and aggregation","Abacavir transport and metabolism",SUMOylation,"Metabolism of steroids","Generic Transcription
 Pathway","Phase I - Functionalization of compounds","M Phase","Leishmania infection","Biosynthesis of specialized proresolving mediators (SPMs)","Response to elevated platelet cytosolic Ca2+","Abacav
ir transmembrane transport","SUMO E3 ligases SUMOylate target proteins","Bile acid and bile salt metabolism","Transcriptional regulation by RUNX2","FOXO-mediated transcription","Ethanol oxidation","Mi
totic Metaphase and Anaphase","Leishmania parasite growth and survival","Biosynthesis of DHA-derived SPMs","Platelet degranulation","Transcriptional regulation by RUNX1","SUMOylation of intracellular 
receptors","Synthesis of bile acids and bile salts","RUNX2 regulates bone development","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","Mitotic Anaphase","Anti-inflamm
atory response favouring Leishmania parasite infection","Biosynthesis of maresins","RUNX1 regulates estrogen receptor mediated transcription","Synthesis of bile acids and bile salts via 24-hydroxychol
esterol","RUNX2 regulates osteoblast differentiation","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Biosynthesis of maresin-like SPMs","Synthesis of bil
e acids and bile salts via 7alpha-hydroxycholesterol","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ESR1,PGR}

> <broad_moa>
{"progesterone receptor agonist"}

> <synonyms>
{"Medroxyprogesterone acetate",71-58-9,71589,"Medroxyprogesterone 17-acetate","Medroxyprogesterone 17acetate",Metigestrona,Provera,Farlutin,Gestapuran,Perlutex,Veramix,Methylacetoxyprogesterone,"Medro
xyacetate progesterone",Depo-Provera,DepoProvera,Depcorlutin,Deporone,Lutopolar,Nadigest,Prodasone,P,S2567,SAM002564220,CPD000653524}

> <pdid>
PD001874

> <targets>
{"Estrogen/progestogen Receptor"}

> <classes>
{"Endocrinology & Hormones"}

> <pubchem_cids>
{6279}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 26  0  0  0  0            999 V2000
   11.6982   -0.7323    0.0000 C   0  0
   10.4003   -1.4841    0.0000 C   0  0
    9.0990   -0.7364    0.0000 C   0  0
    7.8003   -1.4887    0.0000 N   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    5.2029   -2.9932    0.0000 O   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 C   0  0
    1.2947   -3.7531    0.0000 O   0  0
   -1.3039   -3.7494    0.0000 C   0  0
   -1.3070   -5.2502    0.0000 C   0  0
   -2.6078   -5.9988    0.0000 C   0  0
   -2.6131   -7.4988    0.0000 C   0  0
   -3.9147   -8.2443    0.0000 C   0  0
   -5.2111   -7.4898    0.0000 C   0  0
   -5.2060   -5.9898    0.0000 C   0  0
   -3.9043   -5.2443    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
M  END
> <name>
NIHCC_2014

> <id>
6227

> <plate>
NGP-202-02

> <well>
H08

> <supplier_cmpd_name>
CPD001453705

> <ctcr_id>
1674

> <supplier_cmpd_id>
SAM002564228

> <smiles>
CCCNCC(O)COc1ccccc1C(=O)CCc2ccccc2

> <pd_targets>
{LMNA,CYP3A4,ADRB1,ADRB2,KCNA5,KCNH2,ABCB11,ABCB1,ADRA1B,ADRA1A,PMP22,KMT2A,MEN1,HTR1A,HTR2B,HTR2C,HTR6,KCNK3,SLC22A1,SLC6A2,CACNA1C,SLC6A3,SCN5A,CYP1A2,ADRB3,HTR2A,SIGMAR1,KCNK2,MTOR,CYP2D6,ABCC9,KCN
J11,SCN10A,SCN11A,SCN1A,SCN2A,SCN3A,SCN4A,SCN7A,SCN8A,SCN9A,NPSR1,NFO,CHRM1,HIF1A,THPO,TSHR,TP53}

> <pathway_gtopdb>
{"Other nuclear protein",Enzyme,"Membrane receptor","Ion channel",Transporter,"Unclassified protein","Epigenetic regulator","Cytochrome P450","Family A G protein-coupled receptor","Voltage-gated ion c
hannel","Primary active transporter",Reader,"Electrochemical transporter",Kinase,"Cytochrome P450 family 3","Small molecule receptor (family A GPCR)","Potassium channels","ATP-binding cassette",Bromod
omain,"SLC superfamily of solute carriers","Voltage-gated calcium channel","Voltage-gated sodium channel","Cytochrome P450 family 1","Protein Kinase","Cytochrome P450 family 2","Cytochrome P450 family
 3A","Monoamine receptor","Voltage-gated potassium channel","ABCB subfamily","Two-pore domain potassium channel","SLC22 family of organic cation and anion transporters","SLC06 neurotransmitter transpo
rter family","Cytochrome P450 family 1A","Atypical protein kinase group","Cytochrome P450 family 2D","Inwardly rectifying potassium channel","Cytochrome P450 3A4","Adrenergic receptor","Serotonin rece
ptor","Cytochrome P450 1A1","Atypical protein kinase PIKK family","Cytochrome P450 2D6","Atypical protein kinase FRAP subfamily","Transcription factor",Hydrolase,"Peptide receptor (family A GPCR)","Sh
ort peptide receptor (family A GPCR)","Glycohormone receptor","Neuropeptide receptor","Acetylcholine receptor"}

> <pathway_chembl>
{Enzymes,Receptors,"Ion channels",Transporters,"Other protein targets","Cytochrome P450","G protein-coupled receptors","Voltage-gated ion channels","ATP-binding cassette transporter family","SLC super
family of solute carriers","Sigma receptors","Kinases (EC 2.7.x.x)","CYP3 family",Adrenoceptors,"Potassium channels","ABCB subfamily","5-Hydroxytryptamine receptors","SLC22 family of organic cation an
d anion transporters","SLC6 neurotransmitter transporter family","Voltage-gated calcium channels","Voltage-gated sodium channels","CYP1 family",Atypical,"CYP2 family: drug metabolising subset","Voltag
e-gated potassium channels","Two P domain potassium channels","Organic cation transporters (OCT)","Monoamine transporter subfamily","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","FRA
P subfamily","Neuropeptide S receptor","Acetylcholine receptors (muscarinic)","Glycoprotein hormone receptors"}

> <pathway_reactome>
{"Cell Cycle",Metabolism,Disease,"Neuronal System","Muscle contraction","Signal Transduction","Developmental Biology","Transport of small molecules","Gene expression (Transcription)",Mitotic,"Metaboli
sm of lipids","Infectious disease","Potassium Channels","Cardiac conduction","Abacavir transport and metabolism","Signaling by GPCR","Nervous system development","SLC-mediated transmembrane transport"
,"Disorders of transmembrane transporters","Biological oxidations","RNA Polymerase II Transcription","M Phase","Biosynthesis of specialized proresolving mediators (SPMs)","Leishmania infection","Volta
ge gated Potassium channels","Phase 3 - rapid repolarisation","Metabolism of steroids","Abacavir transmembrane transport","GPCR ligand binding","EGR2 and SOX10-mediated initiation of Schwann cell myel
ination","Tandem pore domain potassium channels","Transport of bile salts and organic acids","metal ions and amine compounds","SLC transporter disorders","Axon guidance","Phase I - Functionalization o
f compounds","SARS-CoV Infections","Generic Transcription Pathway","Mitotic Metaphase and Anaphase","Biosynthesis of DHA-derived SPMs","Leishmania parasite growth and survival","Bile acid and bile sal
t metabolism","Class A/1 (Rhodopsin-like receptors)","TWIK-releated acid-sensitive K+ channel (TASK)","Organic cation/anion/zwitterion transport","Defective SLC6A2 causes orthostatic intolerance (OI)"
,"NCAM signaling for neurite out-growth","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","L1CAM interactions","Cytochrome P450 - arranged by substrate type","Potential therapeutics f
or SARS","TWIK related potassium channel (TREK)","Transcriptional Regulation by TP53","Mitotic Anaphase","Biosynthesis of maresins","Anti-inflammatory response favouring Leishmania parasite infection"
,"Synthesis of bile acids and bile salts","Amine ligand-binding receptors","Organic cation transport","NCAM1 interactions","Interaction between L1 and Ankyrins",Xenobiotics,"Regulation of TP53 Activit
y","Nuclear Envelope (NE) Reassembly","Biosynthesis of maresin-like SPMs","ADORA2B mediated anti-inflammatory cytokines production","Synthesis of bile acids and bile salts via 7alpha-hydroxycholestero
l",Adrenoceptors,"Serotonin receptors","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Regulation of TP53 Expression and Degradation","CYP2E1 reactions","Initiation of Nuclear Enve
lope (NE) Reformation","Regulation of TP53 Degradation","Cellular responses to external stimuli",Hemostasis,"Cellular responses to stress","Platelet activation","signaling and aggregation","Cell Cycle
 Checkpoints","Cellular response to hypoxia","Platelet Aggregation (Plug Formation)","G1/S DNA Damage Checkpoints","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","p53-Depen
dent G1/S DNA damage checkpoint","p53-Dependent G1 DNA Damage Response","Muscarinic acetylcholine receptors","Stabilization of p53","Autodegradation of the E3 ubiquitin ligase COP1"}

> <broad_targets>
{ADRB1,ADRB2,KCNA5,KCNH2}

> <broad_moa>
{antiarrhythmic}

> <synonyms>
{propafenone,54063-53-5,54063535,Rythmol,Propafenona,Propafenonum,"Propafenonum (INN-Latin)","Propafenonum (INNLatin)","Propafenona (INN-Spanish)","Propafenona (INNSpanish)",GNF-Pf-4594,GNFPf4594,1-(2
-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone,1(2(2Hydroxy3(propylamino)propoxy)phenyl)3phenyl1propanone,1-(2-(2-hydroxy-3-(propylamino)propoxy)phenyl)-3-phenylpro,1(2(2hydroxy3(prop
ylamino)propoxy)phenyl)3phenylpro,T0866,S2500,SAM002564228,Propafenone,"Propafenone HCl",CPD001453705}

> <pdid>
PD002872

> <targets>
{"Sodium Channel"}

> <classes>
{"Transmembrane Transporters"}

> <pubchem_cids>
{4932}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 22  0  0  0  0            999 V2000
   11.3405   -5.2758    0.0000 C   0  0
    9.8788   -4.9390    0.0000 C   0  0
    8.8563   -6.0365    0.0000 C   0  0
    7.3946   -5.6997    0.0000 C   0  0
    6.9554   -4.2655    0.0000 C   0  0
    7.9779   -3.1680    0.0000 C   0  0
    9.4396   -3.5047    0.0000 C   0  0
    5.4929   -3.9285    0.0000 S   0  0
    4.4707   -5.0263    0.0000 O   0  0
    4.0310   -3.5924    0.0000 O   0  0
    5.0525   -2.4938    0.0000 N   0  0
    3.5900   -2.1568    0.0000 C   0  0
    2.5679   -3.2546    0.0000 O   0  0
    3.1497   -0.7220    0.0000 N   0  0
    1.6852   -0.3846    0.0000 N   0  0
    1.3514    1.0778    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  5  8  1  0
  8  9  2  0
  8 10  2  0
  8 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 15  1  0
M  END
> <name>
NIHCC_2014

> <id>
6228

> <plate>
NGP-202-02

> <well>
H09

> <supplier_cmpd_name>
CPD000058290

> <ctcr_id>
3027

> <supplier_cmpd_id>
SAM002564236

> <smiles>
Cc1ccc(cc1)[S](=O)(=O)NC(=O)NN2CCCCCC2

> <pd_targets>
{CHRM1,GLA,KDM4E,GAA,ALOX15,ALD,CYP3A4,MAPT,ALOX12,NFO,NS1,NFKB1,FFP,ALDH1A1,ABCC8,KCNJ11}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Epigenetic regulator","Other cytosolic protein","Unclassified protein","Ion channel","Family A G protein-coupled receptor",Hydrolase,Eraser,Oxidoreductase,"Cytochrome P450
",Transferase,"Voltage-gated ion channel","Small molecule receptor (family A GPCR)","Lysine demethylase","Cytochrome P450 family 3","Potassium channels","Monoamine receptor","Jumonji domain-containing
","Cytochrome P450 family 3A","Inwardly rectifying potassium channel","Acetylcholine receptor","Cytochrome P450 3A4"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Chromatin modifying enzymes","3.2.1.- Glycosidases","Eicosanoid turnover","Cytochrome P450","Acetylcholine receptors (muscarinic)","1.14.11.- Histone 
demethylases",Lipoxygenases,"CYP3 family"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,Disease,"Neuronal System","Immune System","Signaling by GPCR","Metabolism of lipids","Diseases of metabolism","Transmission across Chemical Synapses","Cytokine Signal
ing in Immune system","Biological oxidations","GPCR ligand binding","Sphingolipid metabolism","Diseases of carbohydrate metabolism","Biosynthesis of specialized proresolving mediators (SPMs)","Neurotr
ansmitter receptors and postsynaptic signal transmission","Signaling by Interleukins","Phase I - Functionalization of compounds","Class A/1 (Rhodopsin-like receptors)","Glycosphingolipid metabolism","
Glycogen storage diseases","Biosynthesis of DPA-derived SPMs","Biosynthesis of DHA-derived SPMs","Activation of NMDA receptors and postsynaptic events","Interleukin-1 family signaling","Ethanol oxidat
ion","Amine ligand-binding receptors","Glycogen storage disease type II (GAA)","Biosynthesis of DPAn-3 SPMs","Biosynthesis of maresins","Post NMDA receptor activation events","Interleukin-1 signaling"
,"Muscarinic acetylcholine receptors","Biosynthesis of DPAn-3-derived protectins and resolvins","Biosynthesis of maresin-like SPMs","Activation of AMPK downstream of NMDARs","Biosynthesis of DPAn-3-de
rived maresins","MAP3K8 (TPL2)-dependent MAPK1/3 activation"}

> <broad_targets>
{ABCC8,KCNJ1,KCNJ10,KCNJ11}

> <broad_moa>
{"ATP channel blocker"}

> <synonyms>
{15619,tolazamide,1156-19-0,1156190,Tolinase,Norglycin,Tolanase,Diabewas,Tolazolamide,Tolazamida,Tolazamidum,1-(Hexahydro-1-azepinyl)-3-p-tolylsulfonylurea,1(Hexahydro1azepinyl)3ptolylsulfonylurea,N-(
p-Toluenesulfonyl)-N'-hexamethyleniminourea,N(pToluenesulfonyl)N'hexamethyleniminourea,U-17835,U17835,4-(p-Tolylsulfonyl)-1,4(pTolylsulfonyl)1,1-hexamethylenesemicarbazi,1hexamethylenesemicarbazi,T133
3,SAM002564236,1501201,Prestw-554,Tolazamide,CPD000058290,TOLAZAMIDE}

> <pdid>
PD001453

> <targets>
{}

> <classes>
{antidiabetic}

> <pubchem_cids>
{5503}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 22  0  0  0  0            999 V2000
   11.4837   -4.5059    0.0000 H   0  3
    8.9837   -4.5059    0.0000 Cl  0  5
    5.1937   -3.0093    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8912   -5.2578    0.0000 N   0  0
    2.5917   -6.0086    0.0000 C   0  0
    2.5912   -7.5095    0.0000 C   0  0
    1.2924   -8.2599    0.0000 Cl  0  0
    5.1894   -6.0109    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    6.4837   -8.2663    0.0000 C   0  0
    6.4785   -9.7663    0.0000 C   0  0
    5.1769  -10.5118    0.0000 C   0  0
    3.8804   -9.7573    0.0000 C   0  0
    3.8856   -8.2573    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  4 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 13 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6229

> <plate>
NGP-202-02

> <well>
H10

> <supplier_cmpd_name>
CPD000058422

> <ctcr_id>
5741

> <supplier_cmpd_id>
SAM002564244

> <smiles>
[H+].[Cl-].CC(COc1ccccc1)N(CCCl)Cc2ccccc2

> <pd_targets>
{TSHR,ALOX15,GLA,SCN1A,SCN2A,SCN3A,ADRA2B,DRD1,DRD2,DRD3,DRD4,DRD5,ADRA1A,ADRA1B,ADRA1D,ALDH1A1,HIF1A,GROES,GROL,KDM4E,TGR,NPSR1,LMNA,CYP3A4,HSPD1,HSPE1,THRB,LEF,NFO,TDP1,KMT2A,MEN1,SLC22A2,SLC22A1,SL
C22A3,ADRA2A,ADRA2C,CALM1,CYP2C19,CHRM1,CYP2D6,NFKB1,CYP2C9,CYP1A2}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Ion channel","Transcription factor","Unclassified protein","Epigenetic regulator","Other nuclear protein","Other cytosolic protein",Transporter,"Family A G protein-coupled
 receptor",Oxidoreductase,Hydrolase,"Voltage-gated ion channel",Eraser,"Cytochrome P450","Nuclear receptor",Protease,Reader,"Electrochemical transporter","Peptide receptor (family A GPCR)","Voltage-ga
ted sodium channel","Small molecule receptor (family A GPCR)","Lysine demethylase","Cytochrome P450 family 3","Nuclear hormone receptor subfamily 1","Metallo protease",Bromodomain,"SLC superfamily of 
solute carriers","Glycohormone receptor","Monoamine receptor","Jumonji domain-containing","Short peptide receptor (family A GPCR)","Cytochrome P450 family 3A","Nuclear hormone receptor subfamily 1 gro
up A","Metallo protease MAE clan","SLC22 family of organic cation and anion transporters","Adrenergic receptor","Dopamine receptor","Neuropeptide receptor","Cytochrome P450 3A4","Nuclear hormone recep
tor subfamily 1 group A member 2","Metallo protease M34 family","Cytochrome P450 family 2","Cytochrome P450 family 1","Cytochrome P450 family 2C","Cytochrome P450 family 2D","Cytochrome P450 family 1A
","Cytochrome P450 2C19","Acetylcholine receptor","Cytochrome P450 2D6","Cytochrome P450 2C9","Cytochrome P450 1A1"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"G protein-coupled receptors","Eicosanoid turnover","Chromatin modifying enzymes","Cytochrome P450","Nuclear hormone receptors","SLC superfamily of solute carriers","Gl
ycoprotein hormone receptors",Lipoxygenases,Adrenoceptors,"1.14.11.- Histone demethylases","Neuropeptide S receptor","CYP3 family","1A. Thyroid hormone receptors","SLC22 family of organic cation and a
nion transporters","Organic cation transporters (OCT)","CYP2 family: drug metabolising subset","Acetylcholine receptors (muscarinic)","CYP1 family"}

> <pathway_reactome>
{Disease,Metabolism,"Signal Transduction","Cellular responses to external stimuli","Cell Cycle","Metabolism of proteins","DNA Repair","Transport of small molecules","Neuronal System","Infectious disea
se","Metabolism of lipids","Signaling by GPCR","Biological oxidations","Cellular responses to stress",Mitotic,"Post-translational protein modification","DNA Double-Strand Break Repair","SLC-mediated t
ransmembrane transport","Transmission across Chemical Synapses","Leishmania infection","Biosynthesis of specialized proresolving mediators (SPMs)","Sphingolipid metabolism","GPCR ligand binding","Phas
e I - Functionalization of compounds","Cellular response to hypoxia","M Phase",SUMOylation,"Uptake and actions of bacterial toxins","Nonhomologous End-Joining (NHEJ)","Transport of bile salts and orga
nic acids","metal ions and amine compounds","Neurotransmitter receptors and postsynaptic signal transmission","Leishmania parasite growth and survival","Biosynthesis of DPA-derived SPMs","Glycosphingo
lipid metabolism","Class A/1 (Rhodopsin-like receptors)","Ethanol oxidation","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Mitotic Metaphase and Anaphase","Biosynthesis o
f DHA-derived SPMs","SUMO E3 ligases SUMOylate target proteins","Uptake and function of anthrax toxins","Organic cation/anion/zwitterion transport","Activation of NMDA receptors and postsynaptic event
s","Anti-inflammatory response favouring Leishmania parasite infection","Biosynthesis of DPAn-3 SPMs","Amine ligand-binding receptors","Mitotic Anaphase","Biosynthesis of maresins","SUMOylation of int
racellular receptors","Organic cation transport","Post NMDA receptor activation events","ADORA2B mediated anti-inflammatory cytokines production","Biosynthesis of DPAn-3-derived protectins and resolvi
ns",Adrenoceptors,"Nuclear Envelope (NE) Reassembly","Biosynthesis of maresin-like SPMs","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","Initiation of Nuclear Envel
ope (NE) Reformation","Ras activation upon Ca2+ influx through NMDA receptor","Immune System","Cytokine Signaling in Immune system","Signaling by Interleukins","Cytochrome P450 - arranged by substrate
 type","Interleukin-1 family signaling",Xenobiotics,"Interleukin-1 signaling","CYP2E1 reactions","Muscarinic acetylcholine receptors","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Aromatic amines can 
be N-hydroxylated or N-dealkylated by CYP1A2"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,ADRA2A,ADRA2B,ADRA2C}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{Dibenzyline,"Bensylyt NEN","Phenoxybenzamine chloride",NCI-C01661,NCIC01661,"Phenoxybenzamine hydrochloride (USP)","N-2-Phenoxyisopropyl-N-benzyl-chloroethylamine hydrochloride","N2PhenoxyisopropylNb
enzylchloroethylamine hydrochloride","Dibenzyline chloride","2-(N-Benzyl-2-chloroethylamino)-1-phenoxypropane hydrochl","2(NBenzyl2chloroethylamino)1phenoxypropane hydrochl",T1158,S2499,SAM002564244,2
300176,Prestw-944,"Phenoxybenzamine hydrochloride","Phenoxybenzamine HCl",CPD000058422,"PHENOXYBENZAMINE HYDROCHLORIDE"}

> <pdid>
PD009637

> <targets>
{"Androgen Receptor"}

> <classes>
{"GPCR & G Protein","alpha adrenergic blocker"}

> <pubchem_cids>
{6141,657233,5284441}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 32  0  0  1  0            999 V2000
    7.7003   -4.8739    0.0000 Na  0  3
    5.1996   -1.4928    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0031   -3.0008    0.0000 C   0  0
   -1.2946   -3.7531    0.0000 O   0  0
    1.3039   -3.7494    0.0000 N   0  0
    1.3070   -5.2502    0.0000 C   0  0  1  0  0  0
    2.3654   -6.2567    0.0000 C   0  0  1  0  0  0
    3.7020   -6.9376    0.0000 S   0  0
    3.4674   -8.4192    0.0000 C   0  0
    3.0577   -9.8621    0.0000 C   0  0
    4.9104   -8.0093    0.0000 C   0  0
    1.9859   -8.6539    0.0000 C   0  0  1  0  0  0
    1.3048   -7.3175    0.0000 N   0  0
    0.2466   -6.2595    0.0000 C   0  0
   -1.2533   -6.2411    0.0000 O   0  0
    1.3086   -9.9904    0.0000 C   0  0
   -0.1892  -10.0716    0.0000 O   0  5
    2.1275  -11.2471    0.0000 O   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13  8  1  0
 13 14  2  0
 14  5  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 18 17  1  1
 18 19  1  0
 19 20  1  1
 20 21  1  0
 21 22  1  0
 21 23  1  0
 21 24  1  0
 24 25  1  0
 25 19  1  0
 25 26  1  0
 26 18  1  0
 26 27  2  0
 24 28  1  6
 28 29  1  0
 28 30  2  0
M  CHG  2   1   1  29  -1
M  END
> <name>
NIHCC_2014

> <id>
6230

> <plate>
NGP-202-02

> <well>
H11

> <supplier_cmpd_name>
CPD000058840

> <ctcr_id>
7037

> <supplier_cmpd_id>
SAM002589927

> <smiles>
[Na+].CCOc1ccc2ccccc2c1C(=O)N[C@H]3[C@H]4SC(C)(C)[C@@H](N4C3=O)C([O-])=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Nafcillin sodium salt","NAFCILLIN SODIUM",985-16-0,985160,"Nafcillin sodium anhydrous",Naftopen,"Nafcillin  Sodium",UNII-SY07234TTS,UNIISY07234TTS,"6-(2-Ethoxy-1-naphthamido)penicillin sodium","6(2E
thoxy1naphthamido)penicillin sodium",MLS000069582,CHEBI:7448,SY07234TTS,6-(2-ETHOXY-1-NAPHTHAMIDO)-PENICIL,6(2ETHOXY1NAPHTHAMIDO)PENICIL,SAM002589927,CPD000058840}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{101534048,23667630}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 24  0  0  0  0            999 V2000
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0031    3.0008    0.0000 N   0  0
    1.3039    3.7494    0.0000 C   0  0
    2.6016    2.9971    0.0000 C   0  0
    1.3070    5.2502    0.0000 C   0  0
    2.6078    5.9988    0.0000 C   0  0
    2.6109    7.4996    0.0000 C   0  0
    3.9110    8.2478    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 N   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    6.4124    1.8725    0.0000 O   0  0
    7.7117    2.6221    0.0000 P   0  0
    7.7117    4.1221    0.0000 O   0  0
    7.7117    1.1221    0.0000 O   0  0
    9.0109    1.8725    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
  5 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 13  1  0
 18 19  2  0
 19  3  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 21 24  2  0
M  END
> <name>
NIHCC_2014

> <id>
6231

> <plate>
NGP-202-03

> <well>
A02

> <supplier_cmpd_name>
CPD000875314

> <ctcr_id>
4061

> <supplier_cmpd_id>
SAM002589929

> <smiles>
COc1cc(NC(C)CCCN)c2ncccc2c1.O[P](O)(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{SCHEMBL41097,"N4-(6-Methoxyquinolin-8-yl)pentane-1,4-diamine phosphate","N4(6Methoxyquinolin8yl)pentane1,4diamine phosphate",NSC149765,MLS001334045,NSC-149765,SMR000875314,NSC619961,CHEMBL994,MLS0021
53831,HMS2234H13,HMS3259B03,Pharmakon1600-01500500,Pharmakon160001500500,EBD11915,NSC757290,AKOS024462450,NC00607,NSC-,NSC,SAM002589929,"NSC 149765",CPD000875314,"Primaquine phosphate"}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{57479320,359247}

$$$$
NIHCC_2014
  SciTegic11012413002D

 18 19  0  0  0  0            999 V2000
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 S   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 N   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -5.1047   -0.0031    0.0000 N   0  0
   -5.8532   -1.3040    0.0000 C   0  0
   -5.1009   -2.6017    0.0000 O   0  0
   -7.3541   -1.3071    0.0000 O   0  0
   -8.1022   -2.6072    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 10 16  2  0
 16 17  1  0
 17  8  1  0
 17 18  2  0
 18  5  1  0
M  END
> <name>
NIHCC_2014

> <id>
6232

> <plate>
NGP-202-03

> <well>
A03

> <supplier_cmpd_name>
CPD000036735

> <ctcr_id>
423

> <supplier_cmpd_id>
SAM002589939

> <smiles>
CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{albendazole,54965-21-8,54965218,Albenza,Eskazole,Valbazen,Zentel,Proftril,Albendazolum,"SK&F 62979","SKF 62979","Methyl 5-(propylthio)-2-benzimidazolecarbamate","Methyl 5(propylthio)2benzimidazolecar
bamate","methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate","methyl N(6propylsulfanyl1Hbenzimidazol2yl)carbamate",SK&F-62979,SK&F62979,5-(Propylthio)-2-ca,5(Propylthio)2ca,SAM002589939,1503903
,Prestw-247,CPD000036735,ALBENDAZOLE,Albendazole}

> <pdid>

> <targets>
{}

> <classes>
{anthelmintic}

> <pubchem_cids>
{2082}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 18  0  0  0  0            999 V2000
    7.0533   -0.4702    0.0000 O   0  0
    6.4430   -1.8405    0.0000 C   0  0
    4.9531   -1.9978    0.0000 C   0  0
    3.9511   -0.8815    0.0000 O   0  0
    2.5987   -1.5004    0.0000 C   0  0
    2.7343   -2.9815    0.0000 C   0  0
    4.2010   -3.2956    0.0000 C   0  0
    4.8089   -4.6669    0.0000 O   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 F   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  3  1  0
  7  8  1  0
  5  9  1  0
  9 10  1  0
 10 11  2  3
 11 12  1  0
 11 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16  9  1  0
 16 17  2  0
M  END
> <name>
NIHCC_2014

> <id>
6233

> <plate>
NGP-202-03

> <well>
A04

> <supplier_cmpd_name>
CPD001496941

> <ctcr_id>
2655

> <supplier_cmpd_id>
SAM002589947

> <smiles>
OCC1OC(CC1O)N2C=C(F)C(=O)NC2=O

> <pd_targets>
{SMN1,MAPT,TMK,TK1,ALDH1A1,TP53,CHRM1,KMT2A,MEN1,MTOR,TYMS,LMNA,TGR,SKA,UL23}

> <pathway_gtopdb>
{"Epigenetic regulator","Other cytosolic protein",Enzyme,"Transcription factor","Membrane receptor",Reader,Transferase,Oxidoreductase,"Family A G protein-coupled receptor",Kinase,"Methyl-lysine/argini
ne binding protein","Small molecule receptor (family A GPCR)",Bromodomain,"Protein Kinase","Tudor domain","Monoamine receptor","Atypical protein kinase group","Acetylcholine receptor","Atypical protei
n kinase PIKK family","Atypical protein kinase FRAP subfamily","Other nuclear protein"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Kinases (EC 2.7.x.x)","Acetylcholine receptors (muscarinic)",Atypical,"Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","FRAP subfamily"
,"2.1.1.- Methyltransferases"}

> <pathway_reactome>
{"Metabolism of RNA","Neuronal System","Cell Cycle",Metabolism,"Signal Transduction","Gene expression (Transcription)","Metabolism of non-coding RNA","Transmission across Chemical Synapses",Mitotic,"B
iological oxidations","Cell Cycle Checkpoints","Signaling by GPCR","RNA Polymerase II Transcription","snRNP Assembly","Neurotransmitter receptors and postsynaptic signal transmission","Mitotic G1 phas
e and G1/S transition","Phase I - Functionalization of compounds","G1/S DNA Damage Checkpoints","GPCR ligand binding","Generic Transcription Pathway","Activation of NMDA receptors and postsynaptic eve
nts","G1/S Transition","Ethanol oxidation","p53-Dependent G1/S DNA damage checkpoint","Class A/1 (Rhodopsin-like receptors)","Transcriptional Regulation by TP53","Post NMDA receptor activation events"
,"G1/S-Specific Transcription","p53-Dependent G1 DNA Damage Response","Amine ligand-binding receptors","Regulation of TP53 Activity","Activation of AMPK downstream of NMDARs","Stabilization of p53","M
uscarinic acetylcholine receptors","Regulation of TP53 Expression and Degradation","Autodegradation of the E3 ubiquitin ligase COP1","Regulation of TP53 Degradation","M Phase","Mitotic Metaphase and A
naphase","Mitotic Anaphase","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{}

> <broad_moa>
{"DNA directed DNA polymerase inhibitor","DNA synthesis inhibitor"}

> <synonyms>
{5-Fluoro-2'-deoxyuridine,5Fluoro2'deoxyuridine,"5 Fluoro 2' deoxyuridine",Floxuridin,FdUrd,Deoxyfluorouridine,"NSC 27640","Uridine, 2'-deoxy-5-fluoro-","Uridine, 2'deoxy5fluoro","Uridine, 2' deoxy 5 
fluoro",2968-28-7,2968287,"2968 28 7",5-FUD,5FUD,27640,SAM002589947,Floxuridine,CPD001496941}

> <pdid>
PD001094

> <targets>
{}

> <classes>
{"Thymidylate synthetase inhibitor"}

> <pubchem_cids>
{3363}

$$$$
NIHCC_2014
  SciTegic11012413002D

 42 43  0  0  0  0            999 V2000
    5.1873   -7.5109    0.0000 C   0  0
    5.1894   -6.0109    0.0000 C   0  0
    3.8912   -5.2578    0.0000 N   0  0
    2.5886   -6.0033    0.0000 C   0  0
    1.2919   -5.2492    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -3.8964   -0.7545    0.0000 Cl  0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.4994    0.7432    0.0000 C   0  0
   -7.7985    1.4932    0.0000 C   0  0
   -7.7985    2.9932    0.0000 C   0  0
   -6.4995    3.7432    0.0000 C   0  0
   -5.2004    2.9933    0.0000 C   0  0
   -2.6030    2.9985    0.0000 C   0  0
   -3.9023    3.7481    0.0000 C   0  0
   -3.9029    5.2481    0.0000 C   0  0
   -2.6041    5.9986    0.0000 C   0  0
   -1.3048    5.2491    0.0000 C   0  0
   -1.3042    3.7491    0.0000 C   0  0
    8.9894   -0.0154    0.0000 O   0  0
    8.9894   -1.5154    0.0000 C   0  0
    7.6901   -2.2650    0.0000 O   0  0
   10.2894   -2.2654    0.0000 C   0  0
   11.5894   -1.5154    0.0000 C   0  0
   12.8879   -2.2662    0.0000 O   0  0
   11.5908   -0.0146    0.0000 C   0  0
   12.8908    0.7354    0.0000 C   0  0
   14.1894   -0.0154    0.0000 O   0  0
   12.8922    2.2354    0.0000 O   0  0
   11.5906   -3.0454    0.0000 C   0  0
   10.2919   -3.7960    0.0000 O   0  0
   12.8897   -3.7951    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 12 15  1  0
 15 16  2  3
 16 17  1  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 15 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 30 31  1  0
 31 32  2  0
 31 33  1  0
 33 34  1  0
 34 35  1  0
 34 36  1  0
 36 37  1  0
 37 38  1  0
 37 39  2  0
 34 40  1  0
 40 41  1  0
 40 42  2  0
M  END
> <name>
NIHCC_2014

> <id>
6234

> <plate>
NGP-202-03

> <well>
A05

> <supplier_cmpd_name>
CPD001317855

> <ctcr_id>
7048

> <supplier_cmpd_id>
SAM002699904

> <smiles>
CCN(CC)CCOc1ccc(cc1)C(=C(Cl)c2ccccc2)c3ccccc3.OC(=O)CC(O)(CC(O)=O)C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"CLOMIPHENE CITRATE",50-41-9,50419,"50 41 9","Clomifene citrate",Clomid,Chloramiphene,"Clomiphene citrate (1:1)",Milophene,Serophene,Clostilbegyt,Clomivid,Clomphid,Dyneric,Genozym,Ikaclomin,43054-45-
1,43054451,"43054 45 1",Omifin,MER-41,MER41,SAM002699904,CPD001317855}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{60974,74388156}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 24  0  0  0  0            999 V2000
    1.7932   -8.3203    0.0000 C   0  0
    2.5451   -7.0223    0.0000 O   0  0
    1.7974   -5.7210    0.0000 C   0  0
    0.2974   -5.7184    0.0000 O   0  0
    2.5497   -4.4224    0.0000 N   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 N   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -2.6030    2.9977    0.0000 O   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2007    1.4909    0.0000 C   0  0
   -6.4972    0.7364    0.0000 C   0  0
   -6.4920   -0.7636    0.0000 C   0  0
   -5.1903   -1.5091    0.0000 C   0  0
   -3.8939   -0.7546    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 13 14  1  0
 14  6  2  0
 11 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
M  END
> <name>
NIHCC_2014

> <id>
6235

> <plate>
NGP-202-03

> <well>
A06

> <supplier_cmpd_name>
CPD000036734

> <ctcr_id>
1318

> <supplier_cmpd_id>
SAM002548959

> <smiles>
COC(=O)Nc1[nH]c2ccc(cc2n1)C(=O)c3ccccc3

> <pd_targets>
{ABL1,KDR,HIF1A,HTT,IMPA1,ALDH1A1,CYP1A2,LMNA,LEF,CDPK1,ABCC4,TUBA1A,TUBB4B}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Unclassified protein","Other nuclear protein",Transporter,"Membrane receptor","Structural protein",Kinase,Hydrolase,Oxidoreductase,"Cytochrome P450",Protease,"Primary a
ctive transporter","Family A G protein-coupled receptor","Protein Kinase","Cytochrome P450 family 1","Metallo protease","ATP-binding cassette","Small molecule receptor (family A GPCR)","TK protein kin
ase group","Cytochrome P450 family 1A","Metallo protease MAE clan","ABCC subfamily","Monoamine-derivative receptor (family A GPCR)","Tyrosine protein kinase Abl family","Tyrosine protein kinase VEGFR 
family","Cytochrome P450 1A1","Metallo protease M34 family","Melatonin receptor"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Other protein targets","Catalytic receptors","Inositol phosphate turnover","Cytochrome P450","ATP-binding cassette transporter family",Tubulins,"Receptor kinases","Ino
sitol monophosphatase","CYP1 family","ABCC subfamily","Receptor guanylyl cyclase (RGC) family","TK: Tyrosine kinase","Nitric oxide (NO)-sensitive (soluble) guanylyl cyclase","Non-receptor tyrosine kin
ases (nRTKs)","Receptor tyrosine kinases (RTKs)","Abl family","Type IV RTKs: VEGF (vascular endothelial growth factor) receptor family"}

> <pathway_reactome>
{Disease,"Signal Transduction","Cellular responses to external stimuli","Gene expression (Transcription)",Metabolism,"Cell Cycle",Hemostasis,"Infectious disease","Signaling by Receptor Tyrosine Kinase
s","Cellular responses to stress","RNA Polymerase II Transcription","Inositol phosphate metabolism","Biological oxidations",Mitotic,"Platelet activation","signaling and aggregation","Leishmania infect
ion","Signaling by VEGF","Cellular response to hypoxia","Generic Transcription Pathway","Synthesis of IP2",IP,"and Ins in the cytosol","Phase I - Functionalization of compounds","M Phase","Uptake and 
actions of bacterial toxins","Response to elevated platelet cytosolic Ca2+","Mitotic G2-G2/M phases","Parasite infection","VEGFA-VEGFR2 Pathway","Oxygen-dependent proline hydroxylation of Hypoxia-indu
cible Factor Alpha","Transcriptional Regulation by MECP2","Ethanol oxidation","Cytochrome P450 - arranged by substrate type","Mitotic Metaphase and Anaphase","Uptake and function of anthrax toxins","P
latelet degranulation","G2/M Transition","Leishmania phagocytosis","VEGFR2 mediated cell proliferation","Regulation of MECP2 expression and activity",Xenobiotics,"Mitotic Anaphase","Centrosome maturat
ion","FCGR3A-mediated phagocytosis","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Nuclear Envelope (NE) Reassembly","Loss of proteins required for interphase microtubule organiza
tion from the centrosome","Initiation of Nuclear Envelope (NE) Reformation","Loss of Nlp from mitotic centrosomes"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{mebendazole,31431-39-7,31431397,Vermox,Telmin,Mebenvet,Pantelmin,Vermirax,Mebenoazole,Ovitelmin,Bantenol,Mebutar,Lomper,MBDZ,Besantin,Vermicidin,Verpanyl,Noverme,Mebendazol,"Methyl (5-benzoyl-1H-benz
o(d)imidazol-2-yl)carbamate","Methyl (5benzoyl1Hbenzo(d)imidazol2yl)carbamate",Mebendazolum,5-Benzoyl,5Benzoyl,T1155,SAM002548959,1501110,Prestw-217,Mebendazole,CPD000036734,MEBENDAZOLE}

> <pdid>
PD001898

> <targets>
{}

> <classes>
{anthelmintic}

> <pubchem_cids>
{4030}

$$$$
NIHCC_2014
  SciTegic11012413002D

 18 19  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
   -0.3115    2.9665    0.0000 N   0  0
    0.6890    4.0818    0.0000 C   0  0
    0.2234    5.5086    0.0000 O   0  0
    1.2255    6.6258    0.0000 C   0  0
    0.7600    8.0526    0.0000 C   0  0
    1.7616    9.1692    0.0000 O   0  0
    2.6947    6.3191    0.0000 C   0  0
    3.6951    7.4368    0.0000 O   0  0
   -1.8032    3.1233    0.0000 C   0  0
   -2.4133    1.7530    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 N   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  8 11  1  0
 11 12  1  0
  5 13  1  0
 13 14  2  0
 14 15  1  0
 15  4  2  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18  2  1  0
M  END
> <name>
NIHCC_2014

> <id>
6236

> <plate>
NGP-202-03

> <well>
A07

> <supplier_cmpd_name>
CPD000058324

> <ctcr_id>
5988

> <supplier_cmpd_id>
SAM002548936

> <smiles>
NC1=Nc2n(COC(CO)CO)cnc2C(=O)N1

> <pd_targets>
{PUNA,LMNA,NFKB1,GRM1,SMN1,HIF1A,KMT2A,MEN1,BLM,CYP3A4,ALDH1A1,GRM5,NFO}

> <pathway_gtopdb>
{Enzyme,"Other nuclear protein","Other cytosolic protein","Membrane receptor","Epigenetic regulator","Transcription factor",Transferase,"Family C G protein-coupled receptor",Reader,"Cytochrome P450",O
xidoreductase,Hydrolase,"Small molecule receptor (family C GPCR)","Methyl-lysine/arginine binding protein",Bromodomain,"Cytochrome P450 family 3","Neurotransmitter receptor (family C GPCR)","Tudor dom
ain","Cytochrome P450 family 3A","Metabotropic glutamate receptor","Cytochrome P450 3A4"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Cytochrome P450","Metabotropic glutamate receptors","CYP3 family"}

> <pathway_reactome>
{"Cell Cycle","Immune System","Signal Transduction","Metabolism of RNA","Cellular responses to external stimuli","DNA Repair",Metabolism,Mitotic,"Cytokine Signaling in Immune system","Signaling by GPC
R","Metabolism of non-coding RNA","Cellular responses to stress","DNA Double-Strand Break Repair","Metabolism of lipids","Biological oxidations","M Phase","Signaling by Interleukins","GPCR downstream 
signalling","snRNP Assembly","Cellular response to hypoxia","Homology Directed Repair","Biosynthesis of specialized proresolving mediators (SPMs)","Phase I - Functionalization of compounds","Mitotic M
etaphase and Anaphase","Interleukin-1 family signaling","G alpha (q) signalling events","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","HDR through Homologous Recombination
 (HRR) or Single Strand Annealing (SSA)","Biosynthesis of DHA-derived SPMs","Ethanol oxidation","Mitotic Anaphase","Interleukin-1 signaling","HDR through Homologous Recombination (HRR)","Biosynthesis 
of maresins","Nuclear Envelope (NE) Reassembly","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Homologous DNA Pairing and Strand Exchange","Biosynthesis of maresin-like SPMs","Initiation of Nuclear Env
elope (NE) Reformation","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{SAM002548936,Prestw-839,Ganciclovir,CPD000058324}

> <pdid>
PD002768

> <targets>
{Antibiotic,CMV,HSV,Nucleoside Antimetabolite/Analog}

> <classes>
{Anti-infection,Cell Cycle/DNA Damage}

> <pubchem_cids>
{3454}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 27  0  0  0  0            999 V2000
   -1.3000   -8.2636    0.0000 F   0  0
   -0.0021   -7.5115    0.0000 C   0  0
   -0.0045   -6.0115    0.0000 C   0  0
    1.2934   -5.2595    0.0000 C   0  0
    2.5937   -6.0074    0.0000 C   0  0
    2.5960   -7.5075    0.0000 C   0  0
    1.2981   -8.2595    0.0000 C   0  0
    3.8934   -5.2570    0.0000 C   0  0
    5.1924   -6.0070    0.0000 C   0  0
    6.4915   -5.2571    0.0000 C   0  0
    6.4915   -3.7571    0.0000 N   0  0
    5.1925   -3.0070    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 O   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  5  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13  8  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 19  1  0
 23 24  2  0
 24 16  1  0
M  END
> <name>
NIHCC_2014

> <id>
6237

> <plate>
NGP-202-03

> <well>
A08

> <supplier_cmpd_name>
CPD001453706

> <ctcr_id>
7056

> <supplier_cmpd_id>
SAM002548935

> <smiles>
Fc1ccc(cc1)C2CCNCC2COc3ccc4OCOc4c3

> <pd_targets>
{KMT2A,MEN1,TGR,KCNH2,SLC6A2,HTR1A,HTR2A,HTR3A,SLC6A4,SLC6A3,ADRA1A,CYP3A4,P2RX4,GRK2,MPO,ADRA2A,ADRA2C,CHRM2,CHRM1,CHRM5,ADRA2B,CHRM3,ADRA1B,ADRA1D,NORA,CYP2D6,CHRM4,THPO,CYP1A2,NFKB1,MAPK1,LMNA,TP53
,NET,PMP22,ABCB11,RORC,TACR1,MTOR,SIGMAR1,CACNA1C,CACNA1D,CACNA1F,CACNA1S,ABCB1,ADRB1,ADRB2,ADRB3,DRD2,HRH1,HTR2B,DRD1,DRD5}

> <pathway_gtopdb>
{"Epigenetic regulator",Enzyme,"Ion channel",Transporter,"Membrane receptor","Unclassified protein","Other cytosolic protein","Other nuclear protein","Transcription factor",Reader,"Voltage-gated ion c
hannel","Electrochemical transporter","Family A G protein-coupled receptor","Ligand-gated ion channel","Cytochrome P450",Kinase,Oxidoreductase,"Primary active transporter","Nuclear receptor",Bromodoma
in,"Potassium channels","SLC superfamily of solute carriers","Small molecule receptor (family A GPCR)","5HT3 receptor","Cytochrome P450 family 3","P2X receptor","Protein Kinase","Cytochrome P450 famil
y 2","Cytochrome P450 family 1","ATP-binding cassette","Nuclear hormone receptor subfamily 1","Peptide receptor (family A GPCR)","Voltage-gated calcium channel","Voltage-gated potassium channel","SLC0
6 neurotransmitter transporter family","Monoamine receptor","Cytochrome P450 family 3A","AGC protein kinase group","Cytochrome P450 family 2D","Cytochrome P450 family 1A","CMGC protein kinase group","
ABCB subfamily","Nuclear hormone receptor subfamily 1 group F","Short peptide receptor (family A GPCR)","Atypical protein kinase group","Serotonin receptor","Adrenergic receptor","Cytochrome P450 3A4"
,"AGC protein kinase GRK family","Acetylcholine receptor","Cytochrome P450 2D6","Cytochrome P450 1A1","CMGC protein kinase MAPK family","Nuclear hormone receptor subfamily 1 group F member 3","Neuroki
nin receptor","Atypical protein kinase PIKK family","Dopamine receptor","Histamine receptor","AGC protein kinase BARK subfamily","CMGC protein kinase ERK1","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{"Ion channels",Receptors,Transporters,Enzymes,"Other protein targets","Voltage-gated ion channels","G protein-coupled receptors","Ligand-gated ion channels","SLC superfamily of solute carriers","Cyto
chrome P450","Kinases (EC 2.7.x.x)","1.-.-.- Oxidoreductases","ATP-binding cassette transporter family","Nuclear hormone receptors","Sigma receptors","Potassium channels","5-Hydroxytryptamine receptor
s","5-HT<sub>3</sub> receptors","SLC6 neurotransmitter transporter family",Adrenoceptors,"CYP3 family","P2X receptors","AGC: Containing PKA",PKG,"PKC families","Acetylcholine receptors (muscarinic)","
CYP2 family: drug metabolising subset","CYP1 family","CMGC: Containing CDK",MAPK,GSK3,"CLK families","ABCB subfamily","1F. Retinoic acid-related orphans","Tachykinin receptors",Atypical,"Dopamine rece
ptors","Histamine receptors","Voltage-gated potassium channels","Monoamine transporter subfamily","G protein-coupled receptor kinases (GRKs)","Mitogen-activated protein kinases (MAP kinases)","Phospha
tidyl inositol 3' kinase-related kinases (PIKK) family","Beta-adrenergic receptor kinases (&beta;ARKs)","ERK subfamily","FRAP subfamily"}

> <pathway_reactome>
{"Muscle contraction","Signal Transduction","Neuronal System",Disease,Metabolism,"Immune System",Hemostasis,"Cell Cycle","Developmental Biology","Gene expression (Transcription)","Cardiac conduction",
"Signaling by GPCR","Transmission across Chemical Synapses","Disorders of transmembrane transporters","Metabolism of lipids","Infectious disease","Intracellular signaling by second messengers","Innate
 Immune System","Biological oxidations","Platelet activation","signaling and aggregation","Cytokine Signaling in Immune system",Mitotic,"Cell Cycle Checkpoints","Nervous system development","RNA Polym
erase II Transcription","Abacavir transport and metabolism","Phase 3 - rapid repolarisation","GPCR ligand binding","Neurotransmitter receptors and postsynaptic signal transmission","Neurotransmitter c
learance","SLC transporter disorders","Biosynthesis of specialized proresolving mediators (SPMs)","Leishmania infection","DAG and IP3 signaling","ROS and RNS production in phagocytes","Phase I - Funct
ionalization of compounds","Platelet Aggregation (Plug Formation)","Signaling by Interleukins","Toll-like Receptor Cascades","M Phase","G1/S DNA Damage Checkpoints","EGR2 and SOX10-mediated initiation
 of Schwann cell myelination","Metabolism of steroids","Generic Transcription Pathway","SARS-CoV Infections","Abacavir transmembrane transport","Class A/1 (Rhodopsin-like receptors)","Serotonin cleara
nce from the synaptic cleft","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Biosynthesis of DHA-derived SPMs","Cell recruitment (pro-inflammatory response)","CaM pathway","Events a
ssociated with phagocytolytic activity of PMN cells","Defective SLC6A2 causes orthostatic intolerance (OI)","Cytochrome P450 - arranged by substrate type","Interleukin-1 family signaling","Toll Like R
eceptor 5 (TLR5) Cascade","Mitotic Metaphase and Anaphase","p53-Dependent G1/S DNA damage checkpoint","Bile acid and bile salt metabolism","Transcriptional regulation by RUNX3","Transcriptional Regula
tion by TP53","Potential therapeutics for SARS","Amine ligand-binding receptors","Biosynthesis of maresins","Purinergic signaling in leishmaniasis infection","Calmodulin induced events",Xenobiotics,"I
nterleukin-1 signaling","MyD88 cascade initiated on plasma membrane","Mitotic Anaphase","p53-Dependent G1 DNA Damage Response","Synthesis of bile acids and bile salts","RUNX3 Regulates Immune Response
 and Cell Migration","Peptide ligand-binding receptors","Regulation of TP53 Activity","Serotonin receptors",Adrenoceptors,"Biosynthesis of maresin-like SPMs","Muscarinic acetylcholine receptors","CYP2
E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","MAP3K8 (TPL2)-dependent MAPK1/3 activation","MAP kinase activation","Nuclear Envelope (NE) Reassembly","Stabilization 
of p53","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Tachykinin receptors bind tachykinins","Regulation of TP53 Expression and Degradation","Dopamine receptors","Histamine r
eceptors","MAPK targets/ Nuclear events mediated by MAP kinases","Initiation of Nuclear Envelope (NE) Reformation","Autodegradation of the E3 ubiquitin ligase COP1","Regulation of TP53 Degradation","E
RK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,HTR2A,SLC6A2,SLC6A4}

> <broad_moa>
{"selective serotonin reuptake inhibitor (SSRI)"}

> <synonyms>
{"3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine","3(1,3benzodioxol5yloxymethyl)4(4fluorophenyl)piperidine","3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine","3((1,3Be
nzodioxol5yloxy)methyl)4(4fluorophenyl)piperidine",Frosinor,Motivan,Paxetil,PaxPar,NCGC00182968-01,NCGC0018296801,paroxetinehydrochloride,"Seroxat (Salt/Mix)",3-((2H-1,3((2H1,3-benzo,3benzo,T1636,SAM0
02548935,"Paroxetine hydrochloride",CPD001453706}

> <pdid>
PD002925

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{4691}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 30  0  0  1  0            999 V2000
   -4.2373   -9.9695    0.0000 C   0  0
   -3.2334   -8.8550    0.0000 N   0  0
   -1.7662   -9.1671    0.0000 C   0  0
   -0.7624   -8.0525    0.0000 C   0  0
   -1.2256   -6.6258    0.0000 N   0  0
   -2.6928   -6.3138    0.0000 C   0  0
   -3.6967   -7.4283    0.0000 C   0  0
   -0.2234   -5.5086    0.0000 C   0  0
    1.2443   -5.8182    0.0000 O   0  0
   -0.6890   -4.0818    0.0000 O   0  0
    0.3114   -2.9665    0.0000 C   0  0  2  0  0  0
    1.8032   -3.1233    0.0000 N   0  0
    2.4133   -1.7530    0.0000 C   0  0
    3.8805   -1.4410    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    2.5536   -4.4230    0.0000 C   0  0
    1.9048   -5.7699    0.0000 C   0  0
    2.7505   -7.0088    0.0000 C   0  0
    4.2462   -6.8959    0.0000 C   0  0
    5.0918   -8.1349    0.0000 Cl  0  0
    4.8963   -5.5441    0.0000 C   0  0
    4.0507   -4.3052    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  2  1  0
  5  8  1  0
  8  9  2  0
  8 10  1  0
 11 10  1  1
 11 12  1  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 11  1  0
 20 15  1  0
 12 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 24 26  1  0
 26 27  2  0
 27 21  1  0
M  END
> <name>
NIHCC_2014

> <id>
6238

> <plate>
NGP-202-03

> <well>
A09

> <supplier_cmpd_name>
CPD000550478

> <ctcr_id>
7060

> <supplier_cmpd_id>
SAM002548982

> <smiles>
CN1CCN(CC1)C(=O)O[C@@H]2N(C(=O)c3nccnc23)c4ccc(Cl)cn4

> <pd_targets>
{GABRA3,GABRB2,GABRG2,GABRA1,GABRA4,GABRA2,GABRA5,GABRA6,GABRB1,GABRB3,GABRD,GABRE,GABRG1,GABRG3,GABRP,GABRQ,MAPT,RECQL,TSPO}

> <pathway_gtopdb>
{"Ion channel","Ligand-gated ion channel","GABA-A receptor","Other cytosolic protein",Enzyme,"Membrane receptor"}

> <pathway_chembl>
{"Ion channels","Ligand-gated ion channels","GABA<sub>A</sub> receptors","Other protein targets","Mitochondrial-associated proteins"}

> <pathway_reactome>
{"Neuronal System","Transmission across Chemical Synapses","Neurotransmitter receptors and postsynaptic signal transmission","GABA receptor activation",Metabolism,"Metabolism of lipids","Metabolism of
 steroids","Activation of NMDA receptors and postsynaptic events","Metabolism of steroid hormones","Post NMDA receptor activation events","Pregnenolone biosynthesis","Activation of AMPK downstream of 
NMDARs"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{Eszopiclone,138729-47-2,138729472,Lunesta,(S)-Zopiclone,(S)Zopiclone,Estorra,Esopiclone,(+)-Zopiclone,(+)Zopiclone,SEP-190,SEP190,UNII-UZX80K71OE,UNIIUZX80K71OE,CHEBI:53760,SEP-225441,SEP225441,UZX80
K71OE,NCGC00159515-02,NCGC0015951502,DSSTox_CID_26086,DSSToxCID26086,DSSTox-CID-26086,"DSSTox CID 26086",DSSTox_RID_81327,DSSToxRID81327,DSSTox-RID-81327,"DSSTox RID 81327",DSSTox_GSID_46086,DSSToxGSI
D46086,DSSTox-GSID-46086,"DSSTox GSID 46086","Eszopiclone (USAN:INN)","( )-Zopiclo","( )Zopiclo",SAM002548982,CPD000550478}

> <pdid>
PD001479

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{969472}

$$$$
NIHCC_2014
  SciTegic11012413002D

 13 13  0  0  0  0            999 V2000
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 11 13  2  0
 13  6  1  0
M  END
> <name>
NIHCC_2014

> <id>
6239

> <plate>
NGP-202-03

> <well>
A10

> <supplier_cmpd_name>
CPD000857209

> <ctcr_id>
4500

> <supplier_cmpd_id>
SAM002699891

> <smiles>
CNCC(O)c1ccc(O)c(O)c1

> <pd_targets>
{TDP1,FFP,RORC,ADRA2B,ADRB3,MAPT,HTR7,ADRA1A,SLC6A2,ADRA1B,DRD2,ADRB2,KMT2A,ALD,GRK2,ADRA2C,APEX1,MEN1,ADRA2A,ADRB1,SLC22A1,PMP22,BLM,TGR,KDM4E,NPSR1,CYP2D6,THPO,ADRA1D,HIF1A,MAPK1,CYP3A4,ALDH1A1,CYP1
A2,ABCC1,RECQL,TSHR,HSD17B10,ALOX15,CHRM1,GAA,RXFP1,NFKB1,MTOR,CA1,TNF}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Membrane receptor","Other cytosolic protein",Transporter,"Epigenetic regulator","Unclassified protein",Hydrolase,Transferase,"Nuclear receptor","Family A G protein-coup
led receptor","Electrochemical transporter",Reader,Kinase,Eraser,"Nuclear hormone receptor subfamily 1","Small molecule receptor (family A GPCR)","SLC superfamily of solute carriers",Bromodomain,"Prot
ein Kinase","Lysine demethylase","Peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1 group F","Monoamine receptor","SLC06 neurotransmitter transporter family","AGC protein kinase 
group","SLC22 family of organic cation and anion transporters","Jumonji domain-containing","Short peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1 group F member 3","Adrenergic 
receptor","Serotonin receptor","Dopamine receptor","AGC protein kinase GRK family","Neuropeptide receptor","AGC protein kinase BARK subfamily","Secreted protein","Cytochrome P450",Oxidoreductase,"Prim
ary active transporter",Lyase,"Cytochrome P450 family 2","Cytochrome P450 family 3","Cytochrome P450 family 1","ATP-binding cassette","Cytochrome P450 family 2D","CMGC protein kinase group","Cytochrom
e P450 family 3A","Cytochrome P450 family 1A","ABCC subfamily","Glycohormone receptor","Relaxin-like peptide receptor (family A GPCR)","Atypical protein kinase group","Cytochrome P450 2D6","CMGC prote
in kinase MAPK family","Cytochrome P450 3A4","Cytochrome P450 1A1","Acetylcholine receptor","Relaxin receptor","Atypical protein kinase PIKK family","CMGC protein kinase ERK1","Atypical protein kinase
 FRAP subfamily"}

> <pathway_chembl>
{Receptors,Transporters,Enzymes,"Nuclear hormone receptors","G protein-coupled receptors","SLC superfamily of solute carriers","Chromatin modifying enzymes","Kinases (EC 2.7.x.x)","1F. Retinoic acid-r
elated orphans",Adrenoceptors,"5-Hydroxytryptamine receptors","SLC6 neurotransmitter transporter family","Dopamine receptors","2.1.1.43 Histone methyltransferases (HMTs)","AGC: Containing PKA",PKG,"PK
C families","SLC22 family of organic cation and anion transporters","1.14.11.- Histone demethylases","Neuropeptide S receptor","Monoamine transporter subfamily","G protein-coupled receptor kinases (GR
Ks)","Organic cation transporters (OCT)","Beta-adrenergic receptor kinases (&beta;ARKs)","Cytochrome P450","ATP-binding cassette transporter family","Eicosanoid turnover","3.2.1.- Glycosidases","Carbo
nic anhydrases","CYP2 family: drug metabolising subset","CMGC: Containing CDK",MAPK,GSK3,"CLK families","CYP3 family","CYP1 family","ABCC subfamily","Glycoprotein hormone receptors",Lipoxygenases,"Ace
tylcholine receptors (muscarinic)","Relaxin family peptide receptors",Atypical,"Mitogen-activated protein kinases (MAP kinases)","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","ERK su
bfamily","FRAP subfamily"}

> <pathway_reactome>
{"DNA Repair","Gene expression (Transcription)","Signal Transduction",Disease,"Neuronal System","Transport of small molecules","Developmental Biology","DNA Double-Strand Break Repair","RNA Polymerase 
II Transcription","Signaling by GPCR","Infectious disease","Transmission across Chemical Synapses","Disorders of transmembrane transporters","Intracellular signaling by second messengers","Base Excisi
on Repair","SLC-mediated transmembrane transport","Nervous system development","Nonhomologous End-Joining (NHEJ)","Generic Transcription Pathway","GPCR ligand binding","Leishmania infection","Neurotra
nsmitter receptors and postsynaptic signal transmission","SLC transporter disorders","DAG and IP3 signaling","Resolution of Abasic Sites (AP sites)","Transport of bile salts and organic acids","metal 
ions and amine compounds","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Homology Directed Repair","Transcriptional regulation by RUNX3","Class A/1 (Rhodopsin-like receptors)","Leis
hmania parasite growth and survival","Activation of NMDA receptors and postsynaptic events","Defective SLC6A2 causes orthostatic intolerance (OI)","Transcriptional regulation by RUNX1","CaM pathway","
Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Organic cation/anion/zwitterion transport","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)",
"RUNX3 Regulates Immune Response and Cell Migration","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Post NMDA receptor activation events","RUNX1
 regulates genes involved in megakaryocyte differentiation and platelet function","Calmodulin induced events","PCNA-Dependent Long Patch Base Excision Repair","Organic cation transport","HDR through H
omologous Recombination (HRR)",Adrenoceptors,"ADORA2B mediated anti-inflammatory cytokines production","Activation of AMPK downstream of NMDARs","Dopamine receptors","Homologous DNA Pairing and Strand
 Exchange","Presynaptic phase of homologous DNA pairing and strand exchange",Metabolism,Hemostasis,"Cellular responses to external stimuli","Immune System","Biological oxidations","Platelet activation
","signaling and aggregation","Cellular responses to stress","Innate Immune System","Metabolism of lipids","Metabolism of amino acids and derivatives","Diseases of metabolism","Cytokine Signaling in I
mmune system","Phase I - Functionalization of compounds","Platelet Aggregation (Plug Formation)","Cellular response to hypoxia","Toll-like Receptor Cascades","Biosynthesis of specialized proresolving 
mediators (SPMs)","Fatty acid metabolism","Branched-chain amino acid catabolism","Diseases of carbohydrate metabolism","Signaling by Interleukins","Cytochrome P450 - arranged by substrate type","Oxyge
n-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Toll Like Receptor 5 (TLR5) Cascade","Biosynthesis of DHA-derived SPMs","Ethanol oxidation","Arachidonic acid metabolism","Biosynt
hesis of DPA-derived SPMs","Glycogen storage diseases","Interleukin-1 family signaling","Transcriptional Regulation by TP53","Interleukin-12 family signaling","Interleukin-10 signaling",Xenobiotics,"M
yD88 cascade initiated on plasma membrane","Biosynthesis of maresins","Synthesis of Leukotrienes (LT) and Eoxins (EX)","Biosynthesis of DPAn-3 SPMs","Glycogen storage disease type II (GAA)","Interleuk
in-1 signaling","Regulation of TP53 Activity","Interleukin-12 signaling","CYP2E1 reactions","MAP kinase activation","Biosynthesis of maresin-like SPMs","Aromatic amines can be N-hydroxylated or N-deal
kylated by CYP1A2","Biosynthesis of DPAn-3-derived protectins and resolvins","Muscarinic acetylcholine receptors","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Regulation of TP53 Expression and Degrad
ation","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","MAPK targets/ Nuclear events mediated by MAP kinases","Regulation of TP53 Degradation","ERK/MAPK targets","
ERKs are inactivated"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,ADRA2A,ADRA2B,ADRA2C,ADRB1,ADRB2,ADRB3,PAH,TNF}

> <broad_moa>
{"adrenergic receptor agonist","carbonic anhydrase activator",neurotransmitter}

> <synonyms>
{ADRENALIN,SDCCGSBI-0050505.P002,SDCCGSBI0050505.P002,DL-Adrenaline,DLAdrenaline,329-65-7,329657,dl-Epinephrine,dlEpinephrine,Racepinefrine,Racepinephrine,adrenaline,"Epinephrine racemic",(+-)-Adrenal
ine,(+)Adrenaline,"4-(1-hydroxy-2-(methylamino)ethyl)benzene-1,2-diol","4(1hydroxy2(methylamino)ethyl)benzene1,2diol",Racepinefrina,Racepinefrinum,(+-)-Epinephrine,(+)Epinephrine,Epire,T1071L,T1071,T1
071L2,S2523,SAM002699891,S2522,"DL-Adrenaline Hydrochloride",L-Adrenaline,DL-Adrenalin,CPD000857209}

> <pdid>
PD003193

> <targets>
{"Adrenergic Receptor",GPCR}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{838,4866774}

$$$$
NIHCC_2014
  SciTegic11012413002D

 18 20  0  0  0  0            999 V2000
    4.1718    0.3758    0.0000 N   0  0
    3.1497   -0.7220    0.0000 C   0  0
    3.5898   -2.1560    0.0000 O   0  0
    1.6852   -0.3846    0.0000 N   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.5913    1.9239    0.0000 C   0  0
    2.4792    3.4197    0.0000 C   0  0
    1.1278    4.0705    0.0000 C   0  0
   -0.1116    3.2255    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 10 11  1  0
 11 12  2  3
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18  4  1  0
 18 13  1  0
M  END
> <name>
NIHCC_2014

> <id>
6240

> <plate>
NGP-202-03

> <well>
A11

> <supplier_cmpd_name>
CPD001227191

> <ctcr_id>
1568

> <supplier_cmpd_id>
SAM002264603

> <smiles>
NC(=O)N1c2ccccc2C=Cc3ccccc13

> <pd_targets>
{TSHR,ALB,FZD8,SCN9A,LMNA,SCN4A,SCN10A,SCN11A,SCN1A,SCN2A,SCN3A,SCN5A,SCN7A,SCN8A,NR1I2}

> <pathway_gtopdb>
{"Membrane receptor","Secreted protein","Ion channel","Other nuclear protein","Transcription factor","Family A G protein-coupled receptor","Frizzled family G protein-coupled receptor","Voltage-gated i
on channel","Nuclear receptor","Peptide receptor (family A GPCR)","Voltage-gated sodium channel","Nuclear hormone receptor subfamily 1","Glycohormone receptor","Nuclear hormone receptor subfamily 1 gr
oup I","Nuclear hormone receptor subfamily 1 group I member 2"}

> <pathway_chembl>
{Receptors,"Ion channels","G protein-coupled receptors","Voltage-gated ion channels","Nuclear hormone receptors","Glycoprotein hormone receptors","Class Frizzled GPCRs","Voltage-gated sodium channels"
,"1I. Vitamin D receptor-like receptors"}

> <pathway_reactome>
{Disease,Metabolism,"Signal Transduction","Developmental Biology","Cell Cycle","Metabolism of proteins","Infectious disease","Metabolism of lipids","Signaling by WNT","Nervous system development",Mito
tic,"Post-translational protein modification","Leishmania infection","Metabolism of steroids","Beta-catenin independent WNT signaling","Axon guidance","M Phase",SUMOylation,"Leishmania parasite growth
 and survival","Bile acid and bile salt metabolism","PCP/CE pathway","L1CAM interactions","Mitotic Metaphase and Anaphase","SUMO E3 ligases SUMOylate target proteins","Anti-inflammatory response favou
ring Leishmania parasite infection","Recycling of bile acids and salts","Asymmetric localization of PCP proteins","Interaction between L1 and Ankyrins","Mitotic Anaphase","SUMOylation of intracellular
 receptors","ADORA2B mediated anti-inflammatory cytokines production","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{SCN10A,SCN11A,SCN1A,SCN2A,SCN3A,SCN4A,SCN5A,SCN7A,SCN8A,SCN9A}

> <broad_moa>
{"carboxamide antiepileptic"}

> <synonyms>
{carbamazepine,298-46-4,298464,Tegretol,Carbamazepen,"5H-Dibenzo(b,f)azepine-5-carboxamide","5HDibenzo(b,f)azepine5carboxamide",Carbazepine,Finlepsin,Biston,Equetro,"5H-Dibenz(b,f)azepine-5-carboxamid
e","5HDibenz(b,f)azepine5carboxamide",Carbamezepine,Tegretal,Epitol,Karbamazepin,Carbatrol,Neurotol,Timonil,Carbamazepin,T0943,SAM002264603,1500159,Prestw-52,Carbamazepine,CPD001227191,CARBAMAZEPINE}

> <pdid>
PD002445

> <targets>
{}

> <classes>
{analgesic,anticonvulsant}

> <pubchem_cids>
{2554}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 31  0  0  0  0            999 V2000
    7.1216   -4.0985    0.0000 Na  0  3
    4.6130   -4.5087    0.0000 C   0  0
    3.9403   -5.8494    0.0000 C   0  0
    4.6216   -7.1858    0.0000 O   0  0
    3.5612   -8.2467    0.0000 N   0  0
    2.2245   -7.5661    0.0000 C   0  0
    0.8835   -8.2398    0.0000 C   0  0
   -0.4263   -7.5195    0.0000 C   0  0
   -1.7090   -8.2972    0.0000 C   0  0
   -1.6768   -9.7968    0.0000 C   0  0
   -0.3620  -10.5188    0.0000 C   0  0
    0.9207   -9.7411    0.0000 C   0  0
    2.4742   -6.0999    0.0000 C   0  0
    1.4149   -5.0368    0.0000 C   0  0
   -0.0346   -5.4229    0.0000 O   0  0
    1.8050   -3.5876    0.0000 N   0  0
    0.7500   -2.5287    0.0000 C   0  0
    0.7500   -1.0323    0.0000 C   0  0
    1.2135    0.3943    0.0000 S   0  0
    0.0000    1.2760    0.0000 C   0  0
   -1.3101    2.0064    0.0000 C   0  0
    1.3100    2.0066    0.0000 C   0  0
   -1.2135    0.3943    0.0000 C   0  0
   -0.7500   -1.0323    0.0000 N   0  0
   -0.7500   -2.5287    0.0000 C   0  0
   -1.8107   -3.5893    0.0000 O   0  0
   -2.6394    0.8543    0.0000 C   0  0
   -2.9539    2.3210    0.0000 O   0  5
   -3.7527   -0.1510    0.0000 O   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  6 13  1  0
 13  3  2  0
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 20 23  1  0
 23 24  1  0
 24 18  1  0
 24 25  1  0
 25 17  1  0
 25 26  2  0
 23 27  1  0
 27 28  1  0
 27 29  2  0
M  CHG  2   1   1  28  -1
M  END
> <name>
NIHCC_2014

> <id>
6241

> <plate>
NGP-202-03

> <well>
B02

> <supplier_cmpd_name>
CPD001496934

> <ctcr_id>
7038

> <supplier_cmpd_id>
SAM002589930

> <smiles>
[Na+].Cc1onc(c2ccccc2)c1C(=O)NC3C4SC(C)(C)C(N4C3=O)C([O-])=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{CHEMBL3182442,HMS3259D03,HMS3604I08,AKOS026749992,MCULE-4344643806,MCULE4344643806,NC00608,DB-041367,DB041367,FT-0603549,FT0603549,FT-0673318,FT0673318,SAM002589930,CPD001496934}

> <pdid>
PD052324

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{3664549,121595923}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 26  0  0  1  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0031    3.0008    0.0000 O   0  0
    1.3032    3.7490    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 C   0  0
   -3.1882    2.6401    0.0000 O   0  0
   -3.6065    0.0000    0.0000 C   0  0  2  0  0  0
   -2.7248   -1.2135    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 Cl  0  0
   -4.9999   -0.6697    0.0000 C   0  0  2  0  0  0
   -5.0761   -2.1678    0.0000 C   0  0
   -6.2788    0.1140    0.0000 C   0  0
   -6.2396    1.6135    0.0000 C   0  0
   -7.5185    2.3973    0.0000 O   0  0
   -4.9213    2.3293    0.0000 C   0  0
   -3.6424    1.5455    0.0000 C   0  0
   -2.3492    2.3081    0.0000 O   0  0
   -2.3624    3.8081    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  5  8  2  0
  8  9  1  0
  9 10  2  0
 11  9  1  6
 11 12  1  0
 12 13  1  0
 13  8  1  0
 13 14  2  0
 14  3  1  0
 14 15  1  0
 11 16  1  0
 16 17  1  6
 16 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  2  3
 22 11  1  0
 22 23  1  0
 23 24  1  0
M  END
> <name>
NIHCC_2014

> <id>
6242

> <plate>
NGP-202-03

> <well>
B03

> <supplier_cmpd_name>
CPD000718755

> <ctcr_id>
5526

> <supplier_cmpd_id>
SAM002589940

> <smiles>
COc1cc(OC)c2C(=O)[C@]3(Oc2c1Cl)[C@H](C)CC(=O)C=C3OC

> <pd_targets>
{HSD17B10,KDM4E,ALDH1A1,TSHR,CYP3A4,HPGD,SLC22A1,CYP51A1,TUB2,KRT12,HTT,HIF1A}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Membrane receptor",Transporter,"Unclassified protein","Transcription factor",Oxidoreductase,Eraser,"Family A G protein-coupled receptor",Protease,"Cytochrome P450","Ele
ctrochemical transporter","Lysine demethylase","Peptide receptor (family A GPCR)","Cysteine protease","Cytochrome P450 family 3","SLC superfamily of solute carriers","Cytochrome P450 family 51","Small
 molecule receptor (family A GPCR)","Jumonji domain-containing","Glycohormone receptor","Cysteine protease CA clan","Cytochrome P450 family 3A","SLC22 family of organic cation and anion transporters",
"Cytochrome P450 family 51A","Monoamine-derivative receptor (family A GPCR)","Cysteine protease C1A family","Cytochrome P450 3A4","Cytochrome P450 51A1","Melatonin receptor"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Chromatin modifying enzymes","G protein-coupled receptors","Cytochrome P450","Eicosanoid turnover","SLC superfamily of solute carriers","Catalytic receptors","1.14.11.
- Histone demethylases","Glycoprotein hormone receptors","CYP3 family","Prostaglandin synthases","SLC22 family of organic cation and anion transporters",CYP39,"CYP46 and CYP51 families","Receptor guan
ylyl cyclase (RGC) family","Organic cation transporters (OCT)","Nitric oxide (NO)-sensitive (soluble) guanylyl cyclase"}

> <pathway_reactome>
{Metabolism,Disease,"Transport of small molecules","Developmental Biology","Gene expression (Transcription)","Cellular responses to external stimuli","Metabolism of amino acids and derivatives","Biolo
gical oxidations","Infectious disease","Metabolism of lipids","SLC-mediated transmembrane transport",Keratinization,"RNA Polymerase II Transcription","Cellular responses to stress","Branched-chain ami
no acid catabolism","Phase I - Functionalization of compounds","Leishmania infection","Biosynthesis of specialized proresolving mediators (SPMs)","Transport of bile salts and organic acids","metal ion
s and amine compounds","Formation of the cornified envelope","Generic Transcription Pathway","Cellular response to hypoxia","Ethanol oxidation","Leishmania parasite growth and survival","Biosynthesis 
of DHA-derived SPMs","Organic cation/anion/zwitterion transport","Cytochrome P450 - arranged by substrate type","Transcriptional Regulation by MECP2","Oxygen-dependent proline hydroxylation of Hypoxia
-inducible Factor Alpha","Anti-inflammatory response favouring Leishmania parasite infection","Biosynthesis of maresins","Biosynthesis of D-series resolvins","Organic cation transport","Endogenous ste
rols","Regulation of MECP2 expression and activity","ADORA2B mediated anti-inflammatory cytokines production","Biosynthesis of maresin-like SPMs"}

> <broad_targets>
{KRT12}

> <broad_moa>
{"tubulin polymerization inhibitor"}

> <synonyms>
{griseofulvin,126-07-8,126078,(+)-Griseofulvin,(+)Griseofulvin,Amudane,Fulvicin,Grisactin,Grisefuline,Griseofulvina,Griseofulvinum,Grizeofulvin,Grifulvin,Grisofulvin,Spirofulvin,Fulcin,Grysio,Lamoryl,
Likuden,Griseofulvine,Poncyl,"Curling factor",Grisovin,Griseofulv,T1382,SAM002589940,200046,Prestw-226,Griseofulvin,CPD000718755,GRISEOFULVIN}

> <pdid>
PD002235

> <targets>
{}

> <classes>
{"inhibits mitosis in metaphase",antifungal}

> <pubchem_cids>
{441140}

$$$$
NIHCC_2014
  SciTegic11012413002D

 34 34  0  0  0  0            999 V2000
   15.4003    1.1322    0.0000 H   0  3
   12.9003    1.1322    0.0000 Cl  0  5
   10.3996   -1.4837    0.0000 O   0  0
    9.0990   -0.7364    0.0000 C   0  0
    7.8003   -1.4887    0.0000 C   0  0
    6.4990   -0.7409    0.0000 N   0  0
    5.2003   -1.4932    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5973    1.5031    0.0000 N   0  0
   -2.5951    3.0039    0.0000 C   0  0
   -3.8933    3.7570    0.0000 C   0  0
   -3.8912    5.2578    0.0000 N   0  0
   -5.1894    6.0109    0.0000 C   0  0
   -5.1873    7.5117    0.0000 C   0  0
   -6.4848    8.2644    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 O   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -3.8971   -3.7500    0.0000 C   0  0
   -5.1961   -3.0000    0.0000 O   0  0
   -3.8971   -5.2500    0.0000 C   0  0
   -2.5980   -6.0000    0.0000 C   0  0
   -1.2990   -5.2500    0.0000 C   0  0
    0.0000   -6.0000    0.0000 O   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    1.2991   -3.7500    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 13 21  1  0
 21 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  2  0
 25 26  1  0
 25 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  1  0
 29 31  2  0
 31 24  1  0
 31 32  1  0
 32 33  2  0
 32 34  1  0
 34 10  1  0
 34 21  2  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6243

> <plate>
NGP-202-03

> <well>
B04

> <supplier_cmpd_name>
CPD001563707

> <ctcr_id>
7043

> <supplier_cmpd_id>
SAM002699896

> <smiles>
[H+].[Cl-].OCCNCCNc1ccc(NCCNCCO)c2C(=O)c3c(O)ccc(O)c3C(=O)c12

> <pd_targets>
{NFKB1,STK33,ALOX15,UBA3,USP2,CSNK2A1,CSNK2A2,CSNK2A3,CSNK2B,MAPT,ROS1,MAPK1,BLM,NPSR1,MPG,KMT2A,MEN1,KDM4E,L3MBTL1,ALD,TP53,LMNA,RECQL,FTL,POLB,DYRK1A,PIM1,APEX1,RORC,PMP22,NFO,ALDH1A1,TOP2A,CHRM1,SL
CO1B3,BTK,CYP2D6,HIF1A,PKM,CYP1A2,POL,LANA1,THPO,IMPA1,BLA(TEM-2),NSD2,HTT,CYP3A4,PYK,SLC22A1,ABCB1,PAX8,ERBB2,HTR2C,CHRM2,ABCC1,MTOR,KCNH2,CHRM4,SLC22A2,NAE1,FYN,SLC47A2,SLC6A2,SLC47A1,CACNA1C,CACNA1
D,CACNA1F,CACNA1S,ABCG2,EGFR,SLC22A3}

> <pathway_gtopdb>
{"Other cytosolic protein",Enzyme,"Membrane receptor","Epigenetic regulator","Transcription factor","Other nuclear protein","Unclassified protein",Transporter,"Ion channel",Kinase,Oxidoreductase,Ligas
e,Protease,"Family A G protein-coupled receptor",Reader,Eraser,"Nuclear receptor",Hydrolase,Isomerase,"Electrochemical transporter","Cytochrome P450",Writer,Transferase,"Primary active transporter","V
oltage-gated ion channel","Protein Kinase","Cysteine protease","Peptide receptor (family A GPCR)",Bromodomain,"Lysine demethylase","Methyl-lysine/arginine binding protein","Nuclear hormone receptor su
bfamily 1","Small molecule receptor (family A GPCR)","SLC superfamily of solute carriers","Cytochrome P450 family 2","Cytochrome P450 family 1","Protein methyltransferase","Cytochrome P450 family 3","
ATP-binding cassette","Potassium channels","Voltage-gated calcium channel","CAMK protein kinase group","Cysteine protease CA clan","Other protein kinase group","TK protein kinase group","CMGC protein 
kinase group","Short peptide receptor (family A GPCR)","Jumonji domain-containing","MBT domain","Nuclear hormone receptor subfamily 1 group F","Monoamine receptor","SLC21/SLCO family of organic anion 
transporting polypeptides","Cytochrome P450 family 2D","Cytochrome P450 family 1A","SET domain","Cytochrome P450 family 3A","SLC22 family of organic cation and anion transporters","ABCB subfamily","AB
CC subfamily","Atypical protein kinase group","Voltage-gated potassium channel","SLC47 family of multidrug and toxin extrusion transporters","SLC06 neurotransmitter transporter family","ABCG subfamily
","CAMK protein kinase unique family","Cysteine protease C19 family","Other protein kinase CK2 family","Tyrosine protein kinase Sev family","CMGC protein kinase MAPK family","Neuropeptide receptor","C
MGC protein kinase DYRK family","CAMK protein kinase PIM family","Nuclear hormone receptor subfamily 1 group F member 3","Acetylcholine receptor","Tyrosine protein kinase Tec family","Cytochrome P450 
2D6","Cytochrome P450 1A1","Cytochrome P450 3A4","Tyrosine protein kinase EGFR family","Serotonin receptor","Atypical protein kinase PIKK family","Tyrosine protein kinase Src family","CMGC protein kin
ase ERK1","CMGC protein kinase Dyrk1 subfamily","Atypical protein kinase FRAP subfamily","Tyrosine protein kinase SrcA"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Ion channels","Kinases (EC 2.7.x.x)","Eicosanoid turnover","Peptidases and proteinases","Catalytic receptors","G protein-coupled receptors","Chromatin modifying enzyme
s","Nuclear hormone receptors","DNA topoisomerases","SLC superfamily of solute carriers","Cytochrome P450","2.7.1.40 Pyruvate kinases","Inositol phosphate turnover","ATP-binding cassette transporter f
amily","Voltage-gated ion channels","CAMK: Calcium/calmodulin-dependent protein kinases",Lipoxygenases,"CA: Cysteine (C) Peptidases","Receptor kinases","CMGC: Containing CDK",MAPK,GSK3,"CLK families",
"Neuropeptide S receptor","1.14.11.- Histone demethylases","2.1.1.43 Histone methyltransferases (HMTs)","1F. Retinoic acid-related orphans","Acetylcholine receptors (muscarinic)","SLCO family of organ
ic anion transporting polypeptides","CYP2 family: drug metabolising subset","CYP1 family","Inositol monophosphatase","CYP3 family","SLC22 family of organic cation and anion transporters","ABCB subfami
ly","5-Hydroxytryptamine receptors","ABCC subfamily",Atypical,"Potassium channels","SLC47 family of multidrug and toxin extrusion transporters","SLC6 neurotransmitter transporter family","ABCG subfami
ly","CAMK-unique family","C19: Ubiquitin-specific protease","TK: Tyrosine kinase","Mitogen-activated protein kinases (MAP kinases)","Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase (DYR
K) family","PIM family","Organic cation transporters (OCT)","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","Voltage-gated potassium channels","Monoamine transporter subfamily","Recept
or tyrosine kinases (RTKs)","ERK subfamily","Dyrk1 subfamily","Non-receptor tyrosine kinases (nRTKs)","FRAP subfamily","Type XVII RTKs: ROS receptors","Tec family","Type I RTKs: ErbB (epidermal growth
 factor) receptor family","Src family"}

> <pathway_reactome>
{"Immune System",Metabolism,"Gene expression (Transcription)","Neuronal System","DNA Repair",Disease,"Cell Cycle","Vesicle-mediated transport","Developmental Biology","Signal Transduction","Cellular r
esponses to external stimuli",Hemostasis,"Transport of small molecules","Muscle contraction","Cytokine Signaling in Immune system","Metabolism of lipids","Innate Immune System","RNA Polymerase II Tran
scription","Transmission across Chemical Synapses","DNA Double-Strand Break Repair","Infectious disease","Base Excision Repair","Cell Cycle Checkpoints",Mitotic,"Membrane Trafficking","Diseases of sig
nal transduction by growth factor receptors and second messengers","Nervous system development","Biological oxidations","Signaling by GPCR","Cellular responses to stress","Metabolism of carbohydrates"
,"Platelet activation","signaling and aggregation","Inositol phosphate metabolism","SLC-mediated transmembrane transport","Abacavir transport and metabolism","Cardiac conduction","Disorders of transme
mbrane transporters","Signaling by Interleukins","Biosynthesis of specialized proresolving mediators (SPMs)","C-type lectin receptors (CLRs)","Generic Transcription Pathway","Neurotransmitter receptor
s and postsynaptic signal transmission","Toll-like Receptor Cascades","Homology Directed Repair","Leishmania infection","Base-Excision Repair","AP Site Formation","G1/S DNA Damage Checkpoints","M Phas
e","trans-Golgi Network Vesicle Budding","Resolution of Abasic Sites (AP sites)","Mitotic G1 phase and G1/S transition","FLT3 signaling in disease","EGR2 and SOX10-mediated initiation of Schwann cell 
myelination","Phase I - Functionalization of compounds","GPCR ligand binding","Metabolism of steroids","Cellular response to hypoxia","Glucose metabolism","Platelet Aggregation (Plug Formation)","Synt
hesis of IP2",IP,"and Ins in the cytosol","Transport of bile salts and organic acids","metal ions and amine compounds","Abacavir transmembrane transport","Axon guidance","Fatty acid metabolism","Phase
 3 - rapid repolarisation","HIV Infection","SLC transporter disorders","GPCR downstream signalling","Interleukin-1 family signaling","Biosynthesis of DPA-derived SPMs","CLEC7A (Dectin-1) signaling","T
ranscriptional Regulation by TP53","Activation of NMDA receptors and postsynaptic events","Toll Like Receptor 5 (TLR5) Cascade","HDR through Homologous Recombination (HRR) or Single Strand Annealing (
SSA)","Leishmania parasite growth and survival",Depurination,"p53-Dependent G1/S DNA damage checkpoint","Mitotic Metaphase and Anaphase","Golgi Associated Vesicle Biogenesis","Resolution of AP sites v
ia the multiple-nucleotide patch replacement pathway","G0 and Early G1","Signaling by FLT3 ITD and TKD mutants","Transcriptional regulation by RUNX1","Transcriptional regulation by RUNX3","Ethanol oxi
dation","Class A/1 (Rhodopsin-like receptors)","Bile acid and bile salt metabolism","Parasite infection","Cytochrome P450 - arranged by substrate type","Oxygen-dependent proline hydroxylation of Hypox
ia-inducible Factor Alpha",Glycolysis,"Transcriptional Regulation by MECP2","Biosynthesis of DHA-derived SPMs","Organic cation/anion/zwitterion transport","Semaphorin interactions","Arachidonic acid m
etabolism","Host Interactions of HIV factors","Defective SLC6A2 causes orthostatic intolerance (OI)","G alpha (q) signalling events","Interleukin-1 signaling","Biosynthesis of DPAn-3 SPMs","Dectin-1 m
ediated noncanonical NF-kB signaling","Regulation of TP53 Activity","Post NMDA receptor activation events","MyD88 cascade initiated on plasma membrane","HDR through Homologous Recombination (HRR)","An
ti-inflammatory response favouring Leishmania parasite infection","Cleavage of the damaged purine","p53-Dependent G1 DNA Damage Response","Mitotic Anaphase","PCNA-Dependent Long Patch Base Excision Re
pair","STAT5 activation downstream of FLT3 ITD mutants","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","RUNX3 Regulates Immune Response and Cell Migration","Tr
anscription of E2F targets under negative control by DREAM complex","Amine ligand-binding receptors","Recycling of bile acids and salts","Leishmania phagocytosis",Xenobiotics,"Processing of DNA double
-strand break ends","Regulation of MECP2 expression and activity","Biosynthesis of maresins","Organic cation transport","Sema4D in semaphorin signaling","Synthesis of Leukotrienes (LT) and Eoxins (EX)
","The role of Nef in HIV-1 replication and disease pathogenesis","Gastrin-CREB signalling pathway via PKC and MAPK","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Biosynthesis of DPAn-3-derived protec
tins and resolvins","Regulation of TP53 Expression and Degradation","Activation of AMPK downstream of NMDARs","MAP kinase activation","Homologous DNA Pairing and Strand Exchange","ADORA2B mediated ant
i-inflammatory cytokines production","Regulation of TP53 Activity through Methylation","Stabilization of p53","Nuclear Envelope (NE) Reassembly","Muscarinic acetylcholine receptors","FCGR3A-mediated p
hagocytosis","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Biosynthesis of maresin-like SPMs","Sema4D induced cell migration and growth-cone collapse","Seroton
in receptors","Nef and signal transduction","EGFR Transactivation by Gastrin","Regulation of TP53 Degradation","MAPK targets/ Nuclear events mediated by MAP kinases","Presynaptic phase of homologous D
NA pairing and strand exchange","Autodegradation of the E3 ubiquitin ligase COP1","Initiation of Nuclear Envelope (NE) Reformation","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{TOP2A}

> <broad_moa>
{"topoisomerase inhibitor"}

> <synonyms>
{DHAD,MLS001333711,NSC301739,SMR000058480,"DHAQ HCl","mitoxantron hydrochloride",SCHEMBL66384,MLS000028811,MLS002222224,C22H28N4O6.ClH,CHEMBL1200827,REGID_for_CID_5458171,REGIDforCID5458171,REGID-for-
CID-5458171,"REGID for CID 5458171",Pharmak,SAM002699896,CPD001563707}

> <pdid>
PD004112

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5458171}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 23  0  0  0  0            999 V2000
    7.5987    2.9995    0.0000 H   0  3
    5.0987    2.9995    0.0000 Cl  0  5
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 N   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.5517    0.8722    0.0000 N   0  0
   -7.5554    1.9869    0.0000 C   0  0
   -6.8054    3.2859    0.0000 C   0  0
   -5.3382    2.9741    0.0000 N   0  0
   -2.6030    2.9985    0.0000 C   0  0
   -3.9023    3.7481    0.0000 C   0  0
   -3.9029    5.2481    0.0000 C   0  0
   -2.6041    5.9986    0.0000 C   0  0
   -2.6047    7.4986    0.0000 O   0  0
   -1.3048    5.2491    0.0000 C   0  0
   -1.3042    3.7491    0.0000 C   0  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  7 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  3
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 12  1  0
 10 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 20 22  1  0
 22 23  2  0
 23 17  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6244

> <plate>
NGP-202-03

> <well>
B05

> <supplier_cmpd_name>
CPD001819784

> <ctcr_id>
7049

> <supplier_cmpd_id>
SAM003107541

> <smiles>
[H+].[Cl-].Cc1ccc(cc1)N(CC2=NCCN2)c3ccc(O)cc3

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{SCHEMBL349939,NC00632,1347884-84-7,1347884847,SAM003107541,CPD001819784}

> <pdid>
PD099833

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{66662074,66147}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 31  0  0  0  0            999 V2000
    7.5987   -4.5184    0.0000 H   0  3
    5.0987   -4.5184    0.0000 Cl  0  5
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 C   0  0
   -2.5951   -3.0039    0.0000 N   0  0
   -3.8915   -3.7585    0.0000 C   0  0
   -3.8863   -5.2585    0.0000 C   0  0
   -2.5847   -6.0040    0.0000 N   0  0
   -1.2883   -5.2495    0.0000 C   0  0
   -1.2935   -3.7495    0.0000 C   0  0
   -2.5775   -7.5047    0.0000 C   0  0
   -1.2739   -8.2485    0.0000 C   0  0
    0.0229   -7.4945    0.0000 C   0  0
    1.3242   -8.2405    0.0000 C   0  0
    1.3289   -9.7405    0.0000 C   0  0
    0.0322  -10.4945    0.0000 C   0  0
   -1.2692   -9.7485    0.0000 C   0  0
   -3.8738   -8.2610    0.0000 C   0  0
   -5.1778   -7.5196    0.0000 C   0  0
   -6.4719   -8.2780    0.0000 C   0  0
   -6.4621   -9.7780    0.0000 C   0  0
   -7.7563  -10.5365    0.0000 Cl  0  0
   -5.1582  -10.5195    0.0000 C   0  0
   -3.8641   -9.7610    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 10  1  0
 13 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 16 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 26 28  1  0
 28 29  2  0
 29 23  1  0
  8 30  2  0
 30  4  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6245

> <plate>
NGP-202-03

> <well>
B06

> <supplier_cmpd_name>
CPD000058736

> <ctcr_id>
7052

> <supplier_cmpd_id>
SAM002548969

> <smiles>
[H+].[Cl-].Cc1cccc(CN2CCN(CC2)C(c3ccccc3)c4ccc(Cl)cc4)c1

> <pd_targets>
{HIF1A,GAA,NR1I3,HPN,KMT2A,MEN1,ALD,ALOX15,RORC,CYP3A4,LMNA,MAPK1,HRH1,CYP2D6,CYP2C19,CYP1A2}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Epigenetic regulator","Other nuclear protein","Membrane receptor",Hydrolase,"Nuclear receptor",Protease,Reader,Oxidoreductase,"Cytochrome P450",Kinase,"Family A G prote
in-coupled receptor","Nuclear hormone receptor subfamily 1","Serine protease",Bromodomain,"Cytochrome P450 family 3","Protein Kinase","Small molecule receptor (family A GPCR)","Cytochrome P450 family 
2","Cytochrome P450 family 1","Nuclear hormone receptor subfamily 1 group I","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family 3A","CMGC protein kinase group","Monoamine receptor"
,"Cytochrome P450 family 2D","Cytochrome P450 family 2C","Cytochrome P450 family 1A","Nuclear hormone receptor subfamily 1 group I member 3","Nuclear hormone receptor subfamily 1 group F member 3","Cy
tochrome P450 3A4","CMGC protein kinase MAPK family","Histamine receptor","Cytochrome P450 2D6","Cytochrome P450 2C19","Cytochrome P450 1A1","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Receptors,"3.2.1.- Glycosidases","Nuclear hormone receptors","Eicosanoid turnover","Cytochrome P450","Kinases (EC 2.7.x.x)","G protein-coupled receptors","1I. Vitamin D receptor-like receptor
s",Lipoxygenases,"1F. Retinoic acid-related orphans","CYP3 family","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Histamine receptors","CYP2 family: drug metabolising subset","CYP1 family","Mitogen-
activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Cellular responses to external stimuli",Disease,"Gene expression (Transcription)","Signal Transduction",Metabolism,"Cell Cycle","Immune System","Cellular responses to stress","Diseases of metabolism
","RNA Polymerase II Transcription","Signaling by Receptor Tyrosine Kinases","Metabolism of lipids",Mitotic,"Innate Immune System","Signaling by GPCR","Biological oxidations","Cellular response to hyp
oxia","Diseases of carbohydrate metabolism","Generic Transcription Pathway","Signaling by MET","Biosynthesis of specialized proresolving mediators (SPMs)","M Phase","Toll-like Receptor Cascades","GPCR
 ligand binding","Phase I - Functionalization of compounds","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Glycogen storage diseases","Nuclear Receptor transcription pathw
ay","MET Receptor Activation","Biosynthesis of DPA-derived SPMs","Transcriptional regulation by RUNX3","Biosynthesis of DHA-derived SPMs","Mitotic Metaphase and Anaphase","Toll Like Receptor 5 (TLR5) 
Cascade","Class A/1 (Rhodopsin-like receptors)","Cytochrome P450 - arranged by substrate type","Glycogen storage disease type II (GAA)","Biosynthesis of DPAn-3 SPMs","RUNX3 Regulates Immune Response a
nd Cell Migration","Biosynthesis of maresins","Mitotic Anaphase","MyD88 cascade initiated on plasma membrane","Amine ligand-binding receptors",Xenobiotics,"Biosynthesis of DPAn-3-derived protectins an
d resolvins","Biosynthesis of maresin-like SPMs","Nuclear Envelope (NE) Reassembly","MAP kinase activation","Histamine receptors","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkyl
ated by CYP1A2","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{NR1I3}

> <broad_moa>
{"constitutive androstane receptor (CAR) agonist"}

> <synonyms>
{"Meclozine hydrochloride","Meclizine Monohydrochloride",Duremesin,"Meclizine hydrochloride",MLS000028709,CHEMBL1085765,Vertizine,Taizer,36236-67-6,36236676,SMR000058736,V-Cline,VCline,"Ancolan dihydr
ochloride","Postafene dihydrochloride",1-((4-Chlorophenyl),1((4Chlorophenyl),T1110,SAM002548969,"Meclizine dihydrochloride",CPD000058736}

> <pdid>
PD010049

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{657217,92303}

$$$$
NIHCC_2014
  SciTegic11012413002D

  8  6  0  0  0  0            999 V2000
    7.7000    1.1254    0.0000 Na  0  3
    1.3000    2.2500    0.0000 O   0  5
    1.3000    0.7500    0.0000 S   0  0
    0.0007    0.0004    0.0000 O   0  0
    0.0011    1.5002    0.0000 O   0  0
    2.6000    0.0000    0.0000 C   0  0
    3.9000    0.7500    0.0000 C   0  0
    5.1992    0.0004    0.0000 S   0  0
  2  3  1  0
  3  4  2  0
  3  5  2  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6246

> <plate>
NGP-202-03

> <well>
B07

> <supplier_cmpd_name>
CPD000059219

> <ctcr_id>
2476

> <supplier_cmpd_id>
SAM002548937

> <smiles>
[Na+].[O-][S](=O)(=O)CCS

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{RESTW148,mesna,19767-45-4,19767454,"Sodium 2-mercaptoethanesulfonate","Sodium 2mercaptoethanesulfonate",Mesnex,Uromitexan,Mistabron,"2-Mercaptoethanesulfonic acid sodium salt","2Mercaptoethanesulfoni
c acid sodium salt",Mistabronco,Mucofluid,"Sodium 2-mercaptoethane sulfonate","Sodium 2mercaptoethane sulfonate","Ethanesulfonic acid, 2-mercapto-, monosodium salt","Ethanesulfonic acid, 2mercapto, mo
nosodium salt",UNII-NR7O,UNIINR7O,T1414,SAM002548937,1502014,Prestw-1487,Mesna,CPD000059219,MESNA}

> <pdid>

> <targets>
{}

> <classes>
{mucolytic}

> <pubchem_cids>
{29769,23662354}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 23  0  0  1  0            999 V2000
    4.9852    2.6764    0.0000 C   0  0
    3.8856    1.6562    0.0000 N   0  0
    4.2194    0.1938    0.0000 C   0  0
    3.1198   -0.8265    0.0000 C   0  0
    1.6852   -0.3846    0.0000 N   0  0
    1.3514    1.0778    0.0000 C   0  0  1  0  0  0
    2.4522    2.0983    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
    0.1115    3.2255    0.0000 C   0  0
   -1.1278    4.0705    0.0000 C   0  0
   -2.4793    3.4196    0.0000 C   0  0
   -2.5914    1.9238    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 N   0  0
    0.7500   -1.5574    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  6
  7  2  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20  5  1  0
 20 15  1  0
M  END
> <name>
NIHCC_2014

> <id>
6247

> <plate>
NGP-202-03

> <well>
B08

> <supplier_cmpd_name>
CPD000550486

> <ctcr_id>
7057

> <supplier_cmpd_id>
SAM002548934

> <smiles>
CN1CCN2[C@@H](C1)c3ccccc3Cc4cccnc24

> <pd_targets>
{ADRA2A,HTR2A,DRD2,HTR2C,HTR7,CYP2C19,CYP2D6,ADRA2C,HTR1A,SLC6A2,TSHR,CYP2C9,ADRA2B,ADRA1A,ADRA1B,ADRA1D,HRH1,CYP1A2,DRD3,HTR3A,OPRK1,AMPC,HTR2B}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,Transporter,"Ion channel","Family A G protein-coupled receptor","Cytochrome P450","Electrochemical transporter","Ligand-gated ion channel",Hydrolase,"Small molecule recepto
r (family A GPCR)","Cytochrome P450 family 2","SLC superfamily of solute carriers","Peptide receptor (family A GPCR)","Cytochrome P450 family 1","5HT3 receptor","Monoamine receptor","Cytochrome P450 f
amily 2C","Cytochrome P450 family 2D","SLC06 neurotransmitter transporter family","Glycohormone receptor","Cytochrome P450 family 1A","Short peptide receptor (family A GPCR)","Adrenergic receptor","Se
rotonin receptor","Dopamine receptor","Cytochrome P450 2C19","Cytochrome P450 2D6","Cytochrome P450 2C9","Histamine receptor","Cytochrome P450 1A1","Opioid receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"Ion channels","G protein-coupled receptors","Cytochrome P450","Ligand-gated ion channels",Adrenoceptors,"5-Hydroxytryptamine receptors","Dopamine receptors","CYP2 family: drug meta
bolising subset","Glycoprotein hormone receptors","Histamine receptors","CYP1 family","5-HT<sub>3</sub> receptors","Opioid receptors"}

> <pathway_reactome>
{"Signal Transduction",Disease,Metabolism,"Neuronal System","Gene expression (Transcription)","Signaling by GPCR","Infectious disease","Biological oxidations","Transmission across Chemical Synapses","
RNA Polymerase II Transcription","GPCR ligand binding","Leishmania infection","Phase I - Functionalization of compounds","Neurotransmitter receptors and postsynaptic signal transmission","Generic Tran
scription Pathway","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","Cytochrome P450 - arranged by substrate type","Transcriptional Regulation by MECP2","Amine ligand-b
inding receptors","Anti-inflammatory response favouring Leishmania parasite infection",Xenobiotics,"MECP2 regulates neuronal receptors and channels",Adrenoceptors,"Serotonin receptors","Dopamine recep
tors","ADORA2B mediated anti-inflammatory cytokines production","CYP2E1 reactions","Histamine receptors","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2"}

> <broad_targets>
{ADRA2A,ADRA2B,ADRA2C,HTR2A,HTR2C}

> <broad_moa>
{"adrenergic receptor antagonist","serotonin receptor antagonist"}

> <synonyms>
{(R)-Mirtazapine,(R)Mirtazapine,61364-37-2,61364372,(-)-Mirtazapine,()Mirtazapine,UNII-0UF1VD57JD,UNII0UF1VD57JD,0UF1VD57JD,R-(-)-Mirtazapine,R()Mirtazapine,"Org 44-19","Org 4419","EINECS 262-735-5","
EINECS 2627355",ZINC509,MLS001165757,BIDD:GT0798,CHEMBL608847,SCHEMBL8271559,Org-44-19,Org4419,CHEBI:94765,HY-B0352B,HYB0352B,DTXSID80210281,HMS2231D15,HMS32,SAM002548934,CPD000550486}

> <pdid>
PD000124

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{3085219}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 29  0  0  0  0            999 V2000
    2.5983   -3.0004    0.0000 N   0  0
    2.5988   -1.5004    0.0000 S   0  0
    3.8983   -0.7512    0.0000 O   0  0
    3.8975   -2.2510    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 N   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -3.8963    3.7531    0.0000 C   0  0
   -3.8942    5.2539    0.0000 C   0  0
   -5.1906    6.0085    0.0000 C   0  0
   -5.1854    7.5085    0.0000 C   0  0
   -3.8838    8.2540    0.0000 C   0  0
   -2.5874    7.4995    0.0000 C   0  0
   -2.5925    5.9995    0.0000 C   0  0
   -1.2991    3.7500    0.0000 N   0  0
    0.0000    3.0000    0.0000 S   0  0
    1.2810    2.2196    0.0000 O   0  0
   -0.0353    4.4996    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0008    0.0000 C   0  0
   -1.2986   -3.7517    0.0000 F   0  0
    1.2993   -3.7504    0.0000 F   0  0
    0.0007   -4.5008    0.0000 F   0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 10 18  1  0
 18 19  1  0
 19  7  1  0
 19 20  2  0
 19 21  2  0
  8 22  1  0
 22 23  2  0
 23  5  1  0
 23 24  1  0
 24 25  1  0
 24 26  1  0
 24 27  1  0
M  END
> <name>
NIHCC_2014

> <id>
6248

> <plate>
NGP-202-03

> <well>
B09

> <supplier_cmpd_name>
CPD000058802

> <ctcr_id>
5931

> <supplier_cmpd_id>
SAM002264598

> <smiles>
N[S](=O)(=O)c1cc2c(NC(Cc3ccccc3)N[S]2(=O)=O)cc1C(F)(F)F

> <pd_targets>
{LMNA,KDM4E,CYP3A4,ABCB11,ALDH1A1,SLC12A3,KCNMA1,CA1,CA2,CA4}

> <pathway_gtopdb>
{"Other nuclear protein","Epigenetic regulator",Enzyme,Transporter,"Ion channel",Eraser,"Cytochrome P450","Primary active transporter",Oxidoreductase,"Electrochemical transporter","Voltage-gated ion c
hannel",Lyase,"Lysine demethylase","Cytochrome P450 family 3","ATP-binding cassette","SLC superfamily of solute carriers","Potassium channels","Jumonji domain-containing","Cytochrome P450 family 3A","
ABCB subfamily","SLC12 family of cation-coupled chloride transporters","Calcium-activated potassium channel","Cytochrome P450 3A4"}

> <pathway_chembl>
{Enzymes,Transporters,"Ion channels","Chromatin modifying enzymes","Cytochrome P450","ATP-binding cassette transporter family","SLC superfamily of solute carriers","Voltage-gated ion channels","Carbon
ic anhydrases","1.14.11.- Histone demethylases","CYP3 family","ABCB subfamily","SLC12 family of cation-coupled chloride transporters","Potassium channels","Calcium- and sodium-activated potassium chan
nels"}

> <pathway_reactome>
{"Cell Cycle",Metabolism,Disease,Hemostasis,"Immune System","Transport of small molecules",Mitotic,"Metabolism of lipids","Biological oxidations","Disorders of transmembrane transporters","Platelet ho
meostasis","Cytokine Signaling in Immune system","O2/CO2 exchange in erythrocytes","M Phase","Biosynthesis of specialized proresolving mediators (SPMs)","Metabolism of steroids","Phase I - Functionali
zation of compounds","SLC transporter disorders","Nitric oxide stimulates guanylate cyclase","Signaling by Interleukins","Erythrocytes take up carbon dioxide and release oxygen","Mitotic Metaphase and
 Anaphase","Biosynthesis of DHA-derived SPMs","Bile acid and bile salt metabolism","Ethanol oxidation","Defective SLC12A3 causes Gitelman syndrome (GS)","cGMP effects","Interleukin-12 family signaling
","Mitotic Anaphase","Biosynthesis of maresins","Synthesis of bile acids and bile salts","Interleukin-12 signaling","Nuclear Envelope (NE) Reassembly","Biosynthesis of maresin-like SPMs","Synthesis of
 bile acids and bile salts via 7alpha-hydroxycholesterol","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{SLC12A1,SLC12A3}

> <broad_moa>
{"sodium/potassium/chloride transporter inhibitor"}

> <synonyms>
{BENDROFLUMETHIAZIDE,Bendrofluazide,73-48-3,73483,Naturetin,Aprinox,Benzhydroflumethiazide,Benzylrodiuran,Berkozide,Centyl,Pluryl,Neo-naclex,Neonaclex,Bentride,Bristuric,Bristuron,Flumesil,Niagaril,Pl
usuril,Poliuron,Sinesalin,Sodiuretic,Thiazidico,Benuron,I,T1204,SAM002264598,1503104,Prestw-784,Bendroflumethiazide,CPD000058802}

> <pdid>
PD001076

> <targets>
{}

> <classes>
{antihypertensive,diuretic}

> <pubchem_cids>
{2315}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 18  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
   -2.5987    1.5004    0.0000 C   0  0  2  0  0  0
   -3.9492    0.8772    0.0000 O   0  0
   -4.9546    1.9903    0.0000 C   0  0  2  0  0  0
   -6.4441    1.8282    0.0000 C   0  0
   -7.0500    0.4561    0.0000 O   0  0
   -4.2067    3.2905    0.0000 C   0  0  1  0  0  0
   -4.8190    4.6599    0.0000 O   0  0
   -2.7390    2.9810    0.0000 C   0  0  1  0  0  0
   -1.6199    3.9798    0.0000 O   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  3
  8  2  1  0
  9  6  1  6
  9 10  1  0
 10 11  1  0
 11 12  1  6
 12 13  1  0
 11 14  1  0
 14 15  1  1
 14 16  1  0
 16  9  1  0
 16 17  1  1
M  END
> <name>
NIHCC_2014

> <id>
6249

> <plate>
NGP-202-03

> <well>
B10

> <supplier_cmpd_name>
CPD000857239

> <ctcr_id>
2127

> <supplier_cmpd_id>
SAM002264595

> <smiles>
NC1=NC(=O)N(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O

> <pd_targets>
{LMNA,THPO,PMP22,BLM,ALDH1A1,NFKB1,AMPC,DNMT1,HBB,GMNN,CHRM1,TP53,HTT,MTOR,DNMT3A}

> <pathway_gtopdb>
{"Other nuclear protein","Unclassified protein",Enzyme,"Other cytosolic protein","Epigenetic regulator","Secreted protein","Membrane receptor","Transcription factor",Oxidoreductase,Hydrolase,Writer,"F
amily A G protein-coupled receptor",Kinase,Reader,"DNA methyltransferase","Small molecule receptor (family A GPCR)","Protein Kinase","Methyl-lysine/arginine binding protein","Monoamine receptor","Atyp
ical protein kinase group","PWWP domain","Acetylcholine receptor","Atypical protein kinase PIKK family","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Enzymes,Receptors,"2.1.1.- Methyltransferases","G protein-coupled receptors","Kinases (EC 2.7.x.x)","Acetylcholine receptors (muscarinic)",Atypical,"Phosphatidyl inositol 3' kinase-related kinases (P
IKK) family","FRAP subfamily"}

> <pathway_reactome>
{"Cell Cycle",Hemostasis,"Developmental Biology","DNA Repair",Metabolism,"Immune System","Metabolism of proteins","Signal Transduction","Gene expression (Transcription)",Mitotic,"Platelet activation",
"signaling and aggregation","Nervous system development","DNA Double-Strand Break Repair","Biological oxidations","Cytokine Signaling in Immune system","Post-translational protein modification","Innat
e Immune System","Signaling by GPCR","Cell Cycle Checkpoints","RNA Polymerase II Transcription","M Phase","Platelet Aggregation (Plug Formation)","EGR2 and SOX10-mediated initiation of Schwann cell my
elination","Homology Directed Repair","Phase I - Functionalization of compounds","Signaling by Interleukins",SUMOylation,"Neutrophil degranulation","Mitotic G1 phase and G1/S transition","GPCR ligand 
binding","G1/S DNA Damage Checkpoints","Generic Transcription Pathway","Mitotic Metaphase and Anaphase","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Ethanol oxidation
","Interleukin-1 family signaling","SUMO E3 ligases SUMOylate target proteins","G1/S Transition","Class A/1 (Rhodopsin-like receptors)","p53-Dependent G1/S DNA damage checkpoint","Transcriptional Regu
lation by MECP2","Transcriptional Regulation by TP53","Mitotic Anaphase","HDR through Homologous Recombination (HRR)","Interleukin-1 signaling","SUMOylation of DNA methylation proteins","Activation of
 the pre-replicative complex","Amine ligand-binding receptors","p53-Dependent G1 DNA Damage Response","Regulation of MECP2 expression and activity","Regulation of TP53 Activity","Nuclear Envelope (NE)
 Reassembly","Homologous DNA Pairing and Strand Exchange","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Muscarinic acetylcholine receptors","Stabilization of p53","Regulation of TP53 Expression and De
gradation","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pairing and strand exchange","Autodegradation of the E3 ubiquitin ligase COP1","Regulation of TP53 Deg
radation"}

> <broad_targets>
{DNMT1,DNMT3A}

> <broad_moa>
{"DNA methyltransferase inhibitor"}

> <synonyms>
{5-azacytidine,5azacytidine,Azacitidine,320-67-2,320672,Ladakamycin,Azacytidine,Vidaza,Mylosar,5-azacitidine,5azacitidine,Azacitidinum,Azacitidina,"Azacitidinum (INN-Latin)","Azacitidinum (INNLatin)",
5-AZAC,5AZAC,"Azacitidina (INN-Spanish)","Azacitidina (INNSpanish)",NSC-102816,NSC102816,C8H12N4O5,U-18496,U18496,4-Amino-1-beta-D-ribofuranosyl-s-triaz,4Amino1betaDribofuranosylstriaz,T1339,S1782,SAM
002264595,1502111,azacitidine,CPD000857239,AZACITIDINE,"5-Aza-2-deoxycytidine (Decitabine)","5-Azacytidine (Vidaza)"}

> <pdid>
PD001379

> <targets>
{}

> <classes>
{"pyrimidine antimetabolite",antineoplastic}

> <pubchem_cids>
{9444}

$$$$
NIHCC_2014
  SciTegic11012413002D

 15 15  0  0  0  0            999 V2000
    7.4300    0.2350    0.0000 H   0  3
    4.9300    0.2350    0.0000 Cl  0  5
    2.4768   -0.6464    0.0000 C   0  0
    1.1700    0.0900    0.0000 C   0  0
    1.1700    1.5200    0.0000 C   0  0
    0.0000    2.2400    0.0000 C   0  0
   -1.3200    1.5200    0.0000 C   0  0
   -1.3200    0.0900    0.0000 C   0  0
   -2.7075    0.6600    0.0000 C   0  0
    0.0000   -0.6200    0.0000 C   0  0
   -2.1100   -0.8400    0.0000 C   0  0
   -1.0400   -0.3900    0.0000 C   0  0
   -1.3177   -1.8641    0.0000 N   0  0
   -1.0400    1.1000    0.0000 C   0  0
    0.0400   -1.0200    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10  4  1  0
  8 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14  6  1  0
 12 15  1  0
 15  4  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6250

> <plate>
NGP-202-03

> <well>
B11

> <supplier_cmpd_name>
CPD000875213

> <ctcr_id>
5993

> <supplier_cmpd_id>
SAM002699890

> <smiles>
[H+].[Cl-].CC12CC3CC(C)(C1)CC(N)(C3)C2

> <pd_targets>
{GRIN1,GRIN2A,GRIN2B,GRIN2C,GRIN2D,GRIN3A,GRIN3B,HTT,LMNA,AMPC,NPSR1,PMP22,MTOR,SLC22A1,HTR3A,CHRNA7,DRD2,GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG
3,GABRP,GABRQ,GLRA1,GLRA2,GLRA3,GLRB}

> <pathway_gtopdb>
{"Ion channel","Unclassified protein","Other nuclear protein",Enzyme,"Membrane receptor",Transporter,"Ligand-gated ion channel",Hydrolase,"Family A G protein-coupled receptor",Kinase,"Electrochemical 
transporter","Ionotropic glutamate receptor","Peptide receptor (family A GPCR)","Protein Kinase","SLC superfamily of solute carriers","5HT3 receptor","Small molecule receptor (family A GPCR)","GABA-A 
receptor","Glycine receptor","NMDA receptor","Short peptide receptor (family A GPCR)","Atypical protein kinase group","SLC22 family of organic cation and anion transporters","Monoamine receptor","Neur
opeptide receptor","Atypical protein kinase PIKK family","Dopamine receptor","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{"Ion channels",Receptors,Enzymes,Transporters,"Ligand-gated ion channels","G protein-coupled receptors","Kinases (EC 2.7.x.x)","SLC superfamily of solute carriers","Ionotropic glutamate receptors","N
europeptide S receptor",Atypical,"SLC22 family of organic cation and anion transporters","5-HT<sub>3</sub> receptors","Dopamine receptors","Phosphatidyl inositol 3' kinase-related kinases (PIKK) famil
y","Organic cation transporters (OCT)","FRAP subfamily"}

> <pathway_reactome>
{"Neuronal System","Gene expression (Transcription)","Cell Cycle",Disease,"Developmental Biology","Transport of small molecules","Signal Transduction","Transmission across Chemical Synapses","RNA Poly
merase II Transcription",Mitotic,"Infectious disease","Nervous system development","SLC-mediated transmembrane transport","Signaling by GPCR","Neurotransmitter receptors and postsynaptic signal transm
ission","Generic Transcription Pathway","M Phase","Leishmania infection","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Transport of bile salts and organic acids","metal ions and am
ine compounds","GPCR ligand binding","Activation of NMDA receptors and postsynaptic events","Transcriptional Regulation by MECP2","Mitotic Metaphase and Anaphase","Leishmania parasite growth and survi
val","Transcriptional Regulation by TP53","Organic cation/anion/zwitterion transport","Class A/1 (Rhodopsin-like receptors)","Post NMDA receptor activation events","Regulation of MECP2 expression and 
activity","Mitotic Anaphase","Anti-inflammatory response favouring Leishmania parasite infection","Regulation of TP53 Activity","Organic cation transport","Amine ligand-binding receptors","Long-term p
otentiation","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Regulation of TP53 Expression and Degradation","Dopamine receptors","CREB1 phosphorylation th
rough NMDA receptor-mediated activation of RAS signaling","Initiation of Nuclear Envelope (NE) Reformation","Regulation of TP53 Degradation","Ras activation upon Ca2+ influx through NMDA receptor"}

> <broad_targets>
{}

> <broad_moa>
{"glutamate receptor antagonist"}

> <synonyms>
{"MEMANTINE HYDROCHLORIDE",41100-52-1,41100521,"41100 52 1","Memantine HCL","3,5-Dimethyl-1-adamantanamine hydrochloride","3,5Dimethyl1adamantanamine hydrochloride","3,5 Dimethyl 1 adamantanamine hydr
ochloride",3,5-dimethyladaman,5dimethyladaman,S2043,SAM002699890,1501121,Prestw-978,"Memantine HCl",CPD000875213,"Memantine Hydrochloride"}

> <pdid>
PD009581

> <targets>
{"AMPA Receptor-kainate Receptor-NMDA Receptor"}

> <classes>
{"muscle relaxant (skeletal)","Neuronal Signaling"}

> <pubchem_cids>
{43834392,181458,66766747}

$$$$
NIHCC_2014
  SciTegic11012413002D

 32 35  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    3.8971    3.7500    0.0000 C   0  0
    3.8971    5.2500    0.0000 C   0  0
    5.1961    6.0001    0.0000 O   0  0
    2.5980    6.0000    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2991    3.7500    0.0000 O   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 O   0  0
   -2.5981    1.5000    0.0000 O   0  0
    0.0000    4.5000    0.0000 O   0  0
    0.0000    6.0000    0.0000 O   0  0
    2.5949    7.5009    0.0000 C   0  0
    1.2948    8.2490    0.0000 O   0  0
    3.8927    8.2531    0.0000 N   0  0
    5.1984    3.0023    0.0000 N   0  0
    6.4964    3.7542    0.0000 C   0  0
    5.2010    1.5023    0.0000 C   0  0
    3.8971    0.7500    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  2  3
 10 11  1  0
 11  5  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14  3  1  0
 14 15  2  3
 15 16  1  0
 16 17  2  3
 17  2  1  0
 17 18  1  0
 18 19  2  3
 19 20  1  0
 20 21  2  3
 21 16  1  0
 21 22  1  0
 15 23  1  0
 11 24  1  0
 10 25  1  0
  9 26  1  0
 26 27  2  0
 26 28  1  0
  6 29  1  0
 29 30  1  0
 29 31  1  0
  4 32  1  0
M  END
> <name>
NIHCC_2014

> <id>
6251

> <plate>
NGP-202-03

> <well>
C02

> <supplier_cmpd_name>
CPD001550033

> <ctcr_id>
7039

> <supplier_cmpd_id>
SAM002589932

> <smiles>
CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{Liviatin,60080-38-8,60080388,3219-99-6,3219996,.alpha.-6-Deoxyoxytetracycline,.alpha.6Deoxyoxytetracycline,SCHEMBL2614979,SCHEMBL4082631,CHEMBL3559889,CHEMBL4586670,6|A-Deoxy-5-hydroxytetracycline,6|
ADeoxy5hydroxytetracycline,HMS3259F03,6-.alpha.-Deoxy-5-oxytetracycline,6.alpha.Deoxy5oxytetracycline,"6-Epidoxycycline;6-Epi Doxycycline","6Epidoxycycline;6Epi Doxycycline",BCP25655,B,SAM002589932,CP
D001550033}

> <pdid>
PD051057

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{54681536}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 28  0  0  1  0            999 V2000
   17.7129   -0.0020    0.0000 Cl  0  5
   12.7120    0.6826    0.0000 C   0  0
   11.2194    0.8311    0.0000 C   0  0
   10.3432   -0.3874    0.0000 C   0  0
    8.8523   -0.2390    0.0000 C   0  0  2  0  0  0
    7.8525   -1.3573    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0  2  0  0  0
    6.6317    0.7404    0.0000 N   0  0
    5.5076    1.7335    0.0000 C   0  0
    8.0978    1.0574    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    5.2029   -2.9932    0.0000 O   0  0
    3.8990   -0.7455    0.0000 N   0  0
    2.6003   -1.4977    0.0000 C   0  0  2  0  0  0
    2.6060   -2.9986    0.0000 C   0  0  1  0  0  0
    1.3096   -3.7531    0.0000 C   0  0
    3.9075   -3.7444    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 O   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
    0.0031    3.0008    0.0000 S   0  0
    1.3032    3.7490    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  2  0  0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.0000   -3.0000    0.0000 O   0  0
   15.2129   -0.0020    0.0000 H   0  3
  2  3  1  0
  3  4  1  0
  5  4  1  6
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10  5  1  0
  7 11  1  1
 11 12  2  0
 11 13  1  0
 14 13  1  6
 14 15  1  0
 15 16  1  6
 15 17  1  0
 14 18  1  0
 18 19  1  6
 19 20  1  0
 20 21  1  1
 21 22  1  0
 20 23  1  0
 23 24  1  1
 23 25  1  0
 25 26  1  6
 25 27  1  0
 27 18  1  0
 27 28  1  1
M  CHG  2   1  -1  29   1
M  END
> <name>
NIHCC_2014

> <id>
6252

> <plate>
NGP-202-03

> <well>
C03

> <supplier_cmpd_name>
CPD000059006

> <ctcr_id>
7041

> <supplier_cmpd_id>
SAM002589936

> <smiles>
[Cl-].CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@@H]2O.[H+]

> <pd_targets>
{ALB,RPLJ,AMPC}

> <pathway_gtopdb>
{"Secreted protein",Enzyme,Hydrolase}

> <pathway_chembl>
{}

> <pathway_reactome>
{Metabolism,"Metabolism of lipids","Metabolism of steroids","Bile acid and bile salt metabolism","Recycling of bile acids and salts"}

> <broad_targets>
{}

> <broad_moa>
{"bacterial 30S ribosomal subunit inhibitor"}

> <synonyms>
{Lincocin,MLS000069450,MLS001076513,859-18-7,859187,SMR000059006,"Lincomycin hydrochloride (Lincocin)",SR-01000000047,SR01000000047,Prestwick_297,Prestwick297,Prestwick-297,"Prestwick 297",Opera_ID_49
2,OperaID492,Opera-ID-492,"Opera ID 492",MLS002222199,CHEMBL1405894,HMS1568N06,s2479,CCG-269159,CCG269159,NC00617,SR-01000000047-4,SR010000000474,SAM002589936,CPD000059006}

> <pdid>
PD013336

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{6419944,657256}

$$$$
NIHCC_2014
  SciTegic11012413002D

 35 35  0  0  1  0            999 V2000
    9.0926   -3.7747    0.0000 C   0  0
    7.7959   -3.0206    0.0000 C   0  0
    6.4933   -3.7660    0.0000 O   0  0
    5.1959   -3.0115    0.0000 C   0  0
    5.2011   -1.5115    0.0000 O   0  0
    3.8933   -3.7570    0.0000 C   0  0  1  0  0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8912   -5.2578    0.0000 N   0  0
    5.1894   -6.0109    0.0000 C   0  0  1  0  0  0
    6.4897   -5.2632    0.0000 C   0  0
    5.1873   -7.5117    0.0000 C   0  0
    3.8869   -8.2595    0.0000 O   0  0
    6.4855   -8.2648    0.0000 N   0  0
    7.8369   -7.6438    0.0000 C   0  0
    8.8406   -8.7585    0.0000 C   0  0
    8.0906  -10.0575    0.0000 C   0  0
    6.6233   -9.7456    0.0000 C   0  0  1  0  0  0
    5.5002  -10.7372    0.0000 C   0  0
    5.7982  -12.2073    0.0000 O   0  0
    4.0780  -10.2606    0.0000 O   0  0
   12.8933   -3.4790    0.0000 O   0  0
   12.8933   -4.9790    0.0000 C   0  0
   11.5940   -5.7286    0.0000 O   0  0
   14.1932   -5.7290    0.0000 C   0  0
   15.4932   -4.9790    0.0000 C   0  0
   15.4947   -3.4782    0.0000 C   0  0
   14.1961   -2.7274    0.0000 O   0  0
   16.7939   -2.7286    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  6
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
  6 15  1  0
 15 16  1  0
 16 17  1  1
 16 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 20  1  0
 24 25  1  1
 25 26  1  0
 25 27  2  0
 28 29  1  0
 29 30  2  0
 29 31  1  0
 31 32  2  0
 32 33  1  0
 33 34  1  0
 33 35  2  0
M  END
> <name>
NIHCC_2014

> <id>
6253

> <plate>
NGP-202-03

> <well>
C04

> <supplier_cmpd_name>
CPD001906784

> <ctcr_id>
7044

> <supplier_cmpd_id>
SAM002699897

> <smiles>
CCOC(=O)[C@@H](CCc1ccccc1)N[C@@H](C)C(=O)N2CCC[C@H]2C(O)=O.OC(=O)\C=C/C(O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{Renitek,"Enalapril maleate salt",77549-59-8,77549598,SCHEMBL1650291,CHEMBL4575031,DTXSID40424140,HMS3259F07,NC00625,A838609,T6486,SAM002699897,"Enalapril Maleate",CPD001906784}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{6435926}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 22  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 F   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.4133   -1.7530    0.0000 N   0  0
   -1.8032   -3.1233    0.0000 C   0  0
   -0.3114   -2.9665    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -3.8813   -1.4408    0.0000 C   0  0  2  0  0  0
   -4.8896   -2.5354    0.0000 O   0  0
   -6.2433   -1.8893    0.0000 C   0  0  2  0  0  0
   -7.5587   -2.6066    0.0000 C   0  0
   -7.5961   -4.1061    0.0000 O   0  0
   -6.0471   -0.4022    0.0000 C   0  0  1  0  0  0
   -7.1349    0.6307    0.0000 O   0  0
   -4.5721   -0.1292    0.0000 C   0  0  2  0  0  0
   -3.9177    1.2205    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11  2  1  0
 11  7  2  0
 12  8  1  6
 12 13  1  0
 13 14  1  0
 14 15  1  6
 15 16  1  0
 14 17  1  0
 17 18  1  1
 17 19  1  0
 19 12  1  0
 19 20  1  6
M  END
> <name>
NIHCC_2014

> <id>
6254

> <plate>
NGP-202-03

> <well>
C05

> <supplier_cmpd_name>
CPD000058874

> <ctcr_id>
4220

> <supplier_cmpd_id>
SAM002548956

> <smiles>
Nc1nc(F)nc2n(cnc12)[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3O

> <pd_targets>
{RRM2,HIF1A,ADORA2A,ADORA1,RRM1,LMNA,ADORA3,POLA1,DCK,ADORA2B,MAPK1,TP53,RXFP1,ADA,AMPC,HSF1}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Membrane receptor","Other nuclear protein",Oxidoreductase,"Family A G protein-coupled receptor",Transferase,"Small molecule receptor (family A GPCR)","Nucleotide-like r
eceptor (family A GPCR)","Adenosine receptor",Kinase,Hydrolase,"Protein Kinase","Peptide receptor (family A GPCR)","CMGC protein kinase group","Relaxin-like peptide receptor (family A GPCR)","CMGC pro
tein kinase MAPK family","Relaxin receptor","CMGC protein kinase ERK1","Other cytosolic protein"}

> <pathway_chembl>
{Enzymes,Receptors,"1.17.4.1 Ribonucleoside-diphosphate reductases","G protein-coupled receptors","Adenosine receptors","Kinases (EC 2.7.x.x)","Adenosine turnover","CMGC: Containing CDK",MAPK,GSK3,"CL
K families","Relaxin family peptide receptors","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Cell Cycle","Cellular responses to external stimuli",Disease,"Signal Transduction",Metabolism,Mitotic,"Cellular responses to stress","Infectious disease","Signaling by GPCR","Metabolism of nucleotid
es","Mitotic G1 phase and G1/S transition","Cellular response to hypoxia","Leishmania infection","GPCR ligand binding","Interconversion of nucleotide di- and triphosphates","M Phase","Nucleotide salva
ge","G1/S Transition","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Mitotic Metaphase and
 Anaphase","Purine salvage","G1/S-Specific Transcription","Anti-inflammatory response favouring Leishmania parasite infection","Nucleotide-like (purinergic) receptors","Mitotic Anaphase","E2F mediated
 regulation of DNA replication","ADORA2B mediated anti-inflammatory cytokines production","Adenosine P1 receptors","Nuclear Envelope (NE) Reassembly","Inhibition of replication initiation of damaged D
NA by RB1/E2F1","Initiation of Nuclear Envelope (NE) Reformation","Immune System","Innate Immune System","Cell Cycle Checkpoints","Toll-like Receptor Cascades","G1/S DNA Damage Checkpoints","Toll Like
 Receptor 5 (TLR5) Cascade","p53-Dependent G1/S DNA damage checkpoint","MyD88 cascade initiated on plasma membrane","p53-Dependent G1 DNA Damage Response","MAP kinase activation","Stabilization of p53
","MAPK targets/ Nuclear events mediated by MAP kinases","Autodegradation of the E3 ubiquitin ligase COP1","ERK/MAPK targets","ERKs are inactivated","Cellular response to heat stress","HSF1-dependent 
transactivation","Attenuation phase"}

> <broad_targets>
{ADORA1,ADORA2A,ADORA2B}

> <broad_moa>
{"adenosine receptor agonist"}

> <synonyms>
{RESTW148,Fludarabine,21679-14-1,21679141,F-Ara-A,FAraA,"2-Fluoro Ara-A","2Fluoro AraA",9-beta-D-Arabinofuranosyl-2-fluoroadenine,9betaDArabinofuranosyl2fluoroadenine,"Fludarabine (INN)",2-F-ara-A,2Fa
raA,"NSC 118218","CCRIS 3382","Fludarabine (Fludara)",2-Fluoro-9-beta-D-arabinofuranosyladenine,2Fluoro9betaDarabinofuranosyladenine,MFCD00132942,MLS000028687,UNII-,UNII,T1038,SAM002548956,Prestw-1483
,CPD000058874}

> <pdid>
PD002993

> <targets>
{Apoptosis,DNA/RNA Synthesis,Nucleoside Antimetabolite/Analog,STAT}

> <classes>
{Apoptosis,Cell Cycle/DNA Damage,JAK/STAT Signaling,Stem Cell/Wnt}

> <pubchem_cids>
{657237}

$$$$
NIHCC_2014
  SciTegic11012413002D

 32 32  0  0  0  0            999 V2000
    1.3000    2.2500    0.0000 C   0  0
    1.3000    0.7500    0.0000 C   0  0
    0.0007    0.0004    0.0000 O   0  0
    2.5993    0.0004    0.0000 O   0  0
   14.1855   -2.6316    0.0000 F   0  0
   14.1876   -1.1316    0.0000 C   0  0
   15.4880   -0.3838    0.0000 F   0  0
   15.4855   -1.8836    0.0000 F   0  0
   12.8894   -0.3785    0.0000 C   0  0
   12.8916    1.1223    0.0000 O   0  0
   11.5933    1.8754    0.0000 C   0  0
   11.5933    3.3754    0.0000 C   0  0
   10.2943    4.1254    0.0000 C   0  0
    8.9953    3.3754    0.0000 C   0  0
    7.6970    4.1285    0.0000 O   0  0
    7.6992    5.6293    0.0000 C   0  0
    6.4010    6.3824    0.0000 C   0  0
    6.4031    7.8824    0.0000 F   0  0
    5.1006    5.6347    0.0000 F   0  0
    5.1031    7.1345    0.0000 F   0  0
    8.9953    1.8754    0.0000 C   0  0
   10.2943    1.1254    0.0000 C   0  0
    7.6971    1.1223    0.0000 C   0  0
    6.3967    1.8701    0.0000 O   0  0
    7.6992   -0.3785    0.0000 N   0  0
    6.4010   -1.1316    0.0000 C   0  0
    6.4031   -2.6324    0.0000 C   0  0
    5.1067   -3.3870    0.0000 C   0  0
    5.1119   -4.8870    0.0000 C   0  0
    6.4135   -5.6325    0.0000 C   0  0
    7.7100   -4.8780    0.0000 C   0  0
    7.7048   -3.3780    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  2  4  2  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  6  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 17 20  1  0
 14 21  1  0
 21 22  2  0
 22 11  1  0
 21 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 27  1  0
M  END
> <name>
NIHCC_2014

> <id>
6255

> <plate>
NGP-202-03

> <well>
C06

> <supplier_cmpd_name>
CPD000058451

> <ctcr_id>
3596

> <supplier_cmpd_id>
SAM002548968

> <smiles>
CC(O)=O.FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)C(=O)NCC2CCCCN2

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{RESTW73,"RESTW 73",HMS1361B19,"Flecainide acetate",54143-56-5,54143565,"54143 56 5","Flecainide (acetate)",Tambocor,"FLECAINIDE MONOACETATE","Flecainide acetate salt",R-818,R818,"R 818","54143-56-5 (
acetate)","54143565 (acetate)","54143 56 5 (a",SAM002548968,1505540,Prestw-735,CPD000058451,"FLECAINIDE ACETATE"}

> <pdid>

> <targets>
{}

> <classes>
{antiarrhythmic,"cardiac depressant"}

> <pubchem_cids>
{46864232,41022}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 20  0  0  0  0            999 V2000
    5.0987   -2.2518    0.0000 Na  0  3
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 Cl  0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 N   0  0
   -2.5951   -3.0039    0.0000 C   0  0
   -1.2935   -3.7495    0.0000 C   0  0
   -1.2883   -5.2495    0.0000 C   0  0
   -2.5847   -6.0040    0.0000 C   0  0
   -3.8863   -5.2585    0.0000 C   0  0
   -3.8915   -3.7585    0.0000 C   0  0
   -5.1954   -3.0153    0.0000 C   0  0
   -5.2033   -1.5153    0.0000 O   0  5
   -6.4908   -3.7717    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 Cl  0  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
  8 19  2  0
 19  3  1  0
 19 20  1  0
M  CHG  2   1   1  17  -1
M  END
> <name>
NIHCC_2014

> <id>
6256

> <plate>
NGP-202-03

> <well>
C07

> <supplier_cmpd_name>
CPD000058785

> <ctcr_id>
6050

> <supplier_cmpd_id>
SAM002548942

> <smiles>
[Na+].Cc1ccc(Cl)c(Nc2ccccc2C([O-])=O)c1Cl

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"MECLOFENAMATE SODIUM",6385-02-0,6385020,Meclomen,"Sodium meclofenamate",Meclonax,Movens,"Meclofenamic acid sodium salt","Meclofenamic acid sodium","Meclofenamate (sodium)",MECLODIUM,"Sodium 2-((2,6-
dichloro-3-methylphenyl)amino)benzoate","Sodium 2((2,6dichloro3methylphenyl)amino)benzoate",UNII-9MMQ0Y,UNII9MMQ0Y,T0260,SAM002548942,1500377,"Meclofenamate Sodium",CPD000058785}

> <pdid>

> <targets>
{}

> <classes>
{antiinflammatory,antipyretic}

> <pubchem_cids>
{4038}

$$$$
NIHCC_2014
  SciTegic11012413002D

 18 19  0  0  0  0            999 V2000
    8.8915   -4.9368    0.0000 C   0  0
    7.7740   -3.9362    0.0000 C   0  0
    6.3476   -4.4031    0.0000 O   0  0
    5.2295   -3.4020    0.0000 C   0  0
    5.5377   -1.9340    0.0000 O   0  0
    3.8056   -3.8679    0.0000 C   0  0
    3.3372   -5.2929    0.0000 C   0  0
    1.8372   -5.2877    0.0000 N   0  0
    1.3786   -3.8595    0.0000 C   0  0
    2.5951   -3.0039    0.0000 N   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10  6  1  0
 10 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
M  END
> <name>
NIHCC_2014

> <id>
6257

> <plate>
NGP-202-03

> <well>
C08

> <supplier_cmpd_name>
CPD000010931

> <ctcr_id>
3429

> <supplier_cmpd_id>
SAM002548930

> <smiles>
CCOC(=O)c1cncn1C(C)c2ccccc2

> <pd_targets>
{GABRA1,GABRB2,GABRG2,ABCB11,CYP11B1,CHRNA1,CHRNB1,CHRND,CHRNG,CYP11B2,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB3,GABRD,GABRE,GABRG1,GABRG3,GABRP,GABRQ,ADRA2B,LEF,CYP1A2,RORC,CYP3A4,CYP2C19,FFP,
LMNA,CYP2C9,AMPC}

> <pathway_gtopdb>
{"Ion channel",Transporter,Enzyme,"Membrane receptor","Transcription factor","Other nuclear protein","Ligand-gated ion channel","Primary active transporter","Cytochrome P450","Family A G protein-coupl
ed receptor",Protease,"Nuclear receptor",Transferase,Hydrolase,"GABA-A receptor","ATP-binding cassette","Cytochrome P450 family 11","Nicotinic acetylcholine receptor","Small molecule receptor (family 
A GPCR)","Metallo protease","Cytochrome P450 family 1","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 3","Cytochrome P450 family 2","ABCB subfamily","Cytochrome P450 family 11B","Nicot
inic acetylcholine receptor alpha subunit","Monoamine receptor","Metallo protease MAE clan","Cytochrome P450 family 1A","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family 3A","Cyto
chrome P450 family 2C","Cytochrome P450 11B1","Cytochrome P450 11B2","Adrenergic receptor","Metallo protease M34 family","Cytochrome P450 1A1","Nuclear hormone receptor subfamily 1 group F member 3","
Cytochrome P450 3A4","Cytochrome P450 2C19","Cytochrome P450 2C9"}

> <pathway_chembl>
{Transporters,Enzymes,"Ion channels",Receptors,"ATP-binding cassette transporter family","Cytochrome P450","Ligand-gated ion channels","G protein-coupled receptors","Nuclear hormone receptors","ABCB s
ubfamily",CYP11,CYP17,CYP19,"CYP20 and CYP21 families","GABA<sub>A</sub> receptors",Adrenoceptors,"CYP1 family","1F. Retinoic acid-related orphans","CYP3 family","CYP2 family: drug metabolising subset
"}

> <pathway_reactome>
{Metabolism,"Neuronal System","Signal Transduction",Disease,"Gene expression (Transcription)","Cell Cycle","Metabolism of lipids","Biological oxidations","Transmission across Chemical Synapses","Signa
ling by GPCR","Infectious disease","RNA Polymerase II Transcription",Mitotic,"Metabolism of steroids","Phase I - Functionalization of compounds","Neurotransmitter receptors and postsynaptic signal tra
nsmission","GPCR ligand binding","Uptake and actions of bacterial toxins","Generic Transcription Pathway","Biosynthesis of specialized proresolving mediators (SPMs)","M Phase","Bile acid and bile salt
 metabolism","Cytochrome P450 - arranged by substrate type","GABA receptor activation","Class A/1 (Rhodopsin-like receptors)","Uptake and function of anthrax toxins","Transcriptional regulation by RUN
X3","Biosynthesis of DHA-derived SPMs","Mitotic Metaphase and Anaphase","Synthesis of bile acids and bile salts","Endogenous sterols","Amine ligand-binding receptors",Xenobiotics,"RUNX3 Regulates Immu
ne Response and Cell Migration","Biosynthesis of maresins","Mitotic Anaphase","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol",Adrenoceptors,"Aromatic amines can be N-hydroxylate
d or N-dealkylated by CYP1A2","Biosynthesis of maresin-like SPMs","CYP2E1 reactions","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ADRA2B,GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG1,GABRG2,GABRG3,GABRP,GABRQ}

> <broad_moa>
{"GABA receptor modulator"}

> <synonyms>
{Etomidate,33125-97-2,33125972,Amidate,Ethnor,"Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate","Ethyl 1(1phenylethyl)1Himidazole5carboxylate",Absele,15301-65-2,15301652,C14H16N2O2,Radenarcon,"1H-I
midazole-5-carboxylic acid, 1-(1-phenylethyl)-, ethyl ester, (R)-","1HImidazole5carboxylic acid, 1(1phenylethyl), ethyl ester, (R)","Amidate (pharmaceutical)",MLS000034952,S,T1089,S1329,SAM002548930,1
505599,CPD000010931,ETOMIDATE}

> <pdid>
PD000355

> <targets>
{"GABA Receptor"}

> <classes>
{sedative,"Neuronal Signaling"}

> <pubchem_cids>
{36339}

$$$$
NIHCC_2014
  SciTegic11012413002D

 36 38  0  0  0  0            999 V2000
   12.5334   -5.2717    0.0000 H   0  3
   10.0334   -5.2717    0.0000 Cl  0  5
    4.4991   -8.4771    0.0000 O   0  0
    3.8490   -7.1253    0.0000 C   0  0
    4.6946   -5.8864    0.0000 C   0  0
    4.0445   -4.5346    0.0000 C   0  0
    2.5536   -4.4230    0.0000 C   0  0
    1.7031   -5.6606    0.0000 C   0  0
    2.3532   -7.0124    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
    0.3114   -2.9665    0.0000 S   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
    0.0000    1.5000    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    2.4133   -1.7530    0.0000 C   0  0
    3.8794   -1.4442    0.0000 C   0  0
    4.3452   -0.0184    0.0000 O   0  0
    4.8823   -2.5608    0.0000 C   0  0
    6.3506   -2.2538    0.0000 C   0  0
    7.3506   -3.3718    0.0000 C   0  0
    6.8824   -4.7969    0.0000 C   0  0
    7.8807   -5.9176    0.0000 O   0  0
    7.4102   -7.3427    0.0000 C   0  0
    8.4085   -8.4634    0.0000 C   0  0
    7.9380   -9.8886    0.0000 N   0  0
    8.9341  -11.0101    0.0000 C   0  0
    8.4610  -12.4335    0.0000 C   0  0
    6.9917  -12.7355    0.0000 C   0  0
    5.9956  -11.6141    0.0000 C   0  0
    6.4687  -10.1906    0.0000 C   0  0
    5.4142   -5.1039    0.0000 C   0  0
    4.4141   -3.9859    0.0000 C   0  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  7 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 16 17  1  0
 17 18  2  0
 18 12  1  0
 18 19  1  0
 19 10  2  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 29  1  0
 25 35  1  0
 35 36  2  0
 36 22  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6258

> <plate>
NGP-202-03

> <well>
C09

> <supplier_cmpd_name>
CPD000058508

> <ctcr_id>
6458

> <supplier_cmpd_id>
SAM002548975

> <smiles>
[H+].[Cl-].Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4

> <pd_targets>
{ESR1,MAPT,FFP,ALOX15,TP53,UBE2N,ESR2,LMNA,ALDH1A1,AMPC,NPSR1,FTL,HTT,LEF,BLM,NFO,NS1,HSD17B10,RORC,PMP22,GMNN,KMT2A,CYP3A4,HLA-A,MEN1,AOX1,PLD1,CYP2D6,ADRA1A,C5,CYP2C19,CYP2C9,NFKB1,HTR1B,GPER1,EBP,T
HPO,SIGMAR1,ERG2,TSHR,CHRM1,PLD2,ADRA1B,RECQL,NR1H4,HTR2B,ADRA2B,DRD3,TACR2,MTOR,SLC6A3,OPRD1,FYN,SLC6A4,NR1I2,ACHE,ADRA1D,OPRK1,OPRM1,HTR2C,ADRA2A,ADRA2C,HTR2A,SLC6A2,DRD2,HTR6,ADORA2A}

> <pathway_gtopdb>
{"Transcription factor","Other cytosolic protein",Enzyme,"Other nuclear protein","Membrane receptor","Unclassified protein","Epigenetic regulator","Surface antigen","Secreted protein",Transporter,"Nuc
lear receptor",Transferase,Oxidoreductase,Aminoacyltransferase,Hydrolase,"Family A G protein-coupled receptor",Protease,Reader,"Cytochrome P450",Isomerase,Kinase,"Electrochemical transporter","Nuclear
 hormone receptor subfamily 3","Peptide receptor (family A GPCR)","Metallo protease","Nuclear hormone receptor subfamily 1",Bromodomain,"Cytochrome P450 family 3","Cytochrome P450 family 2","Small mol
ecule receptor (family A GPCR)","Cysteine protease","Protein Kinase","SLC superfamily of solute carriers","Nuclear hormone receptor subfamily 3 group A","Short peptide receptor (family A GPCR)","Metal
lo protease MAE clan","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family 3A","Cytochrome P450 family 2D","Monoamine receptor","Cytochrome P450 family 2C","Cysteine protease CA clan
","Lipid-like ligand receptor (family A GPCR)","Glycohormone receptor","Nuclear hormone receptor subfamily 1 group H","Atypical protein kinase group","SLC06 neurotransmitter transporter family","TK pr
otein kinase group","Nuclear hormone receptor subfamily 1 group I","Nucleotide-like receptor (family A GPCR)","Nuclear hormone receptor subfamily 3 group A member 1","Nuclear hormone receptor subfamil
y 3 group A member 2","Neuropeptide receptor","Metallo protease M34 family","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 3A4","Cytochrome P450 2D6","Adrenergic receptor","C
ytochrome P450 2C19","Cytochrome P450 2C9","Cysteine protease C1A family","Serotonin receptor","Steroid-like ligand receptor","Acetylcholine receptor","Nuclear hormone receptor subfamily 1 group H mem
ber 4","Dopamine receptor","Neurokinin receptor","Atypical protein kinase PIKK family","Opioid receptor","Tyrosine protein kinase Src family","Nuclear hormone receptor subfamily 1 group I member 2","A
denosine receptor","Atypical protein kinase FRAP subfamily","Tyrosine protein kinase SrcA"}

> <pathway_chembl>
{Receptors,Enzymes,"Other protein targets",Transporters,"Nuclear hormone receptors","Eicosanoid turnover","G protein-coupled receptors","Chromatin modifying enzymes","Cytochrome P450","Glycerophosphol
ipid turnover","Sigma receptors","Kinases (EC 2.7.x.x)","SLC superfamily of solute carriers","Catalytic receptors","Acetylcholine turnover","Steroid hormone receptors",Lipoxygenases,"Neuropeptide S re
ceptor","1F. Retinoic acid-related orphans","2.1.1.43 Histone methyltransferases (HMTs)","CYP3 family","Phosphatidylcholine-specific phospholipase D","CYP2 family: drug metabolising subset",Adrenocept
ors,"5-Hydroxytryptamine receptors","G protein-coupled estrogen receptor","Glycoprotein hormone receptors","Acetylcholine receptors (muscarinic)","1H. Liver X receptor-like receptors","Dopamine recept
ors","Tachykinin receptors",Atypical,"SLC6 neurotransmitter transporter family","Opioid receptors","Receptor kinases","1I. Vitamin D receptor-like receptors","Adenosine receptors","3A. Estrogen recept
ors","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","Monoamine transporter subfamily","TK: Tyrosine kinase","FRAP subfamily","Non-receptor tyrosine kinases (nRTKs)","Src family"}

> <pathway_reactome>
{"Gene expression (Transcription)","Neuronal System",Metabolism,"Cell Cycle","Immune System","Signal Transduction",Disease,"Vesicle-mediated transport","DNA Repair","Developmental Biology",Hemostasis,
"Metabolism of proteins","RNA Polymerase II Transcription","Transmission across Chemical Synapses","Metabolism of lipids","Cell Cycle Checkpoints","Innate Immune System","Intracellular signaling by se
cond messengers",Mitotic,"Biological oxidations","Infectious disease","Membrane Trafficking","DNA Double-Strand Break Repair","Metabolism of amino acids and derivatives","Nervous system development","
Adaptive Immune System","Metabolism of vitamins and cofactors","Signaling by GPCR","Cytokine Signaling in Immune system","Platelet activation","signaling and aggregation","Disorders of transmembrane t
ransporters","Post-translational protein modification","Generic Transcription Pathway","Neurotransmitter receptors and postsynaptic signal transmission","Biosynthesis of specialized proresolving media
tors (SPMs)","G1/S DNA Damage Checkpoints","Toll-like Receptor Cascades","PIP3 activates AKT signaling","M Phase","Phase I - Functionalization of compounds","Leishmania infection","trans-Golgi Network
 Vesicle Budding","Uptake and actions of bacterial toxins","Homology Directed Repair","Branched-chain amino acid catabolism","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Mitotic G
1 phase and G1/S transition","Class I MHC mediated antigen processing & presentation","Metabolism of water-soluble vitamins and cofactors","Phospholipid metabolism","GPCR ligand binding","Signaling by
 Interleukins","Metabolism of steroids","Platelet Aggregation (Plug Formation)","SARS-CoV Infections","SLC transporter disorders","HIV Infection","Neurotransmitter clearance",SUMOylation,"GPCR downstr
eam signalling","Transcriptional regulation by RUNX1","Activation of NMDA receptors and postsynaptic events","Biosynthesis of DPA-derived SPMs","p53-Dependent G1/S DNA damage checkpoint","Toll Like Re
ceptor 4 (TLR4) Cascade","Negative regulation of the PI3K/AKT network","Mitotic Metaphase and Anaphase","Ethanol oxidation","Leishmania parasite growth and survival","Golgi Associated Vesicle Biogenes
is","Transcriptional Regulation by MECP2","Uptake and function of anthrax toxins","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Transcriptional regulation by RUNX3","G
1/S Transition","Biosynthesis of DHA-derived SPMs","Antigen processing-Cross presentation","Vitamins B6 activation to pyridoxal phosphate","Glycerophospholipid biosynthesis","Cytochrome P450 - arrange
d by substrate type","Class A/1 (Rhodopsin-like receptors)","Interleukin-1 family signaling","Cholesterol biosynthesis","Potential therapeutics for SARS","Bile acid and bile salt metabolism","Transcri
ptional Regulation by TP53","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Host Interactions of HIV factors","Serotonin clearance from the synaptic cleft","SUMO E3 ligases SUMOylat
e target proteins","G alpha (i) signalling events","Defective SLC6A2 causes orthostatic intolerance (OI)","RUNX1 regulates estrogen receptor mediated transcription","Post NMDA receptor activation even
ts","Biosynthesis of DPAn-3 SPMs","p53-Dependent G1 DNA Damage Response","MyD88-independent TLR4 cascade",PI5P,"PP2A and IER3 Regulate PI3K/AKT Signaling","Mitotic Anaphase","Anti-inflammatory respons
e favouring Leishmania parasite infection","Regulation of MECP2 expression and activity","HDR through Homologous Recombination (HRR)","RUNX3 Regulates Immune Response and Cell Migration","Activation o
f the pre-replicative complex","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","Biosynthesis of maresins","Endosomal/Vacuolar pathway","Synthesis of PA",Xenobio
tics,"Amine ligand-binding receptors","Peptide ligand-binding receptors","Interleukin-1 signaling","Cholesterol biosynthesis via desmosterol","Synthesis of bile acids and bile salts","Regulation of TP
53 Activity","The role of Nef in HIV-1 replication and disease pathogenesis","SUMOylation of intracellular receptors","Synthesis of PC","MECP2 regulates neuronal receptors and channels","Opioid Signal
ling","Activation of AMPK downstream of NMDARs","Biosynthesis of DPAn-3-derived protectins and resolvins","Stabilization of p53","TRIF(TICAM1)-mediated TLR4 signaling","Nuclear Envelope (NE) Reassembl
y","ADORA2B mediated anti-inflammatory cytokines production","Homologous DNA Pairing and Strand Exchange","Biosynthesis of maresin-like SPMs","CYP2E1 reactions",Adrenoceptors,"MAP3K8 (TPL2)-dependent 
MAPK1/3 activation","Serotonin receptors","Muscarinic acetylcholine receptors","Synthesis of bile acids and bile salts via 27-hydroxycholesterol","Dopamine receptors","Tachykinin receptors bind tachyk
inins","Regulation of TP53 Expression and Degradation","Nef and signal transduction","G-protein activation","Autodegradation of the E3 ubiquitin ligase COP1","IKK complex recruitment mediated by RIP1"
,"Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pairing and strand exchange","Regulation of TP53 Degradation"}

> <broad_targets>
{ESR1,ESR2}

> <broad_moa>
{"estrogen receptor antagonist","selective estrogen receptor modulator (SERM)"}

> <synonyms>
{MLS001304731,HMS2233M16,HMS3372E10,AKOS015960340,SMR000752510,"RALOXIFENE HYDROCHLORIDE",82640-04-8,"Raloxifene Hcl",Evista,"Keoxifene hydrochloride",Keoxifene,"LY 156758","Raloxifene (hydrochloride)
",UNII-4F86W47BR6,C28H28ClNO4S,LY156758,LY-156758,CHEBI:50740,"Evista (Raloxifene Hydrochloride)",4F86W47BR6,Optruma,MFCD01938233,"82640-04-8 (HCl)",DSSTox_CID_14181,DSSTox_RID_79119,DSSTox_GSID_34181
,SMR000058508,NCGC00015889-05,CAS-82640-04-8,C28H27NO4S.HCl,Loxifen,SR-01000076102,CDT-Raloxifene,"Raloxifene-d4 HCl","Evista (TN)",Prestwick_1035,"Raloxifene hydrochloride (USAN:USP)","Methanone, hyd
rochloride",CHEMBL1116,SCHEMBL19077,cc-148,MLS000859902,MLS001332533,MLS001332534,MLS002222293,"Raloxifene hydrochloride, solid","Evista, Raloxifene hydrochloride",DTXSID1034181,"LY-139481 HCl",HMS157
0N05,Pharmakon1600-01505622,AMY23426,BCP05713,"Raloxifene hydrochloride (JAN/USP)",Tox21_110255,Tox21_302369,Tox21_501051,ANW-54600,HY-13738A,NSC706725,NSC759285,s1227,AKOS008131940,Tox21_110255_1,AC-
8390,CCG-213497,CS-1775,DS-2162,KS-1102,LP01051,MCULE-7336063262,NC00665,NSC-706725,NSC-759285,VA11647,NCGC00015889-03,NCGC00015889-11,NCGC00092353-01,NCGC00092353-03,NCGC00094334-01,NCGC00094334-02,N
CGC00255153-01,NCGC00261736-01,AK-54611,AB0020647,EU-0101051,FT-0630912,R0109,SW197106-5,V1611,EN300-52517,D02217,J90021,M-8965,"R 1402",68523-EP2270008A1,68523-EP2292617A1,68523-EP2298768A1,68523-EP2
308855A1,640R048,Q-201656,SR-01000076102-2,SR-01000076102-9,Q27122215,"(6-OXO-1,6-DIHYDRO-PYRIDAZIN-3-YLOXY)-ACETICACID","Raloxifene hydrochloride, European Pharmacopoeia (EP) Reference Standard",AKOS
026750144,S1227,SAM002548975,1505622,Prestw-862,"Raloxifene HCl",CPD000058508,"Raloxifene hydrochloride"}

> <pdid>
PD004108

> <targets>
{"Estrogen/progestogen Receptor"}

> <classes>
{antiestrogen,"Endocrinology & Hormones"}

> <pubchem_cids>
{11071264,54900,25010765}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 31  0  0  0  0            999 V2000
   18.5005   -0.6561    0.0000 H   0  3
   16.0005   -0.6561    0.0000 Cl  0  5
   -0.0060   -2.5971    0.0000 O   0  0
   -0.7540   -1.2970    0.0000 C   0  0
   -2.2621   -1.2970    0.0000 C   0  0
   -3.0162    0.0000    0.0000 C   0  0
   -3.8909    1.2065    0.0000 C   0  0
   -5.3236    0.7390    0.0000 C   0  0
   -5.3236   -0.7540    0.0000 C   0  0
   -3.8909   -1.2065    0.0000 C   0  0
   -2.2621    1.2970    0.0000 C   0  0
   -0.7540    1.2970    0.0000 C   0  0
   -0.0060    2.5971    0.0000 O   0  0
    0.0000    0.0000    0.0000 N   0  0
    1.5008   -0.0031    0.0000 C   0  0
    2.2493   -1.3039    0.0000 C   0  0
    3.7501   -1.3070    0.0000 C   0  0
    4.4987   -2.6078    0.0000 C   0  0
    5.9995   -2.6109    0.0000 N   0  0
    6.7496   -3.9099    0.0000 C   0  0
    8.2496   -3.9100    0.0000 C   0  0
    8.9996   -2.6110    0.0000 N   0  0
    8.2496   -1.3119    0.0000 C   0  0
    6.7496   -1.3119    0.0000 C   0  0
   10.5004   -2.6110    0.0000 C   0  0
   11.2525   -3.9089    0.0000 N   0  0
   12.7525   -3.9065    0.0000 C   0  0
   13.5005   -2.6063    0.0000 C   0  0
   12.7484   -1.3084    0.0000 C   0  0
   11.2484   -1.3108    0.0000 N   0  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10  6  1  0
  6 11  1  0
 11 12  1  0
 12 13  2  0
 12 14  1  0
 14  4  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 19  1  0
 22 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6259

> <plate>
NGP-202-03

> <well>
C10

> <supplier_cmpd_name>
CPD000058186

> <ctcr_id>
523

> <supplier_cmpd_id>
SAM002264597

> <smiles>
[H+].[Cl-].O=C1CC2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)c4ncccn4

> <pd_targets>
{HTR1A,HTR1B,HTR1D,HTR1F,PMP22,HTR2A,HTR2B,HTR2C,KDM4E,ALDH1A1,FFP,ADRA2A,ADRA2B,ADRA2C,DRD2,ADRA1A,ADRA1B,ADRA1D,HIF1A,KCNH2,SIGMAR1,ABCB11,CYP3A4,CYP2D6,DRD1,DRD3,DRD4,DRD5,CHRM1,CYP2C9,HTR7,CYP1A2,
HTR6,SLC22A2,SLC47A2,SLC47A1}

> <pathway_gtopdb>
{"Membrane receptor","Unclassified protein","Epigenetic regulator",Enzyme,"Transcription factor","Ion channel",Transporter,"Family A G protein-coupled receptor",Eraser,Oxidoreductase,Transferase,"Volt
age-gated ion channel","Primary active transporter","Cytochrome P450","Electrochemical transporter","Small molecule receptor (family A GPCR)","Lysine demethylase","Potassium channels","ATP-binding cas
sette","Cytochrome P450 family 3","Cytochrome P450 family 2","Cytochrome P450 family 1","SLC superfamily of solute carriers","Monoamine receptor","Jumonji domain-containing","Voltage-gated potassium c
hannel","ABCB subfamily","Cytochrome P450 family 3A","Cytochrome P450 family 2D","Cytochrome P450 family 2C","Cytochrome P450 family 1A","SLC22 family of organic cation and anion transporters","SLC47 
family of multidrug and toxin extrusion transporters","Serotonin receptor","Adrenergic receptor","Dopamine receptor","Cytochrome P450 3A4","Cytochrome P450 2D6","Acetylcholine receptor","Cytochrome P4
50 2C9","Cytochrome P450 1A1"}

> <pathway_chembl>
{Enzymes,Receptors,"Ion channels","Other protein targets",Transporters,"Chromatin modifying enzymes","G protein-coupled receptors","Voltage-gated ion channels","Sigma receptors","ATP-binding cassette 
transporter family","Cytochrome P450","SLC superfamily of solute carriers","1.14.11.- Histone demethylases","5-Hydroxytryptamine receptors","Dopamine receptors","Potassium channels",Adrenoceptors,"ABC
B subfamily","CYP3 family","CYP2 family: drug metabolising subset","Acetylcholine receptors (muscarinic)","CYP1 family","SLC22 family of organic cation and anion transporters","SLC47 family of multidr
ug and toxin extrusion transporters","Voltage-gated potassium channels","Organic cation transporters (OCT)"}

> <pathway_reactome>
{"Developmental Biology",Metabolism,"Signal Transduction","Cellular responses to external stimuli","Muscle contraction",Disease,"Transport of small molecules","Nervous system development","Biological 
oxidations","Signaling by GPCR","Cellular responses to stress","Cardiac conduction","Infectious disease","Metabolism of lipids","SLC-mediated transmembrane transport","EGR2 and SOX10-mediated initiati
on of Schwann cell myelination","Phase I - Functionalization of compounds","GPCR ligand binding","Cellular response to hypoxia","Phase 3 - rapid repolarisation","SARS-CoV Infections","Metabolism of st
eroids","Biosynthesis of specialized proresolving mediators (SPMs)","Leishmania infection","Transport of bile salts and organic acids","metal ions and amine compounds","Ethanol oxidation","Class A/1 (
Rhodopsin-like receptors)","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Potential therapeutics for SARS","Bile acid and bile salt metabolism","Biosynthesis of DHA-derive
d SPMs","Cytochrome P450 - arranged by substrate type","Leishmania parasite growth and survival","Organic cation/anion/zwitterion transport","Amine ligand-binding receptors","Synthesis of bile acids a
nd bile salts","Biosynthesis of maresins",Xenobiotics,"Anti-inflammatory response favouring Leishmania parasite infection","Organic cation transport","Serotonin receptors","Dopamine receptors",Adrenoc
eptors,"Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Biosynthesis of maresin-like SPMs","CYP2E1 reactions","Muscarinic acetylcholine receptors","ADORA2B mediated anti-inflamm
atory cytokines production","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2"}

> <broad_targets>
{DRD2,HTR1A}

> <broad_moa>
{"serotonin receptor agonist"}

> <synonyms>
{"Buspirone hydrochloride",33386-08-2,33386082,Buspar,"Buspirone HCL",Narol,Buspimen,"Buspirone (hydrochloride)",UNII-207LT9J9OC,UNII207LT9J9OC,"MJ 9022-1","MJ 90221",C21H32ClN5O2,MLS000069796,207LT9J
9OC,CHEBI:3224,Bespar,Apo-Buspirone,ApoBuspirone,MFCD00078569,MJ-9022-1,MJ90221,Ansitec,Anxinil,Anx,T2132,SAM002264597,2300173,Prestw-1283,CPD000058186,"BUSPIRONE HYDROCHLORIDE"}

> <pdid>
PD009997

> <targets>
{}

> <classes>
{anxiolytic,"5HT1a receptor agonist"}

> <pubchem_cids>
{36431,25137845,44658940}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 22  0  0  0  0            999 V2000
   11.9554   -0.0975    0.0000 H   0  3
    9.4554   -0.0975    0.0000 Cl  0  5
    6.9546   -4.2653    0.0000 C   0  0
    5.4929   -3.9285    0.0000 N   0  0
    5.0525   -2.4938    0.0000 C   0  0
    3.5900   -2.1568    0.0000 C   0  0
    3.1497   -0.7220    0.0000 C   0  0
    1.6852   -0.3846    0.0000 N   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.5913    1.9239    0.0000 C   0  0
    2.4792    3.4197    0.0000 C   0  0
    1.1278    4.0705    0.0000 C   0  0
   -0.1116    3.2255    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22  8  1  0
 22 17  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6260

> <plate>
NGP-202-03

> <well>
C11

> <supplier_cmpd_name>
CPD000036827

> <ctcr_id>
3134

> <supplier_cmpd_id>
SAM002264605

> <smiles>
[H+].[Cl-].CNCCCN1c2ccccc2CCc3ccccc13

> <pd_targets>
{SLC6A2,SLC6A4,SLC6A3,SCN1A,SCN2A,SCN3A,HTR3A,HTR7,CHRM3,KCNH2,CHRM1,THPO,CYP2D6,HRH1,HRH2,HTR2A,HTR2C,HTR1A,CYP3A4,CYP1A2,ADRA1A,HTR1B,HTR1D,HTR1F,HTR2B,HTR3B,HTR4,HTR5A,HTR5B,HTR6,CHRM2,ADRA2A,DRD2,
CHRM5,KCNJ6,NFKB1,SIGMAR1,HTT,NET,SLC29A4,ADRA2C,KCNJ5,CHRM4,PMP22,NPSR1,KMT2A,MEN1,AMPC,SLC22A3,CACNA1C,SLC22A1,SLC22A4,SLC22A2,MTOR,SCN5A,ADRB2,ADRB1,SMPD1,ADRA1B,ADRA1D,ADRA2B}

> <pathway_gtopdb>
{Transporter,"Ion channel","Membrane receptor","Unclassified protein",Enzyme,"Other cytosolic protein","Epigenetic regulator","Electrochemical transporter","Voltage-gated ion channel","Ligand-gated io
n channel","Family A G protein-coupled receptor","Cytochrome P450",Reader,Hydrolase,Kinase,"SLC superfamily of solute carriers","Voltage-gated sodium channel","5HT3 receptor","Small molecule receptor 
(family A GPCR)","Potassium channels","Cytochrome P450 family 2","Cytochrome P450 family 3","Cytochrome P450 family 1","Peptide receptor (family A GPCR)",Bromodomain,"Voltage-gated calcium channel","P
rotein Kinase","SLC06 neurotransmitter transporter family","Monoamine receptor","Voltage-gated potassium channel","Cytochrome P450 family 2D","Cytochrome P450 family 3A","Cytochrome P450 family 1A","I
nwardly rectifying potassium channel","SLC28 and SLC29 families of nucleoside transporters","Short peptide receptor (family A GPCR)","SLC22 family of organic cation and anion transporters","Atypical p
rotein kinase group","Serotonin receptor","Acetylcholine receptor","Cytochrome P450 2D6","Histamine receptor","Cytochrome P450 3A4","Cytochrome P450 1A1","Adrenergic receptor","Dopamine receptor","SLC
29 Facilitative nucleoside transporter family","Neuropeptide receptor","Atypical protein kinase PIKK family","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Transporters,"Ion channels",Receptors,Enzymes,"Other protein targets","SLC superfamily of solute carriers","Ligand-gated ion channels","G protein-coupled receptors","Voltage-gated ion channels","Cyto
chrome P450","Sigma receptors","Kinases (EC 2.7.x.x)","Ceramide turnover","SLC6 neurotransmitter transporter family","5-HT<sub>3</sub> receptors","5-Hydroxytryptamine receptors","Acetylcholine recepto
rs (muscarinic)","Potassium channels","CYP2 family: drug metabolising subset","Histamine receptors","CYP3 family","CYP1 family",Adrenoceptors,"Dopamine receptors","SLC28 and SLC29 families of nucleosi
de transporters","Neuropeptide S receptor","SLC22 family of organic cation and anion transporters","Voltage-gated calcium channels",Atypical,"Voltage-gated sodium channels","Sphingomyelin phosphodiest
erase","Monoamine transporter subfamily","Voltage-gated potassium channels","Inwardly rectifying potassium channels","SLC29 family","Organic cation transporters (OCT)","Organic zwitterions/cation tran
sporters (OCTN)","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","FRAP subfamily"}

> <pathway_reactome>
{"Neuronal System",Disease,"Signal Transduction","Muscle contraction",Hemostasis,Metabolism,"Immune System","Gene expression (Transcription)","Transport of small molecules","Developmental Biology","Tr
ansmission across Chemical Synapses","Disorders of transmembrane transporters","Infectious disease","Signaling by GPCR","Cardiac conduction","Platelet activation","signaling and aggregation","Biologic
al oxidations","Metabolism of lipids","Cytokine Signaling in Immune system","RNA Polymerase II Transcription","SLC-mediated transmembrane transport","Nervous system development","Neurotransmitter clea
rance","SLC transporter disorders","Neurotransmitter receptors and postsynaptic signal transmission","Leishmania infection","GPCR ligand binding","Phase 3 - rapid repolarisation","Platelet Aggregation
 (Plug Formation)","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","Signaling by Interleukins","SARS-CoV Infections","Generic Transcription Pathw
ay","Transport of vitamins",nucleosides,"and related molecules","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Transport of bile salts and organic acids","metal ions and amine compo
unds","Axon guidance","Sphingolipid metabolism","Serotonin clearance from the synaptic cleft","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Leishmania parasite growth and survival
","Class A/1 (Rhodopsin-like receptors)","Defective SLC6A2 causes orthostatic intolerance (OI)","Cytochrome P450 - arranged by substrate type","Biosynthesis of DHA-derived SPMs","GABA receptor activat
ion","Interleukin-1 family signaling","Potential therapeutics for SARS","Transcriptional Regulation by MECP2","Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane"
,"Organic cation/anion/zwitterion transport","NCAM signaling for neurite out-growth","Transcriptional Regulation by TP53","L1CAM interactions","Glycosphingolipid metabolism","Anti-inflammatory respons
e favouring Leishmania parasite infection","Amine ligand-binding receptors",Xenobiotics,"Biosynthesis of maresins","GABA B receptor activation","Interleukin-1 signaling","Regulation of MECP2 expressio
n and activity","Organic cation transport","NCAM1 interactions","Regulation of TP53 Activity","Interaction between L1 and Ankyrins","ADORA2B mediated anti-inflammatory cytokines production","Muscarini
c acetylcholine receptors","CYP2E1 reactions","Histamine receptors","Serotonin receptors","Biosynthesis of maresin-like SPMs","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2",Adrenoc
eptors,"Dopamine receptors","Activation of GABAB receptors","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Regulation of TP53 Expression and Degradation","Inhibition  of voltage gated Ca2+ channels via
 Gbeta/gamma subunits","Regulation of TP53 Degradation"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,ADRA2A,ADRA2B,ADRA2C,ADRB1,ADRB2,CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,DRD2,HRH1,HTR1A,HTR2A,HTR2C,SLC6A2,SLC6A4,SMPD1}

> <broad_moa>
{"tricyclic antidepressant"}

> <synonyms>
{RESTW34,"RESTW 34","10,f)azepine hydrochloride","Desipramine hydrochloride",58-28-6,58286,"58 28 6",Norpramin,"Desipramine Hcl",Pertofrane,Pertofran,"DMI hydrochloride",Norpolake,Nortimil,"Desmethyli
mipramine chloride","Desipramine monohydrochl",SAM002264605,1500227,Prestw-343,CPD000036827,"DESIPRAMINE HYDROCHLORIDE"}

> <pdid>
PD009775

> <targets>
{}

> <classes>
{antidepressant}

> <pubchem_cids>
{65327,24207697,657326}

$$$$
NIHCC_2014
  SciTegic11012413002D

 36 39  0  0  1  0            999 V2000
   -1.2144  -10.6204    0.0000 C   0  0
   -0.2327   -9.4862    0.0000 C   0  0
   -0.7235   -8.0679    0.0000 C   0  0
   -2.1965   -7.7844    0.0000 O   0  0
    0.2586   -6.9331    0.0000 O   0  0
   -0.2322   -5.5148    0.0000 C   0  0
    0.7500   -4.3800    0.0000 C   0  0
    2.2230   -4.6635    0.0000 O   0  0
    0.2851   -2.9666    0.0000 C   0  0  1  0  0  0
   -1.1616   -2.6175    0.0000 O   0  0
   -2.1799   -3.7201    0.0000 C   0  0
   -1.7340   -5.1523    0.0000 O   0  0
   -3.6441   -3.3904    0.0000 C   0  0
   -4.6618   -4.4923    0.0000 C   0  0
    1.7758   -3.1329    0.0000 C   0  0  1  0  0  0
    2.2703   -4.0021    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -0.8660    2.5000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
    0.0000    0.5000    0.0000 Cl  0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -0.8141   -2.0807    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  1
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
  9 15  1  0
 15 16  1  6
 15 17  1  0
 18 17  1  6
 18 19  1  0
 19 20  1  1
 20 21  1  0
 21 22  1  0
 22 23  2  3
 23 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  2  3
 27 28  1  0
 28 22  1  0
 28 29  1  6
 28 30  1  0
 30 19  1  0
 30 31  1  1
 30 32  1  0
 32 33  1  6
 32 34  1  0
 34 35  1  0
 35  9  1  0
 35 18  1  0
 35 36  1  6
M  END
> <name>
NIHCC_2014

> <id>
6261

> <plate>
NGP-202-03

> <well>
D02

> <supplier_cmpd_name>
CPD001233361

> <ctcr_id>
3314

> <supplier_cmpd_id>
SAM002699895

> <smiles>
CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]12C

> <pd_targets>
{CYP3A4,FTL,AMPC,ADGRG3,TIM23,NR3C1,MAPT}

> <pathway_gtopdb>
{Enzyme,"Unclassified protein","Membrane receptor","Transcription factor","Cytochrome P450",Protease,Hydrolase,"Family B G protein-coupled receptor","Nuclear receptor","Cytochrome P450 family 3","Cyst
eine protease","Nuclear hormone receptor subfamily 3","Cytochrome P450 family 3A","Cysteine protease CA clan","Nuclear hormone receptor subfamily 3 group C","Cytochrome P450 3A4","Cysteine protease C1
A family","Nuclear hormone receptor subfamily 3 group C member 1","Other cytosolic protein"}

> <pathway_chembl>
{Enzymes,Receptors,"Cytochrome P450","G protein-coupled receptors","Nuclear hormone receptors","CYP3 family","Adhesion Class GPCRs","Steroid hormone receptors","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{Metabolism,"Vesicle-mediated transport","Immune System","Gene expression (Transcription)","Metabolism of lipids","Membrane Trafficking","Innate Immune System","RNA Polymerase II Transcription","Biosy
nthesis of specialized proresolving mediators (SPMs)","trans-Golgi Network Vesicle Budding","Neutrophil degranulation","Generic Transcription Pathway","Biosynthesis of DHA-derived SPMs","Golgi Associa
ted Vesicle Biogenesis","FOXO-mediated transcription","Biosynthesis of maresins","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","Biosynthesis of maresin-like SPMs","N
euronal System","Transmission across Chemical Synapses","Neurotransmitter receptors and postsynaptic signal transmission","Activation of NMDA receptors and postsynaptic events","Post NMDA receptor act
ivation events","Activation of AMPK downstream of NMDARs"}

> <broad_targets>
{NR3C1}

> <broad_moa>
{"anti-inflammatory agent"}

> <synonyms>
{RESTW85,"BECLOMETHASONE DIPROPIONATE","Beclometasone dipropionate",Beclovent,Beconase,5534-09-8,5534098,Beclazone,Vancenase,Becloforte,Beclomet,Beclorhinol,Propaderm,Sanasthmax,Sanasthmyl,Vanceril,Ae
robec,Aldecin,Beclacin,Entyderma,Korbutone,Viarox,Rino-clenil,Rinoclenil,SAM002699895,Prestw-855,CPD001233361,"Beclomethasone dipropionate"}

> <pdid>
PD001048

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{21700}

$$$$
NIHCC_2014
  SciTegic11012413002D

 14 14  0  0  0  0            999 V2000
    1.6317   -2.2458    0.0000 C   0  0
    0.7500   -1.0323    0.0000 N   0  0
    1.2135    0.3943    0.0000 N   0  0
    0.0000    1.2760    0.0000 C   0  0
   -1.2135    0.3943    0.0000 S   0  0
   -0.7500   -1.0323    0.0000 C   0  0
   -1.6332   -2.2426    0.0000 N   0  0
   -3.1255   -2.0835    0.0000 C   0  0
   -3.7332   -0.7122    0.0000 C   0  0
   -4.0097   -3.2952    0.0000 O   0  0
    0.0000    2.7742    0.0000 S   0  0
   -1.2993    3.5238    0.0000 N   0  0
    1.2985    3.5251    0.0000 O   0  0
   -0.0007    4.2742    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  3
  4  5  1  0
  5  6  1  0
  6  2  1  0
  6  7  2  3
  7  8  1  0
  8  9  1  0
  8 10  2  0
  4 11  1  0
 11 12  1  0
 11 13  2  0
 11 14  2  0
M  END
> <name>
NIHCC_2014

> <id>
6262

> <plate>
NGP-202-03

> <well>
D03

> <supplier_cmpd_name>
CPD001496938

> <ctcr_id>
5848

> <supplier_cmpd_id>
SAM002589943

> <smiles>
CN1N=C(SC1=NC(C)=O)[S](N)(=O)=O

> <pd_targets>
{CA2,CA5A,CA5B,CA9,CA4,MTCA1,CA7,CA12,CA6,CA1,CA13,CA14,CA3,HPGD,NCE103,MTCA2,CYNT,HSD17B10,CA15,HTT,CYP2C9,FFP,MAPT,1272966}

> <pathway_gtopdb>
{Enzyme,"Unclassified protein","Other cytosolic protein",Lyase,Oxidoreductase,"Cytochrome P450",Transferase,"Cytochrome P450 family 2","Cytochrome P450 family 2C","Cytochrome P450 2C9"}

> <pathway_chembl>
{Enzymes,"Carbonic anhydrases","Eicosanoid turnover","Cytochrome P450","Prostaglandin synthases","CYP2 family: drug metabolising subset"}

> <pathway_reactome>
{"Transport of small molecules",Metabolism,"Cellular responses to external stimuli","Immune System","Gene expression (Transcription)","Neuronal System","O2/CO2 exchange in erythrocytes","Reversible hy
dration of carbon dioxide","Cellular responses to stress","Cytokine Signaling in Immune system","Metabolism of lipids","Metabolism of amino acids and derivatives","RNA Polymerase II Transcription","Bi
ological oxidations","Transmission across Chemical Synapses","Erythrocytes take up carbon dioxide and release oxygen","Cellular response to hypoxia","Signaling by Interleukins","Biosynthesis of specia
lized proresolving mediators (SPMs)","Branched-chain amino acid catabolism","Generic Transcription Pathway","Phase I - Functionalization of compounds","Neurotransmitter receptors and postsynaptic sign
al transmission","Regulation of gene expression by Hypoxia-inducible Factor","Interleukin-12 family signaling","Biosynthesis of DHA-derived SPMs","Transcriptional Regulation by MECP2","Cytochrome P450
 - arranged by substrate type","Activation of NMDA receptors and postsynaptic events","Interleukin-12 signaling","Biosynthesis of D-series resolvins","Regulation of MECP2 expression and activity",Xeno
biotics,"Post NMDA receptor activation events","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","CYP2E1 reactions","Activation of AMPK downstream of NMDARs"}

> <broad_targets>
{CA1,CA12,CA14,CA2,CA4,CA7}

> <broad_moa>
{"carbonic anhydrase inhibitor"}

> <synonyms>
{methazolamide,554-57-4,554574,Neptazane,Methenamide,Neptazaneat,Naptazane,"N-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide","N(3methyl5sulfamoyl1,3,4thiadiazol2ylidene)acetamide",(Z)-met
hazolamide,(Z)methazolamide,UNII-W733B0S9SD,UNIIW733B0S9SD,CHEBI:6822,L584601,UNII-DA43GW06P1,UNIIDA43GW06P1,MLS000028532,CHEMBL288100,DA43GW06P1,W733B,SAM002589943,Prestw-802,S4039,CPD001496938,Metha
zolamide}

> <pdid>
PD001023

> <targets>
{"Carbonic Anhydrase"}

> <classes>
{Metabolism}

> <pubchem_cids>
{4100}

$$$$
NIHCC_2014
  SciTegic11012413002D

 31 35  0  0  1  0            999 V2000
   -1.0185   -8.8895    0.0000 C   0  0
   -0.8343   -7.4008    0.0000 C   0  0
    0.5474   -6.8149    0.0000 C   0  0
    0.7315   -5.3280    0.0000 C   0  0
    2.0426   -4.5993    0.0000 O   0  0
    1.7758   -3.1329    0.0000 C   0  0  2  0  0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -1.2991    2.2500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  1  0  0  0
   -0.8141   -2.0807    0.0000 C   0  0
    0.2851   -2.9666    0.0000 C   0  0  2  0  0  0
   -0.3667   -4.3062    0.0000 O   0  0
   -1.1988   -2.7813    0.0000 C   0  0
   -2.1035   -3.9778    0.0000 O   0  0
   -1.7835   -1.3990    0.0000 C   0  0
   -3.2720   -1.2134    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  6  5  1  1
  6  7  1  0
  8  7  1  6
  8  9  1  0
  9 10  1  1
 10 11  1  0
 11 12  1  0
 12 13  2  3
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  2  3
 17 18  1  0
 18 12  1  0
 18 19  1  6
 20 18  1  6
 20  9  1  0
 20 21  1  0
 21 22  1  6
 21 23  1  0
 23 24  1  0
 24  8  1  0
 24 25  1  6
 24 26  1  0
 26  6  1  0
 26 27  1  0
 27  4  1  0
 26 28  1  6
 28 29  2  0
 28 30  1  0
 30 31  1  0
M  END
> <name>
NIHCC_2014

> <id>
6263

> <plate>
NGP-202-03

> <well>
D04

> <supplier_cmpd_name>
CPD000058337

> <ctcr_id>
2036

> <supplier_cmpd_id>
SAM002699898

> <smiles>
CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO

> <pd_targets>
{AR,NR3C1,IL5,NFKB1,PGR,RORC,THPO,HSD17B10,CYP3A4,NR3C2,ABCC3,MMP9,ABCC4,ABCB11,IL5RA,ANXA1,PMP22,NPSR1,LMNA,BLM}

> <pathway_gtopdb>
{"Transcription factor","Secreted protein","Other cytosolic protein","Unclassified protein",Enzyme,Transporter,"Membrane receptor","Ion channel","Nuclear receptor",Oxidoreductase,"Cytochrome P450","Pr
imary active transporter",Protease,"Other ion channel","Nuclear hormone receptor subfamily 3","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 3","ATP-binding cassette","Metallo protease
",Annexin,"Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family 3A","ABCC subfamily","Metallo protease MAM clan","ABCB subfamily","Nucle
ar hormone receptor subfamily 3 group C member 4","Nuclear hormone receptor subfamily 3 group C member 1","Nuclear hormone receptor subfamily 3 group C member 3","Nuclear hormone receptor subfamily 1 
group F member 3","Cytochrome P450 3A4","Nuclear hormone receptor subfamily 3 group C member 2","Metallo protease M10A subfamily","Other nuclear protein","Family A G protein-coupled receptor","Peptide
 receptor (family A GPCR)","Short peptide receptor (family A GPCR)","Neuropeptide receptor"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Nuclear hormone receptors","Cytochrome P450","ATP-binding cassette transporter family","Peptidases and proteinases","Catalytic receptors","Steroid hormone receptors","
1F. Retinoic acid-related orphans","CYP3 family","ABCC subfamily","MA: Metallo (M) Peptidases","ABCB subfamily","Cytokine receptor family","3C. 3-Ketosteroid receptors","M10: Matrix metallopeptidase",
"IL-3 receptor family","G protein-coupled receptors","Neuropeptide S receptor"}

> <pathway_reactome>
{"Gene expression (Transcription)","Immune System","Metabolism of proteins",Hemostasis,Metabolism,"Developmental Biology","Signal Transduction","RNA Polymerase II Transcription","Cytokine Signaling in
 Immune system","Post-translational protein modification","Platelet activation","signaling and aggregation","Metabolism of amino acids and derivatives","Metabolism of lipids","Nervous system developme
nt","Signaling by GPCR","Generic Transcription Pathway","Signaling by Interleukins",SUMOylation,"Platelet Aggregation (Plug Formation)","Branched-chain amino acid catabolism","Biosynthesis of speciali
zed proresolving mediators (SPMs)","Metabolism of steroids","Axon guidance","Response to elevated platelet cytosolic Ca2+","GPCR ligand binding","Transcriptional regulation by RUNX2","FOXO-mediated tr
anscription",Interleukin-3,"Interleukin-5 and GM-CSF signaling","Interleukin-1 family signaling","SUMO E3 ligases SUMOylate target proteins","Transcriptional regulation by RUNX3","Biosynthesis of DHA-
derived SPMs","Bile acid and bile salt metabolism","EPH-Ephrin signaling","Platelet degranulation","Class A/1 (Rhodopsin-like receptors)","RUNX2 regulates bone development","FOXO-mediated transcriptio
n of oxidative stress","metabolic and neuronal genes","Interleukin receptor SHC signaling","Interleukin-1 signaling","SUMOylation of intracellular receptors","RUNX3 Regulates Immune Response and Cell 
Migration","Biosynthesis of maresins","Recycling of bile acids and salts","EPH-ephrin mediated repulsion of cells","Synthesis of bile acids and bile salts","Peptide ligand-binding receptors","RUNX2 re
gulates osteoblast differentiation","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Biosynthesis of maresin-like SPMs","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Formyl pept
ide receptors bind formyl peptides and many other ligands",Disease,"Cell Cycle","DNA Repair","Infectious disease",Mitotic,"DNA Double-Strand Break Repair","EGR2 and SOX10-mediated initiation of Schwan
n cell myelination","Leishmania infection","M Phase","Homology Directed Repair","Leishmania parasite growth and survival","Mitotic Metaphase and Anaphase","HDR through Homologous Recombination (HRR) o
r Single Strand Annealing (SSA)","Anti-inflammatory response favouring Leishmania parasite infection","Mitotic Anaphase","HDR through Homologous Recombination (HRR)","ADORA2B mediated anti-inflammator
y cytokines production","Nuclear Envelope (NE) Reassembly","Homologous DNA Pairing and Strand Exchange","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pairing a
nd strand exchange"}

> <broad_targets>
{NR3C1}

> <broad_moa>
{"glucocorticoid receptor agonist"}

> <synonyms>
{RESTW51,budesonide,Entocort,51333-22-3,51333223,Preferid,Pulmicort,"Rhinocort Aqua",Rhinocort,"Entocort EC","Pulmicort Respules",Budesonidum,Uceris,Budeson,"Pulmicort Flexhaler",Cortivent,Micronyl,Re
spules,Spirocort,Bidien,Budenofalk,CHEBI:3207,MAP-0010,MAP0010,51372-2,513722,T0094,SAM002699898,Prestw-518,Budesonide,CPD000058337}

> <pdid>
PD001573

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5281004}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 24  0  0  0  0            999 V2000
    2.6640   -0.1280    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -5.1962    3.0000    0.0000 C   0  0
   -6.4952    3.7500    0.0000 O   0  0
   -3.8971    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -1.2990    2.2500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3326   -2.9571    0.0000 C   0  0
    1.8253   -3.1044    0.0000 C   0  0
    2.4266   -1.7302    0.0000 C   0  0
    3.8900   -1.4008    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  3
 10 11  1  0
 11 12  2  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15  5  1  0
 15  9  1  0
 15 16  1  0
  6 17  1  0
 17  2  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20  2  1  0
 20 21  1  0
M  END
> <name>
NIHCC_2014

> <id>
6264

> <plate>
NGP-202-03

> <well>
D05

> <supplier_cmpd_name>
CPD000109709

> <ctcr_id>
7050

> <supplier_cmpd_id>
SAM002548950

> <smiles>
CC12CCC3C(CCC4=CC(=O)CCC34C)C1CCC2O

> <pd_targets>
{HSD17B10,ERG2,AR,SHBG,SRD5A1,SRD5A2,CYP3A4,TSHR,PGR,NR1I3,LMNA,SERPINA6,SIGMAR1,CYP19A1,CACNA1C,GPBAR1,CYP51A1,NR3C1,SLCO1A1,ESR1,OR51E2}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Secreted protein","Membrane receptor","Other nuclear protein","Ion channel",Transporter,Oxidoreductase,Isomerase,"Nuclear receptor","Cytochrome P450","Family A G protei
n-coupled receptor","Voltage-gated ion channel","Electrochemical transporter","Nuclear hormone receptor subfamily 3","Cytochrome P450 family 3","Peptide receptor (family A GPCR)","Nuclear hormone rece
ptor subfamily 1","Cytochrome P450 family 19","Voltage-gated calcium channel","Small molecule receptor (family A GPCR)","Cytochrome P450 family 51","SLC superfamily of solute carriers","Nuclear hormon
e receptor subfamily 3 group C","Cytochrome P450 family 3A","Glycohormone receptor","Nuclear hormone receptor subfamily 1 group I","Cytochrome P450 family 19A","Lipid-like ligand receptor (family A GP
CR)","Cytochrome P450 family 51A","SLC21/SLCO family of organic anion transporting polypeptides","Nuclear hormone receptor subfamily 3 group A","Nuclear hormone receptor subfamily 3 group C member 4",
"Cytochrome P450 3A4","Nuclear hormone receptor subfamily 3 group C member 3","Nuclear hormone receptor subfamily 1 group I member 3","Cytochrome P450 19A1","Steroid-like ligand receptor","Cytochrome 
P450 51A1","Nuclear hormone receptor subfamily 3 group C member 1","Nuclear hormone receptor subfamily 3 group A member 1","Unclassified protein"}

> <pathway_chembl>
{Receptors,Enzymes,"Other protein targets","Ion channels","Nuclear hormone receptors","Cytochrome P450","G protein-coupled receptors","Sigma receptors","Voltage-gated ion channels","Steroid hormone re
ceptors","CYP3 family","Glycoprotein hormone receptors","1I. Vitamin D receptor-like receptors",CYP11,CYP17,CYP19,"CYP20 and CYP21 families","Voltage-gated calcium channels","Bile acid receptor",CYP39
,"CYP46 and CYP51 families","3C. 3-Ketosteroid receptors","3A. Estrogen receptors"}

> <pathway_reactome>
{Metabolism,"Gene expression (Transcription)",Disease,"Cell Cycle","Developmental Biology","Metabolism of amino acids and derivatives","RNA Polymerase II Transcription","Metabolism of lipids","Infecti
ous disease",Mitotic,"Biological oxidations","Nervous system development","Branched-chain amino acid catabolism","Generic Transcription Pathway","Biosynthesis of specialized proresolving mediators (SP
Ms)","Leishmania infection","M Phase","Metabolism of steroids","SARS-CoV Infections","Phase I - Functionalization of compounds","Axon guidance","Transcriptional regulation by RUNX2","Biosynthesis of D
HA-derived SPMs","Leishmania parasite growth and survival","Nuclear Receptor transcription pathway","Mitotic Metaphase and Anaphase","Metabolism of steroid hormones","Potential therapeutics for SARS",
"Cytochrome P450 - arranged by substrate type","NCAM signaling for neurite out-growth","FOXO-mediated transcription","Transcriptional regulation by RUNX1","RUNX2 regulates bone development","Biosynthe
sis of maresins","Anti-inflammatory response favouring Leishmania parasite infection","Mitotic Anaphase","Glucocorticoid biosynthesis","Endogenous sterols","NCAM1 interactions","FOXO-mediated transcri
ption of oxidative stress","metabolic and neuronal genes","RUNX1 regulates estrogen receptor mediated transcription","RUNX2 regulates osteoblast differentiation","Biosynthesis of maresin-like SPMs","A
DORA2B mediated anti-inflammatory cytokines production","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation","Signal Transduction","Signaling by GPCR","GPCR downstream 
signalling","G alpha (s) signalling events","Olfactory Signaling Pathway"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{17-Hydroxyandrost-4-en-3-one,17Hydroxyandrost4en3one,"Oreton F",Homosteron,Homosterone,Orquisteron,Primoteston,Testandrone,Testopropon,Testosteroid,Andronaq,Andrusol,Neotestis,Perandren,Primotest,Sus
tanon,Sustanone,Testobase,Testrone,Testryl,Virormone,1221910-14-0,1221910140,T,SAM002548950,CPD000109709}

> <pdid>
PD001987

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5408}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 21  0  0  0  0            999 V2000
    8.9106   -2.2509    0.0000 Na  0  3
    6.4099   -1.1887    0.0000 O   0  0
    4.9183   -1.0302    0.0000 C   0  0
    4.1697    0.2696    0.0000 N   0  0
    2.7022   -0.0406    0.0000 C   0  0
    1.9481    0.6162    0.0000 O   0  0
    2.5987   -1.5006    0.0000 C   0  0
    3.9134   -2.1439    0.0000 N   0  5
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    2.5956   -3.0018    0.0000 C   0  0
    3.8931   -3.7545    0.0000 C   0  0
    3.8899   -5.2545    0.0000 C   0  0
    2.5893   -6.0018    0.0000 C   0  0
    1.2919   -5.2491    0.0000 C   0  0
    1.2950   -3.7491    0.0000 C   0  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  8  3  1  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
  7 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
M  CHG  2   1   1   8  -1
M  END
> <name>
NIHCC_2014

> <id>
6265

> <plate>
NGP-202-03

> <well>
D06

> <supplier_cmpd_name>
CPD000146393

> <ctcr_id>
5183

> <supplier_cmpd_id>
SAM002548966

> <smiles>
[Na+].O=C1NC(=O)C([N-]1)(c2ccccc2)c3ccccc3

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"PHENYTOIN SODIUM",630-93-3,630933,"5,5-Diphenylhydantoin sodium salt","5,5Diphenylhydantoin sodium salt","Diphenylhydantoin Sodium",Antisacer,Diphentoin,Epanutin,Solantoin,Solantyl,Eptoin,"Sodium ph
enytoin","Diphenylan sodium","sodium 2,5-dioxo-4,4-diphenylimidazolidin-1-ide","sodium 2,5dioxo4,4diphenylimidazolidin1ide",S2524,SAM002548966,1500485,"Phenytoin sodium",CPD000146393}

> <pdid>

> <targets>
{"Sodium Channel"}

> <classes>
{antieleptic,anticonvulsant,"Transmembrane Transporters"}

> <pubchem_cids>
{657302,23679632,13241308}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 24  0  0  0  0            999 V2000
    2.5985   -0.0004    0.0000 O   0  0
    2.5987   -1.5004    0.0000 C   0  0
    1.2989   -2.2506    0.0000 C   0  0
    1.2977   -3.7514    0.0000 N   0  0
    0.0852   -4.6128    0.0000 C   0  0
    0.5506   -6.0388    0.0000 N   0  0
    2.0506   -6.0369    0.0000 C   0  0
    2.5123   -4.6097    0.0000 N   0  0
    3.8988   -2.2502    0.0000 C   0  0
    5.1987   -1.5000    0.0000 N   0  0
    6.5513   -2.1184    0.0000 C   0  0
    7.5528   -1.0018    0.0000 N   0  0
    6.8004    0.2958    0.0000 C   0  0
    5.3338   -0.0188    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 F   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 F   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  4  1  0
  2  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 10  1  0
  2 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 18 20  1  0
 20 21  2  0
 21 15  1  0
 21 22  1  0
M  END
> <name>
NIHCC_2014

> <id>
6266

> <plate>
NGP-202-03

> <well>
D07

> <supplier_cmpd_name>
CPD000471882

> <ctcr_id>
5811

> <supplier_cmpd_id>
SAM002589905

> <smiles>
OC(Cn1cncn1)(Cn2cncn2)c3ccc(F)cc3F

> <pd_targets>
{CYP51,CYP3A4,CYP2C9,CYP2C19,CYP51A1,HSP90AA1,CYP11B1,HMOX1,CYP121,CYP51B,CYP11B2,CYP19A1,LMNA,CYP125,ERG11}

> <pathway_gtopdb>
{"Unclassified protein",Enzyme,"Other cytosolic protein","Other nuclear protein",Oxidoreductase,"Cytochrome P450","Cytochrome P450 family 3","Cytochrome P450 family 2","Cytochrome P450 family 51","Cyt
ochrome P450 family 11","Cytochrome P450 family 19","Cytochrome P450 family 3A","Cytochrome P450 family 2C","Cytochrome P450 family 51A","Cytochrome P450 family 11B","Cytochrome P450 family 19A","Cyto
chrome P450 3A4","Cytochrome P450 2C9","Cytochrome P450 2C19","Cytochrome P450 51A1","Cytochrome P450 11B1","Cytochrome P450 11B2","Cytochrome P450 19A1"}

> <pathway_chembl>
{Enzymes,"Other protein targets","Cytochrome P450","Heat shock proteins","Haem oxygenase","CYP3 family","CYP2 family: drug metabolising subset",CYP39,"CYP46 and CYP51 families",CYP11,CYP17,CYP19,"CYP2
0 and CYP21 families"}

> <pathway_reactome>
{Metabolism,"Cell Cycle","Immune System","Metabolism of lipids","Biological oxidations",Mitotic,"Cytokine Signaling in Immune system","Biosynthesis of specialized proresolving mediators (SPMs)","Phase
 I - Functionalization of compounds","Mitotic G2-G2/M phases","Signaling by Interleukins","M Phase","Biosynthesis of DHA-derived SPMs","Cytochrome P450 - arranged by substrate type","G2/M Transition",
"Interleukin-4 and Interleukin-13 signaling","Mitotic Metaphase and Anaphase","Biosynthesis of maresins",Xenobiotics,"Endogenous sterols","Centrosome maturation","Mitotic Anaphase","Biosynthesis of ma
resin-like SPMs","CYP2E1 reactions","Loss of proteins required for interphase microtubule organization from the centrosome","Nuclear Envelope (NE) Reassembly","Loss of Nlp from mitotic centrosomes","I
nitiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{CYP51A1}

> <broad_moa>
{"sterol demethylase inhibitor"}

> <synonyms>
{86386-73-4,86386734,Diflucan,Triflucan,Biozolene,Elazor,Biocanol,Fluconazol,Fungata,Fluconazolum,Flucostat,"2-(2,4-DIFLUOROPHENYL)-1,3-DI(1H-1,2,4-TRIAZOL-1-YL)PROPAN-2-OL","2(2,4DIFLUOROPHENYL)1,3DI
(1H1,2,4TRIAZOL1YL)PROPAN2OL","UK 49858",Flusol,Zoltec,2-(2,2(2,4-Difluorophenyl)-1,4Difluorophenyl)1,3-bis(1H-1,3bis(1H1,2,4-,4,T1388,SAM002589905,1503975,Prestw-1417,Fluconazole,CPD000471882,FLUCONA
ZOLE}

> <pdid>
PD000782

> <targets>
{}

> <classes>
{antifungal}

> <pubchem_cids>
{3365}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 22  0  0  0  0            999 V2000
    5.0536    0.2477    0.0000 Cl  0  0
   -0.2237   -5.5078    0.0000 C   0  0
   -0.6890   -4.0818    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.5532   -4.4223    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5973    1.5031    0.0000 C   0  0
   -2.5951    3.0039    0.0000 N   0  0
   -3.8916    3.7585    0.0000 C   0  0
   -3.8864    5.2585    0.0000 C   0  0
   -2.5847    6.0040    0.0000 O   0  0
   -1.2883    5.2495    0.0000 C   0  0
   -1.2935    3.7495    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 13  1  0
 11 19  1  0
 19 20  2  0
 19 21  1  0
 21  4  1  0
 21  8  2  0
M  END
> <name>
NIHCC_2014

> <id>
6267

> <plate>
NGP-202-03

> <well>
D08

> <supplier_cmpd_name>
CPD000499578

> <ctcr_id>
6002

> <supplier_cmpd_id>
SAM002548933

> <smiles>
Cl.CCc1c(C)[nH]c2CCC(CN3CCOCC3)C(=O)c12

> <pd_targets>
{BLM,CYP3A4,LMNA,CHRM1,HTR2A,DRD2,HTR7,HRH1,HTR1A,CYP2C19,CYP1A2,FFP}

> <pathway_gtopdb>
{Enzyme,"Other nuclear protein","Membrane receptor","Cytochrome P450","Family A G protein-coupled receptor",Transferase,"Cytochrome P450 family 3","Small molecule receptor (family A GPCR)","Cytochrome
 P450 family 2","Cytochrome P450 family 1","Cytochrome P450 family 3A","Monoamine receptor","Cytochrome P450 family 2C","Cytochrome P450 family 1A","Cytochrome P450 3A4","Acetylcholine receptor","Sero
tonin receptor","Dopamine receptor","Histamine receptor","Cytochrome P450 2C19","Cytochrome P450 1A1"}

> <pathway_chembl>
{Enzymes,Receptors,"Cytochrome P450","G protein-coupled receptors","CYP3 family","Acetylcholine receptors (muscarinic)","5-Hydroxytryptamine receptors","Dopamine receptors","Histamine receptors","CYP2
 family: drug metabolising subset","CYP1 family"}

> <pathway_reactome>
{"DNA Repair",Metabolism,"Cell Cycle","Signal Transduction",Disease,"DNA Double-Strand Break Repair","Metabolism of lipids",Mitotic,"Signaling by GPCR","Infectious disease","Biological oxidations","Ho
mology Directed Repair","Biosynthesis of specialized proresolving mediators (SPMs)","M Phase","GPCR ligand binding","Leishmania infection","Phase I - Functionalization of compounds","HDR through Homol
ogous Recombination (HRR) or Single Strand Annealing (SSA)","Biosynthesis of DHA-derived SPMs","Mitotic Metaphase and Anaphase","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and s
urvival","Cytochrome P450 - arranged by substrate type","HDR through Homologous Recombination (HRR)","Biosynthesis of maresins","Mitotic Anaphase","Amine ligand-binding receptors","Anti-inflammatory r
esponse favouring Leishmania parasite infection",Xenobiotics,"Homologous DNA Pairing and Strand Exchange","Biosynthesis of maresin-like SPMs","Nuclear Envelope (NE) Reassembly","Muscarinic acetylcholi
ne receptors","Serotonin receptors","Dopamine receptors","ADORA2B mediated anti-inflammatory cytokines production","Histamine receptors","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-
dealkylated by CYP1A2","Presynaptic phase of homologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{DRD2,HRH1,HTR2A}

> <broad_moa>
{"dopamine receptor antagonist"}

> <synonyms>
{"Molindone hydrochloride",15622-65-8,15622658,Moban,"Molindone HCl","Molindone (hydrochloride)",Lidone,EN-1733A,EN1733A,MFCD01718304,DSSTox_CID_25417,DSSToxCID25417,DSSTox-CID-25417,"DSSTox CID 25417
",DSSTox_RID_80866,DSSToxRID80866,DSSTox-RID-80866,"DSSTox RID 80866",DSSTox_GSID_45417,DSSToxGSID45417,DSSTox-GSID-45417,"DSSTox GSID 45417",SMR000499578,"EN 1733A","Molindone hydrochloride (USAN:USP
)","EN 1733 A","Moban (",T0716,SAM002548933,Prestw-1035,CPD000499578}

> <pdid>
PD009446

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{9883259,27421,57455770}

$$$$
NIHCC_2014
  SciTegic11012413002D

 19 20  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 N   0  0
    0.0000    3.0008    0.0000 C   0  0  1  0  0  0
    1.2121    3.8625    0.0000 C   0  0
    0.7463    5.2884    0.0000 C   0  0  2  0  0  0
    1.6276    6.5001    0.0000 N   0  0
    3.1202    6.3434    0.0000 N   0  3
    4.6120    6.1868    0.0000 N   0  5
   -0.7537    5.2860    0.0000 C   0  0  1  0  0  0
   -1.6337    6.4985    0.0000 C   0  0
   -1.0238    7.8689    0.0000 O   0  0
   -1.2149    3.8587    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  5  4  1  6
  5  6  1  0
  6  7  1  0
  7  8  1  1
  8  9  2  0
  9 10  2  0
  7 11  1  0
 11 12  1  6
 12 13  1  0
 11 14  1  0
 14  5  1  0
  4 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18  2  1  0
 18 19  2  0
M  CHG  2   9   1  10  -1
M  END
> <name>
NIHCC_2014

> <id>
6268

> <plate>
NGP-202-03

> <well>
D09

> <supplier_cmpd_name>
CPD000058351

> <ctcr_id>
6679

> <supplier_cmpd_id>
SAM002548971

> <smiles>
CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O

> <pd_targets>
{PMP22,LMNA,BLM,POL,TK1,"REVERSE TRANSCRIPTASE",ALB,PKM,TMK,TERT}

> <pathway_gtopdb>
{"Unclassified protein","Other nuclear protein",Enzyme,"Secreted protein",Hydrolase,Protease,Transferase,"Aspartic protease","Aspartic protease AA clan","Aspartic protease A2A subfamily"}

> <pathway_chembl>
{Enzymes,"2.7.1.40 Pyruvate kinases"}

> <pathway_reactome>
{"Developmental Biology","Cell Cycle","DNA Repair","Nervous system development",Mitotic,"DNA Double-Strand Break Repair","EGR2 and SOX10-mediated initiation of Schwann cell myelination","M Phase","Hom
ology Directed Repair","Mitotic Metaphase and Anaphase","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Mitotic Anaphase","HDR through Homologous Recombination (HRR)","N
uclear Envelope (NE) Reassembly","Homologous DNA Pairing and Strand Exchange","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pairing and strand exchange",Metabo
lism,"Metabolism of lipids","Metabolism of carbohydrates","Chromosome Maintenance","Mitotic G1 phase and G1/S transition","Metabolism of steroids","Glucose metabolism","Telomere Maintenance","G1/S Tra
nsition","Bile acid and bile salt metabolism",Glycolysis,"Extension of Telomeres","G1/S-Specific Transcription","Recycling of bile acids and salts","Telomere Extension By Telomerase"}

> <broad_targets>
{TERT}

> <broad_moa>
{"nucleoside reverse transcriptase inhibitor"}

> <synonyms>
{zidovudine,Azidothymidine,30516-87-1,3'-Azido-3'-deoxythymidine,Retrovir,AZT,"Thymidine, 3'-azido-3'-deoxy-",Zidovudinum,"ZIDOVUDINE (AZT)","Compound S",Trizivir,Zidovudina,"BW A509U",zidovudin,BWA50
9U,ZDV,UNII-4B9XT59T7S,Aztec,BW-A509U,BW-A-509U,MFCD00006536,CHEMBL129,MLS000028548,4B9XT59T7S,CHEBI:10110,3'-Deoxy-3'-azidothymidine,"NSC 602670","Azidothymidine (AZT)",NCGC00023945-05,"Zidovudinum (
Latin)",SMR000058351,"Zidovudina (Spanish)",DSSTox_CID_127,DSSTox_RID_75386,DSSTox_GSID_20127,Propolis+AZT,"3'-Azido-2',3'-Dideoxythymidine",DRG-0004,Retrovir(TM),"AZT & Li & EPO","Retrovir (TN)","CCR
IS 105","Cpd S","Intron A & AZT","HSDB 6515","Racemic Liposomal AZT","Liposomal AZT-SN-1","Liposomal AZT-SN-3","Zidovudine+PRO 140",PC-SOD+AZT,"AZT & srCD4","AZT & rIFN.alpha.2","AZT & rsT4","rIFN-bet
a seron & AZT","3'-Azido-3'-deoxythymidine (AIDS)","AZT & EPO","AZT & GM-CSF","AZT & HPA","AZT & sCD4","AZT & SST",zudovidine,"AZT & Li & GM-CSF","AZT+PRO 140","Met-SDF-1.beta. & AZT","AZT & Li & IL-1
","AZT & Li & IL-6","AZT & IL-1","AZT & IL-2","AZT & IL-6","AZT & Interferon-.alpha.-2","AZT & Concanavalin A (ConA)","AZT & Lymphoblastoid Interferon","AZT & PM-19","Met-SDF-1.beta. & Zidovudine",4lh
m,NSC-602670,"AZT & rsCD4 & rIFN.alpha.A","3'-azido-3'-deoxythymidine, AZT","DS-4152 & AZT","AZT & Colony-stimulating factor 2","AZT & NP (from PHCA or HSA)","1-(3-Azido-2,3-dideoxy-beta-D-ribofuranos
yl)thymine",3''-azido-thymidine,"K7 (P Ti2 W10 O40)","Zidovudine (USAN:USP:INN:BAN:JAN)","Zidovudine & IFNL1","Zidovudine & IFNL2","Zidovudine & IFNL3","Zidovudine (Retrovir)",COMPOUND-S,3&prime;-Azid
o-3&prime;-deoxythymidine,Spectrum_001348,"AZT & CD4(178)-PE 40","AZT & IFN.alpha.","Zidovudine & IL-29","Zidovudine & IL-28A","Zidovudine & IL-28B","AZT & Interleukin 29",Opera_ID_1602,Prestwick3_000
333,Spectrum2_000927,Spectrum3_001507,Spectrum4_000332,Spectrum5_001101,3'azido-3'deoxythymidine,"3'-Azido-3'-deoxythymidine & Erythropoietin","3'-Azido-3'-deoxythymidine & Sho-Saiko-To","Azidothymidi
ne; Zidovudine","Interferon AD + 3'-azido-3'-deoxythymidine","AZT & Interleukin 28A","AZT & Interleukin 28B","3'-Azido-3'-deoxythymidine & Concanavalin A","3'-Azido-3'-deoxythymidine & Interleukin-1",
"3'-Azido-3'-deoxythymidine & Interleukin-2","3'-Azido-3'-deoxythymidine & Interleukin-6",3'-azido3'-deoxythymidine,"AZT & IFNL1","AZT & IFNL2","AZT & IFNL3","AZT & Interferon lambda-1","AZT & Interfe
ron lambda-2","AZT & Interferon lambda-3",3''-Deoxy-3-azidothymidine,BSPBio_000365,BSPBio_003153,KBioGR_000703,KBioSS_001828,MLS001055351,MLS001076358,MLS002153202,MLS002222249,"Zidovudine & Interleuk
in 29",DivK1c_000524,SPECTRUM1502109,3'-deoxy-3'-azido-thymidine,SPBio_000834,"Zidovudine & Interleukin 28A","Zidovudine & Interleukin 28B","AZT & IL-28A","AZT & IL-28B",BPBio1_000403,GTPL4825,"Zidovu
dine (JP17/USP/INN)","3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin","3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1","3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6","3'-Azido-3'-
deoxythymidine & Lymphoblastoid Interferon",DTXSID8020127,SCHEMBL14615088,"SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle)","SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle)","AZT & IL-
29",HMS501K06,KBio1_000524,KBio2_001828,KBio2_004396,KBio2_006964,KBio3_002653,"3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19","racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle)",
3''-Azido-3''-deoxy-thymidine,NINDS_000524,"Zidovudine & Interferon lambda-1","Zidovudine & Interferon lambda-2","Zidovudine & Interferon lambda-3",HMS1921J20,HMS2090G11,HMS2092D06,HMS2096C07,HMS2234K
17,HMS3259H17,HMS3713C07,Pharmakon1600-01502109,ZINC3779042,3''azido-2''3''-dideoxythymidine,Tox21_110062,Tox21_110894,Tox21_202203,Tox21_300578,ANW-26899,BBL033764,BDBM50002692,CCG-39924,CZ0012,NSC75
8185,STK801891,AKOS005622576,AKOS015842610,Tox21_110062_1,"3''-azido-2'',3''-dideoxythymidine",DB00495,MCULE-8664408343,NC00666,NSC-758185,IDI1_000524,NCGC00014918-01,NCGC00023945-03,NCGC00023945-04,N
CGC00023945-06,NCGC00023945-07,NCGC00023945-08,NCGC00023945-09,NCGC00023945-10,NCGC00023945-12,NCGC00023945-13,NCGC00023945-25,NCGC00178237-01,NCGC00178237-02,NCGC00254276-01,NCGC00259752-01,AS-13019,
SBI-0051731.P002,AB0012841,"Propolis & Thymidine, 3'-azido-3'-deoxy-",S2579,SW198799-2,EN300-52518,"3'-Azido-3'-deoxythymidine, >=98 (HPLC)",C07210,D00413,J10271,W-5037,"3'-Azido-3'deoxythymidine & In
terferon .alpha.","3'-Azido-3'-deoxythymidine, >=99.0 (HPLC)",Q198504,SR-01000000098,SR-05000001587,J-700147,SR-01000000098-3,SR-05000001587-1,BRD-K72903603-001-04-6,BRD-K72903603-001-14-5,Z1723414428
,"Zidovudine, European Pharmacopoeia (EP) Reference Standard","3'-Azido-3'-deoxythymidine & Recombinant Interferon-.alpha.-2","Zidovudine, United States Pharmacopeia (USP) Reference Standard","3'-Azid
o-3'-deoxythymidine & CD4-Pseudomonas exotoxin A hybrid","Beta interferon(rIFN-beta seron) & 3'-Azido-3'-deoxythymidine(AZT)","Lecithinized superoxide dismutase & Thymidine, 3'-azido-3'-deoxy-","3'-Az
ido-2',3'-dideoxythymidine & sCD4(soluble recombinant protein)","Sulfated polysaccharide-peptidoglycan DS-4152 & 3'-Azido-3'-deoxythymidine","Thymidine, 3'-azido-3'-deoxy- & PRO 140 (Anti-CCR5 monoclo
nal antibody)","Zidovudine, Pharmaceutical Secondary Standard; Certified Reference Material","4-(4-Azido-5-hydroxy-tetrahydro-furan-2-yl)-5-methyl-3H-pyrazine-2,6-dione",146426-54-2,T1416,SAM002548971
,1502109,Prestw-333,Zidovudine,CPD000058351,"Zidovudine, AZT"}

> <pdid>
PD001380

> <targets>
{CRISPR/Cas9,HIV}

> <classes>
{RT transferase inhibitor,antiviral,Anti-infection,Cell Cycle/DNA Damage}

> <pubchem_cids>
{35370}

$$$$
NIHCC_2014
  SciTegic11012413002D

 15 15  0  0  0  0            999 V2000
    6.7790   -0.3307    0.0000 H   0  3
    4.2790   -0.3307    0.0000 Cl  0  5
    0.7521   -2.0142    0.0000 C   0  0
   -0.6522   -1.4871    0.0000 C   0  0
   -1.8106   -2.4400    0.0000 N   0  0
   -0.8987    0.0000    0.0000 C   0  0
   -2.0541   -1.3755    0.0000 C   0  0
   -0.6052   -0.9721    0.0000 C   0  0
   -0.6052    0.5686    0.0000 C   0  0
    0.4035    1.7790    0.0000 C   0  0
    1.7790    1.2105    0.0000 C   0  0
    1.7607   -0.2751    0.0000 C   0  0
    0.7703   -1.5223    0.0000 C   0  0
    0.3852   -0.6052    0.0000 C   0  0
   -0.8987    1.3205    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13  8  1  0
 12 14  1  0
 14  6  1  0
 10 15  1  0
 15  6  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6269

> <plate>
NGP-202-03

> <well>
D10

> <supplier_cmpd_name>
CPD000436311

> <ctcr_id>
2917

> <supplier_cmpd_id>
SAM002264596

> <smiles>
[H+].[Cl-].CC(N)C12CC3CC(CC(C3)C1)C2

> <pd_targets>
{M,SLC47A1,SLC22A2,PA}

> <pathway_gtopdb>
{"Ion channel",Transporter,"Unclassified protein","Other ion channel","Electrochemical transporter","Miscellaneous ion channel","SLC superfamily of solute carriers","Type A influenza virus matrix-2 ch
annel family","SLC47 family of multidrug and toxin extrusion transporters","SLC22 family of organic cation and anion transporters"}

> <pathway_chembl>
{Transporters,"SLC superfamily of solute carriers","SLC47 family of multidrug and toxin extrusion transporters","SLC22 family of organic cation and anion transporters","Organic cation transporters (OC
T)"}

> <pathway_reactome>
{"Transport of small molecules",Disease,"SLC-mediated transmembrane transport","Infectious disease","Transport of bile salts and organic acids","metal ions and amine compounds","Influenza Infection","
Organic cation/anion/zwitterion transport","Export of Viral Ribonucleoproteins from Nucleus","Organic cation transport","NEP/NS2 Interacts with the Cellular Export Machinery"}

> <broad_targets>
{}

> <broad_moa>
{antiviral,"RNA synthesis inhibitor"}

> <synonyms>
{SCHEMBL14973619,AKOS026750151,AKOS016034989,"Rimantadine hydrochloride",1501-84-4,1501844,"1501 84 4",Flumadine,"Rimantadine HCL",Meradane,"1-(1-ADAMANTYL)ETHYLAMINE HYDROCHLORIDE","1(1ADAMANTYL)ETHY
LAMINE HYDROCHLORIDE","1 (1 ADAMANTYL)ETHYL",SAM002264596,1505460,CPD000436311,"RIMANTADINE HYDROCHLORIDE"}

> <pdid>
PD007704

> <targets>
{}

> <classes>
{antiviral}

> <pubchem_cids>
{71773501,44662334,15165}

$$$$
NIHCC_2014
  SciTegic11012413002D

 15 13  0  0  0  0            999 V2000
   10.1943   -1.8787    0.0000 H   0  3
    7.6943   -1.8787    0.0000 Cl  0  5
    5.1937   -3.0093    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    3.8912   -5.2570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  8  1  0
 14 15  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6270

> <plate>
NGP-202-03

> <well>
D11

> <supplier_cmpd_name>
CPD000326711

> <ctcr_id>
6844

> <supplier_cmpd_id>
SAM002264606

> <smiles>
[H+].[Cl-].CC(N)COc1c(C)cccc1C

> <pd_targets>
{SCN4A,SCN5A,SCN1A,SCN9A,LMNA,SCN2A,SCN3A,SCN10A,KCNH2,CACNA1C,CACNA1D,CACNA1F,CACNA1S,SCN11A,SCN7A,SCN8A,KCNK3,HTR2B,AHR}

> <pathway_gtopdb>
{"Ion channel","Other nuclear protein","Membrane receptor","Transcription factor","Voltage-gated ion channel","Family A G protein-coupled receptor","Voltage-gated sodium channel","Potassium channels",
"Voltage-gated calcium channel","Small molecule receptor (family A GPCR)","Voltage-gated potassium channel","Two-pore domain potassium channel","Monoamine receptor","Serotonin receptor"}

> <pathway_chembl>
{"Ion channels",Receptors,"Other protein targets","Voltage-gated ion channels","G protein-coupled receptors","Aryl hydrocarbon receptor","Voltage-gated sodium channels","Potassium channels","5-Hydroxy
tryptamine receptors","Voltage-gated potassium channels","Two P domain potassium channels"}

> <pathway_reactome>
{"Developmental Biology","Cell Cycle","Muscle contraction","Neuronal System","Signal Transduction",Metabolism,"Nervous system development",Mitotic,"Cardiac conduction","Potassium Channels","Signaling 
by GPCR","Biological oxidations","Axon guidance","M Phase","Phase 3 - rapid repolarisation","Tandem pore domain potassium channels","GPCR ligand binding","Phase I - Functionalization of compounds","L1
CAM interactions","Mitotic Metaphase and Anaphase","TWIK-releated acid-sensitive K+ channel (TASK)","Class A/1 (Rhodopsin-like receptors)","Cytochrome P450 - arranged by substrate type","Interaction b
etween L1 and Ankyrins","Mitotic Anaphase","Amine ligand-binding receptors","Endogenous sterols","Nuclear Envelope (NE) Reassembly","Serotonin receptors","Initiation of Nuclear Envelope (NE) Reformati
on"}

> <broad_targets>
{PLAU,SCN4A,SCN5A}

> <broad_moa>
{"sodium channel blocker"}

> <synonyms>
{AKOS026750013,FT-0601136,FT0601136,Mexitil,CHEBI:6917,"1-Methyl-2-(2,6-xylyloxy)ethylamine hydrochloride","1Methyl2(2,6xylyloxy)ethylamine hydrochloride","1-(2,6-Dimethylphenoxy)-2-aminopropane hydro
chloride","1(2,6Dimethylphenoxy)2aminopropane hydrochloride","(+-)-1-Methyl-2-(2,6-xylyloxy)ethylamine hydrochloride","(+)1Methyl2(2,6xylyloxy)ethylamine hydrochloride",1-(2,1(2,6-dimethylphen,6dimeth
ylphen,SAM002264606,1503929,Prestw-241,CPD000326711,"MEXILETINE HYDROCHLORIDE","Mexiletine hydrochloride"}

> <pdid>
PD006078

> <targets>
{}

> <classes>
{antiarrhythmic}

> <pubchem_cids>
{20148681,44724350,21467}

$$$$
NIHCC_2014
  SciTegic11012413002D

 35 37  0  0  0  0            999 V2000
   18.1031   -1.8679    0.0000 Na  0  3
    5.2029   -2.9932    0.0000 O   0  0
    5.2003   -1.4932    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    1.2991   -3.7500    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -3.8963   -3.7531    0.0000 C   0  0
   -5.1966   -3.0054    0.0000 O   0  5
   -3.8941   -5.2531    0.0000 O   0  0
    6.4990   -0.7409    0.0000 C   0  0
    7.8003   -1.4887    0.0000 O   0  0
    9.0990   -0.7364    0.0000 C   0  0
    9.0939    0.7637    0.0000 C   0  0
   10.3903    1.5181    0.0000 C   0  0
   11.6919    0.7726    0.0000 C   0  0
   11.6971   -0.7274    0.0000 C   0  0
   12.9987   -1.4729    0.0000 O   0  0
   13.0039   -2.9729    0.0000 C   0  0
   11.7075   -3.7273    0.0000 C   0  0
   10.4059   -2.9818    0.0000 C   0  0
    9.1094   -3.7363    0.0000 O   0  0
   10.4007   -1.4818    0.0000 C   0  0
   14.3047   -3.7215    0.0000 C   0  0
   15.6025   -2.9692    0.0000 O   0  5
   14.3078   -5.2215    0.0000 O   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  3
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16  6  1  0
 16 10  2  0
 12 17  1  0
 17 18  1  0
 17 19  2  0
  3 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  2  3
 29 30  1  0
 30 31  2  0
 30 32  1  0
 32 22  1  0
 32 26  2  0
 28 33  1  0
 33 34  1  0
 33 35  2  0
M  CHG  3   1   1  18  -1  34  -1
M  END
> <name>
NIHCC_2014

> <id>
6271

> <plate>
NGP-202-03

> <well>
E02

> <supplier_cmpd_name>
CPD000058721

> <ctcr_id>
7040

> <supplier_cmpd_id>
SAM002589934

> <smiles>
[Na+].OC(COc1cccc2OC(=CC(=O)c12)C([O-])=O)COc3cccc4OC(=CC(=O)c34)C([O-])=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{SMR000058721,MLS000028622,MLS006012006,HMS3259J03,NC00611,T1260,SAM002589934,"Sodium cromoglycate",CPD000058721}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{657312}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 20  0  0  0  0            999 V2000
    5.1887   -6.0105    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    2.5909   -6.0056    0.0000 C   0  0
    3.8883   -6.7578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
    8.9894   -0.3789    0.0000 O   0  0
    8.9894   -1.8789    0.0000 S   0  0
    8.9894   -3.3789    0.0000 O   0  0
    7.6901   -2.6285    0.0000 O   0  0
   10.2887   -2.6285    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
 16  9  1  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
 18 21  2  0
M  END
> <name>
NIHCC_2014

> <id>
6272

> <plate>
NGP-202-03

> <well>
E03

> <supplier_cmpd_name>
CPD001496939

> <ctcr_id>
6117

> <supplier_cmpd_id>
SAM002589944

> <smiles>
CC(C)(C)NCC(O)c1cc(O)cc(O)c1.O[S](O)(=O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"TERBUTALINE HEMISULFATE","Terbutaline (sulfate)",MLS000069693,SMR000058516,MFCD00079584,SR-01000000174,SR01000000174,Opera_ID_498,OperaID498,Opera-ID-498,"Opera ID 498",SCHEMBL41870,MLS001148384,SPE
CTRUM1500558,CHEMBL1160544,REGID_for_CID_657301,REGIDforCID657301,REGID-for-CID-657301,"REGID for CID 657301",HMS500D20,HMS1921C15,HMS2092K19,HMS2231,SAM002589944,1500558,CPD001496939}

> <pdid>

> <targets>
{Adrenergic Receptor,Antibiotic,Bacterial}

> <classes>
{bronchodilator,betaadrenergic agonist,Anti-infection,GPCR/G Protein,Neuronal Signaling}

> <pubchem_cids>
{657301}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 32  0  0  1  0            999 V2000
   -3.4595   -4.0717    0.0000 C   0  0
   -2.5817   -5.2880    0.0000 C   0  0
   -1.0885   -5.1368    0.0000 O   0  0
   -0.2102   -6.3538    0.0000 C   0  0
   -0.8251   -7.7220    0.0000 O   0  0
    1.2830   -6.2026    0.0000 C   0  0  2  0  0  0
    2.1626   -7.4186    0.0000 C   0  0
    1.5502   -8.7888    0.0000 C   0  0
    2.4298  -10.0049    0.0000 C   0  0
    1.8197  -11.3752    0.0000 C   0  0
    2.7014  -12.5888    0.0000 C   0  0
    4.1932  -12.4320    0.0000 C   0  0
    4.8033  -11.0617    0.0000 C   0  0
    3.9217   -9.8482    0.0000 C   0  0
    1.8954   -4.8324    0.0000 N   0  0
    1.0157   -3.6164    0.0000 C   0  0  1  0  0  0
   -0.4763   -3.7706    0.0000 C   0  0
    1.6281   -2.2462    0.0000 C   0  0
    3.1202   -2.0921    0.0000 O   0  0
    0.7500   -1.0323    0.0000 N   0  0
    1.2135    0.3943    0.0000 C   0  0  1  0  0  0
    2.4258    1.2743    0.0000 C   0  0
    1.9623    2.7009    0.0000 C   0  0
    0.4623    2.7009    0.0000 C   0  0
    0.0000    1.2760    0.0000 C   0  0  1  0  0  0
   -1.2135    0.3943    0.0000 C   0  0
   -0.7500   -1.0323    0.0000 C   0  0  1  0  0  0
   -1.6281   -2.2462    0.0000 C   0  0
   -3.1202   -2.0921    0.0000 O   0  0
   -1.0160   -3.6157    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  1
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
  6 15  1  0
 15 16  1  0
 16 17  1  1
 16 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  6
 22 23  1  0
 23 24  1  0
 25 24  1  6
 25 21  1  0
 25 26  1  0
 26 27  1  0
 27 20  1  0
 27 28  1  6
 28 29  1  0
 28 30  2  0
M  END
> <name>
NIHCC_2014

> <id>
6273

> <plate>
NGP-202-03

> <well>
E04

> <supplier_cmpd_name>
CPD000466386

> <ctcr_id>
1822

> <supplier_cmpd_id>
SAM002699899

> <smiles>
CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(O)=O

> <pd_targets>
{ACE,CYP3A4,ALOX15,KMT2A,MEN1,LMNA}

> <pathway_gtopdb>
{Enzyme,Protease,"Cytochrome P450",Oxidoreductase,"Metallo protease","Cytochrome P450 family 3","Metallo protease MAE clan","Cytochrome P450 family 3A","Metallo protease M2 family","Cytochrome P450 3A
4","Epigenetic regulator","Other nuclear protein",Reader,"Cysteine protease",Bromodomain,"Cysteine protease CA clan","Cysteine protease C1A family"}

> <pathway_chembl>
{Enzymes,"Peptidases and proteinases","Cytochrome P450","Eicosanoid turnover","MA: Metallo (M) Peptidases","CYP3 family",Lipoxygenases,"M2: Angiotensin-converting  (ACE and ACE2)"}

> <pathway_reactome>
{"Metabolism of proteins",Metabolism,"Peptide hormone metabolism","Metabolism of lipids","Metabolism of Angiotensinogen to Angiotensins","Biosynthesis of specialized proresolving mediators (SPMs)","Bi
osynthesis of DHA-derived SPMs","Biosynthesis of DPA-derived SPMs","Biosynthesis of maresins","Biosynthesis of DPAn-3 SPMs","Biosynthesis of maresin-like SPMs","Biosynthesis of DPAn-3-derived protecti
ns and resolvins","Cell Cycle",Mitotic,"M Phase","Mitotic Metaphase and Anaphase","Mitotic Anaphase","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ACE}

> <broad_moa>
{"angiotensin converting enzyme inhibitor"}

> <synonyms>
{Vesdil,ramipril,87333-19-5,87333195,Tritace,Altace,Carasel,Ramace,Triatec,Delix,Hoe-498,Hoe498,"Ramiprilum (Latin)",Ramiprilum,"HOE 498",Cardace,Quark,"Altace (TN)",Pramace,UNII-L35JN3I7SJ,UNIIL35JN3
I7SJ,Acovil,C23H32N2O5,Lostapres,MFCD00865775,Hytren,CHEMBL1168,L35JN3I7SJ,Uni,SAM002699899,SAM001246757,1505214,Prestw-1107,CPD000466386,RAMIPRIL,Ramipril}

> <pdid>
PD000535

> <targets>
{}

> <classes>
{antihypertensive,"ACE inhibitor"}

> <pubchem_cids>
{6992028,5362129}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 22  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.6003    1.4978    0.0000 C   0  0
    3.8990    0.7455    0.0000 C   0  0
    5.2003    1.4932    0.0000 C   0  0
    5.2029    2.9932    0.0000 C   0  0
    6.4990    0.7410    0.0000 C   0  0
    7.8003    1.4887    0.0000 C   0  0
    9.0990    0.7365    0.0000 C   0  0
   10.4003    1.4842    0.0000 C   0  0
   10.4029    2.9842    0.0000 C   0  0
   11.6989    0.7320    0.0000 C   0  0
   11.6978   -0.7689    0.0000 C   0  0
   10.3979   -1.5174    0.0000 O   0  0
   12.9957   -1.5207    0.0000 O   0  0
    0.0000    1.5000    0.0000 C   0  0
    1.3164    2.2191    0.0000 C   0  0
   -1.3163    2.2193    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
  3 17  1  0
 17 18  1  0
 17 19  1  0
 17 20  1  0
 20 21  1  0
 21 22  1  0
 22  2  1  0
M  END
> <name>
NIHCC_2014

> <id>
6274

> <plate>
NGP-202-03

> <well>
E05

> <supplier_cmpd_name>
CPD000471891

> <ctcr_id>
4718

> <supplier_cmpd_id>
SAM002548955

> <smiles>
CC1=C(\C=C\C(C)=C\C=C\C(C)=C/C(O)=O)C(C)(C)CCC1

> <pd_targets>
{RARB,RARG,PPARD,NR2E1,RARA,RXRA,RXRB,FFP,RXRG,ALDH1A1,TGR,RORC,CYP3A4,CRABP1,RORB,PIN1,S1PR1,CRABP2,GROES,GROL,HIF1A,KDM4E,FTL,MAPT,MAPK1,RORA,TST,DUSP1,GMNN,NR2C2,KMT2A,MEN1,HSPD1,HSPE1,BLM,RECQL,AD
ORA3,HTR2B,IDO2,RARRES1,THRB,ABCB11,MAPK14,PMP22,ADRA2B,MTOR,OR51E2,NR1H2,NR1H3,NR4A1,VKORC1}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Auxiliary transport protein","Membrane receptor","Unclassified protein","Epigenetic regulator","Other cytosolic protein","Nuclear receptor",Transferase,Oxidoreductase,"
Cytochrome P450","Fatty acid binding protein family",Isomerase,"Family A G protein-coupled receptor",Eraser,Protease,Kinase,Phosphatase,Reader,"Nuclear hormone receptor subfamily 1","Nuclear hormone r
eceptor subfamily 2","Cytochrome P450 family 3","Small molecule receptor (family A GPCR)","Lysine demethylase","Cysteine protease","Protein Kinase","Protein Phosphatase",Bromodomain,"Nuclear hormone r
eceptor subfamily 1 group B","Nuclear hormone receptor subfamily 1 group C","Nuclear hormone receptor subfamily 2 group E","Nuclear hormone receptor subfamily 2 group B","Nuclear hormone receptor subf
amily 1 group F","Cytochrome P450 family 3A","Lipid-like ligand receptor (family A GPCR)","Jumonji domain-containing","Cysteine protease CA clan","CMGC protein kinase group","Serine/threonine/tyrosine
 protein phosphatase","Nuclear hormone receptor subfamily 2 group C","Nucleotide-like receptor (family A GPCR)","Monoamine receptor","Nuclear hormone receptor subfamily 1 group B member 2","Nuclear ho
rmone receptor subfamily 1 group B member 3","Nuclear hormone receptor subfamily 1 group C member 2","Nuclear hormone receptor subfamily 2 group E member 1","Nuclear hormone receptor subfamily 1 group
 B member 1","Nuclear hormone receptor subfamily 2 group B member 1","Nuclear hormone receptor subfamily 2 group B member 2","Nuclear hormone receptor subfamily 2 group B member 3","Nuclear hormone re
ceptor subfamily 1 group F member 3","Cytochrome P450 3A4","EDG receptor","Cysteine protease C1A family","CMGC protein kinase MAPK family","Nuclear hormone receptor subfamily 1 group F member 1","Nucl
ear hormone receptor subfamily 2 group C member 2","Adenosine receptor","Serotonin receptor","CMGC protein kinase ERK1",Transporter,"Primary active transporter","ATP-binding cassette","Nuclear hormone
 receptor subfamily 1 group A","ABCB subfamily","Atypical protein kinase group","Nuclear hormone receptor subfamily 1 group A member 2","Adrenergic receptor","Atypical protein kinase PIKK family","CMG
C protein kinase p38 subfamily","Atypical protein kinase FRAP subfamily","Nuclear hormone receptor subfamily 4","Nuclear hormone receptor subfamily 1 group H","Nuclear hormone receptor subfamily 4 gro
up A","Nuclear hormone receptor subfamily 1 group H member 3","Nuclear hormone receptor subfamily 4 group A member 1"}

> <pathway_chembl>
{Receptors,Enzymes,"Other protein targets","Nuclear hormone receptors","Cytochrome P450","Fatty acid-binding proteins","Peptidyl-prolyl cis/trans isomerases","G protein-coupled receptors","Chromatin m
odifying enzymes","Kinases (EC 2.7.x.x)","1.13.11.- Dioxygenases","1B. Retinoic acid receptors","1C. Peroxisome proliferator-activated receptors","2E. Tailless-like receptors","2B. Retinoid X receptor
s","1F. Retinoic acid-related orphans","CYP3 family","Lysophospholipid (S1P) receptors","1.14.11.- Histone demethylases","CMGC: Containing CDK",MAPK,GSK3,"CLK families","2C. Testicular receptors","Ade
nosine receptors","5-Hydroxytryptamine receptors","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily",Transporters,"ATP-binding cassette transporter family","1A. Thyroid hormone receptor
s","ABCB subfamily",Adrenoceptors,Atypical,"Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","p38 subfamily","FRAP subfamily","1.-.-.- Oxidoreductases","1H. Liver X receptor-like recepto
rs","4A. Nerve growth factor IB-like receptors"}

> <pathway_reactome>
{"Gene expression (Transcription)",Metabolism,"Signal Transduction","Metabolism of proteins","Cellular responses to external stimuli","Vesicle-mediated transport","Neuronal System","Immune System","Ce
ll Cycle","DNA Repair","RNA Polymerase II Transcription","The citric acid (TCA) cycle and respiratory electron transport","Intracellular signaling by second messengers","Post-translational protein mod
ification","Metabolism of lipids","Biological oxidations","Signaling by Nuclear Receptors","Signaling by GPCR","Cellular responses to stress","Membrane Trafficking","Transmission across Chemical Synap
ses","Innate Immune System","Metabolism of amino acids and derivatives","MAPK family signaling cascades",Mitotic,"DNA Double-Strand Break Repair","Generic Transcription Pathway","Pyruvate metabolism a
nd Citric Acid (TCA) cycle","PIP3 activates AKT signaling",SUMOylation,"Metabolism of steroids","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","
Signaling by Retinoic Acid","GPCR ligand binding","Cellular response to hypoxia","trans-Golgi Network Vesicle Budding","Neurotransmitter receptors and postsynaptic signal transmission","Toll-like Rece
ptor Cascades","Sulfur amino acid metabolism","MAPK1/MAPK3 signaling","Mitotic G1 phase and G1/S transition","Homology Directed Repair","Tryptophan catabolism","Nuclear Receptor transcription pathway"
,"Pyruvate metabolism","PTEN Regulation","SUMO E3 ligases SUMOylate target proteins","Bile acid and bile salt metabolism","Ethanol oxidation","Transcriptional regulation by RUNX3","Biosynthesis of DHA
-derived SPMs","RA biosynthesis pathway","Transcriptional Regulation by TP53","Class A/1 (Rhodopsin-like receptors)","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Golgi A
ssociated Vesicle Biogenesis","Activation of NMDA receptors and postsynaptic events","Toll Like Receptor 5 (TLR5) Cascade","Degradation of cysteine and homocysteine","RAF/MAP kinase cascade","G1/S Tra
nsition","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Regulation of pyruvate dehydrogenase (PDH) complex","Regulation of PTEN gene transcription","SUMOylation of intr
acellular receptors","Synthesis of bile acids and bile salts","RUNX3 Regulates Immune Response and Cell Migration","Biosynthesis of maresins","Regulation of TP53 Activity","Lysosphingolipid and LPA re
ceptors","Post NMDA receptor activation events","MyD88 cascade initiated on plasma membrane","Sulfide oxidation to sulfate","Negative regulation of MAPK pathway","Activation of the pre-replicative com
plex","HDR through Homologous Recombination (HRR)","Nucleotide-like (purinergic) receptors","Amine ligand-binding receptors","Synthesis of bile acids and bile salts via 27-hydroxycholesterol","Biosynt
hesis of maresin-like SPMs","Regulation of TP53 Activity through Acetylation","Activation of AMPK downstream of NMDARs","MAP kinase activation","Homologous DNA Pairing and Strand Exchange","Adenosine 
P1 receptors","Serotonin receptors","PI5P Regulates TP53 Acetylation","MAPK targets/ Nuclear events mediated by MAP kinases","Presynaptic phase of homologous DNA pairing and strand exchange","ERK/MAPK
 targets","ERKs are inactivated","Developmental Biology","Nervous system development","EGR2 and SOX10-mediated initiation of Schwann cell myelination","GPCR downstream signalling","G alpha (s) signall
ing events","Olfactory Signaling Pathway","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol",Adrenoceptors,"Regulation of TP53 Expression and Degradation","Regulation of TP53 Degra
dation","Activation of the AP-1 family of transcription factors",Disease,"Diseases of signal transduction by growth factor receptors and second messengers","Metabolism of vitamins and cofactors","PI3K
/AKT Signaling in Cancer","Metabolism of fat-soluble vitamins","Constitutive Signaling by AKT1 E17K in Cancer","Metabolism of vitamin K"}

> <broad_targets>
{ALDH1A1,ALDH1A2,GPRC5A,NR0B1,NR2C2,PPARD,RARA,RARB,RARG,RARRES1,RORB,RORC,RXRB,RXRG}

> <broad_moa>
{"retinoid receptor agonist","retinoid receptor ligand"}

> <synonyms>
{Isotretinoin,"13-cis-Retinoic acid","13cisRetinoic acid",4759-48-2,4759482,Accutane,Roaccutane,"Neovitamin A acid","13-cis-Vitamin A acid","13cisVitamin A acid","13-cis retinoic acid","13cis retinoic
 acid",Claravis,Amnesteem,Isotrex,Teriosal,Sotret,ISOTRETINON,isotretinoino,Isotretinoine,Isotretinoinum,Roaccutan,1,T1611,T1051,SAM002548955,1502013,Prestw-256,Tretinoin,CPD000471891}

> <pdid>
PD001430

> <targets>
{}

> <classes>
{antineoplastic,antiacne}

> <pubchem_cids>
{5282379}

$$$$
NIHCC_2014
  SciTegic11012413002D

 11  9  0  0  0  0            999 V2000
   10.2999    1.1254    0.0000 Cl  0  5
    1.3000    2.2500    0.0000 C   0  0
    1.3000    0.7500    0.0000 C   0  0
    0.0007    0.0004    0.0000 O   0  0
    2.6000    0.0000    0.0000 O   0  0
    3.9000    0.7500    0.0000 C   0  0
    5.2000    0.0000    0.0000 C   0  0
    6.5000    0.7500    0.0000 N   0  3
    7.7992    0.0004    0.0000 C   0  0
    7.7989    1.5002    0.0000 C   0  0
    6.5000    2.2500    0.0000 C   0  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
  8 11  1  0
M  CHG  2   1  -1   8   1
M  END
> <name>
NIHCC_2014

> <id>
6275

> <plate>
NGP-202-03

> <well>
E06

> <supplier_cmpd_name>
CPD000059182

> <ctcr_id>
4120

> <supplier_cmpd_id>
SAM002548945

> <smiles>
[Cl-].CC(=O)OCC[N+](C)(C)C

> <pd_targets>
{POLB,NFO,CHRNA4,BLM}

> <pathway_gtopdb>
{Enzyme,"Ion channel",Hydrolase,"Ligand-gated ion channel","Nicotinic acetylcholine receptor","Nicotinic acetylcholine receptor alpha subunit"}

> <pathway_chembl>
{"Ion channels","Ligand-gated ion channels","Nicotinic acetylcholine receptors"}

> <pathway_reactome>
{"DNA Repair","Neuronal System","Base Excision Repair","Transmission across Chemical Synapses","DNA Double-Strand Break Repair","Resolution of Abasic Sites (AP sites)","Neurotransmitter receptors and 
postsynaptic signal transmission","Homology Directed Repair","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Acetylcholine binding and downstream events","HDR through H
omologous Recombination (HRR) or Single Strand Annealing (SSA)","PCNA-Dependent Long Patch Base Excision Repair","Postsynaptic nicotinic acetylcholine receptors","HDR through Homologous Recombination 
(HRR)","Highly calcium permeable postsynaptic nicotinic acetylcholine receptors","Homologous DNA Pairing and Strand Exchange","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{ACHE,CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,CHRNA2}

> <broad_moa>
{"acetylcholine receptor agonist"}

> <synonyms>
{"ACETYLCHOLINE CHLORIDE",60-31-1,60311,Miochol,Acecoline,"ACH chloride",Chloroacetylcholine,Arterocoline,Acecholin,Ovisot,Azetylcholinchlorid,"Acetylcholine (chloride)","2-(Acetyloxy)-N,N,N-trimethyl
ethanaminium chloride","2(Acetyloxy)N,N,Ntrimethylethanaminium chloride",MIOCHOL-E,MIOCHOLE,Acetylcholinium,T1221,S1805,SAM002548945,1500104,"Acetylcholine chloride","Acetylcholine Chloride",CPD000059
182,ACETYLCHOLINE}

> <pdid>
PD009386

> <targets>
{AChR,Calcium Channel,Endogenous Metabolite,nAChR}

> <classes>
{Neuronal Signaling,vasodilator (peripheral),antiarrhythmic,miotic,Membrane Transporter/Ion Channel,Metabolic Enzyme/Protease}

> <pubchem_cids>
{6060}

$$$$
NIHCC_2014
  SciTegic11012413002D

 15 15  0  0  0  0            999 V2000
    5.1887   -6.0105    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    2.5909   -6.0056    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 10 12  2  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 15  8  1  0
M  END
> <name>
NIHCC_2014

> <id>
6276

> <plate>
NGP-202-03

> <well>
E07

> <supplier_cmpd_name>
CPD001453712

> <ctcr_id>
6686

> <supplier_cmpd_id>
SAM002548965

> <smiles>
CC(C)NCC(O)c1cc(O)cc(O)c1

> <pd_targets>
{RORC,ALD,BLM,APEX1,LMNA,ADRB2,KMT2A,MEN1,FFP}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Other nuclear protein","Membrane receptor","Epigenetic regulator","Nuclear receptor","Family A G protein-coupled receptor",Reader,Transferase,"Nuclear hormone receptor 
subfamily 1","Small molecule receptor (family A GPCR)",Bromodomain,"Nuclear hormone receptor subfamily 1 group F","Monoamine receptor","Nuclear hormone receptor subfamily 1 group F member 3","Adrenerg
ic receptor"}

> <pathway_chembl>
{Receptors,"Nuclear hormone receptors","G protein-coupled receptors","1F. Retinoic acid-related orphans",Adrenoceptors}

> <pathway_reactome>
{"Gene expression (Transcription)","DNA Repair","Cell Cycle",Disease,"RNA Polymerase II Transcription","DNA Double-Strand Break Repair","Base Excision Repair",Mitotic,"Infectious disease","Generic Tra
nscription Pathway","Homology Directed Repair","Resolution of Abasic Sites (AP sites)","M Phase","Leishmania infection","Transcriptional regulation by RUNX3","HDR through Homologous Recombination (HRR
) or Single Strand Annealing (SSA)","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Mitotic Metaphase and Anaphase","Leishmania parasite growth and survival","RUNX3 Reg
ulates Immune Response and Cell Migration","HDR through Homologous Recombination (HRR)","PCNA-Dependent Long Patch Base Excision Repair","Mitotic Anaphase","Anti-inflammatory response favouring Leishm
ania parasite infection","Homologous DNA Pairing and Strand Exchange","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Presynaptic phase of homologous DNA 
pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ADRB2}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{ORCIPRENALINE,586-06-1,586061,Alupent,Orciprenalinum,"Orciprenalinum (INN-Latin)","Orciprenalinum (INNLatin)","Orciprenalina (INN-Spanish)","Orciprenalina (INNSpanish)",Prometa,"Orciprenaline (INN)",
"5-(1-hydroxy-2-(propan-2-ylamino)ethyl)benzene-1,3-diol","5(1hydroxy2(propan2ylamino)ethyl)benzene1,3diol",CHEMBL776,CHEBI:6792,5-(1-hydro,5(1hydro,SAM002548965,1500390,CPD001453712,METAPROTERENOL}

> <pdid>
PD001867

> <targets>
{}

> <classes>
{bronchodilator}

> <pubchem_cids>
{4086}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 32  0  0  1  0            999 V2000
    4.8817   -2.5602    0.0000 C   0  0
    3.8794   -1.4442    0.0000 C   0  0
    4.3452   -0.0184    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
   -0.6928   -4.0817    0.0000 C   0  0
   -2.1743   -3.8808    0.0000 C   0  0
   -3.0913   -5.0679    0.0000 C   0  0
   -2.5218   -6.4556    0.0000 C   0  0
   -3.4388   -7.6426    0.0000 F   0  0
   -1.0353   -6.6562    0.0000 C   0  0
   -0.1183   -5.4691    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
    2.5551   -4.4192    0.0000 C   0  0
    4.0559   -4.4171    0.0000 C   0  0
    4.8090   -5.7153    0.0000 C   0  0  1  0  0  0
    4.0613   -7.0156    0.0000 O   0  0
    6.3098   -5.7131    0.0000 C   0  0
    7.0629   -7.0113    0.0000 C   0  0  1  0  0  0
    6.3152   -8.3117    0.0000 O   0  0
    8.5637   -7.0091    0.0000 C   0  0
    9.3168   -8.3073    0.0000 C   0  0
    8.5691   -9.6077    0.0000 O   0  0
   10.8168   -8.3052    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 12  1  0
 11 19  2  0
 19  4  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  1  6
 22 24  1  0
 24 25  1  0
 25 26  1  6
 25 27  1  0
 27 28  1  0
 28 29  1  0
 28 30  2  0
M  END
> <name>
NIHCC_2014

> <id>
6277

> <plate>
NGP-202-03

> <well>
E08

> <supplier_cmpd_name>
CPD001453708

> <ctcr_id>
7058

> <supplier_cmpd_id>
SAM002548940

> <smiles>
CC(C)n1c2ccccc2c(c3ccc(F)cc3)c1/C=C/[C@@H](O)C[C@@H](O)CC(O)=O

> <pd_targets>
{HMGCR,SLC10A1,USP2,ABCB11,ABCC3,HDAC2,RXRA,RORC,CYP2C9}

> <pathway_gtopdb>
{Enzyme,Transporter,"Epigenetic regulator","Transcription factor",Oxidoreductase,"Electrochemical transporter",Protease,"Primary active transporter",Eraser,"Nuclear receptor","Cytochrome P450","SLC su
perfamily of solute carriers","Cysteine protease","ATP-binding cassette","Histone deacetylase","Nuclear hormone receptor subfamily 2","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 2",
"SLC10 family of sodium-bile acid co-transporters","Cysteine protease CA clan","ABCB subfamily","ABCC subfamily","HDAC class I","Nuclear hormone receptor subfamily 2 group B","Nuclear hormone receptor
 subfamily 1 group F","Cytochrome P450 family 2C","Cysteine protease C19 family","Nuclear hormone receptor subfamily 2 group B member 1","Nuclear hormone receptor subfamily 1 group F member 3","Cytoch
rome P450 2C9"}

> <pathway_chembl>
{Enzymes,Transporters,Receptors,"Lanosterol biosynthesis pathway","SLC superfamily of solute carriers","Peptidases and proteinases","ATP-binding cassette transporter family","Chromatin modifying enzym
es","Nuclear hormone receptors","Cytochrome P450","SLC10 family of sodium-bile acid co-transporters","CA: Cysteine (C) Peptidases","ABCB subfamily","ABCC subfamily","3.5.1.- Histone deacetylases (HDAC
s)","2B. Retinoid X receptors","1F. Retinoic acid-related orphans","CYP2 family: drug metabolising subset","C19: Ubiquitin-specific protease"}

> <pathway_reactome>
{Metabolism,"Gene expression (Transcription)","Metabolism of lipids","RNA Polymerase II Transcription","Biological oxidations","Metabolism of steroids","Generic Transcription Pathway","Phase I - Funct
ionalization of compounds","Regulation of cholesterol biosynthesis by SREBP (SREBF)","Bile acid and bile salt metabolism","Transcriptional Regulation by TP53","Transcriptional regulation by RUNX3","Cy
tochrome P450 - arranged by substrate type","Activation of gene expression by SREBF (SREBP)","Recycling of bile acids and salts","Regulation of TP53 Activity","Synthesis of bile acids and bile salts",
"RUNX3 Regulates Immune Response and Cell Migration",Xenobiotics,"Regulation of TP53 Expression and Degradation","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Regulation of T
P53 Activity through Acetylation","Synthesis of bile acids and bile salts via 27-hydroxycholesterol","CYP2E1 reactions","Regulation of TP53 Degradation"}

> <broad_targets>
{HMGCR}

> <broad_moa>
{"HMGCR inhibitor"}

> <synonyms>
{fluvastatin,93957-54-1,93957541,"93957 54 1","(3R,5S)-fluvastatin","(3R,5S)fluvastatin","(3R,5S) fluvastatin","(+)-(3R,5S)-fluvastatin","(+)(3R,5S)fluvastatin","(+) (3R,5S) fluvastatin",CHEBI:38565,C
HEMBL1078,"Fluvastatin & Primycin",(-)-fluv,()fluv,SAM002548940,CPD001453708}

> <pdid>
PD002988

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{446155}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 26  0  0  0  0            999 V2000
    7.5844   -1.4920    0.0000 C   0  0
    6.1069   -1.2335    0.0000 N   0  0
    5.5920    0.1754    0.0000 C   0  0
    4.1145    0.4339    0.0000 C   0  0
    3.1484   -0.7186    0.0000 N   0  0
    3.6667   -2.1252    0.0000 C   0  0
    5.1442   -2.3838    0.0000 C   0  0
    1.6852   -0.3846    0.0000 C   0  0
    1.3514    1.0778    0.0000 N   0  0
    0.0000    1.7286    0.0000 C   0  0
    0.1115    3.2255    0.0000 C   0  0
   -1.1278    4.0705    0.0000 C   0  0
   -1.0157    5.5663    0.0000 Cl  0  0
   -2.4793    3.4196    0.0000 C   0  0
   -2.5914    1.9238    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 N   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  2  1  0
  5  8  1  0
  8  9  2  3
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 15 16  2  0
 16 10  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23  8  1  0
 23 18  1  0
M  END
> <name>
NIHCC_2014

> <id>
6278

> <plate>
NGP-202-03

> <well>
E09

> <supplier_cmpd_name>
CPD000058365

> <ctcr_id>
3976

> <supplier_cmpd_id>
SAM002548976

> <smiles>
CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24

> <pd_targets>
{ADRA1A,ADRA1B,ADRA1D,DRD2,HTR1A,HTR2A,HTR2B,HTR2C,HTR6,HTR1B,LMNA,LEF,NET,MAPT,CYP2C19,HTR7,DRD3,DRD4,HRH4,CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,ADRA2A,ADRA2B,ADRA2C,KCNH2,HTR3A,CYP3A4,HRH1,ADRB1,HTR1E,HTR1F
,HTR5A,DRD5,SIGMAR1,AOX1,CALM1,DRD1,CYP2C9,CYP2D6,CALM,NFKB1,PMP22,KMT2A,MEN1,BLM,HSD17B10,POLB,ADCY1,ADCY2,ADCY3,ADCY4,ADCY5,ADCY6,ADCY8,HTR1D,HRH3,CYP1A2,SLC6A4,H1-0,ABCB11,ALB,RORC,CYP2J2,IMPA1,HTR
3B,ADORA3,SLC6A2,TSHR,HTR3C,HTR3D,HTR3E,HRH2,CACNA1C,CACNA1D,CACNA1F,CACNA1S,KCNJ6,SLC6A3,OPRM1,CCK,GABRA1,CYSLTR1,GRIN1,ADRB2,OPRD1,OPRK1,TAC1,SCN10A,CCKBR,ARRB1,TBXA2R}

> <pathway_gtopdb>
{"Membrane receptor","Other nuclear protein",Enzyme,Transporter,"Other cytosolic protein","Ion channel","Unclassified protein","Epigenetic regulator","Secreted protein","Transcription factor","Family 
A G protein-coupled receptor",Protease,"Electrochemical transporter","Cytochrome P450","Voltage-gated ion channel","Ligand-gated ion channel",Oxidoreductase,Reader,Lyase,"Primary active transporter","
Nuclear receptor",Hydrolase,"Small molecule receptor (family A GPCR)","Metallo protease","SLC superfamily of solute carriers","Cytochrome P450 family 2","Potassium channels","5HT3 receptor","Cytochrom
e P450 family 3",Bromodomain,"Cytochrome P450 family 1","ATP-binding cassette","Nuclear hormone receptor subfamily 1","Peptide receptor (family A GPCR)","Voltage-gated calcium channel","GABA-A recepto
r","Ionotropic glutamate receptor","Voltage-gated sodium channel","Monoamine receptor","Metallo protease MAE clan","SLC06 neurotransmitter transporter family","Cytochrome P450 family 2C","Voltage-gate
d potassium channel","Cytochrome P450 family 3A","Cytochrome P450 family 2D","Cytochrome P450 family 1A","ABCB subfamily","Nuclear hormone receptor subfamily 1 group F","Nucleotide-like receptor (fami
ly A GPCR)","Glycohormone receptor","Inwardly rectifying potassium channel","Short peptide receptor (family A GPCR)","Lipid-like ligand receptor (family A GPCR)","NMDA receptor","Adrenergic receptor",
"Dopamine receptor","Serotonin receptor","Metallo protease M34 family","Cytochrome P450 2C19","Histamine receptor","Acetylcholine receptor","Cytochrome P450 3A4","Cytochrome P450 2C9","Cytochrome P450
 2D6","Cytochrome P450 1A1","Nuclear hormone receptor subfamily 1 group F member 3","Adenosine receptor","Opioid receptor","Leukotriene receptor","Cholecystokinin receptor","Prostanoid receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"Ion channels","Other protein targets",Transporters,"G protein-coupled receptors","Cytochrome P450","Voltage-gated ion channels","Ligand-gated ion channels","Sigma receptors","SLC s
uperfamily of solute carriers","ATP-binding cassette transporter family","Nuclear hormone receptors","Inositol phosphate turnover","Dopamine receptors","5-Hydroxytryptamine receptors",Adrenoceptors,"C
YP2 family: drug metabolising subset","Histamine receptors","Potassium channels","Acetylcholine receptors (muscarinic)","5-HT<sub>3</sub> receptors","CYP3 family","CYP1 family","SLC6 neurotransmitter 
transporter family","ABCB subfamily","1F. Retinoic acid-related orphans","Inositol monophosphatase","Adenosine receptors","Glycoprotein hormone receptors","Opioid receptors","GABA<sub>A</sub> receptor
s","Leukotriene receptors","Ionotropic glutamate receptors","Voltage-gated calcium channels","Voltage-gated sodium channels","Cholecystokinin receptors","Prostanoid receptors","Voltage-gated potassium
 channels","Monoamine transporter subfamily","Inwardly rectifying potassium channels"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Cell Cycle","Neuronal System",Metabolism,"Muscle contraction","Immune System","Developmental Biology","DNA Repair","Cellular responses to external stimuli","Gene expres
sion (Transcription)","Signaling by GPCR","Infectious disease",Mitotic,"Transmission across Chemical Synapses","Biological oxidations","Cardiac conduction","Metabolism of lipids","Metabolism of vitami
ns and cofactors","Cytokine Signaling in Immune system","Nervous system development","DNA Double-Strand Break Repair","Metabolism of amino acids and derivatives","Base Excision Repair","Cellular respo
nses to stress","RNA Polymerase II Transcription","Inositol phosphate metabolism","Disorders of transmembrane transporters","Diseases of signal transduction by growth factor receptors and second messe
ngers","GPCR ligand binding","Leishmania infection","M Phase","Uptake and actions of bacterial toxins","Neurotransmitter receptors and postsynaptic signal transmission","Phase I - Functionalization of
 compounds","Phase 3 - rapid repolarisation","Biosynthesis of specialized proresolving mediators (SPMs)","SARS-CoV Infections","Metabolism of water-soluble vitamins and cofactors","Signaling by Interl
eukins","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Homology Directed Repair","Branched-chain amino acid catabolism","Resolution of Abasic Sites (AP sites)","Neurotransmitter cle
arance","Cellular Senescence","Metabolism of steroids","Generic Transcription Pathway","Synthesis of IP2",IP,"and Ins in the cytosol","SLC transporter disorders","GPCR downstream signalling","Axon gui
dance","Oncogenic MAPK signaling","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","Mitotic Metaphase and Anaphase","Uptake and function of anthrax toxins","Activation 
of NMDA receptors and postsynaptic events","Cytochrome P450 - arranged by substrate type","Biosynthesis of DHA-derived SPMs","Potential therapeutics for SARS","Vitamins B6 activation to pyridoxal phos
phate","Interleukin-1 family signaling","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Se
rotonin clearance from the synaptic cleft","DNA Damage/Telomere Stress Induced Senescence","Bile acid and bile salt metabolism","Transcriptional regulation by RUNX3","Defective SLC6A2 causes orthostat
ic intolerance (OI)","GABA receptor activation","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","G alpha (i) signalling events","Transcriptional Regulation by MECP2","NCAM signaling 
for neurite out-growth","L1CAM interactions","G alpha (q) signalling events","Signaling by RAS mutants","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infec
tion","Mitotic Anaphase","Post NMDA receptor activation events",Xenobiotics,"Biosynthesis of maresins","Interleukin-1 signaling","HDR through Homologous Recombination (HRR)","PCNA-Dependent Long Patch
 Base Excision Repair","Formation of Senescence-Associated Heterochromatin Foci (SAHF)","Synthesis of bile acids and bile salts","Recycling of bile acids and salts","RUNX3 Regulates Immune Response an
d Cell Migration","Fatty acids","Nucleotide-like (purinergic) receptors","GABA B receptor activation","Opioid Signalling","Peptide ligand-binding receptors","MECP2 regulates neuronal receptors and cha
nnels","NCAM1 interactions","Interaction between L1 and Ankyrins","Gastrin-CREB signalling pathway via PKC and MAPK","Signaling downstream of RAS mutants","Eicosanoid ligand-binding receptors","Dopami
ne receptors","Serotonin receptors","ADORA2B mediated anti-inflammatory cytokines production","Nuclear Envelope (NE) Reassembly",Adrenoceptors,"Activation of AMPK downstream of NMDARs","CYP2E1 reactio
ns","Histamine receptors","Muscarinic acetylcholine receptors","Biosynthesis of maresin-like SPMs","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","MAP3K8 (TPL2)-dep
endent MAPK1/3 activation","Homologous DNA Pairing and Strand Exchange","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Synthesis of bile acids and bile salts via 7alpha-hydroxycho
lesterol","Adenosine P1 receptors","Activation of GABAB receptors","G-protein activation","LTC4-CYSLTR mediated IL4 production","Tachykinin receptors bind tachykinins","Prostanoid ligand receptors","I
nitiation of Nuclear Envelope (NE) Reformation","Ras activation upon Ca2+ influx through NMDA receptor","Presynaptic phase of homologous DNA pairing and strand exchange","Inhibition  of voltage gated 
Ca2+ channels via Gbeta/gamma subunits"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,ADRA2A,ADRA2B,ADRA2C,CALY,CHRM1,CHRM2,CHRM3,CHRM4,CHRM5,DRD1,DRD2,DRD3,DRD4,DRD5,HRH1,HRH4,HTR1A,HTR1B,HTR1D,HTR1E,HTR1F,HTR2A,HTR2B,HTR2C,HTR3A,HTR5A,HTR6,HTR7}

> <broad_moa>
{"dopamine receptor antagonist","serotonin receptor antagonist"}

> <synonyms>
{5786-21-0,5786210,Leponex,Clozapin,CLOZARIL,Fazaclo,Clorazil,Iprox,Clozapina,Clozapinum,"HF 1854",HF-1854,HF1854,"8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine","8Chloro11(4methy
l1piperazinyl)5Hdibenzo(b,e)(1,4)diazepine",W-801,W801,8-chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo(b,8chloro11(4methylpiperazin1yl)5Hdibenzo(b,e)(1,4)diaz,T0455,S2459,SAM002548976,1500685,Prestw-3
50,Clozapine,CPD000058365,CLOZAPINE,Clozapine}

> <pdid>
PD001633

> <targets>
{"5-HT Receptor"}

> <classes>
{antipsychotic,"Neuronal Signaling"}

> <pubchem_cids>
{135398737}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 34  0  0  1  0            999 V2000
    2.6018   -5.9994    0.0000 C   0  0
    3.9008   -5.2492    0.0000 O   0  0
    3.9014   -3.7484    0.0000 C   0  0
    2.6012   -3.0004    0.0000 C   0  0
    2.5987   -1.5004    0.0000 C   0  0
    3.8967   -0.7484    0.0000 C   0  0
    5.1969   -1.4963    0.0000 C   0  0
    6.4939   -0.7411    0.0000 O   0  0
    6.4894    0.7589    0.0000 C   0  0
    5.1993   -2.9963    0.0000 C   0  0
    6.4987   -3.7473    0.0000 O   0  0
    6.4990   -5.2473    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
    0.3114    2.9665    0.0000 C   0  0
    1.8032    3.1233    0.0000 O   0  0
    2.4133    1.7530    0.0000 C   0  0
    3.8805    1.4410    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -3.7124   -4.0030    0.0000 O   0  0
   -3.1022   -5.3733    0.0000 C   0  0
   -1.6105   -5.2165    0.0000 O   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  7 10  2  0
 10  3  1  0
 10 11  1  0
 11 12  1  0
 13  5  1  6
 13 14  1  0
 14 15  1  0
 15 16  1  1
 16 17  1  0
 17 18  1  0
 14 18  1  6
 18 19  2  0
 15 20  1  0
 20 21  1  6
 20 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 24  2  0
 28 29  1  0
 29 30  2  0
 30 13  1  0
 30 22  1  0
M  END
> <name>
NIHCC_2014

> <id>
6279

> <plate>
NGP-202-03

> <well>
E10

> <supplier_cmpd_name>
CPD000059121

> <ctcr_id>
3422

> <supplier_cmpd_id>
SAM002548978

> <smiles>
COc1cc(cc(OC)c1OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](O)c4cc5OCOc5cc24

> <pd_targets>
{TUBB2B,TUBA1A,LMNA,HIF1A,CYP3A4,TUBA1B,TUBA1C,TUBA3C,TUBA3E,TUBA4A,TUBB,TUBB1,TUBB2A,TUBB3,TUBB4A,TUBB4B,TUBB6,TUBB8,E2,LEF,NR3C1,CYP2C19,NR0B1,CYP2C9,TUBB5,TOP2A,IGF1R,GMNN,NFO,NPSR1,MTOR}

> <pathway_gtopdb>
{"Structural protein","Other nuclear protein","Transcription factor",Enzyme,"Cytochrome P450",Protease,"Nuclear receptor",Isomerase,"Cytochrome P450 family 3","Metallo protease","Nuclear hormone recep
tor subfamily 3","Cytochrome P450 family 2","Nuclear hormone receptor subfamily 0","Cytochrome P450 family 3A","Metallo protease MAE clan","Nuclear hormone receptor subfamily 3 group C","Cytochrome P4
50 family 2C","Nuclear hormone receptor subfamily 0 group B","Cytochrome P450 3A4","Metallo protease M34 family","Nuclear hormone receptor subfamily 3 group C member 1","Cytochrome P450 2C19","Nuclear
 hormone receptor subfamily 0 group B member 1","Cytochrome P450 2C9",Kinase,"Protein Kinase","TK protein kinase group","Tyrosine protein kinase InsR family","Unclassified protein","Membrane receptor"
,Hydrolase,"Family A G protein-coupled receptor","Peptide receptor (family A GPCR)","Short peptide receptor (family A GPCR)","Atypical protein kinase group","Neuropeptide receptor","Atypical protein k
inase PIKK family","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Enzymes,Receptors,"Other protein targets","Cytochrome P450","Nuclear hormone receptors",Tubulins,"DNA topoisomerases","CYP3 family","Steroid hormone receptors","CYP2 family: drug metabolising subset"
,"0B. DAX-like receptors","3C. 3-Ketosteroid receptors","Catalytic receptors","Receptor kinases","TK: Tyrosine kinase","Receptor tyrosine kinases (RTKs)","Type II RTKs: Insulin receptor family","G pro
tein-coupled receptors","Kinases (EC 2.7.x.x)","Neuropeptide S receptor",Atypical,"Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","FRAP subfamily"}

> <pathway_reactome>
{"Cell Cycle","Cellular responses to external stimuli",Metabolism,Disease,"Gene expression (Transcription)",Mitotic,"Cellular responses to stress","Metabolism of lipids","Infectious disease","RNA Poly
merase II Transcription","Biological oxidations","M Phase","Cellular response to hypoxia","Biosynthesis of specialized proresolving mediators (SPMs)","Uptake and actions of bacterial toxins","Generic 
Transcription Pathway","Mitotic G2-G2/M phases","Phase I - Functionalization of compounds","Mitotic G1 phase and G1/S transition","Mitotic Metaphase and Anaphase","Oxygen-dependent proline hydroxylati
on of Hypoxia-inducible Factor Alpha","Biosynthesis of DHA-derived SPMs","Uptake and function of anthrax toxins","FOXO-mediated transcription","G2/M Transition","Cytochrome P450 - arranged by substrat
e type","Nuclear Receptor transcription pathway","G0 and Early G1","Mitotic Anaphase","Biosynthesis of maresins","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","Centr
osome maturation",Xenobiotics,"Transcription of E2F targets under negative control by DREAM complex","Nuclear Envelope (NE) Reassembly","Biosynthesis of maresin-like SPMs","Loss of proteins required f
or interphase microtubule organization from the centrosome","CYP2E1 reactions","Sealing of the nuclear envelope (NE) by ESCRT-III","Initiation of Nuclear Envelope (NE) Reformation","Loss of Nlp from m
itotic centrosomes","Signal Transduction","Signaling by Receptor Tyrosine Kinases","Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)","IGF1R signaling cascade","IRS-related events tri
ggered by IGF1R","Leishmania infection","G1/S Transition","Leishmania parasite growth and survival","Transcriptional Regulation by TP53","Activation of the pre-replicative complex","Anti-inflammatory 
response favouring Leishmania parasite infection","Regulation of TP53 Activity","ADORA2B mediated anti-inflammatory cytokines production","Regulation of TP53 Expression and Degradation","Regulation of
 TP53 Degradation"}

> <broad_targets>
{IGF1R,TOP2A,TUBA4A,TUBB}

> <broad_moa>
{"microtubule inhibitor","tubulin polymerization inhibitor"}

> <synonyms>
{RESTW78,"RESTW 78",podophyllotoxin,Podofilox,518-28-5,518285,"518 28 5",Condylox,Condyline,(-)-Podophyllotoxin,()Podophyllotoxin,"( ) Podophyllotoxin",Wartec,"Podophyllinic acid lactone","Podophyllot
oxin 7",Warticon,Podophyllum,"Podofilox (USAN",NSC24818,SAM002548978,2300332,Prestw-782,"NSC 24818",CPD000059121,PODOFILOX,Podophyllotoxin,PODOPHYLLOTOXIN}

> <pdid>
PD000047

> <targets>
{IGF-1R}

> <classes>
{"inhibits microtubule assembly",antineoplastic,"and human DNA topoisomerase II; antimitotic agent"}

> <pubchem_cids>
{10607}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 30  0  0  0  0            999 V2000
    8.6252   -3.4275    0.0000 C   0  0
    7.1475   -3.6853    0.0000 C   0  0
    6.6325   -5.0941    0.0000 C   0  0
    6.1841   -2.5345    0.0000 N   0  0
    4.7057   -2.7925    0.0000 C   0  0
    3.7423   -1.6417    0.0000 C   0  0
    2.2638   -1.8997    0.0000 C   0  0
    2.7882   -0.4624    0.0000 C   0  0
    1.8245    0.6871    0.0000 N   0  0
    4.2654   -0.2022    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    1.7512   -3.3104    0.0000 C   0  0
    0.2741   -3.5716    0.0000 C   0  0
   -0.2382   -4.9814    0.0000 C   0  0
    0.7266   -6.1300    0.0000 C   0  0
    2.2037   -5.8687    0.0000 C   0  0
    2.7160   -4.4589    0.0000 N   0  0
    6.6966   -1.1239    0.0000 C   0  0
    5.7325    0.0252    0.0000 C   0  0
    8.1737   -0.8630    0.0000 C   0  0
   11.6006   -3.0002    0.0000 O   0  0
   12.8998   -2.2507    0.0000 P   0  0
   12.8998   -0.7507    0.0000 O   0  0
   12.8998   -3.7507    0.0000 O   0  0
   14.1991   -3.0002    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  2  0
  7 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  7 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
  4 23  1  0
 23 24  1  0
 23 25  1  0
 26 27  1  0
 27 28  1  0
 27 29  1  0
 27 30  2  0
M  END
> <name>
NIHCC_2014

> <id>
6280

> <plate>
NGP-202-03

> <well>
E11

> <supplier_cmpd_name>
CPD000058438

> <ctcr_id>
1437

> <supplier_cmpd_id>
SAM002264607

> <smiles>
CC(C)N(CCC(C(N)=O)(c1ccccc1)c2ccccn2)C(C)C.O[P](O)(O)=O

> <pd_targets>
{BLM,KCNH2,THRB,PMP22,NS1,SLC22A1,SLC22A2,SLC47A1,SCN5A,CHRM1,CHRM2,CHRM3,KCND2,KCND3,SCN10A,SCN11A,SCN1A,SCN2A,SCN3A,SCN4A,SCN7A,SCN8A,SCN9A}

> <pathway_gtopdb>
{Enzyme,"Ion channel","Transcription factor","Unclassified protein",Transporter,"Membrane receptor","Voltage-gated ion channel","Nuclear receptor","Electrochemical transporter","Family A G protein-cou
pled receptor","Potassium channels","Nuclear hormone receptor subfamily 1","SLC superfamily of solute carriers","Voltage-gated sodium channel","Small molecule receptor (family A GPCR)","Voltage-gated 
potassium channel","Nuclear hormone receptor subfamily 1 group A","SLC22 family of organic cation and anion transporters","SLC47 family of multidrug and toxin extrusion transporters","Monoamine recept
or","Nuclear hormone receptor subfamily 1 group A member 2","Acetylcholine receptor"}

> <pathway_chembl>
{"Ion channels",Receptors,Transporters,"Voltage-gated ion channels","Nuclear hormone receptors","SLC superfamily of solute carriers","G protein-coupled receptors","Potassium channels","1A. Thyroid hor
mone receptors","SLC22 family of organic cation and anion transporters","SLC47 family of multidrug and toxin extrusion transporters","Voltage-gated sodium channels","Acetylcholine receptors (muscarini
c)","Voltage-gated potassium channels","Organic cation transporters (OCT)"}

> <pathway_reactome>
{"DNA Repair","Muscle contraction","Metabolism of proteins","Developmental Biology","Transport of small molecules","Signal Transduction","DNA Double-Strand Break Repair","Cardiac conduction","Post-tra
nslational protein modification","Nervous system development","SLC-mediated transmembrane transport","Signaling by GPCR","Homology Directed Repair","Phase 3 - rapid repolarisation",SUMOylation,"EGR2 a
nd SOX10-mediated initiation of Schwann cell myelination","Transport of bile salts and organic acids","metal ions and amine compounds","Axon guidance","GPCR ligand binding","Phase 1 - inactivation of 
fast Na+ channels","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","SUMO E3 ligases SUMOylate target proteins","Organic cation/anion/zwitterion transport","L1CAM interact
ions","Class A/1 (Rhodopsin-like receptors)","HDR through Homologous Recombination (HRR)","SUMOylation of intracellular receptors","Organic cation transport","Interaction between L1 and Ankyrins","Ami
ne ligand-binding receptors","Homologous DNA Pairing and Strand Exchange","Muscarinic acetylcholine receptors","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3,KCND2,KCND3,KCNH2,SCN5A}

> <broad_moa>
{"sodium channel blocker"}

> <synonyms>
{"DISOPYRAMIDE PHOSPHATE",Norpace,22059-60-5,22059605,"DISOPYRAMIDE PHOSPHATE SALT","Norpace Cr","SC 7031 phosphate","EINECS 244-756-1","EINECS 2447561","SC 7031 (phosphate)",CHEBI:4658,"22059-60-5 (p
hosphate)","22059605 (phosphate)",SC-13957,SC13957,4-(di(propan-2-yl)amino)-2-phenyl-2-pyridin-2-yl,4(di(propan2yl)amino)2phenyl2pyridin2yl,SAM002264607,1500261,CPD000058438}

> <pdid>
PD002749

> <targets>
{}

> <classes>
{antiarrhythmic}

> <pubchem_cids>
{30928}

$$$$
NIHCC_2014
  SciTegic11012413002D

 14 13  0  0  0  0            999 V2000
    8.8056   -1.8965    0.0000 H   0  3
    6.3056   -1.8965    0.0000 Cl  0  5
    1.8372   -5.2877    0.0000 C   0  0
    3.3372   -5.2929    0.0000 C   0  0
    3.8056   -3.8679    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    1.3786   -3.8595    0.0000 N   0  0
  3  4  1  0
  4  5  1  0
  5  6  2  3
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  6 14  1  0
 14  3  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6281

> <plate>
NGP-202-03

> <well>
F02

> <supplier_cmpd_name>
CPD000149600

> <ctcr_id>
3789

> <supplier_cmpd_id>
SAM002589935

> <smiles>
[H+].[Cl-].C1CN=C(Cc2ccccc2)N1

> <pd_targets>
{ADRA2A,ADRA2B,ADRA2C,ADRA1A,TAAR1,TSHR,CYP2D6,ADRA1B,ADRA1D,LMNA,HTR7,CYP1A2,HRH2,HRH1}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Other nuclear protein","Family A G protein-coupled receptor","Cytochrome P450","Small molecule receptor (family A GPCR)","Peptide receptor (family A GPCR)","Cytochrome P45
0 family 2","Cytochrome P450 family 1","Monoamine receptor","Glycohormone receptor","Cytochrome P450 family 2D","Cytochrome P450 family 1A","Adrenergic receptor","Trace amine receptor","Cytochrome P45
0 2D6","Serotonin receptor","Cytochrome P450 1A1","Histamine receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Cytochrome P450",Adrenoceptors,"Trace amine receptor","Glycoprotein hormone receptors","CYP2 family: drug metabolising subset","5-Hydroxytryptamine re
ceptors","CYP1 family","Histamine receptors"}

> <pathway_reactome>
{"Signal Transduction",Disease,Metabolism,"Cell Cycle","Signaling by GPCR","Infectious disease","Biological oxidations",Mitotic,"GPCR ligand binding","Leishmania infection","Phase I - Functionalizatio
n of compounds","M Phase","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","Cytochrome P450 - arranged by substrate type","Mitotic Metaphase and Anaphase","Amine ligand
-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection",Xenobiotics,"Mitotic Anaphase",Adrenoceptors,"ADORA2B mediated anti-inflammatory cytokines production","CYP2E1 
reactions","Nuclear Envelope (NE) Reassembly","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Histamine receptors","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ADRA1A,ADRA2A,ADRA2B,ADRA2C,HRH1,HRH2}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{"Tolazoline hydrochloride",59-97-2,59972,"59 97 2","Tolazoline HCl","2-benzyl-4,5-dihydro-1H-imidazole hydrochloride","2benzyl4,5dihydro1Himidazole hydrochloride","2 benzyl 4,5 dihydro 1H imidazole h
ydrochloride","Tolazoline (hydrochloride)",Benzaz,S4127,S4124,SAM002589935,1500580,Prestw-60,"Terbutaline Sulfate",CPD000149600,"TOLAZOLINE HYDROCHLORIDE"}

> <pdid>
PD009716

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"GPCR & G Protein","adrenergic blocker","Neuronal Signaling"}

> <pubchem_cids>
{6048,74764089}

$$$$
NIHCC_2014
  SciTegic11012413002D

 35 36  0  0  1  0            999 V2000
    7.9258    0.6940    0.0000 C   0  0
    7.9112   -0.8059    0.0000 C   0  0  2  0  0  0
    9.2031   -1.5682    0.0000 O   0  0
    6.6039   -1.5432    0.0000 C   0  0  2  0  0  0
    6.5893   -3.0431    0.0000 C   0  0
    5.3200   -0.7861    0.0000 C   0  0  2  0  0  0
    4.5654    0.5102    0.0000 O   0  0
    3.8990   -0.7455    0.0000 C   0  0  1  0  0  0
    2.6003   -1.4977    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -2.5973    1.5031    0.0000 C   0  0
   -2.5951    3.0039    0.0000 C   0  0
   -1.2948    3.7516    0.0000 C   0  0
   -3.8933    3.7570    0.0000 C   0  0
   -3.8912    5.2578    0.0000 C   0  0
   -2.5909    6.0055    0.0000 O   0  0
   -5.1894    6.0109    0.0000 O   0  0
   -5.1873    7.5117    0.0000 C   0  0
   -6.4855    8.2648    0.0000 C   0  0
   -6.4834    9.7656    0.0000 C   0  0
   -7.7816   10.5187    0.0000 C   0  0
   -7.7794   12.0195    0.0000 C   0  0
   -9.0776   12.7726    0.0000 C   0  0
   -9.0755   14.2734    0.0000 C   0  0
  -10.3737   15.0265    0.0000 C   0  0
  -10.3716   16.5273    0.0000 C   0  0
   -9.0713   17.2751    0.0000 O   0  0
  -11.6691   17.2800    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0  2  0  0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
    0.0000   -3.0000    0.0000 O   0  0
  2  1  1  6
  2  3  1  0
  2  4  1  0
  4  5  1  6
  4  6  1  0
  6  7  1  1
  7  8  1  0
  8  6  1  0
  8  9  1  6
 10  9  1  6
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  6
 14 15  1  0
 15 16  1  0
 15 17  2  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 29 31  2  0
 13 32  1  0
 32 33  1  1
 32 34  1  0
 34 10  1  0
 34 35  1  1
M  END
> <name>
NIHCC_2014

> <id>
6282

> <plate>
NGP-202-03

> <well>
F03

> <supplier_cmpd_name>
CPD000471888

> <ctcr_id>
3803

> <supplier_cmpd_id>
SAM002589979

> <smiles>
C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]2CO[C@@H](C\C(C)=C\C(=O)OCCCCCCCCC(O)=O)[C@H](O)[C@@H]2O

> <pd_targets>
{ILES,IARS1,SKA}

> <pathway_gtopdb>
{Enzyme,Ligase,Kinase}

> <pathway_chembl>
{}

> <pathway_reactome>
{"Metabolism of proteins",Translation,"tRNA Aminoacylation","Cytosolic tRNA aminoacylation"}

> <broad_targets>
{}

> <broad_moa>
{"isoleucyl-tRNA synthetase inhibitor"}

> <synonyms>
{"Mupirocinum (Latin)","Mupirocina (Spanish)",Mupirocin,12650-69-0,"Pseudomonic acid",Bactroban,Mupirocine,Centany,"Pseudomonic acid A",Mupirocina,Mupirocinum,"BRL 4910A",BRL-4910A,UNII-D0GX863OA5,"Ba
ctroban (TN)",CHEMBL719,CHEBI:7025,D0GX863OA5,MRC,Bactoderm,"6-Chloro-2,4-dimethoxy pyrimidine",MFCD01711620,NCGC00164554-03,Plasimine,"mupirocin calcium salt","Mupirocine (French)","Bactroban Ointmen
t",BRL-4910F,80558-54-9,"Centany (TN)","trans-Pseudomonic acid","Mupirocin Neo-Sensitabs","Mupirocin (USP/INN)",SR-05000001947,115074-43-6,1jzs,"Mupirocin (USAN:USP:INN:BAN)","Mupirocin,(S)","mupiroci
n lithium salt",CPD000471888,73346-79-9,SCHEMBL3291,DSSTox_CID_26438,DSSTox_RID_81614,DSSTox_GSID_46438,MLS001074711,BIDD:GT0320,"Mupirocin, Pseudomonic Acid A",cid_446596,SCHEMBL1027618,"Pseudomonic 
acid A lithium salt",DTXSID0046438,CHEBI:94519,GTPL10916,AOB6353,HMS2234E20,HMS3259L05,HMS3712K03,Pharmakon1600-01505706,HY-B0958,ZINC4102194,Tox21_112183,BDBM50290686,MFCD11977847,NSC759182,NSC815348
,AKOS015994756,"Mupirocin, >=92 (HPLC), powder",CCG-213522,DB00410,KS-5137,NC00620,NSC-759182,NSC-815348,NCGC00164554-05,NCGC00164554-06,AS-11580,SMR000471888,SBI-0206892.P001,AB0010371,CAS-12650-69-0
,M2955,S4297,C11758,D01076,M-8680,AB01563109_01,"Mupirocin, Antibiotic for Culture Media Use Only",Q413578,SR-05000001947-1,SR-05000001947-2,BRD-K15262564-001-06-9,"Mupirocin, United States Pharmacope
ia (USP) Reference Standard",T1465,SAM002589979,1505706,MUPIROCIN}

> <pdid>
PD000326

> <targets>
{Antibiotic,Bacterial}

> <classes>
{isoleucyl-tRNA synthetase inhibitor,antimycoplasmal,antibacterial,Anti-infection}

> <pubchem_cids>
{446596}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 33  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
    0.0000    3.0000    0.0000 C   0  0  2  0  0  0
    1.0956    4.0166    0.0000 C   0  0
    0.4767    5.3830    0.0000 C   0  0
   -1.0140    5.2166    0.0000 C   0  0  2  0  0  0
   -1.9861    4.9820    0.0000 O   0  0
   -0.5491    6.6300    0.0000 C   0  0
   -1.5661    7.7325    0.0000 O   0  0
    0.9150    6.9601    0.0000 C   0  0
    1.3620    8.3928    0.0000 O   0  0
    2.8261    8.7229    0.0000 C   0  0
    3.8431    7.6204    0.0000 C   0  0
    3.2729   10.1549    0.0000 O   0  0
   -1.2991    3.7500    0.0000 C   0  0  2  0  0  0
   -2.1132    4.3307    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0  2  0  0  0
   -3.8971    0.7500    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0  2  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    0.0000    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -1.2990   -5.2500    0.0000 O   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  1  1  6
  2  3  1  0
  4  3  1  6
  4  5  1  0
  5  6  1  1
  6  7  1  0
  7  8  1  0
  8  9  1  6
  8 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 14 16  2  0
  8 17  1  0
 17  5  1  0
 17 18  1  1
 17 19  1  0
 19 20  1  0
 20 21  1  1
 22 20  1  1
 22  4  1  0
 22 23  1  0
 23 24  1  1
 23 25  1  0
 25 26  2  3
 26 27  1  0
 27 28  2  0
 27 29  1  0
 29 30  2  3
 30  2  1  0
 30 23  1  0
M  END
> <name>
NIHCC_2014

> <id>
6283

> <plate>
NGP-202-03

> <well>
F04

> <supplier_cmpd_name>
CPD000718757

> <ctcr_id>
7045

> <supplier_cmpd_id>
SAM002699893

> <smiles>
C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)COC(C)=O)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]4(C)C=CC(=O)C=C14

> <pd_targets>
{NR3C1}

> <pathway_gtopdb>
{"Transcription factor","Nuclear receptor","Nuclear hormone receptor subfamily 3","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 3 group C member 1"}

> <pathway_chembl>
{Receptors,"Nuclear hormone receptors","Steroid hormone receptors","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"Gene expression (Transcription)","RNA Polymerase II Transcription","Generic Transcription Pathway","FOXO-mediated transcription","FOXO-mediated transcription of oxidative stress","metabolic and neur
onal genes"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Methylprednisolone acetate",Depo-medrol,Depomedrol,53-36-1,53361,M-Predrol,MPredrol,Depo-Medrate,DepoMedrate,Depo-Medrone,DepoMedrone,"Medrol acetate","Methylprednisolone 21-acetate","Methylpredniso
lone 21acetate",Mepred,"Medrol Enpak","6alpha-Methylprednisolone acetate","6alphaMethylprednisolone acetate",D-Med,DMed,"Urbason crystal suspension",Depomedrone,De,SAM002699893,CPD000718757}

> <pdid>
PD001021

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5877}

$$$$
NIHCC_2014
  SciTegic11012413002D

  7  7  0  0  0  0            999 V2000
    1.6317   -2.2458    0.0000 C   0  0
    0.7500   -1.0323    0.0000 N   0  0
    1.2135    0.3943    0.0000 C   0  0
    0.0000    1.2760    0.0000 C   0  0
   -1.2135    0.3943    0.0000 N   0  0
   -0.7500   -1.0323    0.0000 C   0  0
   -1.6317   -2.2458    0.0000 S   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  3
  4  5  1  0
  5  6  1  0
  6  2  1  0
  6  7  2  0
M  END
> <name>
NIHCC_2014

> <id>
6284

> <plate>
NGP-202-03

> <well>
F05

> <supplier_cmpd_name>
CPD000058376

> <ctcr_id>
4449

> <supplier_cmpd_id>
SAM002548951

> <smiles>
CN1C=CNC1=S

> <pd_targets>
{ALDH1A1,DBH,KMT2A,MEN1,LPO,LMNA,FFP,RORC,TPO}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Other nuclear protein","Transcription factor",Oxidoreductase,Reader,Transferase,"Nuclear receptor",Bromodomain,"Nuclear hormone receptor subfamily 1","Nuclear hormone r
eceptor subfamily 1 group F","Nuclear hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{Enzymes,Receptors,"Catecholamine turnover","Nuclear hormone receptors","Thyroid hormone turnover","1F. Retinoic acid-related orphans"}

> <pathway_reactome>
{Metabolism,"Immune System","Cell Cycle","Gene expression (Transcription)","Biological oxidations","Metabolism of amino acids and derivatives","Innate Immune System",Mitotic,"RNA Polymerase II Transcr
iption","Phase I - Functionalization of compounds","Metabolism of amine-derived hormones","ROS and RNS production in phagocytes","M Phase","Generic Transcription Pathway","Ethanol oxidation","Catechol
amine biosynthesis","Events associated with phagocytolytic activity of PMN cells","Mitotic Metaphase and Anaphase","Transcriptional regulation by RUNX3","Thyroxine biosynthesis","Mitotic Anaphase","RU
NX3 Regulates Immune Response and Cell Migration","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{TPO}

> <broad_moa>
{"antithyroid agent"}

> <synonyms>
{"2-Mercapto-1-methylimidazole, 98","2Mercapto1methylimidazole, 98",methimazole,60-56-0,60560,thiamazole,Tapazole,2-Mercapto-1-methylimidazole,2Mercapto1methylimidazole,Methimazol,1-Methylimidazole-2-
thiol,1Methylimidazole2thiol,Mercazole,Mercazolyl,Metazolo,Thymidazol,Thymidazole,Mercaptazole,Merkazolil,Metothyrin,Met,T0840,SAM002548951,1500396,Prestw-786,Methimazole,CPD000058376,METHIMAZOLE}

> <pdid>
PD000229

> <targets>
{Others}

> <classes>
{antihyperthyroid,Others}

> <pubchem_cids>
{1349907}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 25  0  0  0  0            999 V2000
    6.3982    3.5181    0.0000 Na  0  3
    3.8976   -0.7553    0.0000 O   0  5
    2.5973   -1.5031    0.0000 N   0  3
    2.5951   -3.0031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5987    1.5004    0.0000 C   0  0
   -2.7390    2.9810    0.0000 O   0  0
   -4.2067    3.2905    0.0000 C   0  0
   -4.9546    1.9903    0.0000 C   0  0
   -3.9492    0.8772    0.0000 C   0  0
   -4.8211    4.6570    0.0000 C   0  0
   -6.3142    4.8094    0.0000 N   0  0
   -6.9296    6.1782    0.0000 N   0  0
   -6.1728    7.4585    0.0000 C   0  0
   -7.1783    8.5716    0.0000 C   0  0
   -6.8688   10.0393    0.0000 O   0  0
   -8.5476    7.9593    0.0000 N   0  5
   -8.3884    6.4677    0.0000 C   0  0
   -9.4955    5.4557    0.0000 O   0  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  8 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 11  2  0
 13 16  1  0
 16 17  2  3
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 23 18  1  0
 23 24  2  0
M  CHG  4   1   1   2  -1   3   1  22  -1
M  END
> <name>
NIHCC_2014

> <id>
6285

> <plate>
NGP-202-03

> <well>
F06

> <supplier_cmpd_name>
CPD000326766

> <ctcr_id>
7053

> <supplier_cmpd_id>
SAM002703135

> <smiles>
[Na+].[O-][N+](=O)c1ccc(cc1)c2oc(cc2)C=NN3CC(=O)[N-]C3=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"DANTROLENE SODIUM",14663-23-1,14663231,DSSTox_CID_24585,DSSToxCID24585,DSSTox-CID-24585,"DSSTox CID 24585",DSSTox_RID_80332,DSSToxRID80332,DSSTox-RID-80332,"DSSTox RID 80332",DSSTox_GSID_44585,DSSTo
xGSID44585,DSSTox-GSID-44585,"DSSTox GSID 44585","F 440",CHEBI:4318,"Dantrolene Na",CAS-14663-23-1,CAS14663231,NCGC00163132-01,NCGC0016313201,SCHEMBL40892,CHEMBL1725283,DTXSID4044585,HMS2231K09,HMS325
9L11,HMS3369A09,Tox21_112013,Tox21112013,Tox21-112013,"Tox21 112013",Tox21_,Tox21,Tox21-,SAM002703135,CPD000326766}

> <pdid>
PD001049

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{32731}

$$$$
NIHCC_2014
  SciTegic11012413002D

 16 18  0  0  0  0            999 V2000
    2.5951   -3.0031    0.0000 C   0  0
    2.5973   -1.5031    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.4133    1.7530    0.0000 O   0  0
    1.8032    3.1233    0.0000 C   0  0
    0.3114    2.9665    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -1.2990   -5.2500    0.0000 O   0  0
    0.0000   -3.0000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  4  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 11 12  2  3
 12 13  1  0
 13 14  2  0
 13 15  1  0
 15 16  1  0
 16  3  1  0
 16 10  2  0
M  END
> <name>
NIHCC_2014

> <id>
6286

> <plate>
NGP-202-03

> <well>
F07

> <supplier_cmpd_name>
CPD000071170

> <ctcr_id>
1812

> <supplier_cmpd_id>
SAM002548974

> <smiles>
COc1c2occc2cc3C=CC(=O)Oc13

> <pd_targets>
{CYP3A4,CYP2A13,MAOA,CYP2A6,ACHE,TSHR,CYP2C19,MAPK1,CYP2D6,LEF,CYP1A2}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Cytochrome P450",Oxidoreductase,Hydrolase,"Family A G protein-coupled receptor",Kinase,Protease,"Cytochrome P450 family 3","Cytochrome P450 family 2","Peptide receptor (fa
mily A GPCR)","Protein Kinase","Metallo protease","Cytochrome P450 family 1","Cytochrome P450 family 3A","Cytochrome P450 family 2A","Glycohormone receptor","Cytochrome P450 family 2C","CMGC protein k
inase group","Cytochrome P450 family 2D","Metallo protease MAE clan","Cytochrome P450 family 1A","Cytochrome P450 3A4","Cytochrome P450 2A6","Cytochrome P450 2C19","CMGC protein kinase MAPK family","C
ytochrome P450 2D6","Metallo protease M34 family","Cytochrome P450 1A1","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Enzymes,Receptors,"Cytochrome P450","Catecholamine turnover","Acetylcholine turnover","G protein-coupled receptors","Kinases (EC 2.7.x.x)","CYP3 family","CYP2 family: drug metabolising subset","Glyco
protein hormone receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK families","CYP1 family","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{Metabolism,Disease,"Immune System","Metabolism of lipids","Biological oxidations","Infectious disease","Innate Immune System","Biosynthesis of specialized proresolving mediators (SPMs)","Phase I - Fu
nctionalization of compounds","Phospholipid metabolism","Leishmania infection","Toll-like Receptor Cascades","Uptake and actions of bacterial toxins","Biosynthesis of DHA-derived SPMs","Cytochrome P45
0 - arranged by substrate type","Amine Oxidase reactions","Glycerophospholipid biosynthesis","Leishmania parasite growth and survival","Toll Like Receptor 5 (TLR5) Cascade","Uptake and function of ant
hrax toxins","Biosynthesis of maresins",Xenobiotics,"Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB","Synthesis of PC","Anti-inflammatory response favouring Leishmania parasi
te infection","MyD88 cascade initiated on plasma membrane","Biosynthesis of maresin-like SPMs","CYP2E1 reactions","ADORA2B mediated anti-inflammatory cytokines production","MAP kinase activation","Aro
matic amines can be N-hydroxylated or N-dealkylated by CYP1A2","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{CYP1A1,CYP1A2,CYP2A13,CYP2A6,CYP3A4}

> <broad_moa>
{"DNA synthesis inhibitor"}

> <synonyms>
{8MO,methoxsalen,8-Methoxypsoralen,8Methoxypsoralen,298-81-7,298817,XANTHOTOXIN,Ammoidin,Meladinine,Xanthotoxine,8-MOP,8MOP,Meloxine,Oxsoralen,"9-Methoxy-7H-furo(3,2-g)chromen-7-one","9Methoxy7Hfuro(3
,2g)chromen7one",Meladinin,Oxypsoralen,Puvalen,Meladoxen,Ammodin,Uvadex,Methoxa-Dome,MethoxaDome,8-Methoxypsoralene,8Methoxypsoralene,Ox,T1548,45923,NSC45923,SAM002548974,1500400,"NSC 45923
NSC 45923",Methoxsalen,CPD000071170,METHOXSALEN}

> <pdid>
PD001860

> <targets>
{Cytochrome P450}

> <classes>
{DNA photoadsorption,pigmentation agent,antipsoriatic,Metabolic Enzyme/Protease}

> <pubchem_cids>
{4114}

$$$$
NIHCC_2014
  SciTegic11012413002D

 12 10  0  0  0  0            999 V2000
   10.2999    1.1254    0.0000 Cl  0  5
    3.9000    2.2500    0.0000 C   0  0
    3.9000    0.7500    0.0000 C   0  0
    2.6000    0.0000    0.0000 C   0  0
    1.3000    0.7500    0.0000 N   0  3
    0.0007    0.0004    0.0000 C   0  0
    0.0011    1.5002    0.0000 C   0  0
    1.3000    2.2500    0.0000 C   0  0
    5.2000    0.0000    0.0000 O   0  0
    6.5000    0.7500    0.0000 C   0  0
    6.5000    2.2500    0.0000 N   0  0
    7.7992    0.0004    0.0000 O   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  5  7  1  0
  5  8  1  0
  3  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  2  0
M  CHG  2   1  -1   5   1
M  END
> <name>
NIHCC_2014

> <id>
6287

> <plate>
NGP-202-03

> <well>
F08

> <supplier_cmpd_name>
CPD000058680

> <ctcr_id>
5050

> <supplier_cmpd_id>
SAM002548931

> <smiles>
[Cl-].CC(C[N+](C)(C)C)OC(N)=O

> <pd_targets>
{CHRM2,LMNA,MAPT,CHRM1,CHRM3,CHRM4,CHRM5,GPM2,GPM3,TSHR}

> <pathway_gtopdb>
{"Membrane receptor","Other nuclear protein","Other cytosolic protein","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Peptide receptor (family A GPCR)","Monoamine rec
eptor","Glycohormone receptor","Acetylcholine receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Acetylcholine receptors (muscarinic)","Glycoprotein hormone receptors"}

> <pathway_reactome>
{"Signal Transduction","Cell Cycle","Neuronal System",Disease,"Signaling by GPCR",Mitotic,"Transmission across Chemical Synapses","Infectious disease","GPCR ligand binding","M Phase","Neurotransmitter
 receptors and postsynaptic signal transmission","Leishmania infection","Class A/1 (Rhodopsin-like receptors)","Mitotic Metaphase and Anaphase","Activation of NMDA receptors and postsynaptic events","
Leishmania parasite growth and survival","Amine ligand-binding receptors","Mitotic Anaphase","Post NMDA receptor activation events","Anti-inflammatory response favouring Leishmania parasite infection"
,"Muscarinic acetylcholine receptors","Nuclear Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs","ADORA2B mediated anti-inflammatory cytokines production","Initiation of Nuclear Enve
lope (NE) Reformation"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3,CHRM4}

> <broad_moa>
{"acetylcholine receptor agonist"}

> <synonyms>
{"Bethanechol chloride",590-63-6,590636,Urecholine,Myocholine,"Carbamyl-beta-methylcholine chloride","Carbamylbetamethylcholine chloride",Besacholine,Mechotane,Mechothane,Mecothane,Mictone,Mictrol,Duv
oid,"Bethanechol (chloride)",Uro-Carb,UroCarb,"Urecholine chloride","Carbamylmethylcholine chlori",T3126,S2455,SAM002548931,1500146,Prestw-1073,CPD000058680,"BETHANECHOL CHLORIDE"}

> <pdid>
PD009590

> <targets>
{AChR,mAChR}

> <classes>
{cholinergic,Neuronal Signaling,GPCR/G Protein}

> <pubchem_cids>
{11548}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 26  0  0  0  0            999 V2000
    4.7271    3.0702    0.0000 Na  0  3
    0.1194   -2.3933    0.0000 C   0  0
    0.7500   -1.0323    0.0000 C   0  0
    2.2393   -0.8534    0.0000 C   0  0
    1.2135    0.3943    0.0000 S   0  0
    0.0000    1.2760    0.0000 C   0  0
   -0.8796    2.4866    0.0000 C   0  0
   -0.6484    3.9634    0.0000 N   0  0
   -1.8159    4.9065    0.0000 C   0  0
   -3.2155    4.3669    0.0000 O   0  0
   -1.5838    6.3893    0.0000 C   0  0
   -0.1842    6.9289    0.0000 N   0  0
   -2.7513    7.3324    0.0000 C   0  0
   -2.5215    8.8147    0.0000 C   0  0
   -3.6902    9.7549    0.0000 C   0  0
   -5.0888    9.2129    0.0000 C   0  0
   -5.3187    7.7306    0.0000 C   0  0
   -4.1500    6.7904    0.0000 C   0  0
   -2.0931    1.6049    0.0000 C   0  0
   -3.5746    1.8395    0.0000 O   0  0
   -1.2135    0.3943    0.0000 N   0  0
   -0.7500   -1.0323    0.0000 C   0  0
   -1.6332   -2.2426    0.0000 C   0  0
   -1.0255   -3.6140    0.0000 O   0  5
   -3.1247   -2.0836    0.0000 O   0  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 11 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
  7 19  1  0
 19 20  2  0
 19 21  1  0
 21  6  1  0
 21 22  1  0
 22  3  1  0
 22 23  1  0
 23 24  1  0
 23 25  2  0
M  CHG  2   1   1  24  -1
M  END
> <name>
NIHCC_2014

> <id>
6288

> <plate>
NGP-202-03

> <well>
F09

> <supplier_cmpd_name>
CPD001317850

> <ctcr_id>
7061

> <supplier_cmpd_id>
SAM002264590

> <smiles>
[Na+].CC1(C)SC2C(NC(=O)C(N)c3ccccc3)C(=O)N2C1C([O-])=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"D-(-)-alpha-Aminobenzylpenicillin sodium salt","D()alphaAminobenzylpenicillin sodium salt",MLS002548899,CHEMBL1320119,HMS3259L17,SBB057410,AKOS025116944,NC00668,NCGC00094588-01,NCGC0009458801,NCGC00
094588-02,NCGC0009458802,SMR001317850,DB-055291,DB055291,FT-0602846,FT0602846,DTXSID60988759,SAM002264590,CPD001317850}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{23689391,121595912}

$$$$
NIHCC_2014
  SciTegic11012413002D

  7  7  0  0  1  0            999 V2000
    1.6317   -2.2458    0.0000 N   0  0
    0.7500   -1.0323    0.0000 C   0  0  2  0  0  0
    1.2135    0.3943    0.0000 C   0  0
    0.0000    1.2760    0.0000 O   0  0
   -1.2135    0.3943    0.0000 N   0  0
   -0.7500   -1.0323    0.0000 C   0  0
   -1.6317   -2.2458    0.0000 O   0  0
  2  1  1  1
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  2  1  0
  6  7  2  0
M  END
> <name>
NIHCC_2014

> <id>
6289

> <plate>
NGP-202-03

> <well>
F10

> <supplier_cmpd_name>
CPD000058313

> <ctcr_id>
1288

> <supplier_cmpd_id>
SAM002264599

> <smiles>
N[C@@H]1CONC1=O

> <pd_targets>
{BLM,NFO,SMN1,GRIN2C,CYP3A4,LMNA,HIF1A,GRIN1,GRIN2A,GRIN2B,GRIN2D,GRIN3A,GRIN3B,KMT2A,MEN1,MAPK1,TSHR,HSD17B10,ALR,DDL,DDLA}

> <pathway_gtopdb>
{Enzyme,Hydrolase,"Epigenetic regulator","Ion channel","Other nuclear protein","Transcription factor","Membrane receptor",Reader,"Ligand-gated ion channel","Cytochrome P450",Kinase,"Family A G protein
-coupled receptor",Oxidoreductase,Isomerase,Ligase,"Methyl-lysine/arginine binding protein","Ionotropic glutamate receptor","Cytochrome P450 family 3",Bromodomain,"Protein Kinase","Peptide receptor (f
amily A GPCR)","Tudor domain","NMDA receptor","Cytochrome P450 family 3A","CMGC protein kinase group","Glycohormone receptor","Cytochrome P450 3A4","CMGC protein kinase MAPK family","CMGC protein kina
se ERK1"}

> <pathway_chembl>
{"Ion channels",Enzymes,Receptors,"Ligand-gated ion channels","Cytochrome P450","Kinases (EC 2.7.x.x)","G protein-coupled receptors","Ionotropic glutamate receptors","CYP3 family","CMGC: Containing CD
K",MAPK,GSK3,"CLK families","Glycoprotein hormone receptors","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"DNA Repair","DNA Double-Strand Break Repair","Homology Directed Repair","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","HDR through Homologous Recombination (HRR)","Ho
mologous DNA Pairing and Strand Exchange","Presynaptic phase of homologous DNA pairing and strand exchange","Metabolism of RNA","Neuronal System",Metabolism,"Cell Cycle","Cellular responses to externa
l stimuli","Immune System",Disease,"Metabolism of non-coding RNA","Transmission across Chemical Synapses","Metabolism of lipids",Mitotic,"Cellular responses to stress","Innate Immune System","Infectio
us disease","Metabolism of amino acids and derivatives","snRNP Assembly","Neurotransmitter receptors and postsynaptic signal transmission","Biosynthesis of specialized proresolving mediators (SPMs)","
M Phase","Cellular response to hypoxia","Toll-like Receptor Cascades","Leishmania infection","Branched-chain amino acid catabolism","Activation of NMDA receptors and postsynaptic events","Biosynthesis
 of DHA-derived SPMs","Mitotic Metaphase and Anaphase","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Toll Like Receptor 5 (TLR5) Cascade","Leishmania parasite growth and 
survival","Post NMDA receptor activation events","Biosynthesis of maresins","Mitotic Anaphase","MyD88 cascade initiated on plasma membrane","Anti-inflammatory response favouring Leishmania parasite in
fection","Long-term potentiation","Biosynthesis of maresin-like SPMs","Nuclear Envelope (NE) Reassembly","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","MAP kinase 
activation","ADORA2B mediated anti-inflammatory cytokines production","Initiation of Nuclear Envelope (NE) Reformation","Ras activation upon Ca2+ influx through NMDA receptor","MAPK targets/ Nuclear e
vents mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{GRIN1}

> <broad_moa>
{"bacterial cell wall synthesis inhibitor"}

> <synonyms>
{CYCLOSERIN,D-cycloserine,Dcycloserine,cycloserine,68-41-7,68417,Seromycin,orientomycin,Oxamycin,Cyclo-D-serine,CycloDserine,Cyclorin,D-4-amino-3-isoxazolidinone,D4amino3isoxazolidinone,Cicloserina,Fa
rmiserina,Miroseryn,Tisomycin,Wasserina,Closina,D-4-amino-3-isoxazolidone,D4amino3isoxazolidone,alpha-Cycloserine,alphaCycloserine,(+)-4-Amino-3-iso,(+)4Amino3iso,T0710,T1589,SAM002264599,SAM001247014
,1500215,Prestw-1089,L-Cycloserine,D-Cycloserine,CPD000058313,CYCLOSERINE,(S)-(-)-Cycloserine}

> <pdid>
PD000159

> <targets>
{}

> <classes>
{"antibacterial (tuberculostatic)"}

> <pubchem_cids>
{6234,51670069}

$$$$
NIHCC_2014
  SciTegic11012413002D

 16 17  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 N   0  0
    0.0000    3.0008    0.0000 C   0  0  2  0  0  0
    1.2121    3.8625    0.0000 O   0  0
    0.7463    5.2884    0.0000 C   0  0  2  0  0  0
    1.6276    6.5001    0.0000 C   0  0
    3.1194    6.3435    0.0000 O   0  0
   -0.7537    5.2860    0.0000 C   0  0
   -1.2149    3.8587    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  0
  7  8  1  1
  8  9  1  0
  7 10  1  0
 10 11  2  3
 11  5  1  0
  4 12  1  0
 12 13  2  0
 12 14  1  0
 14 15  1  0
 15  2  1  0
 15 16  2  0
M  END
> <name>
NIHCC_2014

> <id>
6290

> <plate>
NGP-202-03

> <well>
F11

> <supplier_cmpd_name>
CPD000673569

> <ctcr_id>
6699

> <supplier_cmpd_id>
SAM002589948

> <smiles>
CC1=CN([C@@H]2O[C@H](CO)C=C2)C(=O)NC1=O

> <pd_targets>
{BLM,POLB,CHRM1,ALB,"REVERSE TRANSCRIPTASE",POL,LMNA,ALDH1A1}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Secreted protein","Other nuclear protein","Family A G protein-coupled receptor",Hydrolase,Oxidoreductase,"Small molecule receptor (family A GPCR)","Monoamine receptor","Ac
etylcholine receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Acetylcholine receptors (muscarinic)"}

> <pathway_reactome>
{"DNA Repair","Signal Transduction",Metabolism,"Cell Cycle","DNA Double-Strand Break Repair","Base Excision Repair","Signaling by GPCR","Metabolism of lipids",Mitotic,"Biological oxidations","Homology
 Directed Repair","Resolution of Abasic Sites (AP sites)","GPCR ligand binding","Metabolism of steroids","M Phase","Phase I - Functionalization of compounds","HDR through Homologous Recombination (HRR
) or Single Strand Annealing (SSA)","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Class A/1 (Rhodopsin-like receptors)","Bile acid and bile salt metabolism","Mitotic 
Metaphase and Anaphase","Ethanol oxidation","HDR through Homologous Recombination (HRR)","PCNA-Dependent Long Patch Base Excision Repair","Amine ligand-binding receptors","Recycling of bile acids and 
salts","Mitotic Anaphase","Homologous DNA Pairing and Strand Exchange","Muscarinic acetylcholine receptors","Nuclear Envelope (NE) Reassembly","Presynaptic phase of homologous DNA pairing and strand e
xchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{}

> <broad_moa>
{"DNA directed DNA polymerase inhibitor","nucleoside reverse transcriptase inhibitor"}

> <synonyms>
{3056-17-5,3056175,sanilvudine,Zerit,"2',3'-Didehydro-3'-deoxythymidine","2',3'Didehydro3'deoxythymidine","Zerit Xr",BMY-27857,BMY27857,Estavudina,Stavudinum,"Stavudinum (INN-Latin)","Stavudinum (INNL
atin)","2',3'-Anhydrothymidine","2',3'Anhydrothymidine","Estavudina (INN-Spanish)","Estavudina (INNSpanish)",d4T,"Thymidine, 2',3'-didehydro-3'-deoxy-","Thymidine, 2',3'didehydro3'deoxy",3'-Deoxy,3'De
oxy,SAM002589948,SAM001246729,Prestw-1279,CPD000673569,CPD000058350,Stavudine}

> <pdid>
PD001676

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{18283}

$$$$
NIHCC_2014
  SciTegic11012413002D

 10 11  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 S   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.4133   -1.7530    0.0000 N   0  0
   -1.8032   -3.1233    0.0000 C   0  0
   -0.3114   -2.9665    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  2  0
  2  3  1  0
  3  4  1  0
  4  5  2  3
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10  2  1  0
 10  6  2  0
M  END
> <name>
NIHCC_2014

> <id>
6291

> <plate>
NGP-202-03

> <well>
G02

> <supplier_cmpd_name>
CPD000544948

> <ctcr_id>
3739

> <supplier_cmpd_id>
SAM002589937

> <smiles>
S=C1NC=Nc2nc[nH]c12

> <pd_targets>
{ALDH1A1,FFP,ALD,PNP}

> <pathway_gtopdb>
{Enzyme,Oxidoreductase,Transferase}

> <pathway_chembl>
{Enzymes,"2.4.2.1 Purine-nucleoside phosphorylase"}

> <pathway_reactome>
{Metabolism,"Biological oxidations","Metabolism of nucleotides","Phase I - Functionalization of compounds","Nucleobase catabolism","Ethanol oxidation","Purine catabolism"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{RESTW146,6-Mercaptopurine,6Mercaptopurine,mercaptopurine,50-44-2,50442,Purinethol,Mercapurin,6-Thiopurine,6Thiopurine,Leukerin,Leupurin,Mercaleukin,7H-purine-6-thiol,7Hpurine6thiol,6-Thioxopurine,6Th
ioxopurine,Puri-Nethol,PuriNethol,Ismipur,Mern,6-Thiohypoxanthine,6Thiohypoxanthine,6-Mercaptopurin,6Mercaptopurin,6-Purinethiol,6Purinethiol,Purimethol,Purinethiol,6-MP,6MP,1,755,NSC755,SAM002589937,
1500387,Prestw-1469,"NSC 755
NSC 755",Mercaptopurine,CPD000544948,MERCAPTOPURINE}

> <pdid>
PD001959

> <targets>
{}

> <classes>
{antineoplastic,Anti-metabolite,"purine antimetabolite"}

> <pubchem_cids>
{667490}

$$$$
NIHCC_2014
  SciTegic11012413002D

 35 39  0  0  1  0            999 V2000
    5.7014   -3.0617    0.0000 C   0  0
    5.2600   -4.4953    0.0000 C   0  0
    6.2812   -5.5941    0.0000 O   0  0
    3.7969   -4.8296    0.0000 O   0  0
    2.7751   -3.7302    0.0000 C   0  0
    1.3120   -4.0645    0.0000 C   0  0
    0.8706   -5.4981    0.0000 O   0  0
    0.2851   -2.9666    0.0000 C   0  0  1  0  0  0
   -0.3666   -4.3062    0.0000 O   0  0
    0.7315   -5.3280    0.0000 C   0  0
   -0.6573   -5.8949    0.0000 C   0  0
    1.9437   -6.2115    0.0000 C   0  0
    2.0426   -4.5993    0.0000 O   0  0
    1.7758   -3.1329    0.0000 C   0  0  2  0  0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0  2  0  0  0
    3.8971    3.7500    0.0000 F   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -1.2991    2.2500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
    0.0000    0.0000    0.0000 F   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -1.2212   -2.3711    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  8  6  1  6
  8  9  1  0
  9 10  1  0
 10 11  1  0
 10 12  1  0
 10 13  1  0
 14 13  1  1
 14  8  1  0
 14 15  1  0
 16 15  1  6
 16 17  1  0
 17 18  1  1
 18 19  1  0
 19 20  1  1
 19 21  1  0
 21 22  2  3
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  2  3
 26 27  1  0
 27 21  1  0
 27 28  1  6
 27 29  1  0
 29 17  1  0
 29 30  1  1
 29 31  1  0
 31 32  1  6
 31 33  1  0
 33 34  1  0
 34  8  1  0
 34 16  1  0
 34 35  1  6
M  END
> <name>
NIHCC_2014

> <id>
6292

> <plate>
NGP-202-03

> <well>
G03

> <supplier_cmpd_name>
CPD000058331

> <ctcr_id>
268

> <supplier_cmpd_id>
SAM002589945

> <smiles>
CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]23C

> <pd_targets>
{HIF1A,NR3C1,PGR,SMO}

> <pathway_gtopdb>
{"Transcription factor","Membrane receptor","Nuclear receptor","Frizzled family G protein-coupled receptor","Nuclear hormone receptor subfamily 3","Smoothened receptor (frizzled family GPCR)","Nuclear
 hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 3 group C member 1","Nuclear hormone receptor subfamily 3 group C member 3"}

> <pathway_chembl>
{Receptors,"Nuclear hormone receptors","G protein-coupled receptors","Steroid hormone receptors","Class Frizzled GPCRs","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"Cellular responses to external stimuli","Gene expression (Transcription)","Organelle biogenesis and maintenance","Cellular responses to stress","RNA Polymerase II Transcription","Cilium Assembly","C
ellular response to hypoxia","Generic Transcription Pathway","Cargo trafficking to the periciliary membrane","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","FOXO-mediated t
ranscription","BBSome-mediated cargo-targeting to cilium","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes"}

> <broad_targets>
{NR3C1,SERPINA6,SMO}

> <broad_moa>
{"glucocorticoid receptor agonist"}

> <synonyms>
{RESTW77,fluocinonide,356-12-7,356127,Fluocinolide,Lidex,Vanos,"Fluocinolide acetate","Fluocinolone acetonide acetate",Fluonex,LIDEX-E,LIDEXE,Lonide,Lyderm,"Fluocinonidum (INN-Latin)","Fluocinonidum (
INNLatin)","Fluocinonide Emulsified Base","Fluocinonido (INN-Spanish)","Fluocinonido (INNSpanish)","Fluocinolone acetonide",T6502,SAM002589945,Prestw-774,Fluocinonide,CPD000058331}

> <pdid>
PD003197

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{9642}

$$$$
NIHCC_2014
  SciTegic11012413002D

 13 12  0  0  0  0            999 V2000
    6.3982   -1.1283    0.0000 Cl  0  0
    3.8926   -3.7566    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
  9 11  1  0
 11 12  1  0
 11 13  2  0
 13  6  1  0
M  END
> <name>
NIHCC_2014

> <id>
6293

> <plate>
NGP-202-03

> <well>
G04

> <supplier_cmpd_name>
CPD000058383

> <ctcr_id>
7046

> <supplier_cmpd_id>
SAM002699901

> <smiles>
Cl.NCC(O)c1ccc(O)c(O)c1

> <pd_targets>
{ADRA1D,ADRA2A,ADRA2B,ADRB1,ADRB2,ADRB3,NFKB1,RECQL,ADRA1B,ADRA1A,ADRA2C,MAPT,ALD,TDP1,TGR,L3MBTL1,HPGD,LMNA,FFP,KMT2A,MEN1,BLM,APEX1,HSD17B10,PMP22,THPO,HIF1A,MAPK1,CHRM1,TSHR,KDM4E,DRD2,PAH,SLC18A2,
SLC18A1,DRD5,POLB}

> <pathway_gtopdb>
{"Membrane receptor","Other cytosolic protein",Enzyme,"Epigenetic regulator","Other nuclear protein","Unclassified protein","Transcription factor",Transporter,"Family A G protein-coupled receptor",Hyd
rolase,Reader,Transferase,Oxidoreductase,Kinase,Eraser,"Electrochemical transporter","Small molecule receptor (family A GPCR)","Methyl-lysine/arginine binding protein",Bromodomain,"Protein Kinase","Pe
ptide receptor (family A GPCR)","Lysine demethylase","SLC superfamily of solute carriers","Monoamine receptor","MBT domain","CMGC protein kinase group","Glycohormone receptor","Jumonji domain-containi
ng","SLC18 family of vesicular amine transporters","Adrenergic receptor","CMGC protein kinase MAPK family","Acetylcholine receptor","Dopamine receptor","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"G protein-coupled receptors","Eicosanoid turnover","Kinases (EC 2.7.x.x)","Chromatin modifying enzymes","Amino acid hydroxylases","SLC superfamily of solute carriers",
Adrenoceptors,"Prostaglandin synthases","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Acetylcholine receptors (muscarinic)","Glycoprotein hormone receptors","1.14.11.- Histone demethylases","Dopami
ne receptors","SLC18 family of vesicular amine transporters","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Signal Transduction",Disease,"Immune System","Neuronal System","DNA Repair","Gene expression (Transcription)",Metabolism,"Cell Cycle","Developmental Biology",Hemostasis,"Cellular responses to extern
al stimuli","Transport of small molecules","Signaling by GPCR","Infectious disease","Cytokine Signaling in Immune system","Transmission across Chemical Synapses","DNA Double-Strand Break Repair","RNA 
Polymerase II Transcription","Metabolism of lipids",Mitotic,"Base Excision Repair","Metabolism of amino acids and derivatives","Nervous system development","Platelet activation","signaling and aggrega
tion","Cellular responses to stress","Innate Immune System","SLC-mediated transmembrane transport","GPCR ligand binding","Leishmania infection","Signaling by Interleukins","Neurotransmitter receptors 
and postsynaptic signal transmission","Nonhomologous End-Joining (NHEJ)","Generic Transcription Pathway","Biosynthesis of specialized proresolving mediators (SPMs)","M Phase","Homology Directed Repair
","Resolution of Abasic Sites (AP sites)","Branched-chain amino acid catabolism","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Platelet Aggregation (Plug Formation)","Cellular resp
onse to hypoxia","Toll-like Receptor Cascades","Phenylalanine and tyrosine metabolism","Neurotransmitter release cycle","Transport of bile salts and organic acids","metal ions and amine compounds","Cl
ass A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","Interleukin-1 family signaling","Activation of NMDA receptors and postsynaptic events","Transcriptional Regulation by TP5
3","Biosynthesis of DHA-derived SPMs","Mitotic Metaphase and Anaphase","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Resolution of AP sites via the multiple-nucleotide
 patch replacement pathway","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Toll Like Receptor 5 (TLR5) Cascade","Phenylalanine metabolism","Dopamine Neurotransmitter Relea
se Cycle","Na+/Cl- dependent neurotransmitter transporters","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Interleukin-1 signaling","Post NMDA r
eceptor activation events","Regulation of TP53 Activity","Biosynthesis of D-series resolvins","Mitotic Anaphase","HDR through Homologous Recombination (HRR)","PCNA-Dependent Long Patch Base Excision R
epair","MyD88 cascade initiated on plasma membrane",Adrenoceptors,"ADORA2B mediated anti-inflammatory cytokines production","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Activation of AMPK downstream 
of NMDARs","Regulation of TP53 Activity through Methylation","Nuclear Envelope (NE) Reassembly","Homologous DNA Pairing and Strand Exchange","MAP kinase activation","Muscarinic acetylcholine receptors
","Dopamine receptors","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pairing and strand exchange","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/M
APK targets","ERKs are inactivated"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D,ADRA2A,ADRA2B,ADRA2C,ADRB1,ADRB2,ADRB3,PAH,SLC18A1,SLC18A2}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{55-27-6,55276,"dl-Arterenol hydrochloride","dlArterenol hydrochloride","dl-Norepinephrine hydrochloride","dlNorepinephrine hydrochloride","dl-Noradrenaline hydrochloride","dlNoradrenaline hydrochlori
de","Arterenol hydrochloride","DL-Norepinephrine (hydrochloride)","DLNorepinephrine (hydrochloride)","(+/-)-NOREPINEPHRINE HYDROCHLORIDE","(+/)NOREPINEPHRINE HYDROCHLORIDE","Norepinephrine hydrochlori
de",4-(2-am,4(2am,SAM002699901,CPD000058383}

> <pdid>
PD010223

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{74764076,5923,9488}

$$$$
NIHCC_2014
  SciTegic11012413002D

 14 15  0  0  0  0            999 V2000
    1.2443   -5.8182    0.0000 N   0  0
   -0.2234   -5.5086    0.0000 S   0  0
   -1.2250   -6.6252    0.0000 O   0  0
    0.2425   -6.9344    0.0000 O   0  0
   -0.6890   -4.0818    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
    1.8032   -3.1233    0.0000 N   0  0
    2.4133   -1.7530    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  6  1  0
 14  9  1  0
M  END
> <name>
NIHCC_2014

> <id>
6294

> <plate>
NGP-202-03

> <well>
G05

> <supplier_cmpd_name>
CPD000596519

> <ctcr_id>
4313

> <supplier_cmpd_id>
SAM002548957

> <smiles>
N[S](=O)(=O)Cc1noc2ccccc12

> <pd_targets>
{NFO,BLM,CA2,CA9,CA12,CA1,CA15,CA4,CA7,CA13,CA14,CYNT,CA5B,MAO,CA6,MTCA1,CA5A,CA3,NCE103,MAOB,LMNA,1272966,MTCA2,SCN10A,SCN11A,SCN1A,SCN2A,SCN3A,SCN4A,SCN5A,SCN7A,SCN8A,SCN9A,SCN1B,SCN2B,SCN3B,SCN4B,C
ACNA1G,CACNA1H,CACNA1I,CA8,CA10,CA11,MAOA}

> <pathway_gtopdb>
{Enzyme,"Other nuclear protein","Ion channel","Unclassified protein",Hydrolase,Lyase,Oxidoreductase,"Voltage-gated ion channel","Voltage-gated sodium channel","Voltage-gated calcium channel"}

> <pathway_chembl>
{Enzymes,"Ion channels","Carbonic anhydrases","Catecholamine turnover","Voltage-gated ion channels","Voltage-gated sodium channels","Voltage-gated calcium channels"}

> <pathway_reactome>
{"DNA Repair","Transport of small molecules","Cellular responses to external stimuli",Metabolism,"Immune System","Cell Cycle","Developmental Biology","DNA Double-Strand Break Repair","O2/CO2 exchange 
in erythrocytes","Cellular responses to stress","Reversible hydration of carbon dioxide","Cytokine Signaling in Immune system","Biological oxidations",Mitotic,"Nervous system development","Homology Di
rected Repair","Erythrocytes take up carbon dioxide and release oxygen","Cellular response to hypoxia","Signaling by Interleukins","Phase I - Functionalization of compounds","M Phase","Axon guidance",
"HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Regulation of gene expression by Hypoxia-inducible Factor","Interleukin-12 family signaling","Amine Oxidase reactions","M
itotic Metaphase and Anaphase","L1CAM interactions","NCAM signaling for neurite out-growth","HDR through Homologous Recombination (HRR)","Interleukin-12 signaling","Biogenic amines are oxidatively dea
minated to aldehydes by MAOA and MAOB","Mitotic Anaphase","Interaction between L1 and Ankyrins","NCAM1 interactions","Homologous DNA Pairing and Strand Exchange","Gene and protein expression by JAK-ST
AT signaling after Interleukin-12 stimulation","Nuclear Envelope (NE) Reassembly","Presynaptic phase of homologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{CA1,CA10,CA11,CA12,CA13,CA14,CA2,CA3,CA4,CA5A,CA5B,CA6,CA7,CA8,CA9,CACNA1G,CACNA1H,CACNA1I,MAOA,MAOB,SCN10A,SCN11A,SCN1A,SCN1B,SCN2A,SCN2B,SCN3A,SCN3B,SCN4A,SCN4B,SCN5A,SCN7A,SCN8A,SCN9A}

> <broad_moa>
{"sodium channel blocker","T-type calcium channel blocker"}

> <synonyms>
{zonisamide,68291-97-4,68291974,Zonegran,"1,2-Benzisoxazole-3-methanesulfonamide","1,2Benzisoxazole3methanesulfonamide","1,2-benzoxazol-3-ylmethanesulfonamide","1,2benzoxazol3ylmethanesulfonamide",Exc
eglan,Excegram,"Zonisamidum (Latin)","Zonisamida (Spanish)",AD-810,AD810,Zonisamida,Zonisamidum,CI-912,CI912,3-(Sulfamoylmethyl)-1,3(Sulfamoylmethyl)1,2-benzi,2benzi,T0267,SAM002548957,Prestw-1162,Zon
isamide,CPD000596519}

> <pdid>
PD002942

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5734,11967800}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 31  0  0  1  0            999 V2000
    2.2703   -4.0022    0.0000 C   0  0
    1.7758   -3.1329    0.0000 C   0  0  2  0  0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -0.8660    2.5000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  2  0  0  0
    0.0000    0.5000    0.0000 F   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  1  0  0  0
   -0.8141   -2.0807    0.0000 C   0  0
    0.2851   -2.9666    0.0000 C   0  0  2  0  0  0
   -0.6870   -2.7320    0.0000 O   0  0
    0.7500   -4.3800    0.0000 C   0  0
    2.2230   -4.6635    0.0000 O   0  0
   -0.2322   -5.5148    0.0000 C   0  0
    0.2584   -6.9323    0.0000 O   0  0
  2  1  1  1
  2  3  1  0
  4  3  1  6
  4  5  1  0
  5  6  1  1
  6  7  1  0
  7  8  1  0
  8  9  2  3
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  3
 13 14  1  0
 14  8  1  0
 14 15  1  6
 14 16  1  0
 16  5  1  0
 16 17  1  1
 16 18  1  0
 18 19  1  6
 18 20  1  0
 20 21  1  0
 21  4  1  0
 21 22  1  6
 21 23  1  0
 23  2  1  0
 23 24  1  1
 23 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
M  END
> <name>
NIHCC_2014

> <id>
6295

> <plate>
NGP-202-03

> <well>
G06

> <supplier_cmpd_name>
CPD001227192

> <ctcr_id>
7054

> <supplier_cmpd_id>
SAM002548948

> <smiles>
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{dexamethasone,50-02-2,50022,Decadron,Maxidex,Dexamethazone,Dexasone,Hexadrol,Oradexon,"Prednisolone F",Cortisumman,Decaspray,Desametasone,Hexadecadrol,Millicorten,Auxiron,Calonat,Dexacort,Dexason,Azi
um,Fluormethylprednisolone,Aeroseb-Dex,AerosebDex,Deltafluor,T1076,T1652,11015,S1322,SAM002548948,"Dexamethasone (DHAP)",Betamethasone,CPD001227192}

> <pdid>
PD002388

> <targets>
{"IL Receptor"}

> <classes>
{}

> <pubchem_cids>
{5743}

$$$$
NIHCC_2014
  SciTegic11012413002D

 20 20  0  0  0  0            999 V2000
    1.2951   -5.2547    0.0000 O   0  0
    1.2956   -3.7547    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    3.8933   -3.7570    0.0000 N   0  0
    3.8912   -5.2578    0.0000 C   0  0
    2.5909   -6.0056    0.0000 O   0  0
    5.1894   -6.0109    0.0000 C   0  0
    5.1873   -7.5109    0.0000 Cl  0  0
    6.4897   -5.2632    0.0000 Cl  0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 N   0  3
   -2.6030    2.9977    0.0000 O   0  5
   -3.8983    0.7459    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  0
  7  9  1  0
  3 10  1  0
 10 11  1  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 15 18  1  0
 18 19  1  0
 18 20  2  0
M  CHG  2  18   1  19  -1
M  END
> <name>
NIHCC_2014

> <id>
6296

> <plate>
NGP-202-03

> <well>
G07

> <supplier_cmpd_name>
CPD000058224

> <ctcr_id>
7055

> <supplier_cmpd_id>
SAM002548963

> <smiles>
OCC(NC(=O)C(Cl)Cl)C(O)c1ccc(cc1)[N+]([O-])=O

> <pd_targets>
{LMNA,ALDH1A1,LEF,SKA,RPLP,DRAA,CD55}

> <pathway_gtopdb>
{"Other nuclear protein",Enzyme,Oxidoreductase,Protease,Kinase,"Metallo protease","Metallo protease MAE clan","Metallo protease M34 family"}

> <pathway_chembl>
{}

> <pathway_reactome>
{"Cell Cycle",Metabolism,Disease,"Metabolism of proteins",Mitotic,"Biological oxidations","Infectious disease","Post-translational protein modification","M Phase","Phase I - Functionalization of compo
unds","Uptake and actions of bacterial toxins","Asparagine N-linked glycosylation","Mitotic Metaphase and Anaphase","Ethanol oxidation","Uptake and function of anthrax toxins","Transport to the Golgi 
and subsequent modification","Mitotic Anaphase","ER to Golgi Anterograde Transport","Nuclear Envelope (NE) Reassembly","COPI-mediated anterograde transport","Initiation of Nuclear Envelope (NE) Reform
ation"}

> <broad_targets>
{CD55}

> <broad_moa>
{"bacterial 50S ribosomal subunit inhibitor"}

> <synonyms>
{"2,2-dichloro-N-(1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl)acetamide","2,2dichloroN(1,3dihydroxy1(4nitrophenyl)propan2yl)acetamide","2,2 dichloro N (1,3 dihydroxy 1 (4 nitrophenyl)propan 2 yl)acetam
ide",579-51-1,579511,"579 51 1",Tyfomyci,SAM002548963,CPD000058224}

> <pdid>
PD002431

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{298}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 31  0  0  1  0            999 V2000
    7.0592   -0.7054    0.0000 C   0  0
    5.9990   -1.7665    0.0000 O   0  0
    6.3872   -3.2163    0.0000 N   0  0
    5.3265   -4.2780    0.0000 C   0  0
    3.8775   -3.8868    0.0000 C   0  0
    2.8152   -4.9458    0.0000 O   0  0
    3.4909   -2.4366    0.0000 N   0  0
    2.0479   -2.0470    0.0000 C   0  0  1  0  0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 S   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
    0.7488   -2.7970    0.0000 C   0  0
    0.3606   -4.2459    0.0000 O   0  0
   -2.6003   -1.4978    0.0000 C   0  0
   -2.6029   -2.9978    0.0000 O   0  0
   -3.8983   -0.7459    0.0000 O   0  0
   -2.5973    1.5031    0.0000 C   0  0
   -2.5951    3.0039    0.0000 O   0  0
   -3.8933    3.7570    0.0000 C   0  0
   -5.1937    3.0092    0.0000 N   0  0
   -3.8912    5.2570    0.0000 O   0  0
    5.7131   -5.7282    0.0000 C   0  0
    7.1061   -6.2493    0.0000 O   0  0
    7.0226   -7.7470    0.0000 C   0  0
    5.5724   -8.1304    0.0000 C   0  0
    4.7596   -6.8697    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  3
  4  5  1  0
  5  6  2  0
  5  7  1  0
  8  7  1  6
  8  9  1  0
  9 10  1  6
 10 11  1  0
 11 12  1  0
 12 13  2  3
 13 14  1  0
 14  9  1  0
 14 15  1  0
 15  8  1  0
 15 16  2  0
 13 17  1  0
 17 18  1  0
 17 19  2  0
 12 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  2  0
  4 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 25  2  0
M  END
> <name>
NIHCC_2014

> <id>
6297

> <plate>
NGP-202-03

> <well>
G08

> <supplier_cmpd_name>
CPD001496804

> <ctcr_id>
7059

> <supplier_cmpd_id>
SAM002589901

> <smiles>
CON=C(C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(O)=O)COC(N)=O)c3occc3

> <pd_targets>
{MAPT,TDP1,TGR,POLB,PKM,HSD17B10,CTDSP1,DACA,DACB,DACC,FTSI,MRCA,MRCB,MRDA,PBPA}

> <pathway_gtopdb>
{"Other cytosolic protein",Enzyme,Hydrolase,Oxidoreductase,Phosphatase,Protease,"Protein Phosphatase","Serine protease","Serine/threonine protein phosphatase","Serine protease SE clan","Serine proteas
e S11 family"}

> <pathway_chembl>
{Enzymes,"2.7.1.40 Pyruvate kinases"}

> <pathway_reactome>
{"Neuronal System","DNA Repair",Metabolism,"Transmission across Chemical Synapses","DNA Double-Strand Break Repair","Base Excision Repair","Metabolism of carbohydrates","Metabolism of amino acids and 
derivatives","Neurotransmitter receptors and postsynaptic signal transmission","Nonhomologous End-Joining (NHEJ)","Resolution of Abasic Sites (AP sites)","Glucose metabolism","Branched-chain amino aci
d catabolism","Activation of NMDA receptors and postsynaptic events","Resolution of AP sites via the multiple-nucleotide patch replacement pathway",Glycolysis,"Post NMDA receptor activation events","P
CNA-Dependent Long Patch Base Excision Repair","Activation of AMPK downstream of NMDARs"}

> <broad_targets>
{}

> <broad_moa>
{"bacterial cell wall synthesis inhibitor"}

> <synonyms>
{cefuroxime,DSSTox_CID_2774,DSSToxCID2774,DSSTox-CID-2774,"DSSTox CID 2774",55268-75-2,55268752,DSSTox_RID_76724,DSSToxRID76724,DSSTox-RID-76724,"DSSTox RID 76724",DSSTox_GSID_22774,DSSToxGSID22774,DS
STox-GSID-22774,"DSSTox GSID 22774",CAS-55268-75-2,CAS55268752,"Cefuroxime,(S)",NCGC00091560-01,NCGC0009156001,Prestwick0_000720,Prestwick0000720,Prestwick0-000720,"Prestwick0 000720",Prestwick1_00072
0,Prestwick1000720,Prestwick1-000720,"Prestwick1 000720",SPBio_002860,SPBio002860,SPBio-002860,"SPBio 002860",CHEMBL1620506,DTXSID5022774,HMS3259N15,Tox21_111149,Tox21111149,Tox21-111149,"Tox21 111149
",Tox21_113378,Tox21113378,Tox21-113378,"Tox21 113378",Tox21_200,Tox21200,Tox21-200,"Tox21 200",SAM002589901,CPD001496804}

> <pdid>
PD003055

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{41375}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 24  0  0  0  0            999 V2000
   10.1894    1.1269    0.0000 H   0  3
    7.6894    1.1269    0.0000 Cl  0  5
    5.1887   -6.0105    0.0000 C   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    1.2948   -3.7516    0.0000 O   0  0
    2.5973   -1.5031    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5973    1.5031    0.0000 O   0  0
   -2.5951    3.0039    0.0000 C   0  0
   -3.8933    3.7570    0.0000 C   0  0
   -5.1937    3.0092    0.0000 O   0  0
   -3.8912    5.2578    0.0000 C   0  0
   -5.1894    6.0109    0.0000 N   0  0
   -5.1873    7.5117    0.0000 C   0  0
   -6.4848    8.2644    0.0000 C   0  0
   -3.8869    8.2595    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5972   -1.5031    0.0000 C   0  0
   -3.8976   -0.7554    0.0000 C   0  0
   -2.5951   -3.0031    0.0000 O   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 19 21  1  0
 12 22  1  0
 22 23  2  0
 23  9  1  0
 22 24  1  0
 24 25  1  0
 24 26  2  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6298

> <plate>
NGP-202-03

> <well>
G09

> <supplier_cmpd_name>
CPD000058800

> <ctcr_id>
6599

> <supplier_cmpd_id>
SAM002264591

> <smiles>
[H+].[Cl-].CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(c1)C(C)=O

> <pd_targets>
{KDM4E,ADRB1,HTR1A,SLC22A1,ADRB2}

> <pathway_gtopdb>
{"Epigenetic regulator","Membrane receptor",Transporter,Eraser,"Family A G protein-coupled receptor","Electrochemical transporter","Lysine demethylase","Small molecule receptor (family A GPCR)","SLC s
uperfamily of solute carriers","Jumonji domain-containing","Monoamine receptor","SLC22 family of organic cation and anion transporters","Adrenergic receptor","Serotonin receptor"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Chromatin modifying enzymes","G protein-coupled receptors","SLC superfamily of solute carriers","1.14.11.- Histone demethylases",Adrenoceptors,"5-Hydroxytryptamine rec
eptors","SLC22 family of organic cation and anion transporters","Organic cation transporters (OCT)"}

> <pathway_reactome>
{Disease,"Signal Transduction","Transport of small molecules","Infectious disease","Signaling by GPCR","SLC-mediated transmembrane transport","Leishmania infection","GPCR ligand binding","Transport of
 bile salts and organic acids","metal ions and amine compounds","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Organic cation/anion/zwitterion transport","Anti-infla
mmatory response favouring Leishmania parasite infection","Amine ligand-binding receptors","Organic cation transport","ADORA2B mediated anti-inflammatory cytokines production","Serotonin receptors"}

> <broad_targets>
{ADRB1}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{NCGC00018215-06,NCGC0001821506,NCGC00094830-01,NCGC0009483001,"Acebutolol hydrochloride",34381-68-5,34381685,"Acebutolol HCL",Sectral,"Acebutolol (hydrochloride)",Prent,C18H29ClN2O4,MLS000069553,CHEB
I:2380,IL-17803A,IL17803A,"M&B 17803A",SMR000058800,DSSTox_CID_25461,DSSToxCID25461,DSSTox-CID-25461,"DSSTox CID 25461",DSSTox_R,DSSToxR,DSSTox-R,"DSSTox R",T1012,S4010,SAM002264591,1500665,Prestw-69,
"Acebutolol HCl",CPD000058800,"ACEBUTOLOL HYDROCHLORIDE"}

> <pdid>
PD009749

> <targets>
{"Adrenergic Receptor"}

> <classes>
{antianginal,"Neuronal Signaling",antiarrhythmic,antihypertensive}

> <pubchem_cids>
{441307,36816,657184}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 32  0  0  1  0            999 V2000
    5.1422   -5.3703    0.0000 C   0  0
    4.1252   -6.4729    0.0000 C   0  0
    4.5720   -7.9048    0.0000 O   0  0
    2.6611   -6.1428    0.0000 O   0  0
    2.2141   -4.7101    0.0000 C   0  0
    0.7500   -4.3800    0.0000 C   0  0
   -0.2670   -5.4825    0.0000 O   0  0
    0.2851   -2.9666    0.0000 C   0  0  1  0  0  0
   -0.6870   -2.7320    0.0000 O   0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -1.2991    2.2500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  2  0  0  0
   -0.8141   -2.0807    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  1
  8 10  1  0
 10 11  1  0
 12 11  1  6
 12 13  1  0
 13 14  1  1
 14 15  1  0
 15 16  1  0
 16 17  2  3
 17 18  1  0
 18 19  2  0
 18 20  1  0
 20 21  1  0
 21 22  1  0
 22 16  1  0
 22 23  1  6
 22 24  1  0
 24 13  1  0
 24 25  1  6
 25 26  2  0
 25 27  1  0
 27 28  1  0
 28  8  1  0
 28 12  1  0
 28 29  1  6
M  END
> <name>
NIHCC_2014

> <id>
6299

> <plate>
NGP-202-03

> <well>
G10

> <supplier_cmpd_name>
CPD000059124

> <ctcr_id>
7062

> <supplier_cmpd_id>
SAM002264600

> <smiles>
CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C

> <pd_targets>
{CHRM1,BLM,FNTA,FNTB,NR3C1}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Transcription factor","Family A G protein-coupled receptor",Transferase,"Nuclear receptor","Small molecule receptor (family A GPCR)","Nuclear hormone receptor subfamily 3"
,"Monoamine receptor","Nuclear hormone receptor subfamily 3 group C","Acetylcholine receptor","Nuclear hormone receptor subfamily 3 group C member 1"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Nuclear hormone receptors","Acetylcholine receptors (muscarinic)","Steroid hormone receptors","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"Signal Transduction","DNA Repair","Gene expression (Transcription)","Signaling by GPCR","DNA Double-Strand Break Repair","RNA Polymerase II Transcription","GPCR ligand binding","Homology Directed Re
pair","Generic Transcription Pathway","Class A/1 (Rhodopsin-like receptors)","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","FOXO-mediated transcription","Amine ligand-b
inding receptors","HDR through Homologous Recombination (HRR)","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","Muscarinic acetylcholine receptors","Homologous DNA Pai
ring and Strand Exchange","Presynaptic phase of homologous DNA pairing and strand exchange"}

> <broad_targets>
{NR3C1}

> <broad_moa>
{"glucocorticoid receptor agonist"}

> <synonyms>
{"CORTISONE ACETATE","Cortisone 21-acetate","Cortisone 21acetate",50-04-4,50044,"Cortone acetate",Incortin,"Biocort acetate",Artriona,Cortadren,Scheroson,Cortisyl,Adreson,"Irisone acetate",Cortelan,Co
rtistab,Ricortex,"Cortogen acetate","Compound E acetate",Pregn-4-ene-3,Pregn4ene3,11,S2559,SAM002264600,"Cortisone acetate",CPD000059124}

> <pdid>
PD002406

> <targets>
{Others}

> <classes>
{}

> <pubchem_cids>
{5745}

$$$$
NIHCC_2014
  SciTegic11012413002D

 33 37  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 N   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 N   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3032   -3.7490    0.0000 C   0  0
   -1.2991    5.2507    0.0000 N   0  0
   -0.0012    6.0029    0.0000 C   0  0
   -0.0036    7.5029    0.0000 C   0  0
   -1.3039    8.2509    0.0000 N   0  0
   -2.6017    7.4988    0.0000 C   0  0
   -2.5993    5.9988    0.0000 C   0  0
   -1.3093    9.7517    0.0000 C   0  0
   -0.0128   10.5060    0.0000 O   0  0
   -2.6114   10.4982    0.0000 C   0  0
   -2.6190   11.9982    0.0000 C   0  0
   -3.9218   12.7416    0.0000 O   0  0
   -5.2171   11.9850    0.0000 C   0  0
   -6.5199   12.7285    0.0000 C   0  0
   -7.8151   11.9719    0.0000 C   0  0
   -7.8075   10.4719    0.0000 C   0  0
   -6.5047    9.7285    0.0000 C   0  0
   -5.2095   10.4851    0.0000 C   0  0
   -3.9067    9.7416    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 11  5  1  0
 11 12  1  0
 12 13  2  0
 13  3  1  0
 13 14  1  0
 14 15  1  0
  7 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 16  1  0
 19 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 27  1  0
 32 33  1  0
 33 24  1  0
M  END
> <name>
NIHCC_2014

> <id>
6300

> <plate>
NGP-202-03

> <well>
G11

> <supplier_cmpd_name>
CPD000097306

> <ctcr_id>
7063

> <supplier_cmpd_id>
SAM002589981

> <smiles>
COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4COc5ccccc5O4

> <pd_targets>
{GLA,GAA,MAPT,KMT2A,MEN1,ALDH1A1,HPGD,LMNA,KDM4E,FTL,POLB,PMP22,RORC,FFP,BLM,GMNN,NS1,HLA-A,ADRA1D,ADRA1A,ADRA1B,KCNH2,ADRA2C,HTR4,ADRA2A,MMP1,ABCC4,ABCB11,ADRB2,HTR2B,SLC6A4,MTOR,HTR2C,SLC6A3,KCNH6,K
CNH7}

> <pathway_gtopdb>
{Enzyme,"Other cytosolic protein","Epigenetic regulator","Other nuclear protein","Unclassified protein","Transcription factor","Surface antigen","Membrane receptor","Ion channel",Transporter,Hydrolase
,Reader,Oxidoreductase,Eraser,"Nuclear receptor",Transferase,"Family A G protein-coupled receptor","Voltage-gated ion channel",Protease,"Primary active transporter","Electrochemical transporter",Kinas
e,Bromodomain,"Lysine demethylase","Nuclear hormone receptor subfamily 1","Small molecule receptor (family A GPCR)","Potassium channels","Metallo protease","ATP-binding cassette","SLC superfamily of s
olute carriers","Protein Kinase","Jumonji domain-containing","Nuclear hormone receptor subfamily 1 group F","Monoamine receptor","Voltage-gated potassium channel","Metallo protease MAM clan","ABCC sub
family","ABCB subfamily","SLC06 neurotransmitter transporter family","Atypical protein kinase group","Nuclear hormone receptor subfamily 1 group F member 3","Adrenergic receptor","Serotonin receptor",
"Metallo protease M10A subfamily","Atypical protein kinase PIKK family","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Enzymes,Receptors,"Ion channels",Transporters,"3.2.1.- Glycosidases","Eicosanoid turnover","Chromatin modifying enzymes","Nuclear hormone receptors","G protein-coupled receptors","Voltage-gated ion c
hannels","Peptidases and proteinases","ATP-binding cassette transporter family","SLC superfamily of solute carriers","Kinases (EC 2.7.x.x)","Prostaglandin synthases","1.14.11.- Histone demethylases","
1F. Retinoic acid-related orphans",Adrenoceptors,"Potassium channels","5-Hydroxytryptamine receptors","MA: Metallo (M) Peptidases","ABCC subfamily","ABCB subfamily","SLC6 neurotransmitter transporter 
family",Atypical,"2.1.1.43 Histone methyltransferases (HMTs)","Voltage-gated potassium channels","M10: Matrix metallopeptidase","Monoamine transporter subfamily","Phosphatidyl inositol 3' kinase-relat
ed kinases (PIKK) family","FRAP subfamily"}

> <pathway_reactome>
{Metabolism,Disease,"Neuronal System","Cell Cycle","Vesicle-mediated transport","DNA Repair","Developmental Biology","Gene expression (Transcription)","Immune System","Signal Transduction","Muscle con
traction",Hemostasis,"Metabolism of lipids","Diseases of metabolism","Transmission across Chemical Synapses","Biological oxidations",Mitotic,"Membrane Trafficking","Base Excision Repair","Nervous syst
em development","RNA Polymerase II Transcription","DNA Double-Strand Break Repair","Adaptive Immune System","Signaling by GPCR","Cardiac conduction","Infectious disease","Cytokine Signaling in Immune 
system","Platelet activation","signaling and aggregation","Disorders of transmembrane transporters","Sphingolipid metabolism","Diseases of carbohydrate metabolism","Neurotransmitter receptors and post
synaptic signal transmission","Phase I - Functionalization of compounds","Biosynthesis of specialized proresolving mediators (SPMs)","M Phase","trans-Golgi Network Vesicle Budding","Resolution of Abas
ic Sites (AP sites)","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Generic Transcription Pathway","Homology Directed Repair","Mitotic G1 phase and G1/S transition","Class I MHC med
iated antigen processing & presentation","GPCR ligand binding","Phase 3 - rapid repolarisation","Leishmania infection","Signaling by Interleukins","Response to elevated platelet cytosolic Ca2+","Metab
olism of steroids","Neurotransmitter clearance","SLC transporter disorders","Glycosphingolipid metabolism","Glycogen storage diseases","Activation of NMDA receptors and postsynaptic events","Ethanol o
xidation","Biosynthesis of DHA-derived SPMs","Mitotic Metaphase and Anaphase","Golgi Associated Vesicle Biogenesis","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Tran
scriptional regulation by RUNX3","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","G1/S Transition","Antigen processing-Cross presentation","Class A/1 (Rhodopsin-like rece
ptors)","Leishmania parasite growth and survival","Interleukin-4 and Interleukin-13 signaling","Platelet degranulation","Bile acid and bile salt metabolism","Serotonin clearance from the synaptic clef
t","Transcriptional Regulation by TP53","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Transcriptional regulation by RUNX1","Glycogen storage disease type II (GAA)","Post NMDA rece
ptor activation events","Biosynthesis of D-series resolvins","Mitotic Anaphase","PCNA-Dependent Long Patch Base Excision Repair","RUNX3 Regulates Immune Response and Cell Migration","HDR through Homol
ogous Recombination (HRR)","Activation of the pre-replicative complex","Endosomal/Vacuolar pathway","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection
","Synthesis of bile acids and bile salts","Regulation of TP53 Activity","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","Activation of AMPK downstream of NMDAR
s","Nuclear Envelope (NE) Reassembly","Homologous DNA Pairing and Strand Exchange",Adrenoceptors,"ADORA2B mediated anti-inflammatory cytokines production","Synthesis of bile acids and bile salts via 7
alpha-hydroxycholesterol","Serotonin receptors","Regulation of TP53 Expression and Degradation","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pairing and stran
d exchange","Regulation of TP53 Degradation"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{AKOS001681453,AKOS017343634,doxazosin,74191-85-8,74191858,Doxazosine,Doxazosina,Doxazosinum,"UK 33274",CHEBI:4708,UK-33274,UK33274,"Doxazosine (French)","Doxazosinum (Latin)","Doxazosina (Spanish)","
Doxazosin (INN:BAN)",R-Doxazosin,RDoxazosin,"Doxazosin (INN)",Cardura,SAM002589981,CPD000097306}

> <pdid>
PD003016

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{3157}

$$$$
NIHCC_2014
  SciTegic11012413002D

 19 21  0  0  0  0            999 V2000
    2.9076    1.7290    0.0000 C   0  0
    4.0317    0.7359    0.0000 N   0  0
    5.4979    1.0528    0.0000 C   0  0
    6.2524   -0.2436    0.0000 N   0  0
    5.2526   -1.3618    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 S   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.4133   -1.7530    0.0000 N   0  0
   -1.8032   -3.1233    0.0000 C   0  0
   -0.3114   -2.9665    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    5.5609   -2.8279    0.0000 N   0  3
    4.4437   -3.8288    0.0000 O   0  5
    6.9862   -3.2954    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  2  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16  8  2  0
 16 12  1  0
  5 17  1  0
 17 18  1  0
 17 19  2  0
M  CHG  2  17   1  18  -1
M  END
> <name>
NIHCC_2014

> <id>
6301

> <plate>
NGP-202-03

> <well>
H02

> <supplier_cmpd_name>
CPD000427366

> <ctcr_id>
539

> <supplier_cmpd_id>
SAM002589938

> <smiles>
Cn1cnc(c1Sc2[nH]cnc3ncnc23)[N+]([O-])=O

> <pd_targets>
{HBB,BLM,LMNA,CHRM1,TP53,MAPT,PMP22,FFP,CYP3A4,GMNN,TGR,PPAT,RAC1}

> <pathway_gtopdb>
{"Secreted protein",Enzyme,"Other nuclear protein","Membrane receptor","Transcription factor","Other cytosolic protein","Unclassified protein","Family A G protein-coupled receptor",Transferase,"Cytoch
rome P450",Hydrolase,"Small molecule receptor (family A GPCR)","Cytochrome P450 family 3","Monoamine receptor","Cytochrome P450 family 3A","Acetylcholine receptor","Cytochrome P450 3A4"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Cytochrome P450","Peptidases and proteinases","Acetylcholine receptors (muscarinic)","CYP3 family","PB: Threonine (T) Peptidases","C44: Phosphoribosyl
 pyrophosphate amidotransferase"}

> <pathway_reactome>
{"Immune System","DNA Repair","Cell Cycle","Signal Transduction","Neuronal System","Developmental Biology",Metabolism,"Innate Immune System","DNA Double-Strand Break Repair",Mitotic,"Signaling by GPCR
","Cell Cycle Checkpoints","Transmission across Chemical Synapses","Nervous system development","Metabolism of lipids","Metabolism of nucleotides","Neutrophil degranulation","Homology Directed Repair"
,"M Phase","GPCR ligand binding","G1/S DNA Damage Checkpoints","Neurotransmitter receptors and postsynaptic signal transmission","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Biosy
nthesis of specialized proresolving mediators (SPMs)","Mitotic G1 phase and G1/S transition","Nucleobase biosynthesis","Axon guidance","HDR through Homologous Recombination (HRR) or Single Strand Anne
aling (SSA)","Mitotic Metaphase and Anaphase","Class A/1 (Rhodopsin-like receptors)","p53-Dependent G1/S DNA damage checkpoint","Activation of NMDA receptors and postsynaptic events","Biosynthesis of 
DHA-derived SPMs","G1/S Transition","Purine ribonucleoside monophosphate biosynthesis","Semaphorin interactions","HDR through Homologous Recombination (HRR)","Mitotic Anaphase","Amine ligand-binding r
eceptors","p53-Dependent G1 DNA Damage Response","Post NMDA receptor activation events","Biosynthesis of maresins","Activation of the pre-replicative complex","Sema4D in semaphorin signaling","Homolog
ous DNA Pairing and Strand Exchange","Nuclear Envelope (NE) Reassembly","Muscarinic acetylcholine receptors","Stabilization of p53","Activation of AMPK downstream of NMDARs","Biosynthesis of maresin-l
ike SPMs","Sema4D mediated inhibition of cell attachment and migration","Presynaptic phase of homologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation","Autodegrada
tion of the E3 ubiquitin ligase COP1"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{azathioprine,446-86-6,446866,Imuran,Azothioprine,Azathioprin,Azatioprin,Azamun,Azanin,Imurel,Azathiopurine,Azasan,Ccucol,Imurek,Muran,Rorasul,"BW 57-322","BW 57322",NSC-39084,NSC39084,BW-57-322,BW573
22,NCI-C03474,NCIC03474,6-(1-Methyl-4-nitroimidazol-5-yl)thiopurine,6(1Methyl4nitroimidazol5yl)thiopurine,6-((1-methyl-4-nitro,6((1methyl4nitro,S1721,SAM002589938,1500133,Prestw-94,Azathioprine,CPD000
427366,AZATHIOPRINE}

> <pdid>
PD002465

> <targets>
{Others}

> <classes>
{antirheumatic,antineoplastic,Others,immunosuppressant}

> <pubchem_cids>
{2265}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 28  0  0  1  0            999 V2000
    8.9094   -0.7490    0.0000 Cl  0  5
    3.8976   -0.7465    0.0000 O   0  0
    2.5998   -1.4987    0.0000 C   0  0  2  0  0  0
    2.6028   -2.9995    0.0000 C   0  0  1  0  0  0
    1.3063   -3.7540    0.0000 C   0  0
    1.3113   -5.2539    0.0000 C   0  0
    2.6128   -5.9996    0.0000 C   0  0
    3.9094   -5.2452    0.0000 C   0  0
    3.9043   -3.7453    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8978   -0.7496    0.0000 C   0  0
   -5.1973   -1.4988    0.0000 F   0  0
   -3.8974    0.7504    0.0000 F   0  0
   -5.1965    0.0010    0.0000 F   0  0
    0.0000    3.0008    0.0000 C   0  0
    1.2985    3.7517    0.0000 F   0  0
   -1.2993    3.7504    0.0000 F   0  0
   -0.0007    4.5008    0.0000 F   0  0
    6.4094   -0.7490    0.0000 H   0  3
  3  2  1  6
  3  4  1  0
  4  5  1  6
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  4  1  0
  3 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 19 20  1  0
 20 21  1  0
 20 22  1  0
 20 23  1  0
 12 24  1  0
 24 25  1  0
 24 26  1  0
 24 27  1  0
M  CHG  2   1  -1  28   1
M  END
> <name>
NIHCC_2014

> <id>
6302

> <plate>
NGP-202-03

> <well>
H03

> <supplier_cmpd_name>
CPD000875233

> <ctcr_id>
7042

> <supplier_cmpd_id>
SAM002699894

> <smiles>
[Cl-].O[C@H]([C@H]1CCCCN1)c2cc(nc3c2cccc3C(F)(F)F)C(F)(F)F.[H+]

> <pd_targets>
{KCNH2,TSHR,PFMRK,REP,KDM4E,TP53,CYP2D6,LMNA,CYP1A2,ADORA1,ADORA2A,HTT,FFP,CYP3A4,GLRA1,CYP2C19,AMPC}

> <pathway_gtopdb>
{"Ion channel","Membrane receptor",Enzyme,"Epigenetic regulator","Transcription factor","Other nuclear protein","Unclassified protein","Voltage-gated ion channel","Family A G protein-coupled receptor"
,Kinase,Transferase,Eraser,"Cytochrome P450","Ligand-gated ion channel",Hydrolase,"Potassium channels","Peptide receptor (family A GPCR)","Protein Kinase","Lysine demethylase","Cytochrome P450 family 
2","Cytochrome P450 family 1","Small molecule receptor (family A GPCR)","Cytochrome P450 family 3","Glycine receptor","Voltage-gated potassium channel","Glycohormone receptor","CMGC protein kinase gro
up","Jumonji domain-containing","Cytochrome P450 family 2D","Cytochrome P450 family 1A","Nucleotide-like receptor (family A GPCR)","Cytochrome P450 family 3A","Cytochrome P450 family 2C","CMGC protein
 kinase CDK family","Cytochrome P450 2D6","Cytochrome P450 1A1","Adenosine receptor","Cytochrome P450 3A4","Cytochrome P450 2C19"}

> <pathway_chembl>
{"Ion channels",Receptors,"Other protein targets",Enzymes,"Voltage-gated ion channels","G protein-coupled receptors","Anti-infective targets","Chromatin modifying enzymes","Cytochrome P450","Ligand-ga
ted ion channels","Potassium channels","Glycoprotein hormone receptors","Viral protein targets","1.14.11.- Histone demethylases","CYP2 family: drug metabolising subset","CYP1 family","Adenosine recept
ors","CYP3 family","Glycine receptors","Voltage-gated potassium channels","Coronavirus (CoV) proteins"}

> <pathway_reactome>
{"Muscle contraction",Disease,"Cell Cycle",Metabolism,"Signal Transduction","Gene expression (Transcription)","Neuronal System","Cardiac conduction","Infectious disease","Cell Cycle Checkpoints","Biol
ogical oxidations",Mitotic,"Signaling by GPCR","RNA Polymerase II Transcription","Metabolism of lipids","Transmission across Chemical Synapses","Phase 3 - rapid repolarisation","Leishmania infection",
"SARS-CoV Infections","G1/S DNA Damage Checkpoints","Phase I - Functionalization of compounds","M Phase","GPCR ligand binding","Generic Transcription Pathway","Biosynthesis of specialized proresolving
 mediators (SPMs)","Neurotransmitter receptors and postsynaptic signal transmission","Leishmania parasite growth and survival","SARS-CoV-2 Infection","p53-Dependent G1/S DNA damage checkpoint","Cytoch
rome P450 - arranged by substrate type","Mitotic Metaphase and Anaphase","SARS-CoV-1 Infection","Class A/1 (Rhodopsin-like receptors)","Transcriptional Regulation by MECP2","Biosynthesis of DHA-derive
d SPMs","Anti-inflammatory response favouring Leishmania parasite infection","SARS-CoV-2 Genome Replication and Transcription","p53-Dependent G1 DNA Damage Response",Xenobiotics,"Mitotic Anaphase","SA
RS-CoV-1 Genome Replication and Transcription","Nucleotide-like (purinergic) receptors","Regulation of MECP2 expression and activity","Biosynthesis of maresins","ADORA2B mediated anti-inflammatory cyt
okines production","Replication of the SARS-CoV-2 genome","Stabilization of p53","CYP2E1 reactions","Nuclear Envelope (NE) Reassembly","Replication of the SARS-CoV-1 genome","Aromatic amines can be N-
hydroxylated or N-dealkylated by CYP1A2","Adenosine P1 receptors","Biosynthesis of maresin-like SPMs","Autodegradation of the E3 ubiquitin ligase COP1","Initiation of Nuclear Envelope (NE) Reformation
"}

> <broad_targets>
{}

> <broad_moa>
{"adenosine receptor antagonist","hemoglobin antagonist"}

> <synonyms>
{"Mefloquine hydrochloride","Mefloquine HCL",51773-92-3,51773923,Mephaquin,"Mefloquine (hydrochloride)",UNII-326VC85GV6,UNII326VC85GV6,326VC85GV6,"Ro 21-5998/001","Ro 215998/001",DSSTox_CID_27796,DSST
oxCID27796,DSSTox-CID-27796,"DSSTox CID 27796",DSSTox_RID_82568,DSSToxRID82568,DSSTox-RID-82568,"DSSTox RID 82568",DSSTox_GSID_47819,DSSToxGSID47819,DSSTox-GSID-47819,"DSSTox GSID 47819",Loriam,51742-
86-0,51742860,MLS001332559,"WR 142",T0860,SAM002699894,CPD000875233}

> <pdid>
PD010082

> <targets>
{Autophagy,Parasite,Potassium Channel,Reactive Oxygen Species,SARS-CoV}

> <classes>
{Anti-infection,Autophagy,Immunology/Inflammation,Membrane Transporter/Ion Channel,Metabolic Enzyme/Protease,NF-ºB}

> <pubchem_cids>
{65329}

$$$$
NIHCC_2014
  SciTegic11012413002D

 36 41  0  0  0  0            999 V2000
    5.7014   -3.0617    0.0000 C   0  0
    5.2600   -4.4953    0.0000 C   0  0
    6.2812   -5.5941    0.0000 O   0  0
    3.7969   -4.8296    0.0000 O   0  0
    2.7751   -3.7302    0.0000 C   0  0
    1.3120   -4.0645    0.0000 C   0  0
    0.8706   -5.4981    0.0000 O   0  0
    0.2851   -2.9666    0.0000 C   0  0
   -0.3666   -4.3062    0.0000 O   0  0
    0.7315   -5.3280    0.0000 C   0  0
    0.0218   -6.6946    0.0000 C   0  0
    1.0365   -7.7994    0.0000 C   0  0
    2.4007   -7.1758    0.0000 C   0  0
    2.2293   -5.6856    0.0000 C   0  0
    2.0426   -4.5993    0.0000 O   0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2991    2.2500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    0.0000    0.0000 F   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -1.2212   -2.3711    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 10  1  0
 10 15  1  0
 15 16  1  0
 16  8  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  2  3
 23 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  2  3
 27 28  1  0
 28 22  1  0
 28 29  1  0
 28 30  1  0
 30 19  1  0
 30 31  1  0
 30 32  1  0
 32 33  1  0
 32 34  1  0
 34 35  1  0
 35  8  1  0
 35 18  1  0
 35 36  1  0
M  END
> <name>
NIHCC_2014

> <id>
6303

> <plate>
NGP-202-03

> <well>
H04

> <supplier_cmpd_name>
CPD001491664

> <ctcr_id>
7047

> <supplier_cmpd_id>
SAM002699903

> <smiles>
CC(=O)OCC(=O)C12OC3(CCCC3)OC1CC4C5CCC6=CC(=O)C=CC6(C)C5(F)C(O)CC24C

> <pd_targets>
{RORC,HIF1A,NPSR1,NR3C1,ANXA1}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Membrane receptor","Ion channel","Nuclear receptor",Protease,"Family A G protein-coupled receptor","Other ion channel","Nuclear hormone receptor subfamily 1","Cysteine 
protease","Peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 3",Annexin,"Nuclear hormone receptor subfamily 1 group F","Cysteine protease CA clan","Short peptide receptor (family A
 GPCR)","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 1 group F member 3","Cysteine protease C1A family","Neuropeptide receptor","Nuclear hormone receptor subfamil
y 3 group C member 1"}

> <pathway_chembl>
{Receptors,"Nuclear hormone receptors","G protein-coupled receptors","1F. Retinoic acid-related orphans","Neuropeptide S receptor","Steroid hormone receptors","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"Gene expression (Transcription)","Cellular responses to external stimuli",Disease,"Signal Transduction","RNA Polymerase II Transcription","Cellular responses to stress","Infectious disease","Signali
ng by GPCR","Generic Transcription Pathway","Cellular response to hypoxia","Leishmania infection","GPCR ligand binding","Transcriptional regulation by RUNX3","Oxygen-dependent proline hydroxylation of
 Hypoxia-inducible Factor Alpha","Leishmania parasite growth and survival","FOXO-mediated transcription","Class A/1 (Rhodopsin-like receptors)","RUNX3 Regulates Immune Response and Cell Migration","An
ti-inflammatory response favouring Leishmania parasite infection","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","Peptide ligand-binding receptors","ADORA2B mediated 
anti-inflammatory cytokines production","Formyl peptide receptors bind formyl peptides and many other ligands"}

> <broad_targets>
{NR3C1}

> <broad_moa>
{"glucocorticoid receptor agonist"}

> <synonyms>
{Cyclocort,Visderm,Amciderm,Amcinonid,Penticort,CPD001491664,CHEMBL4518366,SCHEMBL13026154,CHEBI:94333,HMS3259P07,NC00630,FT-0661551,FT0661551,BRD-A16478930-001-01-0,BRDA16478930001010,T0261,SAM002699
903,Amcinonide}

> <pdid>
PD000863

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{2133}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 19  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 Br  0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5972    1.5031    0.0000 N   0  0
    2.5951    3.0039    0.0000 C   0  0
    3.8056    3.8680    0.0000 N   0  0
    3.3371    5.2929    0.0000 C   0  0
    1.8371    5.2877    0.0000 C   0  0
    1.3786    3.8595    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 N   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  6  2  3
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  5  1  0
  3 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17  2  1  0
 17 12  1  0
M  END
> <name>
NIHCC_2014

> <id>
6304

> <plate>
NGP-202-03

> <well>
H05

> <supplier_cmpd_name>
CPD000058355

> <ctcr_id>
7051

> <supplier_cmpd_id>
SAM002548958

> <smiles>
Brc1c(NC2=NCCN2)ccc3nccnc13

> <pd_targets>
{ADRA1B,NFO,ALDH1A1,BLM,KCNJ3,ADRA2B,ADRA2A,ADRA2C,MAPT,ADRA1A,ADRA1D,LMNA,KDM4E,FFP,MAPK1,ALD,HPGD,CYP1A2,ALOX15,CYP2D6,AMPC,HSD17B10,CYP3A4,HTR1A}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Ion channel","Other cytosolic protein","Other nuclear protein","Epigenetic regulator","Family A G protein-coupled receptor",Hydrolase,Oxidoreductase,"Voltage-gated ion cha
nnel",Eraser,Transferase,Kinase,"Cytochrome P450","Small molecule receptor (family A GPCR)","Potassium channels","Lysine demethylase","Protein Kinase","Cytochrome P450 family 1","Cytochrome P450 famil
y 2","Cytochrome P450 family 3","Monoamine receptor","Inwardly rectifying potassium channel","Jumonji domain-containing","CMGC protein kinase group","Cytochrome P450 family 1A","Cytochrome P450 family
 2D","Cytochrome P450 family 3A","Adrenergic receptor","CMGC protein kinase MAPK family","Cytochrome P450 1A1","Cytochrome P450 2D6","Cytochrome P450 3A4","Serotonin receptor","CMGC protein kinase ERK
1"}

> <pathway_chembl>
{Receptors,"Ion channels",Enzymes,"G protein-coupled receptors","Voltage-gated ion channels","Chromatin modifying enzymes","Kinases (EC 2.7.x.x)","Eicosanoid turnover","Cytochrome P450",Adrenoceptors,
"Potassium channels","1.14.11.- Histone demethylases","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Prostaglandin synthases","CYP1 family",Lipoxygenases,"CYP2 family: drug metabolising subset","CYP
3 family","5-Hydroxytryptamine receptors","Inwardly rectifying potassium channels","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,"DNA Repair","Neuronal System","Cell Cycle","Immune System","Signaling by GPCR","Biological oxidations","DNA Double-Strand Break Repair","Transmission across Chemical
 Synapses",Mitotic,"Innate Immune System","Metabolism of lipids","Metabolism of amino acids and derivatives","GPCR ligand binding","Phase I - Functionalization of compounds","Homology Directed Repair"
,"Neurotransmitter receptors and postsynaptic signal transmission","M Phase","Toll-like Receptor Cascades","Biosynthesis of specialized proresolving mediators (SPMs)","Branched-chain amino acid catabo
lism","Class A/1 (Rhodopsin-like receptors)","Ethanol oxidation","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","GABA receptor activation","Activation of NMDA receptors 
and postsynaptic events","Mitotic Metaphase and Anaphase","Toll Like Receptor 5 (TLR5) Cascade","Biosynthesis of DHA-derived SPMs","Cytochrome P450 - arranged by substrate type","Biosynthesis of DPA-d
erived SPMs","Amine ligand-binding receptors","HDR through Homologous Recombination (HRR)","GABA B receptor activation","Post NMDA receptor activation events","Mitotic Anaphase","MyD88 cascade initiat
ed on plasma membrane","Biosynthesis of D-series resolvins",Xenobiotics,"Biosynthesis of DPAn-3 SPMs","Biosynthesis of maresins",Adrenoceptors,"Homologous DNA Pairing and Strand Exchange","Activation 
of GABAB receptors","Activation of AMPK downstream of NMDARs","Nuclear Envelope (NE) Reassembly","MAP kinase activation","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Biosynthesi
s of DPAn-3-derived protectins and resolvins","CYP2E1 reactions","Biosynthesis of maresin-like SPMs","Serotonin receptors","Presynaptic phase of homologous DNA pairing and strand exchange","Inhibition
  of voltage gated Ca2+ channels via Gbeta/gamma subunits","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactiv
ated"}

> <broad_targets>
{ADRA2A,ADRA2B,ADRA2C}

> <broad_moa>
{"adrenergic receptor agonist"}

> <synonyms>
{brimonidine,59803-98-4,59803984,"59803 98 4",Bromoxidine,"UK 14,304","5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine","5BromoN(4,5dihydro1Himidazol2yl)6quinoxalinamine","5 Bromo N (4,5 di
hydro 1H imidazol 2 yl) 6 quinoxalinamine",SAM002548958,CPD000058355}

> <pdid>
PD000495

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{2435}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 30  0  0  0  0            999 V2000
   -1.8778    2.7573    0.0000 C   0  0
   -1.0947    1.4779    0.0000 N   0  0
    0.0000    0.6568    0.0000 C   0  0
   -0.6568   -0.6386    0.0000 C   0  0
   -1.8063   -1.3319    0.0000 C   0  0
   -0.8393    0.0000    0.0000 C   0  0
    0.9488    0.0000    0.0000 C   0  0
    1.8975   -0.8028    0.0000 C   0  0
    1.6421    0.6933    0.0000 C   0  0
    2.6654   -2.0798    0.0000 O   0  0
    4.1661   -2.0555    0.0000 C   0  0
    4.9382   -3.3425    0.0000 C   0  0
    6.4381   -3.3203    0.0000 C   0  0
    7.2073   -4.6081    0.0000 C   0  0
    6.4766   -5.9181    0.0000 C   0  0
    4.9767   -5.9403    0.0000 C   0  0
    4.2076   -4.6525    0.0000 C   0  0
    4.8949   -0.7436    0.0000 C   0  0
    6.3947   -0.7167    0.0000 C   0  0
    7.1214    0.5956    0.0000 C   0  0
    6.3483    1.8810    0.0000 C   0  0
    4.8485    1.8542    0.0000 C   0  0
    4.1218    0.5419    0.0000 C   0  0
   11.0072   -0.0912    0.0000 C   0  0
   11.0072   -1.5912    0.0000 S   0  0
   11.0072   -3.0912    0.0000 O   0  0
    9.7080   -2.3408    0.0000 O   0  0
   12.3065   -2.3408    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  2  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9  3  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 11 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 24 25  1  0
 25 26  1  0
 25 27  2  0
 25 28  2  0
M  END
> <name>
NIHCC_2014

> <id>
6305

> <plate>
NGP-202-03

> <well>
H06

> <supplier_cmpd_name>
CPD000394012

> <ctcr_id>
2777

> <supplier_cmpd_id>
SAM002548938

> <smiles>
CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccccc4.C[S](O)(=O)=O

> <pd_targets>
{REP,TSHR,CHRM1,LEF,CYP2D6}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Family A G protein-coupled receptor",Protease,"Cytochrome P450","Peptide receptor (family A GPCR)","Small molecule receptor (family A GPCR)","Metallo protease","Cytochrome
 P450 family 2","Glycohormone receptor","Monoamine receptor","Metallo protease MAE clan","Cytochrome P450 family 2D","Acetylcholine receptor","Metallo protease M34 family","Cytochrome P450 2D6"}

> <pathway_chembl>
{"Other protein targets",Receptors,Enzymes,"Anti-infective targets","G protein-coupled receptors","Cytochrome P450","Viral protein targets","Glycoprotein hormone receptors","Acetylcholine receptors (m
uscarinic)","CYP2 family: drug metabolising subset","Coronavirus (CoV) proteins"}

> <pathway_reactome>
{Disease,"Signal Transduction",Metabolism,"Infectious disease","Signaling by GPCR","Biological oxidations","SARS-CoV Infections","Leishmania infection","GPCR ligand binding","Uptake and actions of bac
terial toxins","Phase I - Functionalization of compounds","SARS-CoV-1 Infection","Leishmania parasite growth and survival","Class A/1 (Rhodopsin-like receptors)","Uptake and function of anthrax toxins
","Cytochrome P450 - arranged by substrate type","SARS-CoV-1 Genome Replication and Transcription","Anti-inflammatory response favouring Leishmania parasite infection","Amine ligand-binding receptors"
,Xenobiotics,"Replication of the SARS-CoV-1 genome","ADORA2B mediated anti-inflammatory cytokines production","Muscarinic acetylcholine receptors","CYP2E1 reactions"}

> <broad_targets>
{CHRM1,HRH1,SLC6A3}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{"BENZTROPINE MESYLATE",132-17-2,132172,"132 17 2","Cogentin mesylate","Benztropine (mesylate)",MLS000737056,NSC42199,"Benzotropine mesylate",SMR000394012,"Cobrentin methanesulfonate","MK 02",3-(Benzh
ydryloxy)-8-methyl-8-azabicyclo(3.2.1)octa,3(Benzhydryloxy)8methyl8azabicyclo(3.2.1)octa,T1336,SAM002548938,"NSC 42199","Benztropine mesylate",CPD000394012}

> <pdid>
PD010149

> <targets>
{Dopamine Receptor,Histamine Receptor,mAChR}

> <classes>
{GPCR/G Protein,Immunology/Inflammation,Neuronal Signaling}

> <pubchem_cids>
{238053,5351770}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 18  0  0  0  0            999 V2000
    6.1607   -2.0183    0.0000 Cl  0  0
    2.5981   -1.5000    0.0000 Cl  0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 N   0  0
   -3.6065    0.0000    0.0000 S   0  0
   -2.7248   -1.2135    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0031   -3.0008    0.0000 N   0  0
    1.3039   -3.7494    0.0000 C   0  0
    1.4469   -5.2297    0.0000 N   0  0
    2.9152   -5.5365    0.0000 C   0  0
    3.6607   -4.2349    0.0000 C   0  0
    2.6532   -3.1236    0.0000 N   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10  6  1  0
 10 11  1  0
 11  3  2  0
 11 12  1  0
 12 13  2  3
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 13  1  0
M  END
> <name>
NIHCC_2014

> <id>
6306

> <plate>
NGP-202-03

> <well>
H07

> <supplier_cmpd_name>
CPD000499584

> <ctcr_id>
6452

> <supplier_cmpd_id>
SAM002548961

> <smiles>
Cl.Clc1ccc2nsnc2c1N=C3NCCN3

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Tizanidine hydrochloride","Tizanidine Hcl",64461-82-1,64461821,Zanaflex,Sirdalud,"Tizanidine (hydrochloride)",UNII-B53E3NMY5C,UNIIB53E3NMY5C,"DS 103-282","DS 103282",B53E3NMY5C,AN021,"5-Chloro-4-(2-
imidazolin-2-ylamino)-2,1,3-benzothiadiazole hydrochloride","5Chloro4(2imidazolin2ylamino)2,1,3benzothiadiazole hydrochloride",MFCD00798231,64461,S1437,SAM002548961,Prestw-1182,"Tizanidine HCl",CPD000
499584}

> <pdid>

> <targets>
{"Adrenergic Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{114869,16413927,91980568}

$$$$
NIHCC_2014
  SciTegic11012413002D

 15 14  0  0  0  0            999 V2000
    6.3572   -1.8683    0.0000 O   0  0
   -1.3359   -5.2323    0.0000 Cl  0  0
   -0.0372   -4.4818    0.0000 C   0  0
   -0.0368   -2.9810    0.0000 C   0  0
    1.2626   -2.2300    0.0000 N   0  0
    2.5609   -2.9829    0.0000 C   0  0
    2.5589   -4.4838    0.0000 C   0  0
    3.8565   -5.2363    0.0000 Cl  0  0
    1.2990   -0.7500    0.0000 P   0  0
    2.5793    0.0316    0.0000 O   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 O   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  5  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15  9  1  0
M  END
> <name>
NIHCC_2014

> <id>
6307

> <plate>
NGP-202-03

> <well>
H08

> <supplier_cmpd_name>
CPD000718805

> <ctcr_id>
2600

> <supplier_cmpd_id>
SAM002548983

> <smiles>
O.ClCCN(CCCl)[P]1(=O)NCCCO1

> <pd_targets>
{NPSR1,ALOX15,KDM4E}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Epigenetic regulator","Family A G protein-coupled receptor",Oxidoreductase,Eraser,"Peptide receptor (family A GPCR)","Lysine demethylase","Short peptide receptor (family A
 GPCR)","Jumonji domain-containing","Neuropeptide receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Eicosanoid turnover","Chromatin modifying enzymes","Neuropeptide S receptor",Lipoxygenases,"1.14.11.- Histone demethylases"}

> <pathway_reactome>
{Disease,Metabolism,"Infectious disease","Metabolism of lipids","Leishmania infection","Biosynthesis of specialized proresolving mediators (SPMs)","Leishmania parasite growth and survival","Biosynthes
is of DPA-derived SPMs","Anti-inflammatory response favouring Leishmania parasite infection","Biosynthesis of DPAn-3 SPMs","ADORA2B mediated anti-inflammatory cytokines production","Biosynthesis of DP
An-3-derived protectins and resolvins"}

> <broad_targets>
{CYP2A6,CYP2B6,CYP2C18,CYP2C19,CYP2C8,CYP2C9,CYP2D6,CYP3A4,CYP3A5,CYP3A7}

> <broad_moa>
{"DNA alkylating agent"}

> <synonyms>
{EN300-52512,EN30052512,"EN300 52512",C06933,"Cyclophosphamide monohydrate",6055-19-2,6055192,"6055 19 2","Cyclophosphamide hydrate",Cytoxan,"2-(Bis(2-chloroethyl)amino)-1,3,2-oxazaphosphinane 2-oxide
 hydrate","2(Bis(2chloroethyl)amino)1,3,2oxazaphosphinane 2oxide hydrate","2 (Bis(2 chloroethyl)amino) 1,3,2 oxazaphosphinane 2 oxide hydrate","Cyclophosphamide (hydrate)",MFCD00149395,"6055-19-2 (hyd
rate)","6055192 (hydrate)","6055 19 2 (hydrate)",C0768,SAM002548983,1500213,cyclophosphamide,CPD000718805,"CYCLOPHOSPHAMIDE HYDRATE"}

> <pdid>
PD002782

> <targets>
{}

> <classes>
{antineoplastic,"alkylating agent"}

> <pubchem_cids>
{22420}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 27  0  0  1  0            999 V2000
    0.1194   -2.3933    0.0000 C   0  0
    0.7500   -1.0323    0.0000 C   0  0
    2.2393   -0.8534    0.0000 C   0  0
    1.2135    0.3943    0.0000 S   0  0
    0.0000    1.2760    0.0000 C   0  0  2  0  0  0
   -0.8796    2.4866    0.0000 C   0  0  2  0  0  0
   -0.6422    3.9624    0.0000 N   0  0
    0.7599    4.4978    0.0000 C   0  0
    1.9236    3.5514    0.0000 O   0  0
    0.9982    5.9795    0.0000 C   0  0  2  0  0  0
   -0.1656    6.9259    0.0000 N   0  0
    2.4003    6.5149    0.0000 C   0  0
    2.6407    7.9956    0.0000 C   0  0
    4.0431    8.5278    0.0000 C   0  0
    5.2052    7.5794    0.0000 C   0  0
    6.6076    8.1116    0.0000 O   0  0
    4.9649    6.0988    0.0000 C   0  0
    3.5625    5.5665    0.0000 C   0  0
   -2.0931    1.6049    0.0000 C   0  0
   -3.5746    1.8395    0.0000 O   0  0
   -1.2135    0.3943    0.0000 N   0  0
   -0.7500   -1.0323    0.0000 C   0  0  1  0  0  0
   -1.6332   -2.2426    0.0000 C   0  0
   -1.0255   -3.6140    0.0000 O   0  0
   -3.1247   -2.0836    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  5  4  1  1
  5  6  1  0
  6  7  1  1
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  6
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 15 17  1  0
 17 18  2  0
 18 12  1  0
  6 19  1  0
 19 20  2  0
 19 21  1  0
 21  5  1  0
 21 22  1  0
 22  2  1  0
 22 23  1  6
 23 24  1  0
 23 25  2  0
M  END
> <name>
NIHCC_2014

> <id>
6308

> <plate>
NGP-202-03

> <well>
H09

> <supplier_cmpd_name>
CPD000058707

> <ctcr_id>
6723

> <supplier_cmpd_id>
SAM002264592

> <smiles>
CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(O)=O

> <pd_targets>
{KDM4E,LMNA,AMPC,DACA,DACB,DACC,FTSI,MRCA,MRCB,MRDA,PBP1}

> <pathway_gtopdb>
{"Epigenetic regulator","Other nuclear protein",Enzyme,Eraser,Hydrolase,Protease,"Lysine demethylase","Serine protease","Jumonji domain-containing","Serine protease SE clan","Serine protease S11 famil
y"}

> <pathway_chembl>
{Enzymes,"Chromatin modifying enzymes","1.14.11.- Histone demethylases"}

> <pathway_reactome>
{"Cell Cycle",Mitotic,"M Phase","Mitotic Metaphase and Anaphase","Mitotic Anaphase","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{CYP2C19,SLC15A1,SLC15A2,SLC22A6}

> <broad_moa>
{"penicillin binding protein inhibitor"}

> <synonyms>
{RESTW35,"RESTW 35",amoxicillin,Amoxycillin,26787-78-0,26787780,"26787 78 0","Amoxicillin anhydrous",Amoxicilline,p-Hydroxyampicillin,pHydroxyampicillin,"p Hydroxyampicillin",Amopenixin,Amolin,Moxal,D
-Amoxicillin,DAmoxicillin,"D Amoxicillin",Cla,SAM002264592,Prestw-357,CPD000058707,Amoxicillin}

> <pdid>
PD002475

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{33613,40467057}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 24  0  0  0  0            999 V2000
   11.9554   -0.6930    0.0000 H   0  3
    9.4554   -0.6930    0.0000 Cl  0  5
    6.9546   -4.2653    0.0000 C   0  0
    5.4929   -3.9285    0.0000 N   0  0
    4.4707   -5.0263    0.0000 C   0  0
    5.0525   -2.4938    0.0000 C   0  0
    3.5900   -2.1568    0.0000 C   0  0
    3.1497   -0.7220    0.0000 C   0  0
    1.6852   -0.3846    0.0000 N   0  0
    1.3514    1.0778    0.0000 C   0  0
    2.5913    1.9239    0.0000 C   0  0
    2.4792    3.4197    0.0000 C   0  0
    1.1278    4.0705    0.0000 C   0  0
   -0.1116    3.2255    0.0000 C   0  0
    0.0000    1.7286    0.0000 C   0  0
   -1.3515    1.0777    0.0000 C   0  0
   -1.6852   -0.3847    0.0000 C   0  0
   -0.7500   -1.5574    0.0000 C   0  0
   -1.5000   -2.8577    0.0000 C   0  0
   -0.7500   -4.1567    0.0000 C   0  0
    0.7500   -4.1567    0.0000 C   0  0
    1.5000   -5.4558    0.0000 Cl  0  0
    1.5000   -2.8577    0.0000 C   0  0
    0.7500   -1.5574    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 23  1  0
 23 24  2  0
 24  9  1  0
 24 18  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6309

> <plate>
NGP-202-03

> <well>
H10

> <supplier_cmpd_name>
CPD000058295

> <ctcr_id>
2517

> <supplier_cmpd_id>
SAM002264601

> <smiles>
[H+].[Cl-].CN(C)CCCN1c2ccccc2CCc3ccc(Cl)cc13

> <pd_targets>
{SLC6A3,KCNJ6,DRD2,HRH1,HTR2A,TPR,SLC6A2,SLC6A4,ADRA1A,TSHR,CYP2D6,ADRA1B,IMPA1,TP53,CYP3A4,CYP1A2,ADRA1D,HTR7,HTR2C,HRH2,KMT2A,MEN1,RORC,THPO,LEF,CHRM1,ABCB11,NPSR1,ADRA2A,ADRA2B,ADRA2C,HTR2B,HTR1A,H
TR1B,HTR1D,HTR1F,HTR3A,HTR3B,HTR4,HTR5A,HTR5B,HTR6,PSMA6,TIM10,DRD3,REP,LMNA,PMP22,FFP,FTL,KDM4E,MAPT,THRB,CHRM4,SIGMAR1,SLC22A1,MTOR,CACNA1C,CHRM5,CHRM3,CHRM2,KCNJ5,GSTP1}

> <pathway_gtopdb>
{Transporter,"Ion channel","Membrane receptor",Enzyme,"Transcription factor","Epigenetic regulator","Unclassified protein","Other nuclear protein","Other cytosolic protein","Electrochemical transporte
r","Voltage-gated ion channel","Family A G protein-coupled receptor",Oxidoreductase,"Cytochrome P450",Hydrolase,Reader,"Nuclear receptor",Protease,"Primary active transporter","Ligand-gated ion channe
l",Transferase,Eraser,Kinase,"SLC superfamily of solute carriers","Potassium channels","Small molecule receptor (family A GPCR)","Peptide receptor (family A GPCR)","Cytochrome P450 family 2","Cytochro
me P450 family 3","Cytochrome P450 family 1",Bromodomain,"Nuclear hormone receptor subfamily 1","Metallo protease","ATP-binding cassette","5HT3 receptor","Lysine demethylase","Protein Kinase","Voltage
-gated calcium channel","SLC06 neurotransmitter transporter family","Inwardly rectifying potassium channel","Monoamine receptor","Glycohormone receptor","Cytochrome P450 family 2D","Cytochrome P450 fa
mily 3A","Cytochrome P450 family 1A","Nuclear hormone receptor subfamily 1 group F","Metallo protease MAE clan","ABCB subfamily","Short peptide receptor (family A GPCR)","Jumonji domain-containing","N
uclear hormone receptor subfamily 1 group A","SLC22 family of organic cation and anion transporters","Atypical protein kinase group","Dopamine receptor","Histamine receptor","Serotonin receptor","Adre
nergic receptor","Cytochrome P450 2D6","Cytochrome P450 3A4","Cytochrome P450 1A1","Nuclear hormone receptor subfamily 1 group F member 3","Metallo protease M34 family","Acetylcholine receptor","Neuro
peptide receptor","Nuclear hormone receptor subfamily 1 group A member 2","Atypical protein kinase PIKK family","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Transporters,"Ion channels",Receptors,Enzymes,"Other protein targets","SLC superfamily of solute carriers","Voltage-gated ion channels","G protein-coupled receptors","Cytochrome P450","Inositol phosp
hate turnover","Nuclear hormone receptors","ATP-binding cassette transporter family","Ligand-gated ion channels","Anti-infective targets","Chromatin modifying enzymes","Sigma receptors","Kinases (EC 2
.7.x.x)","SLC6 neurotransmitter transporter family","Potassium channels","Dopamine receptors","Histamine receptors","5-Hydroxytryptamine receptors",Adrenoceptors,"Glycoprotein hormone receptors","CYP2
 family: drug metabolising subset","Inositol monophosphatase","CYP3 family","CYP1 family","1F. Retinoic acid-related orphans","Acetylcholine receptors (muscarinic)","ABCB subfamily","Neuropeptide S re
ceptor","5-HT<sub>3</sub> receptors","Viral protein targets","1.14.11.- Histone demethylases","1A. Thyroid hormone receptors","SLC22 family of organic cation and anion transporters",Atypical,"Voltage-
gated calcium channels","Monoamine transporter subfamily","Inwardly rectifying potassium channels","Coronavirus (CoV) proteins","Organic cation transporters (OCT)","Phosphatidyl inositol 3' kinase-rel
ated kinases (PIKK) family","FRAP subfamily"}

> <pathway_reactome>
{Disease,"Neuronal System","Signal Transduction",Metabolism,"Cell Cycle","Gene expression (Transcription)",Hemostasis,"Developmental Biology","Vesicle-mediated transport","Metabolism of proteins","Tra
nsport of small molecules","Disorders of transmembrane transporters","Transmission across Chemical Synapses","Signaling by GPCR","Infectious disease","Biological oxidations","Inositol phosphate metabo
lism","Cell Cycle Checkpoints","Metabolism of lipids","RNA Polymerase II Transcription","Platelet activation","signaling and aggregation",Mitotic,"Nervous system development","Membrane Trafficking","P
ost-translational protein modification","SLC-mediated transmembrane transport","SLC transporter disorders","Neurotransmitter receptors and postsynaptic signal transmission","GPCR ligand binding","Leis
hmania infection","Neurotransmitter clearance","Phase I - Functionalization of compounds","Synthesis of IP2",IP,"and Ins in the cytosol","G1/S DNA Damage Checkpoints","Biosynthesis of specialized pror
esolving mediators (SPMs)","Generic Transcription Pathway","Platelet Aggregation (Plug Formation)","Uptake and actions of bacterial toxins","Metabolism of steroids","Regulation of mitotic cell cycle",
"SARS-CoV Infections","M Phase","EGR2 and SOX10-mediated initiation of Schwann cell myelination","trans-Golgi Network Vesicle Budding",SUMOylation,"Transport of bile salts and organic acids","metal io
ns and amine compounds","Axon guidance","Phase II - Conjugation of compounds","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","GABA receptor activation","Class A/1 (Rhodopsin-like re
ceptors)","Defective SLC6A2 causes orthostatic intolerance (OI)","Leishmania parasite growth and survival","Serotonin clearance from the synaptic cleft","Cytochrome P450 - arranged by substrate type",
"p53-Dependent G1/S DNA damage checkpoint","Biosynthesis of DHA-derived SPMs","Transcriptional regulation by RUNX3","Uptake and function of anthrax toxins","Bile acid and bile salt metabolism","APC/C-
mediated degradation of cell cycle proteins","SARS-CoV-1 Infection","Mitotic Metaphase and Anaphase","Golgi Associated Vesicle Biogenesis","Activation of NMDA receptors and postsynaptic events","SUMO 
E3 ligases SUMOylate target proteins","Potential therapeutics for SARS","Organic cation/anion/zwitterion transport","Transcriptional Regulation by TP53","NCAM signaling for neurite out-growth","Glutat
hione conjugation","GABA B receptor activation","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection",Xenobiotics,"p53-Dependent G1 DNA Damage Response"
,"Biosynthesis of maresins","RUNX3 Regulates Immune Response and Cell Migration","Synthesis of bile acids and bile salts","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins"
,"SARS-CoV-1 Genome Replication and Transcription","Mitotic Anaphase","Post NMDA receptor activation events","SUMOylation of intracellular receptors","Organic cation transport","Regulation of TP53 Act
ivity","NCAM1 interactions","Activation of GABAB receptors","Dopamine receptors","Histamine receptors","Serotonin receptors","ADORA2B mediated anti-inflammatory cytokines production",Adrenoceptors,"CY
P2E1 reactions","Stabilization of p53","Biosynthesis of maresin-like SPMs","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Muscarinic acetylcholine receptors","Synthesis of bile ac
ids and bile salts via 7alpha-hydroxycholesterol","APC/C:Cdc20 mediated degradation of mitotic proteins","Replication of the SARS-CoV-1 genome","Nuclear Envelope (NE) Reassembly","Activation of AMPK d
ownstream of NMDARs","Regulation of TP53 Expression and Degradation","Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits","Autodegradation of the E3 ubiquitin ligase COP1","APC:Cdc20 
mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint","Initiation of Nuclear Envelope (NE) Reformation","Regulation of TP53 Degradation","Cdc20:Phospho-APC/C m
ediated degradation of Cyclin A"}

> <broad_targets>
{GSTP1,HTR2A,HTR2B,HTR2C,SLC6A2,SLC6A3,SLC6A4}

> <broad_moa>
{"serotonin transporter (SERT) inhibitor"}

> <synonyms>
{732177,"Clomipramine hydrochloride",17321-77-6,17321776,"Clomipramine HCL",Anafranil,"3-Chloroimipramine hydrochloride","3Chloroimipramine hydrochloride","Chloroimipramine monohydrochloride",UNII-2LX
W0L6GWJ,UNII2LXW0L6GWJ,"Chlorimipramine hydrochloride","Clomipramine (hydrochloride)","Clomipramine Monohydroc",T0255,SAM002264601,2300061,Prestw-269,CPD000058295,"CLOMIPRAMINE HYDROCHLORIDE"}

> <pdid>
PD009943

> <targets>
{}

> <classes>
{antidepressant}

> <pubchem_cids>
{68539,25010313,25210450,657299}

$$$$
NIHCC_2014
  SciTegic11012413002D

 15 16  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 O   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 N   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 N   0  0
   -2.5987    1.5004    0.0000 N   0  0
   -2.6012    3.0004    0.0000 C   0  0
   -3.9015    3.7484    0.0000 C   0  0
   -5.1993    2.9963    0.0000 C   0  0
   -5.1969    1.4963    0.0000 C   0  0
   -3.8967    0.7484    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  3  5  1  0
  5  6  1  0
  6  7  2  3
  7  8  1  0
  8  2  1  0
  8  9  2  0
  6 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 10  1  0
M  END
> <name>
NIHCC_2014

> <id>
6310

> <plate>
NGP-202-03

> <well>
H11

> <supplier_cmpd_name>
CPD000058963

> <ctcr_id>
7064

> <supplier_cmpd_id>
SAM002589949

> <smiles>
ON1C(=N)NC(=CC1=N)N2CCCCC2

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{AK-49175,AK49175,SAM002589949,CPD000058963}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{135743713}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 20  0  0  0  0            999 V2000
   15.4003   -1.1250    0.0000 H   0  3
   12.9003   -1.1250    0.0000 Cl  0  5
   10.3996   -1.4837    0.0000 C   0  0
    9.0990   -0.7364    0.0000 C   0  0
    9.0964    0.7636    0.0000 C   0  0
    7.8003   -1.4887    0.0000 N   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    5.2029   -2.9932    0.0000 O   0  0
    3.8990   -0.7455    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 12  1  0
 21 16  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6311

> <plate>
NGP-202-04

> <well>
A02

> <supplier_cmpd_name>
CPD000059167

> <ctcr_id>
2371

> <supplier_cmpd_id>
SAM002699889

> <smiles>
[H+].[Cl-].CC(C)NCC(O)COc1cccc2ccccc12

> <pd_targets>
{PMP22,LMNA,AMPC,APEX1,NFKB1,LEF,HTR2A,HTR2B,HTR2C,CYP2D6,CHRM1,THPO,CYP1A2,HSD17B10,ADRB2,SLC10A1,SCN1A,SCN2A,SCN3A,TSHR,HTR1B,CACNA1S,HTR1A,MAPK1,TP53,CYP2D26,CYP2C9,ADRB1,SLC6A4,SIGMAR1,CACNA1C,CAC
NA1D,ALDH1A1,ADRB3,KCNH2,DRD2,ABCB1,SCN5A,HTR6,SLC22A1,HTR5A,HTR1D,HTR1F}

> <pathway_gtopdb>
{"Unclassified protein","Other nuclear protein",Enzyme,"Other cytosolic protein","Membrane receptor",Transporter,"Ion channel","Transcription factor",Hydrolase,Protease,"Family A G protein-coupled rec
eptor","Cytochrome P450",Oxidoreductase,"Electrochemical transporter","Voltage-gated ion channel",Kinase,"Metallo protease","Small molecule receptor (family A GPCR)","Cytochrome P450 family 2","Cytoch
rome P450 family 1","SLC superfamily of solute carriers","Voltage-gated sodium channel","Peptide receptor (family A GPCR)","Voltage-gated calcium channel","Protein Kinase","Metallo protease MAE clan",
"Monoamine receptor","Cytochrome P450 family 2D","Cytochrome P450 family 1A","SLC10 family of sodium-bile acid co-transporters","Glycohormone receptor","CMGC protein kinase group","Cytochrome P450 fam
ily 2C","SLC06 neurotransmitter transporter family","Metallo protease M34 family","Serotonin receptor","Cytochrome P450 2D6","Acetylcholine receptor","Cytochrome P450 1A1","Adrenergic receptor","CMGC 
protein kinase MAPK family","Cytochrome P450 2D2","Cytochrome P450 2C9","CMGC protein kinase ERK1","Primary active transporter","Potassium channels","ATP-binding cassette","Voltage-gated potassium cha
nnel","ABCB subfamily","SLC22 family of organic cation and anion transporters","Dopamine receptor"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Ion channels","Other protein targets","Cytochrome P450","G protein-coupled receptors","SLC superfamily of solute carriers","Voltage-gated ion channels","Kinases (EC 2.
7.x.x)","Sigma receptors","CYP2 family: drug metabolising subset","Acetylcholine receptors (muscarinic)","CYP1 family",Adrenoceptors,"SLC10 family of sodium-bile acid co-transporters","Glycoprotein ho
rmone receptors","5-Hydroxytryptamine receptors","Voltage-gated calcium channels","CMGC: Containing CDK",MAPK,GSK3,"CLK families","SLC6 neurotransmitter transporter family","Mitogen-activated protein 
kinases (MAP kinases)","Monoamine transporter subfamily","ERK subfamily","ATP-binding cassette transporter family","Potassium channels","Dopamine receptors","ABCB subfamily","Voltage-gated sodium chan
nels","SLC22 family of organic cation and anion transporters","Voltage-gated potassium channels","Organic cation transporters (OCT)"}

> <pathway_reactome>
{"Developmental Biology","Cell Cycle","DNA Repair","Immune System",Disease,Metabolism,"Signal Transduction",Hemostasis,"Neuronal System","Nervous system development",Mitotic,"Base Excision Repair","Cy
tokine Signaling in Immune system","Infectious disease","Biological oxidations","Signaling by GPCR","Platelet activation","signaling and aggregation","Metabolism of amino acids and derivatives","Metab
olism of lipids","Innate Immune System","Cell Cycle Checkpoints","Transmission across Chemical Synapses","EGR2 and SOX10-mediated initiation of Schwann cell myelination","M Phase","Resolution of Abasi
c Sites (AP sites)","Signaling by Interleukins","Uptake and actions of bacterial toxins","Phase I - Functionalization of compounds","GPCR ligand binding","Platelet Aggregation (Plug Formation)","Branc
hed-chain amino acid catabolism","Leishmania infection","Metabolism of steroids","Axon guidance","Toll-like Receptor Cascades","G1/S DNA Damage Checkpoints","Neurotransmitter clearance","SARS-CoV Infe
ctions","Mitotic Metaphase and Anaphase","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Interleukin-1 family signaling","Uptake and function of anthrax toxins","Cytoch
rome P450 - arranged by substrate type","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","Bile acid and bile salt metabolism","NCAM signaling for neurite out-growth","T
oll Like Receptor 5 (TLR5) Cascade","p53-Dependent G1/S DNA damage checkpoint","Serotonin clearance from the synaptic cleft","Potential therapeutics for SARS","Mitotic Anaphase","PCNA-Dependent Long P
atch Base Excision Repair","Interleukin-1 signaling",Xenobiotics,"Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Recycling of bile acids and salt
s","NCAM1 interactions","MyD88 cascade initiated on plasma membrane","p53-Dependent G1 DNA Damage Response","Nuclear Envelope (NE) Reassembly","MAP3K8 (TPL2)-dependent MAPK1/3 activation","CYP2E1 reac
tions","Muscarinic acetylcholine receptors","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","ADORA2B mediated anti-inflammatory cytokines production","Serotonin receptors","MAP kina
se activation","Stabilization of p53","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","Autodegradation of the E3 ubiquitin ligase COP1","ERK/MA
PK targets","ERKs are inactivated","Muscle contraction","Transport of small molecules","Cardiac conduction","Abacavir transport and metabolism","SLC-mediated transmembrane transport","Phase 3 - rapid 
repolarisation","Abacavir transmembrane transport","Transport of bile salts and organic acids","metal ions and amine compounds","Ethanol oxidation","L1CAM interactions","Organic cation/anion/zwitterio
n transport","Interaction between L1 and Ankyrins","Organic cation transport","Dopamine receptors"}

> <broad_targets>
{ADRB1,HTR1A,HTR5A,SLC10A1}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{Efektolol,"Propranolol hydrochloride",318-98-9,318989,"Propranolol Hcl",Inderal,Anaprilin,Avlocardyl,Berkolol,Caridolol,Herzbase,Inderalici,Naprilin,Pronovan,Dociton,Ikopal,Kemi,"Beta Neg","InnoPran 
XL","Propranolol chloride",Inderex,propranol,S4076,SAM002699889,1505270,"Propranolol HCl",CPD000059167,"PROPRANOLOL HYDROCHLORIDE (+/-)"}

> <pdid>
PD007086

> <targets>
{"Adrenergic Receptor"}

> <classes>
{antianginal,"GPCR & G Protein",antiarrhythmic,antihypertensive}

> <pubchem_cids>
{62882,43834240,25137848}

$$$$
NIHCC_2014
  SciTegic11012413002D

 14 13  0  0  0  0            999 V2000
    3.9032   -2.2490    0.0000 C   0  0
    2.6031   -1.5008    0.0000 C   0  0
    2.6000    0.0000    0.0000 C   0  0
    1.3000    0.7500    0.0000 C   0  0
    0.0007    0.0004    0.0000 O   0  0
    3.9000    0.7500    0.0000 N   0  0
    5.2000    0.0000    0.0000 C   0  0
    6.5000    0.7500    0.0000 C   0  0
    7.7999    0.0000    0.0000 N   0  0
    9.0999    0.7500    0.0000 C   0  0
    9.1030    2.2508    0.0000 C   0  0
   10.4031    2.9990    0.0000 C   0  0
   10.3999    0.0000    0.0000 C   0  0
   11.6992    0.7496    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  3  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 10 13  1  0
 13 14  1  0
M  END
> <name>
NIHCC_2014

> <id>
6312

> <plate>
NGP-202-04

> <well>
A03

> <supplier_cmpd_name>
CPD000046147

> <ctcr_id>
7069

> <supplier_cmpd_id>
SAM002589988

> <smiles>
CCC(CO)NCCNC(CC)CO

> <pd_targets>
{LMNA,FFP,ABCC3,EMBC,EMBB,EMBA}

> <pathway_gtopdb>
{"Other nuclear protein",Enzyme,Transporter,Transferase,"Primary active transporter","ATP-binding cassette","ABCC subfamily"}

> <pathway_chembl>
{Transporters,"ATP-binding cassette transporter family","ABCC subfamily"}

> <pathway_reactome>
{"Cell Cycle",Metabolism,Mitotic,"Metabolism of lipids","M Phase","Metabolism of steroids","Mitotic Metaphase and Anaphase","Bile acid and bile salt metabolism","Mitotic Anaphase","Recycling of bile a
cids and salts","Nuclear Envelope (NE) Reassembly","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{}

> <broad_moa>
{"bacterial cell wall synthesis inhibitor"}

> <synonyms>
{Etambutol,Tibutol,"Ethambutol, (R,R)-","Ethambutol, (R,R)",Diambutol,MLS000082702,10054-05-4,10054054,2-(2-(1-hydroxybutan-2-ylamino)ethylamino)butan-1-ol,2(2(1hydroxybutan2ylamino)ethylamino)butan1o
l,74-55-5,74555,SMR000046147,"Ethambutol, racemic mixture",Purderal,EMB,2,2'-(ethane-1,2'(ethane1,2-diylbis(azanediyl))bis(butan-1-ol),2diylbis(azanediyl))bis(butan1ol),SAM002589988,CPD000046147}

> <pdid>
PD003004

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{3279}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 23  0  0  1  0            999 V2000
    3.8917   -5.2577    0.0000 C   0  0
    3.8934   -3.7577    0.0000 O   0  0
    2.5949   -3.0050    0.0000 C   0  0
    1.2948   -3.7531    0.0000 O   0  0
    2.5966   -1.5042    0.0000 C   0  0  1  0  0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 S   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    3.8990   -0.7582    0.0000 C   0  0
    5.1956   -1.5125    0.0000 C   0  0
    6.4972   -0.7669    0.0000 C   0  0
    6.5023    0.7331    0.0000 C   0  0
    5.2058    1.4875    0.0000 C   0  0
    3.9042    0.7419    0.0000 C   0  0
    2.6078    1.4964    0.0000 Cl  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  5  3  1  1
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13  9  2  0
 13 14  1  0
 14  6  1  0
  5 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 20 21  1  0
M  END
> <name>
NIHCC_2014

> <id>
6313

> <plate>
NGP-202-04

> <well>
A04

> <supplier_cmpd_name>
CPD000550475

> <ctcr_id>
7074

> <supplier_cmpd_id>
SAM002589956

> <smiles>
COC(=O)[C@@H](N1CCc2sccc2C1)c3ccccc3Cl

> <pd_targets>
{CYP2B6,CYP2C19,SLC6A4,ABCB11,P2RY12,ALD,THRB,FFP,RORC}

> <pathway_gtopdb>
{Enzyme,Transporter,"Membrane receptor","Transcription factor","Cytochrome P450","Electrochemical transporter","Primary active transporter","Family A G protein-coupled receptor","Nuclear receptor",Tra
nsferase,"Cytochrome P450 family 2","SLC superfamily of solute carriers","ATP-binding cassette","Small molecule receptor (family A GPCR)","Nuclear hormone receptor subfamily 1","Cytochrome P450 family
 2B","Cytochrome P450 family 2C","SLC06 neurotransmitter transporter family","ABCB subfamily","Nucleotide-like receptor (family A GPCR)","Nuclear hormone receptor subfamily 1 group A","Nuclear hormone
 receptor subfamily 1 group F","Cytochrome P450 2B6","Cytochrome P450 2C19","Purine receptor","Nuclear hormone receptor subfamily 1 group A member 2","Nuclear hormone receptor subfamily 1 group F memb
er 3"}

> <pathway_chembl>
{Enzymes,Transporters,Receptors,"Cytochrome P450","SLC superfamily of solute carriers","ATP-binding cassette transporter family","G protein-coupled receptors","Nuclear hormone receptors","CYP2 family:
 drug metabolising subset","SLC6 neurotransmitter transporter family","ABCB subfamily","P2Y receptors","1A. Thyroid hormone receptors","1F. Retinoic acid-related orphans","Monoamine transporter subfam
ily"}

> <pathway_reactome>
{Metabolism,"Neuronal System","Signal Transduction","Metabolism of proteins","Gene expression (Transcription)","Biological oxidations","Transmission across Chemical Synapses","Metabolism of lipids","S
ignaling by GPCR","Post-translational protein modification","RNA Polymerase II Transcription","Phase I - Functionalization of compounds","Neurotransmitter clearance","Metabolism of steroids","GPCR lig
and binding",SUMOylation,"Generic Transcription Pathway","Cytochrome P450 - arranged by substrate type","Serotonin clearance from the synaptic cleft","Bile acid and bile salt metabolism","Class A/1 (R
hodopsin-like receptors)","SUMO E3 ligases SUMOylate target proteins","Transcriptional regulation by RUNX3",Xenobiotics,"Synthesis of bile acids and bile salts","Nucleotide-like (purinergic) receptors
","SUMOylation of intracellular receptors","RUNX3 Regulates Immune Response and Cell Migration","CYP2E1 reactions","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","P2Y receptors
"}

> <broad_targets>
{P2RY12}

> <broad_moa>
{"purinergic receptor antagonist"}

> <synonyms>
{clopidogrel,113665-84-2,113665842,(S)-Clopidogrel,(S)Clopidogrel,Plavix,(+)-Clopidogrel,(+)Clopidogrel,"CLOPIDOGREL SULFATE",(+)-(S)-Clopidogrel,(+)(S)Clopidogrel,UNII-A74586SNO7,UNIIA74586SNO7,"SR 2
5990",CHEBI:37941,A74586SNO7,"R 130964",Zyllt,"Clopidogrel (TN)","Plavix (TN)",SR-25990C,SR25990C,Thrombo,"Clopidogrel (INN:B",SAM002589956,CPD000550475}

> <pdid>
PD003042

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{60606}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 26  0  0  0  0            999 V2000
   -5.0019    0.8454    0.0000 C   0  0
   -3.5348    0.5331    0.0000 N   0  0
   -2.5311    1.6478    0.0000 C   0  0
   -3.0705   -0.8941    0.0000 C   0  0
   -1.6026   -1.2066    0.0000 C   0  0
   -1.1384   -2.6339    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
    1.8032   -3.1233    0.0000 O   0  0
    2.4133   -1.7530    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000    3.0008    0.0000 C   0  0
    0.0000    4.5008    0.0000 N   0  0
    0.7935   -4.3741    0.0000 C   0  0
   -0.1925   -5.5045    0.0000 C   0  0
    0.2934   -6.9236    0.0000 C   0  0
    1.7654   -7.2123    0.0000 C   0  0
    2.2513   -8.6314    0.0000 F   0  0
    2.7514   -6.0819    0.0000 C   0  0
    2.2654   -4.6628    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15  7  1  0
 15 10  1  0
 12 16  1  0
 16 17  3  0
  7 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 21 23  1  0
 23 24  2  0
 24 18  1  0
M  END
> <name>
NIHCC_2014

> <id>
6314

> <plate>
NGP-202-04

> <well>
A05

> <supplier_cmpd_name>
CPD000465669

> <ctcr_id>
6039

> <supplier_cmpd_id>
SAM002589960

> <smiles>
CN(C)CCCC1(OCc2cc(ccc12)C#N)c3ccc(F)cc3

> <pd_targets>
{SLC6A2,SLC6A4,NET,ADRA1A,ADRA1B,KCNH2,SLC6A3,NPC1,HTR1A,ALDH1A1,MAPK1,BLM,PMP22,NPSR1,SLC22A1,HRH1,HTR2C,HTR2B,SIGMAR1,ADRA1D,CACNA1C,LMNA,RORC,ALOX15,CHRM1,CYP3A4,CYP2C9,CYP2D6,CYP2C19,NFKB1,HTR2A,A
DRA2A,ADRA2B,ADRA2C,DRD2}

> <pathway_gtopdb>
{Transporter,"Membrane receptor","Ion channel",Enzyme,"Unclassified protein","Electrochemical transporter","Family A G protein-coupled receptor","Voltage-gated ion channel",Oxidoreductase,Kinase,"SLC 
superfamily of solute carriers","Small molecule receptor (family A GPCR)","Potassium channels","Protein Kinase","Peptide receptor (family A GPCR)","Voltage-gated calcium channel","SLC06 neurotransmitt
er transporter family","Monoamine receptor","Voltage-gated potassium channel","CMGC protein kinase group","Short peptide receptor (family A GPCR)","SLC22 family of organic cation and anion transporter
s","Adrenergic receptor","Serotonin receptor","CMGC protein kinase MAPK family","Neuropeptide receptor","Histamine receptor","CMGC protein kinase ERK1","Other nuclear protein","Transcription factor","
Other cytosolic protein","Nuclear receptor","Cytochrome P450","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 3","Cytochrome P450 family 2","Nuclear hormone receptor subfamily 1 group F
","Cytochrome P450 family 3A","Cytochrome P450 family 2C","Cytochrome P450 family 2D","Nuclear hormone receptor subfamily 1 group F member 3","Acetylcholine receptor","Cytochrome P450 3A4","Cytochrome
 P450 2C9","Cytochrome P450 2D6","Cytochrome P450 2C19","Dopamine receptor"}

> <pathway_chembl>
{Transporters,Receptors,"Ion channels",Enzymes,"Other protein targets","SLC superfamily of solute carriers","G protein-coupled receptors","Voltage-gated ion channels","Kinases (EC 2.7.x.x)","Sigma rec
eptors","SLC6 neurotransmitter transporter family",Adrenoceptors,"Potassium channels","SLC65 NPC-type cholesterol transporters","5-Hydroxytryptamine receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK fa
milies","Neuropeptide S receptor","SLC22 family of organic cation and anion transporters","Histamine receptors","Voltage-gated calcium channels","Monoamine transporter subfamily","Voltage-gated potass
ium channels","Mitogen-activated protein kinases (MAP kinases)","Organic cation transporters (OCT)","ERK subfamily","Nuclear hormone receptors","Eicosanoid turnover","Cytochrome P450","1F. Retinoic ac
id-related orphans",Lipoxygenases,"Acetylcholine receptors (muscarinic)","CYP3 family","CYP2 family: drug metabolising subset","Dopamine receptors"}

> <pathway_reactome>
{"Neuronal System","Signal Transduction","Muscle contraction",Disease,"Transport of small molecules",Metabolism,"Immune System","DNA Repair","Developmental Biology","Transmission across Chemical Synap
ses","Signaling by GPCR","Cardiac conduction","Disorders of transmembrane transporters","Plasma lipoprotein assembly",remodeling,"and clearance","Biological oxidations","Innate Immune System","DNA Dou
ble-Strand Break Repair","Nervous system development","Infectious disease","SLC-mediated transmembrane transport","Neurotransmitter clearance","GPCR ligand binding","Phase 3 - rapid repolarisation","S
LC transporter disorders","Plasma lipoprotein clearance","Phase I - Functionalization of compounds","Toll-like Receptor Cascades","Homology Directed Repair","EGR2 and SOX10-mediated initiation of Schw
ann cell myelination","Leishmania infection","Transport of bile salts and organic acids","metal ions and amine compounds","SARS-CoV Infections","Axon guidance","Serotonin clearance from the synaptic c
left","Class A/1 (Rhodopsin-like receptors)","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","LDL clearance","Ethanol oxidation","Toll Like Receptor 5 (TLR5) Cascade","HDR through Ho
mologous Recombination (HRR) or Single Strand Annealing (SSA)","Leishmania parasite growth and survival","Organic cation/anion/zwitterion transport","Potential therapeutics for SARS","Defective SLC6A2
 causes orthostatic intolerance (OI)","NCAM signaling for neurite out-growth","Amine ligand-binding receptors","MyD88 cascade initiated on plasma membrane","HDR through Homologous Recombination (HRR)"
,"Anti-inflammatory response favouring Leishmania parasite infection","Organic cation transport","NCAM1 interactions",Adrenoceptors,"Serotonin receptors","MAP kinase activation","Homologous DNA Pairin
g and Strand Exchange","ADORA2B mediated anti-inflammatory cytokines production","Histamine receptors","MAPK targets/ Nuclear events mediated by MAP kinases","Presynaptic phase of homologous DNA pairi
ng and strand exchange","ERK/MAPK targets","ERKs are inactivated","Cell Cycle","Gene expression (Transcription)",Mitotic,"RNA Polymerase II Transcription","Metabolism of lipids","Cytokine Signaling in
 Immune system","M Phase","Generic Transcription Pathway","Biosynthesis of specialized proresolving mediators (SPMs)","Signaling by Interleukins","Mitotic Metaphase and Anaphase","Transcriptional regu
lation by RUNX3","Biosynthesis of DPA-derived SPMs","Biosynthesis of DHA-derived SPMs","Cytochrome P450 - arranged by substrate type","Interleukin-1 family signaling","Mitotic Anaphase","RUNX3 Regulat
es Immune Response and Cell Migration","Biosynthesis of DPAn-3 SPMs","Biosynthesis of maresins",Xenobiotics,"Interleukin-1 signaling","Nuclear Envelope (NE) Reassembly","Biosynthesis of DPAn-3-derived
 protectins and resolvins","Muscarinic acetylcholine receptors","Biosynthesis of maresin-like SPMs","CYP2E1 reactions","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Dopamine receptors","Initiation of 
Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{SLC6A4}

> <broad_moa>
{"selective serotonin reuptake inhibitor (SSRI)"}

> <synonyms>
{citalopram,59729-33-8,59729338,Nitalapram,Celexa,Cipram,Bonitrile,(3H)Citalopram,"Lu 10-171","Lu 10171",Lu-10-171,Lu10171,CHEMBL549,CHEBI:77397,1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthal
ancarbonitrile,1(3(Dimethylamino)propyl)1(pfluorophenyl)5phthalancarbonitrile,"Nitalapram HBr",(3H)-Citalopram,"Citalopramum (INN-Latin)","Citalopramum (INNLatin)",T1483,SAM002589960,1504172,"Citalopr
am HBr",CPD000465669,CITALOPRAM}

> <pdid>
PD000475

> <targets>
{}

> <classes>
{antidepressant,"5HT reuptake inhibitor"}

> <pubchem_cids>
{2771}

$$$$
NIHCC_2014
  SciTegic11012413002D

 30 32  0  0  1  0            999 V2000
    7.7996   -1.4883    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0
    5.2029   -2.9932    0.0000 C   0  0
    6.5005   -2.2411    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    3.8964    0.7545    0.0000 O   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0  2  0  0  0
   -1.2990   -5.2500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0  2  0  0  0
    1.2982   -3.7531    0.0000 C   0  0
    1.2961   -5.2539    0.0000 C   0  0
    2.5943   -6.0070    0.0000 C   0  0  2  0  0  0
    2.5944   -7.5070    0.0000 C   0  0
    3.8934   -8.2570    0.0000 C   0  0  1  0  0  0
    3.8934   -9.7570    0.0000 O   0  0
    5.1924   -7.5071    0.0000 C   0  0
    5.1925   -6.0071    0.0000 C   0  0
    6.4915   -5.2571    0.0000 O   0  0
    3.8935   -5.2570    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0  1  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  3  6  1  0
  6  7  2  0
  6  8  1  0
  9  8  1  6
  9 10  1  0
 10 11  1  0
 11 12  1  6
 11 13  1  0
 13 14  2  3
 14 15  1  0
 15 16  2  3
 16 17  1  0
 17 18  1  1
 17 19  1  0
 19 20  1  1
 20 21  1  0
 22 21  1  1
 22 23  1  0
 23 24  1  0
 24 25  1  6
 24 26  1  0
 26 27  1  0
 27 28  2  0
 27 29  1  0
 29 22  1  0
 19 30  1  0
 30  9  1  0
 30 14  1  6
M  END
> <name>
NIHCC_2014

> <id>
6315

> <plate>
NGP-202-04

> <well>
A06

> <supplier_cmpd_name>
CPD000718785

> <ctcr_id>
3301

> <supplier_cmpd_id>
SAM002589969

> <smiles>
CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12

> <pd_targets>
{HMGCR,AMPC,BCHE,CYP2C8,HMG1,ABCB11,FTL,ACHE,ABCB1,SLCO1B1,ABCC2,ITGAL,HDAC2,ALDH1A1,USP2,KDM4E,SMN1,RORC,CYP3A4}

> <pathway_gtopdb>
{Enzyme,Transporter,"Unclassified protein",Adhesion,"Epigenetic regulator","Transcription factor",Oxidoreductase,Hydrolase,"Cytochrome P450","Primary active transporter","Electrochemical transporter",
Eraser,Protease,Reader,"Nuclear receptor","Cytochrome P450 family 2","ATP-binding cassette","SLC superfamily of solute carriers","Histone deacetylase","Cysteine protease","Lysine demethylase","Methyl-
lysine/arginine binding protein","Nuclear hormone receptor subfamily 1","Cytochrome P450 family 3","Cytochrome P450 family 2C","ABCB subfamily","SLC21/SLCO family of organic anion transporting polypep
tides","ABCC subfamily","HDAC class I","Cysteine protease CA clan","Jumonji domain-containing","Tudor domain","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family 3A","Cytochrome P45
0 2C8","Cysteine protease C19 family","Cysteine protease C1A family","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 3A4"}

> <pathway_chembl>
{Enzymes,Transporters,Receptors,"Lanosterol biosynthesis pathway","Acetylcholine turnover","Cytochrome P450","ATP-binding cassette transporter family","SLC superfamily of solute carriers","Catalytic r
eceptors","Chromatin modifying enzymes","Peptidases and proteinases","Nuclear hormone receptors","CYP2 family: drug metabolising subset","ABCB subfamily","SLCO family of organic anion transporting pol
ypeptides","ABCC subfamily",Integrins,"3.5.1.- Histone deacetylases (HDACs)","CA: Cysteine (C) Peptidases","1.14.11.- Histone demethylases","1F. Retinoic acid-related orphans","CYP3 family","C19: Ubiq
uitin-specific protease"}

> <pathway_reactome>
{Metabolism,"Vesicle-mediated transport",Disease,"Gene expression (Transcription)","Metabolism of RNA","Metabolism of lipids","Biological oxidations","Membrane Trafficking","Abacavir transport and met
abolism","Disorders of transmembrane transporters","RNA Polymerase II Transcription","Metabolism of non-coding RNA","Metabolism of steroids","Phospholipid metabolism","Phase I - Functionalization of c
ompounds","trans-Golgi Network Vesicle Budding","Abacavir transmembrane transport","ABC transporter disorders","Generic Transcription Pathway","snRNP Assembly","Biosynthesis of specialized proresolvin
g mediators (SPMs)","Regulation of cholesterol biosynthesis by SREBP (SREBF)","Glycerophospholipid biosynthesis","Cytochrome P450 - arranged by substrate type","Bile acid and bile salt metabolism","Go
lgi Associated Vesicle Biogenesis","Defective ABCC2 causes DJS","Transcriptional regulation by RUNX3","Transcriptional Regulation by TP53","Ethanol oxidation","Biosynthesis of DHA-derived SPMs","Activ
ation of gene expression by SREBF (SREBP)","Synthesis of PC",Xenobiotics,"Synthesis of bile acids and bile salts","Recycling of bile acids and salts","RUNX3 Regulates Immune Response and Cell Migratio
n","Regulation of TP53 Activity","Biosynthesis of maresins","CYP2E1 reactions","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Regulation of TP53 Activity through Acetylation",
"Regulation of TP53 Expression and Degradation","Biosynthesis of maresin-like SPMs","Regulation of TP53 Degradation"}

> <broad_targets>
{HMGCR,ITGB2}

> <broad_moa>
{"HMGCR inhibitor"}

> <synonyms>
{79902-63-9,79902639,"79902 63 9",Zocor,Synvinolin,Sinvacor,Denan,Lipex,MK-733,MK733,"MK 733",Sivastin,Lodales,Simvastatine,Cholestat,Colemin,Simovil,Medipo,Pantok,Simvastatina,Simvastatinum,Velostati
n,Zocord,Zorced,"Simvastatin lactone","Simvastatin (Zocor)",Lipovas,T0687,1965,SAM002589969,1504236,Prestw-865,Simvastatin,CPD000718785,SIMVASTATIN}

> <pdid>
PD001216

> <targets>
{Apoptosis,Autophagy,Ferroptosis,HMG-CoA Reductase (HMGCR),Mitophagy}

> <classes>
{antihyperlipidemic,HMGCoA reductase inhibitor,Apoptosis,Autophagy,Metabolic Enzyme/Protease}

> <pubchem_cids>
{54454}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 16  0  0  0  0            999 V2000
    7.6943   -1.8787    0.0000 O   0  0
    1.2948   -3.7516    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
    1.2704   -2.2385    0.0000 N   0  0
   -0.0294   -2.9873    0.0000 N   0  0
    3.8933   -3.7570    0.0000 C   0  0
    5.1937   -3.0093    0.0000 O   0  0
    3.8912   -5.2570    0.0000 O   0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 10 12  2  0
 12  5  1  0
  3 13  1  0
 13 14  1  0
  3 15  1  0
 15 16  1  0
 15 17  2  0
M  END
> <name>
NIHCC_2014

> <id>
6316

> <plate>
NGP-202-04

> <well>
A07

> <supplier_cmpd_name>
CPD001566944

> <ctcr_id>
7082

> <supplier_cmpd_id>
SAM002703129

> <smiles>
O.CC(Cc1ccc(O)c(O)c1)(NN)C(O)=O

> <pd_targets>
{KDM4E,ALDH1A1,FFP,MAPK1,HSD17B10,HPGD,CYP3A4,LMNA,MAPT,ALD,REP,THPO,ALOX15,POLB,TDP1,CYP1A2,LCK,FYN,DDC,HIF1A,MTOR}

> <pathway_gtopdb>
{"Epigenetic regulator",Enzyme,"Other nuclear protein","Other cytosolic protein","Unclassified protein",Eraser,Oxidoreductase,Transferase,Kinase,"Cytochrome P450",Hydrolase,Lyase,"Lysine demethylase",
"Protein Kinase","Cytochrome P450 family 3","Cytochrome P450 family 1","Jumonji domain-containing","CMGC protein kinase group","Cytochrome P450 family 3A","Cytochrome P450 family 1A","TK protein kinas
e group","CMGC protein kinase MAPK family","Cytochrome P450 3A4","Cytochrome P450 1A1","Tyrosine protein kinase Src family","CMGC protein kinase ERK1","Tyrosine protein kinase SrcA","Transcription fac
tor","Atypical protein kinase group","Atypical protein kinase PIKK family","Atypical protein kinase FRAP subfamily"}

> <pathway_chembl>
{Enzymes,"Other protein targets",Receptors,"Chromatin modifying enzymes","Kinases (EC 2.7.x.x)","Eicosanoid turnover","Cytochrome P450","Anti-infective targets","Catalytic receptors","Carboxylases and
 decarboxylases","1.14.11.- Histone demethylases","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Prostaglandin synthases","CYP3 family","Viral protein targets",Lipoxygenases,"CYP1 family","Receptor 
kinases",Decarboxylases,"Mitogen-activated protein kinases (MAP kinases)","Coronavirus (CoV) proteins","TK: Tyrosine kinase","ERK subfamily","Non-receptor tyrosine kinases (nRTKs)","Src family",Atypic
al,"Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","FRAP subfamily"}

> <pathway_reactome>
{Metabolism,"Immune System","Cell Cycle","Neuronal System",Disease,Hemostasis,"DNA Repair","Biological oxidations","Innate Immune System","Metabolism of amino acids and derivatives","Metabolism of lip
ids",Mitotic,"Transmission across Chemical Synapses","Infectious disease","Platelet activation","signaling and aggregation","Base Excision Repair","DNA Double-Strand Break Repair","Phase I - Functiona
lization of compounds","Toll-like Receptor Cascades","Branched-chain amino acid catabolism","Biosynthesis of specialized proresolving mediators (SPMs)","M Phase","Neurotransmitter receptors and postsy
naptic signal transmission","SARS-CoV Infections","Platelet Aggregation (Plug Formation)","Resolution of Abasic Sites (AP sites)","Nonhomologous End-Joining (NHEJ)","HIV Infection","Metabolism of amin
e-derived hormones","Ethanol oxidation","Toll Like Receptor 5 (TLR5) Cascade","Biosynthesis of DHA-derived SPMs","Mitotic Metaphase and Anaphase","Activation of NMDA receptors and postsynaptic events"
,"SARS-CoV-2 Infection","Biosynthesis of DPA-derived SPMs","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Cytochrome P450 - arranged by substrate type","Host Interacti
ons of HIV factors","Catecholamine biosynthesis","MyD88 cascade initiated on plasma membrane","Biosynthesis of D-series resolvins","Biosynthesis of maresins","Mitotic Anaphase","Post NMDA receptor act
ivation events","SARS-CoV-2 Genome Replication and Transcription","Biosynthesis of DPAn-3 SPMs","PCNA-Dependent Long Patch Base Excision Repair",Xenobiotics,"The role of Nef in HIV-1 replication and d
isease pathogenesis","MAP kinase activation","Biosynthesis of maresin-like SPMs","Nuclear Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs","Replication of the SARS-CoV-2 genome","Bi
osynthesis of DPAn-3-derived protectins and resolvins","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Nef-mediates down modulation of cell surface receptors by recruiting them to 
clathrin adapters","Nef and signal transduction","MAPK targets/ Nuclear events mediated by MAP kinases","Initiation of Nuclear Envelope (NE) Reformation","Nef Mediated CD4 Down-regulation","ERK/MAPK t
argets","ERKs are inactivated","Cellular responses to external stimuli","Gene expression (Transcription)","Cellular responses to stress","RNA Polymerase II Transcription","Cellular response to hypoxia
","Generic Transcription Pathway","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Transcriptional Regulation by TP53","Regulation of TP53 Activity","Regulation of TP53 Expr
ession and Degradation","Regulation of TP53 Degradation"}

> <broad_targets>
{DDC}

> <broad_moa>
{"aromatic L-amino acid decarboxylase inhibitor"}

> <synonyms>
{"Carbidopa hydrate",38821-49-7,38821497,"38821-49-7 (hydrate)","38821497 (hydrate)","3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid hydrate","3(3,4dihydroxyphenyl)2hydrazinyl2methylpropa
noic acid hydrate","3-(3,4-dihydroxyphenyl)-2-hydrazineyl-2-methylpropanoic acid hydrate","3(3,4dihydroxyphenyl)2hydrazineyl2methylpropanoic acid hydrate",CHEMBL71946,SCHEMBL9064019,HMS3259B14,BCP2850
8,SAM002703129,CPD001566944}

> <pdid>
PD001371

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{441291}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 18  0  0  0  0            999 V2000
    3.1202   -2.0921    0.0000 N   0  0
    1.6281   -2.2462    0.0000 C   0  0
    1.0161   -3.6157    0.0000 O   0  0
    0.7500   -1.0323    0.0000 C   0  0
    1.2135    0.3943    0.0000 N   0  0
    0.0000    1.2760    0.0000 C   0  0
   -1.2135    0.3943    0.0000 N   0  0
   -0.7500   -1.0323    0.0000 N   0  0
   -2.6408    0.8580    0.0000 C   0  0
   -3.7580   -0.1251    0.0000 O   0  0
   -5.0368    0.6589    0.0000 C   0  0
   -6.4199    0.0830    0.0000 C   0  0
   -6.6139   -1.4044    0.0000 O   0  0
   -4.6863    2.1174    0.0000 C   0  0
   -5.6602    3.2582    0.0000 O   0  0
   -3.1909    2.2347    0.0000 C   0  0
   -2.3989    3.5086    0.0000 O   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  4  2  0
  7  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 11 14  1  0
 14 15  1  0
 14 16  1  0
 16  9  1  0
 16 17  1  0
M  END
> <name>
NIHCC_2014

> <id>
6317

> <plate>
NGP-202-04

> <well>
B02

> <supplier_cmpd_name>
CPD001496943

> <ctcr_id>
7065

> <supplier_cmpd_id>
SAM002589951

> <smiles>
NC(=O)c1ncn(n1)C2OC(CO)C(O)C2O

> <pd_targets>
{LMNA,SMN1,CHRM1,THPO,TOP1,ALDH1A1,IMPDH2,IMPDH1,GLA,CYP3A4,TSHR,PMP22,PA,PB1,ADORA1,NS5B,FFP}

> <pathway_gtopdb>
{"Other nuclear protein","Epigenetic regulator","Membrane receptor","Unclassified protein",Enzyme,Reader,"Family A G protein-coupled receptor",Isomerase,Oxidoreductase,Hydrolase,"Cytochrome P450",Tran
sferase,"Methyl-lysine/arginine binding protein","Small molecule receptor (family A GPCR)","Cytochrome P450 family 3","Peptide receptor (family A GPCR)","Tudor domain","Monoamine receptor","Cytochrome
 P450 family 3A","Glycohormone receptor","Nucleotide-like receptor (family A GPCR)","Acetylcholine receptor","Cytochrome P450 3A4","Adenosine receptor"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","DNA topoisomerases","1.-.-.- Oxidoreductases","Cytochrome P450","Acetylcholine receptors (muscarinic)","CYP3 family","Glycoprotein hormone receptors",
"Adenosine receptors"}

> <pathway_reactome>
{"Cell Cycle","Metabolism of RNA","Signal Transduction",Hemostasis,"Metabolism of proteins",Metabolism,Disease,"Developmental Biology",Mitotic,"Metabolism of non-coding RNA","Signaling by GPCR","Plate
let activation","signaling and aggregation","Post-translational protein modification","Biological oxidations","Infectious disease","Metabolism of lipids","Nervous system development","M Phase","snRNP 
Assembly","GPCR ligand binding","Platelet Aggregation (Plug Formation)",SUMOylation,"Phase I - Functionalization of compounds","SARS-CoV Infections","Sphingolipid metabolism","Biosynthesis of speciali
zed proresolving mediators (SPMs)","Leishmania infection","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Mitotic Metaphase and Anaphase","Class A/1 (Rhodopsin-like receptors)","SUMO
 E3 ligases SUMOylate target proteins","Ethanol oxidation","Potential therapeutics for SARS","Glycosphingolipid metabolism","Biosynthesis of DHA-derived SPMs","Leishmania parasite growth and survival"
,"Mitotic Anaphase","Amine ligand-binding receptors","SUMOylation of DNA replication proteins","Biosynthesis of maresins","Anti-inflammatory response favouring Leishmania parasite infection","Nucleoti
de-like (purinergic) receptors","Nuclear Envelope (NE) Reassembly","Muscarinic acetylcholine receptors","Biosynthesis of maresin-like SPMs","ADORA2B mediated anti-inflammatory cytokines production","A
denosine P1 receptors","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ADK,ENPP1,IMPDH1,IMPDH2,NT5C2}

> <broad_moa>
{antiviral}

> <synonyms>
{"1-pentofuranosyl-1h-1,2,4-triazole-3-carboxamide","1pentofuranosyl1h1,2,4triazole3carboxamide","1 pentofuranosyl 1h 1,2,4 triazole 3 carboxamide",Ribasphere,"ICN 1229",RTCA,"NSC 163039",Ribamide,Rib
amidil,1H-1,1H1,2,4-Triazole-3-carboxamide,4Triazole3carboxamide,1-,1,SAM002589951,CPD001496943}

> <pdid>
PD000797

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5064}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 29  0  0  0  0            999 V2000
    6.4897   -5.2632    0.0000 O   0  0
    5.1894   -6.0109    0.0000 C   0  0
    5.1873   -7.5109    0.0000 O   0  0
    3.8912   -5.2578    0.0000 C   0  0
    3.8933   -3.7570    0.0000 O   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5998    1.4986    0.0000 C   0  0
   -3.8983    0.7460    0.0000 C   0  0
   -3.8989   -0.7540    0.0000 C   0  0
   -5.1982   -1.5035    0.0000 C   0  0
   -6.4970   -0.7530    0.0000 C   0  0
   -6.4964    0.7470    0.0000 C   0  0
   -5.1971    1.4965    0.0000 C   0  0
   -2.6013    2.9994    0.0000 C   0  0
   -1.3046    3.7535    0.0000 C   0  0
   -1.3092    5.2535    0.0000 C   0  0
   -2.6105    5.9995    0.0000 C   0  0
   -2.6152    7.4995    0.0000 Cl  0  0
   -3.9073    5.2455    0.0000 C   0  0
   -3.9027    3.7455    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13  8  1  0
 11 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 14 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 24 26  1  0
 26 27  2  0
 27 21  1  0
M  END
> <name>
NIHCC_2014

> <id>
6318

> <plate>
NGP-202-04

> <well>
B03

> <supplier_cmpd_name>
CPD001453715

> <ctcr_id>
7070

> <supplier_cmpd_id>
SAM002589989

> <smiles>
OC(=O)COCCN1CCN(CC1)C(c2ccccc2)c3ccc(Cl)cc3

> <pd_targets>
{HRH1,TEK,KCNH2}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Ion channel",Protease,"Family A G protein-coupled receptor",Kinase,"Voltage-gated ion channel","Cysteine protease","Small molecule receptor (family A GPCR)","Protein Kinas
e","Potassium channels","Cysteine protease CA clan","Monoamine receptor","TK protein kinase group","Voltage-gated potassium channel","Cysteine protease C1A family","Histamine receptor","Tyrosine prote
in kinase Tie family"}

> <pathway_chembl>
{Receptors,"Ion channels","G protein-coupled receptors","Catalytic receptors","Voltage-gated ion channels","Histamine receptors","Receptor kinases","Potassium channels","TK: Tyrosine kinase","Voltage-
gated potassium channels","Receptor tyrosine kinases (RTKs)","Type XII RTKs: TIE family of angiopoietin receptors"}

> <pathway_reactome>
{"Signal Transduction","Muscle contraction","Signaling by GPCR","MAPK family signaling cascades","Cardiac conduction","GPCR ligand binding","MAPK1/MAPK3 signaling","Phase 3 - rapid repolarisation","Cl
ass A/1 (Rhodopsin-like receptors)","RAF/MAP kinase cascade","Amine ligand-binding receptors","Histamine receptors"}

> <broad_targets>
{HRH1}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{AC-5545,AC5545,CS-0886,CS0886,DB00341,cetirizine,83881-51-0,83881510,Cetirizina,Cetirizin,Virlix,Cetirizinum,Zirtek,"2-(2-(4-((4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic acid","2(2(4(
(4chlorophenyl)(phenyl)methyl)piperazin1yl)ethoxy)acetic acid","CETIRIZINE HYDROCHLORIDE",2-(2-(4-((4-chlorophenyl)-phenylmethyl)pipera,2(2(4((4chlorophenyl)phenylmethyl)pipera,SAM002589989,CPD0014537
15}

> <pdid>
PD003052

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{2678}

$$$$
NIHCC_2014
  SciTegic11012413002D

 31 32  0  0  0  0            999 V2000
    9.6061   -2.1359    0.0000 Na  0  3
    7.0592   -0.7054    0.0000 C   0  0
    5.9990   -1.7665    0.0000 O   0  0
    6.3872   -3.2163    0.0000 N   0  0
    5.3265   -4.2780    0.0000 C   0  0
    3.8775   -3.8868    0.0000 C   0  0
    2.8152   -4.9458    0.0000 O   0  0
    3.4909   -2.4366    0.0000 N   0  0
    2.0479   -2.0470    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 S   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
    0.7488   -2.7970    0.0000 C   0  0
    0.3606   -4.2459    0.0000 O   0  0
   -2.6003   -1.4978    0.0000 C   0  0
   -3.8983   -0.7459    0.0000 O   0  0
   -2.6029   -2.9978    0.0000 O   0  5
   -2.5973    1.5031    0.0000 C   0  0
   -2.5951    3.0039    0.0000 O   0  0
   -3.8933    3.7570    0.0000 C   0  0
   -3.8912    5.2570    0.0000 O   0  0
   -5.1937    3.0092    0.0000 C   0  0
    5.7131   -5.7282    0.0000 C   0  0
    7.1061   -6.2493    0.0000 C   0  0
    7.0226   -7.7470    0.0000 S   0  0
    5.5724   -8.1304    0.0000 C   0  0
    5.0302   -9.5289    0.0000 N   0  0
    4.7596   -6.8697    0.0000 N   0  0
  2  3  1  0
  3  4  1  0
  4  5  2  3
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  3
 14 15  1  0
 15 10  1  0
 15 16  1  0
 16  9  1  0
 16 17  2  0
 14 18  1  0
 18 19  2  0
 18 20  1  0
 13 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
  5 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 29 31  2  0
 31 26  1  0
M  CHG  2   1   1  20  -1
M  END
> <name>
NIHCC_2014

> <id>
6319

> <plate>
NGP-202-04

> <well>
B04

> <supplier_cmpd_name>
CPD001551784

> <ctcr_id>
7075

> <supplier_cmpd_id>
SAM002643511

> <smiles>
[Na+].CON=C(C(=O)NC1C2SCC(=C(N2C1=O)C(=O)[O-])COC(=O)C)c3csc(N)n3

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"CEFOTAXIME SODIUM",64485-93-4,64485934,SCHEMBL9491367,CHEMBL4552387,HMS3259D08,HMS3373G07,MCULE-9988072641,MCULE9988072641,NC00704,NE54506,FT-0603036,FT0603036,A834407,SAM002643511,CPD001551784}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{44134618}

$$$$
NIHCC_2014
  SciTegic11012413002D

 52 54  0  0  1  0            999 V2000
   -2.4321    1.3050    0.0000 C   0  0
   -1.2845    2.2709    0.0000 C   0  0
    0.1168    1.7642    0.0000 C   0  0  1  0  0  0
    0.8253   -0.0900    0.0000 O   0  0
    2.3035    0.1702    0.0000 C   0  0
    2.8165    1.5797    0.0000 O   0  0
    3.2685   -0.9792    0.0000 C   0  0  2  0  0  0
    2.7555   -2.3888    0.0000 C   0  0
    4.7467   -0.7191    0.0000 C   0  0  1  0  0  0
    5.7090    0.4326    0.0000 O   0  0
    7.1877    0.1760    0.0000 C   0  0  1  0  0  0
    7.6999    1.5858    0.0000 C   0  0
    9.1770    1.8473    0.0000 C   0  0  1  0  0  0
   10.6600    2.0724    0.0000 C   0  0
    8.1970    2.9569    0.0000 O   0  0
    8.6385    4.3905    0.0000 C   0  0
   10.1419    0.6988    0.0000 C   0  0  1  0  0  0
   11.6189    0.9603    0.0000 O   0  0
    9.6298   -0.7110    0.0000 C   0  0  2  0  0  0
   10.5947   -1.8595    0.0000 C   0  0
    8.1528   -0.9725    0.0000 O   0  0
    5.7117   -1.8685    0.0000 C   0  0  2  0  0  0
    5.1987   -3.2780    0.0000 C   0  0
    7.1899   -1.6083    0.0000 C   0  0  1  0  0  0
    8.1522   -2.7600    0.0000 O   0  0
    7.6369   -4.1696    0.0000 C   0  0  2  0  0  0
    6.1587   -4.4250    0.0000 O   0  0
    5.6408   -5.8328    0.0000 C   0  0  2  0  0  0
    4.1627   -6.0881    0.0000 C   0  0
    6.6010   -6.9852    0.0000 C   0  0
    8.0791   -6.7298    0.0000 C   0  0  1  0  0  0
    8.5970   -5.3221    0.0000 C   0  0  1  0  0  0
   10.0751   -5.0668    0.0000 O   0  0
    9.0422   -7.8809    0.0000 N   0  0
   10.5199   -7.6234    0.0000 C   0  0
    8.5267   -9.2896    0.0000 C   0  0
    7.7029   -0.1988    0.0000 C   0  0  2  0  0  0
    8.1823    1.2225    0.0000 C   0  0
    8.6400   -1.3700    0.0000 O   0  0
    6.7378    0.9506    0.0000 C   0  0
    7.2508    2.3601    0.0000 C   0  0  1  0  0  0
    8.7280    2.6208    0.0000 C   0  0
    6.2858    3.5095    0.0000 C   0  0
    4.8076    3.2494    0.0000 N   0  0
    4.2946    1.8399    0.0000 C   0  0
    3.8426    4.3988    0.0000 C   0  0  2  0  0  0
    4.3556    5.8083    0.0000 C   0  0
    2.3644    4.1386    0.0000 C   0  0  1  0  0  0
    1.4004    5.2879    0.0000 O   0  0
    1.8514    2.7291    0.0000 C   0  0  1  0  0  0
    1.5225    1.2656    0.0000 C   0  0
    3.2446    3.2849    0.0000 O   0  0
  1  2  1  0
  3  2  1  6
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  1
  7  9  1  0
  9 10  1  1
 11 10  1  1
 11 12  1  0
 12 13  1  0
 13 14  1  6
 13 15  1  0
 15 16  1  0
 13 17  1  0
 17 18  1  1
 17 19  1  0
 19 20  1  6
 19 21  1  0
 21 11  1  0
  9 22  1  0
 22 23  1  1
 22 24  1  0
 24 25  1  6
 26 25  1  1
 26 27  1  0
 27 28  1  0
 28 29  1  1
 28 30  1  0
 30 31  1  0
 31 32  1  0
 32 26  1  0
 32 33  1  6
 31 34  1  1
 34 35  1  0
 34 36  1  0
 24 37  1  0
 37 38  1  6
 37 39  1  0
 37 40  1  0
 40 41  1  0
 41 42  1  6
 41 43  1  0
 43 44  1  0
 44 45  1  0
 44 46  1  0
 46 47  1  1
 46 48  1  0
 48 49  1  6
 48 50  1  0
 50  3  1  0
 50 51  1  1
 50 52  1  0
M  END
> <name>
NIHCC_2014

> <id>
6320

> <plate>
NGP-202-04

> <well>
B05

> <supplier_cmpd_name>
CPD000471864

> <ctcr_id>
2012

> <supplier_cmpd_id>
SAM002589961

> <smiles>
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O

> <pd_targets>
{LMNA,MLNR,CYP3A4,TSHR,PADI4}

> <pathway_gtopdb>
{"Other nuclear protein","Membrane receptor",Enzyme,"Family A G protein-coupled receptor","Cytochrome P450","Peptide receptor (family A GPCR)","Cytochrome P450 family 3","Short peptide receptor (famil
y A GPCR)","Cytochrome P450 family 3A","Glycohormone receptor","Motilin receptor","Cytochrome P450 3A4"}

> <pathway_chembl>
{Receptors,Enzymes,"G protein-coupled receptors","Cytochrome P450","3.5.3.15 Peptidyl arginine deiminases (PADI)","Motilin receptor","CYP3 family","Glycoprotein hormone receptors"}

> <pathway_reactome>
{"Cell Cycle","Signal Transduction",Metabolism,Disease,"Chromatin organization",Mitotic,"Signaling by GPCR","Metabolism of lipids","Infectious disease","Chromatin modifying enzymes","M Phase","GPCR li
gand binding","Biosynthesis of specialized proresolving mediators (SPMs)","Leishmania infection","Mitotic Metaphase and Anaphase","Class A/1 (Rhodopsin-like receptors)","Biosynthesis of DHA-derived SP
Ms","Leishmania parasite growth and survival","Mitotic Anaphase","Peptide ligand-binding receptors","Biosynthesis of maresins","Anti-inflammatory response favouring Leishmania parasite infection","Nuc
lear Envelope (NE) Reassembly","Biosynthesis of maresin-like SPMs","ADORA2B mediated anti-inflammatory cytokines production","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{MLNR}

> <broad_moa>
{"bacterial 50S ribosomal subunit inhibitor"}

> <synonyms>
{azithromycin,Zithromax,83905-01-5,83905015,Sumamed,Zitromax,Zmax,Azithromycine,Azithromycinum,Hemomycin,Azasite,Azenil,"Azithromycine (French)","Azithromycinum (Latin)","AZITHROMYCIN DIHYDRATE",CP-62
993,CP62993,Azitromax,Misultina,Tromix,"CP 62993",C38H72N2O1,SAM002589961,1503679,Prestw-1234,CPD000471864,AZITHROMYCIN,Azithromycin}

> <pdid>
PD000892

> <targets>
{Antibiotic,Autophagy,Bacterial}

> <classes>
{antibacterial,Anti-infection,Autophagy}

> <pubchem_cids>
{447043}

$$$$
NIHCC_2014
  SciTegic11012413002D

 61 66  0  0  1  0            999 V2000
    7.6899   -0.0398    0.0000 C   0  0
    6.3791   -0.7692    0.0000 O   0  0
    5.0900    0.0000    0.0000 C   0  0  1  0  0  0
    5.0900    1.6400    0.0000 C   0  0
    6.2800    2.4100    0.0000 C   0  0
    6.2800    3.9400    0.0000 O   0  0
    3.9000    3.9400    0.0000 C   0  0  1  0  0  0
    4.9607    2.8793    0.0000 C   0  0
    3.9000    2.4100    0.0000 O   0  0
    2.7100    1.6400    0.0000 C   0  0
    2.7100    0.0000    0.0000 C   0  0
    4.0276   -0.7168    0.0000 C   0  0
    1.5200   -0.7700    0.0000 C   0  0
    1.5200   -2.2700    0.0000 O   0  0
    0.3300    0.0000    0.0000 C   0  0
   -0.8500   -0.7700    0.0000 C   0  0
   -2.0400    0.0000    0.0000 C   0  0
   -3.2300   -0.7700    0.0000 N   0  0
   -3.2300   -2.2000    0.0000 C   0  0
   -1.9103   -2.9129    0.0000 O   0  0
   -4.4200   -2.9800    0.0000 C   0  0
   -4.4200   -4.9700    0.0000 C   0  0
   -3.2300   -5.8400    0.0000 C   0  0
   -2.0400   -4.9700    0.0000 C   0  0
   -0.8500   -5.8400    0.0000 C   0  0  2  0  0  0
   -0.8470   -7.3400    0.0000 C   0  0
    0.3300   -4.9700    0.0000 C   0  0  2  0  0  0
    0.3270   -3.4700    0.0000 O   0  0
    1.5200   -5.8400    0.0000 C   0  0  1  0  0  0
    1.4216   -7.3368    0.0000 C   0  0
    2.7100   -5.1900    0.0000 C   0  0  1  0  0  0
    4.0001   -5.9553    0.0000 O   0  0
    2.7100   -3.2000    0.0000 C   0  0  1  0  0  0
    1.3688   -2.5283    0.0000 C   0  0
    3.9000   -2.3100    0.0000 C   0  0  2  0  0  0
    5.2343   -3.0003    0.0000 O   0  0
    5.3042   -4.4995    0.0000 C   0  0
    4.0412   -5.3088    0.0000 C   0  0
    6.6363   -5.1890    0.0000 O   0  0
    3.9000   -0.7700    0.0000 C   0  0  2  0  0  0
    2.5824   -0.0532    0.0000 C   0  0
   -5.7397   -2.2671    0.0000 C   0  0
   -2.0400    1.6400    0.0000 C   0  0
   -3.2300    2.4100    0.0000 N   0  0
   -3.2300    3.9400    0.0000 C   0  0
   -4.4200    3.1800    0.0000 C   0  0
   -5.6100    3.9400    0.0000 C   0  0
   -5.6100    5.6000    0.0000 N   0  0
   -4.4200    6.3700    0.0000 C   0  0
   -3.2300    5.6000    0.0000 C   0  0
   -6.8932    6.3788    0.0000 C   0  0
   -6.8598    7.8793    0.0000 C   0  0
   -8.1414    8.6588    0.0000 C   0  0
   -5.5442    8.5998    0.0000 C   0  0
   -0.8500    3.9400    0.0000 N   0  0
   -0.8500    2.4100    0.0000 C   0  0
    0.3300    1.6400    0.0000 C   0  0
    1.5200    2.4100    0.0000 C   0  0
    1.5200    3.9400    0.0000 C   0  0
    0.4593    5.0007    0.0000 O   0  0
   -0.8471   -2.2700    0.0000 O   0  0
  1  2  1  0
  3  2  1  6
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  6
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 13 15  2  0
 15 16  1  0
 16 17  2  3
 17 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  1  1
 25 27  1  0
 27 28  1  6
 27 29  1  0
 29 30  1  6
 29 31  1  0
 31 32  1  6
 31 33  1  0
 33 34  1  1
 33 35  1  0
 35 36  1  1
 36 37  1  0
 37 38  1  0
 37 39  2  0
 35 40  1  0
 40  3  1  0
 40 41  1  6
 21 42  1  0
 17 43  1  0
 43 44  2  3
 44 45  1  0
 45 46  1  0
 46 47  1  0
 47 48  1  0
 48 49  1  0
 49 50  1  0
 50 45  1  0
 48 51  1  0
 51 52  1  0
 52 53  1  0
 52 54  1  0
 45 55  1  0
 55 56  2  3
 56 43  1  0
 56 57  1  0
 57 15  1  0
 57 58  2  0
 58 10  1  0
 58 59  1  0
 59  7  1  0
 59 60  2  0
 16 61  1  0
M  END
> <name>
NIHCC_2014

> <id>
6321

> <plate>
NGP-202-04

> <well>
B06

> <supplier_cmpd_name>
CPD001227203

> <ctcr_id>
7079

> <supplier_cmpd_id>
SAM002589970

> <smiles>
CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4C(=C(NC(=O)C(=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)/C)C5=NC6(CCN(CC6)CC(C)C)N=C5c4c3C2=O)O

> <pd_targets>
{FTL,NPSR1,POLB,MAPT}

> <pathway_gtopdb>
{"Unclassified protein","Membrane receptor",Enzyme,"Other cytosolic protein","Family A G protein-coupled receptor","Peptide receptor (family A GPCR)","Short peptide receptor (family A GPCR)","Neuropep
tide receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Neuropeptide S receptor"}

> <pathway_reactome>
{"Vesicle-mediated transport",Disease,"DNA Repair","Neuronal System","Membrane Trafficking","Infectious disease","Base Excision Repair","Transmission across Chemical Synapses","trans-Golgi Network Ves
icle Budding","Leishmania infection","Resolution of Abasic Sites (AP sites)","Neurotransmitter receptors and postsynaptic signal transmission","Golgi Associated Vesicle Biogenesis","Leishmania parasit
e growth and survival","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Activation of NMDA receptors and postsynaptic events","Anti-inflammatory response favouring Leish
mania parasite infection","PCNA-Dependent Long Patch Base Excision Repair","Post NMDA receptor activation events","ADORA2B mediated anti-inflammatory cytokines production","Activation of AMPK downstre
am of NMDARs"}

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{CHEBI:45367,"Rifabutin (JAN/USP/INN)",CHEMBL287414,CHEMBL444633,DTXSID0033960,BDBM50237607,AKOS015963033,NC00720,AC-19109,AC19109,"AC 19109",D00424,SAM002589970,CPD001227203}

> <pdid>
PD002887

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{135415564}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 31  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 N   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 N   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.0031   -3.0008    0.0000 O   0  0
   -1.3032   -3.7490    0.0000 C   0  0
   -1.2991    5.2507    0.0000 N   0  0
   -0.0012    6.0029    0.0000 C   0  0
   -0.0036    7.5029    0.0000 C   0  0
   -1.3039    8.2509    0.0000 N   0  0
   -2.6017    7.4988    0.0000 C   0  0
   -2.5993    5.9988    0.0000 C   0  0
   -1.3093    9.7517    0.0000 C   0  0
   -0.0128   10.5060    0.0000 O   0  0
   -2.6114   10.4982    0.0000 C   0  0
   -2.7567   11.9783    0.0000 C   0  0
   -4.2255   12.2827    0.0000 C   0  0
   -4.9689   10.9799    0.0000 C   0  0
   -3.9596    9.8703    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
  9 11  2  0
 11  5  1  0
 11 12  1  0
 12 13  2  0
 13  3  1  0
 13 14  1  0
 14 15  1  0
  7 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 16  1  0
 19 22  1  0
 22 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 24  1  0
M  END
> <name>
NIHCC_2014

> <id>
6322

> <plate>
NGP-202-04

> <well>
C02

> <supplier_cmpd_name>
CPD000058309

> <ctcr_id>
7066

> <supplier_cmpd_id>
SAM002589982

> <smiles>
COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4

> <pd_targets>
{ADRA1A,ADRA1D,ADRA2A,ADRA2C,NFO,KMT2A,MEN1,FFP,ADRA1B,ADRA2B,KDM4E,GLA,GAA,ALDH1A1,KCNH2,HPGD,HTT,SMN1,AMPC,LMNA,HSD17B10,MAPK1,ALD,SLC22A1,ABCC4,KCNH6,KCNH7,TGFB1,TSHR,LEF,TP53,CHRM1,RORC}

> <pathway_gtopdb>
{"Membrane receptor",Enzyme,"Epigenetic regulator","Ion channel","Unclassified protein","Other nuclear protein",Transporter,"Secreted protein","Transcription factor","Family A G protein-coupled recept
or",Hydrolase,Reader,Transferase,Eraser,Oxidoreductase,"Voltage-gated ion channel",Kinase,"Electrochemical transporter","Primary active transporter",Protease,"Small molecule receptor (family A GPCR)",
Bromodomain,"Lysine demethylase","Potassium channels","Methyl-lysine/arginine binding protein","Protein Kinase","SLC superfamily of solute carriers","ATP-binding cassette","Peptide receptor (family A 
GPCR)","Metallo protease","Monoamine receptor","Jumonji domain-containing","Voltage-gated potassium channel","Tudor domain","CMGC protein kinase group","SLC22 family of organic cation and anion transp
orters","ABCC subfamily","Glycohormone receptor","Metallo protease MAE clan","Adrenergic receptor","CMGC protein kinase MAPK family","Metallo protease M34 family","Acetylcholine receptor","CMGC protei
n kinase ERK1","Nuclear receptor","Nuclear hormone receptor subfamily 1","Nuclear hormone receptor subfamily 1 group F","Nuclear hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{Receptors,Enzymes,"Ion channels",Transporters,"G protein-coupled receptors","Chromatin modifying enzymes","3.2.1.- Glycosidases","Voltage-gated ion channels","Eicosanoid turnover","Kinases (EC 2.7.x.
x)","SLC superfamily of solute carriers","ATP-binding cassette transporter family",Adrenoceptors,"1.14.11.- Histone demethylases","Potassium channels","Prostaglandin synthases","CMGC: Containing CDK",
MAPK,GSK3,"CLK families","SLC22 family of organic cation and anion transporters","ABCC subfamily","Glycoprotein hormone receptors","Acetylcholine receptors (muscarinic)","Voltage-gated potassium chann
els","Mitogen-activated protein kinases (MAP kinases)","Organic cation transporters (OCT)","ERK subfamily","Nuclear hormone receptors","1F. Retinoic acid-related orphans"}

> <pathway_reactome>
{"Signal Transduction",Metabolism,Disease,"Muscle contraction","Gene expression (Transcription)","Metabolism of RNA","Cell Cycle","Immune System","Transport of small molecules",Hemostasis,"Neuronal Sy
stem","Signaling by GPCR","Metabolism of lipids","Diseases of metabolism","Biological oxidations","Cardiac conduction","RNA Polymerase II Transcription","Metabolism of non-coding RNA",Mitotic,"Metabol
ism of amino acids and derivatives","Innate Immune System","SLC-mediated transmembrane transport","Platelet activation","signaling and aggregation","Potassium Channels","Diseases of signal transductio
n by growth factor receptors and second messengers","Infectious disease","Cell Cycle Checkpoints","GPCR ligand binding","Sphingolipid metabolism","Diseases of carbohydrate metabolism","Phase I - Funct
ionalization of compounds","Phase 3 - rapid repolarisation","Biosynthesis of specialized proresolving mediators (SPMs)","Generic Transcription Pathway","snRNP Assembly","M Phase","Branched-chain amino
 acid catabolism","Toll-like Receptor Cascades","Transport of bile salts and organic acids","metal ions and amine compounds","Response to elevated platelet cytosolic Ca2+","Voltage gated Potassium cha
nnels","Signaling by TGF-beta Receptor Complex in Cancer","Leishmania infection","Uptake and actions of bacterial toxins","G1/S DNA Damage Checkpoints","Class A/1 (Rhodopsin-like receptors)","Glycosph
ingolipid metabolism","Glycogen storage diseases","Ethanol oxidation","Biosynthesis of DHA-derived SPMs","Transcriptional Regulation by MECP2","Mitotic Metaphase and Anaphase","Toll Like Receptor 5 (T
LR5) Cascade","Organic cation/anion/zwitterion transport","Platelet degranulation","Loss of Function of SMAD2/3 in Cancer","Leishmania parasite growth and survival","Uptake and function of anthrax tox
ins","p53-Dependent G1/S DNA damage checkpoint","Amine ligand-binding receptors","Glycogen storage disease type II (GAA)","Biosynthesis of D-series resolvins","Regulation of MECP2 expression and activ
ity","Mitotic Anaphase","MyD88 cascade initiated on plasma membrane","Organic cation transport","SMAD2/3 Phosphorylation Motif Mutants in Cancer","Anti-inflammatory response favouring Leishmania paras
ite infection","p53-Dependent G1 DNA Damage Response",Adrenoceptors,"Nuclear Envelope (NE) Reassembly","MAP kinase activation","ADORA2B mediated anti-inflammatory cytokines production","Stabilization 
of p53","Muscarinic acetylcholine receptors","Initiation of Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","Autodegradation of the E3 ubiquitin ligase COP1",
"ERK/MAPK targets","ERKs are inactivated","Transcriptional regulation by RUNX3","RUNX3 Regulates Immune Response and Cell Migration"}

> <broad_targets>
{ADRA1A,ADRA1B,ADRA1D}

> <broad_moa>
{"adrenergic receptor antagonist"}

> <synonyms>
{Opera_ID_1910,OperaID1910,Opera-ID-1910,"Opera ID 1910",Prestwick0_000751,Prestwick0000751,Prestwick0-000751,"Prestwick0 000751",Prestwick1_000751,Prestwick1000751,Prestwick1-000751,"Prestwick1 00075
1",Prestwick2_000751,Prestwick2000751,Prestwick2-000751,"Prestwick2 000751",Prestwick3_000751,Prestwick3000751,Prestwick3-000751,"Prestwick3 000751",141269-44-5,141269445,SCHEMBL6528,Lopac0_001138,Lop
ac0001138,Lopac0-001138,"Lopac0 001138",REGID_for_CID_5401,REGIDforCID5401,REGID-for-CID-5401,"REGID for CID 5401",BSPBio_000762,BSPBio000762,BSPBio-000762,"BSPBio 000762",MLS001201836,MLS006011889,SP
Bio_002701,SPBio002701,SPBio-002701,"SPBio 002701",BPBio1_000840,BPBio1000840,BPBio1-000840,"BPBio1 000840",GTPL7302,MET029,DTXSID3023639,HMS20,T0197,SAM002589982,"Terazosin hydrochloride",CPD00005830
9}

> <pdid>
PD002848

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{5401}

$$$$
NIHCC_2014
  SciTegic11012413002D

 31 33  0  0  1  0            999 V2000
    7.1216   -4.0950    0.0000 Na  0  3
    4.6130   -4.5087    0.0000 C   0  0
    3.9403   -5.8494    0.0000 C   0  0
    4.6216   -7.1858    0.0000 O   0  0
    3.5612   -8.2467    0.0000 N   0  0
    2.2245   -7.5661    0.0000 C   0  0
    2.4742   -6.0999    0.0000 C   0  0
    1.4149   -5.0368    0.0000 C   0  0
   -0.0346   -5.4229    0.0000 O   0  0
    1.8050   -3.5876    0.0000 N   0  0
    0.7500   -2.5287    0.0000 C   0  0  1  0  0  0
    0.7500   -1.0323    0.0000 C   0  0  1  0  0  0
    1.2135    0.3943    0.0000 S   0  0
    0.0000    1.2760    0.0000 C   0  0
   -1.3101    2.0064    0.0000 C   0  0
    1.3100    2.0066    0.0000 C   0  0
   -1.2135    0.3943    0.0000 C   0  0  1  0  0  0
   -0.7500   -1.0323    0.0000 N   0  0
   -0.7500   -2.5287    0.0000 C   0  0
   -1.8107   -3.5893    0.0000 O   0  0
   -2.6375    0.8602    0.0000 C   0  0
   -3.7540   -0.1415    0.0000 O   0  5
   -2.9472    2.3279    0.0000 O   0  0
    0.8835   -8.2398    0.0000 C   0  0
   -0.4263   -7.5195    0.0000 C   0  0
   -0.4580   -6.0198    0.0000 Cl  0  0
   -1.7090   -8.2972    0.0000 C   0  0
   -1.6768   -9.7968    0.0000 C   0  0
   -0.3620  -10.5188    0.0000 C   0  0
    0.9207   -9.7411    0.0000 C   0  0
    2.2367  -10.4609    0.0000 Cl  0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  3  2  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 11 10  1  6
 11 12  1  0
 12 13  1  6
 13 14  1  0
 14 15  1  0
 14 16  1  0
 14 17  1  0
 17 18  1  0
 18 12  1  0
 18 19  1  0
 19 11  1  0
 19 20  2  0
 17 21  1  1
 21 22  1  0
 21 23  2  0
  6 24  1  0
 24 25  2  0
 25 26  1  0
 25 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 24  1  0
 30 31  1  0
M  CHG  2   1   1  22  -1
M  END
> <name>
NIHCC_2014

> <id>
6323

> <plate>
NGP-202-04

> <well>
C03

> <supplier_cmpd_name>
CPD000539527

> <ctcr_id>
3587

> <supplier_cmpd_id>
SAM002589990

> <smiles>
[Na+].Cc1onc(c1C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C([O-])=O)c4c(Cl)cccc4Cl

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"Dicloxacillin sodium",343-55-5,343555,HMS502A20,"Sodium dicloxacillin",Dynapen,"Dicloxacillin sodium salt",UNII-4CKS6MOL6Z,UNII4CKS6MOL6Z,Pathocil,Dycill,4CKS6MOL6Z,Veracillin,CHEBI:34691,13412-64-1
,13412641,"Dicloxacillin (sodium)","P 1011",Dichlor-Stapenor,DichlorStapenor,SMR,SAM002589990,1500238,CPD000539527,"DICLOXACILLIN SODIUM"}

> <pdid>
PD002381

> <targets>
{}

> <classes>
{antibacterial}

> <pubchem_cids>
{101327128,23667628}

$$$$
NIHCC_2014
  SciTegic11012413002D

 15 16  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 N   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5987    1.5004    0.0000 C   0  0  2  0  0  0
   -2.7390    2.9810    0.0000 C   0  0
   -4.2067    3.2905    0.0000 S   0  0
   -4.9546    1.9903    0.0000 C   0  0  2  0  0  0
   -6.4447    1.8344    0.0000 C   0  0
   -7.3266    3.0478    0.0000 O   0  0
   -3.9492    0.8772    0.0000 O   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  3
  8  2  1  0
  9  6  1  1
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  1
 13 14  1  0
 12 15  1  0
 15  9  1  0
M  END
> <name>
NIHCC_2014

> <id>
6324

> <plate>
NGP-202-04

> <well>
C04

> <supplier_cmpd_name>
CPD000466319

> <ctcr_id>
512

> <supplier_cmpd_id>
SAM002589994

> <smiles>
NC1=NC(=O)N(C=C1)[C@@H]2CS[C@H](CO)O2

> <pd_targets>
{POL,ALB,LMNA,MAPT,CACNA1C,CACNA1D,CACNA1F,CACNA1S,HSF1,P,POLA1,POLA2,POLD1,POLD2,POLD3,POLD4,POLE,POLE2,POLE3,PRIM1,PRIM2}

> <pathway_gtopdb>
{Enzyme,"Secreted protein","Other nuclear protein","Other cytosolic protein","Ion channel",Hydrolase,"Voltage-gated ion channel",Transferase,"Voltage-gated calcium channel"}

> <pathway_chembl>
{}

> <pathway_reactome>
{Metabolism,"Cell Cycle","Neuronal System","Cellular responses to external stimuli","Metabolism of lipids",Mitotic,"Transmission across Chemical Synapses","Cellular responses to stress","Metabolism of
 steroids","M Phase","Neurotransmitter receptors and postsynaptic signal transmission","Cellular response to heat stress","Bile acid and bile salt metabolism","Mitotic Metaphase and Anaphase","Activat
ion of NMDA receptors and postsynaptic events","HSF1-dependent transactivation","Recycling of bile acids and salts","Mitotic Anaphase","Post NMDA receptor activation events","Attenuation phase","Nucle
ar Envelope (NE) Reassembly","Activation of AMPK downstream of NMDARs","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{}

> <broad_moa>
{"nucleoside reverse transcriptase inhibitor"}

> <synonyms>
{lamivudine,134678-17-4,134678174,Epivir,Zeffix,Heptovir,Epivir-HBV,EpivirHBV,Heptodin,3TC,BCH-189,BCH189,(-)-2'-Deoxy-3'-thiacytidine,()2'Deoxy3'thiacytidine,"2',3'-Dideoxy-3'-thiacytidine","2',3'Did
eoxy3'thiacytidine","3'-Thia-2',3'-dideoxycytidine","3'Thia2',3'dideoxycytidine",GR-109714X,GR109714X,(-)-BCH-189,()BCH189,"beta-L-2',3'-Dideoxy-3'-thiacytidine","betaL2',3'Dideoxy3'thiacytidine",beta
-L-3'-,betaL3',T0682,SAM002589994,SAM001246582,Prestw-1298,Lamivudine,CPD000466319}

> <pdid>
PD000853

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{60825}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 31  0  0  1  0            999 V2000
    7.7996   -1.4883    0.0000 C   0  0
    6.4990   -0.7409    0.0000 C   0  0
    5.2003   -1.4932    0.0000 C   0  0  2  0  0  0
    5.2029   -2.9932    0.0000 C   0  0
    3.8990   -0.7455    0.0000 C   0  0
    3.8964    0.7545    0.0000 O   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0  2  0  0  0
   -1.2990   -5.2500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0  2  0  0  0
    1.2982   -3.7531    0.0000 C   0  0
    1.2961   -5.2539    0.0000 C   0  0
    2.5943   -6.0070    0.0000 C   0  0  2  0  0  0
    2.5944   -7.5070    0.0000 C   0  0
    3.8934   -8.2570    0.0000 C   0  0  1  0  0  0
    3.8934   -9.7570    0.0000 O   0  0
    5.1924   -7.5071    0.0000 C   0  0
    5.1925   -6.0071    0.0000 C   0  0
    6.4915   -5.2571    0.0000 O   0  0
    3.8935   -5.2570    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0  1  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  6
  3  5  1  0
  5  6  2  0
  5  7  1  0
  8  7  1  6
  8  9  1  0
  9 10  1  0
 10 11  1  6
 10 12  1  0
 12 13  2  3
 13 14  1  0
 14 15  2  3
 15 16  1  0
 16 17  1  1
 16 18  1  0
 18 19  1  1
 19 20  1  0
 21 20  1  1
 21 22  1  0
 22 23  1  0
 23 24  1  6
 23 25  1  0
 25 26  1  0
 26 27  2  0
 26 28  1  0
 28 21  1  0
 18 29  1  0
 29  8  1  0
 29 13  1  6
M  END
> <name>
NIHCC_2014

> <id>
6325

> <plate>
NGP-202-04

> <well>
C05

> <supplier_cmpd_name>
CPD000673570

> <ctcr_id>
3349

> <supplier_cmpd_id>
SAM002589963

> <smiles>
CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12

> <pd_targets>
{ALOX15,HMGCR,HDAC6,FTL,HDAC1,RORC,ITGAL,NR1I2,ACAT,TGR,LMNA,TSHR,MAPT,AR,HDAC2,ABCB1,ICAM1,HIF1A,FFP,CYP3A4,BCHE,ITGB2,SMN1,ALD,ACHE,KDM4E,ABCB11,SLC6A2,TACR2,ADORA1,SLC6A3,SLCO1B1}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator","Unclassified protein","Transcription factor",Adhesion,"Other nuclear protein","Membrane receptor","Other cytosolic protein",Transporter,Oxidoreductase,Eraser,"Nuclear r
eceptor","Family A G protein-coupled receptor",Protease,"Primary active transporter",Transferase,"Cytochrome P450",Hydrolase,Reader,"Electrochemical transporter","Histone deacetylase","Nuclear hormone
 receptor subfamily 1","Peptide receptor (family A GPCR)","Cysteine protease","Nuclear hormone receptor subfamily 3","ATP-binding cassette","Cytochrome P450 family 3","Methyl-lysine/arginine binding p
rotein","Lysine demethylase","SLC superfamily of solute carriers","Small molecule receptor (family A GPCR)","HDAC class IIb","HDAC class I","Nuclear hormone receptor subfamily 1 group F","Nuclear horm
one receptor subfamily 1 group I","Glycohormone receptor","Cysteine protease CA clan","Nuclear hormone receptor subfamily 3 group C","ABCB subfamily","Cytochrome P450 family 3A","Tudor domain","Jumonj
i domain-containing","SLC06 neurotransmitter transporter family","Short peptide receptor (family A GPCR)","Nucleotide-like receptor (family A GPCR)","SLC21/SLCO family of organic anion transporting po
lypeptides","Nuclear hormone receptor subfamily 1 group F member 3","Nuclear hormone receptor subfamily 1 group I member 2","Cysteine protease C1A family","Nuclear hormone receptor subfamily 3 group C
 member 4","Cytochrome P450 3A4","Neurokinin receptor","Adenosine receptor"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"Eicosanoid turnover","Lanosterol biosynthesis pathway","Chromatin modifying enzymes","Nuclear hormone receptors","Catalytic receptors","G protein-coupled receptors","A
TP-binding cassette transporter family","Cytochrome P450","Acetylcholine turnover","SLC superfamily of solute carriers",Lipoxygenases,"3.5.1.- Histone deacetylases (HDACs)","1F. Retinoic acid-related 
orphans",Integrins,"1I. Vitamin D receptor-like receptors","Glycoprotein hormone receptors","Steroid hormone receptors","ABCB subfamily","CYP3 family","1.14.11.- Histone demethylases","SLC6 neurotrans
mitter transporter family","Tachykinin receptors","Adenosine receptors","SLCO family of organic anion transporting polypeptides","3C. 3-Ketosteroid receptors","Monoamine transporter subfamily"}

> <pathway_reactome>
{Metabolism,"Gene expression (Transcription)","Vesicle-mediated transport",Disease,"Metabolism of proteins","Cell Cycle","Neuronal System","Immune System","Cellular responses to external stimuli","Met
abolism of RNA","Signal Transduction","Metabolism of lipids","RNA Polymerase II Transcription","Membrane Trafficking","Disorders of Developmental Biology","Post-translational protein modification",Mit
otic,"Infectious disease","Transmission across Chemical Synapses","Abacavir transport and metabolism","Cytokine Signaling in Immune system","Cellular responses to stress","Metabolism of non-coding RNA
","Disorders of transmembrane transporters","Signaling by GPCR","Biosynthesis of specialized proresolving mediators (SPMs)","Metabolism of steroids","Generic Transcription Pathway","trans-Golgi Networ
k Vesicle Budding","Disorders of Nervous System Development",SUMOylation,"M Phase","Leishmania infection","Neurotransmitter receptors and postsynaptic signal transmission","Abacavir transmembrane tran
sport","Interferon Signaling","Cellular response to hypoxia","Phospholipid metabolism","snRNP Assembly","SLC transporter disorders","GPCR ligand binding","Biosynthesis of DPA-derived SPMs","Regulation
 of cholesterol biosynthesis by SREBP (SREBF)","Transcriptional regulation by RUNX2","Golgi Associated Vesicle Biogenesis","Pervasive developmental disorders","Transcriptional regulation by RUNX3","SU
MO E3 ligases SUMOylate target proteins","Mitotic Metaphase and Anaphase","Leishmania parasite growth and survival","Activation of NMDA receptors and postsynaptic events","Transcriptional Regulation b
y TP53","Interferon gamma signaling","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Biosynthesis of DHA-derived SPMs","Glycerophospholipid biosynthesis","Bile acid and bil
e salt metabolism","Defective SLC6A2 causes orthostatic intolerance (OI)","Class A/1 (Rhodopsin-like receptors)","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Biosynthesis of DPAn
-3 SPMs","Activation of gene expression by SREBF (SREBP)","RUNX2 regulates bone development","Loss of function of MECP2 in Rett syndrome","RUNX3 Regulates Immune Response and Cell Migration","SUMOylat
ion of intracellular receptors","Mitotic Anaphase","Anti-inflammatory response favouring Leishmania parasite infection","Post NMDA receptor activation events","Regulation of TP53 Activity","Biosynthes
is of maresins","Synthesis of PC","Synthesis of bile acids and bile salts","Peptide ligand-binding receptors","Nucleotide-like (purinergic) receptors","Recycling of bile acids and salts","Biosynthesis
 of DPAn-3-derived protectins and resolvins","RUNX2 regulates osteoblast differentiation","Loss of MECP2 binding ability to 5mC-DNA","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammat
ory cytokines production","Activation of AMPK downstream of NMDARs","Regulation of TP53 Activity through Acetylation","Biosynthesis of maresin-like SPMs","Synthesis of bile acids and bile salts via 7a
lpha-hydroxycholesterol","Tachykinin receptors bind tachykinins","Adenosine P1 receptors","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{HDAC2,HMGCR,ITGAL,NR1I2}

> <broad_moa>
{"HMGCR inhibitor"}

> <synonyms>
{DSSTox_RID_75788,DSSToxRID75788,DSSTox-RID-75788,"DSSTox RID 75788",lovastatin,DSSTox_GSID_20784,DSSToxGSID20784,DSSTox-GSID-20784,"DSSTox GSID 20784",Liposcler,"6 alpha-Methylcompactin","6 alphaMeth
ylcompactin",Rextat,"Monakolin K","Mevacor (TN)",CHEMBL503,"Lovastatin & Primycin","Lovastatin (USP/INN)",SR-05000001880,SR05000001880,"BRN 3631989","Mevinolin from Aspergillus sp.",CCRIS,T1207,100103
38,SAM002589963,1503977,Prestw-516,Lovastatin,CPD000673570,LOVASTATIN}

> <pdid>
PD003114

> <targets>
{Autophagy,Ferroptosis,HMG-CoA Reductase (HMGCR)}

> <classes>
{antihyperlipidemic,HMGCoA reductase inhibitor,Apoptosis,Autophagy,Metabolic Enzyme/Protease}

> <pubchem_cids>
{53232}

$$$$
NIHCC_2014
  SciTegic11012413002D

 25 26  0  0  0  0            999 V2000
    3.8912   -5.2570    0.0000 C   0  0
    3.8933   -3.7570    0.0000 C   0  0
    2.5951   -3.0039    0.0000 O   0  0
    2.5973   -1.5031    0.0000 C   0  0
    3.8976   -0.7553    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 N   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.5133   -2.9102    0.0000 C   0  0
   -0.4490   -4.0610    0.0000 C   0  0
    0.0662   -5.4697    0.0000 C   0  0
    1.5439   -5.7278    0.0000 C   0  0
    2.5062   -4.5772    0.0000 C   0  0
    1.9910   -3.1685    0.0000 C   0  0
   -0.8961   -6.6203    0.0000 Cl  0  0
   -1.9267   -3.8029    0.0000 Cl  0  0
   -2.5972   -1.5031    0.0000 C   0  0
   -3.8976   -0.7554    0.0000 O   0  0
   -2.5951   -3.0039    0.0000 O   0  0
   -3.8926   -3.7566    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  2  3
  7  8  1  0
  8  9  1  0
  9 10  2  3
 10 11  1  0
 11  6  1  0
 11 12  1  0
 12 13  2  3
 13 14  1  0
 14 15  2  3
 15 16  1  0
 16 17  2  3
 17 12  1  0
 14 18  1  0
 13 19  1  0
 10 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
  9 24  1  0
  7 25  1  0
M  END
> <name>
NIHCC_2014

> <id>
6326

> <plate>
NGP-202-04

> <well>
C06

> <supplier_cmpd_name>
CPD001496951

> <ctcr_id>
7080

> <supplier_cmpd_id>
SAM002589971

> <smiles>
CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C

> <pd_targets>
{SCN1A,SCN2A,SCN3A,AURKB,LMNA,NPSR1,NS1,BLM,GMNN,NR1H4,CFTR,NFO,NR1I2,PMP22,KDM4E,MAPT,ABCB1,ADORA3,ABCB11,CYP2C9,MTOR,CACNA1C,CACNA1D,CACNA1F,CACNA1S,NR3C2,CACNA2D1,CACNB2,CACNA1H,CACNA2D2,CALM1,PDE1
B,PDE1A,TNNC2,TNNC1,HSD17B10,CYP2C19,ALDH1A1,LEF,CYP1A2,HIF1A,CYP3A4,HPGD}

> <pathway_gtopdb>
{"Ion channel",Enzyme,"Other nuclear protein","Membrane receptor","Unclassified protein","Transcription factor","Epigenetic regulator","Other cytosolic protein",Transporter,"Auxiliary transport protei
n","Voltage-gated ion channel",Protease,Kinase,"Family A G protein-coupled receptor","Nuclear receptor","Other ion channel",Hydrolase,Eraser,"Primary active transporter","Cytochrome P450","Calcium cha
nnel auxiliary subunit alpha2delta family","Calcium channel auxiliary subunit beta family",Phosphodiesterase,Oxidoreductase,"Voltage-gated sodium channel","Cysteine protease","Protein Kinase","Peptide
 receptor (family A GPCR)","Nuclear hormone receptor subfamily 1","Chloride channel","Lysine demethylase","ATP-binding cassette","Small molecule receptor (family A GPCR)","Cytochrome P450 family 2","V
oltage-gated calcium channel","Nuclear hormone receptor subfamily 3","Phosphodiesterase 1","Metallo protease","Cytochrome P450 family 1","Cytochrome P450 family 3","Cysteine protease CA clan","Other p
rotein kinase group","Short peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1 group H","Cystic fibrosis transmembrane conductance regulator","Nuclear hormone receptor subfamily 1
 group I","Jumonji domain-containing","ABCB subfamily","Nucleotide-like receptor (family A GPCR)","Cytochrome P450 family 2C","Atypical protein kinase group","Nuclear hormone receptor subfamily 3 grou
p C","Phosphodiesterase 1B","Phosphodiesterase 1A","Metallo protease MAE clan","Cytochrome P450 family 1A","Cytochrome P450 family 3A","Cysteine protease C1A family","Other protein kinase AUR family",
"Neuropeptide receptor","Nuclear hormone receptor subfamily 1 group H member 4","Nuclear hormone receptor subfamily 1 group I member 2","Adenosine receptor","Cytochrome P450 2C9","Atypical protein kin
ase PIKK family","Nuclear hormone receptor subfamily 3 group C member 2","Cytochrome P450 2C19","Metallo protease M34 family","Cytochrome P450 1A1","Cytochrome P450 3A4","Atypical protein kinase FRAP 
subfamily"}

> <pathway_chembl>
{Receptors,"Ion channels",Enzymes,Transporters,"Catalytic receptors","G protein-coupled receptors","Nuclear hormone receptors","Other ion channels","Chromatin modifying enzymes","ATP-binding cassette 
transporter family","Cytochrome P450","Kinases (EC 2.7.x.x)","Voltage-gated ion channels","Cyclic nucleotide turnover/signalling","Eicosanoid turnover","Receptor kinases","Neuropeptide S receptor","1H
. Liver X receptor-like receptors","Chloride channels","1I. Vitamin D receptor-like receptors","1.14.11.- Histone demethylases","ABCB subfamily","Adenosine receptors","CYP2 family: drug metabolising s
ubset",Atypical,"Steroid hormone receptors","Voltage-gated calcium channels",Phosphodiesterases,3',"5'-cyclic nucleotide (PDEs)","CYP1 family","CYP3 family","Prostaglandin synthases","Other protein ki
nases",CFTR,"Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","3C. 3-Ketosteroid receptors","Aurora kinase (Aur) family","FRAP subfamily"}

> <pathway_reactome>
{"Cell Cycle",Disease,"DNA Repair",Metabolism,Autophagy,"Metabolism of proteins","Developmental Biology","Neuronal System","Signal Transduction","Gene expression (Transcription)","Muscle contraction",
"Cellular responses to external stimuli",Mitotic,"Infectious disease","DNA Double-Strand Break Repair","Metabolism of lipids",Macroautophagy,"Post-translational protein modification","Nervous system d
evelopment","Transmission across Chemical Synapses","Abacavir transport and metabolism","Signaling by GPCR","Biological oxidations","RNA Polymerase II Transcription","Integration of energy metabolism"
,"Intracellular signaling by second messengers","Striated Muscle Contraction","Metabolism of amino acids and derivatives","Cellular responses to stress","M Phase","Leishmania infection","Homology Dire
cted Repair","Mitotic G1 phase and G1/S transition","Metabolism of steroids","Selective autophagy",SUMOylation,"EGR2 and SOX10-mediated initiation of Schwann cell myelination","Neurotransmitter recept
ors and postsynaptic signal transmission","Abacavir transmembrane transport","GPCR ligand binding","Phase I - Functionalization of compounds","Generic Transcription Pathway","Axon guidance","Regulatio
n of insulin secretion","DAG and IP3 signaling","Branched-chain amino acid catabolism","Uptake and actions of bacterial toxins","Cellular response to hypoxia","Biosynthesis of specialized proresolving
 mediators (SPMs)","Mitotic Metaphase and Anaphase","Leishmania parasite growth and survival","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","G1/S Transition","Bile acid
 and bile salt metabolism",Aggrephagy,"SUMO E3 ligases SUMOylate target proteins","Activation of NMDA receptors and postsynaptic events","Class A/1 (Rhodopsin-like receptors)","Cytochrome P450 - arran
ged by substrate type","Transcriptional Regulation by TP53","NCAM signaling for neurite out-growth",Adrenaline,"noradrenaline inhibits insulin secretion","CaM pathway","Ethanol oxidation","Uptake and 
function of anthrax toxins","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Biosynthesis of DHA-derived SPMs","Mitotic Anaphase","Anti-inflammatory response favouring Leish
mania parasite infection","HDR through Homologous Recombination (HRR)","Activation of the pre-replicative complex","Synthesis of bile acids and bile salts","SUMOylation of intracellular receptors","Po
st NMDA receptor activation events","Nucleotide-like (purinergic) receptors",Xenobiotics,"Regulation of TP53 Activity","NCAM1 interactions","Calmodulin induced events","Biosynthesis of maresins","Bios
ynthesis of D-series resolvins","Separation of Sister Chromatids","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory cytokines production","Homologous DNA Pairing and Strand Exchan
ge","Synthesis of bile acids and bile salts via 27-hydroxycholesterol","Activation of AMPK downstream of NMDARs","Adenosine P1 receptors","Synthesis of bile acids and bile salts via 7alpha-hydroxychol
esterol","CYP2E1 reactions","Regulation of TP53 Expression and Degradation","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","Cam-PDE 1 activation","Aromatic amines c
an be N-hydroxylated or N-dealkylated by CYP1A2","Biosynthesis of maresin-like SPMs","Initiation of Nuclear Envelope (NE) Reformation","Presynaptic phase of homologous DNA pairing and strand exchange"
,"Regulation of TP53 Degradation","Ras activation upon Ca2+ influx through NMDA receptor"}

> <broad_targets>
{CFTR}

> <broad_moa>
{"calcium channel blocker"}

> <synonyms>
{felodipine,72509-76-3,72509763,Plendil,Flodil,Renedil,Feloday,Munobal,Splendil,dl-Felodipine,dlFelodipine,Perfudal,Prevex,Hydac,Modip,Agon,Felodipina,Felodipinum,"Felodipinum (INN-Latin)","Felodipinu
m (INNLatin)","Felodipina (INN-Spanish)","Felodipina (INNSpanish)",C18H19Cl2NO4,86189-69-7,86189697,"Felodipine (Plendil)",H,SAM002589971,CPD001496951}

> <pdid>
PD000685

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{3333}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 24  0  0  0  0            999 V2000
   -0.2125   -9.4726    0.0000 N   0  0
   -0.6977   -8.0533    0.0000 S   0  0
   -2.1696   -7.7642    0.0000 O   0  0
   -1.6841   -9.1833    0.0000 O   0  0
    0.2898   -6.9231    0.0000 C   0  0
   -0.1949   -5.5036    0.0000 C   0  0
    0.7921   -4.3740    0.0000 C   0  0
    2.2638   -4.6640    0.0000 C   0  0
    2.7485   -6.0835    0.0000 C   0  0
    1.7615   -7.2131    0.0000 C   0  0
    2.2463   -8.6326    0.0000 Cl  0  0
    0.3114   -2.9665    0.0000 C   0  0
   -1.1510   -2.6328    0.0000 O   0  0
    1.8032   -3.1233    0.0000 N   0  0
    2.4133   -1.7530    0.0000 C   0  0
    3.8805   -1.4410    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  2  0
  2  4  2  0
  2  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 10 11  1  0
  7 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 12  1  0
 22 17  1  0
M  END
> <name>
NIHCC_2014

> <id>
6327

> <plate>
NGP-202-04

> <well>
D02

> <supplier_cmpd_name>
CPD000058635

> <ctcr_id>
1271

> <supplier_cmpd_id>
SAM002589983

> <smiles>
N[S](=O)(=O)c1cc(ccc1Cl)C2(O)NC(=O)c3ccccc23

> <pd_targets>
{CA1,CA4,CA6,CA12,CA7,CA9,CA14,MAPT,CA5B,CA13,CA2,CA3,CA5A,SLC12A3,SLC12A1}

> <pathway_gtopdb>
{Enzyme,"Other cytosolic protein",Transporter,Lyase,"Electrochemical transporter","SLC superfamily of solute carriers","SLC12 family of cation-coupled chloride transporters"}

> <pathway_chembl>
{Enzymes,Transporters,"Carbonic anhydrases","SLC superfamily of solute carriers","SLC12 family of cation-coupled chloride transporters"}

> <pathway_reactome>
{"Immune System","Transport of small molecules",Metabolism,"Cellular responses to external stimuli","Neuronal System",Disease,"Cytokine Signaling in Immune system","O2/CO2 exchange in erythrocytes","R
eversible hydration of carbon dioxide","Cellular responses to stress","Transmission across Chemical Synapses","Disorders of transmembrane transporters","Signaling by Interleukins","Erythrocytes take u
p carbon dioxide and release oxygen","Cellular response to hypoxia","Neurotransmitter receptors and postsynaptic signal transmission","SLC transporter disorders","Interleukin-12 family signaling","Reg
ulation of gene expression by Hypoxia-inducible Factor","Activation of NMDA receptors and postsynaptic events","Defective SLC12A3 causes Gitelman syndrome (GS)","Defective SLC12A1 causes Bartter syndr
ome 1 (BS1)","Interleukin-12 signaling","Post NMDA receptor activation events","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","Activation of AMPK downstream of NM
DARs"}

> <broad_targets>
{CA1,CA12,CA14,CA2,CA4,CA7,SLC12A1}

> <broad_moa>
{"carbonic anhydrase inhibitor"}

> <synonyms>
{chlorthalidone,Chlortalidone,77-36-1,77361,Phthalamudine,Chlorphthalidolone,Chlorthalidon,Hygroton,Phthalamodine,Chlorothalidone,Thalitone,Chlorphthalidone,Natriuran,Saluretin,Zambesil,Igroton,Isoren
,Oradil,Renon,Hydro-Long,HydroLong,Oxodolin,Chlortalidonum,O,T1091,SAM002589983,1500187,Prestw-351,CPD000058635,CHLORTHALIDONE,Chlorthalidone}

> <pdid>
PD002421

> <targets>
{}

> <classes>
{antihypertensive,diuretic}

> <pubchem_cids>
{2732}

$$$$
NIHCC_2014
  SciTegic11012413002D

 23 25  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 S   0  0
   -1.3164   -2.2191    0.0000 O   0  0
    1.3163   -2.2193    0.0000 O   0  0
    2.5972    1.5031    0.0000 C   0  0
    3.8976    0.7554    0.0000 O   0  0
    2.5951    3.0039    0.0000 N   0  0
    3.8933    3.7570    0.0000 C   0  0
    4.0312    5.2379    0.0000 S   0  0
    5.4984    5.5498    0.0000 C   0  0
    6.1085    6.9201    0.0000 C   0  0
    6.2484    4.2507    0.0000 C   0  0
    5.2447    3.1360    0.0000 N   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  3
  4  5  1  0
  4  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
 11 12  1  0
 12  2  1  0
 12 13  2  0
 12 14  2  0
  3 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 20 22  2  0
 22 23  1  0
 23 18  2  0
M  END
> <name>
NIHCC_2014

> <id>
6328

> <plate>
NGP-202-04

> <well>
D03

> <supplier_cmpd_name>
CPD000718800

> <ctcr_id>
6694

> <supplier_cmpd_id>
SAM002589991

> <smiles>
CN1C(=C(O)c2ccccc2[S]1(=O)=O)C(=O)Nc3sc(C)cn3

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{PTGS1,PTGS2}

> <broad_moa>
{"cyclooxygenase inhibitor"}

> <synonyms>
{meloxicam,71125-38-7,71125387,Mobic,Metacam,Movalis,Mobicox,"Meloxicam (Mobic)",Mobec,Movatec,Parocin,"Meloxicamum (Latin)","UH-AC 62XX","UHAC 62XX",Meloxicamum,UNII-VG2QF83CGL,UNIIVG2QF83CGL,UHAC-62
XX,UHAC62XX,C14H13N3O4S2,VG2QF83CGL,CHEMBL599,MLS000028587,CHEBI:6741,MFCD00868752,NCGC0,T0826,SAM002589991,Prestw-369,Meloxicam,CPD000718800}

> <pdid>
PD001257

> <targets>
{Apoptosis,Autophagy,COX}

> <classes>
{Apoptosis,Autophagy,Immunology/Inflammation}

> <pubchem_cids>
{54677470}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 25  0  0  0  0            999 V2000
    3.8805   -1.4410    0.0000 C   0  0
    2.4133   -1.7530    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5973    1.5031    0.0000 C   0  0
   -2.5951    3.0039    0.0000 N   0  0
   -1.3786    3.8595    0.0000 C   0  0
   -1.8372    5.2877    0.0000 C   0  0
   -3.3372    5.2929    0.0000 N   0  0
   -3.8056    3.8679    0.0000 C   0  0
   -5.2311    3.4009    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.3114   -2.9665    0.0000 C   0  0
   -0.5701   -4.1788    0.0000 C   0  0
    0.0400   -5.5491    0.0000 C   0  0
    1.5318   -5.7059    0.0000 C   0  0
    2.4135   -4.4923    0.0000 C   0  0
    1.8032   -3.1233    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  8  1  0
 12 13  1  0
  6 14  1  0
 14 15  2  0
 14 16  1  0
 16  3  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22  2  1  0
 22 17  1  0
M  END
> <name>
NIHCC_2014

> <id>
6329

> <plate>
NGP-202-04

> <well>
D04

> <supplier_cmpd_name>
CPD001307702

> <ctcr_id>
7076

> <supplier_cmpd_id>
SAM002589958

> <smiles>
Cn1c2CCC(Cn3ccnc3C)C(=O)c2c4ccccc14

> <pd_targets>
{HTR3A,HTR3B,HTR2C,HTR4,CCKBR,KCNH2,HTR3C,HTR3D,HTR3E,OPRM1,CHRNA7,HTR1D,HTR2A,HTR2B,CHRM1,SIGMAR1,CHRNA4,CHRNB2,CYP3A4,GABRA1,GABRA2,GABRA3,GABRA4,GABRA5,GABRA6,GABRB1,GABRB2,GABRB3,GABRD,GABRE,GABRG
1,GABRG2,GABRG3,GABRP,GABRQ,HTR1B,CHRNA3,CHRNB4,SLC47A2,SLC22A1,SLC22A2,SLC47A1,SLC22A3,HTR1A}

> <pathway_gtopdb>
{"Ion channel","Membrane receptor",Enzyme,Transporter,"Ligand-gated ion channel","Family A G protein-coupled receptor","Voltage-gated ion channel","Cytochrome P450","Electrochemical transporter","5HT3
 receptor","Small molecule receptor (family A GPCR)","Peptide receptor (family A GPCR)","Potassium channels","Nicotinic acetylcholine receptor","Cytochrome P450 family 3","GABA-A receptor","SLC superf
amily of solute carriers","Monoamine receptor","Short peptide receptor (family A GPCR)","Voltage-gated potassium channel","Nicotinic acetylcholine receptor alpha subunit","Cytochrome P450 family 3A","
SLC47 family of multidrug and toxin extrusion transporters","SLC22 family of organic cation and anion transporters","Serotonin receptor","Cholecystokinin receptor","Opioid receptor","Acetylcholine rec
eptor","Cytochrome P450 3A4"}

> <pathway_chembl>
{"Ion channels",Receptors,"Other protein targets",Enzymes,Transporters,"Ligand-gated ion channels","G protein-coupled receptors","Voltage-gated ion channels","Sigma receptors","Cytochrome P450","SLC s
uperfamily of solute carriers","5-HT<sub>3</sub> receptors","5-Hydroxytryptamine receptors","Cholecystokinin receptors","Potassium channels","Opioid receptors","Nicotinic acetylcholine receptors","Ace
tylcholine receptors (muscarinic)","CYP3 family","SLC47 family of multidrug and toxin extrusion transporters","SLC22 family of organic cation and anion transporters","Voltage-gated potassium channels"
,"Organic cation transporters (OCT)"}

> <pathway_reactome>
{"Neuronal System","Signal Transduction",Disease,"Muscle contraction",Metabolism,"Transport of small molecules","Transmission across Chemical Synapses","Signaling by GPCR","Infectious disease","Cardia
c conduction","Metabolism of lipids","SLC-mediated transmembrane transport","Neurotransmitter receptors and postsynaptic signal transmission","GPCR ligand binding","Leishmania infection","GPCR downstr
eam signalling","Phase 3 - rapid repolarisation","SARS-CoV Infections","Biosynthesis of specialized proresolving mediators (SPMs)","Transport of bile salts and organic acids","metal ions and amine com
pounds","Class A/1 (Rhodopsin-like receptors)","Leishmania parasite growth and survival","G alpha (q) signalling events","G alpha (i) signalling events","Acetylcholine binding and downstream events","
Potential therapeutics for SARS","Biosynthesis of DHA-derived SPMs","Organic cation/anion/zwitterion transport","Amine ligand-binding receptors","Anti-inflammatory response favouring Leishmania parasi
te infection","Gastrin-CREB signalling pathway via PKC and MAPK","Opioid Signalling","Postsynaptic nicotinic acetylcholine receptors","Biosynthesis of maresins","Organic cation transport","Serotonin r
eceptors","ADORA2B mediated anti-inflammatory cytokines production","G-protein activation","Highly calcium permeable postsynaptic nicotinic acetylcholine receptors","Muscarinic acetylcholine receptors
","Biosynthesis of maresin-like SPMs"}

> <broad_targets>
{HTR3A,HTR3B}

> <broad_moa>
{"serotonin receptor antagonist"}

> <synonyms>
{ondansetron,99614-02-5,99614025,Zofran,Zudan,Zophren,Zuplenz,"9-methyl-3-((2-methylimidazol-1-yl)methyl)-2,3-dihydro-1H-carbazol-4-one","9methyl3((2methylimidazol1yl)methyl)2,3dihydro1Hcarbazol4one",
116002-70-1,116002701,"GR 38032X","GR 38032",CHEBI:7773,99614-01-4,99614014,NCGC00179341-02,NCGC0017934102,DSSTox_CID_3393,DSSToxCID3393,DSSTox-CID-3393,"DSSTox CID 3393",DSSTox_RID_77011,DSSToxRID770
11,DSSTox-RID-77011,"DSSTox RID 77011",DSSTox_GS,DSSToxGS,DSSTox-GS,"DSSTox GS",T1478,SAM002589958,"Ondansetron hydrochloride",CPD001307702}

> <pdid>
PD002938

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{4595}

$$$$
NIHCC_2014
  SciTegic11012413002D

 17 18  0  0  0  0            999 V2000
    2.5228   -3.0436    0.0000 C   0  0
    1.2626   -2.2300    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 O   0  0
    2.5629    0.0216    0.0000 C   0  0
    3.8799   -0.6963    0.0000 C   0  0
    5.1602    0.0853    0.0000 C   0  0
    5.1235    1.5848    0.0000 C   0  0
    6.4037    2.3664    0.0000 N   0  0
    3.8064    2.3028    0.0000 C   0  0
    2.5262    1.5212    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  6  8  1  0
  8  9  1  0
  9  3  1  0
  9 10  2  0
  3 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 14 16  1  0
 16 17  2  0
 17 11  1  0
M  END
> <name>
NIHCC_2014

> <id>
6330

> <plate>
NGP-202-04

> <well>
D05

> <supplier_cmpd_name>
CPD000326785

> <ctcr_id>
376

> <supplier_cmpd_id>
SAM002589964

> <smiles>
CCC1(CCC(=O)NC1=O)c2ccc(N)cc2

> <pd_targets>
{CYP19A1,CYP17A1,CYP3A4,CYP11B2,TBXAS1,CYP11A1,PMP22,NFKB1}

> <pathway_gtopdb>
{Enzyme,"Unclassified protein","Other cytosolic protein","Cytochrome P450","Cytochrome P450 family 19","Cytochrome P450 family 17","Cytochrome P450 family 3","Cytochrome P450 family 11","Cytochrome P4
50 family 5","Cytochrome P450 family 19A","Cytochrome P450 family 17A","Cytochrome P450 family 3A","Cytochrome P450 family 11B","Cytochrome P450 family 5A","Cytochrome P450 family 11A","Cytochrome P45
0 19A1","Cytochrome P450 17A1","Cytochrome P450 3A4","Cytochrome P450 11B2","Cytochrome P450 5A1","Cytochrome P450 11A1"}

> <pathway_chembl>
{Enzymes,"Cytochrome P450",CYP11,CYP17,CYP19,"CYP20 and CYP21 families","CYP3 family",CYP5,"CYP7 and CYP8 families"}

> <pathway_reactome>
{Metabolism,"Developmental Biology","Immune System","Biological oxidations","Metabolism of lipids","Nervous system development","Cytokine Signaling in Immune system","Phase I - Functionalization of co
mpounds","Metabolism of steroids","Biosynthesis of specialized proresolving mediators (SPMs)","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Signaling by Interleukins","Cytochrome P
450 - arranged by substrate type","Metabolism of steroid hormones","Biosynthesis of DHA-derived SPMs","Interleukin-1 family signaling","Endogenous sterols","Androgen biosynthesis","Biosynthesis of mar
esins",Eicosanoids,"Interleukin-1 signaling","Biosynthesis of maresin-like SPMs","MAP3K8 (TPL2)-dependent MAPK1/3 activation"}

> <broad_targets>
{CYP11A1,CYP19A1}

> <broad_moa>
{"glucocorticoid receptor antagonist"}

> <synonyms>
{PARA-AMIN,PARAAMIN,aminoglutethimide,125-84-8,125848,dl-Aminoglutethimide,dlAminoglutethimide,Cytadren,Orimeten,p-Aminoglutethimide,pAminoglutethimide,Elipten,"3-(4-aminophenyl)-3-ethylpiperidine-2,6
-dione","3(4aminophenyl)3ethylpiperidine2,6dione","3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione","3(4Aminophenyl)3ethyl2,6piperidinedione",2,6-Piperidinedione,6Piperidinedione,3-(4-aminophenyl)-3,3(4
aminophenyl)3,T1103,SAM002589964,1500115,Prestw-244,Aminoglutethimide,CPD000326785,AMINOGLUTETHIMIDE,"Glutethimide, para-amino"}

> <pdid>
PD002479

> <targets>
{}

> <classes>
{"testosterone suppressant",antineoplastic,"aromatase inhibitor"}

> <pubchem_cids>
{2145}

$$$$
NIHCC_2014
  SciTegic11012413002D

 34 34  0  0  1  0            999 V2000
   17.9985   -0.0001    0.0000 Cl  0  5
    3.8841    3.7529    0.0000 C   0  0
    5.1855    3.0070    0.0000 C   0  0
    5.1912    1.5062    0.0000 O   0  0
    6.4933    0.7599    0.0000 C   0  0
    7.7897    1.5144    0.0000 O   0  0
    6.4990   -0.7409    0.0000 C   0  0  2  0  0  0
    7.8003   -1.4887    0.0000 C   0  0
    9.0990   -0.7364    0.0000 C   0  0
   10.4003   -1.4841    0.0000 C   0  0
   11.6994   -0.7342    0.0000 C   0  0
   12.9984   -1.4841    0.0000 C   0  0
   12.9985   -2.9841    0.0000 C   0  0
   11.6994   -3.7342    0.0000 C   0  0
   10.4004   -2.9842    0.0000 C   0  0
    5.2003   -1.4932    0.0000 N   0  0
    3.8990   -0.7455    0.0000 C   0  0  1  0  0  0
    3.8964    0.7545    0.0000 C   0  0
    2.6003   -1.4977    0.0000 C   0  0
    2.6030   -2.9977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 N   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  1  0  0  0
    0.0031   -3.0008    0.0000 C   0  0
   -1.2946   -3.7531    0.0000 O   0  0
    1.3032   -3.7490    0.0000 O   0  0
   15.4985   -0.0001    0.0000 H   0  3
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  5  7  1  0
  7  8  1  6
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  7 16  1  0
 16 17  1  0
 17 18  1  6
 17 19  1  0
 19 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 28 29  1  0
 29 30  1  0
 30 21  1  0
 30 31  1  6
 31 32  1  0
 31 33  2  0
M  CHG  2   1  -1  34   1
M  END
> <name>
NIHCC_2014

> <id>
6331

> <plate>
NGP-202-04

> <well>
D06

> <supplier_cmpd_name>
CPD000499582

> <ctcr_id>
5895

> <supplier_cmpd_id>
SAM002589972

> <smiles>
[Cl-].CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2Cc3ccccc3C[C@H]2C(O)=O.[H+]

> <pd_targets>
{ACE,ABCB11}

> <pathway_gtopdb>
{Enzyme,Transporter,Protease,"Primary active transporter","Metallo protease","ATP-binding cassette","Metallo protease MAE clan","ABCB subfamily","Metallo protease M2 family"}

> <pathway_chembl>
{Enzymes,Transporters,"Peptidases and proteinases","ATP-binding cassette transporter family","MA: Metallo (M) Peptidases","ABCB subfamily","M2: Angiotensin-converting  (ACE and ACE2)"}

> <pathway_reactome>
{"Metabolism of proteins",Metabolism,"Peptide hormone metabolism","Metabolism of lipids","Metabolism of Angiotensinogen to Angiotensins","Metabolism of steroids","Bile acid and bile salt metabolism","
Synthesis of bile acids and bile salts","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol"}

> <broad_targets>
{ACE}

> <broad_moa>
{"angiotensin converting enzyme inhibitor"}

> <synonyms>
{82586-55-8,82586558,"82586 55 8",Accupril,Accuprin,"QUINAPRIL HCL",Acequin,Quinazil,Korec,Hemokvin,Lidaltrin,Acuitel,Ectren,Conan,"Quinapril (hydrochloride)",Accupro,CI-906,CI906,"CI 906",Accuretic,U
NII-33067B3N2M,UNII33067B3N2M,"UNII 33067B3N2M","Quinapril  hydrochloride",CHEBI:8714,T0805,SAM002589972,1503076,Prestw-927,"Quinapril hydrochloride",CPD000499582,"Quinapril HCl","QUINAPRIL HYDROCHLOR
IDE"}

> <pdid>
PD009666

> <targets>
{}

> <classes>
{antihypertensive,"ACE inhibitor"}

> <pubchem_cids>
{66916691,54891}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 30  0  0  1  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
    0.0000    3.0000    0.0000 C   0  0  2  0  0  0
    1.0956    4.0166    0.0000 C   0  0
    0.4767    5.3830    0.0000 C   0  0
   -1.0140    5.2166    0.0000 C   0  0  2  0  0  0
   -1.9861    4.9820    0.0000 O   0  0
   -0.5491    6.6300    0.0000 C   0  0
   -1.5661    7.7325    0.0000 O   0  0
    0.9150    6.9601    0.0000 C   0  0
    1.3618    8.3920    0.0000 O   0  0
   -1.2991    3.7500    0.0000 C   0  0  2  0  0  0
   -2.1132    4.3307    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0  2  0  0  0
   -3.8971    0.7500    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0  2  0  0  0
   -1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    0.0000    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -1.2990   -5.2500    0.0000 O   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  1  1  6
  2  3  1  0
  4  3  1  6
  4  5  1  0
  5  6  1  1
  6  7  1  0
  7  8  1  0
  8  9  1  6
  8 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
  8 14  1  0
 14  5  1  0
 14 15  1  1
 14 16  1  0
 16 17  1  0
 17 18  1  1
 19 17  1  1
 19  4  1  0
 19 20  1  0
 20 21  1  1
 20 22  1  0
 22 23  2  3
 23 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  2  3
 27  2  1  0
 27 20  1  0
M  END
> <name>
NIHCC_2014

> <id>
6332

> <plate>
NGP-202-04

> <well>
E02

> <supplier_cmpd_name>
CPD000058330

> <ctcr_id>
4741

> <supplier_cmpd_id>
SAM002589984

> <smiles>
C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]4(C)C=CC(=O)C=C14

> <pd_targets>
{NS1,AR,ABCB11,NR3C1,TRPC5,HIF1A,NR1I2,ABCC4,ANXA1,HSD17B10,CYP3A4,ALDH1A1}

> <pathway_gtopdb>
{"Unclassified protein","Transcription factor",Transporter,"Ion channel",Enzyme,"Nuclear receptor","Primary active transporter","Voltage-gated ion channel","Other ion channel",Oxidoreductase,"Cytochro
me P450","Nuclear hormone receptor subfamily 3","ATP-binding cassette","Transient receptor potential channel","Nuclear hormone receptor subfamily 1",Annexin,"Cytochrome P450 family 3","Nuclear hormone
 receptor subfamily 3 group C","ABCB subfamily","Nuclear hormone receptor subfamily 1 group I","ABCC subfamily","Cytochrome P450 family 3A","Nuclear hormone receptor subfamily 3 group C member 4","Nuc
lear hormone receptor subfamily 3 group C member 1","Nuclear hormone receptor subfamily 1 group I member 2","Cytochrome P450 3A4"}

> <pathway_chembl>
{Receptors,Transporters,"Ion channels",Enzymes,"Nuclear hormone receptors","ATP-binding cassette transporter family","Voltage-gated ion channels","Cytochrome P450","Steroid hormone receptors","ABCB su
bfamily","Transient Receptor Potential channels","1I. Vitamin D receptor-like receptors","ABCC subfamily","CYP3 family","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"Gene expression (Transcription)",Metabolism,"Developmental Biology","Cellular responses to external stimuli","Metabolism of proteins",Hemostasis,"Signal Transduction","RNA Polymerase II Transcriptio
n","Metabolism of lipids","Nervous system development","Cellular responses to stress","Post-translational protein modification","Platelet activation","signaling and aggregation","Signaling by GPCR","M
etabolism of amino acids and derivatives","Biological oxidations","Generic Transcription Pathway","Metabolism of steroids","Axon guidance","Cellular response to hypoxia",SUMOylation,"Response to eleva
ted platelet cytosolic Ca2+","GPCR ligand binding","Branched-chain amino acid catabolism","Biosynthesis of specialized proresolving mediators (SPMs)","Phase I - Functionalization of compounds","Transc
riptional regulation by RUNX2","Bile acid and bile salt metabolism","FOXO-mediated transcription","Netrin-1 signaling","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","SUMO 
E3 ligases SUMOylate target proteins","Platelet degranulation","Class A/1 (Rhodopsin-like receptors)","Biosynthesis of DHA-derived SPMs","Ethanol oxidation","RUNX2 regulates bone development","Synthes
is of bile acids and bile salts","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","Role of second messengers in netrin-1 signaling","SUMOylation of intracellular recept
ors","Peptide ligand-binding receptors","Biosynthesis of maresins","RUNX2 regulates osteoblast differentiation","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Formyl peptide r
eceptors bind formyl peptides and many other ligands","Biosynthesis of maresin-like SPMs"}

> <broad_targets>
{NR3C1}

> <broad_moa>
{"glucocorticoid receptor agonist"}

> <synonyms>
{methylprednisolone,83-43-2,83432,Medrol,Medrone,Metilprednisolone,Urbason,6alpha-Methylprednisolone,6alphaMethylprednisolone,Metilbetasone,Medrate,Dopomedrol,Promacortine,Besonia,Medesone,Mesopren,Me
tastab,Metrisone,Moderin,Noretona,Solomet,Urbasone,Wyacort,Methylprednisol,SAM002589984,Prestw-279,CPD000058330,"Methylprednisolone, 6-alpha"}

> <pdid>
PD001857

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{6741}

$$$$
NIHCC_2014
  SciTegic11012413002D

 38 42  0  0  1  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 O   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -3.8971   -3.7500    0.0000 C   0  0
   -5.1961   -3.0000    0.0000 O   0  0
   -3.8971   -5.2500    0.0000 C   0  0
   -5.1961   -6.0000    0.0000 C   0  0
   -5.1961   -7.5000    0.0000 C   0  0  2  0  0  0
   -6.4764   -6.7185    0.0000 O   0  0
   -3.8971   -8.2500    0.0000 C   0  0
   -2.5980   -7.5000    0.0000 C   0  0  2  0  0  0
   -1.2998   -8.2531    0.0000 O   0  0
   -1.3019   -9.7539    0.0000 C   0  0
   -0.0055  -10.5085    0.0000 C   0  0
   -0.0107  -12.0085    0.0000 C   0  0
    1.2858  -12.7630    0.0000 N   0  0
   -1.3123  -12.7540    0.0000 C   0  0
   -1.3175  -14.2540    0.0000 O   0  0
   -2.6087  -11.9995    0.0000 C   0  0
   -3.9104  -12.7450    0.0000 C   0  0
   -2.6036  -10.4995    0.0000 O   0  0
   -2.5980   -6.0000    0.0000 C   0  0
   -1.2990   -5.2500    0.0000 C   0  0
    0.0000   -6.0000    0.0000 O   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    1.2991   -3.7500    0.0000 O   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -5.1596   -8.9800    0.0000 C   0  0
   -6.4587   -9.7299    0.0000 C   0  0
   -3.8609   -9.7306    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  1
 15 17  1  0
 17 18  1  0
 18 19  1  1
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 22 24  1  0
 24 25  1  0
 24 26  1  0
 26 27  1  0
 26 28  1  0
 28 20  1  0
 18 29  1  0
 29 13  2  0
 29 30  1  0
 30 31  1  0
 30 32  2  0
 32 10  1  0
 32 33  1  0
 33 34  2  0
 33 35  1  0
 35  3  1  0
 35  7  2  0
 15 36  1  0
 36 37  1  0
 36 38  2  0
M  END
> <name>
NIHCC_2014

> <id>
6333

> <plate>
NGP-202-04

> <well>
E03

> <supplier_cmpd_name>
CPD001906781

> <ctcr_id>
7071

> <supplier_cmpd_id>
SAM002589992

> <smiles>
COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](OC5CC(N)C(O)C(C)O5)c4c(O)c3C(=O)c12)C(C)=O

> <pd_targets>
{HIF1A,MAPT,RORC,BLM,FTL,ALD,KMT2A,MEN1,HSP90AA1,HSP90AB1,RECQL,USP2,TSHR,MAPK1,NPSR1,FFP,S100A4,BRCA1,POLB,THRB,CYP3A4,LEF,MMP2,NR5A1,ALDH1A1,TP53,CYP1A2,KDM4E,HTT,HSD17B10,APEX1,ABCC1,FPR2,PAX8,ABCB
1,ABCC2,TOP2A,TOP2B}

> <pathway_gtopdb>
{"Unclassified protein","Transcription factor","Other cytosolic protein",Enzyme,"Epigenetic regulator","Membrane receptor",Transporter,"Nuclear receptor",Reader,Protease,"Family A G protein-coupled re
ceptor",Kinase,Transferase,"Cytochrome P450",Oxidoreductase,Eraser,"Primary active transporter",Isomerase,"Nuclear hormone receptor subfamily 1",Bromodomain,"Cysteine protease","Peptide receptor (fami
ly A GPCR)","Protein Kinase","Cytochrome P450 family 3","Metallo protease","Nuclear hormone receptor subfamily 5","Cytochrome P450 family 1","Lysine demethylase","ATP-binding cassette","Nuclear hormon
e receptor subfamily 1 group F","Cysteine protease CA clan","Glycohormone receptor","CMGC protein kinase group","Short peptide receptor (family A GPCR)","Nuclear hormone receptor subfamily 1 group A",
"Cytochrome P450 family 3A","Metallo protease MAE clan","Metallo protease MAM clan","Nuclear hormone receptor subfamily 5 group A","Cytochrome P450 family 1A","Jumonji domain-containing","ABCC subfami
ly","N-formyl methionyl peptide receptor","ABCB subfamily","Nuclear hormone receptor subfamily 1 group F member 3","Cysteine protease C19 family","CMGC protein kinase MAPK family","Neuropeptide recept
or","Nuclear hormone receptor subfamily 1 group A member 2","Cytochrome P450 3A4","Metallo protease M34 family","Metallo protease M10A subfamily","Nuclear hormone receptor subfamily 5 group A member 1
","Cytochrome P450 1A1","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Receptors,Enzymes,"Other protein targets",Transporters,"Nuclear hormone receptors","Chromatin modifying enzymes","Peptidases and proteinases","G protein-coupled receptors","Kinases (EC 2.7.x.x)","Cyt
ochrome P450","Heat shock proteins","ATP-binding cassette transporter family","DNA topoisomerases","1F. Retinoic acid-related orphans","2.1.1.43 Histone methyltransferases (HMTs)","CA: Cysteine (C) Pe
ptidases","Glycoprotein hormone receptors","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Neuropeptide S receptor","1A. Thyroid hormone receptors","CYP3 family","MA: Metallo (M) Peptidases","5A. Fus
hi tarazu F1-like receptors","CYP1 family","1.14.11.- Histone demethylases","ABCC subfamily","Formylpeptide receptors","ABCB subfamily","C19: Ubiquitin-specific protease","Mitogen-activated protein ki
nases (MAP kinases)","M10: Matrix metallopeptidase","ERK subfamily"}

> <pathway_reactome>
{"Cellular responses to external stimuli","Neuronal System","Gene expression (Transcription)","DNA Repair","Vesicle-mediated transport",Disease,"Immune System","Metabolism of proteins",Metabolism,"Dev
elopmental Biology","Cell Cycle","Signal Transduction","Cellular responses to stress","Transmission across Chemical Synapses","RNA Polymerase II Transcription","DNA Double-Strand Break Repair","Membra
ne Trafficking","Infectious disease","Innate Immune System","Base Excision Repair","Post-translational protein modification","Metabolism of lipids","Nervous system development",Mitotic,"Biological oxi
dations","Cell Cycle Checkpoints","Metabolism of amino acids and derivatives","Signaling by GPCR","Abacavir transport and metabolism","Disorders of transmembrane transporters","Cellular response to hy
poxia","Neurotransmitter receptors and postsynaptic signal transmission","Generic Transcription Pathway","Homology Directed Repair","trans-Golgi Network Vesicle Budding","Leishmania infection","Toll-l
ike Receptor Cascades","Resolution of Abasic Sites (AP sites)",SUMOylation,"Biosynthesis of specialized proresolving mediators (SPMs)","Uptake and actions of bacterial toxins","Axon guidance","Mitotic
 G2-G2/M phases","Phase I - Functionalization of compounds","G1/S DNA Damage Checkpoints","Branched-chain amino acid catabolism","Fatty acid metabolism","GPCR ligand binding","Abacavir transmembrane t
ransport","ABC transporter disorders","Mitotic G1 phase and G1/S transition","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Activation of NMDA receptors and postsynaptic e
vents","Transcriptional regulation by RUNX3","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Golgi Associated Vesicle Biogenesis","Transcriptional regulation by RUNX1","
Transcriptional Regulation by TP53","Leishmania parasite growth and survival","Toll Like Receptor 5 (TLR5) Cascade","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","SUMO
 E3 ligases SUMOylate target proteins","Biosynthesis of DHA-derived SPMs","Uptake and function of anthrax toxins","EPH-Ephrin signaling","G2/M Transition","Ethanol oxidation","p53-Dependent G1/S DNA d
amage checkpoint","Cytochrome P450 - arranged by substrate type","Transcriptional Regulation by MECP2","Arachidonic acid metabolism","Class A/1 (Rhodopsin-like receptors)","Defective ABCC2 causes DJS"
,"G0 and Early G1","Post NMDA receptor activation events","RUNX3 Regulates Immune Response and Cell Migration","HDR through Homologous Recombination (HRR)","RUNX1 regulates genes involved in megakaryo
cyte differentiation and platelet function","Regulation of TP53 Activity","Anti-inflammatory response favouring Leishmania parasite infection","MyD88 cascade initiated on plasma membrane","PCNA-Depend
ent Long Patch Base Excision Repair","SUMOylation of intracellular receptors","Biosynthesis of maresins","EPH-ephrin mediated repulsion of cells","Centrosome maturation","p53-Dependent G1 DNA Damage R
esponse",Xenobiotics,"Regulation of MECP2 expression and activity","Synthesis of Leukotrienes (LT) and Eoxins (EX)","Peptide ligand-binding receptors","Transcription of E2F targets under negative cont
rol by DREAM complex","SUMOylation of DNA replication proteins","Activation of AMPK downstream of NMDARs","Homologous DNA Pairing and Strand Exchange","Regulation of TP53 Expression and Degradation","
ADORA2B mediated anti-inflammatory cytokines production","MAP kinase activation","Biosynthesis of maresin-like SPMs","Loss of proteins required for interphase microtubule organization from the centros
ome","Stabilization of p53","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Formyl peptide receptors bind formyl peptides and many other ligands","Presynaptic phase of homologous D
NA pairing and strand exchange","Regulation of TP53 Degradation","MAPK targets/ Nuclear events mediated by MAP kinases","Loss of Nlp from mitotic centrosomes","Autodegradation of the E3 ubiquitin liga
se COP1","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{TOP2A,TOP2B}

> <broad_moa>
{"RNA synthesis inhibitor","topoisomerase inhibitor"}

> <synonyms>
{FI6339,Prestwick0_000487,Prestwick0000487,Prestwick0-000487,"Prestwick0 000487",Prestwick1_000487,Prestwick1000487,Prestwick1-000487,"Prestwick1 000487",Prestwick2_000487,Prestwick2000487,Prestwick2-
000487,"Prestwick2 000487",SAM002589992,CPD001906781}

> <pdid>
PD003035

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{3085107}

$$$$
NIHCC_2014
  SciTegic11012413002D

 28 31  0  0  0  0            999 V2000
    2.2703   -4.0022    0.0000 C   0  0
    1.7758   -3.1329    0.0000 C   0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
   -0.8660    2.5000    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    0.5000    0.0000 F   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -0.8141   -2.0807    0.0000 C   0  0
    0.2851   -2.9666    0.0000 C   0  0
   -0.6870   -2.7320    0.0000 O   0  0
    0.7500   -4.3800    0.0000 C   0  0
    2.2230   -4.6635    0.0000 O   0  0
   -0.2322   -5.5148    0.0000 C   0  0
    0.2584   -6.9323    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  3
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  3
 13 14  1  0
 14  8  1  0
 14 15  1  0
 14 16  1  0
 16  5  1  0
 16 17  1  0
 16 18  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 21  4  1  0
 21 22  1  0
 21 23  1  0
 23  2  1  0
 23 24  1  0
 23 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
M  END
> <name>
NIHCC_2014

> <id>
6334

> <plate>
NGP-202-04

> <well>
E04

> <supplier_cmpd_name>
CPD000339803

> <ctcr_id>
824

> <supplier_cmpd_id>
SAM002589959

> <smiles>
CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO

> <pd_targets>
{PLA2G5,CYP3A4,PGR,NR1I2,NR3C1,NR3C2,FABP1,AR,PLA2G1B,TSHR,PTGS2,NR0B1,ANXA1,NOS2,ABCB11,HIF1A,GAA,RORC,DUSP6}

> <pathway_gtopdb>
{Enzyme,"Transcription factor","Auxiliary transport protein","Membrane receptor","Ion channel",Hydrolase,"Cytochrome P450","Nuclear receptor","Fatty acid binding protein family","Family A G protein-co
upled receptor",Oxidoreductase,"Other ion channel","Cytochrome P450 family 3","Nuclear hormone receptor subfamily 3","Nuclear hormone receptor subfamily 1","Peptide receptor (family A GPCR)","Nuclear 
hormone receptor subfamily 0",Annexin,"Cytochrome P450 family 3A","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 1 group I","Glycohormone receptor","Nuclear hormone
 receptor subfamily 0 group B","Cytochrome P450 3A4","Nuclear hormone receptor subfamily 3 group C member 3","Nuclear hormone receptor subfamily 1 group I member 2","Nuclear hormone receptor subfamily
 3 group C member 1","Nuclear hormone receptor subfamily 3 group C member 2","Nuclear hormone receptor subfamily 3 group C member 4","Nuclear hormone receptor subfamily 0 group B member 1",Transporter
,"Primary active transporter",Phosphatase,"ATP-binding cassette","Protein Phosphatase","ABCB subfamily","Nuclear hormone receptor subfamily 1 group F","Serine/threonine/tyrosine protein phosphatase","
Nuclear hormone receptor subfamily 1 group F member 3"}

> <pathway_chembl>
{Enzymes,Receptors,"Other protein targets","Glycerophospholipid turnover","Cytochrome P450","Nuclear hormone receptors","Fatty acid-binding proteins","G protein-coupled receptors","Eicosanoid turnover
","L-Arginine turnover","Phospholipase A<sub>2</sub>","CYP3 family","1I. Vitamin D receptor-like receptors","Steroid hormone receptors","Glycoprotein hormone receptors",Cyclooxygenase,"0B. DAX-like re
ceptors","Nitric oxide synthases","3C. 3-Ketosteroid receptors",Transporters,"ATP-binding cassette transporter family","3.2.1.- Glycosidases","ABCB subfamily","1F. Retinoic acid-related orphans"}

> <pathway_reactome>
{Metabolism,"Metabolism of proteins","Gene expression (Transcription)",Disease,"Signal Transduction","Metabolism of lipids","Post-translational protein modification","RNA Polymerase II Transcription",
"Infectious disease","Signaling by GPCR","Phospholipid metabolism","Biosynthesis of specialized proresolving mediators (SPMs)",SUMOylation,"Generic Transcription Pathway","Regulation of lipid metaboli
sm by PPARalpha","Leishmania infection","GPCR ligand binding","Infection with Mycobacterium tuberculosis","Glycerophospholipid biosynthesis","Biosynthesis of DHA-derived SPMs","SUMO E3 ligases SUMOyla
te target proteins","FOXO-mediated transcription","PPARA activates gene expression","Transcriptional regulation by RUNX2","Leishmania parasite growth and survival","Biosynthesis of DPA-derived SPMs","
Nuclear Receptor transcription pathway","Class A/1 (Rhodopsin-like receptors)","Response of Mtb to phagocytosis","Acyl chain remodelling of PC","Biosynthesis of maresins","SUMOylation of intracellular
 receptors","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","RUNX2 regulates bone development","Anti-inflammatory response favouring Leishmania parasite infection","Bi
osynthesis of DPAn-3 SPMs","Peptide ligand-binding receptors","Suppression of phagosomal maturation","Biosynthesis of maresin-like SPMs","RUNX2 regulates osteoblast differentiation","ADORA2B mediated 
anti-inflammatory cytokines production","Formyl peptide receptors bind formyl peptides and many other ligands","Inhibition of nitric oxide production","Cellular responses to external stimuli","Immune 
System","Cellular responses to stress","Diseases of metabolism","Innate Immune System","Metabolism of steroids","Cellular response to hypoxia","Diseases of carbohydrate metabolism","Toll-like Receptor
 Cascades","Bile acid and bile salt metabolism","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","Glycogen storage diseases","Transcriptional regulation by RUNX3","Toll Like 
Receptor 5 (TLR5) Cascade","Synthesis of bile acids and bile salts","Glycogen storage disease type II (GAA)","RUNX3 Regulates Immune Response and Cell Migration","MyD88 cascade initiated on plasma mem
brane","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","MAP kinase activation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{ANXA1,NOS2,NR0B1,NR3C1,NR3C2}

> <broad_moa>
{"glucocorticoid receptor agonist"}

> <synonyms>
{Hormezon,Valisone,"9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione","9Fluoro11,17,21trihydroxy16methylpregna1,4diene3,20dione",Celestone,Bebate,.beta.-Methasone,.beta.Methasone,".be
ta.-Methasone alcohol",".beta.Methasone alcohol",NSC39470,9-Fluoro-16.beta.-methylprednisolone,9Fluoro16.beta.methylprednisolone,"Prednisolone, 9-fluoro-16.beta.-methyl-","Prednisolone, 9fluoro16.beta
.methyl",GF12091,SAM002589959,S1322,CPD000339803,"Dexamethasone (DHAP)"}

> <pdid>
PD002388

> <targets>
{"IL Receptor",Autophagy}

> <classes>
{Others}

> <pubchem_cids>
{3003}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 23  0  0  0  0            999 V2000
   11.4915   -1.5060    0.0000 H   0  3
    8.9915   -1.5060    0.0000 Cl  0  5
   -2.6041   -2.9866    0.0000 C   0  0
   -1.3074   -3.7406    0.0000 N   0  0
   -0.0048   -2.9950    0.0000 C   0  0
    1.2926   -3.7495    0.0000 C   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5030    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5988    1.5004    0.0000 C   0  0
   -2.5998    3.0004    0.0000 F   0  0
   -3.8976    0.7500    0.0000 F   0  0
   -3.8982    2.2498    0.0000 F   0  0
    3.8934   -3.7569    0.0000 C   0  0
    5.1961   -3.0132    0.0000 C   0  0
    6.4915   -3.7695    0.0000 C   0  0
    6.4843   -5.2694    0.0000 C   0  0
    5.1817   -6.0132    0.0000 C   0  0
    3.8862   -5.2570    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 12 15  1  0
 15 16  1  0
 15 17  1  0
 15 18  1  0
  7 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6335

> <plate>
NGP-202-04

> <well>
E05

> <supplier_cmpd_name>
CPD000058452

> <ctcr_id>
5037

> <supplier_cmpd_id>
SAM002589965

> <smiles>
[H+].[Cl-].CNCCC(Oc1ccc(cc1)C(F)(F)F)c2ccccc2

> <pd_targets>
{SLC6A4,ACHE,HTT,CYP2C19,ADRA1A,ADRA1B,ADRA1D,SLC6A3,ALB,HRH3,SLC6A2,HTR1A,HTR1B,HTR1D,HTR1F,KCNH2,KCNJ6,HTR2C,SLC29A4,NET,LMNA,SIGMAR1,HTR2B,ADRA2A,ADRA2B,ADRA2C,HTR2A,KCNC1,HTR6,KMT2A,MEN1,FTL,PMP22
,HPGD,GMNN,CYP3A4,CHRM5,KCNK2,MTOR,CHRM3,CACNA1C,CYP2D6,CHRM1,ANO1,CHRNA2,CHRNA3,CHRNB4,APEX1,AMPC,ALDH1A1,KDM4E,LEF,RORC,TP53,TSHR,CYP2C9,CYP1A2,NFKB1,ALOX15,THPO,HRH1,MAPK1,ARRB2}

> <pathway_gtopdb>
{Transporter,"Electrochemical transporter","SLC superfamily of solute carriers","SLC06 neurotransmitter transporter family",Enzyme,"Unclassified protein","Membrane receptor","Secreted protein","Ion ch
annel","Other nuclear protein","Epigenetic regulator",Hydrolase,"Cytochrome P450","Family A G protein-coupled receptor","Voltage-gated ion channel",Reader,Kinase,"Other ion channel","Ligand-gated ion 
channel","Cytochrome P450 family 2","Small molecule receptor (family A GPCR)","Potassium channels",Bromodomain,"Cytochrome P450 family 3","Protein Kinase","Voltage-gated calcium channel","Chloride cha
nnel","Nicotinic acetylcholine receptor","Cytochrome P450 family 2C","Monoamine receptor","Voltage-gated potassium channel","Inwardly rectifying potassium channel","SLC28 and SLC29 families of nucleos
ide transporters","Cytochrome P450 family 3A","Two-pore domain potassium channel","Atypical protein kinase group","Cytochrome P450 family 2D","Calcium-activated chloride channel","Nicotinic acetylchol
ine receptor alpha subunit","Nicotinic acetylcholine receptor beta subunit","Cytochrome P450 2C19","Adrenergic receptor","Histamine receptor","Serotonin receptor","SLC29 Facilitative nucleoside transp
orter family","Cytochrome P450 3A4","Acetylcholine receptor","Atypical protein kinase PIKK family","Cytochrome P450 2D6","Atypical protein kinase FRAP subfamily","Transcription factor","Other cytosoli
c protein",Oxidoreductase,Eraser,Protease,"Nuclear receptor","Lysine demethylase","Metallo protease","Nuclear hormone receptor subfamily 1","Peptide receptor (family A GPCR)","Cytochrome P450 family 1
","Jumonji domain-containing","Metallo protease MAE clan","Nuclear hormone receptor subfamily 1 group F","Glycohormone receptor","Cytochrome P450 family 1A","CMGC protein kinase group","Metallo protea
se M34 family","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 2C9","Cytochrome P450 1A1","CMGC protein kinase MAPK family","CMGC protein kinase ERK1"}

> <pathway_chembl>
{Transporters,"SLC superfamily of solute carriers","SLC6 neurotransmitter transporter family","Monoamine transporter subfamily",Enzymes,Receptors,"Ion channels","Other protein targets","Acetylcholine 
turnover","Cytochrome P450","G protein-coupled receptors","Voltage-gated ion channels","Sigma receptors","Eicosanoid turnover","Kinases (EC 2.7.x.x)","Other ion channels","Ligand-gated ion channels","
CYP2 family: drug metabolising subset","Histamine receptors","Potassium channels","5-Hydroxytryptamine receptors","SLC28 and SLC29 families of nucleoside transporters","Prostaglandin synthases","CYP3 
family",Adrenoceptors,"Acetylcholine receptors (muscarinic)",Atypical,"Voltage-gated calcium channels","Chloride channels","Nicotinic acetylcholine receptors","Voltage-gated potassium channels","Inwar
dly rectifying potassium channels","SLC29 family","Two P domain potassium channels","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","Calcium activated chloride channel","FRAP subfamily
","Chromatin modifying enzymes","Nuclear hormone receptors","1.14.11.- Histone demethylases","1F. Retinoic acid-related orphans","Glycoprotein hormone receptors","CYP1 family",Lipoxygenases,"CMGC: Con
taining CDK",MAPK,GSK3,"CLK families","Mitogen-activated protein kinases (MAP kinases)","ERK subfamily"}

> <pathway_reactome>
{"Neuronal System","Transmission across Chemical Synapses","Neurotransmitter clearance","Serotonin clearance from the synaptic cleft",Metabolism,"Gene expression (Transcription)",Disease,"Signal Trans
duction","Muscle contraction","Transport of small molecules","Cell Cycle","Vesicle-mediated transport","Developmental Biology","Metabolism of lipids","RNA Polymerase II Transcription","Biological oxid
ations","Disorders of transmembrane transporters","Signaling by GPCR","Cardiac conduction","SLC-mediated transmembrane transport",Mitotic,"Infectious disease","Potassium Channels","Membrane Traffickin
g","Nervous system development","Ion channel transport","Phospholipid metabolism","Generic Transcription Pathway","Phase I - Functionalization of compounds","SLC transporter disorders","Metabolism of 
steroids","GPCR ligand binding","Phase 3 - rapid repolarisation","Neurotransmitter receptors and postsynaptic signal transmission","Transport of vitamins",nucleosides,"and related molecules","M Phase"
,"SARS-CoV Infections","Voltage gated Potassium channels","Leishmania infection","trans-Golgi Network Vesicle Budding","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Biosynthesis of
 specialized proresolving mediators (SPMs)","Mitotic G1 phase and G1/S transition","Tandem pore domain potassium channels","Axon guidance","Stimuli-sensing channels","Glycerophospholipid biosynthesis"
,"Transcriptional Regulation by MECP2","Cytochrome P450 - arranged by substrate type","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Bile acid and bile salt metabolism","Class A/1 
(Rhodopsin-like receptors)","Defective SLC6A2 causes orthostatic intolerance (OI)","GABA receptor activation","Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane"
,"Mitotic Metaphase and Anaphase","Potential therapeutics for SARS","Leishmania parasite growth and survival","Golgi Associated Vesicle Biogenesis","Biosynthesis of DHA-derived SPMs","G1/S Transition"
,"TWIK related potassium channel (TREK)","Transcriptional Regulation by TP53","NCAM signaling for neurite out-growth","Acetylcholine binding and downstream events","Synthesis of PC","Regulation of MEC
P2 expression and activity",Xenobiotics,"Recycling of bile acids and salts","Amine ligand-binding receptors","GABA B receptor activation","Mitotic Anaphase","Anti-inflammatory response favouring Leish
mania parasite infection","Biosynthesis of D-series resolvins","Activation of the pre-replicative complex","Biosynthesis of maresins","Regulation of TP53 Activity","NCAM1 interactions","Postsynaptic n
icotinic acetylcholine receptors","CYP2E1 reactions","Histamine receptors","Activation of GABAB receptors","Serotonin receptors","Nuclear Envelope (NE) Reassembly","ADORA2B mediated anti-inflammatory 
cytokines production","Biosynthesis of maresin-like SPMs",Adrenoceptors,"Muscarinic acetylcholine receptors","Regulation of TP53 Expression and Degradation","Highly calcium permeable postsynaptic nico
tinic acetylcholine receptors","Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits","Initiation of Nuclear Envelope (NE) Reformation","Regulation of TP53 Degradation","DNA Repair","Im
mune System",Hemostasis,"Base Excision Repair","Cell Cycle Checkpoints","Cytokine Signaling in Immune system","Platelet activation","signaling and aggregation","Innate Immune System","Resolution of Ab
asic Sites (AP sites)","Uptake and actions of bacterial toxins","G1/S DNA Damage Checkpoints","Signaling by Interleukins","Platelet Aggregation (Plug Formation)","Toll-like Receptor Cascades","Resolut
ion of AP sites via the multiple-nucleotide patch replacement pathway","Ethanol oxidation","Uptake and function of anthrax toxins","Transcriptional regulation by RUNX3","p53-Dependent G1/S DNA damage 
checkpoint","Interleukin-1 family signaling","Biosynthesis of DPA-derived SPMs","Toll Like Receptor 5 (TLR5) Cascade","PCNA-Dependent Long Patch Base Excision Repair","RUNX3 Regulates Immune Response 
and Cell Migration","p53-Dependent G1 DNA Damage Response","Interleukin-1 signaling","Biosynthesis of DPAn-3 SPMs","MyD88 cascade initiated on plasma membrane","Stabilization of p53","Aromatic amines 
can be N-hydroxylated or N-dealkylated by CYP1A2","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Biosynthesis of DPAn-3-derived protectins and resolvins","MAP kinase activation","Autodegradation of the
 E3 ubiquitin ligase COP1","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated"}

> <broad_targets>
{ANO1,HTR2B,SLC6A4}

> <broad_moa>
{"selective serotonin reuptake inhibitor (SSRI)"}

> <synonyms>
{"FLUOXETINE HYDROCHLORIDE",56296-78-7,56296787,"Fluoxetine Hcl",Prozac,59333-67-4,59333674,Sarafem,"Fluoxetine (hydrochloride)",Fluoxeren,Adofen,Fluctin,Lovan,Fluctine,Fluoxac,Fludac,Fluxil,Fontex,"L
Y 110140",LY-110140,LY110140,MFCD00214288,Reconcile,Self,T0450,T0450L,S1333,SAM002589965,1504173,Prestw-511,Fluoxetine,"Fluoxetine hydrochloride","Fluoxetine HCl",CPD000058452,FLUOXETINE}

> <pdid>
PD004343

> <targets>
{"5-HT Receptor"}

> <classes>
{antidepressant,"Neuronal Signaling"}

> <pubchem_cids>
{62857,657320,11824156}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 24  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -5.2029    2.9932    0.0000 C   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.8003    1.4887    0.0000 C   0  0
   -9.0990    0.7364    0.0000 C   0  0
  -10.4003    1.4841    0.0000 C   0  0
  -10.4029    2.9841    0.0000 C   0  0
  -11.6990    0.7318    0.0000 C   0  0
  -13.0003    1.4796    0.0000 C   0  0
  -13.0029    2.9796    0.0000 O   0  0
  -14.2982    0.7277    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  5  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 10 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
  7 21  1  0
 21 22  1  0
 21 23  2  0
 23  3  1  0
 23 24  1  0
M  END
> <name>
NIHCC_2014

> <id>
6336

> <plate>
NGP-202-04

> <well>
E06

> <supplier_cmpd_name>
CPD000499573

> <ctcr_id>
4957

> <supplier_cmpd_id>
SAM002589973

> <smiles>
COc1cc(C)c(\C=C\C(C)=C\C=C\C(C)=C\C(O)=O)c(C)c1C

> <pd_targets>
{SMN1,MAPT,ALDH1A1,ABCB11,ABCC4,RARA,RARB,RARG,RXRA,RXRB,RXRG,RBP1}

> <pathway_gtopdb>
{"Epigenetic regulator","Other cytosolic protein",Enzyme,Transporter,"Transcription factor",Reader,Oxidoreductase,"Primary active transporter","Nuclear receptor","Methyl-lysine/arginine binding protei
n","ATP-binding cassette","Nuclear hormone receptor subfamily 1","Nuclear hormone receptor subfamily 2","Tudor domain","ABCB subfamily","ABCC subfamily","Nuclear hormone receptor subfamily 1 group B",
"Nuclear hormone receptor subfamily 2 group B","Nuclear hormone receptor subfamily 1 group B member 1","Nuclear hormone receptor subfamily 2 group B member 1","Nuclear hormone receptor subfamily 1 gro
up B member 2","Nuclear hormone receptor subfamily 1 group B member 3","Nuclear hormone receptor subfamily 2 group B member 2","Nuclear hormone receptor subfamily 2 group B member 3"}

> <pathway_chembl>
{Transporters,Receptors,"Other protein targets","ATP-binding cassette transporter family","Nuclear hormone receptors","Fatty acid-binding proteins","ABCB subfamily","ABCC subfamily","2B. Retinoid X re
ceptors","1B. Retinoic acid receptors"}

> <pathway_reactome>
{"Metabolism of RNA","Neuronal System",Metabolism,Hemostasis,"Metabolism of proteins","Gene expression (Transcription)","Signal Transduction","Metabolism of non-coding RNA","Transmission across Chemic
al Synapses","Biological oxidations","Metabolism of lipids","Platelet activation","signaling and aggregation","Post-translational protein modification","RNA Polymerase II Transcription","Signaling by 
GPCR","snRNP Assembly","Neurotransmitter receptors and postsynaptic signal transmission","Phase I - Functionalization of compounds","Metabolism of steroids","Response to elevated platelet cytosolic Ca
2+",SUMOylation,"Generic Transcription Pathway","GPCR downstream signalling","Activation of NMDA receptors and postsynaptic events","Ethanol oxidation","Bile acid and bile salt metabolism","Platelet d
egranulation","SUMO E3 ligases SUMOylate target proteins","Nuclear Receptor transcription pathway","G alpha (i) signalling events","Post NMDA receptor activation events","Synthesis of bile acids and b
ile salts","SUMOylation of intracellular receptors","Visual phototransduction","Activation of AMPK downstream of NMDARs","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol","Synthes
is of bile acids and bile salts via 27-hydroxycholesterol","The canonical retinoid cycle in rods (twilight vision)"}

> <broad_targets>
{RARA,RARB,RARG,RBP1,RXRA,RXRB,RXRG,STAT3}

> <broad_moa>
{"retinoid receptor agonist"}

> <synonyms>
{Acitretin,55079-83-9,55079839,Etretin,Soriatane,Neotigason,all-trans-Acitretin,alltransAcitretin,Acitretine,"Retinoid etretin",Acitretina,Acitretinum,TMMP,"Ro 10-1670","Ro 101670",13-cis-Acitretin,13
cisAcitretin,"Ro 10-1670/000","Ro 101670/000",UNII-LCH760E9T7,UNIILCH760E9T7,CHEBI:50173,Ro-101670000,Ro101670000,LCH760E9T7,54757-46-9,54757469,NCGC,T1330,SAM002589973,Prestw-1165,CPD000499573}

> <pdid>
PD003196

> <targets>
{Apoptosis,Autophagy,RAR/RXR}

> <classes>
{Apoptosis,Autophagy,Metabolic Enzyme/Protease}

> <pubchem_cids>
{5284513}

$$$$
NIHCC_2014
  SciTegic11012413002D

 10 10  0  0  0  0            999 V2000
    3.8912   -5.2570    0.0000 N   0  0
    3.8933   -3.7570    0.0000 N   0  0
    2.5951   -3.0039    0.0000 C   0  0
    2.5973   -1.5031    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
M  END
> <name>
NIHCC_2014

> <id>
6337

> <plate>
NGP-202-04

> <well>
F02

> <supplier_cmpd_name>
CPD001496977

> <ctcr_id>
7067

> <supplier_cmpd_id>
SAM002589985

> <smiles>
NNCCc1ccccc1

> <pd_targets>
{MAPT,BLM,PMP22,ALDH1A1,GAA,GFER,RORC,CYP3A4,KDM4E,LMNA,MAOB,NFKB1,RAB9A,SMN1,CYP2C19,CYP2D6,AOC3,CYP2C9,CYP2C8,SLC6A2,TSHR,KDM1A,IDO1,SLC6A3,MAOA,NPC1,CYP1A2,SLC6A4,ABAT,GPT,GPT2,GAD65}

> <pathway_gtopdb>
{"Other cytosolic protein",Enzyme,"Unclassified protein","Transcription factor","Epigenetic regulator","Other nuclear protein",Transporter,"Membrane receptor",Oxidoreductase,Hydrolase,"Nuclear recepto
r","Cytochrome P450",Eraser,Reader,"Electrochemical transporter","Family A G protein-coupled receptor",Transferase,"Nuclear hormone receptor subfamily 1","Cytochrome P450 family 3","Lysine demethylase
","Methyl-lysine/arginine binding protein","Cytochrome P450 family 2","SLC superfamily of solute carriers","Peptide receptor (family A GPCR)","Cytochrome P450 family 1","Nuclear hormone receptor subfa
mily 1 group F","Cytochrome P450 family 3A","Jumonji domain-containing","Tudor domain","Cytochrome P450 family 2C","Cytochrome P450 family 2D","SLC06 neurotransmitter transporter family","Glycohormone
 receptor","Lysine-specific demethylase","Cytochrome P450 family 1A","Nuclear hormone receptor subfamily 1 group F member 3","Cytochrome P450 3A4","Cytochrome P450 2C19","Cytochrome P450 2D6","Cytochr
ome P450 2C9","Cytochrome P450 2C8","Cytochrome P450 1A1"}

> <pathway_chembl>
{Enzymes,Receptors,Transporters,"3.2.1.- Glycosidases","Nuclear hormone receptors","Cytochrome P450","Chromatin modifying enzymes","Catecholamine turnover","1.-.-.- Oxidoreductases","SLC superfamily o
f solute carriers","G protein-coupled receptors","1.13.11.- Dioxygenases","GABA turnover","1F. Retinoic acid-related orphans","CYP3 family","1.14.11.- Histone demethylases","CYP2 family: drug metaboli
sing subset","SLC6 neurotransmitter transporter family","Glycoprotein hormone receptors","SLC65 NPC-type cholesterol transporters","CYP1 family","Monoamine transporter subfamily"}

> <pathway_reactome>
{"Neuronal System","DNA Repair","Developmental Biology",Metabolism,Disease,"Protein localization","Gene expression (Transcription)","Cell Cycle","Immune System","Signal Transduction","Metabolism of RN
A","Transport of small molecules","Transmission across Chemical Synapses","DNA Double-Strand Break Repair","Nervous system development","Biological oxidations","Diseases of metabolism","Mitochondrial 
protein import","RNA Polymerase II Transcription","Metabolism of lipids",Mitotic,"Cytokine Signaling in Immune system","Signaling by Rho GTPases","Metabolism of non-coding RNA","Disorders of transmemb
rane transporters","Infectious disease","Intracellular signaling by second messengers","Metabolism of amino acids and derivatives","Plasma lipoprotein assembly",remodeling,"and clearance","Neurotransm
itter receptors and postsynaptic signal transmission","Homology Directed Repair","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Phase I - Functionalization of compounds","Diseases o
f carbohydrate metabolism","Generic Transcription Pathway","Biosynthesis of specialized proresolving mediators (SPMs)","M Phase","Signaling by Interleukins","Rho GTPase cycle","snRNP Assembly","SLC tr
ansporter disorders","Leishmania infection","PIP3 activates AKT signaling","Tryptophan catabolism","Plasma lipoprotein clearance","Neurotransmitter clearance","Neurotransmitter release cycle","Alanine
 metabolism","Activation of NMDA receptors and postsynaptic events","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Ethanol oxidation","Glycogen storage diseases","Trans
criptional regulation by RUNX3","Biosynthesis of DHA-derived SPMs","Mitotic Metaphase and Anaphase","Amine Oxidase reactions","Interleukin-1 family signaling","RHOBTB GTPase Cycle","Cytochrome P450 - 
arranged by substrate type","Defective SLC6A2 causes orthostatic intolerance (OI)","Leishmania parasite growth and survival","PTEN Regulation","Defective SLC6A3 causes Parkinsonism-dystonia infantile 
(PKDYS)","LDL clearance","Serotonin clearance from the synaptic cleft","GABA synthesis",release,"reuptake and degradation","Post NMDA receptor activation events","HDR through Homologous Recombination 
(HRR)","Glycogen storage disease type II (GAA)","RUNX3 Regulates Immune Response and Cell Migration","Biosynthesis of maresins","Mitotic Anaphase","Biogenic amines are oxidatively deaminated to aldehy
des by MAOA and MAOB","Interleukin-1 signaling","RHOBTB3 ATPase cycle",Xenobiotics,"Anti-inflammatory response favouring Leishmania parasite infection","Regulation of PTEN gene transcription","Degrada
tion of GABA","Activation of AMPK downstream of NMDARs","Homologous DNA Pairing and Strand Exchange","Biosynthesis of maresin-like SPMs","Nuclear Envelope (NE) Reassembly","MAP3K8 (TPL2)-dependent MAP
K1/3 activation","CYP2E1 reactions","ADORA2B mediated anti-inflammatory cytokines production","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Presynaptic phase of homologous DNA pa
iring and strand exchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{ABAT,AOC3,GAD2,GPT,GPT2,MAOA,MAOB,SLC6A2,SLC6A3,SLC6A4}

> <broad_moa>
{"monoamine oxidase inhibitor"}

> <synonyms>
{Phenelzine,Phenethylhydrazine,51-71-8,51718,2-Phenylethylhydrazine,2Phenylethylhydrazine,Nardil,Fenelzyna,Fenelzyne,"Hydrazine, (2-phenylethyl)-","Hydrazine, (2phenylethyl)",beta-Phenylethylhydrazine
,betaPhenylethylhydrazine,Phenelzinum,2-Phenethylhydrazine,2Phenethylhydrazine,1-Hydrazino-2-phenylethane,1Hydrazino2phenylethane,Phenethyl-hydrazine,(2-phenylethyl)hydra,(2phenylethyl)hydra,SAM002589
985,CPD001496977}

> <pdid>
PD002918

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{3675}

$$$$
NIHCC_2014
  SciTegic11012413002D

 63 68  0  0  1  0            999 V2000
   -7.4552   -3.5838    0.0000 C   0  0
   -6.0104   -3.9870    0.0000 O   0  0
   -4.9400   -2.9400    0.0000 C   0  0  1  0  0  0
   -3.3500   -3.2400    0.0000 C   0  0
   -3.1000   -4.8300    0.0000 C   0  0
   -1.5200   -5.1200    0.0000 O   0  0
   -0.7000   -3.7400    0.0000 C   0  0  1  0  0  0
   -2.1973   -3.6507    0.0000 C   0  0
   -1.3600   -2.2500    0.0000 O   0  0
   -0.1600   -1.1700    0.0000 C   0  0
   -0.1600    0.4200    0.0000 C   0  0
   -1.0286    0.9155    0.0000 C   0  0
    1.2100    1.2300    0.0000 C   0  0
    1.2029    2.7300    0.0000 O   0  0
    2.6100    0.4200    0.0000 C   0  0
    4.0000    1.2300    0.0000 C   0  0
    3.9954    2.7300    0.0000 O   0  0
    5.4100    0.4200    0.0000 C   0  0
    6.8200    1.2300    0.0000 N   0  0
    6.4200    3.1700    0.0000 C   0  0
    7.6031    4.0921    0.0000 O   0  0
    5.2400    3.7400    0.0000 C   0  0
    3.6200    3.7900    0.0000 C   0  0
    2.3600    2.7300    0.0000 C   0  0
    1.1200    3.8200    0.0000 C   0  0
   -0.2200    3.0400    0.0000 C   0  0  2  0  0  0
   -0.3675    1.5473    0.0000 C   0  0
   -1.4300    4.1100    0.0000 C   0  0  2  0  0  0
   -1.2537    5.5996    0.0000 O   0  0
   -2.8600    3.3500    0.0000 C   0  0  1  0  0  0
   -4.2023    4.0195    0.0000 C   0  0
   -2.6100    1.7700    0.0000 C   0  0  1  0  0  0
   -1.7116    1.3309    0.0000 O   0  0
   -4.0400    0.9800    0.0000 C   0  0  1  0  0  0
   -5.3935    1.6266    0.0000 C   0  0
   -3.7700   -0.5500    0.0000 C   0  0  2  0  0  0
   -2.4087   -1.1738    0.0000 O   0  0
   -2.2675   -2.6680    0.0000 C   0  0
   -3.0828   -3.2470    0.0000 C   0  0
   -1.3585   -3.0848    0.0000 O   0  0
   -5.2000   -1.3500    0.0000 C   0  0  2  0  0  0
   -6.5511   -0.6985    0.0000 C   0  0
    5.5972    5.1969    0.0000 C   0  0
    5.4100   -1.1700    0.0000 C   0  0
    6.7110   -1.9161    0.0000 C   0  0
    6.7165   -3.4169    0.0000 N   0  0
    8.0185   -4.1634    0.0000 N   0  0
    8.0262   -5.6634    0.0000 C   0  0
    9.3291   -6.4068    0.0000 C   0  0
   10.6243   -5.6502    0.0000 N   0  0
   10.6167   -4.1502    0.0000 C   0  0
    9.3138   -3.4068    0.0000 C   0  0
   11.9278   -6.3940    0.0000 C   0  0
   12.0755   -7.8739    0.0000 C   0  0
   13.5448   -8.1760    0.0000 C   0  0
   14.2861   -6.8719    0.0000 C   0  0
   13.2750   -5.7639    0.0000 C   0  0
    4.0000   -1.9800    0.0000 C   0  0
    3.9954   -3.4800    0.0000 O   0  0
    2.6100   -1.1700    0.0000 C   0  0
    1.2100   -1.9800    0.0000 C   0  0
    0.8800   -3.5500    0.0000 C   0  0
    1.8933   -4.6560    0.0000 O   0  0
  1  2  1  0
  3  2  1  6
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  1  0
  7  8  1  6
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 13 15  2  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
 18 19  1  0
 19 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  1  6
 26 28  1  0
 28 29  1  1
 28 30  1  0
 30 31  1  6
 30 32  1  0
 32 33  1  1
 32 34  1  0
 34 35  1  6
 34 36  1  0
 36 37  1  6
 37 38  1  0
 38 39  1  0
 38 40  2  0
 36 41  1  0
 41  3  1  0
 41 42  1  1
 22 43  1  0
 18 44  1  0
 44 45  1  0
 45 46  2  3
 46 47  1  0
 47 48  1  0
 48 49  1  0
 49 50  1  0
 50 51  1  0
 51 52  1  0
 52 47  1  0
 50 53  1  0
 53 54  1  0
 54 55  1  0
 55 56  1  0
 56 57  1  0
 57 53  1  0
 44 58  2  0
 58 59  1  0
 58 60  1  0
 60 15  1  0
 60 61  2  0
 61 10  1  0
 61 62  1  0
 62  7  1  0
 62 63  2  0
M  END
> <name>
NIHCC_2014

> <id>
6338

> <plate>
NGP-202-04

> <well>
F03

> <supplier_cmpd_name>
CPD001906779

> <ctcr_id>
7072

> <supplier_cmpd_id>
SAM002589953

> <smiles>
CO[C@H]1\C=C\O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(NC(=O)C(=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)/C)c(C=NN5CCN(CC5)C6CCCC6)c(O)c4c3C2=O

> <pd_targets>
{KMT2A,MEN1,KDM4E,MAPT,ALD,FTL,MAPK1,GAA,ABCC4,ABCB11,ABCC3,ABCC2,RPOA,RPOB,RPOC,RPOZ}

> <pathway_gtopdb>
{"Epigenetic regulator","Other cytosolic protein",Enzyme,"Unclassified protein",Reader,Eraser,Kinase,Hydrolase,Bromodomain,"Lysine demethylase","Protein Kinase","Jumonji domain-containing","CMGC prote
in kinase group","CMGC protein kinase MAPK family","CMGC protein kinase ERK1",Transporter,"Primary active transporter",Transferase,"ATP-binding cassette","ABCC subfamily","ABCB subfamily"}

> <pathway_chembl>
{Enzymes,"Chromatin modifying enzymes","Kinases (EC 2.7.x.x)","3.2.1.- Glycosidases","1.14.11.- Histone demethylases","CMGC: Containing CDK",MAPK,GSK3,"CLK families","Mitogen-activated protein kinases
 (MAP kinases)","ERK subfamily",Transporters,"ATP-binding cassette transporter family","ABCC subfamily","ABCB subfamily"}

> <pathway_reactome>
{"Neuronal System","Vesicle-mediated transport","Immune System",Disease,"Transmission across Chemical Synapses","Membrane Trafficking","Innate Immune System","Diseases of metabolism","Neurotransmitter
 receptors and postsynaptic signal transmission","trans-Golgi Network Vesicle Budding","Toll-like Receptor Cascades","Diseases of carbohydrate metabolism","Activation of NMDA receptors and postsynapti
c events","Golgi Associated Vesicle Biogenesis","Toll Like Receptor 5 (TLR5) Cascade","Glycogen storage diseases","Post NMDA receptor activation events","MyD88 cascade initiated on plasma membrane","G
lycogen storage disease type II (GAA)","Activation of AMPK downstream of NMDARs","MAP kinase activation","MAPK targets/ Nuclear events mediated by MAP kinases","ERK/MAPK targets","ERKs are inactivated
",Hemostasis,Metabolism,"Platelet activation","signaling and aggregation","Metabolism of lipids","Disorders of transmembrane transporters","Infectious disease","Response to elevated platelet cytosolic
 Ca2+","Metabolism of steroids","ABC transporter disorders","Infection with Mycobacterium tuberculosis","Platelet degranulation","Bile acid and bile salt metabolism","Defective ABCC2 causes DJS","Anti
microbial action and antimicrobial resistance in Mtb","Synthesis of bile acids and bile salts","Recycling of bile acids and salts","Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
"}

> <broad_targets>
{CYP2C8,CYP2C9,CYP3A4}

> <broad_moa>
{"RNA polymerase inhibitor"}

> <synonyms>
{RIFAPENTINE,61379-65-5,61379655,"3-(4-Cyclopentyl-1-piperazinyl)iminomethylrifamycin SV","3(4Cyclopentyl1piperazinyl)iminomethylrifamycin SV",CHEMBL4538240,HMS3259L06,NC00700,SAM002589953,CPD00190677
9}

> <pdid>
PD002884

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{135968625}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 28  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.5987    1.5004    0.0000 C   0  0
   -3.9492    0.8772    0.0000 C   0  0
   -4.9546    1.9903    0.0000 C   0  0
   -4.2067    3.2905    0.0000 N   0  0
   -2.7390    2.9810    0.0000 N   0  0
   -1.6193    3.9803    0.0000 C   0  0
   -0.1673    3.6256    0.0000 C   0  0
    0.8689    4.7101    0.0000 C   0  0
    0.4478    6.1498    0.0000 C   0  0
   -1.0096    6.5049    0.0000 C   0  0
   -2.0458    5.4204    0.0000 C   0  0
    1.4846    7.2349    0.0000 S   0  0
    1.0630    8.6745    0.0000 N   0  0
    2.9422    6.8807    0.0000 O   0  0
    2.5203    8.3200    0.0000 O   0  0
   -6.4444    1.8313    0.0000 C   0  0
   -7.0532    0.4604    0.0000 F   0  0
   -7.3276    3.0437    0.0000 F   0  0
   -7.9360    1.6729    0.0000 F   0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  5  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12  8  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 16 19  1  0
 19 20  1  0
 19 21  2  0
 19 22  2  0
 10 23  1  0
 23 24  1  0
 23 25  1  0
 23 26  1  0
M  END
> <name>
NIHCC_2014

> <id>
6339

> <plate>
NGP-202-04

> <well>
F04

> <supplier_cmpd_name>
CPD000550473

> <ctcr_id>
1124

> <supplier_cmpd_id>
SAM002589995

> <smiles>
Cc1ccc(cc1)c2cc(nn2c3ccc(cc3)[S](N)(=O)=O)C(F)(F)F

> <pd_targets>
{PTGS2,CA2,CA9,CA4,CA3,PTGS1,CA15,MTCA1,NCE103,LMNA,TSHR,CA1,CA7,PTGES,MT-CO2,CA14,CA12,CYP2C9,CA5A,CA6,CDC42,RAC1,CA13,HDAC1,HDAC10,HDAC11,HDAC2,HDAC3,HDAC4,HDAC5,HDAC6,HDAC7,HDAC8,HDAC9,MT-CO1,CA5B,
1272966,MTCA2,PGR,PDPK1,ALOX5,PDE5A,RAB2A,MAPK14,RAB7A,CYP3A4,EPHX2,ADRA2B,ADRB3,CACNA1C,SLC6A4,ADORA3,SLC6A2,SLC6A3,CYP2D6,CDH11}

> <pathway_gtopdb>
{Enzyme,"Other nuclear protein","Membrane receptor",Transporter,"Epigenetic regulator","Transcription factor","Ion channel",Oxidoreductase,Lyase,"Family A G protein-coupled receptor",Isomerase,"Primar
y active transporter","Cytochrome P450",Hydrolase,Eraser,Protease,"Nuclear receptor",Kinase,Phosphodiesterase,"Voltage-gated ion channel","Electrochemical transporter","Peptide receptor (family A GPCR
)","Oxidoreduction-driven transporters","Cytochrome P450 family 2","Histone deacetylase","Cysteine protease","Nuclear hormone receptor subfamily 3","Protein Kinase","Phosphodiesterase 5","Cytochrome P
450 family 3","Serine protease","Small molecule receptor (family A GPCR)","Voltage-gated calcium channel","SLC superfamily of solute carriers","Glycohormone receptor","Cytochrome P450 family 2C","HDAC
 class I","Cysteine protease CA clan","Nuclear hormone receptor subfamily 3 group C","AGC protein kinase group","Phosphodiesterase 5A","CMGC protein kinase group","Cytochrome P450 family 3A","Serine p
rotease SC clan","Monoamine receptor","SLC06 neurotransmitter transporter family","HDAC class IIb","Nucleotide-like receptor (family A GPCR)","Cytochrome P450 family 2D","Cytochrome P450 2C9","Cystein
e protease C1A family","Nuclear hormone receptor subfamily 3 group C member 3","AGC protein kinase PDK1 subfamily","CMGC protein kinase MAPK family","Cytochrome P450 3A4","Serine protease S33 family",
"Adrenergic receptor","Dopamine receptor","Adenosine receptor","Cytochrome P450 2D6","CMGC protein kinase p38 subfamily"}

> <pathway_chembl>
{Enzymes,Receptors,"Ion channels",Transporters,"Eicosanoid turnover","Carbonic anhydrases","G protein-coupled receptors","Cytochrome P450","Kinases (EC 2.7.x.x)","Cyclic nucleotide turnover/signalling
",Hydrolases,"Voltage-gated ion channels","Chromatin modifying enzymes","SLC superfamily of solute carriers",Cyclooxygenase,"Glycoprotein hormone receptors","Prostaglandin synthases","CYP2 family: dru
g metabolising subset","AGC: Containing PKA",PKG,"PKC families",Lipoxygenases,Phosphodiesterases,3',"5'-cyclic nucleotide (PDEs)","CMGC: Containing CDK",MAPK,GSK3,"CLK families","CYP3 family",Adrenoce
ptors,"Voltage-gated calcium channels","3.5.1.- Histone deacetylases (HDACs)","Dopamine receptors","SLC6 neurotransmitter transporter family","Adenosine receptors","PDK1 family","Mitogen-activated pro
tein kinases (MAP kinases)","Monoamine transporter subfamily","p38 subfamily"}

> <pathway_reactome>
{Metabolism,"Transport of small molecules","Cellular responses to external stimuli","Cell Cycle",Disease,"Immune System","Gene expression (Transcription)","Developmental Biology",Hemostasis,"Signal Tr
ansduction","Neuronal System","Metabolism of lipids","O2/CO2 exchange in erythrocytes","Cellular responses to stress","Reversible hydration of carbon dioxide",Mitotic,"Infectious disease","Cytokine Si
gnaling in Immune system","RNA Polymerase II Transcription","Biological oxidations","Nervous system development","Platelet homeostasis","Innate Immune System","Signaling by GPCR","Disorders of Develop
mental Biology","Transmission across Chemical Synapses","Disorders of transmembrane transporters","Biosynthesis of specialized proresolving mediators (SPMs)","Erythrocytes take up carbon dioxide and r
elease oxygen","Cellular response to hypoxia","Fatty acid metabolism","M Phase","Leishmania infection","Signaling by Interleukins","Generic Transcription Pathway","Phase I - Functionalization of compo
unds","Axon guidance","Nitric oxide stimulates guanylate cyclase","Toll-like Receptor Cascades","Infection with Mycobacterium tuberculosis","GPCR ligand binding","Disorders of Nervous System Developme
nt","Neurotransmitter clearance","SLC transporter disorders","Biosynthesis of DPA-derived SPMs","Regulation of gene expression by Hypoxia-inducible Factor","Arachidonic acid metabolism","Mitotic Metap
hase and Anaphase","Leishmania parasite growth and survival","Interleukin-12 family signaling","Transcriptional Regulation by TP53","Cytochrome P450 - arranged by substrate type","Parasite infection",
"Semaphorin interactions","cGMP effects","Mitotic Prophase","Toll Like Receptor 5 (TLR5) Cascade","Response of Mtb to phagocytosis","Biosynthesis of DHA-derived SPMs","Class A/1 (Rhodopsin-like recept
ors)","NCAM signaling for neurite out-growth","Pervasive developmental disorders","Serotonin clearance from the synaptic cleft","Transcriptional regulation by RUNX2","Defective SLC6A2 causes orthostat
ic intolerance (OI)","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Biosynthesis of DPAn-3 SPMs","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","Mitotic Anaphase","Anti-i
nflammatory response favouring Leishmania parasite infection","Interleukin-12 signaling","TP53 Regulates Metabolic Genes",Xenobiotics,"Leishmania phagocytosis","Sema4D in semaphorin signaling","Regula
tion of TP53 Activity","Golgi Cisternae Pericentriolar Stack Reorganization","MyD88 cascade initiated on plasma membrane","Suppression of phagosomal maturation","Biosynthesis of maresins","Amine ligan
d-binding receptors","NCAM1 interactions","Loss of function of MECP2 in Rett syndrome","RUNX2 regulates bone development","Nucleotide-like (purinergic) receptors","Nuclear Envelope (NE) Reassembly","A
DORA2B mediated anti-inflammatory cytokines production","Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation","CYP2E1 reactions","FCGR3A-mediated phagocytosis","Sema4D m
ediated inhibition of cell attachment and migration","Regulation of TP53 Expression and Degradation","Biosynthesis of DPAn-3-derived 13-series resolvins","MAP kinase activation","Prevention of phagoso
mal-lysosomal fusion","Biosynthesis of maresin-like SPMs",Adrenoceptors,"Loss of MECP2 binding ability to 5mC-DNA","RUNX2 regulates osteoblast differentiation","Adenosine P1 receptors","Initiation of 
Nuclear Envelope (NE) Reformation","Regulation of TP53 Degradation","MAPK targets/ Nuclear events mediated by MAP kinases","Activation of the AP-1 family of transcription factors"}

> <broad_targets>
{CA12,PDPK1,PTGS2}

> <broad_moa>
{"cyclooxygenase inhibitor"}

> <synonyms>
{"Celebrex (TN)",SMR000550473,CAS-169590-42-5,CAS169590425,SR-01000837528,SR01000837528,Celecoxibum,"Celecoxib (USAN:INN:BAN)","CCRIS 9330",TPI-336,TPI336,Celecoxib-(d4),Celecoxib(d4),"Onsenal (TN)",A
I-525,AI525,CEP-33222,CEP33222,CELEBCOXIB,544686-20-6,544686206,Spectrum_000432,Spectrum000432,Spectrum-000432,"Spectrum 000432",1oq5,Spectrum2_001576,Spectrum2001576,Spectrum2-001576,"Spectrum2 00157
6",Spec,T0466,719627,SAM002589995,1503678,Prestw-1371,"NSC 719627",Celecoxib,CPD000550473,CELECOXIB}

> <pdid>
PD000893

> <targets>
{}

> <classes>
{"COX-2 inhibitor","cyclooxygenase2 inhibitor",antiarthritic}

> <pubchem_cids>
{2662}

$$$$
NIHCC_2014
  SciTegic11012413002D

 31 35  0  0  1  0            999 V2000
    1.9438   -6.2113    0.0000 C   0  0
    0.7315   -5.3280    0.0000 C   0  0
   -0.6572   -5.8951    0.0000 C   0  0
    2.0426   -4.5993    0.0000 O   0  0
    1.7758   -3.1329    0.0000 C   0  0  2  0  0  0
    2.3947   -1.7666    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0  2  0  0  0
    2.5981    1.5000    0.0000 C   0  0
    2.5981    3.0000    0.0000 C   0  0  2  0  0  0
    3.8971    3.7500    0.0000 F   0  0
    1.2990    3.7500    0.0000 C   0  0
    1.2990    5.2500    0.0000 C   0  0
    0.0000    6.0000    0.0000 C   0  0
   -0.0001    7.5000    0.0000 O   0  0
   -1.2991    5.2500    0.0000 C   0  0
   -1.2991    3.7500    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0  1  0  0  0
   -1.2991    2.2500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0  1  0  0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -2.5981    1.5000    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0  1  0  0  0
   -0.8141   -2.0807    0.0000 C   0  0
    0.2851   -2.9666    0.0000 C   0  0  2  0  0  0
   -0.3667   -4.3062    0.0000 O   0  0
   -1.1988   -2.7813    0.0000 C   0  0
   -2.1035   -3.9778    0.0000 O   0  0
   -1.7835   -1.3990    0.0000 C   0  0
   -3.2720   -1.2134    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  5  4  1  1
  5  6  1  0
  7  6  1  6
  7  8  1  0
  8  9  1  1
  9 10  1  0
 10 11  1  1
 10 12  1  0
 12 13  2  3
 13 14  1  0
 14 15  2  0
 14 16  1  0
 16 17  2  3
 17 18  1  0
 18 12  1  0
 18 19  1  6
 20 18  1  6
 20  8  1  0
 20 21  1  0
 21 22  1  6
 21 23  1  0
 23 24  1  0
 24  7  1  0
 24 25  1  6
 24 26  1  0
 26  5  1  0
 26 27  1  0
 27  2  1  0
 26 28  1  6
 28 29  2  0
 28 30  1  0
 30 31  1  0
M  END
> <name>
NIHCC_2014

> <id>
6340

> <plate>
NGP-202-04

> <well>
F05

> <supplier_cmpd_name>
CPD001233272

> <ctcr_id>
5682

> <supplier_cmpd_id>
SAM002589966

> <smiles>
CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO

> <pd_targets>
{PGR,NR3C1}

> <pathway_gtopdb>
{"Transcription factor","Nuclear receptor","Nuclear hormone receptor subfamily 3","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 3 group C member 3","Nuclear hormon
e receptor subfamily 3 group C member 1"}

> <pathway_chembl>
{Receptors,"Nuclear hormone receptors","Steroid hormone receptors","3C. 3-Ketosteroid receptors"}

> <pathway_reactome>
{"Gene expression (Transcription)","RNA Polymerase II Transcription","Generic Transcription Pathway","FOXO-mediated transcription","FOXO-mediated transcription of oxidative stress","metabolic and neur
onal genes"}

> <broad_targets>
{NR3C1}

> <broad_moa>
{"cytochrome P450 inhibitor"}

> <synonyms>
{flunisolide,32277-EP2305640A2,32277EP2305640A2,32277-EP2308562A2,32277EP2308562A2,32277-EP2311827A1,32277EP2311827A1,32277-EP2371811A2,32277EP2371811A2,385F033,Q3746835,BRD-K49577446-001-03-1,BRDK495
77446001031,3385-03-3,3385033,Aerobid,Synaclyn,Nasarel,Syntaris,"Flunisolide HFA",Nasalide,Bronalide,Rhinalar,Aerospan,"Flunisolide anhydr",SAM002589966,Prestw-643,CPD001233272,Flunisolide}

> <pdid>
PD001462

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{82153}

$$$$
NIHCC_2014
  SciTegic11012413002D

 39 40  0  0  0  0            999 V2000
    8.8995    2.2439    0.0000 H   0  3
    6.3995    2.2439    0.0000 Cl  0  5
    3.8976   -0.7500    0.0000 C   0  0
    2.5988   -1.5004    0.0000 C   0  0
    3.8982   -2.2498    0.0000 C   0  0
    2.5997   -3.0012    0.0000 C   0  0
    1.3009   -3.7516    0.0000 O   0  0
    3.8988   -3.7512    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -2.6003    1.4977    0.0000 C   0  0
   -2.6030    2.9977    0.0000 O   0  0
   -3.8990    0.7455    0.0000 C   0  0
   -5.2003    1.4932    0.0000 C   0  0
   -6.4990    0.7409    0.0000 C   0  0
   -7.8003    1.4887    0.0000 N   0  0
   -9.0994    0.7387    0.0000 C   0  0
  -10.3984    1.4886    0.0000 C   0  0
  -10.3985    2.9886    0.0000 C   0  0
   -9.0995    3.7387    0.0000 C   0  0
   -7.8004    2.9887    0.0000 C   0  0
  -11.6982    3.7390    0.0000 C   0  0
  -12.9973    4.4890    0.0000 O   0  0
  -12.9977    2.9881    0.0000 C   0  0
  -12.9972    1.4881    0.0000 C   0  0
  -14.2960    0.7377    0.0000 C   0  0
  -15.5953    1.4872    0.0000 C   0  0
  -15.5958    2.9872    0.0000 C   0  0
  -14.2970    3.7377    0.0000 C   0  0
  -11.6978    5.2398    0.0000 C   0  0
  -10.3985    5.9894    0.0000 C   0  0
  -10.3981    7.4894    0.0000 C   0  0
  -11.6969    8.2398    0.0000 C   0  0
  -12.9961    7.4902    0.0000 C   0  0
  -12.9966    5.9902    0.0000 C   0  0
  3  4  1  0
  4  5  1  0
  4  6  1  0
  6  7  1  0
  6  8  2  0
  4  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 12 15  1  0
 15 16  1  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 20  1  0
 23 26  1  0
 26 27  1  0
 26 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 28  1  0
 26 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
 38 39  2  0
 39 34  1  0
M  CHG  2   1   1   2  -1
M  END
> <name>
NIHCC_2014

> <id>
6341

> <plate>
NGP-202-04

> <well>
F06

> <supplier_cmpd_name>
CPD000718798

> <ctcr_id>
3216

> <supplier_cmpd_id>
SAM002700173

> <smiles>
[H+].[Cl-].CC(C)(C(O)=O)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4

> <pd_targets>
{BLM,HRH1,KCNH2,LMNA,APEX1,HSD17B10,ALOX15}

> <pathway_gtopdb>
{Enzyme,"Membrane receptor","Ion channel","Other nuclear protein","Family A G protein-coupled receptor","Voltage-gated ion channel",Oxidoreductase,"Small molecule receptor (family A GPCR)","Potassium 
channels","Monoamine receptor","Voltage-gated potassium channel","Histamine receptor"}

> <pathway_chembl>
{Receptors,"Ion channels",Enzymes,"G protein-coupled receptors","Voltage-gated ion channels","Eicosanoid turnover","Histamine receptors","Potassium channels",Lipoxygenases,"Voltage-gated potassium cha
nnels"}

> <pathway_reactome>
{"DNA Repair","Signal Transduction","Muscle contraction","Cell Cycle",Metabolism,"DNA Double-Strand Break Repair","Signaling by GPCR","Cardiac conduction",Mitotic,"Base Excision Repair","Metabolism of
 amino acids and derivatives","Metabolism of lipids","Homology Directed Repair","GPCR ligand binding","Phase 3 - rapid repolarisation","M Phase","Resolution of Abasic Sites (AP sites)","Branched-chain
 amino acid catabolism","Biosynthesis of specialized proresolving mediators (SPMs)","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Class A/1 (Rhodopsin-like receptors)"
,"Mitotic Metaphase and Anaphase","Resolution of AP sites via the multiple-nucleotide patch replacement pathway","Biosynthesis of DPA-derived SPMs","HDR through Homologous Recombination (HRR)","Amine 
ligand-binding receptors","Mitotic Anaphase","PCNA-Dependent Long Patch Base Excision Repair","Biosynthesis of DPAn-3 SPMs","Homologous DNA Pairing and Strand Exchange","Histamine receptors","Nuclear 
Envelope (NE) Reassembly","Biosynthesis of DPAn-3-derived protectins and resolvins","Presynaptic phase of homologous DNA pairing and strand exchange","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{HRH1}

> <broad_moa>
{"histamine receptor antagonist"}

> <synonyms>
{138452-21-8,138452218,"138452 21 8",AKOS015896119,AKOS015896444,A807389,"FEXOFENADINE HYDROCHLORIDE",153439-40-8,153439408,"153439 40 8","FEXOFENADINE HCL",Telfast,"Fexofenidine hydrochloride","MDL 1
6,455A","Fexofenadine (hydr",T1470L,T1470,S3208,SAM002700173,1504179,Prestw-1102,"Fexofenadine hydrochloride","Fexofenadine HCl",CPD000718798}

> <pdid>
PD002734

> <targets>
{"Histamine Receptor"}

> <classes>
{"Neuronal Signaling","nonsedating H1-antihistamine"}

> <pubchem_cids>
{45108248,63002,16417045}

$$$$
NIHCC_2014
  SciTegic11012413002D

 26 30  0  0  1  0            999 V2000
    9.7549    0.2674    0.0000 Cl  0  0
   -2.6395    3.8685    0.0000 O   0  0
   -1.3618    3.0827    0.0000 C   0  0
    0.0000    3.7710    0.0000 C   0  0
    1.0625    3.0827    0.0000 C   0  0
    1.0625    1.6760    0.0000 C   0  0
    2.3045    0.9727    0.0000 C   0  0
    2.3045   -0.4040    0.0000 C   0  0  1  0  0  0
    3.2622   -1.0625    0.0000 N   0  0
    3.2622   -1.9005    0.0000 C   0  0
    0.0000   -1.9005    0.0000 C   0  0
    0.0000   -0.4040    0.0000 C   0  0  1  0  0  0
   -1.3618   -1.1223    0.0000 C   0  0  1  0  0  0
   -2.5589    0.2394    0.0000 O   0  0
   -1.3618    1.6760    0.0000 C   0  0
    0.0000    0.9727    0.0000 C   0  0
   -1.3618   -2.5589    0.0000 C   0  0
   -2.6462   -3.3336    0.0000 O   0  0
    0.0000   -3.2772    0.0000 C   0  0
    1.0774   -2.5589    0.0000 C   0  0
    1.0774   -1.1373    0.0000 C   0  0  1  0  0  0
    2.3821   -1.8775    0.0000 O   0  0
    4.6577   -0.4958    0.0000 C   0  0
    5.8415   -1.4184    0.0000 C   0  0
    7.2549   -1.5708    0.0000 C   0  0
    6.3315   -2.7529    0.0000 C   0  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  8  7  1  1
  8  9  1  0
  9 10  1  0
 10 11  1  0
 12 11  1  1
 12 13  1  0
 13 14  1  6
 14 15  1  0
 15  3  1  0
 15 16  2  0
 16  6  1  0
 16 12  1  0
 13 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21  8  1  0
 21 12  1  0
 21 22  1  1
  9 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 24  1  0
M  END
> <name>
NIHCC_2014

> <id>
6342

> <plate>
NGP-202-04

> <well>
G02

> <supplier_cmpd_name>
CPD000058767

> <ctcr_id>
7068

> <supplier_cmpd_id>
SAM002589986

> <smiles>
Cl.Oc1ccc2C[C@H]3N(CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O)CC6CC6

> <pd_targets>
{CHRNA7,OPRK1,OPRM1,OPRD1,CHRNA4,TGR,CYP2D6,SIGMAR1}

> <pathway_gtopdb>
{"Ion channel","Membrane receptor",Enzyme,"Ligand-gated ion channel","Family A G protein-coupled receptor","Cytochrome P450","Nicotinic acetylcholine receptor","Peptide receptor (family A GPCR)","Cyto
chrome P450 family 2","Nicotinic acetylcholine receptor alpha subunit","Short peptide receptor (family A GPCR)","Cytochrome P450 family 2D","Opioid receptor","Cytochrome P450 2D6"}

> <pathway_chembl>
{"Ion channels",Receptors,Enzymes,"Ligand-gated ion channels","G protein-coupled receptors","Cytochrome P450","Nicotinic acetylcholine receptors","Opioid receptors","CYP2 family: drug metabolising sub
set"}

> <pathway_reactome>
{"Neuronal System","Gene expression (Transcription)","Signal Transduction",Metabolism,"Transmission across Chemical Synapses","RNA Polymerase II Transcription","Signaling by GPCR","Biological oxidatio
ns","Neurotransmitter receptors and postsynaptic signal transmission","Generic Transcription Pathway","GPCR downstream signalling","GPCR ligand binding","Phase I - Functionalization of compounds","Ace
tylcholine binding and downstream events","Transcriptional Regulation by MECP2","G alpha (i) signalling events","Class A/1 (Rhodopsin-like receptors)","Cytochrome P450 - arranged by substrate type","P
ostsynaptic nicotinic acetylcholine receptors","MECP2 regulates neuronal receptors and channels","Opioid Signalling","Peptide ligand-binding receptors",Xenobiotics,"Highly calcium permeable postsynapt
ic nicotinic acetylcholine receptors","G-protein activation","CYP2E1 reactions"}

> <broad_targets>
{OPRD1,OPRK1,OPRM1,SIGMAR1}

> <broad_moa>
{"opioid receptor antagonist"}

> <synonyms>
{"Naltrexone hydrochloride","Naltrexone Hcl",16676-29-2,16676292,"16676 29 2",Depade,Trexan,Antaxone,ReVia,"Naltrexone (Hydrochloride)","NIH 8503",EN-1639A,EN1639A,"EN 1639A",UNII-Z6375YW9SF,UNIIZ6375
YW9SF,"UNII Z6375YW9SF",Celupan,Nemexin,S2103,SAM002589986,"Naltrexone HCl",CPD000058767}

> <pdid>
PD010071

> <targets>
{"Opioid Receptor"}

> <classes>
{"Neuronal Signaling"}

> <pubchem_cids>
{5485201,5388998,11760614}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 26  0  0  0  0            999 V2000
    0.1194   -2.3933    0.0000 C   0  0
    0.7500   -1.0323    0.0000 C   0  0
    2.2393   -0.8534    0.0000 C   0  0
    1.2135    0.3943    0.0000 S   0  0
    0.0000    1.2760    0.0000 C   0  0
   -0.8796    2.4866    0.0000 C   0  0
   -0.6484    3.9634    0.0000 N   0  0
   -1.8159    4.9065    0.0000 C   0  0
   -3.2155    4.3669    0.0000 O   0  0
   -1.5838    6.3893    0.0000 C   0  0
   -2.7513    7.3324    0.0000 O   0  0
   -2.5192    8.8152    0.0000 C   0  0
   -3.6846    9.7595    0.0000 C   0  0
   -3.4496   11.2410    0.0000 C   0  0
   -2.0492   11.7782    0.0000 C   0  0
   -0.8837   10.8340    0.0000 C   0  0
   -1.1186    9.3525    0.0000 C   0  0
   -2.0931    1.6049    0.0000 C   0  0
   -3.5746    1.8395    0.0000 O   0  0
   -1.2135    0.3943    0.0000 N   0  0
   -0.7500   -1.0323    0.0000 C   0  0
   -1.6332   -2.2426    0.0000 C   0  0
   -1.0255   -3.6140    0.0000 O   0  0
   -3.1247   -2.0836    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
  6 18  1  0
 18 19  2  0
 18 20  1  0
 20  5  1  0
 20 21  1  0
 21  2  1  0
 21 22  1  0
 22 23  1  0
 22 24  2  0
M  END
> <name>
NIHCC_2014

> <id>
6343

> <plate>
NGP-202-04

> <well>
G03

> <supplier_cmpd_name>
CPD000274084

> <ctcr_id>
7073

> <supplier_cmpd_id>
SAM002589954

> <smiles>
CC1(C)SC2C(NC(=O)COc3ccccc3)C(=O)N2C1C(O)=O

> <pd_targets>
{RORC,LMNA,CYP2C19,CYP2D6,CYP1A2,SLC22A8,DACA,DACB,DACC,FTSI,MRCA,MRCB,MRDA,MECA}

> <pathway_gtopdb>
{"Transcription factor","Other nuclear protein",Enzyme,Transporter,"Nuclear receptor","Cytochrome P450","Electrochemical transporter",Protease,"Nuclear hormone receptor subfamily 1","Cytochrome P450 f
amily 2","Cytochrome P450 family 1","SLC superfamily of solute carriers","Serine protease","Nuclear hormone receptor subfamily 1 group F","Cytochrome P450 family 2C","Cytochrome P450 family 2D","Cytoc
hrome P450 family 1A","SLC22 family of organic cation and anion transporters","Serine protease SE clan","Serine protease unclassified","Nuclear hormone receptor subfamily 1 group F member 3","Cytochro
me P450 2C19","Cytochrome P450 2D6","Cytochrome P450 1A1","Serine protease S11 family"}

> <pathway_chembl>
{Receptors,Enzymes,Transporters,"Nuclear hormone receptors","Cytochrome P450","SLC superfamily of solute carriers","1F. Retinoic acid-related orphans","CYP2 family: drug metabolising subset","CYP1 fam
ily","SLC22 family of organic cation and anion transporters","Organic anion transporters (OATs)"}

> <pathway_reactome>
{"Gene expression (Transcription)","Cell Cycle",Metabolism,"Transport of small molecules","RNA Polymerase II Transcription",Mitotic,"Biological oxidations","SLC-mediated transmembrane transport","Gene
ric Transcription Pathway","M Phase","Phase I - Functionalization of compounds","Transport of bile salts and organic acids","metal ions and amine compounds","Transcriptional regulation by RUNX3","Mito
tic Metaphase and Anaphase","Cytochrome P450 - arranged by substrate type","Organic cation/anion/zwitterion transport","RUNX3 Regulates Immune Response and Cell Migration","Mitotic Anaphase",Xenobioti
cs,"Organic anion transport","Nuclear Envelope (NE) Reassembly","CYP2E1 reactions","Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Initiation of Nuclear Envelope (NE) Reformation"}

> <broad_targets>
{}

> <broad_moa>
{"bacterial cell wall synthesis inhibitor"}

> <synonyms>
{Fenoxypen,Phenocillin,Phenopenicillin,Stabicillin,Vebecillin,Fenacilin,Meropenin,Oratren,Apopen,Ospen,"Distaquaine V","Eskacillian V",V-Tablopen,VTablopen,Pen-vee,Penvee,"Acipen V",Pen-Oral,PenOral,V
-Cyline,VCyline,V-Cil,VCil,Oracilline,Orocillin,"Penicillanic acid",6-phenoxyacet,6phenoxyacet,SAM002589954,CPD000274084}

> <pdid>
PD002921

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{4731}

$$$$
NIHCC_2014
  SciTegic11012413002D

 16 15  0  0  0  0            999 V2000
    1.3000    2.2500    0.0000 C   0  0
    1.3000    0.7500    0.0000 C   0  0
    0.0007    0.0004    0.0000 O   0  0
    2.5993    0.0004    0.0000 O   0  0
   11.5939   -1.8764    0.0000 N   0  0
   11.5961   -0.3764    0.0000 C   0  0
   10.2979    0.3767    0.0000 C   0  0
   10.2979    1.8767    0.0000 C   0  0
    8.9988    2.6267    0.0000 C   0  0
    7.6998    1.8767    0.0000 C   0  0
    7.6998    0.3767    0.0000 C   0  0
    8.9988   -0.3733    0.0000 C   0  0
    6.4000    2.6271    0.0000 S   0  0
    5.1012    1.8767    0.0000 N   0  0
    6.3991    4.1271    0.0000 O   0  0
    5.1006    3.3765    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  2  4  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 10 13  1  0
 13 14  1  0
 13 15  2  0
 13 16  2  0
M  END
> <name>
NIHCC_2014

> <id>
6344

> <plate>
NGP-202-04

> <well>
G04

> <supplier_cmpd_name>
CPD000058778

> <ctcr_id>
7077

> <supplier_cmpd_id>
SAM002589996

> <smiles>
CC(O)=O.NCc1ccc(cc1)[S](N)(=O)=O

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{"MAFENIDE ACETATE",13009-99-9,13009999,"4-(AMINOMETHYL)BENZENESULFONAMIDE ACETATE","4(AMINOMETHYL)BENZENESULFONAMIDE ACETATE","Mafenamide acetate","Mafenide (Acetate)",UNII-RQ6LP6Z0WY,UNIIRQ6LP6Z0WY,
"Benzenesulfonamide, 4-(aminomethyl)-, monoacetate","Benzenesulfonamide, 4(aminomethyl), monoacetate","acetic acid;4-(aminomethyl)benzenesulfonamide","acetic acid;4(aminomethyl)benzenesulfonamide",Maf
atate,R,SAM002589996,CPD000058778}

> <pdid>

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{25590}

$$$$
NIHCC_2014
  SciTegic11012413002D

 16 17  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 N   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.7248    1.2135    0.0000 N   0  0
   -3.6065    0.0000    0.0000 C   0  0
   -2.7248   -1.2135    0.0000 N   0  0
   -3.1904   -2.6376    0.0000 C   0  0
   -4.6588   -2.9478    0.0000 O   0  0
   -5.1253   -4.3743    0.0000 C   0  0
   -6.5937   -4.6845    0.0000 C   0  0
   -7.0599   -6.1103    0.0000 O   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 N   0  0
  1  2  1  0
  2  3  2  3
  3  4  1  0
  4  5  2  0
  4  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
  9 15  1  0
 15  6  2  0
 15 16  1  0
 16  2  1  0
M  END
> <name>
NIHCC_2014

> <id>
6345

> <plate>
NGP-202-04

> <well>
G05

> <supplier_cmpd_name>
CPD000058225

> <ctcr_id>
122

> <supplier_cmpd_id>
SAM002589967

> <smiles>
NC1=NC(=O)c2ncn(COCCO)c2N1

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
{PNP}

> <broad_moa>
{"DNA polymerase inhibitor"}

> <synonyms>
{ACYCLOVIR,Prestw-86,Prestw86,Prestw_86,"Prestw 86",SAM002589967,1503603,CPD000058225,Acyclovir}

> <pdid>

> <targets>
{}

> <classes>
{antiviral}

> <pubchem_cids>
{2022}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 30  0  0  0  0            999 V2000
    2.5981   -1.5000    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 C   0  0
    1.0956    4.0166    0.0000 C   0  0
    0.4767    5.3830    0.0000 C   0  0
   -1.0140    5.2166    0.0000 C   0  0
   -1.9861    4.9820    0.0000 O   0  0
   -0.5491    6.6300    0.0000 C   0  0
    0.9239    6.9135    0.0000 C   0  0
   -1.5307    7.7642    0.0000 O   0  0
   -1.2991    3.7500    0.0000 C   0  0
   -2.1132    4.3307    0.0000 C   0  0
   -2.5981    3.0000    0.0000 C   0  0
   -2.5981    1.5000    0.0000 C   0  0
   -3.8971    0.7500    0.0000 O   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.1651    0.2500    0.0000 F   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -1.2990   -1.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
   -1.2990   -5.2500    0.0000 O   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  8 10  1  0
 10 11  1  0
 10 12  2  0
  8 13  1  0
 13  5  1  0
 13 14  1  0
 13 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  0
 18  4  1  0
 18 19  1  0
 18 20  1  0
 20 21  1  0
 20 22  1  0
 22 23  2  3
 23 24  1  0
 24 25  2  0
 24 26  1  0
 26 27  2  3
 27  2  1  0
 27 20  1  0
M  END
> <name>
NIHCC_2014

> <id>
6346

> <plate>
NGP-202-04

> <well>
G06

> <supplier_cmpd_name>
CPD001563899

> <ctcr_id>
7081

> <supplier_cmpd_id>
SAM002700174

> <smiles>
CC1CC2C3CCC(O)(C(C)=O)C3(C)CC(O)C2(F)C4(C)C=CC(=O)C=C14

> <pd_targets>
{RORC,GAA,PGR,HIF1A,NR1I2,AR,NR3C1,HTT}

> <pathway_gtopdb>
{"Transcription factor",Enzyme,"Unclassified protein","Nuclear receptor",Hydrolase,"Nuclear hormone receptor subfamily 1","Nuclear hormone receptor subfamily 3","Nuclear hormone receptor subfamily 1 g
roup F","Nuclear hormone receptor subfamily 3 group C","Nuclear hormone receptor subfamily 1 group I","Nuclear hormone receptor subfamily 1 group F member 3","Nuclear hormone receptor subfamily 3 grou
p C member 3","Nuclear hormone receptor subfamily 1 group I member 2","Nuclear hormone receptor subfamily 3 group C member 4","Nuclear hormone receptor subfamily 3 group C member 1"}

> <pathway_chembl>
{Receptors,Enzymes,"Nuclear hormone receptors","3.2.1.- Glycosidases","1F. Retinoic acid-related orphans","1I. Vitamin D receptor-like receptors","Steroid hormone receptors","3C. 3-Ketosteroid recepto
rs"}

> <pathway_reactome>
{"Gene expression (Transcription)",Disease,"Cellular responses to external stimuli","Metabolism of proteins","RNA Polymerase II Transcription","Diseases of metabolism","Cellular responses to stress","
Post-translational protein modification","Generic Transcription Pathway","Diseases of carbohydrate metabolism","Cellular response to hypoxia",SUMOylation,"Transcriptional regulation by RUNX3","Glycoge
n storage diseases","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","SUMO E3 ligases SUMOylate target proteins","Transcriptional regulation by RUNX2","FOXO-mediated transcri
ption","Transcriptional Regulation by MECP2","RUNX3 Regulates Immune Response and Cell Migration","Glycogen storage disease type II (GAA)","SUMOylation of intracellular receptors","RUNX2 regulates bon
e development","FOXO-mediated transcription of oxidative stress","metabolic and neuronal genes","Regulation of MECP2 expression and activity","RUNX2 regulates osteoblast differentiation"}

> <broad_targets>
{NR3C1}

> <broad_moa>
{"glucocorticoid receptor agonist"}

> <synonyms>
{Fluoromethalone,MLS002702836,SMR001563899,Fluormetholon,"FML S.O.P.",Efflumidex,Fluaton,Loticort,Ursnon,"Neo-Oxylone (Salt/Mix)","NeoOxylone (Salt/Mix)",cid_3384,cid3384,cid-3384,"cid 3384","FML-S Li
quifilm (Salt/Mix)","FMLS Liquifilm (Salt/Mix)",CHEMBL1716015,SCHEMBL13026152,BDBM91406,HMS3259N12,AKOS030228671,MCULE-2724,MCULE2724,SAM002700174,CPD001563899}

> <pdid>
PD002328

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{3384}

$$$$
NIHCC_2014
  SciTegic11012413002D

 24 25  0  0  0  0            999 V2000
   12.0827   -1.5276    0.0000 Br  0  5
    9.5953    1.1799    0.0000 C   0  0
    8.1015    1.0434    0.0000 N   0  3
    7.2002    2.2424    0.0000 C   0  0
    8.8534   -0.2546    0.0000 C   0  0
    7.8513   -1.3707    0.0000 C   0  0
    6.4990   -0.7516    0.0000 C   0  0
    6.6348    0.7294    0.0000 C   0  0
    5.1988   -1.5012    0.0000 O   0  0
    3.8990   -0.7508    0.0000 C   0  0
    3.8995    0.7492    0.0000 O   0  0
    2.5988   -1.5004    0.0000 C   0  0
    2.5993   -0.0004    0.0000 O   0  0
    2.5983   -3.0012    0.0000 C   0  0
    3.8116   -3.8613    0.0000 C   0  0
    3.3476   -5.2877    0.0000 C   0  0
    1.8476   -5.2872    0.0000 C   0  0
    1.3845   -3.8605    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  2  3  1  0
  3  4  1  0
  3  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  3  1  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 14  1  0
 12 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
M  CHG  2   1  -1   3   1
M  END
> <name>
NIHCC_2014

> <id>
6347

> <plate>
NGP-202-04

> <well>
H02

> <supplier_cmpd_name>
CPD000469282

> <ctcr_id>
976

> <supplier_cmpd_id>
SAM002589987

> <smiles>
[Br-].C[N+]1(C)CCC(C1)OC(=O)C(O)(C2CCCC2)c3ccccc3

> <pd_targets>
{CHRM5,CHRM1,CHRM4,CHRM3,CHRM2}

> <pathway_gtopdb>
{"Membrane receptor","Family A G protein-coupled receptor","Small molecule receptor (family A GPCR)","Monoamine receptor","Acetylcholine receptor"}

> <pathway_chembl>
{Receptors,"G protein-coupled receptors","Acetylcholine receptors (muscarinic)"}

> <pathway_reactome>
{"Signal Transduction","Signaling by GPCR","GPCR ligand binding","Class A/1 (Rhodopsin-like receptors)","Amine ligand-binding receptors","Muscarinic acetylcholine receptors"}

> <broad_targets>
{CHRM1,CHRM2,CHRM3,CHRM4,CHRM5}

> <broad_moa>
{"acetylcholine receptor antagonist"}

> <synonyms>
{"RESTW 74",GLYCOPYRROLATE,596-51-0,596510,"596 51 0","glycopyrronium bromide","Glycopyrrolate bromide",Robinul,Gastrodyn,Asecryl,Nodapton,Tarodyl,Tarodyn,Copyrrolate,Cuvposa,"Glycopyrronii bromidum",
AHR-504,AHR504,"AHR 504","Bromuro de glicopirronio","Bromure de glycopyrronium",NVA-237,NVA237,"NVA 237",Rob,T2387,SAM002589987,SAM001246629,Prestw-746,Glycopyrrolate,CPD000469282}

> <pdid>
PD009604

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{11693,521843}

$$$$
NIHCC_2014
  SciTegic11012413002D

 27 30  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    2.5987    1.5004    0.0000 N   0  0
    3.8991    0.7525    0.0000 C   0  0
    5.1969    1.5046    0.0000 C   0  0
    5.1945    3.0046    0.0000 N   0  0
    3.8943    3.7525    0.0000 C   0  0
    3.8919    5.2525    0.0000 C   0  0
    2.5964    3.0004    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
    0.0000    3.0000    0.0000 F   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 O   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 N   0  0
    1.2997   -3.7504    0.0000 C   0  0
    1.9725   -5.0026    0.0000 C   0  0
    2.7205   -3.7024    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
   -3.8963   -3.7531    0.0000 C   0  0
   -5.1966   -3.0054    0.0000 O   0  0
   -3.8941   -5.2531    0.0000 O   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  9 11  1  0
 11  5  1  0
  4 12  1  0
 12 13  1  0
 12 14  2  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 16 18  1  0
 18 19  2  3
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 21  1  0
 20 24  1  0
 24  3  1  0
 24 15  2  0
 18 25  1  0
 25 26  1  0
 25 27  2  0
M  END
> <name>
NIHCC_2014

> <id>
6348

> <plate>
NGP-202-04

> <well>
H03

> <supplier_cmpd_name>
CPD000043336

> <ctcr_id>
1610

> <supplier_cmpd_id>
SAM002589955

> <smiles>
COc1c(N2CCNC(C)C2)c(F)cc3C(=O)C(=CN(C4CC4)c13)C(O)=O

> <pd_targets>
{HSD17B10,GYRA,GYRB,PARC,ALDH1A1,KDM4E,TDP1,ALOX15,CLK4,PRKD3,HPGD,SKA,CLK2,PARE}

> <pathway_gtopdb>
{Enzyme,"Epigenetic regulator",Oxidoreductase,Isomerase,Eraser,Hydrolase,Kinase,Protease,"Lysine demethylase","Protein Kinase","Cysteine protease","Jumonji domain-containing","CMGC protein kinase grou
p","Cysteine protease CA clan","CAMK protein kinase group","CMGC protein kinase CLK family","Cysteine protease C1A family","CAMK protein kinase PKD family"}

> <pathway_chembl>
{Enzymes,"Chromatin modifying enzymes","Eicosanoid turnover","Kinases (EC 2.7.x.x)","1.14.11.- Histone demethylases",Lipoxygenases,"CMGC: Containing CDK",MAPK,GSK3,"CLK families","CAMK: Calcium/calmod
ulin-dependent protein kinases","Prostaglandin synthases","CLK family","Protein kinase D (PKD) family"}

> <pathway_reactome>
{Metabolism,"DNA Repair","Metabolism of amino acids and derivatives","Biological oxidations","DNA Double-Strand Break Repair","Metabolism of lipids","Branched-chain amino acid catabolism","Phase I - F
unctionalization of compounds","Nonhomologous End-Joining (NHEJ)","Biosynthesis of specialized proresolving mediators (SPMs)","Sphingolipid metabolism","Ethanol oxidation","Biosynthesis of DPA-derived
 SPMs","Sphingolipid de novo biosynthesis","Biosynthesis of DHA-derived SPMs","Biosynthesis of DPAn-3 SPMs","Biosynthesis of D-series resolvins","Biosynthesis of DPAn-3-derived protectins and resolvin
s"}

> <broad_targets>
{}

> <broad_moa>
{"bacterial DNA gyrase inhibitor"}

> <synonyms>
{STL048947,AKOS005702286,Gatifloxacin,112811-59-3,112811593,Tequin,Zymar,Gatiflo,AM-1155,AM1155,Zymaxid,"AM 1155","CG 5501",BMS-206584,BMS206584,"gatifloxacin anhydrous",GTFX,"Gatifloxacin hydrate",CH
EMBL31,PD-135432,PD135432,CHEBI:5280,Gatilox,Gatiquin,Gatispan,160738-57-8,160738578,Gait,T1293,SAM002589955,1504272,Prestw-1265,CPD000043336,GATIFLOXACIN}

> <pdid>
PD001202

> <targets>
{}

> <classes>
{antibacterial}

> <pubchem_cids>
{4872633,5379}

$$$$
NIHCC_2014
  SciTegic11012413002D

 29 32  0  0  0  0            999 V2000
    3.8988   -3.7512    0.0000 C   0  0
    2.5997   -3.0012    0.0000 N   0  0
    1.3009   -3.7516    0.0000 C   0  0
    2.5988   -1.5004    0.0000 S   0  0
    3.8982   -2.2498    0.0000 O   0  0
    3.8976   -0.7500    0.0000 O   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -2.5981    1.5000    0.0000 S   0  0
   -3.8971    0.7500    0.0000 C   0  0
   -5.1962    1.5000    0.0000 C   0  0
   -6.4952    0.7500    0.0000 C   0  0
   -6.4952   -0.7500    0.0000 C   0  0
   -5.1961   -1.5000    0.0000 C   0  0
   -3.8971   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5950   -3.0008    0.0000 C   0  0
   -1.2942   -3.7494    0.0000 C   0  0
   -1.2911   -5.2502    0.0000 C   0  0
    0.0098   -5.9988    0.0000 N   0  0
    0.0151   -7.4988    0.0000 C   0  0
    1.3167   -8.2443    0.0000 C   0  0
    2.6131   -7.4898    0.0000 N   0  0
    2.6079   -5.9898    0.0000 C   0  0
    1.3063   -5.2443    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  4  5  2  0
  4  6  2  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 22  1  0
 18 28  1  0
 28 10  1  0
 28 29  2  0
 29  7  1  0
M  END
> <name>
NIHCC_2014

> <id>
6349

> <plate>
NGP-202-04

> <well>
H04

> <supplier_cmpd_name>
CPD001906782

> <ctcr_id>
7078

> <supplier_cmpd_id>
SAM002589997

> <smiles>
CN(C)[S](=O)(=O)c1ccc2Sc3ccccc3C(=C/CCN4CCNCC4)/c2c1

> <pd_targets>
.

> <pathway_gtopdb>
.

> <pathway_chembl>
.

> <pathway_reactome>
.

> <broad_targets>
.

> <broad_moa>
.

> <synonyms>
{UNII-5615VSS3UT,UNII5615VSS3UT,5615VSS3UT,"cis-N,N-Dimethyl-9-(3-(1-piperazinyl)propylidene)thioxanthene-2-sulfonamide","cisN,NDimethyl9(3(1piperazinyl)propylidene)thioxanthene2sulfonamide",HMS3259P0
8,NC00710,47623-22-3,47623223,CPD001906782,BRD-K55070890-001-01-3,BRDK55070890001013,N,N-dimethyl-9-(3-piperazin-1-ylpropylidene)thioxanthene-2-sulfonamide,Ndimethyl9(3piperazin1ylpropylidene)thioxant
hene2sulfonamide,SAM002589997}

> <pdid>
PD002842

> <targets>
{}

> <classes>
{}

> <pubchem_cids>
{6444849}

$$$$
NIHCC_2014
  SciTegic11012413002D

 21 23  0  0  0  0            999 V2000
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 C   0  0
    1.2990   -0.7500    0.0000 C   0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.4133   -1.7530    0.0000 C   0  0
   -3.9040   -1.5957    0.0000 C   0  0
   -4.7856   -2.8092    0.0000 C   0  0
   -4.1755   -4.1795    0.0000 O   0  0
   -2.6837   -4.3363    0.0000 C   0  0
   -1.2077   -4.4547    0.0000 C   0  0
   -0.5962   -5.8244    0.0000 C   0  0
   -3.5829   -5.5124    0.0000 C   0  0
   -5.0756   -5.3565    0.0000 C   0  0
   -5.6861   -3.9864    0.0000 O   0  0
   -5.9572   -6.5701    0.0000 O   0  0
   -1.8032   -3.1233    0.0000 C   0  0
   -0.3114   -2.9665    0.0000 N   0  0
    0.0000   -1.5000    0.0000 C   0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 12 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  2  0
 12 19  1  0
 19  8  2  0
 19 20  1  0
 20 21  1  0
 21  3  1  0
 21  7  2  0
M  END
> <name>
NIHCC_2014

> <id>
6350

> <plate>
NGP-202-04

> <well>
H05

> <supplier_cmpd_name>
CPD000058443

> <ctcr_id>
2853

> <supplier_cmpd_id>
SAM002589968

> <smiles>
CCc1cccc2c3CCOC(CC)(CC(O)=O)c3[nH]c12

> <pd_targets>
{PTGS2,TGR,BLM,NFKB1,ALOX15,PMP22,ALDH1A1,CYP3A4,PTGS1,SLC22A6,RXRA,TSHR,CYP2C9}

> <pathway_gtopdb>
{Enzyme,"Other cytosolic protein","Unclassified protein",Transporter,"Transcription factor","Membrane receptor",Oxidoreductase,"Cytochrome P450","Electrochemical transporter","Nuclear receptor","Famil
y A G protein-coupled receptor","Cytochrome P450 family 3","SLC superfamily of solute carriers","Nuclear hormone receptor subfamily 2","Peptide receptor (family A GPCR)","Cytochrome P450 family 2","Cy
tochrome P450 family 3A","SLC22 family of organic cation and anion transporters","Nuclear hormone receptor subfamily 2 group B","Glycohormone receptor","Cytochrome P450 family 2C","Cytochrome P450 3A4
","Nuclear hormone receptor subfamily 2 group B member 1","Cytochrome P450 2C9"}

> <pathway_chembl>
{Enzymes,Transporters,Receptors,"Eicosanoid turnover","Cytochrome P450","SLC superfamily of solute carriers","Nuclear hormone receptors","G protein-coupled receptors",Cyclooxygenase,Lipoxygenases,"CYP
3 family","SLC22 family of organic cation and anion transporters","2B. Retinoid X receptors","Glycoprotein hormone receptors","CYP2 family: drug metabolising subset","Organic anion transporters (OATs)
"}

> <pathway_reactome>
{Metabolism,"DNA Repair","Immune System","Developmental Biology","Transport of small molecules",Disease,"Metabolism of lipids","DNA Double-Strand Break Repair","Cytokine Signaling in Immune system","N
ervous system development","Biological oxidations","SLC-mediated transmembrane transport","Infectious disease","Biosynthesis of specialized proresolving mediators (SPMs)","Homology Directed Repair","S
ignaling by Interleukins","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Phase I - Functionalization of compounds","Fatty acid metabolism","Transport of bile salts and organic acids
","metal ions and amine compounds","Metabolism of steroids","Leishmania infection","Biosynthesis of DPA-derived SPMs","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","Int
erleukin-1 family signaling","Ethanol oxidation","Biosynthesis of DHA-derived SPMs","Arachidonic acid metabolism","Organic cation/anion/zwitterion transport","Bile acid and bile salt metabolism","Leis
hmania parasite growth and survival","Cytochrome P450 - arranged by substrate type","Biosynthesis of DPAn-3 SPMs","HDR through Homologous Recombination (HRR)","Interleukin-1 signaling","Biosynthesis o
f maresins","Synthesis of Prostaglandins (PG) and Thromboxanes (TX)","Organic anion transport","Synthesis of bile acids and bile salts","Anti-inflammatory response favouring Leishmania parasite infect
ion",Xenobiotics,"Homologous DNA Pairing and Strand Exchange","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Biosynthesis of DPAn-3-derived protectins and resolvins","Biosynthesis of maresin-like SPMs"
,"Synthesis of bile acids and bile salts via 27-hydroxycholesterol","ADORA2B mediated anti-inflammatory cytokines production","CYP2E1 reactions","Presynaptic phase of homologous DNA pairing and strand
 exchange"}

> <broad_targets>
{PTGS2}

> <broad_moa>
{"cyclooxygenase inhibitor"}

> <synonyms>
{etodolac,41340-25-4,41340254,"Etodolic acid",Lodine,Ultradol,"Lodine XL",AY-24236,AY24236,Etodolaco,Etodolacum,"AY 24236","AY-24,236","AY24,236",Edolan,"1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)ind
ole-1-acetic acid","1,3,4,9Tetrahydro1,8diethylpyrano(3,4b)indole1acetic acid",1,8-Diethyl-1,8Diethyl1,3,4,9-tetrahydropyrano(3,9tetrahydropyrano(3,4-b)indole-1-acetic,4b)indole1acetic,SAM002589968,15
01005,S1328,Prestw-231,CPD000058443,ETODOLAC,"Etodolac (Lodine)",Etodolac}

> <pdid>
PD001509

> <targets>
{COX}

> <classes>
{"Neuronal Signaling",antiinflammatory}

> <pubchem_cids>
{3308}

$$$$
NIHCC_2014
  SciTegic11012413002D

 22 22  0  0  1  0            999 V2000
    8.8990    0.7516    0.0000 Cl  0  5
    3.8983   -0.7459    0.0000 C   0  0
    2.6003   -1.4977    0.0000 N   0  0
    1.2990   -0.7500    0.0000 C   0  0  1  0  0  0
    1.2990    0.7500    0.0000 C   0  0
    0.0000    1.5000    0.0000 C   0  0
   -1.2990    0.7500    0.0000 C   0  0  1  0  0  0
   -2.5987    1.5004    0.0000 C   0  0
   -3.8991    0.7525    0.0000 C   0  0
   -5.1969    1.5045    0.0000 C   0  0
   -5.1945    3.0045    0.0000 C   0  0
   -6.4924    3.7566    0.0000 Cl  0  0
   -3.8943    3.7525    0.0000 C   0  0
   -3.8919    5.2525    0.0000 Cl  0  0
   -2.5965    3.0004    0.0000 C   0  0
   -1.2990   -0.7500    0.0000 C   0  0
   -2.5981   -1.5000    0.0000 C   0  0
   -2.5981   -3.0000    0.0000 C   0  0
   -1.2990   -3.7500    0.0000 C   0  0
    0.0000   -3.0000    0.0000 C   0  0
    0.0000   -1.5000    0.0000 C   0  0
    6.3990    0.7516    0.0000 H   0  3
  2  3  1  0
  4  3  1  6
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  6
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 11 13  1  0
 13 14  1  0
 13 15  2  0
 15  8  1  0
  7 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21  4  1  0
 21 16  1  0
M  CHG  2   1  -1  22   1
M  END
> <name>
NIHCC_2014

> <id>
6351

> <plate>
NGP-202-04

> <well>
H06

> <supplier_cmpd_name>
CPD000466298

> <ctcr_id>
412

> <supplier_cmpd_id>
SAM002700175

> <smiles>
[Cl-].CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c3ccccc13.[H+]

> <pd_targets>
{MAPT,LEF,TP53,LMNA,NFKB1,THPO,CYP3A4,SLC6A3,FTL,RORC,PMP22,ALOX15,MAPK1,SLC6A2,CHRM1,SLC6A4,TSHR,KMT2A,MEN1,GMNN,ADRA1B,CYP1A2,AMPC,ABCB11,CYP2J2,CYP2C19,FFP,LUXR,CYP2D6,SIGMAR1,ADRA2B,ADRA2C,MC5R,CH
RM4,HTR2B,ABCB1,MTOR,HTR2A,CACNA1C,CHRM5,KCNH2,HTR2C,ADRA2A,CHRM2,PGRMC1,HRH1,HTR1A,CHRM3,NET,ADRA1A}

> <pathway_gtopdb>
{"Other cytosolic protein",Enzyme,"Transcription factor","Other nuclear protein","Unclassified protein",Transporter,"Membrane receptor","Epigenetic regulator","Ion channel",Protease,"Cytochrome P450",
"Electrochemical transporter","Nuclear receptor",Oxidoreductase,Kinase,"Family A G protein-coupled receptor",Reader,Hydrolase,"Primary active transporter",Transferase,"Voltage-gated ion channel","Meta
llo protease","Cytochrome P450 family 3","SLC superfamily of solute carriers","Nuclear hormone receptor subfamily 1","Protein Kinase","Small molecule receptor (family A GPCR)","Peptide receptor (famil
y A GPCR)",Bromodomain,"Cytochrome P450 family 1","ATP-binding cassette","Cytochrome P450 family 2","Voltage-gated calcium channel","Potassium channels","Metallo protease MAE clan","Cytochrome P450 fa
mily 3A","SLC06 neurotransmitter transporter family","Nuclear hormone receptor subfamily 1 group F","CMGC protein kinase group","Monoamine receptor","Glycohormone receptor","Cytochrome P450 family 1A"
,"ABCB subfamily","Cytochrome P450 family 2C","Cytochrome P450 family 2D","Short peptide receptor (family A GPCR)","Atypical protein kinase group","Voltage-gated potassium channel","Metallo protease M
34 family","Cytochrome P450 3A4","Nuclear hormone receptor subfamily 1 group F member 3","CMGC protein kinase MAPK family","Acetylcholine receptor","Adrenergic receptor","Cytochrome P450 1A1","Cytochr
ome P450 2C19","Cytochrome P450 2D6","Melanocortin receptor","Serotonin receptor","Atypical protein kinase PIKK family","CMGC protein kinase ERK1","Atypical protein kinase FRAP subfamily","Histamine r
eceptor","Dopamine receptor"}

> <pathway_chembl>
{Enzymes,Transporters,Receptors,"Other protein targets","Ion channels","Cytochrome P450","SLC superfamily of solute carriers","Nuclear hormone receptors","Eicosanoid turnover","Kinases (EC 2.7.x.x)","
G protein-coupled receptors","Chromatin modifying enzymes","ATP-binding cassette transporter family","Sigma receptors","Voltage-gated ion channels","CYP3 family","SLC6 neurotransmitter transporter fam
ily","1F. Retinoic acid-related orphans",Lipoxygenases,"CMGC: Containing CDK",MAPK,GSK3,"CLK families","Acetylcholine receptors (muscarinic)","Glycoprotein hormone receptors","2.1.1.43 Histone methylt
ransferases (HMTs)",Adrenoceptors,"CYP1 family","ABCB subfamily","CYP2 family: drug metabolising subset","Melanocortin receptors","5-Hydroxytryptamine receptors",Atypical,"Voltage-gated calcium channe
ls","Potassium channels","Monoamine transporter subfamily","Mitogen-activated protein kinases (MAP kinases)","Phosphatidyl inositol 3' kinase-related kinases (PIKK) family","Voltage-gated potassium ch
annels","ERK subfamily","FRAP subfamily","Histamine receptors","Dopamine receptors"}

> <pathway_reactome>
{"Neuronal System",Disease,"Cell Cycle","Immune System",Hemostasis,Metabolism,"Vesicle-mediated transport","Gene expression (Transcription)","Developmental Biology","Signal Transduction","Muscle contr
action","Transmission across Chemical Synapses","Infectious disease","Cell Cycle Checkpoints",Mitotic,"Cytokine Signaling in Immune system","Platelet activation","signaling and aggregation","Metabolis
m of lipids","Disorders of transmembrane transporters","Membrane Trafficking","RNA Polymerase II Transcription","Nervous system development","Innate Immune System","Signaling by GPCR","Biological oxid
ations","Abacavir transport and metabolism","Cardiac conduction","Neurotransmitter receptors and postsynaptic signal transmission","Uptake and actions of bacterial toxins","G1/S DNA Damage Checkpoints
","M Phase","Signaling by Interleukins","Platelet Aggregation (Plug Formation)","Biosynthesis of specialized proresolving mediators (SPMs)","SLC transporter disorders","trans-Golgi Network Vesicle Bud
ding","Generic Transcription Pathway","EGR2 and SOX10-mediated initiation of Schwann cell myelination","Toll-like Receptor Cascades","GPCR ligand binding","Neurotransmitter clearance","Leishmania infe
ction","Mitotic G1 phase and G1/S transition","Phase I - Functionalization of compounds","Metabolism of steroids","SARS-CoV Infections","Abacavir transmembrane transport","Axon guidance","Phase 3 - ra
pid repolarisation","Activation of NMDA receptors and postsynaptic events","Uptake and function of anthrax toxins","p53-Dependent G1/S DNA damage checkpoint","Mitotic Metaphase and Anaphase","Interleu
kin-1 family signaling","Biosynthesis of DHA-derived SPMs","Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)","Golgi Associated Vesicle Biogenesis","Transcriptional regulation by RUNX3"
,"Biosynthesis of DPA-derived SPMs","Toll Like Receptor 5 (TLR5) Cascade","Class A/1 (Rhodopsin-like receptors)","Serotonin clearance from the synaptic cleft","Leishmania parasite growth and survival"
,"G1/S Transition","Defective SLC6A2 causes orthostatic intolerance (OI)","Transcriptional regulation by RUNX1","Cytochrome P450 - arranged by substrate type","Bile acid and bile salt metabolism","Pot
ential therapeutics for SARS","Transcriptional Regulation by TP53","NCAM signaling for neurite out-growth","Post NMDA receptor activation events","p53-Dependent G1 DNA Damage Response","Mitotic Anapha
se","Interleukin-1 signaling","Biosynthesis of maresins","RUNX3 Regulates Immune Response and Cell Migration","Biosynthesis of DPAn-3 SPMs","MyD88 cascade initiated on plasma membrane","Amine ligand-b
inding receptors","Anti-inflammatory response favouring Leishmania parasite infection","Activation of the pre-replicative complex","RUNX1 regulates genes involved in megakaryocyte differentiation and 
platelet function",Xenobiotics,"Synthesis of bile acids and bile salts","Fatty acids","Regulation of TP53 Activity","NCAM1 interactions","Activation of AMPK downstream of NMDARs","Stabilization of p53
","Nuclear Envelope (NE) Reassembly","MAP3K8 (TPL2)-dependent MAPK1/3 activation","Biosynthesis of maresin-like SPMs","Biosynthesis of DPAn-3-derived protectins and resolvins","MAP kinase activation",
"Muscarinic acetylcholine receptors","ADORA2B mediated anti-inflammatory cytokines production",Adrenoceptors,"Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2","Synthesis of bile acids
 and bile salts via 7alpha-hydroxycholesterol","CYP2E1 reactions","Serotonin receptors","Regulation of TP53 Expression and Degradation","Autodegradation of the E3 ubiquitin ligase COP1","Initiation of
 Nuclear Envelope (NE) Reformation","MAPK targets/ Nuclear events mediated by MAP kinases","Regulation of TP53 Degradation","ERK/MAPK targets","ERKs are inactivated","Histamine receptors"}

> <broad_targets>
{SLC6A3,SLC6A4}

> <broad_moa>
{"selective serotonin reuptake inhibitor (SSRI)"}

> <synonyms>
{AKOS015896266,Zoloft,Lustral,"Cp 51,974-1",Seserine,"Sertraline hydrochloride",79559-97-0,"Sertraline HCl",Gladem,Serad,"Sertraline (hydrochloride)",UNII-UTI8907Y6X,"(+)-sertraline hydrochloride",CHE
BI:9124,UTI8907Y6X,"rac-cis-Sertraline Hydrochloride",C17H18Cl3N,MFCD00895772,Atruline,Tresleen,"Cp-51,974-1",Tatig,CP-51974-1,DSSTox_CID_20243,DSSTox_RID_79456,DSSTox_GSID_40243,79617-95-1,Adjuvin,Ar
emis,MLS001401398,"(+)-cis-(1S,4S)-1-methylamino-4-(3,4-dichlorophenyl)tetralin hydrochloride",CAS-79559-97-0,NCGC00092386-03,SMR000466298,C17H17Cl2N.HCl,Serlift,Sertraline.HCl,79617-99-5,"Sertraline,
 HCl","Sertraline hydrochloride (USAN:USP)","Zoloft (TN)",CPD000466298,CHEMBL1709,SCHEMBL23230,MLS000758929,ARONIS24360,SPECTRUM1505262,"SERTRALINE HYDRECHLORIDE",Methyl2-(Hydroxymethyl)Acrylate,DTXSI
D1040243,"(+/-)-Sertraline Hydrochloride",HY-B0176A,"(1R,4R)-SERTRALINE HCL","(1R,4S)-SERTRALINE HCL",AOB2376,HMS1922P09,Pharmakon1600-01505262,"Sertraline hydrochloride (JAN/USP)",Tox21_111199,Tox21_
500870,AC-740,CCG-39575,CS0024,NSC746308,NSC758948,SBB080777,AKOS005267232,AKOS015846322,Tox21_111199_1,AB07662,CS-2052,KS-1111,LP00870,MCULE-1681469163,NC00198,NC00726,NE57257,NSC-746308,NSC-758948,N
CGC00092386-01,NCGC00092386-13,NCGC00261555-01,"Sertraline hydrochloride Related Compound A","Sertraline hydrochloride, >=98 (HPLC)",CP-5197401,EU-0100870,S4053,D00825,J10439,559S970,Q27108281,"Sertra
line hydrochloride 100 microg/mL in Acetonitrile","Sertraline Hydrochloride 1.0 mg/ml in Methanol (as free base)","Sertraline hydrochloride, British Pharmacopoeia (BP) Reference Standard","Sertraline 
hydrochloride, European Pharmacopoeia (EP) Reference Standard",SAM002700175,SAM001246666,1505262,"SERTRALINE HYDROCHLORIDE"}

> <pdid>
PD004322

> <targets>
{"5-HT Receptor"}

> <classes>
{antidepressant,"5HT uptake inhibitor","Neuronal Signaling"}

> <pubchem_cids>
{50986904,11078406,63009}

$$$$
